10	NAT2	C0023530	Leukopenia	0.2	1	0	CTD_human
10	NAT2	C0028796	Dermatitis, Occupational	0.202407028523288	1	0	CTD_human
10	NAT2	C1956346	Coronary Artery Disease	0.200274726784213	1	0	CTD_human
10	NAT2	C4277682	Chemical and Drug Induced Liver Injury	0.2	4	0	CTD_human
100	ADA	C0002170	Alopecia	0.2	0	0	HPO
100	ADA	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
100	ADA	C0004096	Asthma	0.21105290517153	0	0	HPO
100	ADA	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
100	ADA	C0014457	Eosinophilia	0.2	0	0	HPO
100	ADA	C0020452	Hyperemia	0.202681755307501	2	0	CTD_human
100	ADA	C0024312	Lymphopenia	0.204879569581206	0	0	HPO
100	ADA	C0032285	Pneumonia	0.200274726784213	0	0	HPO
100	ADA	C0037199	Sinusitis	0.2	0	0	HPO
100	ADA	C0085110	Severe Combined Immunodeficiency	0.230429160513024	0	0	HPO
100	ADA	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
100	ADA	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
100	ADA	C0259817	Xerosis	0.2	0	0	HPO
100	ADA	C0268747	Diffuse mesangial sclerosis (disorder)	0.2	0	0	HPO
100	ADA	C0392607	Severe combined immunodeficiency due to adenosine deaminase deficiency	0.410164891015885	0	0	CTD_human;ORPHANET
100	ADA	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
100	ADA	C0401151	Chronic diarrhea	0.2	0	0	HPO
100	ADA	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
100	ADA	C1863236	SCID Due to ADA Deficiency, Early-Onset	0.28	10	37	UNIPROT
100	ADA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
100	ADA	C2700553	Omenn Syndrome	0.200274726784213	0	0	ORPHANET
100	ADA	C3714497	Reactive airway disease	0.2	0	0	HPO
1000	CDH2	C0038220	Status Epilepticus	0.2	1	0	CTD_human
1000	CDH2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
10000	AKT3	C0014544	Epilepsy	0.200274726784213	0	0	HPO
10000	AKT3	C0020255	Hydrocephalus	0.2	0	0	HPO
10000	AKT3	C0263401	Cutis marmorata	0.2	0	0	HPO
10000	AKT3	C0431391	Hemimegalencephaly	0.401373633921066	0	0	HPO;ORPHANET
10000	AKT3	C1863924	Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	0.2	1	0	CTD_human
10000	AKT3	C1955869	Malformations of Cortical Development	0.200549453568426	1	0	CTD_human
10000	AKT3	C4014738	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2	0.2	3	4	UNIPROT
100009675	MRT4	C1970179	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.2	0	0	CTD_human
10002	NR2E3	C0017601	Glaucoma	0.2	0	0	HPO
10002	NR2E3	C0018777	Conductive hearing loss	0.2	0	0	HPO
10002	NR2E3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
10002	NR2E3	C0018975	Hemeralopia	0.2	0	0	HPO
10002	NR2E3	C0020459	Hyperinsulinism	0.2	0	0	HPO
10002	NR2E3	C0020619	Hypogonadism	0.2	0	0	HPO
10002	NR2E3	C0022578	Keratoconus	0.2	0	0	HPO
10002	NR2E3	C0028077	Night Blindness	0.200549453568426	0	0	HPO
10002	NR2E3	C0028738	Nystagmus	0.2	0	0	HPO
10002	NR2E3	C0028754	Obesity	0.2	0	0	HPO
10002	NR2E3	C0029124	Optic Atrophy	0.2	0	0	HPO
10002	NR2E3	C0035334	Retinitis Pigmentosa	0.41433527120477	0	0	HPO;ORPHANET
10002	NR2E3	C0152439	Retinoschisis	0.2	0	0	HPO
10002	NR2E3	C0154850	Cystoid macular retinal degeneration	0.2	0	0	HPO
10002	NR2E3	C0155016	Color Blindness, Red-Green	0.2	0	0	HPO
10002	NR2E3	C0155017	Color Blindness, Blue	0.2	0	0	HPO
10002	NR2E3	C0271051	Macular retinal edema	0.2	0	0	HPO
10002	NR2E3	C0271215	Blindness, Legal	0.2	0	0	HPO
10002	NR2E3	C0339541	Goldmann-Favre syndrome (disorder)	0.201373633921065	0	0	ORPHANET
10002	NR2E3	C0344290	Vitreoretinal degeneration	0.2	0	0	HPO
10002	NR2E3	C1849394	Enhanced S-Cone Syndrome	0.486318716036901	7	7	CTD_human;UNIPROT
10002	NR2E3	C1970163	RETINITIS PIGMENTOSA 37 (disorder)	0.4	2	3	CTD_human;UNIPROT
100034704	RHDNS1	C1835826	Renal Hypodysplasia, Nonsyndromic, 1	0.2	0	0	CTD_human
100034705	MMVP3	C1835814	Mitral Valve Prolapse, Myxomatous 3	0.2	0	0	CTD_human
100038247	PTLS	C1970482	Potocki-Lupski syndrome	0.201373633921065	0	0	CTD_human
100038248	PSNP3	C1970476	Supranuclear Palsy, Progressive, 3	0.2	0	0	CTD_human
100048912	CDKN2B-AS1	C0014175	Endometriosis	0.201373633921065	1	1	CTD_human
100048912	CDKN2B-AS1	C0017612	Glaucoma, Open-Angle	0.200824180352639	1	4	CTD_human
100049159	SPG37	C2936880	SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT (disorder)	0.4	0	0	CTD_human;ORPHANET
100049160	FEB7	C1969087	FEBRILE CONVULSIONS, FAMILIAL, 7 (disorder)	0.2	0	0	CTD_human
100049541	STUT1	C3489627	Stuttering, Familial Persistent 1	0.2	0	0	CTD_human
100049543	STUT2	C1836484	Stuttering, Familial Persistent 2	0.2	0	0	CTD_human
100049544	APMR2	C1835852	Alopecia-Mental Retardation Syndrome 2	0.2	0	0	CTD_human
100049707	SPG38	C2676732	SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT (disorder)	0.4	0	0	CTD_human;ORPHANET
10008	KCNE3	C0018790	Cardiac Arrest	0.2	0	0	HPO
10008	KCNE3	C0042510	Ventricular Fibrillation	0.2	0	0	HPO
10008	KCNE3	C0238357	Hyperkalemic periodic paralysis	0.200824180352639	0	0	CTD_human
10008	KCNE3	C0238358	Hypokalemic periodic paralysis	0.200549453568426	0	0	ORPHANET
10008	KCNE3	C1142166	Brugada Syndrome (disorder)	0.200274726784213	0	0	ORPHANET
10008	KCNE3	C2751089	Brugada Syndrome 6	0.2	0	0	CTD_human
10008	KCNE3	C3714580	Hypokalemic periodic paralysis type 1	0.200549453568426	0	0	CTD_human
10008	KCNE3	C4021553	Periodic hypokalemic paresis	0.2	0	0	HPO
1001	CDH3	C0009324	Ulcerative Colitis	0.202407028523288	1	0	CTD_human
1001	CDH3	C0011334	Dental caries	0.2	0	0	HPO
1001	CDH3	C0024437	Macular degeneration	0.2	0	0	HPO
1001	CDH3	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
1001	CDH3	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
1001	CDH3	C0158113	Contracture of joint of hand	0.2	0	0	HPO
1001	CDH3	C0263490	Brittle hair	0.2	0	0	HPO
1001	CDH3	C0271215	Blindness, Legal	0.2	0	0	HPO
1001	CDH3	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
1001	CDH3	C0730290	Cone dystrophy	0.2	0	0	HPO
1001	CDH3	C0730292	Macular dystrophy	0.202472541057918	0	0	HPO
1001	CDH3	C1832162	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY	0.6	1	3	CTD_human;ORPHANET;UNIPROT
1001	CDH3	C1857041	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	0.600824180352639	1	2	CTD_human;ORPHANET;UNIPROT
1001	CDH3	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
100101424	MRT9	C1970195	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9	0.2	0	0	CTD_human
100101425	MRT10	C1970194	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.2	0	0	CTD_human
100101426	MRT11	C1970193	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11	0.2	0	0	CTD_human
10011	SRA1	C0018418	Gynecomastia	0.2	0	0	HPO
10011	SRA1	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
10011	SRA1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
10011	SRA1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
100124414	GINGF4	C1970245	FIBROMATOSIS, GINGIVAL, HEREDITARY, 4 (disorder)	0.2	0	0	CTD_human
100124415	EKD2	C1970238	Episodic Kinesigenic Dyskinesia 2	0.200549453568426	0	0	CTD_human
100126309	MIR875	C0008370	Cholestasis	0.2	1	0	CTD_human
100126313	MIR744	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
100126594	EJM4	C0270853	Myoclonic Epilepsy, Juvenile	0.2	0	0	CTD_human
100126595	MGS	C1969653	MUNGAN SYNDROME	0.2	0	0	CTD_human
100128927	ZBTB42	C4015686	LETHAL CONGENITAL CONTRACTURE SYNDROME 6	0.200274726784213	1	1	UNIPROT
10013	HDAC6	C0020255	Hydrocephalus	0.2	0	0	HPO
10013	HDAC6	C3275476	CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.2	0	0	ORPHANET
100131801	PET100	C0023264	Leigh Disease	0.200549453568426	0	0	ORPHANET
100133941	CD24	C0026769	Multiple Sclerosis	0.211993755216112	0	0	CTD_human
100134444	KCNJ18	C0268446	Thyrotoxic periodic paralysis	0.200824180352639	0	0	ORPHANET
10014	HDAC5	C0340543	Familial primary pulmonary hypertension	0.2	1	0	CTD_human
100144434	ETL4	C1968847	Epilepsy, Familial Temporal Lobe, 4	0.2	0	0	CTD_human
10015	PDCD6IP	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
100151644	OTSC8	C2677515	OTOSCLEROSIS 8 (disorder)	0.2	0	0	CTD_human
100151683	RNU4ATAC	C1846059	Roifman syndrome	0.400274726784213	1	7	CTD_human;ORPHANET
10018	BCL2L11	C0008313	Cholangitis, Sclerosing	0.2	1	0	CTD_human
100187717	NNO3	C2678467	Nanophthalmos 3	0.2	0	0	CTD_human
100187749	ASDP	C1862936	Anal sphincter dysplasia	0.2	0	0	CTD_human
100187828	HBD	C0271985	Delta-Beta Thalassemia	0.2	0	0	ORPHANET
100188011	DIP	C0238378	Desquamative interstitial pneumonia	0.2	0	0	CTD_human
100188278	FECD2	C1857800	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2	0.2	0	0	CTD_human
100188321	HYT8	C0085580	Essential Hypertension	0.2	0	0	CTD_human
100188328	PNKD2	C1970149	PAROXYSMAL NONKINESIGENIC DYSKINESIA 2 (disorder)	0.2	0	0	CTD_human
100188340	AOS	C0265268	Adams Oliver syndrome	0.200274726784213	0	0	CTD_human
100188397	HLP	C0263420	Hyperkeratosis lenticularis perstans	0.200274726784213	0	0	CTD_human
100188695	DA4	C1836756	ARTHROGRYPOSIS, DISTAL, TYPE 4 (disorder)	0.2	0	0	CTD_human
100188748	STHAG5	C1858210	Tooth Agenesis, Selective, 5	0.2	0	0	CTD_human
100188754	AD14	C1970144	Alzheimer Disease 14	0.200274726784213	0	0	CTD_human
100188765	CFTDX	C2749128	Myopathy, Congenital, With Fiber-Type Disproportion, X-Linked	0.2	0	0	CTD_human
100188767	AGSPX	C0263637	Angioma serpiginosum, X-linked	0.2	0	0	CTD_human
100188768	SCAX5	C2678048	Spinocerebellar Ataxia, X-Linked 5	0.2	0	0	CTD_human
100188771	AGA2	C2678038	Alopecia, Androgenetic, 2	0.2	0	0	CTD_human
100188772	IHPS4	C2678037	Pyloric Stenosis, Infantile Hypertrophic, 4	0.2	0	0	CTD_human
100188773	CFSS	C2678036	Craniofacioskeletal Syndrome	0.2	0	0	CTD_human
100188774	DFCTRPS	C2678011	Deafness, Cataract, Retinitis Pigmentosa, And Sperm Abnormalities	0.2	0	0	CTD_human
100188775	LOAS	C0917796	Optic Atrophy, Hereditary, Leber	0.2	0	0	CTD_human
100188776	HEY	C1839070	Hairy Ears, Y-Linked	0.2	0	0	CTD_human
100188782	NIDDM4	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	0	0	CTD_human
100188782	NIDDM4	C1842642	Diabetes Mellitus, Noninsulin-Dependent, Type 4	0.2	0	0	CTD_human
100188784	AFA1	C0002170	Alopecia	0.2	0	0	CTD_human
100188785	ITC1	C1840362	HYPERTRICHOSIS UNIVERSALIS CONGENITA, AMBRAS TYPE (disorder)	0.2	0	0	CTD_human
100188792	MAFD3	C1864994	Major Affective Disorder 3	0.2	0	0	CTD_human
100188795	AD11	C1853360	Alzheimer Disease 11	0.2	0	0	CTD_human
100188796	GEFSP4	C1853345	Generalized Epilepsy With Febrile Seizures Plus, Type 4	0.2	0	0	CTD_human
100188798	SLEB5	C0024141	Lupus Erythematosus, Systemic	0.2	0	0	CTD_human
100188803	SLEB7	C0024141	Lupus Erythematosus, Systemic	0.2	0	0	CTD_human
100188804	SLEB8	C0024141	Lupus Erythematosus, Systemic	0.2	0	0	CTD_human
100188805	STBMS1	C0038379	Strabismus	0.2	0	0	CTD_human
100188807	HYT5	C0085580	Essential Hypertension	0.2	0	0	CTD_human
100188808	HYT6	C0085580	Essential Hypertension	0.2	0	0	CTD_human
100188812	RLS3	C0035258	Restless Legs Syndrome	0.200549453568426	0	0	CTD_human
100188813	RLS4	C0035258	Restless Legs Syndrome	0.200549453568426	0	0	CTD_human
100188821	OS4	C0029408	Degenerative polyarthritis	0.2	0	0	CTD_human
100188825	HYT7	C0085580	Essential Hypertension	0.2	0	0	CTD_human
100188830	AD12	C1970209	Alzheimer Disease 12	0.200274726784213	0	0	CTD_human
100188836	CHDS8	C0010068	Coronary heart disease	0.2	0	0	CTD_human
100188837	AD13	C1970147	Alzheimer Disease 13	0.2	0	0	CTD_human
100188838	AD15	C1970143	Alzheimer Disease 15	0.2	0	0	CTD_human
100188839	RLS5	C0035258	Restless Legs Syndrome	0.200274726784213	0	0	CTD_human
100188842	ATFB5	C1969099	Atrial Fibrillation, Familial, 5	0.2	0	0	CTD_human
100188845	CODA	C1969063	Cavitary Optic Disc Anomalies	0.2	0	0	CTD_human
100188846	CELIAC6	C0007570	Celiac Disease	0.2	0	0	CTD_human
100188848	FMTLE	C1968848	Epilepsy, Familial Mesial Temporal Lobe	0.2	0	0	CTD_human
100188849	FEB9	C1968846	Febrile Convulsions, Familial, 9	0.2	0	0	CTD_human
100188853	BMND7	C0029456	Osteoporosis	0.2	0	0	CTD_human
100188854	BMND8	C0029456	Osteoporosis	0.2	0	0	CTD_human
100188855	MNDEC	C2678482	Microtia With Nasolacrimal Duct Imperforation And Eye Coloboma	0.2	0	0	CTD_human
100188857	AAA3	C2678470	Aortic Aneurysm, Familial Abdominal 3	0.2	0	0	CTD_human
100188858	ANIB6	C2678469	Aneurysm, Intracranial Berry, 6	0.2	0	0	CTD_human
100188859	EA7	C2677843	Episodic Ataxia, Type 7	0.2	0	0	CTD_human
100188861	EIG5	C0270850	Idiopathic generalized epilepsy	0.2	0	0	CTD_human
100188863	ENDO1	C0014175	Endometriosis	0.200274726784213	0	0	CTD_human
100188864	IH	C1856184	HEMIHYPERPLASIA, ISOLATED	0.2	0	0	CTD_human
100188865	LMPH1B	C2677787	Lymphedema, Hereditary, IB	0.2	0	0	CTD_human
100188870	CELIAC8	C0007570	Celiac Disease	0.2	0	0	CTD_human
100188871	CELIAC9	C0007570	Celiac Disease	0.2	0	0	CTD_human
100188872	CELIAC10	C0007570	Celiac Disease	0.2	0	0	CTD_human
100188873	CELIAC11	C0007570	Celiac Disease	0.2	0	0	CTD_human
100188874	CELIAC12	C0007570	Celiac Disease	0.2	0	0	CTD_human
100188875	CELIAC13	C0007570	Celiac Disease	0.2	0	0	CTD_human
100188876	IHPS3	C2677588	Pyloric Stenosis, Infantile Hypertrophic, 3	0.2	0	0	CTD_human
100188877	CHDS9	C0010068	Coronary heart disease	0.2	0	0	CTD_human
100188880	HPRHP	C2677524	Hypophosphatemic Rickets And Hyperparathyroidism	0.2	0	0	CTD_human
100188881	MFT2	C2677505	Trichoepithelioma, Multiple Familial, 2	0.2	0	0	CTD_human
100188885	ANIB7	C2677337	Aneurysm, Intracranial Berry, 7	0.2	0	0	CTD_human
100188886	ANIB8	C2677336	Aneurysm, Intracranial Berry, 8	0.2	0	0	CTD_human
100188952	IBD12	C2677105	Inflammatory Bowel Disease 12	0.2	0	0	CTD_human
10019	SH2B3	C0007570	Celiac Disease	0.209144173059356	0	0	CTD_human
10019	SH2B3	C0011854	Diabetes Mellitus, Insulin-Dependent	0.210727021230004	0	0	CTD_human
10019	SH2B3	C0024141	Lupus Erythematosus, Systemic	0.202681755307501	1	0	CTD_human
10019	SH2B3	C0027051	Myocardial Infarction	0.405088783830789	1	0	CTD_human;HPO
10019	SH2B3	C0040028	Thrombocythemia, Essential	0.200274726784213	0	0	ORPHANET
10019	SH2B3	C0042900	Vitiligo	0.2	1	0	CTD_human
10019	SH2B3	C0836924	Thrombocytosis	0.2	0	0	HPO
10019	SH2B3	C0917805	Transient Cerebral Ischemia	0.2	0	0	HPO
10019	SH2B3	C1956346	Coronary Artery Disease	0.200549453568426	1	1	CTD_human
100190786	CILD8	C2677085	Ciliary Dyskinesia, Primary, 8	0.2	0	0	CTD_human
100190787	GEFSP6	C2677078	Generalized Epilepsy With Febrile Seizures Plus, Type 6	0.2	0	0	CTD_human
100190788	IBD20	C2676781	Inflammatory Bowel Disease 20	0.2	0	0	CTD_human
100190926	IBD19	C2677079	Inflammatory Bowel Disease 19	0.2	0	0	CTD_human
100190928	SLEB12	C0024141	Lupus Erythematosus, Systemic	0.2	0	0	CTD_human
100190929	IBD15	C2677094	Inflammatory Bowel Disease 15	0.2	0	0	CTD_human
100190930	IBD16	C2677093	Inflammatory Bowel Disease 16	0.2	0	0	CTD_human
100190931	IBD18	C2677090	Inflammatory Bowel Disease 18	0.2	0	0	CTD_human
100190982	POROK5	C2676769	Porokeratosis, Disseminated Superficial Actinic, 3	0.2	0	0	CTD_human
100192306	JAWAD	C0796063	microcephaly-digital anomalies syndrome	0.2	0	0	CTD_human
100192312	IBD21	C2676507	Inflammatory Bowel Disease 21	0.2	0	0	CTD_human
100196910	POROK2	C1867982	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE II	0.2	0	0	CTD_human
100196911	POROK6	C2676508	Porokeratosis, Disseminated Superficial Actinic, 4	0.2	0	0	CTD_human
100196918	SLEB13	C0024141	Lupus Erythematosus, Systemic	0.2	0	0	CTD_human
100196919	SS3	C0036202	Sarcoidosis	0.2	0	0	CTD_human
10020	GNE	C0014544	Epilepsy	0.2	0	0	HPO
10020	GNE	C0020676	Hypothyroidism	0.2	0	0	HPO
10020	GNE	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
10020	GNE	C0085684	Foot-drop	0.2	0	0	HPO
10020	GNE	C0238190	Inclusion Body Myositis (disorder)	0.202956482091714	1	0	CTD_human
10020	GNE	C0342853	Sialuria	0.401373633921066	3	8	CTD_human;UNIPROT
10020	GNE	C1404521	Limb-girdle myopathy	0.2	0	0	HPO
10020	GNE	C1833373	Inclusion Body Myopathy, Autosomal Recessive	0.201098907136852	1	37	CTD_human
10020	GNE	C1842552	Limb-girdle muscle atrophy	0.2	0	0	HPO
10020	GNE	C1848736	Distal amyotrophy	0.2	0	0	HPO
10020	GNE	C1853926	NONAKA MYOPATHY	0.617857240973852	12	23	CTD_human;ORPHANET;UNIPROT
10020	GNE	C2931471	Sialuria, French type	0.2	0	0	ORPHANET
10021	HCN4	C0004238	Atrial Fibrillation	0.401373633921066	1	1	CTD_human;HPO
10021	HCN4	C0037052	Sick Sinus Syndrome	0.400274726784213	0	0	HPO;ORPHANET
10021	HCN4	C0042514	Tachycardia, Ventricular	0.200274726784213	0	0	HPO
10021	HCN4	C1142166	Brugada Syndrome (disorder)	0.2	0	0	ORPHANET
10021	HCN4	C1834144	Sick Sinus Syndrome 2, Autosomal Dominant	0.4	3	4	CTD_human;UNIPROT
10021	HCN4	C2751083	Brugada Syndrome 8	0.2	0	0	CTD_human
100216344	DYT17	C2676281	DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE (disorder)	0.4	0	0	CTD_human;ORPHANET
100216484	NRCLP4	C0027404	Narcolepsy	0.2	0	0	CTD_human
100217387	AGA3	C2676272	Alopecia, Androgenetic, 3	0.2	0	0	CTD_human
100233147	ARHI1	C2676230	Age-Related Hearing Impairment 1	0.2	0	0	CTD_human
100233159	WAGRO	C2675904	Wilms Tumor, Aniridia, Genitourinary Anomalies, Mental Retardation, and Obesity Syndrome	0.2	0	0	CTD_human
100233226	MCI2	C0027051	Myocardial Infarction	0.2	0	0	CTD_human
100233227	SLI4	C2675874	Specific Language Impairment 4	0.2	0	0	CTD_human
100240702	PLSA1	C1968845	Primary Lateral Sclerosis, Adult, 1	0.2	0	0	CTD_human
100240730	DUP7Q11.23	C1857844	Williams-Beuren Region Duplication Syndrome	0.2	0	0	CTD_human
100240731	DEL15Q15.3	C1970187	Deafness, Sensorineural, And Male Infertility	0.2	0	0	CTD_human
100240732	IBD22	C2676485	Inflammatory Bowel Disease 22	0.2	0	0	CTD_human
100240733	IBD23	C2676484	Inflammatory Bowel Disease 23	0.2	0	0	CTD_human
100240736	DEL11P15P14	C1847866	Homozygous 11p15-p14 Deletion Syndrome	0.2	0	0	CTD_human
10025	MED16	C0014175	Endometriosis	0.2	1	0	CTD_human
100270639	IHPS5	C2675862	Pyloric Stenosis, Infantile Hypertrophic, 5	0.2	0	0	CTD_human
100270641	MYP16	C2675523	MYOPIA 16 (disorder)	0.2	0	0	CTD_human
100270679	LINC01432	C2676272	Alopecia, Androgenetic, 3	0.2	0	0	CTD_human
100270798	IBD24	C2675509	Inflammatory Bowel Disease 24	0.2	0	0	CTD_human
100270799	IBD25	C2675508	INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE	0.2	0	0	CTD_human
100270800	SHFLD3	C2675492	Split-Hand-Foot Malformation With Long Bone Deficiency 3	0.2	0	0	CTD_human
100271686	DELXP11.3	C1845136	Chromosome Xp11.3 Deletion Syndrome	0.2	0	0	CTD_human
100271688	ANIB9	C2675485	Aneurysm, Intracranial Berry, 9	0.2	0	0	CTD_human
100271689	ANIB10	C2675484	Aneurysm, Intracranial Berry, 10	0.2	0	0	CTD_human
100271694	MS2	C0026769	Multiple Sclerosis	0.2	0	0	CTD_human
100271695	MS3	C0026769	Multiple Sclerosis	0.2	0	0	CTD_human
100271696	MS4	C0026769	Multiple Sclerosis	0.2	0	0	CTD_human
100271697	IDDM23	C2675472	Diabetes Mellitus, Insulin-Dependent, 23	0.2	0	0	CTD_human
100271718	AD16	C2677888	Alzheimer Disease 16	0.2	0	0	CTD_human
100271719	PSORS11	C0033860	Psoriasis	0.2	0	0	CTD_human
100271837	USH1H	C1568247	Usher Syndrome, Type I	0.200274726784213	0	0	ORPHANET
100271837	USH1H	C2675458	USHER SYNDROME, TYPE IH (disorder)	0.2	0	0	CTD_human
100271838	IBD26	C2675249	Inflammatory Bowel Disease 26	0.2	0	0	CTD_human
100271922	BFIS4	C2675462	Convulsions, Benign Familial Infantile, 4	0.200274726784213	0	0	CTD_human
100271923	FEB10	C2675251	Febrile Convulsions, Familial, 10	0.2	0	0	CTD_human
100271924	DFNA59	C2675238	DEAFNESS, AUTOSOMAL DOMINANT 59 (disorder)	0.2	0	0	CTD_human
100286836	OS6	C0029408	Degenerative polyarthritis	0.2	0	0	CTD_human
100294715	BOP	C2675191	Polymicrogyria, Bilateral Occipital	0.2	0	0	CTD_human
100294716	MYP15	C2675180	MYOPIA 15 (disorder)	0.2	0	0	CTD_human
1003	CDH5	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
100301522	CELIAC7	C0007570	Celiac Disease	0.2	0	0	CTD_human
100301525	DUH2	C2675183	Dyschromatosis Universalis Hereditaria 2	0.200274726784213	0	0	CTD_human
100302058	LKMCD	C1970840	Leukoencephalopathy With Metaphyseal Chondrodysplasia	0.2	0	0	CTD_human
100302059	IBD27	C2748550	Inflammatory Bowel Disease 27	0.2	0	0	CTD_human
100302509	LECD	C2749050	Corneal Dystrophy, Lisch Epithelial	0.2	0	0	CTD_human
100302510	XECD	C2749049	Corneal Dystrophy, Endothelial, X-Linked	0.2	0	0	CTD_human
100302511	EOE1	C0341106	Eosinophilic esophagitis	0.2	0	0	CTD_human
100302512	RLS6	C0035258	Restless Legs Syndrome	0.200549453568426	0	0	CTD_human
100302513	DFNB71	C2748554	DEAFNESS, AUTOSOMAL RECESSIVE 71 (disorder)	0.2	0	0	CTD_human
100302514	NRCLP5	C0027404	Narcolepsy	0.2	0	0	CTD_human
100302515	OFC12	C2748505	Orofacial Cleft 12	0.2	0	0	CTD_human
100302560	MUHH2	C2748535	Hypotrichosis 5	0.2	0	0	CTD_human
100302561	RLS7	C0035258	Restless Legs Syndrome	0.2	0	0	CTD_human
100302680	DELXQ28	C1845408	Contiguous Abcd1-Dxs1375e Deletion Syndrome	0.2	0	0	CTD_human
100302681	PVNH3	C1842562	Heterotopia, Periventricular, associated with Chromosome 5p Anomalies	0.2	0	0	CTD_human
100302682	PVNH5	C2752071	Heterotopia, Periventricular, Associated With Chromosome 5q Deletion	0.2	0	0	CTD_human
100302716	HTGH	C1851120	Hypertrichosis Terminalis, Generalized, with or without Gingival Hyperplasia	0.2	0	0	CTD_human
100302720	CTRCT34	C2751822	Cataract, Autosomal Recessive Congenital 3	0.2	0	0	CTD_human
100302721	ARHI2	C2751814	Presbycusis 2	0.2	0	0	CTD_human
100303453	TSNAX-DISC1	C0220702	SCHIZOPHRENIA 1 (disorder)	0.200274726784213	1	0	PSYGENET
100303715	IDDM24	C2751697	Diabetes Mellitus, Insulin-Dependent, 24	0.2	0	0	CTD_human
100303716	PBC2	C2751696	Biliary Cirrhosis, Primary, 2	0.2	0	0	CTD_human
100303717	PBC3	C2751695	Biliary Cirrhosis, Primary, 3	0.2	0	0	CTD_human
100306979	ATFB8	C2751607	Atrial Fibrillation, Familial, 8	0.2	0	0	CTD_human
100310755	ATOD7	C2751599	Dermatitis, Atopic, 7	0.2	0	0	CTD_human
100312952	PVOP1	C0877015	Pelvic Organ Prolapse	0.2	0	0	CTD_human
100312954	GRD1	C0018213	Graves Disease	0.2	0	0	CTD_human
100312955	PVOP2	C0877015	Pelvic Organ Prolapse	0.2	0	0	CTD_human
100313838	MIR764	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
100313838	MIR764	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
100313923	MIR449C	C0015695	Fatty Liver	0.2	1	0	CTD_human
100313948	BRV2	C2751289	Vertigo, Benign Recurrent, 2	0.2	0	0	CTD_human
100322878	SLEB14	C0024141	Lupus Erythematosus, Systemic	0.2	0	0	CTD_human
100322879	SPG45	C3888209	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE	0.2	0	0	CTD_human
100329167	AAA1	C1853365	AORTIC ANEURYSM, FAMILIAL ABDOMINAL 1	0.2	0	0	CTD_human
100359393	SCA30	C2936793	Spinocerebellar ataxia 30	0.4	0	0	CTD_human;ORPHANET
100359399	DFNB85	C3160740	DEAFNESS, AUTOSOMAL RECESSIVE 85	0.2	0	0	CTD_human
100359400	DFNB83	C3888310	DEAFNESS, AUTOSOMAL RECESSIVE 83	0.2	0	0	CTD_human
100359401	MYP17	C0027092	Myopia	0.2	0	0	CTD_human
100359402	SPG41	C3888208	SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT	0.4	0	0	CTD_human;ORPHANET
100359403	PARK16	C0030567	Parkinson Disease	0.208451017775976	2	0	CTD_human
100359403	PARK16	C2751012	PARKINSON DISEASE 16 (disorder)	0.2	0	0	CTD_human
100359407	MYP14	C1853196	MYOPIA 14 (disorder)	0.2	0	0	CTD_human
100379198	ECT	C0376532	Epilepsy, Rolandic	0.200549453568426	0	0	CTD_human
100379200	SLEB15	C0024141	Lupus Erythematosus, Systemic	0.2	0	0	CTD_human
100379201	SPAX3	C1969645	Ataxia, Spastic, 3, Autosomal Recessive	0.2	0	0	CTD_human
100379215	QTV	C1857828	QT INTERVAL, VARIATION IN	0.2	0	0	CTD_human
10038	PARP2	C0023787	Lipodystrophy	0.2	1	0	CTD_human
100380873	FECD3	C2750451	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3	0.2	0	0	CTD_human
100380874	FECD5	C2750449	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 5	0.2	0	0	CTD_human
100380875	FECD7	C2750447	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 7	0.2	0	0	CTD_human
100380876	NAFLD1	C0400966	Non-alcoholic Fatty Liver Disease	0.2	0	0	CTD_human
100381210	CAMPD1	C2751430	Camptodactyly 1	0.2	0	0	CTD_human
100381211	ARCODS	C1865295	Auriculo-condylar syndrome	0.2	0	0	CTD_human
100415903	HWE1	C0393729	Immersion Related Epilepsy	0.2	0	0	CTD_human
100415904	HWE2	C3150536	EPILEPSY, HOT WATER, 2	0.2	0	0	CTD_human
100415942	DEL2P21	C1848030	Hypotonia-Cystinuria Syndrome	0.2	0	0	CTD_human
100415943	MGR9	C0154723	Migraine with Aura	0.2	0	0	CTD_human
10046	MAMLD1	C1846169	Myotubular Myopathy with Abnormal Genital Development	0.2	0	0	ORPHANET
10046	MAMLD1	C2677879	Hypospadias 2, X-Linked	0.2	0	0	CTD_human
10046	MAMLD1	C2678098	Hypospadias 1, X-Linked	0.4	0	0	CTD_human;ORPHANET
100462676	RCHTS	C2750068	Roifman-Chitayat Syndrome	0.2	0	0	CTD_human
100462724	OFC9	C1835894	Orofacial Cleft 9	0.2	0	0	CTD_human
100462725	NAFLD2	C0400966	Non-alcoholic Fatty Liver Disease	0.2	0	0	CTD_human
10049	DNAJB6	C0026850	Muscular Dystrophy	0.2	0	0	HPO
10049	DNAJB6	C3148763	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.400274726784213	2	8	ORPHANET;UNIPROT
100499166	LPRS6	C0023343	Leprosy	0.2	0	0	CTD_human
100499167	EOE2	C0341106	Eosinophilic esophagitis	0.2	0	0	CTD_human
100499260	AMMEC	C1846242	Alport Syndrome, Mental Retardation, Midface Hypoplasia, and Elliptocytosis	0.200274726784213	0	0	CTD_human
100499532	ATPLS	C2930802	Familial antiphospholipid syndrome	0.2	0	0	CTD_human
100505390	AAA2	C1853364	Aortic Aneurysm, Familial Abdominal 2	0.2	0	0	CTD_human
100505394	EDSS2	C3150809	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2	0.2	0	0	CTD_human
100506658	OCLN	C0019156	Hepatic Veno-Occlusive Disease	0.2	1	0	CTD_human
100506658	OCLN	C2931662	Baraitser Brett Piesowicz syndrome	0.2	0	0	ORPHANET
100506658	OCLN	C3489725	Pseudo-TORCH syndrome	0.600824180352639	1	4	CTD_human;ORPHANET;UNIPROT
100506742	CASP12	C0011854	Diabetes Mellitus, Insulin-Dependent	0.200274726784213	1	0	CTD_human
100507436	MICA	C0029172	Oral Submucous Fibrosis	0.202681755307501	1	0	CTD_human
100526741	DEL8Q13	C1838162	Mesomelia-synostoses syndrome	0.2	0	0	CTD_human
100528023	PPR1	C1868677	PHOTOPAROXYSMAL RESPONSE 1	0.2	0	0	CTD_human
100528024	DEL11P13	C0206115	WAGR Syndrome	0.201373633921065	0	0	CTD_human
100528027	RJBS	C3150910	RAJAB SYNDROME	0.2	0	0	CTD_human
100529146	DER22T11-22	C1836929	Emanuel syndrome	0.2	0	0	CTD_human
100529147	MMRFCGU	C3150939	BEAULIEU-BOYCOTT-INNES SYNDROME	0.2	0	0	CTD_human
100529148	MDNS	C3150946	MAMMARY-DIGITAL-NAIL SYNDROME	0.2	0	0	CTD_human
100529149	DER22T8-22	C3150966	Supernumerary der(22)t(8;22) syndrome	0.2	0	0	CTD_human
100529151	IBD11	C0009324	Ulcerative Colitis	0.2	0	0	CTD_human
100529224	FWS	C3150859	FORSYTHE-WAKELING SYNDROME	0.2	0	0	CTD_human
100529229	FAME3	C3150860	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3	0.2	0	0	CTD_human
100529230	LGMD1H	C3150786	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H	0.2	0	0	CTD_human
100534624	LCR-OPSIN	C0339537	Cone monochromatism	0.2	0	0	CTD_human
10057	ABCC5	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
10058	ABCB6	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
10058	ABCB6	C1306229	Dyschromatosis universalis	0.2	0	0	ORPHANET
10058	ABCB6	C1836705	Pseudohyperkalemia, Familial, 2, due to Red Cell Leak	0.4	2	3	ORPHANET;UNIPROT
10058	ABCB6	C1845877	Microphthalmia, Isolated, with Coloboma 1	0.2	0	0	ORPHANET
10058	ABCB6	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
10058	ABCB6	C3281027	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7	0.2	1	2	UNIPROT
10058	ABCB6	C3809394	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3	0.2	4	4	UNIPROT
10059	DNM1L	C0014306	Enophthalmos	0.2	0	0	HPO
10059	DNM1L	C0029124	Optic Atrophy	0.4	1	0	CTD_human;HPO
10059	DNM1L	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
10059	DNM1L	C0162666	Mitochondrial Encephalomyopathies	0.2	1	0	CTD_human
10059	DNM1L	C0271385	Horizontal Nystagmus	0.2	0	0	HPO
10059	DNM1L	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10059	DNM1L	C3280660	ENCEPHALOPATHY, LETHAL, DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION	0.4	2	10	ORPHANET;UNIPROT
10060	ABCC9	C0014175	Endometriosis	0.2	1	0	CTD_human
10060	ABCC9	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
10060	ABCC9	C0024236	Lymphedema	0.2	0	0	HPO
10060	ABCC9	C0024421	Macroglossia	0.2	0	0	HPO
10060	ABCC9	C0029456	Osteoporosis	0.2	0	0	HPO
10060	ABCC9	C0031039	Pericardial effusion	0.2	0	0	HPO
10060	ABCC9	C0040412	Fissured tongue	0.2	0	0	HPO
10060	ABCC9	C0235480	Paroxysmal atrial fibrillation	0.200274726784213	0	0	HPO
10060	ABCC9	C0795905	Cantu syndrome	0.602747267842131	3	9	CTD_human;ORPHANET;UNIPROT
10060	ABCC9	C0796280	Acromegaloid facial appearance syndrome	0.2	0	0	ORPHANET
10060	ABCC9	C1837839	CARDIOMYOPATHY, DILATED, 1O	0.4	1	2	CTD_human;UNIPROT
10060	ABCC9	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
10060	ABCC9	C1855900	HYPERTRICHOSIS, CONGENITAL GENERALIZED	0.2	0	0	HPO
10060	ABCC9	C3279695	ATRIAL FIBRILLATION, FAMILIAL, 12	0.2	1	1	UNIPROT
10060	ABCC9	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
10060	ABCC9	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
10062	NR1H3	C0008370	Cholestasis	0.2	1	0	CTD_human
10062	NR1H3	C0015695	Fatty Liver	0.201098907136852	1	0	CTD_human
10062	NR1H3	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
10063	COX17	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
100653368	SCA32	C3151343	SPINOCEREBELLAR ATAXIA 32	0.2	0	0	ORPHANET
10075	HUWE1	C1846168	MENTAL RETARDATION, X-LINKED, SYNDROMIC 10	0.2	0	0	CTD_human
10075	HUWE1	C2678046	Mental Retardation, X-Linked, Syndromic, Turner Type	0.6	1	5	CTD_human;ORPHANET;UNIPROT
10082	GPC6	C1850318	Omodysplasia type 1	0.400824180352639	1	2	CTD_human;ORPHANET
100820829	MYZAP	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
10083	USH1C	C0018784	Sensorineural Hearing Loss (disorder)	0.200549453568426	0	0	HPO
10083	USH1C	C0018979	Hemianopsia	0.2	0	0	HPO
10083	USH1C	C0028077	Night Blindness	0.2	0	0	HPO
10083	USH1C	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	HPO
10083	USH1C	C1568247	Usher Syndrome, Type I	0.202197814273705	0	0	ORPHANET
10083	USH1C	C1865870	Deafness, Autosomal Recessive 18	0.28	0	0	CTD_human
10083	USH1C	C2931207	Usher syndrome, type 1C	0.200274726784213	1	0	CTD_human
10084	PQBP1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
10084	PQBP1	C0020490	Hyperopia	0.2	0	0	HPO
10084	PQBP1	C0023882	Little's Disease	0.2	0	0	HPO
10084	PQBP1	C0024421	Macroglossia	0.2	0	0	HPO
10084	PQBP1	C0037773	Spastic Paraplegia, Hereditary	0.2	1	0	CTD_human
10084	PQBP1	C0038379	Strabismus	0.2	0	0	HPO
10084	PQBP1	C0158113	Contracture of joint of hand	0.2	0	0	HPO
10084	PQBP1	C0221260	Dystrophia unguium	0.2	0	0	HPO
10084	PQBP1	C0235946	Cerebral atrophy	0.2	0	0	HPO
10084	PQBP1	C0263490	Brittle hair	0.2	0	0	HPO
10084	PQBP1	C0271215	Blindness, Legal	0.2	0	0	HPO
10084	PQBP1	C0796135	Renpenning syndrome 1	0.402472541057918	4	8	CTD_human;UNIPROT
10084	PQBP1	C1136249	Mental Retardation, X-Linked	0.211495458804998	2	0	CTD_human
10084	PQBP1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
10084	PQBP1	C4020884	Anxiety disease	0.2	0	0	HPO
10085	EDIL3	C0029408	Degenerative polyarthritis	0.200274726784213	1	0	CTD_human
10087	COL4A3BP	C0037036	Sialorrhea	0.2	0	0	HPO
10087	COL4A3BP	C0155320	Blindness, Cortical	0.2	0	0	HPO
10087	COL4A3BP	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
100885773	DYT21	C3281236	DYSTONIA 21	0.2	0	0	ORPHANET
10090	UST	C0014175	Endometriosis	0.2	1	0	CTD_human
100918	NRCLP2	C0027404	Narcolepsy	0.2	0	0	CTD_human
100918	NRCLP2	C1834372	Narcolepsy 1	0.2	0	0	CTD_human
101	ADAM8	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
10102	TSFM	C0014544	Epilepsy	0.2	0	0	HPO
10102	TSFM	C0029124	Optic Atrophy	0.2	0	0	HPO
10102	TSFM	C0042798	Low Vision	0.2	0	0	HPO
10102	TSFM	C0238044	CARDIOMYOPATHY, CONCENTRIC HYPERTROPHIC	0.2	0	0	HPO
10102	TSFM	C1145670	Respiratory Failure	0.2	0	0	HPO
10102	TSFM	C1864840	Combined Oxidative Phosphorylation Deficiency 3	0.6	2	4	CTD_human;ORPHANET;UNIPROT
10102	TSFM	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
10102	TSFM	C3887709	Optic Neuropathy	0.2	0	0	HPO
10102	TSFM	C4020871	Dystonic disease	0.2	0	0	HPO
10105	PPIF	C0041582	Ulcer	0.2	1	0	CTD_human
10108	MKRN3-AS1	C0020459	Hyperinsulinism	0.2	0	0	HPO
10108	MKRN3-AS1	C0020490	Hyperopia	0.2	0	0	HPO
10108	MKRN3-AS1	C0028754	Obesity	0.2	0	0	HPO
10108	MKRN3-AS1	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
10108	MKRN3-AS1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
10108	MKRN3-AS1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
10108	MKRN3-AS1	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
10109	ARPC2	C0009324	Ulcerative Colitis	0.208096423079816	1	0	CTD_human
101101692	HELLPAR	C0162739	HELLP Syndrome	0.200274726784213	0	0	ORPHANET
10111	RAD50	C0004096	Asthma	0.201923087489492	1	1	CTD_human
10111	RAD50	C0020490	Hyperopia	0.2	0	0	HPO
10111	RAD50	C2751318	Nijmegen Breakage Syndrome-Like Disorder	0.4	0	0	CTD_human;ORPHANET
10117	ENAM	C0399368	Amelogenesis Imperfecta, Type IB	0.480274726784213	2	4	CTD_human;UNIPROT
10117	ENAM	C2673923	Amelogenesis Imperfecta, Type Ic	0.4	2	2	CTD_human;UNIPROT
10117	ENAM	C3665628	Hypomineralization of enamel of tooth	0.2	0	0	HPO
10118	EMWX	C1846173	EPISODIC MUSCLE WEAKNESS, X-LINKED	0.2	0	0	CTD_human
101180907	USH1K	C1568247	Usher Syndrome, Type I	0.200274726784213	0	0	ORPHANET
1012	CDH13	C0004763	Barrett Esophagus	0.200274726784213	1	0	CTD_human
10125	RASGRP1	C0003873	Rheumatoid Arthritis	0.2	1	1	CTD_human
10125	RASGRP1	C0014175	Endometriosis	0.2	1	0	CTD_human
10125	RASGRP1	C0024141	Lupus Erythematosus, Systemic	0.280274726784213	1	0	CTD_human
10126	DNAL4	C0454455	Mirror movements disorder	0.200274726784213	0	0	HPO
10128	LRPPRC	C0020456	Hyperglycemia	0.2	0	0	HPO
10128	LRPPRC	C0020615	Hypoglycemia	0.2	0	0	HPO
10128	LRPPRC	C0038379	Strabismus	0.2	0	0	HPO
10128	LRPPRC	C0338474	Central nervous system demyelination	0.2	0	0	HPO
10128	LRPPRC	C1857355	Leigh syndrome , French Canadian type	0.601923087489492	1	7	CTD_human;ORPHANET;UNIPROT
10128	LRPPRC	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1013	CDH15	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
1013	CDH15	C2675488	Mental Retardation, Autosomal Dominant 3	0.4	1	3	CTD_human;UNIPROT
10131	TRAP1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
10133	OPTN	C0002736	Amyotrophic Lateral Sclerosis	0.410714344584311	0	0	HPO;ORPHANET
10133	OPTN	C0027092	Myopia	0.2	0	0	HPO
10133	OPTN	C0029401	Osteitis Deformans	0.201923087489492	1	1	CTD_human
10133	OPTN	C0234958	muscle degeneration	0.2	0	0	HPO
10133	OPTN	C0339573	Glaucoma, Primary Open Angle	0.613186885642229	11	3	CTD_human;HPO;UNIPROT
10133	OPTN	C1145670	Respiratory Failure	0.2	0	0	HPO
10133	OPTN	C3150692	AMYOTROPHIC LATERAL SCLEROSIS 12	0.4	1	2	CTD_human;UNIPROT
10133	OPTN	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
10133	OPTN	C4020884	Anxiety disease	0.2	0	0	HPO
10134	BCAP31	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
10134	BCAP31	C0034372	Quadriplegia	0.2	0	0	HPO
10134	BCAP31	C0038379	Strabismus	0.2	0	0	HPO
10134	BCAP31	C0235946	Cerebral atrophy	0.2	0	0	HPO
10134	BCAP31	C0262404	Cerebellar degeneration	0.2	0	0	HPO
10134	BCAP31	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
10134	BCAP31	C1845408	Contiguous Abcd1-Dxs1375e Deletion Syndrome	0.2	0	0	ORPHANET
10134	BCAP31	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10134	BCAP31	C3806634	DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION	0.2	0	0	ORPHANET
10134	BCAP31	C4020860	Supratentorial atrophy	0.2	0	0	HPO
10134	BCAP31	C4020871	Dystonic disease	0.2	0	0	HPO
10134	BCAP31	C4020873	Infratentorial atrophy	0.2	0	0	HPO
10135	NAMPT	C0009319	Colitis	0.2	1	0	CTD_human
10135	NAMPT	C0028754	Obesity	0.213265074822552	1	0	CTD_human
10135	NAMPT	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
10140	TOB1	C0014175	Endometriosis	0.2	1	0	CTD_human
10140	TOB1	C0263454	Chloracne	0.2	1	0	CTD_human
10142	AKAP9	C0035828	Romano-Ward Syndrome	0.2	0	0	ORPHANET
10142	AKAP9	C2678483	Long Qt Syndrome 11	0.4	1	2	CTD_human;UNIPROT
10144	FAM13A	C0024117	Chronic Obstructive Airway Disease	0.203846174978983	1	6	CTD_human
10144	FAM13A	C1800706	Idiopathic Pulmonary Fibrosis	0.4	1	0	CTD_human;ORPHANET
10149	ADGRG2	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
10149	ADGRG2	C4023106	Obstructive azoospermia	0.2	0	0	HPO
1015	CDH17	C0264423	Asthma, Occupational	0.2	1	0	CTD_human
10154	PLXNC1	C0014175	Endometriosis	0.2	1	0	CTD_human
10157	AASS	C0002871	Anemia	0.2	0	0	HPO
10157	AASS	C0014544	Epilepsy	0.2	0	0	HPO
10157	AASS	C0023882	Little's Disease	0.2	0	0	HPO
10157	AASS	C0268553	Hyperlysinemias	0.600549453568426	0	0	CTD_human;HPO;ORPHANET
10157	AASS	C0268556	Saccharopinuria	0.2	0	0	ORPHANET
10157	AASS	C0268642	Histidinuria renal tubular defect	0.2	0	0	HPO
10157	AASS	C0936256	Lysine Alpha-Ketoglutarate Reductase Deficiency Disease	0.2	0	0	ORPHANET
10157	AASS	C2936921	Saccharopine dehydrogenase deficiency	0.4	0	0	CTD_human;ORPHANET
10159	ATP6AP2	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
10159	ATP6AP2	C1845543	Mental Retardation, X-Linked, with Epilepsy	0.4	0	0	CTD_human;ORPHANET
10159	ATP6AP2	C3806722	PARKINSONISM WITH SPASTICITY, X-LINKED	0.200274726784213	0	0	ORPHANET
10161	LPAR6	C0002170	Alopecia	0.200824180352639	0	0	HPO
10161	LPAR6	C0263490	Brittle hair	0.2	0	0	HPO
10161	LPAR6	C1854310	Hypotrichosis simplex	0.400274726784213	1	0	CTD_human;ORPHANET
10161	LPAR6	C3279470	HYPOTRICHOSIS 8	0.2	1	2	UNIPROT
10165	SLC25A13	C0008372	Intrahepatic Cholestasis	0.207561324888707	0	0	HPO
10165	SLC25A13	C0020443	Hypercholesterolemia	0.2	0	0	HPO
10165	SLC25A13	C0023890	Liver Cirrhosis	0.2	0	0	HPO
10165	SLC25A13	C0030305	Pancreatitis	0.2	0	0	HPO
10165	SLC25A13	C0268621	Hepatic methionine adenosyltransferase deficiency	0.2	0	0	HPO
10165	SLC25A13	C0473527	Hypoalphalipoproteinemias	0.2	0	0	HPO
10165	SLC25A13	C1853942	CITRULLINEMIA, TYPE II, NEONATAL-ONSET	0.605769262468475	1	14	CTD_human;ORPHANET;UNIPROT
10165	SLC25A13	C1863844	Adult-onset citrullinemia type 2	0.412846646323386	1	7	CTD_human;ORPHANET
10165	SLC25A13	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10165	SLC25A13	C2711227	Steatohepatitis	0.200824180352639	0	0	HPO
10166	SLC25A15	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
10166	SLC25A15	C0235946	Cerebral atrophy	0.2	0	0	HPO
10166	SLC25A15	C0267797	Acute hepatitis	0.2	0	0	HPO
10166	SLC25A15	C0268540	HHH syndrome	0.60357144819477	8	17	CTD_human;ORPHANET;UNIPROT
10166	SLC25A15	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
10166	SLC25A15	C1306587	Acute encephalopathy	0.2	0	0	HPO
10166	SLC25A15	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10166	SLC25A15	C4020859	Pyramidal tract disease	0.2	0	0	HPO
10166	SLC25A15	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
10167	CFM1	C1859047	CYSTIC FIBROSIS MODIFIER 1	0.2	0	0	CTD_human
10184	LHFPL2	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
1019	CDK4	C0259817	Xerosis	0.2	0	0	HPO
1019	CDK4	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
101928376	IL12A-AS1	C0004943	Behcet Syndrome	0.200274726784213	0	0	ORPHANET
10194	TSHZ1	C0018777	Conductive hearing loss	0.2	0	0	HPO
10194	TSHZ1	C1857079	Atretic auditory canal	0.2	0	0	HPO
10195	ALG3	C0003886	Arthrogryposis	0.2	0	0	HPO
10195	ALG3	C0014544	Epilepsy	0.2	0	0	HPO
10195	ALG3	C0029124	Optic Atrophy	0.2	0	0	HPO
10195	ALG3	C0038379	Strabismus	0.2	0	0	HPO
10195	ALG3	C0149696	Food intolerance (disorder)	0.2	0	0	HPO
10195	ALG3	C0158113	Contracture of joint of hand	0.2	0	0	HPO
10195	ALG3	C0235946	Cerebral atrophy	0.2	0	0	HPO
10195	ALG3	C0262404	Cerebellar degeneration	0.2	0	0	HPO
10195	ALG3	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
10195	ALG3	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
10195	ALG3	C1301509	Severe visual impairment	0.2	0	0	HPO
10195	ALG3	C1832736	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id	0.601373633921066	2	5	CTD_human;ORPHANET;UNIPROT
10195	ALG3	C1834405	Nail dysplasia	0.2	0	0	HPO
10195	ALG3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10195	ALG3	C4020860	Supratentorial atrophy	0.2	0	0	HPO
10195	ALG3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
102	ADAM10	C0406811	Reticulate acropigmentation of Kitamura	0.400274726784213	1	5	ORPHANET;UNIPROT
102	ADAM10	C3810041	ALZHEIMER DISEASE 18	0.2	2	2	UNIPROT
1020	CDK5	C0003886	Arthrogryposis	0.2	0	0	HPO
1020	CDK5	C0024236	Lymphedema	0.2	0	0	HPO
10203	CALCRL	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
1021	CDK6	C0003873	Rheumatoid Arthritis	0.213408776537506	1	2	CTD_human
1021	CDK6	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
1021	CDK6	C0263454	Chloracne	0.2	1	0	CTD_human
1021	CDK6	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
1021	CDK6	C4015156	MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE	0.2	1	1	UNIPROT
10210	TOPORS	C0017601	Glaucoma	0.2	0	0	HPO
10210	TOPORS	C0018777	Conductive hearing loss	0.2	0	0	HPO
10210	TOPORS	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
10210	TOPORS	C0020459	Hyperinsulinism	0.2	0	0	HPO
10210	TOPORS	C0020619	Hypogonadism	0.2	0	0	HPO
10210	TOPORS	C0022578	Keratoconus	0.2	0	0	HPO
10210	TOPORS	C0028738	Nystagmus	0.2	0	0	HPO
10210	TOPORS	C0028754	Obesity	0.2	0	0	HPO
10210	TOPORS	C0029124	Optic Atrophy	0.2	0	0	HPO
10210	TOPORS	C0035334	Retinitis Pigmentosa	0.407872853452916	0	0	HPO;ORPHANET
10210	TOPORS	C0271215	Blindness, Legal	0.2	0	0	HPO
10210	TOPORS	C1835923	Retinitis Pigmentosa 31	0.2	0	0	CTD_human
10211	FLOT1	C0034362	Q Fever	0.2	1	0	CTD_human
10216	PRG4	C0003864	Arthritis	0.200549453568426	0	0	HPO
10216	PRG4	C0031046	Pericarditis	0.2	1	0	CTD_human
10216	PRG4	C0031048	Pericarditis, Constrictive	0.2	0	0	HPO
10216	PRG4	C0410574	Synovial Hypertrophy	0.2	0	0	HPO
10216	PRG4	C1859690	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	0.402747267842131	1	1	CTD_human;ORPHANET
10221	TRIB1	C1956346	Coronary Artery Disease	0.200824180352639	1	0	CTD_human
10225	CD96	C0010495	Cutis Laxa	0.2	0	0	HPO
10225	CD96	C0014544	Epilepsy	0.2	0	0	HPO
10225	CD96	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
10225	CD96	C0038379	Strabismus	0.2	0	0	HPO
10225	CD96	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
10225	CD96	C0796095	Opitz trigonocephaly syndrome	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
10225	CD96	C0796232	Bohring syndrome	0.200274726784213	0	0	CTD_human
10225	CD96	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10225	CD96	C2930812	Generalized elastolysis	0.2	0	0	HPO
10228	STX6	C0038868	Progressive supranuclear palsy	0.200549453568426	1	1	CTD_human
10228	STX6	C1866282	CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.2	1	0	CTD_human
10229	COQ7	C4225226	COENZYME Q10 DEFICIENCY, PRIMARY, 8	0.2	1	1	UNIPROT
10235	RASGRP2	C4014584	BLEEDING DISORDER, PLATELET-TYPE, 18	0.4	1	1	ORPHANET;UNIPROT
10239	AP3S2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200824180352639	1	1	CTD_human
10243	GPHN	C0014544	Epilepsy	0.200824180352639	0	0	HPO
10243	GPHN	C0268119	Combined molybdoflavoprotein enzyme deficiency	0.4	0	0	CTD_human;HPO
10243	GPHN	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
10243	GPHN	C1835614	Hereditary Hyperexplexia	0.4	0	0	CTD_human;ORPHANET
10243	GPHN	C1854990	Molybdenum Cofactor Deficiency, Complementation Group C	0.48	1	1	ORPHANET;UNIPROT
10246	SLC17A2	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
10257	ABCC4	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
10257	ABCC4	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
1026	CDKN1A	C0001206	Acromegaly	0.2	0	0	HPO
1026	CDKN1A	C0014868	Esophagitis	0.2	0	0	HPO
1026	CDKN1A	C0020437	Hypercalcemia	0.2	0	0	HPO
1026	CDKN1A	C0020502	Hyperparathyroidism	0.2	0	0	HPO
1026	CDKN1A	C0030920	Peptic Ulcer	0.2	0	0	HPO
1026	CDKN1A	C0043515	Zollinger-Ellison syndrome	0.2	0	0	HPO
1026	CDKN1A	C0271844	Parathyroid hyperplasia	0.2	0	0	HPO
1026	CDKN1A	C1864903	Hyperinsulinaemic hypoglycaemia	0.2	0	0	HPO
10261	IGSF6	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
10262	SF3B4	C0018777	Conductive hearing loss	0.2	0	0	HPO
10262	SF3B4	C0020255	Hydrocephalus	0.2	0	0	HPO
10262	SF3B4	C0041105	Trismus	0.2	0	0	HPO
10262	SF3B4	C0042109	Urticaria	0.2	0	0	HPO
10262	SF3B4	C0042454	Velopharyngeal Insufficiency	0.2	0	0	HPO
10262	SF3B4	C0265245	Nager syndrome	0.201923087489492	0	0	ORPHANET
10262	SF3B4	C1838608	Radial aplasia	0.2	0	0	HPO
10262	SF3B4	C1857079	Atretic auditory canal	0.2	0	0	HPO
10262	SF3B4	C2936786	Aqueductal Stenosis	0.2	0	0	HPO
10265	IRX5	C0002884	Hypochromic anemia	0.2	0	0	HPO
10265	IRX5	C0018784	Sensorineural Hearing Loss (disorder)	0.4	1	0	CTD_human;HPO
10265	IRX5	C0020626	Hypoparathyroidism	0.2	0	0	HPO
10265	IRX5	C0027092	Myopia	0.2	1	0	CTD_human
10265	IRX5	C0029453	Osteopenia	0.2	0	0	HPO
10265	IRX5	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
10265	IRX5	C0271183	Severe myopia	0.2	0	0	HPO
10265	IRX5	C0271901	Microcytic hypochromic anemia (disorder)	0.2	1	0	CTD_human
10265	IRX5	C0747078	Generalized osteopenia	0.2	0	0	HPO
10265	IRX5	C1836830	Developmental regression	0.2	0	0	HPO
10265	IRX5	C1970027	Hypertelorism, Severe, With Midface Prominence, Myopia, Mental Retardation, And Bone Fragility	0.4	1	3	ORPHANET;UNIPROT
10266	RAMP2	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
10269	ZMPSTE24	C0002170	Alopecia	0.200274726784213	0	0	HPO
10269	ZMPSTE24	C0013238	Dry Eye Syndromes	0.2	0	0	HPO
10269	ZMPSTE24	C0014390	Entropion	0.2	0	0	HPO
10269	ZMPSTE24	C0015300	Exophthalmos	0.2	0	0	HPO
10269	ZMPSTE24	C0017668	Focal glomerulosclerosis	0.200274726784213	1	0	CTD_human
10269	ZMPSTE24	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
10269	ZMPSTE24	C0020456	Hyperglycemia	0.2	0	0	HPO
10269	ZMPSTE24	C0020459	Hyperinsulinism	0.2	0	0	HPO
10269	ZMPSTE24	C0020473	Hyperlipidemia	0.2	0	0	HPO
10269	ZMPSTE24	C0020490	Hyperopia	0.2	0	0	HPO
10269	ZMPSTE24	C0020620	Hypohidrosis	0.2	0	0	HPO
10269	ZMPSTE24	C0022575	Keratoconjunctivitis Sicca	0.2	0	0	HPO
10269	ZMPSTE24	C0023787	Lipodystrophy	0.201373633921065	1	0	CTD_human
10269	ZMPSTE24	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
10269	ZMPSTE24	C0029456	Osteoporosis	0.200274726784213	0	0	HPO
10269	ZMPSTE24	C0033300	Progeria	0.488516530310606	1	0	CTD_human;ORPHANET
10269	ZMPSTE24	C0043349	Xerophthalmia	0.2	0	0	HPO
10269	ZMPSTE24	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
10269	ZMPSTE24	C0221032	Familial generalized lipodystrophy	0.200824180352639	0	0	HPO
10269	ZMPSTE24	C0221260	Dystrophia unguium	0.2	0	0	HPO
10269	ZMPSTE24	C0238621	Aminoaciduria	0.2	0	0	HPO
10269	ZMPSTE24	C0263490	Brittle hair	0.2	0	0	HPO
10269	ZMPSTE24	C0270254	Hydrops of placenta	0.2	0	0	HPO
10269	ZMPSTE24	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
10269	ZMPSTE24	C0399385	Early tooth exfoliation	0.2	0	0	HPO
10269	ZMPSTE24	C0406585	Lethal tight skin contracture syndrome (disorder)	0.4	0	0	CTD_human;ORPHANET
10269	ZMPSTE24	C0836924	Thrombocytosis	0.2	0	0	HPO
10269	ZMPSTE24	C0854110	Insulin resistant diabetes	0.2	0	0	HPO
10269	ZMPSTE24	C0917990	Acro-Osteolysis	0.200274726784213	2	0	CTD_human
10269	ZMPSTE24	C1136321	HIV-Associated Lipodystrophy Syndrome	0.2	1	0	CTD_human
10269	ZMPSTE24	C1280433	Lipoatrophy	0.2	0	0	HPO
10269	ZMPSTE24	C1834405	Nail dysplasia	0.2	0	0	HPO
10269	ZMPSTE24	C1837756	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.6	3	7	CTD_human;ORPHANET;UNIPROT
10269	ZMPSTE24	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10269	ZMPSTE24	C2711227	Steatohepatitis	0.2	0	0	HPO
10269	ZMPSTE24	C2930821	Keratitis sicca	0.2	0	0	HPO
10269	ZMPSTE24	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
10269	ZMPSTE24	C3887524	Skin Erosion	0.2	0	0	HPO
10269	ZMPSTE24	C4025270	Arteriosclerosis of small cerebral arteries	0.2	0	0	HPO
1027	CDKN1B	C0001206	Acromegaly	0.203231208875927	0	0	HPO
1027	CDKN1B	C0014868	Esophagitis	0.2	0	0	HPO
1027	CDKN1B	C0020437	Hypercalcemia	0.2	0	0	HPO
1027	CDKN1B	C0020502	Hyperparathyroidism	0.200824180352639	0	0	HPO
1027	CDKN1B	C0030920	Peptic Ulcer	0.2	0	0	HPO
1027	CDKN1B	C0043515	Zollinger-Ellison syndrome	0.2	0	0	HPO
1027	CDKN1B	C0263454	Chloracne	0.2	1	0	CTD_human
1027	CDKN1B	C0271844	Parathyroid hyperplasia	0.2	0	0	HPO
1027	CDKN1B	C1864903	Hyperinsulinaemic hypoglycaemia	0.2	0	0	HPO
10273	STUB1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
10273	STUB1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
10273	STUB1	C4014261	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16	0.4	4	10	ORPHANET;UNIPROT
10273	STUB1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
1028	CDKN1C	C0004903	Beckwith-Wiedemann Syndrome	0.427979065857785	2	17	CTD_human;UNIPROT
1028	CDKN1C	C0014173	Endometrial Hyperplasia	0.2	1	0	CTD_human
1028	CDKN1C	C0015300	Exophthalmos	0.2	0	0	HPO
1028	CDKN1C	C0020295	Hydronephrosis	0.2	0	0	HPO
1028	CDKN1C	C0020437	Hypercalcemia	0.2	0	0	HPO
1028	CDKN1C	C0020619	Hypogonadism	0.2	0	0	HPO
1028	CDKN1C	C0024421	Macroglossia	0.200274726784213	0	0	HPO
1028	CDKN1C	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
1028	CDKN1C	C0265294	Pyle metaphyseal dysplasia	0.2	0	0	HPO
1028	CDKN1C	C1846009	Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, And Genital Anomalies	0.401923087489492	1	7	ORPHANET;UNIPROT
1028	CDKN1C	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
10280	SIGMAR1	C0002736	Amyotrophic Lateral Sclerosis	0.402197814273705	1	0	CTD_human;HPO
10280	SIGMAR1	C0026847	Spinal Muscular Atrophy	0.2	0	0	HPO
10280	SIGMAR1	C0085684	Foot-drop	0.2	0	0	HPO
10280	SIGMAR1	C1848736	Distal amyotrophy	0.2	0	0	HPO
10280	SIGMAR1	C1854023	Spinal muscular atrophy, Jerash type	0.2	0	0	ORPHANET
10280	SIGMAR1	C3280587	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE	0.2	1	2	UNIPROT
1029	CDKN2A	C0017601	Glaucoma	0.200824180352639	1	0	CTD_human
1029	CDKN2A	C0022783	Vulvar Lichen Sclerosus	0.200549453568426	1	0	CTD_human
1029	CDKN2A	C0259817	Xerosis	0.2	0	0	HPO
1029	CDKN2A	C1835398	LI-FRAUMENI SYNDROME 1	0.2	0	0	CTD_human
1029	CDKN2A	C1838547	MELANOMA-PANCREATIC CANCER SYNDROME	0.4	0	0	CTD_human;UNIPROT
10290	SPEG	C0376175	Bell Palsy	0.2	0	0	HPO
10290	SPEG	C4014814	MYOPATHY, CENTRONUCLEAR, 5	0.2	1	5	UNIPROT
10293	TRAIP	C0010278	Craniosynostosis	0.2	0	0	HPO
10293	TRAIP	C0017601	Glaucoma	0.2	0	0	HPO
10293	TRAIP	C0265202	Seckel syndrome	0.2	0	0	ORPHANET
10293	TRAIP	C4225212	SECKEL SYNDROME 9	0.2	1	2	UNIPROT
10295	BCKDK	C0014544	Epilepsy	0.200274726784213	0	0	HPO
10295	BCKDK	C3554078	BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY	0.48	2	2	ORPHANET;UNIPROT
10296	MAEA	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200549453568426	1	1	CTD_human
10297	APC2	C0018777	Conductive hearing loss	0.2	0	0	HPO
10297	APC2	C0020615	Hypoglycemia	0.2	0	0	HPO
10297	APC2	C0028754	Obesity	0.2	0	0	HPO
10297	APC2	C0034013	Precocious Puberty	0.2	0	0	HPO
10297	APC2	C0175695	Sotos' syndrome	0.2	0	0	ORPHANET
103	ADAR	C0013423	Dystonia Musculorum Deformans	0.2	0	0	HPO
103	ADAR	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
103	ADAR	C0393591	AICARDI-GOUTIERES SYNDROME	0.201098907136852	0	0	ORPHANET
103	ADAR	C0795996	STRIATONIGRAL DEGENERATION, INFANTILE (disorder)	0.2	0	0	ORPHANET
103	ADAR	C0796126	AICARDI-GOUTIERES SYNDROME 1	0.201923087489492	1	0	CTD_human
103	ADAR	C3539013	AICARDI-GOUTIERES SYNDROME 6	0.2	1	10	UNIPROT
103	ADAR	C4082173	Porencephaly	0.2	0	0	HPO
1030	CDKN2B	C0001206	Acromegaly	0.2	0	0	HPO
1030	CDKN2B	C0014868	Esophagitis	0.2	0	0	HPO
1030	CDKN2B	C0017601	Glaucoma	0.201098907136852	1	0	CTD_human
1030	CDKN2B	C0020437	Hypercalcemia	0.2	0	0	HPO
1030	CDKN2B	C0020502	Hyperparathyroidism	0.2	0	0	HPO
1030	CDKN2B	C0030920	Peptic Ulcer	0.2	0	0	HPO
1030	CDKN2B	C0043515	Zollinger-Ellison syndrome	0.2	0	0	HPO
1030	CDKN2B	C0259817	Xerosis	0.2	0	0	HPO
1030	CDKN2B	C0271844	Parathyroid hyperplasia	0.2	0	0	HPO
1030	CDKN2B	C1864903	Hyperinsulinaemic hypoglycaemia	0.2	0	0	HPO
1030	CDKN2B	C1956346	Coronary Artery Disease	0.214782410458571	1	0	CTD_human
10300	KATNB1	C1857278	Partial or complete agenesis of corpus callosum	0.2	0	0	HPO
10300	KATNB1	C1956147	Microlissencephaly	0.2	0	0	ORPHANET
10305	MMDK	C1835009	MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.200549453568426	0	0	CTD_human
10306	CTPP	C1861825	CATARACT, POSTERIOR POLAR, 1	0.2	0	0	CTD_human
10309	CCNO	C0006267	Bronchiectasis	0.2	0	0	HPO
10309	CCNO	C0022521	Kartagener Syndrome	0.200274726784213	0	0	ORPHANET
10309	CCNO	C4014534	CILIARY DYSKINESIA, PRIMARY, 29	0.2	2	2	UNIPROT
1031	CDKN2C	C0001206	Acromegaly	0.2	0	0	HPO
1031	CDKN2C	C0014868	Esophagitis	0.2	0	0	HPO
1031	CDKN2C	C0020437	Hypercalcemia	0.2	0	0	HPO
1031	CDKN2C	C0020502	Hyperparathyroidism	0.2	0	0	HPO
1031	CDKN2C	C0030920	Peptic Ulcer	0.2	0	0	HPO
1031	CDKN2C	C0043515	Zollinger-Ellison syndrome	0.2	0	0	HPO
1031	CDKN2C	C0271844	Parathyroid hyperplasia	0.2	0	0	HPO
1031	CDKN2C	C1864903	Hyperinsulinaemic hypoglycaemia	0.2	0	0	HPO
10312	TCIRG1	C0002871	Anemia	0.2	0	0	HPO
10312	TCIRG1	C0008711	Chronic rhinitis	0.2	0	0	HPO
10312	TCIRG1	C0010278	Craniosynostosis	0.2	0	0	HPO
10312	TCIRG1	C0011334	Dental caries	0.2	0	0	HPO
10312	TCIRG1	C0014544	Epilepsy	0.2	0	0	HPO
10312	TCIRG1	C0015469	Facial paralysis	0.2	0	0	HPO
10312	TCIRG1	C0020255	Hydrocephalus	0.2	0	0	HPO
10312	TCIRG1	C0028738	Nystagmus	0.2	0	0	HPO
10312	TCIRG1	C0029124	Optic Atrophy	0.200274726784213	0	0	HPO
10312	TCIRG1	C0029443	Osteomyelitis	0.2	0	0	HPO
10312	TCIRG1	C0029454	Osteopetrosis	0.213367389137178	0	0	HPO
10312	TCIRG1	C0029882	Otitis Media	0.2	0	0	HPO
10312	TCIRG1	C0030312	Pancytopenia	0.2	0	0	HPO
10312	TCIRG1	C0039621	Tetany	0.2	0	0	HPO
10312	TCIRG1	C0042798	Low Vision	0.2	0	0	HPO
10312	TCIRG1	C0242567	Opsoclonus	0.2	0	0	HPO
10312	TCIRG1	C0271215	Blindness, Legal	0.2	0	0	HPO
10312	TCIRG1	C0376175	Bell Palsy	0.2	0	0	HPO
10312	TCIRG1	C1850127	Osteopetrosis, Autosomal Recessive 1	0.48	2	6	CTD_human;UNIPROT
10312	TCIRG1	C1859966	Neutropenia, Severe Congenital, Autosomal Dominant 1	0.2	0	0	ORPHANET
10312	TCIRG1	C2242472	Infection of bone	0.2	0	0	HPO
10312	TCIRG1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10318	TNIP1	C0024141	Lupus Erythematosus, Systemic	0.208110778457133	2	4	CTD_human
10318	TNIP1	C0033860	Psoriasis	0.209260842751298	2	1	CTD_human
10318	TNIP1	C0036421	Systemic Scleroderma	0.200824180352639	1	2	CTD_human
10318	TNIP1	C1527336	Sjogren's Syndrome	0.2	1	0	CTD_human
10319	LAMC3	C3279875	CORTICAL MALFORMATIONS, OCCIPITAL	0.4	1	2	ORPHANET;UNIPROT
1032	CDKN2D	C0259817	Xerosis	0.2	0	0	HPO
10320	IKZF1	C0009324	Ulcerative Colitis	0.2	1	0	CTD_human
10320	IKZF1	C0024141	Lupus Erythematosus, Systemic	0.20433011601278	1	0	CTD_human
10320	IKZF1	C0037036	Sialorrhea	0.2	0	0	HPO
10320	IKZF1	C0038325	Stevens-Johnson Syndrome	0.2	0	0	ORPHANET
10320	IKZF1	C4225173	IMMUNODEFICIENCY, COMMON VARIABLE, 13	0.4	1	4	ORPHANET;UNIPROT
10324	KLHL41	C0546125	Nemaline Myopathy, Childhood Onset	0.2	0	0	ORPHANET
10324	KLHL41	C3810384	NEMALINE MYOPATHY 9	0.2	1	5	UNIPROT
10327	AKR1A1	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
10329	TMEM5	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
10329	TMEM5	C0026850	Muscular Dystrophy	0.2	0	0	HPO
10329	TMEM5	C0265221	Walker-Warburg congenital muscular dystrophy	0.2	0	0	ORPHANET
10329	TMEM5	C3554381	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10	0.2	1	7	UNIPROT
10342	TFG	C0020473	Hyperlipidemia	0.2	0	0	HPO
10342	TFG	C0029124	Optic Atrophy	0.2	0	0	HPO
10342	TFG	C0034372	Quadriplegia	0.2	0	0	HPO
10342	TFG	C0037772	Spastic Paraplegia	0.2	0	0	HPO
10342	TFG	C0151313	Sensory neuropathy	0.2	0	0	HPO
10342	TFG	C0235025	Peripheral motor neuropathy	0.2	0	0	HPO
10342	TFG	C0271683	Polyneuropathy, Motor	0.2	0	0	HPO
10342	TFG	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
10342	TFG	C1836451	Muscle atrophy, lower limb, distal	0.2	0	0	HPO
10342	TFG	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
10342	TFG	C1858338	Neuropathy, hereditary motor and sensory, Okinawa type	0.4	1	2	ORPHANET;UNIPROT
10342	TFG	C3714897	SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE	0.4	1	1	ORPHANET;UNIPROT
10344	CCL26	C0341106	Eosinophilic esophagitis	0.202472541057918	0	0	CTD_human
10345	TRDN	C0014544	Epilepsy	0.2	0	0	HPO
10345	TRDN	C0042514	Tachycardia, Ventricular	0.2	0	0	HPO
10345	TRDN	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	0.200549453568426	0	0	ORPHANET
10345	TRDN	C3809536	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS	0.2	1	3	UNIPROT
10346	TRIM22	C0021400	Influenza	0.2	1	0	CTD_human
10347	ABCA7	C0002395	Alzheimer's Disease	0.20796707674218	2	4	CTD_human
1036	CDO1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	0	CTD_human
10363	HMG20A	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.201373633921065	1	2	CTD_human
10367	MICU1	C3810285	MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.2	0	0	ORPHANET
10369	CACNG2	C3280284	MENTAL RETARDATION, AUTOSOMAL DOMINANT 10	0.2	1	0	UNIPROT
10370	CITED2	C0015300	Exophthalmos	0.2	0	0	HPO
10371	SEMA3A	C0162809	Kallmann Syndrome	0.201373633921065	0	0	ORPHANET
10371	SEMA3A	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
10371	SEMA3A	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
10371	SEMA3A	C3554021	HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA	0.2	2	9	UNIPROT
10371	SEMA3A	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
103753527	SCA37	C3889636	SPINOCEREBELLAR ATAXIA 37	0.2	0	0	ORPHANET
10376	TUBA1B	C0029456	Osteoporosis	0.2	1	0	CTD_human
10381	TUBB3	C0015310	Exotropia	0.2	0	0	HPO
10381	TUBB3	C0028738	Nystagmus	0.2	0	0	HPO
10381	TUBB3	C0038379	Strabismus	0.200274726784213	0	0	HPO
10381	TUBB3	C1302995	Congenital Fibrosis of the Extraocular Muscles	0.203021994626344	0	0	HPO
10381	TUBB3	C1851102	Fibrosis Of Extraocular Muscles, Congenital, 1	0.2	0	0	ORPHANET
10381	TUBB3	C2748801	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT	0.48	1	9	CTD_human;UNIPROT
10381	TUBB3	C3808397	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.4	1	6	ORPHANET;UNIPROT
10381	TUBB3	C4024789	Nonprogressive restrictive external ophthalmoplegia	0.2	0	0	HPO
10382	TUBB4A	C1851943	DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT (disorder)	0.4	1	2	ORPHANET;UNIPROT
10382	TUBB4A	C2676244	Leukodystrophy, Hypomyelinating, 6	0.4	1	27	ORPHANET;UNIPROT
10397	NDRG1	C1832334	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D	0.481373633921066	0	0	CTD_human;ORPHANET
10397	NDRG1	C1848736	Distal amyotrophy	0.2	0	0	HPO
104	ADARB1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
1040	CDS1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1041	CDSN	C0004096	Asthma	0.200274726784213	0	0	HPO
1041	CDSN	C0085661	Onycholysis	0.2	0	0	HPO
1041	CDSN	C0263490	Brittle hair	0.2	0	0	HPO
1041	CDSN	C1840299	Hypotrichosis Simplex of Scalp	0.2	0	0	CTD_human
1041	CDSN	C3714497	Reactive airway disease	0.2	0	0	HPO
1041	CDSN	C3891449	PEELING SKIN SYNDROME 1	0.2	0	0	ORPHANET
10410	IFITM3	C0021400	Influenza	0.204120901763196	1	1	CTD_human
10411	RAPGEF3	C0024117	Chronic Obstructive Airway Disease	0.200274726784213	1	0	CTD_human
10412	NSA2	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
10413	YAP1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
10413	YAP1	C0795902	Coloboma, cleft lip-palate and mental retardation syndrome	0.2	0	0	ORPHANET
10436	EMG1	C1859405	Bowen-Conradi syndrome	0.681648360705279	1	1	CTD_human;ORPHANET;UNIPROT
10437	IFI30	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
10449	ACAA2	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
10449	ACAA2	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
10451	VAV3	C0017661	IGA Glomerulonephritis	0.2	1	1	CTD_human
10454	TAB1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
10457	GPNMB	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
10459	MAD2L2	C0015625	Fanconi Anemia	0.2	0	0	ORPHANET
10459	MAD2L2	C0023530	Leukopenia	0.2	0	0	HPO
10459	MAD2L2	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
10461	MERTK	C0017601	Glaucoma	0.2	0	0	HPO
10461	MERTK	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
10461	MERTK	C0018777	Conductive hearing loss	0.2	0	0	HPO
10461	MERTK	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
10461	MERTK	C0020459	Hyperinsulinism	0.2	0	0	HPO
10461	MERTK	C0020619	Hypogonadism	0.2	0	0	HPO
10461	MERTK	C0022578	Keratoconus	0.2	0	0	HPO
10461	MERTK	C0028077	Night Blindness	0.2	0	0	HPO
10461	MERTK	C0028738	Nystagmus	0.2	0	0	HPO
10461	MERTK	C0028754	Obesity	0.2	0	0	HPO
10461	MERTK	C0029124	Optic Atrophy	0.2	0	0	HPO
10461	MERTK	C0034065	Pulmonary Embolism	0.2	1	0	CTD_human
10461	MERTK	C0035334	Retinitis Pigmentosa	0.609535569535511	1	2	CTD_human;HPO;ORPHANET
10461	MERTK	C0271215	Blindness, Legal	0.2	0	0	HPO
10461	MERTK	C1288283	Atrophoderma maculatum	0.2	0	0	HPO
10461	MERTK	C3151228	RETINITIS PIGMENTOSA 38 (disorder)	0.2	1	8	UNIPROT
10461	MERTK	C3553016	Peripheral retinal atrophy	0.2	0	0	HPO
10462	CLEC10A	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
10466	COG5	C0262404	Cerebellar degeneration	0.2	0	0	HPO
10466	COG5	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
10466	COG5	C3150876	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi	0.4	0	0	CTD_human;ORPHANET
10466	COG5	C4020873	Infratentorial atrophy	0.2	0	0	HPO
10466	COG5	C4024900	Brainstem atrophy	0.2	0	0	HPO
10468	FST	C0032460	Polycystic Ovary Syndrome	0.210294237353521	0	0	CTD_human
10468	FST	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
10472	ZBTB18	C0014544	Epilepsy	0.2	0	0	HPO
10472	ZBTB18	C3808184	MENTAL RETARDATION, AUTOSOMAL DOMINANT 22	0.28	0	0	ORPHANET
10472	ZBTB18	C4273897	Distal monosomy 1q	0.2	0	0	ORPHANET
10479	SLC9A6	C0015732	Fecal Incontinence	0.2	0	0	HPO
10479	SLC9A6	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
10479	SLC9A6	C0028738	Nystagmus	0.2	0	0	HPO
10479	SLC9A6	C0037036	Sialorrhea	0.2	0	0	HPO
10479	SLC9A6	C0038379	Strabismus	0.2	0	0	HPO
10479	SLC9A6	C0234533	Generalized seizures	0.2	0	0	HPO
10479	SLC9A6	C0234958	muscle degeneration	0.2	0	0	HPO
10479	SLC9A6	C0235946	Cerebral atrophy	0.2	0	0	HPO
10479	SLC9A6	C0262404	Cerebellar degeneration	0.2	0	0	HPO
10479	SLC9A6	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
10479	SLC9A6	C1836830	Developmental regression	0.2	0	0	HPO
10479	SLC9A6	C1846130	Mental retardation X-linked, South African type	0.2	0	0	ORPHANET
10479	SLC9A6	C1846131	Seizures, tonic-clonic, photosensitive	0.2	0	0	HPO
10479	SLC9A6	C2678194	Mental Retardation, X-Linked, Syndromic, Christianson Type	0.201373633921065	0	0	CTD_human
10479	SLC9A6	C4020871	Dystonic disease	0.2	0	0	HPO
10479	SLC9A6	C4020873	Infratentorial atrophy	0.2	0	0	HPO
10483	SEC23B	C0008350	Cholelithiasis	0.200274726784213	0	0	HPO
10483	SEC23B	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
10483	SEC23B	C0024421	Macroglossia	0.2	0	0	HPO
10483	SEC23B	C0040412	Fissured tongue	0.2	0	0	HPO
10483	SEC23B	C0678199	Dyserythropoietic anemia	0.200274726784213	0	0	HPO
10483	SEC23B	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
10483	SEC23B	C1306589	Congenital dyserythropoietic anemia, type II	0.40439562854741	2	7	ORPHANET;UNIPROT
10483	SEC23B	C4021849	Conjunctival hamartoma	0.2	0	0	HPO
10483	SEC23B	C4225179	COWDEN SYNDROME 7	0.2	1	1	UNIPROT
10484	SEC23A	C0011334	Dental caries	0.2	0	0	HPO
10484	SEC23A	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
10484	SEC23A	C0263490	Brittle hair	0.2	0	0	HPO
10484	SEC23A	C0271165	Punctate cataract	0.2	0	0	HPO
10484	SEC23A	C0399385	Early tooth exfoliation	0.2	0	0	HPO
10484	SEC23A	C1843042	Craniolenticulosutural Dysplasia	0.6	1	2	CTD_human;ORPHANET;UNIPROT
10484	SEC23A	C4023734	Sutural cataract	0.2	0	0	HPO
10487	CAP1	C0029456	Osteoporosis	0.2	1	0	CTD_human
10491	CRTAP	C0015300	Exophthalmos	0.2	0	0	HPO
10491	CRTAP	C0020295	Hydronephrosis	0.2	0	0	HPO
10491	CRTAP	C0029453	Osteopenia	0.2	0	0	HPO
10491	CRTAP	C0268362	Osteogenesis imperfecta type III (disorder)	0.2	0	0	ORPHANET
10491	CRTAP	C0410550	Collapse of vertebra	0.2	0	0	HPO
10491	CRTAP	C0747078	Generalized osteopenia	0.2	0	0	HPO
10491	CRTAP	C1853162	Osteogenesis Imperfecta Type VII	0.280549453568426	2	9	UNIPROT
10491	CRTAP	C2931095	Osteogenesis imperfecta, type 7	0.2	0	0	CTD_human
10498	CARM1	C0033860	Psoriasis	0.2	1	0	CTD_human
1051	CEBPB	C0007786	Brain Ischemia	0.2	1	0	CTD_human
1051	CEBPB	C0015695	Fatty Liver	0.2	1	0	CTD_human
1051	CEBPB	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
10512	SEMA3C	C0021843	Intestinal Obstruction	0.2	0	0	HPO
10516	FBLN5	C0003486	Aortic Aneurysm	0.2	0	0	HPO
10516	FBLN5	C0003499	Supravalvular aortic stenosis	0.2	0	0	HPO
10516	FBLN5	C0010495	Cutis Laxa	0.209037273124398	0	0	HPO
10516	FBLN5	C0016052	Fibromuscular Dysplasia	0.2	0	0	HPO
10516	FBLN5	C0018801	Heart failure	0.2	1	0	CTD_human
10516	FBLN5	C0034067	Pulmonary Emphysema	0.200549453568426	0	0	HPO
10516	FBLN5	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
10516	FBLN5	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
10516	FBLN5	C0268350	Cutis Laxa, Autosomal Dominant	0.2	0	0	ORPHANET
10516	FBLN5	C1258215	Ileus	0.2	0	0	HPO
10516	FBLN5	C1260959	Drusen	0.2	0	0	HPO
10516	FBLN5	C1394691	Bowel diverticula	0.2	0	0	HPO
10516	FBLN5	C1395674	Bowel diverticulosis	0.2	0	0	HPO
10516	FBLN5	C1837187	MACULAR DEGENERATION, AGE-RELATED, 3	0.2	0	0	CTD_human
10516	FBLN5	C2315541	Diverticulum of renal calyx	0.2	0	0	HPO
10516	FBLN5	C2930812	Generalized elastolysis	0.2	0	0	HPO
10516	FBLN5	C2931134	Cutis laxa, recessive	0.200549453568426	1	0	CTD_human
10516	FBLN5	C3276539	CUTIS LAXA, AUTOSOMAL DOMINANT 1	0.2	0	0	CTD_human
10516	FBLN5	C4225406	NEUROPATHY, HEREDITARY, WITH OR WITHOUT AGE-RELATED MACULAR DEGENERATION	0.4	6	11	ORPHANET;UNIPROT
10518	CIB2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
10518	CIB2	C0018979	Hemianopsia	0.2	0	0	HPO
10518	CIB2	C0028077	Night Blindness	0.2	0	0	HPO
10518	CIB2	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
10518	CIB2	C1568247	Usher Syndrome, Type I	0.200274726784213	0	0	ORPHANET
10518	CIB2	C1836199	DEAFNESS, AUTOSOMAL RECESSIVE 48	0.200274726784213	3	3	UNIPROT
10518	CIB2	C3553944	USHER SYNDROME, TYPE IJ	0.400274726784213	1	1	CTD_human;UNIPROT
10518	CIB2	C4023338	Profound sensorineural hearing impairment	0.2	0	0	HPO
1052	CEBPD	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
10522	DEAF1	C4014414	MENTAL RETARDATION, AUTOSOMAL DOMINANT 24	0.2	2	4	UNIPROT
10525	HYOU1	C1846707	SPINOCEREBELLAR ATAXIA 17	0.2	1	0	CTD_human
10528	NOP56	C0241423	Atrophy of tongue	0.200274726784213	0	0	HPO
10528	NOP56	C0262404	Cerebellar degeneration	0.2	0	0	HPO
10528	NOP56	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
10528	NOP56	C3472711	Spinocerebellar ataxia 36	0.201098907136852	0	0	ORPHANET
10528	NOP56	C4020873	Infratentorial atrophy	0.2	0	0	HPO
1053	CEBPE	C0030779	Pelger-Huet Anomaly	0.2	0	0	HPO
1053	CEBPE	C0398593	Specific granule deficiency	0.400274726784213	0	0	CTD_human;ORPHANET
10533	ATG7	C0002871	Anemia	0.2	1	0	CTD_human
10533	ATG7	C0024312	Lymphopenia	0.2	1	0	CTD_human
10535	RNASEH2A	C0020255	Hydrocephalus	0.2	0	0	HPO
10535	RNASEH2A	C0023520	Leukodystrophy	0.2	0	0	HPO
10535	RNASEH2A	C0030312	Pancytopenia	0.2	0	0	HPO
10535	RNASEH2A	C0235946	Cerebral atrophy	0.2	0	0	HPO
10535	RNASEH2A	C0262404	Cerebellar degeneration	0.2	0	0	HPO
10535	RNASEH2A	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
10535	RNASEH2A	C0393591	AICARDI-GOUTIERES SYNDROME	0.200274726784213	0	0	ORPHANET
10535	RNASEH2A	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
10535	RNASEH2A	C1835912	AICARDI-GOUTIERES SYNDROME 4	0.4	2	12	CTD_human;UNIPROT
10535	RNASEH2A	C4020860	Supratentorial atrophy	0.2	0	0	HPO
10535	RNASEH2A	C4020871	Dystonic disease	0.2	0	0	HPO
10535	RNASEH2A	C4020873	Infratentorial atrophy	0.2	0	0	HPO
10535	RNASEH2A	C4082173	Porencephaly	0.2	0	0	HPO
10536	P3H3	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
10537	UBD	C0019188	Hepatitis, Animal	0.2	1	0	CTD_human
10537	UBD	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
10547	PSORS4	C0033860	Psoriasis	0.203021994626344	0	0	CTD_human
10549	PRDX4	C0020456	Hyperglycemia	0.2	1	0	CTD_human
10549	PRDX4	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
1055	CECR	C0265493	Cat eye syndrome	0.200274726784213	1	0	CTD_human
10555	AGPAT2	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
10555	AGPAT2	C0001206	Acromegaly	0.2	0	0	HPO
10555	AGPAT2	C0001339	Acute pancreatitis	0.2	0	0	HPO
10555	AGPAT2	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
10555	AGPAT2	C0011859	Lipoatrophic Diabetes Mellitus	0.2	0	0	ORPHANET
10555	AGPAT2	C0020459	Hyperinsulinism	0.2	0	0	HPO
10555	AGPAT2	C0023787	Lipodystrophy	0.208762546340185	0	0	HPO
10555	AGPAT2	C0023890	Liver Cirrhosis	0.2	0	0	HPO
10555	AGPAT2	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
10555	AGPAT2	C0034013	Precocious Puberty	0.2	0	0	HPO
10555	AGPAT2	C0085605	Liver Failure	0.2	0	0	HPO
10555	AGPAT2	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
10555	AGPAT2	C0221032	Familial generalized lipodystrophy	0.215876731975091	0	0	CTD_human
10555	AGPAT2	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
10555	AGPAT2	C1280433	Lipoatrophy	0.200549453568426	0	0	HPO
10555	AGPAT2	C1720862	Congenital Generalized Lipodystrophy Type 1	0.280549453568426	1	25	UNIPROT
10555	AGPAT2	C2711227	Steatohepatitis	0.200274726784213	0	0	HPO
10558	SPTLC1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
10558	SPTLC1	C0020071	Hereditary Sensory Autonomic Neuropathy, Type 1	0.606868169605328	4	7	CTD_human;ORPHANET;UNIPROT
10558	SPTLC1	C0234958	muscle degeneration	0.2	0	0	HPO
10558	SPTLC1	C4021578	Chronic axonal neuropathy	0.2	0	0	HPO
10558	SPTLC1	C4025737	Osteomyelitis or necrosis, distal, due to sensory neuropathy (feet)	0.2	0	0	HPO
10559	SLC35A1	C0032285	Pneumonia	0.2	0	0	HPO
10559	SLC35A1	C0854107	Haemorrhage subcutaneous	0.2	0	0	HPO
10559	SLC35A1	C1970344	Congenital Disorder Of Glycosylation, Type IIF	0.4	0	0	CTD_human;ORPHANET
1056	CEL	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200274726784213	0	0	ORPHANET
1056	CEL	C0149521	Pancreatitis, Chronic	0.200549453568426	1	0	CTD_human
1056	CEL	C0342276	Maturity onset diabetes mellitus in young	0.201373633921065	0	0	HPO
1056	CEL	C1853297	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION	0.201098907136852	0	0	CTD_human
10560	SLC19A2	C0002888	Anemia, Megaloblastic	0.211755830211894	0	0	HPO
10560	SLC19A2	C0002896	Sideroblastic anemia	0.2	0	0	HPO
10560	SLC19A2	C0003123	Anorexia	0.2	0	0	HPO
10560	SLC19A2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
10560	SLC19A2	C0028738	Nystagmus	0.2	0	0	HPO
10560	SLC19A2	C0029124	Optic Atrophy	0.2	0	0	HPO
10560	SLC19A2	C0035334	Retinitis Pigmentosa	0.200549453568426	0	0	HPO
10560	SLC19A2	C0238621	Aminoaciduria	0.2	0	0	HPO
10560	SLC19A2	C0271972	Thiamine-responsive megaloblastic anemia	0.203296721410557	0	0	HPO
10560	SLC19A2	C0730290	Cone dystrophy	0.2	0	0	HPO
10560	SLC19A2	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
10561	IFI44	C0021400	Influenza	0.2	1	0	CTD_human
10562	OLFM4	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
10564	ARFGEF2	C0014544	Epilepsy	0.2	0	0	HPO
10564	ARFGEF2	C1842563	Heterotopia, Periventricular, Autosomal Recessive	0.2	0	0	CTD_human
10564	ARFGEF2	C1849173	Periventricular neuronal heterotopia	0.2	0	0	HPO
10564	ARFGEF2	C1868720	Periventricular Nodular Heterotopia	0.202197814273705	0	0	ORPHANET
10568	SLC34A2	C0155912	Pulmonary Alveolar Microlithiasis	0.601648360705279	1	3	CTD_human;ORPHANET;UNIPROT
10568	SLC34A2	C1864873	Testicular Microlithiasis	0.400274726784213	0	0	CTD_human;HPO
1057	CELP	C0149521	Pancreatitis, Chronic	0.200274726784213	1	0	CTD_human
10576	CCT2	C0029456	Osteoporosis	0.2	1	0	CTD_human
10577	NPC2	C0007384	Cataplexy	0.2	0	0	HPO
10577	NPC2	C0014544	Epilepsy	0.2	0	0	HPO
10577	NPC2	C0036489	Sea-Blue Histiocyte Syndrome	0.2	0	0	HPO
10577	NPC2	C0339652	Vertical gaze palsy	0.2	0	0	HPO
10577	NPC2	C1145670	Respiratory Failure	0.2	0	0	HPO
10577	NPC2	C1285291	Fetal ascites	0.2	0	0	HPO
10577	NPC2	C1843366	NIEMANN-PICK DISEASE, TYPE C2	0.481923087489492	4	17	CTD_human;UNIPROT
10577	NPC2	C1843369	Vertical supranuclear gaze palsy	0.2	0	0	HPO
10577	NPC2	C4020871	Dystonic disease	0.2	0	0	HPO
10585	POMT1	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
10585	POMT1	C0014544	Epilepsy	0.2	0	0	HPO
10585	POMT1	C0017601	Glaucoma	0.2	0	0	HPO
10585	POMT1	C0020255	Hydrocephalus	0.2	0	0	HPO
10585	POMT1	C0024421	Macroglossia	0.2	0	0	HPO
10585	POMT1	C0026850	Muscular Dystrophy	0.20859471949093	0	0	HPO
10585	POMT1	C0027092	Myopia	0.2	0	0	HPO
10585	POMT1	C0029124	Optic Atrophy	0.2	0	0	HPO
10585	POMT1	C0035305	Retinal Detachment	0.2	0	0	HPO
10585	POMT1	C0038379	Strabismus	0.2	0	0	HPO
10585	POMT1	C0042798	Low Vision	0.2	0	0	HPO
10585	POMT1	C0265221	Walker-Warburg congenital muscular dystrophy	0.606318716036901	4	14	CTD_human;ORPHANET;UNIPROT
10585	POMT1	C0271215	Blindness, Legal	0.2	0	0	HPO
10585	POMT1	C0376175	Bell Palsy	0.2	0	0	HPO
10585	POMT1	C0457133	Muscle eye brain disease	0.200549453568426	0	0	ORPHANET
10585	POMT1	C0521694	Atrophic retina	0.2	0	0	HPO
10585	POMT1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
10585	POMT1	C0699743	Congenital muscular dystrophy (disorder)	0.201373633921065	0	0	HPO
10585	POMT1	C1836373	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K	0.600274726784213	1	7	CTD_human;ORPHANET;UNIPROT
10585	POMT1	C1837229	Muscular Dystrophy, Congenital, Type 1D	0.2	0	0	ORPHANET
10585	POMT1	C1847759	MUSCULAR DYSTROPHY, CONGENITAL, 1C	0.2	0	0	ORPHANET
10585	POMT1	C1857079	Atretic auditory canal	0.2	0	0	HPO
10585	POMT1	C3150415	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	0.6	4	7	CTD_human;ORPHANET;UNIPROT
10585	POMT1	C3150416	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.2	0	0	ORPHANET
10585	POMT1	C3809221	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14	0.2	0	0	ORPHANET
10586	MAB21L2	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
10586	MAB21L2	C0038379	Strabismus	0.2	0	0	HPO
10586	MAB21L2	C4014540	MICROPHTHALMIA, SYNDROMIC 14	0.4	1	4	ORPHANET;UNIPROT
10587	TXNRD2	C0339573	Glaucoma, Primary Open Angle	0.200274726784213	1	0	CTD_human
10587	TXNRD2	C1859974	GLUCOCORTICOID DEFICIENCY 1	0.2	0	0	ORPHANET
10587	TXNRD2	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
10587	TXNRD2	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
10594	PRPF8	C0017601	Glaucoma	0.2	0	0	HPO
10594	PRPF8	C0018777	Conductive hearing loss	0.2	0	0	HPO
10594	PRPF8	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
10594	PRPF8	C0020459	Hyperinsulinism	0.2	0	0	HPO
10594	PRPF8	C0020619	Hypogonadism	0.2	0	0	HPO
10594	PRPF8	C0022578	Keratoconus	0.2	0	0	HPO
10594	PRPF8	C0028077	Night Blindness	0.2	0	0	HPO
10594	PRPF8	C0028738	Nystagmus	0.2	0	0	HPO
10594	PRPF8	C0028754	Obesity	0.2	0	0	HPO
10594	PRPF8	C0029124	Optic Atrophy	0.2	0	0	HPO
10594	PRPF8	C0035334	Retinitis Pigmentosa	0.414228371269812	0	0	HPO;ORPHANET
10594	PRPF8	C0271215	Blindness, Legal	0.2	0	0	HPO
10594	PRPF8	C1838702	Retinitis Pigmentosa 13	0.480549453568426	2	5	CTD_human;UNIPROT
10599	SLCO1B1	C0220991	Rotor Syndrome	0.200824180352639	0	0	ORPHANET
10599	SLCO1B1	C0268307	Conjugated hyperbilirubinemia	0.200274726784213	0	0	HPO
10610	ST6GALNAC2	C0017661	IGA Glomerulonephritis	0.205638237399215	1	0	CTD_human
10611	PDLIM5	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
10616	RBCK1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10616	RBCK1	C4014605	POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY	0.4	1	8	ORPHANET;UNIPROT
10617	STAMBP	C0014544	Epilepsy	0.4	1	0	CTD_human;HPO
10617	STAMBP	C0029124	Optic Atrophy	0.2	0	0	HPO
10617	STAMBP	C0162770	Right Ventricular Hypertrophy	0.2	0	0	HPO
10617	STAMBP	C0235946	Cerebral atrophy	0.2	0	0	HPO
10617	STAMBP	C0575059	Spastic tetraparesis	0.2	0	0	HPO
10617	STAMBP	C1842180	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION (disorder)	0.2	1	0	CTD_human
10617	STAMBP	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10617	STAMBP	C3280296	Microcephaly-capillary malformation syndrome	0.400274726784213	1	11	ORPHANET;UNIPROT
10617	STAMBP	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1062	CENPE	C0010278	Craniosynostosis	0.2	0	0	HPO
1062	CENPE	C0014544	Epilepsy	0.2	0	0	HPO
1062	CENPE	C0017601	Glaucoma	0.2	0	0	HPO
1062	CENPE	C0265202	Seckel syndrome	0.200274726784213	0	0	ORPHANET
1062	CENPE	C1857278	Partial or complete agenesis of corpus callosum	0.2	0	0	HPO
1062	CENPE	C4015080	MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE	0.2	1	2	UNIPROT
10628	TXNIP	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
10628	TXNIP	C0011881	Diabetic Nephropathy	0.201373633921065	1	0	CTD_human
10628	TXNIP	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
1063	CENPF	C0020255	Hydrocephalus	0.2	0	0	HPO
10631	POSTN	C0006287	Bronchopulmonary Dysplasia	0.2	1	0	CTD_human
10631	POSTN	C0013264	Muscular Dystrophy, Duchenne	0.2	1	0	CTD_human
10631	POSTN	C1319853	Asthma, Aspirin-Induced	0.2	1	0	CTD_human
10644	IGF2BP2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.292087978505376	0	0	CTD_human
10653	SPINT2	C0267557	Secretory diarrhea	0.2	0	0	HPO
10653	SPINT2	C0392163	Corneal erosion	0.2	0	0	HPO
10654	PMVK	C0870082	Hyperkeratosis	0.2	0	0	HPO
10654	PMVK	C0949506	Porokeratosis of Mibelli	0.4	0	0	HPO;ORPHANET
10659	CELF2	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
1066	CES1	C0020443	Hypercholesterolemia	0.2	1	0	CTD_human
1066	CES1	C0028754	Obesity	0.201098907136852	1	0	CTD_human
10661	KLF1	C0002871	Anemia	0.201373633921065	0	0	HPO
10661	KLF1	C0014800	Erythroid hyperplasia	0.2	0	0	HPO
10661	KLF1	C0019025	Hemoglobin F Disease	0.200549453568426	0	0	ORPHANET
10661	KLF1	C0020305	Hydrops Fetalis	0.200274726784213	0	0	HPO
10661	KLF1	C0678199	Dyserythropoietic anemia	0.2	0	0	HPO
10661	KLF1	C3150926	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV	0.400274726784213	1	3	ORPHANET;UNIPROT
10664	CTCF	C0020490	Hyperopia	0.2	0	0	HPO
10664	CTCF	C0038379	Strabismus	0.2	0	0	HPO
10664	CTCF	C3809686	MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.4	1	3	ORPHANET;UNIPROT
10666	CD226	C0014175	Endometriosis	0.2	1	0	CTD_human
10666	CD226	C0024141	Lupus Erythematosus, Systemic	0.20350593566014	1	0	CTD_human
10667	FARS2	C0014544	Epilepsy	0.200549453568426	0	0	HPO
10667	FARS2	C0235946	Cerebral atrophy	0.2	0	0	HPO
10667	FARS2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
10667	FARS2	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
10667	FARS2	C3554168	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	0.400274726784213	2	4	ORPHANET;UNIPROT
10667	FARS2	C4020860	Supratentorial atrophy	0.2	0	0	HPO
10667	FARS2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
10674	DURS1	C0013261	Duane Retraction Syndrome	0.200274726784213	0	0	CTD_human
10678	B3GNT2	C0003873	Rheumatoid Arthritis	0.200824180352639	1	0	CTD_human
10678	B3GNT2	C0018213	Graves Disease	0.200549453568426	1	0	CTD_human
10682	EBP	C0002170	Alopecia	0.200274726784213	0	0	HPO
10682	EBP	C0010964	Dandy-Walker Syndrome	0.200274726784213	0	0	HPO
10682	EBP	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
10682	EBP	C0017601	Glaucoma	0.2	0	0	HPO
10682	EBP	C0020295	Hydronephrosis	0.2	0	0	HPO
10682	EBP	C0028738	Nystagmus	0.2	0	0	HPO
10682	EBP	C0029124	Optic Atrophy	0.2	0	0	HPO
10682	EBP	C0040583	Tracheal Stenosis	0.2	0	0	HPO
10682	EBP	C0079583	Ichthyosiform Erythroderma, Congenital	0.200274726784213	0	0	HPO
10682	EBP	C0263627	Calcinosis universalis	0.200274726784213	0	0	ORPHANET
10682	EBP	C0264324	Calcification of trachea	0.2	0	0	HPO
10682	EBP	C0282102	Chondrodysplasia punctata, X-linked dominant type	0.486593442821114	6	36	ORPHANET;UNIPROT
10682	EBP	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10682	EBP	C4085243	MEND SYNDROME	0.400549453568426	4	4	ORPHANET;UNIPROT
10683	DLL3	C0265343	Jarcho-Levin syndrome	0.681923087489492	1	8	CTD_human;ORPHANET;UNIPROT
10686	CLDN16	C0004106	Astigmatism	0.2	0	0	HPO
10686	CLDN16	C0014544	Epilepsy	0.2	0	0	HPO
10686	CLDN16	C0020490	Hyperopia	0.2	0	0	HPO
10686	CLDN16	C0027092	Myopia	0.2	0	0	HPO
10686	CLDN16	C0027709	Nephrocalcinosis	0.208227448149076	0	0	HPO
10686	CLDN16	C0028738	Nystagmus	0.2	0	0	HPO
10686	CLDN16	C0038379	Strabismus	0.2	0	0	HPO
10686	CLDN16	C0039621	Tetany	0.2	0	0	HPO
10686	CLDN16	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
10686	CLDN16	C0268448	Primary hypomagnesemia (disorder)	0.68	3	15	CTD_human;ORPHANET;UNIPROT
10686	CLDN16	C0392525	Nephrolithiasis	0.200549453568426	0	0	HPO
10686	CLDN16	C0740394	Hyperuricemia	0.2	0	0	HPO
10686	CLDN16	C1835171	Hypomagnesemia 2, renal	0.200549453568426	0	0	HPO
10686	CLDN16	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10699	CORIN	C0013537	Eclampsia	0.200549453568426	0	0	HPO
10699	CORIN	C3281288	PREECLAMPSIA/ECLAMPSIA 5	0.2	1	2	UNIPROT
107	ADCY1	C4021806	Prelingual sensorineural hearing impairment	0.2	0	0	HPO
1071	CETP	C0020443	Hypercholesterolemia	0.235137545781727	0	0	HPO
1071	CETP	C0020445	Hypercholesterolemia, Familial	0.212752423034121	1	0	CTD_human
1071	CETP	C0020473	Hyperlipidemia	0.41554107827658	1	0	CTD_human;HPO
1071	CETP	C0020476	Hyperlipoproteinemias	0.207495812354077	2	0	CTD_human
1071	CETP	C0342883	Cholesteryl Ester Transfer Protein Deficiency	0.210439617800098	0	0	HPO
1071	CETP	C0542037	Hypotriglyceridaemia	0.2	0	0	HPO
1071	CETP	C2362324	Pediatric Obesity	0.2	1	0	CTD_human
1071	CETP	C3149462	HYPERALPHALIPOPROTEINEMIA 1	0.607417623173754	2	2	CTD_human;ORPHANET;UNIPROT
10715	CERS1	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
10715	CERS1	C4015619	EPILEPSY, PROGRESSIVE MYOCLONIC, 8	0.4	1	1	ORPHANET;UNIPROT
10716	TBR1	C0014544	Epilepsy	0.2	0	0	HPO
10716	TBR1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
10716	TBR1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10717	AP4B1	C0014544	Epilepsy	0.2	0	0	HPO
10717	AP4B1	C0037772	Spastic Paraplegia	0.200274726784213	0	0	HPO
10717	AP4B1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
10717	AP4B1	C4020871	Dystonic disease	0.2	0	0	HPO
1073	CFL2	C1837658	Gross motor development delay	0.2	0	0	HPO
1073	CFL2	C1850674	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA (disorder)	0.2	0	0	HPO
1073	CFL2	C1853154	Nemaline Myopathy 7	0.4	2	2	CTD_human;UNIPROT
107305681	DHS6S1	C0730294	North Carolina macular dystrophy	0.2	0	0	ORPHANET
10733	PLK4	C0010278	Craniosynostosis	0.2	0	0	HPO
10733	PLK4	C0017601	Glaucoma	0.2	0	0	HPO
10733	PLK4	C0042798	Low Vision	0.2	0	0	HPO
10733	PLK4	C0235946	Cerebral atrophy	0.2	0	0	HPO
10733	PLK4	C0262404	Cerebellar degeneration	0.2	0	0	HPO
10733	PLK4	C0265202	Seckel syndrome	0.2	0	0	ORPHANET
10733	PLK4	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
10733	PLK4	C4020860	Supratentorial atrophy	0.2	0	0	HPO
10733	PLK4	C4020873	Infratentorial atrophy	0.2	0	0	HPO
10734	STAG3	C0025322	Premature Menopause	0.2	0	0	HPO
10734	STAG3	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
10736	SIX2	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
10743	RAI1	C0014306	Enophthalmos	0.2	0	0	HPO
10743	RAI1	C0014544	Epilepsy	0.2	0	0	HPO
10743	RAI1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
10743	RAI1	C0018777	Conductive hearing loss	0.2	0	0	HPO
10743	RAI1	C0020443	Hypercholesterolemia	0.2	0	0	HPO
10743	RAI1	C0027092	Myopia	0.2	0	0	HPO
10743	RAI1	C0028754	Obesity	0.401098907136852	2	0	CTD_human;HPO
10743	RAI1	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
10743	RAI1	C0038379	Strabismus	0.2	0	0	HPO
10743	RAI1	C0042454	Velopharyngeal Insufficiency	0.2	0	0	HPO
10743	RAI1	C0264142	Spade-like hand	0.2	0	0	HPO
10743	RAI1	C0264611	Apraxia of Phonation	0.2	0	0	HPO
10743	RAI1	C0266039	Taurodontism	0.2	0	0	HPO
10743	RAI1	C0267071	Oropharyngeal Dysphagia	0.2	0	0	HPO
10743	RAI1	C0271441	Chronic otitis media	0.2	0	0	HPO
10743	RAI1	C0700201	Dyssomnias	0.200549453568426	1	0	CTD_human
10743	RAI1	C0743359	ear infection chronic	0.2	0	0	HPO
10743	RAI1	C0795864	Smith-Magenis syndrome	0.489890164231672	12	8	CTD_human;ORPHANET
10743	RAI1	C1970482	Potocki-Lupski syndrome	0.281923087489492	1	0	CTD_human
10743	RAI1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
10743	RAI1	C4020884	Anxiety disease	0.2	0	0	HPO
10747	MASP2	C0009324	Ulcerative Colitis	0.2	1	0	CTD_human
10747	MASP2	C0014742	Erythema Multiforme	0.2	1	0	CTD_human
10747	MASP2	C0155862	Streptococcal pneumonia	0.202407028523288	1	0	CTD_human
10747	MASP2	C3151085	MASP2 Deficiency	0.6	1	2	CTD_human;ORPHANET;UNIPROT
10749	KIF1C	C0271385	Horizontal Nystagmus	0.2	0	0	HPO
10749	KIF1C	C1848736	Distal amyotrophy	0.2	0	0	HPO
10749	KIF1C	C1849156	Spastic Ataxia	0.200274726784213	0	0	HPO
10749	KIF1C	C1969796	ATAXIA, SPASTIC, 2, AUTOSOMAL RECESSIVE (disorder)	0.4	1	5	ORPHANET;UNIPROT
1075	CTSC	C0017574	Gingivitis	0.200274726784213	0	0	HPO
1075	CTSC	C0022596	Palmoplantar Keratosis	0.201373633921065	0	0	HPO
1075	CTSC	C0030360	Papillon-Lefevre Disease	0.635324912144952	15	18	CTD_human;ORPHANET;UNIPROT
1075	CTSC	C0031106	Periodontitis, Juvenile	0.405205453522732	1	3	CTD_human;UNIPROT
1075	CTSC	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
1075	CTSC	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
1075	CTSC	C0221260	Dystrophia unguium	0.2	0	0	HPO
1075	CTSC	C0263537	Onychogryposis	0.2	0	0	HPO
1075	CTSC	C0399385	Early tooth exfoliation	0.2	0	0	HPO
1075	CTSC	C0917990	Acro-Osteolysis	0.2	0	0	HPO
1075	CTSC	C1855627	HAIM-MUNK SYNDROME	0.601373633921066	2	1	CTD_human;ORPHANET;UNIPROT
1075	CTSC	C4023521	Chronic furunculosis	0.2	0	0	HPO
1075	CTSC	C4025886	Severe periodontitis	0.200274726784213	0	0	HPO
10752	CHL1	C0015923	Fetal Alcohol Syndrome	0.200274726784213	1	0	PSYGENET
10758	TRAF3IP2	C0003872	Arthritis, Psoriatic	0.204604842796993	2	1	CTD_human
10758	TRAF3IP2	C0005741	Blepharitis	0.2	0	0	HPO
10758	TRAF3IP2	C0006845	Candidiasis, Chronic Mucocutaneous	0.200274726784213	0	0	ORPHANET
10758	TRAF3IP2	C0007971	Cheilitis	0.2	0	0	HPO
10758	TRAF3IP2	C0024421	Macroglossia	0.2	0	0	HPO
10758	TRAF3IP2	C0033860	Psoriasis	0.207561324888707	3	3	CTD_human
10758	TRAF3IP2	C0040261	Onychomycosis	0.2	0	0	HPO
10758	TRAF3IP2	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
10758	TRAF3IP2	C0870082	Hyperkeratosis	0.2	0	0	HPO
10758	TRAF3IP2	C3714992	CANDIDIASIS, FAMILIAL, 8	0.2	1	1	UNIPROT
10763	NES	C0014549	Tonic-Clonic Epilepsy	0.2	1	0	CTD_human
10763	NES	C0027720	Nephrosis	0.2	1	0	CTD_human
10766	TOB2	C0042900	Vitiligo	0.2	1	0	CTD_human
10769	PLK2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
10772	SRSF10	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
10774	DHS	C1863769	Dehydrated Hereditary Stomatocytosis, Pseudohyperkalemia, and Perinatal Edema	0.2	0	0	CTD_human
108	ADCY2	C0004096	Asthma	0.2	1	0	CTD_human
1080	CFTR	C0004096	Asthma	0.225784158472789	0	0	HPO
1080	CFTR	C0004509	Azoospermia	0.418563072902925	1	0	CTD_human;HPO
1080	CFTR	C0006267	Bronchiectasis	0.2121661676857	0	0	HPO
1080	CFTR	C0008312	Primary biliary cirrhosis	0.200274726784213	0	0	HPO
1080	CFTR	C0010674	Cystic Fibrosis	1	52	416	CTD_human;ORPHANET;UNIPROT
1080	CFTR	C0023892	Biliary cirrhosis	0.202407028523288	0	0	HPO
1080	CFTR	C0030293	Pancreatic Insufficiency	0.205219808900049	0	0	HPO
1080	CFTR	C0030305	Pancreatitis	0.305938564295626	2	0	CTD_human
1080	CFTR	C0034069	Pulmonary Fibrosis	0.200274726784213	0	0	HPO
1080	CFTR	C0034072	Cor pulmonale	0.200274726784213	0	0	HPO
1080	CFTR	C0034888	Rectal Prolapse	0.2	0	0	HPO
1080	CFTR	C0035455	Rhinitis	0.207221085569864	1	0	CTD_human
1080	CFTR	C0037199	Sinusitis	0.208319992706716	1	0	CTD_human
1080	CFTR	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
1080	CFTR	C0149521	Pancreatitis, Chronic	0.251485542144921	1	0	CTD_human
1080	CFTR	C0238339	Hereditary pancreatitis	0.401098907136852	0	0	CTD_human;ORPHANET
1080	CFTR	C0267963	Exocrine pancreatic insufficiency	0.224750763870566	0	0	HPO
1080	CFTR	C0339985	Idiopathic bronchiectasis	0.200549453568426	0	0	ORPHANET
1080	CFTR	C0398349	Distal intestinal obstruction syndrome	0.200274726784213	0	0	HPO
1080	CFTR	C0694550	Recurrent pneumonia	0.2	0	0	HPO
1080	CFTR	C0746102	Chronic lung disease	0.201098907136852	0	0	HPO
1080	CFTR	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
1080	CFTR	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
1080	CFTR	C2749757	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	0.2	0	0	CTD_human
1080	CFTR	C2939175	Meconium ileus	0.202472541057918	0	0	HPO
1080	CFTR	C3714497	Reactive airway disease	0.2	0	0	HPO
1080	CFTR	C4021107	Non-obstructive azoospermia	0.200274726784213	0	0	HPO
1080	CFTR	C4023106	Obstructive azoospermia	0.204670355331623	0	0	HPO
10800	CYSLTR1	C1319853	Asthma, Aspirin-Induced	0.200549453568426	3	0	CTD_human
10801	SEPT9	C0014306	Enophthalmos	0.2	0	0	HPO
10801	SEPT9	C0152025	Polyneuropathy	0.2	0	0	HPO
10801	SEPT9	C0221759	Brachial Plexus Neuritis	0.400274726784213	1	0	CTD_human;ORPHANET
10801	SEPT9	C0234958	muscle degeneration	0.2	0	0	HPO
10801	SEPT9	C1834304	AMYOTROPHY, HEREDITARY NEURALGIC	0.204120901763196	1	3	UNIPROT
10803	CCR9	C0032285	Pneumonia	0.2	1	0	CTD_human
10803	CCR9	C0038220	Status Epilepticus	0.2	1	0	CTD_human
10804	GJB6	C0002170	Alopecia	0.200274726784213	0	0	HPO
10804	GJB6	C0005741	Blepharitis	0.2	0	0	HPO
10804	GJB6	C0009763	Conjunctivitis	0.2	0	0	HPO
10804	GJB6	C0018777	Conductive hearing loss	0.2	0	0	HPO
10804	GJB6	C0018784	Sensorineural Hearing Loss (disorder)	0.221295985367738	0	0	HPO
10804	GJB6	C0020620	Hypohidrosis	0.2	0	0	HPO
10804	GJB6	C0020757	Ichthyoses	0.2	0	0	HPO
10804	GJB6	C0022568	Keratitis	0.200274726784213	0	0	HPO
10804	GJB6	C0022596	Palmoplantar Keratosis	0.200824180352639	0	0	HPO
10804	GJB6	C0038379	Strabismus	0.2	0	0	HPO
10804	GJB6	C0040412	Fissured tongue	0.2	0	0	HPO
10804	GJB6	C0042798	Low Vision	0.2	0	0	HPO
10804	GJB6	C0085109	Corneal Neovascularization	0.2	0	0	HPO
10804	GJB6	C0085661	Onycholysis	0.2	0	0	HPO
10804	GJB6	C0162361	Hidrotic Ectodermal Dysplasia	0.483296721410557	2	4	ORPHANET;UNIPROT
10804	GJB6	C0221260	Dystrophia unguium	0.2	0	0	HPO
10804	GJB6	C0263490	Brittle hair	0.2	0	0	HPO
10804	GJB6	C0263504	Alopecia totalis	0.2	0	0	HPO
10804	GJB6	C0263537	Onychogryposis	0.2	0	0	HPO
10804	GJB6	C0265336	Senter syndrome	0.200549453568426	0	0	ORPHANET
10804	GJB6	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
10804	GJB6	C1834405	Nail dysplasia	0.2	0	0	HPO
10804	GJB6	C1843156	Hearing loss, progressive sensorineural	0.200274726784213	0	0	HPO
10804	GJB6	C2673759	DEAFNESS, AUTOSOMAL RECESSIVE 1A (disorder)	0.28	0	0	CTD_human
10804	GJB6	C2675235	Deafness, Autosomal Recessive 1b	0.2	0	0	CTD_human
10804	GJB6	C2675237	Deafness, Autosomal Dominant 3B	0.4	1	1	CTD_human;UNIPROT
10804	GJB6	C2675750	DEAFNESS, AUTOSOMAL DOMINANT 3A (disorder)	0.2	0	0	CTD_human
10804	GJB6	C3665333	Keratitis-Ichthyosis-Deafness Syndrome	0.200549453568426	0	0	ORPHANET
10804	GJB6	C4021534	Adult onset sensorineural hearing impairment	0.2	0	0	HPO
10806	SDCCAG8	C0004096	Asthma	0.2	0	0	HPO
10806	SDCCAG8	C0006271	Bronchiolitis	0.2	0	0	HPO
10806	SDCCAG8	C0020619	Hypogonadism	0.2	0	0	HPO
10806	SDCCAG8	C0022679	Cystic kidney	0.2	0	0	HPO
10806	SDCCAG8	C0025322	Premature Menopause	0.2	0	0	HPO
10806	SDCCAG8	C0028738	Nystagmus	0.2	0	0	HPO
10806	SDCCAG8	C0028754	Obesity	0.203231208875927	0	0	HPO
10806	SDCCAG8	C0035078	Kidney Failure	0.2	0	0	HPO
10806	SDCCAG8	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
10806	SDCCAG8	C0038379	Strabismus	0.2	0	0	HPO
10806	SDCCAG8	C0042798	Low Vision	0.2	0	0	HPO
10806	SDCCAG8	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
10806	SDCCAG8	C0162283	Nephrogenic Diabetes Insipidus	0.2	0	0	HPO
10806	SDCCAG8	C0239946	Fibrosis, Liver	0.2	0	0	HPO
10806	SDCCAG8	C0403553	Renal dysplasia and retinal aplasia (disorder)	0.200274726784213	0	0	ORPHANET
10806	SDCCAG8	C0687120	Nephronophthisis	0.2	0	0	HPO
10806	SDCCAG8	C0747085	Recurrent otitis media	0.2	0	0	HPO
10806	SDCCAG8	C0752166	Bardet-Biedl Syndrome	0.200549453568426	0	0	ORPHANET
10806	SDCCAG8	C1565489	Renal Insufficiency	0.2	0	0	HPO
10806	SDCCAG8	C2316810	Chronic kidney disease stage 5	0.200274726784213	0	0	HPO
10806	SDCCAG8	C3714497	Reactive airway disease	0.2	0	0	HPO
10806	SDCCAG8	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
1081	CGA	C0028960	Oligospermia	0.2	1	0	CTD_human
10810	WASF3	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
10815	CPLX1	C0014544	Epilepsy	0.2	0	0	HPO
10815	CPLX1	C0015300	Exophthalmos	0.2	0	0	HPO
10815	CPLX1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
10815	CPLX1	C0028738	Nystagmus	0.2	0	0	HPO
10815	CPLX1	C0034013	Precocious Puberty	0.2	0	0	HPO
10815	CPLX1	C0038379	Strabismus	0.2	0	0	HPO
10815	CPLX1	C0265341	Rieger syndrome	0.2	0	0	HPO
10815	CPLX1	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
10815	CPLX1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1082	CGB3	C0015951	Fetal Resorption	0.2	1	0	CTD_human
1082	CGB3	C0020619	Hypogonadism	0.2	2	0	CTD_human
10826	FAXDC2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
1083	CGF1	C1848140	COGNITIVE FUNCTION 1, SOCIAL	0.2	0	0	CTD_human
10840	ALDH1L1	C0028754	Obesity	0.2	1	0	CTD_human
10841	FTCD	C0002888	Anemia, Megaloblastic	0.200274726784213	0	0	HPO
10841	FTCD	C0238621	Aminoaciduria	0.2	0	0	HPO
10841	FTCD	C0268609	Glutamate formiminotransferase deficiency	0.600274726784213	1	6	CTD_human;ORPHANET;UNIPROT
10842	PPP1R17	C0745103	Hyperlipoproteinemia Type IIa	0.2	0	0	CTD_human
10847	SRCAP	C0007570	Celiac Disease	0.2	0	0	HPO
10847	SRCAP	C0014306	Enophthalmos	0.2	0	0	HPO
10847	SRCAP	C0729582	Floating-harbor syndrome	0.201648360705279	0	0	ORPHANET
10847	SRCAP	C0747085	Recurrent otitis media	0.2	0	0	HPO
10850	CCL27	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
10855	HPSE	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
10855	HPSE	C0027720	Nephrosis	0.2	1	0	CTD_human
10858	CYP46A1	C0002395	Alzheimer's Disease	0.262723536431733	1	0	CTD_human
10861	SLC26A1	C0020500	Hyperoxaluria	0.400549453568426	1	0	CTD_human;HPO
10861	SLC26A1	C0027709	Nephrocalcinosis	0.2	1	0	CTD_human
10861	SLC26A1	C0451641	Urolithiasis	0.200274726784213	2	0	CTD_human
10861	SLC26A1	C1833683	NEPHROLITHIASIS, CALCIUM OXALATE	0.400274726784213	1	2	HPO;UNIPROT
10875	FGL2	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
10878	CFHR3	C0017661	IGA Glomerulonephritis	0.200549453568426	1	0	CTD_human
10878	CFHR3	C1864205	Macular Degeneration, Age-Related, 1	0.2	0	0	CTD_human
10878	CFHR3	C2931788	Atypical Hemolytic Uremic Syndrome	0.204604842796993	0	0	CTD_human
10891	PPARGC1A	C0002736	Amyotrophic Lateral Sclerosis	0.401648360705279	0	0	HPO;ORPHANET
10891	PPARGC1A	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.372302712726192	2	0	CTD_human
10891	PPARGC1A	C0018801	Heart failure	0.201373633921065	2	0	CTD_human
10891	PPARGC1A	C0026851	Muscular Dystrophy, Animal	0.2	1	0	CTD_human
10891	PPARGC1A	C0027051	Myocardial Infarction	0.28	1	0	CTD_human
10891	PPARGC1A	C0234958	muscle degeneration	0.2	0	0	HPO
10891	PPARGC1A	C1145670	Respiratory Failure	0.2	0	0	HPO
10891	PPARGC1A	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	0.2	1	0	CTD_human
10891	PPARGC1A	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
10891	PPARGC1A	C4020884	Anxiety disease	0.2	0	0	HPO
10892	MALT1	C0002871	Anemia	0.2	0	0	HPO
10892	MALT1	C3809583	IMMUNODEFICIENCY 12	0.4	1	2	ORPHANET;UNIPROT
109	ADCY3	C0011875	Diabetic Angiopathies	0.2	1	0	CTD_human
10902	BRD8	C0014175	Endometriosis	0.2	1	0	CTD_human
10907	TXNL4A	C0018777	Conductive hearing loss	0.2	0	0	HPO
10907	TXNL4A	C1837822	Burn-Mckeown syndrome	0.200549453568426	0	0	ORPHANET
10908	PNPLA6	C0018418	Gynecomastia	0.2	0	0	HPO
10908	PNPLA6	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
10908	PNPLA6	C0023138	Laurence-Moon Syndrome	0.4	1	1	ORPHANET;UNIPROT
10908	PNPLA6	C0028738	Nystagmus	0.2	0	0	HPO
10908	PNPLA6	C0028754	Obesity	0.2	0	0	HPO
10908	PNPLA6	C0029124	Optic Atrophy	0.2	0	0	HPO
10908	PNPLA6	C0035078	Kidney Failure	0.2	0	0	HPO
10908	PNPLA6	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	HPO
10908	PNPLA6	C0037050	Sick Building Syndrome	0.200274726784213	1	0	CTD_human
10908	PNPLA6	C0037772	Spastic Paraplegia	0.200824180352639	0	0	HPO
10908	PNPLA6	C0037773	Spastic Paraplegia, Hereditary	0.201648360705279	1	0	CTD_human
10908	PNPLA6	C0085084	Motor Neuron Disease	0.203831819601666	2	0	CTD_human
10908	PNPLA6	C0087012	Ataxia, Spinocerebellar	0.2	0	0	HPO
10908	PNPLA6	C0152025	Polyneuropathy	0.2	1	0	CTD_human
10908	PNPLA6	C0262404	Cerebellar degeneration	0.2	0	0	HPO
10908	PNPLA6	C0270921	Axonal neuropathy	0.2	0	0	HPO
10908	PNPLA6	C0271623	Hypogonadotropic hypogonadism	0.200274726784213	0	0	HPO
10908	PNPLA6	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
10908	PNPLA6	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
10908	PNPLA6	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
10908	PNPLA6	C1389102	Atrophic spinal cord	0.2	0	0	HPO
10908	PNPLA6	C1565489	Renal Insufficiency	0.2	0	0	HPO
10908	PNPLA6	C1848736	Distal amyotrophy	0.2	0	0	HPO
10908	PNPLA6	C1848745	Oliver-McFarlane syndrome	0.400549453568426	1	3	ORPHANET;UNIPROT
10908	PNPLA6	C1857627	Chorioretinal dystrophy	0.200274726784213	0	0	HPO
10908	PNPLA6	C1859093	Chorioretinal Dystrophy, Spinocerebellar Ataxia, and Hypogonadotropic Hypogonadism	0.401373633921066	2	7	ORPHANET;UNIPROT
10908	PNPLA6	C1859305	Cerebellar Ataxia and Hypogonadotropic Hypogonadism	0.200549453568426	0	0	ORPHANET
10908	PNPLA6	C2677586	Spastic Paraplegia 39, Autosomal Recessive	0.601098907136852	2	5	CTD_human;ORPHANET;UNIPROT
10908	PNPLA6	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
10908	PNPLA6	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
10908	PNPLA6	C4020873	Infratentorial atrophy	0.2	0	0	HPO
10911	UTS2	C0043049	Water Intoxication	0.2	1	0	CTD_human
10913	EDAR	C0002170	Alopecia	0.2	0	0	HPO
10913	EDAR	C0003028	Anhidrosis	0.2	0	0	HPO
10913	EDAR	C0020620	Hypohidrosis	0.2	0	0	HPO
10913	EDAR	C0162359	Christ-Siemens-Touraine syndrome	0.203846174978983	0	0	HPO
10913	EDAR	C0259817	Xerosis	0.2	0	0	HPO
10913	EDAR	C0265331	Autosomal dominant hypohidrotic ectodermal dysplasia syndrome (disorder)	0.2	0	0	ORPHANET
10913	EDAR	C1834405	Nail dysplasia	0.2	0	0	HPO
10913	EDAR	C3887494	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	0.282197814273705	9	10	UNIPROT
10913	EDAR	C3888065	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT	0.202197814273705	6	1	UNIPROT
10916	MAGED2	C1866495	Bartter syndrome, antenatal type 1	0.2	0	0	ORPHANET
10919	EHMT2	C0266999	Vesicular Stomatitis	0.2	1	0	CTD_human
10924	SMPDL3A	C0014175	Endometriosis	0.2	1	0	CTD_human
10928	RALBP1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
10935	PRDX3	C0029456	Osteoporosis	0.2	1	0	CTD_human
10935	PRDX3	C0085084	Motor Neuron Disease	0.200274726784213	1	0	CTD_human
10939	AFG3L2	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
10939	AFG3L2	C0087012	Ataxia, Spinocerebellar	0.200274726784213	1	0	CTD_human
10939	AFG3L2	C0234958	muscle degeneration	0.2	0	0	HPO
10939	AFG3L2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
10939	AFG3L2	C0271390	Nystagmus, End-Position	0.2	0	0	HPO
10939	AFG3L2	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
10939	AFG3L2	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
10939	AFG3L2	C0751778	Myoclonic Epilepsies, Progressive	0.4	1	0	CTD_human;HPO
10939	AFG3L2	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
10939	AFG3L2	C1849156	Spastic Ataxia	0.200549453568426	0	0	HPO
10939	AFG3L2	C1853249	SPINOCEREBELLAR ATAXIA 28	0.681648360705279	5	11	CTD_human;ORPHANET;UNIPROT
10939	AFG3L2	C3280977	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.4	1	3	ORPHANET;UNIPROT
10939	AFG3L2	C3489733	Oculomotor apraxia	0.2	0	0	HPO
10939	AFG3L2	C4020871	Dystonic disease	0.2	0	0	HPO
10939	AFG3L2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
10939	AFG3L2	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
10940	POP1	C1846796	Anauxetic dysplasia	0.200274726784213	0	0	ORPHANET
10950	BTG3	C3495559	Juvenile arthritis	0.200274726784213	1	0	CTD_human
10959	TMED2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
10964	IFI44L	C0021400	Influenza	0.2	1	0	CTD_human
10965	ACOT2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
10971	YWHAQ	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
10978	CLP1	C0014877	Esotropia	0.2	0	0	HPO
10978	CLP1	C0015300	Exophthalmos	0.2	0	0	HPO
10978	CLP1	C0028738	Nystagmus	0.2	0	0	HPO
10978	CLP1	C0235946	Cerebral atrophy	0.2	0	0	HPO
10978	CLP1	C4014347	PONTOCEREBELLAR HYPOPLASIA, TYPE 10	0.48	1	1	ORPHANET;UNIPROT
10979	FERMT2	C0017605	Angle Closure Glaucoma	0.2	1	0	CTD_human
10981	RAB32	C0023343	Leprosy	0.200549453568426	1	0	CTD_human
10981	RAB32	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
10982	MAPRE2	C0473586	Michelin tire baby syndrome	0.200274726784213	0	0	ORPHANET
10984	KCNQ1OT1	C0004903	Beckwith-Wiedemann Syndrome	0.229584360431111	0	0	CTD_human
10984	KCNQ1OT1	C0015300	Exophthalmos	0.2	0	0	HPO
10984	KCNQ1OT1	C0024421	Macroglossia	0.2	0	0	HPO
10984	KCNQ1OT1	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
10986	IGAD1	C2931161	Immunoglobulin a deficiency 1	0.2	0	0	CTD_human
10987	COPS5	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
10989	IMMT	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
10999	SLC27A4	C0014457	Eosinophilia	0.2	0	0	HPO
10999	SLC27A4	C0020757	Ichthyoses	0.200549453568426	0	0	HPO
10999	SLC27A4	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
10999	SLC27A4	C1837610	ICHTHYOSIS PREMATURITY SYNDROME	0.681373633921066	2	6	CTD_human;ORPHANET;UNIPROT
11004	KIF2C	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
11005	SPINK5	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
11005	SPINK5	C0004096	Asthma	0.222278222812648	0	0	HPO
11005	SPINK5	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
11005	SPINK5	C0013595	Eczema	0.207352110639124	0	0	HPO
11005	SPINK5	C0014544	Epilepsy	0.2	0	0	HPO
11005	SPINK5	C0034067	Pulmonary Emphysema	0.2	0	0	HPO
11005	SPINK5	C0042109	Urticaria	0.2	0	0	HPO
11005	SPINK5	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
11005	SPINK5	C0263485	Clastothrix	0.2	0	0	HPO
11005	SPINK5	C0263490	Brittle hair	0.2	0	0	HPO
11005	SPINK5	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
11005	SPINK5	C1840253	IgE RESPONSIVENESS, ATOPIC	0.2	0	0	CTD_human
11005	SPINK5	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
11005	SPINK5	C3714497	Reactive airway disease	0.2	0	0	HPO
11019	LIAS	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
11019	LIAS	C0014544	Epilepsy	0.200274726784213	0	0	HPO
11019	LIAS	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
11019	LIAS	C3280887	HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.4	1	3	ORPHANET;UNIPROT
11019	LIAS	C3553450	Profound global developmental delay	0.2	0	0	HPO
11020	IFT27	C0020619	Hypogonadism	0.2	0	0	HPO
11020	IFT27	C0028738	Nystagmus	0.2	0	0	HPO
11020	IFT27	C0028754	Obesity	0.2	0	0	HPO
11020	IFT27	C0035078	Kidney Failure	0.2	0	0	HPO
11020	IFT27	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
11020	IFT27	C0752166	Bardet-Biedl Syndrome	0.200274726784213	0	0	ORPHANET
11020	IFT27	C1565489	Renal Insufficiency	0.2	0	0	HPO
11020	IFT27	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
11020	IFT27	C3889475	BARDET-BIEDL SYNDROME 19	0.2	1	1	UNIPROT
11023	VAX1	C3553077	MICROPHTHALMIA, SYNDROMIC 11	0.2	1	1	UNIPROT
1103	CHAT	C0003886	Arthrogryposis	0.2	0	0	HPO
1103	CHAT	C0017605	Angle Closure Glaucoma	0.2	1	0	CTD_human
1103	CHAT	C0038379	Strabismus	0.2	0	0	HPO
1103	CHAT	C0393929	Familial infantile myasthenia	0.480274726784213	2	17	CTD_human;UNIPROT
1103	CHAT	C0751884	Congenital Myasthenic Syndromes, Presynaptic	0.2	0	0	ORPHANET
1103	CHAT	C0947912	Myasthenias	0.200274726784213	0	0	HPO
1103	CHAT	C1301959	Bulbar weakness	0.2	0	0	HPO
1103	CHAT	C4025671	Sudden episodic apnea	0.2	0	0	HPO
1103	CHAT	C4082299	Bulbar palsy	0.2	0	0	HPO
11041	B4GAT1	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
11041	B4GAT1	C0014544	Epilepsy	0.2	0	0	HPO
11041	B4GAT1	C0020255	Hydrocephalus	0.2	0	0	HPO
11041	B4GAT1	C0026850	Muscular Dystrophy	0.200274726784213	0	0	HPO
11041	B4GAT1	C0265221	Walker-Warburg congenital muscular dystrophy	0.200274726784213	0	0	ORPHANET
11041	B4GAT1	C3809042	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13	0.2	1	2	UNIPROT
11043	MID2	C0038379	Strabismus	0.2	0	0	HPO
11043	MID2	C3890168	MENTAL RETARDATION, X-LINKED 101	0.2	1	1	UNIPROT
1106	CHD2	C0009952	Febrile Convulsions	0.2	0	0	HPO
1106	CHD2	C0014544	Epilepsy	0.202197814273705	1	0	CTD_human
1106	CHD2	C0014550	Epilepsies, Myoclonic	0.200274726784213	0	0	HPO
1106	CHD2	C0014553	Absence Epilepsy	0.2	0	0	HPO
1106	CHD2	C0038220	Status Epilepticus	0.2	0	0	HPO
1106	CHD2	C0238111	Lennox-Gastaut syndrome	0.200274726784213	0	0	ORPHANET
1106	CHD2	C0270846	Epileptic drop attack	0.2	0	0	HPO
1106	CHD2	C0393702	Myoclonic Astatic Epilepsy	0.200274726784213	0	0	HPO
1106	CHD2	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
1106	CHD2	C0543888	Epileptic encephalopathy	0.200824180352639	0	0	HPO
1106	CHD2	C0595948	Atypical absence seizure	0.2	0	0	HPO
1106	CHD2	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
1106	CHD2	C1836830	Developmental regression	0.2	0	0	HPO
1106	CHD2	C3809278	EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET	0.2	1	23	UNIPROT
1106	CHD2	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
11067	C10orf10	C0014175	Endometriosis	0.2	1	0	CTD_human
11067	C10orf10	C0023794	Lipoidosis	0.2	3	0	CTD_human
11078	TRIOBP	C1853276	Deafness, Autosomal Recessive 28	0.4	1	7	CTD_human;UNIPROT
11078	TRIOBP	C4021533	Severe sensorineural hearing impairment	0.2	0	0	HPO
11081	KERA	C0003742	Arcus Senilis	0.2	0	0	HPO
11081	KERA	C0020490	Hyperopia	0.2	0	0	HPO
11081	KERA	C1096274	Corneal thinning	0.2	0	0	HPO
11081	KERA	C1857574	CORNEA PLANA 2	0.481373633921066	2	8	CTD_human;UNIPROT
1109	AKR1C4	C1839840	MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE	0.2	0	0	ORPHANET
11093	ADAMTS13	C0019061	Hemolytic-Uremic Syndrome	0.207403267796436	0	0	HPO
11093	ADAMTS13	C0034155	Purpura, Thrombotic Thrombocytopenic	0.31221358455981	1	0	CTD_human
11093	ADAMTS13	C0221021	Microangiopathic hemolytic anemia	0.200274726784213	0	0	HPO
11093	ADAMTS13	C0398650	Immune thrombocytopenic purpura	0.2	1	0	CTD_human
11093	ADAMTS13	C1268935	Congenital Thrombotic Thrombocytopenic Purpura	0.499714815928713	16	52	ORPHANET;UNIPROT
111	ADCY5	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.210243080196208	2	3	CTD_human
111	ADCY5	C0013384	Dyskinetic syndrome	0.201373633921065	0	0	HPO
111	ADCY5	C0029456	Osteoporosis	0.2	1	0	CTD_human
111	ADCY5	C0393584	Benign Hereditary Chorea	0.200274726784213	0	0	ORPHANET
111	ADCY5	C1847627	Dyskinesia, Familial, with Facial Myokymia	0.4	1	5	ORPHANET;UNIPROT
111	ADCY5	C4020858	Choreatic disease	0.2	0	0	HPO
111	ADCY5	C4020871	Dystonic disease	0.2	0	0	HPO
111	ADCY5	C4020884	Anxiety disease	0.2	0	0	HPO
11107	PRDM5	C0010036	Corneal dystrophy	0.2	0	0	HPO
11107	PRDM5	C0018777	Conductive hearing loss	0.2	0	0	HPO
11107	PRDM5	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
11107	PRDM5	C0022578	Keratoconus	0.200549453568426	0	0	HPO
11107	PRDM5	C0027092	Myopia	0.200274726784213	0	0	HPO
11107	PRDM5	C0029456	Osteoporosis	0.2	0	0	HPO
11107	PRDM5	C0268344	Ehlers-Danlos syndrome 6B	0.201373633921065	0	0	ORPHANET
11107	PRDM5	C0271183	Severe myopia	0.2	0	0	HPO
11107	PRDM5	C3280011	BRITTLE CORNEA SYNDROME 2	0.200274726784213	1	2	UNIPROT
11113	CIT	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
11113	CIT	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
11127	KIF3A	C0004096	Asthma	0.200549453568426	1	0	CTD_human
11128	POLR3A	C0023520	Leukodystrophy	0.201923087489492	0	0	HPO
11128	POLR3A	C0027092	Myopia	0.2	0	0	HPO
11128	POLR3A	C0037036	Sialorrhea	0.2	0	0	HPO
11128	POLR3A	C0235946	Cerebral atrophy	0.2	0	0	HPO
11128	POLR3A	C0262404	Cerebellar degeneration	0.2	0	0	HPO
11128	POLR3A	C0271623	Hypogonadotropic hypogonadism	0.201373633921065	0	0	HPO
11128	POLR3A	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
11128	POLR3A	C0948896	Primary hypogonadism	0.2	0	0	HPO
11128	POLR3A	C2676243	Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism	0.401098907136852	4	19	ORPHANET;UNIPROT
11128	POLR3A	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
11128	POLR3A	C4020871	Dystonic disease	0.2	0	0	HPO
11128	POLR3A	C4020873	Infratentorial atrophy	0.2	0	0	HPO
11132	CAPN10	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.328526153164498	1	1	CTD_human
11132	CAPN10	C1832544	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1 (disorder)	0.2	0	0	CTD_human
11133	KPTN	C3810225	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41	0.2	0	0	ORPHANET
11133	KPTN	C4020884	Anxiety disease	0.2	0	0	HPO
11136	SLC7A9	C0010691	Cystinuria	0.729925140376951	8	24	CTD_human;HPO;ORPHANET;UNIPROT
11136	SLC7A9	C0035078	Kidney Failure	0.2	0	0	HPO
11136	SLC7A9	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
11136	SLC7A9	C0392525	Nephrolithiasis	0.200549453568426	0	0	HPO
11136	SLC7A9	C1565489	Renal Insufficiency	0.2	0	0	HPO
11141	IL1RAPL1	C0796206	Atkin syndrome	0.2	0	0	CTD_human
11141	IL1RAPL1	C1136249	Mental Retardation, X-Linked	0.204930726738519	1	0	CTD_human
11146	GLMN	C1841984	GLOMUVENOUS MALFORMATIONS	0.483296721410557	0	0	CTD_human;ORPHANET
11149	BVES	C4225199	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2X	0.4	1	1	ORPHANET;UNIPROT
11151	CORO1A	C0024312	Lymphopenia	0.200549453568426	0	0	HPO
11151	CORO1A	C0041296	Tuberculosis	0.201098907136852	1	0	CTD_human
11151	CORO1A	C3809383	IMMUNODEFICIENCY 8	0.4	1	3	ORPHANET;UNIPROT
11152	WDR45	C0013363	Dysautonomia	0.2	0	0	HPO
11152	WDR45	C0235946	Cerebral atrophy	0.2	0	0	HPO
11152	WDR45	C0262404	Cerebellar degeneration	0.2	0	0	HPO
11152	WDR45	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
11152	WDR45	C2931845	Neurodegeneration with brain iron accumulation (NBIA)	0.202747267842131	1	0	CTD_human
11152	WDR45	C3550973	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5	0.203021994626344	0	0	ORPHANET
11152	WDR45	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
11152	WDR45	C4020860	Supratentorial atrophy	0.2	0	0	HPO
11152	WDR45	C4020871	Dystonic disease	0.2	0	0	HPO
11152	WDR45	C4020873	Infratentorial atrophy	0.2	0	0	HPO
11154	AP4S1	C0007789	Cerebral Palsy	0.200274726784213	0	0	HPO
11154	AP4S1	C0037772	Spastic Paraplegia	0.2	0	0	HPO
11155	LDB3	C0152025	Polyneuropathy	0.2	0	0	HPO
11155	LDB3	C1832244	CARDIOMYOPATHY, DILATED, 1C (disorder)	0.48	2	5	CTD_human;UNIPROT
11155	LDB3	C1836155	Myopathy, Myofibrillar, Zasp-Related	0.4	0	0	CTD_human;ORPHANET
11155	LDB3	C1960469	Left ventricular noncompaction	0.200274726784213	0	0	ORPHANET
11155	LDB3	C2678065	Myofibrillar Myopathy	0.200549453568426	0	0	HPO
11155	LDB3	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
11155	LDB3	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
1116	CHI3L1	C0029408	Degenerative polyarthritis	0.201098907136852	1	0	CTD_human
11160	ERLIN2	C0037772	Spastic Paraplegia	0.200274726784213	0	0	HPO
11160	ERLIN2	C0038379	Strabismus	0.2	0	0	HPO
11160	ERLIN2	C0234958	muscle degeneration	0.2	0	0	HPO
11160	ERLIN2	C0575059	Spastic tetraparesis	0.2	0	0	HPO
11160	ERLIN2	C1853396	Primary lateral sclerosis juvenile	0.200274726784213	0	0	ORPHANET
11160	ERLIN2	C2749936	SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE (disorder)	0.2	0	0	ORPHANET
11167	FSTL1	C0003504	Aortic Valve Insufficiency	0.2	1	0	CTD_human
11173	ADAMTS7	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
11173	ADAMTS7	C1956346	Coronary Artery Disease	0.202472541057918	1	0	CTD_human
1118	CHIT1	C0017205	Gaucher Disease	0.210685633829676	1	0	CTD_human
11181	TREH	C0268187	alpha, alpha-Trehalase deficiency	0.4	0	0	CTD_human;ORPHANET
11186	RASSF1	C0007194	Hypertrophic Cardiomyopathy	0.2	1	0	CTD_human
11186	RASSF1	C0036323	Schistosomiasis	0.2	1	0	CTD_human
112	ADCY6	C0003886	Arthrogryposis	0.200274726784213	0	0	HPO
112	ADCY6	C4225385	LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.2	1	2	UNIPROT
1120	CHKB	C0014544	Epilepsy	0.2	0	0	HPO
1120	CHKB	C0020757	Ichthyoses	0.2	0	0	HPO
1120	CHKB	C0027404	Narcolepsy	0.201098907136852	1	0	CTD_human
1120	CHKB	C0376175	Bell Palsy	0.2	0	0	HPO
1120	CHKB	C0699743	Congenital muscular dystrophy (disorder)	0.201098907136852	0	0	HPO
1120	CHKB	C1865233	Muscular Dystrophy, Congenital, Megaconial Type	0.280549453568426	0	0	ORPHANET
1120	CHKB	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
11200	CHEK2	C1836482	Li-Fraumeni Syndrome 2	0.4	6	2	CTD_human;UNIPROT
11200	CHEK2	C4280575	Progressive brain disease	0.2	0	0	HPO
1121	CHM	C0008525	Choroideremia	0.707675628318937	3	13	CTD_human;HPO;ORPHANET;UNIPROT
1121	CHM	C0027092	Myopia	0.2	0	0	HPO
1121	CHM	C0028077	Night Blindness	0.2	0	0	HPO
1121	CHM	C0042798	Low Vision	0.2	0	0	HPO
1121	CHM	C0521683	Chorioretinal degeneration	0.2	0	0	HPO
1121	CHM	C4048273	Chorioretinal atrophy	0.2	0	0	HPO
11222	MRPL3	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
11222	MRPL3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
11222	MRPL3	C3281234	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9	0.4	1	1	ORPHANET;UNIPROT
1123	CHN1	C0013261	Duane Retraction Syndrome	0.607663639203332	0	0	CTD_human;HPO;ORPHANET
1123	CHN1	C0014306	Enophthalmos	0.2	0	0	HPO
1123	CHN1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1123	CHN1	C0028866	Oculomotor Nerve Paralysis	0.2	0	0	HPO
1123	CHN1	C0038379	Strabismus	0.200274726784213	0	0	HPO
1123	CHN1	C0751083	Duane Retraction Syndrome, Type 2	0.200274726784213	1	9	UNIPROT
11231	SEC63	C0022679	Cystic kidney	0.2	0	0	HPO
11232	POLG2	C0162674	Chronic progressive external ophthalmoplegia	0.203231208875927	0	0	HPO
11232	POLG2	C0376175	Bell Palsy	0.2	0	0	HPO
11232	POLG2	C1834846	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1	0.2	0	0	ORPHANET
11232	POLG2	C1864668	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 4	0.4	1	2	CTD_human;UNIPROT
11234	HPS5	C2931875	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells	0.2	0	0	CTD_human
11234	HPS5	C3888004	HERMANSKY-PUDLAK SYNDROME 5	0.280274726784213	1	7	UNIPROT
11235	PDCD10	C0014544	Epilepsy	0.2	0	0	HPO
11235	PDCD10	C1864040	Cerebral Cavernous Malformations 3	0.282197814273705	0	0	CTD_human
112476	PRRT2	C0220669	Familial benign neonatal epilepsy	0.202197814273705	0	0	ORPHANET
112476	PRRT2	C1842534	DYSTONIA 18 (disorder)	0.200274726784213	0	0	ORPHANET
112476	PRRT2	C1853995	SEIZURES, BENIGN FAMILIAL INFANTILE, 2	0.2	1	4	UNIPROT
112476	PRRT2	C1865926	Infantile convulsions and paroxysmal choreoathetosis, familial (disorder)	0.403846174978983	1	7	ORPHANET;UNIPROT
112476	PRRT2	C1868682	Paroxysmal kinesigenic choreoathetosis	0.615384699915934	4	10	CTD_human;ORPHANET;UNIPROT
112476	PRRT2	C1869117	Paroxysmal nonkinesigenic dyskinesia	0.200274726784213	0	0	ORPHANET
11249	NXPH2	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
11251	PTGDR2	C0004096	Asthma	0.21538302118431	1	0	CTD_human
11251	PTGDR2	C1319853	Asthma, Aspirin-Induced	0.2	1	0	CTD_human
11252	PACSIN2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
11253	MAN1B1	C0014544	Epilepsy	0.2	0	0	HPO
11253	MAN1B1	C3280127	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15	0.2	1	4	UNIPROT
11254	SLC6A14	C0021843	Intestinal Obstruction	0.2	1	0	CTD_human
11254	SLC6A14	C1859047	CYSTIC FIBROSIS MODIFIER 1	0.2	1	0	CTD_human
112574	SNX18	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
112744	IL17F	C0006845	Candidiasis, Chronic Mucocutaneous	0.200549453568426	0	0	ORPHANET
112744	IL17F	C3151405	CANDIDIASIS, FAMILIAL, 6	0.2	1	1	UNIPROT
112755	STX1B	C0009952	Febrile Convulsions	0.200549453568426	1	0	CTD_human
112755	STX1B	C0014544	Epilepsy	0.200549453568426	1	0	CTD_human
112755	STX1B	C1858672	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1	0.2	0	0	ORPHANET
112755	STX1B	C4015395	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9	0.2	1	4	UNIPROT
11277	TREX1	C0014544	Epilepsy	0.2	0	0	HPO
11277	TREX1	C0021400	Influenza	0.2	1	0	CTD_human
11277	TREX1	C0023520	Leukodystrophy	0.201098907136852	0	0	HPO
11277	TREX1	C0024141	Lupus Erythematosus, Systemic	0.411993755216112	2	8	CTD_human;UNIPROT
11277	TREX1	C0024145	Chilblain lupus 1	0.602197814273705	3	1	CTD_human;ORPHANET;UNIPROT
11277	TREX1	C0028738	Nystagmus	0.2	0	0	HPO
11277	TREX1	C0031256	Petechiae	0.2	0	0	HPO
11277	TREX1	C0034150	Purpura	0.2	0	0	HPO
11277	TREX1	C0038379	Strabismus	0.2	0	0	HPO
11277	TREX1	C0039446	Telangiectasis	0.2	0	0	HPO
11277	TREX1	C0042798	Low Vision	0.2	0	0	HPO
11277	TREX1	C0235946	Cerebral atrophy	0.2	0	0	HPO
11277	TREX1	C0236048	Polyposis, Gastric	0.2	0	0	HPO
11277	TREX1	C0262988	Vasculitis of the skin	0.2	0	0	HPO
11277	TREX1	C0271051	Macular retinal edema	0.2	0	0	HPO
11277	TREX1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
11277	TREX1	C0393591	AICARDI-GOUTIERES SYNDROME	0.204945082115836	0	0	ORPHANET
11277	TREX1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
11277	TREX1	C0796126	AICARDI-GOUTIERES SYNDROME 1	0.48796707674218	8	22	CTD_human;UNIPROT
11277	TREX1	C1860518	Vasculopathy, Retinal, With Cerebral Leukodystrophy	0.400274726784213	0	0	CTD_human;ORPHANET
11277	TREX1	C4020859	Pyramidal tract disease	0.2	0	0	HPO
11277	TREX1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
11277	TREX1	C4020871	Dystonic disease	0.2	0	0	HPO
11277	TREX1	C4082173	Porencephaly	0.2	0	0	HPO
11277	TREX1	C4280575	Progressive brain disease	0.2	0	0	HPO
1128	CHRM1	C0007786	Brain Ischemia	0.2	1	0	CTD_human
1128	CHRM1	C0014544	Epilepsy	0.2	1	0	CTD_human
11280	SCN11A	C0002768	Congenital Pain Insensitivity	0.400549453568426	1	0	CTD_human;ORPHANET
11280	SCN11A	C0013363	Dysautonomia	0.2	0	0	HPO
11280	SCN11A	C0014544	Epilepsy	0.2	0	0	HPO
11280	SCN11A	C0014805	Primary Erythermalgia	0.2	0	0	ORPHANET
11280	SCN11A	C0020075	Hereditary Sensory Autonomic Neuropathy, Type 5	0.2	0	0	ORPHANET
11280	SCN11A	C1833661	PAROXYSMAL EXTREME PAIN DISORDER	0.2	0	0	ORPHANET
11280	SCN11A	C3809882	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII	0.48	2	1	ORPHANET;UNIPROT
11280	SCN11A	C3809899	EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.4	4	5	ORPHANET;UNIPROT
112802	KRT71	C4014616	HYPOTRICHOSIS 13	0.28	1	1	UNIPROT
112817	HOGA1	C3150878	HYPEROXALURIA, PRIMARY, TYPE III	0.680274726784213	1	29	CTD_human;ORPHANET;UNIPROT
11284	PNKP	C0014544	Epilepsy	0.2	0	0	HPO
11284	PNKP	C0034372	Quadriplegia	0.2	0	0	HPO
11284	PNKP	C0234958	muscle degeneration	0.2	0	0	HPO
11284	PNKP	C0262404	Cerebellar degeneration	0.200274726784213	0	0	HPO
11284	PNKP	C0393706	Early infantile epileptic encephalopathy with suppression bursts	0.2	0	0	ORPHANET
11284	PNKP	C0543888	Epileptic encephalopathy	0.2	0	0	HPO
11284	PNKP	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
11284	PNKP	C3150667	MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.400274726784213	2	7	CTD_human;UNIPROT
11284	PNKP	C3489733	Oculomotor apraxia	0.2	0	0	HPO
11284	PNKP	C4020871	Dystonic disease	0.2	0	0	HPO
11284	PNKP	C4020873	Infratentorial atrophy	0.2	0	0	HPO
11284	PNKP	C4225397	ATAXIA-OCULOMOTOR APRAXIA 4	0.4	1	4	ORPHANET;UNIPROT
11285	B4GALT7	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
11285	B4GALT7	C0010495	Cutis Laxa	0.2	0	0	HPO
11285	B4GALT7	C0015300	Exophthalmos	0.2	0	0	HPO
11285	B4GALT7	C0017574	Gingivitis	0.2	0	0	HPO
11285	B4GALT7	C0023787	Lipodystrophy	0.2	0	0	HPO
11285	B4GALT7	C0029453	Osteopenia	0.2	0	0	HPO
11285	B4GALT7	C0037856	Spermatic Cord Torsion	0.2	0	0	HPO
11285	B4GALT7	C0234958	muscle degeneration	0.2	0	0	HPO
11285	B4GALT7	C0747078	Generalized osteopenia	0.2	0	0	HPO
11285	B4GALT7	C1869122	EHLERS-DANLOS SYNDROME, PROGEROID FORM	0.600824180352639	1	7	CTD_human;ORPHANET;UNIPROT
11285	B4GALT7	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
11285	B4GALT7	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
11285	B4GALT7	C2930812	Generalized elastolysis	0.2	0	0	HPO
112869	SGF29	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1129	CHRM2	C0005697	Neurogenic Urinary Bladder	0.202732912464814	1	0	CTD_human
1129	CHRM2	C0011854	Diabetes Mellitus, Insulin-Dependent	0.2	1	0	CTD_human
1129	CHRM2	C0014544	Epilepsy	0.2	1	0	CTD_human
113	ADCY7	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
1130	LYST	C0002871	Anemia	0.2	0	0	HPO
1130	LYST	C0007965	Chediak-Higashi Syndrome	0.688776901717502	2	41	CTD_human;ORPHANET;UNIPROT
1130	LYST	C0014544	Epilepsy	0.2	0	0	HPO
1130	LYST	C0017574	Gingivitis	0.2	0	0	HPO
1130	LYST	C0023530	Leukopenia	0.2	0	0	HPO
1130	LYST	C0028738	Nystagmus	0.2	0	0	HPO
1130	LYST	C0031099	Periodontitis	0.2	0	0	HPO
1130	LYST	C0038379	Strabismus	0.2	0	0	HPO
1130	LYST	C0042798	Low Vision	0.2	0	0	HPO
1130	LYST	C0085684	Foot-drop	0.2	0	0	HPO
1130	LYST	C0151311	Cranial nerve palsies	0.2	0	0	HPO
1130	LYST	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
1130	LYST	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
1130	LYST	C4025196	Recurrent systemic pyogenic infections	0.2	0	0	HPO
1131	CHRM3	C0020295	Hydronephrosis	0.2	0	0	HPO
1131	CHRM3	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
1131	CHRM3	C0033770	Prune Belly Syndrome	0.600274726784213	1	1	CTD_human;HPO;ORPHANET
1131	CHRM3	C0035078	Kidney Failure	0.2	0	0	HPO
1131	CHRM3	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
1131	CHRM3	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
1131	CHRM3	C0265363	Urethral obstruction sequence	0.2	0	0	ORPHANET
1131	CHRM3	C1565489	Renal Insufficiency	0.2	0	0	HPO
1131	CHRM3	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
1131	CHRM3	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
11311	VPS45	C0002871	Anemia	0.2	0	0	HPO
11311	VPS45	C0020455	Hypergammaglobulinemia	0.2	0	0	HPO
11311	VPS45	C0023530	Leukopenia	0.2	0	0	HPO
11311	VPS45	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
11311	VPS45	C2613439	Extramedullary Hematopoiesis (disorder)	0.2	0	0	HPO
11311	VPS45	C2931351	Familial myelofibrosis	0.2	1	0	CTD_human
11311	VPS45	C3809031	NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE	0.4	1	2	ORPHANET;UNIPROT
11315	PARK7	C0005747	Blepharospasm	0.2	0	0	HPO
11315	PARK7	C0029456	Osteoporosis	0.2	1	0	CTD_human
11315	PARK7	C0030567	Parkinson Disease	0.305236237771581	9	0	CTD_human
11315	PARK7	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
11315	PARK7	C0543859	Amyotrophic Lateral Sclerosis, Guam Form	0.2	0	0	ORPHANET
11315	PARK7	C1853445	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.481373633921066	4	5	CTD_human;UNIPROT
11315	PARK7	C3809811	PARKINSON DISEASE 19, JUVENILE-ONSET	0.2	0	0	ORPHANET
11315	PARK7	C4020884	Anxiety disease	0.2	0	0	HPO
11315	PARK7	C4275179	Young onset Parkinson disease	0.204945082115836	0	0	ORPHANET
113179	ADAT3	C3809039	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36	0.4	1	1	ORPHANET;UNIPROT
113189	CHST14	C1866294	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 1	0.601098907136852	2	10	CTD_human;ORPHANET;UNIPROT
11322	TMC6	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
11322	TMC6	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
11322	TMC6	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
113235	SLC46A1	C0002871	Anemia	0.2	1	0	CTD_human
113235	SLC46A1	C0030312	Pancytopenia	0.2	1	0	CTD_human
113235	SLC46A1	C0342705	Folate Malabsorption, Hereditary	0.605494535684262	5	15	CTD_human;ORPHANET;UNIPROT
113235	SLC46A1	C0598608	Hyperhomocysteinemia	0.2	1	0	CTD_human
113246	C12orf57	C1857512	Temtamy syndrome	0.4	1	3	ORPHANET;UNIPROT
113251	LARP4	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
11326	VSIG4	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
113278	SLC52A3	C0030442	Progressive bulbar palsy	0.200274726784213	0	0	CTD_human
113278	SLC52A3	C0796274	Brown-Vialetto-Van Laere syndrome	0.602747267842131	4	28	CTD_human;ORPHANET;UNIPROT
11330	CTRC	C0149521	Pancreatitis, Chronic	0.214074899797874	1	0	CTD_human
11330	CTRC	C0238339	Hereditary pancreatitis	0.601648360705279	1	8	CTD_human;ORPHANET;UNIPROT
11330	CTRC	C1842402	TROPICAL CALCIFIC PANCREATITIS	0.200549453568426	0	0	ORPHANET
1134	CHRNA1	C0003886	Arthrogryposis	0.2	0	0	HPO
1134	CHRNA1	C0024591	Malignant hyperpyrexia due to anesthesia	0.2	0	0	HPO
1134	CHRNA1	C0085623	Akinesia	0.2	0	0	HPO
1134	CHRNA1	C0376175	Bell Palsy	0.2	0	0	HPO
1134	CHRNA1	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	0.2	0	0	ORPHANET
1134	CHRNA1	C0947912	Myasthenias	0.2	0	0	HPO
1134	CHRNA1	C1276035	Pena-Shokeir syndrome type I	0.2	0	0	HPO
1134	CHRNA1	C1301959	Bulbar weakness	0.2	0	0	HPO
1134	CHRNA1	C1837122	Myasthenic Syndrome, Congenital, Fast-Channel	0.2	0	0	CTD_human
1134	CHRNA1	C1854678	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	0.6	1	1	CTD_human;ORPHANET;UNIPROT
1134	CHRNA1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
1134	CHRNA1	C2931107	Myasthenic syndrome, congenital, postsynaptic slow-channel	0.2	0	0	CTD_human
1134	CHRNA1	C4082299	Bulbar palsy	0.2	0	0	HPO
1134	CHRNA1	C4084823	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL	0.2	5	7	UNIPROT
1134	CHRNA1	C4225405	MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL	0.2	3	4	UNIPROT
11340	EXOSC8	C0026847	Spinal Muscular Atrophy	0.2	0	0	HPO
11340	EXOSC8	C0042798	Low Vision	0.2	0	0	HPO
11340	EXOSC8	C0235946	Cerebral atrophy	0.2	0	0	HPO
11340	EXOSC8	C0575059	Spastic tetraparesis	0.2	0	0	HPO
11340	EXOSC8	C1145670	Respiratory Failure	0.2	0	0	HPO
11340	EXOSC8	C1843504	Pontocerebellar Hypoplasia Type 1	0.2	0	0	ORPHANET
11340	EXOSC8	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
11340	EXOSC8	C4015160	PONTOCEREBELLAR HYPOPLASIA, TYPE 1C	0.200274726784213	1	2	UNIPROT
11343	MGLL	C0029456	Osteoporosis	0.2	1	0	CTD_human
1135	CHRNA2	C0014544	Epilepsy	0.203231208875927	0	0	HPO
1135	CHRNA2	C1835905	Epilepsy, Nocturnal Frontal Lobe, Type 4	0.4	1	1	CTD_human;UNIPROT
113612	CYP2U1	C3539507	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE	0.4	1	5	ORPHANET;UNIPROT
1137	CHRNA4	C0014544	Epilepsy	0.208385505241346	0	0	HPO
1137	CHRNA4	C0085541	Epilepsy, Frontal Lobe	0.215760062283148	3	0	CTD_human
1137	CHRNA4	C1838049	Epilepsy, Nocturnal Frontal Lobe, Type 1	0.4	2	5	CTD_human;UNIPROT
113877	DFNB32	C1837608	DEAFNESS, AUTOSOMAL RECESSIVE 32	0.2	0	0	CTD_human
1139	CHRNA7	C0002395	Alzheimer's Disease	0.227348065645787	1	0	CTD_human
1139	CHRNA7	C0014548	Epilepsy, Generalized	0.202956482091714	1	0	CTD_human
1139	CHRNA7	C0038644	Sudden infant death syndrome	0.2	1	0	CTD_human
114	ADCY8	C0011875	Diabetic Angiopathies	0.2	1	0	CTD_human
1140	CHRNB1	C0234958	muscle degeneration	0.2	0	0	HPO
1140	CHRNB1	C0376175	Bell Palsy	0.2	0	0	HPO
1140	CHRNB1	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	0.2	0	0	ORPHANET
1140	CHRNB1	C1837091	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.2	0	0	CTD_human
1140	CHRNB1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
1140	CHRNB1	C2931107	Myasthenic syndrome, congenital, postsynaptic slow-channel	0.2	0	0	CTD_human
1140	CHRNB1	C4225374	MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL	0.2	3	2	UNIPROT
114086	DBA2	C1853666	Anemia, Diamond-Blackfan, 2	0.202472541057918	0	0	CTD_human
1141	CHRNB2	C0002395	Alzheimer's Disease	0.220732176421995	1	0	CTD_human
1141	CHRNB2	C0014544	Epilepsy	0.200824180352639	0	0	HPO
1141	CHRNB2	C0038644	Sudden infant death syndrome	0.2	1	0	CTD_human
1141	CHRNB2	C0085541	Epilepsy, Frontal Lobe	0.21739406761111	1	0	CTD_human
1141	CHRNB2	C1854335	Epilepsy, Nocturnal Frontal Lobe, Type 3	0.48	2	5	CTD_human;UNIPROT
114293	ANBC	C0152244	Bone Cysts, Aneurysmal	0.200274726784213	0	0	CTD_human
114294	LACTB	C0028754	Obesity	0.2	1	0	CTD_human
114327	EFHC1	C0014553	Absence Epilepsy	0.200824180352639	0	0	CTD_human
114327	EFHC1	C0270853	Myoclonic Epilepsy, Juvenile	0.704001865809541	4	6	CTD_human;ORPHANET;UNIPROT
1144	CHRND	C0024591	Malignant hyperpyrexia due to anesthesia	0.2	0	0	HPO
1144	CHRND	C0085623	Akinesia	0.2	0	0	HPO
1144	CHRND	C0376175	Bell Palsy	0.2	0	0	HPO
1144	CHRND	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	0.2	0	0	ORPHANET
1144	CHRND	C1276035	Pena-Shokeir syndrome type I	0.200274726784213	0	0	HPO
1144	CHRND	C1837122	Myasthenic Syndrome, Congenital, Fast-Channel	0.2	0	0	CTD_human
1144	CHRND	C1854678	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	0.6	1	3	CTD_human;ORPHANET;UNIPROT
1144	CHRND	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
1144	CHRND	C2931107	Myasthenic syndrome, congenital, postsynaptic slow-channel	0.2	0	0	CTD_human
1144	CHRND	C4225370	MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.2	1	1	UNIPROT
1144	CHRND	C4225371	MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL	0.2	3	5	UNIPROT
1144	CHRND	C4225372	MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL	0.28	2	2	UNIPROT
114475	AD7	C1853555	Alzheimer Disease 7	0.2	0	0	CTD_human
114477	ATOD6	C1853899	Dermatitis, Atopic, 6	0.2	0	0	CTD_human
114477	ATOD6	C1864155	Dermatitis, Atopic, 1	0.2	0	0	CTD_human
1145	CHRNE	C0003886	Arthrogryposis	0.2	0	0	HPO
1145	CHRNE	C0024636	Malocclusion	0.2	0	0	HPO
1145	CHRNE	C0038379	Strabismus	0.2	0	0	HPO
1145	CHRNE	C0234958	muscle degeneration	0.2	0	0	HPO
1145	CHRNE	C0376175	Bell Palsy	0.2	0	0	HPO
1145	CHRNE	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	0.2	0	0	ORPHANET
1145	CHRNE	C0947912	Myasthenias	0.200274726784213	0	0	HPO
1145	CHRNE	C1301959	Bulbar weakness	0.2	0	0	HPO
1145	CHRNE	C1837091	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.48	1	15	CTD_human;UNIPROT
1145	CHRNE	C1837122	Myasthenic Syndrome, Congenital, Fast-Channel	0.2	0	0	CTD_human
1145	CHRNE	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
1145	CHRNE	C2931107	Myasthenic syndrome, congenital, postsynaptic slow-channel	0.2	0	0	CTD_human
1145	CHRNE	C4025671	Sudden episodic apnea	0.2	0	0	HPO
1145	CHRNE	C4082299	Bulbar palsy	0.2	0	0	HPO
1145	CHRNE	C4225369	MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL	0.2	3	5	UNIPROT
1145	CHRNE	C4225413	MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL	0.28	5	4	UNIPROT
1145	CHRNE	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
114548	NLRP3	C0010346	Crohn Disease	0.218940114001763	1	0	CTD_human
114548	NLRP3	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
114548	NLRP3	C0268390	Muckle-Wells Syndrome	0.690164891015885	5	8	CTD_human;ORPHANET;UNIPROT
114548	NLRP3	C0343068	Familial cold urticaria	0.688516530310606	7	17	CTD_human;ORPHANET;UNIPROT
114548	NLRP3	C0409818	Chronic Infantile Neurological, Cutaneous, and Articular Syndrome	0.49236270528959	8	18	ORPHANET;UNIPROT
114548	NLRP3	C2316212	Cryopyrin-Associated Periodic Syndromes	0.208241803526393	3	0	CTD_human
1146	CHRNG	C0003886	Arthrogryposis	0.400549453568426	2	0	CTD_human;HPO
1146	CHRNG	C0018777	Conductive hearing loss	0.2	0	0	HPO
1146	CHRNG	C0020619	Hypogonadism	0.2	0	0	HPO
1146	CHRNG	C0024591	Malignant hyperpyrexia due to anesthesia	0.2	0	0	HPO
1146	CHRNG	C0085623	Akinesia	0.2	0	0	HPO
1146	CHRNG	C0155411	Exostosis of external ear canal	0.2	0	0	HPO
1146	CHRNG	C0751882	Myasthenic Syndromes, Congenital	0.2	1	0	CTD_human
1146	CHRNG	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
1146	CHRNG	C1276035	Pena-Shokeir syndrome type I	0.200274726784213	0	0	HPO
1146	CHRNG	C1854678	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	0.600274726784213	0	0	CTD_human;ORPHANET;UNIPROT
1146	CHRNG	C1867439	Pterygium, Antecubital	0.2	0	0	HPO
114609	TIRAP	C0004610	Bacteremia	0.2	1	0	CTD_human
114609	TIRAP	C0024530	Malaria	0.200274726784213	1	0	CTD_human
114609	TIRAP	C0041296	Tuberculosis	0.216467572943845	1	0	CTD_human
114609	TIRAP	C1835828	Invasive Pneumococcal Disease, Recurrent Isolated, 1	0.2	0	0	CTD_human
114610	SAX1	C1970107	ATAXIA, SPASTIC, 1, AUTOSOMAL DOMINANT	0.2	0	0	CTD_human
1147	CHUK	C3150891	COCOON SYNDROME	0.480549453568426	0	0	CTD_human;ORPHANET
114781	BTBD9	C0035258	Restless Legs Syndrome	0.2146243533663	1	3	CTD_human
114798	SLITRK1	C0040517	Gilles de la Tourette syndrome	0.308237758533057	0	0	CTD_human
114822	RHPN1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
1149	CIDEA	C0018801	Heart failure	0.2	1	0	CTD_human
1149	CIDEA	C0028754	Obesity	0.204879569581206	1	0	CTD_human
114902	C1QTNF5	C0242383	Age related macular degeneration	0.204055389228567	1	0	CTD_human
114902	C1QTNF5	C1854065	LATE-ONSET RETINAL DEGENERATION (disorder)	0.681923087489492	1	1	CTD_human;ORPHANET;UNIPROT
114904	C1QTNF6	C0011854	Diabetes Mellitus, Insulin-Dependent	0.202956482091714	1	1	CTD_human
115019	SLC26A9	C0021843	Intestinal Obstruction	0.2	1	0	CTD_human
115019	SLC26A9	C1859047	CYSTIC FIBROSIS MODIFIER 1	0.2	1	0	CTD_human
1152	CKB	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
1152	CKB	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
1152	CKB	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
115286	SLC25A26	C4225206	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.4	1	4	ORPHANET;UNIPROT
1153	CIRBP	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
1153	CIRBP	C0751865	Alcohol-Induced Disorders, Nervous System	0.2	1	0	CTD_human
115352	FCRL3	C0018213	Graves Disease	0.206737144536068	1	1	CTD_human
115352	FCRL3	C0920350	Autoimmune thyroiditis	0.202681755307501	1	0	CTD_human
1154	CISH	C0024530	Malaria	0.2	0	0	CTD_human
1154	CISH	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
115650	TNFRSF13C	C0009447	Common Variable Immunodeficiency	0.407887208830233	0	0	CTD_human;ORPHANET
1158	CKM	C0027051	Myocardial Infarction	0.2	2	0	CTD_human
1158	CKM	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
1158	CKM	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
115948	CCDC151	C0022521	Kartagener Syndrome	0.200549453568426	0	0	ORPHANET
116	ADCYAP1	C0020452	Hyperemia	0.2	1	0	CTD_human
116	ADCYAP1	C0026205	Miosis disorder	0.2	1	0	CTD_human
116	ADCYAP1	C0878773	Overactive Bladder	0.2	1	0	CTD_human
116039	OSR2	C0014175	Endometriosis	0.2	1	0	CTD_human
116085	SLC22A12	C0473219	Renal hypouricemia	0.606868169605328	7	10	CTD_human;ORPHANET;UNIPROT
1161	ERCC8	C0003028	Anhidrosis	0.2	0	0	HPO
1161	ERCC8	C0009207	Cockayne Syndrome	0.220979871183197	2	0	CTD_human
1161	ERCC8	C0011334	Dental caries	0.2	0	0	HPO
1161	ERCC8	C0014544	Epilepsy	0.2	0	0	HPO
1161	ERCC8	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1161	ERCC8	C0020258	Hydrocephalus, Normal Pressure	0.2	0	0	HPO
1161	ERCC8	C0020490	Hyperopia	0.2	0	0	HPO
1161	ERCC8	C0020619	Hypogonadism	0.2	0	0	HPO
1161	ERCC8	C0024636	Malocclusion	0.2	0	0	HPO
1161	ERCC8	C0028738	Nystagmus	0.2	0	0	HPO
1161	ERCC8	C0029124	Optic Atrophy	0.2	0	0	HPO
1161	ERCC8	C0035078	Kidney Failure	0.200274726784213	0	0	HPO
1161	ERCC8	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
1161	ERCC8	C0038379	Strabismus	0.2	0	0	HPO
1161	ERCC8	C0152025	Polyneuropathy	0.2	0	0	HPO
1161	ERCC8	C0235946	Cerebral atrophy	0.2	0	0	HPO
1161	ERCC8	C0259817	Xerosis	0.2	0	0	HPO
1161	ERCC8	C0751037	Cockayne Syndrome, Type III	0.2	0	0	ORPHANET
1161	ERCC8	C0751038	Cockayne Syndrome, Type II	0.200824180352639	0	0	ORPHANET
1161	ERCC8	C0751039	Cockayne Syndrome, Type I	0.482197814273705	3	10	ORPHANET;UNIPROT
1161	ERCC8	C1565489	Renal Insufficiency	0.2	0	0	HPO
1161	ERCC8	C3553298	UV-SENSITIVE SYNDROME 2	0.2	1	1	UNIPROT
1161	ERCC8	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1161	ERCC8	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
116369	SLC26A8	C1847540	Azoospermia, Nonobstructive	0.2	1	3	UNIPROT
1164	CKS2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
116442	RAB39B	C0014544	Epilepsy	0.200274726784213	1	0	CTD_human
116442	RAB39B	C0796195	Waisman syndrome	0.4	1	2	ORPHANET;UNIPROT
116442	RAB39B	C1136249	Mental Retardation, X-Linked	0.200274726784213	1	0	CTD_human
116442	RAB39B	C1846038	MENTAL RETARDATION, X-LINKED 72	0.2	0	0	CTD_human
116443	GRIN3A	C0242350	Erectile dysfunction	0.2	1	0	CTD_human
116449	CLNK	C0042900	Vitiligo	0.2	1	1	CTD_human
1165	SCAR2	C1859298	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2	0.2	0	0	CTD_human
116519	APOA5	C0020479	Hyperlipoproteinemia Type III	0.203231208875927	1	0	CTD_human
116519	APOA5	C0020480	Hyperlipoproteinemia Type IV	0.200274726784213	0	0	CTD_human
116519	APOA5	C0020481	Hyperlipoproteinemia Type V	0.400274726784213	0	0	CTD_human;ORPHANET
116519	APOA5	C1956346	Coronary Artery Disease	0.222577074731163	1	0	CTD_human
116519	APOA5	C2362324	Pediatric Obesity	0.200274726784213	1	0	CTD_human
116629	HTX3	C1853444	Heterotaxy, Visceral, 3, Autosomal	0.2	0	0	CTD_human
1167	CLA3	C1842676	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6 (disorder)	0.2	0	0	CTD_human
116833	ANIB1	C1862932	ANEURYSM, INTRACRANIAL BERRY, 1 (disorder)	0.2	0	0	CTD_human
116840	CNTROB	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
117	ADCYAP1R1	C0004096	Asthma	0.200274726784213	1	0	CTD_human
117084	CANDF1	C2751429	CANDIDIASIS, FAMILIAL, 1	0.2	0	0	CTD_human
117144	CATSPER1	C2751811	Spermatogenic Failure 7	0.2	0	0	CTD_human
117155	CATSPER2	C1970187	Deafness, Sensorineural, And Male Infertility	0.2	0	0	ORPHANET
117156	SCGB3A2	C0004096	Asthma	0.222981147853012	0	0	CTD_human
117187	ATOD3	C1853964	Dermatitis, Atopic, 3	0.2	0	0	CTD_human
117187	ATOD3	C1864155	Dermatitis, Atopic, 1	0.2	0	0	CTD_human
117188	ATOD5	C1853900	Dermatitis, Atopic, 5	0.2	0	0	CTD_human
117188	ATOD5	C1864155	Dermatitis, Atopic, 1	0.2	0	0	CTD_human
117189	GRDX	C0018213	Graves Disease	0.2	0	0	CTD_human
117190	HPE6	C1853830	Holoprosencephaly 6	0.2	0	0	CTD_human
117191	HYT1	C0085580	Essential Hypertension	0.2	0	0	CTD_human
117289	TAGAP	C0003873	Rheumatoid Arthritis	0.205912964183428	2	0	CTD_human
117289	TAGAP	C0010346	Crohn Disease	0.200549453568426	1	0	CTD_human
117289	TAGAP	C0033860	Psoriasis	0.2	1	0	CTD_human
117289	TAGAP	C2675865	DIABETES MELLITUS, INSULIN-DEPENDENT, 21 (disorder)	0.2	0	0	CTD_human
1174	AP1S1	C0008370	Cholestasis	0.2	0	0	HPO
1174	AP1S1	C0008372	Intrahepatic Cholestasis	0.4	1	0	CTD_human;HPO
1174	AP1S1	C0020757	Ichthyoses	0.200274726784213	0	0	HPO
1174	AP1S1	C0023794	Lipoidosis	0.2	1	0	CTD_human
1174	AP1S1	C0023890	Liver Cirrhosis	0.2	0	0	HPO
1174	AP1S1	C0239946	Fibrosis, Liver	0.2	0	0	HPO
1174	AP1S1	C0268070	Hypocupremia	0.200274726784213	0	0	HPO
1174	AP1S1	C0870082	Hyperkeratosis	0.2	0	0	HPO
1174	AP1S1	C1836330	ERYTHROKERATODERMIA VARIABILIS 3 (disorder)	0.400549453568426	1	0	CTD_human;ORPHANET
1175	AP2S1	C0020437	Hypercalcemia	0.200549453568426	0	0	HPO
1175	AP2S1	C0030305	Pancreatitis	0.2	0	0	HPO
1175	AP2S1	C0151714	Hypermagnesemia	0.2	0	0	HPO
1175	AP2S1	C0221002	Hyperparathyroidism, Primary	0.200549453568426	0	0	HPO
1175	AP2S1	C0553730	Calcium pyrophosphate deposition disease	0.2	0	0	HPO
1175	AP2S1	C1833372	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.6	2	2	CTD_human;ORPHANET;UNIPROT
117531	TMC1	C1832978	Deafness, Autosomal Recessive 7	0.48	1	9	CTD_human;UNIPROT
117531	TMC1	C1847626	Deafness, Autosomal Dominant 36	0.480274726784213	1	2	CTD_human;UNIPROT
117579	RLN3	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
117581	TWIST2	C1319466	Barber Say syndrome	0.400274726784213	1	3	ORPHANET;UNIPROT
117581	TWIST2	C1860224	ABLEPHARON-MACROSTOMIA SYNDROME	0.400274726784213	1	1	ORPHANET;UNIPROT
118	ADD1	C0085580	Essential Hypertension	0.211263798152737	0	0	CTD_human
1180	CLCN1	C0027127	Myotonia Congenita	0.427349744377411	1	29	CTD_human;ORPHANET
1180	CLCN1	C0751360	Becker Generalized Myotonia	0.284120901763197	24	24	UNIPROT
1180	CLCN1	C2936781	Generalized Myotonia of Thomsen	0.61593415348436	14	16	CTD_human;ORPHANET;UNIPROT
1181	CLCN2	C0014553	Absence Epilepsy	0.203007639249027	0	0	CTD_human
1181	CLCN2	C0270850	Idiopathic generalized epilepsy	0.201098907136852	0	0	CTD_human
1181	CLCN2	C0270853	Myoclonic Epilepsy, Juvenile	0.400824180352639	0	0	CTD_human;ORPHANET
1181	CLCN2	C3810242	LEUKOENCEPHALOPATHY WITH ATAXIA	0.4	1	20	ORPHANET;UNIPROT
1183	CLCN4	C3887959	MENTAL RETARDATION, X-LINKED 49	0.2	2	1	UNIPROT
1184	CLCN5	C0017668	Focal glomerulosclerosis	0.2	0	0	HPO
1184	CLCN5	C0027709	Nephrocalcinosis	0.201648360705279	0	0	HPO
1184	CLCN5	C0029442	Osteomalacia	0.2	0	0	HPO
1184	CLCN5	C0035078	Kidney Failure	0.201923087489492	0	0	HPO
1184	CLCN5	C0035579	Rickets	0.2	0	0	HPO
1184	CLCN5	C0178664	Glomerulosclerosis (disorder)	0.200274726784213	0	0	HPO
1184	CLCN5	C0238621	Aminoaciduria	0.2	0	0	HPO
1184	CLCN5	C0392525	Nephrolithiasis	0.206043989252688	0	0	HPO
1184	CLCN5	C0403720	X-linked recessive nephrolithiasis with renal failure	0.400549453568426	1	1	CTD_human;UNIPROT
1184	CLCN5	C0878681	Dent's disease	0.22026426949714	3	0	CTD_human
1184	CLCN5	C1565489	Renal Insufficiency	0.200274726784213	0	0	HPO
1184	CLCN5	C1704375	Hypophosphatemic Rickets	0.200274726784213	0	0	HPO
1184	CLCN5	C1839874	Low Molecular Weight Proteinuria with Hypercalciuria and Nephrocalcinosis	0.4	3	3	CTD_human;UNIPROT
1184	CLCN5	C1845168	Hypophosphatemic Rickets, X-Linked Recessive	0.201098907136852	6	1	UNIPROT
1184	CLCN5	C1848336	Dent disease 1	0.681098907136852	12	23	CTD_human;ORPHANET;UNIPROT
1184	CLCN5	C3536983	Familial Hypophosphatemic Rickets	0.200274726784213	0	0	CTD_human
118429	ANTXR2	C0017567	Gingival Hypertrophy	0.2	2	0	CTD_human
118429	ANTXR2	C0029456	Osteoporosis	0.2	1	0	CTD_human
118429	ANTXR2	C0038013	Ankylosing spondylitis	0.202472541057918	2	2	CTD_human
118429	ANTXR2	C2745948	Hyalinosis, Systemic	0.604120901763197	2	11	CTD_human;ORPHANET;UNIPROT
1186	CLCN7	C0002871	Anemia	0.2	0	0	HPO
1186	CLCN7	C0003864	Arthritis	0.2	0	0	HPO
1186	CLCN7	C0008711	Chronic rhinitis	0.2	0	0	HPO
1186	CLCN7	C0010278	Craniosynostosis	0.2	0	0	HPO
1186	CLCN7	C0015469	Facial paralysis	0.2	0	0	HPO
1186	CLCN7	C0020255	Hydrocephalus	0.2	0	0	HPO
1186	CLCN7	C0028738	Nystagmus	0.2	0	0	HPO
1186	CLCN7	C0029124	Optic Atrophy	0.200274726784213	0	0	HPO
1186	CLCN7	C0029408	Degenerative polyarthritis	0.200274726784213	0	0	HPO
1186	CLCN7	C0029410	Osteoarthritis of hip	0.2	0	0	HPO
1186	CLCN7	C0029454	Osteopetrosis	0.42683709258898	0	0	CTD_human;HPO
1186	CLCN7	C0029882	Otitis Media	0.2	0	0	HPO
1186	CLCN7	C0042798	Low Vision	0.2	0	0	HPO
1186	CLCN7	C0242567	Opsoclonus	0.2	0	0	HPO
1186	CLCN7	C0376175	Bell Palsy	0.2	0	0	HPO
1186	CLCN7	C0432261	Osteopetrosis - intermediate type	0.2	0	0	ORPHANET
1186	CLCN7	C1290708	Osteomyelitis of mandible	0.2	0	0	HPO
1186	CLCN7	C1969106	Osteopetrosis, Autosomal Recessive 4	0.48	6	12	CTD_human;UNIPROT
1186	CLCN7	C3179239	Osteopetrosis Autosomal Dominant Type 2	0.48	5	5	ORPHANET;UNIPROT
1187	CLCNKA	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1187	CLCNKA	C0020428	Hyperaldosteronism	0.2	0	0	HPO
1187	CLCNKA	C0035078	Kidney Failure	0.2	0	0	HPO
1187	CLCNKA	C0085680	Hypochloremia (disorder)	0.2	0	0	HPO
1187	CLCNKA	C0740896	Hypokalemic hypochloremic metabolic alkalosis	0.2	0	0	HPO
1187	CLCNKA	C1565489	Renal Insufficiency	0.2	0	0	HPO
1187	CLCNKA	C1865270	BARTTER SYNDROME, TYPE 4A	0.2	0	0	CTD_human
1187	CLCNKA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1187	CLCNKA	C2751312	BARTTER SYNDROME, TYPE 4B	0.4	1	2	CTD_human;UNIPROT
1187	CLCNKA	C3671887	Sodium concentration in urine above normal	0.2	0	0	HPO
1188	CLCNKB	C0004775	Bartter Disease	0.221631639066249	1	0	CTD_human
1188	CLCNKB	C0018784	Sensorineural Hearing Loss (disorder)	0.201098907136852	0	0	HPO
1188	CLCNKB	C0020428	Hyperaldosteronism	0.2	0	0	HPO
1188	CLCNKB	C0035078	Kidney Failure	0.200274726784213	0	0	HPO
1188	CLCNKB	C0085680	Hypochloremia (disorder)	0.2	0	0	HPO
1188	CLCNKB	C0268450	Gitelman Syndrome	0.202197814273705	0	0	ORPHANET
1188	CLCNKB	C0740896	Hypokalemic hypochloremic metabolic alkalosis	0.2	0	0	HPO
1188	CLCNKB	C0740898	Hypokalemic metabolic alkalosis	0.2	0	0	HPO
1188	CLCNKB	C1565489	Renal Insufficiency	0.2	0	0	HPO
1188	CLCNKB	C1846343	Bartter syndrome, type 3	0.60357144819477	1	7	CTD_human;ORPHANET;UNIPROT
1188	CLCNKB	C1865270	BARTTER SYNDROME, TYPE 4A	0.2	0	0	CTD_human
1188	CLCNKB	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1188	CLCNKB	C3671887	Sodium concentration in urine above normal	0.2	0	0	HPO
118813	ZFYVE27	C1853251	Spastic Paraplegia 33, Autosomal Dominant	0.4	1	1	CTD_human;UNIPROT
118856	MMP21	C3178805	Heterotaxy Syndrome	0.2	1	0	CTD_human
118856	MMP21	C4225217	HETEROTAXY, VISCERAL, 7, AUTOSOMAL	0.2	2	5	UNIPROT
1191	CLU	C0002395	Alzheimer's Disease	0.258134727743681	3	5	CTD_human
1191	CLU	C0024141	Lupus Erythematosus, Systemic	0.204106546385879	1	0	CTD_human
1191	CLU	C0029408	Degenerative polyarthritis	0.200549453568426	2	0	CTD_human
1191	CLU	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
1191	CLU	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
1191	CLU	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1192	CLIC1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
1193	CLIC2	C0014544	Epilepsy	0.2	0	0	HPO
1193	CLIC2	C0018801	Heart failure	0.2	0	0	HPO
1193	CLIC2	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
1193	CLIC2	C3550913	MENTAL RETARDATION, X-LINKED, SYNDROMIC 32	0.4	1	1	ORPHANET;UNIPROT
119559	SFXN4	C3810001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.2	0	0	ORPHANET
12	SERPINA3	C0023794	Lipoidosis	0.2	3	0	CTD_human
12	SERPINA3	C0400965	Antichymotrypsin deficiency-alpha-1	0.2	0	0	ORPHANET
120	ADD3	C0007786	Brain Ischemia	0.2	1	0	CTD_human
120	ADD3	C2751938	Cerebral Palsy, Spastic Quadriplegic, 1	0.2	0	0	ORPHANET
1200	TPP1	C0002395	Alzheimer's Disease	0.2	1	0	CTD_human
1200	TPP1	C0014544	Epilepsy	0.200549453568426	0	0	HPO
1200	TPP1	C0027877	Neuronal Ceroid-Lipofuscinoses	0.222129935477362	2	2	CTD_human
1200	TPP1	C0235946	Cerebral atrophy	0.200274726784213	0	0	HPO
1200	TPP1	C1836474	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7	0.400274726784213	1	3	ORPHANET;UNIPROT
1200	TPP1	C1836830	Developmental regression	0.2	0	0	HPO
1200	TPP1	C1876161	CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.682197814273705	15	46	CTD_human;ORPHANET;UNIPROT
1200	TPP1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1201	CLN3	C0014544	Epilepsy	0.200274726784213	0	0	HPO
1201	CLN3	C0024437	Macular degeneration	0.2	0	0	HPO
1201	CLN3	C0027877	Neuronal Ceroid-Lipofuscinoses	0.235534126394535	0	0	CTD_human
1201	CLN3	C0029124	Optic Atrophy	0.200274726784213	0	0	HPO
1201	CLN3	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	HPO
1201	CLN3	C0235946	Cerebral atrophy	0.200274726784213	0	0	HPO
1201	CLN3	C0271215	Blindness, Legal	0.2	0	0	HPO
1201	CLN3	C0751383	Juvenile Neuronal Ceroid Lipofuscinosis	0.513725881923581	2	64	ORPHANET;UNIPROT
1201	CLN3	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1201	CLN3	C4020884	Anxiety disease	0.2	0	0	HPO
120227	CYP2R1	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
120227	CYP2R1	C0268689	Vitamin D-dependent rickets, type 1	0.2	0	0	ORPHANET
120227	CYP2R1	C1838657	Vitamin D Hydroxylation-Deficient Rickets, Type 1B	0.4	1	1	CTD_human;UNIPROT
120237	DBX1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
1203	CLN5	C0014544	Epilepsy	0.200274726784213	0	0	HPO
1203	CLN5	C1836830	Developmental regression	0.2	0	0	HPO
1203	CLN5	C1850442	CEROID LIPOFUSCINOSIS, NEURONAL, 5	0.680274726784213	5	43	CTD_human;ORPHANET;UNIPROT
120892	LRRK2	C0014175	Endometriosis	0.2	1	0	CTD_human
120892	LRRK2	C0030567	Parkinson Disease	0.44	10	3	CTD_human
120892	LRRK2	C1846862	PARKINSON DISEASE 8 (disorder)	0.480824180352639	10	28	CTD_human;UNIPROT
120892	LRRK2	C3809811	PARKINSON DISEASE 19, JUVENILE-ONSET	0.2	0	0	ORPHANET
120892	LRRK2	C4274355	Autosomal dominant late onset Parkinson disease	0.201373633921065	0	0	ORPHANET
120892	LRRK2	C4275179	Young onset Parkinson disease	0.203021994626344	0	0	ORPHANET
121260	SLC15A4	C0024141	Lupus Erythematosus, Systemic	0.203231208875927	1	3	CTD_human
121391	KRT74	C3151432	HYPOTRICHOSIS 3	0.2	1	1	UNIPROT
121391	KRT74	C3554117	ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE	0.2	1	1	UNIPROT
1215	CMA1	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
1215	CMA1	C0149721	Left Ventricular Hypertrophy	0.202681755307501	1	0	CTD_human
121512	FGD4	C1836336	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H	0.681098907136852	2	7	CTD_human;ORPHANET;UNIPROT
121601	ANO4	C0014175	Endometriosis	0.2	1	0	CTD_human
1218	CMD1B	C0340427	Familial dilated cardiomyopathy	0.200549453568426	0	0	CTD_human
122	ADFN	C1845068	ALBINISM-DEAFNESS SYNDROME	0.2	0	0	CTD_human
122416	ANKRD9	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
122618	PLD4	C0003873	Rheumatoid Arthritis	0.2	1	2	CTD_human
122961	ISCA2	C4225348	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4	0.4	1	1	ORPHANET;UNIPROT
123	PLIN2	C0015695	Fatty Liver	0.2	1	0	CTD_human
1230	CCR1	C0003864	Arthritis	0.2	0	0	HPO
1230	CCR1	C0004943	Behcet Syndrome	0.400549453568426	1	0	CTD_human;ORPHANET
1230	CCR1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
1230	CCR1	C0025289	Meningitis	0.2	0	0	HPO
1230	CCR1	C0032285	Pneumonia	0.2	1	0	CTD_human
1230	CCR1	C0038363	Aphthous Stomatitis	0.2	0	0	HPO
1230	CCR1	C0042384	Vasculitis	0.2	0	0	HPO
1230	CCR1	C0149745	Oral Ulcer	0.2	0	0	HPO
1230	CCR1	C0702166	Acne	0.2	0	0	HPO
1230	CCR1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
1230	CCR1	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
1230	CCR1	C2937365	Recurrent aphthous ulcer	0.200274726784213	0	0	HPO
123016	TTC8	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
123016	TTC8	C0752166	Bardet-Biedl Syndrome	0.406238848124954	0	0	CTD_human;ORPHANET
123016	TTC8	C3150715	RETINITIS PIGMENTOSA 51	0.2	0	0	CTD_human
123041	SLC24A4	C4014578	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5	0.2	2	3	UNIPROT
123096	SLC25A29	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1232	CCR3	C0011615	Dermatitis, Atopic	0.200824180352639	1	0	CTD_human
1232	CCR3	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
1232	CCR3	C0038220	Status Epilepticus	0.2	1	0	CTD_human
1232	CCR3	C1319853	Asthma, Aspirin-Induced	0.2	1	0	CTD_human
123263	MTFMT	C0023264	Leigh Disease	0.200824180352639	0	0	ORPHANET
123263	MTFMT	C3554182	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15	0.4	2	9	ORPHANET;UNIPROT
123264	SLC51B	C0008370	Cholestasis	0.203007639249027	2	0	CTD_human
123264	SLC51B	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
1233	CCR4	C0007570	Celiac Disease	0.2	1	0	CTD_human
1233	CCR4	C0007786	Brain Ischemia	0.2	1	0	CTD_human
1234	CCR5	C0011615	Dermatitis, Atopic	0.2	1	0	CTD_human
1234	CCR5	C0019196	Hepatitis C	0.239020522540706	0	0	CTD_human
1234	CCR5	C0027697	Nephritis	0.2	1	0	CTD_human
1234	CCR5	C0043124	West Nile Fever	0.206187690967642	0	0	CTD_human
1234	CCR5	C2675864	DIABETES MELLITUS, INSULIN-DEPENDENT, 22 (disorder)	0.2	0	0	CTD_human
1235	CCR6	C0003864	Arthritis	0.200549453568426	0	0	HPO
1235	CCR6	C0003873	Rheumatoid Arthritis	0.208161935614446	3	4	CTD_human
1235	CCR6	C0009324	Ulcerative Colitis	0.201098907136852	1	0	CTD_human
1235	CCR6	C0011334	Dental caries	0.2	0	0	HPO
1235	CCR6	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
1235	CCR6	C0032285	Pneumonia	0.2	1	0	CTD_human
1235	CCR6	C0034069	Pulmonary Fibrosis	0.2	0	0	HPO
1235	CCR6	C0042900	Vitiligo	0.204814057046576	1	0	CTD_human
1235	CCR6	C0206138	CREST Syndrome	0.2	0	0	ORPHANET
1235	CCR6	C0748540	Scleroderma, Limited	0.2	0	0	ORPHANET
1235	CCR6	C1258104	Diffuse Scleroderma	0.2	0	0	ORPHANET
1236	CCR7	C0038220	Status Epilepticus	0.2	1	0	CTD_human
123606	NIPA1	C1838192	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT (disorder)	0.600549453568426	2	2	CTD_human;ORPHANET;UNIPROT
123624	AGBL1	C0016781	Fuchs Endothelial Dystrophy	0.200274726784213	0	0	ORPHANET
123624	AGBL1	C3809798	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8	0.2	1	2	UNIPROT
1237	CCR8	C0038220	Status Epilepticus	0.2	1	0	CTD_human
123872	DNAAF1	C0022521	Kartagener Syndrome	0.200824180352639	0	0	ORPHANET
123872	DNAAF1	C2750790	CILIARY DYSKINESIA, PRIMARY, 13	0.4	1	5	CTD_human;UNIPROT
124093	CCDC78	C3553709	MYOPATHY, CENTRONUCLEAR, 4	0.2	0	0	ORPHANET
1244	ABCC2	C0002170	Alopecia	0.200274726784213	1	0	CTD_human
1244	ABCC2	C0003873	Rheumatoid Arthritis	0.202407028523288	1	0	CTD_human
1244	ABCC2	C0008370	Cholestasis	0.282197814273705	3	0	CTD_human
1244	ABCC2	C0020433	Hyperbilirubinemia	0.201648360705279	1	0	CTD_human
1244	ABCC2	C0022350	Jaundice, Chronic Idiopathic	0.701631639066249	5	15	CTD_human;ORPHANET;UNIPROT
1244	ABCC2	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
1244	ABCC2	C0038220	Status Epilepticus	0.2	1	0	CTD_human
1244	ABCC2	C0268307	Conjugated hyperbilirubinemia	0.203296721410557	0	0	HPO
1244	ABCC2	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
124404	SEPT12	C3553793	SPERMATOGENIC FAILURE 10	0.2	1	2	UNIPROT
124454	EARS2	C3554079	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12	0.400824180352639	3	12	ORPHANET;UNIPROT
124583	CANT1	C0432242	Desbuquois syndrome	0.402197814273705	0	0	CTD_human;ORPHANET
124583	CANT1	C4012146	DESBUQUOIS DYSPLASIA 1	0.2	4	17	UNIPROT
124590	USH1G	C1568247	Usher Syndrome, Type I	0.201373633921065	0	0	ORPHANET
124590	USH1G	C1847089	USHER SYNDROME, TYPE IG	0.480274726784213	2	7	CTD_human;UNIPROT
124997	WDR81	C0394006	Dysequilibrium syndrome	0.200274726784213	0	0	ORPHANET
124997	WDR81	C2750234	Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 2	0.2	1	2	UNIPROT
125	ADH1B	C0007785	Cerebral Infarction	0.205414667772315	1	0	CTD_human
125	ADH1B	C0028754	Obesity	0.200549453568426	1	0	CTD_human
1253	CMTX2	C1844873	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2 (disorder)	0.2	0	0	CTD_human
125336	LOXHD1	C2746083	DEAFNESS, AUTOSOMAL RECESSIVE 77 (disorder)	0.2	0	0	CTD_human
1254	CMTX3	C1844865	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3 (disorder)	0.2	0	0	CTD_human
1255	CNA1	C1852557	CORNEA PLANA 1	0.2	0	0	CTD_human
1257	CNC2	C0406810	Carney Complex	0.200824180352639	0	0	CTD_human
1258	CNGB1	C0017601	Glaucoma	0.2	0	0	HPO
1258	CNGB1	C0018777	Conductive hearing loss	0.2	0	0	HPO
1258	CNGB1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1258	CNGB1	C0020459	Hyperinsulinism	0.2	0	0	HPO
1258	CNGB1	C0020619	Hypogonadism	0.2	0	0	HPO
1258	CNGB1	C0022578	Keratoconus	0.2	0	0	HPO
1258	CNGB1	C0028077	Night Blindness	0.2	0	0	HPO
1258	CNGB1	C0028738	Nystagmus	0.2	0	0	HPO
1258	CNGB1	C0028754	Obesity	0.2	0	0	HPO
1258	CNGB1	C0029124	Optic Atrophy	0.2	0	0	HPO
1258	CNGB1	C0035334	Retinitis Pigmentosa	0.603231208875927	1	2	CTD_human;HPO;ORPHANET
1258	CNGB1	C0271215	Blindness, Legal	0.2	0	0	HPO
1258	CNGB1	C3151066	RETINITIS PIGMENTOSA 45	0.2	1	6	UNIPROT
125893	ZNF816	C0033860	Psoriasis	0.203231208875927	2	1	CTD_human
1259	CNGA1	C0017601	Glaucoma	0.2	0	0	HPO
1259	CNGA1	C0018777	Conductive hearing loss	0.2	0	0	HPO
1259	CNGA1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1259	CNGA1	C0020459	Hyperinsulinism	0.2	0	0	HPO
1259	CNGA1	C0020619	Hypogonadism	0.2	0	0	HPO
1259	CNGA1	C0022578	Keratoconus	0.2	0	0	HPO
1259	CNGA1	C0028077	Night Blindness	0.2	0	0	HPO
1259	CNGA1	C0028738	Nystagmus	0.2	0	0	HPO
1259	CNGA1	C0028754	Obesity	0.2	0	0	HPO
1259	CNGA1	C0029124	Optic Atrophy	0.2	0	0	HPO
1259	CNGA1	C0035334	Retinitis Pigmentosa	0.606015278498054	1	4	CTD_human;HPO;ORPHANET
1259	CNGA1	C0271215	Blindness, Legal	0.2	0	0	HPO
1259	CNGA1	C3151059	RETINITIS PIGMENTOSA 49	0.2	1	3	UNIPROT
125972	CALR3	C3151266	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 19	0.2	1	1	UNIPROT
126	ADH1C	C3160718	PARKINSON DISEASE, LATE-ONSET	0.2	0	0	CTD_human
1261	CNGA3	C0015310	Exotropia	0.2	0	0	HPO
1261	CNGA3	C0018975	Hemeralopia	0.200274726784213	0	0	HPO
1261	CNGA3	C0020490	Hyperopia	0.2	0	0	HPO
1261	CNGA3	C0028077	Night Blindness	0.2	0	0	HPO
1261	CNGA3	C0028738	Nystagmus	0.200274726784213	0	0	HPO
1261	CNGA3	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
1261	CNGA3	C0042798	Low Vision	0.2	0	0	HPO
1261	CNGA3	C0152200	Achromatopsia	0.208791257094819	0	0	ORPHANET
1261	CNGA3	C0271215	Blindness, Legal	0.2	0	0	HPO
1261	CNGA3	C0271388	Pendular Nystagmus	0.2	0	0	HPO
1261	CNGA3	C0302129	Achromatopsia 1	0.208791257094819	0	0	HPO
1261	CNGA3	C0858618	Dyschromatopsia	0.2	0	0	HPO
1261	CNGA3	C1857618	Achromatopsia 2	0.480549453568426	7	32	CTD_human;UNIPROT
1261	CNGA3	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
126129	CPT1C	C4225387	SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT	0.4	1	1	ORPHANET;UNIPROT
126133	ALDH16A1	C0018099	Gout	0.2	1	0	CTD_human
126133	ALDH16A1	C0268117	Gout, HPRT-Related	0.2	1	0	CTD_human
126133	ALDH16A1	C0740394	Hyperuricemia	0.200274726784213	1	0	CTD_human
126306	JSRP1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
126326	GIPC3	C1866094	DEAFNESS, AUTOSOMAL RECESSIVE 15	0.2	2	6	UNIPROT
126328	NDUFA11	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.2	0	0	CTD_human
126328	NDUFA11	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
126410	CYP4F22	C1858133	Ichthyosis, Nonlamellar and Nonerythrodermic, Congenital, Autosomal Recessive	0.2	1	5	UNIPROT
126410	CYP4F22	C1858142	ICHTHYOSIS, LAMELLAR, 3	0.2	0	0	CTD_human
126792	B3GALT6	C1869122	EHLERS-DANLOS SYNDROME, PROGEROID FORM	0.2	0	0	ORPHANET
126792	B3GALT6	C3809210	EHLERS-DANLOS SYNDROME, PROGEROID TYPE, 2	0.2	1	5	UNIPROT
1268	CNR1	C0014175	Endometriosis	0.2	1	0	CTD_human
1268	CNR1	C0014556	Epilepsy, Temporal Lobe	0.2	1	0	CTD_human
1268	CNR1	C0020179	Huntington Disease	0.201373633921065	1	0	CTD_human
1268	CNR1	C0023890	Liver Cirrhosis	0.202732912464814	2	0	CTD_human
1268	CNR1	C0026769	Multiple Sclerosis	0.206187690967642	1	0	CTD_human
1268	CNR1	C0028754	Obesity	0.234784629817191	1	0	CTD_human
1268	CNR1	C0030305	Pancreatitis	0.2	1	0	CTD_human
1268	CNR1	C0038220	Status Epilepticus	0.2	1	0	CTD_human
1269	CNR2	C0004153	Atherosclerosis	0.201098907136852	1	0	CTD_human
1269	CNR2	C0023890	Liver Cirrhosis	0.200274726784213	1	0	CTD_human
1269	CNR2	C0030305	Pancreatitis	0.200274726784213	1	0	CTD_human
1270	CNTF	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
1272	CNTN1	C0085623	Akinesia	0.2	0	0	HPO
1272	CNTN1	C0158113	Contracture of joint of hand	0.2	0	0	HPO
1272	CNTN1	C1276035	Pena-Shokeir syndrome type I	0.2	0	0	HPO
1272	CNTN1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
1272	CNTN1	C2675527	Myopathy, Congenital, Compton-North	0.48	0	0	CTD_human;ORPHANET
1275	COD2	C1848139	CONE-ROD DYSTROPHY, X-LINKED, 2	0.2	0	0	CTD_human
127534	GJB4	C0079153	Hyperkeratosis, Epidermolytic	0.2	1	0	CTD_human
127534	GJB4	C0265961	Erythrokeratodermia variabilis	0.601923087489492	1	6	CTD_human;ORPHANET;UNIPROT
1277	COL1A1	C0002949	Aneurysm, Dissecting	0.2	1	0	CTD_human
1277	COL1A1	C0003504	Aortic Valve Insufficiency	0.2	1	0	CTD_human
1277	COL1A1	C0008311	Cholangitis	0.2	1	0	CTD_human
1277	COL1A1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
1277	COL1A1	C0018801	Heart failure	0.2	0	0	HPO
1277	COL1A1	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
1277	COL1A1	C0020497	Cortical Congenital Hyperostosis	0.604381273170092	1	3	CTD_human;ORPHANET;UNIPROT
1277	COL1A1	C0023890	Liver Cirrhosis	0.202681755307501	4	0	CTD_human
1277	COL1A1	C0023931	Lobstein's Disease	0.488516530310606	12	25	ORPHANET;UNIPROT
1277	COL1A1	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
1277	COL1A1	C0027092	Myopia	0.210177567661578	0	0	HPO
1277	COL1A1	C0029172	Oral Submucous Fibrosis	0.202681755307501	1	0	CTD_human
1277	COL1A1	C0029408	Degenerative polyarthritis	0.209470057000881	0	0	HPO
1277	COL1A1	C0029453	Osteopenia	0.203780662444353	0	0	HPO
1277	COL1A1	C0029456	Osteoporosis	0.273161475500207	0	0	CTD_human
1277	COL1A1	C0029899	Otosclerosis	0.213301876602548	0	0	HPO
1277	COL1A1	C0042345	Varicosity	0.2	0	0	HPO
1277	COL1A1	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
1277	COL1A1	C0238669	Aortic root dilatation	0.2	0	0	HPO
1277	COL1A1	C0268335	Ehlers-Danlos syndrome type 1	0.4	0	0	CTD_human;ORPHANET
1277	COL1A1	C0268336	Ehlers-Danlos syndrome type 2	0.2	0	0	ORPHANET
1277	COL1A1	C0268345	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE	0.400274726784213	0	0	CTD_human;ORPHANET
1277	COL1A1	C0268362	Osteogenesis imperfecta type III (disorder)	0.682747267842131	18	10	CTD_human;ORPHANET;UNIPROT
1277	COL1A1	C0426824	Beading of ribs	0.2	0	0	HPO
1277	COL1A1	C0455988	Hydrops Fetalis, Non-Immune	0.2	0	0	HPO
1277	COL1A1	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
1277	COL1A1	C0747078	Generalized osteopenia	0.2	0	0	HPO
1277	COL1A1	C1394691	Bowel diverticula	0.2	0	0	HPO
1277	COL1A1	C1395674	Bowel diverticulosis	0.2	0	0	HPO
1277	COL1A1	C1619692	Nephrogenic Fibrosing Dermopathy	0.2	1	0	CTD_human
1277	COL1A1	C1835121	Premature osteoarthritis	0.2	0	0	HPO
1277	COL1A1	C1837658	Gross motor development delay	0.2	0	0	HPO
1277	COL1A1	C1844597	Molluscoid pseudotumors	0.2	0	0	HPO
1277	COL1A1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
1277	COL1A1	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
1277	COL1A1	C4225429	Ehlers-Danlos syndrome classic type	0.2	2	0	UNIPROT
1278	COL1A2	C0003504	Aortic Valve Insufficiency	0.200274726784213	0	0	HPO
1278	COL1A2	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
1278	COL1A2	C0018801	Heart failure	0.2	0	0	HPO
1278	COL1A2	C0018802	Congestive heart failure	0.2	0	0	HPO
1278	COL1A2	C0023890	Liver Cirrhosis	0.202732912464814	1	0	CTD_human
1278	COL1A2	C0023931	Lobstein's Disease	0.402747267842131	6	8	ORPHANET;UNIPROT
1278	COL1A2	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
1278	COL1A2	C0029172	Oral Submucous Fibrosis	0.202956482091714	1	0	CTD_human
1278	COL1A2	C0029408	Degenerative polyarthritis	0.200274726784213	1	0	CTD_human
1278	COL1A2	C0029453	Osteopenia	0.200274726784213	0	0	HPO
1278	COL1A2	C0029456	Osteoporosis	0.204055389228567	0	0	CTD_human
1278	COL1A2	C0029899	Otosclerosis	0.200549453568426	0	0	HPO
1278	COL1A2	C0036421	Systemic Scleroderma	0.210085023103938	1	0	CTD_human
1278	COL1A2	C0268345	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE	0.402472541057918	0	0	CTD_human;ORPHANET
1278	COL1A2	C0268362	Osteogenesis imperfecta type III (disorder)	0.681648360705279	17	30	CTD_human;ORPHANET;UNIPROT
1278	COL1A2	C0426824	Beading of ribs	0.2	0	0	HPO
1278	COL1A2	C0455988	Hydrops Fetalis, Non-Immune	0.2	0	0	HPO
1278	COL1A2	C0747078	Generalized osteopenia	0.2	0	0	HPO
1278	COL1A2	C0854107	Haemorrhage subcutaneous	0.2	0	0	HPO
1278	COL1A2	C1835121	Premature osteoarthritis	0.2	0	0	HPO
1278	COL1A2	C1837658	Gross motor development delay	0.2	0	0	HPO
1278	COL1A2	C1857034	Ehlers-Danlos syndrome, cardiac valvular form	0.4	1	4	CTD_human;ORPHANET
1278	COL1A2	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
1278	COL1A2	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
127833	SYT2	C0751884	Congenital Myasthenic Syndromes, Presynaptic	0.200274726784213	0	0	ORPHANET
127833	SYT2	C4015038	MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC	0.2	1	2	UNIPROT
1280	COL2A1	C0003864	Arthritis	0.200549453568426	2	0	CTD_human
1280	COL2A1	C0014084	Enchondromatosis	0.2	0	0	HPO
1280	COL2A1	C0015300	Exophthalmos	0.2	0	0	HPO
1280	COL2A1	C0015814	Femur Head Necrosis	0.2	0	0	CTD_human
1280	COL2A1	C0017601	Glaucoma	0.2	0	0	HPO
1280	COL2A1	C0018777	Conductive hearing loss	0.2	0	0	HPO
1280	COL2A1	C0018784	Sensorineural Hearing Loss (disorder)	0.403007639249027	1	0	CTD_human;HPO
1280	COL2A1	C0020305	Hydrops Fetalis	0.200274726784213	0	0	HPO
1280	COL2A1	C0023234	Legg-Calve-Perthes Disease	0.60433011601278	0	0	CTD_human;HPO;ORPHANET;UNIPROT
1280	COL2A1	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
1280	COL2A1	C0027092	Myopia	0.405363510615002	1	0	CTD_human;HPO
1280	COL2A1	C0029408	Degenerative polyarthritis	0.513304095961168	2	0	CTD_human;HPO
1280	COL2A1	C0029410	Osteoarthritis of hip	0.203557092817453	0	0	HPO
1280	COL2A1	C0035305	Retinal Detachment	0.406513574909167	1	0	CTD_human;HPO
1280	COL2A1	C0038015	Spondyloepiphyseal Dysplasia	0.205494535684262	0	0	HPO
1280	COL2A1	C0039103	Synovitis	0.202732912464814	1	0	CTD_human
1280	COL2A1	C0085581	Restrictive lung disease	0.2	0	0	HPO
1280	COL2A1	C0149645	Cervical myelopathy	0.2	0	0	HPO
1280	COL2A1	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
1280	COL2A1	C0234958	muscle degeneration	0.2	0	0	HPO
1280	COL2A1	C0264112	Wedging of vertebra	0.2	0	0	HPO
1280	COL2A1	C0264142	Spade-like hand	0.2	0	0	HPO
1280	COL2A1	C0265294	Pyle metaphyseal dysplasia	0.2	0	0	HPO
1280	COL2A1	C0271055	Rhegmatogenous retinal detachment	0.200274726784213	0	0	HPO
1280	COL2A1	C0271215	Blindness, Legal	0.2	0	0	HPO
1280	COL2A1	C0344290	Vitreoretinal degeneration	0.200274726784213	0	0	HPO
1280	COL2A1	C0409959	Osteoarthritis, Knee	0.200274726784213	0	0	HPO
1280	COL2A1	C0410632	Schmorl's nodes	0.2	0	0	HPO
1280	COL2A1	C0432221	Spondylometaphyseal dysplasia, 'corner fracture' type	0.2	0	0	ORPHANET
1280	COL2A1	C0521770	Asteroid hyalosis	0.2	0	0	HPO
1280	COL2A1	C0694550	Recurrent pneumonia	0.2	0	0	HPO
1280	COL2A1	C0700635	Strudwick syndrome	0.600824180352639	2	5	CTD_human;HPO;ORPHANET;UNIPROT
1280	COL2A1	C0747085	Recurrent otitis media	0.2	0	0	HPO
1280	COL2A1	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
1280	COL2A1	C0796173	Spondyloperipheral dysplasia short ulna	0.401373633921066	0	0	CTD_human;ORPHANET
1280	COL2A1	C0948187	Tracheomalacia	0.2	0	0	HPO
1280	COL2A1	C1835121	Premature osteoarthritis	0.200549453568426	0	0	HPO
1280	COL2A1	C1835437	Platyspondylic Lethal Skeletal Dysplasia, Torrance Type	0.680824180352639	3	4	CTD_human;ORPHANET;UNIPROT
1280	COL2A1	C1836080	Stickler Syndrome, Type I, Nonsyndromic Ocular	0.68	4	7	CTD_human;ORPHANET;UNIPROT
1280	COL2A1	C1836683	Czech dysplasia, metatarsal type	0.400824180352639	4	1	ORPHANET;UNIPROT
1280	COL2A1	C1840452	Hyaloideoretinal degeneration of Wagner	0.201648360705279	1	0	CTD_human
1280	COL2A1	C1848488	Pierre Robin syndrome with fetal chondrodysplasia	0.200274726784213	0	0	ORPHANET
1280	COL2A1	C1851536	Epiphyseal Dysplasia, Multiple, with Myopia and Conductive Deafness	0.6	2	1	CTD_human;ORPHANET;UNIPROT
1280	COL2A1	C1858079	Osteoarthritis with Mild Chondrodysplasia	0.6	5	1	CTD_human;ORPHANET;UNIPROT
1280	COL2A1	C1866688	Spondylometaphyseal dysplasia, Algerian type	0.2	0	0	ORPHANET
1280	COL2A1	C2020284	Stickler syndrome, type 1	0.614560519563294	2	37	CTD_human;ORPHANET;UNIPROT
1280	COL2A1	C3887524	Skin Erosion	0.2	0	0	HPO
1280	COL2A1	C4225273	SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.400274726784213	1	1	ORPHANET;UNIPROT
1281	COL3A1	C0002170	Alopecia	0.2	0	0	HPO
1281	COL3A1	C0002949	Aneurysm, Dissecting	0.200549453568426	0	0	HPO
1281	COL3A1	C0003504	Aortic Valve Insufficiency	0.2	1	0	CTD_human
1281	COL3A1	C0011334	Dental caries	0.2	0	0	HPO
1281	COL3A1	C0013720	Ehlers-Danlos Syndrome	0.21453180880866	0	0	CTD_human
1281	COL3A1	C0015300	Exophthalmos	0.2	0	0	HPO
1281	COL3A1	C0015695	Fatty Liver	0.2	1	0	CTD_human
1281	COL3A1	C0017601	Glaucoma	0.2	0	0	HPO
1281	COL3A1	C0020443	Hypercholesterolemia	0.2	1	0	CTD_human
1281	COL3A1	C0020456	Hyperglycemia	0.200274726784213	1	0	CTD_human
1281	COL3A1	C0020459	Hyperinsulinism	0.200274726784213	1	0	CTD_human
1281	COL3A1	C0022578	Keratoconus	0.2	0	0	HPO
1281	COL3A1	C0023890	Liver Cirrhosis	0.202681755307501	5	0	CTD_human
1281	COL3A1	C0023891	Liver Cirrhosis, Alcoholic	0.2	1	0	CTD_human
1281	COL3A1	C0026267	Mitral Valve Prolapse Syndrome	0.205689394556528	0	0	HPO
1281	COL3A1	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
1281	COL3A1	C0031099	Periodontitis	0.2	0	0	HPO
1281	COL3A1	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
1281	COL3A1	C0042345	Varicosity	0.2	0	0	HPO
1281	COL3A1	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
1281	COL3A1	C0149781	Spontaneous pneumothorax	0.2	0	0	HPO
1281	COL3A1	C0238590	Acrogeria	0.200549453568426	0	0	ORPHANET
1281	COL3A1	C0268337	Ehlers-Danlos syndrome, type 3 (disorder)	0.4	1	2	CTD_human;UNIPROT
1281	COL3A1	C0268338	Ehlers-Danlos Syndrome, Type IV	0.493121373107599	23	344	ORPHANET;UNIPROT
1281	COL3A1	C0340643	Dissection of aorta	0.2	0	0	HPO
1281	COL3A1	C0399385	Early tooth exfoliation	0.2	0	0	HPO
1281	COL3A1	C0406584	Acrogeria, gottron type	0.2	0	0	ORPHANET
1281	COL3A1	C0751003	Brain Aneurysm	0.2	0	0	HPO
1281	COL3A1	C0917990	Acro-Osteolysis	0.2	0	0	HPO
1281	COL3A1	C1280433	Lipoatrophy	0.2	0	0	HPO
1281	COL3A1	C1290398	Cerebral arterial aneurysm	0.2	0	0	HPO
1281	COL3A1	C1844597	Molluscoid pseudotumors	0.2	0	0	HPO
1281	COL3A1	C1853365	AORTIC ANEURYSM, FAMILIAL ABDOMINAL 1	0.4	2	2	ORPHANET;UNIPROT
1281	COL3A1	C1862932	ANEURYSM, INTRACRANIAL BERRY, 1 (disorder)	0.2	0	0	ORPHANET
1281	COL3A1	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
1281	COL3A1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
128178	EDARADD	C0265331	Autosomal dominant hypohidrotic ectodermal dysplasia syndrome (disorder)	0.2	0	0	ORPHANET
128178	EDARADD	C3539920	ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	0.202197814273705	2	2	UNIPROT
128178	EDARADD	C3541517	ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT	0.202197814273705	2	1	UNIPROT
1282	COL4A1	C0002878	Anemia, Hemolytic	0.200274726784213	0	0	HPO
1282	COL4A1	C0011881	Diabetic Nephropathy	0.200274726784213	1	0	CTD_human
1282	COL4A1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
1282	COL4A1	C0015310	Exotropia	0.2	0	0	HPO
1282	COL4A1	C0017668	Focal glomerulosclerosis	0.2	2	0	CTD_human
1282	COL4A1	C0020255	Hydrocephalus	0.2	0	0	HPO
1282	COL4A1	C0022679	Cystic kidney	0.2	0	0	HPO
1282	COL4A1	C0035078	Kidney Failure	0.2	0	0	HPO
1282	COL4A1	C0038379	Strabismus	0.2	0	0	HPO
1282	COL4A1	C0154723	Migraine with Aura	0.2	0	0	HPO
1282	COL4A1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
1282	COL4A1	C0265221	Walker-Warburg congenital muscular dystrophy	0.280549453568426	0	0	ORPHANET
1282	COL4A1	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
1282	COL4A1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
1282	COL4A1	C0751003	Brain Aneurysm	0.2	0	0	HPO
1282	COL4A1	C0948008	Ischemic stroke	0.200274726784213	0	0	HPO
1282	COL4A1	C1290398	Cerebral arterial aneurysm	0.200274726784213	0	0	HPO
1282	COL4A1	C1565489	Renal Insufficiency	0.2	0	0	HPO
1282	COL4A1	C1843512	BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE	0.200549453568426	0	0	CTD_human
1282	COL4A1	C1867983	PORENCEPHALY, FAMILIAL	0.481373633921066	3	6	ORPHANET;UNIPROT
1282	COL4A1	C2673195	Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps	0.600549453568426	3	6	CTD_human;ORPHANET;UNIPROT
1282	COL4A1	C4013035	BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES	0.48	8	0	ORPHANET;UNIPROT
1282	COL4A1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
1282	COL4A1	C4024975	Posterior leukoencephalopathy	0.2	0	0	HPO
1282	COL4A1	C4082173	Porencephaly	0.404945082115836	0	0	CTD_human;HPO
128338	DRAM2	C0035334	Retinitis Pigmentosa	0.2	0	0	ORPHANET
1284	COL4A2	C0014544	Epilepsy	0.2	0	0	HPO
1284	COL4A2	C1867983	PORENCEPHALY, FAMILIAL	0.200274726784213	0	0	ORPHANET
1284	COL4A2	C3280970	PORENCEPHALY 2	0.2	1	2	UNIPROT
1284	COL4A2	C4082173	Porencephaly	0.201923087489492	0	0	HPO
1285	COL4A3	C0017658	Glomerulonephritis	0.203557092817453	0	0	HPO
1285	COL4A3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1285	COL4A3	C0027092	Myopia	0.2	0	0	HPO
1285	COL4A3	C0027697	Nephritis	0.200274726784213	0	0	HPO
1285	COL4A3	C0027706	Hereditary nephritis	0.219679840822122	1	0	CTD_human
1285	COL4A3	C0027709	Nephrocalcinosis	0.2	0	0	HPO
1285	COL4A3	C0241908	Hematuria, Benign Familial	0.402197814273705	1	5	CTD_human;UNIPROT
1285	COL4A3	C0242528	Azotemia	0.2	0	0	HPO
1285	COL4A3	C0392163	Corneal erosion	0.2	0	0	HPO
1285	COL4A3	C1567743	Alport Syndrome, Autosomal Dominant	0.400549453568426	1	3	ORPHANET;UNIPROT
1285	COL4A3	C1567744	Alport Syndrome, Autosomal Recessive	0.48439562854741	2	11	ORPHANET;UNIPROT
1285	COL4A3	C1855179	CATARACT, ANTERIOR POLAR	0.2	0	0	HPO
1285	COL4A3	C2316810	Chronic kidney disease stage 5	0.201373633921065	0	0	HPO
1285	COL4A3	C2931253	Alport syndrome, dominant type	0.2	0	0	ORPHANET
1285	COL4A3	C2931254	Alport syndrome, recessive type	0.2	0	0	CTD_human
1286	COL4A4	C0027092	Myopia	0.2	0	0	HPO
1286	COL4A4	C0027697	Nephritis	0.2	0	0	HPO
1286	COL4A4	C0241908	Hematuria, Benign Familial	0.202747267842131	3	5	UNIPROT
1286	COL4A4	C0392163	Corneal erosion	0.2	0	0	HPO
1286	COL4A4	C1567743	Alport Syndrome, Autosomal Dominant	0.200274726784213	0	0	ORPHANET
1286	COL4A4	C1567744	Alport Syndrome, Autosomal Recessive	0.48357144819477	2	7	ORPHANET;UNIPROT
1286	COL4A4	C2316810	Chronic kidney disease stage 5	0.200549453568426	0	0	HPO
1286	COL4A4	C2931253	Alport syndrome, dominant type	0.2	0	0	ORPHANET
1286	COL4A4	C2931254	Alport syndrome, recessive type	0.2	0	0	CTD_human
128637	TBC1D20	C1838625	Warburg Sjo Fledelius syndrome	0.200549453568426	0	0	ORPHANET
128674	PROKR2	C0162809	Kallmann Syndrome	0.422339149726945	0	0	CTD_human;ORPHANET
128674	PROKR2	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
128674	PROKR2	C3550478	HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA	0.2	4	16	UNIPROT
1287	COL4A5	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
1287	COL4A5	C0020626	Hypoparathyroidism	0.2	0	0	HPO
1287	COL4A5	C0020757	Ichthyoses	0.2	0	0	HPO
1287	COL4A5	C0027092	Myopia	0.2	0	0	HPO
1287	COL4A5	C0027697	Nephritis	0.201373633921065	0	0	HPO
1287	COL4A5	C0392163	Corneal erosion	0.2	0	0	HPO
1287	COL4A5	C1567742	Alport Syndrome, X-Linked	0.697307787405425	17	500	CTD_human;ORPHANET;UNIPROT
1287	COL4A5	C1839884	Leiomyomatosis, esophageal and vulval, with nephropathy	0.200824180352639	0	0	ORPHANET
1287	COL4A5	C2316810	Chronic kidney disease stage 5	0.200824180352639	0	0	HPO
1287	COL4A5	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
1288	COL4A6	C1839884	Leiomyomatosis, esophageal and vulval, with nephropathy	0.400549453568426	0	0	CTD_human;ORPHANET
1288	COL4A6	C3806737	DEAFNESS, X-LINKED 6	0.2	1	1	UNIPROT
128866	CHMP4B	C1854311	Cataract, posterior polar, 3	0.4	1	2	CTD_human;UNIPROT
128866	CHMP4B	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
1289	COL5A1	C0002949	Aneurysm, Dissecting	0.2	0	0	HPO
1289	COL5A1	C0011334	Dental caries	0.2	0	0	HPO
1289	COL5A1	C0015300	Exophthalmos	0.2	0	0	HPO
1289	COL5A1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
1289	COL5A1	C0017601	Glaucoma	0.2	0	0	HPO
1289	COL5A1	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
1289	COL5A1	C0027092	Myopia	0.2	0	0	HPO
1289	COL5A1	C0029408	Degenerative polyarthritis	0.200274726784213	0	0	HPO
1289	COL5A1	C0042345	Varicosity	0.2	0	0	HPO
1289	COL5A1	C0238669	Aortic root dilatation	0.2	0	0	HPO
1289	COL5A1	C0268335	Ehlers-Danlos syndrome type 1	0.400824180352639	3	19	CTD_human;ORPHANET
1289	COL5A1	C0268336	Ehlers-Danlos syndrome type 2	0.400824180352639	2	0	CTD_human;ORPHANET
1289	COL5A1	C0268338	Ehlers-Danlos Syndrome, Type IV	0.2	0	0	ORPHANET
1289	COL5A1	C0340643	Dissection of aorta	0.2	0	0	HPO
1289	COL5A1	C1394691	Bowel diverticula	0.2	0	0	HPO
1289	COL5A1	C1395674	Bowel diverticulosis	0.2	0	0	HPO
1289	COL5A1	C1844597	Molluscoid pseudotumors	0.2	0	0	HPO
1289	COL5A1	C4225429	Ehlers-Danlos syndrome classic type	0.28	4	2	UNIPROT
128989	TANGO2	C4225171	METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION	0.2	1	3	UNIPROT
1290	COL5A2	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
1290	COL5A2	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
1290	COL5A2	C0026267	Mitral Valve Prolapse Syndrome	0.200274726784213	0	0	HPO
1290	COL5A2	C0027092	Myopia	0.2	0	0	HPO
1290	COL5A2	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
1290	COL5A2	C0042345	Varicosity	0.2	0	0	HPO
1290	COL5A2	C0238669	Aortic root dilatation	0.2	0	0	HPO
1290	COL5A2	C0268335	Ehlers-Danlos syndrome type 1	0.4	0	0	CTD_human;ORPHANET
1290	COL5A2	C0268336	Ehlers-Danlos syndrome type 2	0.200274726784213	0	0	ORPHANET
1290	COL5A2	C1394691	Bowel diverticula	0.2	0	0	HPO
1290	COL5A2	C1395674	Bowel diverticulosis	0.2	0	0	HPO
1290	COL5A2	C1844597	Molluscoid pseudotumors	0.2	0	0	HPO
1290	COL5A2	C4225429	Ehlers-Danlos syndrome classic type	0.28	1	0	UNIPROT
1291	COL6A1	C0026850	Muscular Dystrophy	0.214763469460921	1	0	CTD_human
1291	COL6A1	C0334013	Phrynoderma	0.2	0	0	HPO
1291	COL6A1	C0376175	Bell Palsy	0.2	0	0	HPO
1291	COL6A1	C0410179	Scleroatonic muscular dystrophy	0.607626837423337	3	35	CTD_human;ORPHANET;UNIPROT
1291	COL6A1	C0699743	Congenital muscular dystrophy (disorder)	0.2	0	0	HPO
1291	COL6A1	C1389113	Generalized amyotrophy	0.2	0	0	HPO
1291	COL6A1	C1834674	Bethlem myopathy	0.68357144819477	5	33	CTD_human;ORPHANET;UNIPROT
1291	COL6A1	C1865343	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE	0.202407028523288	0	0	CTD_human
1291	COL6A1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
1291	COL6A1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1292	COL6A2	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
1292	COL6A2	C0234958	muscle degeneration	0.2	0	0	HPO
1292	COL6A2	C0334013	Phrynoderma	0.2	0	0	HPO
1292	COL6A2	C0376175	Bell Palsy	0.2	0	0	HPO
1292	COL6A2	C0410179	Scleroatonic muscular dystrophy	0.604120901763197	2	25	CTD_human;ORPHANET;UNIPROT
1292	COL6A2	C0699743	Congenital muscular dystrophy (disorder)	0.200274726784213	0	0	HPO
1292	COL6A2	C0749379	Thoracolumbar scoliosis	0.2	0	0	HPO
1292	COL6A2	C1389113	Generalized amyotrophy	0.2	0	0	HPO
1292	COL6A2	C1611706	Myosclerosis	0.2	0	0	ORPHANET
1292	COL6A2	C1834674	Bethlem myopathy	0.602197814273705	4	28	CTD_human;ORPHANET;UNIPROT
1292	COL6A2	C1850671	Myosclerosis, Autosomal Recessive	0.200274726784213	0	0	CTD_human
1292	COL6A2	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
1292	COL6A2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1293	COL6A3	C0154676	Organic writer's cramp	0.2	0	0	HPO
1293	COL6A3	C0334013	Phrynoderma	0.2	0	0	HPO
1293	COL6A3	C0376175	Bell Palsy	0.2	0	0	HPO
1293	COL6A3	C0410179	Scleroatonic muscular dystrophy	0.683296721410557	1	21	CTD_human;ORPHANET;UNIPROT
1293	COL6A3	C0699743	Congenital muscular dystrophy (disorder)	0.2	0	0	HPO
1293	COL6A3	C1389113	Generalized amyotrophy	0.2	0	0	HPO
1293	COL6A3	C1834674	Bethlem myopathy	0.603296721410557	4	25	CTD_human;ORPHANET;UNIPROT
1293	COL6A3	C1963946	Laryngeal dystonia	0.2	0	0	HPO
1293	COL6A3	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
1293	COL6A3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1293	COL6A3	C4225336	DYSTONIA 27	0.4	1	5	ORPHANET;UNIPROT
1294	COL7A1	C0002170	Alopecia	0.2	0	0	HPO
1294	COL7A1	C0002871	Anemia	0.2	0	0	HPO
1294	COL7A1	C0002893	Refractory anemias	0.2	0	0	HPO
1294	COL7A1	C0005741	Blepharitis	0.2	0	0	HPO
1294	COL7A1	C0007971	Cheilitis	0.2	0	0	HPO
1294	COL7A1	C0009763	Conjunctivitis	0.2	0	0	HPO
1294	COL7A1	C0011334	Dental caries	0.2	0	0	HPO
1294	COL7A1	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
1294	COL7A1	C0013592	Ectropion	0.2	0	0	HPO
1294	COL7A1	C0029453	Osteopenia	0.2	0	0	HPO
1294	COL7A1	C0029456	Osteoporosis	0.2	0	0	HPO
1294	COL7A1	C0079294	Epidermolysis Bullosa Dystrophica	0.274574188449211	0	0	CTD_human
1294	COL7A1	C0079474	Hallopeau-Siemens Disease	0.501153962384409	16	27	ORPHANET;UNIPROT
1294	COL7A1	C0162429	Malnutrition	0.2	0	0	HPO
1294	COL7A1	C0221260	Dystrophia unguium	0.200549453568426	0	0	HPO
1294	COL7A1	C0238115	Boerhaave syndrome	0.2	0	0	HPO
1294	COL7A1	C0241423	Atrophy of tongue	0.2	0	0	HPO
1294	COL7A1	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
1294	COL7A1	C0392163	Corneal erosion	0.2	0	0	HPO
1294	COL7A1	C0747078	Generalized osteopenia	0.2	0	0	HPO
1294	COL7A1	C1275114	Epidermolysis Bullosa Pruriginosa	0.603296721410557	1	2	CTD_human;ORPHANET;UNIPROT
1294	COL7A1	C1834405	Nail dysplasia	0.2	0	0	HPO
1294	COL7A1	C1843477	Epidermolysis Bullosa Simplex Superficialis	0.2	0	0	ORPHANET
1294	COL7A1	C1843761	TOENAIL DYSTROPHY, ISOLATED	0.4	1	4	CTD_human;UNIPROT
1294	COL7A1	C1851573	Transient bullous dermolysis of the newborn	0.600824180352639	2	3	CTD_human;ORPHANET;UNIPROT
1294	COL7A1	C3887524	Skin Erosion	0.2	0	0	HPO
129563	DIS3L2	C0796113	Nephroblastomatosis, fetal ascites, macrosomia and Wilms tumor	0.601373633921066	1	2	CTD_human;ORPHANET;UNIPROT
1296	COL8A2	C0010036	Corneal dystrophy	0.201373633921065	0	0	HPO
1296	COL8A2	C0016781	Fuchs Endothelial Dystrophy	0.205978476718058	0	0	ORPHANET
1296	COL8A2	C0155118	Corneal degeneration	0.2	0	0	HPO
1296	COL8A2	C0271288	Corneal guttata	0.2	0	0	HPO
1296	COL8A2	C0339284	Polymorphous corneal dystrophy	0.400824180352639	0	0	CTD_human;ORPHANET
1296	COL8A2	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
1296	COL8A2	C1850959	Corneal dystrophy, Fuchs' endothelial, 1	0.480274726784213	2	6	CTD_human;UNIPROT
1296	COL8A2	C1852795	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2	0.4	0	0	CTD_human;UNIPROT
1297	COL9A1	C0004106	Astigmatism	0.2	0	0	HPO
1297	COL9A1	C0018784	Sensorineural Hearing Loss (disorder)	0.4	1	0	CTD_human;HPO
1297	COL9A1	C0027092	Myopia	0.4	1	0	CTD_human;HPO
1297	COL9A1	C0029408	Degenerative polyarthritis	0.205638237399215	0	0	HPO
1297	COL9A1	C0035305	Retinal Detachment	0.2	0	0	HPO
1297	COL9A1	C0271183	Severe myopia	0.2	0	0	HPO
1297	COL9A1	C0344290	Vitreoretinal degeneration	0.2	0	0	HPO
1297	COL9A1	C0410632	Schmorl's nodes	0.2	0	0	HPO
1297	COL9A1	C1843486	Degenerative vitreoretinopathy	0.2	0	0	HPO
129787	TMEM18	C0028754	Obesity	0.243457538488444	1	0	CTD_human
1298	COL9A2	C0004106	Astigmatism	0.2	0	0	HPO
1298	COL9A2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1298	COL9A2	C0027092	Myopia	0.2	0	0	HPO
1298	COL9A2	C0029408	Degenerative polyarthritis	0.202956482091714	0	0	HPO
1298	COL9A2	C0035305	Retinal Detachment	0.2	0	0	HPO
1298	COL9A2	C0271183	Severe myopia	0.2	0	0	HPO
1298	COL9A2	C0344290	Vitreoretinal degeneration	0.2	0	0	HPO
1298	COL9A2	C0409959	Osteoarthritis, Knee	0.2	0	0	HPO
1298	COL9A2	C1838429	Epiphyseal dysplasia, multiple, 2	0.2	0	0	CTD_human
129880	BBS5	C0752166	Bardet-Biedl Syndrome	0.406839458850693	0	0	CTD_human;ORPHANET
129880	BBS5	C3892039	BARDET-BIEDL SYNDROME 5	0.200549453568426	2	3	UNIPROT
1299	COL9A3	C0004106	Astigmatism	0.2	0	0	HPO
1299	COL9A3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1299	COL9A3	C0027092	Myopia	0.2	0	0	HPO
1299	COL9A3	C0029408	Degenerative polyarthritis	0.205363510615002	0	0	HPO
1299	COL9A3	C0035305	Retinal Detachment	0.2	0	0	HPO
1299	COL9A3	C0344290	Vitreoretinal degeneration	0.2	0	0	HPO
1299	COL9A3	C1832998	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3	0.4	1	1	CTD_human;UNIPROT
1300	COL10A1	C0010278	Craniosynostosis	0.2	0	0	HPO
1300	COL10A1	C0020437	Hypercalcemia	0.2	0	0	HPO
1300	COL10A1	C0265289	Metaphyseal chondrodysplasia Schmid type	0.681373633921066	2	14	CTD_human;ORPHANET;UNIPROT
1301	COL11A1	C0004106	Astigmatism	0.2	0	0	HPO
1301	COL11A1	C0014877	Esotropia	0.2	0	0	HPO
1301	COL11A1	C0015300	Exophthalmos	0.2	0	0	HPO
1301	COL11A1	C0017601	Glaucoma	0.200549453568426	0	0	HPO
1301	COL11A1	C0017605	Angle Closure Glaucoma	0.200274726784213	2	0	CTD_human
1301	COL11A1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1301	COL11A1	C0020305	Hydrops Fetalis	0.2	0	0	HPO
1301	COL11A1	C0020620	Hypohidrosis	0.2	0	0	HPO
1301	COL11A1	C0021818	Intervertebral Disk Displacement	0.204814057046576	1	0	CTD_human
1301	COL11A1	C0027092	Myopia	0.2	0	0	HPO
1301	COL11A1	C0029408	Degenerative polyarthritis	0.202956482091714	0	0	HPO
1301	COL11A1	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
1301	COL11A1	C0035305	Retinal Detachment	0.2	0	0	HPO
1301	COL11A1	C0038015	Spondyloepiphyseal Dysplasia	0.2	0	0	HPO
1301	COL11A1	C0042798	Low Vision	0.2	0	0	HPO
1301	COL11A1	C0158113	Contracture of joint of hand	0.2	0	0	HPO
1301	COL11A1	C0265235	Marshall syndrome	0.481098907136852	1	3	CTD_human;ORPHANET
1301	COL11A1	C0267048	Glossoptosis	0.2	0	0	HPO
1301	COL11A1	C0271183	Severe myopia	0.200274726784213	0	0	HPO
1301	COL11A1	C0344290	Vitreoretinal degeneration	0.2	0	0	HPO
1301	COL11A1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
1301	COL11A1	C0740852	Upper airway obstruction	0.2	0	0	HPO
1301	COL11A1	C1397139	Calcification of falx cerebri	0.2	0	0	HPO
1301	COL11A1	C1858084	STICKLER SYNDROME, TYPE II (disorder)	0.681373633921066	3	7	CTD_human;ORPHANET;UNIPROT
1301	COL11A1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
1301	COL11A1	C3278138	FIBROCHONDROGENESIS 1	0.2	1	0	UNIPROT
1302	COL11A2	C0015300	Exophthalmos	0.2	0	0	HPO
1302	COL11A2	C0018784	Sensorineural Hearing Loss (disorder)	0.401098907136852	1	1	CTD_human;HPO
1302	COL11A2	C0029408	Degenerative polyarthritis	0.203231208875927	0	0	HPO
1302	COL11A2	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
1302	COL11A2	C0267048	Glossoptosis	0.2	0	0	HPO
1302	COL11A2	C0694550	Recurrent pneumonia	0.2	0	0	HPO
1302	COL11A2	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
1302	COL11A2	C1835121	Premature osteoarthritis	0.2	0	0	HPO
1302	COL11A2	C1848488	Pierre Robin syndrome with fetal chondrodysplasia	0.600549453568426	1	1	CTD_human;ORPHANET;UNIPROT
1302	COL11A2	C1861481	Stickler syndrome, type 3	0.48	0	0	CTD_human;ORPHANET
1302	COL11A2	C1864746	Deafness, Autosomal Recessive 53	0.400274726784213	2	3	CTD_human;UNIPROT
1302	COL11A2	C1866095	Deafness, Autosomal Dominant 13	0.480274726784213	1	2	CTD_human;UNIPROT
1303	COL12A1	C0376175	Bell Palsy	0.2	0	0	HPO
1303	COL12A1	C0410179	Scleroatonic muscular dystrophy	0.2	0	0	ORPHANET
1303	COL12A1	C0699743	Congenital muscular dystrophy (disorder)	0.2	0	0	HPO
1303	COL12A1	C1834674	Bethlem myopathy	0.2	0	0	ORPHANET
1303	COL12A1	C4225313	BETHLEM MYOPATHY 2	0.2	2	3	UNIPROT
130340	AP1S3	C0030246	Pustulosis of Palms and Soles	0.2	0	0	ORPHANET
130340	AP1S3	C0343055	Generalized pustular psoriasis	0.2	0	0	ORPHANET
1305	COL13A1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
1305	COL13A1	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	0.2	0	0	ORPHANET
1305	COL13A1	C0751884	Congenital Myasthenic Syndromes, Presynaptic	0.2	0	0	ORPHANET
1305	COL13A1	C1301959	Bulbar weakness	0.2	0	0	HPO
1305	COL13A1	C4082299	Bulbar palsy	0.2	0	0	HPO
130557	ZNF513	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
130557	ZNF513	C3150879	RETINITIS PIGMENTOSA 58	0.4	1	1	CTD_human;UNIPROT
1308	COL17A1	C0002871	Anemia	0.2	0	0	HPO
1308	COL17A1	C0011334	Dental caries	0.2	0	0	HPO
1308	COL17A1	C0152227	Excessive tearing	0.2	0	0	HPO
1308	COL17A1	C0221260	Dystrophia unguium	0.2	0	0	HPO
1308	COL17A1	C0268374	Adult junctional epidermolysis bullosa (disorder)	0.6	6	7	CTD_human;ORPHANET;UNIPROT
1308	COL17A1	C0392163	Corneal erosion	0.2	0	0	HPO
1308	COL17A1	C1274743	Hyperhidrosis Palmaris Et Plantaris	0.2	0	0	HPO
1308	COL17A1	C1834405	Nail dysplasia	0.2	0	0	HPO
1308	COL17A1	C1852551	Epithelial Recurrent Erosion Dystrophy	0.400549453568426	1	2	ORPHANET;UNIPROT
1311	COMP	C0023234	Legg-Calve-Perthes Disease	0.2	0	0	HPO
1311	COMP	C0029408	Degenerative polyarthritis	0.412543208784538	1	0	CTD_human;HPO
1311	COMP	C0029410	Osteoarthritis of hip	0.200274726784213	0	0	HPO
1311	COMP	C0151313	Sensory neuropathy	0.2	0	0	HPO
1311	COMP	C0264112	Wedging of vertebra	0.2	0	0	HPO
1311	COMP	C1257915	Intestinal Polyposis	0.2	0	0	HPO
1311	COMP	C1838280	Epiphyseal dysplasia, multiple, 1	0.681098907136852	9	13	CTD_human;ORPHANET;UNIPROT
131118	DNAJC19	C1857776	3-@METHYLGLUTACONIC ACIDURIA, TYPE V	0.400824180352639	0	0	CTD_human;ORPHANET
1312	COMT	C0011334	Dental caries	0.2	0	0	HPO
1312	COMT	C0012236	DiGeorge Syndrome	0.436064040448992	1	0	CTD_human;ORPHANET
1312	COMT	C0018777	Conductive hearing loss	0.2	0	0	HPO
1312	COMT	C0020626	Hypoparathyroidism	0.2	0	0	HPO
1312	COMT	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
1312	COMT	C0039621	Tetany	0.2	0	0	HPO
1312	COMT	C0085109	Corneal Neovascularization	0.2	0	0	HPO
1312	COMT	C0220704	Shprintzen syndrome	0.208176290991763	0	0	ORPHANET
1312	COMT	C0271441	Chronic otitis media	0.2	0	0	HPO
1312	COMT	C0702166	Acne	0.2	0	0	HPO
1312	COMT	C0743359	ear infection chronic	0.2	0	0	HPO
1312	COMT	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	0.2	0	0	ORPHANET
1312	COMT	C2936346	22q11 Deletion Syndrome	0.204055389228567	0	0	ORPHANET
1312	COMT	C3266101	22q11 partial monosomy syndrome	0.2	0	0	ORPHANET
1312	COMT	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
1312	COMT	C4024912	Occipital myelomeningocele	0.2	0	0	HPO
131377	KLHL40	C3809209	NEMALINE MYOPATHY 8	0.28	1	9	UNIPROT
1314	COPA	C0003864	Arthritis	0.200274726784213	1	0	CTD_human
1314	COPA	C4225334	AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE	0.4	1	4	ORPHANET;UNIPROT
131566	DCBLD2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
131669	UROC1	C0268514	Urocanase deficiency	0.600274726784213	1	2	CTD_human;ORPHANET;UNIPROT
1319	CORD1	C1833564	CONE-ROD DYSTROPHY 1 (disorder)	0.2	0	0	CTD_human
132	ADK	C0008370	Cholestasis	0.2	0	0	HPO
132	ADK	C0014544	Epilepsy	0.201373633921065	0	0	HPO
132	ADK	C0234958	muscle degeneration	0.2	0	0	HPO
132	ADK	C0235946	Cerebral atrophy	0.2	0	0	HPO
132	ADK	C0268621	Hepatic methionine adenosyltransferase deficiency	0.200274726784213	0	0	HPO
132	ADK	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
132	ADK	C2711227	Steatohepatitis	0.2	0	0	HPO
132	ADK	C3280381	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.6	1	3	CTD_human;ORPHANET;UNIPROT
132	ADK	C4020860	Supratentorial atrophy	0.2	0	0	HPO
132158	GLYCTK	C0342765	D-Glyceric aciduria	0.200274726784213	1	1	UNIPROT
132158	GLYCTK	C1291386	D-glycericacidemia	0.200274726784213	0	0	ORPHANET
1326	MAP3K8	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
132789	GNPDA2	C0028754	Obesity	0.234313365429088	1	0	CTD_human
132884	EVC2	C0013903	Ellis-Van Creveld Syndrome	0.69013618026125	2	12	CTD_human;ORPHANET;UNIPROT
132884	EVC2	C0457013	Weyers acrofacial dysostosis	0.201098907136852	0	0	ORPHANET
1329	COX5B	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
133	ADM	C0017658	Glomerulonephritis	0.200274726784213	2	0	CTD_human
133	ADM	C0038358	Gastric ulcer	0.2	1	0	CTD_human
133	ADM	C0243026	Sepsis	0.292580010564534	1	0	CTD_human
133396	IL31RA	C0268398	Familial lichen amyloidosis	0.200274726784213	0	0	ORPHANET
133396	IL31RA	C3151404	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2	0.2	1	0	UNIPROT
133418	EMB	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
133522	PPARGC1B	C0020473	Hyperlipidemia	0.2	1	0	CTD_human
133522	PPARGC1B	C0028754	Obesity	0.205429023149632	0	0	CTD_human
133686	NADK2	C1857252	2,4-Dienoyl-CoA Reductase Deficiency	0.2	0	0	ORPHANET
1337	COX6A1	C0085684	Foot-drop	0.2	0	0	HPO
1337	COX6A1	C4015029	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D	0.28	0	0	ORPHANET
134	ADORA1	C0007787	Transient Ischemic Attack	0.2	1	0	CTD_human
134	ADORA1	C0027051	Myocardial Infarction	0.202407028523288	1	0	CTD_human
134	ADORA1	C0038525	Subarachnoid Hemorrhage	0.2	1	0	CTD_human
134	ADORA1	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
1340	COX6B1	C0002871	Anemia	0.2	0	0	HPO
1340	COX6B1	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
1340	COX6B1	C0014544	Epilepsy	0.2	0	0	HPO
1340	COX6B1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1340	COX6B1	C0029124	Optic Atrophy	0.2	0	0	HPO
1340	COX6B1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
1340	COX6B1	C0151747	Renal tubular disorder	0.2	0	0	HPO
1340	COX6B1	C0238621	Aminoaciduria	0.2	0	0	HPO
1340	COX6B1	C0341703	Adult Fanconi syndrome	0.2	0	0	HPO
1340	COX6B1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
134430	WDR36	C0004096	Asthma	0.202681755307501	1	0	CTD_human
134430	WDR36	C0339573	Glaucoma, Primary Open Angle	0.205494535684262	0	0	CTD_human
134430	WDR36	C1835933	Glaucoma 1, Open Angle, G	0.4	1	2	CTD_human;UNIPROT
134701	RIPPLY2	C0265343	Jarcho-Levin syndrome	0.2	0	0	ORPHANET
134728	IRAK1BP1	C1527336	Sjogren's Syndrome	0.2	1	0	CTD_human
1349	COX7B	C0796070	MICROPHTHALMIA, SYNDROMIC 7	0.200549453568426	0	0	ORPHANET
135	ADORA2A	C0003873	Rheumatoid Arthritis	0.205088783830789	1	0	CTD_human
135	ADORA2A	C0021603	Sleep Initiation and Maintenance Disorders	0.202407028523288	1	0	CTD_human
1350	COX7C	C0028754	Obesity	0.2	1	0	CTD_human
135138	PACRG	C0023343	Leprosy	0.207286598104494	0	0	CTD_human
1352	COX10	C0002871	Anemia	0.200274726784213	0	0	HPO
1352	COX10	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
1352	COX10	C0014544	Epilepsy	0.2	0	0	HPO
1352	COX10	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1352	COX10	C0020555	Hypertrichosis	0.2	0	0	HPO
1352	COX10	C0028738	Nystagmus	0.2	0	0	HPO
1352	COX10	C0029124	Optic Atrophy	0.2	0	0	HPO
1352	COX10	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
1352	COX10	C0038379	Strabismus	0.2	0	0	HPO
1352	COX10	C0151747	Renal tubular disorder	0.2	0	0	HPO
1352	COX10	C0238621	Aminoaciduria	0.2	0	0	HPO
1352	COX10	C0338474	Central nervous system demyelination	0.2	0	0	HPO
1352	COX10	C0341703	Adult Fanconi syndrome	0.2	0	0	HPO
1352	COX10	C1145670	Respiratory Failure	0.2	0	0	HPO
1352	COX10	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1352	COX10	C4020871	Dystonic disease	0.2	0	0	HPO
135228	CD109	C3854603	FNAITP	0.2	0	0	ORPHANET
1355	COX15	C0014544	Epilepsy	0.2	0	0	HPO
1355	COX15	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1355	COX15	C0020555	Hypertrichosis	0.2	0	0	HPO
1355	COX15	C0023264	Leigh Disease	0.60328236603324	1	2	CTD_human;ORPHANET;UNIPROT
1355	COX15	C0028738	Nystagmus	0.2	0	0	HPO
1355	COX15	C0029124	Optic Atrophy	0.2	0	0	HPO
1355	COX15	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
1355	COX15	C0038379	Strabismus	0.2	0	0	HPO
1355	COX15	C0338474	Central nervous system demyelination	0.2	0	0	HPO
1355	COX15	C1145670	Respiratory Failure	0.2	0	0	HPO
1355	COX15	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1355	COX15	C2711227	Steatohepatitis	0.2	0	0	HPO
1355	COX15	C3554534	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2	0.2	3	1	UNIPROT
1355	COX15	C4020871	Dystonic disease	0.2	0	0	HPO
1355	COX15	C4273730	Fatal infantile cytochrome C oxidase deficiency	0.2	0	0	ORPHANET
1356	CP	C0002871	Anemia	0.201373633921065	0	0	HPO
1356	CP	C0002893	Refractory anemias	0.200274726784213	0	0	HPO
1356	CP	C0003873	Rheumatoid Arthritis	0.203007639249027	1	0	CTD_human
1356	CP	C0005747	Blepharospasm	0.200274726784213	0	0	HPO
1356	CP	C0011854	Diabetes Mellitus, Insulin-Dependent	0.202681755307501	1	0	CTD_human
1356	CP	C0013384	Dyskinetic syndrome	0.2	1	0	CTD_human
1356	CP	C0018995	Hemochromatosis	0.20328236603324	1	0	CTD_human
1356	CP	C0019189	Hepatitis, Chronic	0.200274726784213	1	0	CTD_human
1356	CP	C0019202	Hepatolenticular Degeneration	0.211263798152737	3	0	CTD_human
1356	CP	C0022716	Menkes Kinky Hair Syndrome	0.200824180352639	1	0	CTD_human
1356	CP	C0023890	Liver Cirrhosis	0.2	2	0	CTD_human
1356	CP	C0030567	Parkinson Disease	0.215210608714722	2	0	CTD_human
1356	CP	C0033860	Psoriasis	0.2	1	0	CTD_human
1356	CP	C0282193	Iron Overload	0.203296721410557	1	0	CTD_human
1356	CP	C0878682	Ceruloplasmin deficiency	0.287142896389541	0	0	ORPHANET
1356	CP	C2931082	Familial apoceruloplasmin deficiency	0.4	3	0	CTD_human;ORPHANET
1356	CP	C3854388	Hyperferritinaemia	0.2	0	0	HPO
1356	CP	C4020858	Choreatic disease	0.2	0	0	HPO
1356	CP	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
135656	DPCR1	C0878555	Diffuse panbronchiolitis	0.400274726784213	1	0	CTD_human;ORPHANET
1357	CPA1	C0149521	Pancreatitis, Chronic	0.200549453568426	1	0	CTD_human
1357	CPA1	C0238339	Hereditary pancreatitis	0.2	0	0	ORPHANET
135935	NOBOX	C1969060	Premature Ovarian Failure 5	0.4	2	6	CTD_human;UNIPROT
1361	CPB2	C0028754	Obesity	0.2	1	0	CTD_human
1363	CPE	C0028754	Obesity	0.28350593566014	2	0	CTD_human
1364	CLDN4	C0032460	Polycystic Ovary Syndrome	0.200274726784213	1	0	CTD_human
136647	MPLKIP	C1313961	Trichorrhexis nodosa syndrome	0.2	1	5	UNIPROT
136647	MPLKIP	C1955934	Trichothiodystrophy Syndromes	0.401373633921066	0	0	CTD_human;ORPHANET
1368	CPM	C0014175	Endometriosis	0.2	1	0	CTD_human
1368	CPM	C0037116	Silicosis	0.2	1	0	CTD_human
1369	CPN1	C0398782	Carboxypeptidase N Deficiency	0.4	1	1	CTD_human;UNIPROT
1371	CPOX	C0162531	Hereditary Coproporphyria	0.68767799458065	10	9	CTD_human;ORPHANET;UNIPROT
1371	CPOX	C0162566	Porphyria Cutanea Tarda	0.2	1	0	CTD_human
1371	CPOX	C4020827	Neonatal hemolytic anemia	0.2	0	0	HPO
1371	CPOX	C4020884	Anxiety disease	0.2	0	0	HPO
1373	CPS1	C0014544	Epilepsy	0.202407028523288	0	0	HPO
1373	CPS1	C0031190	Persistent Fetal Circulation Syndrome	0.2	1	0	CTD_human
1373	CPS1	C0238621	Aminoaciduria	0.2	0	0	HPO
1373	CPS1	C0751753	Carbamoyl-Phosphate Synthase I Deficiency Disease	0.400549453568426	2	7	CTD_human;ORPHANET
1373	CPS1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1373	CPS1	C4082171	Hyperammonemia Due to Carbamoyl Phosphate Synthetase 1 Deficiency	0.480274726784213	10	35	ORPHANET;UNIPROT
1374	CPT1A	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200549453568426	1	0	CTD_human
1374	CPT1A	C0014544	Epilepsy	0.2	0	0	HPO
1374	CPT1A	C0020615	Hypoglycemia	0.201373633921065	0	0	HPO
1374	CPT1A	C0022661	Kidney Failure, Chronic	0.200274726784213	1	0	CTD_human
1374	CPT1A	C0085605	Liver Failure	0.2	0	0	HPO
1374	CPT1A	C0234958	muscle degeneration	0.2	0	0	HPO
1374	CPT1A	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
1374	CPT1A	C1829703	Carnitine palmitoyl transferase 1A deficiency	0.68	6	48	CTD_human;ORPHANET;UNIPROT
1374	CPT1A	C2711227	Steatohepatitis	0.200824180352639	0	0	HPO
137492	VPS37A	C3539494	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.4	1	1	ORPHANET;UNIPROT
1375	CPT1B	C0027404	Narcolepsy	0.201373633921065	1	0	CTD_human
1375	CPT1B	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
1376	CPT2	C0014544	Epilepsy	0.2	0	0	HPO
1376	CPT2	C0020295	Hydronephrosis	0.2	0	0	HPO
1376	CPT2	C0035078	Kidney Failure	0.2	0	0	HPO
1376	CPT2	C0085605	Liver Failure	0.2	0	0	HPO
1376	CPT2	C1145670	Respiratory Failure	0.2	0	0	HPO
1376	CPT2	C1565489	Renal Insufficiency	0.2	0	0	HPO
1376	CPT2	C1696466	Hepatic calcification	0.2	0	0	HPO
1376	CPT2	C1833508	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET	0.6	9	36	CTD_human;ORPHANET;UNIPROT
1376	CPT2	C1833511	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.600274726784213	2	26	CTD_human;ORPHANET;UNIPROT
1376	CPT2	C1833518	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	0.4	0	0	CTD_human;ORPHANET
1376	CPT2	C1837251	Basal ganglia cysts	0.2	0	0	HPO
1376	CPT2	C1837273	Long-chain dicarboxylic aciduria	0.2	0	0	HPO
1376	CPT2	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
1376	CPT2	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
137682	NDUFAF6	C0023264	Leigh Disease	0.400549453568426	0	0	CTD_human;ORPHANET
137682	NDUFAF6	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.2	2	3	UNIPROT
1378	CR1	C0002395	Alzheimer's Disease	0.218497560368295	2	4	CTD_human
1378	CR1	C0024530	Malaria	0.20433011601278	0	0	CTD_human
1378	CR1	C0024535	Malaria, Falciparum	0.205638237399215	2	0	CTD_human
137814	NKX2-6	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
137814	NKX2-6	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	0.4	3	2	CTD_human;UNIPROT
1380	CR2	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
1380	CR2	C0006267	Bronchiectasis	0.2	0	0	HPO
1380	CR2	C0009447	Common Variable Immunodeficiency	0.202472541057918	0	0	ORPHANET
1380	CR2	C0009763	Conjunctivitis	0.2	0	0	HPO
1380	CR2	C0024141	Lupus Erythematosus, Systemic	0.209470057000881	0	0	CTD_human
1380	CR2	C0024312	Lymphopenia	0.2	0	0	HPO
1380	CR2	C0025289	Meningitis	0.2	0	0	HPO
1380	CR2	C0032285	Pneumonia	0.200274726784213	0	0	HPO
1380	CR2	C0034150	Purpura	0.2	0	0	HPO
1380	CR2	C0086438	Hypogammaglobulinemia	0.200824180352639	0	0	HPO
1380	CR2	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
1380	CR2	C0162539	IgG Deficiency	0.2	0	0	HPO
1380	CR2	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
1380	CR2	C0271441	Chronic otitis media	0.2	0	0	HPO
1380	CR2	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
1380	CR2	C0401151	Chronic diarrhea	0.2	0	0	HPO
1380	CR2	C0581354	Recurrent sinusitis	0.2	0	0	HPO
1380	CR2	C0694550	Recurrent pneumonia	0.2	0	0	HPO
1380	CR2	C0741796	Recurrent bronchitis	0.2	0	0	HPO
1380	CR2	C0743359	ear infection chronic	0.2	0	0	HPO
1380	CR2	C0747085	Recurrent otitis media	0.2	0	0	HPO
1380	CR2	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
1380	CR2	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
1380	CR2	C4280333	Recurrent sinus disease	0.2	0	0	HPO
138050	HGSNAT	C0026706	Mucopolysaccharidosis III	0.2	0	0	CTD_human
138050	HGSNAT	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
138050	HGSNAT	C0086649	MPS III C	0.481923087489492	8	14	ORPHANET;UNIPROT
138050	HGSNAT	C4225287	RETINITIS PIGMENTOSA 73	0.2	1	2	UNIPROT
1385	CREB1	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
1387	CREBBP	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
1387	CREBBP	C0013261	Duane Retraction Syndrome	0.2	0	0	HPO
1387	CREBBP	C0014306	Enophthalmos	0.2	0	0	HPO
1387	CREBBP	C0014544	Epilepsy	0.200274726784213	0	0	HPO
1387	CREBBP	C0015300	Exophthalmos	0.2	0	0	HPO
1387	CREBBP	C0017601	Glaucoma	0.2	0	0	HPO
1387	CREBBP	C0023234	Legg-Calve-Perthes Disease	0.2	0	0	HPO
1387	CREBBP	C0024636	Malocclusion	0.2	0	0	HPO
1387	CREBBP	C0035934	Rubinstein-Taybi Syndrome	0.709258476489586	3	77	CTD_human;ORPHANET;UNIPROT
1387	CREBBP	C0038379	Strabismus	0.2	0	0	HPO
1387	CREBBP	C0080218	Tethered Cord Syndrome	0.2	0	0	HPO
1387	CREBBP	C0454455	Mirror movements disorder	0.2	0	0	HPO
1387	CREBBP	C0520679	Sleep Apnea, Obstructive	0.2	0	0	HPO
1387	CREBBP	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
1387	CREBBP	C1857627	Chorioretinal dystrophy	0.2	0	0	HPO
1387	CREBBP	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
1387	CREBBP	C1864648	CHROMOSOME 16p13.3 DELETION SYNDROME, PROXIMAL	0.2	0	0	ORPHANET
1387	CREBBP	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1387	CREBBP	C4020889	Cornela disease	0.2	0	0	HPO
1387	CREBBP	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
1390	CREM	C0011875	Diabetic Angiopathies	0.2	1	0	CTD_human
1390	CREM	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
1390	CREM	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
1390	CREM	C0263454	Chloracne	0.2	1	0	CTD_human
1390	CREM	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
139105	BEND2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
139189	DGKK	C1845672	Mental Retardation, X-Linked 63	0.2	0	0	CTD_human
1392	CRH	C0002170	Alopecia	0.200274726784213	1	0	CTD_human
1392	CRH	C0002395	Alzheimer's Disease	0.200549453568426	1	0	CTD_human
1392	CRH	C0003123	Anorexia	0.200824180352639	1	0	CTD_human
1392	CRH	C0010481	Cushing Syndrome	0.201098907136852	1	0	CTD_human
1392	CRH	C0032001	Pituitary Apoplexy	0.2	2	0	CTD_human
1392	CRH	C0035333	Retinitis	0.2	1	0	CTD_human
1392	CRH	C0037769	West Syndrome	0.200274726784213	1	0	CTD_human
1392	CRH	C0038220	Status Epilepticus	0.2	1	0	CTD_human
1392	CRH	C0271583	ACTH Deficiency, Isolated	0.2	0	0	CTD_human
139285	AMER1	C0432268	Osteopathia striata cranial sclerosis	0.481923087489492	1	5	CTD_human;ORPHANET
1394	CRHR1	C0003123	Anorexia	0.2	1	0	CTD_human
1394	CRHR1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
139411	PTCHD1	C1136249	Mental Retardation, X-Linked	0.2	1	0	CTD_human
1395	CRHR2	C0003123	Anorexia	0.200824180352639	1	0	CTD_human
1398	CRK	C0151744	Myocardial Ischemia	0.200274726784213	1	0	CTD_human
1399	CRKL	C0012236	DiGeorge Syndrome	0.280274726784213	1	0	CTD_human
1399	CRKL	C0014306	Enophthalmos	0.2	0	0	HPO
1399	CRKL	C2678480	Chromosome 22q11.2 Deletion Syndrome, Distal	0.2	0	0	ORPHANET
140	ADORA3	C0027051	Myocardial Infarction	0.202407028523288	2	0	CTD_human
1401	CRP	C0003873	Rheumatoid Arthritis	0.314753012173848	1	0	CTD_human
1401	CRP	C0004153	Atherosclerosis	0.276827745500561	1	0	CTD_human
1401	CRP	C0010346	Crohn Disease	0.211993755216112	1	0	CTD_human
1401	CRP	C0011854	Diabetes Mellitus, Insulin-Dependent	0.202472541057918	1	0	CTD_human
1401	CRP	C0011884	Diabetic Retinopathy	0.200549453568426	1	0	CTD_human
1401	CRP	C0018801	Heart failure	0.202472541057918	1	0	CTD_human
1401	CRP	C0020503	Hyperparathyroidism, Secondary	0.2	1	0	CTD_human
1401	CRP	C0022661	Kidney Failure, Chronic	0.208371149864029	1	0	CTD_human
1401	CRP	C0023281	Leishmaniasis	0.2	1	0	CTD_human
1401	CRP	C0023290	Leishmaniasis, Visceral	0.2	1	0	CTD_human
1401	CRP	C0024141	Lupus Erythematosus, Systemic	0.226827322831996	1	0	CTD_human
1401	CRP	C0024530	Malaria	0.201648360705279	1	0	CTD_human
1401	CRP	C0025289	Meningitis	0.200274726784213	1	0	CTD_human
1401	CRP	C0027059	Myocarditis	0.200274726784213	1	0	CTD_human
1401	CRP	C0027707	Nephritis, Interstitial	0.2	1	0	CTD_human
1401	CRP	C0028754	Obesity	0.229826871055662	1	0	CTD_human
1401	CRP	C0031099	Periodontitis	0.202197814273705	1	0	CTD_human
1401	CRP	C0033860	Psoriasis	0.201373633921065	1	0	CTD_human
1401	CRP	C0151744	Myocardial Ischemia	0.210243080196208	1	0	CTD_human
1401	CRP	C0524620	Metabolic Syndrome X	0.21908549444834	1	0	CTD_human
1401	CRP	C0948089	Acute Coronary Syndrome	0.217408422988427	2	0	CTD_human
1401	CRP	C1956346	Coronary Artery Disease	0.259499190424081	1	0	CTD_human
1404	HAPLN1	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
140451	SCA9	C0087012	Ataxia, Spinocerebellar	0.2	0	0	CTD_human
140454	PSORS8	C0033860	Psoriasis	0.200274726784213	0	0	CTD_human
140560	LI5	C1847849	ICHTHYOSIS, LAMELLAR, 5	0.2	0	0	CTD_human
1406	CRX	C0014544	Epilepsy	0.2	0	0	HPO
1406	CRX	C0017601	Glaucoma	0.2	0	0	HPO
1406	CRX	C0018777	Conductive hearing loss	0.2	0	0	HPO
1406	CRX	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1406	CRX	C0020459	Hyperinsulinism	0.2	0	0	HPO
1406	CRX	C0020619	Hypogonadism	0.2	0	0	HPO
1406	CRX	C0022578	Keratoconus	0.2	0	0	HPO
1406	CRX	C0028077	Night Blindness	0.2	0	0	HPO
1406	CRX	C0028738	Nystagmus	0.200274726784213	0	0	HPO
1406	CRX	C0028754	Obesity	0.2	0	0	HPO
1406	CRX	C0029124	Optic Atrophy	0.2	0	0	HPO
1406	CRX	C0035334	Retinitis Pigmentosa	0.610099378481255	5	7	CTD_human;HPO;ORPHANET;UNIPROT
1406	CRX	C0042798	Low Vision	0.200274726784213	0	0	HPO
1406	CRX	C0271215	Blindness, Legal	0.2	0	0	HPO
1406	CRX	C0271388	Pendular Nystagmus	0.2	0	0	HPO
1406	CRX	C0339527	Leber Congenital Amaurosis	0.40439562854741	2	1	CTD_human;ORPHANET
1406	CRX	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
1406	CRX	C0730290	Cone dystrophy	0.2	0	0	HPO
1406	CRX	C1301509	Severe visual impairment	0.200824180352639	0	0	HPO
1406	CRX	C3151192	LEBER CONGENITAL AMAUROSIS 7	0.28	3	4	UNIPROT
1406	CRX	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
1406	CRX	C4048273	Chorioretinal atrophy	0.2	0	0	HPO
1406	CRX	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
140628	GATA5	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
140803	TRPM6	C1865974	Hypomagnesemia 1, Intestinal	0.604945082115836	2	6	CTD_human;ORPHANET;UNIPROT
140805	HT	C0677607	Hashimoto Disease	0.226099044500245	0	0	CTD_human
140821	RSS	C0175693	Russell-Silver syndrome	0.20439562854741	0	0	CTD_human
140892	TCPT	C1861178	Thrombocytopenia Paris-Trousseau type	0.2	0	0	CTD_human
1409	CRYAA	C0017601	Glaucoma	0.2	0	0	HPO
1409	CRYAA	C0027092	Myopia	0.200274726784213	0	0	HPO
1409	CRYAA	C0028738	Nystagmus	0.2	0	0	HPO
1409	CRYAA	C0038379	Strabismus	0.2	0	0	HPO
1409	CRYAA	C0042164	Uveitis	0.2	2	0	CTD_human
1409	CRYAA	C0042798	Low Vision	0.2	0	0	HPO
1409	CRYAA	C0392557	Nuclear cataract	0.200824180352639	0	0	ORPHANET
1409	CRYAA	C1112705	Nuclear non-senile cataract	0.200824180352639	0	0	ORPHANET
1409	CRYAA	C1855179	CATARACT, ANTERIOR POLAR	0.2	0	0	ORPHANET
1409	CRYAA	C1858679	CATARACT, AUTOSOMAL DOMINANT	0.28	5	7	UNIPROT
1409	CRYAA	C1861829	Cataract microcornea syndrome	0.200274726784213	0	0	ORPHANET
1409	CRYAA	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
140906	SPG18	C2749936	SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE (disorder)	0.2	0	0	CTD_human
140907	SPG19	C1846685	SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT (disorder)	0.4	0	0	CTD_human;ORPHANET
1410	CRYAB	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
1410	CRYAB	C0026850	Muscular Dystrophy	0.2	0	0	HPO
1410	CRYAB	C0085684	Foot-drop	0.2	0	0	HPO
1410	CRYAB	C0392557	Nuclear cataract	0.200274726784213	0	0	ORPHANET
1410	CRYAB	C1112705	Nuclear non-senile cataract	0.200274726784213	0	0	ORPHANET
1410	CRYAB	C1145670	Respiratory Failure	0.200274726784213	0	0	HPO
1410	CRYAB	C1837317	Alpha-B Crystallinopathy	0.68	3	7	CTD_human;ORPHANET;UNIPROT
1410	CRYAB	C3151236	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	0.2	0	0	ORPHANET
1410	CRYAB	C3554649	CARDIOMYOPATHY, DILATED, 1II	0.2	2	2	UNIPROT
1410	CRYAB	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
1410	CRYAB	C3808377	CATARACT 16, MULTIPLE TYPES	0.28	0	0	ORPHANET
1410	CRYAB	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
1411	CRYBA1	C0392557	Nuclear cataract	0.2	0	0	ORPHANET
1411	CRYBA1	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
1411	CRYBA1	C1833229	Cataract, Congenital Zonular, with Sutural Opacities	0.28	0	0	CTD_human
1411	CRYBA1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
1411	CRYBA1	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
1412	CRYBA2	C0392557	Nuclear cataract	0.2	0	0	ORPHANET
1412	CRYBA2	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
1412	CRYBA2	C1855179	CATARACT, ANTERIOR POLAR	0.2	0	0	ORPHANET
1412	CRYBA2	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
1412	CRYBA2	C4011454	CATARACT 42	0.2	1	0	UNIPROT
1413	CRYBA4	C0027092	Myopia	0.2	0	0	HPO
1413	CRYBA4	C1861829	Cataract microcornea syndrome	0.2	0	0	ORPHANET
1413	CRYBA4	C3808012	CATARACT 23	0.4	1	2	CTD_human;UNIPROT
1413	CRYBA4	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
1414	CRYBB1	C0027092	Myopia	0.2	0	0	HPO
1414	CRYBB1	C0392557	Nuclear cataract	0.4	0	0	HPO;ORPHANET
1414	CRYBB1	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
1414	CRYBB1	C1833118	Cataract, Pulverulent	0.200274726784213	0	0	ORPHANET
1414	CRYBB1	C1861829	Cataract microcornea syndrome	0.200549453568426	0	0	ORPHANET
1414	CRYBB1	C1969062	Cataract, Congenital Nuclear, Autosomal Recessive 3	0.2	0	0	CTD_human
1414	CRYBB1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
1414	CRYBB1	C3888124	CATARACT 17, MULTIPLE TYPES	0.2	1	0	UNIPROT
1415	CRYBB2	C0027092	Myopia	0.2	0	0	HPO
1415	CRYBB2	C0042164	Uveitis	0.2	2	0	CTD_human
1415	CRYBB2	C0392557	Nuclear cataract	0.200274726784213	0	0	ORPHANET
1415	CRYBB2	C1112705	Nuclear non-senile cataract	0.200274726784213	0	0	ORPHANET
1415	CRYBB2	C1832175	Cataract, Congenital, Cerulean Type, 2	0.28	0	0	CTD_human
1415	CRYBB2	C1833118	Cataract, Pulverulent	0.2	0	0	ORPHANET
1415	CRYBB2	C1852438	CATARACT, COPPOCK-LIKE	0.2	0	0	CTD_human
1415	CRYBB2	C1861829	Cataract microcornea syndrome	0.2	0	0	ORPHANET
1415	CRYBB2	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
1415	CRYBB2	C4023734	Sutural cataract	0.2	0	0	HPO
1417	CRYBB3	C0392557	Nuclear cataract	0.4	0	0	HPO;ORPHANET
1417	CRYBB3	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
1417	CRYBB3	C1855179	CATARACT, ANTERIOR POLAR	0.2	0	0	ORPHANET
1417	CRYBB3	C1857853	Cataract, Congenital Nuclear, Autosomal Recessive 2	0.4	2	2	CTD_human;UNIPROT
1417	CRYBB3	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
1419	CRYGB	C1855179	CATARACT, ANTERIOR POLAR	0.2	0	0	ORPHANET
1419	CRYGB	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
1419	CRYGB	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
142	PARP1	C0002170	Alopecia	0.2	1	0	CTD_human
142	PARP1	C0002871	Anemia	0.200274726784213	1	0	CTD_human
142	PARP1	C0004096	Asthma	0.204604842796993	1	0	CTD_human
142	PARP1	C0004153	Atherosclerosis	0.200274726784213	1	0	CTD_human
142	PARP1	C0007786	Brain Ischemia	0.2	1	0	CTD_human
142	PARP1	C0011603	Dermatitis	0.200274726784213	1	0	CTD_human
142	PARP1	C0019158	Hepatitis	0.200274726784213	1	0	CTD_human
142	PARP1	C0028754	Obesity	0.200274726784213	1	0	CTD_human
142	PARP1	C0032285	Pneumonia	0.200274726784213	1	0	CTD_human
142	PARP1	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
142	PARP1	C0042842	Vitamin A Deficiency	0.2	1	0	CTD_human
142	PARP1	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	0.2	1	0	CTD_human
1420	CRYGC	C0027092	Myopia	0.2	0	0	HPO
1420	CRYGC	C0028738	Nystagmus	0.2	0	0	HPO
1420	CRYGC	C0042798	Low Vision	0.2	0	0	HPO
1420	CRYGC	C0392557	Nuclear cataract	0.2	0	0	ORPHANET
1420	CRYGC	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
1420	CRYGC	C1833118	Cataract, Pulverulent	0.200274726784213	0	0	ORPHANET
1420	CRYGC	C1852438	CATARACT, COPPOCK-LIKE	0.48	2	5	CTD_human;UNIPROT
1420	CRYGC	C1861829	Cataract microcornea syndrome	0.2	0	0	ORPHANET
1420	CRYGC	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
1421	CRYGD	C0027092	Myopia	0.2	0	0	HPO
1421	CRYGD	C0392557	Nuclear cataract	0.200549453568426	0	0	ORPHANET
1421	CRYGD	C1112705	Nuclear non-senile cataract	0.200549453568426	0	0	ORPHANET
1421	CRYGD	C1833118	Cataract, Pulverulent	0.2	0	0	ORPHANET
1421	CRYGD	C1861829	Cataract microcornea syndrome	0.2	0	0	ORPHANET
1421	CRYGD	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
1421	CRYGD	C3540850	CATARACT 4, MULTIPLE TYPES	0.48	6	4	CTD_human;UNIPROT
1421	CRYGD	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
142680	SLC34A3	C1853271	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.600274726784213	2	10	CTD_human;ORPHANET;UNIPROT
1427	CRYGS	C0524524	Pseudoaphakia	0.2	0	0	HPO
1427	CRYGS	C3805410	CATARACT 20, MULTIPLE TYPES	0.28	1	1	UNIPROT
1427	CRYGS	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
1428	CRYM	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1428	CRYM	C4084708	DEAFNESS, AUTOSOMAL DOMINANT 40	0.2	1	2	UNIPROT
1431	CS	C0018801	Heart failure	0.2	1	0	CTD_human
1431	CS	C0028754	Obesity	0.2	1	0	CTD_human
1432	MAPK14	C0008370	Cholestasis	0.2	1	0	CTD_human
1432	MAPK14	C0151744	Myocardial Ischemia	0.200549453568426	1	0	CTD_human
1433	CSE	C1832855	CHOREOATHETOSIS/SPASTICITY, EPISODIC	0.2	0	0	CTD_human
1435	CSF1	C0029401	Osteitis Deformans	0.20350593566014	1	0	CTD_human
1436	CSF1R	C0338455	Dementia of frontal lobe type	0.2	0	0	HPO
1436	CSF1R	C0338474	Central nervous system demyelination	0.2	0	0	HPO
1436	CSF1R	C3711381	Hereditary Diffuse Leukoencephalopathy with Spheroids	0.485494535684262	2	43	ORPHANET;UNIPROT
143689	PIWIL4	C0028960	Oligospermia	0.202681755307501	1	0	CTD_human
1437	CSF2	C0001824	Agranulocytosis	0.200549453568426	2	0	CTD_human
1437	CSF2	C0002871	Anemia	0.201098907136852	2	0	CTD_human
1437	CSF2	C0002874	Aplastic Anemia	0.201373633921065	2	0	CTD_human
1437	CSF2	C0003873	Rheumatoid Arthritis	0.207692349957967	1	0	CTD_human
1437	CSF2	C0018801	Heart failure	0.2	1	0	CTD_human
1437	CSF2	C0023290	Leishmaniasis, Visceral	0.200274726784213	1	0	CTD_human
1437	CSF2	C0027947	Neutropenia	0.202747267842131	2	0	CTD_human
1437	CSF2	C0032285	Pneumonia	0.201373633921065	1	0	CTD_human
1437	CSF2	C0033860	Psoriasis	0.200274726784213	1	0	CTD_human
1437	CSF2	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
1437	CSF2	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
1437	CSF2	C2931245	Bone Marrow failure syndromes	0.2	1	0	CTD_human
1438	CSF2RA	C2677877	Surfactant Metabolism Dysfunction, Pulmonary, 4	0.4	1	1	CTD_human;UNIPROT
1438	CSF2RA	C2931035	Pulmonary alveolar proteinosis, congenital	0.2	0	0	ORPHANET
1439	CSF2RB	C0034050	Pulmonary Alveolar Proteinosis	0.200274726784213	0	0	HPO
1439	CSF2RB	C1968602	Surfactant Metabolism Dysfunction, Pulmonary, 1	0.28	0	0	CTD_human
1439	CSF2RB	C2931035	Pulmonary alveolar proteinosis, congenital	0.2	0	0	ORPHANET
1440	CSF3	C0001824	Agranulocytosis	0.201098907136852	1	0	CTD_human
1440	CSF3	C0002871	Anemia	0.200824180352639	3	0	CTD_human
1440	CSF3	C0002874	Aplastic Anemia	0.201923087489492	6	0	CTD_human
1440	CSF3	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
1440	CSF3	C0019156	Hepatic Veno-Occlusive Disease	0.2	1	0	CTD_human
1440	CSF3	C0020433	Hyperbilirubinemia	0.2	1	0	CTD_human
1440	CSF3	C0023530	Leukopenia	0.212912158858016	4	0	CTD_human
1440	CSF3	C0027947	Neutropenia	0.215370344538616	12	0	CTD_human
1440	CSF3	C0030312	Pancytopenia	0.200274726784213	2	0	CTD_human
1440	CSF3	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
1440	CSF3	C0036420	Localized scleroderma	0.2	1	0	CTD_human
1440	CSF3	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
1440	CSF3	C0038362	Stomatitis	0.2	1	0	CTD_human
1440	CSF3	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
1440	CSF3	C0243026	Sepsis	0.208213092771759	1	0	CTD_human
1440	CSF3	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1441	CSF3R	C0543669	Neutrophilia, Hereditary	0.680824180352639	1	1	CTD_human;ORPHANET;UNIPROT
144100	PLEKHA7	C0017605	Angle Closure Glaucoma	0.200274726784213	2	0	CTD_human
144165	PRICKLE1	C0751785	Unverricht-Lundborg Syndrome	0.200274726784213	0	0	ORPHANET
144165	PRICKLE1	C2676254	Prickle1-Related Progressive Myoclonus Epilepsy with Ataxia	0.4	1	4	CTD_human;UNIPROT
1442	CSH1	C0175693	Russell-Silver syndrome	0.200824180352639	1	0	CTD_human
1445	CSK	C0024141	Lupus Erythematosus, Systemic	0.200549453568426	1	0	CTD_human
144568	A2ML1	C0028326	Noonan Syndrome	0.2	0	0	ORPHANET
144568	A2ML1	C0029882	Otitis Media	0.2	1	0	CTD_human
144577	C12orf66	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
144811	LACC1	C1384600	Systemic onset juvenile chronic arthritis	0.200549453568426	0	0	ORPHANET
144811	LACC1	C1858558	Rheumatoid Arthritis, Systemic Juvenile	0.2	0	0	ORPHANET
145173	B3GLCT	C0796012	Krause-Kivlin syndrome	0.402472541057918	1	6	CTD_human;ORPHANET
145226	RDH12	C0035334	Retinitis Pigmentosa	0.40678830169338	1	2	CTD_human;ORPHANET
145226	RDH12	C0339527	Leber Congenital Amaurosis	0.201923087489492	0	0	ORPHANET
145226	RDH12	C1858677	LEBER CONGENITAL AMAUROSIS 3 (disorder)	0.2	0	0	CTD_human
145226	RDH12	C2675186	LEBER CONGENITAL AMAUROSIS 13	0.4	6	17	CTD_human;UNIPROT
145258	GSC	C1865361	SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL ABNORMALITIES	0.200824180352639	0	0	ORPHANET
145270	PRIMA1	C0026850	Muscular Dystrophy	0.200274726784213	1	0	CTD_human
145282	MIPOL1	C1851100	LAURIN-SANDROW SYNDROME	0.2	0	0	CTD_human
1453	CSNK1D	C3807327	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1	0.2	0	0	ORPHANET
1453	CSNK1D	C3808874	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2	0.2	1	2	UNIPROT
145741	C2CD4A	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200824180352639	1	0	CTD_human
145873	MESP2	C0265343	Jarcho-Levin syndrome	0.200824180352639	0	0	ORPHANET
145873	MESP2	C1837549	SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 2	0.2	0	0	CTD_human
146057	TTBK2	C0087012	Ataxia, Spinocerebellar	0.20350593566014	1	0	CTD_human
146057	TTBK2	C1858351	SPINOCEREBELLAR ATAXIA 11	0.4	0	0	CTD_human;ORPHANET
146059	CDAN1	C0271933	Congenital dyserythropoietic anemia, type I	0.401648360705279	2	11	ORPHANET;UNIPROT
146167	SLC38A8	C3807873	FOVEAL HYPOPLASIA 2	0.4	2	4	ORPHANET;UNIPROT
146183	OTOA	C1846896	Deafness, Autosomal Recessive 22	0.28	0	0	CTD_human
1462	VCAN	C0014175	Endometriosis	0.2	1	0	CTD_human
1462	VCAN	C0017601	Glaucoma	0.2	0	0	HPO
1462	VCAN	C0027092	Myopia	0.2	0	0	HPO
1462	VCAN	C0029124	Optic Atrophy	0.2	0	0	HPO
1462	VCAN	C0344290	Vitreoretinal degeneration	0.2	0	0	HPO
1462	VCAN	C1840452	Hyaloideoretinal degeneration of Wagner	0.402747267842131	0	0	CTD_human;ORPHANET
1462	VCAN	C4048273	Chorioretinal atrophy	0.2	0	0	HPO
146225	CMTM2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
146227	BEAN1	C1861736	SPINOCEREBELLAR ATAXIA 31 (disorder)	0.400549453568426	0	0	CTD_human;ORPHANET
146433	IL34	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
1465	CSRP1	C0014173	Endometrial Hyperplasia	0.2	1	0	CTD_human
146664	MGAT5B	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
146862	UNC45B	C0392557	Nuclear cataract	0.2	0	0	ORPHANET
146862	UNC45B	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
146862	UNC45B	C4225389	CATARACT 43	0.2	1	1	UNIPROT
1469	CST1	C0018621	Hay fever	0.200274726784213	1	0	CTD_human
1471	CST3	C0002395	Alzheimer's Disease	0.26617831493456	2	0	CTD_human
1471	CST3	C0029172	Oral Submucous Fibrosis	0.202681755307501	1	0	CTD_human
1471	CST3	C0085220	Cerebral Amyloid Angiopathy	0.204930726738519	0	0	HPO
1471	CST3	C0268393	Familial Cerebral Amyloid Angiopathy	0.200274726784213	1	0	CTD_human
1471	CST3	C1527338	Hereditary Cerebral Amyloid Angiopathy, Icelandic Type	0.401923087489492	2	1	ORPHANET;UNIPROT
1471	CST3	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
1471	CST3	C2677774	Age-Related Macular Degeneration type 11	0.4	2	1	CTD_human;UNIPROT
147183	KRT25	C4225214	WOOLLY HAIR, AUTOSOMAL RECESSIVE 3	0.2	2	1	UNIPROT
147372	CCBE1	C0020305	Hydrops Fetalis	0.200274726784213	1	0	CTD_human
147372	CCBE1	C0340834	Hennekam lymphangiectasia lymphedema syndrome	0.4	2	6	CTD_human;ORPHANET
147372	CCBE1	C4012050	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1	0.2	2	5	UNIPROT
147409	DSG4	C1854310	Hypotrichosis simplex	0.2	0	0	ORPHANET
147495	APCDD1	C1854310	Hypotrichosis simplex	0.600549453568426	1	1	CTD_human;ORPHANET;UNIPROT
1475	CSTA	C0013595	Eczema	0.200274726784213	0	0	HPO
1475	CSTA	C0020757	Ichthyoses	0.200824180352639	0	0	HPO
1475	CSTA	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
1476	CSTB	C0014553	Absence Epilepsy	0.2	0	0	HPO
1476	CSTB	C0494475	Tonic - clonic seizures	0.200274726784213	0	0	HPO
1476	CSTB	C0751785	Unverricht-Lundborg Syndrome	0.69236270528959	3	13	CTD_human;ORPHANET;UNIPROT
147906	DACT3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
147912	SIX5	C0265234	Branchio-Oto-Renal Syndrome	0.403557092817453	0	0	CTD_human;ORPHANET
147912	SIX5	C1970479	Branchiootorenal Syndrome 2	0.2	1	4	UNIPROT
148	ADRA1A	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
148022	TICAM1	C0032273	Pneumoconiosis	0.200274726784213	1	0	CTD_human
148022	TICAM1	C0276226	Herpes encephalitis	0.200824180352639	0	0	ORPHANET
148022	TICAM1	C0477341	Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.2	0	0	ORPHANET
1482	NKX2-5	C0004238	Atrial Fibrillation	0.401373633921066	1	0	CTD_human;HPO
1482	NKX2-5	C0015300	Exophthalmos	0.2	0	0	HPO
1482	NKX2-5	C0020676	Hypothyroidism	0.2	0	0	HPO
1482	NKX2-5	C0024421	Macroglossia	0.2	0	0	HPO
1482	NKX2-5	C0027126	Myotonic Dystrophy	0.200274726784213	1	0	CTD_human
1482	NKX2-5	C0151516	Thyroid Hypoplasia	0.2	0	0	HPO
1482	NKX2-5	C0152101	Hypoplastic Left Heart Syndrome	0.40328236603324	0	0	HPO;ORPHANET
1482	NKX2-5	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
1482	NKX2-5	C0917799	Hypersomnia	0.2	0	0	HPO
1482	NKX2-5	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
1482	NKX2-5	C1879286	Hereditary bundle branch system defect	0.2	0	0	ORPHANET
1482	NKX2-5	C2673630	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5 (disorder)	0.4	1	3	CTD_human;UNIPROT
1482	NKX2-5	C3276096	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	0.6	6	24	CTD_human;ORPHANET;UNIPROT
1483	CTAA1	C3887926	CATARACT 32, MULTIPLE TYPES	0.2	0	0	CTD_human
1484	CTAA2	C1832609	Anterior polar cataract 2	0.2	0	0	CTD_human
1487	CTBP1	C0014544	Epilepsy	0.2	0	0	HPO
1487	CTBP1	C0015300	Exophthalmos	0.2	0	0	HPO
1487	CTBP1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
1487	CTBP1	C0028738	Nystagmus	0.2	0	0	HPO
1487	CTBP1	C0034013	Precocious Puberty	0.2	0	0	HPO
1487	CTBP1	C0038379	Strabismus	0.2	0	0	HPO
1487	CTBP1	C0265341	Rieger syndrome	0.2	0	0	HPO
1487	CTBP1	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
1487	CTBP1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
148738	HFE2	C0018995	Hemochromatosis	0.251083295696476	4	0	CTD_human
148738	HFE2	C0268060	Juvenile hemochromatosis	0.404945082115836	0	0	CTD_human;ORPHANET
148738	HFE2	C1865614	HEMOCHROMATOSIS, TYPE 2A	0.48	3	12	ORPHANET;UNIPROT
148789	B3GALNT2	C0265221	Walker-Warburg congenital muscular dystrophy	0.2	0	0	ORPHANET
148789	B3GALNT2	C0457133	Muscle eye brain disease	0.2	0	0	ORPHANET
148789	B3GALNT2	C3554638	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11	0.2	1	6	UNIPROT
1489	CTF1	C0020443	Hypercholesterolemia	0.2	1	0	CTD_human
1489	CTF1	C0028754	Obesity	0.200274726784213	1	0	CTD_human
1490	CTGF	C0003504	Aortic Valve Insufficiency	0.200274726784213	1	0	CTD_human
1490	CTGF	C0003864	Arthritis	0.200274726784213	0	0	HPO
1490	CTGF	C0003873	Rheumatoid Arthritis	0.201098907136852	1	0	CTD_human
1490	CTGF	C0011334	Dental caries	0.2	0	0	HPO
1490	CTGF	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
1490	CTGF	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
1490	CTGF	C0017668	Focal glomerulosclerosis	0.200274726784213	1	0	CTD_human
1490	CTGF	C0018801	Heart failure	0.201923087489492	1	0	CTD_human
1490	CTGF	C0023890	Liver Cirrhosis	0.206462417751855	3	0	CTD_human
1490	CTGF	C0034069	Pulmonary Fibrosis	0.402747267842131	3	0	CTD_human;HPO
1490	CTGF	C0036421	Systemic Scleroderma	0.223075371142277	1	0	CTD_human
1490	CTGF	C0206138	CREST Syndrome	0.2	0	0	ORPHANET
1490	CTGF	C0524909	Hepatitis B, Chronic	0.200824180352639	1	0	CTD_human
1490	CTGF	C0748540	Scleroderma, Limited	0.2	0	0	ORPHANET
1490	CTGF	C1258104	Diffuse Scleroderma	0.200274726784213	0	0	ORPHANET
1491	CTH	C0268616	Gamma-cystathionase deficiency	0.400824180352639	0	0	CTD_human;ORPHANET
149111	CNIH3	C0014175	Endometriosis	0.2	1	0	CTD_human
149233	IL23R	C0004943	Behcet Syndrome	0.207077383854911	0	0	ORPHANET
149233	IL23R	C0009324	Ulcerative Colitis	0.278604854027156	3	5	CTD_human
149233	IL23R	C0010346	Crohn Disease	0.336985261965835	2	15	CTD_human
149233	IL23R	C0023343	Leprosy	0.200824180352639	1	0	CTD_human
149233	IL23R	C0033860	Psoriasis	0.27033143285742	3	5	CTD_human
149233	IL23R	C0038013	Ankylosing spondylitis	0.237242815497792	2	2	CTD_human
149233	IL23R	C2677091	Inflammatory Bowel Disease 17	0.2	0	0	CTD_human
1493	CTLA4	C0002170	Alopecia	0.2	0	0	HPO
1493	CTLA4	C0002171	Alopecia Areata	0.202407028523288	1	0	CTD_human
1493	CTLA4	C0002880	Autoimmune hemolytic anemia	0.205740551713841	0	0	HPO
1493	CTLA4	C0003873	Rheumatoid Arthritis	0.29911346082225	2	1	CTD_human
1493	CTLA4	C0007570	Celiac Disease	0.256103061587607	0	0	CTD_human
1493	CTLA4	C0007786	Brain Ischemia	0.202407028523288	0	0	HPO
1493	CTLA4	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
1493	CTLA4	C0013595	Eczema	0.201098907136852	0	0	HPO
1493	CTLA4	C0018133	Graft-vs-Host Disease	0.210452294445791	1	0	CTD_human
1493	CTLA4	C0018213	Graves Disease	0.309077972994637	3	0	CTD_human
1493	CTLA4	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
1493	CTLA4	C0024117	Chronic Obstructive Airway Disease	0.203231208875927	0	0	HPO
1493	CTLA4	C0029172	Oral Submucous Fibrosis	0.202681755307501	1	0	CTD_human
1493	CTLA4	C0034069	Pulmonary Fibrosis	0.200274726784213	0	0	HPO
1493	CTLA4	C0037199	Sinusitis	0.2	0	0	HPO
1493	CTLA4	C0042384	Vasculitis	0.202407028523288	0	0	HPO
1493	CTLA4	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
1493	CTLA4	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
1493	CTLA4	C0221260	Dystrophia unguium	0.2	0	0	HPO
1493	CTLA4	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
1493	CTLA4	C0259817	Xerosis	0.2	0	0	HPO
1493	CTLA4	C0392777	Poikiloderma	0.2	0	0	HPO
1493	CTLA4	C0398650	Immune thrombocytopenic purpura	0.205638237399215	0	0	HPO
1493	CTLA4	C0521173	Granulomatosis	0.2	0	0	HPO
1493	CTLA4	C0677607	Hashimoto Disease	0.233326542363846	0	0	CTD_human
1493	CTLA4	C0917798	Cerebral Ischemia	0.2	0	0	HPO
1493	CTLA4	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
1493	CTLA4	C1832392	DIABETES MELLITUS, INSULIN-DEPENDENT, 12	0.200274726784213	0	0	CTD_human
1493	CTLA4	C3495559	Juvenile arthritis	0.205638237399215	1	0	CTD_human
1493	CTLA4	C3495801	Granulomatosis with polyangiitis	0.214009387263244	0	0	ORPHANET
1493	CTLA4	C4015214	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V	0.4	1	6	ORPHANET;UNIPROT
149461	CLDN19	C1855466	Hypomagnesemia 5, Renal, with Ocular Involvement	0.4	1	3	CTD_human;UNIPROT
149461	CLDN19	C2931121	Meier Blumberg Imahorn syndrome	0.2	0	0	ORPHANET
1495	CTNNA1	C1837029	Macular Dystrophy, Butterfly-Shaped Pigmentary, 2	0.28	1	4	UNIPROT
1495	CTNNA1	C1864690	Microphthalmia, Syndromic 5	0.2	0	0	ORPHANET
1495	CTNNA1	C1868569	Patterned dystrophy of retinal pigment epithelium	0.2	1	0	CTD_human
149628	PYHIN1	C0004096	Asthma	0.200824180352639	1	1	CTD_human
1497	CTNS	C0010043	Corneal Ulcer	0.2	0	0	HPO
1497	CTNS	C0020620	Hypohidrosis	0.2	0	0	HPO
1497	CTNS	C0030293	Pancreatic Insufficiency	0.2	0	0	HPO
1497	CTNS	C0035078	Kidney Failure	0.2	0	0	HPO
1497	CTNS	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
1497	CTNS	C0035579	Rickets	0.2	0	0	HPO
1497	CTNS	C0041349	Nephritis, Tubulointerstitial	0.2	0	0	HPO
1497	CTNS	C0042798	Low Vision	0.2	0	0	HPO
1497	CTNS	C0151747	Renal tubular disorder	0.2	0	0	HPO
1497	CTNS	C0155119	Recurrent erosion of cornea	0.2	0	0	HPO
1497	CTNS	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
1497	CTNS	C0234958	muscle degeneration	0.2	0	0	HPO
1497	CTNS	C0235946	Cerebral atrophy	0.2	0	0	HPO
1497	CTNS	C0238621	Aminoaciduria	0.2	0	0	HPO
1497	CTNS	C0267963	Exocrine pancreatic insufficiency	0.2	0	0	HPO
1497	CTNS	C0341703	Adult Fanconi syndrome	0.200274726784213	0	0	HPO
1497	CTNS	C0392525	Nephrolithiasis	0.2	0	0	HPO
1497	CTNS	C0426824	Beading of ribs	0.2	0	0	HPO
1497	CTNS	C0700502	Acquired hypothyroidism	0.2	0	0	HPO
1497	CTNS	C1565489	Renal Insufficiency	0.2	0	0	HPO
1497	CTNS	C1704375	Hypophosphatemic Rickets	0.2	0	0	HPO
1497	CTNS	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1497	CTNS	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
1497	CTNS	C2931013	Cystinosis, benign, nonnephropathic	0.6	1	2	CTD_human;ORPHANET;UNIPROT
1497	CTNS	C2931187	Nephropathic cystinosis	0.70109654087514	10	37	CTD_human;ORPHANET;UNIPROT
1497	CTNS	C4020860	Supratentorial atrophy	0.2	0	0	HPO
149775	GNAS-AS1	C0033805	Pseudohypoaldosteronism	0.2	0	0	CTD_human
1499	CTNNB1	C0020514	Hyperprolactinemia	0.2	0	0	HPO
1499	CTNNB1	C0023882	Little's Disease	0.2	0	0	HPO
1499	CTNNB1	C0023890	Liver Cirrhosis	0.200824180352639	1	0	CTD_human
1499	CTNNB1	C0028754	Obesity	0.200549453568426	0	0	HPO
1499	CTNNB1	C0030353	Papilledema	0.2	0	0	HPO
1499	CTNNB1	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
1499	CTNNB1	C0038379	Strabismus	0.2	0	0	HPO
1499	CTNNB1	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
1499	CTNNB1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
1499	CTNNB1	C0687720	Central Diabetes Insipidus	0.2	0	0	HPO
1499	CTNNB1	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
1499	CTNNB1	C0948387	Secondary Adrenal Insufficiency	0.2	0	0	HPO
1499	CTNNB1	C1257915	Intestinal Polyposis	0.2	0	0	HPO
1499	CTNNB1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
1499	CTNNB1	C3554449	MENTAL RETARDATION, AUTOSOMAL DOMINANT 19	0.4	1	6	ORPHANET;UNIPROT
1499	CTNNB1	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
1499	CTNNB1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
149998	LIPI	C0020480	Hyperlipoproteinemia Type IV	0.4	1	1	CTD_human;UNIPROT
150	ADRA2A	C0014544	Epilepsy	0.2	1	0	CTD_human
150094	SIK1	C0037769	West Syndrome	0.200274726784213	0	0	ORPHANET
150094	SIK1	C0270855	Early myoclonic encephalopathy	0.200274726784213	0	0	ORPHANET
150094	SIK1	C0393706	Early infantile epileptic encephalopathy with suppression bursts	0.2	0	0	ORPHANET
150094	SIK1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
150094	SIK1	C4225360	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30	0.2	1	5	UNIPROT
1501	CTNND2	C0010314	Cri-du-Chat Syndrome	0.401098907136852	0	0	CTD_human;ORPHANET
1503	CTPS1	C0024312	Lymphopenia	0.2	0	0	HPO
1503	CTPS1	C4014617	IMMUNODEFICIENCY 24	0.2	0	0	ORPHANET
150468	CKAP2L	C0795940	Filippi syndrome	0.200274726784213	0	0	ORPHANET
150684	COMMD1	C0019189	Hepatitis, Chronic	0.200549453568426	2	0	CTD_human
150684	COMMD1	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
150684	COMMD1	C1876165	Copper-Overload Cirrhosis	0.2	1	0	CTD_human
1509	CTSD	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
1509	CTSD	C0010278	Craniosynostosis	0.2	0	0	HPO
1509	CTSD	C0029408	Degenerative polyarthritis	0.200274726784213	1	0	CTD_human
1509	CTSD	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
1509	CTSD	C0038220	Status Epilepticus	0.2	0	0	HPO
1509	CTSD	C0235946	Cerebral atrophy	0.2	0	0	HPO
1509	CTSD	C0262404	Cerebellar degeneration	0.2	0	0	HPO
1509	CTSD	C0521694	Atrophic retina	0.2	0	0	HPO
1509	CTSD	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
1509	CTSD	C1145670	Respiratory Failure	0.200274726784213	0	0	HPO
1509	CTSD	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
1509	CTSD	C1864669	NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCY	0.68	2	6	CTD_human;ORPHANET;UNIPROT
1509	CTSD	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1509	CTSD	C4020873	Infratentorial atrophy	0.2	0	0	HPO
151	ADRA2B	C0005747	Blepharospasm	0.2	0	0	HPO
151	ADRA2B	C0234533	Generalized seizures	0.2	0	0	HPO
151	ADRA2B	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
151	ADRA2B	C1832841	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1	0.2	0	0	ORPHANET
1510	CTSE	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
151056	PLB1	C0003873	Rheumatoid Arthritis	0.201098907136852	1	0	CTD_human
1512	CTSH	C0007384	Cataplexy	0.2	0	0	HPO
1512	CTSH	C0011854	Diabetes Mellitus, Insulin-Dependent	0.205638237399215	1	1	CTD_human
1512	CTSH	C0027404	Narcolepsy	0.200824180352639	0	0	ORPHANET
1512	CTSH	C0751362	Narcolepsy-Cataplexy Syndrome	0.2	0	0	ORPHANET
1513	CTSK	C0011334	Dental caries	0.2	0	0	HPO
1513	CTSK	C0015300	Exophthalmos	0.2	0	0	HPO
1513	CTSK	C0029464	Osteosclerosis	0.200274726784213	0	0	HPO
1513	CTSK	C0038016	Spondylolisthesis	0.2	0	0	HPO
1513	CTSK	C0038018	Spondylolysis	0.2	0	0	HPO
1513	CTSK	C0238402	Pycnodysostosis	0.689065983879032	5	23	CTD_human;ORPHANET;UNIPROT
151306	GPBAR1	C0010346	Crohn Disease	0.2	1	0	CTD_human
151354	FAM84A	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
151507	MSL3P1	C0022336	Creutzfeldt-Jakob disease	0.2	1	0	CTD_human
151648	SGO1	C4015474	CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA	0.400549453568426	1	1	ORPHANET;UNIPROT
151742	PPM1L	C0028754	Obesity	0.2	1	0	CTD_human
151887	CCDC80	C0011615	Dermatitis, Atopic	0.2	1	0	CTD_human
151887	CCDC80	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
152	ADRA2C	C0018801	Heart failure	0.211551201582644	1	0	CTD_human
1520	CTSS	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
1520	CTSS	C0028754	Obesity	0.20350593566014	1	0	CTD_human
152137	CCDC50	C1843895	Deafness, Autosomal Dominant 44	0.2	0	0	CTD_human
1524	CX3CR1	C0010068	Coronary heart disease	0.202472541057918	0	0	CTD_human
1524	CX3CR1	C0263454	Chloracne	0.2	1	0	CTD_human
1524	CX3CR1	C1864205	Macular Degeneration, Age-Related, 1	0.2	0	0	CTD_human
152518	NFXL1	C0008370	Cholestasis	0.2	1	0	CTD_human
152518	NFXL1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1528	CYB5A	C0014175	Endometriosis	0.2	1	0	CTD_human
1528	CYB5A	C0025637	Methemoglobinemia	0.200824180352639	0	0	HPO
1528	CYB5A	C0028754	Obesity	0.2	1	0	CTD_human
1528	CYB5A	C0029456	Osteoporosis	0.2	0	0	HPO
1528	CYB5A	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
1528	CYB5A	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
1528	CYB5A	C0268285	Adrenal hyperplasia, congenital, type 5	0.2	0	0	ORPHANET
1528	CYB5A	C0948896	Primary hypogonadism	0.2	0	0	HPO
1528	CYB5A	C2673427	METHEMOGLOBINEMIA TYPE IV	0.2	0	0	CTD_human
1528	CYB5A	C4024641	Enlarged polycystic ovaries	0.2	0	0	HPO
152926	PPM1K	C1621920	Intermediate Maple Syrup Urine Disease	0.2	0	0	ORPHANET
153	ADRB1	C0018801	Heart failure	0.249985468774928	5	0	CTD_human
153	ADRB1	C0020452	Hyperemia	0.202732912464814	1	0	CTD_human
153	ADRB1	C0028754	Obesity	0.231356883337374	1	0	CTD_human
153	ADRB1	C0151744	Myocardial Ischemia	0.212361026557966	1	0	CTD_human
153020	RASGEF1B	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
153090	DAB2IP	C0027051	Myocardial Infarction	0.202407028523288	1	0	CTD_human
153090	DAB2IP	C0034065	Pulmonary Embolism	0.2	1	0	CTD_human
153090	DAB2IP	C0162871	Aortic Aneurysm, Abdominal	0.201098907136852	1	1	CTD_human
153201	SLC36A2	C0543541	HYPERGLYCINURIA (disorder)	0.4	1	1	CTD_human;UNIPROT
153241	CEP120	C4225378	SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY	0.2	1	1	UNIPROT
1535	CYBA	C0004153	Atherosclerosis	0.225662903160513	1	0	CTD_human
1535	CYBA	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.215057137242784	1	0	CTD_human
1535	CYBA	C0013595	Eczema	0.2	0	0	HPO
1535	CYBA	C0022661	Kidney Failure, Chronic	0.208645876648242	1	0	CTD_human
1535	CYBA	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
1535	CYBA	C0024117	Chronic Obstructive Airway Disease	0.202681755307501	0	0	HPO
1535	CYBA	C0024138	Lupus Erythematosus, Discoid	0.2	0	0	HPO
1535	CYBA	C0024205	Lymphadenitis	0.2	0	0	HPO
1535	CYBA	C0029882	Otitis Media	0.2	0	0	HPO
1535	CYBA	C0037199	Sinusitis	0.2	0	0	HPO
1535	CYBA	C0520743	Mediastinal lymphadenopathy	0.2	0	0	HPO
1535	CYBA	C0521173	Granulomatosis	0.2	0	0	HPO
1535	CYBA	C0694550	Recurrent pneumonia	0.2	0	0	HPO
1535	CYBA	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
1535	CYBA	C1565489	Renal Insufficiency	0.2	1	0	CTD_human
1535	CYBA	C1856255	Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Negative	0.4	5	12	CTD_human;UNIPROT
1535	CYBA	C3806330	Osteomyelitis due to immunodeficiency	0.2	0	0	HPO
153562	MARVELD2	C1857811	DEAFNESS, AUTOSOMAL RECESSIVE 49	0.280274726784213	0	0	CTD_human
1536	CYBB	C0013595	Eczema	0.2	0	0	HPO
1536	CYBB	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
1536	CYBB	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
1536	CYBB	C0024117	Chronic Obstructive Airway Disease	0.202407028523288	0	0	HPO
1536	CYBB	C0024138	Lupus Erythematosus, Discoid	0.200274726784213	0	0	HPO
1536	CYBB	C0024205	Lymphadenitis	0.200274726784213	0	0	HPO
1536	CYBB	C0029882	Otitis Media	0.2	0	0	HPO
1536	CYBB	C0037199	Sinusitis	0.2	0	0	HPO
1536	CYBB	C0520743	Mediastinal lymphadenopathy	0.2	0	0	HPO
1536	CYBB	C0521173	Granulomatosis	0.2	0	0	HPO
1536	CYBB	C0694550	Recurrent pneumonia	0.2	0	0	HPO
1536	CYBB	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
1536	CYBB	C0751955	Brain Infarction	0.2	1	0	CTD_human
1536	CYBB	C1833487	Varicella, Severe Recurrent	0.2	0	0	HPO
1536	CYBB	C1844376	Granulomatous Disease, Chronic, X-Linked	0.297307787405425	20	61	UNIPROT
1536	CYBB	C1970859	Atypical Mycobacteriosis, Familial, X-Linked 2	0.4	1	2	ORPHANET;UNIPROT
1536	CYBB	C3806330	Osteomyelitis due to immunodeficiency	0.2	0	0	HPO
1537	CYC1	C0162557	Liver Failure, Acute	0.2	0	0	HPO
1537	CYC1	C3809553	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6	0.2	1	2	UNIPROT
154	ADRB2	C0004096	Asthma	0.354032677964365	0	0	CTD_human
154	ADRB2	C0020473	Hyperlipidemia	0.204814057046576	1	0	CTD_human
154	ADRB2	C0028754	Obesity	0.296483607052786	1	1	CTD_human
154	ADRB2	C0151744	Myocardial Ischemia	0.210228724818891	1	0	CTD_human
1540	CYLD	C0023860	Listeriosis	0.2	1	0	CTD_human
1540	CYLD	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
1540	CYLD	C1857941	Brooke-Spiegler syndrome	0.206043989252688	0	0	UNIPROT
154064	RAET1L	C0002171	Alopecia Areata	0.2	1	0	CTD_human
1543	CYP1A1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
1543	CYP1A1	C0023976	Long QT Syndrome	0.2	1	0	CTD_human
1543	CYP1A1	C0024117	Chronic Obstructive Airway Disease	0.213734660479031	1	0	CTD_human
1543	CYP1A1	C0039239	Sinus Tachycardia	0.2	1	0	CTD_human
1543	CYP1A1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
1544	CYP1A2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	0	CTD_human
1544	CYP1A2	C0024117	Chronic Obstructive Airway Disease	0.212910480126392	1	0	CTD_human
1544	CYP1A2	C0025637	Methemoglobinemia	0.2	1	0	CTD_human
1544	CYP1A2	C0162566	Porphyria Cutanea Tarda	0.209195330216668	1	0	CTD_human
1545	CYP1B1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
1545	CYP1B1	C0339573	Glaucoma, Primary Open Angle	0.406868169605328	7	9	CTD_human;UNIPROT
1545	CYP1B1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
1545	CYP1B1	C1842028	GLAUCOMA 1, OPEN ANGLE, A	0.4	8	1	CTD_human;UNIPROT
1545	CYP1B1	C1856441	Late onset congenital glaucoma	0.2	0	0	HPO
1545	CYP1B1	C2981140	Glaucoma of childhood	0.201648360705279	0	0	ORPHANET
1548	CYP2A6	C0019163	Hepatitis B	0.2	1	0	CTD_human
1548	CYP2A6	C0019196	Hepatitis C	0.200274726784213	1	0	CTD_human
1548	CYP2A6	C0029106	Opisthorchiasis	0.2	1	0	CTD_human
1548	CYP2A6	C0034067	Pulmonary Emphysema	0.200274726784213	1	0	CTD_human
1548	CYP2A6	C0850715	Abnormality of blood and blood-forming tissues	0.2	0	0	HPO
1548	CYP2A6	C4277682	Chemical and Drug Induced Liver Injury	0.28	1	0	CTD_human
154881	KCTD7	C2673257	EPILEPSY, PROGRESSIVE MYOCLONIC 3	0.6	4	7	CTD_human;ORPHANET;UNIPROT
155	ADRB3	C0018801	Heart failure	0.202681755307501	2	0	CTD_human
155	ADRB3	C0020473	Hyperlipidemia	0.205088783830789	1	0	CTD_human
155	ADRB3	C0028754	Obesity	0.306099044500245	0	0	CTD_human
155	ADRB3	C0149721	Left Ventricular Hypertrophy	0.202407028523288	1	0	CTD_human
1555	CYP2B6	C0022661	Kidney Failure, Chronic	0.203231208875927	1	0	CTD_human
1557	CYP2C19	C0022661	Kidney Failure, Chronic	0.200274726784213	1	0	CTD_human
1557	CYP2C19	C0085215	Ovarian Failure, Premature	0.202681755307501	1	0	CTD_human
1557	CYP2C19	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1559	CYP2C9	C0027707	Nephritis, Interstitial	0.2	1	0	CTD_human
1559	CYP2C9	C0850715	Abnormality of blood and blood-forming tissues	0.2	0	0	HPO
1559	CYP2C9	C4277682	Chemical and Drug Induced Liver Injury	0.28	2	0	CTD_human
156	GRK2	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
156	GRK2	C0018801	Heart failure	0.208176290991763	1	0	CTD_human
156	GRK2	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
1565	CYP2D6	C0002395	Alzheimer's Disease	0.223009858607647	1	0	CTD_human
1565	CYP2D6	C0014549	Tonic-Clonic Epilepsy	0.202407028523288	1	0	CTD_human
1565	CYP2D6	C0027707	Nephritis, Interstitial	0.2	1	0	CTD_human
1565	CYP2D6	C0030567	Parkinson Disease	0.254721336641181	2	0	CTD_human
1571	CYP2E1	C0015695	Fatty Liver	0.205964121340741	1	0	CTD_human
1571	CYP2E1	C0015696	Fatty Liver, Alcoholic	0.2	1	0	CTD_human
1571	CYP2E1	C0023891	Liver Cirrhosis, Alcoholic	0.223912228140609	1	0	CTD_human
1571	CYP2E1	C0028754	Obesity	0.205154296365419	1	0	CTD_human
1571	CYP2E1	C0030567	Parkinson Disease	0.211551201582644	1	0	CTD_human
1571	CYP2E1	C0400966	Non-alcoholic Fatty Liver Disease	0.201098907136852	1	0	CTD_human
1571	CYP2E1	C4277682	Chemical and Drug Induced Liver Injury	0.2	3	0	CTD_human
157570	ESCO2	C0392475	Roberts-SC phocomelia syndrome	0.604670355331623	4	28	CTD_human;ORPHANET;UNIPROT
1576	CYP3A4	C0019196	Hepatitis C	0.200549453568426	1	0	CTD_human
1576	CYP3A4	C0040479	Torsades de Pointes	0.2	1	0	CTD_human
157657	C8orf37	C0035334	Retinitis Pigmentosa	0.200824180352639	0	0	ORPHANET
157657	C8orf37	C3281045	CONE-ROD DYSTROPHY 16	0.2	2	2	UNIPROT
1577	CYP3A5	C0085580	Essential Hypertension	0.2	0	0	CTD_human
157922	CAMSAP1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
158	ADSL	C0014544	Epilepsy	0.2	0	0	HPO
158	ADSL	C0028738	Nystagmus	0.2	0	0	HPO
158	ADSL	C0038379	Strabismus	0.2	0	0	HPO
158	ADSL	C0234958	muscle degeneration	0.2	0	0	HPO
158	ADSL	C0235946	Cerebral atrophy	0.2	0	0	HPO
158	ADSL	C0262404	Cerebellar degeneration	0.2	0	0	HPO
158	ADSL	C0268126	Adenylosuccinate lyase deficiency (disorder)	0.601923087489492	8	20	CTD_human;ORPHANET;UNIPROT
158	ADSL	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
158	ADSL	C4020860	Supratentorial atrophy	0.2	0	0	HPO
158	ADSL	C4020873	Infratentorial atrophy	0.2	0	0	HPO
1581	CYP7A1	C0008370	Cholestasis	0.400824180352639	2	0	CTD_human;HPO
1581	CYP7A1	C0010054	Coronary Arteriosclerosis	0.205363510615002	0	0	HPO
1581	CYP7A1	C0019158	Hepatitis	0.2	0	0	HPO
1581	CYP7A1	C0020443	Hypercholesterolemia	0.40777053913829	1	0	CTD_human;HPO
1581	CYP7A1	C0020445	Hypercholesterolemia, Familial	0.200549453568426	0	0	HPO
1581	CYP7A1	C0028754	Obesity	0.202681755307501	0	0	HPO
1581	CYP7A1	C0856727	Cholesterol gallstones	0.201098907136852	0	0	HPO
1581	CYP7A1	C4025020	acute fatty liver	0.2	0	0	HPO
1582	CYP8B1	C0008370	Cholestasis	0.2	1	0	CTD_human
1582	CYP8B1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1583	CYP11A1	C0018418	Gynecomastia	0.2	0	0	HPO
1583	CYP11A1	C0020428	Hyperaldosteronism	0.2	0	0	HPO
1583	CYP11A1	C0020595	Hypoaldosteronism	0.2	0	0	HPO
1583	CYP11A1	C0029456	Osteoporosis	0.2	0	0	HPO
1583	CYP11A1	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
1583	CYP11A1	C0342474	Lipoid congenital adrenal hyperplasia	0.2	1	0	CTD_human
1583	CYP11A1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1583	CYP11A1	C3151055	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	0.400274726784213	4	7	ORPHANET;UNIPROT
1583	CYP11A1	C3671887	Sodium concentration in urine above normal	0.2	0	0	HPO
158314	LINC00475	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
158326	FREM1	C1609433	Congenital absence of kidneys syndrome	0.200274726784213	1	0	CTD_human
158326	FREM1	C1855425	Marles Greenberg Persaud syndrome	0.681373633921066	2	2	CTD_human;ORPHANET;UNIPROT
158326	FREM1	C2750433	Bifid Nose With Or Without Anorectal And Renal Anomalies	0.600824180352639	2	2	CTD_human;ORPHANET;UNIPROT
1584	CYP11B1	C0020428	Hyperaldosteronism	0.408096423079816	1	0	CTD_human;HPO
1584	CYP11B1	C0020595	Hypoaldosteronism	0.2	0	0	HPO
1584	CYP11B1	C0029456	Osteoporosis	0.2	0	0	HPO
1584	CYP11B1	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
1584	CYP11B1	C0238669	Aortic root dilatation	0.2	0	0	HPO
1584	CYP11B1	C0268292	Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency	0.609340710663245	8	32	CTD_human;ORPHANET;UNIPROT
1584	CYP11B1	C0302280	Adrenogenital Syndrome	0.2	0	0	HPO
1584	CYP11B1	C0342546	Premature adrenarche	0.2	0	0	HPO
1584	CYP11B1	C0546817	Fluid overload	0.2	0	0	HPO
1584	CYP11B1	C1260386	Glucocorticoid-remediable aldosteronism	0.403846174978983	0	0	CTD_human;ORPHANET
1584	CYP11B1	C1621895	Adrenal hyperplasia	0.200549453568426	0	0	HPO
1584	CYP11B1	C4020713	Penile melanosis	0.2	0	0	HPO
1584	CYP11B1	C4020743	Glucocorticoid-remediable familial primary aldosteronism	0.2	0	0	HPO
1584	CYP11B1	C4020744	Familial primary hyperaldosteronism type 1	0.2	0	0	HPO
1584	CYP11B1	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
1584	CYP11B1	C4023209	Dexamethasone-suppresible primary hyperaldosteronism	0.2	0	0	HPO
1584	CYP11B1	C4024641	Enlarged polycystic ovaries	0.2	0	0	HPO
1585	CYP11B2	C0020428	Hyperaldosteronism	0.211667871274586	1	0	CTD_human
1585	CYP11B2	C0020595	Hypoaldosteronism	0.402747267842131	1	0	CTD_human;HPO
1585	CYP11B2	C0268293	Corticosterone Methyl Oxidase Type I Deficiency	0.400274726784213	1	2	CTD_human;UNIPROT
1585	CYP11B2	C1260386	Glucocorticoid-remediable aldosteronism	0.205769262468475	0	0	ORPHANET
1585	CYP11B2	C1621895	Adrenal hyperplasia	0.200274726784213	0	0	HPO
1585	CYP11B2	C2315100	Pediatric failure to thrive	0.200549453568426	0	0	HPO
1585	CYP11B2	C3463917	Corticosterone Methyl Oxidase Type II Deficiency	0.200274726784213	7	6	UNIPROT
1585	CYP11B2	C4020743	Glucocorticoid-remediable familial primary aldosteronism	0.2	0	0	HPO
1585	CYP11B2	C4020744	Familial primary hyperaldosteronism type 1	0.2	0	0	HPO
1585	CYP11B2	C4023209	Dexamethasone-suppresible primary hyperaldosteronism	0.2	0	0	HPO
1586	CYP17A1	C0018418	Gynecomastia	0.2	0	0	HPO
1586	CYP17A1	C0020428	Hyperaldosteronism	0.200824180352639	0	0	HPO
1586	CYP17A1	C0020540	Malignant Hypertension	0.2	1	0	CTD_human
1586	CYP17A1	C0020619	Hypogonadism	0.2	1	0	CTD_human
1586	CYP17A1	C0020635	Hypopituitarism	0.2	1	0	CTD_human
1586	CYP17A1	C0029456	Osteoporosis	0.20678830169338	0	0	HPO
1586	CYP17A1	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
1586	CYP17A1	C0085570	Hypokalemic alkalosis	0.2	0	0	HPO
1586	CYP17A1	C0232939	Primary physiologic amenorrhea	0.200824180352639	0	0	HPO
1586	CYP17A1	C0238669	Aortic root dilatation	0.2	0	0	HPO
1586	CYP17A1	C0268285	Adrenal hyperplasia, congenital, type 5	0.605219808900049	14	18	CTD_human;ORPHANET;UNIPROT
1586	CYP17A1	C0302280	Adrenogenital Syndrome	0.2	0	0	HPO
1586	CYP17A1	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
1586	CYP17A1	C0546817	Fluid overload	0.2	0	0	HPO
1586	CYP17A1	C0948896	Primary hypogonadism	0.200274726784213	0	0	HPO
1586	CYP17A1	C1621895	Adrenal hyperplasia	0.2	0	0	HPO
1586	CYP17A1	C4024641	Enlarged polycystic ovaries	0.2	0	0	HPO
1588	CYP19A1	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
1588	CYP19A1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200549453568426	0	0	HPO
1588	CYP19A1	C0014175	Endometriosis	0.322140245861343	2	0	CTD_human
1588	CYP19A1	C0015695	Fatty Liver	0.2	1	0	CTD_human
1588	CYP19A1	C0018418	Gynecomastia	0.208422307021342	0	0	HPO
1588	CYP19A1	C0020473	Hyperlipidemia	0.2	0	0	HPO
1588	CYP19A1	C0020619	Hypogonadism	0.200274726784213	1	0	CTD_human
1588	CYP19A1	C0020635	Hypopituitarism	0.2	1	0	CTD_human
1588	CYP19A1	C0028754	Obesity	0.216639985413433	0	0	HPO
1588	CYP19A1	C0029453	Osteopenia	0.201648360705279	0	0	HPO
1588	CYP19A1	C0029456	Osteoporosis	0.41007066772662	1	0	CTD_human;HPO
1588	CYP19A1	C0029927	Ovarian Cysts	0.2	0	0	HPO
1588	CYP19A1	C0032460	Polycystic Ovary Syndrome	0.309117681663341	4	0	CTD_human
1588	CYP19A1	C0232939	Primary physiologic amenorrhea	0.200274726784213	0	0	HPO
1588	CYP19A1	C0236663	Alcohol withdrawal syndrome	0.200274726784213	1	0	PSYGENET
1588	CYP19A1	C0242341	Sexual Infantilism	0.2	1	0	CTD_human
1588	CYP19A1	C0747078	Generalized osteopenia	0.2	0	0	HPO
1588	CYP19A1	C0948896	Primary hypogonadism	0.2	0	0	HPO
1588	CYP19A1	C1960539	Aromatase deficiency	0.602472541057918	6	10	CTD_human;ORPHANET;UNIPROT
1588	CYP19A1	C1970109	AROMATASE EXCESS SYNDROME	0.284604842796993	0	0	ORPHANET
1588	CYP19A1	C2711227	Steatohepatitis	0.2	0	0	HPO
1588	CYP19A1	C4024641	Enlarged polycystic ovaries	0.2	0	0	HPO
158866	ZDHHC15	C1845142	MENTAL RETARDATION, X-LINKED 91 (disorder)	0.2	0	0	CTD_human
1589	CYP21A2	C0018418	Gynecomastia	0.2	0	0	HPO
1589	CYP21A2	C0020615	Hypoglycemia	0.2	0	0	HPO
1589	CYP21A2	C0302280	Adrenogenital Syndrome	0.2	0	0	HPO
1589	CYP21A2	C1621895	Adrenal hyperplasia	0.201648360705279	0	0	HPO
1591	CYP24A1	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
1591	CYP24A1	C0020437	Hypercalcemia	0.207626837423337	1	0	CTD_human
1591	CYP24A1	C0027709	Nephrocalcinosis	0.201923087489492	0	0	HPO
1591	CYP24A1	C0029456	Osteoporosis	0.2	1	0	CTD_human
1591	CYP24A1	C0392525	Nephrolithiasis	0.201648360705279	1	0	CTD_human
1591	CYP24A1	C1565489	Renal Insufficiency	0.2	1	0	CTD_human
1591	CYP24A1	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
1591	CYP24A1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1592	CYP26A1	C0004763	Barrett Esophagus	0.2	1	0	CTD_human
1592	CYP26A1	C0014175	Endometriosis	0.2	1	0	CTD_human
159296	NKX2-3	C0009324	Ulcerative Colitis	0.215657747968523	3	1	CTD_human
159296	NKX2-3	C0010346	Crohn Disease	0.233331127984178	3	2	CTD_human
1593	CYP27A1	C0004153	Atherosclerosis	0.203831819601666	2	0	CTD_human
1593	CYP27A1	C0008350	Cholelithiasis	0.2	0	0	HPO
1593	CYP27A1	C0008370	Cholestasis	0.200274726784213	1	0	CTD_human
1593	CYP27A1	C0014544	Epilepsy	0.2	0	0	HPO
1593	CYP27A1	C0020443	Hypercholesterolemia	0.200274726784213	0	0	HPO
1593	CYP27A1	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
1593	CYP27A1	C0027051	Myocardial Infarction	0.2	0	0	HPO
1593	CYP27A1	C0029456	Osteoporosis	0.2	0	0	HPO
1593	CYP27A1	C0033790	Pseudobulbar Palsy	0.2	0	0	HPO
1593	CYP27A1	C0155210	Eyelid Xanthoma	0.2	0	0	HPO
1593	CYP27A1	C0221253	Xanthoma tendinosum	0.2	0	0	HPO
1593	CYP27A1	C0235946	Cerebral atrophy	0.2	0	0	HPO
1593	CYP27A1	C0238052	Xanthomatosis, Cerebrotendinous	0.63891071571704	9	52	CTD_human;ORPHANET;UNIPROT
1593	CYP27A1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
1593	CYP27A1	C0302314	Xanthoma	0.201098907136852	0	0	HPO
1593	CYP27A1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
1593	CYP27A1	C1836830	Developmental regression	0.2	0	0	HPO
1593	CYP27A1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1593	CYP27A1	C4020871	Dystonic disease	0.2	0	0	HPO
1593	CYP27A1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
1593	CYP27A1	C4280602	Xanthelasma of periocular region	0.2	0	0	HPO
1594	CYP27B1	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
1594	CYP27B1	C0020437	Hypercalcemia	0.200549453568426	1	0	CTD_human
1594	CYP27B1	C0020503	Hyperparathyroidism, Secondary	0.200274726784213	0	0	HPO
1594	CYP27B1	C0035579	Rickets	0.402747267842131	1	0	CTD_human;HPO
1594	CYP27B1	C0085655	Polymyositis	0.2	1	0	CTD_human
1594	CYP27B1	C0268689	Vitamin D-dependent rickets, type 1	0.685494535684262	5	17	CTD_human;ORPHANET;UNIPROT
1594	CYP27B1	C1855841	Hypocalcaemic seizure	0.2	0	0	HPO
1594	CYP27B1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
16	AARS	C0005747	Blepharospasm	0.2	0	0	HPO
16	AARS	C0028738	Nystagmus	0.2	0	0	HPO
16	AARS	C0085684	Foot-drop	0.2	0	0	HPO
16	AARS	C0234958	muscle degeneration	0.2	0	0	HPO
16	AARS	C0235946	Cerebral atrophy	0.2	0	0	HPO
16	AARS	C0270921	Axonal neuropathy	0.200274726784213	0	0	HPO
16	AARS	C0543888	Epileptic encephalopathy	0.200274726784213	0	0	HPO
16	AARS	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
16	AARS	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
16	AARS	C2750090	Charcot-Marie-Tooth Disease, Axonal, Type 2n	0.6	3	2	CTD_human;ORPHANET;UNIPROT
16	AARS	C4020858	Choreatic disease	0.2	0	0	HPO
16	AARS	C4020860	Supratentorial atrophy	0.2	0	0	HPO
16	AARS	C4225361	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29	0.2	1	2	UNIPROT
160364	CLEC12A	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
1604	CD55	C0014175	Endometriosis	0.2	1	0	CTD_human
1605	DAG1	C0020255	Hydrocephalus	0.2	0	0	HPO
1605	DAG1	C0023092	Lassa Fever	0.200274726784213	1	0	CTD_human
1605	DAG1	C0023520	Leukodystrophy	0.200274726784213	0	0	HPO
1605	DAG1	C0026850	Muscular Dystrophy	0.226619787314036	0	0	HPO
1605	DAG1	C0027092	Myopia	0.2	0	0	HPO
1605	DAG1	C0265221	Walker-Warburg congenital muscular dystrophy	0.207142896389541	0	0	ORPHANET
1605	DAG1	C1145670	Respiratory Failure	0.2	0	0	HPO
1605	DAG1	C3151184	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9	0.48	2	4	ORPHANET;UNIPROT
1605	DAG1	C4225291	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9	0.4	1	2	ORPHANET;UNIPROT
160728	SLC5A8	C0740394	Hyperuricemia	0.2	1	0	CTD_human
160760	PPTC7	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
160851	DGKH	C0011881	Diabetic Nephropathy	0.2	1	0	CTD_human
1609	DGKQ	C1527336	Sjogren's Syndrome	0.2	1	0	CTD_human
1610	DAO	C0002736	Amyotrophic Lateral Sclerosis	0.400274726784213	0	0	HPO;ORPHANET
1610	DAO	C0234958	muscle degeneration	0.2	0	0	HPO
1610	DAO	C1145670	Respiratory Failure	0.2	0	0	HPO
1610	DAO	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
1610	DAO	C4020884	Anxiety disease	0.2	0	0	HPO
1611	DAP	C0009324	Ulcerative Colitis	0.200549453568426	1	2	CTD_human
1612	DAPK1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
161497	STRC	C1863561	Deafness, Autosomal Recessive 16	0.280274726784213	0	0	CTD_human
161497	STRC	C1970187	Deafness, Sensorineural, And Male Infertility	0.2	0	0	ORPHANET
1615	DARS	C0028738	Nystagmus	0.2	0	0	HPO
1615	DARS	C3809008	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY	0.400274726784213	1	8	ORPHANET;UNIPROT
161582	DYX1C1	C0022521	Kartagener Syndrome	0.400549453568426	1	0	CTD_human;ORPHANET
1617	DAZ1	C0004509	Azoospermia	0.214573196208988	0	0	HPO
1617	DAZ1	C0028960	Oligospermia	0.21567210334584	0	0	HPO
1617	DAZ1	C4021107	Non-obstructive azoospermia	0.200549453568426	0	0	HPO
161742	SPRED1	C1969623	NEUROFIBROMATOSIS, TYPE 1-LIKE SYNDROME	0.683296721410557	2	10	CTD_human;ORPHANET;UNIPROT
1621	DBH	C0014544	Epilepsy	0.200549453568426	0	0	HPO
1621	DBH	C0028734	Nocturia	0.2	0	0	HPO
1621	DBH	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
1621	DBH	C0342687	dopamine beta hydroxylase deficiency	0.680274726784213	1	8	CTD_human;ORPHANET;UNIPROT
1621	DBH	C3160718	PARKINSON DISEASE, LATE-ONSET	0.2	0	0	CTD_human
162417	NAGS	C0268543	Hyperammonemia, type III	0.681098907136852	3	10	CTD_human;ORPHANET;UNIPROT
162514	TRPV3	C2609071	Olmsted syndrome	0.402197814273705	2	3	ORPHANET;UNIPROT
162514	TRPV3	C4225339	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2	0.4	1	1	ORPHANET;UNIPROT
1629	DBT	C0014544	Epilepsy	0.2	0	0	HPO
1629	DBT	C0020615	Hypoglycemia	0.2	0	0	HPO
1629	DBT	C0022638	Ketosis	0.2	0	0	HPO
1629	DBT	C0024776	Maple Syrup Urine Disease	0.695001394465139	2	19	CTD_human;ORPHANET;UNIPROT
1629	DBT	C0030305	Pancreatitis	0.2	0	0	HPO
1629	DBT	C0268568	Classic Maple Syrup Urine Disease	0.2	0	0	ORPHANET
1629	DBT	C0268569	Intermittent Maple Syrup Urine Disease	0.2	0	0	ORPHANET
1629	DBT	C0751285	Maple Syrup Urine Disease, Thiamine Responsive	0.200274726784213	0	0	ORPHANET
1629	DBT	C1621920	Intermediate Maple Syrup Urine Disease	0.2	0	0	ORPHANET
1630	DCC	C0454455	Mirror movements disorder	0.201098907136852	0	0	HPO
1634	DCN	C0027707	Nephritis, Interstitial	0.2	1	0	CTD_human
1634	DCN	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
1634	DCN	C1864738	Corneal Dystrophy, Congenital Stromal	0.481373633921066	0	0	CTD_human;ORPHANET
163486	DENND1B	C0010346	Crohn Disease	0.2	1	2	CTD_human
163486	DENND1B	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
1636	ACE	C0002395	Alzheimer's Disease	0.319445813908148	4	0	CTD_human
1636	ACE	C0004238	Atrial Fibrillation	0.238862465448436	1	0	CTD_human
1636	ACE	C0007786	Brain Ischemia	0.245733541942472	1	0	CTD_human
1636	ACE	C0010068	Coronary heart disease	0.330810099702106	1	0	CTD_human
1636	ACE	C0011881	Diabetic Nephropathy	0.416576939058233	4	0	CTD_human
1636	ACE	C0017205	Gaucher Disease	0.202407028523288	1	0	CTD_human
1636	ACE	C0017661	IGA Glomerulonephritis	0.2584732883309	2	0	CTD_human
1636	ACE	C0017924	Glycogen Storage Disease Type V	0.213785817636344	1	0	CTD_human
1636	ACE	C0018801	Heart failure	0.359299688042159	1	0	CTD_human
1636	ACE	C0022661	Kidney Failure, Chronic	0.305520880177184	2	0	CTD_human
1636	ACE	C0027051	Myocardial Infarction	0.42696155846141	2	0	CTD_human
1636	ACE	C0032310	Pneumonia, Viral	0.202407028523288	1	0	CTD_human
1636	ACE	C0149721	Left Ventricular Hypertrophy	0.396741612197969	1	0	CTD_human
1636	ACE	C0266313	Allanson Pantzar McLeod syndrome	0.601098907136852	2	7	CTD_human;HPO;ORPHANET
1636	ACE	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
1636	ACE	C0948480	Coronary Restenosis	0.223586344199084	1	0	CTD_human
1636	ACE	C1175175	Severe Acute Respiratory Syndrome	0.205363510615002	1	0	CTD_human
1636	ACE	C1565489	Renal Insufficiency	0.208110778457133	1	0	CTD_human
1636	ACE	C1956346	Coronary Artery Disease	0.361435945760801	1	0	CTD_human
1637	DCR	C0013080	Down Syndrome	0.201648360705279	0	0	CTD_human
163702	IFNLR1	C0033860	Psoriasis	0.200549453568426	1	0	CTD_human
163786	SASS6	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
163786	SASS6	C4225338	MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE	0.2	1	1	UNIPROT
1639	DCTN1	C0002736	Amyotrophic Lateral Sclerosis	0.403780662444354	0	0	HPO;ORPHANET
1639	DCTN1	C0042928	Vocal Cord Paralysis	0.2	0	0	HPO
1639	DCTN1	C0234958	muscle degeneration	0.2	0	0	HPO
1639	DCTN1	C0339652	Vertical gaze palsy	0.2	0	0	HPO
1639	DCTN1	C0376175	Bell Palsy	0.2	0	0	HPO
1639	DCTN1	C1145670	Respiratory Failure	0.200274726784213	0	0	HPO
1639	DCTN1	C1843315	Neuronopathy, Distal Hereditary Motor, Type Viib	0.4	5	1	CTD_human;UNIPROT
1639	DCTN1	C1843369	Vertical supranuclear gaze palsy	0.2	0	0	HPO
1639	DCTN1	C1848736	Distal amyotrophy	0.2	0	0	HPO
1639	DCTN1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.4	2	3	CTD_human;UNIPROT
1639	DCTN1	C1868594	Perry Syndrome	0.602472541057918	6	9	CTD_human;ORPHANET;UNIPROT
1639	DCTN1	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
1639	DCTN1	C4020884	Anxiety disease	0.2	0	0	HPO
164045	HFM1	C3810376	PREMATURE OVARIAN FAILURE 9	0.2	1	4	UNIPROT
1641	DCX	C0014544	Epilepsy	0.205205453522732	0	0	HPO
1641	DCX	C0028738	Nystagmus	0.2	0	0	HPO
1641	DCX	C1848199	X-Linked Lissencephaly	0.404120901763197	11	21	ORPHANET;UNIPROT
1641	DCX	C1848201	Subcortical Band Heterotopia	0.210989071368524	0	0	ORPHANET
1641	DCX	C1955870	Classical Lissencephalies and Subcortical Band Heterotopias	0.202681755307501	0	0	CTD_human
1643	DDB2	C0009763	Conjunctivitis	0.2	0	0	HPO
1643	DDB2	C0013592	Ectropion	0.2	0	0	HPO
1643	DDB2	C0014390	Entropion	0.2	0	0	HPO
1643	DDB2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1643	DDB2	C0020619	Hypogonadism	0.2	0	0	HPO
1643	DDB2	C0022568	Keratitis	0.2	0	0	HPO
1643	DDB2	C0029124	Optic Atrophy	0.2	0	0	HPO
1643	DDB2	C0038379	Strabismus	0.2	0	0	HPO
1643	DDB2	C0039446	Telangiectasis	0.2	0	0	HPO
1643	DDB2	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
1643	DDB2	C0259817	Xerosis	0.2	0	0	HPO
1643	DDB2	C0392777	Poikiloderma	0.2	0	0	HPO
1643	DDB2	C0870082	Hyperkeratosis	0.2	0	0	HPO
1643	DDB2	C1836830	Developmental regression	0.2	0	0	HPO
1643	DDB2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
164395	TTLL9	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
1644	DDC	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
1644	DDC	C0026205	Miosis disorder	0.2	0	0	HPO
1644	DDC	C0030567	Parkinson Disease	0.20357144819477	2	0	CTD_human
1644	DDC	C0085583	Choreoathetosis	0.2	0	0	HPO
1644	DDC	C0342686	Aromatic amino acid decarboxylase deficiency	0.200549453568426	0	0	CTD_human
1644	DDC	C1291564	Deficiency of aromatic-L-amino-acid decarboxylase	0.48	2	8	ORPHANET;UNIPROT
1645	AKR1C1	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
1645	AKR1C1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
1645	AKR1C1	C0032460	Polycystic Ovary Syndrome	0.200549453568426	1	0	CTD_human
1646	AKR1C2	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
1646	AKR1C2	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
1646	AKR1C2	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
1646	AKR1C2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
1646	AKR1C2	C1839840	MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE	0.4	1	3	ORPHANET;UNIPROT
164656	TMPRSS6	C0085576	Iron-Refractory Iron Deficiency Anemia	0.607417623173754	7	22	CTD_human;ORPHANET;UNIPROT
164656	TMPRSS6	C0162316	Iron deficiency anemia	0.203021994626344	2	0	CTD_human
1647	GADD45A	C0263454	Chloracne	0.2	1	0	CTD_human
1647	GADD45A	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
1647	GADD45A	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1649	DDIT3	C0003949	Asbestosis	0.2	1	0	CTD_human
1649	DDIT3	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
1649	DDIT3	C0011854	Diabetes Mellitus, Insulin-Dependent	0.200274726784213	1	0	CTD_human
1649	DDIT3	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
1649	DDIT3	C0027720	Nephrosis	0.2	1	0	CTD_human
1649	DDIT3	C0028754	Obesity	0.200549453568426	1	0	CTD_human
1649	DDIT3	C0028840	Ocular Hypertension	0.200274726784213	1	0	CTD_human
1649	DDIT3	C0041582	Ulcer	0.2	1	0	CTD_human
1649	DDIT3	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
1649	DDIT3	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
1650	DDOST	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
1650	DDOST	C0038379	Strabismus	0.2	0	0	HPO
1650	DDOST	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1650	DDOST	C3281084	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir	0.4	1	2	ORPHANET;UNIPROT
1653	DDX1	C0014173	Endometrial Hyperplasia	0.2	1	0	CTD_human
1654	DDX3X	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
1654	DDX3X	C4085582	MENTAL RETARDATION, X-LINKED 102	0.4	1	16	ORPHANET;UNIPROT
1655	DDX5	C0014175	Endometriosis	0.2	1	0	CTD_human
1656	DDX6	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
165918	RNF168	C2677792	Riddle Syndrome	0.480824180352639	0	0	CTD_human;ORPHANET
166	AES	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
1663	DDX11	C0155299	Coloboma of optic disc	0.2	0	0	HPO
1663	DDX11	C0263401	Cutis marmorata	0.2	0	0	HPO
1663	DDX11	C3150658	WARSAW BREAKAGE SYNDROME	0.601923087489492	1	3	CTD_human;ORPHANET;UNIPROT
166378	SPATA5	C4225276	EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME	0.4	1	11	ORPHANET;UNIPROT
166379	BBS12	C0752166	Bardet-Biedl Syndrome	0.401648360705279	0	0	CTD_human;ORPHANET
166379	BBS12	C1859570	BARDET-BIEDL SYNDROME 12	0.2	2	12	UNIPROT
1666	DECR1	C1857252	2,4-Dienoyl-CoA Reductase Deficiency	0.2	1	0	CTD_human
166785	MMAA	C1855109	Methylmalonic aciduria cblA type	0.6	3	19	CTD_human;ORPHANET;UNIPROT
1670	DEFA5	C0009324	Ulcerative Colitis	0.200274726784213	1	0	CTD_human
1670	DEFA5	C0017661	IGA Glomerulonephritis	0.2	2	0	CTD_human
1670	DEFA5	C0031269	Peutz-Jeghers Syndrome	0.2	1	0	CTD_human
1671	DEFA6	C0009324	Ulcerative Colitis	0.2	1	0	CTD_human
1672	DEFB1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
1673	DEFB4A	C0155862	Streptococcal pneumonia	0.2	1	0	CTD_human
1674	DES	C0004238	Atrial Fibrillation	0.2	1	0	CTD_human
1674	DES	C0007194	Hypertrophic Cardiomyopathy	0.205363510615002	0	0	HPO
1674	DES	C0017658	Glomerulonephritis	0.2	1	0	CTD_human
1674	DES	C0026850	Muscular Dystrophy	0.200824180352639	0	0	HPO
1674	DES	C0027720	Nephrosis	0.2	1	0	CTD_human
1674	DES	C0085684	Foot-drop	0.2	0	0	HPO
1674	DES	C0376175	Bell Palsy	0.2	0	0	HPO
1674	DES	C0598608	Hyperhomocysteinemia	0.2	1	0	CTD_human
1674	DES	C1301959	Bulbar weakness	0.2	0	0	HPO
1674	DES	C1389118	Peroneal muscle atrophy	0.2	0	0	HPO
1674	DES	C1832370	MYOPATHY, MYOFIBRILLAR, DESMIN-RELATED	0.683846174978983	18	38	CTD_human;ORPHANET;UNIPROT
1674	DES	C1858154	CARDIOMYOPATHY, DILATED, 1I	0.48	5	3	CTD_human;UNIPROT
1674	DES	C1867005	Scapuloperoneal Syndrome, Neurogenic, Kaeser Type	0.6	3	1	CTD_human;ORPHANET;UNIPROT
1674	DES	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
1674	DES	C3809137	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R	0.2	0	0	ORPHANET
1674	DES	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
1674	DES	C4082299	Bulbar palsy	0.2	0	0	HPO
1675	CFD	C0003949	Asbestosis	0.2	1	0	CTD_human
1675	CFD	C0014175	Endometriosis	0.2	1	0	CTD_human
1675	CFD	C0017658	Glomerulonephritis	0.2	1	0	CTD_human
1675	CFD	C0018801	Heart failure	0.2	1	0	CTD_human
1675	CFD	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
1675	CFD	C0032285	Pneumonia	0.2	1	0	CTD_human
1675	CFD	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
1675	CFD	C0398764	Complement Factor D Deficiency	0.4	1	3	ORPHANET;UNIPROT
167691	LCA5	C0339527	Leber Congenital Amaurosis	0.201923087489492	0	0	ORPHANET
167691	LCA5	C1858301	LEBER CONGENITAL AMAUROSIS 5	0.280549453568426	0	0	CTD_human
167691	LCA5	C4274354	Severe early childhood onset retinal dystrophy	0.2	0	0	ORPHANET
1678	TIMM8A	C0027092	Myopia	0.2	0	0	HPO
1678	TIMM8A	C0029124	Optic Atrophy	0.2	0	0	HPO
1678	TIMM8A	C0042798	Low Vision	0.2	0	0	HPO
1678	TIMM8A	C0155320	Blindness, Cortical	0.200274726784213	0	0	HPO
1678	TIMM8A	C0271215	Blindness, Legal	0.2	0	0	HPO
1678	TIMM8A	C0796074	MOHR-TRANEBJAERG SYNDROME	0.605494535684262	2	9	CTD_human;ORPHANET;UNIPROT
1678	TIMM8A	C1389113	Generalized amyotrophy	0.2	0	0	HPO
1678	TIMM8A	C1839564	Jensen syndrome	0.200274726784213	1	0	CTD_human
1678	TIMM8A	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
1678	TIMM8A	C4020871	Dystonic disease	0.2	0	0	HPO
1680	DFNX3	C3888089	Deafness, X-Linked 3	0.2	0	0	CTD_human
168667	BMPER	C1842691	Diaphanospondylodysostosis	0.400824180352639	1	3	ORPHANET;UNIPROT
168667	BMPER	C4274732	Ischio-vertebral syndrome	0.2	0	0	ORPHANET
1687	DFNA5	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
1687	DFNA5	C1832932	DEAFNESS, AUTOSOMAL DOMINANT 5 (disorder)	0.200274726784213	0	0	CTD_human
1687	DFNA5	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
1689	DFNA7	C1832379	DEAFNESS, AUTOSOMAL DOMINANT 7 (disorder)	0.2	0	0	CTD_human
1690	COCH	C1832425	Deafness, Autosomal Dominant 9	0.481648360705279	8	9	CTD_human;UNIPROT
169026	SLC30A8	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.301703415952835	6	2	CTD_human
1694	DFNA16	C1858916	DEAFNESS, AUTOSOMAL DOMINANT 16	0.2	0	0	CTD_human
169522	KCNV2	C1835897	Retinal Cone Dystrophy 3B	0.600274726784213	1	10	CTD_human;ORPHANET;UNIPROT
1697	DFNB5	C1833319	DEAFNESS, AUTOSOMAL RECESSIVE 5 (disorder)	0.2	0	0	CTD_human
169792	GLIS3	C0011854	Diabetes Mellitus, Insulin-Dependent	0.202681755307501	1	2	CTD_human
169792	GLIS3	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.201923087489492	1	3	CTD_human
169792	GLIS3	C0017605	Angle Closure Glaucoma	0.2	1	0	CTD_human
169792	GLIS3	C1857775	Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism	0.48	0	0	CTD_human;ORPHANET
170302	ARX	C0037769	West Syndrome	0.226533655050133	0	0	ORPHANET
170302	ARX	C0393706	Early infantile epileptic encephalopathy with suppression bursts	0.201923087489492	0	0	ORPHANET
170302	ARX	C0796124	Proud Syndrome	0.6	1	2	CTD_human;ORPHANET;UNIPROT
170302	ARX	C0796244	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED (disorder)	0.4	1	4	CTD_human;UNIPROT
170302	ARX	C0796250	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME	0.401098907136852	0	0	CTD_human;ORPHANET
170302	ARX	C1846171	Lissencephaly, X-Linked, 2	0.681373633921066	2	26	CTD_human;ORPHANET;UNIPROT
170302	ARX	C3463992	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	0.68	1	8	CTD_human;ORPHANET;UNIPROT
170394	PWWP2B	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
170474	HFM	C0265240	Goldenhar Syndrome	0.200274726784213	0	0	CTD_human
1705	DFNB13	C1864199	DEAFNESS, AUTOSOMAL RECESSIVE 13	0.2	0	0	CTD_human
170507	DFNA52	C1843232	DEAFNESS, AUTOSOMAL DOMINANT 52	0.2	0	0	CTD_human
170508	DFNB33	C1846576	DEAFNESS, AUTOSOMAL RECESSIVE 33	0.2	0	0	CTD_human
170532	OTSC3	C1842353	OTOSCLEROSIS 3	0.2	0	0	CTD_human
170534	PARK10	C1847360	PARKINSON DISEASE 10	0.2	0	0	CTD_human
170534	PARK10	C3160718	PARKINSON DISEASE, LATE-ONSET	0.200549453568426	0	0	CTD_human
170594	WS2C	C1847722	Waardenburg Syndrome, Type 2C	0.2	0	0	CTD_human
170595	IBD8	C1847719	INFLAMMATORY BOWEL DISEASE 8	0.2	0	0	CTD_human
1706	DFNB14	C1863613	DEAFNESS, AUTOSOMAL RECESSIVE 14	0.2	0	0	CTD_human
170679	PSORS1C1	C0004943	Behcet Syndrome	0.2	1	1	CTD_human
170679	PSORS1C1	C0036421	Systemic Scleroderma	0.200549453568426	1	1	CTD_human
170682	SLEH1	C0024141	Lupus Erythematosus, Systemic	0.20328236603324	0	0	CTD_human
170691	ADAMTS17	C2750787	Weill-Marchesani-Like Syndrome	0.400549453568426	0	0	CTD_human;ORPHANET
170692	ADAMTS18	C3809567	MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS	0.400274726784213	1	4	ORPHANET;UNIPROT
170825	GSX2	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
1709	DFNB17	C1864276	DEAFNESS, AUTOSOMAL RECESSIVE 17 (disorder)	0.2	0	0	CTD_human
171	AFD1	C0265245	Nager syndrome	0.2	0	0	CTD_human
171013	SLI1	C1847614	SPECIFIC LANGUAGE IMPAIRMENT 1	0.2	0	0	CTD_human
171014	SLI2	C1847605	SPECIFIC LANGUAGE IMPAIRMENT 2	0.2	0	0	CTD_human
171023	ASXL1	C0796232	Bohring syndrome	0.401923087489492	1	5	CTD_human;ORPHANET
171157	SHFM5	C1847622	SPLIT-HAND/FOOT MALFORMATION 5 (disorder)	0.2	0	0	CTD_human
1713	DFNB20	C1858840	DEAFNESS, AUTOSOMAL RECESSIVE 20	0.2	0	0	CTD_human
1714	DGCR	C0012236	DiGeorge Syndrome	0.208791257094819	0	0	CTD_human
171513	PAOD1	C1847493	Peripheral Arterial Occlusive Disease 1	0.2	0	0	CTD_human
171558	PTCRA	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
1716	DGUOK	C0014544	Epilepsy	0.2	0	0	HPO
1716	DGUOK	C0020541	Hypertension, Portal	0.2	0	0	HPO
1716	DGUOK	C0020615	Hypoglycemia	0.2	0	0	HPO
1716	DGUOK	C0028738	Nystagmus	0.2	0	0	HPO
1716	DGUOK	C0085605	Liver Failure	0.201648360705279	0	0	HPO
1716	DGUOK	C0152025	Polyneuropathy	0.2	0	0	HPO
1716	DGUOK	C0235946	Cerebral atrophy	0.2	0	0	HPO
1716	DGUOK	C0239981	Hypoalbuminemia	0.2	0	0	HPO
1716	DGUOK	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
1716	DGUOK	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1716	DGUOK	C2711227	Steatohepatitis	0.2	0	0	HPO
1716	DGUOK	C3151513	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.6	2	11	CTD_human;ORPHANET;UNIPROT
1716	DGUOK	C3711385	Deoxyguanosine Kinase Deficiency	0.200824180352639	1	0	CTD_human
1716	DGUOK	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1717	DHCR7	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
1717	DHCR7	C0013595	Eczema	0.2	0	0	HPO
1717	DHCR7	C0014544	Epilepsy	0.2	0	0	HPO
1717	DHCR7	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
1717	DHCR7	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
1717	DHCR7	C0020255	Hydrocephalus	0.2	0	0	HPO
1717	DHCR7	C0020295	Hydronephrosis	0.2	0	0	HPO
1717	DHCR7	C0022679	Cystic kidney	0.2	0	0	HPO
1717	DHCR7	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
1717	DHCR7	C0028738	Nystagmus	0.2	0	0	HPO
1717	DHCR7	C0034013	Precocious Puberty	0.2	0	0	HPO
1717	DHCR7	C0038379	Strabismus	0.2	0	0	HPO
1717	DHCR7	C0040583	Tracheal Stenosis	0.2	0	0	HPO
1717	DHCR7	C0151718	Hypocholesterolemia	0.2	0	0	HPO
1717	DHCR7	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
1717	DHCR7	C0175694	Smith-Lemli-Opitz Syndrome	0.73474087615515	16	61	CTD_human;ORPHANET;UNIPROT
1717	DHCR7	C0263401	Cutis marmorata	0.2	0	0	HPO
1717	DHCR7	C0747085	Recurrent otitis media	0.2	0	0	HPO
1717	DHCR7	C0860204	Cholestatic liver disease	0.2	0	0	HPO
1717	DHCR7	C1849173	Periventricular neuronal heterotopia	0.2	0	0	HPO
1717	DHCR7	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1717	DHCR7	C2713347	7-Dehydrocholesterol Reductase Deficiency	0.200274726784213	0	0	ORPHANET
1718	DHCR24	C0002395	Alzheimer's Disease	0.213967999862916	1	0	CTD_human
1718	DHCR24	C0003886	Arthrogryposis	0.2	0	0	HPO
1718	DHCR24	C0014544	Epilepsy	0.2	0	0	HPO
1718	DHCR24	C0020255	Hydrocephalus	0.2	0	0	HPO
1718	DHCR24	C0028738	Nystagmus	0.2	0	0	HPO
1718	DHCR24	C0034362	Q Fever	0.2	1	0	CTD_human
1718	DHCR24	C0038379	Strabismus	0.2	0	0	HPO
1718	DHCR24	C1857278	Partial or complete agenesis of corpus callosum	0.2	0	0	HPO
1718	DHCR24	C1865596	Desmosterolosis	0.601373633921066	1	8	CTD_human;ORPHANET;UNIPROT
1718	DHCR24	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1719	DHFR	C0002888	Anemia, Megaloblastic	0.400274726784213	2	0	CTD_human;HPO
1719	DHFR	C0003873	Rheumatoid Arthritis	0.201098907136852	1	0	CTD_human
1719	DHFR	C0014553	Absence Epilepsy	0.2	0	0	HPO
1719	DHFR	C0016412	Folic Acid Deficiency	0.202407028523288	1	0	CTD_human
1719	DHFR	C0030312	Pancytopenia	0.4	1	0	CTD_human;HPO
1719	DHFR	C0235946	Cerebral atrophy	0.2	0	0	HPO
1719	DHFR	C3151205	Megaloblastic Anemia due to Dihydrofolate Reductase Deficiency	0.400274726784213	2	2	ORPHANET;UNIPROT
1719	DHFR	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1719	DHFR	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1723	DHODH	C0002895	Anemia, Sickle Cell	0.2	1	0	CTD_human
1723	DHODH	C0005283	beta Thalassemia	0.2	1	0	CTD_human
1723	DHODH	C0013592	Ectropion	0.2	0	0	HPO
1723	DHODH	C0018777	Conductive hearing loss	0.2	0	0	HPO
1723	DHODH	C0037889	Hereditary spherocytosis	0.2	1	0	CTD_human
1723	DHODH	C0265257	Genee-Wiedemann syndrome	0.401098907136852	1	8	ORPHANET;UNIPROT
1723	DHODH	C0521736	Lower eyelid ectropion	0.2	0	0	HPO
1727	CYB5R3	C0025637	Methemoglobinemia	0.409311999908611	1	0	CTD_human;HPO
1727	CYB5R3	C0032461	Polycythemia	0.2	0	0	HPO
1727	CYB5R3	C0038379	Strabismus	0.2	0	0	HPO
1727	CYB5R3	C0268193	NADH cytochrome B5 reductase deficiency	0.4	9	9	CTD_human;UNIPROT
1728	NQO1	C0004096	Asthma	0.216639985413433	1	0	CTD_human
1728	NQO1	C0008370	Cholestasis	0.2	1	0	CTD_human
1728	NQO1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
1728	NQO1	C0019061	Hemolytic-Uremic Syndrome	0.2	1	0	CTD_human
1728	NQO1	C0020456	Hyperglycemia	0.2	1	0	CTD_human
1728	NQO1	C0028754	Obesity	0.2	1	0	CTD_human
1728	NQO1	C0030567	Parkinson Disease	0.220406292480469	1	0	CTD_human
1728	NQO1	C0236663	Alcohol withdrawal syndrome	0.200274726784213	1	0	PSYGENET
1728	NQO1	C1846707	SPINOCEREBELLAR ATAXIA 17	0.2	1	0	CTD_human
1729	DIAPH1	C0014544	Epilepsy	0.2	0	0	HPO
1729	DIAPH1	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
1729	DIAPH1	C0029124	Optic Atrophy	0.2	0	0	HPO
1729	DIAPH1	C0155320	Blindness, Cortical	0.2	0	0	HPO
1729	DIAPH1	C0271514	Low frequency deafness	0.200274726784213	0	0	HPO
1729	DIAPH1	C1852282	DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)	0.2	0	0	CTD_human
1730	DIAPH2	C0025322	Premature Menopause	0.201373633921065	0	0	HPO
1730	DIAPH2	C1845293	Premature Ovarian Failure 2a	0.2	0	0	CTD_human
1733	DIO1	C0020551	Hyperthyroxinemia	0.2	1	0	CTD_human
1734	DIO2	C0014175	Endometriosis	0.2	1	0	CTD_human
1736	DKC1	C0002170	Alopecia	0.2	0	0	HPO
1736	DKC1	C0002871	Anemia	0.2	0	0	HPO
1736	DKC1	C0005741	Blepharitis	0.2	0	0	HPO
1736	DKC1	C0009763	Conjunctivitis	0.2	0	0	HPO
1736	DKC1	C0011334	Dental caries	0.2	0	0	HPO
1736	DKC1	C0023530	Leukopenia	0.2	0	0	HPO
1736	DKC1	C0023890	Liver Cirrhosis	0.2	0	0	HPO
1736	DKC1	C0029124	Optic Atrophy	0.2	0	0	HPO
1736	DKC1	C0029456	Osteoporosis	0.2	0	0	HPO
1736	DKC1	C0030312	Pancytopenia	0.201373633921065	0	0	HPO
1736	DKC1	C0031099	Periodontitis	0.2	0	0	HPO
1736	DKC1	C0034069	Pulmonary Fibrosis	0.2	0	0	HPO
1736	DKC1	C0038379	Strabismus	0.2	0	0	HPO
1736	DKC1	C0085581	Restrictive lung disease	0.2	0	0	HPO
1736	DKC1	C0152227	Excessive tearing	0.2	0	0	HPO
1736	DKC1	C0221260	Dystrophia unguium	0.2	0	0	HPO
1736	DKC1	C0235946	Cerebral atrophy	0.2	0	0	HPO
1736	DKC1	C0265965	Dyskeratosis Congenita	0.421906365850462	2	0	CTD_human;ORPHANET
1736	DKC1	C0266039	Taurodontism	0.2	0	0	HPO
1736	DKC1	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
1736	DKC1	C0399385	Early tooth exfoliation	0.2	0	0	HPO
1736	DKC1	C1148551	X-Linked Dyskeratosis Congenita	0.286593442821114	11	40	UNIPROT
1736	DKC1	C1846142	HOYERAAL-HREIDARSSON SYNDROME	0.201648360705279	0	0	ORPHANET
1736	DKC1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1736	DKC1	C4023400	Generalized hypopigmentation of hair	0.2	0	0	HPO
1737	DLAT	C0028738	Nystagmus	0.2	0	0	HPO
1737	DLAT	C0037036	Sialorrhea	0.2	0	0	HPO
1737	DLAT	C0085583	Choreoathetosis	0.2	0	0	HPO
1737	DLAT	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
1737	DLAT	C1837658	Gross motor development delay	0.2	0	0	HPO
1737	DLAT	C1855565	Pyruvate Dehydrogenase E2 Deficiency	0.4	0	0	CTD_human;ORPHANET
1737	DLAT	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
1737	DLAT	C3489733	Oculomotor apraxia	0.2	0	0	HPO
1738	DLD	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
1738	DLD	C0014544	Epilepsy	0.2	0	0	HPO
1738	DLD	C0020615	Hypoglycemia	0.2	0	0	HPO
1738	DLD	C0023264	Leigh Disease	0.200549453568426	0	0	CTD_human
1738	DLD	C0024776	Maple Syrup Urine Disease	0.200274726784213	0	0	CTD_human
1738	DLD	C0268193	NADH cytochrome B5 reductase deficiency	0.402472541057918	8	17	ORPHANET;UNIPROT
1738	DLD	C4020871	Dystonic disease	0.2	0	0	HPO
174	AFP	C1863081	alpha-Fetoprotein Deficiency	0.2	0	0	ORPHANET
1741	DLG3	C0038379	Strabismus	0.2	0	0	HPO
1741	DLG3	C1136249	Mental Retardation, X-Linked	0.204120901763196	1	0	CTD_human
1742	DLG4	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
1742	DLG4	C0175702	Williams Syndrome	0.280274726784213	1	0	CTD_human
1747	DLX3	C0029464	Osteosclerosis	0.200274726784213	0	0	HPO
1747	DLX3	C0265333	Tricho-dento-osseous syndrome (disorder)	0.406253203502271	0	0	CTD_human;ORPHANET
1747	DLX3	C0266039	Taurodontism	0.200824180352639	0	0	HPO
1747	DLX3	C1863012	Amelogenesis Imperfecta, Type IV	0.200274726784213	0	0	CTD_human
1749	DLX5	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
1749	DLX5	C1857344	Split-Hand-Foot Malformation With Sensorineural Hearing Loss	0.4	1	1	ORPHANET;UNIPROT
175	AGA	C0002986	Fabry Disease	0.200274726784213	0	0	HPO
175	AGA	C0011334	Dental caries	0.2	0	0	HPO
175	AGA	C0013384	Dyskinetic syndrome	0.2	0	0	HPO
175	AGA	C0014544	Epilepsy	0.2	0	0	HPO
175	AGA	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
175	AGA	C0024421	Macroglossia	0.2	0	0	HPO
175	AGA	C0038016	Spondylolisthesis	0.2	0	0	HPO
175	AGA	C0038018	Spondylolysis	0.2	0	0	HPO
175	AGA	C0086795	Pfaundler-Hurler Syndrome	0.2	0	0	HPO
175	AGA	C0235946	Cerebral atrophy	0.2	0	0	HPO
175	AGA	C0264112	Wedging of vertebra	0.2	0	0	HPO
175	AGA	C0702166	Acne	0.2	0	0	HPO
175	AGA	C1836830	Developmental regression	0.2	0	0	HPO
175	AGA	C2931840	Aspartylglucosamidase (AGA) deficiency	0.2	0	0	ORPHANET
175	AGA	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1756	DMD	C0013264	Muscular Dystrophy, Duchenne	0.851089561087121	16	285	CTD_human;ORPHANET;UNIPROT
1756	DMD	C0018801	Heart failure	0.204120901763196	0	0	HPO
1756	DMD	C0018802	Congestive heart failure	0.20439562854741	0	0	HPO
1756	DMD	C0026850	Muscular Dystrophy	0.494945209939527	4	0	CTD_human;HPO
1756	DMD	C0026851	Muscular Dystrophy, Animal	0.2	1	0	CTD_human
1756	DMD	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
1756	DMD	C0038220	Status Epilepticus	0.28	1	0	CTD_human
1756	DMD	C0917713	Becker Muscular Dystrophy	0.561528342376661	1	174	ORPHANET;UNIPROT
1756	DMD	C1145670	Respiratory Failure	0.200549453568426	0	0	HPO
1756	DMD	C3668940	Dmd-Associated Dilated Cardiomyopathy	0.412022465970747	4	220	CTD_human;UNIPROT
1756	DMD	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
1756	DMD	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
1758	DMP1	C0010278	Craniosynostosis	0.2	0	0	HPO
1758	DMP1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1758	DMP1	C0029442	Osteomalacia	0.200824180352639	0	0	HPO
1758	DMP1	C0029464	Osteosclerosis	0.2	0	0	HPO
1758	DMP1	C0035579	Rickets	0.203831819601666	0	0	HPO
1758	DMP1	C0162323	Polyarthritis	0.2	0	0	HPO
1758	DMP1	C1282952	Enthesitis	0.2	0	0	HPO
1758	DMP1	C1704375	Hypophosphatemic Rickets	0.203021994626344	0	0	HPO
1758	DMP1	C4024631	Renal hypophosphatemia	0.2	0	0	HPO
1759	DNM1	C0014544	Epilepsy	0.200824180352639	0	0	HPO
1759	DNM1	C0238111	Lennox-Gastaut syndrome	0.2	0	0	ORPHANET
1759	DNM1	C0270846	Epileptic drop attack	0.2	0	0	HPO
1759	DNM1	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
1759	DNM1	C0543888	Epileptic encephalopathy	0.200549453568426	0	0	HPO
1759	DNM1	C0595948	Atypical absence seizure	0.2	0	0	HPO
1759	DNM1	C1836830	Developmental regression	0.2	0	0	HPO
1759	DNM1	C4225357	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31	0.2	2	6	UNIPROT
176	ACAN	C0003873	Rheumatoid Arthritis	0.20761248204602	1	0	CTD_human
176	ACAN	C0029408	Degenerative polyarthritis	0.295919798107043	0	0	HPO
176	ACAN	C0029421	Osteochondritis Dissecans	0.200274726784213	0	0	HPO
176	ACAN	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
176	ACAN	C0038015	Spondyloepiphyseal Dysplasia	0.200549453568426	0	0	HPO
176	ACAN	C1842149	Spondyloepiphyseal Dysplasia, Kimberley Type	0.4	0	0	CTD_human;ORPHANET
176	ACAN	C2748544	Spondyloepimetaphyseal Dysplasia, Aggrecan Type	0.6	1	1	CTD_human;ORPHANET;UNIPROT
176	ACAN	C3665488	Familial Osteochondritis Dissecans	0.600274726784213	1	0	CTD_human;ORPHANET;UNIPROT
1760	DMPK	C0008350	Cholelithiasis	0.2	0	0	HPO
1760	DMPK	C0020619	Hypogonadism	0.200549453568426	0	0	HPO
1760	DMPK	C0027126	Myotonic Dystrophy	0.329024155769426	1	0	CTD_human
1760	DMPK	C0085614	First degree atrioventricular block	0.2	0	0	HPO
1760	DMPK	C0156312	Atrophy of testis	0.2	0	0	HPO
1760	DMPK	C0234958	muscle degeneration	0.2	0	0	HPO
1760	DMPK	C0235946	Cerebral atrophy	0.2	0	0	HPO
1760	DMPK	C0376175	Bell Palsy	0.2	0	0	HPO
1760	DMPK	C3250443	MYOTONIC DYSTROPHY 1	0.290989071368524	0	0	ORPHANET
1760	DMPK	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1760	DMPK	C4083212	Alopecia, Male Pattern	0.2	0	0	HPO
1761	DMRT1	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
1761	DMRT1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
1761	DMRT1	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
1761	DMRT1	C2936694	Swyer Syndrome	0.2	0	0	ORPHANET
1761	DMRT1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
1763	DNA2	C0037926	Compression of spinal cord	0.2	0	0	HPO
1763	DNA2	C0162674	Chronic progressive external ophthalmoplegia	0.2	0	0	HPO
1763	DNA2	C0376175	Bell Palsy	0.2	0	0	HPO
1763	DNA2	C1389113	Generalized amyotrophy	0.2	0	0	HPO
1763	DNA2	C3554599	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 6	0.4	1	2	ORPHANET;UNIPROT
1767	DNAH5	C0004096	Asthma	0.2	1	0	CTD_human
1767	DNAH5	C0022521	Kartagener Syndrome	0.213041505195652	0	0	ORPHANET
1767	DNAH5	C1837618	CILIARY DYSKINESIA, PRIMARY, 3	0.48	3	16	CTD_human;UNIPROT
177	AGER	C0003873	Rheumatoid Arthritis	0.209572371315507	1	0	CTD_human
177	AGER	C0004153	Atherosclerosis	0.298232603341066	2	0	CTD_human
177	AGER	C0011875	Diabetic Angiopathies	0.210396551668146	1	0	CTD_human
177	AGER	C0020456	Hyperglycemia	0.201923087489492	1	0	CTD_human
177	AGER	C0029408	Degenerative polyarthritis	0.286839458850693	1	0	CTD_human
177	AGER	C0752347	Lewy Body Disease	0.2	1	0	CTD_human
1773	DNASE1	C0024141	Lupus Erythematosus, Systemic	0.2946243533663	0	0	CTD_human
1776	DNASE1L3	C0003864	Arthritis	0.2	0	0	HPO
1776	DNASE1L3	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
1776	DNASE1L3	C0009763	Conjunctivitis	0.2	0	0	HPO
1776	DNASE1L3	C0014583	Episcleritis	0.2	0	0	HPO
1776	DNASE1L3	C0024141	Lupus Erythematosus, Systemic	0.400824180352639	1	0	CTD_human;HPO
1776	DNASE1L3	C0027697	Nephritis	0.2	0	0	HPO
1776	DNASE1L3	C0035078	Kidney Failure	0.2	0	0	HPO
1776	DNASE1L3	C0042164	Uveitis	0.2	0	0	HPO
1776	DNASE1L3	C0343206	Hypocomplementemic urticarial vasculitis	0.200274726784213	0	0	ORPHANET
1776	DNASE1L3	C1565489	Renal Insufficiency	0.2	0	0	HPO
1776	DNASE1L3	C3280742	SYSTEMIC LUPUS ERYTHEMATOSUS 16	0.2	0	0	ORPHANET
1776	DNASE1L3	C4023113	Small vessel vasculitis	0.2	0	0	HPO
1778	DYNC1H1	C0014544	Epilepsy	0.2	0	0	HPO
1778	DYNC1H1	C0026847	Spinal Muscular Atrophy	0.202197814273705	0	0	HPO
1778	DYNC1H1	C1834690	Spinal Muscular Atrophy, Childhood, Proximal, Autosomal Dominant	0.400274726784213	2	7	ORPHANET;UNIPROT
1778	DYNC1H1	C1955869	Malformations of Cortical Development	0.200549453568426	1	0	CTD_human
1778	DYNC1H1	C3280220	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O	0.4	4	2	ORPHANET;UNIPROT
1778	DYNC1H1	C3281202	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.2	4	11	UNIPROT
178	AGL	C0014306	Enophthalmos	0.2	0	0	HPO
178	AGL	C0017922	Glycogen Storage Disease Type III	0.701594837286253	4	70	CTD_human;ORPHANET;UNIPROT
178	AGL	C0020473	Hyperlipidemia	0.2	0	0	HPO
178	AGL	C0020615	Hypoglycemia	0.200549453568426	0	0	HPO
178	AGL	C0239946	Fibrosis, Liver	0.2	0	0	HPO
178	AGL	C0340279	Ventricular hypertrophy	0.2	0	0	HPO
178	AGL	C1848736	Distal amyotrophy	0.2	0	0	HPO
178	AGL	C2936915	Amylo-1,6-glucosidase deficiency	0.2	0	0	ORPHANET
1785	DNM2	C0162292	External Ophthalmoplegia	0.2	0	0	HPO
1785	DNM2	C0162674	Chronic progressive external ophthalmoplegia	0.2	0	0	HPO
1785	DNM2	C0376175	Bell Palsy	0.2	0	0	HPO
1785	DNM2	C0752282	Congenital Structural Myopathy	0.208473464178654	1	0	CTD_human
1785	DNM2	C1834558	Myopathy, Centronuclear, Autosomal Dominant	0.683846174978983	9	9	CTD_human;ORPHANET;UNIPROT
1785	DNM2	C1847902	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B (disorder)	0.600274726784213	4	5	CTD_human;ORPHANET;UNIPROT
1785	DNM2	C1848736	Distal amyotrophy	0.2	0	0	HPO
1785	DNM2	C3809272	LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.4	1	1	ORPHANET;UNIPROT
1786	DNMT1	C0004096	Asthma	0.2	1	0	CTD_human
1786	DNMT1	C0007384	Cataplexy	0.2	0	0	HPO
1786	DNMT1	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
1786	DNMT1	C0027404	Narcolepsy	0.201648360705279	0	0	HPO
1786	DNMT1	C0029443	Osteomyelitis	0.2	0	0	HPO
1786	DNMT1	C0151313	Sensory neuropathy	0.200274726784213	0	0	HPO
1786	DNMT1	C0235946	Cerebral atrophy	0.2	0	0	HPO
1786	DNMT1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
1786	DNMT1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
1786	DNMT1	C2242472	Infection of bone	0.2	0	0	HPO
1786	DNMT1	C3279885	Hereditary Sensory and Autonomic Neuropathy Type Ie	0.400274726784213	1	3	ORPHANET;UNIPROT
1786	DNMT1	C3807295	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT	0.401373633921066	1	3	ORPHANET;UNIPROT
1786	DNMT1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1786	DNMT1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
1788	DNMT3A	C0010346	Crohn Disease	0.2	1	1	CTD_human
1788	DNMT3A	C4014545	TATTON-BROWN-RAHMAN SYNDROME	0.400274726784213	1	10	ORPHANET;UNIPROT
1789	DNMT3B	C0002871	Anemia	0.2	0	0	HPO
1789	DNMT3B	C0006267	Bronchiectasis	0.2	0	0	HPO
1789	DNMT3B	C0008677	Bronchitis, Chronic	0.2	0	0	HPO
1789	DNMT3B	C0009451	Communicating Hydrocephalus	0.2	0	0	HPO
1789	DNMT3B	C0024312	Lymphopenia	0.2	0	0	HPO
1789	DNMT3B	C0024421	Macroglossia	0.2	0	0	HPO
1789	DNMT3B	C0032285	Pneumonia	0.2	0	0	HPO
1789	DNMT3B	C0037199	Sinusitis	0.2	0	0	HPO
1789	DNMT3B	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
1789	DNMT3B	C0398788	Immunodeficiency syndrome, variable	0.480549453568426	10	10	CTD_human;UNIPROT
1789	DNMT3B	C1834671	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B	0.2	1	0	UNIPROT
1789	DNMT3B	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1789	DNMT3B	C2931322	T-Lymphocytopenia	0.2	0	0	HPO
179	AGMX2	C1845903	AGAMMAGLOBULINEMIA, X-LINKED, TYPE 2 (disorder)	0.2	0	0	CTD_human
1794	DOCK2	C4225328	IMMUNODEFICIENCY 40	0.4	1	2	ORPHANET;UNIPROT
1798	DPAGT1	C0014544	Epilepsy	0.2	0	0	HPO
1798	DPAGT1	C0015310	Exotropia	0.2	0	0	HPO
1798	DPAGT1	C0028738	Nystagmus	0.2	0	0	HPO
1798	DPAGT1	C2931004	Congenital disorder of glycosylation type 1J	0.600824180352639	1	7	CTD_human;ORPHANET;UNIPROT
1798	DPAGT1	C3553645	MYASTHENIC SYNDROME, CONGENITAL, 13	0.2	1	7	UNIPROT
18	ABAT	C0014544	Epilepsy	0.2	0	0	HPO
18	ABAT	C0017168	Gastroesophageal reflux disease	0.200274726784213	1	0	CTD_human
18	ABAT	C0023520	Leukodystrophy	0.2	0	0	HPO
18	ABAT	C0342708	Gamma aminobutyric acid transaminase deficiency	0.6	1	4	CTD_human;ORPHANET;UNIPROT
1804	DPP6	C0002736	Amyotrophic Lateral Sclerosis	0.211877085524169	1	1	CTD_human
1804	DPP6	C0152205	Alternating esotropia	0.2	0	0	HPO
1804	DPP6	C0220693	Microcephaly autosomal dominant	0.200274726784213	0	0	ORPHANET
1804	DPP6	C0340493	Paroxysmal familial ventricular fibrillation	0.200824180352639	0	0	CTD_human
1804	DPP6	C0521683	Chorioretinal degeneration	0.2	0	0	HPO
1804	DPP6	C2751898	Ventricular Fibrillation, Paroxysmal Familial, 1	0.2	0	0	ORPHANET
1805	DPT	C0042345	Varicosity	0.2	1	0	CTD_human
1806	DPYD	C0004106	Astigmatism	0.2	0	0	HPO
1806	DPYD	C0014306	Enophthalmos	0.2	0	0	HPO
1806	DPYD	C0014544	Epilepsy	0.2	0	0	HPO
1806	DPYD	C0027092	Myopia	0.2	0	0	HPO
1806	DPYD	C0027947	Neutropenia	0.201098907136852	1	0	CTD_human
1806	DPYD	C0028738	Nystagmus	0.2	0	0	HPO
1806	DPYD	C0028754	Obesity	0.4	1	0	CTD_human;HPO
1806	DPYD	C0029124	Optic Atrophy	0.2	0	0	HPO
1806	DPYD	C0034372	Quadriplegia	0.2	0	0	HPO
1806	DPYD	C0235946	Cerebral atrophy	0.2	0	0	HPO
1806	DPYD	C1959620	Dihydropyrimidine Dehydrogenase Deficiency	0.618968824756397	4	47	CTD_human;HPO;ORPHANET;UNIPROT
1806	DPYD	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1806	DPYD	C4020860	Supratentorial atrophy	0.2	0	0	HPO
1807	DPYS	C0014544	Epilepsy	0.2	0	0	HPO
1807	DPYS	C0342803	Dihydropyrimidinase deficiency	0.6	1	5	CTD_human;ORPHANET;UNIPROT
1807	DPYS	C1848528	Extrapyramidal dyskinesia	0.2	0	0	HPO
1807	DPYS	C1959620	Dihydropyrimidine Dehydrogenase Deficiency	0.2	0	0	HPO
1807	DPYS	C4020859	Pyramidal tract disease	0.2	0	0	HPO
1808	DPYSL2	C0002395	Alzheimer's Disease	0.205754907091158	1	0	CTD_human
1808	DPYSL2	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
181	AGRP	C0028754	Obesity	0.2121661676857	0	0	CTD_human
1811	SLC26A3	C0009324	Ulcerative Colitis	0.200274726784213	1	0	CTD_human
1811	SLC26A3	C0020428	Hyperaldosteronism	0.2	0	0	HPO
1811	SLC26A3	C0085680	Hypochloremia (disorder)	0.2	0	0	HPO
1811	SLC26A3	C0220983	Metabolic alkalosis	0.200274726784213	0	0	HPO
1811	SLC26A3	C0267662	Congenital chloride diarrhea	0.482747267842131	8	54	ORPHANET;UNIPROT
1811	SLC26A3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1812	DRD1	C0013386	Dyskinesia, Drug-Induced	0.2	4	0	CTD_human
1812	DRD1	C0030567	Parkinson Disease	0.282956482091714	1	0	CTD_human
1813	DRD2	C0013384	Dyskinetic syndrome	0.212030556996107	1	0	CTD_human
1813	DRD2	C0013386	Dyskinesia, Drug-Induced	0.202407028523288	3	0	CTD_human
1813	DRD2	C0020514	Hyperprolactinemia	0.209144173059356	2	0	CTD_human
1813	DRD2	C0030567	Parkinson Disease	0.247303713467427	1	0	CTD_human
1813	DRD2	C0154676	Organic writer's cramp	0.2	0	0	HPO
1813	DRD2	C1834570	Myoclonic dystonia	0.401923087489492	0	0	CTD_human;ORPHANET
1813	DRD2	C4020884	Anxiety disease	0.2	0	0	HPO
1814	DRD3	C0013386	Dyskinesia, Drug-Induced	0.202407028523288	1	0	CTD_human
1814	DRD3	C0040517	Gilles de la Tourette syndrome	0.205912964183428	1	0	CTD_human
1814	DRD3	C1860861	TREMOR, HEREDITARY ESSENTIAL, 1	0.2	0	0	CTD_human
1815	DRD4	C3160718	PARKINSON DISEASE, LATE-ONSET	0.2	0	0	CTD_human
1816	DRD5	C0005747	Blepharospasm	0.202681755307501	1	0	CTD_human
1816	DRD5	C2930898	Benign essential blepharospasm	0.200274726784213	0	0	CTD_human
182	JAG1	C0014306	Enophthalmos	0.2	0	0	HPO
182	JAG1	C0015300	Exophthalmos	0.2	0	0	HPO
182	JAG1	C0020443	Hypercholesterolemia	0.2	0	0	HPO
182	JAG1	C0023890	Liver Cirrhosis	0.200274726784213	0	0	HPO
182	JAG1	C0027092	Myopia	0.2	0	0	HPO
182	JAG1	C0030293	Pancreatic Insufficiency	0.2	0	0	HPO
182	JAG1	C0038379	Strabismus	0.2	0	0	HPO
182	JAG1	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
182	JAG1	C0155120	Corneal Dystrophy, Band-Shaped	0.2	0	0	HPO
182	JAG1	C0267963	Exocrine pancreatic insufficiency	0.2	0	0	HPO
182	JAG1	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
182	JAG1	C0687120	Nephronophthisis	0.2	0	0	HPO
182	JAG1	C1956125	Alagille Syndrome 1	0.480274726784213	13	28	ORPHANET;UNIPROT
182	JAG1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
182	JAG1	C4020790	Medullary sponge kidney disease	0.2	0	0	HPO
182	JAG1	C4024644	Multiple small medullary renal cysts	0.2	0	0	HPO
182	JAG1	C4048273	Chorioretinal atrophy	0.2	0	0	HPO
1822	ATN1	C0085583	Choreoathetosis	0.2	0	0	HPO
1822	ATN1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	CTD_human
1822	ATN1	C0751781	Dentatorubral-Pallidoluysian Atrophy	0.210714344584311	0	0	ORPHANET
1824	DSC2	C0022596	Palmoplantar Keratosis	0.200274726784213	0	0	HPO
1824	DSC2	C0085612	Ventricular arrhythmia	0.2	0	0	HPO
1824	DSC2	C1864850	Arrhythmogenic Right Ventricular Dysplasia, Familial, 11	0.4	2	5	CTD_human;UNIPROT
1824	DSC2	C2063326	Cardiomyopathy, right ventricular	0.200274726784213	0	0	HPO
1824	DSC2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1825	DSC3	C2751292	Hypotrichosis And Recurrent Skin Vesicles	0.400274726784213	0	0	CTD_human;ORPHANET
1827	RCAN1	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
1827	RCAN1	C0013080	Down Syndrome	0.22766127294162	1	0	CTD_human
1827	RCAN1	C0020179	Huntington Disease	0.200274726784213	1	0	CTD_human
1828	DSG1	C0011603	Dermatitis	0.200549453568426	1	0	CTD_human
1828	DSG1	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
1828	DSG1	C0022596	Palmoplantar Keratosis	0.205205453522732	0	0	HPO
1828	DSG1	C2931122	Keratosis palmoplantaris striata 1	0.4	0	0	CTD_human;ORPHANET
1828	DSG1	C3809719	ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE	0.200824180352639	0	0	ORPHANET
1829	DSG2	C0042514	Tachycardia, Ventricular	0.202681755307501	0	0	HPO
1829	DSG2	C1857777	Arrhythmogenic Right Ventricular Dysplasia, Familial, 10	0.4	2	12	CTD_human;UNIPROT
1829	DSG2	C2063326	Cardiomyopathy, right ventricular	0.200274726784213	0	0	HPO
1829	DSG2	C2752072	Cardiomyopathy, Dilated, 1BB	0.2	0	0	CTD_human
1829	DSG2	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
1829	DSG2	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
183	AGT	C0002871	Anemia	0.2	1	0	CTD_human
183	AGT	C0002949	Aneurysm, Dissecting	0.202407028523288	1	0	CTD_human
183	AGT	C0003486	Aortic Aneurysm	0.201648360705279	1	0	CTD_human
183	AGT	C0004153	Atherosclerosis	0.321847658294784	2	0	CTD_human
183	AGT	C0007192	Cardiomyopathy, Alcoholic	0.2	1	0	CTD_human
183	AGT	C0011881	Diabetic Nephropathy	0.239454985148814	2	0	CTD_human
183	AGT	C0011884	Diabetic Retinopathy	0.288371149864029	1	0	CTD_human
183	AGT	C0017658	Glomerulonephritis	0.203780662444353	1	0	CTD_human
183	AGT	C0017661	IGA Glomerulonephritis	0.240720040403297	1	0	CTD_human
183	AGT	C0017668	Focal glomerulosclerosis	0.204106546385879	1	0	CTD_human
183	AGT	C0018801	Heart failure	0.297595190835332	3	0	CTD_human
183	AGT	C0020452	Hyperemia	0.2	1	0	CTD_human
183	AGT	C0020540	Malignant Hypertension	0.204381273170092	1	0	CTD_human
183	AGT	C0020544	Renal hypertension	0.207221085569864	1	0	CTD_human
183	AGT	C0023890	Liver Cirrhosis	0.218325147898707	1	0	CTD_human
183	AGT	C0027051	Myocardial Infarction	0.249892924217288	2	0	CTD_human
183	AGT	C0027720	Nephrosis	0.2	1	0	CTD_human
183	AGT	C0035344	Retinopathy of Prematurity	0.2	1	0	CTD_human
183	AGT	C0085580	Essential Hypertension	0.254892520953684	0	0	CTD_human
183	AGT	C0149721	Left Ventricular Hypertrophy	0.254301229410391	6	0	CTD_human
183	AGT	C0151744	Myocardial Ischemia	0.216207201536949	1	0	CTD_human
183	AGT	C0162871	Aortic Aneurysm, Abdominal	0.212571919539173	4	0	CTD_human
183	AGT	C0266313	Allanson Pantzar McLeod syndrome	0.600274726784213	2	4	CTD_human;HPO;ORPHANET;UNIPROT
183	AGT	C1565489	Renal Insufficiency	0.204879569581206	1	0	CTD_human
1831	TSC22D3	C0020459	Hyperinsulinism	0.2	1	0	CTD_human
1832	DSP	C0002170	Alopecia	0.200274726784213	0	0	HPO
1832	DSP	C0018801	Heart failure	0.201098907136852	0	0	HPO
1832	DSP	C0018802	Congestive heart failure	0.201098907136852	0	0	HPO
1832	DSP	C0022596	Palmoplantar Keratosis	0.205205453522732	0	0	HPO
1832	DSP	C0042510	Ventricular Fibrillation	0.2	0	0	HPO
1832	DSP	C0042514	Tachycardia, Ventricular	0.202956482091714	0	0	HPO
1832	DSP	C0079153	Hyperkeratosis, Epidermolytic	0.2	0	0	HPO
1832	DSP	C0221260	Dystrophia unguium	0.2	0	0	HPO
1832	DSP	C0263505	Alopecia universalis	0.2	0	0	HPO
1832	DSP	C1800706	Idiopathic Pulmonary Fibrosis	0.4	1	0	CTD_human;ORPHANET
1832	DSP	C1834405	Nail dysplasia	0.2	0	0	HPO
1832	DSP	C1843292	Skin Fragility-Woolly Hair Syndrome	0.600549453568426	1	5	CTD_human;ORPHANET;UNIPROT
1832	DSP	C1843896	Arrhythmogenic Right Ventricular Dysplasia, Familial, 8	0.48	3	7	CTD_human;UNIPROT
1832	DSP	C1852127	KERATOSIS PALMOPLANTARIS STRIATA II	0.2	0	0	CTD_human
1832	DSP	C1854063	Cardiomyopathy dilated with Woolly hair and keratoderma	0.481923087489492	1	6	CTD_human;ORPHANET
1832	DSP	C1864826	Epidermolysis bullosa, lethal acantholytic	0.400824180352639	0	0	CTD_human;ORPHANET
1832	DSP	C2063326	Cardiomyopathy, right ventricular	0.2	0	0	HPO
1832	DSP	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1832	DSP	C2931122	Keratosis palmoplantaris striata 1	0.2	0	0	ORPHANET
1832	DSP	C3809719	ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE	0.2	0	0	ORPHANET
1832	DSP	C3887524	Skin Erosion	0.2	0	0	HPO
1832	DSP	C4014393	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS	0.2	2	3	UNIPROT
1832	DSP	C4021633	Patchy palmoplantar keratoderma	0.2	0	0	HPO
1834	DSPP	C0011430	Dentin Dysplasia	0.204381273170092	0	0	HPO
1834	DSPP	C0018780	Hearing Loss, High-Frequency	0.2	0	0	HPO
1834	DSPP	C0031029	Periapical Granuloma	0.2	0	0	HPO
1834	DSPP	C0034543	Radicular Cyst	0.2	0	0	HPO
1834	DSPP	C0399379	Dentin dysplasia, type 1	0.200274726784213	0	0	ORPHANET
1834	DSPP	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
1834	DSPP	C1527284	Dental Pulp Stone	0.2	0	0	HPO
1834	DSPP	C1854146	Deafness, Autosomal Dominant 39, with Dentinogenesis Imperfecta 1	0.4	3	2	CTD_human;UNIPROT
1834	DSPP	C2973527	Dentinogenesis imperfecta without osteogenesis imperfecta	0.401923087489492	4	2	ORPHANET;UNIPROT
1836	SLC26A2	C0020305	Hydrops Fetalis	0.2	0	0	HPO
1836	SLC26A2	C0029408	Degenerative polyarthritis	0.200274726784213	0	0	HPO
1836	SLC26A2	C0029464	Osteosclerosis	0.2	0	0	HPO
1836	SLC26A2	C0037926	Compression of spinal cord	0.2	0	0	HPO
1836	SLC26A2	C1847593	EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.600824180352639	2	32	CTD_human;ORPHANET;UNIPROT
1836	SLC26A2	C1850554	Atelosteogenesis type 2	0.601923087489492	2	30	CTD_human;ORPHANET;UNIPROT
1836	SLC26A2	C1857269	Hitchhiker thumb	0.2	0	0	HPO
1836	SLC26A2	C4023720	Cystic lesions of the pinnae	0.2	0	0	HPO
1837	DTNA	C0004238	Atrial Fibrillation	0.2	0	0	HPO
1837	DTNA	C0018801	Heart failure	0.2	0	0	HPO
1837	DTNA	C0018802	Congestive heart failure	0.2	0	0	HPO
1837	DTNA	C0085612	Ventricular arrhythmia	0.2	0	0	HPO
1837	DTNA	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
1837	DTNA	C0152101	Hypoplastic Left Heart Syndrome	0.2	0	0	HPO
1837	DTNA	C1858725	NONCOMPACTION OF LEFT VENTRICULAR MYOCARDIUM, FAMILIAL ISOLATED, AUTOSOMAL DOMINANT 1	0.4	1	1	CTD_human;UNIPROT
1837	DTNA	C1960469	Left ventricular noncompaction	0.4	0	0	HPO;ORPHANET
1837	DTNA	C4021133	Left Ventricular Non-Compaction Syndrome	0.200549453568426	0	0	HPO
1839	HBEGF	C0014175	Endometriosis	0.2	1	0	CTD_human
1839	HBEGF	C0014549	Tonic-Clonic Epilepsy	0.2	1	0	CTD_human
1839	HBEGF	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
1839	HBEGF	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
1839	HBEGF	C0520459	Necrotizing Enterocolitis	0.200549453568426	1	0	CTD_human
1839	HBEGF	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
1843	DUSP1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
1843	DUSP1	C0014175	Endometriosis	0.2	1	0	CTD_human
1843	DUSP1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
1843	DUSP1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
1844	DUSP2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
1846	DUSP4	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
1848	DUSP6	C0018418	Gynecomastia	0.2	0	0	HPO
1848	DUSP6	C0029453	Osteopenia	0.2	0	0	HPO
1848	DUSP6	C0029456	Osteoporosis	0.2	0	0	HPO
1848	DUSP6	C0151721	Testicular hypogonadism	0.2	0	0	HPO
1848	DUSP6	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
1848	DUSP6	C0162809	Kallmann Syndrome	0.2	0	0	ORPHANET
1848	DUSP6	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
1848	DUSP6	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
1848	DUSP6	C0242350	Erectile dysfunction	0.2	0	0	HPO
1848	DUSP6	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
1848	DUSP6	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
1848	DUSP6	C0747078	Generalized osteopenia	0.2	0	0	HPO
1848	DUSP6	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
1848	DUSP6	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
1848	DUSP6	C3808981	HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA	0.2	1	4	UNIPROT
1848	DUSP6	C4020884	Anxiety disease	0.2	0	0	HPO
1848	DUSP6	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
1848	DUSP6	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
185	AGTR1	C0011884	Diabetic Retinopathy	0.205414667772315	1	0	CTD_human
185	AGTR1	C0018801	Heart failure	0.298115933649124	3	0	CTD_human
185	AGTR1	C0085580	Essential Hypertension	0.221781605133158	0	0	CTD_human
185	AGTR1	C0162871	Aortic Aneurysm, Abdominal	0.214009387263244	1	0	CTD_human
185	AGTR1	C0266313	Allanson Pantzar McLeod syndrome	0.6	1	5	CTD_human;HPO;ORPHANET;UNIPROT
1855	DVL1	C0015300	Exophthalmos	0.2	0	0	HPO
1855	DVL1	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
1855	DVL1	C0020295	Hydronephrosis	0.2	0	0	HPO
1855	DVL1	C0024421	Macroglossia	0.2	0	0	HPO
1855	DVL1	C0024636	Malocclusion	0.2	0	0	HPO
1855	DVL1	C0265205	Robinow Syndrome	0.200824180352639	0	0	ORPHANET
1855	DVL1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
1857	DVL3	C0265205	Robinow Syndrome	0.200274726784213	0	0	ORPHANET
1858	DWS	C0010964	Dandy-Walker Syndrome	0.2	0	0	CTD_human
1859	DYRK1A	C0009952	Febrile Convulsions	0.200274726784213	0	0	HPO
1859	DYRK1A	C0014306	Enophthalmos	0.2	0	0	HPO
1859	DYRK1A	C0235946	Cerebral atrophy	0.2	0	0	HPO
186	AGTR2	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
186	AGTR2	C0149721	Left Ventricular Hypertrophy	0.218925758624446	1	0	CTD_human
186	AGTR2	C0853897	Diabetic Cardiomyopathies	0.2	2	0	CTD_human
186	AGTR2	C1136249	Mental Retardation, X-Linked	0.205740551713841	1	0	CTD_human
1861	TOR1A	C0005747	Blepharospasm	0.202407028523288	0	0	HPO
1861	TOR1A	C0013423	Dystonia Musculorum Deformans	0.225990465833663	0	0	HPO
1861	TOR1A	C0154676	Organic writer's cramp	0.202472541057918	0	0	HPO
1861	TOR1A	C0393598	Idiopathic familial dystonia	0.2	0	0	ORPHANET
1861	TOR1A	C1834570	Myoclonic dystonia	0.202472541057918	0	0	ORPHANET
1861	TOR1A	C1851945	DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.282197814273705	2	4	UNIPROT
1861	TOR1A	C3888090	Early onset torsion dystonia	0.217307787405425	0	0	CTD_human
1862	DYT2	C1857093	DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)	0.2	0	0	CTD_human
1866	DYT7	C1865819	CERVICAL DYSTONIA, PRIMARY	0.2	0	0	CTD_human
1878	E11S	C1851888	ECHO VIRUS 11 SENSITIVITY	0.2	0	0	CTD_human
1879	EBF1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
1880	GPR183	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
1881	EBM	C0795974	Hereditary macular epidermolysis bullosa	0.2	0	0	CTD_human
1889	ECE1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	0	CTD_human
1889	ECE1	C0013363	Dysautonomia	0.2	0	0	HPO
1889	ECE1	C0021843	Intestinal Obstruction	0.2	0	0	HPO
1889	ECE1	C0085580	Essential Hypertension	0.200274726784213	0	0	CTD_human
1889	ECE1	C3151237	Hirschsprung Disease, Cardiac Defects, and Autonomic Dysfunction	0.2	1	1	UNIPROT
189	AGXT	C0004245	Atrioventricular Block	0.2	0	0	HPO
189	AGXT	C0017086	Gangrene	0.2	0	0	HPO
189	AGXT	C0020500	Hyperoxaluria	0.204055389228567	0	0	HPO
189	AGXT	C0027709	Nephrocalcinosis	0.200824180352639	0	0	HPO
189	AGXT	C0029124	Optic Atrophy	0.2	0	0	HPO
189	AGXT	C0029464	Osteosclerosis	0.2	0	0	HPO
189	AGXT	C0035078	Kidney Failure	0.202472541057918	0	0	HPO
189	AGXT	C0263401	Cutis marmorata	0.2	0	0	HPO
189	AGXT	C0268164	Primary hyperoxaluria, type I	0.69950560167913	10	164	CTD_human;ORPHANET;UNIPROT
189	AGXT	C0750145	vascular disease occlusive	0.2	0	0	HPO
189	AGXT	C1306889	Peripheral arterial occlusive disease	0.2	0	0	HPO
189	AGXT	C1401086	Peripheral vascular insufficiency	0.2	0	0	HPO
189	AGXT	C1565489	Renal Insufficiency	0.2	0	0	HPO
189	AGXT	C1833683	NEPHROLITHIASIS, CALCIUM OXALATE	0.2	0	0	HPO
189	AGXT	C1841659	Atrioventricular nodal disease	0.2	0	0	HPO
189	AGXT	C3887709	Optic Neuropathy	0.2	0	0	HPO
1890	TYMP	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1890	TYMP	C0152020	Gastroparesis	0.2	0	0	HPO
1890	TYMP	C0162429	Malnutrition	0.2	0	0	HPO
1890	TYMP	C0162674	Chronic progressive external ophthalmoplegia	0.200274726784213	0	0	HPO
1890	TYMP	C0872218	MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME	0.603296721410557	4	15	CTD_human;ORPHANET;UNIPROT
1890	TYMP	C1848736	Distal amyotrophy	0.2	0	0	HPO
1890	TYMP	C2749861	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.2	0	0	ORPHANET
1890	TYMP	C3150914	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE)	0.2	0	0	ORPHANET
1892	ECHS1	C0023264	Leigh Disease	0.200824180352639	0	0	ORPHANET
1892	ECHS1	C0028738	Nystagmus	0.2	0	0	HPO
1892	ECHS1	C0028754	Obesity	0.2	1	0	CTD_human
1892	ECHS1	C4225391	MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY	0.2	5	13	UNIPROT
1893	ECM1	C0002170	Alopecia	0.2	0	0	HPO
1893	ECM1	C0009324	Ulcerative Colitis	0.207337755261807	1	0	CTD_human
1893	ECM1	C0014544	Epilepsy	0.2	0	0	HPO
1893	ECM1	C0023795	Lipoid Proteinosis of Urbach and Wiethe	0.606593442821114	1	9	CTD_human;ORPHANET;UNIPROT
1893	ECM1	C0702166	Acne	0.2	0	0	HPO
1893	ECM1	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
1893	ECM1	C0870082	Hyperkeratosis	0.2	0	0	HPO
1893	ECM1	C4020871	Dystonic disease	0.2	0	0	HPO
1896	EDA	C0003028	Anhidrosis	0.200274726784213	0	0	HPO
1896	EDA	C0013595	Eczema	0.2	0	0	HPO
1896	EDA	C0020620	Hypohidrosis	0.2	0	0	HPO
1896	EDA	C0162359	Christ-Siemens-Touraine syndrome	0.612912158858016	25	21	CTD_human;HPO;ORPHANET;UNIPROT
1896	EDA	C0259817	Xerosis	0.2	0	0	HPO
1896	EDA	C0263490	Brittle hair	0.2	0	0	HPO
1896	EDA	C0266039	Taurodontism	0.2	0	0	HPO
1896	EDA	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
1896	EDA	C1970757	Tooth Agenesis, Selective, X-Linked, 1	0.4	6	8	CTD_human;UNIPROT
19	ABCA1	C0002871	Anemia	0.200274726784213	0	0	HPO
19	ABCA1	C0004153	Atherosclerosis	0.26675707777394	1	0	CTD_human
19	ABCA1	C0013592	Ectropion	0.2	0	0	HPO
19	ABCA1	C0020443	Hypercholesterolemia	0.210778178387317	1	0	CTD_human
19	ABCA1	C0020445	Hypercholesterolemia, Familial	0.203780662444353	1	0	CTD_human
19	ABCA1	C0022661	Kidney Failure, Chronic	0.202681755307501	1	0	CTD_human
19	ABCA1	C0027051	Myocardial Infarction	0.220248235388199	0	0	HPO
19	ABCA1	C0039292	Tangier Disease	0.719162996098574	19	20	CTD_human;ORPHANET;UNIPROT
19	ABCA1	C0042798	Low Vision	0.2	0	0	HPO
19	ABCA1	C0043325	Xanthomatosis	0.2	0	0	HPO
19	ABCA1	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
19	ABCA1	C0151718	Hypocholesterolemia	0.200274726784213	0	0	HPO
19	ABCA1	C0221260	Dystrophia unguium	0.2	0	0	HPO
19	ABCA1	C0242231	Coronary Stenosis	0.205088783830789	0	0	HPO
19	ABCA1	C0259817	Xerosis	0.2	0	0	HPO
19	ABCA1	C0270921	Axonal neuropathy	0.2	0	0	HPO
19	ABCA1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
19	ABCA1	C0473527	Hypoalphalipoproteinemias	0.407063028477594	0	0	CTD_human;HPO
19	ABCA1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
19	ABCA1	C0745103	Hyperlipoproteinemia Type IIa	0.201098907136852	0	0	CTD_human
19	ABCA1	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
19	ABCA1	C1704429	Hypoalphalipoproteinemia, Familial	0.40796707674218	4	6	ORPHANET;UNIPROT
19	ABCA1	C1834405	Nail dysplasia	0.2	0	0	HPO
19	ABCA1	C1848736	Distal amyotrophy	0.2	0	0	HPO
19	ABCA1	C2931838	Familial HDL deficiency	0.205219808900049	2	0	CTD_human
190	NR0B1	C0004509	Azoospermia	0.200824180352639	0	0	HPO
190	NR0B1	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
190	NR0B1	C0018418	Gynecomastia	0.2	0	0	HPO
190	NR0B1	C0020595	Hypoaldosteronism	0.200274726784213	0	0	HPO
190	NR0B1	C0026850	Muscular Dystrophy	0.200274726784213	0	0	HPO
190	NR0B1	C0029456	Osteoporosis	0.2	0	0	HPO
190	NR0B1	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
190	NR0B1	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
190	NR0B1	C0220766	Congenital hypoplasia of adrenal gland	0.70390123022654	13	8	CTD_human;ORPHANET;UNIPROT
190	NR0B1	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
190	NR0B1	C0266427	Testicular regression syndrome	0.2	0	0	HPO
190	NR0B1	C0271623	Hypogonadotropic hypogonadism	0.218956148110704	0	0	HPO
190	NR0B1	C0948896	Primary hypogonadism	0.2	0	0	HPO
190	NR0B1	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
190	NR0B1	C1848296	DOSAGE-SENSITIVE SEX REVERSAL	0.204670355331623	0	0	CTD_human
190	NR0B1	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
190	NR0B1	C2936694	Swyer Syndrome	0.2	0	0	ORPHANET
190	NR0B1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
1906	EDN1	C0004096	Asthma	0.222380537127273	1	0	CTD_human
1906	EDN1	C0004238	Atrial Fibrillation	0.200274726784213	1	0	CTD_human
1906	EDN1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.209693626627782	1	0	CTD_human
1906	EDN1	C0017668	Focal glomerulosclerosis	0.2	1	0	CTD_human
1906	EDN1	C0018801	Heart failure	0.298064776491811	7	0	CTD_human
1906	EDN1	C0019212	Hepatorenal Syndrome	0.2	1	0	CTD_human
1906	EDN1	C0020443	Hypercholesterolemia	0.2	1	0	CTD_human
1906	EDN1	C0027720	Nephrosis	0.2	1	0	CTD_human
1906	EDN1	C0030567	Parkinson Disease	0.2	1	0	CTD_human
1906	EDN1	C0030920	Peptic Ulcer	0.2	1	0	CTD_human
1906	EDN1	C0034069	Pulmonary Fibrosis	0.207114185634906	1	0	CTD_human
1906	EDN1	C0035222	Respiratory Distress Syndrome, Adult	0.28	1	0	CTD_human
1906	EDN1	C0038525	Subarachnoid Hemorrhage	0.204381273170092	1	0	CTD_human
1906	EDN1	C0149721	Left Ventricular Hypertrophy	0.293459933694818	2	0	CTD_human
1906	EDN1	C0149745	Oral Ulcer	0.2	1	0	CTD_human
1906	EDN1	C0151744	Myocardial Ischemia	0.200549453568426	3	0	CTD_human
1906	EDN1	C0242350	Erectile dysfunction	0.200274726784213	1	0	CTD_human
1906	EDN1	C0267048	Glossoptosis	0.2	0	0	HPO
1906	EDN1	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
1906	EDN1	C0752347	Lewy Body Disease	0.200274726784213	1	0	CTD_human
1906	EDN1	C0878773	Overactive Bladder	0.2	1	0	CTD_human
1906	EDN1	C1565489	Renal Insufficiency	0.200274726784213	1	0	CTD_human
1906	EDN1	C1865295	Auriculo-condylar syndrome	0.200274726784213	0	0	ORPHANET
1906	EDN1	C3810332	AURICULOCONDYLAR SYNDROME 3	0.2	1	2	UNIPROT
1908	EDN3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1908	EDN3	C0021843	Intestinal Obstruction	0.2	0	0	HPO
1908	EDN3	C1275808	Congenital central hypoventilation	0.4	1	0	CTD_human;ORPHANET
1908	EDN3	C1848519	WAARDENBURG SYNDROME, TYPE 4A	0.401648360705279	3	0	CTD_human;ORPHANET
1908	EDN3	C2750457	Waardenburg Syndrome, Type 4b	0.48	2	5	CTD_human;UNIPROT
1909	EDNRA	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200549453568426	1	0	CTD_human
1909	EDNRA	C0018777	Conductive hearing loss	0.2	0	0	HPO
1909	EDNRA	C0242350	Erectile dysfunction	0.2	1	0	CTD_human
1909	EDNRA	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
1909	EDNRA	C0520679	Sleep Apnea, Obstructive	0.205363510615002	1	0	CTD_human
1909	EDNRA	C4225349	MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA	0.480274726784213	1	2	ORPHANET;UNIPROT
191	AHCY	C0019202	Hepatolenticular Degeneration	0.200274726784213	1	0	CTD_human
191	AHCY	C0268621	Hepatic methionine adenosyltransferase deficiency	0.2	0	0	HPO
191	AHCY	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
191	AHCY	C3151058	Hypermethioninemia with Deficiency of S-Adenosylhomocysteine Hydrolase	0.4	2	5	ORPHANET;UNIPROT
1910	EDNRB	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200274726784213	1	0	CTD_human
1910	EDNRB	C0018784	Sensorineural Hearing Loss (disorder)	0.28	0	0	HPO
1910	EDNRB	C0021843	Intestinal Obstruction	0.200274726784213	0	0	HPO
1910	EDNRB	C0023520	Leukodystrophy	0.2	0	0	HPO
1910	EDNRB	C0027720	Nephrosis	0.2	1	0	CTD_human
1910	EDNRB	C0028738	Nystagmus	0.2	0	0	HPO
1910	EDNRB	C0038525	Subarachnoid Hemorrhage	0.2	1	0	CTD_human
1910	EDNRB	C0152025	Polyneuropathy	0.2	0	0	HPO
1910	EDNRB	C1838099	ABCD syndrome	0.200274726784213	0	0	CTD_human
1910	EDNRB	C1848519	WAARDENBURG SYNDROME, TYPE 4A	0.682747267842131	2	3	CTD_human;ORPHANET;UNIPROT
1911	PHC1	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
1911	PHC1	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
1911	PHC1	C3809431	MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE	0.2	1	1	UNIPROT
1913	EEC1	C1851841	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	0.2	0	0	CTD_human
1917	EEF1A2	C0014306	Enophthalmos	0.2	0	0	HPO
1917	EEF1A2	C0014544	Epilepsy	0.200549453568426	0	0	HPO
1917	EEF1A2	C0543888	Epileptic encephalopathy	0.200274726784213	0	0	HPO
1917	EEF1A2	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
1917	EEF1A2	C4225337	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33	0.2	2	2	UNIPROT
1917	EEF1A2	C4225343	MENTAL RETARDATION, AUTOSOMAL DOMINANT 38	0.2	1	2	UNIPROT
192	AIC	C0175713	Aicardi's syndrome	0.2	0	0	CTD_human
192142	RLS1	C0035258	Restless Legs Syndrome	0.203021994626344	0	0	CTD_human
192644	DFNA21	C1846922	DEAFNESS, AUTOSOMAL DOMINANT 21 (disorder)	0.2	0	0	CTD_human
192676	DFNA43	C1842108	DEAFNESS, AUTOSOMAL DOMINANT 43 (disorder)	0.2	0	0	CTD_human
1938	EEF2	C0028738	Nystagmus	0.2	0	0	HPO
1938	EEF2	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
1938	EEF2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
1938	EEF2	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
1938	EEF2	C1836395	SPINOCEREBELLAR ATAXIA 26	0.4	1	1	ORPHANET;UNIPROT
1938	EEF2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
1947	EFNB1	C0010278	Craniosynostosis	0.40350593566014	1	0	CTD_human;HPO
1947	EFNB1	C0015310	Exotropia	0.2	0	0	HPO
1947	EFNB1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
1947	EFNB1	C0028738	Nystagmus	0.2	0	0	HPO
1947	EFNB1	C0028754	Obesity	0.2	1	0	CTD_human
1947	EFNB1	C0220767	Craniofrontonasal dysplasia	0.685494535684262	3	10	CTD_human;ORPHANET;UNIPROT
1947	EFNB1	C1856266	Coronal craniosynostosis	0.2	0	0	HPO
1950	EGF	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
1950	EGF	C0038358	Gastric ulcer	0.200274726784213	2	0	CTD_human
1950	EGF	C2673648	Hypomagnesemia 4, Renal	0.4	1	1	CTD_human;UNIPROT
1950	EGF	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
1952	CELSR2	C0014173	Endometrial Hyperplasia	0.2	1	0	CTD_human
1954	MEGF8	C0010278	Craniosynostosis	0.2	0	0	HPO
1954	MEGF8	C0010495	Cutis Laxa	0.2	0	0	HPO
1954	MEGF8	C0028754	Obesity	0.2	0	0	HPO
1954	MEGF8	C1275078	Acrocephalopolysyndactyly type 2	0.200274726784213	0	0	ORPHANET
1954	MEGF8	C1866339	Preaxial Hallucal Polydactyly	0.2	0	0	HPO
1954	MEGF8	C2930812	Generalized elastolysis	0.2	0	0	HPO
1954	MEGF8	C3554247	CARPENTER SYNDROME 2	0.28	1	3	UNIPROT
1954	MEGF8	C4020889	Cornela disease	0.2	0	0	HPO
1956	EGFR	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200274726784213	1	0	CTD_human
1956	EGFR	C0014175	Endometriosis	0.20761248204602	1	0	CTD_human
1956	EGFR	C0263454	Chloracne	0.200274726784213	1	0	CTD_human
1956	EGFR	C0694550	Recurrent pneumonia	0.2	0	0	HPO
1956	EGFR	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
1956	EGFR	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
1956	EGFR	C4015130	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2	0.2	1	1	UNIPROT
1957	EGI	C0270850	Idiopathic generalized epilepsy	0.2	0	0	CTD_human
1958	EGR1	C0007786	Brain Ischemia	0.2	1	0	CTD_human
1958	EGR1	C0008311	Cholangitis	0.2	1	0	CTD_human
1958	EGR1	C0008370	Cholestasis	0.200274726784213	1	0	CTD_human
1958	EGR1	C0008372	Intrahepatic Cholestasis	0.2	2	0	CTD_human
1958	EGR1	C0020295	Hydronephrosis	0.2	1	0	CTD_human
1958	EGR1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
1959	EGR2	C0011195	Dejerine-Sottas Disease (disorder)	0.400824180352639	3	1	ORPHANET;UNIPROT
1959	EGR2	C0035372	Rett Syndrome	0.203007639249027	1	0	CTD_human
1959	EGR2	C0037921	Spinal ataxia	0.2	0	0	HPO
1959	EGR2	C0085684	Foot-drop	0.2	0	0	HPO
1959	EGR2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
1959	EGR2	C0393818	Congenital hypomyelinating neuropathy	0.682472541057918	1	3	CTD_human;ORPHANET;UNIPROT
1959	EGR2	C1843247	Charcot-Marie-Tooth disease, Type 1D (disorder)	0.600274726784213	5	6	CTD_human;ORPHANET;UNIPROT
1959	EGR2	C1848736	Distal amyotrophy	0.2	0	0	HPO
1959	EGR2	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
196	AHR	C0003873	Rheumatoid Arthritis	0.201373633921065	1	0	CTD_human
196	AHR	C0004153	Atherosclerosis	0.200824180352639	1	0	CTD_human
196	AHR	C0005683	Urinary Bladder Calculi (disorder)	0.2	1	0	CTD_human
196	AHR	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
196	AHR	C0028754	Obesity	0.200274726784213	1	0	CTD_human
196	AHR	C0032285	Pneumonia	0.200274726784213	1	0	CTD_human
196	AHR	C0037116	Silicosis	0.2	1	0	CTD_human
196	AHR	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
196	AHR	C2931037	Pancreatic cancer, adult	0.2	1	0	CTD_human
196	AHR	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1962	EHHADH	C0035579	Rickets	0.2	0	0	HPO
1962	EHHADH	C0238621	Aminoaciduria	0.2	0	0	HPO
1962	EHHADH	C0341703	Adult Fanconi syndrome	0.200549453568426	0	0	ORPHANET
1962	EHHADH	C3810100	FANCONI RENOTUBULAR SYNDROME 3	0.2	1	1	UNIPROT
196441	ZFC3H1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
196475	RMST	C0028754	Obesity	0.2	1	1	CTD_human
1965	EIF2S1	C0002395	Alzheimer's Disease	0.205740551713841	1	0	CTD_human
1965	EIF2S1	C0038220	Status Epilepticus	0.2	1	0	CTD_human
196527	ANO6	C0038013	Ankylosing spondylitis	0.200274726784213	1	1	CTD_human
196527	ANO6	C0796149	Scott Syndrome	0.401373633921066	0	0	CTD_human;ORPHANET
1967	EIF2B1	C0014544	Epilepsy	0.2	0	0	HPO
1967	EIF2B1	C0025322	Premature Menopause	0.2	0	0	HPO
1967	EIF2B1	C0029124	Optic Atrophy	0.2	0	0	HPO
1967	EIF2B1	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
1967	EIF2B1	C0338474	Central nervous system demyelination	0.2	0	0	HPO
1967	EIF2B1	C1836830	Developmental regression	0.2	0	0	HPO
1967	EIF2B1	C1847967	OVARIOLEUKODYSTROPHY	0.401098907136852	0	0	CTD_human;ORPHANET
1967	EIF2B1	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	0.405494535684262	2	8	ORPHANET;UNIPROT
1969	EPHA2	C0008525	Choroideremia	0.2	0	0	HPO
1969	EPHA2	C0027092	Myopia	0.2	0	0	HPO
1969	EPHA2	C0028326	Noonan Syndrome	0.200274726784213	1	0	CTD_human
1969	EPHA2	C0175704	LEOPARD Syndrome	0.200274726784213	1	0	CTD_human
1969	EPHA2	C0392557	Nuclear cataract	0.2	0	0	ORPHANET
1969	EPHA2	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
1969	EPHA2	C1861825	CATARACT, POSTERIOR POLAR, 1	0.28	2	3	UNIPROT
1969	EPHA2	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
1969	EPHA2	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
197131	UBR1	C0175692	Johanson-Blizzard syndrome	0.683021994626344	1	5	CTD_human;ORPHANET;UNIPROT
197322	ACSF3	C0342793	Malonic aciduria	0.2	1	0	CTD_human
197322	ACSF3	C3280314	Combined Malonic and Methylmalonic Aciduria	0.400549453568426	1	8	ORPHANET;UNIPROT
1981	EIF4G1	C3280271	PARKINSON DISEASE 18	0.2	1	2	UNIPROT
1981	EIF4G1	C4274355	Autosomal dominant late onset Parkinson disease	0.200274726784213	0	0	ORPHANET
199	AIF1	C0030567	Parkinson Disease	0.2	1	0	CTD_human
199	AIF1	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
199	AIF1	C0752347	Lewy Body Disease	0.2	1	0	CTD_human
1990	CELA1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
1991	ELANE	C0002871	Anemia	0.2	0	0	HPO
1991	ELANE	C0014457	Eosinophilia	0.2	0	0	HPO
1991	ELANE	C0020455	Hypergammaglobulinemia	0.2	0	0	HPO
1991	ELANE	C0027947	Neutropenia	0.228614799631895	1	0	CTD_human
1991	ELANE	C0031099	Periodontitis	0.200274726784213	0	0	HPO
1991	ELANE	C0036690	Septicemia	0.200549453568426	0	0	HPO
1991	ELANE	C0085702	Monocytosis	0.2	0	0	HPO
1991	ELANE	C0149745	Oral Ulcer	0.2	0	0	HPO
1991	ELANE	C0221023	Cyclic neutropenia	0.605494535684262	4	8	CTD_human;ORPHANET;UNIPROT
1991	ELANE	C0836924	Thrombocytosis	0.2	0	0	HPO
1991	ELANE	C1859966	Neutropenia, Severe Congenital, Autosomal Dominant 1	0.6	14	13	CTD_human;ORPHANET;UNIPROT
1994	ELAVL1	C0014175	Endometriosis	0.2	1	0	CTD_human
1995	ELAVL3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
199713	NLRP7	C3463897	HYDATIDIFORM MOLE, RECURRENT, 1	0.204120901763196	1	8	UNIPROT
1998	ELF2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
199857	ALG14	C4015596	MYASTHENIC SYNDROME, CONGENITAL, 15	0.2	1	2	UNIPROT
2	A2M	C0002395	Alzheimer's Disease	0.263324147157471	3	0	CTD_human
2	A2M	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
2	A2M	C0023890	Liver Cirrhosis	0.202407028523288	1	0	CTD_human
2000	ELF4	C0472813	X-linked agammaglobulinemia with growth hormone deficiency	0.2	0	0	ORPHANET
200205	IBA57	C3809165	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3	0.4	1	1	ORPHANET;UNIPROT
200205	IBA57	C4225322	SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
200315	APOBEC3A	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
200576	PIKFYVE	C1562113	Fleck corneal dystrophy	0.601373633921066	1	4	CTD_human;ORPHANET;UNIPROT
2006	ELN	C0003499	Supravalvular aortic stenosis	0.619700460551396	2	25	CTD_human;HPO;ORPHANET
2006	ELN	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
2006	ELN	C0007786	Brain Ischemia	0.2	0	0	HPO
2006	ELN	C0010495	Cutis Laxa	0.411235087398103	1	0	CTD_human;HPO
2006	ELN	C0012819	Diverticular disease of colon	0.200274726784213	0	0	HPO
2006	ELN	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
2006	ELN	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2006	ELN	C0020437	Hypercalcemia	0.200549453568426	0	0	HPO
2006	ELN	C0020545	Hypertension, Renovascular	0.2	0	0	HPO
2006	ELN	C0024117	Chronic Obstructive Airway Disease	0.205754907091158	1	0	CTD_human
2006	ELN	C0024421	Macroglossia	0.2	0	0	HPO
2006	ELN	C0024636	Malocclusion	0.2	0	0	HPO
2006	ELN	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
2006	ELN	C0028754	Obesity	0.2	0	0	HPO
2006	ELN	C0029453	Osteopenia	0.2	0	0	HPO
2006	ELN	C0029456	Osteoporosis	0.2	0	0	HPO
2006	ELN	C0034067	Pulmonary Emphysema	0.403296721410557	1	0	CTD_human;HPO
2006	ELN	C0034069	Pulmonary Fibrosis	0.200549453568426	2	0	CTD_human
2006	ELN	C0034888	Rectal Prolapse	0.2	0	0	HPO
2006	ELN	C0035078	Kidney Failure	0.2	0	0	HPO
2006	ELN	C0038379	Strabismus	0.2	0	0	HPO
2006	ELN	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
2006	ELN	C0042798	Low Vision	0.2	0	0	HPO
2006	ELN	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
2006	ELN	C0151744	Myocardial Ischemia	0.200274726784213	1	0	CTD_human
2006	ELN	C0175702	Williams Syndrome	0.439646937132371	0	0	CTD_human;ORPHANET
2006	ELN	C0242231	Coronary Stenosis	0.2	0	0	HPO
2006	ELN	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
2006	ELN	C0268350	Cutis Laxa, Autosomal Dominant	0.201648360705279	0	0	ORPHANET
2006	ELN	C0271441	Chronic otitis media	0.2	0	0	HPO
2006	ELN	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
2006	ELN	C0743359	ear infection chronic	0.2	0	0	HPO
2006	ELN	C0747078	Generalized osteopenia	0.2	0	0	HPO
2006	ELN	C0747085	Recurrent otitis media	0.2	0	0	HPO
2006	ELN	C0917798	Cerebral Ischemia	0.2	0	0	HPO
2006	ELN	C1394691	Bowel diverticula	0.2	0	0	HPO
2006	ELN	C1395674	Bowel diverticulosis	0.2	0	0	HPO
2006	ELN	C1565489	Renal Insufficiency	0.2	0	0	HPO
2006	ELN	C1956257	Pulmonary Stenosis	0.200549453568426	0	0	HPO
2006	ELN	C2930812	Generalized elastolysis	0.2	0	0	HPO
2006	ELN	C3276539	CUTIS LAXA, AUTOSOMAL DOMINANT 1	0.2	0	0	CTD_human
2006	ELN	C4020884	Anxiety disease	0.2	0	0	HPO
2006	ELN	C4025272	Peripheral arterial stenosis	0.2	0	0	HPO
2006	ELN	C4025788	Nystagmus-induced head nodding	0.2	0	0	HPO
2006	ELN	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
200728	TMEM17	C2745997	OROFACIODIGITAL SYNDROME VI	0.2	1	1	UNIPROT
200734	SPRED2	C0003873	Rheumatoid Arthritis	0.202407028523288	2	2	CTD_human
200879	LIPH	C1836672	Total Hypotrichosis, Mari type	0.202472541057918	1	1	UNIPROT
200879	LIPH	C1854310	Hypotrichosis simplex	0.201098907136852	0	0	ORPHANET
200894	ARL13B	C0431399	Familial aplasia of the vermis	0.203296721410557	0	0	ORPHANET
200894	ARL13B	C2676771	JOUBERT SYNDROME 8 (disorder)	0.4	2	7	CTD_human;UNIPROT
2009	EML1	C0014544	Epilepsy	0.2	0	0	HPO
2009	EML1	C1838239	Band Heterotopia of Brain	0.2	1	3	UNIPROT
2009	EML1	C1848201	Subcortical Band Heterotopia	0.2	0	0	ORPHANET
200931	SLC51A	C0008370	Cholestasis	0.203007639249027	2	0	CTD_human
200931	SLC51A	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
201	AIH3	C1845051	AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 2	0.2	0	0	CTD_human
2010	EMD	C0004245	Atrioventricular Block	0.2	0	0	HPO
2010	EMD	C0410189	Muscular Dystrophy, Emery-Dreifuss	0.237811808580187	0	0	CTD_human
2010	EMD	C0751337	X-Linked Emery-Dreifuss Muscular Dystrophy	0.407142896389541	3	10	ORPHANET;UNIPROT
2010	EMD	C1841659	Atrioventricular nodal disease	0.2	0	0	HPO
2010	EMD	C4023180	Type 1 muscle fiber atrophy	0.2	0	0	HPO
201163	FLCN	C0346010	Multiple fibrofolliculomas	0.695109973131721	5	56	CTD_human;ORPHANET;UNIPROT
201163	FLCN	C1868193	PNEUMOTHORAX, PRIMARY SPONTANEOUS	0.601648360705279	2	8	CTD_human;ORPHANET;UNIPROT
201294	UNC13D	C1837174	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3	0.281098907136852	0	0	CTD_human
2013	EMP2	C0403397	Steroid-resistant nephrotic syndrome	0.2	0	0	HPO
2013	EMP2	C4014507	NEPHROTIC SYNDROME, TYPE 10	0.2	1	3	UNIPROT
201475	RAB12	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
201595	STT3B	C3810067	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix	0.2	0	0	ORPHANET
2017	CTTN	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
2018	EMX2	C0014544	Epilepsy	0.2	0	0	HPO
2018	EMX2	C0038379	Strabismus	0.2	0	0	HPO
2018	EMX2	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
2018	EMX2	C2931870	Familial schizencephaly	0.200549453568426	0	0	CTD_human
2018	EMX2	C4082173	Porencephaly	0.2	0	0	HPO
201973	PRIMPOL	C3809464	MYOPIA 22, AUTOSOMAL DOMINANT	0.2	1	1	UNIPROT
202018	TAPT1	C4225162	OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.4	1	2	ORPHANET;UNIPROT
2022	ENG	C0002871	Anemia	0.2	0	0	HPO
2022	ENG	C0006105	Brain Abscess	0.200274726784213	0	0	HPO
2022	ENG	C0008325	Cholecystitis	0.2	0	0	HPO
2022	ENG	C0014544	Epilepsy	0.2	0	0	HPO
2022	ENG	C0020541	Hypertension, Portal	0.2	0	0	HPO
2022	ENG	C0023890	Liver Cirrhosis	0.202681755307501	0	0	HPO
2022	ENG	C0032461	Polycythemia	0.2	0	0	HPO
2022	ENG	C0038525	Subarachnoid Hemorrhage	0.202956482091714	0	0	HPO
2022	ENG	C0039445	Hereditary hemorrhagic telangiectasia	0.738478472467552	12	16	CTD_human;ORPHANET;UNIPROT
2022	ENG	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
2022	ENG	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
2022	ENG	C0264969	Aneurysm of celiac artery	0.2	0	0	HPO
2022	ENG	C0340543	Familial primary pulmonary hypertension	0.200274726784213	0	0	ORPHANET
2022	ENG	C0742747	High-output congestive heart failure	0.2	0	0	HPO
2022	ENG	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
2022	ENG	C0854242	Gastrointestinal angiodysplasia	0.2	0	0	HPO
2022	ENG	C0917805	Transient Cerebral Ischemia	0.2	0	0	HPO
2022	ENG	C0948008	Ischemic stroke	0.200274726784213	0	0	HPO
2022	ENG	C1619711	Gastrointestinal telangiectasia	0.2	0	0	HPO
2022	ENG	C1697453	Spontaneous haematoma	0.2	0	0	HPO
2022	ENG	C1862932	ANEURYSM, INTRACRANIAL BERRY, 1 (disorder)	0.2	0	0	ORPHANET
2022	ENG	C4021977	Visceral angiomatosis	0.2	0	0	HPO
2022	ENG	C4023119	Mesenteric artery aneurysm	0.2	0	0	HPO
2023	ENO1	C0002395	Alzheimer's Disease	0.205465824929628	1	0	CTD_human
2023	ENO1	C0003873	Rheumatoid Arthritis	0.206029633875371	1	0	CTD_human
2023	ENO1	C0029408	Degenerative polyarthritis	0.200274726784213	1	0	CTD_human
2023	ENO1	C0029456	Osteoporosis	0.2	1	0	CTD_human
2023	ENO1	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
2023	ENO1	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
2023	ENO1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2027	ENO3	C2752027	Glycogen Storage Disease XIII	0.6	1	2	CTD_human;ORPHANET;UNIPROT
2029	ENSA	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
203	AK1	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
203	AK1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
203	AK1	C2675459	Adenylate Kinase Deficiency, Hemolytic Anemia Due To	0.6	3	8	CTD_human;ORPHANET;UNIPROT
2030	SLC29A1	C0586323	Alcohol Withdrawal Seizures	0.200274726784213	1	0	CTD_human
203068	TUBB	C0473586	Michelin tire baby syndrome	0.4	1	2	ORPHANET;UNIPROT
203068	TUBB	C4014283	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6	0.2	1	4	UNIPROT
2032	ENUR2	C1833268	ENURESIS, NOCTURNAL, 2 (disorder)	0.2	0	0	CTD_human
203228	C9orf72	C0002736	Amyotrophic Lateral Sclerosis	0.272253144248045	0	0	ORPHANET
203228	C9orf72	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
203228	C9orf72	C3888102	Frontotemporal Dementia With Motor Neuron Disease	0.202197814273705	1	0	CTD_human
203228	C9orf72	C4011788	Behavioral variant of frontotemporal dementia	0.202747267842131	0	0	ORPHANET
203286	ANKS6	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
203286	ANKS6	C1855681	Nephronophthisis, familial juvenile	0.2	0	0	ORPHANET
203286	ANKS6	C1865872	NEPHRONOPHTHISIS 2	0.2	0	0	ORPHANET
203286	ANKS6	C3809320	NEPHRONOPHTHISIS 16	0.2	1	5	UNIPROT
2033	EP300	C0011334	Dental caries	0.2	0	0	HPO
2033	EP300	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
2033	EP300	C0013261	Duane Retraction Syndrome	0.2	0	0	HPO
2033	EP300	C0014306	Enophthalmos	0.2	0	0	HPO
2033	EP300	C0014544	Epilepsy	0.2	0	0	HPO
2033	EP300	C0015300	Exophthalmos	0.2	0	0	HPO
2033	EP300	C0017601	Glaucoma	0.2	0	0	HPO
2033	EP300	C0023234	Legg-Calve-Perthes Disease	0.2	0	0	HPO
2033	EP300	C0024636	Malocclusion	0.2	0	0	HPO
2033	EP300	C0028754	Obesity	0.2	1	0	CTD_human
2033	EP300	C0035934	Rubinstein-Taybi Syndrome	0.209861453477037	0	0	CTD_human
2033	EP300	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
2033	EP300	C0038379	Strabismus	0.2	0	0	HPO
2033	EP300	C0080218	Tethered Cord Syndrome	0.2	0	0	HPO
2033	EP300	C0266063	Deep overbite	0.2	0	0	HPO
2033	EP300	C0454455	Mirror movements disorder	0.2	0	0	HPO
2033	EP300	C0520679	Sleep Apnea, Obstructive	0.2	0	0	HPO
2033	EP300	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
2033	EP300	C1857627	Chorioretinal dystrophy	0.2	0	0	HPO
2033	EP300	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2033	EP300	C3150941	RUBINSTEIN-TAYBI SYNDROME 2	0.2	0	0	ORPHANET
2033	EP300	C4020889	Cornela disease	0.2	0	0	HPO
2033	EP300	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
2034	EPAS1	C2673187	Erythrocytosis, Familial, 4	0.4	4	2	CTD_human;UNIPROT
2035	EPB41	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
2035	EPB41	C0013902	Elliptocytosis, Hereditary	0.400549453568426	0	0	HPO;ORPHANET
2035	EPB41	C2678497	Elliptocytosis 1	0.28	0	0	CTD_human
203547	VMA21	C1839615	MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY (disorder)	0.4	0	0	CTD_human;ORPHANET
2036	EPB41L1	C3280285	MENTAL RETARDATION, AUTOSOMAL DOMINANT 11	0.2	1	0	UNIPROT
2038	EPB42	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
2038	EPB42	C0037889	Hereditary spherocytosis	0.203007639249027	0	0	ORPHANET
2038	EPB42	C0221409	Anemia, hereditary spherocytic hemolytic	0.2	0	0	ORPHANET
2038	EPB42	C2675192	Spherocytosis, Type 5	0.4	4	10	CTD_human;UNIPROT
203859	ANO5	C1833736	Osteogenesis imperfecta, Levin type	0.601923087489492	2	2	CTD_human;ORPHANET;UNIPROT
203859	ANO5	C1969785	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L (disorder)	0.600549453568426	1	37	CTD_human;ORPHANET;UNIPROT
203859	ANO5	C2750076	Miyoshi Muscular Dystrophy 3	0.600549453568426	1	14	CTD_human;ORPHANET;UNIPROT
204	AK2	C0002871	Anemia	0.2	0	0	HPO
204	AK2	C0023530	Leukopenia	0.2	0	0	HPO
204	AK2	C0024312	Lymphopenia	0.2	0	0	HPO
204	AK2	C0036690	Septicemia	0.2	0	0	HPO
204	AK2	C0085110	Severe Combined Immunodeficiency	0.4	2	0	CTD_human;HPO
204	AK2	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
204	AK2	C0271441	Chronic otitis media	0.2	0	0	HPO
204	AK2	C0272167	Reticular dysgenesis	0.601098907136852	1	8	CTD_human;ORPHANET;UNIPROT
204	AK2	C0743359	ear infection chronic	0.2	0	0	HPO
204	AK2	C1282908	De Vaal's syndrome	0.2	0	0	ORPHANET
204	AK2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2040	STOM	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
2041	EPHA1	C0002395	Alzheimer's Disease	0.202472541057918	2	0	CTD_human
204219	CERS3	C2750787	Weill-Marchesani-Like Syndrome	0.2	0	0	ORPHANET
2043	EPHA4	C0002736	Amyotrophic Lateral Sclerosis	0.400824180352639	0	0	HPO;ORPHANET
2043	EPHA4	C0234958	muscle degeneration	0.2	0	0	HPO
2043	EPHA4	C1145670	Respiratory Failure	0.2	0	0	HPO
2043	EPHA4	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
2043	EPHA4	C4020884	Anxiety disease	0.2	0	0	HPO
205	AK4	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
2052	EPHX1	C0024117	Chronic Obstructive Airway Disease	0.252047672359041	1	0	CTD_human
2052	EPHX1	C0034067	Pulmonary Emphysema	0.202197814273705	1	0	CTD_human
2052	EPHX1	C0035579	Rickets	0.2	0	0	HPO
2052	EPHX1	C0042880	Vitamin K Deficiency	0.2	0	0	HPO
2052	EPHX1	C1843139	Hypercholanemia, Familial	0.2	0	0	ORPHANET
2052	EPHX1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2052	EPHX1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2053	EPHX2	C0018801	Heart failure	0.200549453568426	1	0	CTD_human
2053	EPHX2	C0745103	Hyperlipoproteinemia Type IIa	0.200274726784213	0	0	CTD_human
2055	CLN8	C0014544	Epilepsy	0.200824180352639	0	0	HPO
2055	CLN8	C0149958	Complex partial seizures	0.2	0	0	HPO
2055	CLN8	C0235946	Cerebral atrophy	0.2	0	0	HPO
2055	CLN8	C0262404	Cerebellar degeneration	0.2	0	0	HPO
2055	CLN8	C0270834	Complex partial seizure with impairment of consciousness	0.2	0	0	HPO
2055	CLN8	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
2055	CLN8	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
2055	CLN8	C1836830	Developmental regression	0.2	0	0	HPO
2055	CLN8	C1838570	CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.680824180352639	5	30	CTD_human;ORPHANET;UNIPROT
2055	CLN8	C1864923	Northern epilepsy syndrome	0.401098907136852	2	1	ORPHANET;UNIPROT
2055	CLN8	C4020860	Supratentorial atrophy	0.2	0	0	HPO
2055	CLN8	C4020873	Infratentorial atrophy	0.2	0	0	HPO
2056	EPO	C0002871	Anemia	0.240919935470435	64	0	CTD_human
2056	EPO	C0002878	Anemia, Hemolytic	0.200824180352639	3	0	CTD_human
2056	EPO	C0005283	beta Thalassemia	0.201373633921065	1	0	CTD_human
2056	EPO	C0019061	Hemolytic-Uremic Syndrome	0.2	1	0	CTD_human
2056	EPO	C0022661	Kidney Failure, Chronic	0.208227448149076	1	0	CTD_human
2056	EPO	C0027051	Myocardial Infarction	0.202197814273705	1	0	CTD_human
2056	EPO	C0030312	Pancytopenia	0.2	1	0	CTD_human
2056	EPO	C0034065	Pulmonary Embolism	0.2	1	0	CTD_human
2056	EPO	C0038220	Status Epilepticus	0.2	2	0	CTD_human
2056	EPO	C0038358	Gastric ulcer	0.2	1	0	CTD_human
2056	EPO	C0041948	Uremia	0.200274726784213	1	0	CTD_human
2056	EPO	C0042510	Ventricular Fibrillation	0.2	1	0	CTD_human
2056	EPO	C0042514	Tachycardia, Ventricular	0.2	1	0	CTD_human
2056	EPO	C0152025	Polyneuropathy	0.2	1	0	CTD_human
2056	EPO	C1565489	Renal Insufficiency	0.200824180352639	1	0	CTD_human
2056	EPO	C1956346	Coronary Artery Disease	0.2	1	0	CTD_human
2057	EPOR	C0032461	Polycythemia	0.409311999908611	1	0	CTD_human;HPO
2057	EPOR	C0152264	Familial erythrocytosis	0.686253203502271	1	4	CTD_human;ORPHANET;UNIPROT
2059	EPS8	C4022756	Profound hearing impairment	0.2	0	0	HPO
2063	NR2F6	C0014175	Endometriosis	0.2	1	0	CTD_human
2065	ERBB3	C0003886	Arthrogryposis	0.200274726784213	0	0	HPO
2065	ERBB3	C0020295	Hydronephrosis	0.2	0	0	HPO
2065	ERBB3	C0085623	Akinesia	0.2	0	0	HPO
2065	ERBB3	C0234958	muscle degeneration	0.2	0	0	HPO
2065	ERBB3	C0271183	Severe myopia	0.2	0	0	HPO
2065	ERBB3	C1145670	Respiratory Failure	0.2	0	0	HPO
2065	ERBB3	C1843478	Lethal Congenital Contracture Syndrome 2	0.4	0	0	CTD_human;ORPHANET
2065	ERBB3	C1843486	Degenerative vitreoretinopathy	0.2	0	0	HPO
2066	ERBB4	C0002736	Amyotrophic Lateral Sclerosis	0.400274726784213	0	0	HPO;ORPHANET
2066	ERBB4	C0234958	muscle degeneration	0.2	0	0	HPO
2066	ERBB4	C1145670	Respiratory Failure	0.2	0	0	HPO
2066	ERBB4	C3715155	AMYOTROPHIC LATERAL SCLEROSIS 19	0.2	1	2	UNIPROT
2066	ERBB4	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
2066	ERBB4	C4020884	Anxiety disease	0.2	0	0	HPO
2067	ERCC1	C0003886	Arthrogryposis	0.2	0	0	HPO
2067	ERCC1	C0010278	Craniosynostosis	0.2	0	0	HPO
2067	ERCC1	C0014306	Enophthalmos	0.2	0	0	HPO
2067	ERCC1	C0014544	Epilepsy	0.2	0	0	HPO
2067	ERCC1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2067	ERCC1	C0020619	Hypogonadism	0.2	0	0	HPO
2067	ERCC1	C0028738	Nystagmus	0.2	0	0	HPO
2067	ERCC1	C0042798	Low Vision	0.2	0	0	HPO
2067	ERCC1	C0235946	Cerebral atrophy	0.2	0	0	HPO
2067	ERCC1	C0751038	Cockayne Syndrome, Type II	0.2	0	0	ORPHANET
2067	ERCC1	C1853100	CEREBROOCULOFACIOSKELETAL SYNDROME 4	0.4	1	2	CTD_human;UNIPROT
2067	ERCC1	C1859312	CAMFAK syndrome	0.2	0	0	ORPHANET
2067	ERCC1	C2931277	Pena Shokeir syndrome Type 2	0.2	0	0	ORPHANET
2068	ERCC2	C0003850	Arteriosclerosis	0.2	0	0	HPO
2068	ERCC2	C0003886	Arthrogryposis	0.2	0	0	HPO
2068	ERCC2	C0004096	Asthma	0.2	0	0	HPO
2068	ERCC2	C0009763	Conjunctivitis	0.2	0	0	HPO
2068	ERCC2	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
2068	ERCC2	C0013592	Ectropion	0.2	0	0	HPO
2068	ERCC2	C0014306	Enophthalmos	0.2	0	0	HPO
2068	ERCC2	C0014390	Entropion	0.2	0	0	HPO
2068	ERCC2	C0014544	Epilepsy	0.2	0	0	HPO
2068	ERCC2	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
2068	ERCC2	C0020255	Hydrocephalus	0.2	0	0	HPO
2068	ERCC2	C0020619	Hypogonadism	0.2	0	0	HPO
2068	ERCC2	C0021843	Intestinal Obstruction	0.2	0	0	HPO
2068	ERCC2	C0022568	Keratitis	0.2	0	0	HPO
2068	ERCC2	C0029124	Optic Atrophy	0.2	0	0	HPO
2068	ERCC2	C0038379	Strabismus	0.2	0	0	HPO
2068	ERCC2	C0039446	Telangiectasis	0.2	0	0	HPO
2068	ERCC2	C0042798	Low Vision	0.2	0	0	HPO
2068	ERCC2	C0079153	Hyperkeratosis, Epidermolytic	0.202407028523288	1	0	CTD_human
2068	ERCC2	C0085583	Choreoathetosis	0.2	0	0	HPO
2068	ERCC2	C0162539	IgG Deficiency	0.2	0	0	HPO
2068	ERCC2	C0235946	Cerebral atrophy	0.2	0	0	HPO
2068	ERCC2	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
2068	ERCC2	C0259817	Xerosis	0.2	0	0	HPO
2068	ERCC2	C0263490	Brittle hair	0.201648360705279	0	0	HPO
2068	ERCC2	C0268138	Xeroderma Pigmentosum, Complementation Group D	0.490989071368524	8	15	CTD_human;UNIPROT
2068	ERCC2	C0270922	Peripheral demyelinating neuropathy	0.2	0	0	HPO
2068	ERCC2	C0392777	Poikiloderma	0.2	0	0	HPO
2068	ERCC2	C0870082	Hyperkeratosis	0.202956482091714	0	0	HPO
2068	ERCC2	C1836830	Developmental regression	0.2	0	0	HPO
2068	ERCC2	C1853102	Cerebrooculofacioskeletal Syndrome 2	0.4	0	0	CTD_human;UNIPROT
2068	ERCC2	C1859312	CAMFAK syndrome	0.2	0	0	ORPHANET
2068	ERCC2	C1866504	Photosensitive Trichothiodystrophy	0.48	6	10	CTD_human;UNIPROT
2068	ERCC2	C1955934	Trichothiodystrophy Syndromes	0.217033060621212	0	0	ORPHANET
2068	ERCC2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2068	ERCC2	C2931277	Pena Shokeir syndrome Type 2	0.2	0	0	ORPHANET
2068	ERCC2	C3714497	Reactive airway disease	0.2	0	0	HPO
2069	EREG	C0162568	Erythropoietic Protoporphyria	0.2	1	0	CTD_human
207	AKT1	C0002982	Angioid Streaks	0.2	0	0	HPO
207	AKT1	C0012819	Diverticular disease of colon	0.2	0	0	HPO
207	AKT1	C0014544	Epilepsy	0.400549453568426	1	0	CTD_human;HPO
207	AKT1	C0018418	Gynecomastia	0.2	0	0	HPO
207	AKT1	C0020550	Hyperthyroidism	0.2	0	0	HPO
207	AKT1	C0020676	Hypothyroidism	0.2	0	0	HPO
207	AKT1	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
207	AKT1	C0024236	Lymphedema	0.2	0	0	HPO
207	AKT1	C0024421	Macroglossia	0.2	0	0	HPO
207	AKT1	C0027092	Myopia	0.2	0	0	HPO
207	AKT1	C0028754	Obesity	0.201923087489492	1	0	CTD_human
207	AKT1	C0029927	Ovarian Cysts	0.2	0	0	HPO
207	AKT1	C0034065	Pulmonary Embolism	0.2	0	0	HPO
207	AKT1	C0037926	Compression of spinal cord	0.2	0	0	HPO
207	AKT1	C0040046	Thrombophlebitis	0.2	0	0	HPO
207	AKT1	C0040147	Thyroiditis	0.2	0	0	HPO
207	AKT1	C0040412	Fissured tongue	0.2	0	0	HPO
207	AKT1	C0042341	Varicocele	0.2	0	0	HPO
207	AKT1	C0149871	Deep Vein Thrombosis	0.2	0	0	HPO
207	AKT1	C0334082	NEVUS, EPIDERMAL (disorder)	0.2	0	0	HPO
207	AKT1	C0428791	Aortic valve calcification	0.2	1	0	CTD_human
207	AKT1	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
207	AKT1	C0870082	Hyperkeratosis	0.2	0	0	HPO
207	AKT1	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
207	AKT1	C3554519	COWDEN SYNDROME 6	0.2	1	2	UNIPROT
207	AKT1	C4021849	Conjunctival hamartoma	0.2	0	0	HPO
207	AKT1	C4021977	Visceral angiomatosis	0.2	0	0	HPO
2070	EYA4	C0018784	Sensorineural Hearing Loss (disorder)	0.205480180306945	0	0	HPO
2070	EYA4	C0018801	Heart failure	0.200274726784213	0	0	HPO
2070	EYA4	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
2070	EYA4	C1832476	Deafness, Autosomal Dominant 10	0.400549453568426	2	2	CTD_human;UNIPROT
2070	EYA4	C1854368	Cardiomyopathy, Dilated, 1J	0.4	0	0	CTD_human;ORPHANET
2071	ERCC3	C0003850	Arteriosclerosis	0.2	0	0	HPO
2071	ERCC3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2071	ERCC3	C0020255	Hydrocephalus	0.2	0	0	HPO
2071	ERCC3	C0020619	Hypogonadism	0.2	0	0	HPO
2071	ERCC3	C0022568	Keratitis	0.2	0	0	HPO
2071	ERCC3	C0029124	Optic Atrophy	0.2	0	0	HPO
2071	ERCC3	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
2071	ERCC3	C0038379	Strabismus	0.2	0	0	HPO
2071	ERCC3	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
2071	ERCC3	C0259817	Xerosis	0.2	0	0	HPO
2071	ERCC3	C0262404	Cerebellar degeneration	0.2	0	0	HPO
2071	ERCC3	C0263490	Brittle hair	0.200549453568426	0	0	HPO
2071	ERCC3	C0268136	Xeroderma pigmentosum, group B	0.481923087489492	2	1	CTD_human;UNIPROT
2071	ERCC3	C0270922	Peripheral demyelinating neuropathy	0.2	0	0	HPO
2071	ERCC3	C0392777	Poikiloderma	0.2	0	0	HPO
2071	ERCC3	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
2071	ERCC3	C0870082	Hyperkeratosis	0.2	0	0	HPO
2071	ERCC3	C1836830	Developmental regression	0.2	0	0	HPO
2071	ERCC3	C1866504	Photosensitive Trichothiodystrophy	0.2	0	0	CTD_human
2071	ERCC3	C1955934	Trichothiodystrophy Syndromes	0.205769262468475	0	0	ORPHANET
2071	ERCC3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2071	ERCC3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
2071	ERCC3	C4225344	TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.2	1	1	UNIPROT
207115	LATD	C1832813	Laterality Defects, Autosomal Dominant	0.2	0	0	CTD_human
2072	ERCC4	C0003850	Arteriosclerosis	0.2	0	0	HPO
2072	ERCC4	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
2072	ERCC4	C0014306	Enophthalmos	0.2	0	0	HPO
2072	ERCC4	C0015625	Fanconi Anemia	0.205205453522732	0	0	ORPHANET
2072	ERCC4	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2072	ERCC4	C0020255	Hydrocephalus	0.2	0	0	HPO
2072	ERCC4	C0020619	Hypogonadism	0.2	0	0	HPO
2072	ERCC4	C0022568	Keratitis	0.2	0	0	HPO
2072	ERCC4	C0023530	Leukopenia	0.200274726784213	0	0	HPO
2072	ERCC4	C0029124	Optic Atrophy	0.2	0	0	HPO
2072	ERCC4	C0038379	Strabismus	0.2	0	0	HPO
2072	ERCC4	C0042798	Low Vision	0.2	0	0	HPO
2072	ERCC4	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
2072	ERCC4	C0259817	Xerosis	0.2	0	0	HPO
2072	ERCC4	C0270922	Peripheral demyelinating neuropathy	0.2	0	0	HPO
2072	ERCC4	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
2072	ERCC4	C0392777	Poikiloderma	0.2	0	0	HPO
2072	ERCC4	C0751039	Cockayne Syndrome, Type I	0.2	0	0	ORPHANET
2072	ERCC4	C0870082	Hyperkeratosis	0.2	0	0	HPO
2072	ERCC4	C1836830	Developmental regression	0.2	0	0	HPO
2072	ERCC4	C1970416	XFE Progeroid Syndrome	0.400549453568426	1	1	CTD_human;UNIPROT
2072	ERCC4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2072	ERCC4	C3808988	FANCONI ANEMIA, COMPLEMENTATION GROUP Q	0.2	2	4	UNIPROT
2073	ERCC5	C0003850	Arteriosclerosis	0.2	0	0	HPO
2073	ERCC5	C0003886	Arthrogryposis	0.200274726784213	0	0	HPO
2073	ERCC5	C0014544	Epilepsy	0.2	0	0	HPO
2073	ERCC5	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2073	ERCC5	C0020255	Hydrocephalus	0.2	0	0	HPO
2073	ERCC5	C0020619	Hypogonadism	0.2	0	0	HPO
2073	ERCC5	C0022568	Keratitis	0.2	0	0	HPO
2073	ERCC5	C0029124	Optic Atrophy	0.2	0	0	HPO
2073	ERCC5	C0038379	Strabismus	0.2	0	0	HPO
2073	ERCC5	C0042798	Low Vision	0.2	0	0	HPO
2073	ERCC5	C0235946	Cerebral atrophy	0.2	0	0	HPO
2073	ERCC5	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
2073	ERCC5	C0259817	Xerosis	0.2	0	0	HPO
2073	ERCC5	C0268141	Xeroderma pigmentosum, group G	0.483846174978983	5	14	CTD_human;UNIPROT
2073	ERCC5	C0270922	Peripheral demyelinating neuropathy	0.2	0	0	HPO
2073	ERCC5	C0392777	Poikiloderma	0.2	0	0	HPO
2073	ERCC5	C0870082	Hyperkeratosis	0.2	0	0	HPO
2073	ERCC5	C1836830	Developmental regression	0.2	0	0	HPO
2073	ERCC5	C1859312	CAMFAK syndrome	0.2	0	0	ORPHANET
2073	ERCC5	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2073	ERCC5	C2931277	Pena Shokeir syndrome Type 2	0.2	0	0	ORPHANET
2074	ERCC6	C0003028	Anhidrosis	0.2	0	0	HPO
2074	ERCC6	C0003886	Arthrogryposis	0.4	1	0	CTD_human;HPO
2074	ERCC6	C0009207	Cockayne Syndrome	0.244860481680463	6	1	CTD_human
2074	ERCC6	C0009763	Conjunctivitis	0.2	0	0	HPO
2074	ERCC6	C0011334	Dental caries	0.2	0	0	HPO
2074	ERCC6	C0013592	Ectropion	0.2	0	0	HPO
2074	ERCC6	C0014306	Enophthalmos	0.2	0	0	HPO
2074	ERCC6	C0014390	Entropion	0.2	0	0	HPO
2074	ERCC6	C0014544	Epilepsy	0.2	0	0	HPO
2074	ERCC6	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2074	ERCC6	C0020258	Hydrocephalus, Normal Pressure	0.2	0	0	HPO
2074	ERCC6	C0020490	Hyperopia	0.2	0	0	HPO
2074	ERCC6	C0020619	Hypogonadism	0.2	0	0	HPO
2074	ERCC6	C0022568	Keratitis	0.2	0	0	HPO
2074	ERCC6	C0024636	Malocclusion	0.2	0	0	HPO
2074	ERCC6	C0028738	Nystagmus	0.2	0	0	HPO
2074	ERCC6	C0029124	Optic Atrophy	0.2	0	0	HPO
2074	ERCC6	C0029456	Osteoporosis	0.2	0	0	HPO
2074	ERCC6	C0035078	Kidney Failure	0.2	0	0	HPO
2074	ERCC6	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
2074	ERCC6	C0038379	Strabismus	0.2	0	0	HPO
2074	ERCC6	C0039446	Telangiectasis	0.2	0	0	HPO
2074	ERCC6	C0042798	Low Vision	0.202407028523288	0	0	HPO
2074	ERCC6	C0085583	Choreoathetosis	0.2	0	0	HPO
2074	ERCC6	C0152025	Polyneuropathy	0.2	0	0	HPO
2074	ERCC6	C0158113	Contracture of joint of hand	0.2	0	0	HPO
2074	ERCC6	C0231341	Premature aging syndrome	0.200824180352639	1	0	CTD_human
2074	ERCC6	C0235946	Cerebral atrophy	0.2	0	0	HPO
2074	ERCC6	C0242383	Age related macular degeneration	0.208371149864029	1	0	CTD_human
2074	ERCC6	C0259817	Xerosis	0.2	0	0	HPO
2074	ERCC6	C0262404	Cerebellar degeneration	0.2	0	0	HPO
2074	ERCC6	C0265201	De Sanctis-Cacchione syndrome	0.2	1	1	CTD_human
2074	ERCC6	C0392777	Poikiloderma	0.2	0	0	HPO
2074	ERCC6	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
2074	ERCC6	C0751037	Cockayne Syndrome, Type III	0.2	0	0	ORPHANET
2074	ERCC6	C0751038	Cockayne Syndrome, Type II	0.482747267842131	2	27	ORPHANET;UNIPROT
2074	ERCC6	C0751039	Cockayne Syndrome, Type I	0.202747267842131	0	0	ORPHANET
2074	ERCC6	C1565489	Renal Insufficiency	0.2	0	0	HPO
2074	ERCC6	C1859312	CAMFAK syndrome	0.2	0	0	ORPHANET
2074	ERCC6	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2074	ERCC6	C2931277	Pena Shokeir syndrome Type 2	0.2	0	0	ORPHANET
2074	ERCC6	C3551173	UV-SENSITIVE SYNDROME 1	0.2	0	0	CTD_human
2074	ERCC6	C4020860	Supratentorial atrophy	0.2	0	0	HPO
2074	ERCC6	C4020873	Infratentorial atrophy	0.2	0	0	HPO
2074	ERCC6	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
2077	ERF	C0009763	Conjunctivitis	0.2	0	0	HPO
2077	ERF	C0010278	Craniosynostosis	0.400274726784213	1	0	CTD_human;HPO
2077	ERF	C0015300	Exophthalmos	0.2	0	0	HPO
2077	ERF	C0018777	Conductive hearing loss	0.2	0	0	HPO
2077	ERF	C0038379	Strabismus	0.2	0	0	HPO
2077	ERF	C0151740	Intracranial Hypertension	0.2	0	0	HPO
2077	ERF	C1833340	Synostotic Posterior Plagiocephaly	0.2	0	0	HPO
2077	ERF	C2931196	Craniofacial dysostosis type 1	0.2	0	0	ORPHANET
2077	ERF	C3806917	CRANIOSYNOSTOSIS 4	0.4	1	2	ORPHANET;UNIPROT
208	AKT2	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
208	AKT2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.680824180352639	1	1	CTD_human;HPO;UNIPROT
208	AKT2	C0014544	Epilepsy	0.2	0	0	HPO
208	AKT2	C0018418	Gynecomastia	0.2	0	0	HPO
208	AKT2	C0023787	Lipodystrophy	0.200824180352639	0	0	HPO
208	AKT2	C0032460	Polycystic Ovary Syndrome	0.282956482091714	0	0	HPO
208	AKT2	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
208	AKT2	C0271694	Familial partial lipodystrophy	0.2	1	0	CTD_human
208	AKT2	C0854110	Insulin resistant diabetes	0.200274726784213	0	0	HPO
208	AKT2	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
208	AKT2	C2711227	Steatohepatitis	0.200549453568426	0	0	HPO
208	AKT2	C2712907	combined hyperlipidemia	0.2	0	0	HPO
208	AKT2	C3278384	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY	0.4	1	1	ORPHANET;UNIPROT
2081	ERN1	C0014544	Epilepsy	0.2	1	0	CTD_human
2098	ESD	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
2099	ESR1	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
2099	ESR1	C0002395	Alzheimer's Disease	0.259450940155477	1	0	CTD_human
2099	ESR1	C0004153	Atherosclerosis	0.214558840831671	1	0	CTD_human
2099	ESR1	C0010054	Coronary Arteriosclerosis	0.21223168022033	0	0	HPO
2099	ESR1	C0017658	Glomerulonephritis	0.2	1	0	CTD_human
2099	ESR1	C0020459	Hyperinsulinism	0.2	0	0	HPO
2099	ESR1	C0027051	Myocardial Infarction	0.225285862061675	1	0	CTD_human
2099	ESR1	C0028754	Obesity	0.309355606667559	1	0	CTD_human
2099	ESR1	C0028960	Oligospermia	0.204814057046576	1	0	CTD_human
2099	ESR1	C0029453	Osteopenia	0.205219808900049	0	0	HPO
2099	ESR1	C0029456	Osteoporosis	0.355541472000484	0	0	HPO
2099	ESR1	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
2099	ESR1	C0702166	Acne	0.2	0	0	HPO
2099	ESR1	C0747078	Generalized osteopenia	0.2	0	0	HPO
2099	ESR1	C1956346	Coronary Artery Disease	0.247406027782053	2	0	CTD_human
2099	ESR1	C3809250	ESTROGEN RESISTANCE	0.403021994626344	2	3	ORPHANET;UNIPROT
2099	ESR1	C4024641	Enlarged polycystic ovaries	0.2	0	0	HPO
21	ABCA3	C0034050	Pulmonary Alveolar Proteinosis	0.2	0	0	HPO
21	ABCA3	C0238378	Desquamative interstitial pneumonia	0.200274726784213	0	0	HPO
21	ABCA3	C1145670	Respiratory Failure	0.202197814273705	0	0	HPO
21	ABCA3	C1970456	Surfactant Metabolism Dysfunction, Pulmonary, 3	0.68	1	8	CTD_human;ORPHANET;UNIPROT
21	ABCA3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
210	ALAD	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
210	ALAD	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
210	ALAD	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
210	ALAD	C0152025	Polyneuropathy	0.2	0	0	HPO
210	ALAD	C0268328	Porphobilinogen synthase deficiency	0.601098907136852	1	6	CTD_human;ORPHANET;UNIPROT
210	ALAD	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2100	ESR2	C0010068	Coronary heart disease	0.202681755307501	1	0	CTD_human
2100	ESR2	C0014175	Endometriosis	0.229387822827222	1	0	CTD_human
2100	ESR2	C1956346	Coronary Artery Disease	0.208697033805555	1	0	CTD_human
2103	ESRRB	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2103	ESRRB	C1837857	DEAFNESS, AUTOSOMAL RECESSIVE 35	0.4	1	2	CTD_human;UNIPROT
2108	ETFA	C0020615	Hypoglycemia	0.2	0	0	HPO
2108	ETFA	C0020617	Hypoglycemic coma	0.2	0	0	HPO
2108	ETFA	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
2108	ETFA	C0268596	Multiple Acyl Coenzyme A Dehydrogenase Deficiency	0.401098907136852	2	4	CTD_human;UNIPROT
2108	ETFA	C0546389	Periportal hepatic necrosis	0.2	0	0	HPO
2108	ETFA	C2711227	Steatohepatitis	0.2	0	0	HPO
2108	ETFA	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
2109	ETFB	C0020615	Hypoglycemia	0.2	0	0	HPO
2109	ETFB	C0020617	Hypoglycemic coma	0.2	0	0	HPO
2109	ETFB	C0268596	Multiple Acyl Coenzyme A Dehydrogenase Deficiency	0.400824180352639	2	2	CTD_human;UNIPROT
2109	ETFB	C0546389	Periportal hepatic necrosis	0.2	0	0	HPO
2109	ETFB	C2711227	Steatohepatitis	0.2	0	0	HPO
2109	ETFB	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
2110	ETFDH	C0020615	Hypoglycemia	0.200274726784213	0	0	HPO
2110	ETFDH	C0020617	Hypoglycemic coma	0.2	0	0	HPO
2110	ETFDH	C0028754	Obesity	0.2	1	0	CTD_human
2110	ETFDH	C0268596	Multiple Acyl Coenzyme A Dehydrogenase Deficiency	0.407626837423337	5	11	CTD_human;UNIPROT
2110	ETFDH	C0546389	Periportal hepatic necrosis	0.2	0	0	HPO
2110	ETFDH	C2711227	Steatohepatitis	0.2	0	0	HPO
2110	ETFDH	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
2112	ETM2	C1865810	TREMOR, HEREDITARY ESSENTIAL, 2	0.2	0	0	CTD_human
2113	ETS1	C0007570	Celiac Disease	0.2	1	1	CTD_human
2113	ETS1	C0024141	Lupus Erythematosus, Systemic	0.209209685593986	1	1	CTD_human
2114	ETS2	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
212	ALAS2	C0002871	Anemia	0.281373633921066	0	0	HPO
212	ALAS2	C0002886	Anemia, Macrocytic	0.200274726784213	0	0	HPO
212	ALAS2	C0002896	Sideroblastic anemia	0.408213092771758	2	0	CTD_human;HPO
212	ALAS2	C0221018	Hereditary sideroblastic anemia	0.609890164231672	10	18	CTD_human;ORPHANET;UNIPROT
212	ALAS2	C0271901	Microcytic hypochromic anemia (disorder)	0.2	0	0	HPO
212	ALAS2	C2677889	Protoporphyria, Erythropoietic, X-Linked Dominant	0.4	0	0	CTD_human;ORPHANET
2120	ETV6	C0031256	Petechiae	0.2	0	0	HPO
2120	ETV6	C1838656	Macrocytosis, Familial	0.2	1	0	CTD_human
2120	ETV6	C1851585	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	0.2	0	0	CTD_human
2120	ETV6	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
2120	ETV6	C4015537	THROMBOCYTOPENIA 5	0.2	1	4	UNIPROT
2121	EVC	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
2121	EVC	C0013903	Ellis-Van Creveld Syndrome	0.684655999954305	3	9	CTD_human;ORPHANET;UNIPROT
2121	EVC	C0038379	Strabismus	0.2	0	0	HPO
2121	EVC	C0221260	Dystrophia unguium	0.2	0	0	HPO
2121	EVC	C0341007	Alveolar ridge abnormality	0.2	0	0	HPO
2121	EVC	C0457013	Weyers acrofacial dysostosis	0.600549453568426	1	1	CTD_human;ORPHANET;UNIPROT
2121	EVC	C1834405	Nail dysplasia	0.2	0	0	HPO
2121	EVC	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2122	MECOM	C0398639	Amegakaryocytic thrombocytopenia	0.2	0	0	HPO
2122	MECOM	C1854273	Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia	0.200274726784213	0	0	ORPHANET
2122	MECOM	C4225221	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.2	1	3	UNIPROT
213	ALB	C0004509	Azoospermia	0.2	1	0	CTD_human
213	ALB	C0007786	Brain Ischemia	0.2	1	0	CTD_human
213	ALB	C0011875	Diabetic Angiopathies	0.2	1	0	CTD_human
213	ALB	C0011881	Diabetic Nephropathy	0.290164891015885	1	0	CTD_human
213	ALB	C0013502	Echinococcosis	0.2	1	0	CTD_human
213	ALB	C0014544	Epilepsy	0.200274726784213	2	0	CTD_human
213	ALB	C0017658	Glomerulonephritis	0.200824180352639	8	0	CTD_human
213	ALB	C0017662	Glomerulonephritis, Membranoproliferative	0.2	1	0	CTD_human
213	ALB	C0017665	Membranous glomerulonephritis	0.201648360705279	6	0	CTD_human
213	ALB	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
213	ALB	C0019061	Hemolytic-Uremic Syndrome	0.2	1	0	CTD_human
213	ALB	C0019158	Hepatitis	0.203557092817453	1	0	CTD_human
213	ALB	C0020473	Hyperlipidemia	0.200274726784213	0	0	HPO
213	ALB	C0022661	Kidney Failure, Chronic	0.20357144819477	1	0	CTD_human
213	ALB	C0023787	Lipodystrophy	0.2	0	0	HPO
213	ALB	C0023890	Liver Cirrhosis	0.204120901763196	2	0	CTD_human
213	ALB	C0025290	Aseptic Meningitis	0.2	3	0	CTD_human
213	ALB	C0027697	Nephritis	0.2	6	0	CTD_human
213	ALB	C0027707	Nephritis, Interstitial	0.2	4	0	CTD_human
213	ALB	C0027720	Nephrosis	0.200274726784213	1	0	CTD_human
213	ALB	C0029456	Osteoporosis	0.2	0	0	HPO
213	ALB	C0030305	Pancreatitis	0.2	1	0	CTD_human
213	ALB	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
213	ALB	C0035457	Rhinitis, Allergic, Perennial	0.2	1	0	CTD_human
213	ALB	C0036830	Serum Sickness	0.2	2	0	CTD_human
213	ALB	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
213	ALB	C0042109	Urticaria	0.2	1	0	CTD_human
213	ALB	C0042164	Uveitis	0.2	1	0	CTD_human
213	ALB	C0162557	Liver Failure, Acute	0.200549453568426	2	0	CTD_human
213	ALB	C0239981	Hypoalbuminemia	0.401373633921066	1	0	CTD_human;HPO
213	ALB	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
2130	EWSR1	C0520743	Mediastinal lymphadenopathy	0.2	0	0	HPO
2130	EWSR1	C1258215	Ileus	0.2	0	0	HPO
2131	EXT1	C0023003	Langer-Giedion Syndrome	0.203021994626344	0	0	ORPHANET
2131	EXT1	C0149645	Cervical myelopathy	0.2	0	0	HPO
2131	EXT1	C0151311	Cranial nerve palsies	0.2	0	0	HPO
2131	EXT1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2132	EXT2	C0014544	Epilepsy	0.2	0	0	HPO
2132	EXT2	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
2132	EXT2	C0028738	Nystagmus	0.2	0	0	HPO
2132	EXT2	C0038379	Strabismus	0.2	0	0	HPO
2132	EXT2	C0149645	Cervical myelopathy	0.2	0	0	HPO
2132	EXT2	C0151311	Cranial nerve palsies	0.2	0	0	HPO
2132	EXT2	C1832588	Chromosome 11p11.2 Deletion Syndrome	0.201098907136852	0	0	ORPHANET
2132	EXT2	C1851413	EXOSTOSES, MULTIPLE, TYPE II	0.48	9	9	CTD_human;UNIPROT
2132	EXT2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2132	EXT2	C4225248	SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME	0.4	1	2	ORPHANET;UNIPROT
2133	EXT3	C1838420	EXOSTOSES, MULTIPLE, TYPE III (disorder)	0.2	0	0	CTD_human
2138	EYA1	C0008373	Cholesteatoma	0.2	0	0	HPO
2138	EYA1	C0018777	Conductive hearing loss	0.400274726784213	1	0	CTD_human;HPO
2138	EYA1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2138	EYA1	C0042580	Vesico-Ureteral Reflux	0.200274726784213	0	0	HPO
2138	EYA1	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
2138	EYA1	C0265234	Branchio-Oto-Renal Syndrome	0.705477814045232	7	19	CTD_human;ORPHANET;UNIPROT
2138	EYA1	C0266063	Deep overbite	0.2	0	0	HPO
2138	EYA1	C0302859	Euthyroid Goiter	0.2	0	0	HPO
2138	EYA1	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
2138	EYA1	C1833691	Otofaciocervical Syndrome	0.200549453568426	0	0	CTD_human
2138	EYA1	C1857079	Atretic auditory canal	0.2	0	0	HPO
2138	EYA1	C1865143	BRANCHIOOTIC SYNDROME 1	0.400549453568426	2	5	ORPHANET;UNIPROT
2138	EYA1	C2931416	Fara Chlupackova syndrome	0.2	0	0	ORPHANET
2138	EYA1	C4021796	Renal steatosis	0.2	0	0	HPO
2146	EZH2	C0010278	Craniosynostosis	0.2	1	0	CTD_human
2146	EZH2	C0010495	Cutis Laxa	0.2	0	0	HPO
2146	EZH2	C0014544	Epilepsy	0.2	0	0	HPO
2146	EZH2	C0038379	Strabismus	0.2	0	0	HPO
2146	EZH2	C0158113	Contracture of joint of hand	0.2	0	0	HPO
2146	EZH2	C0265210	Weaver syndrome	0.401648360705279	1	10	ORPHANET;UNIPROT
2146	EZH2	C2930812	Generalized elastolysis	0.2	0	0	HPO
2147	F2	C0002395	Alzheimer's Disease	0.202956482091714	1	0	CTD_human
2147	F2	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
2147	F2	C0007785	Cerebral Infarction	0.206187690967642	0	0	CTD_human
2147	F2	C0007786	Brain Ischemia	0.256013423918676	2	0	CTD_human
2147	F2	C0012739	Disseminated Intravascular Coagulation	0.280549453568426	1	0	CTD_human
2147	F2	C0015695	Fatty Liver	0.2	1	0	CTD_human
2147	F2	C0020640	Inherited Factor II deficiency	0.6141772141125	11	10	CTD_human;ORPHANET;UNIPROT
2147	F2	C0023890	Liver Cirrhosis	0.210792533764634	1	0	CTD_human
2147	F2	C0027051	Myocardial Infarction	0.263822443568585	3	0	CTD_human
2147	F2	C0027720	Nephrosis	0.28	1	0	CTD_human
2147	F2	C0028754	Obesity	0.29554107827658	1	0	CTD_human
2147	F2	C0030524	Paratuberculosis	0.2	1	0	CTD_human
2147	F2	C0034065	Pulmonary Embolism	0.261130918504099	0	0	HPO
2147	F2	C0037198	Sinus Thrombosis, Intracranial	0.216416415786532	1	0	CTD_human
2147	F2	C0085307	Embolism and Thrombosis	0.2	0	0	HPO
2147	F2	C0085605	Liver Failure	0.200549453568426	1	0	CTD_human
2147	F2	C0149871	Deep Vein Thrombosis	0.230167110374505	0	0	HPO
2147	F2	C0151945	Thrombosis of cerebral veins	0.208660232025559	0	0	HPO
2147	F2	C0398623	Thrombophilia	0.392967214105572	1	2	CTD_human
2147	F2	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
2147	F2	C1412000	Mesenteric vascular insufficiency	0.200274726784213	1	0	CTD_human
2149	F2R	C0015695	Fatty Liver	0.2	3	0	CTD_human
2149	F2R	C0019158	Hepatitis	0.2	1	0	CTD_human
2149	F2R	C0023890	Liver Cirrhosis	0.202732912464814	1	0	CTD_human
215	ABCD1	C0001403	Addison Disease	0.200274726784213	0	0	HPO
215	ABCD1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
215	ABCD1	C0015732	Fecal Incontinence	0.2	0	0	HPO
215	ABCD1	C0020619	Hypogonadism	0.2	0	0	HPO
215	ABCD1	C0037772	Spastic Paraplegia	0.2	0	0	HPO
215	ABCD1	C0152025	Polyneuropathy	0.2	0	0	HPO
215	ABCD1	C0162309	Adrenoleukodystrophy	0.740050322724131	23	53	CTD_human;ORPHANET;UNIPROT
215	ABCD1	C0242350	Erectile dysfunction	0.2	0	0	HPO
215	ABCD1	C0271215	Blindness, Legal	0.2	0	0	HPO
215	ABCD1	C0405580	Adrenal cortical hypofunction	0.201648360705279	0	0	HPO
215	ABCD1	C1301959	Bulbar weakness	0.2	0	0	HPO
215	ABCD1	C1527231	Adrenomyeloneuropathy	0.206868169605328	0	0	ORPHANET
215	ABCD1	C1845408	Contiguous Abcd1-Dxs1375e Deletion Syndrome	0.2	0	0	ORPHANET
215	ABCD1	C3806634	DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION	0.2	0	0	ORPHANET
215	ABCD1	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
215	ABCD1	C4082299	Bulbar palsy	0.2	0	0	HPO
2150	F2RL1	C0017160	Gastroenteritis	0.2	1	0	CTD_human
2150	F2RL1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2152	F3	C0012739	Disseminated Intravascular Coagulation	0.284120901763197	3	0	CTD_human
2152	F3	C0023890	Liver Cirrhosis	0.203007639249027	1	0	CTD_human
2152	F3	C0034155	Purpura, Thrombotic Thrombocytopenic	0.2	1	0	CTD_human
2152	F3	C0151744	Myocardial Ischemia	0.202681755307501	1	0	CTD_human
2153	F5	C0007785	Cerebral Infarction	0.211327631955743	0	0	CTD_human
2153	F5	C0007786	Brain Ischemia	0.265315654070302	1	0	CTD_human
2153	F5	C0015499	Factor V Deficiency	0.621332787147734	3	6	CTD_human;HPO;ORPHANET;UNIPROT
2153	F5	C0020541	Hypertension, Portal	0.2	0	0	HPO
2153	F5	C0023890	Liver Cirrhosis	0.40777053913829	1	0	CTD_human;HPO
2153	F5	C0027051	Myocardial Infarction	0.278422671800583	1	0	CTD_human
2153	F5	C0035328	Retinal Vein Occlusion	0.234741563685239	1	0	CTD_human
2153	F5	C0149871	Deep Vein Thrombosis	0.236354801342146	0	0	HPO
2153	F5	C0338575	Sagittal Sinus Thrombosis	0.2	1	0	CTD_human
2153	F5	C0398623	Thrombophilia	0.322828667582609	0	0	HPO
2153	F5	C0600433	Activated Protein C Resistance	0.325547224670106	0	0	HPO
2153	F5	C0856761	Budd-Chiari Syndrome	0.41866538721755	0	0	CTD_human;ORPHANET
2153	F5	C1412000	Mesenteric vascular insufficiency	0.2	1	0	CTD_human
2153	F5	C1853831	Bleeding Disorder, East Texas Type	0.2	0	0	ORPHANET
2153	F5	C1861171	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE (disorder)	0.400549453568426	5	3	CTD_human;UNIPROT
2153	F5	C2584620	Thrombophilia, hereditary	0.205703749933845	1	0	CTD_human
2155	F7	C0012739	Disseminated Intravascular Coagulation	0.2	1	0	CTD_human
2157	F8	C0019069	Hemophilia A	0.737232065443221	62	233	CTD_human;UNIPROT
2157	F8	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
2157	F8	C0272322	Severe hereditary factor VIII deficiency disease	0.210714344584311	0	0	ORPHANET
2157	F8	C0272324	Mild hereditary factor VIII deficiency disease	0.203296721410557	0	0	ORPHANET
2157	F8	C0272325	Factor 8 deficiency, acquired	0.200274726784213	1	0	CTD_human
2157	F8	C0398623	Thrombophilia	0.20328236603324	1	0	CTD_human
2157	F8	C3494187	Factor VIII Deficiency	0.200274726784213	0	0	HPO
2158	F9	C0008533	Hemophilia B	0.58635147282356	37	73	CTD_human;UNIPROT
2158	F9	C0019069	Hemophilia A	0.241025156673769	1	0	CTD_human
2158	F9	C0029408	Degenerative polyarthritis	0.200549453568426	0	0	HPO
2158	F9	C0149871	Deep Vein Thrombosis	0.201098907136852	0	0	HPO
2158	F9	C0398623	Thrombophilia	0.204381273170092	0	0	HPO
2158	F9	C2749016	Thrombophilia, X-Linked, Due To Factor Ix Defect	0.4	1	1	CTD_human;UNIPROT
2159	F10	C0015519	Factor X Deficiency	0.686290005282267	12	22	CTD_human;HPO;ORPHANET;UNIPROT
216	ALDH1A1	C0022336	Creutzfeldt-Jakob disease	0.2	1	0	CTD_human
2160	F11	C0015523	Factor XI Deficiency	0.706691712142403	20	89	CTD_human;HPO;ORPHANET;UNIPROT
2161	F12	C0015526	Factor XII Deficiency	0.688920603432455	8	5	CTD_human;HPO;ORPHANET;UNIPROT
2161	F12	C0019243	Angioedemas, Hereditary	0.203846174978983	1	1	CTD_human
2161	F12	C1857728	Hereditary Angioedema Type III	0.601098907136852	2	1	CTD_human;ORPHANET;UNIPROT
2161	F12	C1960459	Hereditary angioedema with normal C1 esterase inhibitor activity	0.2	0	0	ORPHANET
2162	F13A1	C0015530	Factor XIII Deficiency	0.207114185634906	1	0	CTD_human
2162	F13A1	C0027051	Myocardial Infarction	0.236599138640101	1	0	CTD_human
2162	F13A1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
2162	F13A1	C1697453	Spontaneous haematoma	0.2	0	0	HPO
2165	F13B	C0015530	Factor XIII Deficiency	0.2	1	0	CTD_human
2166	FAAH	C0020179	Huntington Disease	0.203007639249027	1	0	CTD_human
2166	FAAH	C0028754	Obesity	0.223992096052557	2	0	CTD_human
2167	FABP4	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
2168	FABP1	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
2168	FABP1	C0022672	Acute Kidney Tubular Necrosis	0.2	1	0	CTD_human
2168	FABP1	C0023794	Lipoidosis	0.2	2	0	CTD_human
217	ALDH2	C0004096	Asthma	0.206462417751855	2	0	CTD_human
217	ALDH2	C0028796	Dermatitis, Occupational	0.2	1	0	CTD_human
217	ALDH2	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
2171	FABP5	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2175	FANCA	C0002871	Anemia	0.2	0	0	HPO
2175	FANCA	C0015625	Fanconi Anemia	0.434506996144269	0	0	CTD_human;ORPHANET
2175	FANCA	C0023530	Leukopenia	0.2	0	0	HPO
2175	FANCA	C0030312	Pancytopenia	0.2	0	0	HPO
2175	FANCA	C0038379	Strabismus	0.2	0	0	HPO
2175	FANCA	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
2175	FANCA	C0948896	Primary hypogonadism	0.2	0	0	HPO
2175	FANCA	C1838608	Radial aplasia	0.2	0	0	HPO
2175	FANCA	C3469521	FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	0.302252869521261	10	31	UNIPROT
2176	FANCC	C0002871	Anemia	0.2	0	0	HPO
2176	FANCC	C0015625	Fanconi Anemia	0.437211197854448	0	0	CTD_human;ORPHANET
2176	FANCC	C0023530	Leukopenia	0.2	0	0	HPO
2176	FANCC	C0030312	Pancytopenia	0.200274726784213	0	0	HPO
2176	FANCC	C0038379	Strabismus	0.2	0	0	HPO
2176	FANCC	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
2176	FANCC	C0948896	Primary hypogonadism	0.2	0	0	HPO
2176	FANCC	C1838608	Radial aplasia	0.2	0	0	HPO
2176	FANCC	C3468041	FANCONI ANEMIA, COMPLEMENTATION GROUP C	0.480824180352639	2	39	CTD_human;UNIPROT
2177	FANCD2	C0002871	Anemia	0.2	0	0	HPO
2177	FANCD2	C0015625	Fanconi Anemia	0.45073832281552	1	1	CTD_human;ORPHANET
2177	FANCD2	C0023530	Leukopenia	0.2	0	0	HPO
2177	FANCD2	C0030312	Pancytopenia	0.200274726784213	0	0	HPO
2177	FANCD2	C0038379	Strabismus	0.2	0	0	HPO
2177	FANCD2	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
2177	FANCD2	C0948896	Primary hypogonadism	0.2	0	0	HPO
2177	FANCD2	C1838608	Radial aplasia	0.2	0	0	HPO
2177	FANCD2	C3160738	FANCONI ANEMIA, COMPLEMENTATION GROUP D2	0.481923087489492	1	5	CTD_human;UNIPROT
2178	FANCE	C0002871	Anemia	0.2	0	0	HPO
2178	FANCE	C0015625	Fanconi Anemia	0.408213092771758	0	0	CTD_human;ORPHANET
2178	FANCE	C0023530	Leukopenia	0.2	0	0	HPO
2178	FANCE	C0030312	Pancytopenia	0.2	0	0	HPO
2178	FANCE	C0038379	Strabismus	0.2	0	0	HPO
2178	FANCE	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
2178	FANCE	C0948896	Primary hypogonadism	0.2	0	0	HPO
2178	FANCE	C1838608	Radial aplasia	0.2	0	0	HPO
2178	FANCE	C3160739	FANCONI ANEMIA, COMPLEMENTATION GROUP E	0.200274726784213	0	0	CTD_human
2180	ACSL1	C0028754	Obesity	0.200824180352639	1	0	CTD_human
2182	ACSL4	C0013902	Elliptocytosis, Hereditary	0.2	0	0	HPO
2182	ACSL4	C0035078	Kidney Failure	0.2	0	0	HPO
2182	ACSL4	C1565489	Renal Insufficiency	0.2	0	0	HPO
2182	ACSL4	C1845672	Mental Retardation, X-Linked 63	0.400274726784213	1	3	CTD_human;UNIPROT
2182	ACSL4	C1846242	Alport Syndrome, Mental Retardation, Midface Hypoplasia, and Elliptocytosis	0.2	0	0	ORPHANET
2184	FAH	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
2184	FAH	C0020615	Hypoglycemia	0.2	0	0	HPO
2184	FAH	C0023890	Liver Cirrhosis	0.200274726784213	0	0	HPO
2184	FAH	C0027709	Nephrocalcinosis	0.2	0	0	HPO
2184	FAH	C0030446	Paralytic Ileus	0.2	0	0	HPO
2184	FAH	C0035078	Kidney Failure	0.2	0	0	HPO
2184	FAH	C0162557	Liver Failure, Acute	0.200274726784213	0	0	HPO
2184	FAH	C0178664	Glomerulosclerosis (disorder)	0.2	0	0	HPO
2184	FAH	C0268483	Tyrosinemias	0.214806535592873	2	0	CTD_human
2184	FAH	C0268490	Tyrosinemia, Type I	0.491813251721163	8	39	ORPHANET;UNIPROT
2184	FAH	C0268621	Hepatic methionine adenosyltransferase deficiency	0.200274726784213	0	0	HPO
2184	FAH	C0341703	Adult Fanconi syndrome	0.2	0	0	HPO
2184	FAH	C1279412	periodic paralysis (finding)	0.2	0	0	HPO
2184	FAH	C1565489	Renal Insufficiency	0.200274726784213	0	0	HPO
2184	FAH	C1704375	Hypophosphatemic Rickets	0.2	0	0	HPO
2184	FAH	C1879362	Hypertyrosinemia	0.201923087489492	0	0	HPO
2184	FAH	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2185	PTK2B	C0038220	Status Epilepticus	0.2	1	0	CTD_human
2187	FANCB	C0002871	Anemia	0.200274726784213	0	0	HPO
2187	FANCB	C0015625	Fanconi Anemia	0.404106546385879	0	0	CTD_human;ORPHANET
2187	FANCB	C0020255	Hydrocephalus	0.200274726784213	0	0	HPO
2187	FANCB	C0020295	Hydronephrosis	0.2	0	0	HPO
2187	FANCB	C0023530	Leukopenia	0.2	0	0	HPO
2187	FANCB	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
2187	FANCB	C1838608	Radial aplasia	0.2	0	0	HPO
2187	FANCB	C1845292	FANCONI ANEMIA, COMPLEMENTATION GROUP B	0.2	0	0	CTD_human
2187	FANCB	C1848599	VACTERL Association With Hydrocephalus	0.400274726784213	0	0	CTD_human;ORPHANET
2188	FANCF	C0015625	Fanconi Anemia	0.404945082115836	0	0	CTD_human;ORPHANET
2188	FANCF	C0023530	Leukopenia	0.2	0	0	HPO
2188	FANCF	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
2188	FANCF	C3469526	FANCONI ANEMIA, COMPLEMENTATION GROUP F	0.200274726784213	0	0	CTD_human
2189	FANCG	C0002871	Anemia	0.2	0	0	HPO
2189	FANCG	C0015625	Fanconi Anemia	0.413158174887594	2	2	CTD_human;ORPHANET
2189	FANCG	C0023530	Leukopenia	0.2	0	0	HPO
2189	FANCG	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
2189	FANCG	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
2189	FANCG	C3469527	fanconi anemia complementation group g	0.200274726784213	1	8	UNIPROT
2192	FBLN1	C0014175	Endometriosis	0.2	1	0	CTD_human
2192	FBLN1	C1842422	Synpolydactyly 2	0.4	0	0	CTD_human;ORPHANET
219285	SAMD9L	C1327919	Myelocerebellar Disorder	0.4	1	2	ORPHANET;UNIPROT
2194	FASN	C0007194	Hypertrophic Cardiomyopathy	0.2	1	0	CTD_human
2194	FASN	C0018801	Heart failure	0.2	1	0	CTD_human
2194	FASN	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
2194	FASN	C0028754	Obesity	0.209759139162412	1	0	CTD_human
2194	FASN	C0948089	Acute Coronary Syndrome	0.200274726784213	1	0	CTD_human
2194	FASN	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
219736	STOX1	C1836255	Preeclampsia Eclampsia 4	0.2	1	4	UNIPROT
219771	CCNY	C0009324	Ulcerative Colitis	0.210228724818891	1	1	CTD_human
219771	CCNY	C0010346	Crohn Disease	0.215042781865467	1	1	CTD_human
219844	HYLS1	C0431399	Familial aplasia of the vermis	0.2	0	0	ORPHANET
219844	HYLS1	C1856016	HYDROLETHALUS SYNDROME 1	0.4	1	1	CTD_human;UNIPROT
219844	HYLS1	C2931104	Hydrolethalus syndrome	0.200549453568426	0	0	ORPHANET
22	ABCB7	C0002896	Sideroblastic anemia	0.400824180352639	2	0	CTD_human;HPO
22	ABCB7	C0271901	Microcytic hypochromic anemia (disorder)	0.2	0	0	HPO
22	ABCB7	C1845028	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.600824180352639	5	4	CTD_human;ORPHANET;UNIPROT
220	ALDH1A3	C1855052	MICROPHTHALMIA, ISOLATED 1	0.2	0	0	ORPHANET
220	ALDH1A3	C3554524	MICROPHTHALMIA, ISOLATED 8	0.2	6	5	UNIPROT
2200	FBN1	C0003496	Aortic Rupture	0.202681755307501	1	0	CTD_human
2200	FBN1	C0003504	Aortic Valve Insufficiency	0.200274726784213	0	0	HPO
2200	FBN1	C0003507	Aortic Valve Stenosis	0.202407028523288	0	0	HPO
2200	FBN1	C0010495	Cutis Laxa	0.2	0	0	HPO
2200	FBN1	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
2200	FBN1	C0014175	Endometriosis	0.2	1	0	CTD_human
2200	FBN1	C0014306	Enophthalmos	0.2	0	0	HPO
2200	FBN1	C0017601	Glaucoma	0.203831819601666	0	0	HPO
2200	FBN1	C0018801	Heart failure	0.200274726784213	0	0	HPO
2200	FBN1	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
2200	FBN1	C0020456	Hyperglycemia	0.200274726784213	1	0	CTD_human
2200	FBN1	C0020459	Hyperinsulinism	0.200274726784213	1	0	CTD_human
2200	FBN1	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
2200	FBN1	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
2200	FBN1	C0024796	Marfan Syndrome	0.843542591575731	48	353	CTD_human;ORPHANET;UNIPROT
2200	FBN1	C0026267	Mitral Valve Prolapse Syndrome	0.209470057000881	0	0	HPO
2200	FBN1	C0026269	Mitral Valve Stenosis	0.2	0	0	HPO
2200	FBN1	C0027092	Myopia	0.200549453568426	0	0	HPO
2200	FBN1	C0034067	Pulmonary Emphysema	0.200824180352639	0	0	HPO
2200	FBN1	C0035305	Retinal Detachment	0.2	0	0	HPO
2200	FBN1	C0038016	Spondylolisthesis	0.2	0	0	HPO
2200	FBN1	C0040961	Tricuspid Valve Insufficiency	0.2	0	0	HPO
2200	FBN1	C0040962	Tricuspid Valve Prolapse	0.200274726784213	0	0	HPO
2200	FBN1	C0162872	Aortic Aneurysm, Thoracic	0.205429023149632	1	1	CTD_human
2200	FBN1	C0238669	Aortic root dilatation	0.200274726784213	0	0	HPO
2200	FBN1	C0263401	Cutis marmorata	0.2	0	0	HPO
2200	FBN1	C0264142	Spade-like hand	0.2	0	0	HPO
2200	FBN1	C0265313	Weill-Marchesani syndrome	0.402747267842131	0	0	CTD_human;ORPHANET
2200	FBN1	C0271183	Severe myopia	0.200274726784213	0	0	HPO
2200	FBN1	C0271215	Blindness, Legal	0.2	0	0	HPO
2200	FBN1	C0340643	Dissection of aorta	0.201923087489492	0	0	HPO
2200	FBN1	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
2200	FBN1	C0423320	Iridodonesis	0.2	0	0	HPO
2200	FBN1	C0428851	Dilatation of pulmonary artery, unspecified	0.2	0	0	HPO
2200	FBN1	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
2200	FBN1	C1280433	Lipoatrophy	0.2	0	0	HPO
2200	FBN1	C1835121	Premature osteoarthritis	0.2	0	0	HPO
2200	FBN1	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.2	0	0	ORPHANET
2200	FBN1	C1858556	OVERLAP CONNECTIVE TISSUE DISEASE	0.201098907136852	0	0	CTD_human
2200	FBN1	C1861456	Stiff Skin Syndrome	0.600824180352639	1	6	CTD_human;ORPHANET;UNIPROT
2200	FBN1	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
2200	FBN1	C1956346	Coronary Artery Disease	0.204604842796993	0	0	HPO
2200	FBN1	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
2200	FBN1	C2930812	Generalized elastolysis	0.2	0	0	HPO
2200	FBN1	C2931588	GEMSS syndrome	0.2	0	0	ORPHANET
2200	FBN1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
2200	FBN1	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
2200	FBN1	C3280054	GELEOPHYSIC DYSPLASIA 2	0.200274726784213	1	4	UNIPROT
2200	FBN1	C3541518	ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT	0.4	5	2	CTD_human;UNIPROT
2200	FBN1	C4021645	Recurrent abdominal hernia	0.2	0	0	HPO
220074	LRTOMT	C1969621	DEAFNESS, AUTOSOMAL RECESSIVE 63	0.48	2	7	CTD_human;UNIPROT
2201	FBN2	C0003886	Arthrogryposis	0.2	0	0	HPO
2201	FBN2	C0024437	Macular degeneration	0.200274726784213	0	0	HPO
2201	FBN2	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
2201	FBN2	C0027092	Myopia	0.2	0	0	HPO
2201	FBN2	C0029453	Osteopenia	0.2	0	0	HPO
2201	FBN2	C0042798	Low Vision	0.2	0	0	HPO
2201	FBN2	C0238669	Aortic root dilatation	0.200274726784213	0	0	HPO
2201	FBN2	C0265213	Distal arthrogryposis syndrome	0.2	0	0	HPO
2201	FBN2	C0747078	Generalized osteopenia	0.2	0	0	HPO
2201	FBN2	C4015286	MACULAR DEGENERATION, EARLY-ONSET	0.2	1	2	UNIPROT
2202	EFEMP1	C0042798	Low Vision	0.2	0	0	HPO
2202	EFEMP1	C1832174	DOYNE HONEYCOMB RETINAL DYSTROPHY	0.683296721410557	1	1	CTD_human;ORPHANET;UNIPROT
2202	EFEMP1	C4024769	Reticular pigmentary degeneration	0.2	0	0	HPO
220202	ATOH7	C1969783	Persistent Hyperplastic Primary Vitreous, Autosomal Recessive	0.2	2	2	UNIPROT
220202	ATOH7	C3151617	CORNEAL OPACIFICATION WITH OTHER OCULAR ANOMALIES	0.2	0	0	ORPHANET
220296	HEPACAM	C1854416	MACROCEPHALY/AUTISM SYNDROME	0.2	0	0	ORPHANET
220296	HEPACAM	C3151355	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A	0.2	1	6	UNIPROT
220296	HEPACAM	C3151356	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION	0.2	1	4	UNIPROT
2203	FBP1	C0014544	Epilepsy	0.2	0	0	HPO
2203	FBP1	C0016756	Fructose-1,6-Diphosphatase Deficiency	0.600824180352639	2	6	CTD_human;ORPHANET;UNIPROT
2203	FBP1	C0020615	Hypoglycemia	0.2	0	0	HPO
2203	FBP1	C0022638	Ketosis	0.2	0	0	HPO
2203	FBP1	C0030567	Parkinson Disease	0.200274726784213	1	0	CTD_human
2205	FCER1A	C0042109	Urticaria	0.203007639249027	2	0	CTD_human
2206	MS4A2	C1319853	Asthma, Aspirin-Induced	0.202407028523288	1	0	CTD_human
2206	MS4A2	C1840253	IgE RESPONSIVENESS, ATOPIC	0.2	0	0	CTD_human
2208	FCER2	C0014038	Encephalitis	0.200274726784213	1	0	CTD_human
2209	FCGR1A	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
221037	JMJD1C	C0012236	DiGeorge Syndrome	0.2	0	0	ORPHANET
221037	JMJD1C	C0220704	Shprintzen syndrome	0.2	0	0	ORPHANET
221037	JMJD1C	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	0.2	0	0	ORPHANET
221037	JMJD1C	C2936346	22q11 Deletion Syndrome	0.2	0	0	ORPHANET
221037	JMJD1C	C3266101	22q11 partial monosomy syndrome	0.2	0	0	ORPHANET
221037	JMJD1C	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
2212	FCGR2A	C0003873	Rheumatoid Arthritis	0.237214104743157	2	1	CTD_human
2212	FCGR2A	C0009324	Ulcerative Colitis	0.201648360705279	2	1	CTD_human
2212	FCGR2A	C0024141	Lupus Erythematosus, Systemic	0.280880857481184	1	2	CTD_human
2212	FCGR2A	C0026691	Mucocutaneous Lymph Node Syndrome	0.205429023149632	2	1	CTD_human
2212	FCGR2A	C1527336	Sjogren's Syndrome	0.2	1	0	CTD_human
2213	FCGR2B	C0024141	Lupus Erythematosus, Systemic	0.326679576123706	0	0	CTD_human
2213	FCGR2B	C0024530	Malaria	0.203780662444353	0	0	CTD_human
2213	FCGR2B	C0027947	Neutropenia	0.2	1	0	CTD_human
2214	FCGR3A	C0024141	Lupus Erythematosus, Systemic	0.255502450861869	0	0	CTD_human
2214	FCGR3A	C0037199	Sinusitis	0.2	0	0	HPO
2214	FCGR3A	C0581354	Recurrent sinusitis	0.2	0	0	HPO
2214	FCGR3A	C0747085	Recurrent otitis media	0.2	0	0	HPO
2214	FCGR3A	C3810342	IMMUNODEFICIENCY 20	0.4	1	1	ORPHANET;UNIPROT
2214	FCGR3A	C4280333	Recurrent sinus disease	0.2	0	0	HPO
221421	RSPH9	C0022521	Kartagener Syndrome	0.201373633921065	0	0	ORPHANET
221421	RSPH9	C2675228	CILIARY DYSKINESIA, PRIMARY, 12	0.2	0	0	CTD_human
221458	KIF6	C0027051	Myocardial Infarction	0.215108294400097	1	0	CTD_human
221472	FGD2	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
2215	FCGR3B	C0024143	Lupus Nephritis	0.206462417751855	1	0	CTD_human
2215	FCGR3B	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
2215	FCGR3B	C3495801	Granulomatosis with polyangiitis	0.202407028523288	1	0	CTD_human
221692	PHACTR1	C0027051	Myocardial Infarction	0.20433011601278	2	2	CTD_human
221692	PHACTR1	C0338480	Common Migraine	0.2	1	0	CTD_human
221692	PHACTR1	C1956346	Coronary Artery Disease	0.204055389228567	3	1	CTD_human
2218	FKTN	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
2218	FKTN	C0014544	Epilepsy	0.2	0	0	HPO
2218	FKTN	C0017601	Glaucoma	0.2	0	0	HPO
2218	FKTN	C0020255	Hydrocephalus	0.2	0	0	HPO
2218	FKTN	C0020490	Hyperopia	0.2	0	0	HPO
2218	FKTN	C0026850	Muscular Dystrophy	0.41538302118431	1	0	CTD_human;HPO
2218	FKTN	C0027092	Myopia	0.2	0	0	HPO
2218	FKTN	C0029124	Optic Atrophy	0.2	0	0	HPO
2218	FKTN	C0035305	Retinal Detachment	0.2	0	0	HPO
2218	FKTN	C0038379	Strabismus	0.2	0	0	HPO
2218	FKTN	C0042798	Low Vision	0.2	0	0	HPO
2218	FKTN	C0234958	muscle degeneration	0.200274726784213	0	0	HPO
2218	FKTN	C0265221	Walker-Warburg congenital muscular dystrophy	0.401923087489492	0	0	CTD_human;ORPHANET
2218	FKTN	C0271215	Blindness, Legal	0.2	0	0	HPO
2218	FKTN	C0410174	Fukuyama Type Congenital Muscular Dystrophy	0.693461612426442	2	13	CTD_human;ORPHANET;UNIPROT
2218	FKTN	C0457133	Muscle eye brain disease	0.200824180352639	0	0	ORPHANET
2218	FKTN	C0521694	Atrophic retina	0.2	0	0	HPO
2218	FKTN	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
2218	FKTN	C0699743	Congenital muscular dystrophy (disorder)	0.200824180352639	0	0	HPO
2218	FKTN	C1847759	MUSCULAR DYSTROPHY, CONGENITAL, 1C	0.2	0	0	ORPHANET
2218	FKTN	C1857079	Atretic auditory canal	0.2	0	0	HPO
2218	FKTN	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
2218	FKTN	C1969024	CARDIOMYOPATHY, DILATED, 1X	0.4	1	2	CTD_human;UNIPROT
2218	FKTN	C1969040	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2M	0.6	4	11	CTD_human;ORPHANET;UNIPROT
2218	FKTN	C2751052	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.4	3	1	CTD_human;UNIPROT
2218	FKTN	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
2218	FKTN	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
221895	JAZF1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2723418807679	1	3	CTD_human
221895	JAZF1	C0024141	Lupus Erythematosus, Systemic	0.203231208875927	1	4	CTD_human
221927	BRAT1	C3281029	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL	0.2	0	0	ORPHANET
221938	MMD2	C2750077	MIYOSHI MUSCULAR DYSTROPHY 2 (disorder)	0.2	0	0	CTD_human
222256	CDHR3	C0004096	Asthma	0.200274726784213	1	0	CTD_human
2224	FDPS	C0265970	Porokeratosis, Disseminated Superficial Actinic	0.2	0	0	ORPHANET
2224	FDPS	C0949506	Porokeratosis of Mibelli	0.2	0	0	HPO
2224	FDPS	C4225262	POROKERATOSIS 9, MULTIPLE TYPES	0.2	1	2	UNIPROT
222546	RFX6	C2748662	Mitchell-Riley Syndrome	0.200549453568426	2	9	UNIPROT
222662	LHFPL5	C1853223	Deafness, Autosomal Recessive 67	0.4	2	2	CTD_human;UNIPROT
2233	FEB1	C3501856	Febrile Convulsions, Familial, 1	0.2	0	0	CTD_human
2234	FEB2	C1865342	FEBRILE CONVULSIONS, FAMILIAL, 2 (disorder)	0.2	0	0	CTD_human
2235	FECH	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
2235	FECH	C0008350	Cholelithiasis	0.2	0	0	HPO
2235	FECH	C0013595	Eczema	0.2	0	0	HPO
2235	FECH	C0085605	Liver Failure	0.201098907136852	0	0	HPO
2235	FECH	C0162568	Erythropoietic Protoporphyria	0.730918826310469	17	19	CTD_human;ORPHANET;UNIPROT
2239	GPC4	C0006384	Bundle-Branch Block	0.2	0	0	HPO
2239	GPC4	C0020255	Hydrocephalus	0.200274726784213	0	0	HPO
2239	GPC4	C0020295	Hydronephrosis	0.2	0	0	HPO
2239	GPC4	C0020615	Hypoglycemia	0.2	0	0	HPO
2239	GPC4	C0022679	Cystic kidney	0.2	0	0	HPO
2239	GPC4	C0024421	Macroglossia	0.2	0	0	HPO
2239	GPC4	C0024636	Malocclusion	0.2	0	0	HPO
2239	GPC4	C0264142	Spade-like hand	0.2	0	0	HPO
2239	GPC4	C1834405	Nail dysplasia	0.2	0	0	HPO
2239	GPC4	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
2239	GPC4	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
2239	GPC4	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
224	ALDH3A2	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
224	ALDH3A2	C0014544	Epilepsy	0.2	0	0	HPO
224	ALDH3A2	C0020757	Ichthyoses	0.201373633921065	0	0	HPO
224	ALDH3A2	C0023882	Little's Disease	0.200549453568426	0	0	HPO
224	ALDH3A2	C0024437	Macular degeneration	0.2	0	0	HPO
224	ALDH3A2	C0027092	Myopia	0.2	0	0	HPO
224	ALDH3A2	C0037231	Sjogren-Larsson Syndrome	0.637116974565184	6	49	CTD_human;ORPHANET;UNIPROT
224	ALDH3A2	C0259817	Xerosis	0.2	0	0	HPO
224	ALDH3A2	C0338474	Central nervous system demyelination	0.2	0	0	HPO
224	ALDH3A2	C0392163	Corneal erosion	0.2	0	0	HPO
224	ALDH3A2	C0870082	Hyperkeratosis	0.2	0	0	HPO
2243	FGA	C0001733	Afibrinogenemia	0.203831819601666	4	0	CTD_human
2243	FGA	C0008370	Cholestasis	0.4	1	0	CTD_human;HPO
2243	FGA	C0029456	Osteoporosis	0.2	1	0	CTD_human
2243	FGA	C0034065	Pulmonary Embolism	0.28	1	0	CTD_human
2243	FGA	C0268389	Amyloidosis, familial visceral	0.4	1	5	CTD_human;UNIPROT
2243	FGA	C0398623	Thrombophilia	0.2	1	0	CTD_human
2243	FGA	C0553681	Hypofibrinogenemia	0.200549453568426	0	0	HPO
2243	FGA	C0740340	Amyloidosis, Familial	0.2	2	0	CTD_human
2243	FGA	C2584774	Congenital hypofibrinogenemia	0.402472541057918	1	1	ORPHANET;UNIPROT
2243	FGA	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2244	FGB	C0001733	Afibrinogenemia	0.204106546385879	0	0	CTD_human
2244	FGB	C0029456	Osteoporosis	0.2	1	0	CTD_human
2244	FGB	C0030567	Parkinson Disease	0.2	1	0	CTD_human
2244	FGB	C0553681	Hypofibrinogenemia	0.200274726784213	0	0	HPO
2244	FGB	C2584774	Congenital hypofibrinogenemia	0.401373633921066	4	7	ORPHANET;UNIPROT
2245	FGD1	C0020490	Hyperopia	0.2	0	0	HPO
2245	FGD1	C0038379	Strabismus	0.2	0	0	HPO
2245	FGD1	C0175701	Aarskog syndrome	0.60796707674218	6	14	CTD_human;ORPHANET;UNIPROT
2245	FGD1	C0264142	Spade-like hand	0.2	0	0	HPO
2245	FGD1	C1136249	Mental Retardation, X-Linked	0.203007639249027	1	0	CTD_human
2245	FGD1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2246	FGF1	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
2246	FGF1	C0151744	Myocardial Ischemia	0.200274726784213	1	0	CTD_human
2247	FGF2	C0014549	Tonic-Clonic Epilepsy	0.2	1	0	CTD_human
2247	FGF2	C0023890	Liver Cirrhosis	0.208473464178654	1	0	CTD_human
2247	FGF2	C0029172	Oral Submucous Fibrosis	0.203007639249027	1	0	CTD_human
2247	FGF2	C0031030	Periapical Periodontitis	0.202732912464814	1	0	CTD_human
2247	FGF2	C0034069	Pulmonary Fibrosis	0.200824180352639	1	0	CTD_human
2247	FGF2	C0040028	Thrombocythemia, Essential	0.2	1	0	CTD_human
2247	FGF2	C0085109	Corneal Neovascularization	0.203007639249027	1	0	CTD_human
2247	FGF2	C0151744	Myocardial Ischemia	0.200274726784213	2	0	CTD_human
2247	FGF2	C0751955	Brain Infarction	0.2	1	0	CTD_human
2248	FGF3	C0018784	Sensorineural Hearing Loss (disorder)	0.4	1	0	CTD_human;HPO
2248	FGF3	C1833693	Otodental Dysplasia	0.200549453568426	0	0	ORPHANET
2248	FGF3	C1837658	Gross motor development delay	0.2	0	0	HPO
2248	FGF3	C1853144	Deafness, Congenital, with Inner Ear Agenesis, Microtia, and Microdontia	0.600824180352639	2	11	CTD_human;ORPHANET;UNIPROT
2248	FGF3	C2750325	Oculootodental Syndrome	0.2	0	0	ORPHANET
2248	FGF3	C4023338	Profound sensorineural hearing impairment	0.2	0	0	HPO
2251	FGF6	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
2252	FGF7	C0023890	Liver Cirrhosis	0.200274726784213	1	0	CTD_human
2252	FGF7	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
2252	FGF7	C2937421	Prostatic Hyperplasia	0.203007639249027	1	0	CTD_human
2253	FGF8	C0012236	DiGeorge Syndrome	0.28	1	0	CTD_human
2253	FGF8	C0018418	Gynecomastia	0.2	0	0	HPO
2253	FGF8	C0029453	Osteopenia	0.2	0	0	HPO
2253	FGF8	C0029456	Osteoporosis	0.2	0	0	HPO
2253	FGF8	C0151721	Testicular hypogonadism	0.2	0	0	HPO
2253	FGF8	C0162809	Kallmann Syndrome	0.401373633921066	0	0	CTD_human;ORPHANET
2253	FGF8	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
2253	FGF8	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
2253	FGF8	C0242350	Erectile dysfunction	0.2	0	0	HPO
2253	FGF8	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
2253	FGF8	C0271623	Hypogonadotropic hypogonadism	0.201098907136852	0	0	HPO
2253	FGF8	C0747078	Generalized osteopenia	0.2	0	0	HPO
2253	FGF8	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
2253	FGF8	C2936346	22q11 Deletion Syndrome	0.200274726784213	1	0	CTD_human
2253	FGF8	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.200274726784213	0	0	HPO
2253	FGF8	C3552574	HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA	0.2	2	6	UNIPROT
2253	FGF8	C4020884	Anxiety disease	0.2	0	0	HPO
2253	FGF8	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
2253	FGF8	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
2254	FGF9	C0175700	Multiple synostosis syndrome	0.200549453568426	0	0	ORPHANET
2254	FGF9	C0342282	Symphalangism-brachydactyly syndrome	0.200274726784213	0	0	ORPHANET
2254	FGF9	C2751826	Multiple Synostoses Syndrome 3	0.4	1	1	CTD_human;UNIPROT
2254	FGF9	C2930865	Ramer Ladda syndrome	0.2	0	0	HPO
2255	FGF10	C0010043	Corneal Ulcer	0.2	0	0	HPO
2255	FGF10	C0010930	Dacryocystitis	0.2	0	0	HPO
2255	FGF10	C0011334	Dental caries	0.2	0	0	HPO
2255	FGF10	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
2255	FGF10	C0027719	Nephrosclerosis	0.2	0	0	HPO
2255	FGF10	C0155119	Recurrent erosion of cornea	0.2	0	0	HPO
2255	FGF10	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
2255	FGF10	C0265269	Lacrimoauriculodentodigital syndrome	0.680824180352639	2	3	CTD_human;ORPHANET;UNIPROT
2255	FGF10	C0344505	Alacrima	0.2	0	0	HPO
2255	FGF10	C0948060	Iridocele	0.2	0	0	HPO
2255	FGF10	C1838608	Radial aplasia	0.2	0	0	HPO
2255	FGF10	C1867060	Lacrimal Puncta, Absence of	0.2	0	0	HPO
2259	FGF14	C0038379	Strabismus	0.2	0	0	HPO
2259	FGF14	C1836383	SPINOCEREBELLAR ATAXIA 27	0.680274726784213	2	2	CTD_human;ORPHANET;UNIPROT
226	ALDOA	C0008325	Cholecystitis	0.2	0	0	HPO
226	ALDOA	C0008350	Cholelithiasis	0.2	0	0	HPO
226	ALDOA	C0085577	Normocytic anemia	0.2	0	0	HPO
226	ALDOA	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
226	ALDOA	C0272066	Glycogen Storage Disease XII	0.6	3	3	CTD_human;ORPHANET;UNIPROT
226	ALDOA	C4025735	Nonspherocytic hemolytic anemia	0.2	0	0	HPO
2260	FGFR1	C0002170	Alopecia	0.2	0	0	HPO
2260	FGFR1	C0010278	Craniosynostosis	0.214349626582087	0	0	HPO
2260	FGFR1	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
2260	FGFR1	C0014544	Epilepsy	0.2	0	0	HPO
2260	FGFR1	C0015300	Exophthalmos	0.2	0	0	HPO
2260	FGFR1	C0018418	Gynecomastia	0.2	0	0	HPO
2260	FGFR1	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
2260	FGFR1	C0020255	Hydrocephalus	0.2	0	0	HPO
2260	FGFR1	C0020295	Hydronephrosis	0.2	0	0	HPO
2260	FGFR1	C0028738	Nystagmus	0.2	0	0	HPO
2260	FGFR1	C0029453	Osteopenia	0.2	0	0	HPO
2260	FGFR1	C0029456	Osteoporosis	0.200274726784213	0	0	HPO
2260	FGFR1	C0038379	Strabismus	0.2	0	0	HPO
2260	FGFR1	C0042798	Low Vision	0.2	0	0	HPO
2260	FGFR1	C0078981	Arachnoid Cysts	0.2	0	0	HPO
2260	FGFR1	C0151721	Testicular hypogonadism	0.2	0	0	HPO
2260	FGFR1	C0162809	Kallmann Syndrome	0.424276592593754	0	0	CTD_human;ORPHANET
2260	FGFR1	C0220658	Pfeiffer Syndrome	0.284120901763197	2	1	UNIPROT
2260	FGFR1	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
2260	FGFR1	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
2260	FGFR1	C0242350	Erectile dysfunction	0.2	0	0	HPO
2260	FGFR1	C0264142	Spade-like hand	0.2	0	0	HPO
2260	FGFR1	C0264353	Bronchomalacia	0.2	0	0	HPO
2260	FGFR1	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
2260	FGFR1	C0271623	Hypogonadotropic hypogonadism	0.204055389228567	0	0	HPO
2260	FGFR1	C0340375	Subaortic stenosis	0.2	0	0	HPO
2260	FGFR1	C0342384	Idiopathic hypogonadotropic hypogonadism	0.204670355331623	0	0	CTD_human
2260	FGFR1	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
2260	FGFR1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
2260	FGFR1	C0409477	Ankylosis of the elbow joint	0.200274726784213	0	0	HPO
2260	FGFR1	C0454455	Mirror movements disorder	0.2	0	0	HPO
2260	FGFR1	C0747078	Generalized osteopenia	0.2	0	0	HPO
2260	FGFR1	C0795998	JACKSON-WEISS SYNDROME	0.4	0	0	CTD_human;UNIPROT
2260	FGFR1	C0948740	Pituitary hypoplasia	0.2	0	0	HPO
2260	FGFR1	C1290587	Failure of tooth eruption	0.2	0	0	HPO
2260	FGFR1	C1563720	Kallmann Syndrome 2 (disorder)	0.400549453568426	14	35	ORPHANET;UNIPROT
2260	FGFR1	C1845146	Holoprosencephaly, Ectrodactyly, and Bilateral Cleft Lip-Palate	0.400549453568426	2	8	ORPHANET;UNIPROT
2260	FGFR1	C1853235	Sclerocornea	0.2	0	0	HPO
2260	FGFR1	C1856266	Coronal craniosynostosis	0.2	0	0	HPO
2260	FGFR1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2260	FGFR1	C2930865	Ramer Ladda syndrome	0.2	0	0	HPO
2260	FGFR1	C2931888	Pfeiffer type acrocephalosyndactyly	0.2	0	0	CTD_human
2260	FGFR1	C2936791	Antley-Bixler Syndrome, Autosomal Dominant	0.2	0	0	CTD_human
2260	FGFR1	C3150773	CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME	0.202197814273705	0	0	ORPHANET
2260	FGFR1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.201648360705279	0	0	HPO
2260	FGFR1	C4020884	Anxiety disease	0.2	0	0	HPO
2260	FGFR1	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
2260	FGFR1	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
2261	FGFR3	C0000889	Acanthosis Nigricans	0.214777824838238	0	0	HPO
2261	FGFR3	C0005747	Blepharospasm	0.2	0	0	HPO
2261	FGFR3	C0010043	Corneal Ulcer	0.2	0	0	HPO
2261	FGFR3	C0010278	Craniosynostosis	0.229640103208757	0	0	HPO
2261	FGFR3	C0010930	Dacryocystitis	0.2	0	0	HPO
2261	FGFR3	C0011334	Dental caries	0.2	0	0	HPO
2261	FGFR3	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
2261	FGFR3	C0014544	Epilepsy	0.200549453568426	0	0	HPO
2261	FGFR3	C0015300	Exophthalmos	0.2	0	0	HPO
2261	FGFR3	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
2261	FGFR3	C0018777	Conductive hearing loss	0.2	0	0	HPO
2261	FGFR3	C0018784	Sensorineural Hearing Loss (disorder)	0.203007639249027	0	0	HPO
2261	FGFR3	C0020255	Hydrocephalus	0.2	0	0	HPO
2261	FGFR3	C0022603	Seborrheic keratosis	0.215327278406665	21	7	UNIPROT
2261	FGFR3	C0024636	Malocclusion	0.2	0	0	HPO
2261	FGFR3	C0027719	Nephrosclerosis	0.2	0	0	HPO
2261	FGFR3	C0028754	Obesity	0.2	0	0	HPO
2261	FGFR3	C0029882	Otitis Media	0.2	0	0	HPO
2261	FGFR3	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
2261	FGFR3	C0038379	Strabismus	0.200274726784213	0	0	HPO
2261	FGFR3	C0151740	Intracranial Hypertension	0.2	0	0	HPO
2261	FGFR3	C0155119	Recurrent erosion of cornea	0.2	0	0	HPO
2261	FGFR3	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
2261	FGFR3	C0158113	Contracture of joint of hand	0.2	0	0	HPO
2261	FGFR3	C0175699	Saethre-Chotzen Syndrome	0.200274726784213	0	0	ORPHANET
2261	FGFR3	C0234533	Generalized seizures	0.2	0	0	HPO
2261	FGFR3	C0235946	Cerebral atrophy	0.2	0	0	HPO
2261	FGFR3	C0265269	Lacrimoauriculodentodigital syndrome	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
2261	FGFR3	C0270680	Posterior fossa compression syndrome	0.2	0	0	HPO
2261	FGFR3	C0271441	Chronic otitis media	0.2	0	0	HPO
2261	FGFR3	C0334082	NEVUS, EPIDERMAL (disorder)	0.402197814273705	7	3	CTD_human;UNIPROT
2261	FGFR3	C0344505	Alacrima	0.2	0	0	HPO
2261	FGFR3	C0520679	Sleep Apnea, Obstructive	0.202407028523288	0	0	HPO
2261	FGFR3	C0520680	Sleep Apnea, Central	0.2	0	0	HPO
2261	FGFR3	C0740852	Upper airway obstruction	0.2	0	0	HPO
2261	FGFR3	C0743359	ear infection chronic	0.2	0	0	HPO
2261	FGFR3	C0747085	Recurrent otitis media	0.2	0	0	HPO
2261	FGFR3	C0948060	Iridocele	0.2	0	0	HPO
2261	FGFR3	C1300257	Thanatophoric dysplasia, type 2	0.682747267842131	0	0	CTD_human;ORPHANET;UNIPROT
2261	FGFR3	C1535953	Stenosis of foramen magnum	0.2	0	0	HPO
2261	FGFR3	C1838608	Radial aplasia	0.2	0	0	HPO
2261	FGFR3	C1856266	Coronal craniosynostosis	0.202747267842131	0	0	HPO
2261	FGFR3	C1864436	Muenke Syndrome	0.684670355331623	4	1	CTD_human;ORPHANET;UNIPROT
2261	FGFR3	C1864852	CATSHL syndrome	0.6	1	2	CTD_human;ORPHANET;UNIPROT
2261	FGFR3	C1867060	Lacrimal Puncta, Absence of	0.2	0	0	HPO
2261	FGFR3	C2677099	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS (disorder)	0.601923087489492	3	1	CTD_human;ORPHANET;UNIPROT
2261	FGFR3	C2931282	Skeletal dysplasia, San Diego type	0.2	0	0	ORPHANET
2261	FGFR3	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
2263	FGFR2	C0000889	Acanthosis Nigricans	0.200274726784213	0	0	HPO
2263	FGFR2	C0005747	Blepharospasm	0.2	0	0	HPO
2263	FGFR2	C0009763	Conjunctivitis	0.2	0	0	HPO
2263	FGFR2	C0010043	Corneal Ulcer	0.2	0	0	HPO
2263	FGFR2	C0010273	Craniofacial Dysostosis	0.415919798107043	1	16	CTD_human;HPO
2263	FGFR2	C0010278	Craniosynostosis	0.440456762107693	3	0	CTD_human;HPO
2263	FGFR2	C0010930	Dacryocystitis	0.2	0	0	HPO
2263	FGFR2	C0011334	Dental caries	0.2	0	0	HPO
2263	FGFR2	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
2263	FGFR2	C0014544	Epilepsy	0.2	0	0	HPO
2263	FGFR2	C0015300	Exophthalmos	0.200824180352639	0	0	HPO
2263	FGFR2	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
2263	FGFR2	C0018777	Conductive hearing loss	0.2	0	0	HPO
2263	FGFR2	C0020255	Hydrocephalus	0.200274726784213	0	0	HPO
2263	FGFR2	C0020295	Hydronephrosis	0.2	0	0	HPO
2263	FGFR2	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
2263	FGFR2	C0023890	Liver Cirrhosis	0.203007639249027	1	0	CTD_human
2263	FGFR2	C0024636	Malocclusion	0.2	0	0	HPO
2263	FGFR2	C0027719	Nephrosclerosis	0.2	0	0	HPO
2263	FGFR2	C0029124	Optic Atrophy	0.2	0	0	HPO
2263	FGFR2	C0029453	Osteopenia	0.2	0	0	HPO
2263	FGFR2	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
2263	FGFR2	C0038379	Strabismus	0.200549453568426	0	0	HPO
2263	FGFR2	C0042798	Low Vision	0.2	0	0	HPO
2263	FGFR2	C0078981	Arachnoid Cysts	0.2	0	0	HPO
2263	FGFR2	C0151740	Intracranial Hypertension	0.2	0	0	HPO
2263	FGFR2	C0155119	Recurrent erosion of cornea	0.2	0	0	HPO
2263	FGFR2	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
2263	FGFR2	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
2263	FGFR2	C0175699	Saethre-Chotzen Syndrome	0.201098907136852	0	0	ORPHANET
2263	FGFR2	C0220658	Pfeiffer Syndrome	0.29229719275496	10	13	UNIPROT
2263	FGFR2	C0264353	Bronchomalacia	0.2	0	0	HPO
2263	FGFR2	C0265269	Lacrimoauriculodentodigital syndrome	0.600549453568426	1	3	CTD_human;ORPHANET;UNIPROT
2263	FGFR2	C0271441	Chronic otitis media	0.2	0	0	HPO
2263	FGFR2	C0344505	Alacrima	0.2	0	0	HPO
2263	FGFR2	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
2263	FGFR2	C0409477	Ankylosis of the elbow joint	0.200274726784213	0	0	HPO
2263	FGFR2	C0702166	Acne	0.2	0	0	HPO
2263	FGFR2	C0740852	Upper airway obstruction	0.2	0	0	HPO
2263	FGFR2	C0743359	ear infection chronic	0.2	0	0	HPO
2263	FGFR2	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
2263	FGFR2	C0747078	Generalized osteopenia	0.2	0	0	HPO
2263	FGFR2	C0795998	JACKSON-WEISS SYNDROME	0.601373633921066	0	0	CTD_human;ORPHANET;UNIPROT
2263	FGFR2	C0948060	Iridocele	0.2	0	0	HPO
2263	FGFR2	C0948187	Tracheomalacia	0.2	0	0	HPO
2263	FGFR2	C1833340	Synostotic Posterior Plagiocephaly	0.200274726784213	0	0	HPO
2263	FGFR2	C1838608	Radial aplasia	0.2	0	0	HPO
2263	FGFR2	C1852406	Cutis Gyrata Syndrome of Beare And Stevenson	0.682197814273705	1	2	CTD_human;ORPHANET;UNIPROT
2263	FGFR2	C1856266	Coronal craniosynostosis	0.200274726784213	0	0	HPO
2263	FGFR2	C1857079	Atretic auditory canal	0.2	0	0	HPO
2263	FGFR2	C1865070	SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION	0.6	2	1	CTD_human;ORPHANET;UNIPROT
2263	FGFR2	C1867060	Lacrimal Puncta, Absence of	0.2	0	0	HPO
2263	FGFR2	C2350233	Antley-Bixler Syndrome Phenotype	0.2	1	0	CTD_human
2263	FGFR2	C2613439	Extramedullary Hematopoiesis (disorder)	0.2	0	0	HPO
2263	FGFR2	C2930865	Ramer Ladda syndrome	0.200274726784213	0	0	HPO
2263	FGFR2	C2931196	Craniofacial dysostosis type 1	0.492912158858016	21	18	ORPHANET;UNIPROT
2263	FGFR2	C2931888	Pfeiffer type acrocephalosyndactyly	0.2	0	0	CTD_human
2263	FGFR2	C2936786	Aqueductal Stenosis	0.2	0	0	HPO
2263	FGFR2	C2936791	Antley-Bixler Syndrome, Autosomal Dominant	0.601098907136852	0	0	CTD_human;ORPHANET;UNIPROT
2263	FGFR2	C3281247	BENT BONE DYSPLASIA SYNDROME	0.400274726784213	1	2	ORPHANET;UNIPROT
2263	FGFR2	C3551052	Night blindness, stationary	0.2	0	0	HPO
2263	FGFR2	C4021977	Visceral angiomatosis	0.2	0	0	HPO
2263	FGFR2	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
2264	FGFR4	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
2266	FGG	C0553681	Hypofibrinogenemia	0.201923087489492	0	0	HPO
2266	FGG	C2584774	Congenital hypofibrinogenemia	0.481098907136852	1	4	ORPHANET;UNIPROT
2270	FGS2	C0220769	FG syndrome	0.201098907136852	0	0	CTD_human
2271	FH	C0008370	Cholestasis	0.2	0	0	HPO
2271	FH	C0029124	Optic Atrophy	0.2	0	0	HPO
2271	FH	C0032461	Polycythemia	0.200274726784213	0	0	HPO
2271	FH	C0038220	Status Epilepticus	0.2	0	0	HPO
2271	FH	C0042798	Low Vision	0.2	0	0	HPO
2271	FH	C0085605	Liver Failure	0.2	0	0	HPO
2271	FH	C0235946	Cerebral atrophy	0.2	0	0	HPO
2271	FH	C0238621	Aminoaciduria	0.2	0	0	HPO
2271	FH	C0342770	Fumarase deficiency	0.400824180352639	2	12	ORPHANET;UNIPROT
2271	FH	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
2271	FH	C2936826	Fumaric aciduria	0.400274726784213	0	0	CTD_human;ORPHANET
2271	FH	C4020860	Supratentorial atrophy	0.2	0	0	HPO
2273	FHL1	C0007194	Hypertrophic Cardiomyopathy	0.202197814273705	0	0	HPO
2273	FHL1	C0085684	Foot-drop	0.2	0	0	HPO
2273	FHL1	C0234958	muscle degeneration	0.200274726784213	0	0	HPO
2273	FHL1	C0270970	Reducing-body myopathy	0.20357144819477	0	0	ORPHANET
2273	FHL1	C0751337	X-Linked Emery-Dreifuss Muscular Dystrophy	0.2	0	0	ORPHANET
2273	FHL1	C2678015	Myopathy, Reducing Body, X-Linked, Childhood-Onset	0.2	0	0	CTD_human
2273	FHL1	C2678027	Myopathy, Reducing Body, X-Linked, Early-Onset, Severe	0.2	0	0	CTD_human
2273	FHL1	C2678055	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY (disorder)	0.600274726784213	3	4	CTD_human;ORPHANET;UNIPROT
2273	FHL1	C2678061	SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT	0.600549453568426	2	1	CTD_human;ORPHANET;UNIPROT
2273	FHL1	C2678065	Myofibrillar Myopathy	0.201098907136852	0	0	HPO
2273	FHL1	C2931268	Scapuloperoneal myopathy	0.201648360705279	0	0	HPO
2273	FHL1	C4225159	REDUCING BODY MYOPATHY, X-LINKED 1B, WITH LATE CHILDHOOD OR ADULT ONSET	0.2	3	2	UNIPROT
2273	FHL1	C4225423	REDUCING BODY MYOPATHY, X-LINKED 1A, SEVERE, WITH INFANTILE OR EARLY CHILDHOOD ONSET	0.2	2	4	UNIPROT
2274	FHL2	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
2274	FHL2	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
22796	COG2	C0268070	Hypocupremia	0.2	0	0	HPO
22796	COG2	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
22802	CLCA4	C0008312	Primary biliary cirrhosis	0.2	0	0	HPO
22802	CLCA4	C0010674	Cystic Fibrosis	0.203557092817453	0	0	ORPHANET
22802	CLCA4	C0023892	Biliary cirrhosis	0.2	0	0	HPO
22802	CLCA4	C0030293	Pancreatic Insufficiency	0.2	0	0	HPO
22802	CLCA4	C0034069	Pulmonary Fibrosis	0.2	0	0	HPO
22802	CLCA4	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
22802	CLCA4	C0267963	Exocrine pancreatic insufficiency	0.2	0	0	HPO
22806	IKZF3	C0003873	Rheumatoid Arthritis	0.200549453568426	1	0	CTD_human
22806	IKZF3	C0004096	Asthma	0.201098907136852	1	1	CTD_human
22808	MRAS	C1956346	Coronary Artery Disease	0.203780662444353	1	0	CTD_human
22811	MBS3	C1858717	Facial paresis, hereditary, congenital	0.2	0	0	CTD_human
22822	PHLDA1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
22827	PUF60	C0022679	Cystic kidney	0.2	0	0	HPO
22827	PUF60	C0235946	Cerebral atrophy	0.2	0	0	HPO
22827	PUF60	C3810023	VERHEIJ SYNDROME	0.2	1	2	UNIPROT
22827	PUF60	C4020860	Supratentorial atrophy	0.2	0	0	HPO
22845	DOLK	C0014544	Epilepsy	0.2	0	0	HPO
22845	DOLK	C0020757	Ichthyoses	0.2	0	0	HPO
22845	DOLK	C0235946	Cerebral atrophy	0.2	0	0	HPO
22845	DOLK	C0259817	Xerosis	0.2	0	0	HPO
22845	DOLK	C1280433	Lipoatrophy	0.2	0	0	HPO
22845	DOLK	C1835849	Congenital Disorder Of Glycosylation, Type Im	0.600549453568426	1	4	CTD_human;ORPHANET;UNIPROT
22845	DOLK	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
22845	DOLK	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
22845	DOLK	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
22854	NTNG1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
22854	NTNG1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
22854	NTNG1	C0035372	Rett Syndrome	0.203557092817453	0	0	ORPHANET
22854	NTNG1	C0235946	Cerebral atrophy	0.2	0	0	HPO
22854	NTNG1	C0392525	Nephrolithiasis	0.2	0	0	HPO
22854	NTNG1	C1836830	Developmental regression	0.2	0	0	HPO
22854	NTNG1	C2748910	Rett Syndrome, Atypical	0.200274726784213	0	0	ORPHANET
22856	CHSY1	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
22856	CHSY1	C1854466	Temtamy preaxial brachydactyly syndrome	0.400824180352639	1	2	ORPHANET;UNIPROT
22856	CHSY1	C1857269	Hitchhiker thumb	0.2	0	0	HPO
22858	ICK	C0020255	Hydrocephalus	0.2	0	0	HPO
22858	ICK	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
22858	ICK	C2675227	Endocrine-Cerebroosteodysplasia	0.68	1	1	CTD_human;ORPHANET;UNIPROT
22861	NLRP1	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
22861	NLRP1	C0030436	Parakeratosis	0.2	0	0	HPO
22861	NLRP1	C0085109	Corneal Neovascularization	0.2	0	0	HPO
22861	NLRP1	C1847835	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	0.403021994626344	2	1	CTD_human;UNIPROT
22861	NLRP1	C3808876	CORNEAL INTRAEPITHELIAL DYSKERATOSIS AND ECTODERMAL DYSPLASIA	0.4	1	1	ORPHANET;UNIPROT
22864	R3HDM2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
22868	FASTKD2	C0002871	Anemia	0.2	0	0	HPO
22868	FASTKD2	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
22868	FASTKD2	C0014544	Epilepsy	0.2	0	0	HPO
22868	FASTKD2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
22868	FASTKD2	C0029124	Optic Atrophy	0.2	0	0	HPO
22868	FASTKD2	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
22868	FASTKD2	C0151747	Renal tubular disorder	0.2	0	0	HPO
22868	FASTKD2	C0238621	Aminoaciduria	0.2	0	0	HPO
22868	FASTKD2	C0341703	Adult Fanconi syndrome	0.2	0	0	HPO
22868	FASTKD2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
22880	MORC2	C4225243	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z	0.4	2	3	ORPHANET;UNIPROT
2289	FKBP5	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
2289	FKBP5	C0014175	Endometriosis	0.2	1	0	CTD_human
22891	ZNF365	C0007384	Cataplexy	0.2	0	0	HPO
22891	ZNF365	C0011615	Dermatitis, Atopic	0.2	1	2	CTD_human
22891	ZNF365	C0027404	Narcolepsy	0.2	0	0	ORPHANET
22891	ZNF365	C0751362	Narcolepsy-Cataplexy Syndrome	0.2	0	0	ORPHANET
22891	ZNF365	C1456240	Narcolepsy without cataplexy	0.2	0	0	ORPHANET
22897	CEP164	C0025322	Premature Menopause	0.2	0	0	HPO
22897	CEP164	C0042798	Low Vision	0.2	0	0	HPO
22897	CEP164	C0403553	Renal dysplasia and retinal aplasia (disorder)	0.2	0	0	ORPHANET
22897	CEP164	C0687120	Nephronophthisis	0.200274726784213	0	0	HPO
22897	CEP164	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
22897	CEP164	C3541853	NEPHRONOPHTHISIS 15	0.2	1	4	UNIPROT
229	ALDOB	C0014544	Epilepsy	0.2	0	0	HPO
229	ALDOB	C0016751	Hereditary fructose intolerance syndrome	0.694987039087822	9	30	CTD_human;HPO;ORPHANET;UNIPROT
229	ALDOB	C0020615	Hypoglycemia	0.2	0	0	HPO
229	ALDOB	C0023890	Liver Cirrhosis	0.2	0	0	HPO
229	ALDOB	C0162429	Malnutrition	0.2	0	0	HPO
229	ALDOB	C0241910	Hepatitis, Autoimmune	0.2	1	0	CTD_human
229	ALDOB	C0268435	Renal Tubular Acidosis, Type II	0.2	0	0	HPO
229	ALDOB	C0740394	Hyperuricemia	0.2	0	0	HPO
229	ALDOB	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
229	ALDOB	C2711227	Steatohepatitis	0.2	0	0	HPO
229	ALDOB	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2290	FOXG1	C0013384	Dyskinetic syndrome	0.200274726784213	0	0	HPO
2290	FOXG1	C0014544	Epilepsy	0.20433011601278	0	0	HPO
2290	FOXG1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
2290	FOXG1	C0024421	Macroglossia	0.2	0	0	HPO
2290	FOXG1	C0035372	Rett Syndrome	0.212557564161855	0	0	ORPHANET
2290	FOXG1	C0037036	Sialorrhea	0.2	0	0	HPO
2290	FOXG1	C0235946	Cerebral atrophy	0.2	0	0	HPO
2290	FOXG1	C0392525	Nephrolithiasis	0.2	0	0	HPO
2290	FOXG1	C0796147	Acrocallosal Syndrome	0.2	1	0	CTD_human
2290	FOXG1	C1836830	Developmental regression	0.2	0	0	HPO
2290	FOXG1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
2290	FOXG1	C2748910	Rett Syndrome, Atypical	0.200549453568426	0	0	ORPHANET
2290	FOXG1	C3150705	FOXG1 syndrome	0.480824180352639	2	33	CTD_human;UNIPROT
2290	FOXG1	C4020858	Choreatic disease	0.2	0	0	HPO
2290	FOXG1	C4020871	Dystonic disease	0.2	0	0	HPO
22900	CARD8	C0018099	Gout	0.2	1	0	CTD_human
22909	FAN1	C0014544	Epilepsy	0.2	0	0	HPO
22909	FAN1	C0041349	Nephritis, Tubulointerstitial	0.200274726784213	0	0	HPO
22909	FAN1	C0151740	Intracranial Hypertension	0.2	0	0	HPO
22909	FAN1	C0687120	Nephronophthisis	0.2	0	0	HPO
22909	FAN1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
22909	FAN1	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
22909	FAN1	C2931118	Megalocytic interstitial nephritis	0.2	1	0	CTD_human
22909	FAN1	C3553774	INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.400274726784213	1	3	ORPHANET;UNIPROT
22909	FAN1	C4020884	Anxiety disease	0.2	0	0	HPO
22917	ZP1	C4014291	OOCYTE MATURATION DEFECT 1	0.2	0	0	ORPHANET
22919	MAPRE1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
22924	MAPRE3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
22926	ATF6	C0003949	Asbestosis	0.2	1	0	CTD_human
22926	ATF6	C0015310	Exotropia	0.2	0	0	HPO
22926	ATF6	C0020490	Hyperopia	0.2	0	0	HPO
22926	ATF6	C0022336	Creutzfeldt-Jakob disease	0.2	1	0	CTD_human
22926	ATF6	C0035334	Retinitis Pigmentosa	0.2	1	0	CTD_human
22926	ATF6	C0036457	Scrapie	0.2	1	0	CTD_human
22926	ATF6	C0042798	Low Vision	0.2	0	0	HPO
22926	ATF6	C0152200	Achromatopsia	0.200549453568426	0	0	ORPHANET
22926	ATF6	C0271388	Pendular Nystagmus	0.2	0	0	HPO
22926	ATF6	C0858618	Dyschromatopsia	0.2	0	0	HPO
22926	ATF6	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
22926	ATF6	C4225297	ACHROMATOPSIA 7	0.2	1	9	UNIPROT
22930	RAB3GAP1	C0014306	Enophthalmos	0.2	0	0	HPO
22930	RAB3GAP1	C0023882	Little's Disease	0.2	0	0	HPO
22930	RAB3GAP1	C0029124	Optic Atrophy	0.2	0	0	HPO
22930	RAB3GAP1	C0029456	Osteoporosis	0.2	0	0	HPO
22930	RAB3GAP1	C0040412	Fissured tongue	0.2	0	0	HPO
22930	RAB3GAP1	C0155320	Blindness, Cortical	0.2	0	0	HPO
22930	RAB3GAP1	C0235946	Cerebral atrophy	0.2	0	0	HPO
22930	RAB3GAP1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
22930	RAB3GAP1	C0796037	Martsolf syndrome	0.200549453568426	0	0	ORPHANET
22930	RAB3GAP1	C1838625	Warburg Sjo Fledelius syndrome	0.403296721410557	0	0	CTD_human;ORPHANET
22930	RAB3GAP1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
22930	RAB3GAP1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
22930	RAB3GAP1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
22930	RAB3GAP1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
22931	RAB18	C0014544	Epilepsy	0.2	0	0	HPO
22931	RAB18	C0028738	Nystagmus	0.2	0	0	HPO
22931	RAB18	C0029124	Optic Atrophy	0.2	0	0	HPO
22931	RAB18	C0155320	Blindness, Cortical	0.2	0	0	HPO
22931	RAB18	C0235946	Cerebral atrophy	0.2	0	0	HPO
22931	RAB18	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
22931	RAB18	C1838625	Warburg Sjo Fledelius syndrome	0.201373633921065	0	0	ORPHANET
22931	RAB18	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
22931	RAB18	C3280203	WARBURG MICRO SYNDROME 3	0.28	1	4	UNIPROT
22934	RPIA	C0014544	Epilepsy	0.2	0	0	HPO
22934	RPIA	C0029124	Optic Atrophy	0.2	0	0	HPO
22934	RPIA	C0152025	Polyneuropathy	0.2	0	0	HPO
22934	RPIA	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
22934	RPIA	C1291609	Ribose 5-Phosphate Isomerase Deficiency	0.6	1	2	CTD_human;ORPHANET;UNIPROT
2294	FOXF1	C0020295	Hydronephrosis	0.2	0	0	HPO
2294	FOXF1	C0024899	Mastocytosis	0.2	1	0	CTD_human
2294	FOXF1	C0031190	Persistent Fetal Circulation Syndrome	0.404120901763197	2	2	ORPHANET;UNIPROT
2294	FOXF1	C0152101	Hypoplastic Left Heart Syndrome	0.200274726784213	0	0	HPO
2294	FOXF1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
2294	FOXF1	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
22943	DKK1	C0014175	Endometriosis	0.2	1	0	CTD_human
22943	DKK1	C0029456	Osteoporosis	0.201373633921065	0	0	HPO
22943	DKK1	C0264080	Juvenile osteoporosis	0.2	0	0	ORPHANET
22943	DKK1	C0410550	Collapse of vertebra	0.2	0	0	HPO
22948	CCT5	C0020597	Hypobetalipoproteinemias	0.2	0	0	HPO
22948	CCT5	C0037772	Spastic Paraplegia	0.200549453568426	0	0	HPO
22948	CCT5	C0151718	Hypocholesterolemia	0.2	0	0	HPO
22948	CCT5	C0270921	Axonal neuropathy	0.2	0	0	HPO
22948	CCT5	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
22948	CCT5	C1389102	Atrophic spinal cord	0.2	0	0	HPO
22948	CCT5	C1848736	Distal amyotrophy	0.2	0	0	HPO
22948	CCT5	C1850395	Neuropathy, Hereditary Sensory, with Spastic Paraplegia, Autosomal Recessive	0.6	1	1	CTD_human;ORPHANET;UNIPROT
22953	P2RX2	C0014544	Epilepsy	0.2	1	0	CTD_human
22953	P2RX2	C1842371	DEAFNESS, AUTOSOMAL DOMINANT 41 (disorder)	0.2	2	2	UNIPROT
22953	P2RX2	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
22954	TRIM32	C0020619	Hypogonadism	0.2	0	0	HPO
22954	TRIM32	C0026850	Muscular Dystrophy	0.20328236603324	0	0	HPO
22954	TRIM32	C0028738	Nystagmus	0.2	0	0	HPO
22954	TRIM32	C0028754	Obesity	0.200274726784213	0	0	HPO
22954	TRIM32	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
22954	TRIM32	C0240679	Pelvic girdle muscle atrophy	0.2	0	0	HPO
22954	TRIM32	C0376175	Bell Palsy	0.2	0	0	HPO
22954	TRIM32	C0752166	Bardet-Biedl Syndrome	0.405205453522732	0	0	CTD_human;ORPHANET
22954	TRIM32	C1859569	BARDET-BIEDL SYNDROME 11	0.200549453568426	1	1	UNIPROT
22954	TRIM32	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
2296	FOXC1	C0010964	Dandy-Walker Syndrome	0.200549453568426	1	0	CTD_human
2296	FOXC1	C0015300	Exophthalmos	0.2	0	0	HPO
2296	FOXC1	C0017601	Glaucoma	0.213916842705604	0	0	HPO
2296	FOXC1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2296	FOXC1	C0028738	Nystagmus	0.2	0	0	HPO
2296	FOXC1	C0087012	Ataxia, Spinocerebellar	0.2	1	0	CTD_human
2296	FOXC1	C0265341	Rieger syndrome	0.201098907136852	0	0	ORPHANET
2296	FOXC1	C0339573	Glaucoma, Primary Open Angle	0.200549453568426	1	0	CTD_human
2296	FOXC1	C1866560	IRIDOGONIODYSGENESIS, TYPE 1 (disorder)	0.4	2	5	CTD_human;UNIPROT
2296	FOXC1	C2678503	AXENFELD-RIEGER SYNDROME, TYPE 3	0.4	12	9	CTD_human;UNIPROT
2296	FOXC1	C3714873	Axenfeld-Rieger Syndrome, Type 1	0.2	1	0	CTD_human
22976	PAXIP1	C0002395	Alzheimer's Disease	0.200549453568426	0	0	CTD_human
22978	NT5C2	C0027092	Myopia	0.2	0	0	HPO
22978	NT5C2	C0028738	Nystagmus	0.2	0	0	HPO
22978	NT5C2	C0029124	Optic Atrophy	0.2	0	0	HPO
22978	NT5C2	C0037772	Spastic Paraplegia	0.2	0	0	HPO
22978	NT5C2	C3888209	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
2299	FOXI1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2299	FOXI1	C0020676	Hypothyroidism	0.2	0	0	HPO
2299	FOXI1	C0271829	Pendred's syndrome	0.280824180352639	0	0	ORPHANET
2299	FOXI1	C0342162	Compensated hypothyroidism	0.2	0	0	HPO
2299	FOXI1	C3538946	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	0.2	0	0	CTD_human
22995	CEP152	C0010278	Craniosynostosis	0.2	0	0	HPO
22995	CEP152	C0017601	Glaucoma	0.2	0	0	HPO
22995	CEP152	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
22995	CEP152	C0265202	Seckel syndrome	0.400274726784213	1	0	CTD_human;ORPHANET
22995	CEP152	C0454455	Mirror movements disorder	0.2	0	0	HPO
22995	CEP152	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
22995	CEP152	C1858516	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE	0.2	0	0	CTD_human
22995	CEP152	C3151187	SECKEL SYNDROME 5	0.2	1	1	UNIPROT
22995	CEP152	C3553886	MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE	0.2	1	8	UNIPROT
22999	RIMS1	C0028077	Night Blindness	0.2	0	0	HPO
22999	RIMS1	C0035334	Retinitis Pigmentosa	0.404381273170092	0	0	HPO;ORPHANET
22999	RIMS1	C0042798	Low Vision	0.2	0	0	HPO
22999	RIMS1	C0730290	Cone dystrophy	0.2	0	0	HPO
22999	RIMS1	C0730330	Chloroquine retinopathy	0.2	0	0	HPO
22999	RIMS1	C1863634	Cone-Rod Dystrophy 7	0.400824180352639	1	1	CTD_human;UNIPROT
22999	RIMS1	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
23	ABCF1	C0032285	Pneumonia	0.2	1	0	CTD_human
2301	FOXE3	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
2301	FOXE3	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
2301	FOXE3	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
2301	FOXE3	C0263401	Cutis marmorata	0.2	0	0	HPO
2301	FOXE3	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
2301	FOXE3	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.2	0	0	ORPHANET
2301	FOXE3	C1853235	Sclerocornea	0.200274726784213	0	0	HPO
2301	FOXE3	C1862839	Anterior segment mesenchymal dysgenesis	0.600274726784213	2	1	CTD_human;ORPHANET;UNIPROT
2301	FOXE3	C1956346	Coronary Artery Disease	0.2	0	0	HPO
2301	FOXE3	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
2302	FOXJ1	C2607914	Allergic rhinitis (disorder)	0.200274726784213	0	0	CTD_human
23020	SNRNP200	C0017601	Glaucoma	0.2	0	0	HPO
23020	SNRNP200	C0018777	Conductive hearing loss	0.2	0	0	HPO
23020	SNRNP200	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
23020	SNRNP200	C0020459	Hyperinsulinism	0.2	0	0	HPO
23020	SNRNP200	C0020619	Hypogonadism	0.2	0	0	HPO
23020	SNRNP200	C0022578	Keratoconus	0.2	0	0	HPO
23020	SNRNP200	C0028077	Night Blindness	0.2	0	0	HPO
23020	SNRNP200	C0028738	Nystagmus	0.2	0	0	HPO
23020	SNRNP200	C0028754	Obesity	0.2	0	0	HPO
23020	SNRNP200	C0029124	Optic Atrophy	0.2	0	0	HPO
23020	SNRNP200	C0035334	Retinitis Pigmentosa	0.402197814273705	0	0	HPO;ORPHANET
23020	SNRNP200	C0042798	Low Vision	0.2	0	0	HPO
23020	SNRNP200	C0271215	Blindness, Legal	0.2	0	0	HPO
23020	SNRNP200	C1835895	RETINITIS PIGMENTOSA 33 (disorder)	0.4	5	5	CTD_human;UNIPROT
23025	UNC13A	C0002736	Amyotrophic Lateral Sclerosis	0.604055389228567	1	1	CTD_human;HPO;ORPHANET
23025	UNC13A	C0234958	muscle degeneration	0.2	0	0	HPO
23025	UNC13A	C1145670	Respiratory Failure	0.2	0	0	HPO
23025	UNC13A	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
23025	UNC13A	C4020884	Anxiety disease	0.2	0	0	HPO
23028	KDM1A	C4225229	CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.4	1	3	ORPHANET;UNIPROT
2303	FOXC2	C0009763	Conjunctivitis	0.2	0	0	HPO
2303	FOXC2	C0010043	Corneal Ulcer	0.2	0	0	HPO
2303	FOXC2	C0013592	Ectropion	0.2	0	0	HPO
2303	FOXC2	C0024236	Lymphedema	0.208451017775976	0	0	HPO
2303	FOXC2	C0042345	Varicosity	0.201098907136852	0	0	HPO
2303	FOXC2	C0155119	Recurrent erosion of cornea	0.2	0	0	HPO
2303	FOXC2	C0221348	Hereditary lymphedema and yellow nails	0.2	0	0	CTD_human
2303	FOXC2	C0238261	Lymphedema praecox	0.201098907136852	0	0	CTD_human
2303	FOXC2	C0265345	Lymphedema distichiasis syndrome	0.684120901763197	2	3	CTD_human;ORPHANET;UNIPROT
2303	FOXC2	C0392163	Corneal erosion	0.2	0	0	HPO
2304	FOXE1	C0018023	Nodular Goiter	0.2	0	0	HPO
2304	FOXE1	C1855794	Bamforth syndrome	0.680824180352639	5	2	CTD_human;ORPHANET;UNIPROT
23040	MYT1L	C0028754	Obesity	0.200549453568426	0	0	HPO
23043	TNIK	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
23046	KIF21B	C0009324	Ulcerative Colitis	0.200274726784213	1	0	CTD_human
2305	FOXM1	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
23054	NCOA6	C0014175	Endometriosis	0.2	1	0	CTD_human
23064	SETX	C0002736	Amyotrophic Lateral Sclerosis	0.205754907091158	0	0	HPO
23064	SETX	C0020455	Hypergammaglobulinemia	0.2	0	0	HPO
23064	SETX	C0152025	Polyneuropathy	0.200274726784213	0	0	HPO
23064	SETX	C0271390	Nystagmus, End-Position	0.2	0	0	HPO
23064	SETX	C1853761	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	0.610989071368524	7	17	CTD_human;ORPHANET;UNIPROT
23064	SETX	C1865409	Amyotrophic Lateral Sclerosis 4, Juvenile	0.601373633921066	4	7	CTD_human;ORPHANET;UNIPROT
23065	EMC1	C4225172	CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION	0.2	1	3	UNIPROT
23074	UHRF1BP1L	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
2308	FOXO1	C0022578	Keratoconus	0.201098907136852	1	0	CTD_human
23080	AVL9	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
23081	KDM4C	C0236663	Alcohol withdrawal syndrome	0.200274726784213	1	0	PSYGENET
23086	EXPH5	C0870082	Hyperkeratosis	0.2	0	0	HPO
23086	EXPH5	C3554367	EPIDERMOLYSIS BULLOSA, NONSPECIFIC, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
2309	FOXO3	C0024117	Chronic Obstructive Airway Disease	0.200549453568426	1	0	CTD_human
2309	FOXO3	C0028754	Obesity	0.28	1	0	CTD_human
23090	ZNF423	C0028738	Nystagmus	0.2	0	0	HPO
23090	ZNF423	C0271215	Blindness, Legal	0.2	0	0	HPO
23090	ZNF423	C0687120	Nephronophthisis	0.2	0	0	HPO
23090	ZNF423	C1855675	Arima syndrome	0.2	0	0	ORPHANET
23090	ZNF423	C3539071	NEPHRONOPHTHISIS 14	0.2	1	1	UNIPROT
23093	TTLL5	C0028077	Night Blindness	0.2	0	0	HPO
23093	TTLL5	C0035334	Retinitis Pigmentosa	0.4	0	0	HPO;ORPHANET
23093	TTLL5	C0730290	Cone dystrophy	0.2	0	0	HPO
23093	TTLL5	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
23093	TTLL5	C4014501	CONE-ROD DYSTROPHY 19	0.2	1	6	UNIPROT
23093	TTLL5	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
23095	KIF1B	C0018801	Heart failure	0.2	0	0	HPO
23095	KIF1B	C0018802	Congestive heart failure	0.2	0	0	HPO
23095	KIF1B	C0020437	Hypercalcemia	0.2	0	0	HPO
23095	KIF1B	C0026769	Multiple Sclerosis	0.201373633921065	1	1	CTD_human
23095	KIF1B	C0085684	Foot-drop	0.2	0	0	HPO
23095	KIF1B	C0152132	Hypertensive Retinopathy	0.2	0	0	HPO
23095	KIF1B	C1848736	Distal amyotrophy	0.2	0	0	HPO
23095	KIF1B	C1861678	Charcot-Marie-Tooth Disease, Axonal, Type 2a1	0.68	1	1	CTD_human;ORPHANET;UNIPROT
23095	KIF1B	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
23095	KIF1B	C4025619	Peripheral axonal atrophy	0.2	0	0	HPO
23096	IQSEC2	C0014544	Epilepsy	0.2	0	0	HPO
23096	IQSEC2	C0028754	Obesity	0.2	0	0	HPO
23096	IQSEC2	C0034013	Precocious Puberty	0.2	0	0	HPO
23096	IQSEC2	C1136249	Mental Retardation, X-Linked	0.200549453568426	1	0	CTD_human
23096	IQSEC2	C1845181	MENTAL RETARDATION, X-LINKED 78	0.2	1	0	CTD_human
23096	IQSEC2	C2749022	Chromosome Xp11.23-P11.22 Duplication Syndrome	0.2	0	0	ORPHANET
23096	IQSEC2	C2931498	Mental Retardation, X-Linked 1	0.400549453568426	2	6	CTD_human;UNIPROT
231	AKR1B1	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
231	AKR1B1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
23111	SPG20	C0037036	Sialorrhea	0.2	0	0	HPO
23111	SPG20	C0037772	Spastic Paraplegia	0.200274726784213	0	0	HPO
23111	SPG20	C0262404	Cerebellar degeneration	0.2	0	0	HPO
23111	SPG20	C0393559	Troyer syndrome	0.403296721410557	0	0	CTD_human;ORPHANET
23111	SPG20	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
23111	SPG20	C1848736	Distal amyotrophy	0.200274726784213	0	0	HPO
23111	SPG20	C4020873	Infratentorial atrophy	0.2	0	0	HPO
23112	TNRC6B	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
23118	TAB2	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
23118	TAB2	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
23118	TAB2	C0004238	Atrial Fibrillation	0.2	0	0	HPO
23118	TAB2	C0340375	Subaortic stenosis	0.2	0	0	HPO
2312	FLG	C0004096	Asthma	0.262169497242974	0	0	HPO
2312	FLG	C0011615	Dermatitis, Atopic	0.351938112356185	4	0	CTD_human
2312	FLG	C0011616	Contact Dermatitis	0.200549453568426	1	0	CTD_human
2312	FLG	C0013595	Eczema	0.492577890084944	1	0	CTD_human;HPO
2312	FLG	C0020757	Ichthyoses	0.20350593566014	0	0	HPO
2312	FLG	C1853965	Dermatitis, Atopic, 2	0.2	0	0	CTD_human
2312	FLG	C1864155	Dermatitis, Atopic, 1	0.2	0	0	CTD_human
2312	FLG	C3714497	Reactive airway disease	0.2	0	0	HPO
23126	POGZ	C0235946	Cerebral atrophy	0.2	0	0	HPO
23126	POGZ	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
23126	POGZ	C0877056	Hypoglycaemic seizure	0.2	0	0	HPO
23126	POGZ	C4020860	Supratentorial atrophy	0.2	0	0	HPO
23129	PLXND1	C0038379	Strabismus	0.2	0	0	HPO
23129	PLXND1	C0221060	Mobius Syndrome	0.20328236603324	0	0	ORPHANET
23129	PLXND1	C0376175	Bell Palsy	0.2	0	0	HPO
23129	PLXND1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
2313	FLI1	C0038379	Strabismus	0.2	0	0	HPO
2313	FLI1	C0795841	Jacobsen Distal 11q Deletion Syndrome	0.202472541057918	0	0	ORPHANET
2313	FLI1	C1861178	Thrombocytopenia Paris-Trousseau type	0.2	0	0	ORPHANET
2313	FLI1	C1956093	Paris-Trousseau Thrombocytopenia	0.200274726784213	0	0	ORPHANET
23133	PHF8	C1846055	Siderius X-linked mental retardation syndrome	0.600274726784213	1	5	CTD_human;ORPHANET;UNIPROT
2314	FLII	C0014306	Enophthalmos	0.2	0	0	HPO
2314	FLII	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
2314	FLII	C0018777	Conductive hearing loss	0.2	0	0	HPO
2314	FLII	C0020443	Hypercholesterolemia	0.2	0	0	HPO
2314	FLII	C0027092	Myopia	0.2	0	0	HPO
2314	FLII	C0028754	Obesity	0.200274726784213	0	0	HPO
2314	FLII	C0038379	Strabismus	0.2	0	0	HPO
2314	FLII	C0266039	Taurodontism	0.2	0	0	HPO
2314	FLII	C0271441	Chronic otitis media	0.2	0	0	HPO
2314	FLII	C0743359	ear infection chronic	0.2	0	0	HPO
2314	FLII	C0795864	Smith-Magenis syndrome	0.2	0	0	ORPHANET
2314	FLII	C4020884	Anxiety disease	0.2	0	0	HPO
23141	ANKLE2	C0014544	Epilepsy	0.2	0	0	HPO
23141	ANKLE2	C0017601	Glaucoma	0.2	0	0	HPO
23141	ANKLE2	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
23141	ANKLE2	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
23141	ANKLE2	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
23141	ANKLE2	C4225249	MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.2	1	1	UNIPROT
2315	MLANA	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
23152	CIC	C0087012	Ataxia, Spinocerebellar	0.2	1	0	CTD_human
2316	FLNA	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
2316	FLNA	C0014544	Epilepsy	0.401098907136852	1	0	CTD_human;HPO
2316	FLNA	C0015300	Exophthalmos	0.2	0	0	HPO
2316	FLNA	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
2316	FLNA	C0018777	Conductive hearing loss	0.2	0	0	HPO
2316	FLNA	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2316	FLNA	C0018801	Heart failure	0.2	0	0	HPO
2316	FLNA	C0018802	Congestive heart failure	0.2	0	0	HPO
2316	FLNA	C0020255	Hydrocephalus	0.200274726784213	0	0	HPO
2316	FLNA	C0020295	Hydronephrosis	0.2	0	0	HPO
2316	FLNA	C0021847	Intestinal Pseudo-Obstruction	0.403557092817453	0	0	HPO;ORPHANET
2316	FLNA	C0024636	Malocclusion	0.2	0	0	HPO
2316	FLNA	C0025237	Melnick-Needles Syndrome	0.481648360705279	3	3	ORPHANET;UNIPROT
2316	FLNA	C0026267	Mitral Valve Prolapse Syndrome	0.200274726784213	0	0	HPO
2316	FLNA	C0029464	Osteosclerosis	0.2	0	0	HPO
2316	FLNA	C0034072	Cor pulmonale	0.2	0	0	HPO
2316	FLNA	C0038018	Spondylolysis	0.2	0	0	HPO
2316	FLNA	C0038379	Strabismus	0.2	0	0	HPO
2316	FLNA	C0040961	Tricuspid Valve Insufficiency	0.2	0	0	HPO
2316	FLNA	C0040962	Tricuspid Valve Prolapse	0.2	0	0	HPO
2316	FLNA	C0220769	FG syndrome	0.200274726784213	1	0	CTD_human
2316	FLNA	C0221260	Dystrophia unguium	0.2	0	0	HPO
2316	FLNA	C0234958	muscle degeneration	0.2	0	0	HPO
2316	FLNA	C0265251	Oto-Palato-digital syndrome type 1	0.680549453568426	4	14	CTD_human;ORPHANET;UNIPROT
2316	FLNA	C0267048	Glossoptosis	0.2	0	0	HPO
2316	FLNA	C0747085	Recurrent otitis media	0.2	0	0	HPO
2316	FLNA	C0917990	Acro-Osteolysis	0.2	0	0	HPO
2316	FLNA	C1145670	Respiratory Failure	0.2	0	0	HPO
2316	FLNA	C1280433	Lipoatrophy	0.2	0	0	HPO
2316	FLNA	C1834405	Nail dysplasia	0.2	0	0	HPO
2316	FLNA	C1845902	FG SYNDROME 2	0.2	1	2	UNIPROT
2316	FLNA	C1846129	Terminal Osseous Dysplasia and Pigmentary Defects	0.400274726784213	0	0	CTD_human;ORPHANET
2316	FLNA	C1849173	Periventricular neuronal heterotopia	0.2	0	0	HPO
2316	FLNA	C1855733	Neuronal intestinal pseudoobstruction	0.2	0	0	ORPHANET
2316	FLNA	C1868720	Periventricular Nodular Heterotopia	0.490714344584311	2	0	CTD_human;ORPHANET
2316	FLNA	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
2316	FLNA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2316	FLNA	C2746068	Congenital idiopathic intestinal pseudoobstruction	0.200274726784213	0	0	CTD_human
2316	FLNA	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
2316	FLNA	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
2316	FLNA	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
23162	MAPK8IP3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
23165	NUP205	C0029401	Osteitis Deformans	0.2	1	1	CTD_human
23165	NUP205	C1868672	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	0.2	1	0	CTD_human
23165	NUP205	C4225165	NEPHROTIC SYNDROME, TYPE 13	0.2	1	1	UNIPROT
23166	STAB1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
23169	SLC35D1	C0024236	Lymphedema	0.2	0	0	HPO
23169	SLC35D1	C0432194	Schneckenbecken dysplasia	0.480549453568426	0	0	CTD_human;ORPHANET
2317	FLNB	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
2317	FLNB	C0015300	Exophthalmos	0.2	0	0	HPO
2317	FLNB	C0018777	Conductive hearing loss	0.2	0	0	HPO
2317	FLNB	C0020305	Hydrops Fetalis	0.2	0	0	HPO
2317	FLNB	C0022679	Cystic kidney	0.2	0	0	HPO
2317	FLNB	C0023075	Laryngostenosis	0.2	0	0	HPO
2317	FLNB	C0037926	Compression of spinal cord	0.2	0	0	HPO
2317	FLNB	C0038018	Spondylolysis	0.2	0	0	HPO
2317	FLNB	C0040583	Tracheal Stenosis	0.2	0	0	HPO
2317	FLNB	C0085581	Restrictive lung disease	0.2	0	0	HPO
2317	FLNB	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
2317	FLNB	C0175778	Larsen syndrome	0.201923087489492	2	14	UNIPROT
2317	FLNB	C0264112	Wedging of vertebra	0.2	0	0	HPO
2317	FLNB	C0264353	Bronchomalacia	0.2	0	0	HPO
2317	FLNB	C0432201	Boomerang dysplasia	0.600824180352639	1	2	CTD_human;ORPHANET;UNIPROT
2317	FLNB	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
2317	FLNB	C0948187	Tracheomalacia	0.2	0	0	HPO
2317	FLNB	C1838608	Radial aplasia	0.2	0	0	HPO
2317	FLNB	C1848934	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME	0.480549453568426	1	8	CTD_human;ORPHANET
2317	FLNB	C1857269	Hitchhiker thumb	0.2	0	0	HPO
2317	FLNB	C1860105	Severe short-limb dwarfism	0.2	0	0	HPO
2317	FLNB	C2931648	Larsen syndrome, dominant type	0.400274726784213	1	0	CTD_human;ORPHANET
2317	FLNB	C3668942	Atelosteogenesis Type 3	0.600274726784213	1	6	CTD_human;ORPHANET;UNIPROT
2317	FLNB	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
23171	GPD1L	C0015695	Fatty Liver	0.2	1	0	CTD_human
23171	GPD1L	C0038644	Sudden infant death syndrome	0.20328236603324	2	3	UNIPROT
23171	GPD1L	C0042510	Ventricular Fibrillation	0.2	0	0	HPO
23171	GPD1L	C0085614	First degree atrioventricular block	0.2	0	0	HPO
23171	GPD1L	C0085615	Right bundle branch block	0.2	0	0	HPO
23171	GPD1L	C1142166	Brugada Syndrome (disorder)	0.206513574909167	0	0	ORPHANET
23171	GPD1L	C2673193	Brugada Syndrome 2	0.4	3	4	CTD_human;UNIPROT
23175	LPIN1	C0022660	Kidney Failure, Acute	0.2	0	0	HPO
23175	LPIN1	C1849386	Myoglobinuria, Acute Recurrent, Autosomal Recessive	0.2	0	0	CTD_human
23178	PASK	C2931817	Chromosome 2q37 deletion syndrome	0.2	1	0	CTD_human
2318	FLNC	C0348616	Other restrictive cardiomyopathy	0.2	0	0	ORPHANET
2318	FLNC	C1836050	Filaminopathy, autosomal dominant	0.4	0	0	CTD_human;ORPHANET
2318	FLNC	C1836451	Muscle atrophy, lower limb, distal	0.2	0	0	HPO
2318	FLNC	C2678065	Myofibrillar Myopathy	0.204945082115836	0	0	HPO
2318	FLNC	C3279722	MYOPATHY, DISTAL, 4	0.4	1	2	ORPHANET;UNIPROT
2318	FLNC	C4021581	Distal upper limb amyotrophy	0.2	0	0	HPO
23189	KANK1	C0007789	Cerebral Palsy	0.200824180352639	0	0	HPO
23189	KANK1	C0235946	Cerebral atrophy	0.2	0	0	HPO
23189	KANK1	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
23189	KANK1	C2751938	Cerebral Palsy, Spastic Quadriplegic, 1	0.2	0	0	ORPHANET
23189	KANK1	C2752061	Cerebral Palsy, Spastic Quadriplegic, 2	0.2	0	0	CTD_human
23189	KANK1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
23193	GANAB	C3887964	POLYCYSTIC KIDNEY DISEASE 3, AUTOSOMAL DOMINANT	0.2	1	0	UNIPROT
23203	PMPCA	C0028738	Nystagmus	0.2	0	0	HPO
23203	PMPCA	C1859298	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2	0.4	2	4	ORPHANET;UNIPROT
23204	ARL6IP1	C0037772	Spastic Paraplegia	0.2	0	0	HPO
23204	ARL6IP1	C0151313	Sensory neuropathy	0.2	0	0	HPO
23204	ARL6IP1	C3810294	SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
23209	MLC1	C0014544	Epilepsy	0.2	0	0	HPO
2321	FLT1	C0023890	Liver Cirrhosis	0.280274726784213	1	0	CTD_human
2321	FLT1	C0041948	Uremia	0.2	1	0	CTD_human
2321	FLT1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
23216	TBC1D1	C0028754	Obesity	0.204055389228567	3	0	CTD_human
23218	NBEAL2	C0272302	Gray Platelet Syndrome	0.682197814273705	3	9	CTD_human;ORPHANET;UNIPROT
23224	SYNE2	C0004238	Atrial Fibrillation	0.200549453568426	1	1	CTD_human
23224	SYNE2	C0026850	Muscular Dystrophy	0.202732912464814	0	0	HPO
23224	SYNE2	C0410189	Muscular Dystrophy, Emery-Dreifuss	0.200824180352639	0	0	CTD_human
23224	SYNE2	C0410190	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	0.2	0	0	ORPHANET
23224	SYNE2	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
23224	SYNE2	C2751805	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT	0.2	1	1	UNIPROT
23229	ARHGEF9	C0014544	Epilepsy	0.200824180352639	0	0	HPO
23229	ARHGEF9	C0543888	Epileptic encephalopathy	0.200274726784213	0	0	HPO
23229	ARHGEF9	C1136249	Mental Retardation, X-Linked	0.200549453568426	1	0	CTD_human
23229	ARHGEF9	C1845102	Hyperekplexia and Epilepsy	0.600274726784213	2	2	CTD_human;ORPHANET;UNIPROT
23230	VPS13A	C0014544	Epilepsy	0.2	0	0	HPO
23230	VPS13A	C0037036	Sialorrhea	0.2	0	0	HPO
23230	VPS13A	C0151313	Sensory neuropathy	0.2	0	0	HPO
23230	VPS13A	C0152115	Lingual-Facial-Buccal Dyskinesia	0.200274726784213	0	0	HPO
23230	VPS13A	C0234958	muscle degeneration	0.2	0	0	HPO
23230	VPS13A	C0235946	Cerebral atrophy	0.2	0	0	HPO
23230	VPS13A	C0393576	Chorea Acanthocytosis Syndrome	0.687142896389541	2	4	CTD_human;ORPHANET;UNIPROT
23230	VPS13A	C0687751	Acanthocytosis	0.20357144819477	0	0	HPO
23230	VPS13A	C1836830	Developmental regression	0.2	0	0	HPO
23230	VPS13A	C4020858	Choreatic disease	0.2	0	0	HPO
23230	VPS13A	C4020871	Dystonic disease	0.2	0	0	HPO
23230	VPS13A	C4020884	Anxiety disease	0.2	0	0	HPO
23230	VPS13A	C4024613	Progressive distal muscular atrophy	0.2	0	0	HPO
23236	PLCB1	C0037769	West Syndrome	0.200274726784213	0	0	ORPHANET
23236	PLCB1	C0234533	Generalized seizures	0.2	0	0	HPO
23236	PLCB1	C0543888	Epileptic encephalopathy	0.200824180352639	0	0	HPO
23236	PLCB1	C3150988	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12	0.2	0	0	CTD_human
23237	ARC	C0002395	Alzheimer's Disease	0.200549453568426	1	0	CTD_human
2324	FLT4	C0024236	Lymphedema	0.219056783693705	0	0	CTD_human
2324	FLT4	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
2324	FLT4	C0455988	Hydrops Fetalis, Non-Immune	0.2	0	0	HPO
2324	FLT4	C1865871	HEMANGIOMA, CAPILLARY INFANTILE	0.4	1	1	CTD_human;UNIPROT
23245	ASTN2	C0338480	Common Migraine	0.2	1	0	CTD_human
23247	KIAA0556	C0028738	Nystagmus	0.2	0	0	HPO
23247	KIAA0556	C0431399	Familial aplasia of the vermis	0.200274726784213	0	0	ORPHANET
23247	KIAA0556	C3489733	Oculomotor apraxia	0.2	0	0	HPO
23250	ATP11A	C1800706	Idiopathic Pulmonary Fibrosis	0.4	1	0	CTD_human;ORPHANET
23256	SCFD1	C0002736	Amyotrophic Lateral Sclerosis	0.2	1	0	CTD_human
23259	DDHD2	C0037772	Spastic Paraplegia	0.2	0	0	HPO
23259	DDHD2	C0038379	Strabismus	0.2	0	0	HPO
23259	DDHD2	C3539495	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE	0.480824180352639	1	5	ORPHANET;UNIPROT
2326	FMO1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
23261	CAMTA1	C0235946	Cerebral atrophy	0.2	0	0	HPO
23261	CAMTA1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
23261	CAMTA1	C3553661	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION	0.2	0	0	ORPHANET
2327	FMO2	C0014175	Endometriosis	0.2	1	0	CTD_human
23274	CLEC16A	C0001403	Addison Disease	0.20350593566014	1	0	CTD_human
23274	CLEC16A	C0011854	Diabetes Mellitus, Insulin-Dependent	0.231422395872004	2	2	CTD_human
23274	CLEC16A	C0023892	Biliary cirrhosis	0.2	1	1	CTD_human
23274	CLEC16A	C0024141	Lupus Erythematosus, Systemic	0.202681755307501	1	3	CTD_human
23274	CLEC16A	C0026769	Multiple Sclerosis	0.243075911769273	2	3	CTD_human
23274	CLEC16A	C0162538	Immunoglobulin A deficiency (disorder)	0.202407028523288	2	0	CTD_human
2328	FMO3	C0002871	Anemia	0.2	0	0	HPO
2328	FMO3	C0342739	Trimethylaminuria	0.606868169605328	6	11	CTD_human;HPO;ORPHANET;UNIPROT
2328	FMO3	C0694550	Recurrent pneumonia	0.2	0	0	HPO
2328	FMO3	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
2328	FMO3	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
23294	ANKS1A	C1956346	Coronary Artery Disease	0.2	1	0	CTD_human
23299	BICD2	C0026847	Spinal Muscular Atrophy	0.201098907136852	0	0	HPO
23299	BICD2	C3809049	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMAL DOMINANT	0.4	3	7	ORPHANET;UNIPROT
23308	ICOSLG	C0007570	Celiac Disease	0.2	1	1	CTD_human
23308	ICOSLG	C0009324	Ulcerative Colitis	0.202681755307501	1	0	CTD_human
23312	DMXL2	C0271801	Central hypothyroidism	0.2	0	0	HPO
23312	DMXL2	C4015261	POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.2	0	0	ORPHANET
23312	DMXL2	C4020871	Dystonic disease	0.2	0	0	HPO
23314	SATB2	C0014544	Epilepsy	0.2	0	0	HPO
23314	SATB2	C1834405	Nail dysplasia	0.2	0	0	HPO
23314	SATB2	C1970095	Cleft Palate, Isolated, And Mental Retardation	0.2	0	0	CTD_human
23314	SATB2	C2676739	Chromosome 2q32-Q33 Deletion Syndrome	0.2	0	0	ORPHANET
23317	DNAJC13	C0752347	Lewy Body Disease	0.200274726784213	0	0	HPO
23317	DNAJC13	C4274355	Autosomal dominant late onset Parkinson disease	0.2	0	0	ORPHANET
2332	FMR1	C0013363	Dysautonomia	0.2	0	0	HPO
2332	FMR1	C0014306	Enophthalmos	0.2	0	0	HPO
2332	FMR1	C0014544	Epilepsy	0.201923087489492	0	0	HPO
2332	FMR1	C0015732	Fecal Incontinence	0.2	0	0	HPO
2332	FMR1	C0016667	Fragile X Syndrome	0.948716369565796	9	2	CTD_human;ORPHANET;UNIPROT
2332	FMR1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
2332	FMR1	C0018418	Gynecomastia	0.2	0	0	HPO
2332	FMR1	C0020619	Hypogonadism	0.2	0	0	HPO
2332	FMR1	C0020676	Hypothyroidism	0.200549453568426	0	0	HPO
2332	FMR1	C0025322	Premature Menopause	0.217517001655009	0	0	HPO
2332	FMR1	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
2332	FMR1	C0028738	Nystagmus	0.2	0	0	HPO
2332	FMR1	C0037199	Sinusitis	0.2	0	0	HPO
2332	FMR1	C0085215	Ovarian Failure, Premature	0.268176684715667	0	0	CTD_human
2332	FMR1	C0235946	Cerebral atrophy	0.200549453568426	0	0	HPO
2332	FMR1	C0242350	Erectile dysfunction	0.2	0	0	HPO
2332	FMR1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
2332	FMR1	C0271441	Chronic otitis media	0.2	0	0	HPO
2332	FMR1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
2332	FMR1	C0743359	ear infection chronic	0.2	0	0	HPO
2332	FMR1	C0751156	FRAXA Syndrome	0.201648360705279	0	0	ORPHANET
2332	FMR1	C1839780	FRAGILE X TREMOR/ATAXIA SYNDROME	0.523550533620623	1	0	CTD_human;ORPHANET
2332	FMR1	C1849173	Periventricular neuronal heterotopia	0.2	0	0	HPO
2332	FMR1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2332	FMR1	C2749127	Primary Ovarian Insufficiency, Fragile X-Associated	0.200274726784213	1	0	CTD_human
2332	FMR1	C3275521	CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.2	0	0	ORPHANET
2332	FMR1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
2332	FMR1	C4020884	Anxiety disease	0.2	0	0	HPO
23321	TRIM2	C0029408	Degenerative polyarthritis	0.200274726784213	1	0	CTD_human
23321	TRIM2	C0042928	Vocal Cord Paralysis	0.2	0	0	HPO
23321	TRIM2	C0270921	Axonal neuropathy	0.200274726784213	0	0	HPO
23321	TRIM2	C0948187	Tracheomalacia	0.2	0	0	HPO
23321	TRIM2	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
23321	TRIM2	C3809655	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R	0.4	1	3	ORPHANET;UNIPROT
23322	RPGRIP1L	C0020541	Hypertension, Portal	0.2	0	0	HPO
23322	RPGRIP1L	C0023890	Liver Cirrhosis	0.2	0	0	HPO
23322	RPGRIP1L	C0028738	Nystagmus	0.2	0	0	HPO
23322	RPGRIP1L	C0029124	Optic Atrophy	0.2	0	0	HPO
23322	RPGRIP1L	C0035078	Kidney Failure	0.2	0	0	HPO
23322	RPGRIP1L	C0042798	Low Vision	0.2	0	0	HPO
23322	RPGRIP1L	C0155299	Coloboma of optic disc	0.2	0	0	HPO
23322	RPGRIP1L	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
23322	RPGRIP1L	C0239946	Fibrosis, Liver	0.2	0	0	HPO
23322	RPGRIP1L	C0265215	Meckel-Gruber syndrome	0.200549453568426	0	0	ORPHANET
23322	RPGRIP1L	C0267818	Bile duct proliferation	0.2	0	0	HPO
23322	RPGRIP1L	C0687120	Nephronophthisis	0.200824180352639	0	0	HPO
23322	RPGRIP1L	C1565489	Renal Insufficiency	0.2	0	0	HPO
23322	RPGRIP1L	C1846790	JOUBERT SYNDROME 4 (disorder)	0.2	0	0	ORPHANET
23322	RPGRIP1L	C1853235	Sclerocornea	0.2	0	0	HPO
23322	RPGRIP1L	C1857662	COACH syndrome	0.600274726784213	1	2	CTD_human;ORPHANET;UNIPROT
23322	RPGRIP1L	C1969052	MECKEL SYNDROME, TYPE 5	0.48	1	7	CTD_human;UNIPROT
23322	RPGRIP1L	C1969053	JOUBERT SYNDROME 7	0.48	5	21	CTD_human;UNIPROT
23322	RPGRIP1L	C3489733	Oculomotor apraxia	0.2	0	0	HPO
23322	RPGRIP1L	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
23322	RPGRIP1L	C4020790	Medullary sponge kidney disease	0.2	0	0	HPO
23322	RPGRIP1L	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
23322	RPGRIP1L	C4024644	Multiple small medullary renal cysts	0.2	0	0	HPO
23325	WASHC4	C4014386	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43	0.2	1	1	UNIPROT
23327	NEDD4L	C0014175	Endometriosis	0.2	1	0	CTD_human
23327	NEDD4L	C1868720	Periventricular Nodular Heterotopia	0.4	1	0	CTD_human;ORPHANET
23328	SASH1	C3492944	Lentiginosis Profusa	0.2	0	0	ORPHANET
23334	SZT2	C0014553	Absence Epilepsy	0.2	0	0	HPO
23334	SZT2	C0543888	Epileptic encephalopathy	0.200549453568426	0	0	HPO
23334	SZT2	C3809624	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.2	0	0	ORPHANET
2334	AFF2	C0016667	Fragile X Syndrome	0.20350593566014	0	0	CTD_human
2334	AFF2	C0751157	FRAXE Syndrome	0.201098907136852	0	0	ORPHANET
23345	SYNE1	C0026850	Muscular Dystrophy	0.202732912464814	0	0	HPO
23345	SYNE1	C0028738	Nystagmus	0.2	0	0	HPO
23345	SYNE1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
23345	SYNE1	C0410189	Muscular Dystrophy, Emery-Dreifuss	0.201373633921065	0	0	CTD_human
23345	SYNE1	C0410190	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	0.2	0	0	ORPHANET
23345	SYNE1	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
23345	SYNE1	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
23345	SYNE1	C1853116	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8 (disorder)	0.4	0	0	CTD_human;ORPHANET
23345	SYNE1	C2751807	Emery-Dreifuss Muscular Dystrophy 4	0.28	1	9	UNIPROT
23345	SYNE1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
23347	SMCHD1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
23347	SMCHD1	C0020619	Hypogonadism	0.2	0	0	HPO
23347	SMCHD1	C0085684	Foot-drop	0.2	0	0	HPO
23347	SMCHD1	C0234958	muscle degeneration	0.2	0	0	HPO
23347	SMCHD1	C0376175	Bell Palsy	0.2	0	0	HPO
23347	SMCHD1	C0410192	Muscular Dystrophy, Scapulohumeral	0.2	0	0	HPO
23347	SMCHD1	C1834671	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B	0.401098907136852	1	10	CTD_human;UNIPROT
2335	FN1	C0003504	Aortic Valve Insufficiency	0.200274726784213	1	0	CTD_human
2335	FN1	C0010346	Crohn Disease	0.203557092817453	1	0	CTD_human
2335	FN1	C0011881	Diabetic Nephropathy	0.283296721410557	1	0	CTD_human
2335	FN1	C0017668	Focal glomerulosclerosis	0.2	1	0	CTD_human
2335	FN1	C0034069	Pulmonary Fibrosis	0.201373633921065	1	0	CTD_human
2335	FN1	C0035078	Kidney Failure	0.2	0	0	HPO
2335	FN1	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
2335	FN1	C0239981	Hypoalbuminemia	0.2	0	0	HPO
2335	FN1	C0403557	Glomerulopathy with Giant Fibrillar Deposits	0.2	0	0	ORPHANET
2335	FN1	C1565489	Renal Insufficiency	0.2	0	0	HPO
2335	FN1	C1866075	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2 (disorder)	0.2	1	5	UNIPROT
2335	FN1	C2316810	Chronic kidney disease stage 5	0.200274726784213	0	0	HPO
2335	FN1	C3888104	Glomerulopathy with fibronectin deposits	0.200824180352639	0	0	CTD_human
2335	FN1	C4025275	Generalized distal tubular acidosis	0.2	0	0	HPO
23363	OBSL1	C1848862	Miller-McKusick-Malvaux-Syndrome (3M Syndrome)	0.202747267842131	0	0	ORPHANET
23363	OBSL1	C1851996	Dwarfism tall vertebrae	0.2	0	0	ORPHANET
23363	OBSL1	C2752041	Three M Syndrome 2	0.200274726784213	0	0	CTD_human
23384	SPECC1L	C0018777	Conductive hearing loss	0.2	0	0	HPO
23384	SPECC1L	C0038379	Strabismus	0.2	0	0	HPO
23384	SPECC1L	C0235946	Cerebral atrophy	0.2	0	0	HPO
23384	SPECC1L	C1801950	Opitz-G syndrome, type 2	0.400274726784213	1	2	ORPHANET;UNIPROT
23384	SPECC1L	C1838348	Oculomaxillofacial dysostosis	0.400549453568426	1	1	ORPHANET;UNIPROT
23384	SPECC1L	C1840378	Brachycephalofrontonasal dysplasia	0.200274726784213	0	0	ORPHANET
23384	SPECC1L	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
23384	SPECC1L	C3150792	MACROSTOMIA, ISOLATED	0.2	0	0	ORPHANET
23384	SPECC1L	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
23384	SPECC1L	C3489393	Hiatal Hernia	0.2	0	0	HPO
23385	NCSTN	C0002395	Alzheimer's Disease	0.226384769198527	1	0	CTD_human
23385	NCSTN	C0162836	Hidradenitis Suppurativa	0.201098907136852	0	0	HPO
23385	NCSTN	C1840560	Hidradenitis suppurativa, familial	0.400274726784213	2	1	CTD_human;UNIPROT
23389	MED13L	C1837341	Transposition of the Great Arteries, Dextro-Looped 1	0.4	1	4	CTD_human;UNIPROT
23389	MED13L	C4225208	MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.2	0	0	ORPHANET
23394	ADNP	C0015923	Fetal Alcohol Syndrome	0.2	1	0	PSYGENET
23394	ADNP	C0020490	Hyperopia	0.2	0	0	HPO
23394	ADNP	C0028754	Obesity	0.2	0	0	HPO
23394	ADNP	C0038379	Strabismus	0.2	0	0	HPO
23394	ADNP	C0042798	Low Vision	0.2	0	0	HPO
23394	ADNP	C1542327	Fetus or newborn affected by alcohol transmitted via placenta or breast milk	0.2	1	0	PSYGENET
23394	ADNP	C4014538	HELSMOORTEL-VAN DER AA SYNDROME	0.2	0	0	ORPHANET
23395	LARS2	C0025322	Premature Menopause	0.200274726784213	0	0	HPO
23395	LARS2	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
23395	LARS2	C3809105	PERRAULT SYNDROME 4	0.2	2	5	UNIPROT
23396	PIP5K1C	C0003886	Arthrogryposis	0.2	0	0	HPO
23396	PIP5K1C	C0234958	muscle degeneration	0.2	0	0	HPO
23396	PIP5K1C	C1969655	LETHAL CONGENITAL CONTRACTURAL SYNDROME 3	0.6	1	1	CTD_human;ORPHANET;UNIPROT
23400	ATP13A2	C0027877	Neuronal Ceroid-Lipofuscinoses	0.201098907136852	2	0	CTD_human
23400	ATP13A2	C0030567	Parkinson Disease	0.241833302917467	2	0	CTD_human
23400	ATP13A2	C0030569	Secondary Parkinson Disease	0.2	1	0	CTD_human
23400	ATP13A2	C0085623	Akinesia	0.2	0	0	HPO
23400	ATP13A2	C0234517	Anarthria speech disorder	0.2	0	0	HPO
23400	ATP13A2	C1847640	KUFOR-RAKEB SYNDROME	0.68796707674218	8	10	CTD_human;ORPHANET;UNIPROT
23405	DICER1	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
23405	DICER1	C0028960	Oligospermia	0.2	1	0	CTD_human
23405	DICER1	C0302859	Euthyroid Goiter	0.400274726784213	1	1	ORPHANET;UNIPROT
23405	DICER1	C0342208	Multinodular goiter	0.202472541057918	0	0	HPO
23405	DICER1	C1846034	Euthyroid multinodular goiter	0.2	0	0	HPO
23410	SIRT3	C0028754	Obesity	0.280549453568426	1	0	CTD_human
23411	SIRT1	C0004153	Atherosclerosis	0.286579087443797	1	0	CTD_human
23411	SIRT1	C0009319	Colitis	0.200549453568426	3	0	CTD_human
23411	SIRT1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.292440894469913	1	0	CTD_human
23411	SIRT1	C0011884	Diabetic Retinopathy	0.200549453568426	1	0	CTD_human
23411	SIRT1	C0015695	Fatty Liver	0.201923087489492	5	0	CTD_human
23411	SIRT1	C0018801	Heart failure	0.201098907136852	1	0	CTD_human
23411	SIRT1	C0028754	Obesity	0.29573761588047	1	0	CTD_human
23411	SIRT1	C0032285	Pneumonia	0.200549453568426	1	0	CTD_human
23411	SIRT1	C0036421	Systemic Scleroderma	0.200274726784213	1	0	CTD_human
23411	SIRT1	C0155862	Streptococcal pneumonia	0.2	1	0	CTD_human
23411	SIRT1	C0400966	Non-alcoholic Fatty Liver Disease	0.281648360705279	1	0	CTD_human
23411	SIRT1	C0524620	Metabolic Syndrome X	0.284604842796993	1	0	CTD_human
23411	SIRT1	C0751955	Brain Infarction	0.2	1	0	CTD_human
23411	SIRT1	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	0.2	1	0	CTD_human
23414	ZFPM2	C0004509	Azoospermia	0.2	0	0	HPO
23414	ZFPM2	C0015300	Exophthalmos	0.2	0	0	HPO
23414	ZFPM2	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
23414	ZFPM2	C0018418	Gynecomastia	0.2	0	0	HPO
23414	ZFPM2	C0029456	Osteoporosis	0.2	0	0	HPO
23414	ZFPM2	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
23414	ZFPM2	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
23414	ZFPM2	C0266427	Testicular regression syndrome	0.2	0	0	HPO
23414	ZFPM2	C0948896	Primary hypogonadism	0.2	0	0	HPO
23414	ZFPM2	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	0.2	1	2	UNIPROT
23414	ZFPM2	C4015129	46,XY SEX REVERSAL 9	0.2	2	3	UNIPROT
23417	MLYCD	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
23417	MLYCD	C0014544	Epilepsy	0.2	0	0	HPO
23417	MLYCD	C0020615	Hypoglycemia	0.2	0	0	HPO
23417	MLYCD	C0022638	Ketosis	0.2	0	0	HPO
23417	MLYCD	C0342793	Malonic aciduria	0.401923087489492	0	0	CTD_human;ORPHANET
23418	CRB1	C0014544	Epilepsy	0.2	0	0	HPO
23418	CRB1	C0014877	Esotropia	0.2	0	0	HPO
23418	CRB1	C0017601	Glaucoma	0.2	0	0	HPO
23418	CRB1	C0018777	Conductive hearing loss	0.2	0	0	HPO
23418	CRB1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
23418	CRB1	C0020459	Hyperinsulinism	0.2	0	0	HPO
23418	CRB1	C0020490	Hyperopia	0.20328236603324	0	0	HPO
23418	CRB1	C0020619	Hypogonadism	0.2	0	0	HPO
23418	CRB1	C0022578	Keratoconus	0.200549453568426	0	0	HPO
23418	CRB1	C0028738	Nystagmus	0.2	0	0	HPO
23418	CRB1	C0028754	Obesity	0.202407028523288	0	0	HPO
23418	CRB1	C0029124	Optic Atrophy	0.2	0	0	HPO
23418	CRB1	C0035305	Retinal Detachment	0.2	1	0	CTD_human
23418	CRB1	C0035334	Retinitis Pigmentosa	0.610634476672364	3	2	CTD_human;HPO;ORPHANET
23418	CRB1	C0042798	Low Vision	0.200549453568426	0	0	HPO
23418	CRB1	C0271215	Blindness, Legal	0.2	0	0	HPO
23418	CRB1	C0271388	Pendular Nystagmus	0.2	0	0	HPO
23418	CRB1	C0339527	Leber Congenital Amaurosis	0.410099378481255	1	1	CTD_human;ORPHANET
23418	CRB1	C0344290	Vitreoretinal degeneration	0.2	0	0	HPO
23418	CRB1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
23418	CRB1	C1301509	Severe visual impairment	0.2	0	0	HPO
23418	CRB1	C1838647	RETINITIS PIGMENTOSA 12 (disorder)	0.481098907136852	21	28	CTD_human;UNIPROT
23418	CRB1	C1868310	Pigmented Paravenous Chorioretinal Atrophy	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
23418	CRB1	C3151202	LEBER CONGENITAL AMAUROSIS 8	0.28	19	29	UNIPROT
23418	CRB1	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
23418	CRB1	C4072868	Paravenous chorioretinal atrophy	0.2	0	0	HPO
23421	ITGB3BP	C0014175	Endometriosis	0.2	1	0	CTD_human
23424	TDRD7	C0017601	Glaucoma	0.200274726784213	1	0	CTD_human
23424	TDRD7	C0021400	Influenza	0.2	1	0	CTD_human
23426	GRIP1	C0018777	Conductive hearing loss	0.2	0	0	HPO
23426	GRIP1	C0020255	Hydrocephalus	0.2	0	0	HPO
23426	GRIP1	C0023075	Laryngostenosis	0.2	0	0	HPO
23426	GRIP1	C0024636	Malocclusion	0.2	0	0	HPO
23426	GRIP1	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
23426	GRIP1	C0265233	Cryptophthalmos syndrome	0.281098907136852	0	0	ORPHANET
23426	GRIP1	C0271215	Blindness, Legal	0.2	0	0	HPO
23426	GRIP1	C0281890	Laryngeal web	0.2	0	0	HPO
23426	GRIP1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
23426	GRIP1	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
23426	GRIP1	C1857079	Atretic auditory canal	0.2	0	0	HPO
23426	GRIP1	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
23426	GRIP1	C4025208	Severe T-cell immunodeficiency	0.2	0	0	HPO
23426	GRIP1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
23428	SLC7A8	C0014175	Endometriosis	0.2	1	0	CTD_human
23431	AP4E1	C0014544	Epilepsy	0.2	0	0	HPO
23431	AP4E1	C0028738	Nystagmus	0.2	0	0	HPO
23431	AP4E1	C0037036	Sialorrhea	0.2	0	0	HPO
23431	AP4E1	C0037772	Spastic Paraplegia	0.2	0	0	HPO
23431	AP4E1	C0235946	Cerebral atrophy	0.2	0	0	HPO
23431	AP4E1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
23431	AP4E1	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
23431	AP4E1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
23431	AP4E1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
23431	AP4E1	C3489627	Stuttering, Familial Persistent 1	0.2	1	2	UNIPROT
23431	AP4E1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
23432	GPR161	C0020615	Hypoglycemia	0.2	0	0	HPO
23432	GPR161	C0020676	Hypothyroidism	0.2	0	0	HPO
23432	GPR161	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
23432	GPR161	C4053775	Pituitary stalk interruption syndrome	0.400274726784213	0	0	HPO;ORPHANET
23435	TARDBP	C0002736	Amyotrophic Lateral Sclerosis	0.74024991515851	6	0	CTD_human;HPO;ORPHANET
23435	TARDBP	C0234958	muscle degeneration	0.200274726784213	0	0	HPO
23435	TARDBP	C1145670	Respiratory Failure	0.200274726784213	0	0	HPO
23435	TARDBP	C2677565	AMYOTROPHIC LATERAL SCLEROSIS 10 (disorder)	0.28	9	25	UNIPROT
23435	TARDBP	C3502417	Amyotrophic Lateral Sclerosis 10	0.2	0	0	CTD_human
23435	TARDBP	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
23435	TARDBP	C4020884	Anxiety disease	0.2	0	0	HPO
23436	CELA3B	C0267963	Exocrine pancreatic insufficiency	0.200824180352639	1	0	CTD_human
23438	HARS2	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
23438	HARS2	C3554105	PERRAULT SYNDROME 2	0.2	1	2	UNIPROT
23443	SLC35A3	C0003886	Arthrogryposis	0.200274726784213	0	0	HPO
23443	SLC35A3	C0014544	Epilepsy	0.2	0	0	HPO
23443	SLC35A3	C3809910	ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.2	0	0	ORPHANET
23451	SF3B1	C0035305	Retinal Detachment	0.2	0	0	HPO
23459	CMD1H	C2931157	Idiopathic dilation cardiomyopathy	0.2	0	0	CTD_human
23460	ABCA6	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
23461	ABCA5	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
23461	ABCA5	C0399440	Hereditary gingival fibromatosis	0.2	0	0	HPO
23461	ABCA5	C1851120	Hypertrichosis Terminalis, Generalized, with or without Gingival Hyperplasia	0.2	0	0	ORPHANET
23474	ETHE1	C0014544	Epilepsy	0.2	0	0	HPO
23474	ETHE1	C0031256	Petechiae	0.2	0	0	HPO
23474	ETHE1	C0401151	Chronic diarrhea	0.200274726784213	0	0	HPO
23474	ETHE1	C1836830	Developmental regression	0.2	0	0	HPO
23474	ETHE1	C1865349	Ethylmalonic encephalopathy	0.68439562854741	2	7	CTD_human;ORPHANET;UNIPROT
23474	ETHE1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
23476	BRD4	C0002170	Alopecia	0.2	1	0	CTD_human
23479	ISCU	C0002896	Sideroblastic anemia	0.200274726784213	0	0	HPO
23479	ISCU	C1850718	MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.400549453568426	0	0	CTD_human;ORPHANET
23479	ISCU	C4020801	Respiratory complex II deficiency	0.2	0	0	HPO
2348	FOLR1	C0014544	Epilepsy	0.4	1	0	CTD_human;HPO
2348	FOLR1	C1836830	Developmental regression	0.200274726784213	0	0	HPO
2348	FOLR1	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
23483	TGDS	C0014544	Epilepsy	0.2	0	0	HPO
23483	TGDS	C0267048	Glossoptosis	0.2	0	0	HPO
23483	TGDS	C0271441	Chronic otitis media	0.2	0	0	HPO
23483	TGDS	C0743359	ear infection chronic	0.2	0	0	HPO
23483	TGDS	C1844887	Catel Manzke syndrome	0.400274726784213	1	6	ORPHANET;UNIPROT
23483	TGDS	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
23491	CES3	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
23491	CES3	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
23493	HEY2	C0007194	Hypertrophic Cardiomyopathy	0.2	1	0	CTD_human
23493	HEY2	C1142166	Brugada Syndrome (disorder)	0.200824180352639	1	0	CTD_human
23495	TNFRSF13B	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
23495	TNFRSF13B	C0006267	Bronchiectasis	0.200274726784213	0	0	HPO
23495	TNFRSF13B	C0009447	Common Variable Immunodeficiency	0.431823562105144	0	0	CTD_human;ORPHANET
23495	TNFRSF13B	C0009763	Conjunctivitis	0.2	0	0	HPO
23495	TNFRSF13B	C0024312	Lymphopenia	0.2	0	0	HPO
23495	TNFRSF13B	C0025289	Meningitis	0.2	0	0	HPO
23495	TNFRSF13B	C0032285	Pneumonia	0.2	0	0	HPO
23495	TNFRSF13B	C0034150	Purpura	0.2	0	0	HPO
23495	TNFRSF13B	C0086438	Hypogammaglobulinemia	0.201098907136852	0	0	HPO
23495	TNFRSF13B	C0162538	Immunoglobulin A deficiency (disorder)	0.211979399838795	0	0	HPO
23495	TNFRSF13B	C0162539	IgG Deficiency	0.2	0	0	HPO
23495	TNFRSF13B	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
23495	TNFRSF13B	C0271441	Chronic otitis media	0.2	0	0	HPO
23495	TNFRSF13B	C0398650	Immune thrombocytopenic purpura	0.200274726784213	0	0	HPO
23495	TNFRSF13B	C0581354	Recurrent sinusitis	0.2	0	0	HPO
23495	TNFRSF13B	C0694550	Recurrent pneumonia	0.2	0	0	HPO
23495	TNFRSF13B	C0741796	Recurrent bronchitis	0.2	0	0	HPO
23495	TNFRSF13B	C0743359	ear infection chronic	0.2	0	0	HPO
23495	TNFRSF13B	C0747085	Recurrent otitis media	0.2	0	0	HPO
23495	TNFRSF13B	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
23495	TNFRSF13B	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
23495	TNFRSF13B	C1836032	Immunoglobulin a deficiency 2	0.4	0	0	CTD_human;UNIPROT
23495	TNFRSF13B	C3150354	IMMUNODEFICIENCY, COMMON VARIABLE, 2	0.2	1	6	UNIPROT
23495	TNFRSF13B	C4082764	Gastrointestinal infection	0.200274726784213	0	0	HPO
23495	TNFRSF13B	C4280333	Recurrent sinus disease	0.2	0	0	HPO
23503	ZFYVE26	C0015732	Fecal Incontinence	0.2	0	0	HPO
23503	ZFYVE26	C0024437	Macular degeneration	0.2	0	0	HPO
23503	ZFYVE26	C0037772	Spastic Paraplegia	0.201373633921065	0	0	HPO
23503	ZFYVE26	C0042798	Low Vision	0.2	0	0	HPO
23503	ZFYVE26	C0085606	Urgency of micturition	0.2	0	0	HPO
23503	ZFYVE26	C1848736	Distal amyotrophy	0.200274726784213	0	0	HPO
23503	ZFYVE26	C1849128	Spastic paraplegia 15, autosomal recessive	0.481098907136852	0	0	CTD_human;ORPHANET
23503	ZFYVE26	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
23503	ZFYVE26	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
23509	POFUT1	C0334013	Phrynoderma	0.2	0	0	HPO
23509	POFUT1	C3714534	dowling-degos disease	0.200824180352639	0	0	ORPHANET
23522	KAT6B	C0003886	Arthrogryposis	0.2	0	0	HPO
23522	KAT6B	C0014544	Epilepsy	0.2	0	0	HPO
23522	KAT6B	C0015300	Exophthalmos	0.2	0	0	HPO
23522	KAT6B	C0020295	Hydronephrosis	0.2	0	0	HPO
23522	KAT6B	C0028326	Noonan Syndrome	0.200274726784213	0	0	ORPHANET
23522	KAT6B	C0038379	Strabismus	0.2	0	0	HPO
23522	KAT6B	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
23522	KAT6B	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
23522	KAT6B	C1849173	Periventricular neuronal heterotopia	0.2	0	0	HPO
23522	KAT6B	C1853566	Genitopatellar Syndrome	0.202197814273705	0	0	ORPHANET
23522	KAT6B	C1863557	Young Simpson syndrome	0.201098907136852	0	0	ORPHANET
23522	KAT6B	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
23522	KAT6B	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
23522	KAT6B	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
23529	CLCF1	C0020620	Hypohidrosis	0.2	0	0	HPO
23529	CLCF1	C0024591	Malignant hyperpyrexia due to anesthesia	0.2	0	0	HPO
23529	CLCF1	C0376175	Bell Palsy	0.2	0	0	HPO
23529	CLCF1	C0749379	Thoracolumbar scoliosis	0.2	0	0	HPO
23529	CLCF1	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
23529	CLCF1	C1832409	Crisponi syndrome	0.200274726784213	0	0	ORPHANET
23529	CLCF1	C1848947	COLD-INDUCED SWEATING SYNDROME 1	0.2	0	0	ORPHANET
23529	CLCF1	C1853198	COLD-INDUCED SWEATING SYNDROME 2	0.2	1	4	UNIPROT
2353	FOS	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
2353	FOS	C0001206	Acromegaly	0.2	0	0	HPO
2353	FOS	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
2353	FOS	C0011859	Lipoatrophic Diabetes Mellitus	0.2	0	0	ORPHANET
2353	FOS	C0014175	Endometriosis	0.203007639249027	1	0	CTD_human
2353	FOS	C0014544	Epilepsy	0.2	1	0	CTD_human
2353	FOS	C0016063	Osteitis Fibrosa Disseminata	0.2	1	0	CTD_human
2353	FOS	C0020459	Hyperinsulinism	0.2	0	0	HPO
2353	FOS	C0034013	Precocious Puberty	0.2	0	0	HPO
2353	FOS	C0038220	Status Epilepticus	0.2	4	0	CTD_human
2353	FOS	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
2353	FOS	C0085605	Liver Failure	0.2	0	0	HPO
2353	FOS	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
2353	FOS	C1280433	Lipoatrophy	0.2	0	0	HPO
2353	FOS	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
2353	FOS	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
23530	NNT	C0020615	Hypoglycemia	0.2	0	0	HPO
23530	NNT	C1859974	GLUCOCORTICOID DEFICIENCY 1	0.2	0	0	ORPHANET
23530	NNT	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
23530	NNT	C3553587	GLUCOCORTICOID DEFICIENCY 4	0.2	1	13	UNIPROT
23533	PIK3R5	C0028738	Nystagmus	0.2	0	0	HPO
23533	PIK3R5	C0262404	Cerebellar degeneration	0.2	0	0	HPO
23533	PIK3R5	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
23533	PIK3R5	C1853761	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	0.2	0	0	ORPHANET
23533	PIK3R5	C3489733	Oculomotor apraxia	0.200274726784213	0	0	HPO
23533	PIK3R5	C3554690	ATAXIA-OCULOMOTOR APRAXIA 3	0.2	1	1	UNIPROT
23533	PIK3R5	C4020873	Infratentorial atrophy	0.2	0	0	HPO
23534	TNPO3	C0008312	Primary biliary cirrhosis	0.400824180352639	0	0	HPO;ORPHANET
23534	TNPO3	C0020541	Hypertension, Portal	0.2	0	0	HPO
23534	TNPO3	C0023890	Liver Cirrhosis	0.2	0	0	HPO
23534	TNPO3	C0023892	Biliary cirrhosis	0.202407028523288	0	0	HPO
23534	TNPO3	C0040261	Onychomycosis	0.2	0	0	HPO
23534	TNPO3	C0085605	Liver Failure	0.2	0	0	HPO
23534	TNPO3	C0239946	Fibrosis, Liver	0.2	0	0	HPO
23534	TNPO3	C0268307	Conjugated hyperbilirubinemia	0.2	0	0	HPO
23534	TNPO3	C0343065	Symptomatic dermographism	0.2	0	0	HPO
23534	TNPO3	C0859942	Hanot's cirrhosis	0.2	0	0	ORPHANET
23534	TNPO3	C1842062	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1F	0.4	1	2	ORPHANET;UNIPROT
23539	SLC16A8	C0242383	Age related macular degeneration	0.2	1	1	CTD_human
2354	FOSB	C0013386	Dyskinesia, Drug-Induced	0.2	1	0	CTD_human
2354	FOSB	C0014544	Epilepsy	0.2	1	0	CTD_human
2354	FOSB	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
23545	ATP6V0A2	C0010495	Cutis Laxa	0.204381273170092	0	0	HPO
23545	ATP6V0A2	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
23545	ATP6V0A2	C0011334	Dental caries	0.2	0	0	HPO
23545	ATP6V0A2	C0014544	Epilepsy	0.200274726784213	0	0	HPO
23545	ATP6V0A2	C0023787	Lipodystrophy	0.2	0	0	HPO
23545	ATP6V0A2	C0027092	Myopia	0.2	0	0	HPO
23545	ATP6V0A2	C0029453	Osteopenia	0.2	0	0	HPO
23545	ATP6V0A2	C0038379	Strabismus	0.2	0	0	HPO
23545	ATP6V0A2	C0268355	Cutis Laxa, Autosomal Recessive, Type IIA	0.4	0	0	CTD_human;ORPHANET
23545	ATP6V0A2	C0406587	Wrinkly skin syndrome	0.400824180352639	1	1	CTD_human;ORPHANET
23545	ATP6V0A2	C0521533	Atrial septal aneurysm	0.2	0	0	HPO
23545	ATP6V0A2	C0747078	Generalized osteopenia	0.2	0	0	HPO
23545	ATP6V0A2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
23545	ATP6V0A2	C2930812	Generalized elastolysis	0.2	0	0	HPO
2355	FOSL2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
23554	TSPAN12	C1851402	Exudative vitreoretinopathy 1	0.200274726784213	0	0	ORPHANET
23554	TSPAN12	C2750079	Exudative Vitreoretinopathy 5	0.48	3	12	CTD_human;UNIPROT
23554	TSPAN12	C4072980	Exudative vitreoretinopathy	0.2	0	0	HPO
23556	PIGN	C0014544	Epilepsy	0.200824180352639	0	0	HPO
23556	PIGN	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
23556	PIGN	C0020295	Hydronephrosis	0.2	0	0	HPO
23556	PIGN	C0028738	Nystagmus	0.2	0	0	HPO
23556	PIGN	C0085583	Choreoathetosis	0.2	0	0	HPO
23556	PIGN	C0220730	Fryns syndrome	0.2	0	0	ORPHANET
23556	PIGN	C0235946	Cerebral atrophy	0.2	0	0	HPO
23556	PIGN	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
23556	PIGN	C3279775	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1	0.400549453568426	1	10	ORPHANET;UNIPROT
23556	PIGN	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
2356	FPGS	C0003873	Rheumatoid Arthritis	0.20777053913829	1	0	CTD_human
23562	CLDN14	C0022650	Kidney Calculi	0.201098907136852	1	2	CTD_human
23562	CLDN14	C3279660	DEAFNESS, AUTOSOMAL RECESSIVE 29	0.28	2	6	UNIPROT
23564	DDAH2	C1956346	Coronary Artery Disease	0.202956482091714	1	0	CTD_human
23568	ARL2BP	C0017601	Glaucoma	0.2	0	0	HPO
23568	ARL2BP	C0018777	Conductive hearing loss	0.2	0	0	HPO
23568	ARL2BP	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
23568	ARL2BP	C0020459	Hyperinsulinism	0.2	0	0	HPO
23568	ARL2BP	C0020619	Hypogonadism	0.2	0	0	HPO
23568	ARL2BP	C0022578	Keratoconus	0.2	0	0	HPO
23568	ARL2BP	C0028738	Nystagmus	0.2	0	0	HPO
23568	ARL2BP	C0028754	Obesity	0.2	0	0	HPO
23568	ARL2BP	C0029124	Optic Atrophy	0.2	0	0	HPO
23568	ARL2BP	C0035334	Retinitis Pigmentosa	0.400274726784213	0	0	HPO;ORPHANET
23568	ARL2BP	C0271215	Blindness, Legal	0.2	0	0	HPO
23568	ARL2BP	C3809503	RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.2	1	2	UNIPROT
23569	PADI4	C0003873	Rheumatoid Arthritis	0.297722564635159	1	2	CTD_human
2358	FPR2	C0010346	Crohn Disease	0.200274726784213	1	0	CTD_human
23586	DDX58	C0017601	Glaucoma	0.200274726784213	0	0	HPO
23586	DDX58	C0019196	Hepatitis C	0.206253203502271	1	0	CTD_human
23586	DDX58	C0021400	Influenza	0.209875808854354	1	0	CTD_human
23586	DDX58	C0033860	Psoriasis	0.200549453568426	1	1	CTD_human
23586	DDX58	C0870082	Hyperkeratosis	0.2	0	0	HPO
23586	DDX58	C4225380	SINGLETON-MERTEN SYNDROME 2	0.2	1	2	UNIPROT
23586	DDX58	C4225427	SINGLETON-MERTEN SYNDROME 1	0.2	0	0	ORPHANET
23590	PDSS1	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
23590	PDSS1	C0028754	Obesity	0.2	0	0	HPO
23590	PDSS1	C0029124	Optic Atrophy	0.2	0	0	HPO
23590	PDSS1	C0263401	Cutis marmorata	0.2	0	0	HPO
23590	PDSS1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
23590	PDSS1	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
23590	PDSS1	C3551954	COENZYME Q10 DEFICIENCY, PRIMARY, 1	0.2	0	0	CTD_human
23590	PDSS1	C3553354	COENZYME Q10 DEFICIENCY, PRIMARY, 2	0.4	1	1	ORPHANET;UNIPROT
23592	LEMD3	C0011644	Scleroderma	0.2	0	0	HPO
23592	LEMD3	C0020492	Hyperostosis	0.2	0	0	HPO
23592	LEMD3	C0025239	Melorheostosis	0.206839458850693	0	0	CTD_human
23592	LEMD3	C0029455	Osteopoikilosis (disorder)	0.206579087443797	0	0	HPO
23592	LEMD3	C0029464	Osteosclerosis	0.2	0	0	HPO
23592	LEMD3	C0265514	Dermatofibrosis lenticularis disseminata	0.402472541057918	0	0	CTD_human;ORPHANET
23592	LEMD3	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
23592	LEMD3	C1274865	Scleroderma-like secondary cutaneous sclerosis	0.2	0	0	HPO
23592	LEMD3	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
23592	LEMD3	C2931505	Mixed sclerosing bone dystrophy	0.200274726784213	0	0	ORPHANET
23594	ORC6	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
23594	ORC6	C0694550	Recurrent pneumonia	0.2	0	0	HPO
23594	ORC6	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
23594	ORC6	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	0.400824180352639	1	0	CTD_human;ORPHANET
23594	ORC6	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
23594	ORC6	C3151113	MEIER-GORLIN SYNDROME 3	0.2	1	5	UNIPROT
23600	AMACR	C0008370	Cholestasis	0.2	0	0	HPO
23600	AMACR	C0008372	Intrahepatic Cholestasis	0.2	0	0	HPO
23600	AMACR	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	0	0	HPO
23600	AMACR	C0027613	Neonatal hepatitis	0.2	0	0	HPO
23600	AMACR	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
23600	AMACR	C0038220	Status Epilepticus	0.2	0	0	HPO
23600	AMACR	C0042798	Low Vision	0.2	0	0	HPO
23600	AMACR	C0085605	Liver Failure	0.2	0	0	HPO
23600	AMACR	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
23600	AMACR	C0948896	Primary hypogonadism	0.2	0	0	HPO
23600	AMACR	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
23600	AMACR	C1858328	Bile acid synthesis defect, congenital, 4	0.6	1	2	CTD_human;ORPHANET;UNIPROT
23600	AMACR	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
23600	AMACR	C3280428	Alpha-Methylacyl-CoA Racemase Deficiency	0.280274726784213	2	1	UNIPROT
23600	AMACR	C4020697	Giant cell hepatitis on liver biopsy	0.2	0	0	HPO
23601	CLEC5A	C0019100	Severe Dengue	0.200549453568426	1	0	CTD_human
23603	CORO1C	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
23607	CD2AP	C0002395	Alzheimer's Disease	0.202472541057918	2	2	CTD_human
23607	CD2AP	C0017668	Focal glomerulosclerosis	0.404879569581206	0	0	CTD_human;HPO
23607	CD2AP	C0035078	Kidney Failure	0.201373633921065	0	0	HPO
23607	CD2AP	C1565489	Renal Insufficiency	0.2	0	0	HPO
23621	BACE1	C0002395	Alzheimer's Disease	0.36425316589349	1	0	CTD_human
23630	KCNE5	C0013902	Elliptocytosis, Hereditary	0.2	0	0	HPO
23630	KCNE5	C0035078	Kidney Failure	0.2	0	0	HPO
23630	KCNE5	C1565489	Renal Insufficiency	0.2	0	0	HPO
23630	KCNE5	C1846242	Alport Syndrome, Mental Retardation, Midface Hypoplasia, and Elliptocytosis	0.2	0	0	ORPHANET
23636	NUP62	C0029124	Optic Atrophy	0.2	0	0	HPO
23636	NUP62	C0085583	Choreoathetosis	0.2	0	0	HPO
23636	NUP62	C0271388	Pendular Nystagmus	0.2	0	0	HPO
23636	NUP62	C0795996	STRIATONIGRAL DEGENERATION, INFANTILE (disorder)	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
23636	NUP62	C1836830	Developmental regression	0.2	0	0	HPO
23636	NUP62	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
23636	NUP62	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
23636	NUP62	C4020871	Dystonic disease	0.2	0	0	HPO
23639	LRRC6	C0006267	Bronchiectasis	0.2	0	0	HPO
23639	LRRC6	C0008677	Bronchitis, Chronic	0.2	0	0	HPO
23639	LRRC6	C0022521	Kartagener Syndrome	0.201373633921065	0	0	ORPHANET
23639	LRRC6	C0027430	Nasal Polyps	0.2	0	0	HPO
23639	LRRC6	C0035455	Rhinitis	0.2	0	0	HPO
23639	LRRC6	C0581354	Recurrent sinusitis	0.2	0	0	HPO
23639	LRRC6	C0747085	Recurrent otitis media	0.2	0	0	HPO
23639	LRRC6	C3543826	CILIARY DYSKINESIA, PRIMARY, 19	0.2	1	6	UNIPROT
23639	LRRC6	C4280333	Recurrent sinus disease	0.2	0	0	HPO
23643	LY96	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
23657	SLC7A11	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
23658	LSM5	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
23671	TMEFF2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
23691	NNO1	C1838502	NANOPHTHALMOS 1	0.2	0	0	CTD_human
23694	MRX73	C1845860	MENTAL RETARDATION, X-LINKED 73	0.2	0	0	CTD_human
23706	IBGC1	C0393590	Fahr's syndrome (disorder)	0.201098907136852	0	0	CTD_human
23713	DFNB27	C1853941	DEAFNESS, AUTOSOMAL RECESSIVE 27	0.2	0	0	CTD_human
23714	DFNB26	C1854275	DEAFNESS, AUTOSOMAL RECESSIVE 26	0.2	0	0	CTD_human
23719	DFNA30	C1847972	DEAFNESS, AUTOSOMAL DOMINANT 30 (disorder)	0.2	0	0	CTD_human
23722	DFNA27	C3887929	DEAFNESS, AUTOSOMAL DOMINANT 27	0.2	0	0	CTD_human
23723	DFNA24	C1853451	DEAFNESS, AUTOSOMAL DOMINANT 24 (disorder)	0.2	0	0	CTD_human
23729	SHPK	C0003886	Arthrogryposis	0.2	0	0	HPO
23729	SHPK	C0004045	Asphyxia Neonatorum	0.2	0	0	HPO
23729	SHPK	C0019158	Hepatitis	0.2	0	0	HPO
23729	SHPK	C0020541	Hypertension, Portal	0.2	0	0	HPO
23729	SHPK	C0035078	Kidney Failure	0.2	0	0	HPO
23729	SHPK	C0271901	Microcytic hypochromic anemia (disorder)	0.2	0	0	HPO
23729	SHPK	C0860204	Cholestatic liver disease	0.2	0	0	HPO
23729	SHPK	C1565489	Renal Insufficiency	0.2	0	0	HPO
23729	SHPK	C4023018	Subcortical cerebral atrophy	0.2	0	0	HPO
23742	NPAP1	C0020459	Hyperinsulinism	0.2	0	0	HPO
23742	NPAP1	C0020490	Hyperopia	0.2	0	0	HPO
23742	NPAP1	C0028754	Obesity	0.2	0	0	HPO
23742	NPAP1	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
23742	NPAP1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
23742	NPAP1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
23742	NPAP1	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
23746	AIPL1	C0014544	Epilepsy	0.2	0	0	HPO
23746	AIPL1	C0022578	Keratoconus	0.200824180352639	0	0	HPO
23746	AIPL1	C0028077	Night Blindness	0.2	0	0	HPO
23746	AIPL1	C0028738	Nystagmus	0.2	0	0	HPO
23746	AIPL1	C0035334	Retinitis Pigmentosa	0.604381273170092	1	0	CTD_human;HPO;ORPHANET
23746	AIPL1	C0271388	Pendular Nystagmus	0.2	0	0	HPO
23746	AIPL1	C0339527	Leber Congenital Amaurosis	0.207142896389541	0	0	ORPHANET
23746	AIPL1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
23746	AIPL1	C0730290	Cone dystrophy	0.200274726784213	0	0	HPO
23746	AIPL1	C1288283	Atrophoderma maculatum	0.2	0	0	HPO
23746	AIPL1	C1301509	Severe visual impairment	0.2	0	0	HPO
23746	AIPL1	C1858386	Leber Congenital Amaurosis 4	0.480549453568426	2	8	CTD_human;UNIPROT
23746	AIPL1	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
23746	AIPL1	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
23764	MAFF	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
23765	IL17RA	C0006845	Candidiasis, Chronic Mucocutaneous	0.401098907136852	0	0	HPO;ORPHANET
23765	IL17RA	C0007786	Brain Ischemia	0.2	1	0	CTD_human
23765	IL17RA	C0007971	Cheilitis	0.2	0	0	HPO
23765	IL17RA	C0870082	Hyperkeratosis	0.2	0	0	HPO
23767	FLRT3	C0018418	Gynecomastia	0.2	0	0	HPO
23767	FLRT3	C0162809	Kallmann Syndrome	0.2	0	0	ORPHANET
23767	FLRT3	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
23767	FLRT3	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
23767	FLRT3	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
23767	FLRT3	C3808986	HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA	0.2	1	4	UNIPROT
23767	FLRT3	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
23788	MTCH2	C0028754	Obesity	0.230257976200522	1	0	CTD_human
238	ALK	C2931189	Neural crest tumor	0.200274726784213	0	0	ORPHANET
239	ALOX12	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
2395	FXN	C0007194	Hypertrophic Cardiomyopathy	0.201648360705279	0	0	HPO
2395	FXN	C0016719	Friedreich Ataxia	0.505378563387669	8	7	CTD_human;ORPHANET
2395	FXN	C0018801	Heart failure	0.2	0	0	HPO
2395	FXN	C0018802	Congestive heart failure	0.2	0	0	HPO
2395	FXN	C0028738	Nystagmus	0.2	0	0	HPO
2395	FXN	C0029124	Optic Atrophy	0.2	0	0	HPO
2395	FXN	C0151313	Sensory neuropathy	0.200274726784213	0	0	HPO
2395	FXN	C0742191	Cervical spinal cord atrophy	0.2	0	0	HPO
2395	FXN	C1856689	FRIEDREICH ATAXIA 1	0.521758471200391	6	9	CTD_human;UNIPROT
24	ABCA4	C0017601	Glaucoma	0.2	0	0	HPO
24	ABCA4	C0018777	Conductive hearing loss	0.2	0	0	HPO
24	ABCA4	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
24	ABCA4	C0020459	Hyperinsulinism	0.2	0	0	HPO
24	ABCA4	C0020619	Hypogonadism	0.2	0	0	HPO
24	ABCA4	C0022578	Keratoconus	0.2	0	0	HPO
24	ABCA4	C0024437	Macular degeneration	0.20357144819477	0	0	HPO
24	ABCA4	C0028077	Night Blindness	0.2	0	0	HPO
24	ABCA4	C0028738	Nystagmus	0.2	0	0	HPO
24	ABCA4	C0028754	Obesity	0.2	0	0	HPO
24	ABCA4	C0029124	Optic Atrophy	0.2	0	0	HPO
24	ABCA4	C0035334	Retinitis Pigmentosa	0.632270701358945	1	1	CTD_human;HPO;ORPHANET
24	ABCA4	C0042798	Low Vision	0.202681755307501	0	0	HPO
24	ABCA4	C0242383	Age related macular degeneration	0.245638090496123	1	0	CTD_human
24	ABCA4	C0271215	Blindness, Legal	0.200274726784213	0	0	HPO
24	ABCA4	C0730290	Cone dystrophy	0.2	0	0	HPO
24	ABCA4	C1855465	STARGARDT DISEASE 1 (disorder)	0.486043989252688	17	284	CTD_human;UNIPROT
24	ABCA4	C1858806	CONE-ROD DYSTROPHY 3 (disorder)	0.48	4	33	CTD_human;UNIPROT
24	ABCA4	C1866422	RETINITIS PIGMENTOSA 19	0.28	0	0	CTD_human
24	ABCA4	C3495438	Macular Degeneration, Age-Related, 2	0.4	4	11	CTD_human;UNIPROT
24	ABCA4	C4021559	Retinitis pigmentosa inversa	0.2	0	0	HPO
24	ABCA4	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
240	ALOX5	C0003873	Rheumatoid Arthritis	0.201648360705279	1	0	CTD_human
240	ALOX5	C0004096	Asthma	0.251772945574828	0	0	CTD_human
240	ALOX5	C0004153	Atherosclerosis	0.21971313719709	1	0	CTD_human
240	ALOX5	C0009319	Colitis	0.2	1	0	CTD_human
240	ALOX5	C0042109	Urticaria	0.20328236603324	1	0	CTD_human
240	ALOX5	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
241	ALOX5AP	C0004153	Atherosclerosis	0.214232956890145	1	0	CTD_human
241	ALOX5AP	C0007785	Cerebral Infarction	0.201648360705279	0	0	CTD_human
24137	KIF4A	C0014544	Epilepsy	0.200274726784213	0	0	HPO
24138	IFIT5	C0021400	Influenza	0.2	1	0	CTD_human
24140	FTSJ1	C0796215	Mental Retardation, X-Linked 9	0.2	0	0	CTD_human
24140	FTSJ1	C1837658	Gross motor development delay	0.2	0	0	HPO
24148	PRPF6	C0017601	Glaucoma	0.2	0	0	HPO
24148	PRPF6	C0018777	Conductive hearing loss	0.2	0	0	HPO
24148	PRPF6	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
24148	PRPF6	C0020459	Hyperinsulinism	0.2	0	0	HPO
24148	PRPF6	C0020619	Hypogonadism	0.2	0	0	HPO
24148	PRPF6	C0022578	Keratoconus	0.2	0	0	HPO
24148	PRPF6	C0028738	Nystagmus	0.2	0	0	HPO
24148	PRPF6	C0028754	Obesity	0.2	0	0	HPO
24148	PRPF6	C0029124	Optic Atrophy	0.2	0	0	HPO
24148	PRPF6	C0035334	Retinitis Pigmentosa	0.400549453568426	0	0	HPO;ORPHANET
24148	PRPF6	C0042798	Low Vision	0.2	0	0	HPO
24148	PRPF6	C0271215	Blindness, Legal	0.2	0	0	HPO
24148	PRPF6	C3151434	RETINITIS PIGMENTOSA 60	0.2	1	1	UNIPROT
242	ALOX12B	C0002170	Alopecia	0.2	0	0	HPO
242	ALOX12B	C0011606	Exfoliative dermatitis	0.202732912464814	0	0	HPO
242	ALOX12B	C0013592	Ectropion	0.2	0	0	HPO
242	ALOX12B	C0020620	Hypohidrosis	0.2	0	0	HPO
242	ALOX12B	C0020757	Ichthyoses	0.201098907136852	0	0	HPO
242	ALOX12B	C0022568	Keratitis	0.2	0	0	HPO
242	ALOX12B	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
242	ALOX12B	C0079583	Ichthyosiform Erythroderma, Congenital	0.208971760589768	0	0	HPO
242	ALOX12B	C0259817	Xerosis	0.2	0	0	HPO
242	ALOX12B	C0392163	Corneal erosion	0.2	0	0	HPO
242	ALOX12B	C0870082	Hyperkeratosis	0.2	0	0	HPO
242	ALOX12B	C1855789	Self-Healing Collodion Baby	0.2	0	0	ORPHANET
242	ALOX12B	C1855792	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1	0.2	0	0	CTD_human
242	ALOX12B	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2420	FRDA2	C1856689	FRIEDREICH ATAXIA 1	0.2	0	0	CTD_human
2420	FRDA2	C1865981	FRIEDREICH ATAXIA 2	0.2	0	0	CTD_human
2448	FRA12A	C1969893	Mental Retardation, Fra12a Type	0.2	0	0	CTD_human
245972	ATP6V0D2	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
246	ALOX15	C0004153	Atherosclerosis	0.224904235342504	1	0	CTD_human
246213	SLC17A8	C1854158	DEAFNESS, AUTOSOMAL DOMINANT 25 (disorder)	0.48	1	1	CTD_human;UNIPROT
246243	RNASEH1	C4225312	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2	0.2	1	2	UNIPROT
246260	BDA1B	C1846949	Brachydactyly, Type A1, B	0.2	0	0	CTD_human
246260	BDA1B	C1862151	BRACHYDACTYLY, TYPE A1 (disorder)	0.2	0	0	CTD_human
246289	DFNA47	C1837609	DEAFNESS, AUTOSOMAL DOMINANT 47 (disorder)	0.2	0	0	CTD_human
246329	STAC3	C1850625	Native American myopathy	0.400274726784213	1	1	ORPHANET;UNIPROT
246750	MYAS1	C1846838	Myasthenia Gravis with Thymus Hyperplasia	0.2	0	0	CTD_human
246751	SMAR	C1846823	Spinal Muscular Atrophy, Distal, Autosomal Recessive, 3	0.2	0	0	CTD_human
246778	IL27	C0011854	Diabetes Mellitus, Insulin-Dependent	0.202956482091714	1	1	CTD_human
2475	MTOR	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
2475	MTOR	C1846385	FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.200549453568426	0	0	ORPHANET
2475	MTOR	C1955869	Malformations of Cortical Development	0.200549453568426	1	0	CTD_human
2475	MTOR	C4225259	SMITH-KINGSMORE SYNDROME	0.4	1	5	ORPHANET;UNIPROT
2483	FRG1	C0014544	Epilepsy	0.2	0	0	HPO
2483	FRG1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2483	FRG1	C0154822	Serous retinal detachment	0.2	0	0	HPO
2483	FRG1	C0154835	Retinal telangiectasia	0.2	0	0	HPO
2483	FRG1	C0162292	External Ophthalmoplegia	0.2	0	0	HPO
2483	FRG1	C0162674	Chronic progressive external ophthalmoplegia	0.2	0	0	HPO
2483	FRG1	C0234958	muscle degeneration	0.200274726784213	0	0	HPO
2483	FRG1	C0241423	Atrophy of tongue	0.2	0	0	HPO
2483	FRG1	C0376175	Bell Palsy	0.2	0	0	HPO
2483	FRG1	C0410192	Muscular Dystrophy, Scapulohumeral	0.2	0	0	HPO
2487	FRZB	C0029408	Degenerative polyarthritis	0.225677258537831	0	0	CTD_human
2488	FSHB	C0004509	Azoospermia	0.200549453568426	0	0	HPO
2488	FSHB	C0020619	Hypogonadism	0.2	3	0	CTD_human
2488	FSHB	C0023600	Leydig cell hyperplasia	0.2	0	0	HPO
2488	FSHB	C0028960	Oligospermia	0.400274726784213	1	0	CTD_human;HPO
2488	FSHB	C0043019	Lateral Medullary Syndrome	0.2	1	0	CTD_human
2488	FSHB	C0151721	Testicular hypogonadism	0.2	0	0	HPO
2488	FSHB	C0156312	Atrophy of testis	0.2	0	0	HPO
2488	FSHB	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
2488	FSHB	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
2488	FSHB	C0271623	Hypogonadotropic hypogonadism	0.200274726784213	0	0	HPO
2488	FSHB	C0403824	Teratozoospermia	0.2	0	0	HPO
2488	FSHB	C0949173	Delayed menarche	0.2	0	0	HPO
2488	FSHB	C1856716	Follicle-stimulating hormone deficiency, isolated	0.6	1	5	CTD_human;ORPHANET;UNIPROT
2488	FSHB	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
2489	FSHMD1A	C1834673	Facioscapulohumeral muscular dystrophy 1a	0.200274726784213	0	0	CTD_human
249	ALPL	C0002382	Alveolar Bone Loss	0.2	1	0	CTD_human
249	ALPL	C0002871	Anemia	0.2	0	0	HPO
249	ALPL	C0003123	Anorexia	0.2	0	0	HPO
249	ALPL	C0010278	Craniosynostosis	0.2	0	0	HPO
249	ALPL	C0011334	Dental caries	0.2	0	0	HPO
249	ALPL	C0014544	Epilepsy	0.200274726784213	0	0	HPO
249	ALPL	C0015300	Exophthalmos	0.2	0	0	HPO
249	ALPL	C0020437	Hypercalcemia	0.200274726784213	0	0	HPO
249	ALPL	C0020503	Hyperparathyroidism, Secondary	0.2	1	0	CTD_human
249	ALPL	C0027709	Nephrocalcinosis	0.2	0	0	HPO
249	ALPL	C0029442	Osteomalacia	0.2	0	0	HPO
249	ALPL	C0035579	Rickets	0.2	0	0	HPO
249	ALPL	C0268412	Infantile hypophosphatasia	0.685978476718058	5	46	CTD_human;HPO;ORPHANET;UNIPROT
249	ALPL	C0268413	Adult hypophosphatasia (disorder)	0.681098907136852	27	40	CTD_human;ORPHANET;UNIPROT
249	ALPL	C0426824	Beading of ribs	0.2	0	0	HPO
249	ALPL	C0553730	Calcium pyrophosphate deposition disease	0.2	0	0	HPO
249	ALPL	C1840322	ODONTOHYPOPHOSPHATASIA (disorder)	0.200274726784213	0	0	ORPHANET
249	ALPL	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2490	FSHMD1B	C1834671	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B	0.2	0	0	CTD_human
2492	FSHR	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
2492	FSHR	C0025322	Premature Menopause	0.206593442821114	0	0	HPO
2492	FSHR	C0029453	Osteopenia	0.200274726784213	0	0	HPO
2492	FSHR	C0029456	Osteoporosis	0.200274726784213	0	0	HPO
2492	FSHR	C0032460	Polycystic Ovary Syndrome	0.224043253209869	1	1	CTD_human
2492	FSHR	C0085083	Ovarian Hyperstimulation Syndrome	0.626654910362408	7	7	CTD_human;ORPHANET;UNIPROT
2492	FSHR	C0232939	Primary physiologic amenorrhea	0.203021994626344	0	0	HPO
2492	FSHR	C0343084	Capillary Leak Syndrome	0.2	0	0	HPO
2492	FSHR	C0747078	Generalized osteopenia	0.2	0	0	HPO
2492	FSHR	C4024641	Enlarged polycystic ovaries	0.2	0	0	HPO
2492	FSHR	C4025170	Osteoporosis of vertebrae	0.2	0	0	HPO
2495	FTH1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
2495	FTH1	C0282193	Iron Overload	0.20328236603324	1	0	CTD_human
2495	FTH1	C1851316	Iron Overload, Autosomal Dominant	0.2	0	0	ORPHANET
2495	FTH1	C3854388	Hyperferritinaemia	0.2	0	0	HPO
25	ABL1	C0836924	Thrombocytosis	0.201923087489492	0	0	HPO
2512	FTL	C0005747	Blepharospasm	0.2	0	0	HPO
2512	FTL	C0023882	Little's Disease	0.2	0	0	HPO
2512	FTL	C0028754	Obesity	0.200274726784213	1	0	CTD_human
2512	FTL	C0029124	Optic Atrophy	0.2	0	0	HPO
2512	FTL	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
2512	FTL	C0085583	Choreoathetosis	0.2	0	0	HPO
2512	FTL	C0152115	Lingual-Facial-Buccal Dyskinesia	0.2	0	0	HPO
2512	FTL	C0154676	Organic writer's cramp	0.2	0	0	HPO
2512	FTL	C0234517	Anarthria speech disorder	0.2	0	0	HPO
2512	FTL	C1833213	Hyperferritinemia, hereditary, with congenital cataracts	0.60357144819477	1	10	CTD_human;ORPHANET;UNIPROT
2512	FTL	C1853578	Neuroferritinopathy	0.605219808900049	1	5	CTD_human;ORPHANET;UNIPROT
2512	FTL	C1963946	Laryngeal dystonia	0.2	0	0	HPO
2512	FTL	C3810090	L-FERRITIN DEFICIENCY	0.2	0	0	ORPHANET
2512	FTL	C3854388	Hyperferritinaemia	0.2	0	0	HPO
2512	FTL	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
2512	FTL	C4020858	Choreatic disease	0.2	0	0	HPO
2512	FTL	C4020871	Dystonic disease	0.2	0	0	HPO
2512	FTL	C4024952	Cavitation of the basal ganglia	0.2	0	0	HPO
2516	NR5A1	C0004509	Azoospermia	0.200824180352639	0	0	HPO
2516	NR5A1	C0014175	Endometriosis	0.204930726738519	1	0	CTD_human
2516	NR5A1	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
2516	NR5A1	C0018418	Gynecomastia	0.2	0	0	HPO
2516	NR5A1	C0025322	Premature Menopause	0.200549453568426	0	0	HPO
2516	NR5A1	C0029453	Osteopenia	0.2	0	0	HPO
2516	NR5A1	C0029456	Osteoporosis	0.2	0	0	HPO
2516	NR5A1	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
2516	NR5A1	C0085215	Ovarian Failure, Premature	0.20439562854741	1	0	CTD_human
2516	NR5A1	C0156394	Hypertrophy of clitoris	0.200824180352639	0	0	HPO
2516	NR5A1	C0232939	Primary physiologic amenorrhea	0.201098907136852	0	0	HPO
2516	NR5A1	C0266427	Testicular regression syndrome	0.2	0	0	HPO
2516	NR5A1	C0271623	Hypogonadotropic hypogonadism	0.200549453568426	0	0	HPO
2516	NR5A1	C0747078	Generalized osteopenia	0.2	0	0	HPO
2516	NR5A1	C0948896	Primary hypogonadism	0.2	0	0	HPO
2516	NR5A1	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
2516	NR5A1	C2751825	PREMATURE OVARIAN FAILURE 7 (disorder)	0.4	1	7	CTD_human;UNIPROT
2516	NR5A1	C2936694	Swyer Syndrome	0.2	0	0	ORPHANET
2516	NR5A1	C3151406	SPERMATOGENIC FAILURE 8	0.2	2	5	UNIPROT
2516	NR5A1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
2516	NR5A1	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
2516	NR5A1	C4023106	Obstructive azoospermia	0.2	0	0	HPO
2516	NR5A1	C4025170	Osteoporosis of vertebrae	0.2	0	0	HPO
2517	FUCA1	C0003028	Anhidrosis	0.2	0	0	HPO
2517	FUCA1	C0014544	Epilepsy	0.2	0	0	HPO
2517	FUCA1	C0016788	Fucosidase Deficiency Disease	0.602472541057918	3	9	CTD_human;ORPHANET;UNIPROT
2517	FUCA1	C0020676	Hypothyroidism	0.2	0	0	HPO
2517	FUCA1	C0024421	Macroglossia	0.2	0	0	HPO
2517	FUCA1	C0086795	Pfaundler-Hurler Syndrome	0.2	0	0	HPO
2517	FUCA1	C0152025	Polyneuropathy	0.2	0	0	HPO
2517	FUCA1	C0235946	Cerebral atrophy	0.2	0	0	HPO
2517	FUCA1	C0259817	Xerosis	0.2	0	0	HPO
2517	FUCA1	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
2517	FUCA1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
2517	FUCA1	C1280433	Lipoatrophy	0.2	0	0	HPO
2517	FUCA1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2517	FUCA1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
2520	GAST	C0004763	Barrett Esophagus	0.200824180352639	1	0	CTD_human
2520	GAST	C0030920	Peptic Ulcer	0.201648360705279	1	0	CTD_human
2521	FUS	C0002736	Amyotrophic Lateral Sclerosis	0.475612020729985	0	0	HPO;ORPHANET
2521	FUS	C0234958	muscle degeneration	0.2	0	0	HPO
2521	FUS	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
2521	FUS	C1145670	Respiratory Failure	0.2	0	0	HPO
2521	FUS	C1842675	AMYOTROPHIC LATERAL SCLEROSIS 6 (disorder)	0.200824180352639	6	11	UNIPROT
2521	FUS	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
2521	FUS	C2750729	Amyotrophic Lateral Sclerosis 6, Autosomal Recessive	0.2	0	0	CTD_human
2521	FUS	C3539195	TREMOR, HEREDITARY ESSENTIAL, 4	0.2	1	3	UNIPROT
2521	FUS	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
2521	FUS	C4020884	Anxiety disease	0.2	0	0	HPO
2524	FUT2	C0010346	Crohn Disease	0.207286598104494	1	3	CTD_human
252843	AAT2	C1846837	Aortic Aneurysm, Familial Thoracic 2	0.2	0	0	CTD_human
2529	FUT7	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
253	ALS3	C1847735	AMYOTROPHIC LATERAL SCLEROSIS 3 (disorder)	0.2	0	0	CTD_human
253017	TECRL	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	0.2	0	0	ORPHANET
2532	ACKR1	C0024530	Malaria	0.207077383854911	0	0	CTD_human
2533	FYB	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
2535	FZD2	C2750355	Omodysplasia 2	0.2	0	0	ORPHANET
2537	IFI6	C0021400	Influenza	0.2	1	0	CTD_human
2538	G6PC	C0003868	Arthritis, Gouty	0.2	0	0	HPO
2538	G6PC	C0017668	Focal glomerulosclerosis	0.2	0	0	HPO
2538	G6PC	C0017920	Glycogen Storage Disease Type I	0.697502646277691	18	37	CTD_human;ORPHANET;UNIPROT
2538	G6PC	C0018099	Gout	0.2	0	0	HPO
2538	G6PC	C0020473	Hyperlipidemia	0.2	0	0	HPO
2538	G6PC	C0020615	Hypoglycemia	0.201923087489492	0	0	HPO
2538	G6PC	C0029456	Osteoporosis	0.2	0	0	HPO
2538	G6PC	C0030305	Pancreatitis	0.2	0	0	HPO
2538	G6PC	C0043325	Xanthomatosis	0.2	0	0	HPO
2538	G6PC	C0339477	Lipidemia retinalis	0.2	0	0	HPO
2538	G6PC	C0392525	Nephrolithiasis	0.2	0	0	HPO
2538	G6PC	C2919796	Glycogen storage disease type Ia	0.20796707674218	0	0	CTD_human
253827	MSRB3	C2239351	DEAFNESS, AUTOSOMAL RECESSIVE 74	0.480274726784213	1	2	CTD_human;UNIPROT
2539	G6PD	C0002878	Anemia, Hemolytic	0.221869564070466	3	0	CTD_human
2539	G6PD	C0002882	Anemia, Hemolytic, Congenital Nonspherocytic	0.202747267842131	2	0	CTD_human
2539	G6PD	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
2539	G6PD	C0015702	Favism	0.210583319515051	2	0	CTD_human
2539	G6PD	C0031306	Phagocyte Bactericidal Dysfunction	0.2	1	0	CTD_human
2539	G6PD	C0268306	Unconjugated hyperbilirubinemia	0.200549453568426	0	0	HPO
2539	G6PD	C2720289	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.4	17	52	ORPHANET;UNIPROT
2539	G6PD	C2939465	Deficiency of glucose-6-phosphate dehydrogenase	0.327513378291549	3	1	CTD_human
2539	G6PD	C4021648	Fava bean-induced hemolytic anemia	0.2	0	0	HPO
254065	BRWD3	C1970841	MENTAL RETARDATION, X-LINKED 93 (disorder)	0.4	1	5	CTD_human;UNIPROT
2542	SLC37A4	C0003868	Arthritis, Gouty	0.2	0	0	HPO
2542	SLC37A4	C0017668	Focal glomerulosclerosis	0.2	0	0	HPO
2542	SLC37A4	C0018099	Gout	0.2	0	0	HPO
2542	SLC37A4	C0020473	Hyperlipidemia	0.2	0	0	HPO
2542	SLC37A4	C0020615	Hypoglycemia	0.200274726784213	0	0	HPO
2542	SLC37A4	C0022638	Ketosis	0.2	0	0	HPO
2542	SLC37A4	C0029456	Osteoporosis	0.2	0	0	HPO
2542	SLC37A4	C0030305	Pancreatitis	0.2	0	0	HPO
2542	SLC37A4	C0035078	Kidney Failure	0.2	0	0	HPO
2542	SLC37A4	C0043325	Xanthomatosis	0.2	0	0	HPO
2542	SLC37A4	C0149521	Pancreatitis, Chronic	0.2	0	0	HPO
2542	SLC37A4	C0149745	Oral Ulcer	0.2	0	0	HPO
2542	SLC37A4	C0268146	Glucose-6-phosphate transport defect	0.686043989252688	20	40	CTD_human;ORPHANET;UNIPROT
2542	SLC37A4	C0339477	Lipidemia retinalis	0.2	0	0	HPO
2542	SLC37A4	C0342749	GLYCOGEN STORAGE DISEASE Ic	0.400274726784213	1	4	CTD_human;UNIPROT
2542	SLC37A4	C0392525	Nephrolithiasis	0.2	0	0	HPO
2542	SLC37A4	C1565489	Renal Insufficiency	0.2	0	0	HPO
2542	SLC37A4	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
2542	SLC37A4	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
2542	SLC37A4	C4022867	Spider hemangioma	0.2	0	0	HPO
254394	MCM9	C4015409	OVARIAN DYSGENESIS 4	0.2	0	0	ORPHANET
2548	GAA	C0007194	Hypertrophic Cardiomyopathy	0.200824180352639	1	0	CTD_human
2548	GAA	C0017665	Membranous glomerulonephritis	0.2	1	0	CTD_human
2548	GAA	C0017921	Glycogen storage disease type II	0.551609615332135	34	131	CTD_human;UNIPROT
2548	GAA	C0024421	Macroglossia	0.2	0	0	HPO
2548	GAA	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
2548	GAA	C0149721	Left Ventricular Hypertrophy	0.200549453568426	1	0	CTD_human
2548	GAA	C0751003	Brain Aneurysm	0.2	0	0	HPO
2548	GAA	C1290398	Cerebral arterial aneurysm	0.2	0	0	HPO
254887	ZDHHC23	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2549	GAB1	C0032460	Polycystic Ovary Syndrome	0.200549453568426	1	0	CTD_human
255	ALS5	C1865864	AMYOTROPHIC LATERAL SCLEROSIS 5	0.2	0	0	CTD_human
2551	GABPA	C0015923	Fetal Alcohol Syndrome	0.200274726784213	1	0	PSYGENET
2554	GABRA1	C0009952	Febrile Convulsions	0.200274726784213	0	0	HPO
2554	GABRA1	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
2554	GABRA1	C0014553	Absence Epilepsy	0.200274726784213	0	0	HPO
2554	GABRA1	C0019151	Hepatic Encephalopathy	0.280274726784213	1	0	CTD_human
2554	GABRA1	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
2554	GABRA1	C0038220	Status Epilepticus	0.2	0	0	HPO
2554	GABRA1	C0270736	Essential Tremor	0.202956482091714	1	0	CTD_human
2554	GABRA1	C0270846	Epileptic drop attack	0.2	0	0	HPO
2554	GABRA1	C0270853	Myoclonic Epilepsy, Juvenile	0.409195330216668	0	0	CTD_human;ORPHANET
2554	GABRA1	C0543888	Epileptic encephalopathy	0.200274726784213	0	0	HPO
2554	GABRA1	C0751122	Infantile Severe Myoclonic Epilepsy	0.200824180352639	0	0	ORPHANET
2554	GABRA1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
2554	GABRA1	C0752323	Focal Clonic Seizures	0.2	0	0	HPO
2554	GABRA1	C1838604	EPILEPSY, CHILDHOOD ABSENCE, 1	0.2	0	0	ORPHANET
2554	GABRA1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
2554	GABRA1	C3810400	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19	0.2	1	6	UNIPROT
2554	GABRA1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
2554	GABRA1	C4023511	Obtundation status	0.2	0	0	HPO
255520	ELMOD2	C1800706	Idiopathic Pulmonary Fibrosis	0.203007639249027	0	0	CTD_human
2556	GABRA3	C0018213	Graves Disease	0.2	0	0	HPO
2556	GABRA3	C0028754	Obesity	0.2	0	0	HPO
2556	GABRA3	C0034372	Quadriplegia	0.2	0	0	HPO
2556	GABRA3	C0154141	Thyrotoxicosis with toxic single thyroid nodule	0.2	0	0	HPO
2556	GABRA3	C0154143	Toxic multinodular goiter	0.2	0	0	HPO
2556	GABRA3	C0268446	Thyrotoxic periodic paralysis	0.2	0	0	ORPHANET
2556	GABRA3	C4021553	Periodic hypokalemic paresis	0.2	0	0	HPO
255738	PCSK9	C0020443	Hypercholesterolemia	0.245074281550379	1	0	CTD_human
255738	PCSK9	C0342881	Familial hypercholesterolemia - homozygous	0.2	0	0	ORPHANET
255738	PCSK9	C0745103	Hyperlipoproteinemia Type IIa	0.227747405205523	0	0	ORPHANET
255738	PCSK9	C1863551	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3	0.4	3	8	CTD_human;UNIPROT
255738	PCSK9	C1956346	Coronary Artery Disease	0.216287069448896	2	0	CTD_human
2558	GABRA5	C3711376	Isodicentric Chromosome 15 Syndrome	0.2	1	0	CTD_human
2559	GABRA6	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
255928	SYT14	C3280226	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11	0.4	1	1	ORPHANET;UNIPROT
2560	GABRB1	C0019151	Hepatic Encephalopathy	0.28	1	0	CTD_human
2560	GABRB1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
2562	GABRB3	C0014544	Epilepsy	0.20350593566014	1	0	CTD_human
2562	GABRB3	C0014553	Absence Epilepsy	0.213301876602548	1	0	CTD_human
2562	GABRB3	C0021603	Sleep Initiation and Maintenance Disorders	0.2	1	0	CTD_human
2562	GABRB3	C0162635	Angelman Syndrome	0.206043989252688	1	0	CTD_human
2562	GABRB3	C0238111	Lennox-Gastaut syndrome	0.200549453568426	0	0	ORPHANET
2562	GABRB3	C0270846	Epileptic drop attack	0.2	0	0	HPO
2562	GABRB3	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
2562	GABRB3	C0595948	Atypical absence seizure	0.2	0	0	HPO
2562	GABRB3	C1838604	EPILEPSY, CHILDHOOD ABSENCE, 1	0.2	0	0	ORPHANET
2562	GABRB3	C3711376	Isodicentric Chromosome 15 Syndrome	0.200274726784213	1	0	CTD_human
256297	PTF1A	C1836780	PANCREATIC AND CEREBELLAR AGENESIS	0.400274726784213	2	1	CTD_human;ORPHANET
256297	PTF1A	C1850096	Pancreatic Agenesis, Congenital	0.2	2	0	CTD_human
256297	PTF1A	C3891828	PANCREATIC AGENESIS 1	0.2	0	0	ORPHANET
256297	PTF1A	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2563	GABRD	C0014306	Enophthalmos	0.2	0	0	HPO
2563	GABRD	C0014544	Epilepsy	0.203780662444353	0	0	HPO
2563	GABRD	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
2563	GABRD	C0038379	Strabismus	0.2	0	0	HPO
2563	GABRD	C0235946	Cerebral atrophy	0.2	0	0	HPO
2563	GABRD	C0270850	Idiopathic generalized epilepsy	0.2	0	0	CTD_human
2563	GABRD	C0270853	Myoclonic Epilepsy, Juvenile	0.200274726784213	0	0	ORPHANET
2563	GABRD	C1842870	Chromosome 1p36 Deletion Syndrome	0.2	0	0	ORPHANET
2563	GABRD	C1858672	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1	0.4	0	0	CTD_human;ORPHANET
2563	GABRD	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
256471	MFSD8	C1838571	Ceroid Lipofuscinosis, Neuronal, 7	0.681373633921066	7	14	CTD_human;ORPHANET;UNIPROT
256471	MFSD8	C4015371	MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT	0.200274726784213	1	1	UNIPROT
256472	TMEM151A	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
2566	GABRG2	C0009952	Febrile Convulsions	0.422823090760742	1	0	CTD_human;HPO
2566	GABRG2	C0014550	Epilepsies, Myoclonic	0.402407028523288	0	0	CTD_human;HPO
2566	GABRG2	C0014553	Absence Epilepsy	0.405480180306945	0	0	CTD_human;HPO
2566	GABRG2	C0019151	Hepatic Encephalopathy	0.280274726784213	1	0	CTD_human
2566	GABRG2	C0270846	Epileptic drop attack	0.2	0	0	HPO
2566	GABRG2	C0494475	Tonic - clonic seizures	0.200274726784213	0	0	HPO
2566	GABRG2	C0751122	Infantile Severe Myoclonic Epilepsy	0.202747267842131	0	0	ORPHANET
2566	GABRG2	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
2566	GABRG2	C0752323	Focal Clonic Seizures	0.2	0	0	HPO
2566	GABRG2	C1838604	EPILEPSY, CHILDHOOD ABSENCE, 1	0.2	0	0	ORPHANET
2566	GABRG2	C1843244	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2	0.2	1	3	UNIPROT
2566	GABRG2	C1858672	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1	0.4	0	0	CTD_human;ORPHANET
2566	GABRG2	C1858674	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3	0.4	2	5	CTD_human;UNIPROT
2566	GABRG2	C2363129	Benign Rolandic Epilepsy	0.2	0	0	ORPHANET
2566	GABRG2	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
2566	GABRG2	C4023511	Obtundation status	0.2	0	0	HPO
2567	GABRG3	C3711376	Isodicentric Chromosome 15 Syndrome	0.2	1	0	CTD_human
256764	WDR72	C2750771	Amelogenesis Imperfecta, Hypomaturation Type, Iia3	0.28	0	0	CTD_human
256933	NPB	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
257	ALX3	C0018777	Conductive hearing loss	0.2	0	0	HPO
257	ALX3	C0158113	Contracture of joint of hand	0.2	0	0	HPO
257019	FRMD3	C0263454	Chloracne	0.2	1	0	CTD_human
2571	GAD1	C0007789	Cerebral Palsy	0.200549453568426	0	0	HPO
2571	GAD1	C0013386	Dyskinesia, Drug-Induced	0.2	1	0	CTD_human
2571	GAD1	C0014544	Epilepsy	0.203557092817453	0	0	HPO
2571	GAD1	C0020514	Hyperprolactinemia	0.2	1	0	CTD_human
2571	GAD1	C0023882	Little's Disease	0.2	0	0	HPO
2571	GAD1	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
2571	GAD1	C2751938	Cerebral Palsy, Spastic Quadriplegic, 1	0.6	1	1	CTD_human;ORPHANET;UNIPROT
257101	ZNF683	C0263454	Chloracne	0.2	1	0	CTD_human
257106	ARHGAP30	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
257194	NEGR1	C0028754	Obesity	0.234862818997514	1	0	CTD_human
2572	GAD2	C0011884	Diabetic Retinopathy	0.2	1	0	CTD_human
2572	GAD2	C0236663	Alcohol withdrawal syndrome	0.2	1	0	PSYGENET
25778	DSTYK	C0037772	Spastic Paraplegia	0.2	0	0	HPO
25778	DSTYK	C0042900	Vitiligo	0.2	0	0	HPO
25780	RASGRP3	C0024141	Lupus Erythematosus, Systemic	0.202681755307501	1	1	CTD_human
25782	RAB3GAP2	C0018801	Heart failure	0.2	0	0	HPO
25782	RAB3GAP2	C0018802	Congestive heart failure	0.2	0	0	HPO
25782	RAB3GAP2	C0029124	Optic Atrophy	0.2	0	0	HPO
25782	RAB3GAP2	C0040412	Fissured tongue	0.2	0	0	HPO
25782	RAB3GAP2	C0155320	Blindness, Cortical	0.2	0	0	HPO
25782	RAB3GAP2	C0235946	Cerebral atrophy	0.2	0	0	HPO
25782	RAB3GAP2	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
25782	RAB3GAP2	C0796037	Martsolf syndrome	0.600824180352639	1	2	CTD_human;ORPHANET;UNIPROT
25782	RAB3GAP2	C0948187	Tracheomalacia	0.2	0	0	HPO
25782	RAB3GAP2	C1838625	Warburg Sjo Fledelius syndrome	0.200824180352639	0	0	ORPHANET
25782	RAB3GAP2	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
25782	RAB3GAP2	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
25789	TMEM59L	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
25792	CIZ1	C1865819	CERVICAL DYSTONIA, PRIMARY	0.200274726784213	1	0	CTD_human
25793	FBXO7	C1850100	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE (disorder)	0.601648360705279	2	4	CTD_human;ORPHANET;UNIPROT
25793	FBXO7	C4020871	Dystonic disease	0.2	0	0	HPO
25794	FSCN2	C0017601	Glaucoma	0.2	0	0	HPO
25794	FSCN2	C0018777	Conductive hearing loss	0.2	0	0	HPO
25794	FSCN2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
25794	FSCN2	C0020459	Hyperinsulinism	0.2	0	0	HPO
25794	FSCN2	C0020619	Hypogonadism	0.2	0	0	HPO
25794	FSCN2	C0022578	Keratoconus	0.2	0	0	HPO
25794	FSCN2	C0028077	Night Blindness	0.2	0	0	HPO
25794	FSCN2	C0028738	Nystagmus	0.2	0	0	HPO
25794	FSCN2	C0028754	Obesity	0.2	0	0	HPO
25794	FSCN2	C0029124	Optic Atrophy	0.2	0	0	HPO
25794	FSCN2	C0035334	Retinitis Pigmentosa	0.412961637283705	0	0	HPO;ORPHANET
25794	FSCN2	C0042798	Low Vision	0.2	0	0	HPO
25794	FSCN2	C0271215	Blindness, Legal	0.2	0	0	HPO
25794	FSCN2	C1842816	RETINITIS PIGMENTOSA 30	0.28	0	0	CTD_human
25794	FSCN2	C4048273	Chorioretinal atrophy	0.2	0	0	HPO
25796	PGLS	C0029456	Osteoporosis	0.2	1	0	CTD_human
25797	QPCT	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
258	AMBN	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
2580	GAK	C0030567	Parkinson Disease	0.205429023149632	1	2	CTD_human
25802	LMOD1	C0014175	Endometriosis	0.2	1	0	CTD_human
2581	GALC	C0014544	Epilepsy	0.2	0	0	HPO
2581	GALC	C0020255	Hydrocephalus	0.2	0	0	HPO
2581	GALC	C0023521	Globoid cell leukodystrophy	0.505469723019871	10	62	CTD_human;UNIPROT
2581	GALC	C0028738	Nystagmus	0.2	0	0	HPO
2581	GALC	C0029124	Optic Atrophy	0.2	0	0	HPO
2581	GALC	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
2581	GALC	C0268252	Late-Onset Globoid Cell Leukodystrophy	0.201098907136852	0	0	ORPHANET
2581	GALC	C0271215	Blindness, Legal	0.2	0	0	HPO
2581	GALC	C0338474	Central nervous system demyelination	0.200274726784213	0	0	HPO
2581	GALC	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
2581	GALC	C0751273	Infantile Globoid Cell Leukodystrophy	0.201923087489492	0	0	ORPHANET
2581	GALC	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
2581	GALC	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
2581	GALC	C1836830	Developmental regression	0.2	0	0	HPO
2581	GALC	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2581	GALC	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
25814	ATXN10	C0014544	Epilepsy	0.2	0	0	HPO
25814	ATXN10	C0028738	Nystagmus	0.2	0	0	HPO
25814	ATXN10	C0085606	Urgency of micturition	0.2	0	0	HPO
25814	ATXN10	C0262404	Cerebellar degeneration	0.2	0	0	HPO
25814	ATXN10	C0393525	Progressive cerebellar ataxia	0.2	0	0	HPO
25814	ATXN10	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
25814	ATXN10	C1963674	Spinocerebellar Ataxia 10	0.401648360705279	0	0	CTD_human;ORPHANET
25814	ATXN10	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
25814	ATXN10	C4020859	Pyramidal tract disease	0.2	0	0	HPO
25814	ATXN10	C4020873	Infratentorial atrophy	0.2	0	0	HPO
25814	ATXN10	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
25816	TNFAIP8	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
2582	GALE	C0016952	Galactosemias	0.405205453522732	1	0	CTD_human;HPO
2582	GALE	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2582	GALE	C0238621	Aminoaciduria	0.2	0	0	HPO
2582	GALE	C0751161	UDPglucose 4-epimerase deficiency disease	0.201098907136852	3	17	UNIPROT
2582	GALE	C1837658	Gross motor development delay	0.2	0	0	HPO
2582	GALE	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
25821	MTO1	C0007194	Hypertrophic Cardiomyopathy	0.200824180352639	0	0	HPO
25821	MTO1	C0020615	Hypoglycemia	0.2	0	0	HPO
25821	MTO1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
25821	MTO1	C3553529	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.48	1	4	ORPHANET;UNIPROT
25824	PRDX5	C0002171	Alopecia Areata	0.2	1	0	CTD_human
2583	B4GALNT1	C1836632	SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE (disorder)	0.4	1	6	ORPHANET;UNIPROT
25836	NIPBL	C0004106	Astigmatism	0.2	0	0	HPO
25836	NIPBL	C0005741	Blepharitis	0.2	0	0	HPO
25836	NIPBL	C0014544	Epilepsy	0.2	0	0	HPO
25836	NIPBL	C0015300	Exophthalmos	0.2	0	0	HPO
25836	NIPBL	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
25836	NIPBL	C0018777	Conductive hearing loss	0.2	0	0	HPO
25836	NIPBL	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
25836	NIPBL	C0027092	Myopia	0.2	0	0	HPO
25836	NIPBL	C0028738	Nystagmus	0.2	0	0	HPO
25836	NIPBL	C0029124	Optic Atrophy	0.2	0	0	HPO
25836	NIPBL	C0032285	Pneumonia	0.2	0	0	HPO
25836	NIPBL	C0038379	Strabismus	0.2	0	0	HPO
25836	NIPBL	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
25836	NIPBL	C0155299	Coloboma of optic disc	0.2	0	0	HPO
25836	NIPBL	C0263401	Cutis marmorata	0.2	0	0	HPO
25836	NIPBL	C0270972	Cornelia De Lange Syndrome	0.714189203228104	9	233	CTD_human;ORPHANET;UNIPROT
25836	NIPBL	C0271007	Phthisis bulbi	0.2	0	0	HPO
25836	NIPBL	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
25836	NIPBL	C1857079	Atretic auditory canal	0.2	0	0	HPO
25836	NIPBL	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
25836	NIPBL	C2750805	Chromosome 5p13 Duplication Syndrome	0.2	0	0	ORPHANET
25836	NIPBL	C3489393	Hiatal Hernia	0.2	0	0	HPO
25836	NIPBL	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
25836	NIPBL	C4020884	Anxiety disease	0.2	0	0	HPO
25839	COG4	C0235946	Cerebral atrophy	0.2	0	0	HPO
25839	COG4	C3150736	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj	0.6	1	4	CTD_human;ORPHANET;UNIPROT
25839	COG4	C4020860	Supratentorial atrophy	0.2	0	0	HPO
2584	GALK1	C0016952	Galactosemias	0.409795940942407	1	0	CTD_human;HPO
2584	GALK1	C0268155	Deficiency of galactokinase	0.407561324888707	2	9	ORPHANET;UNIPROT
25840	METTL7A	C0014175	Endometriosis	0.2	1	0	CTD_human
25861	WHRN	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
25861	WHRN	C0018979	Hemianopsia	0.2	0	0	HPO
25861	WHRN	C0027092	Myopia	0.2	0	0	HPO
25861	WHRN	C0028077	Night Blindness	0.2	0	0	HPO
25861	WHRN	C0035334	Retinitis Pigmentosa	0.200549453568426	0	0	HPO
25861	WHRN	C1568249	Usher Syndrome, Type II	0.481098907136852	0	0	CTD_human;ORPHANET
25861	WHRN	C1846839	DEAFNESS, AUTOSOMAL RECESSIVE 31	0.28	0	0	CTD_human
25865	PRKD2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
2588	GALNS	C0011334	Dental caries	0.2	0	0	HPO
2588	GALNS	C0026707	Mucopolysaccharidosis IV	0.203296721410557	0	0	CTD_human
2588	GALNS	C0029456	Osteoporosis	0.2	0	0	HPO
2588	GALNS	C0085581	Restrictive lung disease	0.2	0	0	HPO
2588	GALNS	C0086651	Mucopolysaccharidosis, MPS-IV-A	0.489890164231672	8	64	ORPHANET;UNIPROT
2588	GALNS	C0149645	Cervical myelopathy	0.2	0	0	HPO
2588	GALNS	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
25885	POLR1A	C1837822	Burn-Mckeown syndrome	0.2	0	0	ORPHANET
25885	POLR1A	C4225317	ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE	0.2	1	2	UNIPROT
25886	POC1A	C0028960	Oligospermia	0.2	0	0	HPO
25886	POC1A	C1834405	Nail dysplasia	0.2	0	0	HPO
25886	POC1A	C3542022	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME	0.400824180352639	1	2	ORPHANET;UNIPROT
25890	ABI3BP	C0014175	Endometriosis	0.2	1	0	CTD_human
25894	PLEKHG4	C0087012	Ataxia, Spinocerebellar	0.208422307021342	0	0	CTD_human
25894	PLEKHG4	C0752122	Spinocerebellar Ataxia Type 4	0.2	0	0	ORPHANET
25894	PLEKHG4	C1861736	SPINOCEREBELLAR ATAXIA 31 (disorder)	0.200274726784213	0	0	CTD_human
259	AMBP	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2591	GALNT3	C0085681	Hyperphosphatemia (disorder)	0.202197814273705	1	0	CTD_human
2591	GALNT3	C1876187	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	0.483296721410557	0	0	CTD_human;ORPHANET
25913	POT1	C0259817	Xerosis	0.2	0	0	HPO
25914	RTTN	C0014544	Epilepsy	0.2	0	0	HPO
25914	RTTN	C3553831	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES	0.4	1	7	ORPHANET;UNIPROT
25915	NDUFAF3	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
25915	NDUFAF3	C0014544	Epilepsy	0.2	0	0	HPO
25915	NDUFAF3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
25915	NDUFAF3	C0020615	Hypoglycemia	0.2	0	0	HPO
25915	NDUFAF3	C0023520	Leukodystrophy	0.2	0	0	HPO
25915	NDUFAF3	C0028738	Nystagmus	0.2	0	0	HPO
25915	NDUFAF3	C0038379	Strabismus	0.2	0	0	HPO
25915	NDUFAF3	C0085605	Liver Failure	0.2	0	0	HPO
25915	NDUFAF3	C0234958	muscle degeneration	0.2	0	0	HPO
25915	NDUFAF3	C0262404	Cerebellar degeneration	0.2	0	0	HPO
25915	NDUFAF3	C0271215	Blindness, Legal	0.2	0	0	HPO
25915	NDUFAF3	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
25915	NDUFAF3	C1145670	Respiratory Failure	0.2	0	0	HPO
25915	NDUFAF3	C1836830	Developmental regression	0.2	0	0	HPO
25915	NDUFAF3	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.4	1	3	CTD_human;UNIPROT
25915	NDUFAF3	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
25915	NDUFAF3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
25915	NDUFAF3	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
25915	NDUFAF3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
259197	NCR3	C0024530	Malaria	0.205689394556528	0	0	CTD_human
2592	GALT	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
2592	GALT	C0016952	Galactosemias	0.433802392372281	1	2	CTD_human;HPO
2592	GALT	C0020615	Hypoglycemia	0.2	0	0	HPO
2592	GALT	C0023890	Liver Cirrhosis	0.2	0	0	HPO
2592	GALT	C0025322	Premature Menopause	0.201098907136852	0	0	HPO
2592	GALT	C0029456	Osteoporosis	0.2	0	0	HPO
2592	GALT	C0085605	Liver Failure	0.2	0	0	HPO
2592	GALT	C0238621	Aminoaciduria	0.2	0	0	HPO
2592	GALT	C0264611	Apraxia of Phonation	0.2	0	0	HPO
2592	GALT	C0268151	Classical galactosemia	0.416208880268573	20	230	ORPHANET;UNIPROT
2592	GALT	C0948896	Primary hypogonadism	0.2	0	0	HPO
2592	GALT	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
25923	ATL3	C0020071	Hereditary Sensory Autonomic Neuropathy, Type 1	0.2	0	0	ORPHANET
25923	ATL3	C0029443	Osteomyelitis	0.2	0	0	HPO
25923	ATL3	C0870082	Hyperkeratosis	0.2	0	0	HPO
25923	ATL3	C0917990	Acro-Osteolysis	0.2	0	0	HPO
25923	ATL3	C2242472	Infection of bone	0.2	0	0	HPO
25923	ATL3	C3810194	NEUROPATHY, HEREDITARY SENSORY, TYPE IF	0.2	1	1	UNIPROT
259232	NALCN	C0265224	Freeman-Sheldon syndrome	0.2	0	0	ORPHANET
259232	NALCN	C1834523	ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.2	0	0	ORPHANET
259232	NALCN	C3809454	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1	0.2	1	3	UNIPROT
259232	NALCN	C4225398	CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.200274726784213	1	15	UNIPROT
259236	TMIE	C1832992	DEAFNESS, AUTOSOMAL RECESSIVE 6	0.4	1	6	CTD_human;UNIPROT
259266	ASPM	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
259266	ASPM	C1837501	Microcephaly, Primary Autosomal Recessive, 5	0.280274726784213	0	0	CTD_human
259266	ASPM	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
2593	GAMT	C0014544	Epilepsy	0.2	0	0	HPO
2593	GAMT	C0574080	Guanidinoacetate methyltransferase deficiency	0.681098907136852	4	11	CTD_human;ORPHANET;UNIPROT
25932	CLIC4	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
25939	SAMHD1	C0023520	Leukodystrophy	0.2	0	0	HPO
25939	SAMHD1	C0024145	Chilblain lupus 1	0.4	1	0	CTD_human;ORPHANET
25939	SAMHD1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
25939	SAMHD1	C0393591	AICARDI-GOUTIERES SYNDROME	0.205769262468475	0	0	ORPHANET
25939	SAMHD1	C0796126	AICARDI-GOUTIERES SYNDROME 1	0.208241803526393	1	0	CTD_human
25939	SAMHD1	C2749659	AICARDI-GOUTIERES SYNDROME 5 (disorder)	0.4	3	20	CTD_human;UNIPROT
25939	SAMHD1	C3280721	CHILBLAIN LUPUS 2	0.2	0	0	UNIPROT
25939	SAMHD1	C3711385	Deoxyguanosine Kinase Deficiency	0.2	1	0	CTD_human
25939	SAMHD1	C4082173	Porencephaly	0.2	0	0	HPO
25942	SIN3A	C0014306	Enophthalmos	0.2	0	0	HPO
25942	SIN3A	C0020255	Hydrocephalus	0.2	1	0	CTD_human
25942	SIN3A	C0020490	Hyperopia	0.2	0	0	HPO
25942	SIN3A	C0020619	Hypogonadism	0.2	0	0	HPO
25942	SIN3A	C0021828	Intestinal Atresia	0.2	0	0	HPO
25942	SIN3A	C0028738	Nystagmus	0.2	0	0	HPO
25942	SIN3A	C0028754	Obesity	0.2	0	0	HPO
25942	SIN3A	C0038379	Strabismus	0.2	0	0	HPO
25942	SIN3A	C1836830	Developmental regression	0.2	0	0	HPO
25942	SIN3A	C3150674	CHROMOSOME 15q24 DELETION SYNDROME	0.2	0	0	ORPHANET
25942	SIN3A	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
25942	SIN3A	C4025697	Gastrointestinal atresia	0.2	0	0	HPO
25953	PNKD	C1869117	Paroxysmal nonkinesigenic dyskinesia	0.683296721410557	3	3	CTD_human;ORPHANET;UNIPROT
25959	KANK2	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
25959	KANK2	C4015202	PALMOPLANTAR KERATODERMA AND WOOLLY HAIR	0.4	1	1	ORPHANET;UNIPROT
2596	GAP43	C0038220	Status Epilepticus	0.2	1	0	CTD_human
2597	GAPDH	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
2597	GAPDH	C0029456	Osteoporosis	0.2	1	0	CTD_human
2597	GAPDH	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
25970	SH2B1	C0014544	Epilepsy	0.2	0	0	HPO
25970	SH2B1	C0020459	Hyperinsulinism	0.200274726784213	0	0	HPO
25970	SH2B1	C0028754	Obesity	0.438708993976498	1	1	CTD_human;HPO
25970	SH2B1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
25970	SH2B1	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
25970	SH2B1	C0740394	Hyperuricemia	0.2	0	0	HPO
25970	SH2B1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
25970	SH2B1	C3150154	CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.2	0	0	ORPHANET
25970	SH2B1	C3150701	CHROMOSOME 16p11.2 DELETION SYNDROME, 220-KB	0.2	0	0	ORPHANET
25974	MMACHC	C0002888	Anemia, Megaloblastic	0.200274726784213	0	0	HPO
25974	MMACHC	C0003123	Anorexia	0.2	0	0	HPO
25974	MMACHC	C0014544	Epilepsy	0.2	0	0	HPO
25974	MMACHC	C0019061	Hemolytic-Uremic Syndrome	0.2	0	0	HPO
25974	MMACHC	C0019880	Homocystinuria	0.202956482091714	0	0	HPO
25974	MMACHC	C0020255	Hydrocephalus	0.2	0	0	HPO
25974	MMACHC	C0028738	Nystagmus	0.2	0	0	HPO
25974	MMACHC	C0035078	Kidney Failure	0.2	0	0	HPO
25974	MMACHC	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
25974	MMACHC	C0042798	Low Vision	0.2	0	0	HPO
25974	MMACHC	C0085307	Embolism and Thrombosis	0.2	0	0	HPO
25974	MMACHC	C0235946	Cerebral atrophy	0.2	0	0	HPO
25974	MMACHC	C0268618	Cystathioninemia	0.2	0	0	HPO
25974	MMACHC	C1565489	Renal Insufficiency	0.2	0	0	HPO
25974	MMACHC	C1848561	Methylmalonic acidemia with homocystinuria	0.601373633921066	2	18	CTD_human;ORPHANET;UNIPROT
25974	MMACHC	C1855119	Methylmalonic aciduria	0.200549453568426	0	0	HPO
25974	MMACHC	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
25977	NECAP1	C0543888	Epileptic encephalopathy	0.200274726784213	0	0	HPO
25978	CHMP2B	C0002736	Amyotrophic Lateral Sclerosis	0.604055389228567	1	0	CTD_human;HPO;ORPHANET
25978	CHMP2B	C0152115	Lingual-Facial-Buccal Dyskinesia	0.2	0	0	HPO
25978	CHMP2B	C0234958	muscle degeneration	0.2	0	0	HPO
25978	CHMP2B	C0235946	Cerebral atrophy	0.200274726784213	0	0	HPO
25978	CHMP2B	C0338451	Frontotemporal dementia	0.406868169605328	1	0	CTD_human;HPO
25978	CHMP2B	C1145670	Respiratory Failure	0.2	0	0	HPO
25978	CHMP2B	C1833296	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED	0.401098907136852	1	7	CTD_human;UNIPROT
25978	CHMP2B	C1836076	Amyotrophic Lateral Sclerosis, Chmp2B-Related	0.2	2	3	UNIPROT
25978	CHMP2B	C4011788	Behavioral variant of frontotemporal dementia	0.2	0	0	ORPHANET
25978	CHMP2B	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
25978	CHMP2B	C4020871	Dystonic disease	0.2	0	0	HPO
25978	CHMP2B	C4020884	Anxiety disease	0.2	0	0	HPO
25978	CHMP2B	C4021584	Frontotemporal cerebral atrophy	0.2	0	0	HPO
25978	CHMP2B	C4024936	Temporal cortical atrophy	0.2	0	0	HPO
25978	CHMP2B	C4024956	Grammar-specific speech disorder	0.2	0	0	HPO
26005	C2CD3	C0029294	Orofaciodigital Syndromes	0.200274726784213	1	0	CTD_human
26005	C2CD3	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
26005	C2CD3	C4014780	OROFACIODIGITAL SYNDROME XIV	0.4	1	2	ORPHANET;UNIPROT
26011	TENM4	C4225223	TREMOR, HEREDITARY ESSENTIAL, 5	0.2	1	3	UNIPROT
26012	NSMF	C0018418	Gynecomastia	0.2	0	0	HPO
26012	NSMF	C0029453	Osteopenia	0.2	0	0	HPO
26012	NSMF	C0029456	Osteoporosis	0.2	0	0	HPO
26012	NSMF	C0151721	Testicular hypogonadism	0.2	0	0	HPO
26012	NSMF	C0162809	Kallmann Syndrome	0.201098907136852	0	0	ORPHANET
26012	NSMF	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
26012	NSMF	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
26012	NSMF	C0242350	Erectile dysfunction	0.2	0	0	HPO
26012	NSMF	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
26012	NSMF	C0271623	Hypogonadotropic hypogonadism	0.202681755307501	0	0	HPO
26012	NSMF	C0342384	Idiopathic hypogonadotropic hypogonadism	0.200824180352639	0	0	CTD_human
26012	NSMF	C0747078	Generalized osteopenia	0.2	0	0	HPO
26012	NSMF	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
26012	NSMF	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
26012	NSMF	C3553842	HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA	0.2	2	3	UNIPROT
26012	NSMF	C4020884	Anxiety disease	0.2	0	0	HPO
26012	NSMF	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
26012	NSMF	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
26022	TMEM98	C0017601	Glaucoma	0.2	0	0	HPO
26022	TMEM98	C0038379	Strabismus	0.2	0	0	HPO
26022	TMEM98	C4014848	NANOPHTHALMOS 4	0.2	1	3	UNIPROT
260328	ALRH	C2607914	Allergic rhinitis (disorder)	0.206868169605328	0	0	CTD_human
26034	IPCEF1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
26037	SIPA1L1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
26040	SETBP1	C0014544	Epilepsy	0.2	0	0	HPO
26040	SETBP1	C0020295	Hydronephrosis	0.2	0	0	HPO
26040	SETBP1	C0020555	Hypertrichosis	0.2	0	0	HPO
26040	SETBP1	C0024421	Macroglossia	0.2	0	0	HPO
26040	SETBP1	C0235946	Cerebral atrophy	0.200274726784213	0	0	HPO
26040	SETBP1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
26040	SETBP1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
260403	MMEDF	C1846722	Macrocephaly with Multiple Epiphyseal Dysplasia and Distinctive Facies	0.2	0	0	CTD_human
260415	SCASI	C1846492	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4	0.2	0	0	CTD_human
260431	COPD	C0024117	Chronic Obstructive Airway Disease	0.21124944277542	0	0	CTD_human
260432	SLSN3	C1846980	Senior-Loken Syndrome 3	0.2	0	0	CTD_human
26047	CNTNAP2	C0014544	Epilepsy	0.409195330216668	2	0	CTD_human;HPO
26047	CNTNAP2	C1837658	Gross motor development delay	0.2	0	0	HPO
26047	CNTNAP2	C1864887	Cortical Dysplasia-Focal Epilepsy Syndrome	0.48	0	0	CTD_human;ORPHANET
26047	CNTNAP2	C1970431	PITT-HOPKINS SYNDROME	0.201098907136852	1	0	CTD_human
26053	AUTS2	C0003886	Arthrogryposis	0.2	0	0	HPO
26053	AUTS2	C0007789	Cerebral Palsy	0.2	0	0	HPO
26053	AUTS2	C0014544	Epilepsy	0.2	1	0	CTD_human
26053	AUTS2	C4014435	MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.28	0	0	ORPHANET
26058	GIGYF2	C4274355	Autosomal dominant late onset Parkinson disease	0.2	0	0	ORPHANET
26060	APPL1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202956482091714	0	0	ORPHANET
26060	APPL1	C4225299	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14	0.2	1	2	UNIPROT
26061	HACL1	C0008370	Cholestasis	0.2	1	0	CTD_human
26061	HACL1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
26090	ABHD12	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
26090	ABHD12	C0028738	Nystagmus	0.2	0	0	HPO
26090	ABHD12	C0029124	Optic Atrophy	0.2	0	0	HPO
26090	ABHD12	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	HPO
26090	ABHD12	C0152025	Polyneuropathy	0.200824180352639	0	0	HPO
26090	ABHD12	C0262404	Cerebellar degeneration	0.2	0	0	HPO
26090	ABHD12	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
26090	ABHD12	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
26090	ABHD12	C1848736	Distal amyotrophy	0.2	0	0	HPO
26090	ABHD12	C2675204	Polyneuropathy, Hearing Loss, Ataxia, Retinitis Pigmentosa, And Cataract	0.481098907136852	0	0	CTD_human;ORPHANET
26090	ABHD12	C4020873	Infratentorial atrophy	0.2	0	0	HPO
261	AMCN	C1859721	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE (disorder)	0.2	0	0	CTD_human
26119	LDLRAP1	C0004153	Atherosclerosis	0.200549453568426	0	0	HPO
26119	LDLRAP1	C0010054	Coronary Arteriosclerosis	0.2	0	0	HPO
26119	LDLRAP1	C0020443	Hypercholesterolemia	0.214712312303609	0	0	HPO
26119	LDLRAP1	C0020445	Hypercholesterolemia, Familial	0.201923087489492	0	0	HPO
26119	LDLRAP1	C0020473	Hyperlipidemia	0.2	0	0	HPO
26119	LDLRAP1	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
26119	LDLRAP1	C0027051	Myocardial Infarction	0.200274726784213	0	0	HPO
26119	LDLRAP1	C0221253	Xanthoma tendinosum	0.2	0	0	HPO
26119	LDLRAP1	C0342881	Familial hypercholesterolemia - homozygous	0.2	0	0	ORPHANET
26119	LDLRAP1	C0745103	Hyperlipoproteinemia Type IIa	0.201648360705279	0	0	ORPHANET
26119	LDLRAP1	C1848486	Premature arteriosclerosis	0.2	0	0	HPO
26119	LDLRAP1	C1863512	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE	0.483846174978983	1	4	CTD_human;UNIPROT
26119	LDLRAP1	C2711227	Steatohepatitis	0.2	0	0	HPO
26119	LDLRAP1	C4025272	Peripheral arterial stenosis	0.2	0	0	HPO
26119	LDLRAP1	C4280503	Premature hardening of arteries	0.2	0	0	HPO
26121	PRPF31	C0017601	Glaucoma	0.2	0	0	HPO
26121	PRPF31	C0018777	Conductive hearing loss	0.2	0	0	HPO
26121	PRPF31	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
26121	PRPF31	C0020459	Hyperinsulinism	0.2	0	0	HPO
26121	PRPF31	C0020619	Hypogonadism	0.2	0	0	HPO
26121	PRPF31	C0022578	Keratoconus	0.2	0	0	HPO
26121	PRPF31	C0028077	Night Blindness	0.2	0	0	HPO
26121	PRPF31	C0028738	Nystagmus	0.2	0	0	HPO
26121	PRPF31	C0028754	Obesity	0.2	0	0	HPO
26121	PRPF31	C0029124	Optic Atrophy	0.2	0	0	HPO
26121	PRPF31	C0035334	Retinitis Pigmentosa	0.441967833391755	0	0	HPO;ORPHANET
26121	PRPF31	C0271215	Blindness, Legal	0.2	0	0	HPO
26121	PRPF31	C1838601	Retinitis Pigmentosa 11	0.481373633921066	1	7	CTD_human;UNIPROT
26123	TCTN3	C0235946	Cerebral atrophy	0.2	0	0	HPO
26123	TCTN3	C0406727	Orofaciodigital syndrome 4	0.200549453568426	0	0	ORPHANET
26123	TCTN3	C2745997	OROFACIODIGITAL SYNDROME VI	0.2	0	0	ORPHANET
26123	TCTN3	C3553758	JOUBERT SYNDROME 18	0.2	1	2	UNIPROT
26123	TCTN3	C4020860	Supratentorial atrophy	0.2	0	0	HPO
26123	TCTN3	C4082173	Porencephaly	0.2	0	0	HPO
26128	KIF1BP	C0010043	Corneal Ulcer	0.2	0	0	HPO
26128	KIF1BP	C0392163	Corneal erosion	0.2	0	0	HPO
26128	KIF1BP	C1836123	Goldberg-Shprintzen megacolon syndrome	0.401098907136852	1	1	CTD_human;ORPHANET
26128	KIF1BP	C1955869	Malformations of Cortical Development	0.2	1	0	CTD_human
26137	ZBTB20	C0002871	Anemia	0.2	0	0	HPO
26137	ZBTB20	C0014306	Enophthalmos	0.2	0	0	HPO
26137	ZBTB20	C0014544	Epilepsy	0.2	0	0	HPO
26137	ZBTB20	C0018418	Gynecomastia	0.2	0	0	HPO
26137	ZBTB20	C0018777	Conductive hearing loss	0.2	0	0	HPO
26137	ZBTB20	C0020255	Hydrocephalus	0.2	0	0	HPO
26137	ZBTB20	C0020619	Hypogonadism	0.2	0	0	HPO
26137	ZBTB20	C0029456	Osteoporosis	0.2	0	0	HPO
26137	ZBTB20	C0796121	Primrose syndrome	0.600274726784213	1	8	CTD_human;ORPHANET;UNIPROT
26137	ZBTB20	C1836830	Developmental regression	0.2	0	0	HPO
26137	ZBTB20	C1848736	Distal amyotrophy	0.2	0	0	HPO
26137	ZBTB20	C3805887	Generalized osteoporosis with pathologic fractures	0.2	0	0	HPO
26137	ZBTB20	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
26146	TRAF3IP1	C0024437	Macular degeneration	0.2	0	0	HPO
26146	TRAF3IP1	C0025322	Premature Menopause	0.2	0	0	HPO
26146	TRAF3IP1	C0028738	Nystagmus	0.2	0	0	HPO
26146	TRAF3IP1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
26146	TRAF3IP1	C0038379	Strabismus	0.2	0	0	HPO
26146	TRAF3IP1	C0041349	Nephritis, Tubulointerstitial	0.2	0	0	HPO
26146	TRAF3IP1	C0042798	Low Vision	0.2	0	0	HPO
26146	TRAF3IP1	C0403553	Renal dysplasia and retinal aplasia (disorder)	0.2	0	0	ORPHANET
26146	TRAF3IP1	C0687120	Nephronophthisis	0.200274726784213	0	0	HPO
26146	TRAF3IP1	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
26146	TRAF3IP1	C4225263	SENIOR-LOKEN SYNDROME 9	0.2	1	6	UNIPROT
26154	ABCA12	C0002170	Alopecia	0.2	0	0	HPO
26154	ABCA12	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
26154	ABCA12	C0013592	Ectropion	0.2	0	0	HPO
26154	ABCA12	C0015300	Exophthalmos	0.2	0	0	HPO
26154	ABCA12	C0020620	Hypohidrosis	0.2	0	0	HPO
26154	ABCA12	C0020757	Ichthyoses	0.201648360705279	0	0	HPO
26154	ABCA12	C0022568	Keratitis	0.2	0	0	HPO
26154	ABCA12	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
26154	ABCA12	C0079583	Ichthyosiform Erythroderma, Congenital	0.204106546385879	0	0	HPO
26154	ABCA12	C0259817	Xerosis	0.2	0	0	HPO
26154	ABCA12	C0392163	Corneal erosion	0.2	0	0	HPO
26154	ABCA12	C0870082	Hyperkeratosis	0.200549453568426	0	0	HPO
26154	ABCA12	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
26160	IFT172	C0008370	Cholestasis	0.2	0	0	HPO
26160	IFT172	C0017601	Glaucoma	0.2	0	0	HPO
26160	IFT172	C0018777	Conductive hearing loss	0.2	0	0	HPO
26160	IFT172	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
26160	IFT172	C0020459	Hyperinsulinism	0.2	0	0	HPO
26160	IFT172	C0020619	Hypogonadism	0.2	0	0	HPO
26160	IFT172	C0022578	Keratoconus	0.2	0	0	HPO
26160	IFT172	C0028738	Nystagmus	0.2	0	0	HPO
26160	IFT172	C0028754	Obesity	0.2	0	0	HPO
26160	IFT172	C0029124	Optic Atrophy	0.2	0	0	HPO
26160	IFT172	C0030305	Pancreatitis	0.2	0	0	HPO
26160	IFT172	C0035334	Retinitis Pigmentosa	0.4	0	0	HPO;ORPHANET
26160	IFT172	C0085605	Liver Failure	0.2	0	0	HPO
26160	IFT172	C0239946	Fibrosis, Liver	0.2	0	0	HPO
26160	IFT172	C0271215	Blindness, Legal	0.2	0	0	HPO
26160	IFT172	C0687120	Nephronophthisis	0.2	0	0	HPO
26160	IFT172	C0752166	Bardet-Biedl Syndrome	0.200274726784213	0	0	ORPHANET
26160	IFT172	C1849437	Mainzer-Saldino Disease	0.200274726784213	0	0	ORPHANET
26160	IFT172	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
26160	IFT172	C3810175	SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY	0.2	1	6	UNIPROT
26160	IFT172	C4225342	RETINITIS PIGMENTOSA 71	0.2	1	5	UNIPROT
2617	GARS	C1832274	Charcot-Marie-Tooth disease, Type 2D	0.681648360705279	4	8	CTD_human;ORPHANET;UNIPROT
2617	GARS	C1833308	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V	0.403021994626344	5	5	CTD_human;UNIPROT
2617	GARS	C1848736	Distal amyotrophy	0.200274726784213	0	0	HPO
2617	GARS	C4021523	Upper limb amyotrophy	0.2	0	0	HPO
261734	NPHP4	C0403553	Renal dysplasia and retinal aplasia (disorder)	0.200824180352639	0	0	ORPHANET
261734	NPHP4	C1846979	SENIOR-LOKEN SYNDROME 4	0.4	3	6	CTD_human;UNIPROT
261734	NPHP4	C1847013	NEPHRONOPHTHISIS 4	0.48	6	14	CTD_human;UNIPROT
261734	NPHP4	C1855681	Nephronophthisis, familial juvenile	0.2	0	0	ORPHANET
2618	GART	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
26191	PTPN22	C0002170	Alopecia	0.201098907136852	0	0	HPO
26191	PTPN22	C0003123	Anorexia	0.2	0	0	HPO
26191	PTPN22	C0003864	Arthritis	0.209246487373981	0	0	HPO
26191	PTPN22	C0003873	Rheumatoid Arthritis	0.567076009833421	4	1	CTD_human;UNIPROT
26191	PTPN22	C0007786	Brain Ischemia	0.2	0	0	HPO
26191	PTPN22	C0011854	Diabetes Mellitus, Insulin-Dependent	0.59760885868256	11	1	CTD_human;UNIPROT
26191	PTPN22	C0017601	Glaucoma	0.2	0	0	HPO
26191	PTPN22	C0018213	Graves Disease	0.223493799641443	1	0	CTD_human
26191	PTPN22	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
26191	PTPN22	C0022073	Iridocyclitis	0.2	0	0	HPO
26191	PTPN22	C0024117	Chronic Obstructive Airway Disease	0.2	0	0	HPO
26191	PTPN22	C0024141	Lupus Erythematosus, Systemic	0.432871312084684	2	1	CTD_human;UNIPROT
26191	PTPN22	C0024636	Malocclusion	0.2	0	0	HPO
26191	PTPN22	C0034069	Pulmonary Fibrosis	0.2	0	0	HPO
26191	PTPN22	C0035305	Retinal Detachment	0.2	0	0	HPO
26191	PTPN22	C0037199	Sinusitis	0.2	0	0	HPO
26191	PTPN22	C0039483	Giant Cell Arteritis	0.203831819601666	0	0	ORPHANET
26191	PTPN22	C0042170	Uveomeningoencephalitic Syndrome	0.202956482091714	0	0	ORPHANET
26191	PTPN22	C0042384	Vasculitis	0.201098907136852	0	0	HPO
26191	PTPN22	C0042798	Low Vision	0.2	0	0	HPO
26191	PTPN22	C0042900	Vitiligo	0.21433527120477	0	0	HPO
26191	PTPN22	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
26191	PTPN22	C0157917	Pauciarticular juvenile rheumatoid arthritis	0.2	0	0	ORPHANET
26191	PTPN22	C0162323	Polyarthritis	0.2	0	0	HPO
26191	PTPN22	C0221262	Poliosis	0.2	0	0	HPO
26191	PTPN22	C0521173	Granulomatosis	0.2	0	0	HPO
26191	PTPN22	C0917798	Cerebral Ischemia	0.2	0	0	HPO
26191	PTPN22	C1956391	Temporal Arteritis	0.2	0	0	ORPHANET
26191	PTPN22	C3495801	Granulomatosis with polyangiitis	0.205964121340741	0	0	ORPHANET
26191	PTPN22	C3714757	Juvenile rheumatoid arthritis	0.202747267842131	0	0	HPO
26191	PTPN22	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
2621	GAS6	C0011881	Diabetic Nephropathy	0.200549453568426	1	0	CTD_human
2622	GAS8	C0022521	Kartagener Syndrome	0.200274726784213	0	0	ORPHANET
26227	PHGDH	C0002888	Anemia, Megaloblastic	0.2	0	0	HPO
26227	PHGDH	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
26227	PHGDH	C0014544	Epilepsy	0.2	0	0	HPO
26227	PHGDH	C0015300	Exophthalmos	0.2	0	0	HPO
26227	PHGDH	C0028738	Nystagmus	0.2	0	0	HPO
26227	PHGDH	C0033999	Pterygium	0.2	0	0	HPO
26227	PHGDH	C0158113	Contracture of joint of hand	0.2	0	0	HPO
26227	PHGDH	C0265218	Neu-Laxova syndrome	0.400824180352639	1	4	ORPHANET;UNIPROT
26227	PHGDH	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
26227	PHGDH	C0580190	3-Phosphoglycerate dehydrogenase deficiency	0.2	0	0	ORPHANET
26227	PHGDH	C1866174	Phosphoglycerate Dehydrogenase Deficiency	0.4	3	6	CTD_human;UNIPROT
26227	PHGDH	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
26229	B3GAT3	C0010495	Cutis Laxa	0.2	0	0	HPO
26229	B3GAT3	C0014877	Esotropia	0.2	0	0	HPO
26229	B3GAT3	C0020255	Hydrocephalus	0.2	0	0	HPO
26229	B3GAT3	C0020490	Hyperopia	0.2	0	0	HPO
26229	B3GAT3	C0026267	Mitral Valve Prolapse Syndrome	0.200274726784213	0	0	HPO
26229	B3GAT3	C0029453	Osteopenia	0.2	0	0	HPO
26229	B3GAT3	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
26229	B3GAT3	C0238669	Aortic root dilatation	0.2	0	0	HPO
26229	B3GAT3	C0747078	Generalized osteopenia	0.2	0	0	HPO
26229	B3GAT3	C2930812	Generalized elastolysis	0.2	0	0	HPO
26229	B3GAT3	C3278404	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, CRANIOFACIAL DYSMORPHISM, AND CONGENITAL HEART DEFECTS	0.4	2	1	ORPHANET;UNIPROT
2623	GATA1	C0002395	Alzheimer's Disease	0.202407028523288	0	0	HPO
2623	GATA1	C0002871	Anemia	0.202472541057918	0	0	HPO
2623	GATA1	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
2623	GATA1	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
2623	GATA1	C0013080	Down Syndrome	0.259392290489123	0	0	CTD_human
2623	GATA1	C0013902	Elliptocytosis, Hereditary	0.2	0	0	HPO
2623	GATA1	C0018777	Conductive hearing loss	0.2	0	0	HPO
2623	GATA1	C0020555	Hypertrichosis	0.2	0	0	HPO
2623	GATA1	C0020676	Hypothyroidism	0.2	0	0	HPO
2623	GATA1	C0024421	Macroglossia	0.2	0	0	HPO
2623	GATA1	C0029453	Osteopenia	0.2	0	0	HPO
2623	GATA1	C0031256	Petechiae	0.2	0	0	HPO
2623	GATA1	C0162530	Porphyria, Erythropoietic	0.201098907136852	0	0	ORPHANET
2623	GATA1	C0264142	Spade-like hand	0.2	0	0	HPO
2623	GATA1	C0410653	Atlantoaxial instability	0.2	0	0	HPO
2623	GATA1	C0678199	Dyserythropoietic anemia	0.200824180352639	0	0	HPO
2623	GATA1	C0687751	Acanthocytosis	0.2	0	0	HPO
2623	GATA1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
2623	GATA1	C0747078	Generalized osteopenia	0.2	0	0	HPO
2623	GATA1	C1839161	Thrombocytopenia, Platelet Dysfunction, Hemolysis, and Imbalanced Globin Synthesis	0.6	1	2	CTD_human;ORPHANET;UNIPROT
2623	GATA1	C1860788	Transient Myeloproliferative Disorder of Down Syndrome	0.200274726784213	1	0	CTD_human
2623	GATA1	C1863051	ALZHEIMER DISEASE 2	0.2	0	0	HPO
2623	GATA1	C3550789	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA	0.6	4	4	CTD_human;ORPHANET;UNIPROT
2623	GATA1	C3550856	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES	0.2	0	0	ORPHANET
2623	GATA1	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
26235	FBXL4	C0014544	Epilepsy	0.2	0	0	HPO
26235	FBXL4	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
26235	FBXL4	C0023520	Leukodystrophy	0.2	0	0	HPO
26235	FBXL4	C0234958	muscle degeneration	0.2	0	0	HPO
26235	FBXL4	C0235946	Cerebral atrophy	0.2	0	0	HPO
26235	FBXL4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
26235	FBXL4	C3809592	MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE)	0.400274726784213	2	8	ORPHANET;UNIPROT
26235	FBXL4	C4020860	Supratentorial atrophy	0.2	0	0	HPO
2624	GATA2	C0024236	Lymphedema	0.401098907136852	1	0	CTD_human;HPO
2624	GATA2	C0030312	Pancytopenia	0.200274726784213	0	0	HPO
2624	GATA2	C3279664	Emberger syndrome	0.401098907136852	1	5	ORPHANET;UNIPROT
2624	GATA2	C3280030	IMMUNODEFICIENCY 21	0.401648360705279	2	9	ORPHANET;UNIPROT
26249	KLHL3	C0033805	Pseudohypoaldosteronism	0.400274726784213	1	0	CTD_human;HPO
26249	KLHL3	C0085679	Hyperchloremia	0.2	0	0	HPO
26249	KLHL3	C3469605	PSEUDOHYPOALDOSTERONISM, TYPE IID	0.480549453568426	2	27	ORPHANET;UNIPROT
2625	GATA3	C0003873	Rheumatoid Arthritis	0.200549453568426	1	1	CTD_human
2625	GATA3	C0018784	Sensorineural Hearing Loss (disorder)	0.200824180352639	0	0	HPO
2625	GATA3	C0020626	Hypoparathyroidism	0.217799819464583	0	0	HPO
2625	GATA3	C1840333	Barakat syndrome	0.689065983879032	3	7	CTD_human;ORPHANET;UNIPROT
26258	BLOC1S6	C0028738	Nystagmus	0.2	0	0	HPO
26258	BLOC1S6	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
26258	BLOC1S6	C3280026	HERMANSKY-PUDLAK SYNDROME 9	0.28	0	0	ORPHANET
2626	GATA4	C0004509	Azoospermia	0.2	0	0	HPO
2626	GATA4	C0014544	Epilepsy	0.2	0	0	HPO
2626	GATA4	C0015300	Exophthalmos	0.2	0	0	HPO
2626	GATA4	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
2626	GATA4	C0018418	Gynecomastia	0.2	0	0	HPO
2626	GATA4	C0027051	Myocardial Infarction	0.280274726784213	1	0	CTD_human
2626	GATA4	C0029456	Osteoporosis	0.2	0	0	HPO
2626	GATA4	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
2626	GATA4	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
2626	GATA4	C0266427	Testicular regression syndrome	0.2	0	0	HPO
2626	GATA4	C0948896	Primary hypogonadism	0.2	0	0	HPO
2626	GATA4	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
2626	GATA4	C2931638	Chromosome 8, monosomy 8p23 1	0.2	0	0	ORPHANET
2626	GATA4	C3809858	TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE	0.2	1	1	UNIPROT
26266	SLC13A4	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
26266	SLC13A4	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2627	GATA6	C0015300	Exophthalmos	0.2	0	0	HPO
2627	GATA6	C0020456	Hyperglycemia	0.2	0	0	HPO
2627	GATA6	C0030293	Pancreatic Insufficiency	0.2	0	0	HPO
2627	GATA6	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
2627	GATA6	C0267963	Exocrine pancreatic insufficiency	0.200549453568426	0	0	HPO
2627	GATA6	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
2627	GATA6	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	0.2	1	1	UNIPROT
2627	GATA6	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
2627	GATA6	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2627	GATA6	C2931296	Yorifuji Okuno syndrome	0.2	0	0	ORPHANET
2627	GATA6	C4012454	HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES	0.2	1	5	UNIPROT
26270	FBXO6	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
26275	HIBCH	C0014544	Epilepsy	0.2	0	0	HPO
26275	HIBCH	C0028738	Nystagmus	0.2	0	0	HPO
26275	HIBCH	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
26275	HIBCH	C0038379	Strabismus	0.2	0	0	HPO
26275	HIBCH	C0238621	Aminoaciduria	0.2	0	0	HPO
26275	HIBCH	C0342738	Beta-Hydroxyisobutyryl CoA Deacylase Deficiency	0.600274726784213	1	8	CTD_human;ORPHANET;UNIPROT
26275	HIBCH	C1836830	Developmental regression	0.2	0	0	HPO
26275	HIBCH	C4020871	Dystonic disease	0.2	0	0	HPO
26276	VPS33B	C0003886	Arthrogryposis	0.201098907136852	0	0	HPO
26276	VPS33B	C0020757	Ichthyoses	0.20328236603324	0	0	HPO
26276	VPS33B	C0027613	Neonatal hepatitis	0.2	0	0	HPO
26276	VPS33B	C0027709	Nephrocalcinosis	0.2	0	0	HPO
26276	VPS33B	C0162770	Right Ventricular Hypertrophy	0.2	0	0	HPO
26276	VPS33B	C0268307	Conjugated hyperbilirubinemia	0.2	0	0	HPO
26276	VPS33B	C0860204	Cholestatic liver disease	0.2	0	0	HPO
26276	VPS33B	C1859722	Arthrogryposis renal dysfunction cholestasis syndrome	0.684120901763197	2	9	CTD_human;ORPHANET;UNIPROT
26276	VPS33B	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
26276	VPS33B	C4020697	Giant cell hepatitis on liver biopsy	0.2	0	0	HPO
26277	TINF2	C0002170	Alopecia	0.2	0	0	HPO
26277	TINF2	C0002871	Anemia	0.2	0	0	HPO
26277	TINF2	C0002874	Aplastic Anemia	0.200549453568426	0	0	HPO
26277	TINF2	C0011334	Dental caries	0.2	0	0	HPO
26277	TINF2	C0023530	Leukopenia	0.2	0	0	HPO
26277	TINF2	C0023890	Liver Cirrhosis	0.2	0	0	HPO
26277	TINF2	C0024312	Lymphopenia	0.2	0	0	HPO
26277	TINF2	C0028738	Nystagmus	0.2	0	0	HPO
26277	TINF2	C0029456	Osteoporosis	0.2	0	0	HPO
26277	TINF2	C0031099	Periodontitis	0.2	0	0	HPO
26277	TINF2	C0034069	Pulmonary Fibrosis	0.200549453568426	0	0	HPO
26277	TINF2	C0152227	Excessive tearing	0.2	0	0	HPO
26277	TINF2	C0152458	Leukocoria	0.2	0	0	HPO
26277	TINF2	C0206061	Pneumonia, Interstitial	0.2	0	0	HPO
26277	TINF2	C0221260	Dystrophia unguium	0.2	0	0	HPO
26277	TINF2	C0235946	Cerebral atrophy	0.2	0	0	HPO
26277	TINF2	C0259817	Xerosis	0.2	0	0	HPO
26277	TINF2	C0265965	Dyskeratosis Congenita	0.412543208784538	1	0	CTD_human;ORPHANET
26277	TINF2	C0266039	Taurodontism	0.2	0	0	HPO
26277	TINF2	C0399385	Early tooth exfoliation	0.2	0	0	HPO
26277	TINF2	C1327916	REVESZ SYNDROME (disorder)	0.600274726784213	1	4	CTD_human;ORPHANET;UNIPROT
26277	TINF2	C1834405	Nail dysplasia	0.2	0	0	HPO
26277	TINF2	C1846142	HOYERAAL-HREIDARSSON SYNDROME	0.2	0	0	ORPHANET
26277	TINF2	C1851970	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT	0.200274726784213	0	0	CTD_human
26277	TINF2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
26277	TINF2	C3151445	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3	0.28	1	6	UNIPROT
26277	TINF2	C4023400	Generalized hypopigmentation of hair	0.2	0	0	HPO
26278	SACS	C0028738	Nystagmus	0.2	0	0	HPO
26278	SACS	C0085606	Urgency of micturition	0.2	0	0	HPO
26278	SACS	C0751778	Myoclonic Epilepsies, Progressive	0.2	1	0	CTD_human
26278	SACS	C1848736	Distal amyotrophy	0.2	0	0	HPO
26278	SACS	C1849140	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.610714344584311	11	105	CTD_human;ORPHANET;UNIPROT
26278	SACS	C1849156	Spastic Ataxia	0.200824180352639	0	0	HPO
26278	SACS	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
26278	SACS	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
2628	GATM	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
2628	GATM	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2628	GATM	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2628	GATM	C2675179	Arginine:Glycine Amidinotransferase Deficiency	0.601373633921066	1	12	CTD_human;ORPHANET;UNIPROT
26281	FGF20	C1609433	Congenital absence of kidneys syndrome	0.2	0	0	ORPHANET
26281	FGF20	C3160718	PARKINSON DISEASE, LATE-ONSET	0.2	0	0	CTD_human
2629	GBA	C0002871	Anemia	0.200549453568426	0	0	HPO
2629	GBA	C0003123	Anorexia	0.2	0	0	HPO
2629	GBA	C0003886	Arthrogryposis	0.200274726784213	0	0	HPO
2629	GBA	C0013592	Ectropion	0.2	0	0	HPO
2629	GBA	C0014544	Epilepsy	0.2	0	0	HPO
2629	GBA	C0014550	Epilepsies, Myoclonic	0.202732912464814	0	0	HPO
2629	GBA	C0014877	Esotropia	0.2	0	0	HPO
2629	GBA	C0017205	Gaucher Disease	0.324300964548867	5	19	CTD_human
2629	GBA	C0020255	Hydrocephalus	0.2	0	0	HPO
2629	GBA	C0020305	Hydrops Fetalis	0.2	0	0	HPO
2629	GBA	C0020455	Hypergammaglobulinemia	0.202407028523288	0	0	HPO
2629	GBA	C0020532	Hypersplenism	0.2	0	0	HPO
2629	GBA	C0029453	Osteopenia	0.200274726784213	0	0	HPO
2629	GBA	C0029464	Osteosclerosis	0.2	0	0	HPO
2629	GBA	C0030312	Pancytopenia	0.2	0	0	HPO
2629	GBA	C0030567	Parkinson Disease	0.315490167940078	2	0	CTD_human
2629	GBA	C0031256	Petechiae	0.2	0	0	HPO
2629	GBA	C0034150	Purpura	0.2	0	0	HPO
2629	GBA	C0038379	Strabismus	0.2	0	0	HPO
2629	GBA	C0041105	Trismus	0.2	0	0	HPO
2629	GBA	C0085605	Liver Failure	0.2	0	0	HPO
2629	GBA	C0085623	Akinesia	0.2	0	0	HPO
2629	GBA	C0235946	Cerebral atrophy	0.2	0	0	HPO
2629	GBA	C0268250	Gaucher Disease, Type 2 (disorder)	0.480824180352639	12	10	ORPHANET;UNIPROT
2629	GBA	C0268251	Gaucher Disease, Type 3 (disorder)	0.480824180352639	1	11	ORPHANET;UNIPROT
2629	GBA	C0271385	Horizontal Nystagmus	0.2	0	0	HPO
2629	GBA	C0410550	Collapse of vertebra	0.2	0	0	HPO
2629	GBA	C0455988	Hydrops Fetalis, Non-Immune	0.2	0	0	HPO
2629	GBA	C0747078	Generalized osteopenia	0.2	0	0	HPO
2629	GBA	C0747651	Recurrent aspiration pneumonia	0.2	0	0	HPO
2629	GBA	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
2629	GBA	C0752347	Lewy Body Disease	0.213800173013661	1	0	CTD_human
2629	GBA	C0870082	Hyperkeratosis	0.2	0	0	HPO
2629	GBA	C1276035	Pena-Shokeir syndrome type I	0.2	0	0	HPO
2629	GBA	C1288283	Atrophoderma maculatum	0.2	0	0	HPO
2629	GBA	C1408507	Supranuclear ophthalmoplegia	0.2	0	0	HPO
2629	GBA	C1842704	GAUCHER DISEASE, PERINATAL LETHAL	0.4	0	0	CTD_human;ORPHANET
2629	GBA	C1856476	Gaucher Disease, Type Iiic	0.2	0	0	CTD_human
2629	GBA	C1961835	Gaucher Disease, Type 1	0.486318716036901	40	114	ORPHANET;UNIPROT
2629	GBA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2629	GBA	C2931585	Gaucher-like disease	0.2	0	0	ORPHANET
2629	GBA	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
2629	GBA	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
2629	GBA	C3489733	Oculomotor apraxia	0.2	0	0	HPO
2629	GBA	C4020860	Supratentorial atrophy	0.2	0	0	HPO
2629	GBA	C4020871	Dystonic disease	0.2	0	0	HPO
2629	GBA	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
2629	GBA	C4024794	Horizontal supranuclear gaze palsy	0.2	0	0	HPO
2629	GBA	C4274355	Autosomal dominant late onset Parkinson disease	0.2	0	0	ORPHANET
26291	FGF21	C0011854	Diabetes Mellitus, Insulin-Dependent	0.2	1	0	CTD_human
26291	FGF21	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.206579087443797	1	0	CTD_human
26291	FGF21	C0015695	Fatty Liver	0.202197814273705	1	0	CTD_human
26291	FGF21	C0028754	Obesity	0.206593442821114	2	0	CTD_human
26291	FGF21	C0400966	Non-alcoholic Fatty Liver Disease	0.201648360705279	1	0	CTD_human
26291	FGF21	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
2632	GBE1	C0003886	Arthrogryposis	0.2	0	0	HPO
2632	GBE1	C0005697	Neurogenic Urinary Bladder	0.2	0	0	HPO
2632	GBE1	C0017922	Glycogen Storage Disease Type III	0.200274726784213	0	0	ORPHANET
2632	GBE1	C0017923	Glycogen Storage Disease Type IV	0.693158174887594	5	14	CTD_human;ORPHANET;UNIPROT
2632	GBE1	C0020305	Hydrops Fetalis	0.2	0	0	HPO
2632	GBE1	C0020541	Hypertension, Portal	0.2	0	0	HPO
2632	GBE1	C0023890	Liver Cirrhosis	0.200549453568426	0	0	HPO
2632	GBE1	C0085605	Liver Failure	0.200274726784213	0	0	HPO
2632	GBE1	C0234958	muscle degeneration	0.2	0	0	HPO
2632	GBE1	C1849722	Polyglucosan Body Disease, Adult Form	0.40439562854741	1	2	ORPHANET;UNIPROT
2632	GBE1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2633	GBP1	C0021400	Influenza	0.200274726784213	1	0	CTD_human
26330	GAPDHS	C0002395	Alzheimer's Disease	0.209628114093152	1	0	CTD_human
2634	GBP2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
26353	HSPB8	C0270921	Axonal neuropathy	0.2	0	0	HPO
26353	HSPB8	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
26353	HSPB8	C1834692	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA	0.4	2	2	CTD_human;UNIPROT
26353	HSPB8	C1837552	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L (disorder)	0.600274726784213	0	0	CTD_human;ORPHANET;UNIPROT
26353	HSPB8	C1848736	Distal amyotrophy	0.2	0	0	HPO
2637	GBX2	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
2638	GC	C0003873	Rheumatoid Arthritis	0.202956482091714	1	0	CTD_human
2638	GC	C0018213	Graves Disease	0.202956482091714	1	0	CTD_human
2638	GC	C0019151	Hepatic Encephalopathy	0.2	1	0	CTD_human
2638	GC	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
2638	GC	C0162557	Liver Failure, Acute	0.205465824929628	2	0	CTD_human
2638	GC	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2639	GCDH	C0013384	Dyskinetic syndrome	0.200824180352639	0	0	HPO
2639	GCDH	C0020615	Hypoglycemia	0.2	0	0	HPO
2639	GCDH	C0022638	Ketosis	0.2	0	0	HPO
2639	GCDH	C0023882	Little's Disease	0.2	0	0	HPO
2639	GCDH	C0085583	Choreoathetosis	0.2	0	0	HPO
2639	GCDH	C0162275	Ketonuria	0.2	0	0	HPO
2639	GCDH	C0268595	Glutaric aciduria, type 1	0.609065983879032	7	70	CTD_human;ORPHANET;UNIPROT
2639	GCDH	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2639	GCDH	C4020871	Dystonic disease	0.2	0	0	HPO
2639	GCDH	C4024972	Symmetrical progressive peripheral demyelination	0.2	0	0	HPO
2641	GCG	C0009319	Colitis	0.200274726784213	1	0	CTD_human
2641	GCG	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.240057274606176	1	0	CTD_human
2641	GCG	C0018801	Heart failure	0.2	1	0	CTD_human
2641	GCG	C0020456	Hyperglycemia	0.208516530310606	2	0	CTD_human
2641	GCG	C0020459	Hyperinsulinism	0.201923087489492	1	0	CTD_human
2641	GCG	C0020473	Hyperlipidemia	0.2	1	0	CTD_human
2641	GCG	C0028754	Obesity	0.210648832049681	1	0	CTD_human
2641	GCG	C0039239	Sinus Tachycardia	0.2	1	0	CTD_human
2642	GCGR	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.214847922993201	0	0	CTD_human
2642	GCGR	C1857451	Acth-Independent Macronodular Adrenal Hyperplasia	0.2	1	0	CTD_human
2643	GCH1	C0013386	Dyskinesia, Drug-Induced	0.2	1	0	CTD_human
2643	GCH1	C0014544	Epilepsy	0.2	0	0	HPO
2643	GCH1	C0037036	Sialorrhea	0.2	0	0	HPO
2643	GCH1	C0085583	Choreoathetosis	0.2	0	0	HPO
2643	GCH1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2643	GCH1	C0154676	Organic writer's cramp	0.2	0	0	HPO
2643	GCH1	C0268467	Hyperphenylalaninemia, BH4-Deficient, B	0.601373633921066	4	5	CTD_human;ORPHANET;UNIPROT
2643	GCH1	C0751435	Hyperphenylalaninaemia	0.202472541057918	0	0	HPO
2643	GCH1	C1851920	Dopa-Responsive Dystonia	0.63186830696872	14	12	CTD_human;ORPHANET;UNIPROT
2643	GCH1	C4020871	Dystonic disease	0.2	0	0	HPO
2645	GCK	C0003886	Arthrogryposis	0.2	0	0	HPO
2645	GCK	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.898965770964596	4	2	CTD_human;HPO;ORPHANET
2645	GCK	C0014544	Epilepsy	0.2	0	0	HPO
2645	GCK	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
2645	GCK	C0020456	Hyperglycemia	0.437845104955154	1	0	CTD_human;HPO
2645	GCK	C0020617	Hypoglycemic coma	0.2	0	0	HPO
2645	GCK	C0162275	Ketonuria	0.2	0	0	HPO
2645	GCK	C0342276	Maturity onset diabetes mellitus in young	0.437088115868769	0	0	CTD_human;HPO
2645	GCK	C0342277	Diabetes mellitus autosomal dominant type II (disorder)	0.486868169605328	13	101	CTD_human;UNIPROT
2645	GCK	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
2645	GCK	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
2645	GCK	C0877056	Hypoglycaemic seizure	0.2	0	0	HPO
2645	GCK	C1833104	DIABETES MELLITUS, PERMANENT NEONATAL	0.403296721410557	0	0	CTD_human;ORPHANET
2645	GCK	C1864903	Hyperinsulinaemic hypoglycaemia	0.202472541057918	0	0	HPO
2645	GCK	C1865290	Hyperinsulinemic hypoglycemia, familial, 3	0.6	1	3	CTD_human;ORPHANET;UNIPROT
2645	GCK	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2645	GCK	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
2646	GCKR	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.239258447544924	1	1	CTD_human
26471	NUPR1	C0023794	Lipoidosis	0.2	1	0	CTD_human
26471	NUPR1	C0030305	Pancreatitis	0.200274726784213	1	0	CTD_human
265	AMELX	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
265	AMELX	C1845052	AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1	0.200549453568426	0	0	CTD_human
265	AMELX	C1845053	Amelogenesis Imperfecta, Hypomaturation Type, with Snow-Capped Teeth	0.2	3	3	UNIPROT
26503	SLC17A5	C0014544	Epilepsy	0.2	0	0	HPO
26503	SLC17A5	C0015310	Exotropia	0.2	0	0	HPO
26503	SLC17A5	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
26503	SLC17A5	C0018801	Heart failure	0.2	0	0	HPO
26503	SLC17A5	C0018802	Congestive heart failure	0.2	0	0	HPO
26503	SLC17A5	C0020255	Hydrocephalus	0.2	0	0	HPO
26503	SLC17A5	C0020305	Hydrops Fetalis	0.2	0	0	HPO
26503	SLC17A5	C0028738	Nystagmus	0.2	0	0	HPO
26503	SLC17A5	C0029453	Osteopenia	0.2	0	0	HPO
26503	SLC17A5	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
26503	SLC17A5	C0235946	Cerebral atrophy	0.2	0	0	HPO
26503	SLC17A5	C0268307	Conjugated hyperbilirubinemia	0.2	0	0	HPO
26503	SLC17A5	C0342853	Sialuria	0.202747267842131	0	0	CTD_human
26503	SLC17A5	C0747078	Generalized osteopenia	0.2	0	0	HPO
26503	SLC17A5	C1096902	Infantile Sialic Acid Storage Disease	0.281923087489492	2	4	UNIPROT
26503	SLC17A5	C1096903	Sialic Acid Storage Disease, Finnish Type (disorder)	0.482747267842131	4	29	ORPHANET;UNIPROT
26503	SLC17A5	C1963905	Infantile free sialic acid storage disease	0.2	0	0	ORPHANET
26503	SLC17A5	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
26503	SLC17A5	C4020860	Supratentorial atrophy	0.2	0	0	HPO
26504	CNNM4	C0011334	Dental caries	0.2	0	0	HPO
26504	CNNM4	C0028077	Night Blindness	0.2	0	0	HPO
26504	CNNM4	C0028738	Nystagmus	0.2	0	0	HPO
26504	CNNM4	C0029124	Optic Atrophy	0.2	0	0	HPO
26504	CNNM4	C0035334	Retinitis Pigmentosa	0.200824180352639	0	0	HPO
26504	CNNM4	C0042798	Low Vision	0.2	0	0	HPO
26504	CNNM4	C0152200	Achromatopsia	0.200274726784213	0	0	HPO
26504	CNNM4	C0730290	Cone dystrophy	0.2	0	0	HPO
26504	CNNM4	C1857588	Amaurosis hypertrichosis	0.2	0	0	CTD_human
26504	CNNM4	C1857618	Achromatopsia 2	0.2	0	0	HPO
26504	CNNM4	C2931074	Cone rod dystrophy amelogenesis imperfecta	0.2	0	0	ORPHANET
26504	CNNM4	C3495589	Jalili syndrome	0.201373633921065	2	3	UNIPROT
26504	CNNM4	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
2651	GCNT2	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
2651	GCNT2	C3805373	CATARACT 13 WITH ADULT i PHENOTYPE	0.2	1	2	UNIPROT
2652	OPN1MW	C0027092	Myopia	0.2	0	0	HPO
2652	OPN1MW	C0028077	Night Blindness	0.2	0	0	HPO
2652	OPN1MW	C0028738	Nystagmus	0.2	0	0	HPO
2652	OPN1MW	C0035334	Retinitis Pigmentosa	0.2	0	0	ORPHANET
2652	OPN1MW	C0042798	Low Vision	0.2	0	0	HPO
2652	OPN1MW	C0155016	Color Blindness, Red-Green	0.2	0	0	HPO
2652	OPN1MW	C0271388	Pendular Nystagmus	0.2	0	0	HPO
2652	OPN1MW	C0339537	Cone monochromatism	0.600549453568426	1	2	CTD_human;HPO;ORPHANET;UNIPROT
2652	OPN1MW	C2931753	Achromatopsia incomplete, X-linked	0.2	0	0	ORPHANET
2652	OPN1MW	C3887938	COLORBLINDNESS, PARTIAL, DEUTAN SERIES	0.400274726784213	3	3	CTD_human;UNIPROT
2652	OPN1MW	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
26525	IL36RN	C0030246	Pustulosis of Palms and Soles	0.2	0	0	ORPHANET
26525	IL36RN	C0030436	Parakeratosis	0.2	0	0	HPO
26525	IL36RN	C0033860	Psoriasis	0.201373633921065	0	0	HPO
26525	IL36RN	C0343055	Generalized pustular psoriasis	0.403296721410557	3	8	ORPHANET;UNIPROT
2653	GCSH	C0014544	Epilepsy	0.2	0	0	HPO
2653	GCSH	C0543541	HYPERGLYCINURIA (disorder)	0.2	0	0	HPO
2653	GCSH	C0751748	Nonketotic Hyperglycinemia	0.204604842796993	0	0	CTD_human
2657	GDF1	C0015300	Exophthalmos	0.2	0	0	HPO
2657	GDF1	C0175707	Asplenia Syndrome	0.2	0	0	ORPHANET
2657	GDF1	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
2657	GDF1	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	0.4	1	1	CTD_human;UNIPROT
2657	GDF1	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
2657	GDF1	C3151221	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 3	0.2	1	1	UNIPROT
2658	GDF2	C0008325	Cholecystitis	0.2	0	0	HPO
2658	GDF2	C0020541	Hypertension, Portal	0.2	0	0	HPO
2658	GDF2	C0039445	Hereditary hemorrhagic telangiectasia	0.200549453568426	0	0	ORPHANET
2658	GDF2	C0039446	Telangiectasis	0.2	0	0	HPO
2658	GDF2	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
2658	GDF2	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
2658	GDF2	C1697453	Spontaneous haematoma	0.2	0	0	HPO
2658	GDF2	C3809710	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5	0.2	1	3	UNIPROT
2658	GDF2	C4021977	Visceral angiomatosis	0.2	0	0	HPO
26580	BSCL2	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
26580	BSCL2	C0001206	Acromegaly	0.2	0	0	HPO
26580	BSCL2	C0001339	Acute pancreatitis	0.2	0	0	HPO
26580	BSCL2	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
26580	BSCL2	C0011859	Lipoatrophic Diabetes Mellitus	0.2	0	0	ORPHANET
26580	BSCL2	C0014544	Epilepsy	0.2	0	0	HPO
26580	BSCL2	C0020459	Hyperinsulinism	0.200274726784213	0	0	HPO
26580	BSCL2	C0023787	Lipodystrophy	0.410410907045463	1	0	CTD_human;HPO
26580	BSCL2	C0023890	Liver Cirrhosis	0.2	0	0	HPO
26580	BSCL2	C0028960	Oligospermia	0.2	1	0	CTD_human
26580	BSCL2	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
26580	BSCL2	C0034013	Precocious Puberty	0.2	0	0	HPO
26580	BSCL2	C0037772	Spastic Paraplegia	0.200274726784213	0	0	HPO
26580	BSCL2	C0085605	Liver Failure	0.2	0	0	HPO
26580	BSCL2	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
26580	BSCL2	C0221032	Familial generalized lipodystrophy	0.218074546248796	0	0	CTD_human
26580	BSCL2	C0235946	Cerebral atrophy	0.2	0	0	HPO
26580	BSCL2	C0403823	Asthenozoospermia	0.2	1	0	CTD_human
26580	BSCL2	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
26580	BSCL2	C1280433	Lipoatrophy	0.200274726784213	0	0	HPO
26580	BSCL2	C1833308	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V	0.401648360705279	0	0	CTD_human;UNIPROT
26580	BSCL2	C1836830	Developmental regression	0.2	0	0	HPO
26580	BSCL2	C1848736	Distal amyotrophy	0.200274726784213	0	0	HPO
26580	BSCL2	C2711227	Steatohepatitis	0.200824180352639	0	0	HPO
26580	BSCL2	C2931276	Spastic paraplegia 17	0.605978476718058	3	2	CTD_human;ORPHANET;UNIPROT
26580	BSCL2	C4014700	ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY	0.2	0	0	ORPHANET
26580	BSCL2	C4020860	Supratentorial atrophy	0.2	0	0	HPO
26580	BSCL2	C4020871	Dystonic disease	0.2	0	0	HPO
26585	GREM1	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
26585	GREM1	C1832587	POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.200274726784213	0	0	ORPHANET
266	AMELY	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
2660	MSTN	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
26608	TBL2	C0003499	Supravalvular aortic stenosis	0.2	0	0	HPO
26608	TBL2	C0007786	Brain Ischemia	0.2	0	0	HPO
26608	TBL2	C0012819	Diverticular disease of colon	0.2	0	0	HPO
26608	TBL2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
26608	TBL2	C0020437	Hypercalcemia	0.2	0	0	HPO
26608	TBL2	C0020545	Hypertension, Renovascular	0.2	0	0	HPO
26608	TBL2	C0024421	Macroglossia	0.2	0	0	HPO
26608	TBL2	C0024636	Malocclusion	0.2	0	0	HPO
26608	TBL2	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
26608	TBL2	C0028754	Obesity	0.2	0	0	HPO
26608	TBL2	C0035078	Kidney Failure	0.2	0	0	HPO
26608	TBL2	C0038379	Strabismus	0.2	0	0	HPO
26608	TBL2	C0042798	Low Vision	0.2	0	0	HPO
26608	TBL2	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
26608	TBL2	C0175702	Williams Syndrome	0.200274726784213	0	0	ORPHANET
26608	TBL2	C0271441	Chronic otitis media	0.2	0	0	HPO
26608	TBL2	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
26608	TBL2	C0743359	ear infection chronic	0.2	0	0	HPO
26608	TBL2	C0917798	Cerebral Ischemia	0.2	0	0	HPO
26608	TBL2	C1565489	Renal Insufficiency	0.2	0	0	HPO
26608	TBL2	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
26608	TBL2	C4020884	Anxiety disease	0.2	0	0	HPO
26608	TBL2	C4025788	Nystagmus-induced head nodding	0.2	0	0	HPO
26608	TBL2	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
2661	GDF9	C0032460	Polycystic Ovary Syndrome	0.205154296365419	1	0	CTD_human
26610	ELP4	C0017601	Glaucoma	0.2	0	0	HPO
26610	ELP4	C0028738	Nystagmus	0.2	0	0	HPO
2664	GDI1	C0796208	MENTAL RETARDATION, X-LINKED 3	0.2	0	0	CTD_human
2664	GDI1	C1136249	Mental Retardation, X-Linked	0.200824180352639	2	0	CTD_human
2664	GDI1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
2664	GDI1	C3887939	MENTAL RETARDATION, X-LINKED 41	0.28	2	4	UNIPROT
266678	MRX81	C1845531	MENTAL RETARDATION, X-LINKED 81	0.2	0	0	CTD_human
266719	RRDX	C1845717	Radial Ray Deficiency, X-Linked	0.2	0	0	CTD_human
266789	EPPS	C1846609	EPILEPSY, PARTIAL, WITH PERICENTRAL SPIKES	0.2	0	0	CTD_human
266790	HCA1	C1846573	HYPERCALCIURIA, ABSORPTIVE, 1 (disorder)	0.2	0	0	CTD_human
2668	GDNF	C0013386	Dyskinesia, Drug-Induced	0.2	1	0	CTD_human
2668	GDNF	C0020179	Huntington Disease	0.20328236603324	1	0	CTD_human
2668	GDNF	C0021843	Intestinal Obstruction	0.2	0	0	HPO
2668	GDNF	C0030567	Parkinson Disease	0.220055055247556	2	0	CTD_human
2668	GDNF	C0030569	Secondary Parkinson Disease	0.2	1	0	CTD_human
2668	GDNF	C0038220	Status Epilepticus	0.2	2	0	CTD_human
2668	GDNF	C1275808	Congenital central hypoventilation	0.4	1	1	CTD_human;ORPHANET
266979	CTRCT27	C1846520	CATARACT, NUCLEAR PROGRESSIVE	0.2	0	0	CTD_human
267	AMFR	C0002395	Alzheimer's Disease	0.2	1	0	CTD_human
2670	GFAP	C0002736	Amyotrophic Lateral Sclerosis	0.202472541057918	1	0	CTD_human
2670	GFAP	C0014544	Epilepsy	0.401098907136852	1	0	CTD_human;HPO
2670	GFAP	C0020255	Hydrocephalus	0.2	0	0	HPO
2670	GFAP	C0027873	Neuromyelitis Optica	0.201098907136852	1	0	CTD_human
2670	GFAP	C0030567	Parkinson Disease	0.201648360705279	1	0	CTD_human
2670	GFAP	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
2670	GFAP	C0270726	Alexander Disease	0.568956031190961	20	91	CTD_human;UNIPROT
2670	GFAP	C0752347	Lewy Body Disease	0.200274726784213	1	0	CTD_human
2670	GFAP	C1836830	Developmental regression	0.2	0	0	HPO
2670	GFAP	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
2670	GFAP	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	0.2	1	0	CTD_human
2671	GFER	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
2671	GFER	C0162557	Liver Failure, Acute	0.200274726784213	1	0	CTD_human
2671	GFER	C2751320	Myopathy, Mitochondrial Progressive, With Congenital Cataract, Hearing Loss, And Developmental Delay	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
2671	GFER	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
2672	GFI1	C0085702	Monocytosis	0.2	0	0	HPO
2672	GFI1	C0087012	Ataxia, Spinocerebellar	0.2	1	0	CTD_human
2672	GFI1	C1842930	Neutropenia, Nonimmune Chronic Idiopathic, Adult	0.4	1	1	CTD_human;UNIPROT
2672	GFI1	C1859966	Neutropenia, Severe Congenital, Autosomal Dominant 1	0.4	0	0	CTD_human;ORPHANET
2672	GFI1	C2751288	Neutropenia, Severe Congenital, Autosomal Dominant 2	0.48	2	1	CTD_human;UNIPROT
2673	GFPT1	C0003886	Arthrogryposis	0.2	0	0	HPO
2673	GFPT1	C0024636	Malocclusion	0.2	0	0	HPO
2673	GFPT1	C0028754	Obesity	0.202407028523288	1	0	CTD_human
2673	GFPT1	C0038379	Strabismus	0.2	0	0	HPO
2673	GFPT1	C0234958	muscle degeneration	0.2	0	0	HPO
2673	GFPT1	C0376175	Bell Palsy	0.2	0	0	HPO
2673	GFPT1	C0947912	Myasthenias	0.200274726784213	0	0	HPO
2673	GFPT1	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
2673	GFPT1	C3552335	MYASTHENIC SYNDROME, CONGENITAL, 12	0.2	1	4	UNIPROT
2673	GFPT1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
26762	HAVCR1	C0017668	Focal glomerulosclerosis	0.2	1	0	CTD_human
26762	HAVCR1	C1840253	IgE RESPONSIVENESS, ATOPIC	0.2	0	0	CTD_human
26762	HAVCR1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2677	GGCX	C0002982	Angioid Streaks	0.2	0	0	HPO
2677	GGCX	C0004153	Atherosclerosis	0.202407028523288	0	0	HPO
2677	GGCX	C0010495	Cutis Laxa	0.2	0	0	HPO
2677	GGCX	C0015519	Factor X Deficiency	0.2	0	0	HPO
2677	GGCX	C0028077	Night Blindness	0.2	0	0	HPO
2677	GGCX	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
2677	GGCX	C0038379	Strabismus	0.2	0	0	HPO
2677	GGCX	C1835813	Pseudoxanthoma Elasticum-Like Disorder with Multiple Coagulation Factor Deficiency	0.6	1	8	CTD_human;ORPHANET;UNIPROT
2677	GGCX	C1848534	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1	0.600274726784213	4	4	CTD_human;ORPHANET;UNIPROT
2677	GGCX	C2930812	Generalized elastolysis	0.2	0	0	HPO
2678	GGT1	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
2678	GGT1	C0031099	Periodontitis	0.200274726784213	1	0	CTD_human
2678	GGT1	C0268524	gamma-Glutamyltransferase deficiency	0.48	0	0	CTD_human;ORPHANET
2683	B4GALT1	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
2683	B4GALT1	C0020255	Hydrocephalus	0.202732912464814	0	0	HPO
2683	B4GALT1	C1846816	Congenital Disorder Of Glycosylation, Type IIID	0.2	0	0	ORPHANET
2683	B4GALT1	C2931009	Congenital disorder of glycosylation type 2D	0.2	0	0	CTD_human
26873	OPLAH	C0014356	Enterocolitis	0.2	0	0	HPO
26873	OPLAH	C0268525	5-oxoprolinase deficiency	0.400274726784213	0	0	HPO;ORPHANET
26873	OPLAH	C0268534	Prolinuria	0.2	0	0	HPO
26873	OPLAH	C1833683	NEPHROLITHIASIS, CALCIUM OXALATE	0.2	0	0	HPO
2688	GH1	C0001206	Acromegaly	0.210714344584311	7	0	CTD_human
2688	GH1	C0013338	Pituitary dwarfism	0.216692821302369	0	0	HPO
2688	GH1	C0020615	Hypoglycemia	0.203021994626344	0	0	HPO
2688	GH1	C0028754	Obesity	0.211263798152737	1	0	CTD_human
2688	GH1	C0032461	Polycythemia	0.2	1	0	CTD_human
2688	GH1	C0041408	Turner Syndrome	0.214560519563294	1	0	CTD_human
2688	GH1	C0242528	Azotemia	0.2	1	0	CTD_human
2688	GH1	C0271567	Isolated Growth Hormone Deficiency, Type II	0.601648360705279	2	7	CTD_human;ORPHANET;UNIPROT
2688	GH1	C1849779	Kowarski syndrome	0.600274726784213	3	3	CTD_human;ORPHANET;UNIPROT
2688	GH1	C1858656	Short Stature, Idiopathic, Autosomal	0.2	0	0	CTD_human
2688	GH1	C2748571	Isolated Growth Hormone Deficiency, Type IB	0.6	1	4	CTD_human;ORPHANET;UNIPROT
2688	GH1	C3714796	Isolated somatotropin deficiency	0.214835246347507	0	0	HPO
2689	GH2	C0175693	Russell-Silver syndrome	0.2	1	0	CTD_human
2690	GHR	C0020615	Hypoglycemia	0.2	0	0	HPO
2690	GHR	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2690	GHR	C0271568	Laron Syndrome	0.712085612243664	12	18	CTD_human;ORPHANET;UNIPROT
2690	GHR	C0745103	Hyperlipoproteinemia Type IIa	0.200274726784213	0	0	CTD_human
2690	GHR	C0949173	Delayed menarche	0.2	0	0	HPO
2690	GHR	C1858656	Short Stature, Idiopathic, Autosomal	0.600549453568426	1	6	CTD_human;ORPHANET;UNIPROT
2692	GHRHR	C2748571	Isolated Growth Hormone Deficiency, Type IB	0.601098907136852	3	9	CTD_human;ORPHANET;UNIPROT
2692	GHRHR	C3714796	Isolated somatotropin deficiency	0.204945082115836	0	0	HPO
2693	GHSR	C0020615	Hypoglycemia	0.2	0	0	HPO
2693	GHSR	C0022638	Ketosis	0.2	0	0	HPO
2693	GHSR	C1858656	Short Stature, Idiopathic, Autosomal	0.6	2	3	CTD_human;ORPHANET;UNIPROT
2694	GIF	C0002888	Anemia, Megaloblastic	0.201098907136852	0	0	HPO
2694	GIF	C1394891	Intrinsic Factor Deficiency	0.400274726784213	1	2	CTD_human;UNIPROT
2697	GJA1	C0002170	Alopecia	0.2	0	0	HPO
2697	GJA1	C0005697	Neurogenic Urinary Bladder	0.2	0	0	HPO
2697	GJA1	C0011334	Dental caries	0.200274726784213	0	0	HPO
2697	GJA1	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
2697	GJA1	C0014544	Epilepsy	0.200824180352639	0	0	HPO
2697	GJA1	C0017601	Glaucoma	0.204106546385879	0	0	HPO
2697	GJA1	C0018522	Hallermann's Syndrome	0.40328236603324	1	1	CTD_human;UNIPROT
2697	GJA1	C0018777	Conductive hearing loss	0.2	0	0	HPO
2697	GJA1	C0018801	Heart failure	0.204106546385879	0	0	HPO
2697	GJA1	C0018802	Congestive heart failure	0.201648360705279	0	0	HPO
2697	GJA1	C0022596	Palmoplantar Keratosis	0.204106546385879	0	0	HPO
2697	GJA1	C0024636	Malocclusion	0.2	0	0	HPO
2697	GJA1	C0027092	Myopia	0.2	0	0	HPO
2697	GJA1	C0029124	Optic Atrophy	0.2	0	0	HPO
2697	GJA1	C0029454	Osteopetrosis	0.2	0	0	HPO
2697	GJA1	C0042798	Low Vision	0.2	0	0	HPO
2697	GJA1	C0085614	First degree atrioventricular block	0.2	0	0	HPO
2697	GJA1	C0152101	Hypoplastic Left Heart Syndrome	0.602407028523288	1	2	CTD_human;HPO;ORPHANET;UNIPROT
2697	GJA1	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
2697	GJA1	C0259817	Xerosis	0.2	0	0	HPO
2697	GJA1	C0265294	Pyle metaphyseal dysplasia	0.2	0	0	HPO
2697	GJA1	C0265961	Erythrokeratodermia variabilis	0.400549453568426	1	2	ORPHANET;UNIPROT
2697	GJA1	C0376175	Bell Palsy	0.2	0	0	HPO
2697	GJA1	C0399385	Early tooth exfoliation	0.2	0	0	HPO
2697	GJA1	C1834405	Nail dysplasia	0.2	0	0	HPO
2697	GJA1	C1861366	SYNDACTYLY, TYPE III	0.600549453568426	1	1	CTD_human;ORPHANET;UNIPROT
2697	GJA1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2697	GJA1	C2749477	Oculodentodigital Dysplasia, Autosomal Recessive	0.2	0	0	CTD_human
2697	GJA1	C2931244	Craniometaphyseal dysplasia, autosomal recessive type	0.2	1	1	UNIPROT
2697	GJA1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
2697	GJA1	C3151468	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1	0.400274726784213	1	1	ORPHANET;UNIPROT
2697	GJA1	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
2697	GJA1	C3275750	ATRIOVENTRICULAR SEPTAL DEFECT 3	0.4	0	0	CTD_human;UNIPROT
2697	GJA1	C4020952	Fingernail dysplasia	0.2	0	0	HPO
2697	GJA1	C4021633	Patchy palmoplantar keratoderma	0.2	0	0	HPO
2697	GJA1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
270	AMPD1	C0268123	Muscle AMP deaminase deficiency	0.200549453568426	0	0	ORPHANET
270	AMPD1	C2931781	Adenosine monophosphate deaminase deficiency	0.4	3	0	CTD_human;ORPHANET
270	AMPD1	C3714933	MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.2	1	2	UNIPROT
2700	GJA3	C0392557	Nuclear cataract	0.2	0	0	ORPHANET
2700	GJA3	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
2700	GJA3	C1833118	Cataract, Pulverulent	0.200274726784213	0	0	ORPHANET
2700	GJA3	C1861821	CATARACT, MARNER TYPE	0.2	0	0	HPO
2700	GJA3	C1866078	Cataract, Zonular Pulverulent 3	0.48	18	9	CTD_human;UNIPROT
2700	GJA3	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
27010	TPK1	C3280866	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.4	1	3	ORPHANET;UNIPROT
27010	TPK1	C4020871	Dystonic disease	0.2	0	0	HPO
27019	DNAI1	C0006267	Bronchiectasis	0.2	0	0	HPO
27019	DNAI1	C0008711	Chronic rhinitis	0.2	0	0	HPO
27019	DNAI1	C0009451	Communicating Hydrocephalus	0.2	0	0	HPO
27019	DNAI1	C0018777	Conductive hearing loss	0.2	0	0	HPO
27019	DNAI1	C0022521	Kartagener Syndrome	0.686802657070698	2	6	CTD_human;ORPHANET;UNIPROT
27019	DNAI1	C0027430	Nasal Polyps	0.2	0	0	HPO
27019	DNAI1	C0032285	Pneumonia	0.2	0	0	HPO
27019	DNAI1	C0037199	Sinusitis	0.2	0	0	HPO
27019	DNAI1	C0149516	Chronic sinusitis	0.2	0	0	HPO
27019	DNAI1	C0271441	Chronic otitis media	0.2	0	0	HPO
27019	DNAI1	C0743359	ear infection chronic	0.2	0	0	HPO
27019	DNAI1	C0748720	Chronic sinus disease	0.2	0	0	HPO
27019	DNAI1	C4020889	Cornela disease	0.2	0	0	HPO
2702	GJA5	C0004238	Atrial Fibrillation	0.227376776400422	0	0	HPO
2702	GJA5	C0014117	Endocardial Fibroelastosis	0.2	0	0	HPO
2702	GJA5	C0014306	Enophthalmos	0.2	0	0	HPO
2702	GJA5	C0015300	Exophthalmos	0.2	0	0	HPO
2702	GJA5	C0033036	Atrial Premature Complexes	0.2	0	0	HPO
2702	GJA5	C0085614	First degree atrioventricular block	0.2	0	0	HPO
2702	GJA5	C1838539	CARDIOMYOPATHY, FAMILIAL, WITH CONDUCTION DISTURBANCE	0.401098907136852	1	2	CTD_human;UNIPROT
2702	GJA5	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.4	0	0	CTD_human;ORPHANET
2702	GJA5	C3279693	ATRIAL FIBRILLATION, FAMILIAL, 11	0.2	1	6	UNIPROT
2702	GJA5	C4021885	Atrial cardiomyopathy	0.2	0	0	HPO
27020	NPTN	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2703	GJA8	C0014306	Enophthalmos	0.2	0	0	HPO
2703	GJA8	C0027092	Myopia	0.2	0	0	HPO
2703	GJA8	C0392557	Nuclear cataract	0.400549453568426	0	0	HPO;ORPHANET
2703	GJA8	C1112705	Nuclear non-senile cataract	0.200549453568426	0	0	ORPHANET
2703	GJA8	C1833118	Cataract, Pulverulent	0.400824180352639	0	0	HPO;ORPHANET
2703	GJA8	C1861828	Cataract, Zonular Pulverulent 1	0.481098907136852	7	8	CTD_human;UNIPROT
2703	GJA8	C1861829	Cataract microcornea syndrome	0.400274726784213	1	0	CTD_human;ORPHANET
2703	GJA8	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
27030	MLH3	C0014544	Epilepsy	0.2	0	0	HPO
27030	MLH3	C0151740	Intracranial Hypertension	0.2	0	0	HPO
27030	MLH3	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
27030	MLH3	C4020884	Anxiety disease	0.2	0	0	HPO
27031	NPHP3	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
27031	NPHP3	C0008312	Primary biliary cirrhosis	0.2	0	0	HPO
27031	NPHP3	C0008370	Cholestasis	0.2	0	0	HPO
27031	NPHP3	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
27031	NPHP3	C0023890	Liver Cirrhosis	0.2	0	0	HPO
27031	NPHP3	C0023892	Biliary cirrhosis	0.2	0	0	HPO
27031	NPHP3	C0025322	Premature Menopause	0.2	0	0	HPO
27031	NPHP3	C0030283	Pancreatic Cyst	0.2	0	0	HPO
27031	NPHP3	C0035078	Kidney Failure	0.2	0	0	HPO
27031	NPHP3	C0042798	Low Vision	0.2	0	0	HPO
27031	NPHP3	C0239946	Fibrosis, Liver	0.200549453568426	0	0	HPO
27031	NPHP3	C0267818	Bile duct proliferation	0.2	0	0	HPO
27031	NPHP3	C0267834	Liver cyst	0.2	0	0	HPO
27031	NPHP3	C0267952	Fibrosis of pancreas	0.2	0	0	HPO
27031	NPHP3	C0403553	Renal dysplasia and retinal aplasia (disorder)	0.200274726784213	0	0	ORPHANET
27031	NPHP3	C0687120	Nephronophthisis	0.202472541057918	0	0	HPO
27031	NPHP3	C1565489	Renal Insufficiency	0.2	0	0	HPO
27031	NPHP3	C1858392	NEPHRONOPHTHISIS 3	0.481098907136852	1	15	CTD_human;UNIPROT
27031	NPHP3	C1968619	Corticomedullary renal cysts	0.2	0	0	HPO
27031	NPHP3	C2316810	Chronic kidney disease stage 5	0.200549453568426	0	0	HPO
27031	NPHP3	C2673885	Renal hepatic pancreatic dysplasia Dandy Walker cyst	0.4	0	0	CTD_human;ORPHANET
27031	NPHP3	C3715199	RENAL-HEPATIC-PANCREATIC DYSPLASIA 1	0.4	1	1	CTD_human;UNIPROT
27032	ATP2C1	C0085106	Familial benign pemphigus	0.6530960208549	7	5	CTD_human;ORPHANET;UNIPROT
27032	ATP2C1	C0870082	Hyperkeratosis	0.2	0	0	HPO
27032	ATP2C1	C3887524	Skin Erosion	0.2	0	0	HPO
27034	ACAD8	C0002871	Anemia	0.2	0	0	HPO
27034	ACAD8	C1969809	Isobutyryl-CoA dehydrogenase deficiency	0.600274726784213	2	12	CTD_human;ORPHANET;UNIPROT
27035	NOX1	C0018801	Heart failure	0.2	1	0	CTD_human
27035	NOX1	C0020443	Hypercholesterolemia	0.2	1	0	CTD_human
27038	ARVD6	C1858378	Arrhythmogenic Right Ventricular Dysplasia, Familial, 6	0.2	0	0	CTD_human
27040	LAT	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
2705	GJB1	C0011195	Dejerine-Sottas Disease (disorder)	0.200549453568426	0	0	UNIPROT
2705	GJB1	C0151313	Sensory neuropathy	0.201098907136852	0	0	HPO
2705	GJB1	C0393808	Charcot-Marie-Tooth disease, X-linked, 1	0.693736339210655	60	49	CTD_human;ORPHANET;UNIPROT
2705	GJB1	C0796205	SPINOCEREBELLAR ATAXIA, X-LINKED 1	0.2	0	0	ORPHANET
2705	GJB1	C1836451	Muscle atrophy, lower limb, distal	0.2	0	0	HPO
2705	GJB1	C1848736	Distal amyotrophy	0.2	0	0	HPO
2705	GJB1	C4021581	Distal upper limb amyotrophy	0.2	0	0	HPO
2706	GJB2	C0002170	Alopecia	0.200274726784213	0	0	HPO
2706	GJB2	C0010043	Corneal Ulcer	0.2	0	0	HPO
2706	GJB2	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
2706	GJB2	C0013238	Dry Eye Syndromes	0.2	0	0	HPO
2706	GJB2	C0018777	Conductive hearing loss	0.20328236603324	0	0	HPO
2706	GJB2	C0018784	Sensorineural Hearing Loss (disorder)	0.626311617251763	1	12	CTD_human;HPO
2706	GJB2	C0020620	Hypohidrosis	0.2	0	0	HPO
2706	GJB2	C0020757	Ichthyoses	0.401098907136852	1	0	CTD_human;HPO
2706	GJB2	C0022568	Keratitis	0.405219808900049	1	0	CTD_human;HPO
2706	GJB2	C0022575	Keratoconjunctivitis Sicca	0.2	0	0	HPO
2706	GJB2	C0022596	Palmoplantar Keratosis	0.413092662352964	1	0	CTD_human;HPO
2706	GJB2	C0033860	Psoriasis	0.20350593566014	2	0	CTD_human
2706	GJB2	C0040412	Fissured tongue	0.2	0	0	HPO
2706	GJB2	C0042798	Low Vision	0.2	0	0	HPO
2706	GJB2	C0043349	Xerophthalmia	0.2	0	0	HPO
2706	GJB2	C0085109	Corneal Neovascularization	0.2	0	0	HPO
2706	GJB2	C0155119	Recurrent erosion of cornea	0.2	0	0	HPO
2706	GJB2	C0162836	Hidradenitis Suppurativa	0.2	1	0	CTD_human
2706	GJB2	C0221259	Trichiasis	0.2	0	0	HPO
2706	GJB2	C0221260	Dystrophia unguium	0.2	0	0	HPO
2706	GJB2	C0265336	Senter syndrome	0.689615437447459	4	8	CTD_human;ORPHANET;UNIPROT
2706	GJB2	C0271215	Blindness, Legal	0.2	0	0	HPO
2706	GJB2	C0271623	Hypogonadotropic hypogonadism	0.200274726784213	0	0	HPO
2706	GJB2	C0334166	Pseudoainhum	0.2	0	0	HPO
2706	GJB2	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
2706	GJB2	C0870082	Hyperkeratosis	0.201098907136852	0	0	HPO
2706	GJB2	C1562761	Punctate epithelial keratitis	0.2	0	0	HPO
2706	GJB2	C1834405	Nail dysplasia	0.2	0	0	HPO
2706	GJB2	C1835672	Palmoplantar Keratoderma with Deafness	0.600824180352639	6	6	CTD_human;ORPHANET;UNIPROT
2706	GJB2	C1843156	Hearing loss, progressive sensorineural	0.200824180352639	0	0	HPO
2706	GJB2	C1865234	ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS	0.400274726784213	0	0	CTD_human;UNIPROT
2706	GJB2	C2673759	DEAFNESS, AUTOSOMAL RECESSIVE 1A (disorder)	0.48	20	73	CTD_human;UNIPROT
2706	GJB2	C2675750	DEAFNESS, AUTOSOMAL DOMINANT 3A (disorder)	0.4	7	32	CTD_human;UNIPROT
2706	GJB2	C2930821	Keratitis sicca	0.2	0	0	HPO
2706	GJB2	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
2706	GJB2	C3665333	Keratitis-Ichthyosis-Deafness Syndrome	0.212637432073803	0	0	ORPHANET
27063	ANKRD1	C0014175	Endometriosis	0.2	1	0	CTD_human
27063	ANKRD1	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
27063	ANKRD1	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
2707	GJB3	C0002170	Alopecia	0.2	0	0	HPO
2707	GJB3	C0017601	Glaucoma	0.2	0	0	HPO
2707	GJB3	C0018780	Hearing Loss, High-Frequency	0.200549453568426	0	0	HPO
2707	GJB3	C0018784	Sensorineural Hearing Loss (disorder)	0.401373633921066	1	0	CTD_human;HPO
2707	GJB3	C0079153	Hyperkeratosis, Epidermolytic	0.2	1	0	CTD_human
2707	GJB3	C0259817	Xerosis	0.2	0	0	HPO
2707	GJB3	C0265961	Erythrokeratodermia variabilis	0.684945082115836	3	7	CTD_human;ORPHANET;UNIPROT
2707	GJB3	C2673759	DEAFNESS, AUTOSOMAL RECESSIVE 1A (disorder)	0.2	0	0	CTD_human
2707	GJB3	C2675236	Deafness, Autosomal Dominant 2B	0.4	1	3	CTD_human;UNIPROT
2707	GJB3	C2677637	Deafness, Autosomal Dominant 2A	0.2	0	0	CTD_human
2707	GJB3	C4021633	Patchy palmoplantar keratoderma	0.2	0	0	HPO
27071	DAPP1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
27074	LAMP3	C0021400	Influenza	0.202747267842131	1	0	CTD_human
27077	B9D1	C0028738	Nystagmus	0.2	0	0	HPO
27077	B9D1	C0029124	Optic Atrophy	0.2	0	0	HPO
27077	B9D1	C0265215	Meckel-Gruber syndrome	0.200274726784213	0	0	ORPHANET
27077	B9D1	C0431399	Familial aplasia of the vermis	0.2	0	0	ORPHANET
27077	B9D1	C1853235	Sclerocornea	0.2	0	0	HPO
27077	B9D1	C3489733	Oculomotor apraxia	0.2	0	0	HPO
27077	B9D1	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
27086	FOXP1	C0002871	Anemia	0.2	0	0	HPO
27086	FOXP1	C0042900	Vitiligo	0.202407028523288	1	0	CTD_human
27086	FOXP1	C1837658	Gross motor development delay	0.2	0	0	HPO
27086	FOXP1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
27086	FOXP1	C4013764	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.6	1	3	CTD_human;ORPHANET;UNIPROT
27087	B3GAT1	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
27089	UQCRQ	C1852372	MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)	0.200274726784213	0	0	CTD_human
27089	UQCRQ	C3554607	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4	0.2	1	1	UNIPROT
27089	UQCRQ	C4020871	Dystonic disease	0.2	0	0	HPO
271	AMPD2	C0014544	Epilepsy	0.2	0	0	HPO
271	AMPD2	C0029124	Optic Atrophy	0.2	0	0	HPO
271	AMPD2	C0037772	Spastic Paraplegia	0.2	0	0	HPO
271	AMPD2	C0155320	Blindness, Cortical	0.2	0	0	HPO
271	AMPD2	C0235946	Cerebral atrophy	0.2	0	0	HPO
271	AMPD2	C3810295	SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
271	AMPD2	C4014354	PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.4	1	6	ORPHANET;UNIPROT
2710	GK	C0014544	Epilepsy	0.2	0	0	HPO
2710	GK	C0020615	Hypoglycemia	0.2	0	0	HPO
2710	GK	C0026850	Muscular Dystrophy	0.2	0	0	HPO
2710	GK	C0029456	Osteoporosis	0.2	0	0	HPO
2710	GK	C0038379	Strabismus	0.2	0	0	HPO
2710	GK	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2710	GK	C0268418	Deficiency of glycerol kinase	0.402747267842131	3	5	CTD_human;UNIPROT
27102	EIF2AK1	C0002878	Anemia, Hemolytic	0.2	1	0	CTD_human
27102	EIF2AK1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
27102	EIF2AK1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
27113	BBC3	C0007786	Brain Ischemia	0.2	1	0	CTD_human
27125	AFF4	C0015300	Exophthalmos	0.2	0	0	HPO
27125	AFF4	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
27125	AFF4	C0028754	Obesity	0.400274726784213	1	0	CTD_human;HPO
27125	AFF4	C0032290	Aspiration Pneumonia	0.2	0	0	HPO
27125	AFF4	C0040583	Tracheal Stenosis	0.2	0	0	HPO
27125	AFF4	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
27125	AFF4	C0746102	Chronic lung disease	0.2	0	0	HPO
27125	AFF4	C4085597	CHOPS SYNDROME	0.400274726784213	1	3	ORPHANET;UNIPROT
27130	INVS	C0025322	Premature Menopause	0.2	0	0	HPO
27130	INVS	C0042798	Low Vision	0.2	0	0	HPO
27130	INVS	C0238304	Chronic interstitial nephritis	0.2	0	0	HPO
27130	INVS	C0403553	Renal dysplasia and retinal aplasia (disorder)	0.2	0	0	ORPHANET
27130	INVS	C0687120	Nephronophthisis	0.202747267842131	0	0	HPO
27130	INVS	C1145670	Respiratory Failure	0.2	0	0	HPO
27130	INVS	C1865872	NEPHRONOPHTHISIS 2	0.680824180352639	1	6	CTD_human;ORPHANET;UNIPROT
27130	INVS	C2316810	Chronic kidney disease stage 5	0.200549453568426	0	0	HPO
2717	GLA	C0002871	Anemia	0.2	0	0	HPO
2717	GLA	C0002986	Fabry Disease	0.799071836466372	32	168	CTD_human;ORPHANET;UNIPROT
2717	GLA	C0003123	Anorexia	0.2	0	0	HPO
2717	GLA	C0003864	Arthritis	0.2	0	0	HPO
2717	GLA	C0004245	Atrioventricular Block	0.2	0	0	HPO
2717	GLA	C0006384	Bundle-Branch Block	0.2	0	0	HPO
2717	GLA	C0010036	Corneal dystrophy	0.200274726784213	0	0	HPO
2717	GLA	C0013363	Dysautonomia	0.2	0	0	HPO
2717	GLA	C0014544	Epilepsy	0.2	0	0	HPO
2717	GLA	C0018801	Heart failure	0.2	0	0	HPO
2717	GLA	C0018802	Congestive heart failure	0.2	0	0	HPO
2717	GLA	C0020473	Hyperlipidemia	0.2	0	0	HPO
2717	GLA	C0020620	Hypohidrosis	0.200274726784213	0	0	HPO
2717	GLA	C0024236	Lymphedema	0.2	0	0	HPO
2717	GLA	C0027051	Myocardial Infarction	0.200549453568426	0	0	HPO
2717	GLA	C0029124	Optic Atrophy	0.2	0	0	HPO
2717	GLA	C0034067	Pulmonary Emphysema	0.2	0	0	HPO
2717	GLA	C0035078	Kidney Failure	0.201373633921065	0	0	HPO
2717	GLA	C0149721	Left Ventricular Hypertrophy	0.201373633921065	0	0	HPO
2717	GLA	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
2717	GLA	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
2717	GLA	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
2717	GLA	C0870082	Hyperkeratosis	0.2	0	0	HPO
2717	GLA	C0917805	Transient Cerebral Ischemia	0.200274726784213	0	0	HPO
2717	GLA	C1565489	Renal Insufficiency	0.200824180352639	0	0	HPO
2717	GLA	C1841659	Atrioventricular nodal disease	0.2	0	0	HPO
2719	GPC3	C0006384	Bundle-Branch Block	0.2	0	0	HPO
2719	GPC3	C0020255	Hydrocephalus	0.2	0	0	HPO
2719	GPC3	C0020295	Hydronephrosis	0.2	0	0	HPO
2719	GPC3	C0020615	Hypoglycemia	0.2	0	0	HPO
2719	GPC3	C0022679	Cystic kidney	0.2	0	0	HPO
2719	GPC3	C0024421	Macroglossia	0.2	0	0	HPO
2719	GPC3	C0024636	Malocclusion	0.2	0	0	HPO
2719	GPC3	C0264142	Spade-like hand	0.2	0	0	HPO
2719	GPC3	C1834405	Nail dysplasia	0.2	0	0	HPO
2719	GPC3	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
2719	GPC3	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
2719	GPC3	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
272	AMPD3	C0268123	Muscle AMP deaminase deficiency	0.2	0	0	ORPHANET
272	AMPD3	C2752073	Erythrocyte Amp Deaminase Deficiency	0.2	4	7	UNIPROT
272	AMPD3	C2931781	Adenosine monophosphate deaminase deficiency	0.2	0	0	ORPHANET
2720	GLB1	C0002986	Fabry Disease	0.200274726784213	0	0	HPO
2720	GLB1	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
2720	GLB1	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
2720	GLB1	C0011334	Dental caries	0.2	0	0	HPO
2720	GLB1	C0011615	Dermatitis, Atopic	0.2	1	1	CTD_human
2720	GLB1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
2720	GLB1	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
2720	GLB1	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
2720	GLB1	C0018801	Heart failure	0.200274726784213	0	0	HPO
2720	GLB1	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
2720	GLB1	C0020555	Hypertrichosis	0.2	0	0	HPO
2720	GLB1	C0026707	Mucopolysaccharidosis IV	0.200274726784213	2	0	CTD_human
2720	GLB1	C0029124	Optic Atrophy	0.2	0	0	HPO
2720	GLB1	C0029456	Osteoporosis	0.200274726784213	0	0	HPO
2720	GLB1	C0036489	Sea-Blue Histiocyte Syndrome	0.2	0	0	HPO
2720	GLB1	C0085131	Gangliosidosis GM1	0.430986705106811	0	0	CTD_human;HPO
2720	GLB1	C0085581	Restrictive lung disease	0.2	0	0	HPO
2720	GLB1	C0086652	Mucopolysaccharidosis type IVB	0.407142896389541	13	27	ORPHANET;UNIPROT
2720	GLB1	C0149645	Cervical myelopathy	0.2	0	0	HPO
2720	GLB1	C0234958	muscle degeneration	0.2	0	0	HPO
2720	GLB1	C0235946	Cerebral atrophy	0.2	0	0	HPO
2720	GLB1	C0264112	Wedging of vertebra	0.2	0	0	HPO
2720	GLB1	C0268271	Gangliosidosis, Generalized GM1, Type 1 (disorder)	0.401923087489492	23	35	ORPHANET;UNIPROT
2720	GLB1	C0268272	Gangliosidosis, Generalized GM1, Type 2	0.480549453568426	14	23	ORPHANET;UNIPROT
2720	GLB1	C0268273	Gangliosidosis, Generalized GM1, Type 3	0.400549453568426	13	23	ORPHANET;UNIPROT
2720	GLB1	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
2720	GLB1	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
2720	GLB1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
2720	GLB1	C0850715	Abnormality of blood and blood-forming tissues	0.2	0	0	HPO
2720	GLB1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
2720	GLB1	C4020871	Dystonic disease	0.2	0	0	HPO
2720	GLB1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
2720	GLB1	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
2722	GLC1B	C0339573	Glaucoma, Primary Open Angle	0.201373633921065	0	0	CTD_human
2722	GLC1B	C3887942	GLAUCOMA 1, OPEN ANGLE, B	0.2	0	0	CTD_human
27229	TUBGCP4	C0014544	Epilepsy	0.2	0	0	HPO
27229	TUBGCP4	C0028738	Nystagmus	0.2	0	0	HPO
27229	TUBGCP4	C0029124	Optic Atrophy	0.2	0	0	HPO
27229	TUBGCP4	C0038379	Strabismus	0.2	0	0	HPO
27229	TUBGCP4	C0042798	Low Vision	0.2	0	0	HPO
27229	TUBGCP4	C0235946	Cerebral atrophy	0.2	0	0	HPO
27229	TUBGCP4	C3278481	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
2723	GLC1C	C1866483	GLAUCOMA 1, OPEN ANGLE, C	0.2	0	0	CTD_human
27232	GNMT	C0019158	Hepatitis	0.2	1	0	CTD_human
27232	GNMT	C0019189	Hepatitis, Chronic	0.200549453568426	1	0	CTD_human
27232	GNMT	C0268621	Hepatic methionine adenosyltransferase deficiency	0.2	0	0	HPO
27232	GNMT	C0598608	Hyperhomocysteinemia	0.2	1	0	CTD_human
27232	GNMT	C1847720	Glycine N-Methyltransferase Deficiency	0.48	2	3	ORPHANET;UNIPROT
27235	COQ2	C0002871	Anemia	0.200274726784213	0	0	HPO
27235	COQ2	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
27235	COQ2	C0014544	Epilepsy	0.2	0	0	HPO
27235	COQ2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
27235	COQ2	C0028738	Nystagmus	0.2	0	0	HPO
27235	COQ2	C0030312	Pancytopenia	0.2	0	0	HPO
27235	COQ2	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
27235	COQ2	C0085605	Liver Failure	0.2	0	0	HPO
27235	COQ2	C0178664	Glomerulosclerosis (disorder)	0.2	0	0	HPO
27235	COQ2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
27235	COQ2	C0270733	Striatonigral Degeneration	0.2	0	0	ORPHANET
27235	COQ2	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
27235	COQ2	C0948896	Primary hypogonadism	0.2	0	0	HPO
27235	COQ2	C3551954	COENZYME Q10 DEFICIENCY, PRIMARY, 1	0.4	6	0	CTD_human;UNIPROT
27235	COQ2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
2724	GLC1D	C1865427	GLAUCOMA 1, OPEN ANGLE, D (disorder)	0.2	0	0	CTD_human
27241	BBS9	C0010278	Craniosynostosis	0.2	1	1	CTD_human
27241	BBS9	C0020619	Hypogonadism	0.2	0	0	HPO
27241	BBS9	C0028738	Nystagmus	0.2	0	0	HPO
27241	BBS9	C0028754	Obesity	0.200274726784213	0	0	HPO
27241	BBS9	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	HPO
27241	BBS9	C0752166	Bardet-Biedl Syndrome	0.403557092817453	0	0	CTD_human;ORPHANET
27241	BBS9	C1859567	BARDET-BIEDL SYNDROME 9	0.2	1	11	UNIPROT
27241	BBS9	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
27242	TNFRSF21	C0002736	Amyotrophic Lateral Sclerosis	0.200274726784213	1	0	CTD_human
27245	AHDC1	C0014877	Esotropia	0.2	0	0	HPO
27245	AHDC1	C0520679	Sleep Apnea, Obstructive	0.2	0	0	HPO
27245	AHDC1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
27245	AHDC1	C4014419	XIA-GIBBS SYNDROME	0.2	0	0	ORPHANET
27247	NFU1	C1145670	Respiratory Failure	0.2	0	0	HPO
27247	NFU1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
27247	NFU1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
27247	NFU1	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
27247	NFU1	C3276432	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1	0.4	1	1	ORPHANET;UNIPROT
27248	ERLEC1	C0008370	Cholestasis	0.2	1	0	CTD_human
27248	ERLEC1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
27249	MMADHC	C0002888	Anemia, Megaloblastic	0.2	0	0	HPO
27249	MMADHC	C0003123	Anorexia	0.2	0	0	HPO
27249	MMADHC	C0014544	Epilepsy	0.2	0	0	HPO
27249	MMADHC	C0019880	Homocystinuria	0.200549453568426	0	0	HPO
27249	MMADHC	C0028738	Nystagmus	0.2	0	0	HPO
27249	MMADHC	C0235946	Cerebral atrophy	0.2	0	0	HPO
27249	MMADHC	C1848552	Methylmalonic Aciduria and Homocystinuria, CblD Type	0.6	2	13	CTD_human;ORPHANET;UNIPROT
27249	MMADHC	C1849156	Spastic Ataxia	0.2	0	0	HPO
27249	MMADHC	C1855119	Methylmalonic aciduria	0.200549453568426	0	0	HPO
27249	MMADHC	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
27249	MMADHC	C4020871	Dystonic disease	0.2	0	0	HPO
27259	HPLH1	C0024291	Lymphohistiocytosis, Hemophagocytic	0.2	0	0	CTD_human
2728	GLC3B	C1832977	GLAUCOMA 3, PRIMARY INFANTILE, B	0.2	0	0	CTD_human
27283	TINAG	C0011881	Diabetic Nephropathy	0.2	1	0	CTD_human
27286	SRPX2	C0264611	Apraxia of Phonation	0.2	0	0	HPO
27286	SRPX2	C1845070	Rolandic Epilepsy, Mental Retardation, and Speech Dyspraxia, X-Linked	0.400274726784213	1	2	CTD_human;UNIPROT
27286	SRPX2	C2363129	Benign Rolandic Epilepsy	0.2	0	0	ORPHANET
27286	SRPX2	C3806402	EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION	0.2	0	0	ORPHANET
2729	GCLC	C0002871	Anemia	0.2	0	0	HPO
2729	GCLC	C0002878	Anemia, Hemolytic	0.400824180352639	1	0	CTD_human;HPO
2729	GCLC	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
2729	GCLC	C0027051	Myocardial Infarction	0.202956482091714	1	0	CTD_human
2729	GCLC	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2729	GCLC	C0152025	Polyneuropathy	0.2	0	0	HPO
2729	GCLC	C1856603	Gamma-Glutamylcysteine Synthetase Deficiency, Hemolytic Anemia due to	0.6	3	2	CTD_human;ORPHANET;UNIPROT
2729	GCLC	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2730	GCLM	C0027051	Myocardial Infarction	0.208096423079816	2	0	CTD_human
2731	GLDC	C0014544	Epilepsy	0.2	0	0	HPO
2731	GLDC	C0543541	HYPERGLYCINURIA (disorder)	0.2	0	0	HPO
2731	GLDC	C0751748	Nonketotic Hyperglycinemia	0.494741023058243	6	88	CTD_human;UNIPROT
27315	PGAP2	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
27315	PGAP2	C3280153	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 17	0.2	2	6	UNIPROT
27316	RBMX	C0028754	Obesity	0.2	0	0	HPO
27328	PCDH11X	C0002395	Alzheimer's Disease	0.203007639249027	1	1	CTD_human
27329	ANGPTL3	C0020597	Hypobetalipoproteinemias	0.201373633921065	0	0	HPO
27329	ANGPTL3	C0542037	Hypotriglyceridaemia	0.200274726784213	0	0	HPO
27329	ANGPTL3	C1857970	Hypobetalipoproteinemia, Familial, 2	0.2	0	0	CTD_human
2733	GLE1	C0003886	Arthrogryposis	0.2	0	0	HPO
2733	GLE1	C0154681	Anterior Horn Cell Disease	0.2	0	0	HPO
2733	GLE1	C0234958	muscle degeneration	0.2	0	0	HPO
2733	GLE1	C0334166	Pseudoainhum	0.2	0	0	HPO
2733	GLE1	C1276035	Pena-Shokeir syndrome type I	0.200274726784213	0	0	HPO
2733	GLE1	C1854664	LETHAL CONGENITAL CONTRACTURE SYNDROME 1	0.600824180352639	1	2	CTD_human;ORPHANET;UNIPROT
2733	GLE1	C2678471	Lethal Arthrogryposis With Anterior Horn Cell Disease	0.600549453568426	1	3	CTD_human;ORPHANET;UNIPROT
27348	TOR1B	C0021400	Influenza	0.2	1	0	CTD_human
2736	GLI2	C0014544	Epilepsy	0.2	0	0	HPO
2736	GLI2	C0020255	Hydrocephalus	0.2	0	0	HPO
2736	GLI2	C0020615	Hypoglycemia	0.2	0	0	HPO
2736	GLI2	C0020635	Hypopituitarism	0.202197814273705	0	0	HPO
2736	GLI2	C0024636	Malocclusion	0.2	0	0	HPO
2736	GLI2	C0029453	Osteopenia	0.2	0	0	HPO
2736	GLI2	C0242343	Panhypopituitarism	0.201098907136852	0	0	HPO
2736	GLI2	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
2736	GLI2	C0747078	Generalized osteopenia	0.2	0	0	HPO
2736	GLI2	C0948740	Pituitary hypoplasia	0.200274726784213	0	0	HPO
2736	GLI2	C1835819	PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES (disorder)	0.4	1	10	CTD_human;UNIPROT
2736	GLI2	C1857278	Partial or complete agenesis of corpus callosum	0.2	0	0	HPO
2736	GLI2	C2751608	Pituitary Hormone Deficiency, Combined, 1	0.2	0	0	ORPHANET
2736	GLI2	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
2736	GLI2	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
2736	GLI2	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
2736	GLI2	C4014479	CULLER-JONES SYNDROME	0.4	2	4	ORPHANET;UNIPROT
2736	GLI2	C4053775	Pituitary stalk interruption syndrome	0.2	0	0	HPO
2736	GLI2	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
2737	GLI3	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
2737	GLI3	C0014544	Epilepsy	0.202732912464814	0	0	HPO
2737	GLI3	C0022679	Cystic kidney	0.2	0	0	HPO
2737	GLI3	C0034013	Precocious Puberty	0.2	0	0	HPO
2737	GLI3	C0162835	Hypopigmentation disorder	0.200274726784213	1	0	CTD_human
2737	GLI3	C0220697	POLYDACTYLY, POSTAXIAL	0.200824180352639	0	0	CTD_human
2737	GLI3	C0242343	Panhypopituitarism	0.2	0	0	HPO
2737	GLI3	C0265220	Pallister-Hall syndrome	0.490359749888151	2	30	CTD_human;ORPHANET
2737	GLI3	C0796147	Acrocallosal Syndrome	0.401098907136852	0	0	CTD_human;ORPHANET
2737	GLI3	C1834405	Nail dysplasia	0.2	0	0	HPO
2737	GLI3	C1857079	Atretic auditory canal	0.2	0	0	HPO
2737	GLI3	C1866339	Preaxial Hallucal Polydactyly	0.2	0	0	HPO
2737	GLI3	C1868111	Polydactyly, preaxial 4	0.2	0	0	CTD_human
2737	GLI3	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
2737	GLI3	C3887487	Postaxial polydactyly type A	0.200824180352639	1	1	UNIPROT
274	BIN1	C0002395	Alzheimer's Disease	0.212781133788756	1	1	CTD_human
274	BIN1	C0376175	Bell Palsy	0.2	0	0	HPO
274	BIN1	C0752282	Congenital Structural Myopathy	0.202732912464814	1	0	CTD_human
274	BIN1	C1389113	Generalized amyotrophy	0.2	0	0	HPO
274	BIN1	C1834558	Myopathy, Centronuclear, Autosomal Dominant	0.200274726784213	0	0	ORPHANET
274	BIN1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
2741	GLRA1	C0014544	Epilepsy	0.2	0	0	HPO
2741	GLRA1	C1835614	Hereditary Hyperexplexia	0.680274726784213	6	24	CTD_human;ORPHANET;UNIPROT
27429	HTRA2	C0007787	Transient Ischemic Attack	0.28	1	0	CTD_human
27429	HTRA2	C3809811	PARKINSON DISEASE 19, JUVENILE-ONSET	0.2	0	0	ORPHANET
27429	HTRA2	C4275179	Young onset Parkinson disease	0.2	0	0	ORPHANET
2743	GLRB	C1835614	Hereditary Hyperexplexia	0.4	0	0	CTD_human;ORPHANET
2743	GLRB	C3553291	HYPEREKPLEXIA 2	0.28	2	3	UNIPROT
2744	GLS	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
27445	PCLO	C0014544	Epilepsy	0.2	0	0	HPO
27445	PCLO	C0015300	Exophthalmos	0.2	0	0	HPO
27445	PCLO	C0029124	Optic Atrophy	0.2	0	0	HPO
27445	PCLO	C0235946	Cerebral atrophy	0.2	0	0	HPO
27445	PCLO	C0262404	Cerebellar degeneration	0.2	0	0	HPO
27445	PCLO	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
27445	PCLO	C1842687	PONTOCEREBELLAR HYPOPLASIA TYPE 3 (disorder)	0.2	0	0	ORPHANET
27445	PCLO	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
27445	PCLO	C4020860	Supratentorial atrophy	0.2	0	0	HPO
27445	PCLO	C4020873	Infratentorial atrophy	0.2	0	0	HPO
2746	GLUD1	C0020459	Hyperinsulinism	0.207887208830233	1	0	CTD_human
2746	GLUD1	C0020617	Hypoglycemic coma	0.2	0	0	HPO
2746	GLUD1	C0877056	Hypoglycaemic seizure	0.2	0	0	HPO
2746	GLUD1	C1847555	Hyperinsulinemic hypoglycemia, familial, 6	0.601373633921066	3	10	CTD_human;ORPHANET;UNIPROT
2746	GLUD1	C1864903	Hyperinsulinaemic hypoglycaemia	0.201648360705279	0	0	HPO
275	AMT	C0014544	Epilepsy	0.200274726784213	0	0	HPO
275	AMT	C0543541	HYPERGLYCINURIA (disorder)	0.2	0	0	HPO
275	AMT	C0751748	Nonketotic Hyperglycinemia	0.40433011601278	7	26	CTD_human;UNIPROT
2752	GLUL	C0014544	Epilepsy	0.201373633921065	0	0	HPO
2752	GLUL	C0019151	Hepatic Encephalopathy	0.2	1	0	CTD_human
2752	GLUL	C0028754	Obesity	0.2	1	0	CTD_human
2752	GLUL	C0235946	Cerebral atrophy	0.2	0	0	HPO
2752	GLUL	C0236663	Alcohol withdrawal syndrome	0.2	1	0	PSYGENET
2752	GLUL	C1864910	Glutamine deficiency, congenital	0.600549453568426	1	2	CTD_human;ORPHANET;UNIPROT
2759	GLYS1	C0017980	Glycosuria, Renal	0.2	0	0	CTD_human
2760	GM2A	C0014544	Epilepsy	0.2	0	0	HPO
2760	GM2A	C0268275	Tay-Sachs Disease, AB Variant	0.680549453568426	2	4	CTD_human;ORPHANET;UNIPROT
2760	GM2A	C0271215	Blindness, Legal	0.2	0	0	HPO
2766	GMPR	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
2767	GNA11	C0002170	Alopecia	0.2	0	0	HPO
2767	GNA11	C0027709	Nephrocalcinosis	0.2	0	0	HPO
2767	GNA11	C0035305	Retinal Detachment	0.2	0	0	HPO
2767	GNA11	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
2767	GNA11	C0154676	Organic writer's cramp	0.2	0	0	HPO
2767	GNA11	C0259817	Xerosis	0.2	0	0	HPO
2767	GNA11	C0947912	Myasthenias	0.2	0	0	HPO
2767	GNA11	C1840347	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II (disorder)	0.4	1	2	ORPHANET;UNIPROT
2767	GNA11	C3698239	Cerebral cortex myoclonus	0.2	0	0	HPO
2767	GNA11	C3715128	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.2	0	0	ORPHANET
2767	GNA11	C3809243	HYPOCALCEMIA, AUTOSOMAL DOMINANT 2	0.2	2	5	UNIPROT
2767	GNA11	C4020884	Anxiety disease	0.2	0	0	HPO
2768	GNA12	C0009324	Ulcerative Colitis	0.200274726784213	1	2	CTD_human
2768	GNA12	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2771	GNAI2	C0004245	Atrioventricular Block	0.2	1	0	CTD_human
2771	GNAI2	C0030591	Paroxysmal ventricular tachycardia	0.2	0	0	HPO
2771	GNAI2	C0340485	Familial ventricular tachycardia	0.2	0	0	CTD_human
2773	GNAI3	C0024636	Malocclusion	0.2	0	0	HPO
2773	GNAI3	C1865295	Auriculo-condylar syndrome	0.401098907136852	1	2	ORPHANET;UNIPROT
2773	GNAI3	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
2774	GNAL	C1963946	Laryngeal dystonia	0.2	0	0	HPO
2774	GNAL	C3554447	DYSTONIA 25	0.400274726784213	1	6	ORPHANET;UNIPROT
2775	GNAO1	C0235946	Cerebral atrophy	0.2	0	0	HPO
2775	GNAO1	C0393706	Early infantile epileptic encephalopathy with suppression bursts	0.200274726784213	0	0	ORPHANET
2775	GNAO1	C0543888	Epileptic encephalopathy	0.201098907136852	0	0	HPO
2775	GNAO1	C3809606	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17	0.200274726784213	4	7	UNIPROT
2775	GNAO1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
2776	GNAQ	C0014544	Epilepsy	0.2	0	0	HPO
2776	GNAQ	C0017601	Glaucoma	0.2	0	0	HPO
2776	GNAQ	C0017668	Focal glomerulosclerosis	0.2	1	0	CTD_human
2776	GNAQ	C0029124	Optic Atrophy	0.2	0	0	HPO
2776	GNAQ	C0035305	Retinal Detachment	0.2	0	0	HPO
2776	GNAQ	C0038379	Strabismus	0.2	0	0	HPO
2776	GNAQ	C0235946	Cerebral atrophy	0.2	0	0	HPO
2778	GNAS	C0001206	Acromegaly	0.401098907136852	1	0	CTD_human;HPO
2778	GNAS	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
2778	GNAS	C0014544	Epilepsy	0.2	0	0	HPO
2778	GNAS	C0016064	Fibrous Dysplasia, Monostotic	0.200274726784213	0	0	ORPHANET
2778	GNAS	C0020502	Hyperparathyroidism	0.2	0	0	HPO
2778	GNAS	C0020514	Hyperprolactinemia	0.2	0	0	HPO
2778	GNAS	C0020550	Hyperthyroidism	0.200274726784213	0	0	HPO
2778	GNAS	C0020619	Hypogonadism	0.2	0	0	HPO
2778	GNAS	C0020676	Hypothyroidism	0.200824180352639	0	0	HPO
2778	GNAS	C0028738	Nystagmus	0.2	0	0	HPO
2778	GNAS	C0028754	Obesity	0.401923087489492	1	0	CTD_human;HPO
2778	GNAS	C0029453	Osteopenia	0.2	0	0	HPO
2778	GNAS	C0029456	Osteoporosis	0.2	0	0	HPO
2778	GNAS	C0029464	Osteosclerosis	0.2	0	0	HPO
2778	GNAS	C0032460	Polycystic Ovary Syndrome	0.200274726784213	1	0	CTD_human
2778	GNAS	C0033805	Pseudohypoaldosteronism	0.2	0	0	CTD_human
2778	GNAS	C0033806	Pseudohypoparathyroidism	0.463939711776847	3	10	CTD_human;HPO
2778	GNAS	C0033835	Pseudopseudohypoparathyroidism	0.484945082115836	1	6	CTD_human;ORPHANET
2778	GNAS	C0034013	Precocious Puberty	0.40656473206648	2	0	CTD_human;HPO
2778	GNAS	C0085681	Hyperphosphatemia (disorder)	0.201373633921065	0	0	HPO
2778	GNAS	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
2778	GNAS	C0151940	Hypocalcemic tetany	0.2	0	0	HPO
2778	GNAS	C0234958	muscle degeneration	0.2	0	0	HPO
2778	GNAS	C0242292	McCune-Albright Syndrome	0.411813251721163	5	5	ORPHANET;UNIPROT
2778	GNAS	C0271215	Blindness, Legal	0.2	0	0	HPO
2778	GNAS	C0342198	Thyrotoxicosis due to pituitary thyroid hormone resistance	0.2	0	0	HPO
2778	GNAS	C0392525	Nephrolithiasis	0.2	0	0	HPO
2778	GNAS	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
2778	GNAS	C0747078	Generalized osteopenia	0.2	0	0	HPO
2778	GNAS	C1257915	Intestinal Polyposis	0.2	0	0	HPO
2778	GNAS	C1857451	Acth-Independent Macronodular Adrenal Hyperplasia	0.4	3	2	ORPHANET;UNIPROT
2778	GNAS	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
2778	GNAS	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
2778	GNAS	C2931404	Albright's hereditary osteodystrophy	0.219165362360287	4	0	CTD_human
2778	GNAS	C2932715	Pseudohypoparathyroidism Type 1B	0.401923087489492	1	0	CTD_human;ORPHANET
2778	GNAS	C2932716	Pseudohypoparathyroidism Type 1C	0.400824180352639	1	2	ORPHANET;UNIPROT
2778	GNAS	C3494506	Pseudohypoparathyroidism, Type Ia	0.703351776658114	13	7	CTD_human;ORPHANET;UNIPROT
2778	GNAS	C3665358	Galactorrhea	0.2	0	0	HPO
2778	GNAS	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
2778	GNAS	C4020884	Anxiety disease	0.2	0	0	HPO
2778	GNAS	C4025760	Primary hypercorticolism	0.2	0	0	HPO
2779	GNAT1	C0028077	Night Blindness	0.202407028523288	0	0	HPO
2779	GNAT1	C0271183	Severe myopia	0.2	0	0	HPO
2779	GNAT1	C1864870	Night Blindness, Congenital Stationary, Autosomal Dominant 3	0.4	2	2	CTD_human;UNIPROT
2779	GNAT1	C3551052	Night blindness, stationary	0.200549453568426	0	0	HPO
2779	GNAT1	C4225345	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G	0.2	1	1	UNIPROT
2780	GNAT2	C0015310	Exotropia	0.2	0	0	HPO
2780	GNAT2	C0020490	Hyperopia	0.2	0	0	HPO
2780	GNAT2	C0028738	Nystagmus	0.2	0	0	HPO
2780	GNAT2	C0042798	Low Vision	0.2	0	0	HPO
2780	GNAT2	C0152200	Achromatopsia	0.202197814273705	0	0	ORPHANET
2780	GNAT2	C0271092	Progressive cone dystrophy (without rod involvement)	0.2	0	0	ORPHANET
2780	GNAT2	C0271388	Pendular Nystagmus	0.2	0	0	HPO
2780	GNAT2	C0302129	Achromatopsia 1	0.202197814273705	0	0	HPO
2780	GNAT2	C0858618	Dyschromatopsia	0.2	0	0	HPO
2780	GNAT2	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
2784	GNB3	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.229001011971399	1	0	CTD_human
2784	GNB3	C0028754	Obesity	0.255348979389931	2	0	CTD_human
2784	GNB3	C0085580	Essential Hypertension	0.209065983879032	0	0	CTD_human
2784	GNB3	C1956346	Coronary Artery Disease	0.21433527120477	1	0	CTD_human
2791	GNG11	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
2796	GNRH1	C0018418	Gynecomastia	0.2	0	0	HPO
2796	GNRH1	C0020514	Hyperprolactinemia	0.2	1	0	CTD_human
2796	GNRH1	C0020619	Hypogonadism	0.205414667772315	1	0	CTD_human
2796	GNRH1	C0029453	Osteopenia	0.2	0	0	HPO
2796	GNRH1	C0029456	Osteoporosis	0.2	0	0	HPO
2796	GNRH1	C0034013	Precocious Puberty	0.200549453568426	1	0	CTD_human
2796	GNRH1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
2796	GNRH1	C0151721	Testicular hypogonadism	0.2	0	0	HPO
2796	GNRH1	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
2796	GNRH1	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
2796	GNRH1	C0242350	Erectile dysfunction	0.2	0	0	HPO
2796	GNRH1	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
2796	GNRH1	C0271623	Hypogonadotropic hypogonadism	0.20350593566014	0	0	HPO
2796	GNRH1	C0342384	Idiopathic hypogonadotropic hypogonadism	0.202197814273705	1	0	CTD_human
2796	GNRH1	C0747078	Generalized osteopenia	0.2	0	0	HPO
2796	GNRH1	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
2796	GNRH1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.200274726784213	0	0	HPO
2796	GNRH1	C4020884	Anxiety disease	0.2	0	0	HPO
2796	GNRH1	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
2798	GNRHR	C0018418	Gynecomastia	0.2	0	0	HPO
2798	GNRHR	C0020619	Hypogonadism	0.218976915781758	1	0	CTD_human
2798	GNRHR	C0029453	Osteopenia	0.2	0	0	HPO
2798	GNRHR	C0029456	Osteoporosis	0.2	0	0	HPO
2798	GNRHR	C0151721	Testicular hypogonadism	0.2	0	0	HPO
2798	GNRHR	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
2798	GNRHR	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
2798	GNRHR	C0242350	Erectile dysfunction	0.2	0	0	HPO
2798	GNRHR	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
2798	GNRHR	C0271582	Isolated lutropin deficiency (disorder)	0.200274726784213	0	0	CTD_human
2798	GNRHR	C0271623	Hypogonadotropic hypogonadism	0.211198285618107	0	0	HPO
2798	GNRHR	C0342384	Idiopathic hypogonadotropic hypogonadism	0.287142896389541	8	11	UNIPROT
2798	GNRHR	C0747078	Generalized osteopenia	0.2	0	0	HPO
2798	GNRHR	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
2798	GNRHR	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.201648360705279	0	0	HPO
2798	GNRHR	C4020884	Anxiety disease	0.2	0	0	HPO
2798	GNRHR	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
2799	GNS	C0014544	Epilepsy	0.2	0	0	HPO
2799	GNS	C0026706	Mucopolysaccharidosis III	0.205740551713841	1	0	CTD_human
2799	GNS	C0037036	Sialorrhea	0.2	0	0	HPO
2799	GNS	C0086650	MPS III D	0.401923087489492	1	5	ORPHANET;UNIPROT
2799	GNS	C0086795	Pfaundler-Hurler Syndrome	0.2	0	0	HPO
2799	GNS	C0205700	Asymmetric Septal Hypertrophy	0.2	0	0	HPO
2799	GNS	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
28	ABO	C0013295	Duodenal Ulcer	0.201098907136852	1	0	CTD_human
28	ABO	C1956346	Coronary Artery Disease	0.206462417751855	1	0	CTD_human
2805	GOT1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2811	GP1BA	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
2811	GP1BA	C0005129	Bernard-Soulier Syndrome	0.702273637192316	6	4	CTD_human;ORPHANET;UNIPROT
2811	GP1BA	C0031256	Petechiae	0.2	0	0	HPO
2811	GP1BA	C0034150	Purpura	0.2	0	0	HPO
2811	GP1BA	C1280798	Von Willebrand disease, platelet type	0.602747267842131	4	2	CTD_human;ORPHANET;UNIPROT
2811	GP1BA	C3277076	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT	0.4	2	2	CTD_human;UNIPROT
2811	GP1BA	C3854603	FNAITP	0.2	0	0	ORPHANET
2812	GP1BB	C0005129	Bernard-Soulier Syndrome	0.696085946224674	1	2	CTD_human;ORPHANET;UNIPROT
2812	GP1BB	C0011334	Dental caries	0.2	0	0	HPO
2812	GP1BB	C0012236	DiGeorge Syndrome	0.202732912464814	0	0	ORPHANET
2812	GP1BB	C0018777	Conductive hearing loss	0.2	0	0	HPO
2812	GP1BB	C0020626	Hypoparathyroidism	0.2	0	0	HPO
2812	GP1BB	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
2812	GP1BB	C0034150	Purpura	0.2	0	0	HPO
2812	GP1BB	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
2812	GP1BB	C0039621	Tetany	0.2	0	0	HPO
2812	GP1BB	C0085109	Corneal Neovascularization	0.2	0	0	HPO
2812	GP1BB	C0220704	Shprintzen syndrome	0.2	0	0	ORPHANET
2812	GP1BB	C0271441	Chronic otitis media	0.2	0	0	HPO
2812	GP1BB	C0702166	Acne	0.2	0	0	HPO
2812	GP1BB	C0743359	ear infection chronic	0.2	0	0	HPO
2812	GP1BB	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	0.2	0	0	ORPHANET
2812	GP1BB	C2936346	22q11 Deletion Syndrome	0.2	0	0	ORPHANET
2812	GP1BB	C3266101	22q11 partial monosomy syndrome	0.2	0	0	ORPHANET
2812	GP1BB	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
2812	GP1BB	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
2812	GP1BB	C3854603	FNAITP	0.2	0	0	ORPHANET
2812	GP1BB	C4024912	Occipital myelomeningocele	0.2	0	0	HPO
2815	GP9	C0005129	Bernard-Soulier Syndrome	0.625635871137503	7	7	CTD_human;ORPHANET;UNIPROT
2815	GP9	C0034150	Purpura	0.2	0	0	HPO
2819	GPD1	C0239946	Fibrosis, Liver	0.2	0	0	HPO
2819	GPD1	C2711227	Steatohepatitis	0.2	0	0	HPO
2819	GPD1	C3280953	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE	0.4	1	2	ORPHANET;UNIPROT
282	ANCR	C0162635	Angelman Syndrome	0.2	0	0	CTD_human
2820	GPD2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.203780662444353	1	1	CTD_human
2820	GPD2	C0029456	Osteoporosis	0.2	1	0	CTD_human
2821	GPI	C0002878	Anemia, Hemolytic	0.204655999954305	1	0	CTD_human
2821	GPI	C0008325	Cholecystitis	0.2	0	0	HPO
2821	GPI	C0037921	Spinal ataxia	0.2	0	0	HPO
2821	GPI	C1291611	Deficiency of glucose-6-phosphate isomerase	0.2	0	0	HPO
2821	GPI	C3150730	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	0.68	6	16	CTD_human;ORPHANET;UNIPROT
2821	GPI	C4025184	Spontaneous hemolytic crises	0.2	0	0	HPO
2821	GPI	C4025735	Nonspherocytic hemolytic anemia	0.200274726784213	0	0	HPO
28234	SLCO1B3	C0220991	Rotor Syndrome	0.201098907136852	0	0	ORPHANET
28234	SLCO1B3	C0268307	Conjugated hyperbilirubinemia	0.200274726784213	0	0	HPO
2826	CCR10	C0038220	Status Epilepticus	0.2	1	0	CTD_human
282617	IFNL3	C0004096	Asthma	0.200274726784213	1	0	CTD_human
282617	IFNL3	C0011615	Dermatitis, Atopic	0.2	1	0	CTD_human
282617	IFNL3	C0019196	Hepatitis C	0.296849199663016	0	0	CTD_human
282631	GCCD2	C1846284	GLUCOCORTICOID DEFICIENCY 2	0.2	0	0	CTD_human
282808	RAB40AL	C1136249	Mental Retardation, X-Linked	0.2	1	0	CTD_human
282808	RAB40AL	C1845285	Martin-Probst Deafness-Mental Retardation Syndrome	0.4	1	1	CTD_human;UNIPROT
282809	POC1B	C0035334	Retinitis Pigmentosa	0.200549453568426	0	0	ORPHANET
282809	POC1B	C4014856	CONE-ROD DYSTROPHY 20	0.2	1	3	UNIPROT
282996	RBM20	C2750995	Cardiomyopathy, Dilated, 1DD	0.4	4	7	CTD_human;UNIPROT
282996	RBM20	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
282996	RBM20	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
283	ANG	C0002736	Amyotrophic Lateral Sclerosis	0.424434649686025	0	0	HPO;ORPHANET
283	ANG	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
283	ANG	C0234958	muscle degeneration	0.2	0	0	HPO
283	ANG	C1145670	Respiratory Failure	0.2	0	0	HPO
283	ANG	C1848736	Distal amyotrophy	0.2	0	0	HPO
283	ANG	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	0	0	CTD_human
283	ANG	C2678468	Amyotrophic Lateral Sclerosis 9	0.4	5	10	CTD_human;UNIPROT
283	ANG	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
283	ANG	C4020884	Anxiety disease	0.2	0	0	HPO
283120	H19	C0004903	Beckwith-Wiedemann Syndrome	0.214242726647129	0	0	CTD_human
283120	H19	C0019188	Hepatitis, Animal	0.2	1	0	CTD_human
283120	H19	C0175693	Russell-Silver syndrome	0.203846174978983	1	0	CTD_human
283120	H19	C1853800	Familial Wilms tumor 2	0.2	0	0	CTD_human
283131	NEAT1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
283234	CCDC88B	C0023343	Leprosy	0.200274726784213	1	1	CTD_human
2833	CXCR3	C0002171	Alopecia Areata	0.2	1	0	CTD_human
2833	CXCR3	C0011615	Dermatitis, Atopic	0.200274726784213	1	0	CTD_human
2833	CXCR3	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
2833	CXCR3	C0017658	Glomerulonephritis	0.2	1	0	CTD_human
2833	CXCR3	C0032285	Pneumonia	0.200274726784213	1	0	CTD_human
283375	SLC39A5	C4014762	MYOPIA 24, AUTOSOMAL DOMINANT	0.2	1	2	UNIPROT
283450	HECTD4	C1956346	Coronary Artery Disease	0.2	1	0	CTD_human
283989	TSEN54	C1843504	Pontocerebellar Hypoplasia Type 1	0.2	0	0	ORPHANET
283989	TSEN54	C1848526	Pontocerebellar Hypoplasia Type 2A	0.400274726784213	2	4	CTD_human;UNIPROT
283989	TSEN54	C1856974	PONTOCEREBELLAR HYPOPLASIA TYPE 4 (disorder)	0.600274726784213	2	5	CTD_human;ORPHANET;UNIPROT
283989	TSEN54	C1857762	Olivopontocerebellar hypoplasia, fetal-onset	0.200274726784213	0	0	ORPHANET
284	ANGPT1	C0243026	Sepsis	0.203557092817453	1	0	CTD_human
2840	GPR17	C0751955	Brain Infarction	0.2	1	0	CTD_human
284058	KANSL1	C1864871	Chromosome 17q21.31 Deletion Syndrome	0.200274726784213	0	0	ORPHANET
284086	NEK8	C1865872	NEPHRONOPHTHISIS 2	0.2	0	0	ORPHANET
284086	NEK8	C3151188	NEPHRONOPHTHISIS 9	0.200549453568426	1	3	UNIPROT
284098	PIGW	C4014958	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 5	0.2	1	2	UNIPROT
284111	SLC13A5	C0015695	Fatty Liver	0.200274726784213	1	0	CTD_human
284119	PTRF	C2750069	Lipodystrophy, Congenital Generalized, Type 4	0.480824180352639	0	0	CTD_human;ORPHANET
284217	LAMA1	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
284217	LAMA1	C4014821	PORETTI-BOLTSHAUSER SYNDROME	0.200274726784213	0	0	ORPHANET
284252	KCTD1	C1867020	SCALP-EAR-NIPPLE SYNDROME	0.400274726784213	1	8	ORPHANET;UNIPROT
284382	ACTL9	C0011615	Dermatitis, Atopic	0.200549453568426	1	0	CTD_human
284403	WDR62	C1838491	Kuzniecky syndrome	0.2	0	0	CTD_human
284403	WDR62	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
284403	WDR62	C1858535	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 2 (disorder)	0.2	3	21	UNIPROT
284403	WDR62	C1955869	Malformations of Cortical Development	0.2	1	0	CTD_human
28515	HYPLIP2	C0020474	Hyperlipidemia, Familial Combined	0.2	0	0	CTD_human
285175	UNC80	C4225203	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2	0.2	2	8	UNIPROT
285203	EOGT	C0265268	Adams Oliver syndrome	0.201098907136852	0	0	ORPHANET
285203	EOGT	C3809092	ADAMS-OLIVER SYNDROME 4	0.2	1	3	UNIPROT
285362	SUMF1	C0268263	Multiple Sulfatase Deficiency Disease	0.68357144819477	3	21	CTD_human;ORPHANET;UNIPROT
285362	SUMF1	C1720864	Sulfatidosis, Juvenile, Austin Type	0.2	0	0	ORPHANET
285440	CYP4V2	C1859486	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY	0.687417623173754	2	35	CTD_human;ORPHANET;UNIPROT
285489	DOK7	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	0.2	0	0	ORPHANET
285489	DOK7	C1276035	Pena-Shokeir syndrome type I	0.400274726784213	0	0	CTD_human;ORPHANET
285489	DOK7	C1850792	Congenital myasthenic syndrome ib	0.480274726784213	3	20	CTD_human;UNIPROT
285590	SH3PXD2B	C1855305	Ter Haar syndrome	0.681373633921066	1	5	CTD_human;ORPHANET;UNIPROT
2857	GPR34	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
285704	RGMB	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
285848	PNPLA1	C0020757	Ichthyoses	0.2	1	0	CTD_human
285848	PNPLA1	C3554355	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10	0.2	1	0	UNIPROT
2859	GPR35	C0566602	Primary sclerosing cholangitis	0.200274726784213	0	0	ORPHANET
286	ANK1	C0002878	Anemia, Hemolytic	0.200274726784213	0	0	HPO
286	ANK1	C0004509	Azoospermia	0.2	0	0	HPO
286	ANK1	C0008350	Cholelithiasis	0.2	0	0	HPO
286	ANK1	C0028738	Nystagmus	0.2	0	0	HPO
286	ANK1	C0037889	Hereditary spherocytosis	0.210359749888151	0	0	ORPHANET
286	ANK1	C0221409	Anemia, hereditary spherocytic hemolytic	0.2	0	0	ORPHANET
286	ANK1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
286	ANK1	C2674218	SPHEROCYTOSIS, TYPE 1 (disorder)	0.480274726784213	2	5	CTD_human;UNIPROT
286	ANK1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
286204	CRB2	C1857423	Cystic Kidney Disease with Ventriculomegaly	0.4	1	4	ORPHANET;UNIPROT
286204	CRB2	C4015555	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9	0.2	1	5	UNIPROT
286262	TPRN	C2750082	Deafness, Autosomal Recessive 79	0.2	0	0	CTD_human
286676	ILDR1	C1864818	DEAFNESS, AUTOSOMAL RECESSIVE 42 (disorder)	0.48	1	4	CTD_human;UNIPROT
286751	OTSC4	C1969046	OTOSCLEROSIS 4	0.2	0	0	CTD_human
286887	KRT6C	C3810394	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE	0.4	1	1	ORPHANET;UNIPROT
287	ANK2	C0004238	Atrial Fibrillation	0.200549453568426	0	0	HPO
287	ANK2	C0035828	Romano-Ward Syndrome	0.2	0	0	ORPHANET
287	ANK2	C1970119	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	0.401098907136852	1	5	CTD_human;UNIPROT
2870	GRK6	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
2875	GPT	C0015695	Fatty Liver	0.215327278406665	1	0	CTD_human
2875	GPT	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
28755	TRAC	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
28755	TRAC	C3809332	T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.2	0	0	ORPHANET
2876	GPX1	C0007786	Brain Ischemia	0.2	1	0	CTD_human
2876	GPX1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.20859471949093	2	0	CTD_human
2876	GPX1	C0014544	Epilepsy	0.2	1	0	CTD_human
2876	GPX1	C0015695	Fatty Liver	0.2	1	0	CTD_human
2876	GPX1	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
2876	GPX1	C0020456	Hyperglycemia	0.200274726784213	1	0	CTD_human
2876	GPX1	C0020459	Hyperinsulinism	0.200274726784213	2	0	CTD_human
2876	GPX1	C0020550	Hyperthyroidism	0.28	1	0	CTD_human
2876	GPX1	C0028754	Obesity	0.200549453568426	1	0	CTD_human
2876	GPX1	C0029456	Osteoporosis	0.200274726784213	1	0	CTD_human
2876	GPX1	C0030567	Parkinson Disease	0.203007639249027	1	0	CTD_human
2876	GPX1	C0857007	Hyperbilirubinemia, Neonatal	0.2	0	0	HPO
2876	GPX1	C4025283	Compensated hemolytic anemia	0.2	0	0	HPO
2878	GPX3	C0014175	Endometriosis	0.2	2	0	CTD_human
2878	GPX3	C0015624	Fanconi Syndrome	0.2	1	0	CTD_human
2878	GPX3	C0028754	Obesity	0.200549453568426	2	0	CTD_human
2879	GPX4	C0004245	Atrioventricular Block	0.2	0	0	HPO
2879	GPX4	C0015695	Fatty Liver	0.2	1	0	CTD_human
2879	GPX4	C0018801	Heart failure	0.2	1	0	CTD_human
2879	GPX4	C0700635	Strudwick syndrome	0.2	0	0	HPO
2879	GPX4	C1841659	Atrioventricular nodal disease	0.2	0	0	HPO
2879	GPX4	C1855229	Spondylometaphyseal dysplasia, Sedaghatian type	0.200274726784213	0	0	ORPHANET
2879	GPX4	C4082173	Porencephaly	0.2	0	0	HPO
288	ANK3	C0033300	Progeria	0.202732912464814	1	0	CTD_human
288	ANK3	C0038220	Status Epilepticus	0.28	1	0	CTD_human
288	ANK3	C3809672	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.2	0	0	ORPHANET
2888	GRB14	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200549453568426	1	0	CTD_human
289	ANOP1	C1844948	MICROPHTHALMIA, SYNDROMIC 4 (disorder)	0.2	0	0	CTD_human
2891	GRIA2	C0038220	Status Epilepticus	0.200274726784213	1	0	CTD_human
2892	GRIA3	C0014306	Enophthalmos	0.2	0	0	HPO
2892	GRIA3	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
2892	GRIA3	C2678051	MENTAL RETARDATION, X-LINKED 94 (disorder)	0.6	1	8	CTD_human;ORPHANET;UNIPROT
2893	GRIA4	C0027092	Myopia	0.2	1	0	CTD_human
2895	GRID2	C0014877	Esotropia	0.2	0	0	HPO
2895	GRID2	C0028738	Nystagmus	0.2	0	0	HPO
2895	GRID2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
2895	GRID2	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
2895	GRID2	C3489733	Oculomotor apraxia	0.2	0	0	HPO
2895	GRID2	C4015505	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.48	1	0	ORPHANET;UNIPROT
2895	GRID2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
28952	CCDC22	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
28952	CCDC22	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
28952	CCDC22	C0020255	Hydrocephalus	0.2	0	0	HPO
28952	CCDC22	C0152101	Hypoplastic Left Heart Syndrome	0.2	0	0	HPO
28952	CCDC22	C0796137	3C syndrome	0.200274726784213	0	0	ORPHANET
28952	CCDC22	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
28952	CCDC22	C4225419	RITSCHER-SCHINZEL SYNDROME 2	0.2	2	2	UNIPROT
28956	LAMTOR2	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
28956	LAMTOR2	C1835829	Immunodeficiency due to Defect in MAPBP-Interacting Protein	0.4	0	0	CTD_human;ORPHANET
2896	GRN	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
2896	GRN	C0029124	Optic Atrophy	0.2	0	0	HPO
2896	GRN	C0042798	Low Vision	0.2	0	0	HPO
2896	GRN	C0235946	Cerebral atrophy	0.201923087489492	0	0	HPO
2896	GRN	C0262404	Cerebellar degeneration	0.2	0	0	HPO
2896	GRN	C0338451	Frontotemporal dementia	0.444034474654419	2	7	CTD_human;HPO
2896	GRN	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
2896	GRN	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
2896	GRN	C1843792	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.482197814273705	1	9	CTD_human;UNIPROT
2896	GRN	C3539123	CEROID LIPOFUSCINOSIS, NEURONAL, 11	0.2	0	0	ORPHANET
2896	GRN	C4011788	Behavioral variant of frontotemporal dementia	0.201648360705279	0	0	ORPHANET
2896	GRN	C4020873	Infratentorial atrophy	0.2	0	0	HPO
2896	GRN	C4020884	Anxiety disease	0.2	0	0	HPO
2896	GRN	C4021584	Frontotemporal cerebral atrophy	0.2	0	0	HPO
2896	GRN	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
2896	GRN	C4024936	Temporal cortical atrophy	0.2	0	0	HPO
2896	GRN	C4024956	Grammar-specific speech disorder	0.2	0	0	HPO
28960	DCPS	C0014306	Enophthalmos	0.2	0	0	HPO
28960	DCPS	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
28960	DCPS	C4085595	AL-RAQAD SYNDROME	0.2	1	2	UNIPROT
28962	OSTM1	C0020255	Hydrocephalus	0.2	0	0	HPO
28962	OSTM1	C0029454	Osteopetrosis	0.213953644485599	0	0	HPO
28962	OSTM1	C1838258	Osteopetrosis and infantile neuroaxonal dystrophy	0.2	0	0	ORPHANET
28962	OSTM1	C1850127	Osteopetrosis, Autosomal Recessive 1	0.2	0	0	CTD_human
28962	OSTM1	C1968603	Osteopetrosis, Autosomal Recessive 5	0.48	0	0	CTD_human;ORPHANET
28976	ACAD9	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
28976	ACAD9	C0018801	Heart failure	0.2	0	0	HPO
28976	ACAD9	C0018802	Congestive heart failure	0.2	0	0	HPO
28976	ACAD9	C0020615	Hypoglycemia	0.2	0	0	HPO
28976	ACAD9	C0085605	Liver Failure	0.2	0	0	HPO
28976	ACAD9	C1970173	Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of	0.600274726784213	7	11	CTD_human;ORPHANET;UNIPROT
2898	GRIK2	C1970198	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6	0.2	0	0	CTD_human
28982	FLVCR1	C0014848	Esophageal Achalasia	0.2	0	0	HPO
28982	FLVCR1	C0028077	Night Blindness	0.2	0	0	HPO
28982	FLVCR1	C0029124	Optic Atrophy	0.2	0	0	HPO
28982	FLVCR1	C0035334	Retinitis Pigmentosa	0.200549453568426	0	0	HPO
28982	FLVCR1	C0037921	Spinal ataxia	0.2	0	0	HPO
28982	FLVCR1	C0158113	Contracture of joint of hand	0.2	0	0	HPO
28982	FLVCR1	C0234958	muscle degeneration	0.2	0	0	HPO
28982	FLVCR1	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
28982	FLVCR1	C0271215	Blindness, Legal	0.2	0	0	HPO
28982	FLVCR1	C1836916	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA	0.600824180352639	2	3	CTD_human;ORPHANET;UNIPROT
28984	RGCC	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
290	ANPEP	C0149821	ACUTE ALCOHOL WITHDRAWAL	0.2	1	0	PSYGENET
29015	SLC43A3	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
2902	GRIN1	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
2902	GRIN1	C3280282	MENTAL RETARDATION, AUTOSOMAL DOMINANT 8	0.2	1	3	UNIPROT
2903	GRIN2A	C0014544	Epilepsy	0.404120901763197	2	0	CTD_human;HPO
2903	GRIN2A	C0264611	Apraxia of Phonation	0.2	0	0	HPO
2903	GRIN2A	C0376532	Epilepsy, Rolandic	0.200824180352639	1	0	CTD_human
2903	GRIN2A	C2363129	Benign Rolandic Epilepsy	0.200274726784213	0	0	ORPHANET
2903	GRIN2A	C3806402	EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION	0.4	7	11	ORPHANET;UNIPROT
2904	GRIN2B	C0014544	Epilepsy	0.400274726784213	1	1	CTD_human;HPO
2904	GRIN2B	C0037769	West Syndrome	0.200274726784213	0	0	ORPHANET
2904	GRIN2B	C0543888	Epileptic encephalopathy	0.2	0	0	HPO
2904	GRIN2B	C3151411	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6	0.2	3	11	UNIPROT
2904	GRIN2B	C4015316	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27	0.2	1	4	UNIPROT
29058	TMEM230	C0030567	Parkinson Disease	0.2	1	0	CTD_human
29071	C1GALT1C1	C0272137	Tn Syndrome	0.4	1	5	CTD_human;UNIPROT
29072	SETD2	C0018777	Conductive hearing loss	0.2	0	0	HPO
29072	SETD2	C0020615	Hypoglycemia	0.200549453568426	0	0	HPO
29072	SETD2	C0028754	Obesity	0.200274726784213	0	0	HPO
29072	SETD2	C0034013	Precocious Puberty	0.2	0	0	HPO
29072	SETD2	C0175695	Sotos' syndrome	0.2	0	0	ORPHANET
29078	NDUFAF4	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
29078	NDUFAF4	C0014544	Epilepsy	0.2	0	0	HPO
29078	NDUFAF4	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
29078	NDUFAF4	C0020615	Hypoglycemia	0.2	0	0	HPO
29078	NDUFAF4	C0023520	Leukodystrophy	0.2	0	0	HPO
29078	NDUFAF4	C0028738	Nystagmus	0.2	0	0	HPO
29078	NDUFAF4	C0038379	Strabismus	0.2	0	0	HPO
29078	NDUFAF4	C0085605	Liver Failure	0.2	0	0	HPO
29078	NDUFAF4	C0234958	muscle degeneration	0.2	0	0	HPO
29078	NDUFAF4	C0262404	Cerebellar degeneration	0.2	0	0	HPO
29078	NDUFAF4	C0271215	Blindness, Legal	0.2	0	0	HPO
29078	NDUFAF4	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
29078	NDUFAF4	C1145670	Respiratory Failure	0.2	0	0	HPO
29078	NDUFAF4	C1836830	Developmental regression	0.2	0	0	HPO
29078	NDUFAF4	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.4	1	1	CTD_human;UNIPROT
29078	NDUFAF4	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
29078	NDUFAF4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
29078	NDUFAF4	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
29078	NDUFAF4	C4020873	Infratentorial atrophy	0.2	0	0	HPO
29079	MED4	C0014175	Endometriosis	0.2	1	0	CTD_human
2908	NR3C1	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
2908	NR3C1	C0020595	Hypoaldosteronism	0.2	0	0	HPO
2908	NR3C1	C0020615	Hypoglycemia	0.202732912464814	0	0	HPO
2908	NR3C1	C0028840	Ocular Hypertension	0.20328236603324	1	0	CTD_human
2908	NR3C1	C0220983	Metabolic alkalosis	0.2	0	0	HPO
2908	NR3C1	C0702166	Acne	0.2	0	0	HPO
2908	NR3C1	C1621895	Adrenal hyperplasia	0.2	0	0	HPO
2908	NR3C1	C1841972	Glucocorticoid Receptor Deficiency	0.416208880268573	9	8	ORPHANET;UNIPROT
29089	UBE2T	C0002871	Anemia	0.2	0	0	HPO
29089	UBE2T	C0015625	Fanconi Anemia	0.203831819601666	0	0	ORPHANET
29089	UBE2T	C0023530	Leukopenia	0.2	0	0	HPO
29089	UBE2T	C0030312	Pancytopenia	0.2	0	0	HPO
29089	UBE2T	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
29089	UBE2T	C4084840	FANCONI ANEMIA, COMPLEMENTATION GROUP T	0.2	1	2	UNIPROT
291	SLC25A4	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
291	SLC25A4	C0027092	Myopia	0.2	0	0	HPO
291	SLC25A4	C0028738	Nystagmus	0.2	0	0	HPO
291	SLC25A4	C0038379	Strabismus	0.2	0	0	HPO
291	SLC25A4	C0162674	Chronic progressive external ophthalmoplegia	0.214451940896713	0	0	HPO
291	SLC25A4	C0376175	Bell Palsy	0.2	0	0	HPO
291	SLC25A4	C0853897	Diabetic Cardiomyopathies	0.2	1	0	CTD_human
291	SLC25A4	C1834846	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1	0.4	0	0	CTD_human;ORPHANET
291	SLC25A4	C1836460	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 2	0.4	4	4	CTD_human;UNIPROT
291	SLC25A4	C1859317	Cataract and cardiomyopathy	0.200274726784213	0	0	ORPHANET
291	SLC25A4	C3495498	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	0.2	0	0	CTD_human
29108	PYCARD	C0598608	Hyperhomocysteinemia	0.2	1	0	CTD_human
2911	GRM1	C0014544	Epilepsy	0.2	1	0	CTD_human
2911	GRM1	C0014556	Epilepsy, Temporal Lobe	0.283007639249027	1	0	CTD_human
2911	GRM1	C0014877	Esotropia	0.2	0	0	HPO
2911	GRM1	C0038220	Status Epilepticus	0.2	2	0	CTD_human
2911	GRM1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
2911	GRM1	C0271385	Horizontal Nystagmus	0.2	0	0	HPO
2911	GRM1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
2911	GRM1	C3553816	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.28	0	0	ORPHANET
2911	GRM1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
29110	TBK1	C0002736	Amyotrophic Lateral Sclerosis	0.402747267842131	0	0	HPO;ORPHANET
29110	TBK1	C0234958	muscle degeneration	0.2	0	0	HPO
29110	TBK1	C0235946	Cerebral atrophy	0.2	0	0	HPO
29110	TBK1	C0276226	Herpes encephalitis	0.200549453568426	0	0	ORPHANET
29110	TBK1	C0338451	Frontotemporal dementia	0.201098907136852	0	0	HPO
29110	TBK1	C0477341	Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.2	0	0	ORPHANET
29110	TBK1	C1145670	Respiratory Failure	0.2	0	0	HPO
29110	TBK1	C1301959	Bulbar weakness	0.2	0	0	HPO
29110	TBK1	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
29110	TBK1	C4020884	Anxiety disease	0.2	0	0	HPO
29110	TBK1	C4082299	Bulbar palsy	0.2	0	0	HPO
29110	TBK1	C4225325	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4	0.2	2	10	UNIPROT
29116	MYLIP	C0014175	Endometriosis	0.2	1	0	CTD_human
29119	CTNNA3	C0004096	Asthma	0.201373633921065	1	1	CTD_human
29119	CTNNA3	C0006384	Bundle-Branch Block	0.2	0	0	HPO
29119	CTNNA3	C0042514	Tachycardia, Ventricular	0.2	0	0	HPO
29119	CTNNA3	C3810138	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13	0.2	1	2	UNIPROT
2912	GRM2	C0014556	Epilepsy, Temporal Lobe	0.200274726784213	1	0	CTD_human
29123	ANKRD11	C0014544	Epilepsy	0.2	0	0	HPO
29123	ANKRD11	C0220687	KBG syndrome	0.203296721410557	0	0	ORPHANET
29123	ANKRD11	C1849173	Periventricular neuronal heterotopia	0.2	0	0	HPO
29127	RACGAP1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
2913	GRM3	C0014556	Epilepsy, Temporal Lobe	0.2	1	0	CTD_human
2914	GRM4	C0014556	Epilepsy, Temporal Lobe	0.2	1	0	CTD_human
2915	GRM5	C0014556	Epilepsy, Temporal Lobe	0.200274726784213	1	0	CTD_human
2915	GRM5	C0038220	Status Epilepticus	0.2	2	0	CTD_human
2916	GRM6	C0018975	Hemeralopia	0.2	0	0	HPO
2916	GRM6	C0027092	Myopia	0.202681755307501	0	0	HPO
2916	GRM6	C0028077	Night Blindness	0.202681755307501	0	0	HPO
2916	GRM6	C0271183	Severe myopia	0.200274726784213	0	0	HPO
2916	GRM6	C1850362	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	0.280274726784213	2	9	UNIPROT
2916	GRM6	C3551052	Night blindness, stationary	0.2	0	0	HPO
2918	GRM8	C0001957	Alcohol Withdrawal Delirium	0.200274726784213	1	0	PSYGENET
2919	CXCL1	C0024117	Chronic Obstructive Airway Disease	0.200274726784213	1	0	CTD_human
2919	CXCL1	C0032285	Pneumonia	0.200824180352639	1	0	CTD_human
2919	CXCL1	C0085129	Bronchial Hyperreactivity	0.2	1	0	CTD_human
2919	CXCL1	C0241910	Hepatitis, Autoimmune	0.2	1	0	CTD_human
2919	CXCL1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
2919	CXCL1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2920	CXCL2	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
2920	CXCL2	C0008370	Cholestasis	0.2	1	0	CTD_human
2920	CXCL2	C0018801	Heart failure	0.2	1	0	CTD_human
2920	CXCL2	C0024117	Chronic Obstructive Airway Disease	0.200274726784213	1	0	CTD_human
2920	CXCL2	C0029408	Degenerative polyarthritis	0.200824180352639	1	0	CTD_human
2920	CXCL2	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
2920	CXCL2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2920	CXCL2	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
2920	CXCL2	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
2923	PDIA3	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
2923	PDIA3	C1846707	SPINOCEREBELLAR ATAXIA 17	0.2	1	0	CTD_human
2932	GSK3B	C0002395	Alzheimer's Disease	0.31313168349158	2	0	CTD_human
2932	GSK3B	C0018801	Heart failure	0.2	1	0	CTD_human
2932	GSK3B	C0027051	Myocardial Infarction	0.280274726784213	1	0	CTD_human
2932	GSK3B	C0031154	Peritonitis	0.2	1	0	CTD_human
2932	GSK3B	C1866282	CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.2	1	0	CTD_human
2934	GSN	C0010495	Cutis Laxa	0.200549453568426	0	0	HPO
2934	GSN	C0029456	Osteoporosis	0.2	1	0	CTD_human
2934	GSN	C0030524	Paratuberculosis	0.2	1	0	CTD_human
2934	GSN	C0035078	Kidney Failure	0.200274726784213	0	0	HPO
2934	GSN	C0152025	Polyneuropathy	0.200549453568426	0	0	HPO
2934	GSN	C0155127	Familial Amyloid Polyneuropathy, Type V	0.200549453568426	0	0	HPO
2934	GSN	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
2934	GSN	C1301959	Bulbar weakness	0.2	0	0	HPO
2934	GSN	C1565489	Renal Insufficiency	0.2	0	0	HPO
2934	GSN	C1622345	Meretoja syndrome	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
2934	GSN	C2930812	Generalized elastolysis	0.2	0	0	HPO
2934	GSN	C4082299	Bulbar palsy	0.2	0	0	HPO
2934	GSN	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2936	GSR	C0002736	Amyotrophic Lateral Sclerosis	0.200274726784213	1	0	CTD_human
2936	GSR	C0002871	Anemia	0.2	1	0	CTD_human
2936	GSR	C0002878	Anemia, Hemolytic	0.2	1	0	CTD_human
2936	GSR	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
2936	GSR	C0020550	Hyperthyroidism	0.2	1	0	CTD_human
2936	GSR	C0020615	Hypoglycemia	0.2	1	0	CTD_human
2936	GSR	C0033626	Protein Deficiency	0.2	1	0	CTD_human
2936	GSR	C1456865	Ureteral Calculi	0.2	1	0	CTD_human
2936	GSR	C4277682	Chemical and Drug Induced Liver Injury	0.28	1	0	CTD_human
2937	GSS	C0002878	Anemia, Hemolytic	0.200274726784213	0	0	HPO
2937	GSS	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
2937	GSS	C0014544	Epilepsy	0.2	0	0	HPO
2937	GSS	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
2937	GSS	C0398746	Gluthathione synthetase deficiency	0.600549453568426	1	8	CTD_human;HPO;ORPHANET;UNIPROT
2937	GSS	C0575059	Spastic tetraparesis	0.2	0	0	HPO
2937	GSS	C0740749	Chronic metabolic acidosis	0.200274726784213	0	0	HPO
2937	GSS	C1856399	Glutathione Synthetase Deficiency of Erythrocytes, Hemolytic Anemia due to	0.4	0	0	CTD_human;ORPHANET
2938	GSTA1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2938	GSTA1	C0400966	Non-alcoholic Fatty Liver Disease	0.200274726784213	1	0	CTD_human
2941	GSTA4	C0003850	Arteriosclerosis	0.2	2	0	CTD_human
2941	GSTA4	C0030567	Parkinson Disease	0.205414667772315	1	0	CTD_human
2944	GSTM1	C0004096	Asthma	0.31420739984503	2	0	CTD_human
2944	GSTM1	C0004153	Atherosclerosis	0.220904588891583	1	0	CTD_human
2944	GSTM1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.22420131030214	1	0	CTD_human
2944	GSTM1	C0030567	Parkinson Disease	0.244933486724135	1	0	CTD_human
2944	GSTM1	C0034734	Raynaud Disease	0.202407028523288	1	0	CTD_human
2944	GSTM1	C0042109	Urticaria	0.2	1	0	CTD_human
2944	GSTM1	C0236663	Alcohol withdrawal syndrome	0.200274726784213	1	0	PSYGENET
2944	GSTM1	C0263454	Chloracne	0.200274726784213	1	0	CTD_human
2944	GSTM1	C0400966	Non-alcoholic Fatty Liver Disease	0.200824180352639	1	0	CTD_human
2944	GSTM1	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
2946	GSTM2	C0013080	Down Syndrome	0.2	1	0	CTD_human
2946	GSTM2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2946	GSTM2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2947	GSTM3	C0263454	Chloracne	0.2	1	0	CTD_human
2947	GSTM3	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2948	GSTM4	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
2950	GSTP1	C0002736	Amyotrophic Lateral Sclerosis	0.202732912464814	1	0	CTD_human
2950	GSTP1	C0004096	Asthma	0.305203087261019	3	0	CTD_human
2950	GSTP1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
2950	GSTP1	C0022650	Kidney Calculi	0.2	1	0	CTD_human
2950	GSTP1	C0030567	Parkinson Disease	0.226268099506585	2	0	CTD_human
2950	GSTP1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2950	GSTP1	C0400966	Non-alcoholic Fatty Liver Disease	0.200824180352639	1	0	CTD_human
2950	GSTP1	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
2950	GSTP1	C1456865	Ureteral Calculi	0.2	1	0	CTD_human
2950	GSTP1	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
2952	GSTT1	C0003949	Asbestosis	0.202956482091714	1	0	CTD_human
2952	GSTT1	C0034734	Raynaud Disease	0.202407028523288	1	0	CTD_human
2952	GSTT1	C0400966	Non-alcoholic Fatty Liver Disease	0.200549453568426	1	0	CTD_human
2952	GSTT1	C0403823	Asthenozoospermia	0.200274726784213	1	0	CTD_human
2952	GSTT1	C4277682	Chemical and Drug Induced Liver Injury	0.2	3	0	CTD_human
2956	MSH6	C0014544	Epilepsy	0.2	0	0	HPO
2956	MSH6	C0151740	Intracranial Hypertension	0.2	0	0	HPO
2956	MSH6	C0265325	Turcot syndrome (disorder)	0.404120901763197	0	0	CTD_human;ORPHANET
2956	MSH6	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
2956	MSH6	C4020884	Anxiety disease	0.2	0	0	HPO
2961	GTF2E2	C1955934	Trichothiodystrophy Syndromes	0.200274726784213	0	0	ORPHANET
2969	GTF2I	C0003499	Supravalvular aortic stenosis	0.2	0	0	HPO
2969	GTF2I	C0007786	Brain Ischemia	0.2	0	0	HPO
2969	GTF2I	C0012819	Diverticular disease of colon	0.2	0	0	HPO
2969	GTF2I	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2969	GTF2I	C0020437	Hypercalcemia	0.2	0	0	HPO
2969	GTF2I	C0020545	Hypertension, Renovascular	0.2	0	0	HPO
2969	GTF2I	C0024421	Macroglossia	0.2	0	0	HPO
2969	GTF2I	C0024636	Malocclusion	0.2	0	0	HPO
2969	GTF2I	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
2969	GTF2I	C0028754	Obesity	0.2	0	0	HPO
2969	GTF2I	C0035078	Kidney Failure	0.2	0	0	HPO
2969	GTF2I	C0038379	Strabismus	0.2	0	0	HPO
2969	GTF2I	C0042798	Low Vision	0.2	0	0	HPO
2969	GTF2I	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
2969	GTF2I	C0175702	Williams Syndrome	0.488516530310606	2	0	CTD_human;ORPHANET
2969	GTF2I	C0271441	Chronic otitis media	0.2	0	0	HPO
2969	GTF2I	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
2969	GTF2I	C0743359	ear infection chronic	0.2	0	0	HPO
2969	GTF2I	C0917798	Cerebral Ischemia	0.2	0	0	HPO
2969	GTF2I	C1527336	Sjogren's Syndrome	0.2	1	1	CTD_human
2969	GTF2I	C1565489	Renal Insufficiency	0.2	0	0	HPO
2969	GTF2I	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
2969	GTF2I	C4020884	Anxiety disease	0.2	0	0	HPO
2969	GTF2I	C4025788	Nystagmus-induced head nodding	0.2	0	0	HPO
2969	GTF2I	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
2972	BRF1	C0024636	Malocclusion	0.2	0	0	HPO
2972	BRF1	C0266039	Taurodontism	0.2	0	0	HPO
2972	BRF1	C4015495	CEREBELLOFACIODENTAL SYNDROME	0.4	1	4	ORPHANET;UNIPROT
2972	BRF1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
2973	GTS	C0040517	Gilles de la Tourette syndrome	0.201923087489492	0	0	CTD_human
29760	BLNK	C0001768	Agammaglobulinemia	0.200549453568426	0	0	HPO
29760	BLNK	C0003864	Arthritis	0.200824180352639	0	0	HPO
29760	BLNK	C0009763	Conjunctivitis	0.2	0	0	HPO
29760	BLNK	C0029443	Osteomyelitis	0.2	0	0	HPO
29760	BLNK	C0037199	Sinusitis	0.2	0	0	HPO
29760	BLNK	C0149516	Chronic sinusitis	0.200274726784213	0	0	HPO
29760	BLNK	C0271441	Chronic otitis media	0.2	0	0	HPO
29760	BLNK	C0694550	Recurrent pneumonia	0.2	0	0	HPO
29760	BLNK	C0743359	ear infection chronic	0.2	0	0	HPO
29760	BLNK	C0747085	Recurrent otitis media	0.2	0	0	HPO
29760	BLNK	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
29760	BLNK	C0748720	Chronic sinus disease	0.2	0	0	HPO
29760	BLNK	C2242472	Infection of bone	0.2	0	0	HPO
29760	BLNK	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
29760	BLNK	C3150752	AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE	0.2	0	0	CTD_human
29760	BLNK	C3152144	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
29764	DDU	C1852145	Familial dermographism	0.2	0	0	CTD_human
2978	GUCA1A	C0028077	Night Blindness	0.2	0	0	HPO
2978	GUCA1A	C0035334	Retinitis Pigmentosa	0.402197814273705	0	0	HPO;ORPHANET
2978	GUCA1A	C0042798	Low Vision	0.2	0	0	HPO
2978	GUCA1A	C0271092	Progressive cone dystrophy (without rod involvement)	0.2	0	0	ORPHANET
2978	GUCA1A	C0730290	Cone dystrophy	0.201648360705279	0	0	HPO
2978	GUCA1A	C1865869	CONE DYSTROPHY 3 (disorder)	0.480549453568426	3	5	CTD_human;UNIPROT
2978	GUCA1A	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
29785	CYP2S1	C0033860	Psoriasis	0.200274726784213	1	0	CTD_human
2979	GUCA1B	C0017601	Glaucoma	0.2	0	0	HPO
2979	GUCA1B	C0018777	Conductive hearing loss	0.2	0	0	HPO
2979	GUCA1B	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
2979	GUCA1B	C0020459	Hyperinsulinism	0.2	0	0	HPO
2979	GUCA1B	C0020619	Hypogonadism	0.2	0	0	HPO
2979	GUCA1B	C0022578	Keratoconus	0.2	0	0	HPO
2979	GUCA1B	C0028738	Nystagmus	0.2	0	0	HPO
2979	GUCA1B	C0028754	Obesity	0.2	0	0	HPO
2979	GUCA1B	C0029124	Optic Atrophy	0.2	0	0	HPO
2979	GUCA1B	C0035334	Retinitis Pigmentosa	0.603231208875927	1	0	CTD_human;HPO;ORPHANET
2979	GUCA1B	C0042798	Low Vision	0.2	0	0	HPO
2979	GUCA1B	C0271215	Blindness, Legal	0.2	0	0	HPO
2979	GUCA1B	C3151190	RETINITIS PIGMENTOSA 48	0.200274726784213	1	1	UNIPROT
2981	GUCA2B	C0022661	Kidney Failure, Chronic	0.203007639249027	1	0	CTD_human
2982	GUCY1A3	C0014848	Esophageal Achalasia	0.200274726784213	0	0	HPO
2982	GUCY1A3	C0242350	Erectile dysfunction	0.2	0	0	HPO
2982	GUCY1A3	C0340100	High altitude pulmonary edema	0.2	1	0	CTD_human
2982	GUCY1A3	C1956346	Coronary Artery Disease	0.2	1	1	CTD_human
2982	GUCY1A3	C3810403	MOYAMOYA DISEASE 6 WITH ACHALASIA	0.2	0	0	ORPHANET
2982	GUCY1A3	C4023169	Moyamoya phenomenon	0.2	0	0	HPO
2984	GUCY2C	C0398349	Distal intestinal obstruction syndrome	0.2	0	0	HPO
2984	GUCY2C	C2939175	Meconium ileus	0.600549453568426	1	1	HPO;ORPHANET;UNIPROT
2984	GUCY2C	C3553270	DIARRHEA 6	0.4	1	1	ORPHANET;UNIPROT
29851	ICOS	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
29851	ICOS	C0006267	Bronchiectasis	0.2	0	0	HPO
29851	ICOS	C0009447	Common Variable Immunodeficiency	0.408711389182872	0	0	CTD_human;ORPHANET
29851	ICOS	C0009763	Conjunctivitis	0.2	0	0	HPO
29851	ICOS	C0024312	Lymphopenia	0.2	0	0	HPO
29851	ICOS	C0025289	Meningitis	0.2	0	0	HPO
29851	ICOS	C0032285	Pneumonia	0.200274726784213	0	0	HPO
29851	ICOS	C0034150	Purpura	0.2	0	0	HPO
29851	ICOS	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
29851	ICOS	C0162538	Immunoglobulin A deficiency (disorder)	0.202407028523288	0	0	HPO
29851	ICOS	C0162539	IgG Deficiency	0.2	0	0	HPO
29851	ICOS	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
29851	ICOS	C0271441	Chronic otitis media	0.2	0	0	HPO
29851	ICOS	C0398650	Immune thrombocytopenic purpura	0.200274726784213	0	0	HPO
29851	ICOS	C0581354	Recurrent sinusitis	0.2	0	0	HPO
29851	ICOS	C0694550	Recurrent pneumonia	0.2	0	0	HPO
29851	ICOS	C0741796	Recurrent bronchitis	0.2	0	0	HPO
29851	ICOS	C0743359	ear infection chronic	0.2	0	0	HPO
29851	ICOS	C0747085	Recurrent otitis media	0.2	0	0	HPO
29851	ICOS	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
29851	ICOS	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
29851	ICOS	C4280333	Recurrent sinus disease	0.2	0	0	HPO
29887	SNX10	C0002871	Anemia	0.2	0	0	HPO
29887	SNX10	C0008711	Chronic rhinitis	0.2	0	0	HPO
29887	SNX10	C0010278	Craniosynostosis	0.2	0	0	HPO
29887	SNX10	C0020255	Hydrocephalus	0.2	0	0	HPO
29887	SNX10	C0028738	Nystagmus	0.2	0	0	HPO
29887	SNX10	C0029124	Optic Atrophy	0.2	0	0	HPO
29887	SNX10	C0029454	Osteopetrosis	0.201373633921065	0	0	HPO
29887	SNX10	C0029882	Otitis Media	0.2	0	0	HPO
29887	SNX10	C0042798	Low Vision	0.2	0	0	HPO
29887	SNX10	C0242567	Opsoclonus	0.2	0	0	HPO
29887	SNX10	C0376175	Bell Palsy	0.2	0	0	HPO
29887	SNX10	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
29887	SNX10	C3554478	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8	0.2	2	4	UNIPROT
2989	GULOP	C0036474	Scurvy	0.2	0	0	CTD_human
29893	PSMC3IP	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
29893	PSMC3IP	C0025322	Premature Menopause	0.200274726784213	0	0	HPO
29893	PSMC3IP	C0029453	Osteopenia	0.2	0	0	HPO
29893	PSMC3IP	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
29893	PSMC3IP	C0747078	Generalized osteopenia	0.2	0	0	HPO
29893	PSMC3IP	C4025170	Osteoporosis of vertebrae	0.2	0	0	HPO
29899	GPSM2	C0020255	Hydrocephalus	0.2	0	0	HPO
29899	GPSM2	C0078981	Arachnoid Cysts	0.2	0	0	HPO
29899	GPSM2	C0266491	Neuronal heterotopia	0.2	0	0	HPO
29899	GPSM2	C1857278	Partial or complete agenesis of corpus callosum	0.2	0	0	HPO
29899	GPSM2	C1858695	Chudley-Mccullough syndrome	0.481098907136852	1	7	CTD_human;ORPHANET
29899	GPSM2	C4021533	Severe sensorineural hearing impairment	0.2	0	0	HPO
2990	GUSB	C0019158	Hepatitis	0.2	0	0	HPO
2990	GUSB	C0020255	Hydrocephalus	0.2	0	0	HPO
2990	GUSB	C0020305	Hydrops Fetalis	0.200274726784213	0	0	HPO
2990	GUSB	C0024236	Lymphedema	0.2	0	0	HPO
2990	GUSB	C0085132	Mucopolysaccharidosis VII	0.694560519563294	10	29	CTD_human;ORPHANET;UNIPROT
2990	GUSB	C0086795	Pfaundler-Hurler Syndrome	0.2	0	0	HPO
2990	GUSB	C0521719	Clouding of corneal stroma	0.200549453568426	0	0	HPO
2990	GUSB	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
29914	UBIAD1	C0010036	Corneal dystrophy	0.200274726784213	0	0	HPO
29914	UBIAD1	C0271287	Schnyder crystalline corneal dystrophy	0.60357144819477	7	11	CTD_human;HPO;ORPHANET;UNIPROT
2992	GYG1	C0085612	Ventricular arrhythmia	0.2	0	0	HPO
2992	GYG1	C0085615	Right bundle branch block	0.2	0	0	HPO
2992	GYG1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
2992	GYG1	C0234958	muscle degeneration	0.2	0	0	HPO
2992	GYG1	C3150754	GLYCOGEN STORAGE DISEASE XV	0.6	1	1	CTD_human;ORPHANET;UNIPROT
2992	GYG1	C4015452	POLYGLUCOSAN BODY MYOPATHY 2	0.4	1	5	ORPHANET;UNIPROT
29920	PYCR2	C0023520	Leukodystrophy	0.2	0	0	HPO
29920	PYCR2	C0234958	muscle degeneration	0.2	0	0	HPO
29920	PYCR2	C4225332	LEUKODYSTROPHY, HYPOMYELINATING, 10	0.2	1	7	UNIPROT
29925	GMPPB	C0014544	Epilepsy	0.2	0	0	HPO
29925	GMPPB	C0017601	Glaucoma	0.2	0	0	HPO
29925	GMPPB	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
29925	GMPPB	C0020255	Hydrocephalus	0.2	0	0	HPO
29925	GMPPB	C0026850	Muscular Dystrophy	0.200549453568426	0	0	HPO
29925	GMPPB	C0027092	Myopia	0.2	0	0	HPO
29925	GMPPB	C0029124	Optic Atrophy	0.2	0	0	HPO
29925	GMPPB	C0038379	Strabismus	0.2	0	0	HPO
29925	GMPPB	C0042798	Low Vision	0.2	0	0	HPO
29925	GMPPB	C0457133	Muscle eye brain disease	0.2	0	0	ORPHANET
29925	GMPPB	C0699743	Congenital muscular dystrophy (disorder)	0.2	0	0	HPO
29925	GMPPB	C1837229	Muscular Dystrophy, Congenital, Type 1D	0.2	0	0	ORPHANET
29925	GMPPB	C1847759	MUSCULAR DYSTROPHY, CONGENITAL, 1C	0.2	0	0	ORPHANET
29925	GMPPB	C3150415	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	0.2	0	0	ORPHANET
29925	GMPPB	C3150416	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.2	0	0	ORPHANET
29925	GMPPB	C3714932	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14	0.4	1	10	ORPHANET;UNIPROT
29925	GMPPB	C3809216	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14	0.2	1	3	UNIPROT
29925	GMPPB	C3809221	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14	0.4	1	4	ORPHANET;UNIPROT
29926	GMPPA	C0013363	Dysautonomia	0.2	0	0	HPO
29926	GMPPA	C0014544	Epilepsy	0.2	0	0	HPO
29926	GMPPA	C0014848	Esophageal Achalasia	0.2	0	0	HPO
29926	GMPPA	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
29926	GMPPA	C0042798	Low Vision	0.2	0	0	HPO
29926	GMPPA	C0271742	Glucocorticoid deficiency with achalasia	0.2	0	0	ORPHANET
29926	GMPPA	C0344505	Alacrima	0.2	0	0	HPO
29926	GMPPA	C3809738	ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.2	1	5	UNIPROT
29929	ALG6	C0014544	Epilepsy	0.2	0	0	HPO
29929	ALG6	C0015523	Factor XI Deficiency	0.2	0	0	HPO
29929	ALG6	C0038379	Strabismus	0.2	0	0	HPO
29929	ALG6	C0085605	Liver Failure	0.2	0	0	HPO
29929	ALG6	C0272375	Antithrombin III Deficiency	0.2	0	0	HPO
29929	ALG6	C2930997	Congenital disorder of glycosylation type 1C	0.601648360705279	5	5	CTD_human;ORPHANET;UNIPROT
2993	GYPA	C0024530	Malaria	0.205912964183428	0	0	CTD_human
29940	DSE	C1837658	Gross motor development delay	0.2	0	0	HPO
29940	DSE	C1866294	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 1	0.2	0	0	ORPHANET
29940	DSE	C3809845	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 2	0.2	1	1	UNIPROT
29949	IL19	C0011854	Diabetes Mellitus, Insulin-Dependent	0.202407028523288	1	0	CTD_human
29949	IL19	C0403447	Chronic Kidney Insufficiency	0.2	1	0	CTD_human
2995	GYPC	C0013902	Elliptocytosis, Hereditary	0.200824180352639	0	0	ORPHANET
2995	GYPC	C0024530	Malaria	0.205964121340741	0	0	CTD_human
29951	PDZRN4	C0037116	Silicosis	0.2	1	0	CTD_human
29954	POMT2	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
29954	POMT2	C0014544	Epilepsy	0.2	0	0	HPO
29954	POMT2	C0017601	Glaucoma	0.2	0	0	HPO
29954	POMT2	C0020255	Hydrocephalus	0.2	0	0	HPO
29954	POMT2	C0020490	Hyperopia	0.2	0	0	HPO
29954	POMT2	C0024421	Macroglossia	0.2	0	0	HPO
29954	POMT2	C0026850	Muscular Dystrophy	0.20859471949093	0	0	HPO
29954	POMT2	C0027092	Myopia	0.2	0	0	HPO
29954	POMT2	C0029124	Optic Atrophy	0.2	0	0	HPO
29954	POMT2	C0035305	Retinal Detachment	0.2	0	0	HPO
29954	POMT2	C0038379	Strabismus	0.2	0	0	HPO
29954	POMT2	C0042798	Low Vision	0.2	0	0	HPO
29954	POMT2	C0235946	Cerebral atrophy	0.2	0	0	HPO
29954	POMT2	C0265221	Walker-Warburg congenital muscular dystrophy	0.402197814273705	0	0	CTD_human;ORPHANET
29954	POMT2	C0271215	Blindness, Legal	0.2	0	0	HPO
29954	POMT2	C0376175	Bell Palsy	0.2	0	0	HPO
29954	POMT2	C0457133	Muscle eye brain disease	0.200824180352639	0	0	ORPHANET
29954	POMT2	C0521694	Atrophic retina	0.2	0	0	HPO
29954	POMT2	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
29954	POMT2	C0699743	Congenital muscular dystrophy (disorder)	0.201648360705279	0	0	HPO
29954	POMT2	C1837229	Muscular Dystrophy, Congenital, Type 1D	0.2	0	0	ORPHANET
29954	POMT2	C1847759	MUSCULAR DYSTROPHY, CONGENITAL, 1C	0.2	0	0	ORPHANET
29954	POMT2	C1857079	Atretic auditory canal	0.2	0	0	HPO
29954	POMT2	C3150411	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	0.4	6	13	CTD_human;UNIPROT
29954	POMT2	C3150415	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	0.2	0	0	ORPHANET
29954	POMT2	C3150416	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.6	5	8	CTD_human;ORPHANET;UNIPROT
29954	POMT2	C3150418	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2	0.6	2	8	CTD_human;ORPHANET;UNIPROT
29954	POMT2	C3809221	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14	0.2	0	0	ORPHANET
29958	DMGDH	C1853892	Dimethylglycine Dehydrogenase Deficiency	0.6	1	1	CTD_human;ORPHANET;UNIPROT
29968	PSAT1	C0014544	Epilepsy	0.2	0	0	HPO
29968	PSAT1	C0020757	Ichthyoses	0.2	0	0	HPO
29968	PSAT1	C0265218	Neu-Laxova syndrome	0.2	0	0	ORPHANET
29968	PSAT1	C1970253	Phosphoserine Aminotransferase Deficiency	0.6	1	2	CTD_human;ORPHANET;UNIPROT
29968	PSAT1	C4015019	NEU-LAXOVA SYNDROME 2	0.2	1	3	UNIPROT
2997	GYS1	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
2997	GYS1	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
2997	GYS1	C1969054	Glycogen Storage Disease 0, Muscle	0.48	0	0	CTD_human;ORPHANET
29978	UBQLN2	C0002736	Amyotrophic Lateral Sclerosis	0.40796707674218	0	0	HPO;ORPHANET
29978	UBQLN2	C0234958	muscle degeneration	0.2	0	0	HPO
29978	UBQLN2	C0338451	Frontotemporal dementia	0.202197814273705	0	0	HPO
29978	UBQLN2	C1145670	Respiratory Failure	0.2	0	0	HPO
29978	UBQLN2	C3275459	AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	0.2	3	6	UNIPROT
29978	UBQLN2	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
29978	UBQLN2	C4020871	Dystonic disease	0.2	0	0	HPO
29978	UBQLN2	C4020884	Anxiety disease	0.2	0	0	HPO
2998	GYS2	C0014544	Epilepsy	0.2	0	0	HPO
2998	GYS2	C0022638	Ketosis	0.2	0	0	HPO
2998	GYS2	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
2998	GYS2	C1855861	Glycogen Storage Disease 0, Liver	0.680274726784213	1	9	CTD_human;ORPHANET;UNIPROT
29995	LMCD1	C0026267	Mitral Valve Prolapse Syndrome	0.2	1	1	CTD_human
29997	GLTSCR2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
3000	GUCY2D	C0014544	Epilepsy	0.2	0	0	HPO
3000	GUCY2D	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
3000	GUCY2D	C0022578	Keratoconus	0.2	0	0	HPO
3000	GUCY2D	C0028077	Night Blindness	0.2	0	0	HPO
3000	GUCY2D	C0028738	Nystagmus	0.200274726784213	0	0	HPO
3000	GUCY2D	C0035334	Retinitis Pigmentosa	0.609875808854354	1	0	CTD_human;HPO;ORPHANET
3000	GUCY2D	C0271215	Blindness, Legal	0.2	0	0	HPO
3000	GUCY2D	C0339527	Leber Congenital Amaurosis	0.206318716036901	0	0	ORPHANET
3000	GUCY2D	C0344297	Choroidal sclerosis	0.2	0	0	ORPHANET
3000	GUCY2D	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
3000	GUCY2D	C0730290	Cone dystrophy	0.200549453568426	0	0	HPO
3000	GUCY2D	C1301509	Severe visual impairment	0.200274726784213	0	0	HPO
3000	GUCY2D	C1536451	Central areolar choroidal sclerosis	0.200274726784213	0	0	ORPHANET
3000	GUCY2D	C1832976	Cone-Rod Dystrophy 5	0.200274726784213	0	0	CTD_human
3000	GUCY2D	C1866293	Retinal cone dystrophy 2	0.481648360705279	8	5	CTD_human;UNIPROT
3000	GUCY2D	C2931258	Amaurosis congenita of Leber, type 1	0.411263798152737	6	17	CTD_human;UNIPROT
3000	GUCY2D	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
30000	TNPO2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
30008	EFEMP2	C0003486	Aortic Aneurysm	0.2	0	0	HPO
30008	EFEMP2	C0010495	Cutis Laxa	0.201098907136852	0	0	HPO
30008	EFEMP2	C0015300	Exophthalmos	0.2	0	0	HPO
30008	EFEMP2	C0016052	Fibromuscular Dysplasia	0.2	0	0	HPO
30008	EFEMP2	C0034067	Pulmonary Emphysema	0.200274726784213	0	0	HPO
30008	EFEMP2	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
30008	EFEMP2	C0428851	Dilatation of pulmonary artery, unspecified	0.2	0	0	HPO
30008	EFEMP2	C1258215	Ileus	0.2	0	0	HPO
30008	EFEMP2	C2315541	Diverticulum of renal calyx	0.2	0	0	HPO
30008	EFEMP2	C2930812	Generalized elastolysis	0.2	0	0	HPO
30008	EFEMP2	C3280798	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.28	3	9	UNIPROT
30009	TBX21	C0004096	Asthma	0.431352297717041	1	0	CTD_human;HPO
30009	TBX21	C0027430	Nasal Polyps	0.2	0	0	HPO
30009	TBX21	C1319853	Asthma, Aspirin-Induced	0.400274726784213	1	0	CTD_human;HPO
30009	TBX21	C1859648	Asthma, Nasal Polyps, And Aspirin Intolerance	0.2	0	0	CTD_human
30009	TBX21	C3714497	Reactive airway disease	0.2	0	0	HPO
3002	GZMB	C0019158	Hepatitis	0.200274726784213	1	0	CTD_human
30061	SLC40A1	C0002871	Anemia	0.206290005282267	1	0	CTD_human
30061	SLC40A1	C0014175	Endometriosis	0.2	1	0	CTD_human
30061	SLC40A1	C0018995	Hemochromatosis	0.233154129894258	2	0	CTD_human
30061	SLC40A1	C0282193	Iron Overload	0.221152283652785	1	0	CTD_human
30061	SLC40A1	C1853733	HEMOCHROMATOSIS, TYPE 4	0.682472541057918	7	9	CTD_human;ORPHANET;UNIPROT
30061	SLC40A1	C2711227	Steatohepatitis	0.2	0	0	HPO
30061	SLC40A1	C2931082	Familial apoceruloplasmin deficiency	0.2	1	0	CTD_human
30061	SLC40A1	C3854388	Hyperferritinaemia	0.2	0	0	HPO
30062	RAX	C1853235	Sclerocornea	0.200549453568426	0	0	HPO
30062	RAX	C1855052	MICROPHTHALMIA, ISOLATED 1	0.2	0	0	ORPHANET
30062	RAX	C1970237	Microphthalmia, Isolated 3	0.4	1	3	CTD_human;UNIPROT
3012	HIST1H2AE	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
302	ANXA2	C0029456	Osteoporosis	0.200274726784213	1	0	CTD_human
302	ANXA2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3026	HABP2	C0018023	Nodular Goiter	0.2	0	0	HPO
3026	HABP2	C0398623	Thrombophilia	0.200274726784213	0	0	CTD_human
3028	HSD17B10	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
3028	HSD17B10	C0014544	Epilepsy	0.2	0	0	HPO
3028	HSD17B10	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
3028	HSD17B10	C0020615	Hypoglycemia	0.2	0	0	HPO
3028	HSD17B10	C0028738	Nystagmus	0.2	0	0	HPO
3028	HSD17B10	C0085583	Choreoathetosis	0.2	0	0	HPO
3028	HSD17B10	C0796223	MENTAL RETARDATION, X-LINKED 17	0.2	0	0	CTD_human
3028	HSD17B10	C1836830	Developmental regression	0.2	0	0	HPO
3028	HSD17B10	C1845517	Hydroxyacyl-CoA Dehydrogenase, Type 2, Deficiency	0.400274726784213	3	6	CTD_human;UNIPROT
3028	HSD17B10	C1846168	MENTAL RETARDATION, X-LINKED, SYNDROMIC 10	0.400549453568426	0	0	CTD_human;ORPHANET
3030	HADHA	C0018801	Heart failure	0.2	0	0	HPO
3030	HADHA	C0018802	Congestive heart failure	0.2	0	0	HPO
3030	HADHA	C0020305	Hydrops Fetalis	0.200274726784213	0	0	HPO
3030	HADHA	C0020615	Hypoglycemia	0.200824180352639	0	0	HPO
3030	HADHA	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
3030	HADHA	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
3030	HADHA	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3030	HADHA	C0949658	Cardiomyopathy, Hypertrophic, Familial	0.2	0	0	ORPHANET
3030	HADHA	C1145670	Respiratory Failure	0.2	0	0	HPO
3030	HADHA	C1455728	Acute fatty liver of pregnancy	0.204055389228567	0	0	ORPHANET
3030	HADHA	C1969443	Trifunctional Protein Deficiency With Myopathy And Neuropathy	0.603296721410557	5	35	CTD_human;HPO;ORPHANET;UNIPROT
3030	HADHA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3030	HADHA	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3032	HADHB	C0015695	Fatty Liver	0.2	1	0	CTD_human
3032	HADHB	C0018801	Heart failure	0.2	0	0	HPO
3032	HADHB	C0018802	Congestive heart failure	0.2	0	0	HPO
3032	HADHB	C0020305	Hydrops Fetalis	0.2	0	0	HPO
3032	HADHB	C0949658	Cardiomyopathy, Hypertrophic, Familial	0.2	0	0	ORPHANET
3032	HADHB	C1145670	Respiratory Failure	0.2	0	0	HPO
3032	HADHB	C1969443	Trifunctional Protein Deficiency With Myopathy And Neuropathy	0.681648360705279	1	12	CTD_human;ORPHANET;UNIPROT
3032	HADHB	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3033	HADH	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
3033	HADH	C0020617	Hypoglycemic coma	0.2	0	0	HPO
3033	HADH	C0028754	Obesity	0.2	1	0	CTD_human
3033	HADH	C0149877	Hypoglycemic encephalopathy	0.2	0	0	HPO
3033	HADH	C0162557	Liver Failure, Acute	0.2	0	0	HPO
3033	HADH	C0877056	Hypoglycaemic seizure	0.2	0	0	HPO
3033	HADH	C1291230	3-Hydroxyacyl-CoA Dehydrogenase Deficiency	0.6	0	0	CTD_human;ORPHANET;UNIPROT
3033	HADH	C1864903	Hyperinsulinaemic hypoglycaemia	0.201648360705279	0	0	HPO
3033	HADH	C1864948	Hyperinsulinemic Hypoglycemia, Familial, 4	0.6	1	3	CTD_human;ORPHANET;UNIPROT
3033	HADH	C2711227	Steatohepatitis	0.2	0	0	HPO
3035	HARS	C0004106	Astigmatism	0.2	0	0	HPO
3035	HARS	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
3035	HARS	C0018979	Hemianopsia	0.2	0	0	HPO
3035	HARS	C0028077	Night Blindness	0.2	0	0	HPO
3035	HARS	C0042798	Low Vision	0.2	0	0	HPO
3035	HARS	C0271385	Horizontal Nystagmus	0.2	0	0	HPO
3035	HARS	C1568248	Usher Syndrome, Type III	0.2	0	0	ORPHANET
3035	HARS	C1837658	Gross motor development delay	0.2	0	0	HPO
3035	HARS	C3281066	USHER SYNDROME, TYPE IIIB	0.2	1	1	UNIPROT
3035	HARS	C4225265	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.2	2	5	UNIPROT
3039	HBA1	C0002312	alpha-Thalassemia	0.299161563149073	1	1	CTD_human
3039	HBA1	C0002871	Anemia	0.21140749986769	0	0	HPO
3039	HBA1	C0002878	Anemia, Hemolytic	0.201648360705279	0	0	HPO
3039	HBA1	C0007785	Cerebral Infarction	0.2	1	0	CTD_human
3039	HBA1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.201373633921065	1	0	CTD_human
3039	HBA1	C0018801	Heart failure	0.2	0	0	HPO
3039	HBA1	C0018802	Congestive heart failure	0.2	0	0	HPO
3039	HBA1	C0020255	Hydrocephalus	0.2	0	0	HPO
3039	HBA1	C0020305	Hydrops Fetalis	0.20439562854741	0	0	HPO
3039	HBA1	C0025637	Methemoglobinemia	0.2	1	0	CTD_human
3039	HBA1	C0032461	Polycythemia	0.200274726784213	1	0	CTD_human
3039	HBA1	C0085576	Iron-Refractory Iron Deficiency Anemia	0.200549453568426	0	0	HPO
3039	HBA1	C0263454	Chloracne	0.2	1	0	CTD_human
3039	HBA1	C0271901	Microcytic hypochromic anemia (disorder)	0.203780662444353	0	0	HPO
3039	HBA1	C0455988	Hydrops Fetalis, Non-Immune	0.2	0	0	ORPHANET
3039	HBA1	C0475813	Alpha thalassemia-mental retardation syndrome	0.2	0	0	ORPHANET
3039	HBA1	C0700299	Heinz Body Anemias	0.4	0	0	CTD_human;HPO
3039	HBA1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3039	HBA1	C3161174	Hemoglobin H Disease	0.407142896389541	0	0	HPO;ORPHANET
3039	HBA1	C3665425	Hemoglobin M Disease	0.2	0	0	ORPHANET
3039	HBA1	C4025735	Nonspherocytic hemolytic anemia	0.2	0	0	HPO
3040	HBA2	C0002312	alpha-Thalassemia	0.352144565581464	2	4	CTD_human
3040	HBA2	C0002871	Anemia	0.207692349957967	0	0	HPO
3040	HBA2	C0002878	Anemia, Hemolytic	0.201648360705279	0	0	HPO
3040	HBA2	C0005283	beta Thalassemia	0.251004958574372	1	0	CTD_human
3040	HBA2	C0018801	Heart failure	0.2	0	0	HPO
3040	HBA2	C0018802	Congestive heart failure	0.2	0	0	HPO
3040	HBA2	C0020255	Hydrocephalus	0.2	0	0	HPO
3040	HBA2	C0020305	Hydrops Fetalis	0.204945082115836	0	0	HPO
3040	HBA2	C0085576	Iron-Refractory Iron Deficiency Anemia	0.200824180352639	0	0	HPO
3040	HBA2	C0263454	Chloracne	0.2	1	0	CTD_human
3040	HBA2	C0271901	Microcytic hypochromic anemia (disorder)	0.201373633921065	0	0	HPO
3040	HBA2	C0455988	Hydrops Fetalis, Non-Immune	0.2	0	0	ORPHANET
3040	HBA2	C0475813	Alpha thalassemia-mental retardation syndrome	0.2	0	0	ORPHANET
3040	HBA2	C0700299	Heinz Body Anemias	0.4	0	0	CTD_human;HPO
3040	HBA2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3040	HBA2	C3161174	Hemoglobin H Disease	0.407142896389541	0	0	HPO;ORPHANET
3040	HBA2	C3665425	Hemoglobin M Disease	0.2	0	0	ORPHANET
3040	HBA2	C4025735	Nonspherocytic hemolytic anemia	0.2	0	0	HPO
3043	HBB	C0002312	alpha-Thalassemia	0.25063723665798	0	0	CTD_human
3043	HBB	C0002871	Anemia	0.299112526471351	0	0	HPO
3043	HBB	C0002875	Cooley's anemia	0.209890164231672	0	0	ORPHANET
3043	HBB	C0002878	Anemia, Hemolytic	0.201648360705279	0	0	HPO
3043	HBB	C0002895	Anemia, Sickle Cell	0.703148082379763	3	4	CTD_human;ORPHANET;UNIPROT
3043	HBB	C0005283	beta Thalassemia	0.80372659943702	14	39	CTD_human;ORPHANET;UNIPROT
3043	HBB	C0008350	Cholelithiasis	0.204814057046576	0	0	HPO
3043	HBB	C0013502	Echinococcosis	0.2	1	0	CTD_human
3043	HBB	C0019021	Hemoglobin C Disease	0.202407028523288	0	0	ORPHANET
3043	HBB	C0019025	Hemoglobin F Disease	0.203021994626344	0	0	ORPHANET
3043	HBB	C0019034	Hemoglobin SC Disease	0.20777053913829	0	0	ORPHANET
3043	HBB	C0020532	Hypersplenism	0.2	0	0	HPO
3043	HBB	C0024535	Malaria, Falciparum	0.217948106799868	1	0	CTD_human
3043	HBB	C0025637	Methemoglobinemia	0.2	1	0	CTD_human
3043	HBB	C0029443	Osteomyelitis	0.2	0	0	HPO
3043	HBB	C0029456	Osteoporosis	0.2	0	0	HPO
3043	HBB	C0032461	Polycythemia	0.2	2	0	CTD_human
3043	HBB	C0033117	Priapism	0.2	0	0	HPO
3043	HBB	C0085576	Iron-Refractory Iron Deficiency Anemia	0.201098907136852	0	0	HPO
3043	HBB	C0162316	Iron deficiency anemia	0.202407028523288	0	0	HPO
3043	HBB	C0221019	Sickle cell-beta-thalassemia	0.200274726784213	0	0	ORPHANET
3043	HBB	C0238159	Hemoglobin E disease	0.2	0	0	ORPHANET
3043	HBB	C0263454	Chloracne	0.2	1	0	CTD_human
3043	HBB	C0271901	Microcytic hypochromic anemia (disorder)	0.200549453568426	0	0	HPO
3043	HBB	C0271985	Delta-Beta Thalassemia	0.204670355331623	0	0	ORPHANET
3043	HBB	C0272080	Hemoglobin D disease	0.2	0	0	ORPHANET
3043	HBB	C0272084	Hemoglobin SD disease	0.2	0	0	ORPHANET
3043	HBB	C0272085	Sickle cell-hemoglobin E disease	0.2	0	0	ORPHANET
3043	HBB	C0472767	Beta thalassemia intermedia	0.204945082115836	0	0	ORPHANET
3043	HBB	C0472777	Hemoglobin E/beta thalassemia disease	0.2	0	0	ORPHANET
3043	HBB	C0700299	Heinz Body Anemias	0.6	0	0	CTD_human;HPO;ORPHANET
3043	HBB	C0836924	Thrombocytosis	0.2	0	0	HPO
3043	HBB	C0857812	Sickle cell-beta^+^-thalassemia	0.200274726784213	0	0	ORPHANET
3043	HBB	C1387532	Chronic hemolytic anemia	0.2	0	0	HPO
3043	HBB	C1858990	Beta Thalassemia, Dominant Inclusion Body Type	0.4	0	0	CTD_human;ORPHANET
3043	HBB	C2242472	Infection of bone	0.2	0	0	HPO
3043	HBB	C3665425	Hemoglobin M Disease	0.2	0	0	ORPHANET
3043	HBB	C3854388	Hyperferritinaemia	0.2	0	0	HPO
3043	HBB	C4020884	Anxiety disease	0.2	0	0	HPO
3043	HBB	C4025735	Nonspherocytic hemolytic anemia	0.2	0	0	HPO
3045	HBD	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
3045	HBD	C0263454	Chloracne	0.2	1	0	CTD_human
3045	HBD	C0271985	Delta-Beta Thalassemia	0.201648360705279	0	0	ORPHANET
3047	HBG1	C0002871	Anemia	0.201648360705279	0	0	HPO
3047	HBG1	C0019025	Hemoglobin F Disease	0.20796707674218	0	0	ORPHANET
3047	HBG1	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
3047	HBG1	C0263454	Chloracne	0.2	1	0	CTD_human
3047	HBG1	C0271985	Delta-Beta Thalassemia	0.201648360705279	0	0	ORPHANET
3048	HBG2	C0002871	Anemia	0.200274726784213	0	0	HPO
3048	HBG2	C0019025	Hemoglobin F Disease	0.200274726784213	0	0	ORPHANET
3048	HBG2	C0025637	Methemoglobinemia	0.200274726784213	0	0	HPO
3048	HBG2	C3151421	CYANOSIS, TRANSIENT NEONATAL	0.400274726784213	5	4	ORPHANET;UNIPROT
3052	HCCS	C0014544	Epilepsy	0.2	0	0	HPO
3052	HCCS	C0020255	Hydrocephalus	0.2	0	0	HPO
3052	HCCS	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
3052	HCCS	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
3052	HCCS	C0796070	MICROPHTHALMIA, SYNDROMIC 7	0.68357144819477	1	3	CTD_human;ORPHANET;UNIPROT
3052	HCCS	C1708371	Histiocytoid Cardiomyopathy	0.2	0	0	HPO
3052	HCCS	C1853235	Sclerocornea	0.200274726784213	0	0	HPO
3053	SERPIND1	C0007274	Carotid Artery Thrombosis	0.2	1	0	CTD_human
3053	SERPIND1	C0012739	Disseminated Intravascular Coagulation	0.200274726784213	0	0	HPO
3053	SERPIND1	C0025472	Mesenteric Vascular Occlusion	0.2	1	0	CTD_human
3053	SERPIND1	C0398623	Thrombophilia	0.200274726784213	1	0	CTD_human
3053	SERPIND1	C0398626	Heparin cofactor II deficiency (disorder)	0.4	3	5	CTD_human;UNIPROT
3054	HCFC1	C0796208	MENTAL RETARDATION, X-LINKED 3	0.4	1	6	ORPHANET;UNIPROT
3054	HCFC1	C1855119	Methylmalonic aciduria	0.2	0	0	HPO
3054	HCFC1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3059	HCLS1	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
306	ANXA3	C0003873	Rheumatoid Arthritis	0.2	1	1	CTD_human
306	ANXA3	C0024141	Lupus Erythematosus, Systemic	0.200274726784213	1	0	CTD_human
3060	HCRT	C0007384	Cataplexy	0.209890164231672	0	0	HPO
3060	HCRT	C0027404	Narcolepsy	0.42711808372515	0	0	HPO;ORPHANET
3060	HCRT	C0751362	Narcolepsy-Cataplexy Syndrome	0.20357144819477	0	0	ORPHANET
3060	HCRT	C1456240	Narcolepsy without cataplexy	0.200274726784213	0	0	ORPHANET
3060	HCRT	C1834372	Narcolepsy 1	0.48	1	1	CTD_human;UNIPROT
3060	HCRT	C4025713	Paroxysmal drowsiness	0.2	0	0	HPO
3062	HCRTR2	C0027404	Narcolepsy	0.202472541057918	1	0	CTD_human
3064	HTT	C0014544	Epilepsy	0.2	0	0	HPO
3064	HTT	C0020179	Huntington Disease	0.762380931889865	9	0	CTD_human;ORPHANET
3064	HTT	C0235946	Cerebral atrophy	0.200549453568426	0	0	HPO
3064	HTT	C0262404	Cerebellar degeneration	0.2	0	0	HPO
3064	HTT	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
3064	HTT	C0751208	Juvenile Huntington Disease	0.200549453568426	0	0	ORPHANET
3064	HTT	C1836830	Developmental regression	0.2	0	0	HPO
3064	HTT	C4020858	Choreatic disease	0.2	0	0	HPO
3064	HTT	C4020873	Infratentorial atrophy	0.2	0	0	HPO
3065	HDAC1	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
3065	HDAC1	C0340543	Familial primary pulmonary hypertension	0.2	1	0	CTD_human
3066	HDAC2	C0014175	Endometriosis	0.280274726784213	1	0	CTD_human
3066	HDAC2	C0024117	Chronic Obstructive Airway Disease	0.282747267842131	2	0	CTD_human
3069	HDLBP	C2931817	Chromosome 2q37 deletion syndrome	0.2	1	0	CTD_human
3070	HELLS	C0002871	Anemia	0.2	0	0	HPO
3070	HELLS	C0009451	Communicating Hydrocephalus	0.2	0	0	HPO
3070	HELLS	C0024312	Lymphopenia	0.2	0	0	HPO
3070	HELLS	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
3070	HELLS	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
3073	HEXA	C0014544	Epilepsy	0.200274726784213	0	0	HPO
3073	HEXA	C0039373	Tay-Sachs Disease	0.509105005017648	22	75	CTD_human;UNIPROT
3073	HEXA	C0271215	Blindness, Legal	0.2	0	0	HPO
3073	HEXA	C1848916	Tay-Sachs Disease, Variant B1	0.2	0	0	ORPHANET
3074	HEXB	C0020620	Hypohidrosis	0.2	0	0	HPO
3074	HEXB	C0024421	Macroglossia	0.2	0	0	HPO
3074	HEXB	C0036161	Sandhoff Disease	0.502129935477362	8	15	CTD_human;UNIPROT
3074	HEXB	C0234958	muscle degeneration	0.2	0	0	HPO
3074	HEXB	C0242350	Erectile dysfunction	0.2	0	0	HPO
3074	HEXB	C0271215	Blindness, Legal	0.2	0	0	HPO
3074	HEXB	C0401151	Chronic diarrhea	0.2	0	0	HPO
3074	HEXB	C0751489	Adult Sandhoff Disease	0.200549453568426	0	0	ORPHANET
3074	HEXB	C0751490	Infantile Sandhoff Disease	0.200824180352639	0	0	ORPHANET
3074	HEXB	C0751491	Juvenile Sandhoff Disease	0.200824180352639	0	0	ORPHANET
3075	CFH	C0017662	Glomerulonephritis, Membranoproliferative	0.212059267750742	1	0	CTD_human
3075	CFH	C0162739	HELLP Syndrome	0.203007639249027	0	0	ORPHANET
3075	CFH	C0242383	Age related macular degeneration	0.44	6	13	CTD_human
3075	CFH	C0268742	Membranoproliferative Glomerulonephritis, Type I	0.200274726784213	0	0	ORPHANET
3075	CFH	C0268743	Membranoproliferative Glomerulonephritis, Type II	0.406318716036901	0	0	HPO;ORPHANET
3075	CFH	C0398777	Complement Factor H Deficiency	0.602472541057918	7	7	CTD_human;ORPHANET;UNIPROT
3075	CFH	C0730295	BASAL LAMINAR DRUSEN (disorder)	0.201648360705279	0	0	CTD_human
3075	CFH	C1720821	Membranoproliferative Glomerulonephritis, Type III	0.2	0	0	ORPHANET
3075	CFH	C1832174	DOYNE HONEYCOMB RETINAL DYSTROPHY	0.2	0	0	ORPHANET
3075	CFH	C1853147	MACULAR DEGENERATION, AGE-RELATED, 4 (disorder)	0.48	0	0	CTD_human;UNIPROT
3075	CFH	C2931788	Atypical Hemolytic Uremic Syndrome	0.31530873009423	2	1	CTD_human
3077	HFE	C0002170	Alopecia	0.2	0	0	HPO
3077	HFE	C0002395	Alzheimer's Disease	0.248490579541588	2	0	CTD_human
3077	HFE	C0004509	Azoospermia	0.2	0	0	HPO
3077	HFE	C0018418	Gynecomastia	0.2	0	0	HPO
3077	HFE	C0018801	Heart failure	0.207495812354077	0	0	HPO
3077	HFE	C0018802	Congestive heart failure	0.200549453568426	0	0	HPO
3077	HFE	C0018995	Hemochromatosis	0.44	14	0	CTD_human
3077	HFE	C0019196	Hepatitis C	0.243574208180386	1	0	CTD_human
3077	HFE	C0020619	Hypogonadism	0.200824180352639	0	0	HPO
3077	HFE	C0023890	Liver Cirrhosis	0.285159816336651	0	0	HPO
3077	HFE	C0029456	Osteoporosis	0.2	0	0	HPO
3077	HFE	C0030567	Parkinson Disease	0.21964762466246	1	0	CTD_human
3077	HFE	C0039446	Telangiectasis	0.2	0	0	HPO
3077	HFE	C0156312	Atrophy of testis	0.2	0	0	HPO
3077	HFE	C0162566	Porphyria Cutanea Tarda	0.46468342570122	0	0	CTD_human;ORPHANET
3077	HFE	C0242350	Erectile dysfunction	0.2	0	0	HPO
3077	HFE	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
3077	HFE	C0553730	Calcium pyrophosphate deposition disease	0.210228724818891	0	0	HPO
3077	HFE	C1867968	Porphyria Cutanea Tarda, Type I	0.2	0	0	ORPHANET
3077	HFE	C2711227	Steatohepatitis	0.203021994626344	0	0	HPO
3077	HFE	C2936913	Porphyria, South African type	0.2	0	0	CTD_human
3077	HFE	C3469186	HEMOCHROMATOSIS, TYPE 1	0.56	7	10	ORPHANET;UNIPROT
3077	HFE	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
3077	HFE	C3854388	Hyperferritinaemia	0.2	0	0	HPO
3078	CFHR1	C0017661	IGA Glomerulonephritis	0.200549453568426	1	0	CTD_human
3078	CFHR1	C0268743	Membranoproliferative Glomerulonephritis, Type II	0.2	0	0	ORPHANET
3078	CFHR1	C1864205	Macular Degeneration, Age-Related, 1	0.2	0	0	CTD_human
3078	CFHR1	C2931788	Atypical Hemolytic Uremic Syndrome	0.207077383854911	0	0	CTD_human
3078	CFHR1	C3553720	CFHR5 DEFICIENCY	0.2	0	0	ORPHANET
308	ANXA5	C0019202	Hepatolenticular Degeneration	0.28	1	0	CTD_human
3081	HGD	C0002066	Alkaptonuria	0.695081262377086	8	60	CTD_human;ORPHANET;UNIPROT
3081	HGD	C0003864	Arthritis	0.200274726784213	0	0	HPO
3081	HGD	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
3081	HGD	C0033581	prostatitis	0.2	0	0	HPO
3081	HGD	C0158266	Intervertebral Disc Degeneration	0.2	0	0	HPO
3081	HGD	C0238621	Aminoaciduria	0.2	0	0	HPO
3081	HGD	C0392525	Nephrolithiasis	0.2	0	0	HPO
3081	HGD	C0410607	Intervertebral disk calcification	0.2	0	0	HPO
3081	HGD	C0428791	Aortic valve calcification	0.2	0	0	HPO
3081	HGD	C0919718	Calcification of mitral valve	0.2	0	0	HPO
3081	HGD	C0919997	Thickened Achilles tendon	0.2	0	0	HPO
3081	HGD	C2931645	Ochronosis, hereditary	0.2	0	0	ORPHANET
3081	HGD	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
30813	VSX1	C0004106	Astigmatism	0.2	0	0	HPO
30813	VSX1	C0010035	Hereditary corneal dystrophy	0.2	1	0	CTD_human
30813	VSX1	C0010036	Corneal dystrophy	0.200824180352639	0	0	HPO
30813	VSX1	C0014008	Empty Sella Syndrome	0.2	1	0	CTD_human
30813	VSX1	C0017601	Glaucoma	0.2	0	0	HPO
30813	VSX1	C0020255	Hydrocephalus	0.2	0	0	HPO
30813	VSX1	C0022568	Keratitis	0.2	0	0	HPO
30813	VSX1	C0022578	Keratoconus	0.427875072811535	2	0	CTD_human;HPO
30813	VSX1	C0028754	Obesity	0.2	0	0	HPO
30813	VSX1	C0339284	Polymorphous corneal dystrophy	0.603021994626344	0	0	CTD_human;HPO;ORPHANET
30813	VSX1	C1835677	Keratoconus 1	0.4	4	3	CTD_human;UNIPROT
30813	VSX1	C3280099	CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME	0.2	1	1	UNIPROT
30817	ADGRE2	C0035854	Rosacea	0.2	0	0	HPO
30817	ADGRE2	C0042109	Urticaria	0.2	0	0	HPO
3082	HGF	C0004763	Barrett Esophagus	0.2	1	0	CTD_human
3082	HGF	C0019189	Hepatitis, Chronic	0.206290005282267	1	0	CTD_human
3082	HGF	C0023890	Liver Cirrhosis	0.20685381422801	1	0	CTD_human
3082	HGF	C0030305	Pancreatitis	0.2	1	0	CTD_human
3082	HGF	C0030567	Parkinson Disease	0.200274726784213	1	0	CTD_human
3082	HGF	C0034069	Pulmonary Fibrosis	0.203021994626344	1	0	CTD_human
3082	HGF	C0151744	Myocardial Ischemia	0.201648360705279	1	0	CTD_human
3082	HGF	C0162557	Liver Failure, Acute	0.201923087489492	1	0	CTD_human
3082	HGF	C1842342	DEAFNESS, AUTOSOMAL RECESSIVE 39 (disorder)	0.2	0	0	CTD_human
3082	HGF	C1876165	Copper-Overload Cirrhosis	0.2	1	0	CTD_human
3082	HGF	C4021806	Prelingual sensorineural hearing impairment	0.2	0	0	HPO
30829	IBD3	C1858303	INFLAMMATORY BOWEL DISEASE 3	0.200274726784213	0	0	CTD_human
30835	CD209	C0011311	Dengue Fever	0.203296721410557	1	0	CTD_human
30835	CD209	C0041327	Tuberculosis, Pulmonary	0.206238848124954	1	0	CTD_human
3084	NRG1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3084	NRG1	C0018801	Heart failure	0.201098907136852	1	0	CTD_human
3084	NRG1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
3084	NRG1	C0038358	Gastric ulcer	0.2	1	0	CTD_human
3084	NRG1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
3087	HHEX	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.294285792779081	1	0	CTD_human
3087	HHEX	C0015695	Fatty Liver	0.2	1	0	CTD_human
3090	HIC1	C0014544	Epilepsy	0.2	0	0	HPO
3090	HIC1	C0235946	Cerebral atrophy	0.2	0	0	HPO
3090	HIC1	C0265219	Miller Dieker syndrome	0.280274726784213	0	0	ORPHANET
3091	HIF1A	C0007786	Brain Ischemia	0.280274726784213	1	0	CTD_human
3091	HIF1A	C0008313	Cholangitis, Sclerosing	0.2	1	0	CTD_human
3091	HIF1A	C0018801	Heart failure	0.281923087489492	1	0	CTD_human
3091	HIF1A	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
3091	HIF1A	C0752308	Hypoxia-Ischemia, Brain	0.280274726784213	1	0	CTD_human
3094	HINT1	C0085684	Foot-drop	0.2	0	0	HPO
3094	HINT1	C0234958	muscle degeneration	0.2	0	0	HPO
3094	HINT1	C0242287	Isaacs syndrome	0.401648360705279	1	7	ORPHANET;UNIPROT
3094	HINT1	C2932678	Inherited Peripheral Neuropathy	0.2	1	0	CTD_human
30968	STOML2	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3097	HIVEP2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3098	HK1	C0008325	Cholecystitis	0.2	0	0	HPO
3098	HK1	C0008350	Cholelithiasis	0.2	0	0	HPO
3098	HK1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.205638237399215	1	0	CTD_human
3098	HK1	C0085577	Normocytic anemia	0.2	0	0	HPO
3098	HK1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3098	HK1	C1854449	Neuropathy, hereditary motor and sensory, Russe type	0.2	0	0	ORPHANET
3098	HK1	C3150343	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.68	2	2	CTD_human;ORPHANET;UNIPROT
3098	HK1	C4025735	Nonspherocytic hemolytic anemia	0.200274726784213	0	0	HPO
3099	HK2	C0028754	Obesity	0.200549453568426	1	0	CTD_human
3099	HK2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
31	ACACA	C0018801	Heart failure	0.2	1	0	CTD_human
3105	HLA-A	C0024440	Macular Edema, Cystoid	0.2	0	0	HPO
3105	HLA-A	C0024441	Macular Holes	0.2	0	0	HPO
3105	HLA-A	C0030491	Parapsoriasis	0.2	1	0	CTD_human
3105	HLA-A	C0038013	Ankylosing spondylitis	0.216691142570745	0	0	CTD_human
3105	HLA-A	C0038325	Stevens-Johnson Syndrome	0.219047013936721	0	0	CTD_human
3105	HLA-A	C0235812	Vitritis	0.2	0	0	HPO
3105	HLA-A	C1853959	Birdshot chorioretinopathy	0.200549453568426	0	0	ORPHANET
3105	HLA-A	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3106	HLA-B	C0002871	Anemia	0.202681755307501	0	0	HPO
3106	HLA-B	C0002940	Aneurysm	0.2	0	0	HPO
3106	HLA-B	C0003123	Anorexia	0.2	0	0	HPO
3106	HLA-B	C0003864	Arthritis	0.214833567615884	0	0	HPO
3106	HLA-B	C0004943	Behcet Syndrome	0.511261431891024	2	0	CTD_human;ORPHANET
3106	HLA-B	C0007194	Hypertrophic Cardiomyopathy	0.202956482091714	0	0	HPO
3106	HLA-B	C0011603	Dermatitis	0.205414667772315	2	0	CTD_human
3106	HLA-B	C0011633	Dermatomyositis	0.2	1	0	CTD_human
3106	HLA-B	C0014544	Epilepsy	0.209144173059356	0	0	HPO
3106	HLA-B	C0017086	Gangrene	0.2	0	0	HPO
3106	HLA-B	C0025289	Meningitis	0.200274726784213	0	0	HPO
3106	HLA-B	C0026896	Myasthenia Gravis	0.207495812354077	2	0	CTD_human
3106	HLA-B	C0027051	Myocardial Infarction	0.2	0	0	HPO
3106	HLA-B	C0027697	Nephritis	0.2	1	0	CTD_human
3106	HLA-B	C0037036	Sialorrhea	0.2	0	0	HPO
3106	HLA-B	C0038013	Ankylosing spondylitis	0.336970906588518	3	0	CTD_human
3106	HLA-B	C0038325	Stevens-Johnson Syndrome	0.457454249105995	9	0	CTD_human;ORPHANET
3106	HLA-B	C0038363	Aphthous Stomatitis	0.202407028523288	0	0	HPO
3106	HLA-B	C0039103	Synovitis	0.202681755307501	1	0	CTD_human
3106	HLA-B	C0039263	Takayasu Arteritis	0.220914358648567	0	0	ORPHANET
3106	HLA-B	C0042384	Vasculitis	0.201373633921065	0	0	HPO
3106	HLA-B	C0149745	Oral Ulcer	0.2	0	0	HPO
3106	HLA-B	C0702166	Acne	0.2	0	0	HPO
3106	HLA-B	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
3106	HLA-B	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
3106	HLA-B	C2937365	Recurrent aphthous ulcer	0.2	0	0	HPO
3106	HLA-B	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
3106	HLA-B	C3203102	Idiopathic pulmonary arterial hypertension	0.200549453568426	0	0	HPO
3106	HLA-B	C3697982	Pulmonary arterial hypertension associated with connective tissue disease	0.2	0	0	ORPHANET
3106	HLA-B	C4020848	Aneurysmal disease	0.2	0	0	HPO
3106	HLA-B	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3107	HLA-C	C0003872	Arthritis, Psoriatic	0.249761899148028	1	1	CTD_human
3107	HLA-C	C0033860	Psoriasis	0.340860147699453	2	0	CTD_human
3107	HLA-C	C0038325	Stevens-Johnson Syndrome	0.209902840877365	1	0	CTD_human
3107	HLA-C	C0524909	Hepatitis B, Chronic	0.20777053913829	1	0	CTD_human
3108	HLA-DMA	C0011616	Contact Dermatitis	0.202407028523288	1	0	CTD_human
3108	HLA-DMA	C0028796	Dermatitis, Occupational	0.2	1	0	CTD_human
311	ANXA11	C0036202	Sarcoidosis	0.206737144536068	1	0	CTD_human
3110	MNX1	C0005697	Neurogenic Urinary Bladder	0.2	0	0	HPO
3110	MNX1	C0031019	Perianal abscess	0.2	0	0	HPO
3110	MNX1	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
3110	MNX1	C0080218	Tethered Cord Syndrome	0.2	0	0	HPO
3110	MNX1	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
3110	MNX1	C1531773	Currarino triad	0.605219808900049	4	4	CTD_human;ORPHANET;UNIPROT
3113	HLA-DPA1	C0524909	Hepatitis B, Chronic	0.20350593566014	1	1	CTD_human
3115	HLA-DPB1	C0003873	Rheumatoid Arthritis	0.211132773083477	2	0	CTD_human
3115	HLA-DPB1	C0004096	Asthma	0.225113449592087	2	1	CTD_human
3115	HLA-DPB1	C0007570	Celiac Disease	0.212715621254126	1	0	CTD_human
3115	HLA-DPB1	C0007786	Brain Ischemia	0.2	0	0	HPO
3115	HLA-DPB1	C0014175	Endometriosis	0.205363510615002	1	0	CTD_human
3115	HLA-DPB1	C0024117	Chronic Obstructive Airway Disease	0.200549453568426	0	0	HPO
3115	HLA-DPB1	C0026769	Multiple Sclerosis	0.230663728053994	1	0	CTD_human
3115	HLA-DPB1	C0026896	Myasthenia Gravis	0.201098907136852	1	0	CTD_human
3115	HLA-DPB1	C0034069	Pulmonary Fibrosis	0.200549453568426	0	0	HPO
3115	HLA-DPB1	C0036202	Sarcoidosis	0.207011871320281	3	0	CTD_human
3115	HLA-DPB1	C0037199	Sinusitis	0.2	0	0	HPO
3115	HLA-DPB1	C0042109	Urticaria	0.202681755307501	1	0	CTD_human
3115	HLA-DPB1	C0042384	Vasculitis	0.200549453568426	0	0	HPO
3115	HLA-DPB1	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
3115	HLA-DPB1	C0221052	Chronic berylliosis	0.204945082115836	0	0	ORPHANET
3115	HLA-DPB1	C0521173	Granulomatosis	0.2	0	0	HPO
3115	HLA-DPB1	C0524909	Hepatitis B, Chronic	0.206802657070698	1	1	CTD_human
3115	HLA-DPB1	C0917798	Cerebral Ischemia	0.2	0	0	HPO
3115	HLA-DPB1	C1319853	Asthma, Aspirin-Induced	0.200549453568426	1	1	CTD_human
3115	HLA-DPB1	C3495801	Granulomatosis with polyangiitis	0.203780662444353	0	0	ORPHANET
3117	HLA-DQA1	C0004096	Asthma	0.215592235433893	1	1	CTD_human
3117	HLA-DQA1	C0007570	Celiac Disease	0.304914005099489	0	0	CTD_human
3117	HLA-DQA1	C0011603	Dermatitis	0.202407028523288	1	0	CTD_human
3117	HLA-DQA1	C0011854	Diabetes Mellitus, Insulin-Dependent	0.304421973040331	1	1	CTD_human
3117	HLA-DQA1	C0014848	Esophageal Achalasia	0.400274726784213	1	0	CTD_human;HPO
3117	HLA-DQA1	C0017665	Membranous glomerulonephritis	0.203231208875927	1	2	CTD_human
3117	HLA-DQA1	C0023290	Leishmaniasis, Visceral	0.200274726784213	1	0	CTD_human
3117	HLA-DQA1	C0024141	Lupus Erythematosus, Systemic	0.21636525862922	1	2	CTD_human
3117	HLA-DQA1	C0030305	Pancreatitis	0.200274726784213	1	0	CTD_human
3117	HLA-DQA1	C0085179	Eosinophilia-Myalgia Syndrome	0.202407028523288	1	0	CTD_human
3117	HLA-DQA1	C0859976	Idiopathic achalasia of esophagus	0.2	0	0	ORPHANET
3118	HLA-DQA2	C0003873	Rheumatoid Arthritis	0.202407028523288	1	0	CTD_human
3119	HLA-DQB1	C0004096	Asthma	0.246399665202841	1	0	CTD_human
3119	HLA-DQB1	C0007384	Cataplexy	0.212990348038339	0	0	HPO
3119	HLA-DQB1	C0007570	Celiac Disease	0.305723830074811	0	0	CTD_human
3119	HLA-DQB1	C0011854	Diabetes Mellitus, Insulin-Dependent	0.331330842515898	1	0	CTD_human
3119	HLA-DQB1	C0013595	Eczema	0.2	0	0	HPO
3119	HLA-DQB1	C0014848	Esophageal Achalasia	0.400274726784213	1	0	CTD_human;HPO
3119	HLA-DQB1	C0017661	IGA Glomerulonephritis	0.203780662444353	1	0	CTD_human
3119	HLA-DQB1	C0022336	Creutzfeldt-Jakob disease	0.2	0	0	CTD_human
3119	HLA-DQB1	C0026769	Multiple Sclerosis	0.302716190825784	0	0	CTD_human
3119	HLA-DQB1	C0027404	Narcolepsy	0.448179050977379	1	0	CTD_human;ORPHANET
3119	HLA-DQB1	C0030805	Bullous pemphigoid	0.205638237399215	0	0	ORPHANET
3119	HLA-DQB1	C0033860	Psoriasis	0.214991624708154	0	0	HPO
3119	HLA-DQB1	C0036421	Systemic Scleroderma	0.22764173342765	1	0	CTD_human
3119	HLA-DQB1	C0042109	Urticaria	0.409902840877365	1	0	CTD_human;HPO
3119	HLA-DQB1	C0751362	Narcolepsy-Cataplexy Syndrome	0.20433011601278	0	0	ORPHANET
3119	HLA-DQB1	C0859976	Idiopathic achalasia of esophagus	0.2	0	0	ORPHANET
3119	HLA-DQB1	C1456240	Narcolepsy without cataplexy	0.2	0	0	ORPHANET
3119	HLA-DQB1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3122	HLA-DRA	C0002170	Alopecia	0.2	0	0	HPO
3122	HLA-DRA	C0026769	Multiple Sclerosis	0.213459933694818	1	2	CTD_human
3122	HLA-DRA	C0030567	Parkinson Disease	0.202472541057918	1	1	CTD_human
3122	HLA-DRA	C4024867	Perifollicular hyperkeratosis	0.2	0	0	HPO
3122	HLA-DRA	C4273658	Graham Little Piccardi Lassueur syndrome	0.2	0	0	ORPHANET
3123	HLA-DRB1	C0003864	Arthritis	0.261964868613723	0	0	HPO
3123	HLA-DRB1	C0003873	Rheumatoid Arthritis	0.44	3	0	CTD_human
3123	HLA-DRB1	C0004096	Asthma	0.255609350796826	1	0	CTD_human
3123	HLA-DRB1	C0007384	Cataplexy	0.205154296365419	0	0	HPO
3123	HLA-DRB1	C0009324	Ulcerative Colitis	0.269149152403592	1	0	CTD_human
3123	HLA-DRB1	C0010346	Crohn Disease	0.228857310256445	1	0	CTD_human
3123	HLA-DRB1	C0011334	Dental caries	0.205088783830789	0	0	HPO
3123	HLA-DRB1	C0011854	Diabetes Mellitus, Insulin-Dependent	0.365368253003688	1	0	CTD_human
3123	HLA-DRB1	C0013595	Eczema	0.200549453568426	0	0	HPO
3123	HLA-DRB1	C0014743	Erythema Nodosum	0.201373633921065	0	0	HPO
3123	HLA-DRB1	C0017168	Gastroesophageal reflux disease	0.200274726784213	0	0	HPO
3123	HLA-DRB1	C0017665	Membranous glomerulonephritis	0.200549453568426	1	0	CTD_human
3123	HLA-DRB1	C0023290	Leishmaniasis, Visceral	0.200274726784213	1	0	CTD_human
3123	HLA-DRB1	C0023530	Leukopenia	0.200274726784213	0	0	HPO
3123	HLA-DRB1	C0024141	Lupus Erythematosus, Systemic	0.317565792550609	1	0	CTD_human
3123	HLA-DRB1	C0026769	Multiple Sclerosis	0.411925336831461	1	0	CTD_human
3123	HLA-DRB1	C0027404	Narcolepsy	0.43748883152737	1	0	CTD_human;ORPHANET
3123	HLA-DRB1	C0030305	Pancreatitis	0.207821696295603	1	0	CTD_human
3123	HLA-DRB1	C0030805	Bullous pemphigoid	0.205638237399215	0	0	ORPHANET
3123	HLA-DRB1	C0033860	Psoriasis	0.244607602782609	0	0	HPO
3123	HLA-DRB1	C0034069	Pulmonary Fibrosis	0.203231208875927	0	0	HPO
3123	HLA-DRB1	C0036202	Sarcoidosis	0.472691889843728	1	0	CTD_human;ORPHANET
3123	HLA-DRB1	C0041466	Typhoid Fever	0.20777053913829	1	0	CTD_human
3123	HLA-DRB1	C0042109	Urticaria	0.420131565696256	1	0	CTD_human;HPO
3123	HLA-DRB1	C0042164	Uveitis	0.211602358739956	0	0	HPO
3123	HLA-DRB1	C0085179	Eosinophilia-Myalgia Syndrome	0.202681755307501	1	0	CTD_human
3123	HLA-DRB1	C0206138	CREST Syndrome	0.200274726784213	0	0	ORPHANET
3123	HLA-DRB1	C0520743	Mediastinal lymphadenopathy	0.2	0	0	HPO
3123	HLA-DRB1	C0748540	Scleroderma, Limited	0.2	0	0	ORPHANET
3123	HLA-DRB1	C0751362	Narcolepsy-Cataplexy Syndrome	0.200549453568426	0	0	ORPHANET
3123	HLA-DRB1	C1258104	Diffuse Scleroderma	0.203780662444353	0	0	ORPHANET
3123	HLA-DRB1	C1384600	Systemic onset juvenile chronic arthritis	0.200274726784213	0	0	ORPHANET
3123	HLA-DRB1	C1456240	Narcolepsy without cataplexy	0.2	0	0	ORPHANET
3123	HLA-DRB1	C1858558	Rheumatoid Arthritis, Systemic Juvenile	0.2	0	0	ORPHANET
3123	HLA-DRB1	C3714757	Juvenile rheumatoid arthritis	0.206868169605328	0	0	HPO
3123	HLA-DRB1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3133	HLA-E	C0030491	Parapsoriasis	0.2	1	0	CTD_human
3135	HLA-G	C0004096	Asthma	0.209744783785095	0	0	CTD_human
3141	HLCS	C0002170	Alopecia	0.2	0	0	HPO
3141	HLCS	C0003123	Anorexia	0.2	0	0	HPO
3141	HLCS	C0014544	Epilepsy	0.2	0	0	HPO
3141	HLCS	C0022573	Keratoconjunctivitis	0.2	0	0	HPO
3141	HLCS	C0268581	Holocarboxylase Synthetase Deficiency	0.603296721410557	10	17	CTD_human;ORPHANET;UNIPROT
3141	HLCS	C1396126	Perioral eczema	0.2	0	0	HPO
3145	HMBS	C0003123	Anorexia	0.2	0	0	HPO
3145	HMBS	C0014544	Epilepsy	0.2	0	0	HPO
3145	HMBS	C0030446	Paralytic Ileus	0.2	0	0	HPO
3145	HMBS	C0162565	Acute intermittent porphyria	0.752839547538248	31	31	CTD_human;ORPHANET;UNIPROT
3145	HMBS	C4020884	Anxiety disease	0.2	0	0	HPO
3146	HMGB1	C0027051	Myocardial Infarction	0.280549453568426	1	0	CTD_human
3146	HMGB1	C0034069	Pulmonary Fibrosis	0.203007639249027	1	0	CTD_human
3146	HMGB1	C0151744	Myocardial Ischemia	0.200824180352639	1	0	CTD_human
3146	HMGB1	C0243026	Sepsis	0.214415139116717	2	0	CTD_human
3146	HMGB1	C1850383	Neuropathy, Painful	0.2	1	0	CTD_human
3146	HMGB1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3148	HMGB2	C0028754	Obesity	0.2	1	0	CTD_human
3149	HMGB3	C0014877	Esotropia	0.2	0	0	HPO
3149	HMGB3	C0271388	Pendular Nystagmus	0.2	0	0	HPO
3149	HMGB3	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
3155	HMGCL	C0020615	Hypoglycemia	0.200274726784213	0	0	HPO
3155	HMGCL	C0268601	HMG CoA lyase deficiency	0.401373633921066	9	11	CTD_human;UNIPROT
3155	HMGCL	C1533587	Hydroxymethylglutaric aciduria	0.2	0	0	ORPHANET
3156	HMGCR	C0020443	Hypercholesterolemia	0.211169574863473	1	0	CTD_human
3156	HMGCR	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
3156	HMGCR	C0034362	Q Fever	0.2	1	0	CTD_human
3158	HMGCS2	C0014544	Epilepsy	0.2	0	0	HPO
3158	HMGCS2	C0020615	Hypoglycemia	0.2	0	0	HPO
3158	HMGCS2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3158	HMGCS2	C2751532	3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency	0.6	3	6	CTD_human;ORPHANET;UNIPROT
3159	HMGA1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.285154296365419	1	0	CTD_human
3159	HMGA1	C0020456	Hyperglycemia	0.2	1	0	CTD_human
3159	HMGA1	C0524620	Metabolic Syndrome X	0.200274726784213	1	0	CTD_human
3161	HMMR	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
3162	HMOX1	C0002395	Alzheimer's Disease	0.222771933603429	1	0	CTD_human
3162	HMOX1	C0002878	Anemia, Hemolytic	0.4	1	0	CTD_human;HPO
3162	HMOX1	C0004096	Asthma	0.208645876648242	1	0	CTD_human
3162	HMOX1	C0009319	Colitis	0.280824180352639	2	0	CTD_human
3162	HMOX1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3162	HMOX1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.297240596139172	3	0	CTD_human
3162	HMOX1	C0011875	Diabetic Angiopathies	0.202407028523288	1	0	CTD_human
3162	HMOX1	C0018801	Heart failure	0.281098907136852	1	0	CTD_human
3162	HMOX1	C0019158	Hepatitis	0.200549453568426	1	0	CTD_human
3162	HMOX1	C0019212	Hepatorenal Syndrome	0.200274726784213	1	0	CTD_human
3162	HMOX1	C0020459	Hyperinsulinism	0.2	1	0	CTD_human
3162	HMOX1	C0022661	Kidney Failure, Chronic	0.205363510615002	1	0	CTD_human
3162	HMOX1	C0023290	Leishmaniasis, Visceral	0.200274726784213	1	0	CTD_human
3162	HMOX1	C0024117	Chronic Obstructive Airway Disease	0.298013619334498	0	0	CTD_human
3162	HMOX1	C0028754	Obesity	0.203231208875927	3	0	CTD_human
3162	HMOX1	C0030567	Parkinson Disease	0.210568964137734	1	0	CTD_human
3162	HMOX1	C0032285	Pneumonia	0.203231208875927	1	0	CTD_human
3162	HMOX1	C0034067	Pulmonary Emphysema	0.200824180352639	1	0	CTD_human
3162	HMOX1	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
3162	HMOX1	C0038220	Status Epilepticus	0.2	1	0	CTD_human
3162	HMOX1	C0151744	Myocardial Ischemia	0.205689394556528	1	0	CTD_human
3162	HMOX1	C0152020	Gastroparesis	0.2	1	0	CTD_human
3162	HMOX1	C0162309	Adrenoleukodystrophy	0.2	1	0	CTD_human
3162	HMOX1	C0221013	Mastocytosis, Systemic	0.2	1	0	CTD_human
3162	HMOX1	C1846707	SPINOCEREBELLAR ATAXIA 17	0.2	1	0	CTD_human
3162	HMOX1	C1956346	Coronary Artery Disease	0.225504846068243	1	0	CTD_human
3162	HMOX1	C4277682	Chemical and Drug Induced Liver Injury	0.28	2	0	CTD_human
3164	NR4A1	C0014175	Endometriosis	0.2	1	0	CTD_human
3164	NR4A1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3166	HMX1	C0028738	Nystagmus	0.2	0	0	HPO
3166	HMX1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
3166	HMX1	C1853235	Sclerocornea	0.2	0	0	HPO
3166	HMX1	C2677500	Oculoauricular Syndrome	0.48	0	0	CTD_human;ORPHANET
3169	FOXA1	C0015695	Fatty Liver	0.200274726784213	1	0	CTD_human
317	APAF1	C0035305	Retinal Detachment	0.2	1	0	CTD_human
3172	HNF4A	C0009324	Ulcerative Colitis	0.201648360705279	1	0	CTD_human
3172	HNF4A	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.728843946080663	4	2	CTD_human;ORPHANET;UNIPROT
3172	HNF4A	C0014544	Epilepsy	0.200274726784213	0	0	HPO
3172	HNF4A	C0020615	Hypoglycemia	0.206513574909167	0	0	HPO
3172	HNF4A	C0027709	Nephrocalcinosis	0.200274726784213	0	0	HPO
3172	HNF4A	C0035579	Rickets	0.2	0	0	HPO
3172	HNF4A	C0158986	Neonatal hypoglycemia	0.201098907136852	0	0	HPO
3172	HNF4A	C0238621	Aminoaciduria	0.2	0	0	HPO
3172	HNF4A	C0341703	Adult Fanconi syndrome	0.2	0	0	HPO
3172	HNF4A	C0342276	Maturity onset diabetes mellitus in young	0.426582985534041	0	0	CTD_human;HPO
3172	HNF4A	C0431693	Renal cysts and diabetes syndrome	0.200274726784213	0	0	ORPHANET
3172	HNF4A	C1704375	Hypophosphatemic Rickets	0.2	0	0	HPO
3172	HNF4A	C1852093	Maturity-Onset Diabetes of the Young, Type 1	0.482747267842131	5	14	CTD_human;UNIPROT
3172	HNF4A	C1864903	Hyperinsulinaemic hypoglycaemia	0.203296721410557	0	0	HPO
3172	HNF4A	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
3172	HNF4A	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
3172	HNF4A	C4014962	FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG	0.2	2	1	UNIPROT
3172	HNF4A	C4274078	Hyperinsulinism due to HNF4A deficiency	0.2	0	0	ORPHANET
3176	HNMT	C0004096	Asthma	0.211276474798431	1	0	CTD_human
3176	HNMT	C0035455	Rhinitis	0.200274726784213	1	0	CTD_human
3176	HNMT	C0042109	Urticaria	0.202681755307501	1	0	CTD_human
3176	HNMT	C4225220	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.2	1	2	UNIPROT
317664	DFNA49	C1842136	DEAFNESS, AUTOSOMAL DOMINANT 49 (disorder)	0.2	0	0	CTD_human
317668	MCDR3	C3888009	MACULAR DYSTROPHY, RETINAL, 3	0.2	0	0	CTD_human
317669	IBD9	C1838019	INFLAMMATORY BOWEL DISEASE 9	0.2	0	0	CTD_human
317682	OTSC5	C1837422	OTOSCLEROSIS 5	0.2	0	0	CTD_human
317685	NYS4	C1860433	NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT (disorder)	0.2	0	0	CTD_human
317714	DYT15	C1834570	Myoclonic dystonia	0.200274726784213	0	0	ORPHANET
317714	DYT15	C1843786	DYSTONIA 15, MYOCLONIC	0.2	0	0	CTD_human
317719	KLHL10	C3554453	SPERMATOGENIC FAILURE 11	0.2	1	2	UNIPROT
317782	CELIAC2	C0007570	Celiac Disease	0.204106546385879	0	0	CTD_human
3178	HNRNPA1	C0002736	Amyotrophic Lateral Sclerosis	0.401373633921066	0	0	HPO;ORPHANET
3178	HNRNPA1	C0026850	Muscular Dystrophy	0.2	0	0	HPO
3178	HNRNPA1	C0234958	muscle degeneration	0.2	0	0	HPO
3178	HNRNPA1	C1145670	Respiratory Failure	0.2	0	0	HPO
3178	HNRNPA1	C1833662	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	0.2	0	0	ORPHANET
3178	HNRNPA1	C3715156	AMYOTROPHIC LATERAL SCLEROSIS 20	0.2	2	2	UNIPROT
3178	HNRNPA1	C3809469	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3	0.2	2	1	UNIPROT
3178	HNRNPA1	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
3178	HNRNPA1	C4020884	Anxiety disease	0.2	0	0	HPO
3181	HNRNPA2B1	C0026850	Muscular Dystrophy	0.2	0	0	HPO
3181	HNRNPA2B1	C0027121	Myositis	0.2	0	0	HPO
3181	HNRNPA2B1	C0234958	muscle degeneration	0.2	0	0	HPO
3181	HNRNPA2B1	C0338451	Frontotemporal dementia	0.2	0	0	HPO
3181	HNRNPA2B1	C1833662	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	0.2	0	0	ORPHANET
3181	HNRNPA2B1	C3809468	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2	0.2	1	1	UNIPROT
3190	HNRNPK	C0010278	Craniosynostosis	0.2	0	0	HPO
3190	HNRNPK	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
3190	HNRNPK	C4225274	AU-KLINE SYNDROME	0.2	0	0	ORPHANET
319101	KRT73	C0022336	Creutzfeldt-Jakob disease	0.2	1	0	CTD_human
3198	HOXA1	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
3198	HOXA1	C1832215	Athabaskan brainstem dysgenesis	0.48	1	1	CTD_human;ORPHANET
3198	HOXA1	C1832216	Bosley-Salih-Alorainy Syndrome	0.200549453568426	0	0	ORPHANET
3198	HOXA1	C1837658	Gross motor development delay	0.2	0	0	HPO
3199	HOXA2	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
3199	HOXA2	C1833486	Microtia-Anotia	0.2	0	0	ORPHANET
3199	HOXA2	C2676772	Microtia, Hearing Impairment, And Cleft Palate	0.6	2	2	CTD_human;ORPHANET;UNIPROT
32	ACACB	C0028754	Obesity	0.201098907136852	1	0	CTD_human
3207	HOXA11	C0002874	Aplastic Anemia	0.2	0	0	HPO
3207	HOXA11	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
3207	HOXA11	C0031256	Petechiae	0.2	0	0	HPO
3207	HOXA11	C0034150	Purpura	0.2	0	0	HPO
3207	HOXA11	C0398639	Amegakaryocytic thrombocytopenia	0.200274726784213	0	0	HPO
3207	HOXA11	C1854273	Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia	0.400274726784213	1	1	CTD_human;ORPHANET
3208	HPCA	C0005747	Blepharospasm	0.2	0	0	HPO
3208	HPCA	C0013423	Dystonia Musculorum Deformans	0.2	0	0	HPO
3208	HPCA	C1857093	DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)	0.4	1	3	ORPHANET;UNIPROT
3209	HOXA13	C0035078	Kidney Failure	0.2	0	0	HPO
3209	HOXA13	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
3209	HOXA13	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
3209	HOXA13	C1565489	Renal Insufficiency	0.2	0	0	HPO
3209	HOXA13	C1841679	Hand foot uterus syndrome	0.68357144819477	5	3	CTD_human;ORPHANET;UNIPROT
3209	HOXA13	C1867801	Preaxial deficiency, postaxial polydactyly and hypospadias	0.600549453568426	2	0	CTD_human;ORPHANET;UNIPROT
3211	HOXB1	C0376175	Bell Palsy	0.2	0	0	HPO
3211	HOXB1	C1858717	Facial paresis, hereditary, congenital	0.2	1	0	CTD_human
3211	HOXB1	C3553625	FACIAL PARESIS, HEREDITARY CONGENITAL, 3	0.2	1	1	UNIPROT
3215	HOXB5	C0028754	Obesity	0.200274726784213	1	1	CTD_human
3229	HOXC13	C0221260	Dystrophia unguium	0.2	0	0	HPO
3229	HOXC13	C1865951	Ectodermal Dysplasia, Pure Hair-Nail Type	0.2	1	0	CTD_human
323	APBB2	C0002395	Alzheimer's Disease	0.210778178387317	0	0	CTD_human
3236	HOXD10	C0003864	Arthritis	0.2	0	0	HPO
3236	HOXD10	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
3236	HOXD10	C0007959	Charcot-Marie-Tooth Disease	0.203007639249027	1	0	CTD_human
3237	HOXD11	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
3239	HOXD13	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
3239	HOXD13	C0020295	Hydronephrosis	0.2	0	0	HPO
3239	HOXD13	C0023075	Laryngostenosis	0.2	0	0	HPO
3239	HOXD13	C0040583	Tracheal Stenosis	0.2	0	0	HPO
3239	HOXD13	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
3239	HOXD13	C0080218	Tethered Cord Syndrome	0.2	0	0	HPO
3239	HOXD13	C0158113	Contracture of joint of hand	0.2	0	0	HPO
3239	HOXD13	C0220708	VATER Association	0.4	1	0	CTD_human;ORPHANET
3239	HOXD13	C0265312	Brachydactyly syndrome type E	0.2	0	0	ORPHANET
3239	HOXD13	C1838608	Radial aplasia	0.2	0	0	HPO
3239	HOXD13	C1853137	BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.600274726784213	2	1	CTD_human;ORPHANET;UNIPROT
3239	HOXD13	C1861348	Syndactyly, type v	0.600274726784213	3	2	CTD_human;ORPHANET;UNIPROT
3239	HOXD13	C1861367	Synpolydactyly 1	0.681648360705279	4	9	CTD_human;ORPHANET;UNIPROT
3239	HOXD13	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
324	APC	C0017097	Gardner Syndrome	0.206527930286485	0	0	ORPHANET
324	APC	C0020473	Hyperlipidemia	0.200274726784213	1	0	CTD_human
324	APC	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
324	APC	C0236048	Polyposis, Gastric	0.2	0	0	HPO
324	APC	C0265325	Turcot syndrome (disorder)	0.203021994626344	1	0	CTD_human
324	APC	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
324	APC	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
324	APC	C1257915	Intestinal Polyposis	0.201373633921065	0	0	HPO
324	APC	C1851124	Desmoid disease, hereditary	0.201098907136852	0	0	CTD_human
324	APC	C1859309	Syndactyly Cenani Lenz type	0.2	0	0	ORPHANET
3240	HP	C0002871	Anemia	0.205912964183428	1	0	CTD_human
3240	HP	C0002895	Anemia, Sickle Cell	0.206187690967642	1	0	CTD_human
3240	HP	C0003864	Arthritis	0.2	1	0	CTD_human
3240	HP	C0004153	Atherosclerosis	0.204879569581206	1	0	CTD_human
3240	HP	C0011854	Diabetes Mellitus, Insulin-Dependent	0.294023742640562	1	0	CTD_human
3240	HP	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.292990348038339	1	0	CTD_human
3240	HP	C0011875	Diabetic Angiopathies	0.203780662444353	1	0	CTD_human
3240	HP	C0018995	Hemochromatosis	0.200549453568426	1	0	CTD_human
3240	HP	C0019163	Hepatitis B	0.200824180352639	1	0	CTD_human
3240	HP	C0024530	Malaria	0.209759139162412	2	0	CTD_human
3240	HP	C0027051	Myocardial Infarction	0.21433527120477	3	0	CTD_human
3240	HP	C0035305	Retinal Detachment	0.2	1	0	CTD_human
3240	HP	C0041296	Tuberculosis	0.203557092817453	1	0	CTD_human
3240	HP	C0524909	Hepatitis B, Chronic	0.2	1	0	CTD_human
3240	HP	C0524910	Hepatitis C, Chronic	0.200274726784213	1	0	CTD_human
3240	HP	C3279786	ANHAPTOGLOBINEMIA	0.200549453568426	1	1	UNIPROT
3242	HPD	C0014544	Epilepsy	0.2	0	0	HPO
3242	HPD	C0268483	Tyrosinemias	0.200274726784213	0	0	CTD_human
3242	HPD	C0268623	Tyrosinemia, Type III	0.481098907136852	2	5	ORPHANET;UNIPROT
3242	HPD	C1879362	Hypertyrosinemia	0.2	0	0	HPO
3242	HPD	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3242	HPD	C2931042	Hawkinsinuria	0.400824180352639	0	0	CTD_human;ORPHANET
3242	HPD	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
3248	HPGD	C0003864	Arthritis	0.2	0	0	HPO
3248	HPGD	C0013595	Eczema	0.2	0	0	HPO
3248	HPGD	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
3248	HPGD	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
3248	HPGD	C0029411	Osteoarthropathy, Primary Hypertrophic	0.605205453522732	2	5	CTD_human;ORPHANET;UNIPROT
3248	HPGD	C0029443	Osteomyelitis	0.2	0	0	HPO
3248	HPGD	C0029453	Osteopenia	0.2	0	0	HPO
3248	HPGD	C0029456	Osteoporosis	0.2	0	0	HPO
3248	HPGD	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
3248	HPGD	C0263417	Cutis verticis gyrata	0.2	0	0	HPO
3248	HPGD	C0702166	Acne	0.2	0	0	HPO
3248	HPGD	C0747078	Generalized osteopenia	0.2	0	0	HPO
3248	HPGD	C0917990	Acro-Osteolysis	0.200274726784213	0	0	HPO
3248	HPGD	C2242472	Infection of bone	0.2	0	0	HPO
3248	HPGD	C2930922	Reginato Schiapachasse syndrome	0.2	0	0	ORPHANET
3248	HPGD	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
3248	HPGD	C4072877	Scalp folds	0.2	0	0	HPO
3249	HPN	C0023794	Lipoidosis	0.2	2	0	CTD_human
325	APCS	C0018801	Heart failure	0.2	1	0	CTD_human
325	APCS	C1956346	Coronary Artery Disease	0.200824180352639	1	0	CTD_human
3251	HPRT1	C0002871	Anemia	0.2	0	0	HPO
3251	HPRT1	C0002888	Anemia, Megaloblastic	0.2	0	0	HPO
3251	HPRT1	C0003868	Arthritis, Gouty	0.201648360705279	0	0	HPO
3251	HPRT1	C0018099	Gout	0.20328236603324	0	0	HPO
3251	HPRT1	C0023374	Lesch-Nyhan Syndrome	0.7336660941526	13	21	CTD_human;ORPHANET;UNIPROT
3251	HPRT1	C0035078	Kidney Failure	0.2	0	0	HPO
3251	HPRT1	C0085583	Choreoathetosis	0.200549453568426	0	0	HPO
3251	HPRT1	C0156312	Atrophy of testis	0.2	0	0	HPO
3251	HPRT1	C0221168	Podagra	0.2	0	0	HPO
3251	HPRT1	C0268117	Gout, HPRT-Related	0.60357144819477	15	15	CTD_human;ORPHANET;UNIPROT
3251	HPRT1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
3251	HPRT1	C0392525	Nephrolithiasis	0.200274726784213	0	0	HPO
3251	HPRT1	C0740394	Hyperuricemia	0.211509814182316	1	0	CTD_human
3251	HPRT1	C1565489	Renal Insufficiency	0.2	0	0	HPO
3251	HPRT1	C4020871	Dystonic disease	0.2	0	0	HPO
3257	HPS1	C0028738	Nystagmus	0.2	0	0	HPO
3257	HPS1	C0034069	Pulmonary Fibrosis	0.201373633921065	0	0	HPO
3257	HPS1	C0035078	Kidney Failure	0.2	0	0	HPO
3257	HPS1	C0085581	Restrictive lung disease	0.200274726784213	0	0	HPO
3257	HPS1	C1301509	Severe visual impairment	0.2	0	0	HPO
3257	HPS1	C1565489	Renal Insufficiency	0.2	0	0	HPO
3257	HPS1	C2931875	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells	0.280549453568426	0	0	CTD_human
326	AIRE	C0002170	Alopecia	0.201648360705279	0	0	HPO
326	AIRE	C0002871	Anemia	0.2	0	0	HPO
326	AIRE	C0006840	Candidiasis	0.208436662398659	1	0	CTD_human
326	AIRE	C0006845	Candidiasis, Chronic Mucocutaneous	0.202197814273705	0	0	HPO
326	AIRE	C0008350	Cholelithiasis	0.2	0	0	HPO
326	AIRE	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
326	AIRE	C0011854	Diabetes Mellitus, Insulin-Dependent	0.204604842796993	0	0	HPO
326	AIRE	C0017154	Gastritis, Atrophic	0.200274726784213	0	0	HPO
326	AIRE	C0020595	Hypoaldosteronism	0.2	0	0	HPO
326	AIRE	C0020626	Hypoparathyroidism	0.208319992706716	0	0	HPO
326	AIRE	C0022573	Keratoconjunctivitis	0.2	0	0	HPO
326	AIRE	C0042798	Low Vision	0.2	0	0	HPO
326	AIRE	C0042900	Vitiligo	0.205088783830789	0	0	HPO
326	AIRE	C0085859	Polyglandular Type I Autoimmune Syndrome	0.314615574810851	8	50	UNIPROT
326	AIRE	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
326	AIRE	C0520463	Chronic active hepatitis	0.2	0	0	HPO
326	AIRE	C1621895	Adrenal hyperplasia	0.2	0	0	HPO
326	AIRE	C3494489	Autoimmune polyendocrinopathy syndrome, type 1	0.421153962384409	0	0	CTD_human;ORPHANET
3263	HPX	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	0	CTD_human
3263	HPX	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3265	HRAS	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
3265	HRAS	C0002170	Alopecia	0.2	0	0	HPO
3265	HRAS	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
3265	HRAS	C0014544	Epilepsy	0.2	0	0	HPO
3265	HRAS	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
3265	HRAS	C0020255	Hydrocephalus	0.2	0	0	HPO
3265	HRAS	C0020615	Hypoglycemia	0.2	0	0	HPO
3265	HRAS	C0020757	Ichthyoses	0.2	0	0	HPO
3265	HRAS	C0022578	Keratoconus	0.2	0	0	HPO
3265	HRAS	C0024421	Macroglossia	0.2	0	0	HPO
3265	HRAS	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
3265	HRAS	C0028326	Noonan Syndrome	0.200824180352639	1	0	CTD_human
3265	HRAS	C0029453	Osteopenia	0.2	0	0	HPO
3265	HRAS	C0038379	Strabismus	0.2	0	0	HPO
3265	HRAS	C0162835	Hypopigmentation disorder	0.200274726784213	0	0	HPO
3265	HRAS	C0235946	Cerebral atrophy	0.2	0	0	HPO
3265	HRAS	C0264353	Bronchomalacia	0.2	0	0	HPO
3265	HRAS	C0431391	Hemimegalencephaly	0.2	0	0	HPO
3265	HRAS	C0520679	Sleep Apnea, Obstructive	0.2	0	0	HPO
3265	HRAS	C0587248	Costello syndrome (disorder)	0.697033060621212	13	16	CTD_human;ORPHANET;UNIPROT
3265	HRAS	C0747078	Generalized osteopenia	0.2	0	0	HPO
3265	HRAS	C0870082	Hyperkeratosis	0.200274726784213	0	0	HPO
3265	HRAS	C0919997	Thickened Achilles tendon	0.2	0	0	HPO
3265	HRAS	C0948187	Tracheomalacia	0.2	0	0	HPO
3265	HRAS	C1145670	Respiratory Failure	0.2	0	0	HPO
3265	HRAS	C1704375	Hypophosphatemic Rickets	0.2	0	0	HPO
3265	HRAS	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
3265	HRAS	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
3265	HRAS	C2931658	Phacomatosis pigmentokeratotica	0.200549453568426	0	0	ORPHANET
3265	HRAS	C3854181	Nevus sebaceous	0.600274726784213	1	2	CTD_human;HPO;ORPHANET;UNIPROT
3265	HRAS	C4020860	Supratentorial atrophy	0.2	0	0	HPO
3265	HRAS	C4082173	Porencephaly	0.2	0	0	HPO
326625	MMAB	C1855102	Methylmalonic aciduria cblB type	0.600549453568426	2	19	CTD_human;ORPHANET;UNIPROT
3269	HRH1	C0004153	Atherosclerosis	0.200274726784213	1	0	CTD_human
3269	HRH1	C0035455	Rhinitis	0.200274726784213	1	0	CTD_human
3269	HRH1	C2607914	Allergic rhinitis (disorder)	0.201373633921065	1	0	CTD_human
3273	HRG	C0398623	Thrombophilia	0.200549453568426	0	0	HPO
3273	HRG	C2751090	Thrombophilia Due To Histidine-Rich Glycoprotein Deficiency	0.4	2	2	ORPHANET;UNIPROT
3273	HRG	C2751091	Thrombophilia Due To Elevated Histidine-Rich Glycoprotein	0.2	0	0	CTD_human
3274	HRH2	C0242231	Coronary Stenosis	0.2	1	0	CTD_human
3274	HRH2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3283	HSD3B1	C0032460	Polycystic Ovary Syndrome	0.205139940988102	1	0	CTD_human
3284	HSD3B2	C0018418	Gynecomastia	0.2	0	0	HPO
3284	HSD3B2	C0020595	Hypoaldosteronism	0.2	0	0	HPO
3284	HSD3B2	C0029456	Osteoporosis	0.2	0	0	HPO
3284	HSD3B2	C0032460	Polycystic Ovary Syndrome	0.200549453568426	1	0	CTD_human
3284	HSD3B2	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
3284	HSD3B2	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
3284	HSD3B2	C0302280	Adrenogenital Syndrome	0.2	0	0	HPO
3284	HSD3B2	C0342527	Deficiency of testosterone biosynthesis	0.2	0	0	HPO
3284	HSD3B2	C0342546	Premature adrenarche	0.2	0	0	HPO
3284	HSD3B2	C1621895	Adrenal hyperplasia	0.2	0	0	HPO
3284	HSD3B2	C2931782	Adrenal hyperplasia 2	0.2	0	0	CTD_human
3284	HSD3B2	C3671887	Sodium concentration in urine above normal	0.2	0	0	HPO
3284	HSD3B2	C4020713	Penile melanosis	0.2	0	0	HPO
3284	HSD3B2	C4024641	Enlarged polycystic ovaries	0.2	0	0	HPO
3290	HSD11B1	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
3290	HSD11B1	C0020456	Hyperglycemia	0.2	1	0	CTD_human
3290	HSD11B1	C0028754	Obesity	0.220551672927046	2	0	CTD_human
3290	HSD11B1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
3290	HSD11B1	C1291245	Cortisone reductase deficiency	0.201373633921065	1	0	CTD_human
3291	HSD11B2	C0004096	Asthma	0.2	1	0	CTD_human
3291	HSD11B2	C0011854	Diabetes Mellitus, Insulin-Dependent	0.205414667772315	1	0	CTD_human
3291	HSD11B2	C0020595	Hypoaldosteronism	0.2	0	0	HPO
3291	HSD11B2	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
3291	HSD11B2	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
3291	HSD11B2	C0152132	Hypertensive Retinopathy	0.2	0	0	HPO
3291	HSD11B2	C0220983	Metabolic alkalosis	0.2	0	0	HPO
3291	HSD11B2	C0342488	Mineralocorticoid Excess Syndrome, Apparent	0.400824180352639	1	0	CTD_human;ORPHANET
3291	HSD11B2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3291	HSD11B2	C2936861	Cortisol 11-beta-ketoreductase deficiency	0.2	0	0	ORPHANET
3291	HSD11B2	C3887949	Apparent mineralocorticoid excess	0.489615437447459	12	8	CTD_human;UNIPROT
3292	HSD17B1	C0014175	Endometriosis	0.213027149818335	1	0	CTD_human
3293	HSD17B3	C0018418	Gynecomastia	0.200549453568426	0	0	HPO
3293	HSD17B3	C0020676	Hypothyroidism	0.2	0	0	HPO
3293	HSD17B3	C0268296	17-Hydroxysteroid Dehydrogenase Deficiency	0.601373633921066	7	16	CTD_human;ORPHANET;UNIPROT
3293	HSD17B3	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
3293	HSD17B3	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
3294	HSD17B2	C0014175	Endometriosis	0.206290005282267	2	0	CTD_human
3295	HSD17B4	C0001403	Addison Disease	0.2	0	0	HPO
3295	HSD17B4	C0008370	Cholestasis	0.2	0	0	HPO
3295	HSD17B4	C0014544	Epilepsy	0.2	0	0	HPO
3295	HSD17B4	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
3295	HSD17B4	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
3295	HSD17B4	C0022679	Cystic kidney	0.2	0	0	HPO
3295	HSD17B4	C0028738	Nystagmus	0.2	0	0	HPO
3295	HSD17B4	C0029453	Osteopenia	0.2	0	0	HPO
3295	HSD17B4	C0029456	Osteoporosis	0.2	0	0	HPO
3295	HSD17B4	C0037769	West Syndrome	0.200274726784213	1	0	CTD_human
3295	HSD17B4	C0038379	Strabismus	0.2	0	0	HPO
3295	HSD17B4	C0042798	Low Vision	0.2	0	0	HPO
3295	HSD17B4	C0043459	Zellweger Syndrome	0.200824180352639	1	0	CTD_human
3295	HSD17B4	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
3295	HSD17B4	C0267818	Bile duct proliferation	0.2	0	0	HPO
3295	HSD17B4	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
3295	HSD17B4	C0431370	Atrophy of corpus callosum	0.2	0	0	HPO
3295	HSD17B4	C0747078	Generalized osteopenia	0.2	0	0	HPO
3295	HSD17B4	C1285291	Fetal ascites	0.200274726784213	0	0	HPO
3295	HSD17B4	C2267233	Neonatal Hypotonia	0.200274726784213	0	0	HPO
3295	HSD17B4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3295	HSD17B4	C2711227	Steatohepatitis	0.2	0	0	HPO
3295	HSD17B4	C4024945	Generalized cerebral atrophy/hypoplasia	0.2	0	0	HPO
3297	HSF1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
3299	HSF4	C0392557	Nuclear cataract	0.2	0	0	HPO
3299	HSF4	C1833118	Cataract, Pulverulent	0.2	0	0	HPO
3299	HSF4	C1855179	CATARACT, ANTERIOR POLAR	0.2	0	0	HPO
3299	HSF4	C1861821	CATARACT, MARNER TYPE	0.400824180352639	0	0	CTD_human;HPO
3299	HSF4	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
3299	HSF4	C3888417	CATARACT 5, MULTIPLE TYPES	0.28	2	4	UNIPROT
33	ACADL	C0220711	Long chain acyl-CoA dehydrogenase deficiency	0.2	0	0	ORPHANET
330	BIRC3	C0002871	Anemia	0.2	0	0	HPO
330	BIRC3	C0015695	Fatty Liver	0.2	1	0	CTD_human
3300	DNAJB2	C0026847	Spinal Muscular Atrophy	0.2	0	0	HPO
3300	DNAJB2	C0085684	Foot-drop	0.2	0	0	HPO
3300	DNAJB2	C3553989	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.4	1	5	ORPHANET;UNIPROT
3303	HSPA1A	C0030567	Parkinson Disease	0.202681755307501	1	0	CTD_human
3303	HSPA1A	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3304	HSPA1B	C0004153	Atherosclerosis	0.200274726784213	1	0	CTD_human
3306	HSPA2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3309	HSPA5	C0003949	Asbestosis	0.2	1	0	CTD_human
3309	HSPA5	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
3309	HSPA5	C0028754	Obesity	0.200274726784213	1	0	CTD_human
3309	HSPA5	C1846707	SPINOCEREBELLAR ATAXIA 17	0.200274726784213	1	0	CTD_human
331	XIAP	C0002871	Anemia	0.2	0	0	HPO
331	XIAP	C0014038	Encephalitis	0.2	0	0	HPO
331	XIAP	C0019151	Hepatic Encephalopathy	0.2	0	0	HPO
331	XIAP	C0025289	Meningitis	0.2	0	0	HPO
331	XIAP	C0030312	Pancytopenia	0.2	0	0	HPO
331	XIAP	C0086438	Hypogammaglobulinemia	0.200274726784213	0	0	HPO
331	XIAP	C0162539	IgG Deficiency	0.200274726784213	0	0	HPO
331	XIAP	C0302809	Fulminant hepatitis	0.2	0	0	HPO
331	XIAP	C1845076	Lymphoproliferative Syndrome, X-Linked, 2	0.201923087489492	0	0	CTD_human
331	XIAP	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
3310	HSPA6	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
3312	HSPA8	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
3312	HSPA8	C1846707	SPINOCEREBELLAR ATAXIA 17	0.200274726784213	1	0	CTD_human
3313	HSPA9	C0002896	Sideroblastic anemia	0.2	0	0	HPO
3313	HSPA9	C0030567	Parkinson Disease	0.207337755261807	1	0	CTD_human
3313	HSPA9	C0042164	Uveitis	0.2	1	0	CTD_human
3313	HSPA9	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3313	HSPA9	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
3313	HSPA9	C4225180	EVEN-PLUS SYNDROME	0.200274726784213	1	3	UNIPROT
3313	HSPA9	C4274077	Autosomal recessive sideroblastic anemia	0.2	0	0	ORPHANET
3315	HSPB1	C0007194	Hypertrophic Cardiomyopathy	0.2	1	0	CTD_human
3315	HSPB1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3315	HSPB1	C0018801	Heart failure	0.2	1	0	CTD_human
3315	HSPB1	C0038220	Status Epilepticus	0.2	1	0	CTD_human
3315	HSPB1	C0085684	Foot-drop	0.2	0	0	HPO
3315	HSPB1	C1847823	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F	0.601373633921066	6	6	CTD_human;ORPHANET;UNIPROT
3315	HSPB1	C1848736	Distal amyotrophy	0.2	0	0	HPO
3315	HSPB1	C2608087	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB	0.4	9	7	CTD_human;UNIPROT
3315	HSPB1	C4021578	Chronic axonal neuropathy	0.2	0	0	HPO
3320	HSP90AA1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3321	IGSF3	C0152227	Excessive tearing	0.2	0	0	HPO
3329	HSPD1	C0007194	Hypertrophic Cardiomyopathy	0.2	1	0	CTD_human
3329	HSPD1	C0014544	Epilepsy	0.2	0	0	HPO
3329	HSPD1	C0023520	Leukodystrophy	0.200549453568426	0	0	HPO
3329	HSPD1	C0028738	Nystagmus	0.2	0	0	HPO
3329	HSPD1	C0037772	Spastic Paraplegia	0.200824180352639	0	0	HPO
3329	HSPD1	C0038379	Strabismus	0.2	0	0	HPO
3329	HSPD1	C0085583	Choreoathetosis	0.2	0	0	HPO
3329	HSPD1	C0085606	Urgency of micturition	0.2	0	0	HPO
3329	HSPD1	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
3329	HSPD1	C0948089	Acute Coronary Syndrome	0.200549453568426	1	0	CTD_human
3329	HSPD1	C1854467	Spastic paraplegia 13, autosomal dominant	0.680549453568426	2	2	CTD_human;ORPHANET;UNIPROT
3329	HSPD1	C2677109	Leukodystrophy, Hypomyelinating, 4	0.600824180352639	1	1	CTD_human;ORPHANET;UNIPROT
3329	HSPD1	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
3329	HSPD1	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
3339	HSPG2	C0003886	Arthrogryposis	0.2	0	0	HPO
3339	HSPG2	C0024591	Malignant hyperpyrexia due to anesthesia	0.2	0	0	HPO
3339	HSPG2	C0027092	Myopia	0.2	0	0	HPO
3339	HSPG2	C0029456	Osteoporosis	0.2	0	0	HPO
3339	HSPG2	C0036391	Schwartz-Jampel Syndrome	0.482197814273705	1	4	ORPHANET;UNIPROT
3339	HSPG2	C0038379	Strabismus	0.2	0	0	HPO
3339	HSPG2	C0041105	Trismus	0.2	0	0	HPO
3339	HSPG2	C0042798	Low Vision	0.2	0	0	HPO
3339	HSPG2	C0158113	Contracture of joint of hand	0.2	0	0	HPO
3339	HSPG2	C0234958	muscle degeneration	0.2	0	0	HPO
333929	SNAI3	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
334	APLP2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3340	NDST1	C1955869	Malformations of Cortical Development	0.2	1	0	CTD_human
3340	NDST1	C4015283	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.2	1	4	UNIPROT
3342	HTC2	C1855900	HYPERTRICHOSIS, CONGENITAL GENERALIZED	0.201648360705279	0	0	CTD_human
335	APOA1	C0002871	Anemia	0.2	0	0	HPO
335	APOA1	C0004943	Behcet Syndrome	0.2	1	0	CTD_human
335	APOA1	C0008370	Cholestasis	0.2	0	0	HPO
335	APOA1	C0017665	Membranous glomerulonephritis	0.2	1	0	CTD_human
335	APOA1	C0043325	Xanthomatosis	0.2	0	0	HPO
335	APOA1	C0268389	Amyloidosis, familial visceral	0.400274726784213	2	5	CTD_human;UNIPROT
335	APOA1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
335	APOA1	C0473527	Hypoalphalipoproteinemias	0.408986115967085	0	0	CTD_human;HPO
335	APOA1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
335	APOA1	C0853897	Diabetic Cardiomyopathies	0.200274726784213	1	0	CTD_human
335	APOA1	C1704429	Hypoalphalipoproteinemia, Familial	0.202472541057918	0	0	ORPHANET
335	APOA1	C1848533	Ataxia with vitamin E deficiency	0.2	1	0	CTD_human
335	APOA1	C1956346	Coronary Artery Disease	0.257826704584501	1	0	CTD_human
335	APOA1	C2362324	Pediatric Obesity	0.2	1	0	CTD_human
335	APOA1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3350	HTR1A	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
3356	HTR2A	C0013384	Dyskinetic syndrome	0.200274726784213	1	0	CTD_human
3356	HTR2A	C0024117	Chronic Obstructive Airway Disease	0.202681755307501	1	0	CTD_human
3356	HTR2A	C0028754	Obesity	0.214507683674358	1	0	CTD_human
3357	HTR2B	C0018801	Heart failure	0.28	1	0	CTD_human
3358	HTR2C	C0028754	Obesity	0.226333612041215	2	0	CTD_human
3358	HTR2C	C0524620	Metabolic Syndrome X	0.206737144536068	3	0	CTD_human
336	APOA2	C0020445	Hypercholesterolemia, Familial	0.200274726784213	1	0	CTD_human
336	APOA2	C0745103	Hyperlipoproteinemia Type IIa	0.200274726784213	0	0	CTD_human
3360	HTR4	C0003123	Anorexia	0.2	1	0	CTD_human
3360	HTR4	C0004238	Atrial Fibrillation	0.200549453568426	1	0	CTD_human
337	APOA4	C0004153	Atherosclerosis	0.20761248204602	1	0	CTD_human
337	APOA4	C0020445	Hypercholesterolemia, Familial	0.203231208875927	1	0	CTD_human
3371	TNC	C0004096	Asthma	0.210345394510833	1	0	CTD_human
3371	TNC	C0014175	Endometriosis	0.203007639249027	1	0	CTD_human
3371	TNC	C0042345	Varicosity	0.2	1	0	CTD_human
3371	TNC	C3810170	DEAFNESS, AUTOSOMAL DOMINANT 56	0.2	1	2	UNIPROT
3373	HYAL1	C0747085	Recurrent otitis media	0.2	0	0	HPO
3373	HYAL1	C1291490	Hyaluronidase Deficiency	0.68	1	1	CTD_human;ORPHANET;UNIPROT
3375	IAPP	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.266263366983159	2	0	CTD_human
3375	IAPP	C0038358	Gastric ulcer	0.2	1	0	CTD_human
3378	IBD2	C1832321	INFLAMMATORY BOWEL DISEASE 2	0.2	0	0	CTD_human
337867	UBAC2	C0004943	Behcet Syndrome	0.203231208875927	0	0	ORPHANET
337991	DFNB38	C1842381	DEAFNESS, AUTOSOMAL RECESSIVE 38	0.2	0	0	CTD_human
338	APOB	C0003742	Arcus Senilis	0.2	0	0	HPO
338	APOB	C0004943	Behcet Syndrome	0.2	1	0	CTD_human
338	APOB	C0010054	Coronary Arteriosclerosis	0.236629528126359	0	0	HPO
338	APOB	C0010068	Coronary heart disease	0.259284792037846	1	0	CTD_human
338	APOB	C0015695	Fatty Liver	0.204120901763196	2	0	CTD_human
338	APOB	C0020443	Hypercholesterolemia	0.457281836636407	1	0	CTD_human;HPO
338	APOB	C0020445	Hypercholesterolemia, Familial	0.484818348860723	1	5	CTD_human;HPO
338	APOB	C0020473	Hyperlipidemia	0.424527194243666	1	0	CTD_human;HPO
338	APOB	C0020597	Hypobetalipoproteinemias	0.247216353046439	0	0	HPO
338	APOB	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
338	APOB	C0027051	Myocardial Infarction	0.244002406436537	0	0	HPO
338	APOB	C0155210	Eyelid Xanthoma	0.200549453568426	0	0	HPO
338	APOB	C0302314	Xanthoma	0.200549453568426	0	0	HPO
338	APOB	C0342881	Familial hypercholesterolemia - homozygous	0.2	0	0	ORPHANET
338	APOB	C0687751	Acanthocytosis	0.200549453568426	0	0	HPO
338	APOB	C0745103	Hyperlipoproteinemia Type IIa	0.231318853400293	0	0	ORPHANET
338	APOB	C1704299	Hypobetalipoproteinemia, Familial, Apolipoprotein B	0.200274726784213	3	0	CTD_human
338	APOB	C1704417	Hyperlipoproteinemia Type IIb	0.209340710663245	4	4	UNIPROT
338	APOB	C1848486	Premature arteriosclerosis	0.2	0	0	HPO
338	APOB	C1848533	Ataxia with vitamin E deficiency	0.2	1	0	CTD_human
338	APOB	C1862596	Familial hypobetalipoproteinemia	0.21950560167913	1	19	UNIPROT
338	APOB	C1956346	Coronary Artery Disease	0.268256552627614	0	0	HPO
338	APOB	C2711227	Steatohepatitis	0.204945082115836	0	0	HPO
338	APOB	C4025272	Peripheral arterial stenosis	0.2	0	0	HPO
338	APOB	C4280503	Premature hardening of arteries	0.2	0	0	HPO
338	APOB	C4280602	Xanthelasma of periocular region	0.2	0	0	HPO
338090	SPG24	C1843569	SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE (disorder)	0.2	0	0	ORPHANET
338090	SPG24	C2931354	Spastic paraplegia 24	0.2	0	0	CTD_human
3383	ICAM1	C0004096	Asthma	0.218218247963749	2	0	CTD_human
3383	ICAM1	C0004153	Atherosclerosis	0.224643863935608	1	0	CTD_human
3383	ICAM1	C0004943	Behcet Syndrome	0.214284114047457	2	0	CTD_human
3383	ICAM1	C0006267	Bronchiectasis	0.2	1	0	CTD_human
3383	ICAM1	C0007786	Brain Ischemia	0.202407028523288	2	0	CTD_human
3383	ICAM1	C0008370	Cholestasis	0.2	1	0	CTD_human
3383	ICAM1	C0009324	Ulcerative Colitis	0.215159451557409	1	0	CTD_human
3383	ICAM1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.230476960207089	1	0	CTD_human
3383	ICAM1	C0011884	Diabetic Retinopathy	0.300299392545511	1	0	CTD_human
3383	ICAM1	C0020443	Hypercholesterolemia	0.2	1	0	CTD_human
3383	ICAM1	C0024530	Malaria	0.214950237307826	0	0	CTD_human
3383	ICAM1	C0026769	Multiple Sclerosis	0.215485335498935	1	0	CTD_human
3383	ICAM1	C0027051	Myocardial Infarction	0.298222833584082	1	0	CTD_human
3383	ICAM1	C0027720	Nephrosis	0.2	1	0	CTD_human
3383	ICAM1	C0028754	Obesity	0.204055389228567	1	0	CTD_human
3383	ICAM1	C0032231	Pleurisy	0.2	1	0	CTD_human
3383	ICAM1	C0041948	Uremia	0.2	1	0	CTD_human
3383	ICAM1	C0042109	Urticaria	0.2	1	0	CTD_human
3383	ICAM1	C0085129	Bronchial Hyperreactivity	0.2	1	0	CTD_human
3383	ICAM1	C0151744	Myocardial Ischemia	0.201098907136852	1	0	CTD_human
3383	ICAM1	C0282548	Leukostasis	0.200274726784213	1	0	CTD_human
3383	ICAM1	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
338324	S100A7A	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
338328	GPIHBP1	C4014767	HYPERLIPOPROTEINEMIA, TYPE ID	0.2	4	9	UNIPROT
338331	AZON	C1847540	Azoospermia, Nonobstructive	0.2	0	0	CTD_human
338332	CELIAC5	C0007570	Celiac Disease	0.2	0	0	CTD_human
338333	PAPA3	C1846452	Polydactyly, Postaxial, Type A3	0.2	0	0	CTD_human
338334	CHDS1	C0010068	Coronary heart disease	0.2	0	0	CTD_human
338342	MGR4	C0338480	Common Migraine	0.2	0	0	CTD_human
338382	RAB7B	C0029456	Osteoporosis	0.2	1	0	CTD_human
338382	RAB7B	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
338411	TELAB1	C0406502	Hereditary benign telangiectasia (disorder)	0.2	0	0	CTD_human
338434	CANDN1	C1843306	CANDIDIASIS, FAMILIAL CHRONIC NAIL, WITH ICAM1 DEFICIENCY	0.2	0	0	CTD_human
338435	SCA25	C1837518	Spinocerebellar ataxia 25	0.400274726784213	0	0	CTD_human;ORPHANET
338442	HCAR2	C0033860	Psoriasis	0.2	1	0	CTD_human
3385	ICAM3	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
338917	VSX2	C1845877	Microphthalmia, Isolated, with Coloboma 1	0.2	0	0	ORPHANET
338917	VSX2	C1855052	MICROPHTHALMIA, ISOLATED 1	0.2	0	0	ORPHANET
338917	VSX2	C1864720	MICROPHTHALMIA, ISOLATED 2	0.4	2	2	CTD_human;UNIPROT
338917	VSX2	C1864721	Microphthalmia, Isolated, with Coloboma 3	0.4	2	2	CTD_human;UNIPROT
339145	FAM92B	C0010346	Crohn Disease	0.205638237399215	1	0	CTD_human
3394	IRF8	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
3394	IRF8	C0026769	Multiple Sclerosis	0.211825928366857	1	0	CTD_human
3394	IRF8	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3394	IRF8	C3808589	IMMUNODEFICIENCY 32A	0.4	1	1	ORPHANET;UNIPROT
3394	IRF8	C4016741	IMMUNODEFICIENCY 32B	0.2	2	1	UNIPROT
339453	TMEM240	C1843891	SPINOCEREBELLAR ATAXIA 21	0.400274726784213	1	6	ORPHANET;UNIPROT
3397	ID1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	0	CTD_human
3397	ID1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
339829	CCDC39	C0022521	Kartagener Syndrome	0.201373633921065	0	0	ORPHANET
3399	ID3	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
34	ACADM	C0014544	Epilepsy	0.2	0	0	HPO
34	ACADM	C0020615	Hypoglycemia	0.200549453568426	0	0	HPO
34	ACADM	C0028754	Obesity	0.2	1	0	CTD_human
34	ACADM	C0085605	Liver Failure	0.2	1	0	CTD_human
34	ACADM	C0220710	Medium-chain acyl-coenzyme A dehydrogenase deficiency	0.699661980039777	10	78	CTD_human;ORPHANET;UNIPROT
34	ACADM	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
34	ACADM	C0543541	HYPERGLYCINURIA (disorder)	0.2	0	0	HPO
34	ACADM	C2711227	Steatohepatitis	0.2	0	0	HPO
340024	SLC6A19	C0018609	Hartnup Disease	0.683021994626344	2	4	CTD_human;ORPHANET;UNIPROT
340024	SLC6A19	C0543541	HYPERGLYCINURIA (disorder)	0.200274726784213	0	0	CTD_human
340061	TMEM173	C0024145	Chilblain lupus 1	0.2	1	0	CTD_human
340061	TMEM173	C4014722	STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET	0.400274726784213	1	3	ORPHANET;UNIPROT
3402	IDDM3	C1838262	DIABETES MELLITUS, INSULIN-DEPENDENT, 3	0.2	0	0	CTD_human
340205	TREML1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
3403	IDDM4	C1838261	DIABETES MELLITUS, INSULIN-DEPENDENT, 4	0.200824180352639	0	0	CTD_human
3405	IDDM6	C1866041	DIABETES MELLITUS, INSULIN-DEPENDENT, 6	0.2	0	0	CTD_human
340533	KIAA2022	C3806730	MENTAL RETARDATION, X-LINKED 98	0.2	0	0	ORPHANET
3406	IDDM7	C1838259	DIABETES MELLITUS, INSULIN-DEPENDENT, 7	0.200549453568426	0	0	CTD_human
340665	CYP26C1	C3554246	FOCAL FACIAL DERMAL DYSPLASIA 4	0.2	0	0	ORPHANET
3407	IDDM8	C1833218	DIABETES MELLITUS, INSULIN-DEPENDENT, 8	0.200274726784213	0	0	CTD_human
340990	OTOG	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
340990	OTOG	C3554163	DEAFNESS, AUTOSOMAL RECESSIVE 18B	0.200274726784213	1	2	UNIPROT
341	APOC1	C0018801	Heart failure	0.2	1	0	CTD_human
3410	IDDM11	C1832605	DIABETES MELLITUS, INSULIN-DEPENDENT, 11	0.2	0	0	CTD_human
3412	IDDM13	C1832474	DIABETES MELLITUS, INSULIN-DEPENDENT, 13	0.2	0	0	CTD_human
3414	IDDM15	C1866519	DIABETES MELLITUS, INSULIN-DEPENDENT, 15	0.2	0	0	CTD_human
3416	IDE	C0002395	Alzheimer's Disease	0.256523168818397	1	0	CTD_human
341640	FREM2	C0265233	Cryptophthalmos syndrome	0.683846174978983	2	3	CTD_human;ORPHANET;UNIPROT
3417	IDH1	C0014084	Enchondromatosis	0.601923087489492	2	0	CTD_human;HPO;ORPHANET
3417	IDH1	C0024454	Maffucci Syndrome	0.202197814273705	0	0	ORPHANET
3417	IDH1	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
3417	IDH1	C3553958	METAPHYSEAL ENCHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA	0.200274726784213	0	0	ORPHANET
3417	IDH1	C4021977	Visceral angiomatosis	0.2	0	0	HPO
3418	IDH2	C0014084	Enchondromatosis	0.601373633921066	2	0	CTD_human;HPO;ORPHANET
3418	IDH2	C0014544	Epilepsy	0.200274726784213	0	0	HPO
3418	IDH2	C0024454	Maffucci Syndrome	0.201648360705279	0	0	ORPHANET
3418	IDH2	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
3418	IDH2	C0029456	Osteoporosis	0.2	1	0	CTD_human
3418	IDH2	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
3418	IDH2	C1833429	D-2-hydroxyglutaric aciduria	0.201098907136852	0	0	HPO
3418	IDH2	C2746066	Combined D-2- and L-2-hydroxyglutaric aciduria	0.201373633921065	0	0	CTD_human
3418	IDH2	C3150909	D-2-HYDROXYGLUTARIC ACIDURIA 2	0.2	1	2	UNIPROT
3418	IDH2	C3152055	D-2-HYDROXYGLUTARIC ACIDURIA 1	0.200549453568426	0	0	ORPHANET
3418	IDH2	C4021977	Visceral angiomatosis	0.2	0	0	HPO
3419	IDH3A	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
3420	IDH3B	C0017601	Glaucoma	0.2	0	0	HPO
3420	IDH3B	C0018777	Conductive hearing loss	0.2	0	0	HPO
3420	IDH3B	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
3420	IDH3B	C0020459	Hyperinsulinism	0.2	0	0	HPO
3420	IDH3B	C0020619	Hypogonadism	0.2	0	0	HPO
3420	IDH3B	C0022578	Keratoconus	0.2	0	0	HPO
3420	IDH3B	C0028738	Nystagmus	0.2	0	0	HPO
3420	IDH3B	C0028754	Obesity	0.2	0	0	HPO
3420	IDH3B	C0029124	Optic Atrophy	0.2	0	0	HPO
3420	IDH3B	C0035334	Retinitis Pigmentosa	0.602732912464814	1	0	CTD_human;HPO;ORPHANET
3420	IDH3B	C0042798	Low Vision	0.2	0	0	HPO
3420	IDH3B	C0271215	Blindness, Legal	0.2	0	0	HPO
3420	IDH3B	C2675496	Retinitis Pigmentosa 46	0.2	1	1	UNIPROT
3423	IDS	C0004096	Asthma	0.2	0	0	HPO
3423	IDS	C0014544	Epilepsy	0.2	0	0	HPO
3423	IDS	C0018801	Heart failure	0.2	0	0	HPO
3423	IDS	C0018802	Congestive heart failure	0.2	0	0	HPO
3423	IDS	C0020255	Hydrocephalus	0.2	0	0	HPO
3423	IDS	C0020555	Hypertrichosis	0.2	0	0	HPO
3423	IDS	C0021847	Intestinal Pseudo-Obstruction	0.2	0	0	HPO
3423	IDS	C0024421	Macroglossia	0.2	0	0	HPO
3423	IDS	C0026705	Mucopolysaccharidosis II	0.516220869384177	28	65	CTD_human;UNIPROT
3423	IDS	C0030353	Papilledema	0.2	0	0	HPO
3423	IDS	C0086795	Pfaundler-Hurler Syndrome	0.200549453568426	0	0	HPO
3423	IDS	C0340231	Tracheobronchomalacia	0.2	0	0	HPO
3423	IDS	C0520679	Sleep Apnea, Obstructive	0.2	0	0	HPO
3423	IDS	C0747085	Recurrent otitis media	0.2	0	0	HPO
3423	IDS	C3714497	Reactive airway disease	0.2	0	0	HPO
3423	IDS	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
342371	ATXN1L	C0087012	Ataxia, Spinocerebellar	0.202732912464814	1	0	CTD_human
3425	IDUA	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
3425	IDUA	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
3425	IDUA	C0007789	Cerebral Palsy	0.2	0	0	HPO
3425	IDUA	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
3425	IDUA	C0017601	Glaucoma	0.2	0	0	HPO
3425	IDUA	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
3425	IDUA	C0020255	Hydrocephalus	0.2	0	0	HPO
3425	IDUA	C0023786	Mucopolysaccharidosis I	0.232309181870564	5	3	CTD_human
3425	IDUA	C0024421	Macroglossia	0.2	0	0	HPO
3425	IDUA	C0026708	Mucopolysaccharidosis V	0.481098907136852	8	10	ORPHANET;UNIPROT
3425	IDUA	C0035455	Rhinitis	0.2	0	0	HPO
3425	IDUA	C0040583	Tracheal Stenosis	0.2	0	0	HPO
3425	IDUA	C0086431	Hurler-Scheie Syndrome	0.481373633921066	11	16	ORPHANET;UNIPROT
3425	IDUA	C0086795	Pfaundler-Hurler Syndrome	0.692571919539173	9	36	HPO;ORPHANET;UNIPROT
3425	IDUA	C0401151	Chronic diarrhea	0.2	0	0	HPO
3425	IDUA	C0520679	Sleep Apnea, Obstructive	0.2	0	0	HPO
3425	IDUA	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
3425	IDUA	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
3425	IDUA	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
3425	IDUA	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
3426	CFI	C0003864	Arthritis	0.2	0	0	HPO
3426	CFI	C0017658	Glomerulonephritis	0.2	0	0	HPO
3426	CFI	C0034186	Pyelonephritis	0.2	0	0	HPO
3426	CFI	C0035078	Kidney Failure	0.2	0	0	HPO
3426	CFI	C0042384	Vasculitis	0.2	0	0	HPO
3426	CFI	C0162739	HELLP Syndrome	0.203007639249027	0	0	ORPHANET
3426	CFI	C0242383	Age related macular degeneration	0.216756655105375	3	2	CTD_human
3426	CFI	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
3426	CFI	C0581354	Recurrent sinusitis	0.2	0	0	HPO
3426	CFI	C0746495	Recurrent meningitis	0.2	0	0	HPO
3426	CFI	C0747085	Recurrent otitis media	0.2	0	0	HPO
3426	CFI	C1565489	Renal Insufficiency	0.2	0	0	HPO
3426	CFI	C1832174	DOYNE HONEYCOMB RETINAL DYSTROPHY	0.2	0	0	ORPHANET
3426	CFI	C2931788	Atypical Hemolytic Uremic Syndrome	0.20433011601278	0	0	CTD_human
3426	CFI	C3463916	Complement Factor I (C3 inactivator) deficiency	0.600274726784213	2	2	CTD_human;ORPHANET;UNIPROT
3426	CFI	C3809523	MACULAR DEGENERATION, AGE-RELATED, 13	0.2	0	0	UNIPROT
3426	CFI	C4280333	Recurrent sinus disease	0.2	0	0	HPO
3429	IFI27	C0021400	Influenza	0.200274726784213	1	0	CTD_human
3430	IFI35	C0021400	Influenza	0.2	1	0	CTD_human
343035	RD3	C0339527	Leber Congenital Amaurosis	0.2	0	0	ORPHANET
343035	RD3	C1857743	LEBER CONGENITAL AMAUROSIS 12 (disorder)	0.280274726784213	0	0	CTD_human
3431	SP110	C0162539	IgG Deficiency	0.2	0	0	HPO
3431	SP110	C1856128	Hepatic venoocclusive disease with immunodeficiency	0.400274726784213	0	0	CTD_human;ORPHANET
3433	IFIT2	C0021400	Influenza	0.2	1	0	CTD_human
3434	IFIT1	C0014175	Endometriosis	0.2	1	0	CTD_human
3434	IFIT1	C0021400	Influenza	0.200549453568426	1	0	CTD_human
343637	RSPO4	C3277900	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4	0.400274726784213	1	4	ORPHANET;UNIPROT
343641	TGM6	C3888031	SPINOCEREBELLAR ATAXIA 35	0.4	2	5	ORPHANET;UNIPROT
3437	IFIT3	C0021400	Influenza	0.2	1	0	CTD_human
3439	IFNA1	C0019163	Hepatitis B	0.213736339210655	1	0	CTD_human
3439	IFNA1	C0023890	Liver Cirrhosis	0.209275198128616	1	0	CTD_human
344	APOC2	C0023817	Hyperlipoproteinemia Type I	0.202197814273705	0	0	CTD_human
344	APOC2	C0030305	Pancreatitis	0.20350593566014	0	0	HPO
344	APOC2	C0221252	Eruptive xanthoma	0.2	0	0	HPO
344	APOC2	C0268199	Familial apolipoprotein C-II deficiency	0.200274726784213	0	0	ORPHANET
344	APOC2	C0339477	Lipidemia retinalis	0.2	0	0	HPO
344	APOC2	C1720779	Apolipoprotein C-II Deficiency (disorder)	0.201373633921065	1	4	UNIPROT
3440	IFNA2	C0002871	Anemia	0.200549453568426	5	0	CTD_human
3440	IFNA2	C0002878	Anemia, Hemolytic	0.2	3	0	CTD_human
3440	IFNA2	C0003123	Anorexia	0.2	1	0	CTD_human
3440	IFNA2	C0015695	Fatty Liver	0.2	1	0	CTD_human
3440	IFNA2	C0019163	Hepatitis B	0.209535569535511	3	0	CTD_human
3440	IFNA2	C0019189	Hepatitis, Chronic	0.202197814273705	1	0	CTD_human
3440	IFNA2	C0019196	Hepatitis C	0.224659898044549	7	0	CTD_human
3440	IFNA2	C0021845	Intestinal Perforation	0.2	1	0	CTD_human
3440	IFNA2	C0023530	Leukopenia	0.2	5	0	CTD_human
3440	IFNA2	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
3440	IFNA2	C0027947	Neutropenia	0.2	1	0	CTD_human
3440	IFNA2	C0033999	Pterygium	0.2	1	0	CTD_human
3440	IFNA2	C0034734	Raynaud Disease	0.2	1	0	CTD_human
3440	IFNA2	C0035305	Retinal Detachment	0.2	2	0	CTD_human
3440	IFNA2	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
3440	IFNA2	C0038362	Stomatitis	0.2	1	0	CTD_human
3440	IFNA2	C0040028	Thrombocythemia, Essential	0.201648360705279	1	0	CTD_human
3440	IFNA2	C0042170	Uveomeningoencephalitic Syndrome	0.2	4	0	CTD_human
3440	IFNA2	C0042749	Viremia	0.200274726784213	1	0	CTD_human
3440	IFNA2	C0155305	Optic Neuropathy, Ischemic	0.2	1	0	CTD_human
3440	IFNA2	C0243026	Sepsis	0.2	1	0	CTD_human
3440	IFNA2	C0524909	Hepatitis B, Chronic	0.206043989252688	7	0	CTD_human
3440	IFNA2	C0524910	Hepatitis C, Chronic	0.23901120335826	10	0	CTD_human
3440	IFNA2	C1565489	Renal Insufficiency	0.2	1	0	CTD_human
3440	IFNA2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
344018	FIGLA	C2676742	Premature Ovarian Failure 6	0.2	0	0	CTD_human
345	APOC3	C0020443	Hypercholesterolemia	0.205912964183428	0	0	HPO
345	APOC3	C0020445	Hypercholesterolemia, Familial	0.202407028523288	1	0	CTD_human
345	APOC3	C0020473	Hyperlipidemia	0.216416415786532	0	0	HPO
345	APOC3	C0020476	Hyperlipoproteinemias	0.2	1	0	CTD_human
345	APOC3	C0020597	Hypobetalipoproteinemias	0.2	0	0	HPO
345	APOC3	C0342883	Cholesteryl Ester Transfer Protein Deficiency	0.200549453568426	0	0	HPO
345	APOC3	C0542037	Hypotriglyceridaemia	0.200274726784213	0	0	HPO
345	APOC3	C1956346	Coronary Artery Disease	0.232241990604311	1	0	CTD_human
345	APOC3	C3149462	HYPERALPHALIPOPROTEINEMIA 1	0.2	0	0	ORPHANET
345	APOC3	C3151467	Apolipoprotein C-III Deficiency	0.200274726784213	1	5	UNIPROT
345193	LRIT3	C3554399	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F	0.28	1	4	UNIPROT
3455	IFNAR2	C0019163	Hepatitis B	0.200824180352639	0	0	CTD_human
3456	IFNB1	C0019163	Hepatitis B	0.202197814273705	1	0	CTD_human
3456	IFNB1	C0026769	Multiple Sclerosis	0.253506210386925	3	0	CTD_human
345611	IRGM	C0009324	Ulcerative Colitis	0.203780662444353	1	1	CTD_human
345611	IRGM	C0010346	Crohn Disease	0.254534568794276	4	4	CTD_human
3458	IFNG	C0002874	Aplastic Anemia	0.2946243533663	0	0	CTD_human
3458	IFNG	C0003615	Appendicitis	0.2	1	0	CTD_human
3458	IFNG	C0003873	Rheumatoid Arthritis	0.228346337199638	1	0	CTD_human
3458	IFNG	C0004153	Atherosclerosis	0.210792533764634	1	0	CTD_human
3458	IFNG	C0006272	Bronchiolitis Obliterans	0.20328236603324	1	0	CTD_human
3458	IFNG	C0009319	Colitis	0.203846174978983	1	0	CTD_human
3458	IFNG	C0010346	Crohn Disease	0.212883448103381	1	0	CTD_human
3458	IFNG	C0011615	Dermatitis, Atopic	0.212333994534955	1	0	CTD_human
3458	IFNG	C0011854	Diabetes Mellitus, Insulin-Dependent	0.387981972746493	1	0	CTD_human
3458	IFNG	C0014324	Entamoebiasis	0.2	1	0	CTD_human
3458	IFNG	C0017658	Glomerulonephritis	0.200274726784213	1	0	CTD_human
3458	IFNG	C0018133	Graft-vs-Host Disease	0.229275738755612	1	0	CTD_human
3458	IFNG	C0018790	Cardiac Arrest	0.200549453568426	1	0	CTD_human
3458	IFNG	C0018801	Heart failure	0.202681755307501	2	0	CTD_human
3458	IFNG	C0019158	Hepatitis	0.201648360705279	1	0	CTD_human
3458	IFNG	C0019163	Hepatitis B	0.241572931510571	2	0	CTD_human
3458	IFNG	C0019196	Hepatitis C	0.234128276313807	0	0	CTD_human
3458	IFNG	C0023241	Legionnaires' Disease	0.2	1	0	CTD_human
3458	IFNG	C0023281	Leishmaniasis	0.207114185634906	2	0	CTD_human
3458	IFNG	C0023283	Leishmaniasis, Cutaneous	0.204604842796993	3	0	CTD_human
3458	IFNG	C0023290	Leishmaniasis, Visceral	0.202747267842131	2	0	CTD_human
3458	IFNG	C0029172	Oral Submucous Fibrosis	0.2	1	0	CTD_human
3458	IFNG	C0031154	Peritonitis	0.200824180352639	1	0	CTD_human
3458	IFNG	C0032285	Pneumonia	0.201923087489492	1	0	CTD_human
3458	IFNG	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
3458	IFNG	C0040954	Infection by Trichuris trichiura	0.2	1	0	CTD_human
3458	IFNG	C0162309	Adrenoleukodystrophy	0.2	1	0	CTD_human
3458	IFNG	C0162820	Dermatitis, Allergic Contact	0.200824180352639	2	0	CTD_human
3458	IFNG	C0241910	Hepatitis, Autoimmune	0.200824180352639	1	0	CTD_human
3458	IFNG	C0243026	Sepsis	0.211602358739956	1	0	CTD_human
3458	IFNG	C0348890	Aplastic anemia, idiopathic	0.2	0	0	ORPHANET
3458	IFNG	C1328252	Mucocutaneous leishmaniasis	0.200274726784213	1	0	CTD_human
3458	IFNG	C1565489	Renal Insufficiency	0.202407028523288	2	0	CTD_human
3458	IFNG	C1854465	TUBEROUS SCLEROSIS 1 (disorder)	0.2	0	0	CTD_human
3458	IFNG	C1860707	TUBEROUS SCLEROSIS 2 (disorder)	0.200274726784213	0	0	CTD_human
3458	IFNG	C3887645	Job Syndrome	0.200824180352639	1	0	CTD_human
3458	IFNG	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
345895	RSPH4A	C0022521	Kartagener Syndrome	0.200824180352639	0	0	ORPHANET
345895	RSPH4A	C2675229	CILIARY DYSKINESIA, PRIMARY, 11	0.4	1	7	CTD_human;UNIPROT
3459	IFNGR1	C0014175	Endometriosis	0.2	1	0	CTD_human
3459	IFNGR1	C0019163	Hepatitis B	0.200549453568426	0	0	CTD_human
3459	IFNGR1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3459	IFNGR1	C0152491	Salmonella osteomyelitis	0.2	0	0	HPO
3459	IFNGR1	C0850715	Abnormality of blood and blood-forming tissues	0.2	0	0	HPO
3459	IFNGR1	C2930924	Interferon gamma, receptor 1, deficiency	0.2	0	0	ORPHANET
3459	IFNGR1	C3806330	Osteomyelitis due to immunodeficiency	0.2	0	0	HPO
3459	IFNGR1	C4011949	IMMUNODEFICIENCY 27A	0.4	2	2	ORPHANET;UNIPROT
3459	IFNGR1	C4014863	IMMUNODEFICIENCY 27B	0.2	0	0	ORPHANET
3460	IFNGR2	C4013947	IMMUNODEFICIENCY 28	0.4	1	4	ORPHANET;UNIPROT
346007	EYS	C0035334	Retinitis Pigmentosa	0.411719028431899	1	16	CTD_human;ORPHANET
346007	EYS	C1864446	Retinitis Pigmentosa 25	0.4	2	28	CTD_human;UNIPROT
346171	ZFP57	C1832386	Diabetes Mellitus, Transient Neonatal, 1	0.600549453568426	1	8	CTD_human;ORPHANET;UNIPROT
347088	ADGRD2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
347344	ZNF81	C1845333	Mental Retardation, X-Linked 45	0.4	1	1	CTD_human;UNIPROT
3475	IFRD1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
3475	IFRD1	C1843884	SPINOCEREBELLAR ATAXIA 18	0.2	0	0	ORPHANET
3476	IGBP1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
3476	IGBP1	C0028738	Nystagmus	0.2	0	0	HPO
3476	IGBP1	C0042798	Low Vision	0.2	0	0	HPO
3476	IGBP1	C0155299	Coloboma of optic disc	0.2	0	0	HPO
3476	IGBP1	C1845446	Corpus Callosum, Agenesis of, with Mental Retardation, Ocular Coloboma, and Micrognathia	0.4	0	0	CTD_human;ORPHANET
347688	TUBB8	C4225210	OOCYTE MATURATION DEFECT 2	0.2	2	10	UNIPROT
347733	TUBB2B	C1851102	Fibrosis Of Extraocular Muscles, Congenital, 1	0.2	0	0	ORPHANET
347733	TUBB2B	C1955869	Malformations of Cortical Development	0.200549453568426	1	0	CTD_human
347733	TUBB2B	C3552236	POLYMICROGYRIA, SYMMETRIC OR ASYMMETRIC	0.68	1	3	CTD_human;ORPHANET;UNIPROT
347737	DFNA31	C1837617	DEAFNESS, AUTOSOMAL DOMINANT 31 (disorder)	0.2	0	0	CTD_human
3479	IGF1	C0001206	Acromegaly	0.215304832003986	4	0	CTD_human
3479	IGF1	C0002395	Alzheimer's Disease	0.213642115921391	1	0	CTD_human
3479	IGF1	C0008370	Cholestasis	0.280274726784213	1	0	CTD_human
3479	IGF1	C0009319	Colitis	0.2	1	0	CTD_human
3479	IGF1	C0010346	Crohn Disease	0.201373633921065	1	0	CTD_human
3479	IGF1	C0011854	Diabetes Mellitus, Insulin-Dependent	0.204879569581206	1	0	CTD_human
3479	IGF1	C0014175	Endometriosis	0.203831819601666	1	0	CTD_human
3479	IGF1	C0018784	Sensorineural Hearing Loss (disorder)	0.201373633921065	0	0	HPO
3479	IGF1	C0020619	Hypogonadism	0.200274726784213	0	0	HPO
3479	IGF1	C0022661	Kidney Failure, Chronic	0.200549453568426	1	0	CTD_human
3479	IGF1	C0029453	Osteopenia	0.200824180352639	0	0	HPO
3479	IGF1	C0029456	Osteoporosis	0.290294237353521	0	0	HPO
3479	IGF1	C0034013	Precocious Puberty	0.2	1	0	CTD_human
3479	IGF1	C0034069	Pulmonary Fibrosis	0.204106546385879	1	0	CTD_human
3479	IGF1	C0151744	Myocardial Ischemia	0.203831819601666	1	0	CTD_human
3479	IGF1	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
3479	IGF1	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
3479	IGF1	C0747078	Generalized osteopenia	0.2	0	0	HPO
3479	IGF1	C0853897	Diabetic Cardiomyopathies	0.2	1	0	CTD_human
3479	IGF1	C0857007	Hyperbilirubinemia, Neonatal	0.2	0	0	HPO
3479	IGF1	C1837475	Insulin-Like Growth Factor I Deficiency	0.402747267842131	0	0	CTD_human;ORPHANET
3479	IGF1	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
3479	IGF1	C4021806	Prelingual sensorineural hearing impairment	0.2	0	0	HPO
3479	IGF1	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
348	APOE	C0002395	Alzheimer's Disease	0.64	4	2	CTD_human;HPO
348	APOE	C0002726	Amyloidosis	0.284814057046576	1	0	CTD_human
348	APOE	C0003742	Arcus Senilis	0.2	0	0	HPO
348	APOE	C0003850	Arteriosclerosis	0.29203514261644	2	0	CTD_human
348	APOE	C0004153	Atherosclerosis	0.587329124648138	25	0	CTD_human;HPO
348	APOE	C0005741	Blepharitis	0.2	0	0	HPO
348	APOE	C0007282	Carotid Stenosis	0.210727021230004	1	0	CTD_human
348	APOE	C0010068	Coronary heart disease	0.343925208457749	1	0	CTD_human
348	APOE	C0019202	Hepatolenticular Degeneration	0.203231208875927	1	0	CTD_human
348	APOE	C0020443	Hypercholesterolemia	0.488154778939985	4	0	CTD_human;HPO
348	APOE	C0020445	Hypercholesterolemia, Familial	0.418628585437554	1	0	CTD_human;HPO
348	APOE	C0020473	Hyperlipidemia	0.385766896206762	4	0	CTD_human
348	APOE	C0020479	Hyperlipoproteinemia Type III	0.43229941211358	3	9	CTD_human;ORPHANET
348	APOE	C0023890	Liver Cirrhosis	0.213185206910605	0	0	HPO
348	APOE	C0026769	Multiple Sclerosis	0.316712901443335	1	0	CTD_human
348	APOE	C0027051	Myocardial Infarction	0.302744901580418	1	1	CTD_human
348	APOE	C0028754	Obesity	0.479210050373227	1	0	CTD_human;HPO
348	APOE	C0031256	Petechiae	0.2	0	0	HPO
348	APOE	C0033860	Psoriasis	0.208869446275143	1	0	CTD_human
348	APOE	C0035078	Kidney Failure	0.208869446275143	0	0	HPO
348	APOE	C0036489	Sea-Blue Histiocyte Syndrome	0.6	1	1	CTD_human;HPO;ORPHANET
348	APOE	C0085220	Cerebral Amyloid Angiopathy	0.451108501046083	1	0	CTD_human;HPO
348	APOE	C0155210	Eyelid Xanthoma	0.200549453568426	0	0	HPO
348	APOE	C0221253	Xanthoma tendinosum	0.2	0	0	HPO
348	APOE	C0242383	Age related macular degeneration	0.277194418326095	1	1	CTD_human
348	APOE	C0302314	Xanthoma	0.200824180352639	0	0	HPO
348	APOE	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
348	APOE	C0473527	Hypoalphalipoproteinemias	0.2	0	0	HPO
348	APOE	C0520743	Mediastinal lymphadenopathy	0.2	0	0	HPO
348	APOE	C0745103	Hyperlipoproteinemia Type IIa	0.205769262468475	0	0	UNIPROT
348	APOE	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
348	APOE	C0751967	Multiple Sclerosis, Relapsing-Remitting	0.202956482091714	1	0	CTD_human
348	APOE	C1565489	Renal Insufficiency	0.401098907136852	1	0	CTD_human;HPO
348	APOE	C1863051	ALZHEIMER DISEASE 2	0.404120901763197	0	0	CTD_human;HPO
348	APOE	C1864205	Macular Degeneration, Age-Related, 1	0.2	0	0	CTD_human
348	APOE	C2673196	LIPOPROTEIN GLOMERULOPATHY	0.613880040925608	3	2	CTD_human;ORPHANET;UNIPROT
348	APOE	C2711227	Steatohepatitis	0.200824180352639	0	0	HPO
348	APOE	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
348	APOE	C4280602	Xanthelasma of periocular region	0.2	0	0	HPO
3480	IGF1R	C0002395	Alzheimer's Disease	0.282956482091714	1	0	CTD_human
3480	IGF1R	C0030567	Parkinson Disease	0.28	1	0	CTD_human
3480	IGF1R	C0752347	Lewy Body Disease	0.2	1	0	CTD_human
3480	IGF1R	C1849157	Insulin-Like Growth Factor I, Resistance To	0.601923087489492	3	5	CTD_human;ORPHANET;UNIPROT
3480	IGF1R	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
3480	IGF1R	C4020884	Anxiety disease	0.2	0	0	HPO
3481	IGF2	C0002395	Alzheimer's Disease	0.286187690967642	1	0	CTD_human
3481	IGF2	C0002871	Anemia	0.2	1	0	CTD_human
3481	IGF2	C0004153	Atherosclerosis	0.205689394556528	1	0	CTD_human
3481	IGF2	C0004903	Beckwith-Wiedemann Syndrome	0.222736810555057	2	0	CTD_human
3481	IGF2	C0015300	Exophthalmos	0.2	0	0	HPO
3481	IGF2	C0020615	Hypoglycemia	0.204945082115836	1	0	CTD_human
3481	IGF2	C0024421	Macroglossia	0.2	0	0	HPO
3481	IGF2	C0028754	Obesity	0.217804405084915	1	0	CTD_human
3481	IGF2	C0030567	Parkinson Disease	0.205689394556528	1	0	CTD_human
3481	IGF2	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
3481	IGF2	C0175693	Russell-Silver syndrome	0.206868169605328	1	0	CTD_human
3481	IGF2	C0752347	Lewy Body Disease	0.200274726784213	1	0	CTD_human
3481	IGF2	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
3482	IGF2R	C0002395	Alzheimer's Disease	0.205414667772315	1	0	CTD_human
3482	IGF2R	C0030567	Parkinson Disease	0.200274726784213	1	0	CTD_human
3482	IGF2R	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
3482	IGF2R	C0752347	Lewy Body Disease	0.2	1	0	CTD_human
3483	IGFALS	C3900122	ACID-LABILE SUBUNIT DEFICIENCY	0.600274726784213	6	7	HPO;ORPHANET;UNIPROT
3484	IGFBP1	C0014175	Endometriosis	0.204381273170092	1	0	CTD_human
3484	IGFBP1	C0023890	Liver Cirrhosis	0.203007639249027	1	0	CTD_human
3484	IGFBP1	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
3485	IGFBP2	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3485	IGFBP2	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
3485	IGFBP2	C0028754	Obesity	0.200549453568426	1	0	CTD_human
3486	IGFBP3	C0003873	Rheumatoid Arthritis	0.200549453568426	1	0	CTD_human
3486	IGFBP3	C0151744	Myocardial Ischemia	0.200549453568426	1	0	CTD_human
3489	IGFBP6	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3489	IGFBP6	C0014175	Endometriosis	0.2	1	0	CTD_human
3489	IGFBP6	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
348938	NIPAL4	C2677065	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6	0.4	3	5	CTD_human;UNIPROT
348980	HCN1	C0014544	Epilepsy	0.202197814273705	1	0	CTD_human
348980	HCN1	C3463992	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	0.2	1	0	CTD_human
348980	HCN1	C4014531	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24	0.2	1	5	UNIPROT
3490	IGFBP7	C0154822	Serous retinal detachment	0.2	0	0	HPO
3490	IGFBP7	C1956257	Pulmonary Stenosis	0.200274726784213	0	0	HPO
3490	IGFBP7	C3280205	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS	0.2	0	0	ORPHANET
3491	CYR61	C0003873	Rheumatoid Arthritis	0.204106546385879	1	0	CTD_human
3492	IGH	C0002871	Anemia	0.200274726784213	0	0	HPO
3492	IGH	C0003123	Anorexia	0.2	0	0	HPO
3492	IGH	C0520743	Mediastinal lymphadenopathy	0.2	0	0	HPO
349565	NMNAT3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
35	ACADS	C0014544	Epilepsy	0.200274726784213	0	0	HPO
35	ACADS	C0342783	Deficiency of butyryl-CoA dehydrogenase	0.682472541057918	2	35	CTD_human;ORPHANET;UNIPROT
35	ACADS	C0376175	Bell Palsy	0.2	0	0	HPO
35	ACADS	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
350	APOH	C4277682	Chemical and Drug Induced Liver Injury	0.28	1	0	CTD_human
3500	IGHG1	C0027121	Myositis	0.2	1	0	CTD_human
3500	IGHG1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
3501	IGHG2	C0027121	Myositis	0.2	1	0	CTD_human
3501	IGHG2	C3279824	Kappa-Chain Deficiency	0.2	0	0	ORPHANET
3507	IGHM	C0001768	Agammaglobulinemia	0.2	0	0	HPO
3507	IGHM	C0003864	Arthritis	0.2	0	0	HPO
3507	IGHM	C0006267	Bronchiectasis	0.2	0	0	HPO
3507	IGHM	C0009763	Conjunctivitis	0.2	0	0	HPO
3507	IGHM	C0010346	Crohn Disease	0.2	0	0	HPO
3507	IGHM	C0029443	Osteomyelitis	0.2	0	0	HPO
3507	IGHM	C0037199	Sinusitis	0.2	0	0	HPO
3507	IGHM	C0271441	Chronic otitis media	0.2	0	0	HPO
3507	IGHM	C0581354	Recurrent sinusitis	0.2	0	0	HPO
3507	IGHM	C0694550	Recurrent pneumonia	0.2	0	0	HPO
3507	IGHM	C0743359	ear infection chronic	0.2	0	0	HPO
3507	IGHM	C0747085	Recurrent otitis media	0.2	0	0	HPO
3507	IGHM	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
3507	IGHM	C2242472	Infection of bone	0.2	0	0	HPO
3507	IGHM	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3507	IGHM	C3152144	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE	0.4	0	0	CTD_human;ORPHANET
3507	IGHM	C4280333	Recurrent sinus disease	0.2	0	0	HPO
3508	IGHMBP2	C0026847	Spinal Muscular Atrophy	0.201098907136852	0	0	HPO
3508	IGHMBP2	C0085684	Foot-drop	0.2	0	0	HPO
3508	IGHMBP2	C1145670	Respiratory Failure	0.201098907136852	0	0	HPO
3508	IGHMBP2	C1848736	Distal amyotrophy	0.2	0	0	HPO
3508	IGHMBP2	C1858517	SPINAL MUSCULAR ATROPHY WITH RESPIRATORY DISTRESS 1	0.687142896389541	8	22	CTD_human;ORPHANET;UNIPROT
3508	IGHMBP2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3508	IGHMBP2	C4015349	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S	0.4	1	3	ORPHANET;UNIPROT
351	APP	C0002395	Alzheimer's Disease	0.885733541942472	55	13	CTD_human;HPO;ORPHANET;UNIPROT
351	APP	C0002726	Amyloidosis	0.288198737394441	1	0	CTD_human
351	APP	C0007786	Brain Ischemia	0.200549453568426	0	0	HPO
351	APP	C0009952	Febrile Convulsions	0.2	0	0	HPO
351	APP	C0014544	Epilepsy	0.200549453568426	0	0	HPO
351	APP	C0016667	Fragile X Syndrome	0.201098907136852	1	0	CTD_human
351	APP	C0085220	Cerebral Amyloid Angiopathy	0.428196371132729	1	0	CTD_human;HPO
351	APP	C0231341	Premature aging syndrome	0.2	1	0	CTD_human
351	APP	C0268394	Hereditary Cerebral Amyloid Angiopathy, Dutch Type	0.203296721410557	0	0	ORPHANET
351	APP	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
351	APP	C0917798	Cerebral Ischemia	0.200824180352639	0	0	HPO
351	APP	C1863051	ALZHEIMER DISEASE 2	0.200274726784213	0	0	HPO
351	APP	C2751536	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED	0.4	5	5	ORPHANET;UNIPROT
351	APP	C2931672	Cerebral hemorrhage with amyloidosis, hereditary, Dutch type	0.4	2	0	CTD_human;ORPHANET
351	APP	C4025264	Recurrent cerebral hemorrhage	0.200274726784213	0	0	HPO
3514	IGKC	C0013374	Dysgammaglobulinemia	0.2	1	0	CTD_human
3514	IGKC	C0027121	Myositis	0.2	1	0	CTD_human
3514	IGKC	C3279824	Kappa-Chain Deficiency	0.4	1	0	ORPHANET;UNIPROT
3516	RBPJ	C0003873	Rheumatoid Arthritis	0.205363510615002	2	0	CTD_human
3516	RBPJ	C0014175	Endometriosis	0.2	1	0	CTD_human
3516	RBPJ	C0020255	Hydrocephalus	0.2	0	0	HPO
3516	RBPJ	C0038379	Strabismus	0.2	0	0	HPO
3516	RBPJ	C0263401	Cutis marmorata	0.2	0	0	HPO
3516	RBPJ	C0265268	Adams Oliver syndrome	0.2	0	0	ORPHANET
3516	RBPJ	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3516	RBPJ	C3553748	ADAMS-OLIVER SYNDROME 3	0.2	1	2	UNIPROT
352909	DNAAF3	C0022521	Kartagener Syndrome	0.401098907136852	1	3	CTD_human;ORPHANET
352909	DNAAF3	C1847554	CILIARY DYSKINESIA, PRIMARY, 2 (disorder)	0.28	1	3	UNIPROT
352956	MMVP2	C1843003	MITRAL VALVE PROLAPSE, MYXOMATOUS 2	0.2	0	0	CTD_human
353	APRT	C0035078	Kidney Failure	0.201923087489492	0	0	HPO
353	APRT	C0268120	Adenine phosphoribosyltransferase deficiency	0.483021994626344	5	11	ORPHANET;UNIPROT
353	APRT	C0392525	Nephrolithiasis	0.200824180352639	0	0	HPO
353	APRT	C0451641	Urolithiasis	0.200824180352639	2	0	CTD_human
353	APRT	C1565489	Renal Insufficiency	0.200274726784213	0	0	HPO
353124	EIG2	C0270850	Idiopathic generalized epilepsy	0.2	0	0	CTD_human
353126	BMIQ10	C0028754	Obesity	0.2	0	0	CTD_human
353128	AD8	C0002395	Alzheimer's Disease	0.2	0	0	CTD_human
353128	AD8	C1846735	ALZHEIMER DISEASE 8	0.2	0	0	CTD_human
353143	LCE3B	C0033860	Psoriasis	0.221636224686581	1	0	CTD_human
353144	LCE3C	C0033860	Psoriasis	0.221636224686581	1	0	CTD_human
353147	POROK4	C2676508	Porokeratosis, Disseminated Superficial Actinic, 4	0.2	0	0	CTD_human
353173	ZLS	C0796013	Zimmerman Laband syndrome	0.2	0	0	CTD_human
353293	SPG23	C0796019	SPASTIC PARAPLEGIA 23 (disorder)	0.4	0	0	CTD_human;ORPHANET
353347	DFNA53	C1864957	DEAFNESS, AUTOSOMAL DOMINANT 53 (disorder)	0.2	0	0	CTD_human
353514	LILRA5	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
354	KLK3	C2937421	Prostatic Hyperplasia	0.210880492701942	1	0	CTD_human
3543	IGLL1	C0001768	Agammaglobulinemia	0.4	0	0	CTD_human;HPO
3543	IGLL1	C0003864	Arthritis	0.2	0	0	HPO
3543	IGLL1	C0009763	Conjunctivitis	0.2	0	0	HPO
3543	IGLL1	C0025289	Meningitis	0.2	0	0	HPO
3543	IGLL1	C0029443	Osteomyelitis	0.2	0	0	HPO
3543	IGLL1	C0037199	Sinusitis	0.2	0	0	HPO
3543	IGLL1	C0271441	Chronic otitis media	0.2	0	0	HPO
3543	IGLL1	C0694550	Recurrent pneumonia	0.2	0	0	HPO
3543	IGLL1	C0743359	ear infection chronic	0.2	0	0	HPO
3543	IGLL1	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
3543	IGLL1	C2242472	Infection of bone	0.2	0	0	HPO
3543	IGLL1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3543	IGLL1	C3150750	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE	0.2	1	3	UNIPROT
3543	IGLL1	C3152144	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
3547	IGSF1	C0020676	Hypothyroidism	0.200274726784213	0	0	HPO
3547	IGSF1	C3550963	HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	0.4	1	4	ORPHANET;UNIPROT
3548	IHG1	C1839928	IRIS HYPOPLASIA WITH GLAUCOMA	0.2	0	0	CTD_human
3549	IHH	C0014175	Endometriosis	0.2	1	0	CTD_human
3549	IHH	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
3549	IHH	C0264142	Spade-like hand	0.2	0	0	HPO
3549	IHH	C1843096	Acrocapitofemoral Dysplasia	0.600549453568426	1	2	CTD_human;ORPHANET;UNIPROT
3549	IHH	C1862151	BRACHYDACTYLY, TYPE A1 (disorder)	0.682197814273705	3	9	CTD_human;ORPHANET;UNIPROT
355	FAS	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
355	FAS	C0003864	Arthritis	0.200274726784213	0	0	HPO
355	FAS	C0004943	Behcet Syndrome	0.200824180352639	0	0	ORPHANET
355	FAS	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202681755307501	1	0	CTD_human
355	FAS	C0014457	Eosinophilia	0.2	0	0	HPO
355	FAS	C0017601	Glaucoma	0.202732912464814	0	0	HPO
355	FAS	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
355	FAS	C0020532	Hypersplenism	0.2	1	0	CTD_human
355	FAS	C0022073	Iridocyclitis	0.2	0	0	HPO
355	FAS	C0024535	Malaria, Falciparum	0.2	1	0	CTD_human
355	FAS	C0024636	Malocclusion	0.2	0	0	HPO
355	FAS	C0025289	Meningitis	0.2	0	0	HPO
355	FAS	C0026896	Myasthenia Gravis	0.2	1	0	CTD_human
355	FAS	C0027697	Nephritis	0.2	1	0	CTD_human
355	FAS	C0032963	Pregnancy Complications, Cardiovascular	0.2	1	0	CTD_human
355	FAS	C0035305	Retinal Detachment	0.28	0	0	HPO
355	FAS	C0038363	Aphthous Stomatitis	0.2	0	0	HPO
355	FAS	C0042109	Urticaria	0.2	0	0	HPO
355	FAS	C0042170	Uveomeningoencephalitic Syndrome	0.200274726784213	0	0	ORPHANET
355	FAS	C0042384	Vasculitis	0.200274726784213	0	0	HPO
355	FAS	C0042798	Low Vision	0.2	0	0	HPO
355	FAS	C0042900	Vitiligo	0.205088783830789	0	0	HPO
355	FAS	C0149745	Oral Ulcer	0.2	0	0	HPO
355	FAS	C0157917	Pauciarticular juvenile rheumatoid arthritis	0.2	0	0	ORPHANET
355	FAS	C0162316	Iron deficiency anemia	0.2	0	0	HPO
355	FAS	C0162323	Polyarthritis	0.2	0	0	HPO
355	FAS	C0162557	Liver Failure, Acute	0.203557092817453	1	0	CTD_human
355	FAS	C0221262	Poliosis	0.2	0	0	HPO
355	FAS	C0242584	Autoimmune thrombocytopenia	0.200274726784213	0	0	HPO
355	FAS	C0340971	Autoimmune neutropenia	0.2	0	0	HPO
355	FAS	C0398650	Immune thrombocytopenic purpura	0.200549453568426	0	0	HPO
355	FAS	C0400966	Non-alcoholic Fatty Liver Disease	0.200824180352639	1	0	CTD_human
355	FAS	C0520736	Coombs positive hemolytic anemia	0.2	0	0	HPO
355	FAS	C0702166	Acne	0.2	0	0	HPO
355	FAS	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
355	FAS	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
355	FAS	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
355	FAS	C1328840	Autoimmune Lymphoproliferative Syndrome	0.69147301240232	11	8	CTD_human;ORPHANET;UNIPROT
355	FAS	C2937365	Recurrent aphthous ulcer	0.2	0	0	HPO
355	FAS	C3714757	Juvenile rheumatoid arthritis	0.200549453568426	0	0	HPO
355	FAS	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
3551	IKBKB	C0001768	Agammaglobulinemia	0.2	0	0	HPO
3551	IKBKB	C0401151	Chronic diarrhea	0.2	0	0	HPO
3551	IKBKB	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3551	IKBKB	C3810043	IMMUNODEFICIENCY 15	0.2	0	0	ORPHANET
3552	IL1A	C0003165	Anthracosis	0.202681755307501	1	0	CTD_human
3552	IL1A	C0007786	Brain Ischemia	0.202407028523288	1	0	CTD_human
3552	IL1A	C0011633	Dermatomyositis	0.205689394556528	1	0	CTD_human
3552	IL1A	C0019061	Hemolytic-Uremic Syndrome	0.2	1	0	CTD_human
3552	IL1A	C0022541	Kearns-Sayre syndrome	0.2	1	0	CTD_human
3552	IL1A	C0085655	Polymyositis	0.200549453568426	1	0	CTD_human
3552	IL1A	C0151744	Myocardial Ischemia	0.200549453568426	1	0	CTD_human
3552	IL1A	C0162671	MELAS Syndrome	0.2	1	0	CTD_human
3552	IL1A	C0162672	MERRF Syndrome	0.2	1	0	CTD_human
3552	IL1A	C0162674	Chronic progressive external ophthalmoplegia	0.2	1	0	CTD_human
3552	IL1A	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
3552	IL1A	C0343755	HIV Wasting Syndrome	0.2	1	0	CTD_human
3552	IL1A	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
3552	IL1A	C0917796	Optic Atrophy, Hereditary, Leber	0.2	1	0	CTD_human
3552	IL1A	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3553	IL1B	C0002395	Alzheimer's Disease	0.369224975322202	1	0	CTD_human
3553	IL1B	C0003123	Anorexia	0.202681755307501	1	0	CTD_human
3553	IL1B	C0003165	Anthracosis	0.202407028523288	1	0	CTD_human
3553	IL1B	C0003873	Rheumatoid Arthritis	0.322684221486932	3	0	CTD_human
3553	IL1B	C0004096	Asthma	0.236143908360939	1	0	CTD_human
3553	IL1B	C0006287	Bronchopulmonary Dysplasia	0.20328236603324	1	0	CTD_human
3553	IL1B	C0007786	Brain Ischemia	0.21203514261644	4	0	CTD_human
3553	IL1B	C0009319	Colitis	0.281923087489492	2	0	CTD_human
3553	IL1B	C0009324	Ulcerative Colitis	0.224643863935608	4	0	CTD_human
3553	IL1B	C0011615	Dermatitis, Atopic	0.211327631955743	1	0	CTD_human
3553	IL1B	C0011633	Dermatomyositis	0.205689394556528	1	0	CTD_human
3553	IL1B	C0014324	Entamoebiasis	0.2	1	0	CTD_human
3553	IL1B	C0017154	Gastritis, Atrophic	0.232074163755055	1	0	CTD_human
3553	IL1B	C0017658	Glomerulonephritis	0.201098907136852	2	0	CTD_human
3553	IL1B	C0018099	Gout	0.202681755307501	1	0	CTD_human
3553	IL1B	C0018801	Heart failure	0.201373633921065	1	0	CTD_human
3553	IL1B	C0019061	Hemolytic-Uremic Syndrome	0.2	1	0	CTD_human
3553	IL1B	C0020452	Hyperemia	0.200274726784213	1	0	CTD_human
3553	IL1B	C0020615	Hypoglycemia	0.205465824929628	1	0	CTD_human
3553	IL1B	C0022541	Kearns-Sayre syndrome	0.2	1	0	CTD_human
3553	IL1B	C0023283	Leishmaniasis, Cutaneous	0.200274726784213	1	0	CTD_human
3553	IL1B	C0023290	Leishmaniasis, Visceral	0.200274726784213	1	0	CTD_human
3553	IL1B	C0024312	Lymphopenia	0.2	1	0	CTD_human
3553	IL1B	C0026769	Multiple Sclerosis	0.233121913734595	1	0	CTD_human
3553	IL1B	C0027051	Myocardial Infarction	0.301021258583525	3	0	CTD_human
3553	IL1B	C0027947	Neutropenia	0.202407028523288	1	0	CTD_human
3553	IL1B	C0029408	Degenerative polyarthritis	0.346921399218167	1	0	CTD_human
3553	IL1B	C0029458	Osteoporosis, Postmenopausal	0.205363510615002	1	0	CTD_human
3553	IL1B	C0030920	Peptic Ulcer	0.225718645938159	1	0	CTD_human
3553	IL1B	C0032231	Pleurisy	0.200274726784213	1	0	CTD_human
3553	IL1B	C0032285	Pneumonia	0.208487819555972	1	0	CTD_human
3553	IL1B	C0033860	Psoriasis	0.208451017775976	1	0	CTD_human
3553	IL1B	C0034069	Pulmonary Fibrosis	0.285912964183428	2	0	CTD_human
3553	IL1B	C0037116	Silicosis	0.210503451603104	1	0	CTD_human
3553	IL1B	C0038358	Gastric ulcer	0.226319256663897	1	0	CTD_human
3553	IL1B	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
3553	IL1B	C0042109	Urticaria	0.200824180352639	1	0	CTD_human
3553	IL1B	C0085655	Polymyositis	0.200824180352639	1	0	CTD_human
3553	IL1B	C0151744	Myocardial Ischemia	0.201373633921065	1	0	CTD_human
3553	IL1B	C0162671	MELAS Syndrome	0.2	1	0	CTD_human
3553	IL1B	C0162672	MERRF Syndrome	0.2	1	0	CTD_human
3553	IL1B	C0162674	Chronic progressive external ophthalmoplegia	0.2	1	0	CTD_human
3553	IL1B	C0343755	HIV Wasting Syndrome	0.2	1	0	CTD_human
3553	IL1B	C0740392	Infarction, Middle Cerebral Artery	0.28	1	0	CTD_human
3553	IL1B	C0917796	Optic Atrophy, Hereditary, Leber	0.2	1	0	CTD_human
3553	IL1B	C4277682	Chemical and Drug Induced Liver Injury	0.28	1	0	CTD_human
3554	IL1R1	C0014175	Endometriosis	0.21656988725847	2	0	CTD_human
3554	IL1R1	C0032285	Pneumonia	0.2	1	0	CTD_human
3557	IL1RN	C0003123	Anorexia	0.28	1	0	CTD_human
3557	IL1RN	C0003165	Anthracosis	0.202407028523288	1	0	CTD_human
3557	IL1RN	C0003873	Rheumatoid Arthritis	0.259348625840852	2	0	CTD_human
3557	IL1RN	C0004096	Asthma	0.234913976154827	1	0	CTD_human
3557	IL1RN	C0007786	Brain Ischemia	0.214716897923941	1	0	CTD_human
3557	IL1RN	C0018099	Gout	0.2	1	0	CTD_human
3557	IL1RN	C0027051	Myocardial Infarction	0.206462417751855	2	0	CTD_human
3557	IL1RN	C0027121	Myositis	0.200549453568426	1	0	CTD_human
3557	IL1RN	C0029443	Osteomyelitis	0.200549453568426	0	0	HPO
3557	IL1RN	C0031111	Periostitis	0.2	0	0	HPO
3557	IL1RN	C0034069	Pulmonary Fibrosis	0.205363510615002	1	0	CTD_human
3557	IL1RN	C0038220	Status Epilepticus	0.2	1	0	CTD_human
3557	IL1RN	C0038362	Stomatitis	0.2	0	0	HPO
3557	IL1RN	C0085129	Bronchial Hyperreactivity	0.202681755307501	1	0	CTD_human
3557	IL1RN	C0149704	Gingivostomatitis	0.2	0	0	HPO
3557	IL1RN	C0162557	Liver Failure, Acute	0.200824180352639	1	0	CTD_human
3557	IL1RN	C0524988	Schnitzler Syndrome	0.200549453568426	1	0	CTD_human
3557	IL1RN	C0870082	Hyperkeratosis	0.2	0	0	HPO
3557	IL1RN	C2242472	Infection of bone	0.2	0	0	HPO
3557	IL1RN	C2748507	INTERLEUKIN 1 RECEPTOR ANTAGONIST DEFICIENCY	0.401098907136852	0	0	CTD_human;ORPHANET
3557	IL1RN	C3495559	Juvenile arthritis	0.212859322969079	1	0	CTD_human
3558	IL2	C0002871	Anemia	0.2	1	0	CTD_human
3558	IL2	C0003123	Anorexia	0.2	1	0	CTD_human
3558	IL2	C0014324	Entamoebiasis	0.2	1	0	CTD_human
3558	IL2	C0017658	Glomerulonephritis	0.200549453568426	2	0	CTD_human
3558	IL2	C0023530	Leukopenia	0.2	1	0	CTD_human
3558	IL2	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
3558	IL2	C0241910	Hepatitis, Autoimmune	0.200274726784213	1	0	CTD_human
3559	IL2RA	C0002170	Alopecia	0.200549453568426	0	0	HPO
3559	IL2RA	C0002171	Alopecia Areata	0.200549453568426	1	1	CTD_human
3559	IL2RA	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
3559	IL2RA	C0003873	Rheumatoid Arthritis	0.215397376561627	3	2	CTD_human
3559	IL2RA	C0010346	Crohn Disease	0.203780662444353	1	3	CTD_human
3559	IL2RA	C0011854	Diabetes Mellitus, Insulin-Dependent	0.250182006378818	3	3	CTD_human
3559	IL2RA	C0013595	Eczema	0.200824180352639	0	0	HPO
3559	IL2RA	C0017658	Glomerulonephritis	0.200274726784213	1	0	CTD_human
3559	IL2RA	C0022073	Iridocyclitis	0.2	0	0	HPO
3559	IL2RA	C0024636	Malocclusion	0.2	0	0	HPO
3559	IL2RA	C0026769	Multiple Sclerosis	0.26608577037692	4	4	CTD_human
3559	IL2RA	C0157917	Pauciarticular juvenile rheumatoid arthritis	0.2	0	0	ORPHANET
3559	IL2RA	C0162323	Polyarthritis	0.2	0	0	HPO
3559	IL2RA	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
3559	IL2RA	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
3559	IL2RA	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
3559	IL2RA	C0401151	Chronic diarrhea	0.2	0	0	HPO
3559	IL2RA	C1853392	Interleukin 2 Receptor, Alpha, Deficiency of	0.600274726784213	2	5	CTD_human;ORPHANET;UNIPROT
3559	IL2RA	C1866040	DIABETES MELLITUS, INSULIN-DEPENDENT, 10	0.2	0	0	CTD_human
3559	IL2RA	C2931322	T-Lymphocytopenia	0.2	0	0	HPO
3559	IL2RA	C3714757	Juvenile rheumatoid arthritis	0.200549453568426	0	0	HPO
3559	IL2RA	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
356	FASLG	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
356	FASLG	C0003873	Rheumatoid Arthritis	0.203831819601666	1	0	CTD_human
356	FASLG	C0004153	Atherosclerosis	0.202732912464814	1	0	CTD_human
356	FASLG	C0011875	Diabetic Angiopathies	0.2	1	0	CTD_human
356	FASLG	C0014457	Eosinophilia	0.2	0	0	HPO
356	FASLG	C0019158	Hepatitis	0.200274726784213	1	0	CTD_human
356	FASLG	C0020474	Hyperlipidemia, Familial Combined	0.2	1	0	CTD_human
356	FASLG	C0024141	Lupus Erythematosus, Systemic	0.217841206864911	0	0	CTD_human
356	FASLG	C0042109	Urticaria	0.2	0	0	HPO
356	FASLG	C0042384	Vasculitis	0.2	0	0	HPO
356	FASLG	C0162316	Iron deficiency anemia	0.2	0	0	HPO
356	FASLG	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
356	FASLG	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
356	FASLG	C0340971	Autoimmune neutropenia	0.2	0	0	HPO
356	FASLG	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
356	FASLG	C0520736	Coombs positive hemolytic anemia	0.2	0	0	HPO
356	FASLG	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
356	FASLG	C1328840	Autoimmune Lymphoproliferative Syndrome	0.480824180352639	1	2	ORPHANET;UNIPROT
3560	IL2RB	C0003873	Rheumatoid Arthritis	0.205912964183428	2	2	CTD_human
3560	IL2RB	C0022073	Iridocyclitis	0.2	0	0	HPO
3560	IL2RB	C0024636	Malocclusion	0.2	0	0	HPO
3560	IL2RB	C0032285	Pneumonia	0.2	1	0	CTD_human
3560	IL2RB	C0157917	Pauciarticular juvenile rheumatoid arthritis	0.2	0	0	ORPHANET
3560	IL2RB	C0162323	Polyarthritis	0.2	0	0	HPO
3560	IL2RB	C3714757	Juvenile rheumatoid arthritis	0.2	0	0	HPO
3560	IL2RB	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
3561	IL2RG	C0001768	Agammaglobulinemia	0.2	0	0	HPO
3561	IL2RG	C0002170	Alopecia	0.2	0	0	HPO
3561	IL2RG	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
3561	IL2RG	C0014457	Eosinophilia	0.2	0	0	HPO
3561	IL2RG	C0029882	Otitis Media	0.2	0	0	HPO
3561	IL2RG	C0032285	Pneumonia	0.2	0	0	HPO
3561	IL2RG	C0037199	Sinusitis	0.2	0	0	HPO
3561	IL2RG	C0085110	Severe Combined Immunodeficiency	0.219360221232553	0	0	HPO
3561	IL2RG	C0162539	IgG Deficiency	0.2	0	0	HPO
3561	IL2RG	C0259817	Xerosis	0.2	0	0	HPO
3561	IL2RG	C0401151	Chronic diarrhea	0.2	0	0	HPO
3561	IL2RG	C0494261	Combined immunodeficiency	0.200549453568426	0	0	HPO
3561	IL2RG	C0741796	Recurrent bronchitis	0.2	0	0	HPO
3561	IL2RG	C1279481	X-Linked Combined Immunodeficiency Diseases	0.619975187335609	12	21	CTD_human;ORPHANET;UNIPROT
3561	IL2RG	C1845604	Recurrent bacterial meningitis	0.2	0	0	HPO
3561	IL2RG	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3561	IL2RG	C2700553	Omenn Syndrome	0.200549453568426	0	0	ORPHANET
3561	IL2RG	C4024599	Chronic oral candidiasis	0.2	0	0	HPO
3562	IL3	C0002871	Anemia	0.200549453568426	2	0	CTD_human
3562	IL3	C0023530	Leukopenia	0.2	1	0	CTD_human
3562	IL3	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
3565	IL4	C0004096	Asthma	0.440351394001266	1	0	CTD_human
3565	IL4	C0009319	Colitis	0.201098907136852	1	0	CTD_human
3565	IL4	C0011615	Dermatitis, Atopic	0.306503117622094	3	0	CTD_human
3565	IL4	C0023283	Leishmaniasis, Cutaneous	0.203780662444353	1	0	CTD_human
3565	IL4	C0024141	Lupus Erythematosus, Systemic	0.219764294354402	1	0	CTD_human
3565	IL4	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
3565	IL4	C0032285	Pneumonia	0.204106546385879	1	0	CTD_human
3565	IL4	C0033860	Psoriasis	0.216258358694262	1	0	CTD_human
3565	IL4	C0034069	Pulmonary Fibrosis	0.285638237399215	2	0	CTD_human
3565	IL4	C0035455	Rhinitis	0.201648360705279	1	0	CTD_human
3565	IL4	C0041307	Tuberculosis, Bovine	0.2	1	0	CTD_human
3565	IL4	C0162820	Dermatitis, Allergic Contact	0.202681755307501	2	0	CTD_human
3565	IL4	C0241910	Hepatitis, Autoimmune	0.200824180352639	1	0	CTD_human
3565	IL4	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
3565	IL4	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
3566	IL4R	C1840253	IgE RESPONSIVENESS, ATOPIC	0.2	0	0	CTD_human
3567	IL5	C0004096	Asthma	0.326724320987281	2	0	CTD_human
3567	IL5	C0011615	Dermatitis, Atopic	0.206304360659584	2	0	CTD_human
3567	IL5	C0014324	Entamoebiasis	0.2	1	0	CTD_human
3567	IL5	C0014457	Eosinophilia	0.30928718724422	2	0	CTD_human
3567	IL5	C0034069	Pulmonary Fibrosis	0.202732912464814	1	0	CTD_human
3567	IL5	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
3567	IL5	C0241910	Hepatitis, Autoimmune	0.200549453568426	1	0	CTD_human
3568	IL5RA	C0032285	Pneumonia	0.2	1	0	CTD_human
3569	IL6	C0003873	Rheumatoid Arthritis	0.296828138185776	2	0	CTD_human
3569	IL6	C0004153	Atherosclerosis	0.253054034938252	1	0	CTD_human
3569	IL6	C0007786	Brain Ischemia	0.212309869400653	2	0	CTD_human
3569	IL6	C0008370	Cholestasis	0.200274726784213	1	0	CTD_human
3569	IL6	C0009319	Colitis	0.210150535638567	2	0	CTD_human
3569	IL6	C0010346	Crohn Disease	0.220653987241671	2	0	CTD_human
3569	IL6	C0011615	Dermatitis, Atopic	0.208110778457133	1	0	CTD_human
3569	IL6	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.305502275014114	0	0	CTD_human
3569	IL6	C0014324	Entamoebiasis	0.2	1	0	CTD_human
3569	IL6	C0017531	Angiolymphoid hyperplasia	0.205754907091158	1	0	CTD_human
3569	IL6	C0017658	Glomerulonephritis	0.205689394556528	1	0	CTD_human
3569	IL6	C0018801	Heart failure	0.205429023149632	2	0	CTD_human
3569	IL6	C0019061	Hemolytic-Uremic Syndrome	0.200274726784213	1	0	CTD_human
3569	IL6	C0019202	Hepatolenticular Degeneration	0.200549453568426	1	0	CTD_human
3569	IL6	C0020437	Hypercalcemia	0.200824180352639	1	0	CTD_human
3569	IL6	C0020500	Hyperoxaluria	0.2	1	0	CTD_human
3569	IL6	C0020503	Hyperparathyroidism, Secondary	0.2	1	0	CTD_human
3569	IL6	C0022661	Kidney Failure, Chronic	0.233382285141491	1	0	CTD_human
3569	IL6	C0023281	Leishmaniasis	0.2	1	0	CTD_human
3569	IL6	C0023290	Leishmaniasis, Visceral	0.200274726784213	3	0	CTD_human
3569	IL6	C0023890	Liver Cirrhosis	0.205154296365419	1	0	CTD_human
3569	IL6	C0023891	Liver Cirrhosis, Alcoholic	0.202956482091714	1	0	CTD_human
3569	IL6	C0024141	Lupus Erythematosus, Systemic	0.230361969246771	1	0	CTD_human
3569	IL6	C0025290	Aseptic Meningitis	0.2	1	0	CTD_human
3569	IL6	C0027051	Myocardial Infarction	0.272468320216827	2	0	CTD_human
3569	IL6	C0028754	Obesity	0.376374136063699	2	0	CTD_human
3569	IL6	C0029456	Osteoporosis	0.218419371187971	1	0	CTD_human
3569	IL6	C0029458	Osteoporosis, Postmenopausal	0.220355135323156	1	0	CTD_human
3569	IL6	C0030567	Parkinson Disease	0.211276474798431	1	0	CTD_human
3569	IL6	C0032231	Pleurisy	0.2	1	0	CTD_human
3569	IL6	C0032285	Pneumonia	0.207128541012223	1	0	CTD_human
3569	IL6	C0032963	Pregnancy Complications, Cardiovascular	0.2	1	0	CTD_human
3569	IL6	C0033860	Psoriasis	0.213367389137178	1	0	CTD_human
3569	IL6	C0034069	Pulmonary Fibrosis	0.20783605167292	2	0	CTD_human
3569	IL6	C0085655	Polymyositis	0.2	1	0	CTD_human
3569	IL6	C0151744	Myocardial Ischemia	0.206187690967642	1	0	CTD_human
3569	IL6	C0239981	Hypoalbuminemia	0.2	1	0	CTD_human
3569	IL6	C0241910	Hepatitis, Autoimmune	0.2	1	0	CTD_human
3569	IL6	C0343755	HIV Wasting Syndrome	0.2	1	0	CTD_human
3569	IL6	C0524620	Metabolic Syndrome X	0.225416887130935	1	0	CTD_human
3569	IL6	C0740392	Infarction, Middle Cerebral Artery	0.2	3	0	CTD_human
3569	IL6	C0948089	Acute Coronary Syndrome	0.220848846113937	1	0	CTD_human
3569	IL6	C1384600	Systemic onset juvenile chronic arthritis	0.204604842796993	0	0	ORPHANET
3569	IL6	C1858558	Rheumatoid Arthritis, Systemic Juvenile	0.400274726784213	0	0	CTD_human;ORPHANET
3569	IL6	C3714757	Juvenile rheumatoid arthritis	0.201923087489492	0	0	HPO
3569	IL6	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
3570	IL6R	C0003873	Rheumatoid Arthritis	0.206253203502271	2	1	CTD_human
3570	IL6R	C0029456	Osteoporosis	0.2	1	0	CTD_human
3572	IL6ST	C0003873	Rheumatoid Arthritis	0.284055389228567	1	0	CTD_human
3572	IL6ST	C0032285	Pneumonia	0.203007639249027	1	0	CTD_human
3572	IL6ST	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3572	IL6ST	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
3574	IL7	C0024312	Lymphopenia	0.204381273170092	1	0	CTD_human
3574	IL7	C0026769	Multiple Sclerosis	0.209484412378199	1	0	CTD_human
3575	IL7R	C0002170	Alopecia	0.2	0	0	HPO
3575	IL7R	C0009324	Ulcerative Colitis	0.200549453568426	1	1	CTD_human
3575	IL7R	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
3575	IL7R	C0013595	Eczema	0.2	0	0	HPO
3575	IL7R	C0014175	Endometriosis	0.2	1	0	CTD_human
3575	IL7R	C0014457	Eosinophilia	0.2	0	0	HPO
3575	IL7R	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
3575	IL7R	C0026769	Multiple Sclerosis	0.270280275700107	4	1	CTD_human
3575	IL7R	C0029882	Otitis Media	0.2	0	0	HPO
3575	IL7R	C0032285	Pneumonia	0.2	0	0	HPO
3575	IL7R	C0085110	Severe Combined Immunodeficiency	0.205154296365419	0	0	HPO
3575	IL7R	C0259817	Xerosis	0.2	0	0	HPO
3575	IL7R	C0401151	Chronic diarrhea	0.2	0	0	HPO
3575	IL7R	C1833275	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, NK Cell-Negative	0.2	0	0	CTD_human
3575	IL7R	C1837028	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive	0.4	0	0	CTD_human;ORPHANET
3575	IL7R	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3575	IL7R	C2700553	Omenn Syndrome	0.200824180352639	0	0	ORPHANET
3575	IL7R	C4025203	Severe T lymphocytopenia	0.2	0	0	HPO
3576	CXCL8	C0002965	Angina, Unstable	0.2	1	0	CTD_human
3576	CXCL8	C0003872	Arthritis, Psoriatic	0.200274726784213	1	0	CTD_human
3576	CXCL8	C0003873	Rheumatoid Arthritis	0.223532280153062	2	0	CTD_human
3576	CXCL8	C0004763	Barrett Esophagus	0.202956482091714	1	0	CTD_human
3576	CXCL8	C0004943	Behcet Syndrome	0.207663639203332	1	0	CTD_human
3576	CXCL8	C0008370	Cholestasis	0.2	1	0	CTD_human
3576	CXCL8	C0009324	Ulcerative Colitis	0.210634476672364	2	0	CTD_human
3576	CXCL8	C0013080	Down Syndrome	0.200274726784213	1	0	CTD_human
3576	CXCL8	C0014869	Peptic Esophagitis	0.203831819601666	1	0	CTD_human
3576	CXCL8	C0015695	Fatty Liver	0.200274726784213	1	0	CTD_human
3576	CXCL8	C0017168	Gastroesophageal reflux disease	0.204655999954305	2	0	CTD_human
3576	CXCL8	C0017658	Glomerulonephritis	0.201098907136852	2	0	CTD_human
3576	CXCL8	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
3576	CXCL8	C0022568	Keratitis	0.200824180352639	1	0	CTD_human
3576	CXCL8	C0023283	Leishmaniasis, Cutaneous	0.2	1	0	CTD_human
3576	CXCL8	C0023290	Leishmaniasis, Visceral	0.200549453568426	1	0	CTD_human
3576	CXCL8	C0024117	Chronic Obstructive Airway Disease	0.21895446937908	2	0	CTD_human
3576	CXCL8	C0030805	Bullous pemphigoid	0.2	1	0	CTD_human
3576	CXCL8	C0032768	Postherpetic neuralgia	0.2	1	0	CTD_human
3576	CXCL8	C0034069	Pulmonary Fibrosis	0.200274726784213	2	0	CTD_human
3576	CXCL8	C0155862	Streptococcal pneumonia	0.2	1	0	CTD_human
3577	CXCR1	C0009324	Ulcerative Colitis	0.2	1	0	CTD_human
3578	IL9	C0241910	Hepatitis, Autoimmune	0.2	1	0	CTD_human
3579	CXCR2	C0009324	Ulcerative Colitis	0.200274726784213	1	0	CTD_human
3579	CXCR2	C0024894	Mastitis	0.2	1	0	CTD_human
3579	CXCR2	C0032285	Pneumonia	0.201098907136852	1	0	CTD_human
3579	CXCR2	C0243026	Sepsis	0.2	1	0	CTD_human
3579	CXCR2	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
3579	CXCR2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
358	AQP1	C0013608	Edema, Cardiac	0.2	1	0	CTD_human
358	AQP1	C0020550	Hyperthyroidism	0.2	1	0	CTD_human
3586	IL10	C0003615	Appendicitis	0.2	1	0	CTD_human
3586	IL10	C0003864	Arthritis	0.224043253209869	0	0	HPO
3586	IL10	C0003873	Rheumatoid Arthritis	0.285706363016369	1	0	CTD_human
3586	IL10	C0004943	Behcet Syndrome	0.413539801606765	2	2	CTD_human;ORPHANET
3586	IL10	C0009319	Colitis	0.304436328417649	4	0	CTD_human
3586	IL10	C0009324	Ulcerative Colitis	0.25092631881951	2	1	CTD_human
3586	IL10	C0010346	Crohn Disease	0.247327838601729	1	0	CTD_human
3586	IL10	C0011615	Dermatitis, Atopic	0.218353858653341	1	0	CTD_human
3586	IL10	C0011854	Diabetes Mellitus, Insulin-Dependent	0.234821431597186	1	0	CTD_human
3586	IL10	C0014324	Entamoebiasis	0.2	1	0	CTD_human
3586	IL10	C0014356	Enterocolitis	0.202472541057918	1	0	CTD_human
3586	IL10	C0017658	Glomerulonephritis	0.206238848124954	1	0	CTD_human
3586	IL10	C0019202	Hepatolenticular Degeneration	0.200274726784213	1	0	CTD_human
3586	IL10	C0022104	Irritable Bowel Syndrome	0.213749015856349	1	0	CTD_human
3586	IL10	C0023281	Leishmaniasis	0.206290005282267	2	0	CTD_human
3586	IL10	C0023283	Leishmaniasis, Cutaneous	0.204604842796993	1	0	CTD_human
3586	IL10	C0023290	Leishmaniasis, Visceral	0.205754907091158	3	0	CTD_human
3586	IL10	C0024141	Lupus Erythematosus, Systemic	0.319898473133181	2	1	CTD_human
3586	IL10	C0025289	Meningitis	0.201373633921065	0	0	HPO
3586	IL10	C0027051	Myocardial Infarction	0.228344658468014	2	0	CTD_human
3586	IL10	C0032231	Pleurisy	0.2	1	0	CTD_human
3586	IL10	C0033581	prostatitis	0.284814057046576	1	0	CTD_human
3586	IL10	C0038363	Aphthous Stomatitis	0.204814057046576	0	0	HPO
3586	IL10	C0042384	Vasculitis	0.203780662444353	0	0	HPO
3586	IL10	C0149745	Oral Ulcer	0.202681755307501	0	0	HPO
3586	IL10	C0162820	Dermatitis, Allergic Contact	0.200274726784213	1	0	CTD_human
3586	IL10	C0241910	Hepatitis, Autoimmune	0.205363510615002	1	0	CTD_human
3586	IL10	C0243026	Sepsis	0.34191371145641	1	0	CTD_human
3586	IL10	C0702166	Acne	0.200274726784213	0	0	HPO
3586	IL10	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
3586	IL10	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
3586	IL10	C2937365	Recurrent aphthous ulcer	0.201098907136852	0	0	HPO
3587	IL10RA	C0014356	Enterocolitis	0.201098907136852	0	0	HPO
3587	IL10RA	C0023290	Leishmaniasis, Visceral	0.2	1	0	CTD_human
3587	IL10RA	C0031019	Perianal abscess	0.2	0	0	HPO
3587	IL10RA	C0034212	Pyoderma	0.2	0	0	HPO
3587	IL10RA	C2751053	INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE	0.4	2	6	CTD_human;UNIPROT
3588	IL10RB	C0007786	Brain Ischemia	0.2	1	0	CTD_human
3588	IL10RB	C0014356	Enterocolitis	0.200274726784213	0	0	HPO
3588	IL10RB	C0019163	Hepatitis B	0.200824180352639	0	0	CTD_human
3588	IL10RB	C0031019	Perianal abscess	0.2	0	0	HPO
3588	IL10RB	C2675508	INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE	0.2	0	0	CTD_human
3589	IL11	C0010692	Cystitis	0.2	1	0	CTD_human
3589	IL11	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
3589	IL11	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
359	AQP2	C0003123	Anorexia	0.2	0	0	HPO
359	AQP2	C0014544	Epilepsy	0.2	0	0	HPO
359	AQP2	C0162283	Nephrogenic Diabetes Insipidus	0.639706185315044	4	5	CTD_human;HPO;ORPHANET
359	AQP2	C1112601	Hypertonic dehydration	0.2	0	0	HPO
359	AQP2	C1563706	Nephrogenic Diabetes Insipidus, Type II	0.28	14	19	UNIPROT
359	AQP2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3590	IL11RA	C0030353	Papilledema	0.2	0	0	HPO
3590	IL11RA	C1856266	Coronal craniosynostosis	0.2	0	0	HPO
3590	IL11RA	C3280073	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES	0.4	1	4	ORPHANET;UNIPROT
3592	IL12A	C0003864	Arthritis	0.209628114093152	0	0	HPO
3592	IL12A	C0004943	Behcet Syndrome	0.200274726784213	0	0	ORPHANET
3592	IL12A	C0008312	Primary biliary cirrhosis	0.400824180352639	0	0	HPO;ORPHANET
3592	IL12A	C0020541	Hypertension, Portal	0.2	0	0	HPO
3592	IL12A	C0023890	Liver Cirrhosis	0.2	0	0	HPO
3592	IL12A	C0023892	Biliary cirrhosis	0.4	1	0	CTD_human;HPO
3592	IL12A	C0025289	Meningitis	0.2	0	0	HPO
3592	IL12A	C0026769	Multiple Sclerosis	0.210177567661578	1	1	CTD_human
3592	IL12A	C0038363	Aphthous Stomatitis	0.202407028523288	0	0	HPO
3592	IL12A	C0040261	Onychomycosis	0.2	0	0	HPO
3592	IL12A	C0042384	Vasculitis	0.2	0	0	HPO
3592	IL12A	C0085605	Liver Failure	0.2	0	0	HPO
3592	IL12A	C0149745	Oral Ulcer	0.2	0	0	HPO
3592	IL12A	C0239946	Fibrosis, Liver	0.2	0	0	HPO
3592	IL12A	C0268307	Conjugated hyperbilirubinemia	0.2	0	0	HPO
3592	IL12A	C0343065	Symptomatic dermographism	0.2	0	0	HPO
3592	IL12A	C0702166	Acne	0.2	0	0	HPO
3592	IL12A	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
3592	IL12A	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
3592	IL12A	C0859942	Hanot's cirrhosis	0.2	0	0	ORPHANET
3592	IL12A	C1527336	Sjogren's Syndrome	0.203007639249027	1	0	CTD_human
3592	IL12A	C2937365	Recurrent aphthous ulcer	0.2	0	0	HPO
3593	IL12B	C0002871	Anemia	0.205689394556528	0	0	HPO
3593	IL12B	C0002940	Aneurysm	0.2	0	0	HPO
3593	IL12B	C0003123	Anorexia	0.2	0	0	HPO
3593	IL12B	C0003864	Arthritis	0.204814057046576	0	0	HPO
3593	IL12B	C0003872	Arthritis, Psoriatic	0.213250719445235	1	0	CTD_human
3593	IL12B	C0004096	Asthma	0.234690406527927	0	0	CTD_human
3593	IL12B	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
3593	IL12B	C0009324	Ulcerative Colitis	0.212151812308383	3	0	CTD_human
3593	IL12B	C0010346	Crohn Disease	0.219112526471351	1	0	CTD_human
3593	IL12B	C0014544	Epilepsy	0.2	0	0	HPO
3593	IL12B	C0017086	Gangrene	0.2	0	0	HPO
3593	IL12B	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
3593	IL12B	C0024141	Lupus Erythematosus, Systemic	0.205912964183428	2	0	CTD_human
3593	IL12B	C0027051	Myocardial Infarction	0.202681755307501	0	0	HPO
3593	IL12B	C0033860	Psoriasis	0.260311922288112	3	2	CTD_human
3593	IL12B	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
3593	IL12B	C0038013	Ankylosing spondylitis	0.201373633921065	1	0	CTD_human
3593	IL12B	C0039263	Takayasu Arteritis	0.201648360705279	0	0	ORPHANET
3593	IL12B	C0042384	Vasculitis	0.2	0	0	HPO
3593	IL12B	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
3593	IL12B	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
3593	IL12B	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
3593	IL12B	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
3593	IL12B	C4013948	IMMUNODEFICIENCY 29	0.2	0	0	ORPHANET
3593	IL12B	C4020848	Aneurysmal disease	0.2	0	0	HPO
3594	IL12RB1	C0007786	Brain Ischemia	0.2	1	0	CTD_human
3594	IL12RB1	C0008312	Primary biliary cirrhosis	0.400274726784213	0	0	HPO;ORPHANET
3594	IL12RB1	C0020541	Hypertension, Portal	0.2	0	0	HPO
3594	IL12RB1	C0023890	Liver Cirrhosis	0.2	0	0	HPO
3594	IL12RB1	C0023892	Biliary cirrhosis	0.202407028523288	0	0	HPO
3594	IL12RB1	C0040261	Onychomycosis	0.2	0	0	HPO
3594	IL12RB1	C0085605	Liver Failure	0.2	0	0	HPO
3594	IL12RB1	C0239946	Fibrosis, Liver	0.2	0	0	HPO
3594	IL12RB1	C0268307	Conjugated hyperbilirubinemia	0.2	0	0	HPO
3594	IL12RB1	C0343065	Symptomatic dermographism	0.2	0	0	HPO
3594	IL12RB1	C0859942	Hanot's cirrhosis	0.2	0	0	ORPHANET
3594	IL12RB1	C4013949	IMMUNODEFICIENCY 30	0.400549453568426	1	5	ORPHANET;UNIPROT
3596	IL13	C0004096	Asthma	0.376242481353674	1	1	CTD_human
3596	IL13	C0011615	Dermatitis, Atopic	0.303675981868016	2	1	CTD_human
3596	IL13	C0032285	Pneumonia	0.204106546385879	1	0	CTD_human
3596	IL13	C0033860	Psoriasis	0.209810296319724	2	1	CTD_human
3596	IL13	C0034069	Pulmonary Fibrosis	0.200824180352639	1	0	CTD_human
3596	IL13	C0037199	Sinusitis	0.2	1	0	CTD_human
3596	IL13	C0085129	Bronchial Hyperreactivity	0.209195330216668	2	0	CTD_human
3596	IL13	C0241910	Hepatitis, Autoimmune	0.200274726784213	1	0	CTD_human
3596	IL13	C2607914	Allergic rhinitis (disorder)	0.215253674846674	0	0	CTD_human
359825	PSORS9	C0033860	Psoriasis	0.201373633921065	0	0	CTD_human
36	ACADSB	C0014544	Epilepsy	0.2	0	0	HPO
36	ACADSB	C0015310	Exotropia	0.2	0	0	HPO
36	ACADSB	C0020615	Hypoglycemia	0.2	0	0	HPO
36	ACADSB	C1389113	Generalized amyotrophy	0.2	0	0	HPO
36	ACADSB	C1864912	2-Methylbutyryl-CoA Dehydrogenase Deficiency	0.6	1	6	CTD_human;ORPHANET;UNIPROT
3600	IL15	C0007570	Celiac Disease	0.205219808900049	1	0	CTD_human
3600	IL15	C0014175	Endometriosis	0.20328236603324	1	0	CTD_human
3605	IL17A	C0007786	Brain Ischemia	0.200274726784213	1	0	CTD_human
3605	IL17A	C0009319	Colitis	0.20357144819477	1	0	CTD_human
3605	IL17A	C0018133	Graft-vs-Host Disease	0.200549453568426	1	0	CTD_human
3605	IL17A	C0032285	Pneumonia	0.203296721410557	1	0	CTD_human
3605	IL17A	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
3606	IL18	C0003873	Rheumatoid Arthritis	0.236963503093246	1	0	CTD_human
3606	IL18	C0007786	Brain Ischemia	0.204814057046576	1	0	CTD_human
3606	IL18	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3606	IL18	C0017658	Glomerulonephritis	0.200549453568426	1	0	CTD_human
3606	IL18	C0023281	Leishmaniasis	0.2	1	0	CTD_human
3606	IL18	C0032285	Pneumonia	0.200274726784213	1	0	CTD_human
3606	IL18	C0036202	Sarcoidosis	0.22090000327125	1	0	CTD_human
3606	IL18	C0042109	Urticaria	0.200274726784213	1	0	CTD_human
3606	IL18	C0241910	Hepatitis, Autoimmune	0.2	1	0	CTD_human
3606	IL18	C0524620	Metabolic Syndrome X	0.285912964183428	1	0	CTD_human
3606	IL18	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
361	AQP4	C0027873	Neuromyelitis Optica	0.233170164003199	2	0	CTD_human
361	AQP4	C0038220	Status Epilepticus	0.2	1	0	CTD_human
3611	ILK	C0007787	Transient Ischemic Attack	0.2	1	0	CTD_human
3611	ILK	C0014544	Epilepsy	0.2	1	0	CTD_human
3613	IMPA2	C0009952	Febrile Convulsions	0.203231208875927	1	0	CTD_human
3613	IMPA2	C0014175	Endometriosis	0.2	1	0	CTD_human
3614	IMPDH1	C0014544	Epilepsy	0.2	0	0	HPO
3614	IMPDH1	C0017601	Glaucoma	0.2	0	0	HPO
3614	IMPDH1	C0018777	Conductive hearing loss	0.2	0	0	HPO
3614	IMPDH1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
3614	IMPDH1	C0020459	Hyperinsulinism	0.2	0	0	HPO
3614	IMPDH1	C0020619	Hypogonadism	0.2	0	0	HPO
3614	IMPDH1	C0022578	Keratoconus	0.2	0	0	HPO
3614	IMPDH1	C0028077	Night Blindness	0.2	0	0	HPO
3614	IMPDH1	C0028738	Nystagmus	0.2	0	0	HPO
3614	IMPDH1	C0028754	Obesity	0.2	0	0	HPO
3614	IMPDH1	C0029124	Optic Atrophy	0.2	0	0	HPO
3614	IMPDH1	C0035334	Retinitis Pigmentosa	0.623358188951851	2	1	CTD_human;HPO;ORPHANET
3614	IMPDH1	C0042798	Low Vision	0.2	0	0	HPO
3614	IMPDH1	C0271215	Blindness, Legal	0.2	0	0	HPO
3614	IMPDH1	C0339527	Leber Congenital Amaurosis	0.400824180352639	1	0	CTD_human;ORPHANET
3614	IMPDH1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
3614	IMPDH1	C1301509	Severe visual impairment	0.2	0	0	HPO
3614	IMPDH1	C1840284	LEBER CONGENITAL AMAUROSIS 11	0.2	1	2	UNIPROT
3614	IMPDH1	C1867299	Retinitis Pigmentosa 10	0.400549453568426	3	4	CTD_human;UNIPROT
3617	IMPG1	C0008525	Choroideremia	0.2	0	0	HPO
3617	IMPG1	C0042798	Low Vision	0.2	0	0	HPO
3617	IMPG1	C0339510	Vitelliform Macular Dystrophy	0.200824180352639	0	0	HPO
3617	IMPG1	C0730292	Macular dystrophy	0.200549453568426	0	0	HPO
3617	IMPG1	C1842914	Adult-Onset Vitelliform Macular Dystrophy	0.2	0	0	ORPHANET
3617	IMPG1	C4015342	MACULAR DYSTROPHY, VITELLIFORM, 4	0.2	1	4	UNIPROT
362	AQP5	C0022584	Keratoderma, Palmoplantar, Diffuse	0.2	0	0	HPO
362	AQP5	C1838359	Diffuse palmoplantar keratoderma, Bothnian type	0.4	1	5	ORPHANET;UNIPROT
3620	IDO1	C0014175	Endometriosis	0.200549453568426	1	0	CTD_human
3620	IDO1	C0028754	Obesity	0.2	1	0	CTD_human
3621	ING1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3623	INHA	C0342549	Familial Testotoxicosis	0.2	1	0	CTD_human
3624	INHBA	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
3625	INHBB	C0342549	Familial Testotoxicosis	0.2	1	0	CTD_human
3627	CXCL10	C0002171	Alopecia Areata	0.2	1	0	CTD_human
3627	CXCL10	C0007786	Brain Ischemia	0.2	1	0	CTD_human
3627	CXCL10	C0011615	Dermatitis, Atopic	0.200824180352639	1	0	CTD_human
3627	CXCL10	C0021400	Influenza	0.202197814273705	1	0	CTD_human
3627	CXCL10	C0023892	Biliary cirrhosis	0.202732912464814	1	0	CTD_human
3627	CXCL10	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3627	CXCL10	C0282488	Interstitial Cystitis	0.2	1	0	CTD_human
3627	CXCL10	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3630	INS	C0002395	Alzheimer's Disease	0.207821696295603	2	0	CTD_human
3630	INS	C0003886	Arthrogryposis	0.2	0	0	HPO
3630	INS	C0007194	Hypertrophic Cardiomyopathy	0.2	1	0	CTD_human
3630	INS	C0011854	Diabetes Mellitus, Insulin-Dependent	0.624778099565023	1	1	CTD_human;HPO
3630	INS	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.601961421098018	10	0	CTD_human;ORPHANET
3630	INS	C0011880	Diabetic Ketoacidosis	0.200274726784213	1	0	CTD_human
3630	INS	C0011881	Diabetic Nephropathy	0.205154296365419	3	0	CTD_human
3630	INS	C0014544	Epilepsy	0.2	0	0	HPO
3630	INS	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
3630	INS	C0015695	Fatty Liver	0.200274726784213	1	0	CTD_human
3630	INS	C0018790	Cardiac Arrest	0.2	1	0	CTD_human
3630	INS	C0018801	Heart failure	0.2	1	0	CTD_human
3630	INS	C0019158	Hepatitis	0.2	1	0	CTD_human
3630	INS	C0020456	Hyperglycemia	0.48357144819477	2	0	CTD_human;HPO
3630	INS	C0020459	Hyperinsulinism	0.212528853407221	4	0	CTD_human
3630	INS	C0020615	Hypoglycemia	0.203007639249027	7	0	CTD_human
3630	INS	C0028754	Obesity	0.238159540408072	3	0	CTD_human
3630	INS	C0030305	Pancreatitis	0.2	1	0	CTD_human
3630	INS	C0030567	Parkinson Disease	0.205139940988102	1	0	CTD_human
3630	INS	C0032460	Polycystic Ovary Syndrome	0.220746531799312	3	0	CTD_human
3630	INS	C0042510	Ventricular Fibrillation	0.2	1	0	CTD_human
3630	INS	C0042512	Ventricular Outflow Obstruction	0.2	1	0	CTD_human
3630	INS	C0162275	Ketonuria	0.200274726784213	0	0	HPO
3630	INS	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
3630	INS	C0342276	Maturity onset diabetes mellitus in young	0.282472541057918	0	0	HPO
3630	INS	C0342283	Hyperproinsulinemia	0.203296721410557	4	5	UNIPROT
3630	INS	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
3630	INS	C0524620	Metabolic Syndrome X	0.201648360705279	2	0	CTD_human
3630	INS	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
3630	INS	C0752347	Lewy Body Disease	0.2	1	0	CTD_human
3630	INS	C0853897	Diabetic Cardiomyopathies	0.2	1	0	CTD_human
3630	INS	C1565489	Renal Insufficiency	0.2	2	0	CTD_human
3630	INS	C1833104	DIABETES MELLITUS, PERMANENT NEONATAL	0.682472541057918	2	18	CTD_human;ORPHANET;UNIPROT
3630	INS	C1852092	DIABETES MELLITUS, INSULIN-DEPENDENT, 2	0.4	1	2	CTD_human;UNIPROT
3630	INS	C1852093	Maturity-Onset Diabetes of the Young, Type 1	0.2	0	0	CTD_human
3630	INS	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3630	INS	C3150617	Maturity-onset diabetes of the young, type 10	0.4	4	4	CTD_human;UNIPROT
3630	INS	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
3630	INS	C4048800	Telomeric 22q13 Monosomy Syndrome	0.2	1	0	CTD_human
3636	INPPL1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202197814273705	2	0	CTD_human
3636	INPPL1	C0024236	Lymphedema	0.200274726784213	0	0	HPO
3636	INPPL1	C0432194	Schneckenbecken dysplasia	0.2	0	0	ORPHANET
3636	INPPL1	C0432219	Opsismodysplasia	0.401373633921066	1	11	ORPHANET;UNIPROT
3636	INPPL1	C0524620	Metabolic Syndrome X	0.201373633921065	1	0	CTD_human
364	AQP7	C0028754	Obesity	0.202472541057918	1	0	CTD_human
3643	INSR	C0000889	Acanthosis Nigricans	0.205429023149632	0	0	HPO
3643	INSR	C0001206	Acromegaly	0.2	0	0	HPO
3643	INSR	C0002395	Alzheimer's Disease	0.282472541057918	1	0	CTD_human
3643	INSR	C0008370	Cholestasis	0.2	0	0	HPO
3643	INSR	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.563933241593786	3	2	HPO;UNIPROT
3643	INSR	C0011880	Diabetic Ketoacidosis	0.2	0	0	HPO
3643	INSR	C0015300	Exophthalmos	0.2	0	0	HPO
3643	INSR	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
3643	INSR	C0018418	Gynecomastia	0.2	0	0	HPO
3643	INSR	C0020456	Hyperglycemia	0.403846174978983	1	0	CTD_human;HPO
3643	INSR	C0020459	Hyperinsulinism	0.410425262422781	2	0	CTD_human;HPO
3643	INSR	C0020555	Hypertrichosis	0.2	0	0	HPO
3643	INSR	C0020615	Hypoglycemia	0.201098907136852	0	0	HPO
3643	INSR	C0020617	Hypoglycemic coma	0.2	0	0	HPO
3643	INSR	C0029927	Ovarian Cysts	0.2	0	0	HPO
3643	INSR	C0030567	Parkinson Disease	0.200274726784213	1	0	CTD_human
3643	INSR	C0034013	Precocious Puberty	0.2	0	0	HPO
3643	INSR	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
3643	INSR	C0234958	muscle degeneration	0.2	0	0	HPO
3643	INSR	C0239946	Fibrosis, Liver	0.2	0	0	HPO
3643	INSR	C0259817	Xerosis	0.2	0	0	HPO
3643	INSR	C0263536	Hypertrophy of nail	0.2	0	0	HPO
3643	INSR	C0263537	Onychogryposis	0.2	0	0	HPO
3643	INSR	C0265344	Donohue Syndrome	0.616418094518156	14	15	CTD_human;ORPHANET;UNIPROT
3643	INSR	C0271695	Rabson-Mendenhall Syndrome	0.405219808900049	7	8	ORPHANET;UNIPROT
3643	INSR	C0342278	Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans	0.4	18	11	CTD_human;UNIPROT
3643	INSR	C0342336	Insulin resistance - type A	0.205219808900049	0	0	ORPHANET
3643	INSR	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
3643	INSR	C0752347	Lewy Body Disease	0.2	1	0	CTD_human
3643	INSR	C0854110	Insulin resistant diabetes	0.20350593566014	0	0	HPO
3643	INSR	C0870082	Hyperkeratosis	0.2	0	0	HPO
3643	INSR	C0877056	Hypoglycaemic seizure	0.2	0	0	HPO
3643	INSR	C1280433	Lipoatrophy	0.200549453568426	0	0	HPO
3643	INSR	C1834405	Nail dysplasia	0.2	0	0	HPO
3643	INSR	C1864903	Hyperinsulinaemic hypoglycaemia	0.200824180352639	0	0	HPO
3643	INSR	C1864952	Hyperinsulinemic Hypoglycemia, Familial, 5	0.6	3	3	CTD_human;ORPHANET;UNIPROT
3651	PDX1	C0003886	Arthrogryposis	0.2	0	0	HPO
3651	PDX1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.634011606621864	2	0	CTD_human;HPO;ORPHANET
3651	PDX1	C0014544	Epilepsy	0.2	0	0	HPO
3651	PDX1	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
3651	PDX1	C0020456	Hyperglycemia	0.202197814273705	0	0	HPO
3651	PDX1	C0030293	Pancreatic Insufficiency	0.2	0	0	HPO
3651	PDX1	C0162275	Ketonuria	0.2	0	0	HPO
3651	PDX1	C0267963	Exocrine pancreatic insufficiency	0.200549453568426	0	0	HPO
3651	PDX1	C0342276	Maturity onset diabetes mellitus in young	0.286593442821114	0	0	HPO
3651	PDX1	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
3651	PDX1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
3651	PDX1	C1833104	DIABETES MELLITUS, PERMANENT NEONATAL	0.2	0	0	ORPHANET
3651	PDX1	C1833382	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE IV (disorder)	0.480549453568426	3	9	CTD_human;UNIPROT
3651	PDX1	C1850096	Pancreatic Agenesis, Congenital	0.2	0	0	CTD_human
3651	PDX1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3651	PDX1	C3891828	PANCREATIC AGENESIS 1	0.2	0	0	ORPHANET
3651	PDX1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
3653	IPW	C0020459	Hyperinsulinism	0.2	0	0	HPO
3653	IPW	C0020490	Hyperopia	0.2	0	0	HPO
3653	IPW	C0028754	Obesity	0.2	0	0	HPO
3653	IPW	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
3653	IPW	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
3653	IPW	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
3653	IPW	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
3654	IRAK1	C0003873	Rheumatoid Arthritis	0.20350593566014	1	0	CTD_human
3654	IRAK1	C0752308	Hypoxia-Ischemia, Brain	0.2	1	0	CTD_human
3654	IRAK1	C1956346	Coronary Artery Disease	0.200549453568426	1	0	CTD_human
3655	ITGA6	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
3655	ITGA6	C0003886	Arthrogryposis	0.2	0	0	HPO
3655	ITGA6	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
3655	ITGA6	C0013592	Ectropion	0.2	0	0	HPO
3655	ITGA6	C0020295	Hydronephrosis	0.2	0	0	HPO
3655	ITGA6	C0021828	Intestinal Atresia	0.2	0	0	HPO
3655	ITGA6	C0221260	Dystrophia unguium	0.2	0	0	HPO
3655	ITGA6	C0743178	Diarrhea, intractable	0.2	0	0	HPO
3655	ITGA6	C1834405	Nail dysplasia	0.2	0	0	HPO
3655	ITGA6	C1856934	Epidermolysis bullosa with pyloric atresia	0.402197814273705	0	0	CTD_human;ORPHANET
3655	ITGA6	C4021730	Junctional split	0.2	0	0	HPO
3659	IRF1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3659	IRF1	C0740302	5q-syndrome	0.200274726784213	0	0	CTD_human
366	AQP9	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
3663	IRF5	C0003864	Arthritis	0.2	0	0	HPO
3663	IRF5	C0003873	Rheumatoid Arthritis	0.241646535070562	2	2	CTD_human
3663	IRF5	C0008312	Primary biliary cirrhosis	0.401098907136852	0	0	HPO;ORPHANET
3663	IRF5	C0009324	Ulcerative Colitis	0.201923087489492	1	0	CTD_human
3663	IRF5	C0011334	Dental caries	0.2	0	0	HPO
3663	IRF5	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
3663	IRF5	C0020541	Hypertension, Portal	0.2	0	0	HPO
3663	IRF5	C0023890	Liver Cirrhosis	0.2	0	0	HPO
3663	IRF5	C0023892	Biliary cirrhosis	0.202407028523288	0	0	HPO
3663	IRF5	C0024141	Lupus Erythematosus, Systemic	0.309874376943541	2	3	CTD_human
3663	IRF5	C0034069	Pulmonary Fibrosis	0.202956482091714	0	0	HPO
3663	IRF5	C0036421	Systemic Scleroderma	0.215932474752736	1	0	CTD_human
3663	IRF5	C0040261	Onychomycosis	0.2	0	0	HPO
3663	IRF5	C0085605	Liver Failure	0.2	0	0	HPO
3663	IRF5	C0206138	CREST Syndrome	0.2	0	0	ORPHANET
3663	IRF5	C0239946	Fibrosis, Liver	0.2	0	0	HPO
3663	IRF5	C0268307	Conjugated hyperbilirubinemia	0.2	0	0	HPO
3663	IRF5	C0343065	Symptomatic dermographism	0.2	0	0	HPO
3663	IRF5	C0748540	Scleroderma, Limited	0.2	0	0	ORPHANET
3663	IRF5	C0859942	Hanot's cirrhosis	0.2	0	0	ORPHANET
3663	IRF5	C1258104	Diffuse Scleroderma	0.200274726784213	0	0	ORPHANET
3663	IRF5	C2677100	Inflammatory Bowel Disease 14	0.2	0	0	CTD_human
3664	IRF6	C0175697	Van der Woude syndrome	0.697242274870795	12	14	CTD_human;ORPHANET;UNIPROT
3664	IRF6	C0265259	Popliteal pterygium syndrome	0.684120901763197	3	7	CTD_human;ORPHANET;UNIPROT
3664	IRF6	C0751748	Nonketotic Hyperglycinemia	0.2	0	0	HPO
3665	IRF7	C0021400	Influenza	0.201098907136852	1	0	CTD_human
3665	IRF7	C4225358	IMMUNODEFICIENCY 39	0.2	1	2	UNIPROT
3667	IRS1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.669945219479228	7	1	CTD_human;UNIPROT
3667	IRS1	C0020459	Hyperinsulinism	0.201923087489492	1	0	CTD_human
3667	IRS1	C0020473	Hyperlipidemia	0.2	1	0	CTD_human
3667	IRS1	C0028754	Obesity	0.299518278324824	1	0	CTD_human
3667	IRS1	C1956346	Coronary Artery Disease	0.207286598104494	1	0	CTD_human
367	AR	C0002170	Alopecia	0.216914712197646	1	0	CTD_human
367	AR	C0004509	Azoospermia	0.215881317595423	0	0	HPO
367	AR	C0018418	Gynecomastia	0.20433011601278	0	0	HPO
367	AR	C0020619	Hypogonadism	0.204879569581206	0	0	HPO
367	AR	C0029456	Osteoporosis	0.289195330216668	0	0	HPO
367	AR	C0039585	Androgen-Insensitivity Syndrome	0.866543131000932	73	39	CTD_human;ORPHANET;UNIPROT
367	AR	C0151313	Sensory neuropathy	0.2	0	0	HPO
367	AR	C0156312	Atrophy of testis	0.200824180352639	0	0	HPO
367	AR	C0232939	Primary physiologic amenorrhea	0.201098907136852	0	0	HPO
367	AR	C0234958	muscle degeneration	0.2	0	0	HPO
367	AR	C0236663	Alcohol withdrawal syndrome	0.201098907136852	3	0	PSYGENET
367	AR	C0268301	Reifenstein Syndrome	0.416758333836999	49	26	ORPHANET;UNIPROT
367	AR	C0392525	Nephrolithiasis	0.200274726784213	0	0	HPO
367	AR	C0393547	Bulbospinal Neuronopathy	0.201373633921065	0	0	ORPHANET
367	AR	C0752353	Atrophy, Muscular, Spinobulbar	0.214011065994868	0	0	ORPHANET
367	AR	C1301959	Bulbar weakness	0.200274726784213	0	0	HPO
367	AR	C1839259	Bulbo-Spinal Atrophy, X-Linked	0.250209488976367	0	0	ORPHANET
367	AR	C2678098	Hypospadias 1, X-Linked	0.4	0	0	CTD_human;ORPHANET
367	AR	C2931395	Bulbospinal neuronopathy, X-linked recessive	0.201923087489492	0	0	CTD_human
367	AR	C4082299	Bulbar palsy	0.2	0	0	HPO
3670	ISL1	C0005689	Bladder Exstrophy	0.400274726784213	0	0	HPO;ORPHANET
3670	ISL1	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
3670	ISL1	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
3673	ITGA2	C0014175	Endometriosis	0.2	1	0	CTD_human
3673	ITGA2	C0035328	Retinal Vein Occlusion	0.2	1	0	CTD_human
3673	ITGA2	C3854603	FNAITP	0.2	0	0	ORPHANET
3674	ITGA2B	C0002871	Anemia	0.2	0	0	HPO
3674	ITGA2B	C0007274	Carotid Artery Thrombosis	0.2	1	0	CTD_human
3674	ITGA2B	C0031256	Petechiae	0.2	0	0	HPO
3674	ITGA2B	C0034150	Purpura	0.2	0	0	HPO
3674	ITGA2B	C0040015	Thrombasthenia	0.639929754941945	20	23	CTD_human;HPO;ORPHANET;UNIPROT
3674	ITGA2B	C1861195	Glanzmann Thrombasthenia, Autosomal Dominant	0.48	1	2	ORPHANET;UNIPROT
3674	ITGA2B	C2751260	Macrothrombocytopenia	0.200274726784213	0	0	HPO
3674	ITGA2B	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
3674	ITGA2B	C3854603	FNAITP	0.2	0	0	ORPHANET
3675	ITGA3	C0018418	Gynecomastia	0.2	0	0	HPO
3675	ITGA3	C0035078	Kidney Failure	0.2	0	0	HPO
3675	ITGA3	C0239981	Hypoalbuminemia	0.2	0	0	HPO
3675	ITGA3	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
3675	ITGA3	C1565489	Renal Insufficiency	0.2	0	0	HPO
3675	ITGA3	C3553636	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL	0.4	2	5	ORPHANET;UNIPROT
3679	ITGA7	C0234958	muscle degeneration	0.2	0	0	HPO
3679	ITGA7	C0699743	Congenital muscular dystrophy (disorder)	0.200274726784213	0	0	HPO
3679	ITGA7	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
3679	ITGA7	C2750786	Muscular Dystrophy, Congenital, Due To Integrin Alpha-7 Deficiency	0.48	0	0	CTD_human;ORPHANET
368	ABCC6	C0002982	Angioid Streaks	0.203231208875927	0	0	HPO
368	ABCC6	C0007196	Restrictive cardiomyopathy	0.2	0	0	HPO
368	ABCC6	C0018801	Heart failure	0.2	0	0	HPO
368	ABCC6	C0018802	Congestive heart failure	0.2	0	0	HPO
368	ABCC6	C0024437	Macular degeneration	0.2	0	0	HPO
368	ABCC6	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
368	ABCC6	C0026269	Mitral Valve Stenosis	0.2	0	0	HPO
368	ABCC6	C0027092	Myopia	0.2	0	0	HPO
368	ABCC6	C0033847	Pseudoxanthoma Elasticum	0.777909930998383	21	87	CTD_human;ORPHANET;UNIPROT
368	ABCC6	C0035078	Kidney Failure	0.2	0	0	HPO
368	ABCC6	C0042798	Low Vision	0.2	0	0	HPO
368	ABCC6	C0264955	Idiopathic arterial calcification of infancy	0.2	0	0	ORPHANET
368	ABCC6	C1397139	Calcification of falx cerebri	0.2	0	0	HPO
368	ABCC6	C1565489	Renal Insufficiency	0.2	0	0	HPO
368	ABCC6	C1859727	Arterial calcification of infancy	0.201373633921065	0	0	ORPHANET
368	ABCC6	C1867457	Premature occlusive vascular disease	0.2	0	0	HPO
368	ABCC6	C3276161	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2	0.2	7	13	UNIPROT
3683	ITGAL	C0004943	Behcet Syndrome	0.200824180352639	1	0	CTD_human
3684	ITGAM	C0020877	Ileitis	0.2	1	0	CTD_human
3684	ITGAM	C0024141	Lupus Erythematosus, Systemic	0.230505670961724	2	7	CTD_human
3684	ITGAM	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
3687	ITGAX	C0024141	Lupus Erythematosus, Systemic	0.203231208875927	0	0	CTD_human
3688	ITGB1	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
3688	ITGB1	C0018801	Heart failure	0.2	1	0	CTD_human
3689	ITGB2	C0004943	Behcet Syndrome	0.200549453568426	1	0	CTD_human
3689	ITGB2	C0011603	Dermatitis	0.200824180352639	1	0	CTD_human
3689	ITGB2	C0017574	Gingivitis	0.200274726784213	0	0	HPO
3689	ITGB2	C0027720	Nephrosis	0.2	1	0	CTD_human
3689	ITGB2	C0031099	Periodontitis	0.200549453568426	0	0	HPO
3689	ITGB2	C0032285	Pneumonia	0.28	1	0	CTD_human
3689	ITGB2	C0242597	Leukocyte-Adhesion Deficiency Syndrome	0.2	1	0	CTD_human
3689	ITGB2	C0263454	Chloracne	0.2	1	0	CTD_human
3689	ITGB2	C0398738	Leukocyte adhesion deficiency type 1	0.690164891015885	10	22	CTD_human;ORPHANET;UNIPROT
3690	ITGB3	C0002871	Anemia	0.2	0	0	HPO
3690	ITGB3	C0007274	Carotid Artery Thrombosis	0.2	1	0	CTD_human
3690	ITGB3	C0010072	Coronary Thrombosis	0.205154296365419	1	0	CTD_human
3690	ITGB3	C0027051	Myocardial Infarction	0.274143712945116	1	1	CTD_human
3690	ITGB3	C0031256	Petechiae	0.2	0	0	HPO
3690	ITGB3	C0034150	Purpura	0.2	0	0	HPO
3690	ITGB3	C0040015	Thrombasthenia	0.73044129757041	18	21	CTD_human;HPO;ORPHANET;UNIPROT
3690	ITGB3	C0948089	Acute Coronary Syndrome	0.220732176421995	1	0	CTD_human
3690	ITGB3	C1861195	Glanzmann Thrombasthenia, Autosomal Dominant	0.48	1	3	ORPHANET;UNIPROT
3690	ITGB3	C2751260	Macrothrombocytopenia	0.200824180352639	0	0	HPO
3690	ITGB3	C3853779	Neonatal Alloimmune Thrombocytopenia	0.20678830169338	2	0	CTD_human
3690	ITGB3	C3854603	FNAITP	0.2	0	0	ORPHANET
3691	ITGB4	C0002871	Anemia	0.2	0	0	HPO
3691	ITGB4	C0003886	Arthrogryposis	0.2	0	0	HPO
3691	ITGB4	C0011334	Dental caries	0.2	0	0	HPO
3691	ITGB4	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
3691	ITGB4	C0013592	Ectropion	0.2	0	0	HPO
3691	ITGB4	C0020295	Hydronephrosis	0.2	0	0	HPO
3691	ITGB4	C0021828	Intestinal Atresia	0.2	0	0	HPO
3691	ITGB4	C0036690	Septicemia	0.2	0	0	HPO
3691	ITGB4	C0079298	Epidermolysis Bullosa Simplex	0.2	0	0	CTD_human
3691	ITGB4	C0079301	Junctional Epidermolysis Bullosa	0.201923087489492	1	0	CTD_human
3691	ITGB4	C0178664	Glomerulosclerosis (disorder)	0.2	0	0	HPO
3691	ITGB4	C0221260	Dystrophia unguium	0.2	0	0	HPO
3691	ITGB4	C0268374	Adult junctional epidermolysis bullosa (disorder)	0.68	1	1	CTD_human;ORPHANET;UNIPROT
3691	ITGB4	C0743178	Diarrhea, intractable	0.2	0	0	HPO
3691	ITGB4	C1834405	Nail dysplasia	0.2	0	0	HPO
3691	ITGB4	C1856934	Epidermolysis bullosa with pyloric atresia	0.684120901763197	9	12	CTD_human;ORPHANET;UNIPROT
3691	ITGB4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3691	ITGB4	C2677349	Epidermolysis Bullosa Simplex With Pyloric Atresia	0.2	0	0	ORPHANET
3691	ITGB4	C3887524	Skin Erosion	0.2	0	0	HPO
3691	ITGB4	C4021730	Junctional split	0.2	0	0	HPO
3693	ITGB5	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
3694	ITGB6	C0002170	Alopecia	0.2	0	0	HPO
3694	ITGB6	C0008311	Cholangitis	0.2	1	0	CTD_human
3694	ITGB6	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
3694	ITGB6	C0014544	Epilepsy	0.2	0	0	HPO
3694	ITGB6	C0020757	Ichthyoses	0.2	0	0	HPO
3694	ITGB6	C0034067	Pulmonary Emphysema	0.200824180352639	1	0	CTD_human
3694	ITGB6	C0524910	Hepatitis C, Chronic	0.2	1	0	CTD_human
3694	ITGB6	C0948896	Primary hypogonadism	0.2	0	0	HPO
3694	ITGB6	C4015557	AMELOGENESIS IMPERFECTA, TYPE IH	0.2	2	4	UNIPROT
3696	ITGB8	C0014175	Endometriosis	0.2	1	0	CTD_human
37	ACADVL	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
37	ACADVL	C2711227	Steatohepatitis	0.200274726784213	0	0	HPO
37	ACADVL	C3887523	Very long chain acyl-CoA dehydrogenase deficiency	0.682197814273705	4	26	CTD_human;ORPHANET;UNIPROT
3700	ITIH4	C0745103	Hyperlipoproteinemia Type IIa	0.2	0	0	CTD_human
3702	ITK	C0002871	Anemia	0.2	0	0	HPO
3702	ITK	C0030312	Pancytopenia	0.2	0	0	HPO
3702	ITK	C0038363	Aphthous Stomatitis	0.2	0	0	HPO
3702	ITK	C0162539	IgG Deficiency	0.2	0	0	HPO
3702	ITK	C2751686	Lymphoproliferative Syndrome, Ebv-Associated, Autosomal, 1	0.2	0	0	CTD_human
3702	ITK	C2937365	Recurrent aphthous ulcer	0.2	0	0	HPO
3702	ITK	C3552634	LYMPHOPROLIFERATIVE SYNDROME 1	0.2	1	1	UNIPROT
3703	STT3A	C0014544	Epilepsy	0.2	0	0	HPO
3703	STT3A	C0262404	Cerebellar degeneration	0.2	0	0	HPO
3703	STT3A	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
3703	STT3A	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3703	STT3A	C3810062	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw	0.4	1	1	ORPHANET;UNIPROT
3703	STT3A	C4020873	Infratentorial atrophy	0.2	0	0	HPO
3704	ITPA	C0002878	Anemia, Hemolytic	0.208385505241346	1	0	CTD_human
3704	ITPA	C0342800	Inosine Triphosphatase Deficiency	0.2	1	2	UNIPROT
3704	ITPA	C4225256	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.2	0	0	ORPHANET
3708	ITPR1	C0431401	Gillespie syndrome	0.4	2	8	ORPHANET;UNIPROT
3708	ITPR1	C1847725	SPINOCEREBELLAR ATAXIA 15	0.600824180352639	2	2	CTD_human;ORPHANET;UNIPROT
3708	ITPR1	C1861732	SPINOCEREBELLAR ATAXIA 29	0.600549453568426	2	4	CTD_human;ORPHANET;UNIPROT
3708	ITPR1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3709	ITPR2	C0003028	Anhidrosis	0.200274726784213	0	0	HPO
3709	ITPR2	C1862871	ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS	0.48	1	1	ORPHANET;UNIPROT
3710	ITPR3	C0011854	Diabetes Mellitus, Insulin-Dependent	0.203231208875927	0	0	CTD_human
3712	IVD	C0014544	Epilepsy	0.2	0	0	HPO
3712	IVD	C0023530	Leukopenia	0.2	0	0	HPO
3712	IVD	C0030312	Pancytopenia	0.2	0	0	HPO
3712	IVD	C0268575	Isovaleryl-CoA dehydrogenase deficiency	0.60439562854741	5	21	CTD_human;ORPHANET;UNIPROT
3712	IVD	C0543541	HYPERGLYCINURIA (disorder)	0.2	0	0	HPO
3717	JAK2	C0007786	Brain Ischemia	0.2	0	0	HPO
3717	JAK2	C0009324	Ulcerative Colitis	0.207011871320281	2	0	CTD_human
3717	JAK2	C0020541	Hypertension, Portal	0.2	0	0	HPO
3717	JAK2	C0023890	Liver Cirrhosis	0.200274726784213	0	0	HPO
3717	JAK2	C0025472	Mesenteric Vascular Occlusion	0.2	1	0	CTD_human
3717	JAK2	C0027051	Myocardial Infarction	0.28	0	0	HPO
3717	JAK2	C0032461	Polycythemia	0.222599521133841	1	0	CTD_human
3717	JAK2	C0040028	Thrombocythemia, Essential	0.632640290938448	8	0	CTD_human;ORPHANET
3717	JAK2	C0085307	Embolism and Thrombosis	0.2	0	0	HPO
3717	JAK2	C0151744	Myocardial Ischemia	0.200274726784213	2	0	CTD_human
3717	JAK2	C0750145	vascular disease occlusive	0.2	0	0	HPO
3717	JAK2	C0836924	Thrombocytosis	0.443397210090466	2	0	CTD_human;HPO
3717	JAK2	C0856761	Budd-Chiari Syndrome	0.616207201536949	2	1	CTD_human;HPO;ORPHANET
3717	JAK2	C0917798	Cerebral Ischemia	0.200274726784213	0	0	HPO
3717	JAK2	C0917805	Transient Cerebral Ischemia	0.2	0	0	HPO
3717	JAK2	C1306889	Peripheral arterial occlusive disease	0.2	0	0	HPO
3717	JAK2	C1401086	Peripheral vascular insufficiency	0.2	0	0	HPO
3717	JAK2	C3275998	THROMBOCYTHEMIA 2	0.2	0	0	ORPHANET
3717	JAK2	C3277671	THROMBOCYTHEMIA 1	0.28	0	0	ORPHANET
3717	JAK2	C3281125	THROMBOCYTHEMIA 3	0.4	1	1	ORPHANET;UNIPROT
3718	JAK3	C0021843	Intestinal Obstruction	0.2	0	0	HPO
3718	JAK3	C0025289	Meningitis	0.2	0	0	HPO
3718	JAK3	C0032285	Pneumonia	0.200274726784213	0	0	HPO
3718	JAK3	C0085110	Severe Combined Immunodeficiency	0.220994226560514	0	0	HPO
3718	JAK3	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
3718	JAK3	C1833275	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, NK Cell-Negative	0.2	0	0	ORPHANET
3718	JAK3	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
3718	JAK3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3719	JBS	C0795841	Jacobsen Distal 11q Deletion Syndrome	0.200274726784213	0	0	CTD_human
3725	JUN	C0007786	Brain Ischemia	0.2	1	0	CTD_human
3725	JUN	C0038220	Status Epilepticus	0.2	1	0	CTD_human
3725	JUN	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
3726	JUNB	C0038220	Status Epilepticus	0.2	1	0	CTD_human
3726	JUNB	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3726	JUNB	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
3727	JUND	C0017658	Glomerulonephritis	0.203007639249027	1	0	CTD_human
3727	JUND	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
3727	JUND	C0038220	Status Epilepticus	0.2	1	0	CTD_human
3727	JUND	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
3728	JUP	C0002170	Alopecia	0.2	0	0	HPO
3728	JUP	C0018801	Heart failure	0.2	0	0	HPO
3728	JUP	C0018802	Congestive heart failure	0.2	0	0	HPO
3728	JUP	C0022596	Palmoplantar Keratosis	0.200274726784213	0	0	HPO
3728	JUP	C0042514	Tachycardia, Ventricular	0.200274726784213	0	0	HPO
3728	JUP	C0085612	Ventricular arrhythmia	0.2	0	0	HPO
3728	JUP	C0085661	Onycholysis	0.2	0	0	HPO
3728	JUP	C0221260	Dystrophia unguium	0.2	0	0	HPO
3728	JUP	C1832600	Naxos disease	0.48	0	0	CTD_human;ORPHANET
3728	JUP	C1864826	Epidermolysis bullosa, lethal acantholytic	0.2	0	0	ORPHANET
3728	JUP	C1969081	Arrhythmogenic Right Ventricular Dysplasia, Familial, 12	0.48	1	2	CTD_human;UNIPROT
3728	JUP	C2063326	Cardiomyopathy, right ventricular	0.2	0	0	HPO
3728	JUP	C3887524	Skin Erosion	0.2	0	0	HPO
3730	ANOS1	C0018418	Gynecomastia	0.2	0	0	HPO
3730	ANOS1	C0029453	Osteopenia	0.2	0	0	HPO
3730	ANOS1	C0029456	Osteoporosis	0.2	0	0	HPO
3730	ANOS1	C0151721	Testicular hypogonadism	0.2	0	0	HPO
3730	ANOS1	C0156312	Atrophy of testis	0.2	0	0	HPO
3730	ANOS1	C0162809	Kallmann Syndrome	0.438496872838206	0	0	CTD_human;ORPHANET
3730	ANOS1	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
3730	ANOS1	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
3730	ANOS1	C0242350	Erectile dysfunction	0.2	0	0	HPO
3730	ANOS1	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
3730	ANOS1	C0271623	Hypogonadotropic hypogonadism	0.202197814273705	0	0	HPO
3730	ANOS1	C0454455	Mirror movements disorder	0.200549453568426	0	0	HPO
3730	ANOS1	C0747078	Generalized osteopenia	0.2	0	0	HPO
3730	ANOS1	C1563719	Kallmann Syndrome 1	0.200274726784213	9	14	UNIPROT
3730	ANOS1	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
3730	ANOS1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.200274726784213	0	0	HPO
3730	ANOS1	C4020884	Anxiety disease	0.2	0	0	HPO
3730	ANOS1	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
3730	ANOS1	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
373073	CLAM	C1842687	PONTOCEREBELLAR HYPOPLASIA TYPE 3 (disorder)	0.2	0	0	CTD_human
373156	GSTK1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
3735	KARS	C0085684	Foot-drop	0.2	0	0	HPO
3735	KARS	C3150897	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B	0.6	1	3	CTD_human;ORPHANET;UNIPROT
3735	KARS	C3151351	DEAFNESS, AUTOSOMAL RECESSIVE 89	0.2	1	2	UNIPROT
3736	KCNA1	C1719788	Episodic ataxia type 1	0.684670355331623	12	17	CTD_human;ORPHANET;UNIPROT
3736	KCNA1	C1720189	Episodic Ataxia	0.203296721410557	0	0	HPO
3737	KCNA2	C0014544	Epilepsy	0.200274726784213	0	0	HPO
3737	KCNA2	C0543888	Epileptic encephalopathy	0.200549453568426	0	0	HPO
3737	KCNA2	C4225350	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32	0.2	1	4	UNIPROT
374	AREG	C0004096	Asthma	0.204655999954305	1	0	CTD_human
374	AREG	C0014175	Endometriosis	0.2	1	0	CTD_human
374	AREG	C0034069	Pulmonary Fibrosis	0.200549453568426	1	0	CTD_human
374	AREG	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
374	AREG	C0162568	Erythropoietic Protoporphyria	0.2	1	0	CTD_human
374	AREG	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
3741	KCNA5	C0004238	Atrial Fibrillation	0.211602358739956	1	0	CTD_human
3741	KCNA5	C0235480	Paroxysmal atrial fibrillation	0.2	0	0	HPO
3741	KCNA5	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
3741	KCNA5	C2677106	Atrial Fibrillation, Familial, 7	0.2	0	0	CTD_human
374291	NDUFS7	C0023264	Leigh Disease	0.406839458850693	0	0	CTD_human;ORPHANET
374291	NDUFS7	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.2	1	1	UNIPROT
374291	NDUFS7	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
374393	FAM111B	C3810325	POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS	0.4	1	6	ORPHANET;UNIPROT
374407	DNAJB13	C0022521	Kartagener Syndrome	0.2	0	0	ORPHANET
374462	PTPRQ	C3150654	DEAFNESS, AUTOSOMAL RECESSIVE 84A	0.4	1	3	CTD_human;UNIPROT
3745	KCNB1	C0543888	Epileptic encephalopathy	0.200824180352639	0	0	HPO
3745	KCNB1	C4015119	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26	0.2	3	3	UNIPROT
374569	ASPG	C0002871	Anemia	0.2	1	0	CTD_human
374569	ASPG	C0008350	Cholelithiasis	0.2	1	0	CTD_human
374569	ASPG	C0023530	Leukopenia	0.2	1	0	CTD_human
374569	ASPG	C0701818	Choledocholithiasis	0.2	1	0	CTD_human
3746	KCNC1	C0014544	Epilepsy	0.2	0	0	HPO
3746	KCNC1	C0751778	Myoclonic Epilepsies, Progressive	0.200274726784213	1	0	CTD_human
3746	KCNC1	C4015420	EPILEPSY, PROGRESSIVE MYOCLONIC 7	0.4	1	1	ORPHANET;UNIPROT
374654	KIF7	C0265220	Pallister-Hall syndrome	0.2	1	1	UNIPROT
374654	KIF7	C0796147	Acrocallosal Syndrome	0.681923087489492	1	11	CTD_human;ORPHANET;UNIPROT
374654	KIF7	C1846722	Macrocephaly with Multiple Epiphyseal Dysplasia and Distinctive Facies	0.4	1	1	ORPHANET;UNIPROT
374654	KIF7	C2745997	OROFACIODIGITAL SYNDROME VI	0.2	0	0	ORPHANET
374654	KIF7	C2931104	Hydrolethalus syndrome	0.4	1	0	CTD_human;ORPHANET
374654	KIF7	C2936862	Bardet-Biedl syndrome 1 (disorder)	0.2	1	3	UNIPROT
374654	KIF7	C3279899	Hydrolethalus Syndrome 2	0.28	1	2	UNIPROT
3748	KCNC3	C0028738	Nystagmus	0.2	0	0	HPO
3748	KCNC3	C0262404	Cerebellar degeneration	0.200274726784213	0	0	HPO
3748	KCNC3	C0393525	Progressive cerebellar ataxia	0.200274726784213	0	0	HPO
3748	KCNC3	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
3748	KCNC3	C1854488	Spinocerebellar ataxia 13	0.600824180352639	2	4	CTD_human;ORPHANET;UNIPROT
3748	KCNC3	C4020859	Pyramidal tract disease	0.2	0	0	HPO
3748	KCNC3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
3749	KCNC4	C0014556	Epilepsy, Temporal Lobe	0.2	1	0	CTD_human
374920	C19orf68	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
374955	SPATA21	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
375056	MIA3	C0027051	Myocardial Infarction	0.203231208875927	1	2	CTD_human
375056	MIA3	C1956346	Coronary Artery Disease	0.20777053913829	1	1	CTD_human
3752	KCND3	C0262404	Cerebellar degeneration	0.2	0	0	HPO
3752	KCND3	C0393525	Progressive cerebellar ataxia	0.200274726784213	0	0	HPO
3752	KCND3	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
3752	KCND3	C1142166	Brugada Syndrome (disorder)	0.201098907136852	0	0	ORPHANET
3752	KCND3	C1846367	Spinocerebellar ataxia 19	0.4	2	5	ORPHANET;UNIPROT
3752	KCND3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
3752	KCND3	C4225340	BRUGADA SYNDROME 9	0.2	2	3	UNIPROT
375298	CERKL	C0035334	Retinitis Pigmentosa	0.207337755261807	0	0	ORPHANET
375298	CERKL	C1842127	Retinitis Pigmentosa 26	0.4	1	6	CTD_human;UNIPROT
3753	KCNE1	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
3753	KCNE1	C0022387	Jervell-Lange Nielsen Syndrome	0.409586726692824	1	1	CTD_human;ORPHANET
3753	KCNE1	C0023976	Long QT Syndrome	0.241730988602842	3	4	CTD_human
3753	KCNE1	C0035828	Romano-Ward Syndrome	0.201648360705279	0	0	ORPHANET
3753	KCNE1	C0040479	Torsades de Pointes	0.203780662444353	0	0	HPO
3753	KCNE1	C0042510	Ventricular Fibrillation	0.2	0	0	HPO
3753	KCNE1	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
3753	KCNE1	C1867904	LONG QT SYNDROME 5	0.400274726784213	8	6	CTD_human;UNIPROT
3753	KCNE1	C2676723	JERVELL AND LANGE-NIELSEN SYNDROME 2 (disorder)	0.4	3	4	CTD_human;UNIPROT
3756	KCNH1	C0014544	Epilepsy	0.400549453568426	1	0	CTD_human;HPO
3756	KCNH1	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
3756	KCNH1	C0027092	Myopia	0.2	0	0	HPO
3756	KCNH1	C0238669	Aortic root dilatation	0.2	0	0	HPO
3756	KCNH1	C0399440	Hereditary gingival fibromatosis	0.2	0	0	HPO
3756	KCNH1	C0796013	Zimmerman Laband syndrome	0.600824180352639	1	6	CTD_human;ORPHANET;UNIPROT
3756	KCNH1	C2678486	Temple-Baraitser Syndrome	0.600824180352639	2	4	CTD_human;ORPHANET;UNIPROT
3757	KCNH2	C0018790	Cardiac Arrest	0.202956482091714	0	0	HPO
3757	KCNH2	C0023976	Long QT Syndrome	0.34884157981895	18	30	CTD_human
3757	KCNH2	C0035828	Romano-Ward Syndrome	0.204106546385879	0	0	ORPHANET
3757	KCNH2	C0040479	Torsades de Pointes	0.412492051627226	3	0	CTD_human;HPO
3757	KCNH2	C0042510	Ventricular Fibrillation	0.200824180352639	0	0	HPO
3757	KCNH2	C1865020	Short QT Syndrome 1	0.680274726784213	2	1	CTD_human;ORPHANET;UNIPROT
3757	KCNH2	C3150943	Long Qt Syndrome 2	0.406318716036901	28	123	CTD_human;UNIPROT
375748	ERCC6L2	C3810350	BONE MARROW FAILURE SYNDROME 2	0.2	0	0	ORPHANET
375790	AGRN	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	0.2	0	0	ORPHANET
375790	AGRN	C0751884	Congenital Myasthenic Syndromes, Presynaptic	0.2	0	0	ORPHANET
375790	AGRN	C1850792	Congenital myasthenic syndrome ib	0.2	0	0	CTD_human
375790	AGRN	C3808739	MYASTHENIC SYNDROME, CONGENITAL, 8	0.28	3	3	UNIPROT
3758	KCNJ1	C0004775	Bartter Disease	0.212883448103381	3	0	CTD_human
3758	KCNJ1	C0014544	Epilepsy	0.2	0	0	HPO
3758	KCNJ1	C0020428	Hyperaldosteronism	0.200274726784213	0	0	HPO
3758	KCNJ1	C0027709	Nephrocalcinosis	0.200549453568426	0	0	HPO
3758	KCNJ1	C0029453	Osteopenia	0.2	0	0	HPO
3758	KCNJ1	C0039621	Tetany	0.2	0	0	HPO
3758	KCNJ1	C0085680	Hypochloremia (disorder)	0.2	0	0	HPO
3758	KCNJ1	C0553730	Calcium pyrophosphate deposition disease	0.2	0	0	HPO
3758	KCNJ1	C0740898	Hypokalemic metabolic alkalosis	0.2	0	0	HPO
3758	KCNJ1	C0747078	Generalized osteopenia	0.2	0	0	HPO
3758	KCNJ1	C1855849	Bartter syndrome, antenatal , type 2	0.480274726784213	3	11	CTD_human;UNIPROT
3758	KCNJ1	C1866495	Bartter syndrome, antenatal type 1	0.2	0	0	ORPHANET
3758	KCNJ1	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
3759	KCNJ2	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
3759	KCNJ2	C0042514	Tachycardia, Ventricular	0.200549453568426	1	1	CTD_human
3759	KCNJ2	C0235480	Paroxysmal atrial fibrillation	0.2	0	0	HPO
3759	KCNJ2	C1563715	Andersen Syndrome	0.63123272113639	7	17	CTD_human;ORPHANET;UNIPROT
3759	KCNJ2	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
3759	KCNJ2	C1865018	Short QT Syndrome 3	0.400824180352639	1	1	CTD_human;UNIPROT
3759	KCNJ2	C1865020	Short QT Syndrome 1	0.200274726784213	0	0	ORPHANET
3759	KCNJ2	C3151431	ATRIAL FIBRILLATION, FAMILIAL, 9	0.2	1	1	UNIPROT
3759	KCNJ2	C4021553	Periodic hypokalemic paresis	0.2	0	0	HPO
3761	KCNJ4	C0030567	Parkinson Disease	0.2	1	0	CTD_human
3762	KCNJ5	C0004245	Atrioventricular Block	0.2	0	0	HPO
3762	KCNJ5	C0018790	Cardiac Arrest	0.2	0	0	HPO
3762	KCNJ5	C0018801	Heart failure	0.2	0	0	HPO
3762	KCNJ5	C0018802	Congestive heart failure	0.2	0	0	HPO
3762	KCNJ5	C0020428	Hyperaldosteronism	0.202472541057918	0	0	HPO
3762	KCNJ5	C0034065	Pulmonary Embolism	0.2	0	0	HPO
3762	KCNJ5	C0035828	Romano-Ward Syndrome	0.2	0	0	ORPHANET
3762	KCNJ5	C0235480	Paroxysmal atrial fibrillation	0.2	0	0	HPO
3762	KCNJ5	C1563715	Andersen Syndrome	0.200274726784213	0	0	ORPHANET
3762	KCNJ5	C1621895	Adrenal hyperplasia	0.200274726784213	0	0	HPO
3762	KCNJ5	C1841659	Atrioventricular nodal disease	0.2	0	0	HPO
3762	KCNJ5	C1956346	Coronary Artery Disease	0.2	0	0	HPO
3762	KCNJ5	C3150733	LONG QT SYNDROME 13	0.4	1	1	CTD_human;UNIPROT
3762	KCNJ5	C3150933	HYPERALDOSTERONISM, FAMILIAL, TYPE III	0.4	9	5	ORPHANET;UNIPROT
3762	KCNJ5	C4020742	Familial primary hyperaldosteronism type 2	0.2	0	0	HPO
3762	KCNJ5	C4023208	Glucocortocoid-insensitive primary hyperaldosteronism	0.2	0	0	HPO
3763	KCNJ6	C0015300	Exophthalmos	0.2	0	0	HPO
3763	KCNJ6	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
3763	KCNJ6	C0221032	Familial generalized lipodystrophy	0.2	0	0	HPO
3763	KCNJ6	C0575059	Spastic tetraparesis	0.2	0	0	HPO
3763	KCNJ6	C0694550	Recurrent pneumonia	0.2	0	0	HPO
3763	KCNJ6	C0740852	Upper airway obstruction	0.2	0	0	HPO
3763	KCNJ6	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
3763	KCNJ6	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3763	KCNJ6	C3279800	KEPPEN-LUBINSKY SYNDROME	0.400274726784213	1	2	ORPHANET;UNIPROT
3764	KCNJ8	C0029456	Osteoporosis	0.2	0	0	HPO
3764	KCNJ8	C0038644	Sudden infant death syndrome	0.200274726784213	1	1	UNIPROT
3764	KCNJ8	C0042510	Ventricular Fibrillation	0.200549453568426	1	0	CTD_human
3764	KCNJ8	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3764	KCNJ8	C0795905	Cantu syndrome	0.200824180352639	0	0	ORPHANET
3764	KCNJ8	C1142166	Brugada Syndrome (disorder)	0.202956482091714	0	0	ORPHANET
3766	KCNJ10	C0014544	Epilepsy	0.205703749933845	0	0	HPO
3766	KCNJ10	C0018784	Sensorineural Hearing Loss (disorder)	0.28	0	0	HPO
3766	KCNJ10	C0020428	Hyperaldosteronism	0.2	0	0	HPO
3766	KCNJ10	C0020676	Hypothyroidism	0.2	0	0	HPO
3766	KCNJ10	C0026769	Multiple Sclerosis	0.2	1	0	CTD_human
3766	KCNJ10	C0262404	Cerebellar degeneration	0.2	0	0	HPO
3766	KCNJ10	C0271829	Pendred's syndrome	0.201098907136852	0	0	ORPHANET
3766	KCNJ10	C0342162	Compensated hypothyroidism	0.2	0	0	HPO
3766	KCNJ10	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
3766	KCNJ10	C0740898	Hypokalemic metabolic alkalosis	0.2	0	0	HPO
3766	KCNJ10	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3766	KCNJ10	C2748572	SeSAME syndrome	0.68357144819477	3	10	CTD_human;ORPHANET;UNIPROT
3766	KCNJ10	C4020873	Infratentorial atrophy	0.2	0	0	HPO
3767	KCNJ11	C0003886	Arthrogryposis	0.2	0	0	HPO
3767	KCNJ11	C0011854	Diabetes Mellitus, Insulin-Dependent	0.216090531845007	1	0	CTD_human
3767	KCNJ11	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.502252869521261	2	2	CTD_human;ORPHANET
3767	KCNJ11	C0014544	Epilepsy	0.20984709809972	0	0	HPO
3767	KCNJ11	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
3767	KCNJ11	C0020456	Hyperglycemia	0.213613405166756	0	0	HPO
3767	KCNJ11	C0020615	Hypoglycemia	0.206513574909167	0	0	HPO
3767	KCNJ11	C0039841	Thiamine Deficiency	0.2	0	0	HPO
3767	KCNJ11	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
3767	KCNJ11	C0162275	Ketonuria	0.2	0	0	HPO
3767	KCNJ11	C0342273	Transient neonatal diabetes mellitus	0.200824180352639	0	0	HPO
3767	KCNJ11	C0342276	Maturity onset diabetes mellitus in young	0.200549453568426	0	0	HPO
3767	KCNJ11	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
3767	KCNJ11	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
3767	KCNJ11	C1832386	Diabetes Mellitus, Transient Neonatal, 1	0.200824180352639	0	0	ORPHANET
3767	KCNJ11	C1833104	DIABETES MELLITUS, PERMANENT NEONATAL	0.689065983879032	12	21	CTD_human;ORPHANET;UNIPROT
3767	KCNJ11	C1864623	DIABETES MELLITUS, TRANSIENT NEONATAL, 3 (disorder)	0.4	2	3	CTD_human;UNIPROT
3767	KCNJ11	C1864903	Hyperinsulinaemic hypoglycaemia	0.202747267842131	0	0	HPO
3767	KCNJ11	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3767	KCNJ11	C2931833	Hyperinsulinemic hypoglycemia, familial, 2	0.4	12	1	ORPHANET;UNIPROT
3767	KCNJ11	C4020778	maternal hyperglycemia	0.2	0	0	HPO
3767	KCNJ11	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
3767	KCNJ11	C4225365	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.2	1	1	UNIPROT
3767	KCNJ11	C4274081	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	0.2	0	0	ORPHANET
3769	KCNJ13	C0014544	Epilepsy	0.2	0	0	HPO
3769	KCNJ13	C0022578	Keratoconus	0.2	0	0	HPO
3769	KCNJ13	C0028077	Night Blindness	0.2	0	0	HPO
3769	KCNJ13	C0028738	Nystagmus	0.2	0	0	HPO
3769	KCNJ13	C0042798	Low Vision	0.2	0	0	HPO
3769	KCNJ13	C0339527	Leber Congenital Amaurosis	0.200549453568426	0	0	ORPHANET
3769	KCNJ13	C0344290	Vitreoretinal degeneration	0.200274726784213	0	0	HPO
3769	KCNJ13	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
3769	KCNJ13	C1301509	Severe visual impairment	0.2	0	0	HPO
3769	KCNJ13	C1860405	Snowflake vitreoretinal degeneration	0.600824180352639	1	1	CTD_human;ORPHANET;UNIPROT
3769	KCNJ13	C3280062	LEBER CONGENITAL AMAUROSIS 16	0.200274726784213	1	5	UNIPROT
3772	KCNJ15	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
3777	KCNK3	C0340543	Familial primary pulmonary hypertension	0.200274726784213	0	0	ORPHANET
3777	KCNK3	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
3777	KCNK3	C3203102	Idiopathic pulmonary arterial hypertension	0.202197814273705	0	0	HPO
3777	KCNK3	C3809198	PULMONARY HYPERTENSION, PRIMARY, 4	0.2	1	5	UNIPROT
3778	KCNMA1	C0014553	Absence Epilepsy	0.2	0	0	HPO
3778	KCNMA1	C0028756	Obesity, Morbid	0.2	1	0	CTD_human
3778	KCNMA1	C0038220	Status Epilepticus	0.2	1	0	CTD_human
3778	KCNMA1	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
3778	KCNMA1	C0752210	Dyskinesias, Paroxysmal	0.2	0	0	HPO
3778	KCNMA1	C1836173	Generalized Epilepsy and Paroxysmal Dyskinesia	0.600549453568426	1	2	CTD_human;ORPHANET;UNIPROT
3779	KCNMB1	C1837739	Hypertension, Diastolic, Resistance to	0.2	0	0	CTD_human
3782	KCNN3	C0004238	Atrial Fibrillation	0.203846174978983	1	2	CTD_human
3783	KCNN4	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
3783	KCNN4	C0272051	Xerocytosis	0.200549453568426	0	0	ORPHANET
3783	KCNN4	C0687751	Acanthocytosis	0.2	0	0	HPO
3783	KCNN4	C4225242	DEHYDRATED HEREDITARY STOMATOCYTOSIS 2	0.2	2	1	UNIPROT
3784	KCNQ1	C0004238	Atrial Fibrillation	0.215565203410882	0	0	HPO
3784	KCNQ1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.297563909026569	3	11	CTD_human
3784	KCNQ1	C0015300	Exophthalmos	0.2	0	0	HPO
3784	KCNQ1	C0022387	Jervell-Lange Nielsen Syndrome	0.704862847942176	9	16	CTD_human;ORPHANET;UNIPROT
3784	KCNQ1	C0023976	Long QT Syndrome	0.380059945578023	7	43	CTD_human
3784	KCNQ1	C0024421	Macroglossia	0.2	0	0	HPO
3784	KCNQ1	C0035828	Romano-Ward Syndrome	0.698377983787643	36	138	CTD_human;ORPHANET;UNIPROT
3784	KCNQ1	C0040479	Torsades de Pointes	0.20761248204602	0	0	HPO
3784	KCNQ1	C0042510	Ventricular Fibrillation	0.200274726784213	0	0	HPO
3784	KCNQ1	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
3784	KCNQ1	C1112433	Thromboembolic stroke	0.2	0	0	HPO
3784	KCNQ1	C1837014	Atrial Fibrillation, Familial, 3	0.4	1	5	CTD_human;UNIPROT
3784	KCNQ1	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
3784	KCNQ1	C1865019	SHORT QT SYNDROME 2 (disorder)	0.400549453568426	1	1	CTD_human;UNIPROT
3784	KCNQ1	C1865020	Short QT Syndrome 1	0.2	0	0	ORPHANET
378484	MRX82	C1845286	MENTAL RETARDATION, X-LINKED 82	0.2	0	0	CTD_human
3785	KCNQ2	C0013384	Dyskinetic syndrome	0.200274726784213	0	0	HPO
3785	KCNQ2	C0014306	Enophthalmos	0.2	0	0	HPO
3785	KCNQ2	C0014544	Epilepsy	0.419960831958292	1	0	CTD_human;HPO
3785	KCNQ2	C0085583	Choreoathetosis	0.2	0	0	HPO
3785	KCNQ2	C0220669	Familial benign neonatal epilepsy	0.214560519563294	0	0	ORPHANET
3785	KCNQ2	C0270851	Benign neonatal epilepsy	0.204930726738519	1	0	CTD_human
3785	KCNQ2	C0494475	Tonic - clonic seizures	0.200549453568426	0	0	HPO
3785	KCNQ2	C0543888	Epileptic encephalopathy	0.202747267842131	0	0	HPO
3785	KCNQ2	C0575059	Spastic tetraparesis	0.2	0	0	HPO
3785	KCNQ2	C0752323	Focal Clonic Seizures	0.2	0	0	HPO
3785	KCNQ2	C3149074	SEIZURES, BENIGN FAMILIAL NEONATAL, 1	0.48	6	9	CTD_human;UNIPROT
3785	KCNQ2	C3150986	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.6	1	77	CTD_human;ORPHANET;UNIPROT
3785	KCNQ2	C4020871	Dystonic disease	0.2	0	0	HPO
3786	KCNQ3	C0013384	Dyskinetic syndrome	0.2	0	0	HPO
3786	KCNQ3	C0014306	Enophthalmos	0.2	0	0	HPO
3786	KCNQ3	C0014544	Epilepsy	0.208227448149076	0	0	HPO
3786	KCNQ3	C0085583	Choreoathetosis	0.2	0	0	HPO
3786	KCNQ3	C0220669	Familial benign neonatal epilepsy	0.208791257094819	0	0	ORPHANET
3786	KCNQ3	C0270853	Myoclonic Epilepsy, Juvenile	0.205964121340741	0	0	ORPHANET
3786	KCNQ3	C0494475	Tonic - clonic seizures	0.200274726784213	0	0	HPO
3786	KCNQ3	C0752323	Focal Clonic Seizures	0.2	0	0	HPO
3786	KCNQ3	C1852581	EPILEPSY, BENIGN NEONATAL, 2	0.482747267842131	2	9	CTD_human;UNIPROT
378882	MRX84	C1845297	MENTAL RETARDATION, X-LINKED 84	0.2	0	0	CTD_human
378884	NHLRC1	C0751778	Myoclonic Epilepsies, Progressive	0.201098907136852	1	0	CTD_human
378884	NHLRC1	C0751783	Lafora Disease	0.698298115875696	6	11	CTD_human;ORPHANET;UNIPROT
378888	HSN1B	C1842586	Neuropathy, Hereditary Sensory And Autonomic, Type I, With Cough And Gastroesophageal Reflux	0.2	0	0	CTD_human
378938	MALAT1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
378938	MALAT1	C0236663	Alcohol withdrawal syndrome	0.200274726784213	1	0	PSYGENET
379003	DFNB40	C1842345	DEAFNESS, AUTOSOMAL RECESSIVE 40 (disorder)	0.2	0	0	CTD_human
3791	KDR	C0011881	Diabetic Nephropathy	0.200274726784213	1	0	CTD_human
3791	KDR	C0014556	Epilepsy, Temporal Lobe	0.2	1	0	CTD_human
3791	KDR	C0041948	Uremia	0.2	1	0	CTD_human
3791	KDR	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3791	KDR	C1865871	HEMANGIOMA, CAPILLARY INFANTILE	0.4	2	2	CTD_human;UNIPROT
3795	KHK	C0268160	Deficiency of fructokinase	0.600549453568426	3	2	CTD_human;ORPHANET;UNIPROT
3796	KIF2A	C0014544	Epilepsy	0.2	0	0	HPO
3796	KIF2A	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
3796	KIF2A	C1955869	Malformations of Cortical Development	0.2	1	0	CTD_human
3796	KIF2A	C3809414	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3	0.2	1	2	UNIPROT
3797	KIF3C	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
3798	KIF5A	C0003873	Rheumatoid Arthritis	0.212309869400653	1	1	CTD_human
3798	KIF5A	C0037772	Spastic Paraplegia	0.202472541057918	0	0	HPO
3798	KIF5A	C0085606	Urgency of micturition	0.2	0	0	HPO
3798	KIF5A	C1858712	Spastic paraplegia 10, autosomal dominant	0.600824180352639	5	10	CTD_human;ORPHANET;UNIPROT
3798	KIF5A	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
3798	KIF5A	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
38	ACAT1	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
38	ACAT1	C1536500	Deficiency of acetyl-CoA acetyltransferase	0.603846174978984	4	21	CTD_human;ORPHANET;UNIPROT
3800	KIF5C	C0003886	Arthrogryposis	0.2	0	0	HPO
3800	KIF5C	C0014544	Epilepsy	0.2	0	0	HPO
3800	KIF5C	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
3800	KIF5C	C1276035	Pena-Shokeir syndrome type I	0.2	0	0	HPO
3800	KIF5C	C1955869	Malformations of Cortical Development	0.2	1	0	CTD_human
3800	KIF5C	C3809013	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2	0.2	1	2	UNIPROT
3814	KISS1	C0018418	Gynecomastia	0.2	0	0	HPO
3814	KISS1	C0029453	Osteopenia	0.2	0	0	HPO
3814	KISS1	C0029456	Osteoporosis	0.2	0	0	HPO
3814	KISS1	C0151721	Testicular hypogonadism	0.2	0	0	HPO
3814	KISS1	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
3814	KISS1	C0232940	Secondary physiologic amenorrhea	0.200274726784213	0	0	HPO
3814	KISS1	C0242350	Erectile dysfunction	0.2	0	0	HPO
3814	KISS1	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
3814	KISS1	C0271623	Hypogonadotropic hypogonadism	0.201373633921065	0	0	HPO
3814	KISS1	C0747078	Generalized osteopenia	0.2	0	0	HPO
3814	KISS1	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
3814	KISS1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.200549453568426	0	0	HPO
3814	KISS1	C3541462	HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA	0.28	1	1	UNIPROT
3814	KISS1	C4020884	Anxiety disease	0.2	0	0	HPO
3814	KISS1	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
3815	KIT	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
3815	KIT	C0014457	Eosinophilia	0.200824180352639	0	0	HPO
3815	KIT	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
3815	KIT	C0021843	Intestinal Obstruction	0.2	0	0	HPO
3815	KIT	C0024899	Mastocytosis	0.320493563887688	0	0	HPO
3815	KIT	C0042109	Urticaria	0.2	0	0	HPO
3815	KIT	C0221013	Mastocytosis, Systemic	0.243255187107136	1	1	CTD_human
3815	KIT	C0263402	Telangiectasia macularis eruptiva perstans	0.4	0	0	HPO;ORPHANET
3815	KIT	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
3815	KIT	C4024848	Absent pigmentation of the ventral chest	0.2	0	0	HPO
3816	KLK1	C0011881	Diabetic Nephropathy	0.200274726784213	1	0	CTD_human
3816	KLK1	C0027051	Myocardial Infarction	0.201373633921065	1	0	CTD_human
3816	KLK1	C0853897	Diabetic Cardiomyopathies	0.200549453568426	1	0	CTD_human
3818	KLKB1	C0007274	Carotid Artery Thrombosis	0.2	1	0	CTD_human
3818	KLKB1	C0034065	Pulmonary Embolism	0.2	1	0	CTD_human
3818	KLKB1	C0272339	Prekallikrein deficiency	0.680824180352639	3	5	CTD_human;ORPHANET;UNIPROT
3822	KLRC2	C0022336	Creutzfeldt-Jakob disease	0.2	1	0	CTD_human
3827	KNG1	C0019243	Angioedemas, Hereditary	0.210439617800098	1	0	CTD_human
3827	KNG1	C0020452	Hyperemia	0.2	1	0	CTD_human
3827	KNG1	C0272340	High molecular weight kininogen deficiency	0.401098907136852	0	0	CTD_human;ORPHANET
3827	KNG1	C2931758	Acquired angioedema	0.201098907136852	1	0	CTD_human
383	ARG1	C0003123	Anorexia	0.200274726784213	0	0	HPO
383	ARG1	C0004096	Asthma	0.210294237353521	2	0	CTD_human
383	ARG1	C0014544	Epilepsy	0.2	0	0	HPO
383	ARG1	C0023281	Leishmaniasis	0.2	1	0	CTD_human
383	ARG1	C0037116	Silicosis	0.2	1	0	CTD_human
383	ARG1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
383	ARG1	C4024698	Diaminoaciduria	0.2	0	0	HPO
383	ARG1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3832	KIF11	C0024236	Lymphedema	0.200549453568426	0	0	HPO
3832	KIF11	C1835265	Lymphedema, microcephaly and chorioretinopathy syndrome	0.401098907136852	1	12	ORPHANET;UNIPROT
3835	KIF22	C0023075	Laryngostenosis	0.2	0	0	HPO
3835	KIF22	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
3835	KIF22	C1834405	Nail dysplasia	0.2	0	0	HPO
3835	KIF22	C1863732	Spondyloepimetaphyseal dysplasia with multiple dislocations	0.400824180352639	2	3	ORPHANET;UNIPROT
384	ARG2	C0004096	Asthma	0.207286598104494	1	0	CTD_human
3845	KRAS	C0002170	Alopecia	0.2	0	0	HPO
3845	KRAS	C0014175	Endometriosis	0.208920603432455	1	0	CTD_human
3845	KRAS	C0014544	Epilepsy	0.200274726784213	0	0	HPO
3845	KRAS	C0015300	Exophthalmos	0.2	0	0	HPO
3845	KRAS	C0017154	Gastritis, Atrophic	0.200274726784213	0	0	HPO
3845	KRAS	C0020757	Ichthyoses	0.2	0	0	HPO
3845	KRAS	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
3845	KRAS	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
3845	KRAS	C0027092	Myopia	0.2	0	0	HPO
3845	KRAS	C0028326	Noonan Syndrome	0.426343381798199	4	8	CTD_human;ORPHANET
3845	KRAS	C0028738	Nystagmus	0.2	0	0	HPO
3845	KRAS	C0029453	Osteopenia	0.2	0	0	HPO
3845	KRAS	C0036651	Senile lentigo	0.2	0	0	HPO
3845	KRAS	C0038379	Strabismus	0.2	0	0	HPO
3845	KRAS	C0151740	Intracranial Hypertension	0.2	0	0	HPO
3845	KRAS	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
3845	KRAS	C0259817	Xerosis	0.2	0	0	HPO
3845	KRAS	C0263490	Brittle hair	0.2	0	0	HPO
3845	KRAS	C0270921	Axonal neuropathy	0.2	0	0	HPO
3845	KRAS	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
3845	KRAS	C0431391	Hemimegalencephaly	0.2	0	0	HPO
3845	KRAS	C0521533	Atrial septal aneurysm	0.2	0	0	HPO
3845	KRAS	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
3845	KRAS	C0587248	Costello syndrome (disorder)	0.202197814273705	2	0	CTD_human
3845	KRAS	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
3845	KRAS	C0747078	Generalized osteopenia	0.2	0	0	HPO
3845	KRAS	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
3845	KRAS	C1328931	Multiple lentigines	0.2	0	0	HPO
3845	KRAS	C1704375	Hypophosphatemic Rickets	0.2	0	0	HPO
3845	KRAS	C1838329	APLASIA CUTIS CONGENITA WITH EPIBULBAR DERMOIDS	0.2	0	0	ORPHANET
3845	KRAS	C1860991	NOONAN SYNDROME 3	0.48	3	9	CTD_human;UNIPROT
3845	KRAS	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
3845	KRAS	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
3845	KRAS	C2674723	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER	0.2	0	0	ORPHANET
3845	KRAS	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
3845	KRAS	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
3845	KRAS	C3809005	CARDIOFACIOCUTANEOUS SYNDROME 2	0.2	5	7	UNIPROT
3845	KRAS	C3854181	Nevus sebaceous	0.600549453568426	1	0	CTD_human;HPO;ORPHANET
3845	KRAS	C4020884	Anxiety disease	0.2	0	0	HPO
3845	KRAS	C4082173	Porencephaly	0.2	0	0	HPO
3848	KRT1	C0011606	Exfoliative dermatitis	0.200549453568426	0	0	HPO
3848	KRT1	C0013595	Eczema	0.200274726784213	0	0	HPO
3848	KRT1	C0020757	Ichthyoses	0.2	0	0	HPO
3848	KRT1	C0022584	Keratoderma, Palmoplantar, Diffuse	0.200824180352639	0	0	HPO
3848	KRT1	C0022596	Palmoplantar Keratosis	0.204120901763196	0	0	HPO
3848	KRT1	C0079153	Hyperkeratosis, Epidermolytic	0.692348349912272	11	16	CTD_human;HPO;ORPHANET;UNIPROT
3848	KRT1	C0221260	Dystrophia unguium	0.2	0	0	HPO
3848	KRT1	C1721006	Keratoderma, Palmoplantar, Epidermolytic	0.601923087489492	0	0	CTD_human;HPO;ORPHANET
3848	KRT1	C1833030	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC	0.600274726784213	1	1	CTD_human;HPO;UNIPROT
3848	KRT1	C1840296	Ichthyosis hystrix, Curth Macklin type	0.400274726784213	0	0	CTD_human;ORPHANET
3848	KRT1	C1843463	Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis	0.6	4	2	CTD_human;ORPHANET;UNIPROT
3848	KRT1	C2931122	Keratosis palmoplantaris striata 1	0.4	0	0	CTD_human;ORPHANET
3848	KRT1	C2931123	Keratosis palmoplantaris striata 3	0.2	0	0	CTD_human
3848	KRT1	C2931735	Epidermolytic palmoplantar keratoderma Vorner type	0.2	0	0	ORPHANET
3848	KRT1	C3665704	Congenital reticular ichthyosiform erythroderma	0.200549453568426	0	0	ORPHANET
3849	KRT2	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3849	KRT2	C0079153	Hyperkeratosis, Epidermolytic	0.201648360705279	0	0	HPO
3850	KRT3	C0010036	Corneal dystrophy	0.2	0	0	HPO
3850	KRT3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
3851	KRT4	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3851	KRT4	C1721005	Leukokeratosis, Hereditary Mucosal	0.201098907136852	0	0	CTD_human
3851	KRT4	C4011926	WHITE SPONGE NEVUS 1	0.48	1	0	ORPHANET;UNIPROT
3852	KRT5	C0022596	Palmoplantar Keratosis	0.200274726784213	0	0	HPO
3852	KRT5	C0079295	Epidermolysis Bullosa Herpetiformis Dowling-Meara	0.480274726784213	11	13	ORPHANET;UNIPROT
3852	KRT5	C0079298	Epidermolysis Bullosa Simplex	0.23473865679653	0	0	CTD_human
3852	KRT5	C0080333	Weber-Cockayne Syndrome	0.401373633921066	15	23	ORPHANET;UNIPROT
3852	KRT5	C0221260	Dystrophia unguium	0.2	0	0	HPO
3852	KRT5	C0263537	Onychogryposis	0.2	0	0	HPO
3852	KRT5	C0854107	Haemorrhage subcutaneous	0.2	0	0	HPO
3852	KRT5	C1834405	Nail dysplasia	0.2	0	0	HPO
3852	KRT5	C1836284	Epidermolysis Bullosa Simplex with Migratory Circinate Erythema	0.400549453568426	0	0	CTD_human;ORPHANET
3852	KRT5	C3714534	dowling-degos disease	0.403021994626344	0	0	CTD_human;ORPHANET
3852	KRT5	C4024851	Punctate palmoplantar hyperkeratosis	0.2	0	0	HPO
3852	KRT5	C4024872	Progressive reticulate hyperpigmentation	0.2	0	0	HPO
3853	KRT6A	C0011334	Dental caries	0.2	0	0	HPO
3853	KRT6A	C0017574	Gingivitis	0.2	0	0	HPO
3853	KRT6A	C0020757	Ichthyoses	0.2	0	0	HPO
3853	KRT6A	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
3853	KRT6A	C0040412	Fissured tongue	0.200274726784213	0	0	HPO
3853	KRT6A	C0221260	Dystrophia unguium	0.2	0	0	HPO
3853	KRT6A	C0263449	Perioral Dermatitis	0.2	0	0	HPO
3853	KRT6A	C0263537	Onychogryposis	0.2	0	0	HPO
3853	KRT6A	C3714948	PACHYONYCHIA CONGENITA 3	0.2	9	20	UNIPROT
3853	KRT6A	C4023710	Palmar hyperkeratosis	0.2	0	0	HPO
3854	KRT6B	C0011334	Dental caries	0.2	0	0	HPO
3854	KRT6B	C0020757	Ichthyoses	0.2	0	0	HPO
3854	KRT6B	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
3854	KRT6B	C0221260	Dystrophia unguium	0.200274726784213	0	0	HPO
3854	KRT6B	C0263537	Onychogryposis	0.2	0	0	HPO
3854	KRT6B	C3714949	PACHYONYCHIA CONGENITA 4	0.2	1	1	UNIPROT
3855	KRT7	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
3855	KRT7	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
3855	KRT7	C1876165	Copper-Overload Cirrhosis	0.2	1	0	CTD_human
3856	KRT8	C0023890	Liver Cirrhosis	0.206238848124954	1	0	CTD_human
3856	KRT8	C0162557	Liver Failure, Acute	0.202956482091714	1	0	CTD_human
3856	KRT8	C1861556	Cirrhosis, Familial	0.4	1	5	CTD_human;UNIPROT
3857	KRT9	C0013595	Eczema	0.2	0	0	HPO
3857	KRT9	C0022596	Palmoplantar Keratosis	0.214228371269812	0	0	HPO
3857	KRT9	C1721006	Keratoderma, Palmoplantar, Epidermolytic	0.609615437447459	16	14	CTD_human;HPO;ORPHANET;UNIPROT
3857	KRT9	C2931735	Epidermolytic palmoplantar keratoderma Vorner type	0.2	0	0	ORPHANET
3858	KRT10	C0011606	Exfoliative dermatitis	0.200549453568426	0	0	HPO
3858	KRT10	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
3858	KRT10	C0022596	Palmoplantar Keratosis	0.201373633921065	0	0	HPO
3858	KRT10	C0079153	Hyperkeratosis, Epidermolytic	0.617553803435004	9	12	CTD_human;HPO;ORPHANET;UNIPROT
3858	KRT10	C1843463	Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis	0.600824180352639	2	2	CTD_human;ORPHANET;UNIPROT
3858	KRT10	C3665704	Congenital reticular ichthyosiform erythroderma	0.401923087489492	0	0	CTD_human;ORPHANET
3859	KRT12	C0010036	Corneal dystrophy	0.200274726784213	0	0	HPO
3860	KRT13	C1721005	Leukokeratosis, Hereditary Mucosal	0.200824180352639	0	0	CTD_human
3860	KRT13	C4011926	WHITE SPONGE NEVUS 1	0.2	0	0	ORPHANET
3860	KRT13	C4014321	WHITE SPONGE NEVUS 2	0.2	4	5	UNIPROT
3861	KRT14	C0002170	Alopecia	0.2	0	0	HPO
3861	KRT14	C0002871	Anemia	0.2	0	0	HPO
3861	KRT14	C0011334	Dental caries	0.2	0	0	HPO
3861	KRT14	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
3861	KRT14	C0020620	Hypohidrosis	0.2	0	0	HPO
3861	KRT14	C0022584	Keratoderma, Palmoplantar, Diffuse	0.2	0	0	HPO
3861	KRT14	C0022596	Palmoplantar Keratosis	0.200274726784213	0	0	HPO
3861	KRT14	C0079295	Epidermolysis Bullosa Herpetiformis Dowling-Meara	0.480824180352639	18	14	ORPHANET;UNIPROT
3861	KRT14	C0079298	Epidermolysis Bullosa Simplex	0.232056901489029	0	0	CTD_human
3861	KRT14	C0080333	Weber-Cockayne Syndrome	0.4	10	15	ORPHANET;UNIPROT
3861	KRT14	C0221260	Dystrophia unguium	0.2	0	0	HPO
3861	KRT14	C0263537	Onychogryposis	0.2	0	0	HPO
3861	KRT14	C0343111	Naegeli syndrome	0.400549453568426	1	0	CTD_human;ORPHANET
3861	KRT14	C0399385	Early tooth exfoliation	0.2	0	0	HPO
3861	KRT14	C0854107	Haemorrhage subcutaneous	0.2	0	0	HPO
3861	KRT14	C1832926	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE (disorder)	0.2	0	0	CTD_human
3861	KRT14	C1834405	Nail dysplasia	0.2	0	0	HPO
3861	KRT14	C3715082	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1	0.48	1	1	ORPHANET;UNIPROT
3861	KRT14	C4021831	Hypohidrosis or hyperhidrosis	0.2	0	0	HPO
386653	IL31	C0011615	Dermatitis, Atopic	0.211770185589212	1	0	CTD_human
3868	KRT16	C0011334	Dental caries	0.2	0	0	HPO
3868	KRT16	C0013595	Eczema	0.2	0	0	HPO
3868	KRT16	C0020757	Ichthyoses	0.2	0	0	HPO
3868	KRT16	C0022596	Palmoplantar Keratosis	0.200274726784213	0	0	HPO
3868	KRT16	C0221260	Dystrophia unguium	0.200274726784213	0	0	HPO
3868	KRT16	C0263537	Onychogryposis	0.2	0	0	HPO
3868	KRT16	C0334013	Phrynoderma	0.2	0	0	HPO
3868	KRT16	C1706595	Pachyonychia Congenita, Jadassohn Lewandowsky Type	0.281373633921066	11	12	UNIPROT
3868	KRT16	C1721006	Keratoderma, Palmoplantar, Epidermolytic	0.6	0	0	CTD_human;HPO;ORPHANET
3868	KRT16	C1833030	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC	0.201098907136852	0	0	CTD_human
3868	KRT16	C2931735	Epidermolytic palmoplantar keratoderma Vorner type	0.2	0	0	ORPHANET
3868	KRT16	C2931923	Hyperkeratosis of the palms and soles and esophageal papillomas	0.481373633921066	5	2	CTD_human;UNIPROT
387082	SUMO4	C1838260	DIABETES MELLITUS, INSULIN-DEPENDENT, 5	0.2	0	0	CTD_human
387129	NPSR1	C0004096	Asthma	0.259967097348936	3	0	CTD_human
387129	NPSR1	C1837811	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2	0.2	0	0	CTD_human
3872	KRT17	C0011334	Dental caries	0.2	0	0	HPO
3872	KRT17	C0020757	Ichthyoses	0.2	0	0	HPO
3872	KRT17	C0022596	Palmoplantar Keratosis	0.200274726784213	0	0	HPO
3872	KRT17	C0038605	Subungual hyperkeratosis	0.2	0	0	HPO
3872	KRT17	C0221260	Dystrophia unguium	0.200274726784213	0	0	HPO
3872	KRT17	C0263454	Chloracne	0.2	1	0	CTD_human
3872	KRT17	C0263537	Onychogryposis	0.200274726784213	0	0	HPO
3872	KRT17	C1274743	Hyperhidrosis Palmaris Et Plantaris	0.2	0	0	HPO
3872	KRT17	C1834405	Nail dysplasia	0.2	0	0	HPO
387281	LCRB	C0002312	alpha-Thalassemia	0.2	0	0	CTD_human
387357	THEMIS	C0007570	Celiac Disease	0.200274726784213	1	0	CTD_human
387496	RASL11A	C0014175	Endometriosis	0.2	1	0	CTD_human
3875	KRT18	C0023890	Liver Cirrhosis	0.200274726784213	1	0	CTD_human
3875	KRT18	C0162557	Liver Failure, Acute	0.202681755307501	1	0	CTD_human
3875	KRT18	C1861556	Cirrhosis, Familial	0.4	1	4	CTD_human;UNIPROT
3875	KRT18	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
387570	DUH1	C2675711	Dyschromatosis Universalis Hereditaria 1	0.2	0	0	CTD_human
387573	CHDS3	C0010068	Coronary heart disease	0.2	0	0	CTD_human
387574	CMTDIA	C1847896	Charcot-Marie-Tooth Disease, Dominant Intermediate A	0.2	0	0	CTD_human
387575	HYT3	C0085580	Essential Hypertension	0.2	0	0	CTD_human
387578	AITD1	C0920350	Autoimmune thyroiditis	0.2	0	0	CTD_human
387579	AITD2	C0920350	Autoimmune thyroiditis	0.2	0	0	CTD_human
387581	AITD4	C0920350	Autoimmune thyroiditis	0.2	0	0	CTD_human
387582	KAZA1	C0023290	Leishmaniasis, Visceral	0.2	0	0	CTD_human
387583	SPG25	C2936860	Spastic paraplegia 25, autosomal recessive	0.4	0	0	CTD_human;ORPHANET
387584	CHDS2	C0010068	Coronary heart disease	0.2	0	0	CTD_human
387585	CHDS4	C0010068	Coronary heart disease	0.2	0	0	CTD_human
387700	SLC16A12	C2677587	Cataract, Juvenile, With Microcornea And Glucosuria	0.4	0	0	CTD_human;ORPHANET
387715	ARMS2	C0242383	Age related macular degeneration	0.36853577601839	3	3	CTD_human
387733	IFITM5	C1970414	Osteogenesis Imperfecta, Type V	0.203296721410557	1	3	UNIPROT
387733	IFITM5	C2931093	Osteogenesis imperfecta, type 5	0.2	0	0	ORPHANET
388	RHOB	C0036421	Systemic Scleroderma	0.200824180352639	1	0	CTD_human
3880	KRT19	C0004096	Asthma	0.200274726784213	1	0	CTD_human
3880	KRT19	C0008311	Cholangitis	0.2	1	0	CTD_human
3880	KRT19	C0019189	Hepatitis, Chronic	0.200274726784213	1	0	CTD_human
3880	KRT19	C1876165	Copper-Overload Cirrhosis	0.2	1	0	CTD_human
388015	RTL1	C1842466	Uniparental disomy, paternal, chromosome 14	0.200274726784213	0	0	ORPHANET
388125	C2CD4B	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.205363510615002	1	0	CTD_human
388389	CCDC103	C0022521	Kartagener Syndrome	0.200549453568426	0	0	ORPHANET
388389	CCDC103	C3542550	CILIARY DYSKINESIA, PRIMARY, 17	0.2	1	2	UNIPROT
388551	CEACAM16	C3281297	DEAFNESS, AUTOSOMAL DOMINANT 4B	0.2	2	2	UNIPROT
388552	BLOC1S3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
388552	BLOC1S3	C2931875	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells	0.2	0	0	CTD_human
388552	BLOC1S3	C3888026	HERMANSKY-PUDLAK SYNDROME 8	0.280274726784213	0	0	ORPHANET
388662	SLC6A17	C4225395	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48	0.4	1	2	ORPHANET;UNIPROT
3887	KRT81	C0002170	Alopecia	0.2	0	0	HPO
3887	KRT81	C0221260	Dystrophia unguium	0.2	0	0	HPO
3887	KRT81	C0263490	Brittle hair	0.2	0	0	HPO
3887	KRT81	C0334013	Phrynoderma	0.2	0	0	HPO
3887	KRT81	C1834405	Nail dysplasia	0.2	0	0	HPO
3887	KRT81	C4024867	Perifollicular hyperkeratosis	0.2	0	0	HPO
388753	COA6	C4225304	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4	0.2	2	2	UNIPROT
388753	COA6	C4273730	Fatal infantile cytochrome C oxidase deficiency	0.2	0	0	ORPHANET
3889	KRT83	C0002170	Alopecia	0.2	0	0	HPO
3889	KRT83	C0221260	Dystrophia unguium	0.2	0	0	HPO
3889	KRT83	C0263490	Brittle hair	0.2	0	0	HPO
3889	KRT83	C0334013	Phrynoderma	0.2	0	0	HPO
3889	KRT83	C1834405	Nail dysplasia	0.2	0	0	HPO
3889	KRT83	C4024867	Perifollicular hyperkeratosis	0.2	0	0	HPO
388939	C2orf71	C0035334	Retinitis Pigmentosa	0.401098907136852	0	0	CTD_human;ORPHANET
388939	C2orf71	C3150691	RETINITIS PIGMENTOSA 54	0.48	2	10	CTD_human;UNIPROT
388962	BOLA3	C3280378	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA	0.4	1	3	ORPHANET;UNIPROT
389	RHOC	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
3891	KRT85	C0002170	Alopecia	0.2	0	0	HPO
3891	KRT85	C0085661	Onycholysis	0.2	0	0	HPO
3891	KRT85	C0221260	Dystrophia unguium	0.2	0	0	HPO
3891	KRT85	C0263490	Brittle hair	0.2	0	0	HPO
3891	KRT85	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
3891	KRT85	C1865951	Ectodermal Dysplasia, Pure Hair-Nail Type	0.4	1	1	CTD_human;UNIPROT
3892	KRT86	C0002170	Alopecia	0.2	0	0	HPO
3892	KRT86	C0221260	Dystrophia unguium	0.2	0	0	HPO
3892	KRT86	C0263490	Brittle hair	0.2	0	0	HPO
3892	KRT86	C0334013	Phrynoderma	0.2	0	0	HPO
3892	KRT86	C1834405	Nail dysplasia	0.2	0	0	HPO
3892	KRT86	C4024867	Perifollicular hyperkeratosis	0.2	0	0	HPO
389207	GRXCR1	C1414017	DEAFNESS, AUTOSOMAL RECESSIVE 25	0.4	2	7	CTD_human;UNIPROT
389421	LIN28B	C2931189	Neural crest tumor	0.2	0	0	ORPHANET
389434	IYD	C0342195	Thyroid Dyshormonogenesis 4	0.400824180352639	1	4	CTD_human;UNIPROT
389434	IYD	C1848805	Thyroid Dyshormonogenesis 1	0.2	0	0	ORPHANET
389549	FEZF1	C0162809	Kallmann Syndrome	0.200274726784213	0	0	ORPHANET
389549	FEZF1	C4014988	HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA	0.2	1	1	UNIPROT
389558	FAM180A	C0014175	Endometriosis	0.2	1	0	CTD_human
3897	L1CAM	C0014544	Epilepsy	0.2	0	0	HPO
3897	L1CAM	C0020255	Hydrocephalus	0.209586726692824	0	0	HPO
3897	L1CAM	C0037772	Spastic Paraplegia	0.202747267842131	0	0	HPO
3897	L1CAM	C0038379	Strabismus	0.2	0	0	HPO
3897	L1CAM	C0151740	Intracranial Hypertension	0.2	0	0	HPO
3897	L1CAM	C0265216	X-linked hydrocephalus syndrome	0.612087978505376	17	15	CTD_human;ORPHANET;UNIPROT
3897	L1CAM	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
3897	L1CAM	C0751830	Gait Disorders, Neurologic	0.2	1	0	CTD_human
3897	L1CAM	C0795953	MASA SYNDROME (disorder)	0.685494535684262	12	9	CTD_human;ORPHANET;UNIPROT
3897	L1CAM	C1839909	CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.6	0	0	CTD_human;ORPHANET;UNIPROT
3897	L1CAM	C1857278	Partial or complete agenesis of corpus callosum	0.2	0	0	HPO
3897	L1CAM	C2936786	Aqueductal Stenosis	0.200549453568426	0	0	HPO
3899	AFF3	C0003873	Rheumatoid Arthritis	0.206737144536068	2	0	CTD_human
39	ACAT2	C4020858	Choreatic disease	0.2	0	0	HPO
3903	LAIR1	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
390594	KBTBD13	C0546125	Nemaline Myopathy, Childhood Onset	0.2	0	0	ORPHANET
390594	KBTBD13	C1836472	Nemaline myopathy 6	0.4	1	2	CTD_human;UNIPROT
3908	LAMA2	C0014544	Epilepsy	0.200274726784213	0	0	HPO
3908	LAMA2	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
3908	LAMA2	C0024421	Macroglossia	0.2	0	0	HPO
3908	LAMA2	C0026850	Muscular Dystrophy	0.430640201436012	2	0	CTD_human;HPO
3908	LAMA2	C0027092	Myopia	0.200274726784213	1	1	CTD_human
3908	LAMA2	C0027121	Myositis	0.200274726784213	0	0	HPO
3908	LAMA2	C0266941	Derangement of temporomandibular joint	0.2	0	0	HPO
3908	LAMA2	C0376175	Bell Palsy	0.2	0	0	HPO
3908	LAMA2	C0699743	Congenital muscular dystrophy (disorder)	0.217857240973852	0	0	HPO
3908	LAMA2	C1145670	Respiratory Failure	0.200549453568426	0	0	HPO
3908	LAMA2	C1263858	Muscular dystrophy congenital, merosin negative	0.687142896389541	3	50	CTD_human;ORPHANET;UNIPROT
3909	LAMA3	C0002871	Anemia	0.2	0	0	HPO
3909	LAMA3	C0011334	Dental caries	0.2	0	0	HPO
3909	LAMA3	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
3909	LAMA3	C0023066	Laryngismus	0.2	0	0	HPO
3909	LAMA3	C0023075	Laryngostenosis	0.2	0	0	HPO
3909	LAMA3	C0030578	Paronychia Inflammation	0.2	0	0	HPO
3909	LAMA3	C0079301	Junctional Epidermolysis Bullosa	0.209586726692824	1	0	CTD_human
3909	LAMA3	C0079683	Herlitz Disease	0.200274726784213	0	0	ORPHANET
3909	LAMA3	C0221260	Dystrophia unguium	0.2	0	0	HPO
3909	LAMA3	C0268374	Adult junctional epidermolysis bullosa (disorder)	0.48	0	0	CTD_human;ORPHANET
3909	LAMA3	C1328355	Laryngoonychocutaneous syndrome	0.400274726784213	1	0	CTD_human;ORPHANET
3909	LAMA3	C1834405	Nail dysplasia	0.2	0	0	HPO
3909	LAMA3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3909	LAMA3	C3887524	Skin Erosion	0.2	0	0	HPO
3909	LAMA3	C4021730	Junctional split	0.2	0	0	HPO
3910	LAMA4	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
3910	LAMA4	C3808935	CARDIOMYOPATHY, DILATED, 1JJ	0.2	1	2	UNIPROT
3910	LAMA4	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
391051	UOX	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
391051	UOX	C0041364	Tumor Lysis Syndrome	0.200274726784213	1	0	CTD_human
3912	LAMB1	C0009324	Ulcerative Colitis	0.200824180352639	1	1	CTD_human
3912	LAMB1	C0014175	Endometriosis	0.2	1	0	CTD_human
3912	LAMB1	C0014544	Epilepsy	0.202732912464814	0	0	HPO
3912	LAMB1	C0020255	Hydrocephalus	0.2	0	0	HPO
3912	LAMB1	C0266491	Neuronal heterotopia	0.2	0	0	HPO
3912	LAMB1	C3554657	LISSENCEPHALY 5	0.2	0	0	ORPHANET
3913	LAMB2	C0020639	Hypoproteinemia	0.2	0	0	HPO
3913	LAMB2	C0027092	Myopia	0.2	0	0	HPO
3913	LAMB2	C0028738	Nystagmus	0.200274726784213	0	0	HPO
3913	LAMB2	C0038379	Strabismus	0.2	0	0	HPO
3913	LAMB2	C0268747	Diffuse mesangial sclerosis (disorder)	0.400824180352639	1	0	CTD_human;HPO
3913	LAMB2	C0271215	Blindness, Legal	0.2	0	0	HPO
3913	LAMB2	C1836876	Pierson syndrome	0.683846174978983	2	8	CTD_human;ORPHANET;UNIPROT
3913	LAMB2	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
3913	LAMB2	C3280113	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES	0.4	1	4	ORPHANET;UNIPROT
3914	LAMB3	C0002871	Anemia	0.2	0	0	HPO
3914	LAMB3	C0011334	Dental caries	0.2	0	0	HPO
3914	LAMB3	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
3914	LAMB3	C0023066	Laryngismus	0.2	0	0	HPO
3914	LAMB3	C0023075	Laryngostenosis	0.2	0	0	HPO
3914	LAMB3	C0030578	Paronychia Inflammation	0.2	0	0	HPO
3914	LAMB3	C0079301	Junctional Epidermolysis Bullosa	0.217264721273474	0	0	CTD_human
3914	LAMB3	C0079683	Herlitz Disease	0.480549453568426	1	39	ORPHANET;UNIPROT
3914	LAMB3	C0221260	Dystrophia unguium	0.2	0	0	HPO
3914	LAMB3	C0268374	Adult junctional epidermolysis bullosa (disorder)	0.68	2	9	CTD_human;ORPHANET;UNIPROT
3914	LAMB3	C1834405	Nail dysplasia	0.2	0	0	HPO
3914	LAMB3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3914	LAMB3	C3887524	Skin Erosion	0.2	0	0	HPO
3914	LAMB3	C4021730	Junctional split	0.2	0	0	HPO
3915	LAMC1	C0024796	Marfan Syndrome	0.2	1	0	CTD_human
3915	LAMC1	C0877015	Pelvic Organ Prolapse	0.200824180352639	0	0	CTD_human
3918	LAMC2	C0002871	Anemia	0.200549453568426	0	0	HPO
3918	LAMC2	C0011334	Dental caries	0.2	0	0	HPO
3918	LAMC2	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
3918	LAMC2	C0023066	Laryngismus	0.2	0	0	HPO
3918	LAMC2	C0023075	Laryngostenosis	0.2	0	0	HPO
3918	LAMC2	C0023890	Liver Cirrhosis	0.200274726784213	1	0	CTD_human
3918	LAMC2	C0030578	Paronychia Inflammation	0.2	0	0	HPO
3918	LAMC2	C0079301	Junctional Epidermolysis Bullosa	0.20767799458065	0	0	CTD_human
3918	LAMC2	C0079683	Herlitz Disease	0.280549453568426	0	0	ORPHANET
3918	LAMC2	C0221260	Dystrophia unguium	0.2	0	0	HPO
3918	LAMC2	C0268374	Adult junctional epidermolysis bullosa (disorder)	0.48	1	1	CTD_human;ORPHANET
3918	LAMC2	C1834405	Nail dysplasia	0.2	0	0	HPO
3918	LAMC2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3918	LAMC2	C2673609	Epidermolysis bullosa inversa dystrophica	0.200274726784213	0	0	ORPHANET
3918	LAMC2	C3887524	Skin Erosion	0.2	0	0	HPO
3918	LAMC2	C4021730	Junctional split	0.2	0	0	HPO
3920	LAMP2	C0007194	Hypertrophic Cardiomyopathy	0.208762546340185	0	0	HPO
3920	LAMP2	C0038220	Status Epilepticus	0.2	1	0	CTD_human
3920	LAMP2	C0042798	Low Vision	0.2	0	0	HPO
3920	LAMP2	C0043202	Wolff-Parkinson-White Syndrome	0.202732912464814	0	0	HPO
3920	LAMP2	C0878677	Glycogen Storage Disease Type IIb	0.704928360476806	1	26	CTD_human;ORPHANET;UNIPROT
3920	LAMP2	C1389113	Generalized amyotrophy	0.2	0	0	HPO
3920	LAMP2	C1442837	Myocardial necrosis	0.2	0	0	HPO
392255	GDF6	C0339527	Leber Congenital Amaurosis	0.200274726784213	0	0	ORPHANET
392255	GDF6	C1845877	Microphthalmia, Isolated, with Coloboma 1	0.2	0	0	ORPHANET
392255	GDF6	C1861689	KLIPPEL-FEIL SYNDROME, AUTOSOMAL DOMINANT	0.400824180352639	4	4	CTD_human;UNIPROT
392255	GDF6	C2751307	MICROPHTHALMIA, ISOLATED 4 (disorder)	0.4	1	4	CTD_human;UNIPROT
392255	GDF6	C3150968	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.2	0	0	CTD_human
392255	GDF6	C3715164	LEBER CONGENITAL AMAUROSIS 17	0.2	2	3	UNIPROT
392255	GDF6	C4083048	SPONDYLOCOSTAL DYSOSTOSIS 5	0.2	0	0	CTD_human
3929	LBP	C0028754	Obesity	0.280824180352639	1	0	CTD_human
3929	LBP	C0243026	Sepsis	0.208869446275143	1	0	CTD_human
3929	LBP	C0524620	Metabolic Syndrome X	0.200549453568426	1	0	CTD_human
3929	LBP	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3930	LBR	C0003864	Arthritis	0.2	0	0	HPO
3930	LBR	C0008312	Primary biliary cirrhosis	0.2	0	0	HPO
3930	LBR	C0011644	Scleroderma	0.200274726784213	0	0	HPO
3930	LBR	C0013238	Dry Eye Syndromes	0.2	0	0	HPO
3930	LBR	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
3930	LBR	C0022575	Keratoconjunctivitis Sicca	0.2	0	0	HPO
3930	LBR	C0023892	Biliary cirrhosis	0.2	0	0	HPO
3930	LBR	C0024236	Lymphedema	0.2	0	0	HPO
3930	LBR	C0030779	Pelger-Huet Anomaly	0.685480180306945	1	8	CTD_human;HPO;UNIPROT
3930	LBR	C0043349	Xerophthalmia	0.2	0	0	HPO
3930	LBR	C0150988	Sclerodactyly	0.2	0	0	HPO
3930	LBR	C0264142	Spade-like hand	0.2	0	0	HPO
3930	LBR	C0264324	Calcification of trachea	0.2	0	0	HPO
3930	LBR	C0455988	Hydrops Fetalis, Non-Immune	0.2	0	0	HPO
3930	LBR	C0748397	Reynolds syndrome	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
3930	LBR	C1274865	Scleroderma-like secondary cutaneous sclerosis	0.2	0	0	HPO
3930	LBR	C1696466	Hepatic calcification	0.2	0	0	HPO
3930	LBR	C1859158	Laryngeal calcification	0.2	0	0	HPO
3930	LBR	C1860105	Severe short-limb dwarfism	0.2	0	0	HPO
3930	LBR	C2613439	Extramedullary Hematopoiesis (disorder)	0.2	0	0	HPO
3930	LBR	C2930821	Keratitis sicca	0.2	0	0	HPO
3930	LBR	C2931048	HEM dysplasia	0.401648360705279	0	0	CTD_human;ORPHANET
393093	MYP4	C0027092	Myopia	0.2	0	0	CTD_human
3931	LCAT	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
3931	LCAT	C0020445	Hypercholesterolemia, Familial	0.200274726784213	0	0	HPO
3931	LCAT	C0023195	Lecithin Acyltransferase Deficiency	0.693656471298708	14	15	CTD_human;ORPHANET;UNIPROT
3931	LCAT	C0035078	Kidney Failure	0.200824180352639	0	0	HPO
3931	LCAT	C0342895	Fish-Eye Disease	0.486802657070698	8	11	ORPHANET;UNIPROT
3931	LCAT	C0473527	Hypoalphalipoproteinemias	0.205088783830789	0	0	HPO
3931	LCAT	C0521719	Clouding of corneal stroma	0.200274726784213	0	0	HPO
3931	LCAT	C1565489	Renal Insufficiency	0.200274726784213	0	0	HPO
3932	LCK	C0030326	Panniculitis	0.2	0	0	HPO
3932	LCK	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3932	LCK	C4014233	IMMUNODEFICIENCY 22	0.4	1	1	ORPHANET;UNIPROT
3934	LCN2	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
3934	LCN2	C0005283	beta Thalassemia	0.203007639249027	1	0	CTD_human
3934	LCN2	C0011616	Contact Dermatitis	0.200274726784213	1	0	CTD_human
3934	LCN2	C0019188	Hepatitis, Animal	0.2	1	0	CTD_human
3934	LCN2	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
3934	LCN2	C0403447	Chronic Kidney Insufficiency	0.2	1	0	CTD_human
3934	LCN2	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
3938	LCT	C0022951	Lactose Intolerance	0.277547334290631	0	0	HPO
3938	LCT	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
3938	LCT	C0268181	Lactose Intolerance, Adult Type	0.204670355331623	0	0	CTD_human
3939	LDHA	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
3939	LDHA	C0035078	Kidney Failure	0.2	0	0	HPO
3939	LDHA	C1565489	Renal Insufficiency	0.2	0	0	HPO
3939	LDHA	C2931743	Lactate dehydrogenase deficiency type A	0.4	0	0	CTD_human;ORPHANET
3945	LDHB	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
3945	LDHB	C3279904	Lactate Dehydrogenase B Deficiency	0.4	7	5	ORPHANET;UNIPROT
3949	LDLR	C0003742	Arcus Senilis	0.2	0	0	HPO
3949	LDLR	C0004153	Atherosclerosis	0.26187568151933	4	1	CTD_human
3949	LDLR	C0010054	Coronary Arteriosclerosis	0.221088449849779	0	0	HPO
3949	LDLR	C0010068	Coronary heart disease	0.248832497592054	1	0	CTD_human
3949	LDLR	C0015695	Fatty Liver	0.201098907136852	1	0	CTD_human
3949	LDLR	C0020443	Hypercholesterolemia	0.516026944862811	4	28	CTD_human;HPO
3949	LDLR	C0020445	Hypercholesterolemia, Familial	0.622856986690716	6	1072	CTD_human;HPO
3949	LDLR	C0020473	Hyperlipidemia	0.410583319515051	2	0	CTD_human;HPO
3949	LDLR	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
3949	LDLR	C0027051	Myocardial Infarction	0.215881317595423	0	0	HPO
3949	LDLR	C0028754	Obesity	0.216980224732276	1	0	CTD_human
3949	LDLR	C0034362	Q Fever	0.2	1	0	CTD_human
3949	LDLR	C0155210	Eyelid Xanthoma	0.2	0	0	HPO
3949	LDLR	C0302314	Xanthoma	0.201373633921065	0	0	HPO
3949	LDLR	C0342881	Familial hypercholesterolemia - homozygous	0.200274726784213	0	0	ORPHANET
3949	LDLR	C0400966	Non-alcoholic Fatty Liver Disease	0.201373633921065	3	0	CTD_human
3949	LDLR	C0745103	Hyperlipoproteinemia Type IIa	0.76	32	46	CTD_human;ORPHANET;UNIPROT
3949	LDLR	C1848486	Premature arteriosclerosis	0.2	0	0	HPO
3949	LDLR	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
3949	LDLR	C1956346	Coronary Artery Disease	0.237779592420524	2	0	CTD_human
3949	LDLR	C2711227	Steatohepatitis	0.200824180352639	0	0	HPO
3949	LDLR	C4025272	Peripheral arterial stenosis	0.2	0	0	HPO
3949	LDLR	C4280503	Premature hardening of arteries	0.2	0	0	HPO
3949	LDLR	C4280602	Xanthelasma of periocular region	0.2	0	0	HPO
3952	LEP	C0002395	Alzheimer's Disease	0.281923087489492	1	0	CTD_human
3952	LEP	C0010346	Crohn Disease	0.201373633921065	1	0	CTD_human
3952	LEP	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.324762752986171	1	0	CTD_human
3952	LEP	C0015695	Fatty Liver	0.211444301647686	4	0	CTD_human
3952	LEP	C0018418	Gynecomastia	0.200274726784213	0	0	HPO
3952	LEP	C0020443	Hypercholesterolemia	0.200549453568426	1	0	CTD_human
3952	LEP	C0020459	Hyperinsulinism	0.416165814136621	1	0	CTD_human;HPO
3952	LEP	C0020619	Hypogonadism	0.481098907136852	2	0	CTD_human;HPO
3952	LEP	C0028754	Obesity	0.72	13	0	CTD_human;HPO
3952	LEP	C0028756	Obesity, Morbid	0.210648832049681	2	0	CTD_human
3952	LEP	C0032460	Polycystic Ovary Syndrome	0.218009033714166	1	0	CTD_human
3952	LEP	C0038358	Gastric ulcer	0.2	6	0	CTD_human
3952	LEP	C0149745	Oral Ulcer	0.2	1	0	CTD_human
3952	LEP	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
3952	LEP	C0236663	Alcohol withdrawal syndrome	0.200824180352639	3	0	PSYGENET
3952	LEP	C0241910	Hepatitis, Autoimmune	0.2	1	0	CTD_human
3952	LEP	C0400966	Non-alcoholic Fatty Liver Disease	0.201923087489492	1	0	CTD_human
3952	LEP	C0524620	Metabolic Syndrome X	0.299099849825657	2	0	CTD_human
3952	LEP	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
3952	LEP	C0694550	Recurrent pneumonia	0.2	0	0	HPO
3952	LEP	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
3952	LEP	C0854110	Insulin resistant diabetes	0.2	0	0	HPO
3952	LEP	C0948896	Primary hypogonadism	0.2	0	0	HPO
3952	LEP	C3554224	LEPTIN DEFICIENCY OR DYSFUNCTION	0.408241803526393	2	2	ORPHANET;UNIPROT
3952	LEP	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
3953	LEPR	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.320892452872885	4	0	CTD_human
3953	LEPR	C0015695	Fatty Liver	0.20754696951139	1	0	CTD_human
3953	LEPR	C0018418	Gynecomastia	0.200274726784213	0	0	HPO
3953	LEPR	C0020456	Hyperglycemia	0.200274726784213	5	0	CTD_human
3953	LEPR	C0020459	Hyperinsulinism	0.401098907136852	5	0	CTD_human;HPO
3953	LEPR	C0020473	Hyperlipidemia	0.2	1	0	CTD_human
3953	LEPR	C0020619	Hypogonadism	0.2	1	0	CTD_human
3953	LEPR	C0028754	Obesity	0.688077187237292	8	2	CTD_human;HPO
3953	LEPR	C0028756	Obesity, Morbid	0.208660232025559	1	0	CTD_human
3953	LEPR	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
3953	LEPR	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
3953	LEPR	C0854110	Insulin resistant diabetes	0.2	0	0	HPO
3953	LEPR	C0948896	Primary hypogonadism	0.2	0	0	HPO
3953	LEPR	C3554225	LEPTIN RECEPTOR DEFICIENCY	0.2	0	0	ORPHANET
3953	LEPR	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
3953	LEPR	C3714796	Isolated somatotropin deficiency	0.200824180352639	0	0	HPO
3954	LETM1	C0014544	Epilepsy	0.201098907136852	0	0	HPO
3954	LETM1	C0015300	Exophthalmos	0.2	0	0	HPO
3954	LETM1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
3954	LETM1	C0028738	Nystagmus	0.2	0	0	HPO
3954	LETM1	C0029124	Optic Atrophy	0.2	0	0	HPO
3954	LETM1	C0034013	Precocious Puberty	0.2	0	0	HPO
3954	LETM1	C0038379	Strabismus	0.2	0	0	HPO
3954	LETM1	C0080218	Tethered Cord Syndrome	0.2	0	0	HPO
3954	LETM1	C0265341	Rieger syndrome	0.2	0	0	HPO
3954	LETM1	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
3954	LETM1	C1956097	Wolf-Hirschhorn Syndrome	0.403846174978983	1	0	CTD_human;ORPHANET
3954	LETM1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3955	LFNG	C0265343	Jarcho-Levin syndrome	0.2	0	0	ORPHANET
3955	LFNG	C1853296	SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 3	0.4	1	1	CTD_human;UNIPROT
3956	LGALS1	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
3956	LGALS1	C0027697	Nephritis	0.2	1	0	CTD_human
3957	LGALS2	C0027051	Myocardial Infarction	0.216207201536949	1	0	CTD_human
3957	LGALS2	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
3958	LGALS3	C0027697	Nephritis	0.203007639249027	1	0	CTD_human
3958	LGALS3	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
3959	LGALS3BP	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
396	ARHGDIA	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
396	ARHGDIA	C0155320	Blindness, Cortical	0.2	0	0	HPO
396	ARHGDIA	C0239981	Hypoalbuminemia	0.2	0	0	HPO
396	ARHGDIA	C0268747	Diffuse mesangial sclerosis (disorder)	0.2	0	0	HPO
3965	LGALS9	C0027697	Nephritis	0.2	1	0	CTD_human
397	ARHGDIB	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
3972	LHB	C0018418	Gynecomastia	0.2	0	0	HPO
3972	LHB	C0020514	Hyperprolactinemia	0.2	1	0	CTD_human
3972	LHB	C0020619	Hypogonadism	0.203231208875927	4	0	CTD_human
3972	LHB	C0032460	Polycystic Ovary Syndrome	0.201098907136852	2	0	CTD_human
3972	LHB	C0034013	Precocious Puberty	0.2	1	0	CTD_human
3972	LHB	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
3972	LHB	C0271582	Isolated lutropin deficiency (disorder)	0.4	1	5	ORPHANET;UNIPROT
3972	LHB	C0342527	Deficiency of testosterone biosynthesis	0.2	0	0	HPO
3972	LHB	C1864873	Testicular Microlithiasis	0.2	0	0	HPO
3973	LHCGR	C0034013	Precocious Puberty	0.20357144819477	0	0	HPO
3973	LHCGR	C0342549	Familial Testotoxicosis	0.608176290991763	15	12	CTD_human;ORPHANET;UNIPROT
3973	LHCGR	C0702166	Acne	0.2	0	0	HPO
3973	LHCGR	C0948896	Primary hypogonadism	0.2	0	0	HPO
3973	LHCGR	C1504412	Testotoxicosis	0.201373633921065	0	0	ORPHANET
3975	LHX1	C3281138	CHROMOSOME 17q12 DELETION SYNDROME	0.2	0	0	ORPHANET
3975	LHX1	C3714581	Multicystic Dysplastic Kidney	0.200274726784213	0	0	HPO
3976	LIF	C0032460	Polycystic Ovary Syndrome	0.200549453568426	1	0	CTD_human
3976	LIF	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
3977	LIFR	C0004096	Asthma	0.2	0	0	HPO
3977	LIFR	C0013363	Dysautonomia	0.2	0	0	HPO
3977	LIFR	C0020620	Hypohidrosis	0.2	0	0	HPO
3977	LIFR	C0029453	Osteopenia	0.2	0	0	HPO
3977	LIFR	C0029456	Osteoporosis	0.2	0	0	HPO
3977	LIFR	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
3977	LIFR	C0041105	Trismus	0.2	0	0	HPO
3977	LIFR	C0155964	Atrophy of tongue papillae	0.2	0	0	HPO
3977	LIFR	C0432240	Stuve-Wiedemann dysplasia	0.2	0	0	ORPHANET
3977	LIFR	C0747078	Generalized osteopenia	0.2	0	0	HPO
3977	LIFR	C0796176	STUVE-WIEDEMANN SYNDROME	0.601923087489492	2	4	CTD_human;ORPHANET;UNIPROT
3977	LIFR	C1504382	Pulmonary artery wall hypertrophy	0.2	0	0	HPO
3977	LIFR	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
3977	LIFR	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
3977	LIFR	C3714497	Reactive airway disease	0.2	0	0	HPO
3981	LIG4	C0002170	Alopecia	0.2	0	0	HPO
3981	LIG4	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
3981	LIG4	C0013595	Eczema	0.2	0	0	HPO
3981	LIG4	C0014457	Eosinophilia	0.2	0	0	HPO
3981	LIG4	C0030312	Pancytopenia	0.200274726784213	0	0	HPO
3981	LIG4	C0032285	Pneumonia	0.2	0	0	HPO
3981	LIG4	C0085110	Severe Combined Immunodeficiency	0.21007066772662	0	0	HPO
3981	LIG4	C0175691	Dubowitz syndrome	0.200274726784213	0	0	ORPHANET
3981	LIG4	C0259817	Xerosis	0.2	0	0	HPO
3981	LIG4	C0401151	Chronic diarrhea	0.2	0	0	HPO
3981	LIG4	C1847827	LIG4 Syndrome	0.682472541057918	1	7	CTD_human;ORPHANET;UNIPROT
3981	LIG4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3981	LIG4	C2700553	Omenn Syndrome	0.2	0	0	ORPHANET
3982	LIM2	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
3982	LIM2	C3809004	CATARACT 19, MULTIPLE TYPES	0.28	1	2	UNIPROT
3982	LIM2	C4021568	Cortical pulverulent cataract	0.2	0	0	HPO
3984	LIMK1	C0003499	Supravalvular aortic stenosis	0.2	0	0	HPO
3984	LIMK1	C0007786	Brain Ischemia	0.202407028523288	0	0	HPO
3984	LIMK1	C0012819	Diverticular disease of colon	0.2	0	0	HPO
3984	LIMK1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
3984	LIMK1	C0020437	Hypercalcemia	0.2	0	0	HPO
3984	LIMK1	C0020545	Hypertension, Renovascular	0.2	0	0	HPO
3984	LIMK1	C0024421	Macroglossia	0.2	0	0	HPO
3984	LIMK1	C0024636	Malocclusion	0.2	0	0	HPO
3984	LIMK1	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
3984	LIMK1	C0028754	Obesity	0.2	0	0	HPO
3984	LIMK1	C0035078	Kidney Failure	0.2	0	0	HPO
3984	LIMK1	C0038379	Strabismus	0.2	0	0	HPO
3984	LIMK1	C0042798	Low Vision	0.2	0	0	HPO
3984	LIMK1	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
3984	LIMK1	C0175702	Williams Syndrome	0.28357144819477	0	0	ORPHANET
3984	LIMK1	C0271441	Chronic otitis media	0.2	0	0	HPO
3984	LIMK1	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
3984	LIMK1	C0743359	ear infection chronic	0.2	0	0	HPO
3984	LIMK1	C0917798	Cerebral Ischemia	0.2	0	0	HPO
3984	LIMK1	C1565489	Renal Insufficiency	0.2	0	0	HPO
3984	LIMK1	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
3984	LIMK1	C4020884	Anxiety disease	0.2	0	0	HPO
3984	LIMK1	C4025788	Nystagmus-induced head nodding	0.2	0	0	HPO
3984	LIMK1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
3988	LIPA	C0002871	Anemia	0.2	0	0	HPO
3988	LIPA	C0003850	Arteriosclerosis	0.200549453568426	0	0	HPO
3988	LIPA	C0008384	Cholesterol Ester Storage Disease	0.409000471344402	1	0	CTD_human;ORPHANET
3988	LIPA	C0020443	Hypercholesterolemia	0.200274726784213	0	0	HPO
3988	LIPA	C0043208	Wolman Disease	0.493186885642229	2	7	ORPHANET;UNIPROT
3988	LIPA	C0085605	Liver Failure	0.2	0	0	HPO
3988	LIPA	C0162429	Malnutrition	0.2	0	0	HPO
3988	LIPA	C0220756	Niemann-Pick Disease, Type C	0.2	1	0	CTD_human
3988	LIPA	C0239946	Fibrosis, Liver	0.200274726784213	0	0	HPO
3988	LIPA	C0271750	Adrenal calcification	0.2	0	0	HPO
3988	LIPA	C1956346	Coronary Artery Disease	0.200824180352639	1	1	CTD_human
3988	LIPA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
3988	LIPA	C2936797	Acid cholesteryl ester hydrolase deficiency, type 2	0.201098907136852	0	0	CTD_human
3988	LIPA	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
3988	LIPA	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
3990	LIPC	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.235896213599737	2	0	CTD_human
3990	LIPC	C0020445	Hypercholesterolemia, Familial	0.200549453568426	1	0	CTD_human
3990	LIPC	C0020452	Hyperemia	0.202407028523288	1	0	CTD_human
3990	LIPC	C0020473	Hyperlipidemia	0.214442171139728	1	0	CTD_human
3990	LIPC	C0020476	Hyperlipoproteinemias	0.204814057046576	1	0	CTD_human
3990	LIPC	C0221252	Eruptive xanthoma	0.2	0	0	HPO
3990	LIPC	C0342883	Cholesteryl Ester Transfer Protein Deficiency	0.201373633921065	0	0	HPO
3990	LIPC	C3151466	HEPATIC LIPASE DEFICIENCY (disorder)	0.400274726784213	2	2	ORPHANET;UNIPROT
3991	LIPE	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
3991	LIPE	C0023787	Lipodystrophy	0.2	0	0	HPO
3991	LIPE	C0032460	Polycystic Ovary Syndrome	0.203007639249027	0	0	HPO
3991	LIPE	C0854110	Insulin resistant diabetes	0.2	0	0	HPO
3991	LIPE	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
3991	LIPE	C2711227	Steatohepatitis	0.200274726784213	0	0	HPO
3991	LIPE	C2712907	combined hyperlipidemia	0.2	0	0	HPO
3991	LIPE	C4014869	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6	0.2	0	0	ORPHANET
3992	FADS1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
399516	OTSC7	C1969044	OTOSCLEROSIS 7	0.2	0	0	CTD_human
399564	GLC1H	C1969811	GLAUCOMA 1, OPEN ANGLE, H (disorder)	0.2	0	0	CTD_human
399565	GLC3C	C3888011	GLAUCOMA 3, PRIMARY CONGENITAL, C	0.2	0	0	CTD_human
3998	LMAN1	C0015499	Factor V Deficiency	0.202407028523288	0	0	HPO
3998	LMAN1	C1856883	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF	0.60357144819477	1	5	CTD_human;ORPHANET;UNIPROT
3998	LMAN1	C3494187	Factor VIII Deficiency	0.200824180352639	0	0	HPO
399909	PCNX3	C0024141	Lupus Erythematosus, Systemic	0.2	1	1	CTD_human
4000	LMNA	C0000889	Acanthosis Nigricans	0.200549453568426	0	0	HPO
4000	LMNA	C0001339	Acute pancreatitis	0.2	0	0	HPO
4000	LMNA	C0002170	Alopecia	0.2	0	0	HPO
4000	LMNA	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
4000	LMNA	C0004153	Atherosclerosis	0.207011871320281	0	0	HPO
4000	LMNA	C0004238	Atrial Fibrillation	0.206513574909167	0	0	HPO
4000	LMNA	C0010054	Coronary Arteriosclerosis	0.203780662444353	0	0	HPO
4000	LMNA	C0011644	Scleroderma	0.200274726784213	0	0	HPO
4000	LMNA	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.213800173013661	0	0	HPO
4000	LMNA	C0013238	Dry Eye Syndromes	0.2	0	0	HPO
4000	LMNA	C0014390	Entropion	0.2	0	0	HPO
4000	LMNA	C0015300	Exophthalmos	0.2	0	0	HPO
4000	LMNA	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
4000	LMNA	C0018794	Heart Block	0.200274726784213	1	0	CTD_human
4000	LMNA	C0018801	Heart failure	0.204879569581206	0	0	HPO
4000	LMNA	C0018802	Congestive heart failure	0.202472541057918	0	0	HPO
4000	LMNA	C0020443	Hypercholesterolemia	0.2	0	0	HPO
4000	LMNA	C0020456	Hyperglycemia	0.2	0	0	HPO
4000	LMNA	C0020459	Hyperinsulinism	0.201373633921065	0	0	HPO
4000	LMNA	C0020473	Hyperlipidemia	0.2	0	0	HPO
4000	LMNA	C0020490	Hyperopia	0.2	0	0	HPO
4000	LMNA	C0020619	Hypogonadism	0.2	0	0	HPO
4000	LMNA	C0020620	Hypohidrosis	0.2	0	0	HPO
4000	LMNA	C0020676	Hypothyroidism	0.2	0	0	HPO
4000	LMNA	C0022575	Keratoconjunctivitis Sicca	0.2	0	0	HPO
4000	LMNA	C0023787	Lipodystrophy	0.226027267613658	0	0	HPO
4000	LMNA	C0025322	Premature Menopause	0.2	0	0	HPO
4000	LMNA	C0026850	Muscular Dystrophy	0.219448180169861	0	0	HPO
4000	LMNA	C0027051	Myocardial Infarction	0.200274726784213	0	0	HPO
4000	LMNA	C0028754	Obesity	0.204604842796993	0	0	HPO
4000	LMNA	C0029408	Degenerative polyarthritis	0.200274726784213	0	0	HPO
4000	LMNA	C0029456	Osteoporosis	0.2	0	0	HPO
4000	LMNA	C0031039	Pericardial effusion	0.2	0	0	HPO
4000	LMNA	C0032460	Polycystic Ovary Syndrome	0.40350593566014	1	0	CTD_human;HPO
4000	LMNA	C0033300	Progeria	0.752630333288665	14	20	CTD_human;ORPHANET;UNIPROT
4000	LMNA	C0034013	Precocious Puberty	0.2	0	0	HPO
4000	LMNA	C0034067	Pulmonary Emphysema	0.2	0	0	HPO
4000	LMNA	C0036420	Localized scleroderma	0.2	1	0	CTD_human
4000	LMNA	C0037188	Sinoatrial Block	0.2	1	0	CTD_human
4000	LMNA	C0042514	Tachycardia, Ventricular	0.200549453568426	1	0	CTD_human
4000	LMNA	C0043119	Werner Syndrome	0.200824180352639	0	0	CTD_human
4000	LMNA	C0043325	Xanthomatosis	0.2	0	0	HPO
4000	LMNA	C0043349	Xerophthalmia	0.2	0	0	HPO
4000	LMNA	C0085612	Ventricular arrhythmia	0.201923087489492	0	0	HPO
4000	LMNA	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
4000	LMNA	C0085684	Foot-drop	0.2	0	0	HPO
4000	LMNA	C0158266	Intervertebral Disc Degeneration	0.2	0	0	HPO
4000	LMNA	C0221032	Familial generalized lipodystrophy	0.201923087489492	0	0	HPO
4000	LMNA	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
4000	LMNA	C0234958	muscle degeneration	0.2	0	0	HPO
4000	LMNA	C0238621	Aminoaciduria	0.2	0	0	HPO
4000	LMNA	C0238669	Aortic root dilatation	0.2	0	0	HPO
4000	LMNA	C0263505	Alopecia universalis	0.2	0	0	HPO
4000	LMNA	C0263625	Subcutaneous calcification	0.2	0	0	HPO
4000	LMNA	C0270254	Hydrops of placenta	0.2	0	0	HPO
4000	LMNA	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
4000	LMNA	C0271694	Familial partial lipodystrophy	0.238599187152831	4	0	CTD_human
4000	LMNA	C0340279	Ventricular hypertrophy	0.2	0	0	HPO
4000	LMNA	C0399385	Early tooth exfoliation	0.2	0	0	HPO
4000	LMNA	C0406585	Lethal tight skin contracture syndrome (disorder)	0.4	0	0	CTD_human;ORPHANET
4000	LMNA	C0410189	Muscular Dystrophy, Emery-Dreifuss	0.234254715762734	1	1	CTD_human
4000	LMNA	C0410190	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	0.487417623173754	19	62	ORPHANET;UNIPROT
4000	LMNA	C0428791	Aortic valve calcification	0.2	0	0	HPO
4000	LMNA	C0432291	Mandibuloacral dysostosis	0.604670355331623	5	12	CTD_human;ORPHANET;UNIPROT
4000	LMNA	C0473527	Hypoalphalipoproteinemias	0.2	0	0	HPO
4000	LMNA	C0553730	Calcium pyrophosphate deposition disease	0.2	0	0	HPO
4000	LMNA	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
4000	LMNA	C0699743	Congenital muscular dystrophy (disorder)	0.202747267842131	0	0	HPO
4000	LMNA	C0796031	Malouf syndrome	0.400274726784213	3	2	ORPHANET;UNIPROT
4000	LMNA	C0796083	Najjar syndrome	0.2	0	0	ORPHANET
4000	LMNA	C0836924	Thrombocytosis	0.2	0	0	HPO
4000	LMNA	C0854110	Insulin resistant diabetes	0.200274726784213	0	0	HPO
4000	LMNA	C0870082	Hyperkeratosis	0.2	0	0	HPO
4000	LMNA	C0917990	Acro-Osteolysis	0.200549453568426	0	0	HPO
4000	LMNA	C0919718	Calcification of mitral valve	0.2	0	0	HPO
4000	LMNA	C0948896	Primary hypogonadism	0.200274726784213	0	0	HPO
4000	LMNA	C1136321	HIV-Associated Lipodystrophy Syndrome	0.200274726784213	1	0	CTD_human
4000	LMNA	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
4000	LMNA	C1274865	Scleroderma-like secondary cutaneous sclerosis	0.2	0	0	HPO
4000	LMNA	C1280433	Lipoatrophy	0.201373633921065	0	0	HPO
4000	LMNA	C1389113	Generalized amyotrophy	0.2	0	0	HPO
4000	LMNA	C1389118	Peroneal muscle atrophy	0.2	0	0	HPO
4000	LMNA	C1449563	Cardiomyopathy, Familial Idiopathic	0.493945553460238	17	34	ORPHANET;UNIPROT
4000	LMNA	C1450051	Autosomal Recessive Emery-Dreifuss Muscular Dystrophy	0.200824180352639	0	0	ORPHANET
4000	LMNA	C1720859	Familial Partial Lipodystrophy, Type 1	0.200274726784213	0	0	ORPHANET
4000	LMNA	C1720860	Familial Partial Lipodystrophy, Type 2	0.403021994626344	10	17	ORPHANET;UNIPROT
4000	LMNA	C1834405	Nail dysplasia	0.2	0	0	HPO
4000	LMNA	C1834653	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B (disorder)	0.604120901763197	7	16	CTD_human;ORPHANET;UNIPROT
4000	LMNA	C1836451	Muscle atrophy, lower limb, distal	0.2	0	0	HPO
4000	LMNA	C1848486	Premature arteriosclerosis	0.2	0	0	HPO
4000	LMNA	C1848736	Distal amyotrophy	0.2	0	0	HPO
4000	LMNA	C1854154	Charcot-Marie-Tooth disease, Type 2B1	0.68	1	1	CTD_human;ORPHANET;UNIPROT
4000	LMNA	C1857829	Heart-hand syndrome, Slovenian type	0.4	0	0	CTD_human;ORPHANET
4000	LMNA	C1956346	Coronary Artery Disease	0.201373633921065	0	0	HPO
4000	LMNA	C1960469	Left ventricular noncompaction	0.200549453568426	0	0	ORPHANET
4000	LMNA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4000	LMNA	C2711227	Steatohepatitis	0.200549453568426	0	0	HPO
4000	LMNA	C2750035	Emery-Dreifuss Muscular Dystrophy 3	0.2	2	3	UNIPROT
4000	LMNA	C2750785	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED (disorder)	0.680274726784213	2	13	CTD_human;ORPHANET;UNIPROT
4000	LMNA	C2930821	Keratitis sicca	0.2	0	0	HPO
4000	LMNA	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
4000	LMNA	C3805887	Generalized osteoporosis with pathologic fractures	0.2	0	0	HPO
4000	LMNA	C3887524	Skin Erosion	0.2	0	0	HPO
4000	LMNA	C4021528	Pelvic girdle amyotrophy	0.2	0	0	HPO
4000	LMNA	C4021573	Patchy hypo- and hyperpigmentation	0.2	0	0	HPO
4000	LMNA	C4021684	Sclerosis of hand bone	0.2	0	0	HPO
4000	LMNA	C4024641	Enlarged polycystic ovaries	0.2	0	0	HPO
4000	LMNA	C4025270	Arteriosclerosis of small cerebral arteries	0.2	0	0	HPO
4000	LMNA	C4025619	Peripheral axonal atrophy	0.2	0	0	HPO
4000	LMNA	C4275075	Atypical Werner syndrome	0.202197814273705	0	0	ORPHANET
4000	LMNA	C4280503	Premature hardening of arteries	0.2	0	0	HPO
4001	LMNB1	C0023520	Leukodystrophy	0.202472541057918	0	0	HPO
4001	LMNB1	C0028738	Nystagmus	0.2	0	0	HPO
4001	LMNB1	C0033790	Pseudobulbar Palsy	0.2	0	0	HPO
4001	LMNB1	C0085606	Urgency of micturition	0.2	0	0	HPO
4001	LMNB1	C0205711	Pelizaeus-Merzbacher Disease	0.200274726784213	0	0	CTD_human
4001	LMNB1	C0242350	Erectile dysfunction	0.2	0	0	HPO
4001	LMNB1	C0431370	Atrophy of corpus callosum	0.2	0	0	HPO
4001	LMNB1	C3164344	Adult onset autosomal dominant leukodystrophy	0.200824180352639	0	0	ORPHANET
4001	LMNB1	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
4001	LMNB1	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
4001	LMNB1	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
4001	LMNB1	C4025212	Autonomic bladder dysfunction	0.2	0	0	HPO
4004	LMO1	C2931189	Neural crest tumor	0.2	0	0	ORPHANET
400916	CHCHD10	C0002736	Amyotrophic Lateral Sclerosis	0.201098907136852	0	0	ORPHANET
400916	CHCHD10	C3554398	SPINAL MUSCULAR ATROPHY, JOKELA TYPE	0.400274726784213	1	1	ORPHANET;UNIPROT
400916	CHCHD10	C4014648	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2	0.2	2	4	UNIPROT
400916	CHCHD10	C4015513	MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT	0.4	1	2	ORPHANET;UNIPROT
400935	IL17REL	C0009324	Ulcerative Colitis	0.200274726784213	1	1	CTD_human
401	PHOX2A	C0015310	Exotropia	0.200549453568426	0	0	HPO
401	PHOX2A	C0042798	Low Vision	0.2	0	0	HPO
401	PHOX2A	C1302995	Congenital Fibrosis of the Extraocular Muscles	0.202472541057918	0	0	HPO
401	PHOX2A	C1851102	Fibrosis Of Extraocular Muscles, Congenital, 1	0.200274726784213	0	0	ORPHANET
401	PHOX2A	C1865915	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2	0.401098907136852	1	1	CTD_human;UNIPROT
4010	LMX1B	C0017601	Glaucoma	0.201648360705279	0	0	HPO
4010	LMX1B	C0017658	Glomerulonephritis	0.2	0	0	HPO
4010	LMX1B	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4010	LMX1B	C0020473	Hyperlipidemia	0.2	1	0	CTD_human
4010	LMX1B	C0021603	Sleep Initiation and Maintenance Disorders	0.2	1	0	CTD_human
4010	LMX1B	C0022578	Keratoconus	0.2	0	0	HPO
4010	LMX1B	C0027341	Nail-Patella Syndrome	0.712852371087034	6	10	CTD_human;ORPHANET;UNIPROT
4010	LMX1B	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
4010	LMX1B	C0035078	Kidney Failure	0.2	0	0	HPO
4010	LMX1B	C1565489	Renal Insufficiency	0.2	0	0	HPO
4010	LMX1B	C1842028	GLAUCOMA 1, OPEN ANGLE, A	0.2	0	0	CTD_human
4010	LMX1B	C1867439	Pterygium, Antecubital	0.2	0	0	HPO
4014	LOR	C0022596	Palmoplantar Keratosis	0.200824180352639	0	0	HPO
4014	LOR	C0030436	Parakeratosis	0.2	0	0	HPO
4014	LOR	C0265961	Erythrokeratodermia variabilis	0.200274726784213	0	0	ORPHANET
4014	LOR	C0870082	Hyperkeratosis	0.200274726784213	0	0	HPO
4014	LOR	C1858805	Vohwinkel Syndrome, Variant Form	0.402472541057918	0	0	CTD_human;ORPHANET
4015	LOX	C0003504	Aortic Valve Insufficiency	0.4	1	0	CTD_human;HPO
4015	LOX	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
4015	LOX	C0019163	Hepatitis B	0.2	1	0	CTD_human
4015	LOX	C0019196	Hepatitis C	0.2	1	0	CTD_human
4015	LOX	C0019202	Hepatolenticular Degeneration	0.20328236603324	1	0	CTD_human
4015	LOX	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
4015	LOX	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
4015	LOX	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
4015	LOX	C0029172	Oral Submucous Fibrosis	0.205363510615002	1	0	CTD_human
4015	LOX	C0263401	Cutis marmorata	0.2	0	0	HPO
4015	LOX	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
4015	LOX	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.2	0	0	ORPHANET
4015	LOX	C1956346	Coronary Artery Disease	0.280274726784213	0	0	HPO
4015	LOX	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
4016	LOXL1	C0206368	Exfoliation Syndrome	0.297554737785903	1	3	CTD_human
4017	LOXL2	C0019163	Hepatitis B	0.2	1	0	CTD_human
4017	LOXL2	C0019196	Hepatitis C	0.2	1	0	CTD_human
4017	LOXL2	C0019202	Hepatolenticular Degeneration	0.203007639249027	1	0	CTD_human
4017	LOXL2	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
4018	LPA	C0004153	Atherosclerosis	0.228491717646215	3	0	CTD_human
4018	LPA	C0010068	Coronary heart disease	0.252051029822288	1	4	CTD_human
4018	LPA	C0020443	Hypercholesterolemia	0.203021994626344	1	0	CTD_human
4018	LPA	C1956346	Coronary Artery Disease	0.25276831023997	2	1	CTD_human
4023	LPL	C0019196	Hepatitis C	0.2	1	0	CTD_human
4023	LPL	C0020443	Hypercholesterolemia	0.413958230105932	1	0	CTD_human;HPO
4023	LPL	C0020445	Hypercholesterolemia, Familial	0.20783605167292	1	0	CTD_human
4023	LPL	C0020473	Hyperlipidemia	0.437437674370058	1	0	CTD_human;HPO
4023	LPL	C0020474	Hyperlipidemia, Familial Combined	0.217371621208431	0	0	CTD_human
4023	LPL	C0020481	Hyperlipoproteinemia Type V	0.200274726784213	0	0	ORPHANET
4023	LPL	C0023817	Hyperlipoproteinemia Type I	0.709381410533485	35	48	CTD_human;ORPHANET;UNIPROT
4023	LPL	C0027051	Myocardial Infarction	0.237712401154271	0	0	HPO
4023	LPL	C0028754	Obesity	0.251699342014837	1	0	CTD_human
4023	LPL	C0030305	Pancreatitis	0.410634476672364	1	0	CTD_human;HPO
4023	LPL	C0221252	Eruptive xanthoma	0.200274726784213	0	0	HPO
4023	LPL	C0339477	Lipidemia retinalis	0.2	0	0	HPO
4023	LPL	C2712907	combined hyperlipidemia	0.200824180352639	0	0	HPO
4026	LPP	C3495559	Juvenile arthritis	0.202956482091714	1	0	CTD_human
4035	LRP1	C0263429	Atrophoderma vermiculatum	0.2	0	0	ORPHANET
4035	LRP1	C0338480	Common Migraine	0.2	1	0	CTD_human
4036	LRP2	C0015300	Exophthalmos	0.2	0	0	HPO
4036	LRP2	C0018784	Sensorineural Hearing Loss (disorder)	0.400274726784213	1	0	CTD_human;HPO
4036	LRP2	C0027092	Myopia	0.2	0	0	HPO
4036	LRP2	C0035305	Retinal Detachment	0.2	0	0	HPO
4036	LRP2	C0042870	Vitamin D Deficiency	0.200274726784213	1	0	CTD_human
4036	LRP2	C1857277	Donnai-Barrow syndrome	0.681373633921066	1	15	CTD_human;ORPHANET;UNIPROT
4036	LRP2	C1857278	Partial or complete agenesis of corpus callosum	0.2	0	0	HPO
4038	LRP4	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4038	LRP4	C0029464	Osteosclerosis	0.2	0	0	HPO
4038	LRP4	C0376175	Bell Palsy	0.2	0	0	HPO
4038	LRP4	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	0.2	0	0	ORPHANET
4038	LRP4	C1834405	Nail dysplasia	0.2	0	0	HPO
4038	LRP4	C1859309	Syndactyly Cenani Lenz type	0.680274726784213	1	5	CTD_human;ORPHANET;UNIPROT
4038	LRP4	C3280402	SCLEROSTEOSIS 2	0.280274726784213	2	2	UNIPROT
4038	LRP4	C4020952	Fingernail dysplasia	0.2	0	0	HPO
4038	LRP4	C4225377	MYASTHENIC SYNDROME, CONGENITAL, 17	0.2	1	2	UNIPROT
4040	LRP6	C1970440	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2 (disorder)	0.4	2	4	CTD_human;UNIPROT
4040	LRP6	C4225231	TOOTH AGENESIS, SELECTIVE, 7	0.2	1	3	UNIPROT
4041	LRP5	C0010278	Craniosynostosis	0.200274726784213	0	0	HPO
4041	LRP5	C0018777	Conductive hearing loss	0.2	0	0	HPO
4041	LRP5	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4041	LRP5	C0024636	Malocclusion	0.2	0	0	HPO
4041	LRP5	C0029453	Osteopenia	0.200824180352639	0	0	HPO
4041	LRP5	C0029454	Osteopetrosis	0.204106546385879	0	0	HPO
4041	LRP5	C0029456	Osteoporosis	0.459864783034311	0	0	CTD_human;HPO
4041	LRP5	C0029464	Osteosclerosis	0.200549453568426	0	0	HPO
4041	LRP5	C0035305	Retinal Detachment	0.2	0	0	HPO
4041	LRP5	C0035344	Retinopathy of Prematurity	0.200549453568426	0	0	ORPHANET
4041	LRP5	C0242852	Proliferative vitreoretinopathy	0.2	1	0	CTD_human
4041	LRP5	C0264080	Juvenile osteoporosis	0.2	0	0	ORPHANET
4041	LRP5	C0271007	Phthisis bulbi	0.2	0	0	HPO
4041	LRP5	C0271215	Blindness, Legal	0.2	0	0	HPO
4041	LRP5	C0376175	Bell Palsy	0.2	0	0	HPO
4041	LRP5	C0410550	Collapse of vertebra	0.2	0	0	HPO
4041	LRP5	C0423319	Atrophic iris	0.2	0	0	HPO
4041	LRP5	C0423361	Posterior Vitreous Detachment	0.2	0	0	HPO
4041	LRP5	C0432252	Osteoporosis with pseudoglioma	0.686043989252688	8	23	CTD_human;ORPHANET;UNIPROT
4041	LRP5	C0432273	Worth disease	0.6	1	3	CTD_human;ORPHANET;UNIPROT
4041	LRP5	C0747078	Generalized osteopenia	0.2	0	0	HPO
4041	LRP5	C1843323	Van Buchem disease type 2	0.4	0	0	CTD_human;UNIPROT
4041	LRP5	C1843330	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1	0.6	1	3	CTD_human;ORPHANET;UNIPROT
4041	LRP5	C1851402	Exudative vitreoretinopathy 1	0.400549453568426	1	1	ORPHANET;UNIPROT
4041	LRP5	C1866176	EXUDATIVE VITREORETINOPATHY 4 (disorder)	0.48	8	18	CTD_human;UNIPROT
4041	LRP5	C1866180	Horizontal pendular nystagmus	0.2	0	0	HPO
4041	LRP5	C4021951	Vertebral body sclerosis	0.2	0	0	HPO
4041	LRP5	C4072980	Exudative vitreoretinopathy	0.200274726784213	0	0	HPO
4041	LRP5	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
4043	LRPAP1	C0042798	Low Vision	0.2	0	0	HPO
4043	LRPAP1	C0271183	Severe myopia	0.200549453568426	0	0	HPO
4046	LSP1	C0009324	Ulcerative Colitis	0.2	1	1	CTD_human
404672	GTF2H5	C1866504	Photosensitive Trichothiodystrophy	0.2	0	0	CTD_human
404672	GTF2H5	C1955934	Trichothiodystrophy Syndromes	0.210989071368524	0	0	ORPHANET
404672	GTF2H5	C4017171	TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE	0.2	1	1	UNIPROT
404677	CIMT	C1838020	CAROTID INTIMAL MEDIAL THICKNESS 2	0.2	0	0	CTD_human
404682	MYP5	C1837972	MYOPIA 5 (disorder)	0.2	0	0	CTD_human
404683	BMIQ7	C0028754	Obesity	0.2	0	0	CTD_human
4047	LSS	C0023794	Lipoidosis	0.2	2	0	CTD_human
4047	LSS	C0034362	Q Fever	0.2	1	0	CTD_human
4047	LSS	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4047	LSS	C4225300	CATARACT 44	0.2	1	2	UNIPROT
404713	SSD	C4078288	Speech-Sound Disorder, hereditary	0.2	0	0	CTD_human
404714	SLEB4	C0024141	Lupus Erythematosus, Systemic	0.200549453568426	0	0	CTD_human
4048	LTA4H	C0004153	Atherosclerosis	0.202956482091714	1	0	CTD_human
4049	LTA	C0003872	Arthritis, Psoriatic	0.207821696295603	1	0	CTD_human
4049	LTA	C0019151	Hepatic Encephalopathy	0.2	1	0	CTD_human
4049	LTA	C0023343	Leprosy	0.202681755307501	1	0	CTD_human
4049	LTA	C0027051	Myocardial Infarction	0.258495734733578	2	2	CTD_human
4049	LTA	C0243026	Sepsis	0.228675128029873	1	0	CTD_human
4049	LTA	C1956346	Coronary Artery Disease	0.225611746003201	1	0	CTD_human
405	ARNT	C0014175	Endometriosis	0.205964121340741	1	0	CTD_human
405	ARNT	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
405	ARNT	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
4053	LTBP2	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
4053	LTBP2	C0017601	Glaucoma	0.401648360705279	2	0	CTD_human;HPO
4053	LTBP2	C0027092	Myopia	0.2	0	0	HPO
4053	LTBP2	C0265313	Weill-Marchesani syndrome	0.200274726784213	0	0	ORPHANET
4053	LTBP2	C0271183	Severe myopia	0.2	0	0	HPO
4053	LTBP2	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
4053	LTBP2	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
4053	LTBP2	C2751316	Glaucoma 3, Primary Congenital, D	0.2	0	0	CTD_human
4053	LTBP2	C3538951	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA	0.2	0	0	ORPHANET
4053	LTBP2	C3553785	WEILL-MARCHESANI SYNDROME 3	0.2	1	1	UNIPROT
4054	LTBP3	C0020555	Hypertrichosis	0.2	0	0	HPO
4054	LTBP3	C0021818	Intervertebral Disk Displacement	0.2	0	0	HPO
4054	LTBP3	C0026267	Mitral Valve Prolapse Syndrome	0.4	1	0	CTD_human;HPO
4054	LTBP3	C0029408	Degenerative polyarthritis	0.2	2	0	CTD_human
4054	LTBP3	C0029464	Osteosclerosis	0.4	2	0	CTD_human;HPO
4054	LTBP3	C0432228	Brachyolmia	0.200274726784213	1	0	CTD_human
4054	LTBP3	C1832594	Verloes Bourguignon syndrome	0.28	0	0	ORPHANET
4055	LTBR	C0024530	Malaria	0.2	1	0	CTD_human
4056	LTC4S	C1319853	Asthma, Aspirin-Induced	0.206462417751855	4	0	CTD_human
4056	LTC4S	C3279662	Leukotriene C4 Synthase Deficiency	0.2	0	0	ORPHANET
4057	LTF	C0006849	Oral candidiasis	0.2	1	0	CTD_human
4057	LTF	C0009324	Ulcerative Colitis	0.2	1	0	CTD_human
4057	LTF	C0014175	Endometriosis	0.202732912464814	1	0	CTD_human
4057	LTF	C0029456	Osteoporosis	0.202732912464814	2	0	CTD_human
4057	LTF	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
4057	LTF	C0700345	Candidiasis, Vulvovaginal	0.2	1	0	CTD_human
4057	LTF	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
405753	DUOXA2	C0342196	Thyroid Dyshormonogenesis 5	0.2	0	0	CTD_human
405753	DUOXA2	C1848805	Thyroid Dyshormonogenesis 1	0.2	0	0	ORPHANET
4058	LTK	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
406	ARNTL	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
4060	LUM	C0023890	Liver Cirrhosis	0.200274726784213	1	0	CTD_human
4061	LY6E	C0021400	Influenza	0.2	1	0	CTD_human
406214	LRSL	C1837884	Larsen-Like Syndrome	0.2	0	0	CTD_human
406215	KTCN3	C1837809	Keratoconus 3	0.2	0	0	CTD_human
406216	ATFB1	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	CTD_human
406237	PDON2	C1969478	Periodontitis, Aggressive, 2	0.2	0	0	CTD_human
406238	ALS7	C1842674	AMYOTROPHIC LATERAL SCLEROSIS 7 (disorder)	0.2	0	0	CTD_human
4068	SH2D1A	C0002871	Anemia	0.2	0	0	HPO
4068	SH2D1A	C0014038	Encephalitis	0.2	0	0	HPO
4068	SH2D1A	C0019151	Hepatic Encephalopathy	0.2	0	0	HPO
4068	SH2D1A	C0025289	Meningitis	0.2	0	0	HPO
4068	SH2D1A	C0030312	Pancytopenia	0.2	0	0	HPO
4068	SH2D1A	C0086438	Hypogammaglobulinemia	0.201373633921065	0	0	HPO
4068	SH2D1A	C0162539	IgG Deficiency	0.2	0	0	HPO
4068	SH2D1A	C0302809	Fulminant hepatitis	0.2	0	0	HPO
406884	MIRLET7B	C0008370	Cholestasis	0.2	1	0	CTD_human
406884	MIRLET7B	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
406886	MIRLET7D	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
406891	MIRLET7I	C0008370	Cholestasis	0.2	1	0	CTD_human
406892	MIR100	C0017658	Glomerulonephritis	0.2	1	0	CTD_human
4069	LYZ	C0008370	Cholestasis	0.2	0	0	HPO
4069	LYZ	C0268389	Amyloidosis, familial visceral	0.4	1	5	CTD_human;UNIPROT
406901	MIR107	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406902	MIR10A	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406903	MIR10B	C0015695	Fatty Liver	0.2	1	0	CTD_human
406903	MIR10B	C0017658	Glomerulonephritis	0.2	1	0	CTD_human
406903	MIR10B	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406906	MIR122	C4277682	Chemical and Drug Induced Liver Injury	0.2	3	0	CTD_human
406913	MIR126	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
406914	MIR127	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
406916	MIR128-2	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
406919	MIR130A	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406920	MIR130B	C0008370	Cholestasis	0.200274726784213	1	0	CTD_human
406921	MIR132	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406924	MIR134	C0015695	Fatty Liver	0.2	1	0	CTD_human
406931	MIR139	C0015695	Fatty Liver	0.2	1	0	CTD_human
406933	MIR141	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406937	MIR145	C0011881	Diabetic Nephropathy	0.2	1	0	CTD_human
406938	MIR146A	C0002395	Alzheimer's Disease	0.205205453522732	1	0	CTD_human
406938	MIR146A	C1956346	Coronary Artery Disease	0.201098907136852	1	0	CTD_human
406940	MIR148A	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406941	MIR149	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406942	MIR150	C0015695	Fatty Liver	0.2	1	0	CTD_human
406946	MIR154	C0015695	Fatty Liver	0.2	1	0	CTD_human
406952	MIR17	C0015695	Fatty Liver	0.200274726784213	1	0	CTD_human
406953	MIR18A	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
406957	MIR181C	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406959	MIR183	C0015695	Fatty Liver	0.2	1	0	CTD_human
406960	MIR184	C0028754	Obesity	0.2	1	0	CTD_human
406960	MIR184	C3280392	EDICT SYNDROME	0.201373633921065	0	0	ORPHANET
406961	MIR185	C0008370	Cholestasis	0.2	1	0	CTD_human
406965	MIR190A	C0008370	Cholestasis	0.2	1	0	CTD_human
406967	MIR192	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406974	MIR197	C0015695	Fatty Liver	0.2	1	0	CTD_human
406979	MIR19A	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
406979	MIR19A	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406985	MIR200C	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
406991	MIR21	C0014175	Endometriosis	0.200549453568426	1	0	CTD_human
406991	MIR21	C0028754	Obesity	0.200824180352639	1	0	CTD_human
406992	MIR210	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
406997	MIR215	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
406997	MIR215	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
406999	MIR217	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
4070	TACSTD2	C0010036	Corneal dystrophy	0.200274726784213	0	0	HPO
4070	TACSTD2	C0014175	Endometriosis	0.2	1	0	CTD_human
4070	TACSTD2	C0042798	Low Vision	0.2	0	0	HPO
4070	TACSTD2	C0339273	Corneal dystrophy, Lattice type 3	0.406043989252688	0	0	CTD_human;ORPHANET
407000	MIR218-1	C0008370	Cholestasis	0.2	1	0	CTD_human
407000	MIR218-1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
407004	MIR22	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
407012	MIR24-1	C0008370	Cholestasis	0.2	1	0	CTD_human
407019	MIR27B	C0008370	Cholestasis	0.2	1	0	CTD_human
407019	MIR27B	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
407025	MIR29B2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
407026	MIR29C	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
407029	MIR30A	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
407029	MIR30A	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
407030	MIR30B	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
407030	MIR30B	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
407032	MIR30C2	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
407040	MIR34A	C0015695	Fatty Liver	0.200549453568426	1	0	CTD_human
407040	MIR34A	C0028754	Obesity	0.200549453568426	1	0	CTD_human
407042	MIR34C	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
407053	MIR96	C3888123	DEAFNESS, AUTOSOMAL DOMINANT 50	0.2	0	0	CTD_human
407055	MIR99A	C0008370	Cholestasis	0.2	1	0	CTD_human
407055	MIR99A	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
4072	EPCAM	C0014544	Epilepsy	0.2	0	0	HPO
4072	EPCAM	C0151740	Intracranial Hypertension	0.2	0	0	HPO
4072	EPCAM	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
4072	EPCAM	C0743178	Diarrhea, intractable	0.2	0	0	HPO
4072	EPCAM	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4072	EPCAM	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4072	EPCAM	C2750737	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL	0.681648360705279	1	7	CTD_human;ORPHANET;UNIPROT
4072	EPCAM	C2931459	Lynch syndrome I (site-specific colonic cancer)	0.2	1	0	CTD_human
4072	EPCAM	C4020884	Anxiety disease	0.2	0	0	HPO
407973	SCA20	C1837541	SPINOCEREBELLAR ATAXIA 20	0.4	0	0	CTD_human;ORPHANET
407975	MIR17HG	C3280489	FEINGOLD SYNDROME 2	0.200274726784213	0	0	ORPHANET
408	ARRB1	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
4082	MARCKS	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
408221	SCA26	C1836395	SPINOCEREBELLAR ATAXIA 26	0.2	0	0	CTD_human
408257	CILD4	C1837616	Primary ciliary dyskinesia, 4	0.2	0	0	CTD_human
4084	MXD1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
4085	MAD2L1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
4087	SMAD2	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
4087	SMAD2	C1876165	Copper-Overload Cirrhosis	0.2	1	0	CTD_human
4088	SMAD3	C0002949	Aneurysm, Dissecting	0.2	1	0	CTD_human
4088	SMAD3	C0003486	Aortic Aneurysm	0.400824180352639	1	0	CTD_human;HPO
4088	SMAD3	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
4088	SMAD3	C0004238	Atrial Fibrillation	0.200274726784213	0	0	HPO
4088	SMAD3	C0010346	Crohn Disease	0.200274726784213	1	2	CTD_human
4088	SMAD3	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
4088	SMAD3	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
4088	SMAD3	C0023890	Liver Cirrhosis	0.202407028523288	1	0	CTD_human
4088	SMAD3	C0023891	Liver Cirrhosis, Alcoholic	0.2	1	0	CTD_human
4088	SMAD3	C0024636	Malocclusion	0.2	0	0	HPO
4088	SMAD3	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
4088	SMAD3	C0029408	Degenerative polyarthritis	0.207952721364863	2	0	CTD_human
4088	SMAD3	C0029410	Osteoarthritis of hip	0.202956482091714	0	0	HPO
4088	SMAD3	C0029421	Osteochondritis Dissecans	0.2	0	0	HPO
4088	SMAD3	C0038016	Spondylolisthesis	0.2	0	0	HPO
4088	SMAD3	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4088	SMAD3	C0158266	Intervertebral Disc Degeneration	0.200274726784213	0	0	HPO
4088	SMAD3	C0263401	Cutis marmorata	0.2	0	0	HPO
4088	SMAD3	C0340643	Dissection of aorta	0.200549453568426	0	0	HPO
4088	SMAD3	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
4088	SMAD3	C0409959	Osteoarthritis, Knee	0.202681755307501	0	0	HPO
4088	SMAD3	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.2	0	0	ORPHANET
4088	SMAD3	C1956346	Coronary Artery Disease	0.205088783830789	0	0	HPO
4088	SMAD3	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
4088	SMAD3	C2697932	Loeys-Dietz Syndrome	0.201098907136852	1	3	CTD_human
4088	SMAD3	C3151087	LOEYS-DIETZ SYNDROME 3	0.401648360705279	2	10	ORPHANET;UNIPROT
4088	SMAD3	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
4088	SMAD3	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
4089	SMAD4	C0002871	Anemia	0.200274726784213	0	0	HPO
4089	SMAD4	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
4089	SMAD4	C0008325	Cholecystitis	0.2	0	0	HPO
4089	SMAD4	C0014306	Enophthalmos	0.2	0	0	HPO
4089	SMAD4	C0014544	Epilepsy	0.2	0	0	HPO
4089	SMAD4	C0020490	Hyperopia	0.2	0	0	HPO
4089	SMAD4	C0020541	Hypertension, Portal	0.2	0	0	HPO
4089	SMAD4	C0031039	Pericardial effusion	0.2	0	0	HPO
4089	SMAD4	C0038379	Strabismus	0.2	0	0	HPO
4089	SMAD4	C0039445	Hereditary hemorrhagic telangiectasia	0.204604842796993	0	0	ORPHANET
4089	SMAD4	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
4089	SMAD4	C0236048	Polyposis, Gastric	0.203780662444353	0	0	HPO
4089	SMAD4	C0239981	Hypoalbuminemia	0.2	0	0	HPO
4089	SMAD4	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4089	SMAD4	C0796081	Growth mental deficiency syndrome of Myhre	0.602197814273705	2	4	CTD_human;ORPHANET;UNIPROT
4089	SMAD4	C1697453	Spontaneous haematoma	0.2	0	0	HPO
4089	SMAD4	C1832942	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME (disorder)	0.401373633921066	2	21	CTD_human;UNIPROT
4089	SMAD4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4089	SMAD4	C4021977	Visceral angiomatosis	0.2	0	0	HPO
4090	SMAD5	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	0	CTD_human
4091	SMAD6	C3542024	AORTIC VALVE DISEASE 2	0.2	1	2	UNIPROT
4091	SMAD6	C3887892	Aortic Valve Disease 1	0.2	0	0	ORPHANET
4092	SMAD7	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
4092	SMAD7	C2931434	Paraquat lung	0.2	1	0	CTD_human
4093	SMAD9	C0340543	Familial primary pulmonary hypertension	0.200824180352639	0	0	ORPHANET
4093	SMAD9	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
4093	SMAD9	C3203102	Idiopathic pulmonary arterial hypertension	0.280824180352639	0	0	HPO
4093	SMAD9	C3888002	PULMONARY HYPERTENSION, PRIMARY, 2	0.2	1	3	UNIPROT
4094	MAF	C0008372	Intrahepatic Cholestasis	0.2	1	0	CTD_human
4094	MAF	C0014544	Epilepsy	0.2	0	0	HPO
4094	MAF	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4094	MAF	C0027092	Myopia	0.2	0	0	HPO
4094	MAF	C1832812	Cataracts, Congenital, with Sensorineural Deafness, Down Syndrome-Like Facial Appearance, Short Stature, and Mental Retardation	0.2	1	6	UNIPROT
4094	MAF	C1833118	Cataract, Pulverulent	0.200549453568426	0	0	ORPHANET
4094	MAF	C1861829	Cataract microcornea syndrome	0.2	0	0	ORPHANET
4094	MAF	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4094	MAF	C3888097	CATARACT 21, MULTIPLE TYPES	0.28	3	2	UNIPROT
4094	MAF	C4021568	Cortical pulverulent cataract	0.2	0	0	HPO
4097	MAFG	C0008372	Intrahepatic Cholestasis	0.2	1	0	CTD_human
4099	MAG	C0004106	Astigmatism	0.2	0	0	HPO
4099	MAG	C0020490	Hyperopia	0.2	0	0	HPO
4099	MAG	C0028738	Nystagmus	0.2	0	0	HPO
4099	MAG	C0029124	Optic Atrophy	0.2	0	0	HPO
4099	MAG	C0030567	Parkinson Disease	0.2	1	0	CTD_human
4099	MAG	C0752347	Lewy Body Disease	0.2	1	0	CTD_human
4099	MAG	C4225250	SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.4	1	2	ORPHANET;UNIPROT
41	ASIC1	C0007786	Brain Ischemia	0.2	1	0	CTD_human
410	ARSA	C0008325	Cholecystitis	0.2	0	0	HPO
410	ARSA	C0014544	Epilepsy	0.200274726784213	0	0	HPO
410	ARSA	C0023522	Leukodystrophy, Metachromatic	0.555550013600383	29	128	CTD_human;UNIPROT
410	ARSA	C0029124	Optic Atrophy	0.2	0	0	HPO
410	ARSA	C0034372	Quadriplegia	0.2	0	0	HPO
410	ARSA	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
410	ARSA	C0751276	Metachromatic leukodystrophy, juvenile type	0.201098907136852	0	0	ORPHANET
410	ARSA	C0751279	Metachromatic Leukodystrophy, Adult-Type (disorder)	0.201098907136852	0	0	ORPHANET
410	ARSA	C1301959	Bulbar weakness	0.2	0	0	HPO
410	ARSA	C4020858	Choreatic disease	0.2	0	0	HPO
410	ARSA	C4020871	Dystonic disease	0.2	0	0	HPO
410	ARSA	C4082299	Bulbar palsy	0.2	0	0	HPO
411	ARSB	C0017601	Glaucoma	0.2	0	0	HPO
411	ARSB	C0020255	Hydrocephalus	0.2	0	0	HPO
411	ARSB	C0024421	Macroglossia	0.2	0	0	HPO
411	ARSB	C0026709	Mucopolysaccharidosis VI	0.498652710571856	11	19	CTD_human;UNIPROT
411	ARSB	C0086795	Pfaundler-Hurler Syndrome	0.200274726784213	0	0	HPO
411	ARSB	C0149645	Cervical myelopathy	0.2	0	0	HPO
411	ARSB	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
4117	MAK	C0017601	Glaucoma	0.2	0	0	HPO
4117	MAK	C0018777	Conductive hearing loss	0.2	0	0	HPO
4117	MAK	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4117	MAK	C0020459	Hyperinsulinism	0.2	0	0	HPO
4117	MAK	C0020619	Hypogonadism	0.2	0	0	HPO
4117	MAK	C0022578	Keratoconus	0.2	0	0	HPO
4117	MAK	C0028077	Night Blindness	0.2	0	0	HPO
4117	MAK	C0028738	Nystagmus	0.2	0	0	HPO
4117	MAK	C0028754	Obesity	0.2	0	0	HPO
4117	MAK	C0029124	Optic Atrophy	0.2	0	0	HPO
4117	MAK	C0035334	Retinitis Pigmentosa	0.401373633921066	0	0	HPO;ORPHANET
4117	MAK	C0271215	Blindness, Legal	0.2	0	0	HPO
4117	MAK	C3280042	RETINITIS PIGMENTOSA 62	0.2	1	6	UNIPROT
412	STS	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
412	STS	C0015695	Fatty Liver	0.2	1	0	CTD_human
412	STS	C0020620	Hypohidrosis	0.2	0	0	HPO
412	STS	C0020757	Ichthyoses	0.203021994626344	0	0	HPO
412	STS	C0028754	Obesity	0.200824180352639	1	0	CTD_human
412	STS	C0079583	Ichthyosiform Erythroderma, Congenital	0.200549453568426	0	0	HPO
412	STS	C0079588	Ichthyosis, X-Linked	0.622462083770844	5	5	CTD_human;ORPHANET;UNIPROT
412	STS	C0259817	Xerosis	0.2	0	0	HPO
412	STS	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
412	STS	C0870082	Hyperkeratosis	0.2	0	0	HPO
412	STS	C2717836	Steroid Sulfatase Deficiency Disease	0.204120901763196	0	0	ORPHANET
412	STS	C4274085	Syndromic recessive X-linked ichthyosis	0.2	0	0	ORPHANET
4125	MAN2B1	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
4125	MAN2B1	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
4125	MAN2B1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4125	MAN2B1	C0020555	Hypertrichosis	0.2	0	0	HPO
4125	MAN2B1	C0024421	Macroglossia	0.2	0	0	HPO
4125	MAN2B1	C0024748	alpha-Mannosidosis	0.483021994626344	4	66	CTD_human;UNIPROT
4125	MAN2B1	C0028738	Nystagmus	0.2	0	0	HPO
4125	MAN2B1	C0038016	Spondylolisthesis	0.2	0	0	HPO
4125	MAN2B1	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
4125	MAN2B1	C0086795	Pfaundler-Hurler Syndrome	0.2	0	0	HPO
4125	MAN2B1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4125	MAN2B1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4125	MAN2B1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4125	MAN2B1	C4024919	Spinocerebellar tract disease in lower limbs	0.2	0	0	HPO
4126	MANBA	C0014544	Epilepsy	0.2	0	0	HPO
4126	MANBA	C4048196	beta-Mannosidosis	0.283021994626344	0	0	ORPHANET
4128	MAOA	C0014175	Endometriosis	0.2	1	0	CTD_human
4128	MAOA	C0019151	Hepatic Encephalopathy	0.200274726784213	3	0	CTD_human
4128	MAOA	C0020179	Huntington Disease	0.200549453568426	1	0	CTD_human
4128	MAOA	C0030567	Parkinson Disease	0.220695374641999	1	0	CTD_human
4128	MAOA	C0745744	End Stage Liver Disease	0.2	1	0	CTD_human
4128	MAOA	C0796275	Brunner Syndrome	0.480274726784213	0	0	CTD_human;ORPHANET
4128	MAOA	C1136249	Mental Retardation, X-Linked	0.2	1	0	CTD_human
4128	MAOA	C1285261	Fetal Nutrition Disorders	0.2	1	0	CTD_human
4129	MAOB	C0002395	Alzheimer's Disease	0.206513574909167	2	0	CTD_human
4129	MAOB	C0002888	Anemia, Megaloblastic	0.2	1	0	CTD_human
4129	MAOB	C0014175	Endometriosis	0.2	1	0	CTD_human
4129	MAOB	C0019151	Hepatic Encephalopathy	0.200274726784213	1	0	CTD_human
4129	MAOB	C0020179	Huntington Disease	0.2	1	0	CTD_human
4129	MAOB	C0030567	Parkinson Disease	0.27805540045873	1	0	CTD_human
4133	MAP2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
4137	MAPT	C0002395	Alzheimer's Disease	0.412954627512336	7	0	CTD_human
4137	MAPT	C0002736	Amyotrophic Lateral Sclerosis	0.208161935614446	0	0	HPO
4137	MAPT	C0030567	Parkinson Disease	0.323045972857553	2	2	CTD_human
4137	MAPT	C0038868	Progressive supranuclear palsy	0.679659466874971	4	6	CTD_human;ORPHANET;UNIPROT
4137	MAPT	C0085623	Akinesia	0.2	0	0	HPO
4137	MAPT	C0236642	Pick Disease of the Brain	0.461249717502204	6	4	CTD_human;UNIPROT
4137	MAPT	C0338451	Frontotemporal dementia	0.701663256709592	24	14	CTD_human;HPO;UNIPROT
4137	MAPT	C0338455	Dementia of frontal lobe type	0.2	0	0	HPO
4137	MAPT	C1850077	Supranuclear Palsy, Progressive, 1, Atypical	0.400274726784213	0	0	CTD_human;ORPHANET
4137	MAPT	C3160718	PARKINSON DISEASE, LATE-ONSET	0.201373633921065	0	0	CTD_human
4137	MAPT	C3887667	Retrocollis	0.2	0	0	HPO
4137	MAPT	C4011788	Behavioral variant of frontotemporal dementia	0.201923087489492	0	0	ORPHANET
4137	MAPT	C4020859	Pyramidal tract disease	0.2	0	0	HPO
4137	MAPT	C4020884	Anxiety disease	0.2	0	0	HPO
4137	MAPT	C4021584	Frontotemporal cerebral atrophy	0.2	0	0	HPO
4137	MAPT	C4024936	Temporal cortical atrophy	0.2	0	0	HPO
4137	MAPT	C4024956	Grammar-specific speech disorder	0.2	0	0	HPO
414058	ACRPV	C1863307	Acropectorovertebral Dysplasia, F-Form	0.2	0	0	CTD_human
4141	MARS	C0002871	Anemia	0.2	0	0	HPO
4141	MARS	C0020676	Hypothyroidism	0.2	0	0	HPO
4141	MARS	C0034050	Pulmonary Alveolar Proteinosis	0.200274726784213	0	0	HPO
4141	MARS	C0085684	Foot-drop	0.2	0	0	HPO
4141	MARS	C0238621	Aminoaciduria	0.2	0	0	HPO
4141	MARS	C0270921	Axonal neuropathy	0.2	0	0	HPO
4141	MARS	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
4141	MARS	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4141	MARS	C2711227	Steatohepatitis	0.2	0	0	HPO
4141	MARS	C4084821	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U	0.4	2	2	ORPHANET;UNIPROT
4141	MARS	C4225400	INTERSTITIAL LUNG AND LIVER DISEASE	0.4	2	6	ORPHANET;UNIPROT
4143	MAT1A	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	0	CTD_human
4143	MAT1A	C0015695	Fatty Liver	0.2	1	0	CTD_human
4143	MAT1A	C0268621	Hepatic methionine adenosyltransferase deficiency	0.682747267842131	3	9	HPO;ORPHANET;UNIPROT
4143	MAT1A	C0338474	Central nervous system demyelination	0.2	0	0	HPO
4143	MAT1A	C4020871	Dystonic disease	0.2	0	0	HPO
4148	MATN3	C0029408	Degenerative polyarthritis	0.410019510569308	0	0	CTD_human;HPO
4148	MATN3	C1835121	Premature osteoarthritis	0.2	0	0	HPO
4148	MATN3	C1837481	Spondyloepimetaphyseal Dysplasia, Matrilin-3 Related	0.6	1	1	CTD_human;ORPHANET;UNIPROT
4148	MATN3	C1846843	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5	0.68	7	9	CTD_human;ORPHANET;UNIPROT
414886	SPG27	C1836899	SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE (disorder)	0.4	0	0	CTD_human;ORPHANET
415	ARSE	C0020619	Hypogonadism	0.2	0	0	HPO
415	ARSE	C0020757	Ichthyoses	0.2	0	0	HPO
415	ARSE	C1844853	Brachytelephalangic Chondrodysplasia Punctata	0.601098907136852	4	11	CTD_human;ORPHANET;UNIPROT
4155	MBP	C0027873	Neuromyelitis Optica	0.2	1	0	CTD_human
4156	MBS1	C2931025	Moebius syndrome 1	0.2	0	0	CTD_human
4157	MC1R	C0028738	Nystagmus	0.2	0	0	HPO
4157	MC1R	C0038379	Strabismus	0.2	0	0	HPO
4157	MC1R	C0042798	Low Vision	0.2	0	0	HPO
4157	MC1R	C0042900	Vitiligo	0.205638237399215	1	0	CTD_human
4157	MC1R	C0259817	Xerosis	0.2	0	0	HPO
4157	MC1R	C0268495	Oculocutaneous albinism type 2	0.403231208875927	0	0	CTD_human;ORPHANET
4158	MC2R	C0014544	Epilepsy	0.2	0	0	HPO
4158	MC2R	C1859974	GLUCOCORTICOID DEFICIENCY 1	0.681923087489492	4	11	CTD_human;ORPHANET;UNIPROT
4158	MC2R	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4159	MC3R	C0028754	Obesity	0.310520026339041	0	0	CTD_human
4160	MC4R	C0020459	Hyperinsulinism	0.20433011601278	1	0	CTD_human
4160	MC4R	C0028754	Obesity	0.913077324600685	13	28	CTD_human;HPO;ORPHANET;UNIPROT
4160	MC4R	C4273958	Obesity due to melanocortin 4 receptor deficiency	0.2	0	0	ORPHANET
4162	MCAM	C0026769	Multiple Sclerosis	0.2	1	0	CTD_human
4166	CHST6	C0010036	Corneal dystrophy	0.200824180352639	0	0	HPO
4166	CHST6	C0010043	Corneal Ulcer	0.2	0	0	HPO
4166	CHST6	C0024439	Macular corneal dystrophy	0.21223168022033	0	0	ORPHANET
4166	CHST6	C0155119	Recurrent erosion of cornea	0.2	0	0	HPO
4166	CHST6	C0730292	Macular dystrophy	0.2	0	0	HPO
4166	CHST6	C1636149	Macular dystrophy, corneal type 1	0.406868169605328	13	33	CTD_human;UNIPROT
4167	MCDR1	C0730294	North Carolina macular dystrophy	0.201648360705279	0	0	CTD_human
4170	MCL1	C0004763	Barrett Esophagus	0.200549453568426	1	0	CTD_human
4170	MCL1	C0023281	Leishmaniasis	0.2	1	0	CTD_human
4173	MCM4	C1864947	Natural Killer Cell Deficiency, Familial Isolated	0.2	0	0	ORPHANET
4175	MCM6	C0022951	Lactose Intolerance	0.205088783830789	0	0	HPO
4175	MCM6	C0268181	Lactose Intolerance, Adult Type	0.2	0	0	CTD_human
4179	CD46	C0025007	Measles	0.212087978505376	1	0	CTD_human
4179	CD46	C0162739	HELLP Syndrome	0.206015278498054	0	0	ORPHANET
4179	CD46	C2931788	Atypical Hemolytic Uremic Syndrome	0.210099378481255	1	0	CTD_human
4183	MCS	C1839735	MILES-CARPENTER X-LINKED MENTAL RETARDATION SYNDROME	0.2	0	0	CTD_human
4189	DNAJB9	C0008370	Cholestasis	0.2	1	0	CTD_human
4189	DNAJB9	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
4190	MDH1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
4190	MDH1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
4192	MDK	C0011881	Diabetic Nephropathy	0.202732912464814	1	0	CTD_human
4193	MDM2	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
4193	MDM2	C4280575	Progressive brain disease	0.2	0	0	HPO
4194	MDM4	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
4195	MDRV	C1866139	VACUOLAR NEUROMYOPATHY (disorder)	0.2	0	0	CTD_human
4199	ME1	C0028754	Obesity	0.2	1	0	CTD_human
4200	ME2	C0270850	Idiopathic generalized epilepsy	0.202956482091714	0	0	CTD_human
4204	MECP2	C0014544	Epilepsy	0.214899080150514	0	0	HPO
4204	MECP2	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
4204	MECP2	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
4204	MECP2	C0035372	Rett Syndrome	0.92	35	277	CTD_human;ORPHANET;UNIPROT
4204	MECP2	C0037036	Sialorrhea	0.2	0	0	HPO
4204	MECP2	C0085583	Choreoathetosis	0.2	0	0	HPO
4204	MECP2	C0162635	Angelman Syndrome	0.206304360659584	0	0	CTD_human
4204	MECP2	C0234958	muscle degeneration	0.2	0	0	HPO
4204	MECP2	C0235946	Cerebral atrophy	0.200274726784213	0	0	HPO
4204	MECP2	C0392525	Nephrolithiasis	0.2	0	0	HPO
4204	MECP2	C1510417	Gait Apraxia	0.2	0	0	HPO
4204	MECP2	C1836830	Developmental regression	0.200549453568426	0	0	HPO
4204	MECP2	C1968550	Mental Retardation, X-Linked, Syndromic 13	0.6	9	29	CTD_human;ORPHANET;UNIPROT
4204	MECP2	C1968556	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.4	0	0	CTD_human;ORPHANET
4204	MECP2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4204	MECP2	C2748910	Rett Syndrome, Atypical	0.203296721410557	0	0	ORPHANET
4204	MECP2	C4020858	Choreatic disease	0.2	0	0	HPO
4204	MECP2	C4020871	Dystonic disease	0.2	0	0	HPO
4204	MECP2	C4020884	Anxiety disease	0.2	0	0	HPO
4205	MEF2A	C1842247	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1	0.200549453568426	0	0	CTD_human
4208	MEF2C	C0014544	Epilepsy	0.400824180352639	1	0	CTD_human;HPO
4208	MEF2C	C0038220	Status Epilepticus	0.2	1	0	CTD_human
4208	MEF2C	C3150700	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.4	0	0	CTD_human;ORPHANET
4209	MEF2D	C0338480	Common Migraine	0.200274726784213	1	0	CTD_human
421	ARVCF	C0011334	Dental caries	0.2	0	0	HPO
421	ARVCF	C0012236	DiGeorge Syndrome	0.2	0	0	ORPHANET
421	ARVCF	C0018777	Conductive hearing loss	0.2	0	0	HPO
421	ARVCF	C0020626	Hypoparathyroidism	0.2	0	0	HPO
421	ARVCF	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
421	ARVCF	C0039621	Tetany	0.2	0	0	HPO
421	ARVCF	C0085109	Corneal Neovascularization	0.2	0	0	HPO
421	ARVCF	C0220704	Shprintzen syndrome	0.2	0	0	ORPHANET
421	ARVCF	C0271441	Chronic otitis media	0.2	0	0	HPO
421	ARVCF	C0702166	Acne	0.2	0	0	HPO
421	ARVCF	C0743359	ear infection chronic	0.2	0	0	HPO
421	ARVCF	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	0.2	0	0	ORPHANET
421	ARVCF	C2936346	22q11 Deletion Syndrome	0.2	0	0	ORPHANET
421	ARVCF	C3266101	22q11 partial monosomy syndrome	0.2	0	0	ORPHANET
421	ARVCF	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
421	ARVCF	C4024912	Occipital myelomeningocele	0.2	0	0	HPO
4210	MEFV	C0003864	Arthritis	0.20859471949093	0	0	HPO
4210	MEFV	C0003872	Arthritis, Psoriatic	0.202681755307501	1	0	CTD_human
4210	MEFV	C0004943	Behcet Syndrome	0.223596113956068	0	0	ORPHANET
4210	MEFV	C0014544	Epilepsy	0.2	0	0	HPO
4210	MEFV	C0014733	Erysipelas	0.2	0	0	HPO
4210	MEFV	C0025289	Meningitis	0.2	0	0	HPO
4210	MEFV	C0031046	Pericarditis	0.200274726784213	0	0	HPO
4210	MEFV	C0031069	Familial Mediterranean Fever	0.872794949577765	22	50	CTD_human;ORPHANET;UNIPROT
4210	MEFV	C0031154	Peritonitis	0.200274726784213	0	0	HPO
4210	MEFV	C0032231	Pleurisy	0.200274726784213	0	0	HPO
4210	MEFV	C0035078	Kidney Failure	0.200274726784213	0	0	HPO
4210	MEFV	C0038363	Aphthous Stomatitis	0.205088783830789	0	0	HPO
4210	MEFV	C0042384	Vasculitis	0.203557092817453	0	0	HPO
4210	MEFV	C0149745	Oral Ulcer	0.2	0	0	HPO
4210	MEFV	C0149910	Intermittent joint effusion	0.200274726784213	0	0	ORPHANET
4210	MEFV	C0162323	Polyarthritis	0.2	0	0	HPO
4210	MEFV	C0268382	Amyloid nephropathy	0.203021994626344	0	0	HPO
4210	MEFV	C0585274	Periodic syndrome	0.200274726784213	0	0	ORPHANET
4210	MEFV	C0702166	Acne	0.2	0	0	HPO
4210	MEFV	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4210	MEFV	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
4210	MEFV	C1565489	Renal Insufficiency	0.2	0	0	HPO
4210	MEFV	C1851347	Familial Mediterranean Fever, Autosomal Dominant	0.4	16	7	CTD_human;UNIPROT
4210	MEFV	C2937365	Recurrent aphthous ulcer	0.200274726784213	0	0	HPO
4211	MEIS1	C0035258	Restless Legs Syndrome	0.212650108719496	1	1	CTD_human
4212	MEIS2	C0014306	Enophthalmos	0.2	0	0	HPO
4212	MEIS2	C4225666	CHROMOSOME 15q14 DELETION SYNDROME	0.2	0	0	ORPHANET
4214	MAP3K1	C0004509	Azoospermia	0.2	0	0	HPO
4214	MAP3K1	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
4214	MAP3K1	C0018418	Gynecomastia	0.2	0	0	HPO
4214	MAP3K1	C0029456	Osteoporosis	0.2	0	0	HPO
4214	MAP3K1	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
4214	MAP3K1	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
4214	MAP3K1	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
4214	MAP3K1	C0266427	Testicular regression syndrome	0.2	0	0	HPO
4214	MAP3K1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
4214	MAP3K1	C0948896	Primary hypogonadism	0.2	0	0	HPO
4214	MAP3K1	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
4214	MAP3K1	C2936694	Swyer Syndrome	0.2	0	0	ORPHANET
4214	MAP3K1	C3151064	46,XY SEX REVERSAL 6	0.2	1	4	UNIPROT
4214	MAP3K1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
4217	MAP3K5	C0030567	Parkinson Disease	0.203831819601666	1	0	CTD_human
4217	MAP3K5	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
4218	RAB8A	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
4221	MEN1	C0001206	Acromegaly	0.201923087489492	0	0	HPO
4221	MEN1	C0014544	Epilepsy	0.2	0	0	HPO
4221	MEN1	C0014868	Esophagitis	0.2	0	0	HPO
4221	MEN1	C0018418	Gynecomastia	0.2	0	0	HPO
4221	MEN1	C0020437	Hypercalcemia	0.203831819601666	0	0	HPO
4221	MEN1	C0020502	Hyperparathyroidism	0.2290251371057	0	0	HPO
4221	MEN1	C0020615	Hypoglycemia	0.202681755307501	0	0	HPO
4221	MEN1	C0027709	Nephrocalcinosis	0.2	0	0	HPO
4221	MEN1	C0029453	Osteopenia	0.2	0	0	HPO
4221	MEN1	C0029456	Osteoporosis	0.2	0	0	HPO
4221	MEN1	C0030920	Peptic Ulcer	0.2	0	0	HPO
4221	MEN1	C0043515	Zollinger-Ellison syndrome	0.200824180352639	0	0	HPO
4221	MEN1	C0151721	Testicular hypogonadism	0.2	0	0	HPO
4221	MEN1	C0221002	Hyperparathyroidism, Primary	0.218261314095701	0	0	HPO
4221	MEN1	C0242350	Erectile dysfunction	0.2	0	0	HPO
4221	MEN1	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
4221	MEN1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
4221	MEN1	C0271710	Reactive hypoglycemia	0.2	0	0	HPO
4221	MEN1	C0271844	Parathyroid hyperplasia	0.203021994626344	0	0	HPO
4221	MEN1	C0342388	Adrenocorticotropic hormone (ACTH) deficiency (disorder)	0.2	0	0	HPO
4221	MEN1	C0553730	Calcium pyrophosphate deposition disease	0.2	0	0	HPO
4221	MEN1	C0747078	Generalized osteopenia	0.2	0	0	HPO
4221	MEN1	C1840402	HYPERPARATHYROIDISM 1	0.685219808900049	6	3	CTD_human;ORPHANET;UNIPROT
4221	MEN1	C1864903	Hyperinsulinaemic hypoglycaemia	0.200549453568426	0	0	HPO
4221	MEN1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
4221	MEN1	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
4221	MEN1	C3665358	Galactorrhea	0.2	0	0	HPO
4221	MEN1	C3805887	Generalized osteoporosis with pathologic fractures	0.2	0	0	HPO
4221	MEN1	C4023211	Adrenocorticotropin deficient adrenal insufficiency	0.2	0	0	HPO
4221	MEN1	C4024716	Secondary growth hormone deficiency	0.2	0	0	HPO
4222	MEOX1	C0018777	Conductive hearing loss	0.2	0	0	HPO
4222	MEOX1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4222	MEOX1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
4223	MEOX2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
4233	MET	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
4233	MET	C0037199	Sinusitis	0.202407028523288	1	0	CTD_human
4233	MET	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
4233	MET	C1876165	Copper-Overload Cirrhosis	0.2	1	0	CTD_human
4233	MET	C4084709	DEAFNESS, AUTOSOMAL RECESSIVE 97	0.2	1	1	UNIPROT
4237	MFAP2	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
424	ARVD3	C1865882	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 3 (disorder)	0.2	0	0	CTD_human
4247	MGAT2	C0014544	Epilepsy	0.2	0	0	HPO
4247	MGAT2	C0015523	Factor XI Deficiency	0.2	0	0	HPO
4247	MGAT2	C0015526	Factor XII Deficiency	0.2	0	0	HPO
4247	MGAT2	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
4247	MGAT2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4247	MGAT2	C0029453	Osteopenia	0.2	0	0	HPO
4247	MGAT2	C0272375	Antithrombin III Deficiency	0.2	0	0	HPO
4247	MGAT2	C0747078	Generalized osteopenia	0.2	0	0	HPO
4247	MGAT2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4247	MGAT2	C2931008	Congenital disorder of glycosylation type 2A	0.680549453568426	2	5	CTD_human;ORPHANET;UNIPROT
425	ARVD4	C1865881	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 4 (disorder)	0.2	0	0	CTD_human
4254	KITLG	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4254	KITLG	C0027430	Nasal Polyps	0.200549453568426	1	0	CTD_human
4254	KITLG	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
4254	KITLG	C0870082	Hyperkeratosis	0.2	0	0	HPO
4254	KITLG	C1840392	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE	0.600274726784213	1	3	CTD_human;ORPHANET;UNIPROT
4254	KITLG	C2681535	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 1	0.2	0	0	ORPHANET
4254	KITLG	C2700265	Waardenburg Syndrome Type 2	0.200274726784213	0	0	ORPHANET
4255	MGMT	C0259817	Xerosis	0.2	0	0	HPO
4256	MGP	C0014544	Epilepsy	0.2	0	0	HPO
4256	MGP	C0041948	Uremia	0.2	1	0	CTD_human
4256	MGP	C0042345	Varicosity	0.203007639249027	1	0	CTD_human
4256	MGP	C0149516	Chronic sinusitis	0.2	0	0	HPO
4256	MGP	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
4256	MGP	C0581354	Recurrent sinusitis	0.2	0	0	HPO
4256	MGP	C0741796	Recurrent bronchitis	0.2	0	0	HPO
4256	MGP	C0747085	Recurrent otitis media	0.2	0	0	HPO
4256	MGP	C0748720	Chronic sinus disease	0.2	0	0	HPO
4256	MGP	C1855607	Keutel syndrome	0.481098907136852	1	4	CTD_human;ORPHANET
4256	MGP	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
4256	MGP	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
4256	MGP	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
4256	MGP	C4280333	Recurrent sinus disease	0.2	0	0	HPO
4261	CIITA	C0001403	Addison Disease	0.205088783830789	1	0	CTD_human
4261	CIITA	C0001768	Agammaglobulinemia	0.2	0	0	HPO
4261	CIITA	C0003873	Rheumatoid Arthritis	0.213800173013661	0	0	CTD_human
4261	CIITA	C0006845	Candidiasis, Chronic Mucocutaneous	0.2	0	0	HPO
4261	CIITA	C0009319	Colitis	0.2	0	0	HPO
4261	CIITA	C0014038	Encephalitis	0.2	0	0	HPO
4261	CIITA	C0026769	Multiple Sclerosis	0.214298469424775	0	0	CTD_human
4261	CIITA	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
4261	CIITA	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
4261	CIITA	C0393441	Chronic lymphocytic meningitis	0.2	0	0	HPO
4261	CIITA	C0451696	Major histocompatibility complex class II deficiency	0.2	0	0	ORPHANET
4261	CIITA	C0473133	Protracted diarrhea	0.2	0	0	HPO
4261	CIITA	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
4261	CIITA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4261	CIITA	C2931418	Bare lymphocyte syndrome 2	0.680824180352639	2	0	CTD_human;ORPHANET;UNIPROT
427	ASAH1	C0003864	Arthritis	0.2	0	0	HPO
427	ASAH1	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
427	ASAH1	C0023794	Lipoidosis	0.2	2	0	CTD_human
427	ASAH1	C0026847	Spinal Muscular Atrophy	0.200824180352639	0	0	HPO
427	ASAH1	C0028738	Nystagmus	0.2	0	0	HPO
427	ASAH1	C0029456	Osteoporosis	0.2	0	0	HPO
427	ASAH1	C0268255	Farber Lipogranulomatosis	0.684670355331623	8	7	CTD_human;ORPHANET;UNIPROT
427	ASAH1	C0376175	Bell Palsy	0.2	0	0	HPO
427	ASAH1	C0751778	Myoclonic Epilepsies, Progressive	0.201098907136852	0	0	HPO
427	ASAH1	C1704214	Lipogranuloma	0.2	0	0	HPO
427	ASAH1	C1834569	Jankovic Rivera syndrome	0.400549453568426	2	3	ORPHANET;UNIPROT
427	ASAH1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
427	ASAH1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
427	ASAH1	C4024613	Progressive distal muscular atrophy	0.2	0	0	HPO
4277	MICB	C0019100	Severe Dengue	0.200549453568426	1	1	CTD_human
4281	MID1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
4281	MID1	C2936904	Opitz GBBB Syndrome, X-Linked	0.685769262468475	3	2	CTD_human;ORPHANET;UNIPROT
4282	MIF	C0003873	Rheumatoid Arthritis	0.227087694238892	1	0	CTD_human
4282	MIF	C0009319	Colitis	0.200274726784213	1	0	CTD_human
4282	MIF	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
4282	MIF	C0243026	Sepsis	0.21082933554463	1	0	CTD_human
4282	MIF	C1384600	Systemic onset juvenile chronic arthritis	0.200549453568426	0	0	ORPHANET
4282	MIF	C1858558	Rheumatoid Arthritis, Systemic Juvenile	0.4	0	0	CTD_human;ORPHANET
4282	MIF	C3714757	Juvenile rheumatoid arthritis	0.200824180352639	0	0	HPO
4283	CXCL9	C0002171	Alopecia Areata	0.2	1	0	CTD_human
4283	CXCL9	C0023892	Biliary cirrhosis	0.202732912464814	1	0	CTD_human
4283	CXCL9	C0032285	Pneumonia	0.2	1	0	CTD_human
4283	CXCL9	C0282488	Interstitial Cystitis	0.2	1	0	CTD_human
4284	MIP	C0392557	Nuclear cataract	0.2	0	0	ORPHANET
4284	MIP	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
4284	MIP	C1858679	CATARACT, AUTOSOMAL DOMINANT	0.200274726784213	0	0	CTD_human
4284	MIP	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
4284	MIP	C3809001	CATARACT 15, MULTIPLE TYPES	0.28	7	6	UNIPROT
4286	MITF	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
4286	MITF	C0020490	Hyperopia	0.2	0	0	HPO
4286	MITF	C0028738	Nystagmus	0.2	0	0	HPO
4286	MITF	C0036651	Senile lentigo	0.2	0	0	HPO
4286	MITF	C0038379	Strabismus	0.2	0	0	HPO
4286	MITF	C0042798	Low Vision	0.2	0	0	HPO
4286	MITF	C0162835	Hypopigmentation disorder	0.201098907136852	0	0	HPO
4286	MITF	C0259817	Xerosis	0.2	0	0	HPO
4286	MITF	C0391816	Tietz syndrome	0.681373633921066	1	1	CTD_human;ORPHANET;UNIPROT
4286	MITF	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4286	MITF	C1328931	Multiple lentigines	0.2	0	0	HPO
4286	MITF	C1845069	ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS (disorder)	0.2	0	0	CTD_human
4286	MITF	C1860339	WAARDENBURG SYNDROME, TYPE IIA	0.484670355331623	1	4	CTD_human;UNIPROT
4286	MITF	C1863198	ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS (disorder)	0.28	0	0	ORPHANET
4286	MITF	C2700265	Waardenburg Syndrome Type 2	0.405219808900049	1	0	CTD_human;ORPHANET
4287	ATXN3	C0015300	Exophthalmos	0.2	0	0	HPO
4287	ATXN3	C0024408	Machado-Joseph Disease	0.294165922392244	0	0	CTD_human
4287	ATXN3	C0262404	Cerebellar degeneration	0.200549453568426	0	0	HPO
4287	ATXN3	C0393525	Progressive cerebellar ataxia	0.2	0	0	HPO
4287	ATXN3	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
4287	ATXN3	C0751668	Machado-Joseph Disease Type I	0.2	0	0	ORPHANET
4287	ATXN3	C0751669	Machado-Joseph Disease Type II	0.2	0	0	ORPHANET
4287	ATXN3	C0751670	Machado-Joseph Disease Type III	0.2	0	0	ORPHANET
4287	ATXN3	C1408507	Supranuclear ophthalmoplegia	0.2	0	0	HPO
4287	ATXN3	C1848736	Distal amyotrophy	0.200549453568426	0	0	HPO
4287	ATXN3	C1866751	Spinocerebellar tract degeneration	0.2	0	0	HPO
4287	ATXN3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4288	MKI67	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
4288	MKI67	C0033860	Psoriasis	0.200549453568426	1	0	CTD_human
4288	MKI67	C1876165	Copper-Overload Cirrhosis	0.2	1	0	CTD_human
429	ASCL1	C0013363	Dysautonomia	0.2	0	0	HPO
429	ASCL1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
429	ASCL1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
429	ASCL1	C0038379	Strabismus	0.2	0	0	HPO
429	ASCL1	C0520680	Sleep Apnea, Central	0.2	0	0	HPO
429	ASCL1	C1275808	Congenital central hypoventilation	0.400274726784213	0	0	CTD_human;ORPHANET
429	ASCL1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4292	MLH1	C0012819	Diverticular disease of colon	0.2	0	0	HPO
4292	MLH1	C0014544	Epilepsy	0.2	0	0	HPO
4292	MLH1	C0151740	Intracranial Hypertension	0.2	0	0	HPO
4292	MLH1	C0265325	Turcot syndrome (disorder)	0.613461612426442	2	6	CTD_human;ORPHANET;UNIPROT
4292	MLH1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4292	MLH1	C1861975	Cafe au lait spots, multiple	0.2	0	0	CTD_human
4292	MLH1	C4020884	Anxiety disease	0.2	0	0	HPO
4297	KMT2A	C0038379	Strabismus	0.2	0	0	HPO
4297	KMT2A	C1854630	Growth Deficiency and Mental Retardation with Facial Dysmorphism	0.201648360705279	0	0	ORPHANET
4297	KMT2A	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
43	ACHE	C0002395	Alzheimer's Disease	0.230218267531817	2	0	CTD_human
43	ACHE	C0002726	Amyloidosis	0.20439562854741	1	0	CTD_human
43	ACHE	C0026850	Muscular Dystrophy	0.2	1	0	CTD_human
4306	NR3C2	C0014175	Endometriosis	0.2	1	0	CTD_human
4306	NR3C2	C0018801	Heart failure	0.203296721410557	2	0	CTD_human
4306	NR3C2	C0020428	Hyperaldosteronism	0.200824180352639	0	0	HPO
4306	NR3C2	C0020595	Hypoaldosteronism	0.200274726784213	0	0	HPO
4306	NR3C2	C0027051	Myocardial Infarction	0.201648360705279	2	0	CTD_human
4306	NR3C2	C0033805	Pseudohypoaldosteronism	0.405754907091158	0	0	CTD_human;HPO
4306	NR3C2	C0565599	Maternal hypertension	0.200274726784213	0	0	HPO
4306	NR3C2	C1449842	Pseudohypoaldosteronism, Type I, Autosomal Dominant	0.481923087489492	4	13	ORPHANET;UNIPROT
4306	NR3C2	C1854631	Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy	0.6	3	1	CTD_human;ORPHANET;UNIPROT
4306	NR3C2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4308	TRPM1	C0013595	Eczema	0.2	0	0	HPO
4308	TRPM1	C0027092	Myopia	0.2	0	0	HPO
4308	TRPM1	C0028077	Night Blindness	0.200274726784213	0	0	HPO
4308	TRPM1	C0028738	Nystagmus	0.2	0	0	HPO
4308	TRPM1	C0259817	Xerosis	0.2	0	0	HPO
4308	TRPM1	C0271183	Severe myopia	0.2	0	0	HPO
4308	TRPM1	C2750747	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	0.2	3	17	UNIPROT
4308	TRPM1	C3551052	Night blindness, stationary	0.2	0	0	HPO
431	ASD1	C1862389	ATRIAL SEPTAL DEFECT 1	0.2	0	0	CTD_human
4311	MME	C1565489	Renal Insufficiency	0.2	1	0	CTD_human
4311	MME	C2316212	Cryopyrin-Associated Periodic Syndromes	0.2	1	0	CTD_human
4312	MMP1	C0002893	Refractory anemias	0.200549453568426	0	0	HPO
4312	MMP1	C0002940	Aneurysm	0.200549453568426	1	0	CTD_human
4312	MMP1	C0004153	Atherosclerosis	0.212477696249908	1	0	CTD_human
4312	MMP1	C0005741	Blepharitis	0.2	0	0	HPO
4312	MMP1	C0011334	Dental caries	0.2	0	0	HPO
4312	MMP1	C0013592	Ectropion	0.2	0	0	HPO
4312	MMP1	C0024117	Chronic Obstructive Airway Disease	0.507692890584963	0	0	CTD_human;HPO
4312	MMP1	C0028840	Ocular Hypertension	0.2	1	0	CTD_human
4312	MMP1	C0029172	Oral Submucous Fibrosis	0.20777053913829	1	0	CTD_human
4312	MMP1	C0029453	Osteopenia	0.2	0	0	HPO
4312	MMP1	C0029456	Osteoporosis	0.200274726784213	0	0	HPO
4312	MMP1	C0079294	Epidermolysis Bullosa Dystrophica	0.200274726784213	0	0	CTD_human
4312	MMP1	C0079474	Hallopeau-Siemens Disease	0.201373633921065	0	0	ORPHANET
4312	MMP1	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
4312	MMP1	C0392163	Corneal erosion	0.2	0	0	HPO
4312	MMP1	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
4312	MMP1	C0747078	Generalized osteopenia	0.2	0	0	HPO
4313	MMP2	C0003496	Aortic Rupture	0.200274726784213	1	0	CTD_human
4313	MMP2	C0003873	Rheumatoid Arthritis	0.212492051627226	1	0	CTD_human
4313	MMP2	C0015300	Exophthalmos	0.2	0	0	HPO
4313	MMP2	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
4313	MMP2	C0023283	Leishmaniasis, Cutaneous	0.2	1	0	CTD_human
4313	MMP2	C0023890	Liver Cirrhosis	0.284814057046576	2	0	CTD_human
4313	MMP2	C0023891	Liver Cirrhosis, Alcoholic	0.2	1	0	CTD_human
4313	MMP2	C0024143	Lupus Nephritis	0.200274726784213	1	0	CTD_human
4313	MMP2	C0024796	Marfan Syndrome	0.200274726784213	1	0	CTD_human
4313	MMP2	C0027051	Myocardial Infarction	0.290778178387317	2	0	CTD_human
4313	MMP2	C0029172	Oral Submucous Fibrosis	0.202681755307501	1	0	CTD_human
4313	MMP2	C0029453	Osteopenia	0.200549453568426	0	0	HPO
4313	MMP2	C0029456	Osteoporosis	0.200549453568426	0	0	HPO
4313	MMP2	C0034067	Pulmonary Emphysema	0.200824180352639	1	0	CTD_human
4313	MMP2	C0034069	Pulmonary Fibrosis	0.20328236603324	1	0	CTD_human
4313	MMP2	C0162872	Aortic Aneurysm, Thoracic	0.201098907136852	1	0	CTD_human
4313	MMP2	C0410550	Collapse of vertebra	0.2	0	0	HPO
4313	MMP2	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
4313	MMP2	C0747078	Generalized osteopenia	0.2	0	0	HPO
4313	MMP2	C1850155	TORG-WINCHESTER SYNDROME	0.682197814273705	2	5	CTD_human;ORPHANET;UNIPROT
4313	MMP2	C4024732	Ankylosis of feet small joints	0.2	0	0	HPO
4313	MMP2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
4314	MMP3	C0948480	Coronary Restenosis	0.200549453568426	1	0	CTD_human
4314	MMP3	C1956346	Coronary Artery Disease	0.225127804969404	1	0	CTD_human
4317	MMP8	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
431708	MDD1	C1837929	Major Depressive Disorder 1	0.2	0	0	CTD_human
431709	MDD2	C1837529	Major Depressive Disorder 2	0.2	0	0	CTD_human
4318	MMP9	C0003486	Aortic Aneurysm	0.206839458850693	1	0	CTD_human
4318	MMP9	C0003496	Aortic Rupture	0.2	1	0	CTD_human
4318	MMP9	C0004096	Asthma	0.226878479989308	2	0	CTD_human
4318	MMP9	C0007786	Brain Ischemia	0.207872853452916	1	0	CTD_human
4318	MMP9	C0009324	Ulcerative Colitis	0.200824180352639	1	0	CTD_human
4318	MMP9	C0024117	Chronic Obstructive Airway Disease	0.249468231366165	1	0	CTD_human
4318	MMP9	C0024143	Lupus Nephritis	0.2	1	0	CTD_human
4318	MMP9	C0024796	Marfan Syndrome	0.2	1	0	CTD_human
4318	MMP9	C0027051	Myocardial Infarction	0.307311263865792	2	0	CTD_human
4318	MMP9	C0028754	Obesity	0.203846174978983	1	0	CTD_human
4318	MMP9	C0029172	Oral Submucous Fibrosis	0.200549453568426	1	0	CTD_human
4318	MMP9	C0031099	Periodontitis	0.211001748014218	2	0	CTD_human
4318	MMP9	C0034067	Pulmonary Emphysema	0.206029633875371	1	0	CTD_human
4318	MMP9	C0034069	Pulmonary Fibrosis	0.200824180352639	1	0	CTD_human
4318	MMP9	C0038358	Gastric ulcer	0.202956482091714	1	0	CTD_human
4318	MMP9	C0162871	Aortic Aneurysm, Abdominal	0.23657210661709	1	0	CTD_human
4318	MMP9	C0162872	Aortic Aneurysm, Thoracic	0.200549453568426	1	0	CTD_human
4318	MMP9	C0243026	Sepsis	0.28328236603324	1	0	CTD_human
4318	MMP9	C0340288	Stable angina	0.201098907136852	1	0	CTD_human
4318	MMP9	C0432226	Metaphyseal anadysplasia	0.200549453568426	0	0	ORPHANET
4318	MMP9	C0432291	Mandibuloacral dysostosis	0.200274726784213	1	0	CTD_human
4318	MMP9	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
4318	MMP9	C0948089	Acute Coronary Syndrome	0.21433527120477	1	0	CTD_human
4318	MMP9	C2751322	Metaphyseal Anadysplasia 2	0.2	0	0	CTD_human
4319	MMP10	C0003873	Rheumatoid Arthritis	0.200549453568426	1	0	CTD_human
4319	MMP10	C0004096	Asthma	0.200274726784213	1	0	CTD_human
4319	MMP10	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
4321	MMP12	C0003873	Rheumatoid Arthritis	0.203231208875927	1	0	CTD_human
4321	MMP12	C0034067	Pulmonary Emphysema	0.203296721410557	2	0	CTD_human
4322	MMP13	C0011334	Dental caries	0.200274726784213	0	0	HPO
4322	MMP13	C0029408	Degenerative polyarthritis	0.316727256820652	0	0	HPO
4322	MMP13	C0432225	Metaphyseal chondrodysplasia Spahr type	0.400549453568426	1	3	ORPHANET;UNIPROT
4322	MMP13	C0432226	Metaphyseal anadysplasia	0.200824180352639	0	0	ORPHANET
4322	MMP13	C1865832	Spondyloepimetaphyseal Dysplasia, Missouri Type	0.600274726784213	2	5	CTD_human;ORPHANET;UNIPROT
4323	MMP14	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
4323	MMP14	C0024117	Chronic Obstructive Airway Disease	0.205414667772315	1	0	CTD_human
4323	MMP14	C0029456	Osteoporosis	0.2	0	0	HPO
4323	MMP14	C0162871	Aortic Aneurysm, Abdominal	0.200549453568426	1	0	CTD_human
4323	MMP14	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
4323	MMP14	C1850155	TORG-WINCHESTER SYNDROME	0.2	0	0	ORPHANET
4323	MMP14	C3805887	Generalized osteoporosis with pathologic fractures	0.2	0	0	HPO
4323	MMP14	C4024579	Osteolysis involving bones of the feet	0.2	0	0	HPO
432400	EIG3	C0270850	Idiopathic generalized epilepsy	0.2	0	0	CTD_human
4327	MMP19	C1969063	Cavitary Optic Disc Anomalies	0.2	0	0	ORPHANET
4329	ALDH6A1	C0028754	Obesity	0.2	1	0	CTD_human
4329	ALDH6A1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
4329	ALDH6A1	C3279840	Methylmalonate Semialdehyde Dehydrogenase Deficiency	0.4	1	5	ORPHANET;UNIPROT
4329	ALDH6A1	C4020871	Dystonic disease	0.2	0	0	HPO
4335	MNT	C1955870	Classical Lissencephalies and Subcortical Band Heterotopias	0.2	1	0	CTD_human
4336	MOBP	C0002736	Amyotrophic Lateral Sclerosis	0.2	1	0	CTD_human
4336	MOBP	C0038868	Progressive supranuclear palsy	0.200274726784213	1	1	CTD_human
4337	MOCS1	C0014544	Epilepsy	0.2	0	0	HPO
4337	MOCS1	C0028738	Nystagmus	0.2	0	0	HPO
4337	MOCS1	C0220988	Xanthinuria	0.2	0	0	HPO
4337	MOCS1	C0235946	Cerebral atrophy	0.2	0	0	HPO
4337	MOCS1	C0268118	Xanthinuria, Type I	0.2	0	0	HPO
4337	MOCS1	C0268119	Combined molybdoflavoprotein enzyme deficiency	0.4	0	0	CTD_human;HPO
4337	MOCS1	C0268624	Sulfite oxidase deficiency	0.2	0	0	HPO
4337	MOCS1	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
4337	MOCS1	C0575059	Spastic tetraparesis	0.2	0	0	HPO
4337	MOCS1	C1291266	Deficiency of aldehyde oxidase	0.2	0	0	HPO
4337	MOCS1	C1854988	Molybdenum Cofactor Deficiency, Complementation Group A	0.4	3	10	ORPHANET;UNIPROT
4337	MOCS1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
4338	MOCS2	C0028738	Nystagmus	0.2	0	0	HPO
4338	MOCS2	C0220988	Xanthinuria	0.2	0	0	HPO
4338	MOCS2	C0235946	Cerebral atrophy	0.2	0	0	HPO
4338	MOCS2	C0268119	Combined molybdoflavoprotein enzyme deficiency	0.4	0	0	CTD_human;HPO
4338	MOCS2	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
4338	MOCS2	C1854989	Molybdenum Cofactor Deficiency, Complementation Group B	0.4	2	9	ORPHANET;UNIPROT
4338	MOCS2	C4020860	Supratentorial atrophy	0.2	0	0	HPO
4340	MOG	C0007384	Cataplexy	0.200274726784213	0	0	HPO
4340	MOG	C0027404	Narcolepsy	0.400824180352639	0	0	HPO;ORPHANET
4340	MOG	C0028754	Obesity	0.2	0	0	HPO
4340	MOG	C0751362	Narcolepsy-Cataplexy Syndrome	0.2	0	0	ORPHANET
4340	MOG	C3280266	NARCOLEPSY 7	0.2	1	1	UNIPROT
435	ASL	C0014544	Epilepsy	0.2	0	0	HPO
435	ASL	C0238621	Aminoaciduria	0.2	0	0	HPO
435	ASL	C0239946	Fibrosis, Liver	0.2	0	0	HPO
435	ASL	C0263485	Clastothrix	0.2	0	0	HPO
435	ASL	C0268547	Argininosuccinic Aciduria	0.683296721410557	6	49	CTD_human;ORPHANET;UNIPROT
435	ASL	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4351	MPI	C0015523	Factor XI Deficiency	0.2	0	0	HPO
4351	MPI	C0020615	Hypoglycemia	0.200274726784213	0	0	HPO
4351	MPI	C0023890	Liver Cirrhosis	0.2	0	0	HPO
4351	MPI	C0024236	Lymphedema	0.2	0	0	HPO
4351	MPI	C0085605	Liver Failure	0.2	0	0	HPO
4351	MPI	C0239946	Fibrosis, Liver	0.200274726784213	0	0	HPO
4351	MPI	C0239981	Hypoalbuminemia	0.2	0	0	HPO
4351	MPI	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
4351	MPI	C0272375	Antithrombin III Deficiency	0.2	0	0	HPO
4351	MPI	C1864903	Hyperinsulinaemic hypoglycaemia	0.2	0	0	HPO
4351	MPI	C1865145	Congenital disorder of glycosylation type 1B	0.602472541057918	6	20	CTD_human;ORPHANET;UNIPROT
4351	MPI	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4352	MPL	C0002871	Anemia	0.201098907136852	0	0	HPO
4352	MPL	C0027051	Myocardial Infarction	0.2	0	0	HPO
4352	MPL	C0030312	Pancytopenia	0.201098907136852	0	0	HPO
4352	MPL	C0040028	Thrombocythemia, Essential	0.45230972249756	0	0	CTD_human;ORPHANET
4352	MPL	C0398639	Amegakaryocytic thrombocytopenia	0.200274726784213	0	0	HPO
4352	MPL	C0750145	vascular disease occlusive	0.2	0	0	HPO
4352	MPL	C0836924	Thrombocytosis	0.418558487282592	2	0	CTD_human;HPO
4352	MPL	C0917805	Transient Cerebral Ischemia	0.2	0	0	HPO
4352	MPL	C1306889	Peripheral arterial occlusive disease	0.2	0	0	HPO
4352	MPL	C1401086	Peripheral vascular insufficiency	0.2	0	0	HPO
4352	MPL	C3275998	THROMBOCYTHEMIA 2	0.4	5	3	ORPHANET;UNIPROT
4352	MPL	C3277671	THROMBOCYTHEMIA 1	0.2	0	0	ORPHANET
4352	MPL	C3281125	THROMBOCYTHEMIA 3	0.2	0	0	ORPHANET
4353	MPO	C0002395	Alzheimer's Disease	0.219922351446673	1	0	CTD_human
4353	MPO	C0003873	Rheumatoid Arthritis	0.200824180352639	2	0	CTD_human
4353	MPO	C0007786	Brain Ischemia	0.2	1	0	CTD_human
4353	MPO	C0009319	Colitis	0.203021994626344	1	0	CTD_human
4353	MPO	C0009324	Ulcerative Colitis	0.200549453568426	3	0	CTD_human
4353	MPO	C0022593	Keratosis	0.2	1	0	CTD_human
4353	MPO	C0023891	Liver Cirrhosis, Alcoholic	0.202681755307501	2	0	CTD_human
4353	MPO	C0030305	Pancreatitis	0.2	1	0	CTD_human
4353	MPO	C0040954	Infection by Trichuris trichiura	0.2	1	0	CTD_human
4353	MPO	C0042109	Urticaria	0.2	1	0	CTD_human
4353	MPO	C0398595	Myeloperoxidase Deficiency	0.681373633921066	3	9	CTD_human;ORPHANET;UNIPROT
4353	MPO	C0850715	Abnormality of blood and blood-forming tissues	0.2	0	0	HPO
4358	MPV17	C0010043	Corneal Ulcer	0.2	0	0	HPO
4358	MPV17	C0017668	Focal glomerulosclerosis	0.200549453568426	1	0	CTD_human
4358	MPV17	C0020615	Hypoglycemia	0.2	0	0	HPO
4358	MPV17	C0023890	Liver Cirrhosis	0.200274726784213	0	0	HPO
4358	MPV17	C0028738	Nystagmus	0.2	0	0	HPO
4358	MPV17	C0155119	Recurrent erosion of cornea	0.2	0	0	HPO
4358	MPV17	C0162557	Liver Failure, Acute	0.2	0	0	HPO
4358	MPV17	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
4358	MPV17	C1850406	NAVAJO NEUROHEPATOPATHY	0.601098907136852	3	21	CTD_human;ORPHANET;UNIPROT
4358	MPV17	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4358	MPV17	C3151513	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.28	0	0	CTD_human
4358	MPV17	C4020871	Dystonic disease	0.2	0	0	HPO
4359	MPZ	C0007959	Charcot-Marie-Tooth Disease	0.263271761843074	0	0	CTD_human
4359	MPZ	C0011195	Dejerine-Sottas Disease (disorder)	0.489065983879032	6	8	ORPHANET;UNIPROT
4359	MPZ	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4359	MPZ	C0037921	Spinal ataxia	0.2	0	0	HPO
4359	MPZ	C0085684	Foot-drop	0.2	0	0	HPO
4359	MPZ	C0205713	Roussy-Levy Syndrome (disorder)	0.4	1	3	ORPHANET;UNIPROT
4359	MPZ	C0270912	Charcot-Marie-Tooth Disease, Type Ib	0.490099378481255	46	43	ORPHANET;UNIPROT
4359	MPZ	C0393818	Congenital hypomyelinating neuropathy	0.48439562854741	1	3	CTD_human;UNIPROT
4359	MPZ	C1843075	Charcot-Marie-Tooth Disease, Dominant Intermediate D	0.6	2	3	CTD_human;ORPHANET;UNIPROT
4359	MPZ	C1843153	Charcot-Marie-Tooth disease, Type 2J	0.600824180352639	12	6	CTD_human;ORPHANET;UNIPROT
4359	MPZ	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4359	MPZ	C1848736	Distal amyotrophy	0.2	0	0	HPO
4359	MPZ	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
4359	MPZ	C3888087	Charcot-Marie-Tooth disease, Type 2I	0.6	19	11	CTD_human;ORPHANET;UNIPROT
4360	MRC1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
4361	MRE11	C0039446	Telangiectasis	0.2	0	0	HPO
4361	MRE11	C0262404	Cerebellar degeneration	0.200549453568426	0	0	HPO
4361	MRE11	C0271390	Nystagmus, End-Position	0.2	0	0	HPO
4361	MRE11	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4361	MRE11	C1848736	Distal amyotrophy	0.2	0	0	HPO
4361	MRE11	C1859598	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	0.200274726784213	0	0	ORPHANET
4361	MRE11	C3489733	Oculomotor apraxia	0.200274726784213	0	0	HPO
4361	MRE11	C4012790	ATAXIA-TELANGIECTASIA-LIKE DISORDER 1	0.4	1	1	CTD_human;UNIPROT
4361	MRE11	C4020858	Choreatic disease	0.2	0	0	HPO
4361	MRE11	C4020871	Dystonic disease	0.2	0	0	HPO
4361	MRE11	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4363	ABCC1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
4364	MRSD	C1839729	MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY	0.2	0	0	CTD_human
4378	MRX14	C0796220	MENTAL RETARDATION, X-LINKED 14	0.2	0	0	CTD_human
438	ASMT	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
4384	MRX20	C0796226	MENTAL RETARDATION, X-LINKED 20	0.2	0	0	CTD_human
4387	MRX23	C0796229	MENTAL RETARDATION, X-LINKED 23	0.2	0	0	CTD_human
4397	MS	C0026769	Multiple Sclerosis	0.226648498068671	0	0	CTD_human
440	ASNS	C0014544	Epilepsy	0.2	0	0	HPO
440	ASNS	C0023794	Lipoidosis	0.2	1	0	CTD_human
440	ASNS	C0155320	Blindness, Cortical	0.2	0	0	HPO
440	ASNS	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
440	ASNS	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
440	ASNS	C3809971	ASPARAGINE SYNTHETASE DEFICIENCY	0.400274726784213	1	5	ORPHANET;UNIPROT
440138	ALG11	C3150913	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip	0.6	2	6	CTD_human;ORPHANET;UNIPROT
440275	EIF2AK4	C0034091	Pulmonary Veno-Occlusive Disease (disorder)	0.401098907136852	1	0	CTD_human;ORPHANET
440275	EIF2AK4	C0340543	Familial primary pulmonary hypertension	0.2	0	0	ORPHANET
440275	EIF2AK4	C0340548	Pulmonary capillary hemangiomatosis	0.200824180352639	0	0	ORPHANET
440275	EIF2AK4	C0340848	PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE	0.2	1	11	UNIPROT
440435	GPR179	C3281215	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.2	2	12	UNIPROT
4406	MRX42	C1845810	MENTAL RETARDATION, X-LINKED 42	0.2	0	0	CTD_human
440822	PIWIL3	C0028960	Oligospermia	0.202681755307501	1	0	CTD_human
440823	MIAT	C0027051	Myocardial Infarction	0.203007639249027	1	0	CTD_human
440836	ODF3B	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
440854	CAPN14	C0341106	Eosinophilic esophagitis	0.200549453568426	1	2	CTD_human
441151	TMEM151B	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
4412	MRX49	C3887959	MENTAL RETARDATION, X-LINKED 49	0.2	0	0	CTD_human
4413	MRX50	C1848087	MENTAL RETARDATION, X-LINKED 50	0.2	0	0	CTD_human
4416	MRX53	C1845889	MENTAL RETARDATION, X-LINKED 53	0.2	0	0	CTD_human
442038	SULT1C3	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
442891	MIR135B	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
442892	MIR148B	C0015695	Fatty Liver	0.2	1	0	CTD_human
442895	MIR302C	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
4429	MRXS7	C1846170	MENTAL RETARDATION, X-LINKED, SYNDROMIC 7	0.2	0	0	CTD_human
442905	MIR337	C0008370	Cholestasis	0.2	1	0	CTD_human
442905	MIR337	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
442905	MIR337	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
442911	MIR346	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
442912	MIR367	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
442913	MIR376C	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
443	ASPA	C0014544	Epilepsy	0.2	0	0	HPO
443	ASPA	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
443	ASPA	C0028738	Nystagmus	0.2	0	0	HPO
443	ASPA	C0029124	Optic Atrophy	0.2	0	0	HPO
443	ASPA	C0206307	Canavan Disease	0.500785012310931	10	35	CTD_human;UNIPROT
443	ASPA	C0234533	Generalized seizures	0.2	0	0	HPO
443	ASPA	C0235946	Cerebral atrophy	0.2	0	0	HPO
443	ASPA	C0271215	Blindness, Legal	0.2	0	0	HPO
443	ASPA	C0338474	Central nervous system demyelination	0.2	0	0	HPO
443	ASPA	C1836830	Developmental regression	0.2	0	0	HPO
4434	MSD	C1412041	Paine syndrome	0.2	0	0	CTD_human
4436	MSH2	C0012819	Diverticular disease of colon	0.2	0	0	HPO
4436	MSH2	C0014544	Epilepsy	0.2	0	0	HPO
4436	MSH2	C0151740	Intracranial Hypertension	0.2	0	0	HPO
4436	MSH2	C0265325	Turcot syndrome (disorder)	0.406043989252688	0	0	CTD_human;ORPHANET
4436	MSH2	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4436	MSH2	C1861975	Cafe au lait spots, multiple	0.200274726784213	0	0	CTD_human
4436	MSH2	C2931459	Lynch syndrome I (site-specific colonic cancer)	0.2	1	0	CTD_human
4436	MSH2	C4020884	Anxiety disease	0.2	0	0	HPO
444	ASPH	C0024636	Malocclusion	0.2	0	0	HPO
444	ASPH	C0423319	Atrophic iris	0.2	0	0	HPO
444	ASPH	C1832167	Ectopia Lentis, Spontaneous Filtering Blebs, and Craniofacial Dysmorphism	0.400274726784213	1	2	ORPHANET;UNIPROT
444	ASPH	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
444980	HYT4	C0085580	Essential Hypertension	0.2	0	0	CTD_human
445	ASS1	C0011875	Diabetic Angiopathies	0.2	1	0	CTD_human
445	ASS1	C0014544	Epilepsy	0.2	0	0	HPO
445	ASS1	C0023890	Liver Cirrhosis	0.2	0	0	HPO
445	ASS1	C0175683	Citrullinemia	0.493447257049125	9	53	CTD_human;UNIPROT
445	ASS1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4478	MSN	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
4478	MSN	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
4478	MSN	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
4481	MSR1	C0004763	Barrett Esophagus	0.200274726784213	0	0	HPO
4481	MSR1	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
4485	MST1	C0008313	Cholangitis, Sclerosing	0.202407028523288	1	1	CTD_human
4485	MST1	C0009324	Ulcerative Colitis	0.209744783785095	2	1	CTD_human
4485	MST1	C0010346	Crohn Disease	0.209968353411995	1	1	CTD_human
4485	MST1	C0566602	Primary sclerosing cholangitis	0.200824180352639	0	0	ORPHANET
4486	MST1R	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
4487	MSX1	C0406735	Hypoplastic enamel-onycholysis-hypohidrosis syndrome	0.200274726784213	0	0	CTD_human
4487	MSX1	C1837210	OROFACIAL CLEFT 5	0.48	2	5	CTD_human;UNIPROT
4487	MSX1	C1956097	Wolf-Hirschhorn Syndrome	0.200824180352639	1	0	CTD_human
4488	MSX2	C0014544	Epilepsy	0.2	0	0	HPO
4488	MSX2	C1858160	CRANIOSYNOSTOSIS, TYPE 2	0.683296721410557	3	1	CTD_human;ORPHANET;UNIPROT
4488	MSX2	C1868597	Parietal Foramina With Cleidocranial Dysplasia	0.400274726784213	0	0	CTD_human;ORPHANET
4489	MT1A	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
448963	DFNB51	C1864968	DEAFNESS, AUTOSOMAL RECESSIVE 51	0.2	0	0	CTD_human
449013	ANIB2	C1837894	ANEURYSM, INTRACRANIAL BERRY, 2 (disorder)	0.2	0	0	CTD_human
449018	EJM3	C0270853	Myoclonic Epilepsy, Juvenile	0.2	0	0	CTD_human
449483	DFNB45	C3888030	DEAFNESS, AUTOSOMAL RECESSIVE 45	0.2	0	0	CTD_human
449488	DFNB46	C1864815	DEAFNESS, AUTOSOMAL RECESSIVE 46 (disorder)	0.2	0	0	CTD_human
449489	DFNB47	C1864964	DEAFNESS, AUTOSOMAL RECESSIVE 47 (disorder)	0.2	0	0	CTD_human
450086	AD9	C0002395	Alzheimer's Disease	0.2	0	0	CTD_human
450086	AD9	C1837149	Alzheimer Disease 9	0.2	0	0	CTD_human
450092	KTCN2	C1837090	Keratoconus 2	0.2	0	0	CTD_human
450096	PAPA4	C1837868	Polydactyly, Postaxial, Type A4	0.2	0	0	CTD_human
450097	RLS2	C0035258	Restless Legs Syndrome	0.200274726784213	0	0	CTD_human
4502	MT2A	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
4502	MT2A	C0403447	Chronic Kidney Insufficiency	0.2	1	0	CTD_human
4504	MT3	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
4507	MTAP	C1862177	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	0.2	0	0	ORPHANET
4508	ATP6	C0014544	Epilepsy	0.2	0	0	HPO
4508	ATP6	C0023264	Leigh Disease	0.212333994534955	7	7	UNIPROT
4508	ATP6	C0028738	Nystagmus	0.2	0	0	HPO
4508	ATP6	C0029124	Optic Atrophy	0.2	0	0	HPO
4508	ATP6	C0035334	Retinitis Pigmentosa	0.201098907136852	0	0	HPO
4508	ATP6	C0151313	Sensory neuropathy	0.2	0	0	HPO
4508	ATP6	C0152025	Polyneuropathy	0.200274726784213	0	0	HPO
4508	ATP6	C0154835	Retinal telangiectasia	0.2	0	0	HPO
4508	ATP6	C0271215	Blindness, Legal	0.2	0	0	HPO
4508	ATP6	C0795996	STRIATONIGRAL DEGENERATION, INFANTILE (disorder)	0.2	0	0	ORPHANET
4508	ATP6	C0917796	Optic Atrophy, Hereditary, Leber	0.60350593566014	2	1	HPO;ORPHANET;UNIPROT
4508	ATP6	C1328349	Neuropathy ataxia and retinis pigmentosa	0.602747267842131	3	2	CTD_human;ORPHANET;UNIPROT
4508	ATP6	C1839022	Striatonigral Degeneration, Infantile, Mitochondrial	0.2	0	0	UNIPROT
4508	ATP6	C2931092	Maternally Inherited Leigh Syndrome	0.400824180352639	1	0	CTD_human;ORPHANET
4508	ATP6	C3887709	Optic Neuropathy	0.2	0	0	HPO
4508	ATP6	C4020871	Dystonic disease	0.2	0	0	HPO
4508	ATP6	C4225415	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 3	0.2	1	1	UNIPROT
4509	ATP8	C0022541	Kearns-Sayre syndrome	0.2	0	0	ORPHANET
4509	ATP8	C0151517	Complete atrioventricular block	0.2	0	0	HPO
4509	ATP8	C0162674	Chronic progressive external ophthalmoplegia	0.2	0	0	HPO
4509	ATP8	C0234958	muscle degeneration	0.2	0	0	HPO
4509	ATP8	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
4511	TRNC	C0018801	Heart failure	0.2	0	0	HPO
4511	TRNC	C0018802	Congestive heart failure	0.2	0	0	HPO
4511	TRNC	C0018979	Hemianopsia	0.2	0	0	HPO
4511	TRNC	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4511	TRNC	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4511	TRNC	C0155320	Blindness, Cortical	0.2	0	0	HPO
4511	TRNC	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4511	TRNC	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4511	TRNC	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4511	TRNC	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4511	TRNC	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4512	COX1	C0003123	Anorexia	0.2	0	0	HPO
4512	COX1	C0007786	Brain Ischemia	0.2	0	0	HPO
4512	COX1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.204814057046576	0	0	HPO
4512	COX1	C0018784	Sensorineural Hearing Loss (disorder)	0.205088783830789	0	0	HPO
4512	COX1	C0018801	Heart failure	0.2	0	0	HPO
4512	COX1	C0018802	Congestive heart failure	0.2	0	0	HPO
4512	COX1	C0018979	Hemianopsia	0.2	0	0	HPO
4512	COX1	C0029124	Optic Atrophy	0.2	0	0	HPO
4512	COX1	C0030305	Pancreatitis	0.2	0	0	HPO
4512	COX1	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4512	COX1	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4512	COX1	C0154835	Retinal telangiectasia	0.2	0	0	HPO
4512	COX1	C0155320	Blindness, Cortical	0.2	0	0	HPO
4512	COX1	C0162671	MELAS Syndrome	0.2	0	0	ORPHANET
4512	COX1	C0235946	Cerebral atrophy	0.2	0	0	HPO
4512	COX1	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4512	COX1	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4512	COX1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4512	COX1	C0917796	Optic Atrophy, Hereditary, Leber	0.2	0	0	ORPHANET
4512	COX1	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4512	COX1	C1836830	Developmental regression	0.2	0	0	HPO
4512	COX1	C1838854	DEAFNESS, AMINOGLYCOSIDE-INDUCED	0.2	0	0	ORPHANET
4512	COX1	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4512	COX1	C3151897	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	0.2	0	0	ORPHANET
4512	COX1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4512	COX1	C4020884	Anxiety disease	0.2	0	0	HPO
4513	COX2	C0003123	Anorexia	0.2	0	0	HPO
4513	COX2	C0007786	Brain Ischemia	0.2	0	0	HPO
4513	COX2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202407028523288	0	0	HPO
4513	COX2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4513	COX2	C0018801	Heart failure	0.200274726784213	0	0	HPO
4513	COX2	C0018802	Congestive heart failure	0.200549453568426	0	0	HPO
4513	COX2	C0018979	Hemianopsia	0.2	0	0	HPO
4513	COX2	C0030305	Pancreatitis	0.2	0	0	HPO
4513	COX2	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4513	COX2	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4513	COX2	C0155320	Blindness, Cortical	0.2	0	0	HPO
4513	COX2	C0162671	MELAS Syndrome	0.200274726784213	0	0	ORPHANET
4513	COX2	C0235946	Cerebral atrophy	0.2	0	0	HPO
4513	COX2	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4513	COX2	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4513	COX2	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4513	COX2	C0917798	Cerebral Ischemia	0.200549453568426	0	0	HPO
4513	COX2	C1836830	Developmental regression	0.2	0	0	HPO
4513	COX2	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4513	COX2	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4513	COX2	C4020884	Anxiety disease	0.2	0	0	HPO
4514	COX3	C0003123	Anorexia	0.2	0	0	HPO
4514	COX3	C0007786	Brain Ischemia	0.2	0	0	HPO
4514	COX3	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202407028523288	0	0	HPO
4514	COX3	C0014556	Epilepsy, Temporal Lobe	0.2	1	0	CTD_human
4514	COX3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4514	COX3	C0018801	Heart failure	0.2	0	0	HPO
4514	COX3	C0018802	Congestive heart failure	0.2	0	0	HPO
4514	COX3	C0018979	Hemianopsia	0.2	0	0	HPO
4514	COX3	C0029124	Optic Atrophy	0.2	0	0	HPO
4514	COX3	C0030305	Pancreatitis	0.2	0	0	HPO
4514	COX3	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4514	COX3	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4514	COX3	C0152025	Polyneuropathy	0.2	0	0	HPO
4514	COX3	C0154835	Retinal telangiectasia	0.2	0	0	HPO
4514	COX3	C0155320	Blindness, Cortical	0.2	0	0	HPO
4514	COX3	C0162671	MELAS Syndrome	0.402732912464814	2	0	ORPHANET;UNIPROT
4514	COX3	C0235946	Cerebral atrophy	0.2	0	0	HPO
4514	COX3	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4514	COX3	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4514	COX3	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4514	COX3	C0917796	Optic Atrophy, Hereditary, Leber	0.600274726784213	1	2	HPO;ORPHANET;UNIPROT
4514	COX3	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4514	COX3	C1836830	Developmental regression	0.2	0	0	HPO
4514	COX3	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4514	COX3	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4514	COX3	C3887709	Optic Neuropathy	0.2	0	0	HPO
4514	COX3	C4020871	Dystonic disease	0.2	0	0	HPO
4514	COX3	C4020884	Anxiety disease	0.2	0	0	HPO
4519	CYTB	C0018801	Heart failure	0.2	0	0	HPO
4519	CYTB	C0018802	Congestive heart failure	0.2	0	0	HPO
4519	CYTB	C0018979	Hemianopsia	0.2	0	0	HPO
4519	CYTB	C0029124	Optic Atrophy	0.2	0	0	HPO
4519	CYTB	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4519	CYTB	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4519	CYTB	C0152025	Polyneuropathy	0.2	0	0	HPO
4519	CYTB	C0154835	Retinal telangiectasia	0.2	0	0	HPO
4519	CYTB	C0155320	Blindness, Cortical	0.2	0	0	HPO
4519	CYTB	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4519	CYTB	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4519	CYTB	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4519	CYTB	C0917796	Optic Atrophy, Hereditary, Leber	0.601098907136852	2	3	HPO;ORPHANET;UNIPROT
4519	CYTB	C1708371	Histiocytoid Cardiomyopathy	0.400274726784213	1	1	ORPHANET;UNIPROT
4519	CYTB	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4519	CYTB	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4519	CYTB	C3887709	Optic Neuropathy	0.2	0	0	HPO
4519	CYTB	C4020871	Dystonic disease	0.2	0	0	HPO
4522	MTHFD1	C1866558	Neural tube defect, folate-sensitive	0.4	2	2	CTD_human;UNIPROT
4524	MTHFR	C0001403	Addison Disease	0.2	0	0	HPO
4524	MTHFR	C0002170	Alopecia	0.200549453568426	1	0	CTD_human
4524	MTHFR	C0002395	Alzheimer's Disease	0.277063393256835	1	0	CTD_human
4524	MTHFR	C0002871	Anemia	0.205638237399215	2	0	CTD_human
4524	MTHFR	C0003873	Rheumatoid Arthritis	0.286635764572342	1	0	CTD_human
4524	MTHFR	C0007786	Brain Ischemia	0.282164853733318	1	0	CTD_human
4524	MTHFR	C0010068	Coronary heart disease	0.321975776475335	1	0	CTD_human
4524	MTHFR	C0011875	Diabetic Angiopathies	0.212309869400653	1	0	CTD_human
4524	MTHFR	C0013080	Down Syndrome	0.320241283506153	4	0	CTD_human
4524	MTHFR	C0014544	Epilepsy	0.223204717479913	0	0	HPO
4524	MTHFR	C0018133	Graft-vs-Host Disease	0.22308804778797	1	0	CTD_human
4524	MTHFR	C0019880	Homocystinuria	0.206737144536068	0	0	HPO
4524	MTHFR	C0023530	Leukopenia	0.204055389228567	1	0	CTD_human
4524	MTHFR	C0027947	Neutropenia	0.20777053913829	1	0	CTD_human
4524	MTHFR	C0034065	Pulmonary Embolism	0.220904588891583	1	0	CTD_human
4524	MTHFR	C0037198	Sinus Thrombosis, Intracranial	0.205638237399215	1	0	CTD_human
4524	MTHFR	C0040156	Thyrotoxicosis	0.200274726784213	1	0	CTD_human
4524	MTHFR	C0162429	Malnutrition	0.205363510615002	1	0	CTD_human
4524	MTHFR	C0206064	Microvascular Angina	0.202681755307501	1	0	CTD_human
4524	MTHFR	C0398623	Thrombophilia	0.298941792733387	1	0	CTD_human
4524	MTHFR	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
4524	MTHFR	C0598608	Hyperhomocysteinemia	0.421414491598346	11	0	CTD_human
4524	MTHFR	C0948480	Coronary Restenosis	0.204814057046576	1	0	CTD_human
4524	MTHFR	C1856058	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY	0.402472541057918	6	60	ORPHANET;UNIPROT
4524	MTHFR	C1856061	Methylenetetrahydrofolate reductase deficiency	0.202681755307501	0	0	CTD_human
4524	MTHFR	C1861537	OROFACIAL CLEFT 1	0.200549453568426	0	0	CTD_human
4524	MTHFR	C1866558	Neural tube defect, folate-sensitive	0.28	0	0	CTD_human
4524	MTHFR	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
4534	MTM1	C0004245	Atrioventricular Block	0.2	0	0	HPO
4534	MTM1	C0014544	Epilepsy	0.2	0	0	HPO
4534	MTM1	C0020255	Hydrocephalus	0.2	0	0	HPO
4534	MTM1	C0162292	External Ophthalmoplegia	0.2	0	0	HPO
4534	MTM1	C0162674	Chronic progressive external ophthalmoplegia	0.2	0	0	HPO
4534	MTM1	C0234958	muscle degeneration	0.2	0	0	HPO
4534	MTM1	C0376175	Bell Palsy	0.2	0	0	HPO
4534	MTM1	C0752282	Congenital Structural Myopathy	0.215616360568195	1	0	CTD_human
4534	MTM1	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
4534	MTM1	C1841659	Atrioventricular nodal disease	0.2	0	0	HPO
4534	MTM1	C1846169	Myotubular Myopathy with Abnormal Genital Development	0.2	0	0	ORPHANET
4535	ND1	C0003123	Anorexia	0.2	0	0	HPO
4535	ND1	C0007786	Brain Ischemia	0.2	0	0	HPO
4535	ND1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.224238112082135	0	0	HPO
4535	ND1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4535	ND1	C0018801	Heart failure	0.2	0	0	HPO
4535	ND1	C0018802	Congestive heart failure	0.2	0	0	HPO
4535	ND1	C0018979	Hemianopsia	0.2	0	0	HPO
4535	ND1	C0029124	Optic Atrophy	0.200274726784213	0	0	HPO
4535	ND1	C0030305	Pancreatitis	0.2	0	0	HPO
4535	ND1	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4535	ND1	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4535	ND1	C0152025	Polyneuropathy	0.2	0	0	HPO
4535	ND1	C0154835	Retinal telangiectasia	0.2	0	0	HPO
4535	ND1	C0155320	Blindness, Cortical	0.2	0	0	HPO
4535	ND1	C0162671	MELAS Syndrome	0.40328236603324	1	4	ORPHANET;UNIPROT
4535	ND1	C0235946	Cerebral atrophy	0.2	0	0	HPO
4535	ND1	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4535	ND1	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4535	ND1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4535	ND1	C0917796	Optic Atrophy, Hereditary, Leber	0.6121661676857	6	11	CTD_human;HPO;ORPHANET;UNIPROT
4535	ND1	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4535	ND1	C1836830	Developmental regression	0.2	0	0	HPO
4535	ND1	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.2	1	2	UNIPROT
4535	ND1	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4535	ND1	C2931092	Maternally Inherited Leigh Syndrome	0.2	0	0	ORPHANET
4535	ND1	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4535	ND1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4535	ND1	C3887709	Optic Neuropathy	0.200549453568426	0	0	HPO
4535	ND1	C4020871	Dystonic disease	0.2	0	0	HPO
4535	ND1	C4020884	Anxiety disease	0.2	0	0	HPO
4536	ND2	C0029124	Optic Atrophy	0.2	0	0	HPO
4536	ND2	C0152025	Polyneuropathy	0.2	0	0	HPO
4536	ND2	C0154835	Retinal telangiectasia	0.2	0	0	HPO
4536	ND2	C0917796	Optic Atrophy, Hereditary, Leber	0.6	3	3	HPO;ORPHANET;UNIPROT
4536	ND2	C2931092	Maternally Inherited Leigh Syndrome	0.2	0	0	ORPHANET
4536	ND2	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4536	ND2	C3887709	Optic Neuropathy	0.2	0	0	HPO
4536	ND2	C4020871	Dystonic disease	0.2	0	0	HPO
4537	ND3	C0023264	Leigh Disease	0.210121824883933	2	5	UNIPROT
4537	ND3	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.2	3	3	UNIPROT
4537	ND3	C2931092	Maternally Inherited Leigh Syndrome	0.200274726784213	0	0	ORPHANET
4537	ND3	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4538	ND4	C0003123	Anorexia	0.2	0	0	HPO
4538	ND4	C0007786	Brain Ischemia	0.2	0	0	HPO
4538	ND4	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.204814057046576	0	0	HPO
4538	ND4	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4538	ND4	C0018979	Hemianopsia	0.2	0	0	HPO
4538	ND4	C0029124	Optic Atrophy	0.200549453568426	0	0	HPO
4538	ND4	C0030305	Pancreatitis	0.2	0	0	HPO
4538	ND4	C0152025	Polyneuropathy	0.2	0	0	HPO
4538	ND4	C0154835	Retinal telangiectasia	0.2	0	0	HPO
4538	ND4	C0162671	MELAS Syndrome	0.400549453568426	1	1	ORPHANET;UNIPROT
4538	ND4	C0235946	Cerebral atrophy	0.2	0	0	HPO
4538	ND4	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4538	ND4	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4538	ND4	C0917796	Optic Atrophy, Hereditary, Leber	0.621101126495472	6	3	CTD_human;HPO;ORPHANET;UNIPROT
4538	ND4	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4538	ND4	C1836830	Developmental regression	0.2	0	0	HPO
4538	ND4	C1838854	DEAFNESS, AMINOGLYCOSIDE-INDUCED	0.200274726784213	0	0	ORPHANET
4538	ND4	C1839040	LEBER OPTIC ATROPHY AND DYSTONIA	0.2	1	1	UNIPROT
4538	ND4	C2931092	Maternally Inherited Leigh Syndrome	0.2	0	0	ORPHANET
4538	ND4	C3887709	Optic Neuropathy	0.200824180352639	0	0	HPO
4538	ND4	C4020871	Dystonic disease	0.2	0	0	HPO
4538	ND4	C4020884	Anxiety disease	0.2	0	0	HPO
4539	ND4L	C0029124	Optic Atrophy	0.2	0	0	HPO
4539	ND4L	C0152025	Polyneuropathy	0.2	0	0	HPO
4539	ND4L	C0154835	Retinal telangiectasia	0.2	0	0	HPO
4539	ND4L	C0917796	Optic Atrophy, Hereditary, Leber	0.601098907136852	1	1	HPO;ORPHANET;UNIPROT
4539	ND4L	C3887709	Optic Neuropathy	0.2	0	0	HPO
4539	ND4L	C4020871	Dystonic disease	0.2	0	0	HPO
4540	ND5	C0003123	Anorexia	0.2	0	0	HPO
4540	ND5	C0007786	Brain Ischemia	0.2	0	0	HPO
4540	ND5	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202681755307501	0	0	HPO
4540	ND5	C0014550	Epilepsies, Myoclonic	0.200274726784213	0	0	HPO
4540	ND5	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4540	ND5	C0018801	Heart failure	0.2	0	0	HPO
4540	ND5	C0018802	Congestive heart failure	0.2	0	0	HPO
4540	ND5	C0018979	Hemianopsia	0.2	0	0	HPO
4540	ND5	C0023264	Leigh Disease	0.208971760589768	3	4	UNIPROT
4540	ND5	C0029124	Optic Atrophy	0.202732912464814	0	0	HPO
4540	ND5	C0030305	Pancreatitis	0.2	0	0	HPO
4540	ND5	C0043202	Wolff-Parkinson-White Syndrome	0.202732912464814	0	0	HPO
4540	ND5	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4540	ND5	C0152025	Polyneuropathy	0.2	0	0	HPO
4540	ND5	C0154835	Retinal telangiectasia	0.2	0	0	HPO
4540	ND5	C0155320	Blindness, Cortical	0.2	0	0	HPO
4540	ND5	C0162671	MELAS Syndrome	0.401098907136852	4	5	ORPHANET;UNIPROT
4540	ND5	C0162672	MERRF Syndrome	0.2	0	0	ORPHANET
4540	ND5	C0235946	Cerebral atrophy	0.2	0	0	HPO
4540	ND5	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4540	ND5	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4540	ND5	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4540	ND5	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
4540	ND5	C0917796	Optic Atrophy, Hereditary, Leber	0.604055389228567	4	7	HPO;ORPHANET;UNIPROT
4540	ND5	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4540	ND5	C1836830	Developmental regression	0.2	0	0	HPO
4540	ND5	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.2	4	4	UNIPROT
4540	ND5	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4540	ND5	C2931092	Maternally Inherited Leigh Syndrome	0.2	0	0	ORPHANET
4540	ND5	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4540	ND5	C3887709	Optic Neuropathy	0.2	0	0	HPO
4540	ND5	C4020871	Dystonic disease	0.2	0	0	HPO
4540	ND5	C4020884	Anxiety disease	0.2	0	0	HPO
4540	ND5	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
4541	ND6	C0003123	Anorexia	0.2	0	0	HPO
4541	ND6	C0007786	Brain Ischemia	0.2	0	0	HPO
4541	ND6	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202407028523288	0	0	HPO
4541	ND6	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4541	ND6	C0018801	Heart failure	0.2	0	0	HPO
4541	ND6	C0018802	Congestive heart failure	0.2	0	0	HPO
4541	ND6	C0018979	Hemianopsia	0.2	0	0	HPO
4541	ND6	C0029124	Optic Atrophy	0.2	0	0	HPO
4541	ND6	C0030305	Pancreatitis	0.2	0	0	HPO
4541	ND6	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4541	ND6	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4541	ND6	C0152025	Polyneuropathy	0.2	0	0	HPO
4541	ND6	C0154835	Retinal telangiectasia	0.2	0	0	HPO
4541	ND6	C0155320	Blindness, Cortical	0.2	0	0	HPO
4541	ND6	C0162671	MELAS Syndrome	0.400274726784213	1	1	ORPHANET;UNIPROT
4541	ND6	C0235946	Cerebral atrophy	0.2	0	0	HPO
4541	ND6	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4541	ND6	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4541	ND6	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4541	ND6	C0917796	Optic Atrophy, Hereditary, Leber	0.694847922993201	7	9	CTD_human;HPO;ORPHANET;UNIPROT
4541	ND6	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4541	ND6	C1836830	Developmental regression	0.2	0	0	HPO
4541	ND6	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.2	3	2	UNIPROT
4541	ND6	C1839040	LEBER OPTIC ATROPHY AND DYSTONIA	0.2	1	2	UNIPROT
4541	ND6	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4541	ND6	C2931092	Maternally Inherited Leigh Syndrome	0.2	0	0	ORPHANET
4541	ND6	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4541	ND6	C3887709	Optic Neuropathy	0.200824180352639	0	0	HPO
4541	ND6	C4020871	Dystonic disease	0.2	0	0	HPO
4541	ND6	C4020884	Anxiety disease	0.2	0	0	HPO
4544	MTNR1B	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.253282190185486	5	1	CTD_human
4544	MTNR1B	C0032460	Polycystic Ovary Syndrome	0.202956482091714	1	0	CTD_human
4547	MTTP	C0000744	Abetalipoproteinemia	0.613172530264912	5	7	CTD_human;HPO;ORPHANET;UNIPROT
4547	MTTP	C0015695	Fatty Liver	0.214074899797874	1	0	CTD_human
4547	MTTP	C0338474	Central nervous system demyelination	0.2	0	0	HPO
4547	MTTP	C0687751	Acanthocytosis	0.2	0	0	HPO
4547	MTTP	C2930930	Abdominal obesity metabolic syndrome	0.2	0	0	CTD_human
4548	MTR	C0002888	Anemia, Megaloblastic	0.200274726784213	0	0	HPO
4548	MTR	C0013080	Down Syndrome	0.23420646549413	0	0	CTD_human
4548	MTR	C0014544	Epilepsy	0.202956482091714	0	0	HPO
4548	MTR	C0019880	Homocystinuria	0.200824180352639	0	0	HPO
4548	MTR	C0162429	Malnutrition	0.202407028523288	1	0	CTD_human
4548	MTR	C0235946	Cerebral atrophy	0.2	0	0	HPO
4548	MTR	C1855128	Methylcobalamin Deficiency, CblG Type	0.6	2	10	CTD_human;ORPHANET;UNIPROT
4548	MTR	C1861537	OROFACIAL CLEFT 1	0.2	0	0	CTD_human
4548	MTR	C1866558	Neural tube defect, folate-sensitive	0.2	0	0	CTD_human
4548	MTR	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4548	MTR	C4020860	Supratentorial atrophy	0.2	0	0	HPO
4549	RNR1	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
4549	RNR1	C0018784	Sensorineural Hearing Loss (disorder)	0.222487437062231	0	0	HPO
4549	RNR1	C0029124	Optic Atrophy	0.2	0	0	HPO
4549	RNR1	C0162672	MERRF Syndrome	0.2	0	0	ORPHANET
4549	RNR1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
4549	RNR1	C1838854	DEAFNESS, AMINOGLYCOSIDE-INDUCED	0.200274726784213	0	0	ORPHANET
4549	RNR1	C3151897	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	0.2	0	0	ORPHANET
4549	RNR1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
4552	MTRR	C0002871	Anemia	0.2	0	0	HPO
4552	MTRR	C0002888	Anemia, Megaloblastic	0.200549453568426	0	0	HPO
4552	MTRR	C0014544	Epilepsy	0.202681755307501	0	0	HPO
4552	MTRR	C0019880	Homocystinuria	0.401648360705279	2	0	CTD_human;HPO
4552	MTRR	C0028738	Nystagmus	0.2	0	0	HPO
4552	MTRR	C0235946	Cerebral atrophy	0.2	0	0	HPO
4552	MTRR	C0598608	Hyperhomocysteinemia	0.221230472833108	2	0	CTD_human
4552	MTRR	C1856057	Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type	0.6	1	3	CTD_human;ORPHANET;UNIPROT
4552	MTRR	C1866558	Neural tube defect, folate-sensitive	0.2	0	0	CTD_human
4552	MTRR	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4552	MTRR	C4020860	Supratentorial atrophy	0.2	0	0	HPO
4556	TRNE	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4556	TRNE	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.204814057046576	0	0	HPO
4556	TRNE	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4556	TRNE	C0018801	Heart failure	0.2	0	0	HPO
4556	TRNE	C0018802	Congestive heart failure	0.2	0	0	HPO
4556	TRNE	C0162292	External Ophthalmoplegia	0.2	0	0	HPO
4556	TRNE	C0162674	Chronic progressive external ophthalmoplegia	0.200274726784213	0	0	HPO
4556	TRNE	C0730292	Macular dystrophy	0.2	0	0	HPO
4556	TRNE	C1839028	Mitochondrial Myopathy with Diabetes	0.2	0	0	ORPHANET
4556	TRNE	C3151898	MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT	0.2	0	0	ORPHANET
4558	TRNF	C0003123	Anorexia	0.2	0	0	HPO
4558	TRNF	C0007786	Brain Ischemia	0.2	0	0	HPO
4558	TRNF	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202407028523288	0	0	HPO
4558	TRNF	C0014544	Epilepsy	0.200274726784213	0	0	HPO
4558	TRNF	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
4558	TRNF	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4558	TRNF	C0018801	Heart failure	0.2	0	0	HPO
4558	TRNF	C0018802	Congestive heart failure	0.2	0	0	HPO
4558	TRNF	C0018979	Hemianopsia	0.2	0	0	HPO
4558	TRNF	C0029124	Optic Atrophy	0.2	0	0	HPO
4558	TRNF	C0030305	Pancreatitis	0.2	0	0	HPO
4558	TRNF	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4558	TRNF	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4558	TRNF	C0155320	Blindness, Cortical	0.2	0	0	HPO
4558	TRNF	C0162671	MELAS Syndrome	0.2	0	0	ORPHANET
4558	TRNF	C0162672	MERRF Syndrome	0.200274726784213	0	0	ORPHANET
4558	TRNF	C0235946	Cerebral atrophy	0.2	0	0	HPO
4558	TRNF	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4558	TRNF	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4558	TRNF	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4558	TRNF	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
4558	TRNF	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4558	TRNF	C1836830	Developmental regression	0.2	0	0	HPO
4558	TRNF	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4558	TRNF	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4558	TRNF	C4020884	Anxiety disease	0.2	0	0	HPO
4558	TRNF	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
4564	TRNH	C0003123	Anorexia	0.2	0	0	HPO
4564	TRNH	C0007786	Brain Ischemia	0.2	0	0	HPO
4564	TRNH	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202407028523288	0	0	HPO
4564	TRNH	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
4564	TRNH	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4564	TRNH	C0018979	Hemianopsia	0.2	0	0	HPO
4564	TRNH	C0029124	Optic Atrophy	0.2	0	0	HPO
4564	TRNH	C0030305	Pancreatitis	0.2	0	0	HPO
4564	TRNH	C0162671	MELAS Syndrome	0.2	0	0	ORPHANET
4564	TRNH	C0162672	MERRF Syndrome	0.2	0	0	ORPHANET
4564	TRNH	C0235946	Cerebral atrophy	0.2	0	0	HPO
4564	TRNH	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4564	TRNH	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4564	TRNH	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
4564	TRNH	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4564	TRNH	C1836830	Developmental regression	0.2	0	0	HPO
4564	TRNH	C3151897	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	0.2	0	0	ORPHANET
4564	TRNH	C4020884	Anxiety disease	0.2	0	0	HPO
4564	TRNH	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
4565	TRNI	C0014544	Epilepsy	0.2	0	0	HPO
4565	TRNI	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
4565	TRNI	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4565	TRNI	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
4565	TRNI	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
4566	TRNK	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4566	TRNK	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.207221085569864	0	0	HPO
4566	TRNK	C0014544	Epilepsy	0.200549453568426	0	0	HPO
4566	TRNK	C0014550	Epilepsies, Myoclonic	0.200549453568426	0	0	HPO
4566	TRNK	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4566	TRNK	C0018801	Heart failure	0.2	0	0	HPO
4566	TRNK	C0018802	Congestive heart failure	0.2	0	0	HPO
4566	TRNK	C0018979	Hemianopsia	0.2	0	0	HPO
4566	TRNK	C0029124	Optic Atrophy	0.2	0	0	HPO
4566	TRNK	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4566	TRNK	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4566	TRNK	C0155320	Blindness, Cortical	0.2	0	0	HPO
4566	TRNK	C0162292	External Ophthalmoplegia	0.2	0	0	HPO
4566	TRNK	C0162672	MERRF Syndrome	0.20433011601278	0	0	ORPHANET
4566	TRNK	C0162674	Chronic progressive external ophthalmoplegia	0.200549453568426	0	0	HPO
4566	TRNK	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4566	TRNK	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4566	TRNK	C0730292	Macular dystrophy	0.2	0	0	HPO
4566	TRNK	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4566	TRNK	C0751778	Myoclonic Epilepsies, Progressive	0.200274726784213	0	0	HPO
4566	TRNK	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4566	TRNK	C2931092	Maternally Inherited Leigh Syndrome	0.2	0	0	ORPHANET
4566	TRNK	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4566	TRNK	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
4567	TRNL1	C0003123	Anorexia	0.2	0	0	HPO
4567	TRNL1	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4567	TRNL1	C0007786	Brain Ischemia	0.2	0	0	HPO
4567	TRNL1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.214442171139728	0	0	HPO
4567	TRNL1	C0014544	Epilepsy	0.2	0	0	HPO
4567	TRNL1	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
4567	TRNL1	C0018784	Sensorineural Hearing Loss (disorder)	0.204814057046576	0	0	HPO
4567	TRNL1	C0018801	Heart failure	0.2	0	0	HPO
4567	TRNL1	C0018802	Congestive heart failure	0.2	0	0	HPO
4567	TRNL1	C0018979	Hemianopsia	0.2	0	0	HPO
4567	TRNL1	C0022541	Kearns-Sayre syndrome	0.2	0	0	ORPHANET
4567	TRNL1	C0029124	Optic Atrophy	0.2	0	0	HPO
4567	TRNL1	C0030305	Pancreatitis	0.202407028523288	0	0	HPO
4567	TRNL1	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4567	TRNL1	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4567	TRNL1	C0151517	Complete atrioventricular block	0.2	0	0	HPO
4567	TRNL1	C0155320	Blindness, Cortical	0.2	0	0	HPO
4567	TRNL1	C0162292	External Ophthalmoplegia	0.2	0	0	HPO
4567	TRNL1	C0162666	Mitochondrial Encephalomyopathies	0.200549453568426	1	0	CTD_human
4567	TRNL1	C0162671	MELAS Syndrome	0.410294237353521	2	0	CTD_human;ORPHANET
4567	TRNL1	C0162672	MERRF Syndrome	0.202681755307501	0	0	ORPHANET
4567	TRNL1	C0162674	Chronic progressive external ophthalmoplegia	0.4	0	0	HPO;ORPHANET
4567	TRNL1	C0234958	muscle degeneration	0.2	0	0	HPO
4567	TRNL1	C0235946	Cerebral atrophy	0.2	0	0	HPO
4567	TRNL1	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4567	TRNL1	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4567	TRNL1	C0730292	Macular dystrophy	0.2	0	0	HPO
4567	TRNL1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4567	TRNL1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
4567	TRNL1	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4567	TRNL1	C1836830	Developmental regression	0.2	0	0	HPO
4567	TRNL1	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4567	TRNL1	C2931092	Maternally Inherited Leigh Syndrome	0.2	0	0	ORPHANET
4567	TRNL1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4567	TRNL1	C4020884	Anxiety disease	0.2	0	0	HPO
4567	TRNL1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
4567	TRNL1	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
4568	TRNL2	C0162674	Chronic progressive external ophthalmoplegia	0.202407028523288	0	0	ORPHANET
4570	TRNN	C0162674	Chronic progressive external ophthalmoplegia	0.2	0	0	ORPHANET
4571	TRNP	C0014544	Epilepsy	0.2	0	0	HPO
4571	TRNP	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
4571	TRNP	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4571	TRNP	C0029124	Optic Atrophy	0.2	0	0	HPO
4571	TRNP	C0162672	MERRF Syndrome	0.2	0	0	ORPHANET
4571	TRNP	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
4571	TRNP	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
4572	TRNQ	C0003123	Anorexia	0.2	0	0	HPO
4572	TRNQ	C0007786	Brain Ischemia	0.2	0	0	HPO
4572	TRNQ	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.204814057046576	0	0	HPO
4572	TRNQ	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
4572	TRNQ	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4572	TRNQ	C0018801	Heart failure	0.2	0	0	HPO
4572	TRNQ	C0018802	Congestive heart failure	0.2	0	0	HPO
4572	TRNQ	C0018979	Hemianopsia	0.2	0	0	HPO
4572	TRNQ	C0029124	Optic Atrophy	0.2	0	0	HPO
4572	TRNQ	C0030305	Pancreatitis	0.2	0	0	HPO
4572	TRNQ	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4572	TRNQ	C0149721	Left Ventricular Hypertrophy	0.202732912464814	0	0	HPO
4572	TRNQ	C0155320	Blindness, Cortical	0.2	0	0	HPO
4572	TRNQ	C0162671	MELAS Syndrome	0.200274726784213	0	0	ORPHANET
4572	TRNQ	C0162672	MERRF Syndrome	0.2	0	0	ORPHANET
4572	TRNQ	C0235946	Cerebral atrophy	0.2	0	0	HPO
4572	TRNQ	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4572	TRNQ	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4572	TRNQ	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4572	TRNQ	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
4572	TRNQ	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4572	TRNQ	C1836830	Developmental regression	0.2	0	0	HPO
4572	TRNQ	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4572	TRNQ	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4572	TRNQ	C4020884	Anxiety disease	0.2	0	0	HPO
4572	TRNQ	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
4574	TRNS1	C0003123	Anorexia	0.2	0	0	HPO
4574	TRNS1	C0007786	Brain Ischemia	0.2	0	0	HPO
4574	TRNS1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202407028523288	0	0	HPO
4574	TRNS1	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
4574	TRNS1	C0018784	Sensorineural Hearing Loss (disorder)	0.207821696295603	0	0	HPO
4574	TRNS1	C0018801	Heart failure	0.2	0	0	HPO
4574	TRNS1	C0018802	Congestive heart failure	0.2	0	0	HPO
4574	TRNS1	C0018979	Hemianopsia	0.2	0	0	HPO
4574	TRNS1	C0029124	Optic Atrophy	0.2	0	0	HPO
4574	TRNS1	C0030305	Pancreatitis	0.2	0	0	HPO
4574	TRNS1	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4574	TRNS1	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4574	TRNS1	C0155320	Blindness, Cortical	0.2	0	0	HPO
4574	TRNS1	C0162671	MELAS Syndrome	0.400274726784213	1	0	CTD_human;ORPHANET
4574	TRNS1	C0162672	MERRF Syndrome	0.2	0	0	ORPHANET
4574	TRNS1	C0162674	Chronic progressive external ophthalmoplegia	0.2	0	0	ORPHANET
4574	TRNS1	C0235946	Cerebral atrophy	0.2	0	0	HPO
4574	TRNS1	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4574	TRNS1	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4574	TRNS1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4574	TRNS1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
4574	TRNS1	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4574	TRNS1	C1835672	Palmoplantar Keratoderma with Deafness	0.2	0	0	ORPHANET
4574	TRNS1	C1836830	Developmental regression	0.2	0	0	HPO
4574	TRNS1	C1838854	DEAFNESS, AMINOGLYCOSIDE-INDUCED	0.2	0	0	ORPHANET
4574	TRNS1	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4574	TRNS1	C3151897	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	0.2	0	0	ORPHANET
4574	TRNS1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4574	TRNS1	C4020884	Anxiety disease	0.2	0	0	HPO
4574	TRNS1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
4575	TRNS2	C0003123	Anorexia	0.2	0	0	HPO
4575	TRNS2	C0004106	Astigmatism	0.2	0	0	HPO
4575	TRNS2	C0007786	Brain Ischemia	0.2	0	0	HPO
4575	TRNS2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202407028523288	0	0	HPO
4575	TRNS2	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
4575	TRNS2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4575	TRNS2	C0018801	Heart failure	0.2	0	0	HPO
4575	TRNS2	C0018802	Congestive heart failure	0.2	0	0	HPO
4575	TRNS2	C0018979	Hemianopsia	0.2	0	0	HPO
4575	TRNS2	C0028077	Night Blindness	0.2	0	0	HPO
4575	TRNS2	C0029124	Optic Atrophy	0.2	0	0	HPO
4575	TRNS2	C0030305	Pancreatitis	0.2	0	0	HPO
4575	TRNS2	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4575	TRNS2	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4575	TRNS2	C0155320	Blindness, Cortical	0.2	0	0	HPO
4575	TRNS2	C0162671	MELAS Syndrome	0.2	0	0	ORPHANET
4575	TRNS2	C0162672	MERRF Syndrome	0.2	0	0	ORPHANET
4575	TRNS2	C0235946	Cerebral atrophy	0.2	0	0	HPO
4575	TRNS2	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4575	TRNS2	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4575	TRNS2	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4575	TRNS2	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
4575	TRNS2	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4575	TRNS2	C1568248	Usher Syndrome, Type III	0.2	0	0	ORPHANET
4575	TRNS2	C1836830	Developmental regression	0.2	0	0	HPO
4575	TRNS2	C1843156	Hearing loss, progressive sensorineural	0.200274726784213	0	0	HPO
4575	TRNS2	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4575	TRNS2	C4020884	Anxiety disease	0.2	0	0	HPO
4575	TRNS2	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
4576	TRNT	C1838876	MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE	0.4	0	0	HPO;ORPHANET
4577	TRNV	C0018801	Heart failure	0.2	0	0	HPO
4577	TRNV	C0018802	Congestive heart failure	0.2	0	0	HPO
4577	TRNV	C0018979	Hemianopsia	0.2	0	0	HPO
4577	TRNV	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4577	TRNV	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4577	TRNV	C0155320	Blindness, Cortical	0.2	0	0	HPO
4577	TRNV	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4577	TRNV	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4577	TRNV	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4577	TRNV	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4577	TRNV	C2931092	Maternally Inherited Leigh Syndrome	0.2	0	0	ORPHANET
4577	TRNV	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4578	TRNW	C0003123	Anorexia	0.2	0	0	HPO
4578	TRNW	C0007786	Brain Ischemia	0.2	0	0	HPO
4578	TRNW	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202407028523288	0	0	HPO
4578	TRNW	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4578	TRNW	C0018801	Heart failure	0.2	0	0	HPO
4578	TRNW	C0018802	Congestive heart failure	0.2	0	0	HPO
4578	TRNW	C0018979	Hemianopsia	0.2	0	0	HPO
4578	TRNW	C0024421	Macroglossia	0.2	0	0	HPO
4578	TRNW	C0030305	Pancreatitis	0.2	0	0	HPO
4578	TRNW	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
4578	TRNW	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
4578	TRNW	C0155320	Blindness, Cortical	0.2	0	0	HPO
4578	TRNW	C0162671	MELAS Syndrome	0.200274726784213	0	0	ORPHANET
4578	TRNW	C0235946	Cerebral atrophy	0.2	0	0	HPO
4578	TRNW	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4578	TRNW	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
4578	TRNW	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4578	TRNW	C0917798	Cerebral Ischemia	0.2	0	0	HPO
4578	TRNW	C1836830	Developmental regression	0.2	0	0	HPO
4578	TRNW	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4578	TRNW	C2931092	Maternally Inherited Leigh Syndrome	0.2	0	0	ORPHANET
4578	TRNW	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4578	TRNW	C4020884	Anxiety disease	0.2	0	0	HPO
4582	MUC1	C0002871	Anemia	0.2	0	0	HPO
4582	MUC1	C0003868	Arthritis, Gouty	0.2	0	0	HPO
4582	MUC1	C0018099	Gout	0.2	0	0	HPO
4582	MUC1	C0041349	Nephritis, Tubulointerstitial	0.200274726784213	0	0	HPO
4582	MUC1	C0178664	Glomerulosclerosis (disorder)	0.2	0	0	HPO
4582	MUC1	C0235946	Cerebral atrophy	0.2	0	0	HPO
4582	MUC1	C1868139	Medullary cystic kidney disease 1	0.202747267842131	1	0	CTD_human
4582	MUC1	C1968619	Corticomedullary renal cysts	0.2	0	0	HPO
4582	MUC1	C2316810	Chronic kidney disease stage 5	0.200824180352639	0	0	HPO
4582	MUC1	C4025730	Renal cortical atrophy	0.2	0	0	HPO
4584	MUC3A	C0009324	Ulcerative Colitis	0.202956482091714	0	0	CTD_human
4589	MUC7	C0004096	Asthma	0.210452294445791	0	0	CTD_human
4591	TRIM37	C0004106	Astigmatism	0.2	0	0	HPO
4591	TRIM37	C0016063	Osteitis Fibrosa Disseminata	0.2	1	0	CTD_human
4591	TRIM37	C0018801	Heart failure	0.2	0	0	HPO
4591	TRIM37	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
4591	TRIM37	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
4591	TRIM37	C0038379	Strabismus	0.2	0	0	HPO
4591	TRIM37	C0524582	Mulibrey Nanism	0.694503098054025	4	13	CTD_human;ORPHANET;UNIPROT
4591	TRIM37	C2931895	Pericardial constriction with growth failure	0.2	0	0	ORPHANET
4593	MUSK	C0003886	Arthrogryposis	0.2	0	0	HPO
4593	MUSK	C0015300	Exophthalmos	0.2	0	0	HPO
4593	MUSK	C0020255	Hydrocephalus	0.2	0	0	HPO
4593	MUSK	C0026896	Myasthenia Gravis	0.210931649859255	2	0	CTD_human
4593	MUSK	C0085623	Akinesia	0.2	0	0	HPO
4593	MUSK	C0376175	Bell Palsy	0.2	0	0	HPO
4593	MUSK	C0409477	Ankylosis of the elbow joint	0.2	0	0	HPO
4593	MUSK	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	0.2	0	0	ORPHANET
4593	MUSK	C1276035	Pena-Shokeir syndrome type I	0.600549453568426	1	2	HPO;ORPHANET;UNIPROT
4593	MUSK	C1389113	Generalized amyotrophy	0.2	0	0	HPO
4593	MUSK	C1837091	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.2	0	0	CTD_human
4593	MUSK	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
4593	MUSK	C4225368	MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.28	5	8	UNIPROT
4594	MUT	C0003123	Anorexia	0.2	0	0	HPO
4594	MUT	C0023530	Leukopenia	0.2	0	0	HPO
4594	MUT	C0028754	Obesity	0.2	1	0	CTD_human
4594	MUT	C0030305	Pancreatitis	0.2	0	0	HPO
4594	MUT	C0041349	Nephritis, Tubulointerstitial	0.2	0	0	HPO
4594	MUT	C1855114	Methylmalonic Aciduria due to Methylmalonyl-CoA Mutase Deficiency	0.68	11	104	CTD_human;ORPHANET;UNIPROT
4594	MUT	C1855119	Methylmalonic aciduria	0.205769262468475	0	0	HPO
4594	MUT	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4594	MUT	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
4594	MUT	C4020871	Dystonic disease	0.2	0	0	HPO
4595	MUTYH	C1837991	Colorectal Adenomatous Polyposis, Autosomal Recessive	0.600274726784213	15	50	CTD_human;ORPHANET;UNIPROT
4597	MVD	C0265970	Porokeratosis, Disseminated Superficial Actinic	0.2	0	0	ORPHANET
4597	MVD	C0949506	Porokeratosis of Mibelli	0.2	0	0	HPO
4597	MVD	C3553549	POROKERATOSIS 7, MULTIPLE TYPES	0.2	2	3	UNIPROT
4598	MVK	C0003864	Arthritis	0.2	0	0	HPO
4598	MVK	C0014544	Epilepsy	0.2	0	0	HPO
4598	MVK	C0028077	Night Blindness	0.2	0	0	HPO
4598	MVK	C0028738	Nystagmus	0.2	0	0	HPO
4598	MVK	C0038363	Aphthous Stomatitis	0.202407028523288	0	0	HPO
4598	MVK	C0042109	Urticaria	0.2	0	0	HPO
4598	MVK	C0042384	Vasculitis	0.2	0	0	HPO
4598	MVK	C0235946	Cerebral atrophy	0.2	0	0	HPO
4598	MVK	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4598	MVK	C0265970	Porokeratosis, Disseminated Superficial Actinic	0.201373633921065	0	0	ORPHANET
4598	MVK	C0342731	Deficiency of mevalonate kinase	0.413121373107599	3	0	CTD_human;ORPHANET
4598	MVK	C0393525	Progressive cerebellar ataxia	0.2	0	0	HPO
4598	MVK	C0398691	Hyperimmunoglobulinemia D	0.408725744560189	7	31	ORPHANET;UNIPROT
4598	MVK	C0431399	Familial aplasia of the vermis	0.2	0	0	HPO
4598	MVK	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4598	MVK	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4598	MVK	C0870082	Hyperkeratosis	0.2	0	0	HPO
4598	MVK	C0949506	Porokeratosis of Mibelli	0.400274726784213	0	0	HPO;ORPHANET
4598	MVK	C1835875	Normocytic hypoplastic anemia	0.2	0	0	HPO
4598	MVK	C1867981	POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 1	0.4	1	7	CTD_human;UNIPROT
4598	MVK	C1959626	Mevalonic Aciduria	0.40439562854741	6	14	ORPHANET;UNIPROT
4598	MVK	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4598	MVK	C2937365	Recurrent aphthous ulcer	0.2	0	0	HPO
4598	MVK	C4020860	Supratentorial atrophy	0.2	0	0	HPO
4598	MVK	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4599	MX1	C0015625	Fanconi Anemia	0.2	1	0	CTD_human
4599	MX1	C0021400	Influenza	0.209311999908611	1	0	CTD_human
4599	MX1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
46	ACLS	C0796147	Acrocallosal Syndrome	0.2	0	0	CTD_human
4600	MX2	C0021400	Influenza	0.2	1	0	CTD_human
4602	MYB	C0004096	Asthma	0.205088783830789	1	0	CTD_human
4603	MYBL1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
4604	MYBPC1	C0003886	Arthrogryposis	0.200274726784213	0	0	HPO
4604	MYBPC1	C0265213	Distal arthrogryposis syndrome	0.201098907136852	0	0	HPO
4604	MYBPC1	C1969655	LETHAL CONGENITAL CONTRACTURAL SYNDROME 3	0.2	0	0	ORPHANET
4604	MYBPC1	C3280526	ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.2	2	2	UNIPROT
4607	MYBPC3	C0007194	Hypertrophic Cardiomyopathy	0.49636328609141	3	52	CTD_human;HPO
4607	MYBPC3	C0949658	Cardiomyopathy, Hypertrophic, Familial	0.20783605167292	3	239	CTD_human
4607	MYBPC3	C1861862	Cardiomyopathy, Familial Hypertrophic, 4	0.48	28	97	CTD_human;UNIPROT
4607	MYBPC3	C1960469	Left ventricular noncompaction	0.400549453568426	0	0	HPO;ORPHANET
4607	MYBPC3	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.4	2	6	ORPHANET;UNIPROT
4607	MYBPC3	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
4609	MYC	C0007194	Hypertrophic Cardiomyopathy	0.2	1	0	CTD_human
4609	MYC	C0015695	Fatty Liver	0.2	1	0	CTD_human
4609	MYC	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
4609	MYC	C0740394	Hyperuricemia	0.2	0	0	HPO
4613	MYCN	C0042928	Vocal Cord Paralysis	0.2	0	0	HPO
4613	MYCN	C0796068	Oculodigitoesophagoduodenal syndrome	0.601373633921066	3	7	CTD_human;ORPHANET;UNIPROT
4613	MYCN	C2931189	Neural crest tumor	0.2	0	0	ORPHANET
4615	MYD88	C0014457	Eosinophilia	0.2	1	0	CTD_human
4615	MYD88	C0032285	Pneumonia	0.200824180352639	1	0	CTD_human
4615	MYD88	C0085577	Normocytic anemia	0.2	0	0	HPO
4615	MYD88	C0152025	Polyneuropathy	0.2	0	0	HPO
4615	MYD88	C0398623	Thrombophilia	0.2	0	0	HPO
4615	MYD88	C2677092	MYD88 Deficiency	0.600549453568426	1	2	CTD_human;ORPHANET;UNIPROT
4618	MYF6	C0013264	Muscular Dystrophy, Duchenne	0.2	0	0	CTD_human
4618	MYF6	C1834558	Myopathy, Centronuclear, Autosomal Dominant	0.4	0	0	CTD_human;ORPHANET
4618	MYF6	C3280703	MYOPATHY, CENTRONUCLEAR, 3	0.2	1	2	UNIPROT
462	SERPINC1	C0012739	Disseminated Intravascular Coagulation	0.200824180352639	3	0	CTD_human
462	SERPINC1	C0034065	Pulmonary Embolism	0.200824180352639	0	0	HPO
462	SERPINC1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
462	SERPINC1	C0149871	Deep Vein Thrombosis	0.203021994626344	0	0	HPO
462	SERPINC1	C0151945	Thrombosis of cerebral veins	0.200274726784213	0	0	HPO
462	SERPINC1	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
462	SERPINC1	C0272375	Antithrombin III Deficiency	0.689759139162412	28	35	CTD_human;HPO;ORPHANET;UNIPROT
462	SERPINC1	C0752143	Intracranial Thrombosis	0.2	1	0	CTD_human
462	SERPINC1	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
4620	MYH2	C1854106	INCLUSION BODY MYOPATHY 3, AUTOSOMAL DOMINANT	0.6	1	10	CTD_human;ORPHANET;UNIPROT
4621	MYH3	C0003886	Arthrogryposis	0.208422307021342	0	0	HPO
4621	MYH3	C0014306	Enophthalmos	0.2	0	0	HPO
4621	MYH3	C0014544	Epilepsy	0.2	0	0	HPO
4621	MYH3	C0024591	Malignant hyperpyrexia due to anesthesia	0.2	0	0	HPO
4621	MYH3	C0038379	Strabismus	0.2	0	0	HPO
4621	MYH3	C0158113	Contracture of joint of hand	0.2	0	0	HPO
4621	MYH3	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4621	MYH3	C0265213	Distal arthrogryposis syndrome	0.20357144819477	0	0	HPO
4621	MYH3	C0265224	Freeman-Sheldon syndrome	0.602747267842131	1	6	CTD_human;ORPHANET;UNIPROT
4621	MYH3	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4621	MYH3	C1834523	ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.601098907136852	1	7	CTD_human;ORPHANET;UNIPROT
4621	MYH3	C1867440	Multiple Pterygium Syndrome, Autosomal Dominant	0.400274726784213	1	4	ORPHANET;UNIPROT
4621	MYH3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4621	MYH3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4624	MYH6	C0007194	Hypertrophic Cardiomyopathy	0.403831819601666	1	0	CTD_human;HPO
4624	MYH6	C0018801	Heart failure	0.200549453568426	0	0	HPO
4624	MYH6	C0018802	Congestive heart failure	0.200549453568426	0	0	HPO
4624	MYH6	C0037052	Sick Sinus Syndrome	0.400824180352639	1	0	CTD_human;ORPHANET
4624	MYH6	C0205700	Asymmetric Septal Hypertrophy	0.2	0	0	HPO
4624	MYH6	C0340375	Subaortic stenosis	0.2	0	0	HPO
4624	MYH6	C0949658	Cardiomyopathy, Hypertrophic, Familial	0.2	1	1	CTD_human
4624	MYH6	C2750466	Cardiomyopathy, Dilated, 1EE	0.4	1	3	CTD_human;UNIPROT
4624	MYH6	C2750467	Cardiomyopathy, Familial Hypertrophic, 14	0.48	2	3	CTD_human;UNIPROT
4624	MYH6	C3495498	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	0.2	0	0	CTD_human
4624	MYH6	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
4624	MYH6	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
4625	MYH7	C0004238	Atrial Fibrillation	0.200549453568426	0	0	HPO
4625	MYH7	C0007194	Hypertrophic Cardiomyopathy	0.263469527604048	0	0	HPO
4625	MYH7	C0018801	Heart failure	0.20328236603324	0	0	HPO
4625	MYH7	C0018802	Congestive heart failure	0.200549453568426	0	0	HPO
4625	MYH7	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
4625	MYH7	C0085615	Right bundle branch block	0.2	0	0	HPO
4625	MYH7	C0205700	Asymmetric Septal Hypertrophy	0.2	0	0	HPO
4625	MYH7	C0221054	Welander Distal Myopathy	0.403296721410557	2	21	ORPHANET;UNIPROT
4625	MYH7	C0242231	Coronary Stenosis	0.2	1	0	CTD_human
4625	MYH7	C0340375	Subaortic stenosis	0.2	0	0	HPO
4625	MYH7	C0376175	Bell Palsy	0.2	0	0	HPO
4625	MYH7	C0410180	Eichsfeld type congenital muscular dystrophy	0.2	0	0	ORPHANET
4625	MYH7	C0751337	X-Linked Emery-Dreifuss Muscular Dystrophy	0.6	0	0	CTD_human;ORPHANET;UNIPROT
4625	MYH7	C0949658	Cardiomyopathy, Hypertrophic, Familial	0.212319639157638	1	90	CTD_human
4625	MYH7	C1301959	Bulbar weakness	0.2	0	0	HPO
4625	MYH7	C1834481	CARDIOMYOPATHY, DILATED, 1S	0.4	6	18	CTD_human;UNIPROT
4625	MYH7	C1838114	Generalized limb muscle atrophy	0.2	0	0	HPO
4625	MYH7	C1842160	MYOPATHY, MYOSIN STORAGE (disorder)	0.403296721410557	4	10	CTD_human;UNIPROT
4625	MYH7	C1850709	Myopathy, Hyaline Body, Autosomal Recessive	0.2	1	2	UNIPROT
4625	MYH7	C1960469	Left ventricular noncompaction	0.201648360705279	0	0	ORPHANET
4625	MYH7	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
4625	MYH7	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4625	MYH7	C2931268	Scapuloperoneal myopathy	0.2	0	0	HPO
4625	MYH7	C3495498	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	0.4	58	137	CTD_human;UNIPROT
4625	MYH7	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
4625	MYH7	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
4625	MYH7	C4023127	Toe extensor amyotrophy	0.2	0	0	HPO
4625	MYH7	C4082299	Bulbar palsy	0.2	0	0	HPO
4626	MYH8	C0003886	Arthrogryposis	0.203007639249027	0	0	HPO
4626	MYH8	C0041105	Trismus	0.2	0	0	HPO
4626	MYH8	C0265213	Distal arthrogryposis syndrome	0.201648360705279	0	0	HPO
4626	MYH8	C0265226	Hecht syndrome (disorder)	0.600824180352639	0	0	CTD_human;ORPHANET;UNIPROT
4626	MYH8	C1837245	Carney Complex Variant	0.6	2	2	CTD_human;ORPHANET;UNIPROT
4627	MYH9	C0017668	Focal glomerulosclerosis	0.213041505195652	1	0	CTD_human
4627	MYH9	C0018780	Hearing Loss, High-Frequency	0.2	0	0	HPO
4627	MYH9	C0020544	Renal hypertension	0.2	1	0	CTD_human
4627	MYH9	C0022661	Kidney Failure, Chronic	0.213814528390978	2	0	CTD_human
4627	MYH9	C0027051	Myocardial Infarction	0.2	0	0	HPO
4627	MYH9	C0027697	Nephritis	0.20328236603324	0	0	HPO
4627	MYH9	C0027706	Hereditary nephritis	0.2	1	0	CTD_human
4627	MYH9	C0398641	Epstein syndrome (disorder)	0.281648360705279	7	6	UNIPROT
4627	MYH9	C0403445	Fechtner syndrome (disorder)	0.281648360705279	9	9	UNIPROT
4627	MYH9	C1834478	MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.4	0	0	CTD_human;UNIPROT
4627	MYH9	C1843156	Hearing loss, progressive sensorineural	0.200274726784213	0	0	HPO
4627	MYH9	C1854520	SEBASTIAN SYNDROME	0.694011065994868	2	7	CTD_human;ORPHANET;UNIPROT
4627	MYH9	C1863659	DEAFNESS, AUTOSOMAL DOMINANT 17	0.200274726784213	1	1	UNIPROT
4627	MYH9	C2316810	Chronic kidney disease stage 5	0.206593442821114	0	0	HPO
4627	MYH9	C2751260	Macrothrombocytopenia	0.206593442821114	0	0	HPO
4627	MYH9	C2931716	Deafness, autosomal dominant nonsyndromic sensorineural 17	0.2	0	0	CTD_human
4627	MYH9	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4627	MYH9	C4021775	High-frequency sensorineural hearing impairment	0.2	0	0	HPO
4627	MYH9	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
4628	MYH10	C0017668	Focal glomerulosclerosis	0.2	1	0	CTD_human
4629	MYH11	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
4629	MYH11	C0012736	Dissecting aortic aneurysm	0.2	0	0	HPO
4629	MYH11	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
4629	MYH11	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
4629	MYH11	C0263401	Cutis marmorata	0.2	0	0	HPO
4629	MYH11	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
4629	MYH11	C0856750	Aneurysm of descending aorta	0.2	0	0	HPO
4629	MYH11	C1608393	Megacystis microcolon intestinal hypoperistalsis syndrome	0.200274726784213	0	0	ORPHANET
4629	MYH11	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.2	0	0	ORPHANET
4629	MYH11	C1851504	Aortic aneurysm, familial thoracic 4	0.4	1	7	CTD_human;UNIPROT
4629	MYH11	C1956346	Coronary Artery Disease	0.2	0	0	HPO
4629	MYH11	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
4629	MYH11	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
463	ZFHX3	C0004238	Atrial Fibrillation	0.204120901763196	3	2	CTD_human
4633	MYL2	C0007194	Hypertrophic Cardiomyopathy	0.411001748014218	1	0	CTD_human;HPO
4633	MYL2	C0042514	Tachycardia, Ventricular	0.2	0	0	HPO
4633	MYL2	C0949658	Cardiomyopathy, Hypertrophic, Familial	0.203007639249027	1	15	CTD_human
4633	MYL2	C1834460	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10	0.4	4	11	CTD_human;UNIPROT
4634	MYL3	C0007194	Hypertrophic Cardiomyopathy	0.213683503321719	0	0	HPO
4634	MYL3	C0007196	Restrictive cardiomyopathy	0.2	0	0	HPO
4634	MYL3	C1837471	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8	0.4	4	5	CTD_human;UNIPROT
4635	MYL4	C0007194	Hypertrophic Cardiomyopathy	0.200824180352639	1	0	CTD_human
4635	MYL4	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
4638	MYLK	C0003486	Aortic Aneurysm	0.2	0	0	HPO
4638	MYLK	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
4638	MYLK	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
4638	MYLK	C0017601	Glaucoma	0.200274726784213	1	0	CTD_human
4638	MYLK	C0020443	Hypercholesterolemia	0.2	1	0	CTD_human
4638	MYLK	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
4638	MYLK	C0032285	Pneumonia	0.202407028523288	1	0	CTD_human
4638	MYLK	C0263401	Cutis marmorata	0.2	0	0	HPO
4638	MYLK	C0340643	Dissection of aorta	0.200274726784213	0	0	HPO
4638	MYLK	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
4638	MYLK	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.2	0	0	ORPHANET
4638	MYLK	C1956346	Coronary Artery Disease	0.202407028523288	0	0	HPO
4638	MYLK	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
4638	MYLK	C3151077	AORTIC ANEURYSM, FAMILIAL THORACIC 7	0.2	1	3	UNIPROT
4640	MYO1A	C0018784	Sensorineural Hearing Loss (disorder)	0.20328236603324	0	0	HPO
4640	MYO1A	C1842939	Deafness, Autosomal Dominant 48	0.2	0	0	CTD_human
4643	MYO1E	C0017668	Focal glomerulosclerosis	0.200824180352639	0	0	HPO
4643	MYO1E	C0239981	Hypoalbuminemia	0.2	0	0	HPO
4643	MYO1E	C3279905	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6	0.2	1	1	UNIPROT
4644	MYO5A	C0014544	Epilepsy	0.2	0	0	HPO
4644	MYO5A	C0020473	Hyperlipidemia	0.2	0	0	HPO
4644	MYO5A	C0028738	Nystagmus	0.2	0	0	HPO
4644	MYO5A	C0162835	Hypopigmentation disorder	0.203007639249027	0	0	HPO
4644	MYO5A	C1836573	GRISCELLI SYNDROME, TYPE 3	0.2	0	0	ORPHANET
4644	MYO5A	C1859194	GRISCELLI SYNDROME, TYPE 1	0.48	0	0	CTD_human;ORPHANET
4644	MYO5A	C1860157	Elejalde Disease	0.28	0	0	ORPHANET
4645	MYO5B	C0162429	Malnutrition	0.2	0	0	HPO
4645	MYO5B	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
4645	MYO5B	C0341306	Microvillus inclusion disease	0.68357144819477	5	7	CTD_human;ORPHANET;UNIPROT
4645	MYO5B	C0473133	Protracted diarrhea	0.2	0	0	HPO
4646	MYO6	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4646	MYO6	C1843028	Deafness, Autosomal Recessive 37	0.48	1	3	CTD_human;UNIPROT
4646	MYO6	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4646	MYO6	C2931767	Deafness, autosomal dominant nonsyndromic sensorineural 22	0.68	2	4	CTD_human;ORPHANET;UNIPROT
4647	MYO7A	C0018784	Sensorineural Hearing Loss (disorder)	0.201098907136852	0	0	HPO
4647	MYO7A	C0018979	Hemianopsia	0.2	0	0	HPO
4647	MYO7A	C0027092	Myopia	0.2	0	0	HPO
4647	MYO7A	C0028077	Night Blindness	0.2	0	0	HPO
4647	MYO7A	C0035334	Retinitis Pigmentosa	0.202197814273705	0	0	HPO
4647	MYO7A	C0271097	Usher Syndrome	0.221529324751623	1	4	CTD_human
4647	MYO7A	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
4647	MYO7A	C1568247	Usher Syndrome, Type I	0.486593442821114	13	121	ORPHANET;UNIPROT
4647	MYO7A	C1568249	Usher Syndrome, Type II	0.2	0	0	ORPHANET
4647	MYO7A	C1832475	Deafness, Autosomal Dominant 11	0.400549453568426	3	5	CTD_human;UNIPROT
4647	MYO7A	C1838701	DEAFNESS, AUTOSOMAL RECESSIVE 2	0.480549453568426	2	9	CTD_human;UNIPROT
4647	MYO7A	C2931206	Usher syndrome, type 1B	0.28439562854741	0	0	CTD_human
4650	MYO9B	C0007570	Celiac Disease	0.239290663704587	0	0	CTD_human
4653	MYOC	C0017601	Glaucoma	0.299042134510203	0	0	HPO
4653	MYOC	C0027092	Myopia	0.204814057046576	0	0	HPO
4653	MYOC	C1842028	GLAUCOMA 1, OPEN ANGLE, A	0.400549453568426	33	26	CTD_human;UNIPROT
4653	MYOC	C2981140	Glaucoma of childhood	0.202747267842131	0	0	ORPHANET
4654	MYOD1	C0003886	Arthrogryposis	0.2	0	0	HPO
4654	MYOD1	C0085623	Akinesia	0.2	0	0	HPO
4654	MYOD1	C1276035	Pena-Shokeir syndrome type I	0.4	0	0	HPO;ORPHANET
4654	MYOD1	C1389113	Generalized amyotrophy	0.2	0	0	HPO
4657	MYP1	C1839612	MYOPIA 1, X-LINKED	0.200274726784213	0	0	CTD_human
4658	MYP2	C1834531	MYOPIA 2 (disorder)	0.200549453568426	0	0	CTD_human
466	ATF1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
4668	NAGA	C0002986	Fabry Disease	0.200824180352639	0	0	HPO
4668	NAGA	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4668	NAGA	C0014544	Epilepsy	0.2	0	0	HPO
4668	NAGA	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4668	NAGA	C0024236	Lymphedema	0.2	0	0	HPO
4668	NAGA	C0028738	Nystagmus	0.2	0	0	HPO
4668	NAGA	C0029124	Optic Atrophy	0.2	0	0	HPO
4668	NAGA	C0029453	Osteopenia	0.2	0	0	HPO
4668	NAGA	C0038379	Strabismus	0.2	0	0	HPO
4668	NAGA	C0155320	Blindness, Cortical	0.2	0	0	HPO
4668	NAGA	C0235946	Cerebral atrophy	0.2	0	0	HPO
4668	NAGA	C0238621	Aminoaciduria	0.2	0	0	HPO
4668	NAGA	C0259817	Xerosis	0.2	0	0	HPO
4668	NAGA	C0270921	Axonal neuropathy	0.2	0	0	HPO
4668	NAGA	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
4668	NAGA	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
4668	NAGA	C0747078	Generalized osteopenia	0.2	0	0	HPO
4668	NAGA	C0870082	Hyperkeratosis	0.2	0	0	HPO
4668	NAGA	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
4668	NAGA	C1389113	Generalized amyotrophy	0.2	0	0	HPO
4668	NAGA	C1836522	Schindler Disease, Type II	0.400274726784213	2	3	ORPHANET;UNIPROT
4668	NAGA	C1836544	Schindler Disease, Type I	0.601648360705279	3	3	CTD_human;ORPHANET;UNIPROT
4668	NAGA	C1836830	Developmental regression	0.2	0	0	HPO
4668	NAGA	C4020860	Supratentorial atrophy	0.2	0	0	HPO
4669	NAGLU	C0014544	Epilepsy	0.2	0	0	HPO
4669	NAGLU	C0026706	Mucopolysaccharidosis III	0.203007639249027	0	0	CTD_human
4669	NAGLU	C0086648	MPS III B	0.487142896389541	14	41	ORPHANET;UNIPROT
4669	NAGLU	C0086795	Pfaundler-Hurler Syndrome	0.2	0	0	HPO
4669	NAGLU	C0205700	Asymmetric Septal Hypertrophy	0.2	0	0	HPO
4669	NAGLU	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
4669	NAGLU	C4225306	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V	0.4	1	1	ORPHANET;UNIPROT
467	ATF3	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200549453568426	1	0	CTD_human
467	ATF3	C0021400	Influenza	0.200274726784213	1	0	CTD_human
467	ATF3	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
4671	NAIP	C0043116	HMN (Hereditary Motor Neuropathy) Proximal Type I	0.200824180352639	0	0	ORPHANET
4671	NAIP	C0152109	Juvenile Spinal Muscular Atrophy	0.200274726784213	0	0	ORPHANET
4671	NAIP	C0393538	Muscular Atrophy, Spinal, Type II	0.2	0	0	ORPHANET
4683	NBN	C0002874	Aplastic Anemia	0.200549453568426	0	0	HPO
4683	NBN	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
4683	NBN	C0006267	Bronchiectasis	0.2	0	0	HPO
4683	NBN	C0013374	Dysgammaglobulinemia	0.2	0	0	HPO
4683	NBN	C0020295	Hydronephrosis	0.2	0	0	HPO
4683	NBN	C0024904	Mastoiditis	0.2	0	0	HPO
4683	NBN	C0029882	Otitis Media	0.2	0	0	HPO
4683	NBN	C0037199	Sinusitis	0.2	0	0	HPO
4683	NBN	C0038362	Stomatitis	0.200274726784213	1	0	CTD_human
4683	NBN	C0085215	Ovarian Failure, Premature	0.2	0	0	HPO
4683	NBN	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
4683	NBN	C0398791	Nijmegen Breakage Syndrome	0.537330086905011	3	47	CTD_human;ORPHANET
4683	NBN	C0401151	Chronic diarrhea	0.2	0	0	HPO
4683	NBN	C0694550	Recurrent pneumonia	0.2	0	0	HPO
4683	NBN	C0741796	Recurrent bronchitis	0.2	0	0	HPO
4683	NBN	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
4683	NBN	C2931322	T-Lymphocytopenia	0.2	0	0	HPO
4683	NBN	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
4683	NBN	C4082764	Gastrointestinal infection	0.2	0	0	HPO
4688	NCF2	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
4688	NCF2	C0013595	Eczema	0.2	0	0	HPO
4688	NCF2	C0024117	Chronic Obstructive Airway Disease	0.202407028523288	0	0	HPO
4688	NCF2	C0024138	Lupus Erythematosus, Discoid	0.200274726784213	0	0	HPO
4688	NCF2	C0024205	Lymphadenitis	0.2	0	0	HPO
4688	NCF2	C0029882	Otitis Media	0.2	0	0	HPO
4688	NCF2	C0037199	Sinusitis	0.2	0	0	HPO
4688	NCF2	C0520743	Mediastinal lymphadenopathy	0.2	0	0	HPO
4688	NCF2	C0521173	Granulomatosis	0.2	0	0	HPO
4688	NCF2	C0694550	Recurrent pneumonia	0.2	0	0	HPO
4688	NCF2	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
4688	NCF2	C1856245	Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type II	0.4	5	21	CTD_human;UNIPROT
4688	NCF2	C3806330	Osteomyelitis due to immunodeficiency	0.2	0	0	HPO
4689	NCF4	C0010346	Crohn Disease	0.208920603432455	1	0	CTD_human
4689	NCF4	C0024117	Chronic Obstructive Airway Disease	0.2	0	0	HPO
4689	NCF4	C0029882	Otitis Media	0.2	0	0	HPO
4689	NCF4	C0037199	Sinusitis	0.2	0	0	HPO
4689	NCF4	C0038363	Aphthous Stomatitis	0.2	0	0	HPO
4689	NCF4	C0520743	Mediastinal lymphadenopathy	0.2	0	0	HPO
4689	NCF4	C0581354	Recurrent sinusitis	0.2	0	0	HPO
4689	NCF4	C1396126	Perioral eczema	0.2	0	0	HPO
4689	NCF4	C2937365	Recurrent aphthous ulcer	0.2	0	0	HPO
4689	NCF4	C3151409	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III	0.2	1	2	UNIPROT
4689	NCF4	C4280333	Recurrent sinus disease	0.2	0	0	HPO
4691	NCL	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
4692	NDN	C0020459	Hyperinsulinism	0.2	0	0	HPO
4692	NDN	C0020490	Hyperopia	0.2	0	0	HPO
4692	NDN	C0028754	Obesity	0.200549453568426	0	0	HPO
4692	NDN	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
4692	NDN	C0271623	Hypogonadotropic hypogonadism	0.200274726784213	0	0	HPO
4692	NDN	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.200274726784213	0	0	HPO
4692	NDN	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
4693	NDP	C0014306	Enophthalmos	0.2	0	0	HPO
4693	NDP	C0014544	Epilepsy	0.2	0	0	HPO
4693	NDP	C0017601	Glaucoma	0.2	0	0	HPO
4693	NDP	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4693	NDP	C0028738	Nystagmus	0.2	0	0	HPO
4693	NDP	C0029124	Optic Atrophy	0.2	0	0	HPO
4693	NDP	C0035305	Retinal Detachment	0.200274726784213	0	0	HPO
4693	NDP	C0035344	Retinopathy of Prematurity	0.216518730101158	0	0	ORPHANET
4693	NDP	C0038379	Strabismus	0.2	0	0	HPO
4693	NDP	C0042485	Venous Insufficiency	0.2	0	0	HPO
4693	NDP	C0271215	Blindness, Legal	0.2	0	0	HPO
4693	NDP	C1844579	Exudative Vitreoretinopathy, Familial, X-Linked Recessive	0.48	10	6	CTD_human;UNIPROT
4693	NDP	C1851402	Exudative vitreoretinopathy 1	0.2	0	0	ORPHANET
4693	NDP	C1853235	Sclerocornea	0.200274726784213	0	0	HPO
4693	NDP	C4020884	Anxiety disease	0.2	0	0	HPO
4693	NDP	C4024788	Anterior chamber synechiae	0.2	0	0	HPO
4693	NDP	C4072980	Exudative vitreoretinopathy	0.200549453568426	0	0	HPO
4694	NDUFA1	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4694	NDUFA1	C0014544	Epilepsy	0.2	0	0	HPO
4694	NDUFA1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4694	NDUFA1	C0020615	Hypoglycemia	0.2	0	0	HPO
4694	NDUFA1	C0023520	Leukodystrophy	0.2	0	0	HPO
4694	NDUFA1	C0028738	Nystagmus	0.2	0	0	HPO
4694	NDUFA1	C0038379	Strabismus	0.2	0	0	HPO
4694	NDUFA1	C0085605	Liver Failure	0.2	0	0	HPO
4694	NDUFA1	C0234958	muscle degeneration	0.2	0	0	HPO
4694	NDUFA1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4694	NDUFA1	C0271215	Blindness, Legal	0.2	0	0	HPO
4694	NDUFA1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4694	NDUFA1	C1145670	Respiratory Failure	0.2	0	0	HPO
4694	NDUFA1	C1836830	Developmental regression	0.2	0	0	HPO
4694	NDUFA1	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.4	1	3	CTD_human;UNIPROT
4694	NDUFA1	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
4694	NDUFA1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4694	NDUFA1	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4694	NDUFA1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4695	NDUFA2	C0014544	Epilepsy	0.2	0	0	HPO
4695	NDUFA2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4695	NDUFA2	C0020555	Hypertrichosis	0.2	0	0	HPO
4695	NDUFA2	C0023264	Leigh Disease	0.400274726784213	0	0	CTD_human;ORPHANET
4695	NDUFA2	C0028738	Nystagmus	0.2	0	0	HPO
4695	NDUFA2	C0029124	Optic Atrophy	0.2	0	0	HPO
4695	NDUFA2	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
4695	NDUFA2	C0038379	Strabismus	0.2	0	0	HPO
4695	NDUFA2	C0338474	Central nervous system demyelination	0.2	0	0	HPO
4695	NDUFA2	C1145670	Respiratory Failure	0.2	0	0	HPO
4695	NDUFA2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4695	NDUFA2	C4020871	Dystonic disease	0.2	0	0	HPO
4697	NDUFA4	C0023264	Leigh Disease	0.2	0	0	ORPHANET
47	ACLY	C0018801	Heart failure	0.2	1	0	CTD_human
47	ACLY	C0028754	Obesity	0.2	1	0	CTD_human
470	ATHS	C0004153	Atherosclerosis	0.2	0	0	CTD_human
4703	NEB	C0003886	Arthrogryposis	0.2	0	0	HPO
4703	NEB	C0376175	Bell Palsy	0.2	0	0	HPO
4703	NEB	C0546125	Nemaline Myopathy, Childhood Onset	0.2	0	0	ORPHANET
4703	NEB	C1301959	Bulbar weakness	0.2	0	0	HPO
4703	NEB	C1850569	Nemaline Myopathy 2	0.280824180352639	0	0	CTD_human
4703	NEB	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
4703	NEB	C4082299	Bulbar palsy	0.2	0	0	HPO
4704	NDUFA9	C0014544	Epilepsy	0.2	0	0	HPO
4704	NDUFA9	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4704	NDUFA9	C0020555	Hypertrichosis	0.2	0	0	HPO
4704	NDUFA9	C0023264	Leigh Disease	0.2	0	0	ORPHANET
4704	NDUFA9	C0028738	Nystagmus	0.2	0	0	HPO
4704	NDUFA9	C0029124	Optic Atrophy	0.2	0	0	HPO
4704	NDUFA9	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
4704	NDUFA9	C0038379	Strabismus	0.2	0	0	HPO
4704	NDUFA9	C0338474	Central nervous system demyelination	0.2	0	0	HPO
4704	NDUFA9	C1145670	Respiratory Failure	0.2	0	0	HPO
4704	NDUFA9	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4704	NDUFA9	C4020871	Dystonic disease	0.2	0	0	HPO
4705	NDUFA10	C0014544	Epilepsy	0.2	0	0	HPO
4705	NDUFA10	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4705	NDUFA10	C0020555	Hypertrichosis	0.2	0	0	HPO
4705	NDUFA10	C0023264	Leigh Disease	0.200274726784213	0	0	ORPHANET
4705	NDUFA10	C0028738	Nystagmus	0.2	0	0	HPO
4705	NDUFA10	C0029124	Optic Atrophy	0.2	0	0	HPO
4705	NDUFA10	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
4705	NDUFA10	C0038379	Strabismus	0.2	0	0	HPO
4705	NDUFA10	C0338474	Central nervous system demyelination	0.2	0	0	HPO
4705	NDUFA10	C1145670	Respiratory Failure	0.2	0	0	HPO
4705	NDUFA10	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4705	NDUFA10	C4020871	Dystonic disease	0.2	0	0	HPO
4709	NDUFB3	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4709	NDUFB3	C0014544	Epilepsy	0.2	0	0	HPO
4709	NDUFB3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4709	NDUFB3	C0020615	Hypoglycemia	0.2	0	0	HPO
4709	NDUFB3	C0023520	Leukodystrophy	0.2	0	0	HPO
4709	NDUFB3	C0028738	Nystagmus	0.2	0	0	HPO
4709	NDUFB3	C0038379	Strabismus	0.2	0	0	HPO
4709	NDUFB3	C0085605	Liver Failure	0.2	0	0	HPO
4709	NDUFB3	C0234958	muscle degeneration	0.2	0	0	HPO
4709	NDUFB3	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4709	NDUFB3	C0271215	Blindness, Legal	0.2	0	0	HPO
4709	NDUFB3	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4709	NDUFB3	C1145670	Respiratory Failure	0.2	0	0	HPO
4709	NDUFB3	C1836830	Developmental regression	0.2	0	0	HPO
4709	NDUFB3	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
4709	NDUFB3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4709	NDUFB3	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4709	NDUFB3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
471	ATIC	C0003873	Rheumatoid Arthritis	0.217724537172968	1	0	CTD_human
471	ATIC	C0014544	Epilepsy	0.2	0	0	HPO
471	ATIC	C0029124	Optic Atrophy	0.2	0	0	HPO
471	ATIC	C0029456	Osteoporosis	0.2	1	0	CTD_human
471	ATIC	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
471	ATIC	C1837530	AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency	0.6	1	1	CTD_human;ORPHANET;UNIPROT
4713	NDUFB7	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
4715	NDUFB9	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4715	NDUFB9	C0014544	Epilepsy	0.2	0	0	HPO
4715	NDUFB9	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4715	NDUFB9	C0020615	Hypoglycemia	0.2	0	0	HPO
4715	NDUFB9	C0023520	Leukodystrophy	0.2	0	0	HPO
4715	NDUFB9	C0028738	Nystagmus	0.2	0	0	HPO
4715	NDUFB9	C0038379	Strabismus	0.2	0	0	HPO
4715	NDUFB9	C0085605	Liver Failure	0.2	0	0	HPO
4715	NDUFB9	C0234958	muscle degeneration	0.2	0	0	HPO
4715	NDUFB9	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4715	NDUFB9	C0271215	Blindness, Legal	0.2	0	0	HPO
4715	NDUFB9	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4715	NDUFB9	C1145670	Respiratory Failure	0.2	0	0	HPO
4715	NDUFB9	C1836830	Developmental regression	0.2	0	0	HPO
4715	NDUFB9	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
4715	NDUFB9	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4715	NDUFB9	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4715	NDUFB9	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4719	NDUFS1	C0007194	Hypertrophic Cardiomyopathy	0.4	1	0	CTD_human;HPO
4719	NDUFS1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
4719	NDUFS1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4719	NDUFS1	C0020615	Hypoglycemia	0.2	0	0	HPO
4719	NDUFS1	C0023264	Leigh Disease	0.20328236603324	0	0	ORPHANET
4719	NDUFS1	C0023520	Leukodystrophy	0.2	0	0	HPO
4719	NDUFS1	C0028738	Nystagmus	0.2	0	0	HPO
4719	NDUFS1	C0038379	Strabismus	0.2	0	0	HPO
4719	NDUFS1	C0085605	Liver Failure	0.2	0	0	HPO
4719	NDUFS1	C0234958	muscle degeneration	0.2	0	0	HPO
4719	NDUFS1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4719	NDUFS1	C0271215	Blindness, Legal	0.2	0	0	HPO
4719	NDUFS1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4719	NDUFS1	C1145670	Respiratory Failure	0.2	0	0	HPO
4719	NDUFS1	C1836830	Developmental regression	0.2	0	0	HPO
4719	NDUFS1	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.400549453568426	1	8	CTD_human;UNIPROT
4719	NDUFS1	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
4719	NDUFS1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4719	NDUFS1	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4719	NDUFS1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
472	ATM	C0003123	Anorexia	0.2	0	0	HPO
472	ATM	C0004135	Ataxia Telangiectasia	0.829100420436003	18	236	CTD_human;ORPHANET;UNIPROT
472	ATM	C0006267	Bronchiectasis	0.2	0	0	HPO
472	ATM	C0014544	Epilepsy	0.2	0	0	HPO
472	ATM	C0024312	Lymphopenia	0.200549453568426	0	0	HPO
472	ATM	C0027051	Myocardial Infarction	0.201923087489492	1	0	CTD_human
472	ATM	C0028738	Nystagmus	0.2	0	0	HPO
472	ATM	C0032460	Polycystic Ovary Syndrome	0.200824180352639	0	0	HPO
472	ATM	C0037199	Sinusitis	0.2	0	0	HPO
472	ATM	C0038379	Strabismus	0.2	0	0	HPO
472	ATM	C0085583	Choreoathetosis	0.2	0	0	HPO
472	ATM	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
472	ATM	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
472	ATM	C0234958	muscle degeneration	0.2	0	0	HPO
472	ATM	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
472	ATM	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
472	ATM	C0741796	Recurrent bronchitis	0.2	0	0	HPO
472	ATM	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
472	ATM	C1876175	Ataxia-Telangiectasia Variant	0.2	0	0	ORPHANET
472	ATM	C4020871	Dystonic disease	0.2	0	0	HPO
4720	NDUFS2	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4720	NDUFS2	C0014544	Epilepsy	0.2	0	0	HPO
4720	NDUFS2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4720	NDUFS2	C0020615	Hypoglycemia	0.2	0	0	HPO
4720	NDUFS2	C0023264	Leigh Disease	0.200824180352639	0	0	ORPHANET
4720	NDUFS2	C0023520	Leukodystrophy	0.2	0	0	HPO
4720	NDUFS2	C0028738	Nystagmus	0.2	0	0	HPO
4720	NDUFS2	C0038379	Strabismus	0.2	0	0	HPO
4720	NDUFS2	C0085605	Liver Failure	0.2	0	0	HPO
4720	NDUFS2	C0162666	Mitochondrial Encephalomyopathies	0.2	1	0	CTD_human
4720	NDUFS2	C0234958	muscle degeneration	0.2	0	0	HPO
4720	NDUFS2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4720	NDUFS2	C0271215	Blindness, Legal	0.2	0	0	HPO
4720	NDUFS2	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4720	NDUFS2	C1145670	Respiratory Failure	0.2	0	0	HPO
4720	NDUFS2	C1836830	Developmental regression	0.2	0	0	HPO
4720	NDUFS2	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.400274726784213	1	3	CTD_human;UNIPROT
4720	NDUFS2	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
4720	NDUFS2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4720	NDUFS2	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4720	NDUFS2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4722	NDUFS3	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4722	NDUFS3	C0014544	Epilepsy	0.2	0	0	HPO
4722	NDUFS3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4722	NDUFS3	C0020555	Hypertrichosis	0.2	0	0	HPO
4722	NDUFS3	C0020615	Hypoglycemia	0.2	0	0	HPO
4722	NDUFS3	C0023264	Leigh Disease	0.400549453568426	1	0	CTD_human;ORPHANET
4722	NDUFS3	C0023520	Leukodystrophy	0.2	0	0	HPO
4722	NDUFS3	C0028738	Nystagmus	0.2	0	0	HPO
4722	NDUFS3	C0029124	Optic Atrophy	0.4	1	0	CTD_human;HPO
4722	NDUFS3	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
4722	NDUFS3	C0038379	Strabismus	0.2	0	0	HPO
4722	NDUFS3	C0085605	Liver Failure	0.2	0	0	HPO
4722	NDUFS3	C0234958	muscle degeneration	0.2	0	0	HPO
4722	NDUFS3	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4722	NDUFS3	C0271215	Blindness, Legal	0.2	0	0	HPO
4722	NDUFS3	C0338474	Central nervous system demyelination	0.2	0	0	HPO
4722	NDUFS3	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4722	NDUFS3	C1145670	Respiratory Failure	0.2	0	0	HPO
4722	NDUFS3	C1836830	Developmental regression	0.2	0	0	HPO
4722	NDUFS3	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
4722	NDUFS3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4722	NDUFS3	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4722	NDUFS3	C4020871	Dystonic disease	0.2	0	0	HPO
4722	NDUFS3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4723	NDUFV1	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4723	NDUFV1	C0014544	Epilepsy	0.2	0	0	HPO
4723	NDUFV1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4723	NDUFV1	C0020615	Hypoglycemia	0.2	0	0	HPO
4723	NDUFV1	C0023264	Leigh Disease	0.600549453568426	1	1	CTD_human;ORPHANET;UNIPROT
4723	NDUFV1	C0023520	Leukodystrophy	0.200274726784213	0	0	HPO
4723	NDUFV1	C0028738	Nystagmus	0.2	0	0	HPO
4723	NDUFV1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
4723	NDUFV1	C0038379	Strabismus	0.2	0	0	HPO
4723	NDUFV1	C0085605	Liver Failure	0.2	0	0	HPO
4723	NDUFV1	C0234958	muscle degeneration	0.2	0	0	HPO
4723	NDUFV1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4723	NDUFV1	C0270726	Alexander Disease	0.2	0	0	CTD_human
4723	NDUFV1	C0271215	Blindness, Legal	0.2	0	0	HPO
4723	NDUFV1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4723	NDUFV1	C1145670	Respiratory Failure	0.2	0	0	HPO
4723	NDUFV1	C1836830	Developmental regression	0.2	0	0	HPO
4723	NDUFV1	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.400549453568426	2	4	CTD_human;UNIPROT
4723	NDUFV1	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
4723	NDUFV1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4723	NDUFV1	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4723	NDUFV1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4724	NDUFS4	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4724	NDUFS4	C0014544	Epilepsy	0.200274726784213	0	0	HPO
4724	NDUFS4	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4724	NDUFS4	C0020555	Hypertrichosis	0.2	0	0	HPO
4724	NDUFS4	C0020615	Hypoglycemia	0.2	0	0	HPO
4724	NDUFS4	C0023264	Leigh Disease	0.485754907091158	1	0	CTD_human;ORPHANET
4724	NDUFS4	C0023520	Leukodystrophy	0.2	0	0	HPO
4724	NDUFS4	C0028738	Nystagmus	0.2	0	0	HPO
4724	NDUFS4	C0029124	Optic Atrophy	0.2	0	0	HPO
4724	NDUFS4	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
4724	NDUFS4	C0038379	Strabismus	0.2	0	0	HPO
4724	NDUFS4	C0085605	Liver Failure	0.2	0	0	HPO
4724	NDUFS4	C0234958	muscle degeneration	0.2	0	0	HPO
4724	NDUFS4	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4724	NDUFS4	C0271215	Blindness, Legal	0.2	0	0	HPO
4724	NDUFS4	C0338474	Central nervous system demyelination	0.2	0	0	HPO
4724	NDUFS4	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4724	NDUFS4	C1145670	Respiratory Failure	0.2	0	0	HPO
4724	NDUFS4	C1836830	Developmental regression	0.2	0	0	HPO
4724	NDUFS4	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.280274726784213	0	0	CTD_human
4724	NDUFS4	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
4724	NDUFS4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4724	NDUFS4	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4724	NDUFS4	C4020871	Dystonic disease	0.2	0	0	HPO
4724	NDUFS4	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4726	NDUFS6	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4726	NDUFS6	C0014544	Epilepsy	0.2	0	0	HPO
4726	NDUFS6	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4726	NDUFS6	C0020615	Hypoglycemia	0.2	0	0	HPO
4726	NDUFS6	C0023520	Leukodystrophy	0.2	0	0	HPO
4726	NDUFS6	C0028738	Nystagmus	0.2	0	0	HPO
4726	NDUFS6	C0038379	Strabismus	0.2	0	0	HPO
4726	NDUFS6	C0085605	Liver Failure	0.2	0	0	HPO
4726	NDUFS6	C0234958	muscle degeneration	0.2	0	0	HPO
4726	NDUFS6	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4726	NDUFS6	C0271215	Blindness, Legal	0.2	0	0	HPO
4726	NDUFS6	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4726	NDUFS6	C1145670	Respiratory Failure	0.2	0	0	HPO
4726	NDUFS6	C1836830	Developmental regression	0.2	0	0	HPO
4726	NDUFS6	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.280274726784213	0	0	CTD_human
4726	NDUFS6	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
4726	NDUFS6	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4726	NDUFS6	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4726	NDUFS6	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4728	NDUFS8	C0014544	Epilepsy	0.2	0	0	HPO
4728	NDUFS8	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4728	NDUFS8	C0020555	Hypertrichosis	0.2	0	0	HPO
4728	NDUFS8	C0023264	Leigh Disease	0.600824180352639	1	3	CTD_human;ORPHANET;UNIPROT
4728	NDUFS8	C0028738	Nystagmus	0.2	0	0	HPO
4728	NDUFS8	C0029124	Optic Atrophy	0.2	0	0	HPO
4728	NDUFS8	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
4728	NDUFS8	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
4728	NDUFS8	C0038379	Strabismus	0.2	0	0	HPO
4728	NDUFS8	C0338474	Central nervous system demyelination	0.2	0	0	HPO
4728	NDUFS8	C1145670	Respiratory Failure	0.2	0	0	HPO
4728	NDUFS8	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4728	NDUFS8	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4728	NDUFS8	C4020871	Dystonic disease	0.2	0	0	HPO
4729	NDUFV2	C0007194	Hypertrophic Cardiomyopathy	0.20328236603324	0	0	HPO
4729	NDUFV2	C0014544	Epilepsy	0.2	0	0	HPO
4729	NDUFV2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4729	NDUFV2	C0020615	Hypoglycemia	0.2	0	0	HPO
4729	NDUFV2	C0023264	Leigh Disease	0.200274726784213	0	0	ORPHANET
4729	NDUFV2	C0023520	Leukodystrophy	0.2	0	0	HPO
4729	NDUFV2	C0028738	Nystagmus	0.2	0	0	HPO
4729	NDUFV2	C0038379	Strabismus	0.2	0	0	HPO
4729	NDUFV2	C0085605	Liver Failure	0.2	0	0	HPO
4729	NDUFV2	C0162666	Mitochondrial Encephalomyopathies	0.2	1	0	CTD_human
4729	NDUFV2	C0234958	muscle degeneration	0.2	0	0	HPO
4729	NDUFV2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4729	NDUFV2	C0271215	Blindness, Legal	0.2	0	0	HPO
4729	NDUFV2	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4729	NDUFV2	C1145670	Respiratory Failure	0.2	0	0	HPO
4729	NDUFV2	C1836830	Developmental regression	0.2	0	0	HPO
4729	NDUFV2	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.2	0	0	CTD_human
4729	NDUFV2	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
4729	NDUFV2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4729	NDUFV2	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
4729	NDUFV2	C3160718	PARKINSON DISEASE, LATE-ONSET	0.2	0	0	CTD_human
4729	NDUFV2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
473	RERE	C0014306	Enophthalmos	0.2	0	0	HPO
473	RERE	C0014544	Epilepsy	0.2	0	0	HPO
473	RERE	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
473	RERE	C0038379	Strabismus	0.2	0	0	HPO
473	RERE	C0235946	Cerebral atrophy	0.2	0	0	HPO
473	RERE	C1842870	Chromosome 1p36 Deletion Syndrome	0.2	0	0	ORPHANET
473	RERE	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
473	RERE	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
4734	NEDD4	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
4734	NEDD4	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
4741	NEFM	C0014175	Endometriosis	0.2	1	0	CTD_human
474168	WG	C3495801	Granulomatosis with polyangiitis	0.225274864147605	0	0	CTD_human
474387	OFC4	C1842143	Orofacial Cleft 4	0.2	0	0	CTD_human
4744	NEFH	C0002736	Amyotrophic Lateral Sclerosis	0.409037273124398	0	0	HPO;ORPHANET
4744	NEFH	C0234958	muscle degeneration	0.2	0	0	HPO
4744	NEFH	C1145670	Respiratory Failure	0.2	0	0	HPO
4744	NEFH	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	0	0	CTD_human
4744	NEFH	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
4744	NEFH	C4020884	Anxiety disease	0.2	0	0	HPO
4745	NELL1	C0010278	Craniosynostosis	0.203831819601666	1	0	CTD_human
4747	NEFL	C0085684	Foot-drop	0.2	0	0	HPO
4747	NEFL	C1843164	Charcot-Marie-Tooth disease, demyelinating, Type 1F	0.6	5	10	CTD_human;ORPHANET;UNIPROT
4747	NEFL	C1843225	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)	0.681098907136852	7	10	CTD_human;ORPHANET;UNIPROT
4747	NEFL	C1843228	Hypotrophy of the small hand muscles	0.2	0	0	HPO
4747	NEFL	C1848736	Distal amyotrophy	0.2	0	0	HPO
475	ATOX1	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
4750	NEK1	C0002736	Amyotrophic Lateral Sclerosis	0.2	2	0	CTD_human
4750	NEK1	C0020305	Hydrops Fetalis	0.2	0	0	HPO
4750	NEK1	C0024507	Majewski Syndrome	0.400549453568426	1	6	ORPHANET;UNIPROT
4750	NEK1	C0036996	Short Rib-Polydactyly Syndrome	0.200274726784213	2	0	CTD_human
4751	NEK2	C0017601	Glaucoma	0.2	0	0	HPO
4751	NEK2	C0018777	Conductive hearing loss	0.2	0	0	HPO
4751	NEK2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4751	NEK2	C0020459	Hyperinsulinism	0.2	0	0	HPO
4751	NEK2	C0020619	Hypogonadism	0.2	0	0	HPO
4751	NEK2	C0022578	Keratoconus	0.2	0	0	HPO
4751	NEK2	C0028738	Nystagmus	0.2	0	0	HPO
4751	NEK2	C0028754	Obesity	0.2	0	0	HPO
4751	NEK2	C0029124	Optic Atrophy	0.2	0	0	HPO
4751	NEK2	C0035334	Retinitis Pigmentosa	0.400274726784213	0	0	HPO;ORPHANET
4751	NEK2	C0271215	Blindness, Legal	0.2	0	0	HPO
4758	NEU1	C0014544	Epilepsy	0.2	0	0	HPO
4758	NEU1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4758	NEU1	C0020305	Hydrops Fetalis	0.2	0	0	HPO
4758	NEU1	C0023806	Lipomucopolysaccharidosis	0.2	0	0	ORPHANET
4758	NEU1	C0028738	Nystagmus	0.2	0	0	HPO
4758	NEU1	C0042798	Low Vision	0.2	0	0	HPO
4758	NEU1	C0086795	Pfaundler-Hurler Syndrome	0.2	0	0	HPO
4758	NEU1	C0234958	muscle degeneration	0.2	0	0	HPO
4758	NEU1	C0238621	Aminoaciduria	0.2	0	0	HPO
4758	NEU1	C0268228	Neuraminidase 1 deficiency	0.481373633921066	5	18	CTD_human;UNIPROT
4758	NEU1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
4758	NEU1	C0542571	Facial edema	0.2	0	0	HPO
4758	NEU1	C0751778	Myoclonic Epilepsies, Progressive	0.2	1	0	CTD_human
4758	NEU1	C0870082	Hyperkeratosis	0.2	0	0	HPO
476	ATP1A1	C0020428	Hyperaldosteronism	0.2	1	0	CTD_human
476	ATP1A1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
4760	NEUROD1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.644658759939922	2	1	CTD_human;ORPHANET;UNIPROT
4760	NEUROD1	C0342276	Maturity onset diabetes mellitus in young	0.203021994626344	0	0	HPO
4760	NEUROD1	C1853371	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6 (disorder)	0.4	1	2	CTD_human;UNIPROT
4763	NF1	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
4763	NF1	C0011351	Dental Enamel Hypoplasia	0.202732912464814	0	0	HPO
4763	NF1	C0020255	Hydrocephalus	0.200274726784213	0	0	HPO
4763	NF1	C0553586	Cafe-au-lait macules with pulmonary stenosis	0.400549453568426	0	0	CTD_human;ORPHANET
4763	NF1	C1834235	NEUROFIBROMATOSIS, FAMILIAL SPINAL	0.400549453568426	1	5	CTD_human;UNIPROT
4763	NF1	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
4763	NF1	C1956257	Pulmonary Stenosis	0.200274726784213	0	0	HPO
4763	NF1	C2931482	Neurofibromatosis-Noonan syndrome	0.602197814273705	5	9	CTD_human;ORPHANET;UNIPROT
4763	NF1	C3150928	NF1 Microdeletion Syndrome	0.200549453568426	0	0	ORPHANET
477	ATP1A2	C0014544	Epilepsy	0.207663639203332	0	0	HPO
477	ATP1A2	C0028738	Nystagmus	0.2	0	0	HPO
477	ATP1A2	C0085583	Choreoathetosis	0.2	0	0	HPO
477	ATP1A2	C0154723	Migraine with Aura	0.212803580191434	0	0	HPO
477	ATP1A2	C0338488	Alternating hemiplegia of childhood	0.400549453568426	0	0	CTD_human;ORPHANET
477	ATP1A2	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
477	ATP1A2	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
477	ATP1A2	C1720189	Episodic Ataxia	0.200274726784213	0	0	HPO
477	ATP1A2	C1863062	Quadriplegia, episodic	0.2	0	0	HPO
477	ATP1A2	C1865322	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	0.402472541057918	6	13	CTD_human;UNIPROT
477	ATP1A2	C3549447	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1	0.2	1	1	UNIPROT
477	ATP1A2	C4020871	Dystonic disease	0.2	0	0	HPO
4771	NF2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4771	NF2	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4774	NFIA	C3151036	CHROMOSOME 1p32-p31 DELETION SYNDROME	0.200274726784213	0	0	ORPHANET
478	ATP1A3	C0018801	Heart failure	0.2	1	0	CTD_human
478	ATP1A3	C0028738	Nystagmus	0.2	0	0	HPO
478	ATP1A3	C0029124	Optic Atrophy	0.2	0	0	HPO
478	ATP1A3	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
478	ATP1A3	C0037036	Sialorrhea	0.2	0	0	HPO
478	ATP1A3	C0038220	Status Epilepticus	0.2	0	0	HPO
478	ATP1A3	C0085583	Choreoathetosis	0.200274726784213	0	0	HPO
478	ATP1A3	C0271215	Blindness, Legal	0.2	0	0	HPO
478	ATP1A3	C0338488	Alternating hemiplegia of childhood	0.407417623173754	2	0	CTD_human;ORPHANET
478	ATP1A3	C1720189	Episodic Ataxia	0.2	0	0	HPO
478	ATP1A3	C1832466	CAPOS syndrome	0.401373633921066	1	2	ORPHANET;UNIPROT
478	ATP1A3	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
478	ATP1A3	C1863062	Quadriplegia, episodic	0.2	0	0	HPO
478	ATP1A3	C1868681	DYSTONIA 12	0.608791257094819	3	18	CTD_human;ORPHANET;UNIPROT
478	ATP1A3	C3553788	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.200274726784213	3	33	UNIPROT
478	ATP1A3	C4020871	Dystonic disease	0.2	0	0	HPO
478	ATP1A3	C4020884	Anxiety disease	0.2	0	0	HPO
4780	NFE2L2	C0008370	Cholestasis	0.2	1	0	CTD_human
4780	NFE2L2	C0011881	Diabetic Nephropathy	0.281923087489492	1	0	CTD_human
4780	NFE2L2	C0020456	Hyperglycemia	0.200824180352639	1	0	CTD_human
4780	NFE2L2	C0022593	Keratosis	0.2	1	0	CTD_human
4780	NFE2L2	C0023890	Liver Cirrhosis	0.280549453568426	1	0	CTD_human
4780	NFE2L2	C0034069	Pulmonary Fibrosis	0.28	1	0	CTD_human
4780	NFE2L2	C0085215	Ovarian Failure, Premature	0.2	1	0	CTD_human
4780	NFE2L2	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
4780	NFE2L2	C0400966	Non-alcoholic Fatty Liver Disease	0.280824180352639	1	0	CTD_human
4780	NFE2L2	C4277682	Chemical and Drug Induced Liver Injury	0.2	4	0	CTD_human
4784	NFIX	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
4784	NFIX	C0235946	Cerebral atrophy	0.2	0	0	HPO
4784	NFIX	C0265211	Marshall-Smith syndrome	0.200824180352639	0	0	ORPHANET
4784	NFIX	C0267048	Glossoptosis	0.2	0	0	HPO
4784	NFIX	C0520679	Sleep Apnea, Obstructive	0.2	0	0	HPO
4784	NFIX	C0747651	Recurrent aspiration pneumonia	0.2	0	0	HPO
4784	NFIX	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4784	NFIX	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
4784	NFIX	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
4784	NFIX	C3553660	SOTOS SYNDROME 2	0.400549453568426	3	5	ORPHANET;UNIPROT
4784	NFIX	C4020860	Supratentorial atrophy	0.2	0	0	HPO
4784	NFIX	C4020884	Anxiety disease	0.2	0	0	HPO
4790	NFKB1	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
4790	NFKB1	C0006267	Bronchiectasis	0.2	0	0	HPO
4790	NFKB1	C0007786	Brain Ischemia	0.200274726784213	1	0	CTD_human
4790	NFKB1	C0009447	Common Variable Immunodeficiency	0.200824180352639	0	0	ORPHANET
4790	NFKB1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.208110778457133	1	0	CTD_human
4790	NFKB1	C0020500	Hyperoxaluria	0.2	1	0	CTD_human
4790	NFKB1	C0022661	Kidney Failure, Chronic	0.200824180352639	1	0	CTD_human
4790	NFKB1	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
4790	NFKB1	C0024117	Chronic Obstructive Airway Disease	0.204604842796993	0	0	HPO
4790	NFKB1	C0024312	Lymphopenia	0.2	0	0	HPO
4790	NFKB1	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
4790	NFKB1	C0032285	Pneumonia	0.207388912419119	0	0	HPO
4790	NFKB1	C0034150	Purpura	0.2	0	0	HPO
4790	NFKB1	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
4790	NFKB1	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
4790	NFKB1	C0271441	Chronic otitis media	0.2	0	0	HPO
4790	NFKB1	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
4790	NFKB1	C0741796	Recurrent bronchitis	0.2	0	0	HPO
4790	NFKB1	C0743359	ear infection chronic	0.2	0	0	HPO
4790	NFKB1	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
4791	NFKB2	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
4791	NFKB2	C0004096	Asthma	0.202681755307501	0	0	HPO
4791	NFKB2	C0006267	Bronchiectasis	0.2	0	0	HPO
4791	NFKB2	C0009447	Common Variable Immunodeficiency	0.201098907136852	0	0	ORPHANET
4791	NFKB2	C0020617	Hypoglycemic coma	0.2	0	0	HPO
4791	NFKB2	C0024312	Lymphopenia	0.2	0	0	HPO
4791	NFKB2	C0032285	Pneumonia	0.2	0	0	HPO
4791	NFKB2	C0034150	Purpura	0.2	0	0	HPO
4791	NFKB2	C0086438	Hypogammaglobulinemia	0.200274726784213	0	0	HPO
4791	NFKB2	C0221260	Dystrophia unguium	0.2	0	0	HPO
4791	NFKB2	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
4791	NFKB2	C0271441	Chronic otitis media	0.2	0	0	HPO
4791	NFKB2	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
4791	NFKB2	C0581354	Recurrent sinusitis	0.2	0	0	HPO
4791	NFKB2	C0694550	Recurrent pneumonia	0.2	0	0	HPO
4791	NFKB2	C0741796	Recurrent bronchitis	0.2	0	0	HPO
4791	NFKB2	C0743359	ear infection chronic	0.2	0	0	HPO
4791	NFKB2	C0747085	Recurrent otitis media	0.2	0	0	HPO
4791	NFKB2	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
4791	NFKB2	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
4791	NFKB2	C0948387	Secondary Adrenal Insufficiency	0.200274726784213	0	0	HPO
4791	NFKB2	C3714497	Reactive airway disease	0.2	0	0	HPO
4791	NFKB2	C3809991	IMMUNODEFICIENCY, COMMON VARIABLE, 10	0.200274726784213	0	0	ORPHANET
4791	NFKB2	C4023211	Adrenocorticotropin deficient adrenal insufficiency	0.2	0	0	HPO
4791	NFKB2	C4280333	Recurrent sinus disease	0.2	0	0	HPO
4792	NFKBIA	C0003028	Anhidrosis	0.2	0	0	HPO
4792	NFKBIA	C0007786	Brain Ischemia	0.2	1	0	CTD_human
4792	NFKBIA	C0020620	Hypohidrosis	0.2	0	0	HPO
4792	NFKBIA	C0033860	Psoriasis	0.205363510615002	1	0	CTD_human
4792	NFKBIA	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
4792	NFKBIA	C1846006	Ectodermal dysplasia, hypohidrotic, with immune deficiency	0.201098907136852	0	0	ORPHANET
4792	NFKBIA	C2677481	Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant	0.4	1	3	CTD_human;UNIPROT
4792	NFKBIA	C4082764	Gastrointestinal infection	0.2	0	0	HPO
4794	NFKBIE	C0003873	Rheumatoid Arthritis	0.202681755307501	1	2	CTD_human
4795	NFKBIL1	C0003873	Rheumatoid Arthritis	0.214661155146296	0	0	CTD_human
4796	TONSL	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
48	ACO1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
4803	NGF	C0002768	Congenital Pain Insensitivity	0.200549453568426	0	0	ORPHANET
4803	NGF	C0010043	Corneal Ulcer	0.2	1	0	CTD_human
4803	NGF	C0010692	Cystitis	0.280549453568426	1	0	CTD_human
4803	NGF	C0014549	Tonic-Clonic Epilepsy	0.2	1	0	CTD_human
4803	NGF	C0017658	Glomerulonephritis	0.203007639249027	1	0	CTD_human
4803	NGF	C0020075	Hereditary Sensory Autonomic Neuropathy, Type 5	0.401923087489492	1	1	ORPHANET;UNIPROT
4803	NGF	C0022661	Kidney Failure, Chronic	0.200274726784213	1	0	CTD_human
4803	NGF	C0027707	Nephritis, Interstitial	0.2	1	0	CTD_human
4803	NGF	C0030567	Parkinson Disease	0.200824180352639	1	0	CTD_human
4803	NGF	C0038220	Status Epilepticus	0.2	2	0	CTD_human
4803	NGF	C0085129	Bronchial Hyperreactivity	0.2	1	0	CTD_human
4803	NGF	C0236663	Alcohol withdrawal syndrome	0.200274726784213	1	0	PSYGENET
4803	NGF	C0403447	Chronic Kidney Insufficiency	0.2	1	0	CTD_human
4803	NGF	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
4803	NGF	C0752347	Lewy Body Disease	0.200274726784213	1	0	CTD_human
4803	NGF	C0878773	Overactive Bladder	0.28	1	0	CTD_human
4803	NGF	C4025742	Acral ulceration and osteomyelitis leading to autoamputation of the digits (feet)	0.2	0	0	HPO
4808	NHLH2	C0028754	Obesity	0.200824180352639	1	0	CTD_human
481	ATP1B1	C0085580	Essential Hypertension	0.200274726784213	0	0	CTD_human
4810	NHS	C0017601	Glaucoma	0.200274726784213	0	0	HPO
4810	NHS	C0028738	Nystagmus	0.2	0	0	HPO
4810	NHS	C0038379	Strabismus	0.2	0	0	HPO
4810	NHS	C0042798	Low Vision	0.2	0	0	HPO
4810	NHS	C0392557	Nuclear cataract	0.2	0	0	ORPHANET
4810	NHS	C0796085	Nance-Horan syndrome	0.48357144819477	0	0	CTD_human;ORPHANET
4810	NHS	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
4810	NHS	C1301509	Severe visual impairment	0.2	0	0	HPO
4810	NHS	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4810	NHS	C4023734	Sutural cataract	0.2	0	0	HPO
4812	NIDDM1	C1832544	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1 (disorder)	0.2	0	0	CTD_human
4813	NIDDM2	C1832387	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (disorder)	0.2	0	0	CTD_human
4814	NINJ1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
4825	NKX6-1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202407028523288	1	0	CTD_human
4827	NM	C3882647	Neutrophil Chemotactic Response, Abnormal	0.2	0	0	CTD_human
4830	NME1	C0002871	Anemia	0.2	0	0	HPO
4830	NME1	C0007194	Hypertrophic Cardiomyopathy	0.2	1	0	CTD_human
4830	NME1	C0019937	Horner Syndrome	0.2	0	0	HPO
4830	NME1	C0037926	Compression of spinal cord	0.2	0	0	HPO
4830	NME1	C0242567	Opsoclonus	0.2	0	0	HPO
4830	NME1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4831	NME2	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
4835	NQO2	C0001824	Agranulocytosis	0.202681755307501	1	0	CTD_human
4835	NQO2	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
4842	NOS1	C0011854	Diabetes Mellitus, Insulin-Dependent	0.200549453568426	1	0	CTD_human
4842	NOS1	C0014848	Esophageal Achalasia	0.200549453568426	0	0	HPO
4842	NOS1	C0015923	Fetal Alcohol Syndrome	0.2	1	0	PSYGENET
4842	NOS1	C0019151	Hepatic Encephalopathy	0.2	2	0	CTD_human
4842	NOS1	C0021845	Intestinal Perforation	0.2	1	0	CTD_human
4842	NOS1	C0030567	Parkinson Disease	0.211825928366857	1	0	CTD_human
4842	NOS1	C0038220	Status Epilepticus	0.2	1	0	CTD_human
4842	NOS1	C0745744	End Stage Liver Disease	0.2	1	0	CTD_human
4842	NOS1	C0859976	Idiopathic achalasia of esophagus	0.2	0	0	ORPHANET
4842	NOS1	C1867403	Pyloric Stenosis, Infantile Hypertrophic 1	0.281373633921066	0	0	CTD_human
4843	NOS2	C0003872	Arthritis, Psoriatic	0.202681755307501	1	1	CTD_human
4843	NOS2	C0003949	Asbestosis	0.2	1	0	CTD_human
4843	NOS2	C0004096	Asthma	0.23076604236862	1	0	CTD_human
4843	NOS2	C0004153	Atherosclerosis	0.201098907136852	1	0	CTD_human
4843	NOS2	C0007786	Brain Ischemia	0.204814057046576	2	0	CTD_human
4843	NOS2	C0008313	Cholangitis, Sclerosing	0.2	1	0	CTD_human
4843	NOS2	C0008370	Cholestasis	0.2	2	0	CTD_human
4843	NOS2	C0009319	Colitis	0.200824180352639	2	0	CTD_human
4843	NOS2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.215266351492367	1	0	CTD_human
4843	NOS2	C0013295	Duodenal Ulcer	0.2	2	0	CTD_human
4843	NOS2	C0017668	Focal glomerulosclerosis	0.2	1	0	CTD_human
4843	NOS2	C0018801	Heart failure	0.203780662444353	1	0	CTD_human
4843	NOS2	C0020452	Hyperemia	0.2	1	0	CTD_human
4843	NOS2	C0024117	Chronic Obstructive Airway Disease	0.208697033805555	1	0	CTD_human
4843	NOS2	C0024530	Malaria	0.219438410412876	0	0	CTD_human
4843	NOS2	C0024796	Marfan Syndrome	0.2	1	0	CTD_human
4843	NOS2	C0027051	Myocardial Infarction	0.200824180352639	2	0	CTD_human
4843	NOS2	C0032290	Aspiration Pneumonia	0.2	1	0	CTD_human
4843	NOS2	C0033860	Psoriasis	0.201373633921065	1	1	CTD_human
4843	NOS2	C0036330	Schistosomiasis mansoni	0.2	1	0	CTD_human
4843	NOS2	C0037116	Silicosis	0.202732912464814	1	0	CTD_human
4843	NOS2	C0038220	Status Epilepticus	0.2	1	0	CTD_human
4843	NOS2	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
4843	NOS2	C0038358	Gastric ulcer	0.202732912464814	3	0	CTD_human
4843	NOS2	C0038525	Subarachnoid Hemorrhage	0.200274726784213	1	0	CTD_human
4843	NOS2	C0039263	Takayasu Arteritis	0.2	1	0	CTD_human
4843	NOS2	C0041408	Turner Syndrome	0.2	1	0	CTD_human
4843	NOS2	C0085580	Essential Hypertension	0.20350593566014	0	0	CTD_human
4843	NOS2	C0206146	Myocardial Stunning	0.2	1	0	CTD_human
4843	NOS2	C0243026	Sepsis	0.281648360705279	2	0	CTD_human
4843	NOS2	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
4843	NOS2	C0752308	Hypoxia-Ischemia, Brain	0.2	1	0	CTD_human
4846	NOS3	C0002395	Alzheimer's Disease	0.236287610075892	2	0	CTD_human
4846	NOS3	C0003850	Arteriosclerosis	0.215109973131721	1	0	CTD_human
4846	NOS3	C0004153	Atherosclerosis	0.254427668859318	2	0	CTD_human
4846	NOS3	C0004238	Atrial Fibrillation	0.213408776537506	1	0	CTD_human
4846	NOS3	C0007785	Cerebral Infarction	0.203831819601666	0	0	CTD_human
4846	NOS3	C0010073	Coronary Artery Vasospasm	0.21895446937908	2	0	CTD_human
4846	NOS3	C0011854	Diabetes Mellitus, Insulin-Dependent	0.220145921073573	1	0	CTD_human
4846	NOS3	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.283041869974894	2	0	CTD_human
4846	NOS3	C0011875	Diabetic Angiopathies	0.205638237399215	1	0	CTD_human
4846	NOS3	C0011881	Diabetic Nephropathy	0.237503186904687	1	0	CTD_human
4846	NOS3	C0018801	Heart failure	0.208934958809773	2	0	CTD_human
4846	NOS3	C0020456	Hyperglycemia	0.207063028477593	1	0	CTD_human
4846	NOS3	C0020459	Hyperinsulinism	0.202956482091714	1	0	CTD_human
4846	NOS3	C0020473	Hyperlipidemia	0.200549453568426	1	0	CTD_human
4846	NOS3	C0020541	Hypertension, Portal	0.283007639249027	1	0	CTD_human
4846	NOS3	C0020545	Hypertension, Renovascular	0.200274726784213	1	0	CTD_human
4846	NOS3	C0021845	Intestinal Perforation	0.2	1	0	CTD_human
4846	NOS3	C0024117	Chronic Obstructive Airway Disease	0.219149328251346	1	0	CTD_human
4846	NOS3	C0027051	Myocardial Infarction	0.368228382499975	2	0	CTD_human
4846	NOS3	C0038358	Gastric ulcer	0.2	1	0	CTD_human
4846	NOS3	C0041948	Uremia	0.200274726784213	1	0	CTD_human
4846	NOS3	C0042514	Tachycardia, Ventricular	0.2	1	0	CTD_human
4846	NOS3	C0085580	Essential Hypertension	0.29147301240232	0	0	CTD_human
4846	NOS3	C0151744	Myocardial Ischemia	0.217189438981859	1	0	CTD_human
4846	NOS3	C0242350	Erectile dysfunction	0.226883065609641	2	0	CTD_human
4846	NOS3	C0243026	Sepsis	0.205912964183428	1	0	CTD_human
4846	NOS3	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
4846	NOS3	C0524620	Metabolic Syndrome X	0.223926583517927	3	0	CTD_human
4846	NOS3	C1956346	Coronary Artery Disease	0.321300817808881	4	1	CTD_human
4851	NOTCH1	C0003507	Aortic Valve Stenosis	0.200274726784213	0	0	HPO
4851	NOTCH1	C0020255	Hydrocephalus	0.2	0	0	HPO
4851	NOTCH1	C0038379	Strabismus	0.2	0	0	HPO
4851	NOTCH1	C0162770	Right Ventricular Hypertrophy	0.2	0	0	HPO
4851	NOTCH1	C0263401	Cutis marmorata	0.2	0	0	HPO
4851	NOTCH1	C0265268	Adams Oliver syndrome	0.200824180352639	0	0	ORPHANET
4851	NOTCH1	C0428791	Aortic valve calcification	0.200824180352639	1	0	CTD_human
4851	NOTCH1	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
4851	NOTCH1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4851	NOTCH1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
4851	NOTCH1	C3203102	Idiopathic pulmonary arterial hypertension	0.200274726784213	0	0	HPO
4851	NOTCH1	C3887892	Aortic Valve Disease 1	0.4	0	0	CTD_human;ORPHANET
4851	NOTCH1	C4014970	ADAMS-OLIVER SYNDROME 5	0.2	1	13	UNIPROT
4852	NPY	C0002395	Alzheimer's Disease	0.281373633921066	1	0	CTD_human
4852	NPY	C0003123	Anorexia	0.281923087489492	3	0	CTD_human
4852	NPY	C0004096	Asthma	0.200549453568426	1	0	CTD_human
4852	NPY	C0007785	Cerebral Infarction	0.28	1	0	CTD_human
4852	NPY	C0008677	Bronchitis, Chronic	0.2	1	0	CTD_human
4852	NPY	C0014544	Epilepsy	0.201373633921065	2	0	CTD_human
4852	NPY	C0014556	Epilepsy, Temporal Lobe	0.200824180352639	1	0	CTD_human
4852	NPY	C0035455	Rhinitis	0.2	1	0	CTD_human
4853	NOTCH2	C0008370	Cholestasis	0.200549453568426	0	0	HPO
4853	NOTCH2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.251371779341687	1	1	CTD_human
4853	NOTCH2	C0018777	Conductive hearing loss	0.2	0	0	HPO
4853	NOTCH2	C0020255	Hydrocephalus	0.2	0	0	HPO
4853	NOTCH2	C0022679	Cystic kidney	0.2	0	0	HPO
4853	NOTCH2	C0024636	Malocclusion	0.2	0	0	HPO
4853	NOTCH2	C0029453	Osteopenia	0.200274726784213	0	0	HPO
4853	NOTCH2	C0029456	Osteoporosis	0.201098907136852	0	0	HPO
4853	NOTCH2	C0031099	Periodontitis	0.2	0	0	HPO
4853	NOTCH2	C0035078	Kidney Failure	0.2	0	0	HPO
4853	NOTCH2	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
4853	NOTCH2	C0399385	Early tooth exfoliation	0.2	0	0	HPO
4853	NOTCH2	C0410550	Collapse of vertebra	0.2	0	0	HPO
4853	NOTCH2	C0747078	Generalized osteopenia	0.2	0	0	HPO
4853	NOTCH2	C0917715	Hajdu-Cheney Syndrome	0.48357144819477	2	5	CTD_human;ORPHANET
4853	NOTCH2	C0917990	Acro-Osteolysis	0.2	0	0	HPO
4853	NOTCH2	C1565489	Renal Insufficiency	0.2	0	0	HPO
4853	NOTCH2	C1857761	Alagille Syndrome 2	0.4	1	10	ORPHANET;UNIPROT
4853	NOTCH2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4853	NOTCH2	C2930971	Acroosteolysis dominant type	0.2	0	0	ORPHANET
4853	NOTCH2	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
4854	NOTCH3	C0007786	Brain Ischemia	0.2	0	0	HPO
4854	NOTCH3	C0014544	Epilepsy	0.2	0	0	HPO
4854	NOTCH3	C0018777	Conductive hearing loss	0.2	0	0	HPO
4854	NOTCH3	C0025299	Meningocele	0.2	0	0	HPO
4854	NOTCH3	C0033790	Pseudobulbar Palsy	0.2	0	0	HPO
4854	NOTCH3	C0039144	Syringomyelia	0.2	0	0	HPO
4854	NOTCH3	C0042345	Varicosity	0.2	0	0	HPO
4854	NOTCH3	C0042798	Low Vision	0.2	0	0	HPO
4854	NOTCH3	C0078981	Arachnoid Cysts	0.2	0	0	HPO
4854	NOTCH3	C0151311	Cranial nerve palsies	0.2	0	0	HPO
4854	NOTCH3	C0151313	Sensory neuropathy	0.2	0	0	HPO
4854	NOTCH3	C0235946	Cerebral atrophy	0.2	0	0	HPO
4854	NOTCH3	C0399440	Hereditary gingival fibromatosis	0.2	0	0	HPO
4854	NOTCH3	C0432284	Infantile myofibromatosis	0.200274726784213	0	0	ORPHANET
4854	NOTCH3	C0553730	Calcium pyrophosphate deposition disease	0.2	0	0	HPO
4854	NOTCH3	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
4854	NOTCH3	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
4854	NOTCH3	C0751587	CADASIL Syndrome	0.782494006124322	20	22	CTD_human;ORPHANET;UNIPROT
4854	NOTCH3	C0917798	Cerebral Ischemia	0.200274726784213	0	0	HPO
4854	NOTCH3	C1836830	Developmental regression	0.2	0	0	HPO
4854	NOTCH3	C1851710	LATERAL MENINGOCELE SYNDROME	0.200549453568426	0	0	ORPHANET
4854	NOTCH3	C1852242	Nonarteritic anterior ischemic optic neuropathy (NAION)	0.2	0	0	HPO
4854	NOTCH3	C3809084	MYOFIBROMATOSIS, INFANTILE, 2	0.2	1	1	UNIPROT
4854	NOTCH3	C4024918	Recurrent subcortical infarcts	0.2	0	0	HPO
4854	NOTCH3	C4024935	Subcortical dementia	0.200274726784213	0	0	HPO
486	FXYD2	C0014544	Epilepsy	0.2	0	0	HPO
486	FXYD2	C0024473	Magnesium Deficiency	0.2	1	0	CTD_human
486	FXYD2	C0268448	Primary hypomagnesemia (disorder)	0.2	1	0	CTD_human
486	FXYD2	C1835171	Hypomagnesemia 2, renal	0.6	1	1	CTD_human;HPO;ORPHANET;UNIPROT
4860	PNP	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
4860	PNP	C0023882	Little's Disease	0.2	0	0	HPO
4860	PNP	C0024312	Lymphopenia	0.2	0	0	HPO
4860	PNP	C0029456	Osteoporosis	0.2	1	0	CTD_human
4860	PNP	C0029882	Otitis Media	0.2	0	0	HPO
4860	PNP	C0032285	Pneumonia	0.2	0	0	HPO
4860	PNP	C0037199	Sinusitis	0.2	0	0	HPO
4860	PNP	C0238051	Cerebral Angiitis	0.2	0	0	HPO
4860	PNP	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
4860	PNP	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
4860	PNP	C0268125	Purine-nucleoside phosphorylase deficiency	0.681098907136852	3	7	CTD_human;ORPHANET;UNIPROT
4860	PNP	C0340971	Autoimmune neutropenia	0.2	0	0	HPO
4860	PNP	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
4860	PNP	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
4860	PNP	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
4860	PNP	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4860	PNP	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
4864	NPC1	C0004153	Atherosclerosis	0.2	1	0	CTD_human
4864	NPC1	C0006309	Brucellosis	0.2	1	0	CTD_human
4864	NPC1	C0007384	Cataplexy	0.2	0	0	HPO
4864	NPC1	C0014544	Epilepsy	0.2	0	0	HPO
4864	NPC1	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
4864	NPC1	C0028754	Obesity	0.209144173059356	1	1	CTD_human
4864	NPC1	C0036489	Sea-Blue Histiocyte Syndrome	0.2	0	0	HPO
4864	NPC1	C0220756	Niemann-Pick Disease, Type C	0.225078326543716	2	2	CTD_human
4864	NPC1	C0339652	Vertical gaze palsy	0.2	0	0	HPO
4864	NPC1	C1285291	Fetal ascites	0.2	0	0	HPO
4864	NPC1	C1843369	Vertical supranuclear gaze palsy	0.2	0	0	HPO
4864	NPC1	C3179455	Niemann-Pick Disease, Type C1	0.285769262468475	16	126	UNIPROT
4864	NPC1	C4020871	Dystonic disease	0.2	0	0	HPO
4867	NPHP1	C0002871	Anemia	0.2	0	0	HPO
4867	NPHP1	C0020619	Hypogonadism	0.2	0	0	HPO
4867	NPHP1	C0025322	Premature Menopause	0.2	0	0	HPO
4867	NPHP1	C0028738	Nystagmus	0.2	0	0	HPO
4867	NPHP1	C0028754	Obesity	0.2	0	0	HPO
4867	NPHP1	C0035078	Kidney Failure	0.200549453568426	0	0	HPO
4867	NPHP1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
4867	NPHP1	C0042798	Low Vision	0.2	0	0	HPO
4867	NPHP1	C0403553	Renal dysplasia and retinal aplasia (disorder)	0.400274726784213	0	0	CTD_human;ORPHANET
4867	NPHP1	C0687120	Nephronophthisis	0.209340710663245	0	0	HPO
4867	NPHP1	C0752166	Bardet-Biedl Syndrome	0.200274726784213	0	0	ORPHANET
4867	NPHP1	C1565489	Renal Insufficiency	0.2	0	0	HPO
4867	NPHP1	C1837658	Gross motor development delay	0.2	0	0	HPO
4867	NPHP1	C1846790	JOUBERT SYNDROME 4 (disorder)	0.4	0	0	CTD_human;ORPHANET
4867	NPHP1	C1855681	Nephronophthisis, familial juvenile	0.604670355331623	1	4	CTD_human;ORPHANET;UNIPROT
4867	NPHP1	C1968619	Corticomedullary renal cysts	0.2	0	0	HPO
4867	NPHP1	C2316810	Chronic kidney disease stage 5	0.200274726784213	0	0	HPO
4867	NPHP1	C3489733	Oculomotor apraxia	0.200274726784213	0	0	HPO
4867	NPHP1	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
4868	NPHS1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
4868	NPHS1	C0017658	Glomerulonephritis	0.2	2	0	CTD_human
4868	NPHS1	C0017668	Focal glomerulosclerosis	0.205703749933845	1	0	CTD_human
4868	NPHS1	C0020473	Hyperlipidemia	0.2	0	0	HPO
4868	NPHS1	C0020639	Hypoproteinemia	0.2	0	0	HPO
4868	NPHS1	C0020676	Hypothyroidism	0.2	0	0	HPO
4868	NPHS1	C0027721	Lipoid nephrosis	0.200274726784213	1	0	CTD_human
4868	NPHS1	C0035078	Kidney Failure	0.200274726784213	0	0	HPO
4868	NPHS1	C0239981	Hypoalbuminemia	0.200274726784213	0	0	HPO
4868	NPHS1	C0268747	Diffuse mesangial sclerosis (disorder)	0.200274726784213	0	0	HPO
4868	NPHS1	C0403399	Finnish congenital nephrotic syndrome	0.482747267842131	8	145	ORPHANET;UNIPROT
4868	NPHS1	C0598608	Hyperhomocysteinemia	0.2	1	0	CTD_human
4868	NPHS1	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
4868	NPHS1	C1565489	Renal Insufficiency	0.200274726784213	0	0	HPO
4868	NPHS1	C3501848	Nephrosis, congenital	0.416692821302369	2	0	CTD_human;HPO
487	ATP2A1	C0018801	Heart failure	0.2	1	0	CTD_human
487	ATP2A1	C1832918	Brody myopathy	0.603021994626344	1	5	CTD_human;ORPHANET;UNIPROT
4878	NPPA	C0003504	Aortic Valve Insufficiency	0.200274726784213	1	0	CTD_human
4878	NPPA	C0004238	Atrial Fibrillation	0.204381273170092	0	0	HPO
4878	NPPA	C0018801	Heart failure	0.282472541057918	4	0	CTD_human
4878	NPPA	C0020544	Renal hypertension	0.28	1	0	CTD_human
4878	NPPA	C0023890	Liver Cirrhosis	0.202407028523288	1	0	CTD_human
4878	NPPA	C0027051	Myocardial Infarction	0.208971760589768	2	0	CTD_human
4878	NPPA	C0149721	Left Ventricular Hypertrophy	0.289246487373981	2	0	CTD_human
4878	NPPA	C0151744	Myocardial Ischemia	0.202407028523288	1	0	CTD_human
4878	NPPA	C0242231	Coronary Stenosis	0.2	1	0	CTD_human
4878	NPPA	C1838539	CARDIOMYOPATHY, FAMILIAL, WITH CONDUCTION DISTURBANCE	0.2	0	0	ORPHANET
4878	NPPA	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
4878	NPPA	C2677294	Atrial Fibrillation, Familial, 6	0.2	0	0	CTD_human
4878	NPPA	C3810401	ATRIAL STANDSTILL 2	0.2	1	1	UNIPROT
4879	NPPB	C0002895	Anemia, Sickle Cell	0.2	1	0	CTD_human
4879	NPPB	C0003504	Aortic Valve Insufficiency	0.205740551713841	1	0	CTD_human
4879	NPPB	C0004238	Atrial Fibrillation	0.20328236603324	1	0	CTD_human
4879	NPPB	C0018801	Heart failure	0.291770185589212	12	0	CTD_human
4879	NPPB	C0042514	Tachycardia, Ventricular	0.2	1	0	CTD_human
4879	NPPB	C1956346	Coronary Artery Disease	0.211206376643468	1	0	CTD_human
488	ATP2A2	C0001202	Acrokeratosis	0.2	0	0	HPO
488	ATP2A2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.282732912464814	1	0	CTD_human
488	ATP2A2	C0014544	Epilepsy	0.2	0	0	HPO
488	ATP2A2	C0018801	Heart failure	0.283021994626344	1	0	CTD_human
488	ATP2A2	C0022595	Keratosis Follicularis	0.723761574543611	4	7	CTD_human;ORPHANET;UNIPROT
488	ATP2A2	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
488	ATP2A2	C0038220	Status Epilepticus	0.2	1	0	CTD_human
488	ATP2A2	C0206146	Myocardial Stunning	0.2	1	0	CTD_human
488	ATP2A2	C0341047	Hypertrophy of parotid gland	0.2	0	0	HPO
488	ATP2A2	C0853897	Diabetic Cardiomyopathies	0.280824180352639	1	0	CTD_human
488	ATP2A2	C0870082	Hyperkeratosis	0.2	0	0	HPO
4881	NPR1	C0018801	Heart failure	0.200549453568426	1	0	CTD_human
4882	NPR2	C0029453	Osteopenia	0.2	0	0	HPO
4882	NPR2	C0264112	Wedging of vertebra	0.2	0	0	HPO
4882	NPR2	C0747078	Generalized osteopenia	0.2	0	0	HPO
4882	NPR2	C1864356	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.681923087489492	3	6	CTD_human;ORPHANET;UNIPROT
4882	NPR2	C4014690	EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE	0.4	4	3	ORPHANET;UNIPROT
4882	NPR2	C4225399	SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES	0.2	2	5	UNIPROT
4886	NPY1R	C0028754	Obesity	0.364814057046576	1	0	CTD_human
4887	NPY2R	C0014544	Epilepsy	0.2	1	0	CTD_human
4887	NPY2R	C0014556	Epilepsy, Temporal Lobe	0.200274726784213	1	0	CTD_human
4889	NPY5R	C0028754	Obesity	0.285912964183428	1	0	CTD_human
489	ATP2A3	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200274726784213	1	0	CTD_human
4891	SLC11A2	C0002871	Anemia	0.210396551668146	0	0	HPO
4891	SLC11A2	C0018995	Hemochromatosis	0.206238848124954	1	0	CTD_human
4891	SLC11A2	C0162316	Iron deficiency anemia	0.200824180352639	1	0	CTD_human
4891	SLC11A2	C2673913	Anemia, Hypochromic Microcytic, With Iron Overload	0.200824180352639	0	0	CTD_human
4891	SLC11A2	C3806153	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1	0.4	3	3	ORPHANET;UNIPROT
4893	NRAS	C0002170	Alopecia	0.2	0	0	HPO
4893	NRAS	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
4893	NRAS	C0014544	Epilepsy	0.2	0	0	HPO
4893	NRAS	C0015300	Exophthalmos	0.2	0	0	HPO
4893	NRAS	C0020455	Hypergammaglobulinemia	0.2	0	0	HPO
4893	NRAS	C0020757	Ichthyoses	0.2	0	0	HPO
4893	NRAS	C0028326	Noonan Syndrome	0.401923087489492	1	2	CTD_human;ORPHANET
4893	NRAS	C0029453	Osteopenia	0.2	0	0	HPO
4893	NRAS	C0030312	Pancytopenia	0.2	0	0	HPO
4893	NRAS	C0038379	Strabismus	0.2	0	0	HPO
4893	NRAS	C0085702	Monocytosis	0.2	0	0	HPO
4893	NRAS	C0151311	Cranial nerve palsies	0.2	0	0	HPO
4893	NRAS	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
4893	NRAS	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
4893	NRAS	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
4893	NRAS	C0334082	NEVUS, EPIDERMAL (disorder)	0.2	2	3	UNIPROT
4893	NRAS	C0398650	Immune thrombocytopenic purpura	0.202407028523288	0	0	HPO
4893	NRAS	C0431391	Hemimegalencephaly	0.2	0	0	HPO
4893	NRAS	C0747078	Generalized osteopenia	0.2	0	0	HPO
4893	NRAS	C0870082	Hyperkeratosis	0.2	0	0	HPO
4893	NRAS	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
4893	NRAS	C1328840	Autoimmune Lymphoproliferative Syndrome	0.200549453568426	1	0	CTD_human
4893	NRAS	C1704375	Hypophosphatemic Rickets	0.2	0	0	HPO
4893	NRAS	C2674723	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER	0.4	2	1	ORPHANET;UNIPROT
4893	NRAS	C2750732	Noonan Syndrome 6	0.4	1	3	CTD_human;UNIPROT
4893	NRAS	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
4893	NRAS	C3854181	Nevus sebaceous	0.4	0	0	HPO;ORPHANET
4893	NRAS	C4082173	Porencephaly	0.2	0	0	HPO
490	ATP2B1	C1956346	Coronary Artery Disease	0.200549453568426	1	1	CTD_human
4901	NRL	C0017601	Glaucoma	0.2	0	0	HPO
4901	NRL	C0018777	Conductive hearing loss	0.2	0	0	HPO
4901	NRL	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4901	NRL	C0020459	Hyperinsulinism	0.2	0	0	HPO
4901	NRL	C0020619	Hypogonadism	0.2	0	0	HPO
4901	NRL	C0022578	Keratoconus	0.2	0	0	HPO
4901	NRL	C0028077	Night Blindness	0.4	2	0	CTD_human;HPO
4901	NRL	C0028738	Nystagmus	0.2	0	0	HPO
4901	NRL	C0028754	Obesity	0.2	0	0	HPO
4901	NRL	C0029124	Optic Atrophy	0.2	0	0	HPO
4901	NRL	C0035334	Retinitis Pigmentosa	0.609195330216668	2	1	CTD_human;HPO;ORPHANET
4901	NRL	C0042798	Low Vision	0.2	0	0	HPO
4901	NRL	C0271215	Blindness, Legal	0.2	0	0	HPO
4901	NRL	C1834329	RETINITIS PIGMENTOSA 27	0.2	2	3	UNIPROT
4901	NRL	C4024765	Peripapillary chorioretinal atrophy	0.2	0	0	HPO
4901	NRL	C4048273	Chorioretinal atrophy	0.2	0	0	HPO
4902	NRTN	C0021843	Intestinal Obstruction	0.2	0	0	HPO
4907	NT5E	C1859372	Calcification of Joints and Arteries	0.600549453568426	1	2	CTD_human;ORPHANET;UNIPROT
4908	NTF3	C0013080	Down Syndrome	0.200274726784213	1	0	CTD_human
4908	NTF3	C0014549	Tonic-Clonic Epilepsy	0.2	1	0	CTD_human
4908	NTF3	C0038220	Status Epilepticus	0.2	1	0	CTD_human
4909	NTF4	C0339573	Glaucoma, Primary Open Angle	0.201373633921065	0	0	HPO
4909	NTF4	C2751294	GLAUCOMA 1, OPEN ANGLE, O	0.2	0	0	CTD_human
491	ATP2B2	C1832394	Deafness, Autosomal Recessive 12	0.2	0	0	CTD_human
4913	NTHL1	C4225157	FAMILIAL ADENOMATOUS POLYPOSIS 3	0.2	0	0	ORPHANET
4914	NTRK1	C0002768	Congenital Pain Insensitivity	0.200824180352639	0	0	ORPHANET
4914	NTRK1	C0003028	Anhidrosis	0.200824180352639	0	0	HPO
4914	NTRK1	C0003892	Neurogenic arthropathy	0.2	0	0	HPO
4914	NTRK1	C0010043	Corneal Ulcer	0.2	0	0	HPO
4914	NTRK1	C0013363	Dysautonomia	0.2	0	0	HPO
4914	NTRK1	C0020074	HSAN Type IV	0.490439617800098	8	22	ORPHANET;UNIPROT
4914	NTRK1	C0020075	Hereditary Sensory Autonomic Neuropathy, Type 5	0.200549453568426	0	0	ORPHANET
4914	NTRK1	C0022568	Keratitis	0.2	0	0	HPO
4914	NTRK1	C0029443	Osteomyelitis	0.2	0	0	HPO
4914	NTRK1	C0155119	Recurrent erosion of cornea	0.2	0	0	HPO
4914	NTRK1	C0221260	Dystrophia unguium	0.2	0	0	HPO
4914	NTRK1	C0752347	Lewy Body Disease	0.2	1	0	CTD_human
4914	NTRK1	C1834405	Nail dysplasia	0.2	0	0	HPO
4914	NTRK1	C2242472	Infection of bone	0.2	0	0	HPO
4915	NTRK2	C0028754	Obesity	0.400824180352639	1	0	CTD_human;HPO
4915	NTRK2	C0038220	Status Epilepticus	0.2	2	0	CTD_human
4915	NTRK2	C0752347	Lewy Body Disease	0.2	1	0	CTD_human
4915	NTRK2	C3146244	Alcohol Related Birth Defect	0.2	1	0	PSYGENET
4915	NTRK2	C3151303	Obesity, Hyperphagia, and Developmental Delay	0.2	1	2	UNIPROT
4916	NTRK3	C0014175	Endometriosis	0.2	1	0	CTD_human
4916	NTRK3	C0038220	Status Epilepticus	0.2	1	0	CTD_human
492	ATP2B3	C0020428	Hyperaldosteronism	0.200274726784213	1	0	CTD_human
492	ATP2B3	C0796205	SPINOCEREBELLAR ATAXIA, X-LINKED 1	0.2	1	1	UNIPROT
492	ATP2B3	C2678048	Spinocerebellar Ataxia, X-Linked 5	0.2	0	0	ORPHANET
4920	ROR2	C0015300	Exophthalmos	0.2	0	0	HPO
4920	ROR2	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
4920	ROR2	C0020295	Hydronephrosis	0.2	0	0	HPO
4920	ROR2	C0024421	Macroglossia	0.2	0	0	HPO
4920	ROR2	C0158113	Contracture of joint of hand	0.2	0	0	HPO
4920	ROR2	C0271441	Chronic otitis media	0.2	0	0	HPO
4920	ROR2	C0743359	ear infection chronic	0.2	0	0	HPO
4920	ROR2	C0749379	Thoracolumbar scoliosis	0.2	0	0	HPO
4920	ROR2	C1300267	Brachydactyly syndrome type B	0.2	0	0	ORPHANET
4920	ROR2	C1849334	Robinow syndrome, autosomal recessive	0.682472541057918	4	8	CTD_human;ORPHANET;UNIPROT
4920	ROR2	C4020952	Fingernail dysplasia	0.2	0	0	HPO
4921	DDR2	C0015300	Exophthalmos	0.2	0	0	HPO
4921	DDR2	C0037926	Compression of spinal cord	0.2	0	0	HPO
4921	DDR2	C0039144	Syringomyelia	0.2	0	0	HPO
4921	DDR2	C0085581	Restrictive lung disease	0.2	0	0	HPO
4921	DDR2	C0264324	Calcification of trachea	0.2	0	0	HPO
4921	DDR2	C0410653	Atlantoaxial instability	0.2	0	0	HPO
4921	DDR2	C0694550	Recurrent pneumonia	0.2	0	0	HPO
4921	DDR2	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
4921	DDR2	C1397139	Calcification of falx cerebri	0.2	0	0	HPO
4921	DDR2	C1849011	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.600549453568426	2	4	CTD_human;ORPHANET;UNIPROT
4924	NUCB1	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
4926	NUMA1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
4929	NR4A2	C0003872	Arthritis, Psoriatic	0.200549453568426	1	0	CTD_human
4929	NR4A2	C0085606	Urgency of micturition	0.2	0	0	HPO
4929	NR4A2	C0752347	Lewy Body Disease	0.203007639249027	0	0	HPO
4929	NR4A2	C3160718	PARKINSON DISEASE, LATE-ONSET	0.200274726784213	0	0	CTD_human
4929	NR4A2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
4929	NR4A2	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
4929	NR4A2	C4020871	Dystonic disease	0.2	0	0	HPO
4929	NR4A2	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
4933	NYS2	C1834079	NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT (disorder)	0.2	0	0	CTD_human
4934	NYS3	C1842186	NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT (disorder)	0.2	0	0	CTD_human
4935	GPR143	C0004106	Astigmatism	0.2	0	0	HPO
4935	GPR143	C0028738	Nystagmus	0.200824180352639	0	0	HPO
4935	GPR143	C0038379	Strabismus	0.2	0	0	HPO
4935	GPR143	C0042798	Low Vision	0.2	0	0	HPO
4935	GPR143	C0271385	Horizontal Nystagmus	0.2	0	0	HPO
4935	GPR143	C0342684	Ocular albinism, type I	0.681923087489492	12	24	CTD_human;ORPHANET;UNIPROT
4935	GPR143	C1847524	Hyperopic astigmatism	0.2	0	0	HPO
4935	GPR143	C3151752	NYSTAGMUS 6, CONGENITAL, X-LINKED	0.4	1	1	CTD_human;UNIPROT
4935	GPR143	C4025788	Nystagmus-induced head nodding	0.2	0	0	HPO
493753	COA5	C4225154	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 3	0.2	1	1	UNIPROT
493753	COA5	C4273730	Fatal infantile cytochrome C oxidase deficiency	0.2	0	0	ORPHANET
4938	OAS1	C0011854	Diabetes Mellitus, Insulin-Dependent	0.206462417751855	0	0	CTD_human
4938	OAS1	C0021400	Influenza	0.200274726784213	1	0	CTD_human
493818	MYMY3	C1837418	MOYAMOYA DISEASE 3	0.2	0	0	CTD_human
493856	CISD2	C0043207	Wolfram Syndrome	0.204381273170092	0	0	ORPHANET
493856	CISD2	C1858028	WOLFRAM SYNDROME 2	0.281098907136852	1	1	CTD_human
493862	CTRCT28	C1836942	Cataract, Age-Related Cortical, 1	0.2	0	0	CTD_human
4939	OAS2	C0021400	Influenza	0.2	1	0	CTD_human
4940	OAS3	C0021400	Influenza	0.2	1	0	CTD_human
494028	CVMRF	C1845450	Cubitus Valgus with Mental Retardation and Unusual Facies	0.2	0	0	CTD_human
4941	OASD	C1845069	ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS (disorder)	0.2	0	0	CTD_human
494148	DFNB55	C1864962	DEAFNESS, AUTOSOMAL RECESSIVE 55	0.2	0	0	CTD_human
4942	OAT	C0018425	Gyrate Atrophy	0.494220280244451	5	28	CTD_human;UNIPROT
4942	OAT	C0027092	Myopia	0.2	0	0	HPO
4942	OAT	C0028077	Night Blindness	0.2	0	0	HPO
4942	OAT	C0271215	Blindness, Legal	0.2	0	0	HPO
4942	OAT	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
4942	OAT	C0858617	Posterior subcapsular cataract	0.2	0	0	HPO
4942	OAT	C4048273	Chorioretinal atrophy	0.2	0	0	HPO
494323	MIR361	C0008370	Cholestasis	0.2	1	0	CTD_human
494326	MIR377	C0008370	Cholestasis	0.2	1	0	CTD_human
494329	MIR380	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
494333	MIR384	C0015695	Fatty Liver	0.2	1	0	CTD_human
494446	NRCLP3	C0027404	Narcolepsy	0.2	0	0	CTD_human
494513	DFNB59	C1857744	DEAFNESS, AUTOSOMAL RECESSIVE 59	0.48	2	4	CTD_human;UNIPROT
4948	OCA2	C0028738	Nystagmus	0.2	0	0	HPO
4948	OCA2	C0038379	Strabismus	0.2	0	0	HPO
4948	OCA2	C0042798	Low Vision	0.2	0	0	HPO
4948	OCA2	C0268495	Oculocutaneous albinism type 2	0.68357144819477	8	38	CTD_human;ORPHANET;UNIPROT
4952	OCRL	C0003864	Arthritis	0.2	0	0	HPO
4952	OCRL	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
4952	OCRL	C0014306	Enophthalmos	0.2	0	0	HPO
4952	OCRL	C0014544	Epilepsy	0.2	0	0	HPO
4952	OCRL	C0017601	Glaucoma	0.2	0	0	HPO
4952	OCRL	C0020443	Hypercholesterolemia	0.2	0	0	HPO
4952	OCRL	C0020502	Hyperparathyroidism	0.2	0	0	HPO
4952	OCRL	C0028738	Nystagmus	0.2	0	0	HPO
4952	OCRL	C0028860	Oculocerebrorenal Syndrome	0.627704339073571	9	40	CTD_human;ORPHANET;UNIPROT
4952	OCRL	C0029442	Osteomalacia	0.2	0	0	HPO
4952	OCRL	C0035078	Kidney Failure	0.200274726784213	0	0	HPO
4952	OCRL	C0035579	Rickets	0.2	0	0	HPO
4952	OCRL	C0042798	Low Vision	0.2	0	0	HPO
4952	OCRL	C0042870	Vitamin D Deficiency	0.2	0	0	HPO
4952	OCRL	C0238621	Aminoaciduria	0.2	0	0	HPO
4952	OCRL	C0268435	Renal Tubular Acidosis, Type II	0.2	0	0	HPO
4952	OCRL	C0341703	Adult Fanconi syndrome	0.2	0	0	HPO
4952	OCRL	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
4952	OCRL	C1565489	Renal Insufficiency	0.2	0	0	HPO
4952	OCRL	C1845167	Dent Disease 2	0.601373633921066	3	8	CTD_human;ORPHANET;UNIPROT
4952	OCRL	C1848336	Dent disease 1	0.200549453568426	0	0	CTD_human
4952	OCRL	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
4952	OCRL	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
4952	OCRL	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
4952	OCRL	C4020884	Anxiety disease	0.2	0	0	HPO
4963	OFC1	C1861537	OROFACIAL CLEFT 1	0.200274726784213	0	0	CTD_human
4964	OFC2	C1864323	OROFACIAL CLEFT 2	0.2	0	0	CTD_human
4965	OFC3	C1833369	OROFACIAL CLEFT 3	0.2	0	0	CTD_human
4967	OGDH	C0020255	Hydrocephalus	0.2	0	0	HPO
4967	OGDH	C0234958	muscle degeneration	0.2	0	0	HPO
4967	OGDH	C2752074	ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.4	0	0	CTD_human;ORPHANET
4968	OGG1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.209418899843569	1	0	CTD_human
4968	OGG1	C0020179	Huntington Disease	0.204055389228567	1	0	CTD_human
497188	GLC1I	C1857852	GLAUCOMA 1, OPEN ANGLE, I	0.2	0	0	CTD_human
497231	CLN9	C1836841	CEROID LIPOFUSCINOSIS, NEURONAL, 9 (disorder)	0.2	0	0	CTD_human
4973	OLR1	C0018801	Heart failure	0.2	1	0	CTD_human
4973	OLR1	C0027051	Myocardial Infarction	0.209744783785095	2	2	CTD_human
4973	OLR1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
4976	OPA1	C0018784	Sensorineural Hearing Loss (disorder)	0.204106546385879	0	0	HPO
4976	OPA1	C0028738	Nystagmus	0.200274726784213	0	0	HPO
4976	OPA1	C0029124	Optic Atrophy	0.235259399610322	0	0	HPO
4976	OPA1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
4976	OPA1	C0038379	Strabismus	0.2	0	0	HPO
4976	OPA1	C0042798	Low Vision	0.2	0	0	HPO
4976	OPA1	C0155016	Color Blindness, Red-Green	0.2	0	0	HPO
4976	OPA1	C0155017	Color Blindness, Blue	0.2	0	0	HPO
4976	OPA1	C0221061	Behr syndrome	0.4	1	5	ORPHANET;UNIPROT
4976	OPA1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
4976	OPA1	C0271385	Horizontal Nystagmus	0.2	0	0	HPO
4976	OPA1	C0338508	Optic Atrophy, Autosomal Dominant	0.767523149087222	21	52	CTD_human;ORPHANET;UNIPROT
4976	OPA1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
4976	OPA1	C1832466	CAPOS syndrome	0.2	0	0	ORPHANET
4976	OPA1	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
4976	OPA1	C1852267	OPTIC ATROPHY 1 AND DEAFNESS	0.2	0	0	CTD_human
4976	OPA1	C3276549	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.204945082115836	10	6	UNIPROT
4976	OPA1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
4976	OPA1	C4225163	MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE)	0.2	1	1	UNIPROT
497657	ANIB3	C1836757	ANEURYSM, INTRACRANIAL BERRY, 3	0.2	0	0	CTD_human
4977	OPA2	C1839576	OPTIC ATROPHY 2 (disorder)	0.400274726784213	0	0	CTD_human;ORPHANET
498	ATP5A1	C0002395	Alzheimer's Disease	0.203007639249027	1	0	CTD_human
498	ATP5A1	C0014544	Epilepsy	0.2	0	0	HPO
498	ATP5A1	C0018801	Heart failure	0.2	0	0	HPO
498	ATP5A1	C0018802	Congestive heart failure	0.2	0	0	HPO
498	ATP5A1	C0028738	Nystagmus	0.2	0	0	HPO
498	ATP5A1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
498	ATP5A1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
498	ATP5A1	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
498	ATP5A1	C3808899	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4	0.2	1	1	UNIPROT
498	ATP5A1	C4015062	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.2	1	1	UNIPROT
4981	OPEM	C1839577	OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA (disorder)	0.2	0	0	CTD_human
4982	TNFRSF11B	C0002982	Angioid Streaks	0.200274726784213	0	0	HPO
4982	TNFRSF11B	C0003873	Rheumatoid Arthritis	0.220155690830558	1	0	CTD_human
4982	TNFRSF11B	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4982	TNFRSF11B	C0020437	Hypercalcemia	0.200824180352639	1	0	CTD_human
4982	TNFRSF11B	C0029124	Optic Atrophy	0.2	0	0	HPO
4982	TNFRSF11B	C0029456	Osteoporosis	0.448030763642093	1	0	CTD_human;HPO
4982	TNFRSF11B	C0029464	Osteosclerosis	0.207114185634906	0	0	HPO
4982	TNFRSF11B	C0041948	Uremia	0.200274726784213	1	0	CTD_human
4982	TNFRSF11B	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
4982	TNFRSF11B	C0268414	Hyperphosphatasemia with bone disease	0.405494535684262	0	0	CTD_human;ORPHANET
4982	TNFRSF11B	C0399385	Early tooth exfoliation	0.2	0	0	HPO
4982	TNFRSF11B	C0740394	Hyperuricemia	0.2	0	0	HPO
4983	OPHN1	C0014306	Enophthalmos	0.2	0	0	HPO
4983	OPHN1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
4983	OPHN1	C0028738	Nystagmus	0.2	0	0	HPO
4983	OPHN1	C0038379	Strabismus	0.200274726784213	0	0	HPO
4983	OPHN1	C1136249	Mental Retardation, X-Linked	0.205754907091158	1	0	CTD_human
4983	OPHN1	C1845366	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	0.48	0	0	CTD_human;ORPHANET
4985	OPRD1	C0014544	Epilepsy	0.2	1	0	CTD_human
4988	OPRM1	C0013384	Dyskinetic syndrome	0.200274726784213	1	0	CTD_human
4988	OPRM1	C0014544	Epilepsy	0.2	1	0	CTD_human
4988	OPRM1	C0019151	Hepatic Encephalopathy	0.2	1	0	CTD_human
4988	OPRM1	C0019196	Hepatitis C	0.2	2	0	CTD_human
4988	OPRM1	C0270850	Idiopathic generalized epilepsy	0.200274726784213	0	0	CTD_human
4988	OPRM1	C1837893	SCHIZOPHRENIA 12	0.2	1	0	PSYGENET
4990	SIX6	C0011848	Diabetes Insipidus	0.2	0	0	HPO
4990	SIX6	C0015300	Exophthalmos	0.2	0	0	HPO
4990	SIX6	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
4990	SIX6	C0023882	Little's Disease	0.2	0	0	HPO
4990	SIX6	C0026205	Miosis disorder	0.2	0	0	HPO
4990	SIX6	C0027092	Myopia	0.2	1	0	CTD_human
4990	SIX6	C0271385	Horizontal Nystagmus	0.2	0	0	HPO
4990	SIX6	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
4990	SIX6	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
4990	SIX6	C0948740	Pituitary hypoplasia	0.2	0	0	HPO
4990	SIX6	C1855052	MICROPHTHALMIA, ISOLATED 1	0.2	0	0	ORPHANET
4990	SIX6	C1857079	Atretic auditory canal	0.2	0	0	HPO
4990	SIX6	C1859311	Microphthalmia, Isolated, with Cataract 2	0.2	0	0	CTD_human
4990	SIX6	C1864825	Frias syndrome	0.2	0	0	ORPHANET
4990	SIX6	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
4990	SIX6	C4225424	OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY	0.2	0	0	ORPHANET
4998	ORC1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
4998	ORC1	C0038379	Strabismus	0.2	0	0	HPO
4998	ORC1	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
4998	ORC1	C0158113	Contracture of joint of hand	0.2	0	0	HPO
4998	ORC1	C1857079	Atretic auditory canal	0.2	0	0	HPO
4998	ORC1	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	0.601098907136852	3	5	CTD_human;ORPHANET;UNIPROT
4998	ORC1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
50	ACO2	C0014544	Epilepsy	0.2	0	0	HPO
50	ACO2	C0028738	Nystagmus	0.2	0	0	HPO
50	ACO2	C0029124	Optic Atrophy	0.200549453568426	0	0	HPO
50	ACO2	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
50	ACO2	C0038379	Strabismus	0.2	0	0	HPO
50	ACO2	C0042798	Low Vision	0.2	0	0	HPO
50	ACO2	C0155016	Color Blindness, Red-Green	0.2	0	0	HPO
50	ACO2	C0235946	Cerebral atrophy	0.2	0	0	HPO
50	ACO2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
50	ACO2	C0270922	Peripheral demyelinating neuropathy	0.2	0	0	HPO
50	ACO2	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
50	ACO2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
50	ACO2	C3281192	INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.400549453568426	2	6	ORPHANET;UNIPROT
50	ACO2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
50	ACO2	C4225384	OPTIC ATROPHY 9	0.2	1	2	UNIPROT
5000	ORC4	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
5000	ORC4	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
5000	ORC4	C0264353	Bronchomalacia	0.2	0	0	HPO
5000	ORC4	C0948187	Tracheomalacia	0.2	0	0	HPO
5000	ORC4	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	0.400274726784213	2	0	CTD_human;ORPHANET
5000	ORC4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5000	ORC4	C3151097	MEIER-GORLIN SYNDROME 2	0.2	1	3	UNIPROT
5004	ORM1	C0085605	Liver Failure	0.2	1	0	CTD_human
5008	OSM	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
5008	OSM	C0263454	Chloracne	0.2	1	0	CTD_human
5008	OSM	C3495559	Juvenile arthritis	0.200274726784213	1	0	CTD_human
5009	OTC	C0014544	Epilepsy	0.2	0	0	HPO
5009	OTC	C0020615	Hypoglycemia	0.2	0	0	HPO
5009	OTC	C0085605	Liver Failure	0.200549453568426	0	0	HPO
5009	OTC	C0238621	Aminoaciduria	0.2	0	0	HPO
5009	OTC	C0268542	Ornithine carbamoyltransferase deficiency	0.699425733767183	29	117	CTD_human;ORPHANET;UNIPROT
5009	OTC	C1720189	Episodic Ataxia	0.2	0	0	HPO
5009	OTC	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
501	ALDH7A1	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
501	ALDH7A1	C0038220	Status Epilepticus	0.2	0	0	HPO
501	ALDH7A1	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
501	ALDH7A1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
501	ALDH7A1	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
501	ALDH7A1	C1291560	Deficiency of glutamate decarboxylase	0.2	0	0	ORPHANET
501	ALDH7A1	C1849508	EPILEPSY, PYRIDOXINE-DEPENDENT	0.608791257094819	2	11	CTD_human;ORPHANET;UNIPROT
501	ALDH7A1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
5010	CLDN11	C0026769	Multiple Sclerosis	0.200549453568426	1	0	CTD_human
5012	OTSC1	C0029899	Otosclerosis	0.201373633921065	0	0	CTD_human
5015	OTX2	C0014544	Epilepsy	0.2	0	0	HPO
5015	OTX2	C0015923	Fetal Alcohol Syndrome	0.2	1	0	PSYGENET
5015	OTX2	C0020615	Hypoglycemia	0.2	0	0	HPO
5015	OTX2	C0028738	Nystagmus	0.2	0	0	HPO
5015	OTX2	C0029453	Osteopenia	0.2	0	0	HPO
5015	OTX2	C0038379	Strabismus	0.2	0	0	HPO
5015	OTX2	C0042798	Low Vision	0.2	0	0	HPO
5015	OTX2	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
5015	OTX2	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
5015	OTX2	C0747078	Generalized osteopenia	0.2	0	0	HPO
5015	OTX2	C0948740	Pituitary hypoplasia	0.2	0	0	HPO
5015	OTX2	C1855052	MICROPHTHALMIA, ISOLATED 1	0.2	0	0	ORPHANET
5015	OTX2	C1864690	Microphthalmia, Syndromic 5	0.6	3	10	CTD_human;ORPHANET;UNIPROT
5015	OTX2	C1876185	Dysgnathia complex	0.200824180352639	0	0	ORPHANET
5015	OTX2	C2751608	Pituitary Hormone Deficiency, Combined, 1	0.2	0	0	ORPHANET
5015	OTX2	C3151380	SCHIZOPHRENIA 15	0.200274726784213	1	0	PSYGENET
5015	OTX2	C3151440	PITUITARY HORMONE DEFICIENCY, COMBINED, 6	0.2	1	1	UNIPROT
5015	OTX2	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
5015	OTX2	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
5015	OTX2	C4053775	Pituitary stalk interruption syndrome	0.200274726784213	0	0	HPO
5016	OVGP1	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
5017	OVOL1	C0011615	Dermatitis, Atopic	0.200274726784213	1	1	CTD_human
5019	OXCT1	C0029456	Osteoporosis	0.2	1	0	CTD_human
5019	OXCT1	C0162275	Ketonuria	0.2	0	0	HPO
5019	OXCT1	C0342792	Succinyl-CoA:3-oxoacid CoA transferase deficiency	0.6	3	8	CTD_human;ORPHANET;UNIPROT
5020	OXT	C0012739	Disseminated Intravascular Coagulation	0.2	1	0	CTD_human
5020	OXT	C0014549	Tonic-Clonic Epilepsy	0.2	2	0	CTD_human
5020	OXT	C0015930	Fetal Distress	0.2	1	0	CTD_human
5020	OXT	C0043049	Water Intoxication	0.2	8	0	CTD_human
5025	P2RX4	C0014544	Epilepsy	0.2	1	0	CTD_human
5025	P2RX4	C0014556	Epilepsy, Temporal Lobe	0.2	1	0	CTD_human
5027	P2RX7	C0014556	Epilepsy, Temporal Lobe	0.2	2	0	CTD_human
5027	P2RX7	C0026769	Multiple Sclerosis	0.200549453568426	1	0	CTD_human
5032	P2RY11	C0007384	Cataplexy	0.2	0	0	HPO
5032	P2RY11	C0027404	Narcolepsy	0.403780662444354	1	0	CTD_human;ORPHANET
5032	P2RY11	C0751362	Narcolepsy-Cataplexy Syndrome	0.2	0	0	ORPHANET
5034	P4HB	C0009451	Communicating Hydrocephalus	0.2	0	0	HPO
5034	P4HB	C0015300	Exophthalmos	0.2	0	0	HPO
5034	P4HB	C0029453	Osteopenia	0.2	0	0	HPO
5034	P4HB	C0029456	Osteoporosis	0.200274726784213	1	0	CTD_human
5034	P4HB	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5034	P4HB	C0410550	Collapse of vertebra	0.2	0	0	HPO
5034	P4HB	C0747078	Generalized osteopenia	0.2	0	0	HPO
5034	P4HB	C1846707	SPINOCEREBELLAR ATAXIA 17	0.2	1	0	CTD_human
5034	P4HB	C1856266	Coronal craniosynostosis	0.2	0	0	HPO
5034	P4HB	C1862178	Cole Carpenter syndrome	0.400274726784213	1	1	ORPHANET;UNIPROT
503613	PSORS10	C0033860	Psoriasis	0.2	0	0	CTD_human
5037	PEBP1	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
5037	PEBP1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5048	PAFAH1B1	C0014544	Epilepsy	0.201373633921065	0	0	HPO
5048	PAFAH1B1	C0235946	Cerebral atrophy	0.2	0	0	HPO
5048	PAFAH1B1	C0265219	Miller Dieker syndrome	0.286593442821114	0	0	ORPHANET
5048	PAFAH1B1	C0431375	Classical Lissencephaly	0.488516530310606	5	91	ORPHANET;UNIPROT
5048	PAFAH1B1	C0575059	Spastic tetraparesis	0.2	0	0	HPO
5048	PAFAH1B1	C1848201	Subcortical Band Heterotopia	0.20357144819477	0	0	ORPHANET
5048	PAFAH1B1	C1955870	Classical Lissencephalies and Subcortical Band Heterotopias	0.202407028523288	0	0	CTD_human
5048	PAFAH1B1	C3808300	CHROMOSOME 17p13.3, CENTROMERIC, DUPLICATION SYNDROME	0.2	0	0	ORPHANET
50484	RRM2B	C0014544	Epilepsy	0.2	0	0	HPO
50484	RRM2B	C0022541	Kearns-Sayre syndrome	0.200274726784213	0	0	ORPHANET
50484	RRM2B	C0151517	Complete atrioventricular block	0.2	0	0	HPO
50484	RRM2B	C0162292	External Ophthalmoplegia	0.2	0	0	HPO
50484	RRM2B	C0162674	Chronic progressive external ophthalmoplegia	0.200824180352639	0	0	HPO
50484	RRM2B	C0234958	muscle degeneration	0.2	0	0	HPO
50484	RRM2B	C0238621	Aminoaciduria	0.2	0	0	HPO
50484	RRM2B	C0872218	MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME	0.4	1	0	CTD_human;ORPHANET
50484	RRM2B	C1834846	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1	0.2	0	0	ORPHANET
50484	RRM2B	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
50484	RRM2B	C2749861	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.4	3	13	ORPHANET;UNIPROT
50484	RRM2B	C2751319	Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5	0.2	0	0	CTD_human
50484	RRM2B	C3150914	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE)	0.2	0	0	ORPHANET
50484	RRM2B	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
50485	SMARCAL1	C0002871	Anemia	0.2	0	0	HPO
50485	SMARCAL1	C0003850	Arteriosclerosis	0.2	0	0	HPO
50485	SMARCAL1	C0004106	Astigmatism	0.2	0	0	HPO
50485	SMARCAL1	C0017668	Focal glomerulosclerosis	0.200274726784213	0	0	HPO
50485	SMARCAL1	C0024312	Lymphopenia	0.2	0	0	HPO
50485	SMARCAL1	C0027092	Myopia	0.2	0	0	HPO
50485	SMARCAL1	C0029453	Osteopenia	0.2	0	0	HPO
50485	SMARCAL1	C0035078	Kidney Failure	0.2	0	0	HPO
50485	SMARCAL1	C0038015	Spondyloepiphyseal Dysplasia	0.200274726784213	0	0	HPO
50485	SMARCAL1	C0747078	Generalized osteopenia	0.2	0	0	HPO
50485	SMARCAL1	C0917805	Transient Cerebral Ischemia	0.2	0	0	HPO
50485	SMARCAL1	C1565489	Renal Insufficiency	0.200274726784213	0	0	HPO
50485	SMARCAL1	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
50489	CD207	C3150657	BIRBECK GRANULE DEFICIENCY	0.2	1	1	UNIPROT
50506	DUOX2	C0020676	Hypothyroidism	0.201648360705279	0	0	HPO
50506	DUOX2	C0024421	Macroglossia	0.2	0	0	HPO
50506	DUOX2	C0917799	Hypersomnia	0.2	0	0	HPO
50506	DUOX2	C1846632	Thyroid Dyshormonogenesis 6	0.48	3	8	CTD_human;UNIPROT
50506	DUOX2	C1848805	Thyroid Dyshormonogenesis 1	0.2	0	0	ORPHANET
50507	NOX4	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
50507	NOX4	C0022661	Kidney Failure, Chronic	0.200274726784213	1	0	CTD_human
50507	NOX4	C1565489	Renal Insufficiency	0.2	1	0	CTD_human
50507	NOX4	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
50511	SYCP3	C0000809	Abortion, Habitual	0.202732912464814	1	0	CTD_human
50511	SYCP3	C0004509	Azoospermia	0.403780662444354	1	0	CTD_human;HPO
50511	SYCP3	C4021107	Non-obstructive azoospermia	0.200274726784213	0	0	HPO
50511	SYCP3	C4023106	Obstructive azoospermia	0.2	0	0	HPO
5052	PRDX1	C0003949	Asbestosis	0.2	1	0	CTD_human
5052	PRDX1	C0036323	Schistosomiasis	0.2	1	0	CTD_human
5053	PAH	C0011644	Scleroderma	0.2	0	0	HPO
5053	PAH	C0013595	Eczema	0.2	0	0	HPO
5053	PAH	C0014544	Epilepsy	0.2	0	0	HPO
5053	PAH	C0085547	Phenylketonuria, Maternal	0.202197814273705	0	0	ORPHANET
5053	PAH	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
5053	PAH	C0259817	Xerosis	0.2	0	0	HPO
5053	PAH	C0751434	Classical phenylketonuria	0.73124288357859	29	183	HPO;ORPHANET;UNIPROT
5053	PAH	C0751435	Hyperphenylalaninaemia	0.232012008683673	0	0	HPO
5053	PAH	C1274865	Scleroderma-like secondary cutaneous sclerosis	0.2	0	0	HPO
5053	PAH	C4020884	Anxiety disease	0.2	0	0	HPO
5054	SERPINE1	C0004153	Atherosclerosis	0.2265669514251	1	0	CTD_human
5054	SERPINE1	C0004943	Behcet Syndrome	0.205088783830789	1	0	CTD_human
5054	SERPINE1	C0008370	Cholestasis	0.2	1	0	CTD_human
5054	SERPINE1	C0011881	Diabetic Nephropathy	0.283846174978983	1	0	CTD_human
5054	SERPINE1	C0015695	Fatty Liver	0.203007639249027	1	0	CTD_human
5054	SERPINE1	C0017668	Focal glomerulosclerosis	0.2	1	0	CTD_human
5054	SERPINE1	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
5054	SERPINE1	C0022661	Kidney Failure, Chronic	0.28777053913829	1	0	CTD_human
5054	SERPINE1	C0028754	Obesity	0.247291036821734	1	0	CTD_human
5054	SERPINE1	C2750067	Plasminogen Activator Inhibitor-1 Deficiency	0.4	0	0	CTD_human;ORPHANET
5055	SERPINB2	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
506	ATP5B	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
506	ATP5B	C1846707	SPINOCEREBELLAR ATAXIA 17	0.2	1	0	CTD_human
50604	IL20	C0011854	Diabetes Mellitus, Insulin-Dependent	0.202407028523288	1	0	CTD_human
50608	IBD4	C1847691	INFLAMMATORY BOWEL DISEASE 4	0.2	0	0	CTD_human
50615	IL21R	C0006267	Bronchiectasis	0.2	0	0	HPO
50615	IL21R	C0008311	Cholangitis	0.2	0	0	HPO
50615	IL21R	C0023890	Liver Cirrhosis	0.2	0	0	HPO
50615	IL21R	C0024141	Lupus Erythematosus, Systemic	0.203780662444353	1	0	CTD_human
50615	IL21R	C0032285	Pneumonia	0.2	0	0	HPO
50615	IL21R	C0085605	Liver Failure	0.2	0	0	HPO
50615	IL21R	C0401151	Chronic diarrhea	0.2	0	0	HPO
50615	IL21R	C0581354	Recurrent sinusitis	0.2	0	0	HPO
50615	IL21R	C1840253	IgE RESPONSIVENESS, ATOPIC	0.2	0	0	CTD_human
50615	IL21R	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
50615	IL21R	C3554687	IL21R IMMUNODEFICIENCY	0.4	1	2	ORPHANET;UNIPROT
50615	IL21R	C3808820	Hepatitis, chronic, due to Cryptosporidium infection	0.2	0	0	HPO
50615	IL21R	C4280333	Recurrent sinus disease	0.2	0	0	HPO
50616	IL22	C0241910	Hepatitis, Autoimmune	0.2	1	0	CTD_human
50616	IL22	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
50616	IL22	C4277682	Chemical and Drug Induced Liver Injury	0.2	3	0	CTD_human
50617	ATP6V0A4	C0027709	Nephrocalcinosis	0.2	0	0	HPO
50617	ATP6V0A4	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
50617	ATP6V0A4	C1704380	Distal Renal Tubular Acidosis	0.20357144819477	0	0	HPO
50617	ATP6V0A4	C1864498	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	0.681648360705279	2	8	CTD_human;ORPHANET;UNIPROT
50617	ATP6V0A4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
50618	ITSN2	C1527336	Sjogren's Syndrome	0.2	1	0	CTD_human
50619	DEF6	C0024141	Lupus Erythematosus, Systemic	0.28	1	0	CTD_human
5063	PAK3	C0014544	Epilepsy	0.200274726784213	0	0	HPO
5063	PAK3	C0037036	Sialorrhea	0.2	0	0	HPO
5063	PAK3	C0796237	Mental Retardation, X-Linked 30	0.4	2	4	CTD_human;UNIPROT
5063	PAK3	C1837658	Gross motor development delay	0.2	0	0	HPO
5063	PAK3	C4020884	Anxiety disease	0.2	0	0	HPO
50640	PNPLA8	C0149958	Complex partial seizures	0.2	0	0	HPO
50640	PNPLA8	C0270834	Complex partial seizure with impairment of consciousness	0.2	0	0	HPO
50640	PNPLA8	C4020871	Dystonic disease	0.2	0	0	HPO
50644	MRXS11	C1846145	MENTAL RETARDATION, X-LINKED, SYNDROMIC 11	0.2	0	0	CTD_human
5066	PAM	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200274726784213	1	0	CTD_human
5067	CNTN3	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
50674	NEUROG3	C1835888	Diarrhea 4, Malabsorptive, Congenital	0.600274726784213	1	2	CTD_human;ORPHANET;UNIPROT
50674	NEUROG3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5069	PAPPA	C0002965	Angina, Unstable	0.200274726784213	1	0	CTD_human
5069	PAPPA	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
5069	PAPPA	C0027051	Myocardial Infarction	0.205740551713841	1	0	CTD_human
5069	PAPPA	C0948089	Acute Coronary Syndrome	0.209022917747081	1	0	CTD_human
5069	PAPPA	C1956346	Coronary Artery Disease	0.200274726784213	1	0	CTD_human
5071	PARK2	C0023343	Leprosy	0.207561324888707	0	0	CTD_human
5071	PARK2	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
5071	PARK2	C0030567	Parkinson Disease	0.413846449705768	12	0	CTD_human
5071	PARK2	C0030569	Secondary Parkinson Disease	0.2	1	0	CTD_human
5071	PARK2	C1868675	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	0.298131967758065	30	24	UNIPROT
5071	PARK2	C3160718	PARKINSON DISEASE, LATE-ONSET	0.20357144819477	12	4	UNIPROT
5071	PARK2	C3809811	PARKINSON DISEASE 19, JUVENILE-ONSET	0.2	0	0	ORPHANET
5071	PARK2	C4020871	Dystonic disease	0.2	0	0	HPO
5071	PARK2	C4275179	Young onset Parkinson disease	0.215109973131721	0	0	ORPHANET
50715	EJM2	C0270853	Myoclonic Epilepsy, Juvenile	0.200824180352639	0	0	CTD_human
50717	DCAF8	C0270921	Axonal neuropathy	0.2	0	0	HPO
50717	DCAF8	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
50717	DCAF8	C1848736	Distal amyotrophy	0.2	0	0	HPO
50717	DCAF8	C4013360	GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT	0.4	1	1	ORPHANET;UNIPROT
5072	PARK3	C1865581	PARKINSON DISEASE 3, AUTOSOMAL DOMINANT LEWY BODY (disorder)	0.2	0	0	CTD_human
5072	PARK3	C3160718	PARKINSON DISEASE, LATE-ONSET	0.200274726784213	0	0	CTD_human
5073	PARN	C0002170	Alopecia	0.2	0	0	HPO
5073	PARN	C0002871	Anemia	0.2	0	0	HPO
5073	PARN	C0011334	Dental caries	0.2	0	0	HPO
5073	PARN	C0031099	Periodontitis	0.2	0	0	HPO
5073	PARN	C0034069	Pulmonary Fibrosis	0.200274726784213	0	0	HPO
5073	PARN	C0221260	Dystrophia unguium	0.2	0	0	HPO
5073	PARN	C0235946	Cerebral atrophy	0.2	0	0	HPO
5073	PARN	C0265965	Dyskeratosis Congenita	0.201098907136852	0	0	ORPHANET
5073	PARN	C0266039	Taurodontism	0.2	0	0	HPO
5073	PARN	C1800706	Idiopathic Pulmonary Fibrosis	0.400274726784213	1	0	CTD_human;ORPHANET
5073	PARN	C1846142	HOYERAAL-HREIDARSSON SYNDROME	0.200274726784213	0	0	ORPHANET
5073	PARN	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5073	PARN	C4023400	Generalized hypopigmentation of hair	0.2	0	0	HPO
5073	PARN	C4225347	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4	0.2	1	4	UNIPROT
5073	PARN	C4225356	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.2	1	2	UNIPROT
5075	PAX1	C0011334	Dental caries	0.2	0	0	HPO
5075	PAX1	C0018777	Conductive hearing loss	0.2	0	0	HPO
5075	PAX1	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
5075	PAX1	C0344505	Alacrima	0.2	0	0	HPO
5075	PAX1	C2931416	Fara Chlupackova syndrome	0.2	0	0	ORPHANET
5075	PAX1	C3714942	OTOFACIOCERVICAL SYNDROME 2	0.2	1	1	UNIPROT
5076	PAX2	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
5076	PAX2	C0014544	Epilepsy	0.2	0	0	HPO
5076	PAX2	C0017668	Focal glomerulosclerosis	0.200824180352639	0	0	HPO
5076	PAX2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5076	PAX2	C0022661	Kidney Failure, Chronic	0.200274726784213	1	0	CTD_human
5076	PAX2	C0027092	Myopia	0.2	0	0	HPO
5076	PAX2	C0035078	Kidney Failure	0.201098907136852	0	0	HPO
5076	PAX2	C0042580	Vesico-Ureteral Reflux	0.204604842796993	0	0	HPO
5076	PAX2	C0042798	Low Vision	0.2	0	0	HPO
5076	PAX2	C0155285	Orbital cyst	0.2	0	0	HPO
5076	PAX2	C0155299	Coloboma of optic disc	0.201373633921065	0	0	HPO
5076	PAX2	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
5076	PAX2	C1565489	Renal Insufficiency	0.203007639249027	0	0	HPO
5076	PAX2	C1852759	Papillorenal syndrome	0.689340710663245	5	8	CTD_human;ORPHANET;UNIPROT
5076	PAX2	C2316810	Chronic kidney disease stage 5	0.200274726784213	0	0	HPO
5076	PAX2	C3714581	Multicystic Dysplastic Kidney	0.200549453568426	0	0	HPO
5076	PAX2	C4014925	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7	0.2	2	2	UNIPROT
5076	PAX2	C4048273	Chorioretinal atrophy	0.2	0	0	HPO
5077	PAX3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5077	PAX3	C0037772	Spastic Paraplegia	0.2	0	0	HPO
5077	PAX3	C0079661	Klein's Syndrome	0.401098907136852	5	3	ORPHANET;UNIPROT
5077	PAX3	C1847800	Waardenburg Syndrome Type 1	0.490439617800098	14	7	ORPHANET;UNIPROT
5077	PAX3	C1852510	Craniofacial deafness hand syndrome	0.600274726784213	2	1	CTD_human;ORPHANET;UNIPROT
5077	PAX3	C3266898	Waardenburg Syndrome	0.21810325700343	1	1	CTD_human
5077	PAX3	C4025777	Autosomal dominant contiguous gene syndrome	0.2	0	0	HPO
5078	PAX4	C0011854	Diabetes Mellitus, Insulin-Dependent	0.411551201582644	1	1	CTD_human;UNIPROT
5078	PAX4	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.618288346118712	1	1	CTD_human;HPO;ORPHANET;UNIPROT
5078	PAX4	C0342276	Maturity onset diabetes mellitus in young	0.201373633921065	0	0	HPO
5078	PAX4	C2677132	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9 (disorder)	0.400274726784213	1	1	CTD_human;UNIPROT
5080	PAX6	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202681755307501	1	0	CTD_human
5080	PAX6	C0017601	Glaucoma	0.200274726784213	0	0	HPO
5080	PAX6	C0022568	Keratitis	0.200274726784213	0	0	HPO
5080	PAX6	C0028738	Nystagmus	0.201098907136852	0	0	HPO
5080	PAX6	C0029124	Optic Atrophy	0.2	0	0	HPO
5080	PAX6	C0035305	Retinal Detachment	0.2	0	0	HPO
5080	PAX6	C0038379	Strabismus	0.2	0	0	HPO
5080	PAX6	C0042798	Low Vision	0.200274726784213	0	0	HPO
5080	PAX6	C0154971	Presenile cataract	0.200274726784213	0	0	HPO
5080	PAX6	C0155299	Coloboma of optic disc	0.6	0	0	CTD_human;HPO;UNIPROT
5080	PAX6	C0206115	WAGR Syndrome	0.20357144819477	0	0	ORPHANET
5080	PAX6	C0431401	Gillespie syndrome	0.400549453568426	0	0	CTD_human;ORPHANET
5080	PAX6	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5080	PAX6	C0549307	Morning glory syndrome	0.200274726784213	0	0	ORPHANET
5080	PAX6	C1833797	Optic Nerve Hypoplasia, Bilateral	0.6	1	2	CTD_human;ORPHANET;UNIPROT
5080	PAX6	C1835698	Keratitis, hereditary	0.48	0	0	CTD_human;ORPHANET
5080	PAX6	C1855496	Contiguous gene syndrome	0.2	0	0	HPO
5080	PAX6	C1858679	CATARACT, AUTOSOMAL DOMINANT	0.2	0	0	CTD_human
5080	PAX6	C2931644	O'Donnell Pappas syndrome	0.2	0	0	CTD_human
5080	PAX6	C2931803	Deletion 11p13	0.2	0	0	ORPHANET
5080	PAX6	C3714873	Axenfeld-Rieger Syndrome, Type 1	0.2	1	0	CTD_human
5080	PAX6	C3805604	FOVEAL HYPOPLASIA 1	0.4	1	2	ORPHANET;UNIPROT
50807	ASAP1	C0041327	Tuberculosis, Pulmonary	0.2	1	0	CTD_human
50814	NSDHL	C0014544	Epilepsy	0.2	0	0	HPO
50814	NSDHL	C0020295	Hydronephrosis	0.2	0	0	HPO
50814	NSDHL	C0030436	Parakeratosis	0.2	0	0	HPO
50814	NSDHL	C0038379	Strabismus	0.2	0	0	HPO
50814	NSDHL	C0079583	Ichthyosiform Erythroderma, Congenital	0.2	0	0	HPO
50814	NSDHL	C0265267	Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects	0.601648360705279	3	15	CTD_human;ORPHANET;UNIPROT
50814	NSDHL	C0870082	Hyperkeratosis	0.2	0	0	HPO
50814	NSDHL	C3151781	CK SYNDROME	0.400549453568426	0	0	CTD_human;ORPHANET
50823	HMU	C2931059	Marie Unna congenital hypotrichosis	0.2	0	0	CTD_human
50829	HDPA	C1846167	Hodgkin disease, X-linked pseudoautosomal	0.2	0	0	CTD_human
5083	PAX9	C1970291	Tooth Agenesis, Selective, 3	0.48	1	8	CTD_human;UNIPROT
50846	DHH	C0018055	Gonadal Dysgenesis, Mixed	0.200549453568426	0	0	HPO
50846	DHH	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
50846	DHH	C0151721	Testicular hypogonadism	0.2	0	0	HPO
50846	DHH	C0152025	Polyneuropathy	0.2	0	0	HPO
50846	DHH	C0232939	Primary physiologic amenorrhea	0.200274726784213	0	0	HPO
50846	DHH	C0234958	muscle degeneration	0.2	0	0	HPO
50846	DHH	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
50846	DHH	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
50846	DHH	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
50846	DHH	C2751325	46,Xy Gonadal Dysgenesis, Partial, With Minifascicular Neuropathy	0.48	0	0	CTD_human;ORPHANET
50846	DHH	C2936694	Swyer Syndrome	0.200549453568426	0	0	ORPHANET
50846	DHH	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
5091	PC	C0014544	Epilepsy	0.2	0	0	HPO
5091	PC	C0020615	Hypoglycemia	0.2	0	0	HPO
5091	PC	C0023529	Leukomalacia, Periventricular	0.2	0	0	HPO
5091	PC	C0034341	Pyruvate Carboxylase Deficiency Disease	0.407417623173754	1	13	CTD_human;UNIPROT
5091	PC	C0268435	Renal Tubular Acidosis, Type II	0.2	0	0	HPO
5092	PCBD1	C0751435	Hyperphenylalaninaemia	0.201098907136852	0	0	HPO
5092	PCBD1	C1849700	Hyperphenylalaninemia with primapterinuria	0.600274726784213	2	6	CTD_human;ORPHANET;UNIPROT
50937	CDON	C0020615	Hypoglycemia	0.2	0	0	HPO
50937	CDON	C0020676	Hypothyroidism	0.2	0	0	HPO
50937	CDON	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
50937	CDON	C3280215	HOLOPROSENCEPHALY 11	0.28	1	6	UNIPROT
50937	CDON	C4053775	Pituitary stalk interruption syndrome	0.400274726784213	0	0	HPO;ORPHANET
50939	IMPG2	C0008525	Choroideremia	0.2	0	0	HPO
50939	IMPG2	C0017601	Glaucoma	0.2	0	0	HPO
50939	IMPG2	C0018777	Conductive hearing loss	0.2	0	0	HPO
50939	IMPG2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
50939	IMPG2	C0020459	Hyperinsulinism	0.2	0	0	HPO
50939	IMPG2	C0020619	Hypogonadism	0.2	0	0	HPO
50939	IMPG2	C0022578	Keratoconus	0.2	0	0	HPO
50939	IMPG2	C0028077	Night Blindness	0.2	0	0	HPO
50939	IMPG2	C0028738	Nystagmus	0.2	0	0	HPO
50939	IMPG2	C0028754	Obesity	0.2	0	0	HPO
50939	IMPG2	C0029124	Optic Atrophy	0.2	0	0	HPO
50939	IMPG2	C0035334	Retinitis Pigmentosa	0.400549453568426	0	0	HPO;ORPHANET
50939	IMPG2	C0042798	Low Vision	0.2	0	0	HPO
50939	IMPG2	C0271215	Blindness, Legal	0.2	0	0	HPO
50939	IMPG2	C0339510	Vitelliform Macular Dystrophy	0.200274726784213	0	0	HPO
50939	IMPG2	C0730292	Macular dystrophy	0.2	0	0	HPO
50939	IMPG2	C0858617	Posterior subcapsular cataract	0.2	0	0	HPO
50939	IMPG2	C1842914	Adult-Onset Vitelliform Macular Dystrophy	0.2	0	0	ORPHANET
50939	IMPG2	C3150819	RETINITIS PIGMENTOSA 56	0.2	0	0	CTD_human
50939	IMPG2	C4015343	MACULAR DYSTROPHY, VITELLIFORM, 5	0.2	2	2	UNIPROT
50940	PDE11A	C0020619	Hypogonadism	0.2	0	0	HPO
50940	PDE11A	C0029453	Osteopenia	0.2	0	0	HPO
50940	PDE11A	C0029456	Osteoporosis	0.2	0	0	HPO
50940	PDE11A	C0234958	muscle degeneration	0.2	0	0	HPO
50940	PDE11A	C0747078	Generalized osteopenia	0.2	0	0	HPO
50940	PDE11A	C1621895	Adrenal hyperplasia	0.200824180352639	0	0	HPO
50940	PDE11A	C1864851	Pigmented Nodular Adrenocortical Disease, Primary, 2	0.2	0	0	CTD_human
50940	PDE11A	C4020884	Anxiety disease	0.2	0	0	HPO
50940	PDE11A	C4025760	Primary hypercorticolism	0.2	0	0	HPO
50941	IBD5	C1853438	INFLAMMATORY BOWEL DISEASE 5	0.200274726784213	0	0	CTD_human
50942	IBD6	C1847692	INFLAMMATORY BOWEL DISEASE 6	0.2	0	0	CTD_human
50943	FOXP3	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
50943	FOXP3	C0003873	Rheumatoid Arthritis	0.205494535684262	1	0	CTD_human
50943	FOXP3	C0011854	Diabetes Mellitus, Insulin-Dependent	0.418419371187971	0	0	CTD_human;HPO
50943	FOXP3	C0013595	Eczema	0.201923087489492	0	0	HPO
50943	FOXP3	C0014457	Eosinophilia	0.2	0	0	HPO
50943	FOXP3	C0020676	Hypothyroidism	0.202681755307501	0	0	HPO
50943	FOXP3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
50943	FOXP3	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
50943	FOXP3	C0342288	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	0.689890164231672	3	11	CTD_human;ORPHANET;UNIPROT
50943	FOXP3	C1258215	Ileus	0.2	0	0	HPO
50945	TBX22	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
50945	TBX22	C1844830	CLEFT PALATE, X-LINKED	0.68357144819477	3	4	CTD_human;ORPHANET;UNIPROT
50945	TBX22	C1844862	Abruzzo Erickson syndrome	0.200274726784213	0	0	ORPHANET
50947	BHD	C1840572	HIP DYSPLASIA, BEUKES TYPE	0.200824180352639	0	0	CTD_human
50948	OHDS	C1840438	Orthostatic Hypotensive Disorder, Streeten Type	0.2	0	0	CTD_human
5095	PCCA	C0002871	Anemia	0.2	0	0	HPO
5095	PCCA	C0013595	Eczema	0.2	0	0	HPO
5095	PCCA	C0014544	Epilepsy	0.2	0	0	HPO
5095	PCCA	C0020615	Hypoglycemia	0.2	0	0	HPO
5095	PCCA	C0029456	Osteoporosis	0.2	0	0	HPO
5095	PCCA	C0030305	Pancreatitis	0.2	0	0	HPO
5095	PCCA	C0030312	Pancytopenia	0.2	0	0	HPO
5095	PCCA	C0235946	Cerebral atrophy	0.2	0	0	HPO
5095	PCCA	C0268579	Propionic acidemia	0.60439562854741	3	37	CTD_human;HPO;ORPHANET;UNIPROT
5095	PCCA	C0311298	Propionic acidemia, type II	0.2	0	0	ORPHANET
5095	PCCA	C0543541	HYPERGLYCINURIA (disorder)	0.2	0	0	HPO
5095	PCCA	C1306587	Acute encephalopathy	0.2	0	0	HPO
5095	PCCA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5095	PCCA	C4020860	Supratentorial atrophy	0.2	0	0	HPO
5095	PCCA	C4020871	Dystonic disease	0.2	0	0	HPO
50951	MMVP1	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	CTD_human
50952	HMN7A	C1834703	Neuropathy, Distal Hereditary Motor, Type VIIA	0.2	0	0	CTD_human
5096	PCCB	C0002871	Anemia	0.2	0	0	HPO
5096	PCCB	C0013595	Eczema	0.2	0	0	HPO
5096	PCCB	C0014544	Epilepsy	0.2	0	0	HPO
5096	PCCB	C0020615	Hypoglycemia	0.2	0	0	HPO
5096	PCCB	C0029456	Osteoporosis	0.2	0	0	HPO
5096	PCCB	C0030305	Pancreatitis	0.2	0	0	HPO
5096	PCCB	C0030312	Pancytopenia	0.2	0	0	HPO
5096	PCCB	C0235946	Cerebral atrophy	0.2	0	0	HPO
5096	PCCB	C0268579	Propionic acidemia	0.606318716036901	5	38	CTD_human;HPO;ORPHANET;UNIPROT
5096	PCCB	C0311298	Propionic acidemia, type II	0.2	0	0	ORPHANET
5096	PCCB	C0543541	HYPERGLYCINURIA (disorder)	0.2	0	0	HPO
5096	PCCB	C1306587	Acute encephalopathy	0.2	0	0	HPO
5096	PCCB	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5096	PCCB	C4020860	Supratentorial atrophy	0.2	0	0	HPO
5096	PCCB	C4020871	Dystonic disease	0.2	0	0	HPO
50960	MYMY1	C2931384	Moyamoya disease 1	0.2	0	0	CTD_human
50963	BRKS1	C1850168	Bruck syndrome 1	0.2	0	0	CTD_human
50964	SOST	C0011989	Camurati-Engelmann Syndrome	0.2	0	0	HPO
50964	SOST	C0014877	Esotropia	0.2	0	0	HPO
50964	SOST	C0015300	Exophthalmos	0.2	0	0	HPO
50964	SOST	C0018777	Conductive hearing loss	0.2	0	0	HPO
50964	SOST	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
50964	SOST	C0024636	Malocclusion	0.2	0	0	HPO
50964	SOST	C0028738	Nystagmus	0.2	0	0	HPO
50964	SOST	C0029124	Optic Atrophy	0.2	0	0	HPO
50964	SOST	C0029464	Osteosclerosis	0.201373633921065	0	0	HPO
50964	SOST	C0030353	Papilledema	0.2	0	0	HPO
50964	SOST	C0151311	Cranial nerve palsies	0.2	0	0	HPO
50964	SOST	C0151740	Intracranial Hypertension	0.2	0	0	HPO
50964	SOST	C0376175	Bell Palsy	0.2	0	0	HPO
50964	SOST	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
50964	SOST	C1834405	Nail dysplasia	0.2	0	0	HPO
50964	SOST	C2675746	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT (disorder)	0.200274726784213	1	1	UNIPROT
50964	SOST	C4020952	Fingernail dysplasia	0.2	0	0	HPO
50964	SOST	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
50966	ECA1	C0014553	Absence Epilepsy	0.200824180352639	0	0	CTD_human
50968	FCMTE1	C1832841	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1	0.2	0	0	CTD_human
50971	ENFL2	C1864125	Epilepsy, Nocturnal Frontal Lobe, Type 2	0.2	0	0	CTD_human
50976	GRD2	C0018213	Graves Disease	0.200274726784213	0	0	CTD_human
50982	NIDDM3	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	0	0	CTD_human
50982	NIDDM3	C1863594	Diabetes Mellitus, Noninsulin-Dependent, 3	0.2	0	0	CTD_human
50986	HYT2	C0085580	Essential Hypertension	0.2	0	0	CTD_human
50987	FPEVF	C1858477	Epilepsy, Partial, with Variable Foci	0.2	0	0	CTD_human
50988	WDM	C2931290	Welander distal myopathy, Swedish type	0.2	0	0	CTD_human
50989	HMSNO	C1858338	Neuropathy, hereditary motor and sensory, Okinawa type	0.2	0	0	CTD_human
51	ACOX1	C0014544	Epilepsy	0.2	0	0	HPO
51	ACOX1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
51	ACOX1	C0023520	Leukodystrophy	0.2	0	0	HPO
51	ACOX1	C0027092	Myopia	0.2	0	0	HPO
51	ACOX1	C0028738	Nystagmus	0.2	0	0	HPO
51	ACOX1	C0029124	Optic Atrophy	0.2	0	0	HPO
51	ACOX1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
51	ACOX1	C0038379	Strabismus	0.2	0	0	HPO
51	ACOX1	C0338474	Central nervous system demyelination	0.2	0	0	HPO
51	ACOX1	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
51	ACOX1	C1836830	Developmental regression	0.2	0	0	HPO
51	ACOX1	C1849678	Peroxisomal ACYL-COA oxidase deficiency	0.680549453568426	1	9	CTD_human;ORPHANET;UNIPROT
51	ACOX1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
51	ACOX1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
51	ACOX1	C4020871	Dystonic disease	0.2	0	0	HPO
51004	COQ6	C0017668	Focal glomerulosclerosis	0.2	0	0	HPO
51004	COQ6	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
51004	COQ6	C3553349	COENZYME Q10 DEFICIENCY, PRIMARY, 6	0.4	1	2	ORPHANET;UNIPROT
51008	ASCC1	C0004763	Barrett Esophagus	0.200274726784213	0	0	HPO
51010	EXOSC3	C0028738	Nystagmus	0.2	0	0	HPO
51010	EXOSC3	C0038379	Strabismus	0.2	0	0	HPO
51010	EXOSC3	C0234958	muscle degeneration	0.2	0	0	HPO
51010	EXOSC3	C0235946	Cerebral atrophy	0.2	0	0	HPO
51010	EXOSC3	C0241423	Atrophy of tongue	0.2	0	0	HPO
51010	EXOSC3	C0262404	Cerebellar degeneration	0.2	0	0	HPO
51010	EXOSC3	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
51010	EXOSC3	C1843504	Pontocerebellar Hypoplasia Type 1	0.401923087489492	1	0	CTD_human;ORPHANET
51010	EXOSC3	C3489733	Oculomotor apraxia	0.2	0	0	HPO
51010	EXOSC3	C3553449	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.2	1	8	UNIPROT
51010	EXOSC3	C4020860	Supratentorial atrophy	0.2	0	0	HPO
51010	EXOSC3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
51014	TMED7	C0008370	Cholestasis	0.2	1	0	CTD_human
51014	TMED7	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
51021	MRPS16	C1864843	Combined Oxidative Phosphorylation Deficiency 2	0.4	0	0	CTD_human;ORPHANET
51021	MRPS16	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
51024	FIS1	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	0.2	1	0	CTD_human
51025	PAM16	C0700635	Strudwick syndrome	0.2	0	0	HPO
51025	PAM16	C2750075	Chondrodysplasia, Megarbane-Dagher-Melki Type	0.4	1	1	ORPHANET;UNIPROT
51025	PAM16	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
51025	PAM16	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
5105	PCK1	C0014544	Epilepsy	0.2	0	0	HPO
5105	PCK1	C0018801	Heart failure	0.2	1	0	CTD_human
5105	PCK1	C0020615	Hypoglycemia	0.2	0	0	HPO
5105	PCK1	C0028754	Obesity	0.200824180352639	1	0	CTD_human
5105	PCK1	C0029124	Optic Atrophy	0.2	0	0	HPO
5105	PCK1	C0085605	Liver Failure	0.2	0	0	HPO
5105	PCK1	C0235946	Cerebral atrophy	0.200274726784213	0	0	HPO
5105	PCK1	C0268194	Phosphoenolpyruvate carboxykinase deficiency	0.4	0	0	CTD_human;ORPHANET
5105	PCK1	C2711227	Steatohepatitis	0.2	0	0	HPO
5105	PCK1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
5105	PCK1	C4021796	Renal steatosis	0.2	0	0	HPO
51053	GMNN	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	0.200274726784213	0	0	ORPHANET
51053	GMNN	C4225188	MEIER-GORLIN SYNDROME 6	0.2	1	1	UNIPROT
51057	WDPCP	C0020619	Hypogonadism	0.2	0	0	HPO
51057	WDPCP	C0028738	Nystagmus	0.2	0	0	HPO
51057	WDPCP	C0028754	Obesity	0.2	0	0	HPO
51057	WDPCP	C0029124	Optic Atrophy	0.2	0	0	HPO
51057	WDPCP	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
51057	WDPCP	C0265215	Meckel-Gruber syndrome	0.2	0	0	ORPHANET
51057	WDPCP	C0340375	Subaortic stenosis	0.2	0	0	HPO
51057	WDPCP	C0752166	Bardet-Biedl Syndrome	0.400274726784213	0	0	CTD_human;ORPHANET
51057	WDPCP	C1853235	Sclerocornea	0.2	0	0	HPO
51057	WDPCP	C1857587	Orstavik Lindemann Solberg syndrome	0.2	1	2	UNIPROT
51057	WDPCP	C2931046	Heart defect, tongue hamartoma and polysyndactyly	0.2	0	0	ORPHANET
51057	WDPCP	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5106	PCK2	C0020615	Hypoglycemia	0.2	0	0	HPO
5106	PCK2	C0085605	Liver Failure	0.2	0	0	HPO
5106	PCK2	C0268194	Phosphoenolpyruvate carboxykinase deficiency	0.2	0	0	ORPHANET
5106	PCK2	C2711227	Steatohepatitis	0.200549453568426	0	0	HPO
5106	PCK2	C2931278	Phosphoenolpyruvate carboxykinase 2 deficiency	0.2	0	0	CTD_human
5106	PCK2	C4021796	Renal steatosis	0.2	0	0	HPO
51062	ATL1	C0020071	Hereditary Sensory Autonomic Neuropathy, Type 1	0.200274726784213	0	0	ORPHANET
51062	ATL1	C0030486	Paraplegia	0.202732912464814	0	0	HPO
51062	ATL1	C0037772	Spastic Paraplegia	0.202747267842131	0	0	HPO
51062	ATL1	C0085606	Urgency of micturition	0.2	0	0	HPO
51062	ATL1	C0221260	Dystrophia unguium	0.2	0	0	HPO
51062	ATL1	C0270921	Axonal neuropathy	0.200824180352639	0	0	HPO
51062	ATL1	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
51062	ATL1	C1834405	Nail dysplasia	0.2	0	0	HPO
51062	ATL1	C1836451	Muscle atrophy, lower limb, distal	0.2	0	0	HPO
51062	ATL1	C1848736	Distal amyotrophy	0.2	0	0	HPO
51062	ATL1	C2931355	Spastic paraplegia 3, autosomal dominant	0.601373633921066	14	16	CTD_human;ORPHANET;UNIPROT
51062	ATL1	C3150972	NEUROPATHY, HEREDITARY SENSORY, TYPE ID	0.2	1	1	UNIPROT
51062	ATL1	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
51062	ATL1	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
51067	YARS2	C0002871	Anemia	0.2	0	0	HPO
51067	YARS2	C0002896	Sideroblastic anemia	0.201098907136852	0	0	HPO
51067	YARS2	C0017601	Glaucoma	0.2	0	0	HPO
51067	YARS2	C0028738	Nystagmus	0.2	0	0	HPO
51067	YARS2	C0038379	Strabismus	0.2	0	0	HPO
51067	YARS2	C1389113	Generalized amyotrophy	0.2	0	0	HPO
51067	YARS2	C1838103	MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.401373633921066	0	0	CTD_human;ORPHANET
51067	YARS2	C1838114	Generalized limb muscle atrophy	0.2	0	0	HPO
51067	YARS2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
51067	YARS2	C3150802	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2	0.200274726784213	2	7	UNIPROT
51079	NDUFA13	C0023264	Leigh Disease	0.2	0	0	ORPHANET
51082	POLR1D	C0018777	Conductive hearing loss	0.2	0	0	HPO
51082	POLR1D	C0038379	Strabismus	0.2	0	0	HPO
51082	POLR1D	C0042798	Low Vision	0.2	0	0	HPO
51082	POLR1D	C0265241	Franceschetti-Klein syndrome	0.2	0	0	ORPHANET
51082	POLR1D	C3150983	TREACHER COLLINS SYNDROME 2	0.4	1	2	CTD_human;UNIPROT
51083	GAL	C0149958	Complex partial seizures	0.2	0	0	HPO
51083	GAL	C0270834	Complex partial seizure with impairment of consciousness	0.2	0	0	HPO
51083	GAL	C4225318	EPILEPSY, FAMILIAL TEMPORAL LOBE, 8	0.2	1	1	UNIPROT
51084	CRYL1	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
51085	MLXIPL	C0010495	Cutis Laxa	0.2	0	0	HPO
51085	MLXIPL	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
51085	MLXIPL	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
51085	MLXIPL	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
51085	MLXIPL	C0024636	Malocclusion	0.2	0	0	HPO
51085	MLXIPL	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
51085	MLXIPL	C0028754	Obesity	0.204055389228567	0	0	HPO
51085	MLXIPL	C0029453	Osteopenia	0.2	0	0	HPO
51085	MLXIPL	C0029456	Osteoporosis	0.2	0	0	HPO
51085	MLXIPL	C0034888	Rectal Prolapse	0.2	0	0	HPO
51085	MLXIPL	C0035078	Kidney Failure	0.2	0	0	HPO
51085	MLXIPL	C0038379	Strabismus	0.2	0	0	HPO
51085	MLXIPL	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
51085	MLXIPL	C0242231	Coronary Stenosis	0.200274726784213	0	0	HPO
51085	MLXIPL	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
51085	MLXIPL	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
51085	MLXIPL	C0747078	Generalized osteopenia	0.2	0	0	HPO
51085	MLXIPL	C0747085	Recurrent otitis media	0.2	0	0	HPO
51085	MLXIPL	C1565489	Renal Insufficiency	0.2	0	0	HPO
51085	MLXIPL	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
51085	MLXIPL	C2930812	Generalized elastolysis	0.2	0	0	HPO
51085	MLXIPL	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
51086	TNNI3K	C0004238	Atrial Fibrillation	0.2	0	0	HPO
51086	TNNI3K	C0264912	Left anterior fascicular block	0.2	0	0	HPO
51086	TNNI3K	C4015285	CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY	0.4	1	1	ORPHANET;UNIPROT
51091	SEPSECS	C0014544	Epilepsy	0.2	0	0	HPO
51091	SEPSECS	C0235946	Cerebral atrophy	0.200549453568426	0	0	HPO
51091	SEPSECS	C0262404	Cerebellar degeneration	0.2	0	0	HPO
51091	SEPSECS	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
51091	SEPSECS	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
51091	SEPSECS	C3151140	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.200824180352639	2	3	UNIPROT
51091	SEPSECS	C4020860	Supratentorial atrophy	0.2	0	0	HPO
51091	SEPSECS	C4020873	Infratentorial atrophy	0.2	0	0	HPO
51094	ADIPOR1	C0022661	Kidney Failure, Chronic	0.280824180352639	1	0	CTD_human
51095	TRNT1	C0002896	Sideroblastic anemia	0.200274726784213	0	0	HPO
51095	TRNT1	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
51095	TRNT1	C0271901	Microcytic hypochromic anemia (disorder)	0.2	0	0	HPO
51095	TRNT1	C4015172	SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY	0.400549453568426	1	8	ORPHANET;UNIPROT
51098	IFT52	C0010278	Craniosynostosis	0.2	0	0	HPO
51098	IFT52	C0029456	Osteoporosis	0.2	0	0	HPO
51099	ABHD5	C0002170	Alopecia	0.2	0	0	HPO
51099	ABHD5	C0013592	Ectropion	0.2	0	0	HPO
51099	ABHD5	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
51099	ABHD5	C0028738	Nystagmus	0.2	0	0	HPO
51099	ABHD5	C0038379	Strabismus	0.2	0	0	HPO
51099	ABHD5	C0268238	Triglyceride storage disease with ichthyosis	0.687417623173754	3	6	CTD_human;ORPHANET;UNIPROT
51099	ABHD5	C0850715	Abnormality of blood and blood-forming tissues	0.2	0	0	HPO
51099	ABHD5	C2711227	Steatohepatitis	0.201648360705279	0	0	HPO
51103	NDUFAF1	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
51103	NDUFAF1	C0014544	Epilepsy	0.2	0	0	HPO
51103	NDUFAF1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
51103	NDUFAF1	C0020615	Hypoglycemia	0.2	0	0	HPO
51103	NDUFAF1	C0023520	Leukodystrophy	0.200274726784213	0	0	HPO
51103	NDUFAF1	C0028738	Nystagmus	0.2	0	0	HPO
51103	NDUFAF1	C0038379	Strabismus	0.2	0	0	HPO
51103	NDUFAF1	C0085605	Liver Failure	0.2	0	0	HPO
51103	NDUFAF1	C0234958	muscle degeneration	0.2	0	0	HPO
51103	NDUFAF1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
51103	NDUFAF1	C0271215	Blindness, Legal	0.2	0	0	HPO
51103	NDUFAF1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
51103	NDUFAF1	C1145670	Respiratory Failure	0.2	0	0	HPO
51103	NDUFAF1	C1836830	Developmental regression	0.2	0	0	HPO
51103	NDUFAF1	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
51103	NDUFAF1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
51103	NDUFAF1	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
51103	NDUFAF1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
51106	TFB1M	C3151897	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	0.28	0	0	ORPHANET
51109	RDH11	C0024636	Malocclusion	0.2	0	0	HPO
51109	RDH11	C4015242	RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME	0.2	0	0	ORPHANET
51109	RDH11	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
5111	PCNA	C0017668	Focal glomerulosclerosis	0.2	1	0	CTD_human
5111	PCNA	C0033860	Psoriasis	0.200274726784213	1	0	CTD_human
5111	PCNA	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
5111	PCNA	C0262404	Cerebellar degeneration	0.2	0	0	HPO
5111	PCNA	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
5111	PCNA	C4014676	ATAXIA-TELANGIECTASIA-LIKE DISORDER 2	0.4	1	1	ORPHANET;UNIPROT
5111	PCNA	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
5111	PCNA	C4020873	Infratentorial atrophy	0.2	0	0	HPO
51114	ZDHHC9	C0038379	Strabismus	0.2	0	0	HPO
51114	ZDHHC9	C3275406	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE	0.4	1	4	CTD_human;UNIPROT
51117	COQ4	C4225392	COENZYME Q10 DEFICIENCY, PRIMARY, 7	0.4	2	8	ORPHANET;UNIPROT
51119	SBDS	C0002871	Anemia	0.2	0	0	HPO
51119	SBDS	C0013595	Eczema	0.2	0	0	HPO
51119	SBDS	C0020757	Ichthyoses	0.2	0	0	HPO
51119	SBDS	C0027709	Nephrocalcinosis	0.2	0	0	HPO
51119	SBDS	C0029453	Osteopenia	0.200274726784213	0	0	HPO
51119	SBDS	C0030293	Pancreatic Insufficiency	0.2	0	0	HPO
51119	SBDS	C0030312	Pancytopenia	0.2	0	0	HPO
51119	SBDS	C0149887	Slipped Capital Femoral Epiphyses	0.2	0	0	HPO
51119	SBDS	C0267963	Exocrine pancreatic insufficiency	0.200274726784213	0	0	HPO
51119	SBDS	C0272170	Shwachman syndrome	0.613186885642229	3	12	CTD_human;ORPHANET;UNIPROT
51119	SBDS	C0348890	Aplastic anemia, idiopathic	0.2	0	0	ORPHANET
51119	SBDS	C0747078	Generalized osteopenia	0.2	0	0	HPO
51119	SBDS	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
51119	SBDS	C1442837	Myocardial necrosis	0.2	0	0	HPO
51119	SBDS	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
51124	IER3IP1	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
51124	IER3IP1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
51124	IER3IP1	C3280240	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.400274726784213	1	3	ORPHANET;UNIPROT
51124	IER3IP1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
51128	SAR1B	C0020597	Hypobetalipoproteinemias	0.200274726784213	0	0	HPO
51128	SAR1B	C0151718	Hypocholesterolemia	0.200824180352639	0	0	HPO
51128	SAR1B	C0162429	Malnutrition	0.2	0	0	HPO
51128	SAR1B	C0239981	Hypoalbuminemia	0.2	0	0	HPO
51128	SAR1B	C0795956	Chylomicron retention disease	0.603296721410557	2	5	CTD_human;ORPHANET;UNIPROT
51128	SAR1B	C0850715	Abnormality of blood and blood-forming tissues	0.2	0	0	HPO
51128	SAR1B	C2315100	Pediatric failure to thrive	0.200549453568426	0	0	HPO
51129	ANGPTL4	C1956346	Coronary Artery Disease	0.201648360705279	1	0	CTD_human
51131	PHF11	C0004096	Asthma	0.228777442344498	0	0	CTD_human
51131	PHF11	C1840253	IgE RESPONSIVENESS, ATOPIC	0.2	0	0	CTD_human
51134	CEP83	C0041349	Nephritis, Tubulointerstitial	0.2	0	0	HPO
51134	CEP83	C0687120	Nephronophthisis	0.2	0	0	HPO
51134	CEP83	C1865872	NEPHRONOPHTHISIS 2	0.200274726784213	0	0	ORPHANET
51134	CEP83	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
51134	CEP83	C3890591	NEPHRONOPHTHISIS 18	0.2	1	7	UNIPROT
51135	IRAK4	C0752308	Hypoxia-Ischemia, Brain	0.2	1	0	CTD_human
51135	IRAK4	C1835828	Invasive Pneumococcal Disease, Recurrent Isolated, 1	0.2	0	0	CTD_human
51135	IRAK4	C1843256	IRAK4 Deficiency	0.600274726784213	1	3	CTD_human;ORPHANET;UNIPROT
51142	CHCHD2	C4225238	PARKINSON DISEASE 22, AUTOSOMAL DOMINANT	0.2	1	3	UNIPROT
51151	SLC45A2	C0028738	Nystagmus	0.200274726784213	0	0	HPO
51151	SLC45A2	C0038379	Strabismus	0.2	0	0	HPO
51151	SLC45A2	C0042798	Low Vision	0.2	0	0	HPO
51151	SLC45A2	C1847836	Oculocutaneous Albinism, Type IV	0.681923087489492	5	20	CTD_human;ORPHANET;UNIPROT
51156	SERPINA10	C0398623	Thrombophilia	0.200274726784213	1	0	CTD_human
5116	PCNT	C0010278	Craniosynostosis	0.2	0	0	HPO
5116	PCNT	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
5116	PCNT	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	0	0	HPO
5116	PCNT	C0017601	Glaucoma	0.2	0	0	HPO
5116	PCNT	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5116	PCNT	C0020490	Hyperopia	0.2	0	0	HPO
5116	PCNT	C0034013	Precocious Puberty	0.2	0	0	HPO
5116	PCNT	C0149887	Slipped Capital Femoral Epiphyses	0.2	0	0	HPO
5116	PCNT	C0259817	Xerosis	0.2	0	0	HPO
5116	PCNT	C0265202	Seckel syndrome	0.401373633921066	1	0	CTD_human;ORPHANET
5116	PCNT	C0751003	Brain Aneurysm	0.2	0	0	HPO
5116	PCNT	C1290398	Cerebral arterial aneurysm	0.2	0	0	HPO
5116	PCNT	C1847572	SECKEL SYNDROME 2	0.2	1	0	CTD_human
5116	PCNT	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
5116	PCNT	C4023169	Moyamoya phenomenon	0.2	0	0	HPO
51163	DBR1	C0002736	Amyotrophic Lateral Sclerosis	0.200274726784213	1	0	CTD_human
51164	DCTN4	C0008312	Primary biliary cirrhosis	0.2	0	0	HPO
51164	DCTN4	C0010674	Cystic Fibrosis	0.400549453568426	1	0	CTD_human;ORPHANET
51164	DCTN4	C0023892	Biliary cirrhosis	0.2	0	0	HPO
51164	DCTN4	C0030293	Pancreatic Insufficiency	0.2	0	0	HPO
51164	DCTN4	C0034069	Pulmonary Fibrosis	0.2	0	0	HPO
51164	DCTN4	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
51164	DCTN4	C0267963	Exocrine pancreatic insufficiency	0.2	0	0	HPO
51168	MYO15A	C1838263	Deafness, Autosomal Recessive 3	0.480274726784213	3	26	CTD_human;UNIPROT
51168	MYO15A	C4023338	Profound sensorineural hearing impairment	0.2	0	0	HPO
51179	HAO2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
5118	PCOLCE	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
5118	PCOLCE	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
51181	DCXR	C0028754	Obesity	0.2	1	0	CTD_human
51181	DCXR	C0268162	Pentosuria	0.4	1	1	CTD_human;ORPHANET
51185	CRBN	C1843942	Mental Retardation, Autosomal Recessive 2	0.2	0	0	CTD_human
5119	CHMP1A	C0004106	Astigmatism	0.2	0	0	HPO
5119	CHMP1A	C0014877	Esotropia	0.2	0	0	HPO
5119	CHMP1A	C0020490	Hyperopia	0.2	0	0	HPO
5119	CHMP1A	C0027092	Myopia	0.2	0	0	HPO
5119	CHMP1A	C3554209	PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.2	0	0	ORPHANET
5119	CHMP1A	C4020858	Choreatic disease	0.2	0	0	HPO
51191	HERC5	C0014175	Endometriosis	0.2	1	0	CTD_human
51191	HERC5	C0021400	Influenza	0.200274726784213	1	0	CTD_human
51196	PLCE1	C0017668	Focal glomerulosclerosis	0.203780662444353	0	0	HPO
51196	PLCE1	C0019100	Severe Dengue	0.200274726784213	1	1	CTD_human
51196	PLCE1	C0239981	Hypoalbuminemia	0.2	0	0	HPO
51196	PLCE1	C0268747	Diffuse mesangial sclerosis (disorder)	0.201373633921065	0	0	HPO
51196	PLCE1	C1853124	NEPHROTIC SYNDROME, TYPE 3	0.400274726784213	1	10	CTD_human;UNIPROT
51196	PLCE1	C2316810	Chronic kidney disease stage 5	0.200274726784213	0	0	HPO
51199	NIN	C0014544	Epilepsy	0.2	0	0	HPO
51199	NIN	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
51199	NIN	C0271801	Central hypothyroidism	0.2	0	0	HPO
51199	NIN	C2748518	Lumbar scoliosis	0.2	0	0	HPO
51199	NIN	C3553870	SECKEL SYNDROME 7	0.4	0	0	ORPHANET;UNIPROT
5120	PCOS1	C0032460	Polycystic Ovary Syndrome	0.200549453568426	0	0	CTD_human
51204	TACO1	C0002871	Anemia	0.2	0	0	HPO
51204	TACO1	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
51204	TACO1	C0014544	Epilepsy	0.2	0	0	HPO
51204	TACO1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
51204	TACO1	C0023264	Leigh Disease	0.400274726784213	1	0	CTD_human;ORPHANET
51204	TACO1	C0029124	Optic Atrophy	0.2	0	0	HPO
51204	TACO1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
51204	TACO1	C0151747	Renal tubular disorder	0.2	0	0	HPO
51204	TACO1	C0238621	Aminoaciduria	0.2	0	0	HPO
51204	TACO1	C0341703	Adult Fanconi syndrome	0.2	0	0	HPO
51204	TACO1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
51206	GP6	C3280120	BLEEDING DISORDER, PLATELET-TYPE, 11	0.4	2	3	ORPHANET;UNIPROT
51218	GLRX5	C0002871	Anemia	0.203007639249027	0	0	HPO
51218	GLRX5	C0002896	Sideroblastic anemia	0.200824180352639	1	0	CTD_human
51218	GLRX5	C2673914	Anemia, Sideroblastic, Pyridoxine-Refractory, Autosomal Recessive	0.2	0	0	CTD_human
51218	GLRX5	C3854388	Hyperferritinaemia	0.2	0	0	HPO
51218	GLRX5	C4225155	ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY	0.4	1	2	ORPHANET;UNIPROT
51218	GLRX5	C4225178	SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.2	0	0	ORPHANET
5122	PCSK1	C0008370	Cholestasis	0.2	0	0	HPO
5122	PCSK1	C0028754	Obesity	0.507288817463114	1	0	CTD_human;HPO
5122	PCSK1	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
5122	PCSK1	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
5122	PCSK1	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
5122	PCSK1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
5122	PCSK1	C0271710	Reactive hypoglycemia	0.2	0	0	HPO
5122	PCSK1	C0948387	Secondary Adrenal Insufficiency	0.2	0	0	HPO
5122	PCSK1	C1833053	Proprotein Convertase 1 3 Deficiency	0.6	2	4	CTD_human;ORPHANET;UNIPROT
5122	PCSK1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
51232	CRIM1	C1865286	MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA	0.200274726784213	0	0	ORPHANET
51244	CCDC174	C4225196	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION	0.2	0	0	ORPHANET
5125	PCSK5	C0220708	VATER Association	0.2	1	0	CTD_human
5125	PCSK5	C1531773	Currarino triad	0.200274726784213	1	0	CTD_human
5125	PCSK5	C1838568	Sacral defect and anterior sacral meningocele	0.2	1	0	CTD_human
51251	NT5C3A	C0002878	Anemia, Hemolytic	0.203557092817453	0	0	HPO
51251	NT5C3A	C0002882	Anemia, Hemolytic, Congenital Nonspherocytic	0.2	1	0	CTD_human
51251	NT5C3A	C0019048	Hemoglobinuria	0.2	0	0	HPO
51251	NT5C3A	C0263454	Chloracne	0.2	1	0	CTD_human
51251	NT5C3A	C1849507	Uridine 5-Prime Monophosphate Hydrolase Deficiency, Hemolytic Anemia due to	0.6	6	9	CTD_human;ORPHANET;UNIPROT
51259	TMEM216	C0014877	Esotropia	0.2	0	0	HPO
51259	TMEM216	C0020255	Hydrocephalus	0.2	0	0	HPO
51259	TMEM216	C0022679	Cystic kidney	0.2	0	0	HPO
51259	TMEM216	C0025299	Meningocele	0.2	0	0	HPO
51259	TMEM216	C0028738	Nystagmus	0.2	0	0	HPO
51259	TMEM216	C0029124	Optic Atrophy	0.2	0	0	HPO
51259	TMEM216	C0042798	Low Vision	0.2	0	0	HPO
51259	TMEM216	C0155299	Coloboma of optic disc	0.2	0	0	HPO
51259	TMEM216	C0265215	Meckel-Gruber syndrome	0.2	0	0	ORPHANET
51259	TMEM216	C0267818	Bile duct proliferation	0.2	0	0	HPO
51259	TMEM216	C0271215	Blindness, Legal	0.2	0	0	HPO
51259	TMEM216	C0431399	Familial aplasia of the vermis	0.200549453568426	0	0	HPO
51259	TMEM216	C0520680	Sleep Apnea, Central	0.2	0	0	HPO
51259	TMEM216	C0687120	Nephronophthisis	0.200274726784213	0	0	HPO
51259	TMEM216	C1842577	JOUBERT SYNDROME 2	0.400549453568426	4	11	CTD_human;UNIPROT
51259	TMEM216	C1853235	Sclerocornea	0.2	0	0	HPO
51259	TMEM216	C1855675	Arima syndrome	0.2	0	0	ORPHANET
51259	TMEM216	C1864148	MECKEL SYNDROME, TYPE 2	0.400274726784213	1	9	CTD_human;UNIPROT
51259	TMEM216	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
51259	TMEM216	C2745997	OROFACIODIGITAL SYNDROME VI	0.2	0	0	ORPHANET
51259	TMEM216	C3489733	Oculomotor apraxia	0.2	0	0	HPO
51259	TMEM216	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5126	PCSK2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.206187690967642	1	0	CTD_human
51284	TLR7	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
51293	CD320	C1855119	Methylmalonic aciduria	0.200274726784213	0	0	HPO
51293	CD320	C3150900	METHYLMALONIC ACIDURIA DUE TO TRANSCOBALAMIN RECEPTOR DEFECT	0.48	0	0	CTD_human;ORPHANET
5130	PCYT1A	C0004106	Astigmatism	0.2	0	0	HPO
5130	PCYT1A	C0024636	Malocclusion	0.2	0	0	HPO
5130	PCYT1A	C0027092	Myopia	0.2	0	0	HPO
5130	PCYT1A	C0028077	Night Blindness	0.2	0	0	HPO
5130	PCYT1A	C0028738	Nystagmus	0.2	0	0	HPO
5130	PCYT1A	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5130	PCYT1A	C0700635	Strudwick syndrome	0.2	0	0	HPO
5130	PCYT1A	C0730290	Cone dystrophy	0.2	0	0	HPO
5130	PCYT1A	C0747085	Recurrent otitis media	0.2	0	0	HPO
5130	PCYT1A	C1837073	Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy	0.400274726784213	2	9	ORPHANET;UNIPROT
5130	PCYT1A	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
5130	PCYT1A	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
5130	PCYT1A	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
51305	KCNK9	C0014553	Absence Epilepsy	0.200549453568426	1	0	CTD_human
51305	KCNK9	C2676770	Birk-Barel Mental Retardation Dysmorphism Syndrome	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
51308	REEP2	C0037772	Spastic Paraplegia	0.2	0	0	HPO
51308	REEP2	C3810160	SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE	0.4	1	3	ORPHANET;UNIPROT
5131	PDB1	C0029401	Osteitis Deformans	0.201648360705279	0	0	CTD_human
51311	TLR8	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
51312	SLC25A37	C0002871	Anemia	0.2	1	0	CTD_human
51314	NME8	C0022521	Kartagener Syndrome	0.203557092817453	0	0	ORPHANET
51314	NME8	C0037199	Sinusitis	0.2	0	0	HPO
51314	NME8	C0581354	Recurrent sinusitis	0.2	0	0	HPO
51314	NME8	C1970506	CILIARY DYSKINESIA, PRIMARY, 6	0.2	0	0	CTD_human
51314	NME8	C4280333	Recurrent sinus disease	0.2	0	0	HPO
51317	PHF21A	C0014544	Epilepsy	0.2	0	0	HPO
51317	PHF21A	C0028738	Nystagmus	0.2	0	0	HPO
51317	PHF21A	C0038379	Strabismus	0.2	0	0	HPO
51317	PHF21A	C1832588	Chromosome 11p11.2 Deletion Syndrome	0.200549453568426	0	0	ORPHANET
51320	MEX3C	C0085580	Essential Hypertension	0.200274726784213	0	0	CTD_human
51320	MEX3C	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
51322	WAC	C4225239	DESANTO-SHINAWI SYNDROME	0.2	0	0	ORPHANET
51324	SPG21	C0037772	Spastic Paraplegia	0.2	0	0	HPO
51324	SPG21	C1855346	MAST SYNDROME	0.401098907136852	0	0	CTD_human;ORPHANET
5133	PDCD1	C0024141	Lupus Erythematosus, Systemic	0.258114108014407	0	0	CTD_human
5133	PDCD1	C0026769	Multiple Sclerosis	0.202956482091714	0	0	CTD_human
51330	TNFRSF12A	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
51338	MS4A4A	C0002395	Alzheimer's Disease	0.200274726784213	1	0	CTD_human
51338	MS4A4A	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
51360	MBTPS2	C0002170	Alopecia	0.200274726784213	0	0	HPO
51360	MBTPS2	C0005741	Blepharitis	0.2	0	0	HPO
51360	MBTPS2	C0009763	Conjunctivitis	0.2	0	0	HPO
51360	MBTPS2	C0010036	Corneal dystrophy	0.200274726784213	0	0	HPO
51360	MBTPS2	C0010043	Corneal Ulcer	0.2	0	0	HPO
51360	MBTPS2	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
51360	MBTPS2	C0013592	Ectropion	0.2	0	0	HPO
51360	MBTPS2	C0014544	Epilepsy	0.2	0	0	HPO
51360	MBTPS2	C0020255	Hydrocephalus	0.2	0	0	HPO
51360	MBTPS2	C0020620	Hypohidrosis	0.2	0	0	HPO
51360	MBTPS2	C0022568	Keratitis	0.2	0	0	HPO
51360	MBTPS2	C0022596	Palmoplantar Keratosis	0.200274726784213	0	0	HPO
51360	MBTPS2	C0030436	Parakeratosis	0.2	0	0	HPO
51360	MBTPS2	C0035854	Rosacea	0.2	0	0	HPO
51360	MBTPS2	C0038605	Subungual hyperkeratosis	0.2	0	0	HPO
51360	MBTPS2	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
51360	MBTPS2	C0155119	Recurrent erosion of cornea	0.2	0	0	HPO
51360	MBTPS2	C0221260	Dystrophia unguium	0.2	0	0	HPO
51360	MBTPS2	C0235946	Cerebral atrophy	0.2	0	0	HPO
51360	MBTPS2	C0259817	Xerosis	0.2	0	0	HPO
51360	MBTPS2	C0263504	Alopecia totalis	0.2	0	0	HPO
51360	MBTPS2	C0334013	Phrynoderma	0.200824180352639	0	0	HPO
51360	MBTPS2	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
51360	MBTPS2	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
51360	MBTPS2	C1834405	Nail dysplasia	0.2	0	0	HPO
51360	MBTPS2	C1839988	Ichthyosis follicularis atrichia photophobia syndrome	0.601098907136852	1	6	CTD_human;ORPHANET;UNIPROT
51360	MBTPS2	C2609071	Olmsted syndrome	0.200824180352639	0	0	ORPHANET
51360	MBTPS2	C3502469	Brain Anomalies, Retardation, Ectodermal Dysplasia, Skeletal Malformations, Hirschsprung Disease, Ear-Eye Anomalies, Cleft Palate-Cryptorchidism, And Kidney Dysplasia-Hypoplasia	0.200549453568426	0	0	ORPHANET
51360	MBTPS2	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
51360	MBTPS2	C3806745	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED	0.2	1	1	UNIPROT
51364	ZMYND10	C0006267	Bronchiectasis	0.2	0	0	HPO
51364	ZMYND10	C0008677	Bronchitis, Chronic	0.2	0	0	HPO
51364	ZMYND10	C0022521	Kartagener Syndrome	0.200824180352639	0	0	ORPHANET
51364	ZMYND10	C0027430	Nasal Polyps	0.2	0	0	HPO
51364	ZMYND10	C0035455	Rhinitis	0.2	0	0	HPO
51364	ZMYND10	C0037199	Sinusitis	0.2	0	0	HPO
51364	ZMYND10	C0581354	Recurrent sinusitis	0.2	0	0	HPO
51364	ZMYND10	C0747085	Recurrent otitis media	0.2	0	0	HPO
51364	ZMYND10	C3809543	CILIARY DYSKINESIA, PRIMARY, 22	0.2	2	8	UNIPROT
51364	ZMYND10	C4280333	Recurrent sinus disease	0.2	0	0	HPO
51371	POMP	C0020757	Ichthyoses	0.2	0	0	HPO
51371	POMP	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
51371	POMP	C0030436	Parakeratosis	0.2	0	0	HPO
51371	POMP	C0221260	Dystrophia unguium	0.2	0	0	HPO
51371	POMP	C0334166	Pseudoainhum	0.2	0	0	HPO
51371	POMP	C1866029	Keratosis Linearis with Ichthyosis Congenita and Sclerosing Keratoderma	0.400274726784213	0	0	CTD_human;ORPHANET
51382	ATP6V1D	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
5139	PDE3A	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
5139	PDE3A	C1862170	Brachydactyly with hypertension	0.600549453568426	1	5	CTD_human;ORPHANET;UNIPROT
514	ATP5E	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
514	ATP5E	C3279708	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3	0.2	1	1	UNIPROT
514	ATP5E	C3696376	3-Methylglutaconic Aciduria	0.2	0	0	HPO
5140	PDE3B	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
5142	PDE4B	C0004096	Asthma	0.200274726784213	1	0	CTD_human
5142	PDE4B	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
51422	PRKAG2	C0004238	Atrial Fibrillation	0.203007639249027	0	0	HPO
51422	PRKAG2	C0004245	Atrioventricular Block	0.200274726784213	0	0	HPO
51422	PRKAG2	C0007194	Hypertrophic Cardiomyopathy	0.211993755216112	0	0	HPO
51422	PRKAG2	C0018801	Heart failure	0.200274726784213	0	0	HPO
51422	PRKAG2	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
51422	PRKAG2	C0023211	Left Bundle-Branch Block	0.2	0	0	HPO
51422	PRKAG2	C0030590	Paroxysmal supraventricular tachycardia	0.2	0	0	HPO
51422	PRKAG2	C0043202	Wolff-Parkinson-White Syndrome	0.606029633875371	4	2	CTD_human;HPO;UNIPROT
51422	PRKAG2	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
51422	PRKAG2	C0205700	Asymmetric Septal Hypertrophy	0.2	0	0	HPO
51422	PRKAG2	C0235480	Paroxysmal atrial fibrillation	0.2	0	0	HPO
51422	PRKAG2	C0281788	Biventricular hypertrophy	0.2	0	0	HPO
51422	PRKAG2	C0559106	Ventricular preexcitation	0.202472541057918	0	0	HPO
51422	PRKAG2	C1833236	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (disorder)	0.4	3	9	CTD_human;UNIPROT
51422	PRKAG2	C1841659	Atrioventricular nodal disease	0.2	0	0	HPO
51422	PRKAG2	C1849813	Glycogen Storage Disease of Heart, Lethal Congenital	0.6	1	2	CTD_human;ORPHANET;UNIPROT
5144	PDE4D	C0004096	Asthma	0.204604842796993	2	1	CTD_human
5144	PDE4D	C0020619	Hypogonadism	0.2	0	0	HPO
5144	PDE4D	C0028754	Obesity	0.202407028523288	0	0	HPO
5144	PDE4D	C0033806	Pseudohypoparathyroidism	0.200274726784213	0	0	HPO
5144	PDE4D	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
5144	PDE4D	C0151740	Intracranial Hypertension	0.2	0	0	HPO
5144	PDE4D	C0151945	Thrombosis of cerebral veins	0.2	0	0	HPO
5144	PDE4D	C0220659	Acrodysostosis	0.202197814273705	0	0	ORPHANET
5144	PDE4D	C3553250	ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.2	4	9	UNIPROT
5144	PDE4D	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
51447	IP6K2	C0020179	Huntington Disease	0.2	1	0	CTD_human
5145	PDE6A	C0017601	Glaucoma	0.2	0	0	HPO
5145	PDE6A	C0018777	Conductive hearing loss	0.2	0	0	HPO
5145	PDE6A	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5145	PDE6A	C0020459	Hyperinsulinism	0.2	0	0	HPO
5145	PDE6A	C0020619	Hypogonadism	0.2	0	0	HPO
5145	PDE6A	C0022578	Keratoconus	0.2	0	0	HPO
5145	PDE6A	C0028077	Night Blindness	0.2	0	0	HPO
5145	PDE6A	C0028738	Nystagmus	0.2	0	0	HPO
5145	PDE6A	C0028754	Obesity	0.2	0	0	HPO
5145	PDE6A	C0029124	Optic Atrophy	0.2	0	0	HPO
5145	PDE6A	C0035334	Retinitis Pigmentosa	0.685912964183428	2	0	CTD_human;HPO;ORPHANET
5145	PDE6A	C0042798	Low Vision	0.2	0	0	HPO
5145	PDE6A	C0271215	Blindness, Legal	0.2	0	0	HPO
5145	PDE6A	C3151139	RETINITIS PIGMENTOSA 43	0.2	2	10	UNIPROT
5146	PDE6C	C0015310	Exotropia	0.2	0	0	HPO
5146	PDE6C	C0020490	Hyperopia	0.2	0	0	HPO
5146	PDE6C	C0028738	Nystagmus	0.2	0	0	HPO
5146	PDE6C	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5146	PDE6C	C0042798	Low Vision	0.2	0	0	HPO
5146	PDE6C	C0152200	Achromatopsia	0.201098907136852	0	0	ORPHANET
5146	PDE6C	C0271092	Progressive cone dystrophy (without rod involvement)	0.2	0	0	ORPHANET
5146	PDE6C	C0271388	Pendular Nystagmus	0.2	0	0	HPO
5146	PDE6C	C0730290	Cone dystrophy	0.200274726784213	0	0	HPO
5146	PDE6C	C0858618	Dyschromatopsia	0.2	0	0	HPO
5146	PDE6C	C2751308	CONE DYSTROPHY 4 (disorder)	0.4	1	4	CTD_human;UNIPROT
5146	PDE6C	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
5146	PDE6C	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
5147	PDE6D	C2745997	OROFACIODIGITAL SYNDROME VI	0.2	0	0	ORPHANET
51473	DCDC2	C0008370	Cholestasis	0.2	0	0	HPO
51473	DCDC2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
51473	DCDC2	C0239946	Fibrosis, Liver	0.2	0	0	HPO
51473	DCDC2	C0267818	Bile duct proliferation	0.2	0	0	HPO
51473	DCDC2	C0687120	Nephronophthisis	0.2	0	0	HPO
51473	DCDC2	C1857750	DEAFNESS, AUTOSOMAL RECESSIVE 66	0.2	1	1	UNIPROT
51473	DCDC2	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
51477	ISYNA1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
5148	PDE6G	C0017601	Glaucoma	0.2	0	0	HPO
5148	PDE6G	C0018777	Conductive hearing loss	0.2	0	0	HPO
5148	PDE6G	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5148	PDE6G	C0020459	Hyperinsulinism	0.2	0	0	HPO
5148	PDE6G	C0020619	Hypogonadism	0.2	0	0	HPO
5148	PDE6G	C0022578	Keratoconus	0.2	0	0	HPO
5148	PDE6G	C0024440	Macular Edema, Cystoid	0.2	0	0	HPO
5148	PDE6G	C0028077	Night Blindness	0.2	0	0	HPO
5148	PDE6G	C0028738	Nystagmus	0.2	0	0	HPO
5148	PDE6G	C0028754	Obesity	0.2	0	0	HPO
5148	PDE6G	C0029124	Optic Atrophy	0.2	0	0	HPO
5148	PDE6G	C0035334	Retinitis Pigmentosa	0.480549453568426	0	0	HPO;ORPHANET
5148	PDE6G	C0271215	Blindness, Legal	0.2	0	0	HPO
5148	PDE6G	C3150821	RETINITIS PIGMENTOSA 57	0.2	0	0	CTD_human
5149	PDE6H	C0015310	Exotropia	0.2	0	0	HPO
5149	PDE6H	C0020490	Hyperopia	0.2	0	0	HPO
5149	PDE6H	C0028077	Night Blindness	0.2	0	0	HPO
5149	PDE6H	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5149	PDE6H	C0042798	Low Vision	0.2	0	0	HPO
5149	PDE6H	C0152200	Achromatopsia	0.200549453568426	0	0	ORPHANET
5149	PDE6H	C0271388	Pendular Nystagmus	0.2	0	0	HPO
5149	PDE6H	C0730290	Cone dystrophy	0.200274726784213	0	0	HPO
5149	PDE6H	C0858618	Dyschromatopsia	0.2	0	0	HPO
5149	PDE6H	C1864900	Retinal Cone Dystrophy 3A	0.2	0	0	CTD_human
5149	PDE6H	C3665342	Progressive cone dystrophy	0.2	0	0	HPO
5149	PDE6H	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
5149	PDE6H	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
51501	HIKESHI	C4225170	LEUKODYSTROPHY, HYPOMYELINATING, 13	0.2	1	1	UNIPROT
51520	LARS	C0002871	Anemia	0.2	0	0	HPO
51520	LARS	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
51520	LARS	C0014544	Epilepsy	0.2	0	0	HPO
51520	LARS	C0162557	Liver Failure, Acute	0.2	0	0	HPO
51520	LARS	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
51520	LARS	C2711227	Steatohepatitis	0.2	0	0	HPO
51520	LARS	C3809522	INFANTILE LIVER FAILURE SYNDROME 1	0.4	1	1	ORPHANET;UNIPROT
51524	TMEM138	C0028738	Nystagmus	0.2	0	0	HPO
51524	TMEM138	C0271215	Blindness, Legal	0.2	0	0	HPO
51524	TMEM138	C1855675	Arima syndrome	0.2	0	0	ORPHANET
51524	TMEM138	C3280906	JOUBERT SYNDROME 16	0.2	1	4	UNIPROT
51524	TMEM138	C3489733	Oculomotor apraxia	0.2	0	0	HPO
51530	ZC3HC1	C1956346	Coronary Artery Disease	0.200824180352639	1	1	CTD_human
5154	PDGFA	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
5154	PDGFA	C0040028	Thrombocythemia, Essential	0.2	1	0	CTD_human
5154	PDGFA	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
51547	SIRT7	C0015695	Fatty Liver	0.200274726784213	1	0	CTD_human
51547	SIRT7	C0036421	Systemic Scleroderma	0.2	1	0	CTD_human
5155	PDGFB	C0013384	Dyskinetic syndrome	0.2	0	0	HPO
5155	PDGFB	C0014544	Epilepsy	0.200274726784213	0	0	HPO
5155	PDGFB	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
5155	PDGFB	C0040028	Thrombocythemia, Essential	0.2	1	0	CTD_human
5155	PDGFB	C0393590	Fahr's syndrome (disorder)	0.4	1	0	CTD_human;ORPHANET
5155	PDGFB	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5155	PDGFB	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
5155	PDGFB	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
5155	PDGFB	C0854107	Haemorrhage subcutaneous	0.2	0	0	HPO
5155	PDGFB	C3809645	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5	0.2	1	5	UNIPROT
5155	PDGFB	C4020858	Choreatic disease	0.2	0	0	HPO
5155	PDGFB	C4020871	Dystonic disease	0.2	0	0	HPO
5155	PDGFB	C4020884	Anxiety disease	0.2	0	0	HPO
5156	PDGFRA	C0007196	Restrictive cardiomyopathy	0.2	0	0	HPO
5156	PDGFRA	C0014457	Eosinophilia	0.214546164185977	0	0	HPO
5156	PDGFRA	C0015923	Fetal Alcohol Syndrome	0.200274726784213	1	0	PSYGENET
5156	PDGFRA	C0021843	Intestinal Obstruction	0.2	0	0	HPO
5156	PDGFRA	C0042109	Urticaria	0.2	0	0	HPO
5156	PDGFRA	C1540912	Hypereosinophilic syndrome	0.220243649767866	1	0	CTD_human
51561	IL23A	C0003873	Rheumatoid Arthritis	0.209861453477037	1	0	CTD_human
51561	IL23A	C0033860	Psoriasis	0.218052099846117	2	0	CTD_human
5157	PDGFRL	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
51574	LARP7	C3554439	ALAZAMI SYNDROME	0.200549453568426	0	0	ORPHANET
5158	PDE6B	C0017601	Glaucoma	0.2	0	0	HPO
5158	PDE6B	C0018777	Conductive hearing loss	0.2	0	0	HPO
5158	PDE6B	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5158	PDE6B	C0020459	Hyperinsulinism	0.2	0	0	HPO
5158	PDE6B	C0020619	Hypogonadism	0.2	0	0	HPO
5158	PDE6B	C0022578	Keratoconus	0.2	0	0	HPO
5158	PDE6B	C0028077	Night Blindness	0.202407028523288	0	0	HPO
5158	PDE6B	C0028738	Nystagmus	0.2	0	0	HPO
5158	PDE6B	C0028754	Obesity	0.2	0	0	HPO
5158	PDE6B	C0029124	Optic Atrophy	0.2	0	0	HPO
5158	PDE6B	C0035334	Retinitis Pigmentosa	0.69210065515107	1	8	CTD_human;HPO;ORPHANET
5158	PDE6B	C0271183	Severe myopia	0.2	0	0	HPO
5158	PDE6B	C0271215	Blindness, Legal	0.2	0	0	HPO
5158	PDE6B	C1876182	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2	0.48	1	1	CTD_human;UNIPROT
5158	PDE6B	C3151107	RETINITIS PIGMENTOSA 40 (disorder)	0.28	7	17	UNIPROT
5158	PDE6B	C3551052	Night blindness, stationary	0.200274726784213	0	0	HPO
5159	PDGFRB	C0014457	Eosinophilia	0.204945082115836	0	0	HPO
5159	PDGFRB	C0014544	Epilepsy	0.200274726784213	0	0	HPO
5159	PDGFRB	C0015300	Exophthalmos	0.2	0	0	HPO
5159	PDGFRB	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5159	PDGFRB	C0020490	Hyperopia	0.2	0	0	HPO
5159	PDGFRB	C0029453	Osteopenia	0.2	0	0	HPO
5159	PDGFRB	C0393590	Fahr's syndrome (disorder)	0.200274726784213	0	0	ORPHANET
5159	PDGFRB	C0399440	Hereditary gingival fibromatosis	0.2	0	0	HPO
5159	PDGFRB	C0432284	Infantile myofibromatosis	0.401098907136852	2	3	ORPHANET;UNIPROT
5159	PDGFRB	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5159	PDGFRB	C0553730	Calcium pyrophosphate deposition disease	0.2	0	0	HPO
5159	PDGFRB	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
5159	PDGFRB	C0747078	Generalized osteopenia	0.2	0	0	HPO
5159	PDGFRB	C0749379	Thoracolumbar scoliosis	0.2	0	0	HPO
5159	PDGFRB	C0854107	Haemorrhage subcutaneous	0.2	0	0	HPO
5159	PDGFRB	C0870082	Hyperkeratosis	0.2	0	0	HPO
5159	PDGFRB	C0917990	Acro-Osteolysis	0.2	0	0	HPO
5159	PDGFRB	C1280433	Lipoatrophy	0.2	0	0	HPO
5159	PDGFRB	C1851585	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	0.4	0	0	CTD_human;HPO
5159	PDGFRB	C1866182	Penttinen-Aula syndrome	0.4	1	0	ORPHANET;UNIPROT
5159	PDGFRB	C3554321	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4	0.2	3	3	UNIPROT
5159	PDGFRB	C4020858	Choreatic disease	0.2	0	0	HPO
5159	PDGFRB	C4020871	Dystonic disease	0.2	0	0	HPO
5159	PDGFRB	C4225270	KOSAKI OVERGROWTH SYNDROME	0.2	1	1	UNIPROT
51594	NBAS	C0010495	Cutis Laxa	0.2	0	0	HPO
51594	NBAS	C0015300	Exophthalmos	0.2	0	0	HPO
51594	NBAS	C0029124	Optic Atrophy	0.200274726784213	0	0	HPO
51594	NBAS	C2930812	Generalized elastolysis	0.2	0	0	HPO
51594	NBAS	C3541319	SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY	0.400549453568426	1	1	ORPHANET;UNIPROT
51594	NBAS	C3809651	INFANTILE LIVER FAILURE SYNDROME 2	0.4	1	7	ORPHANET;UNIPROT
5160	PDHA1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
5160	PDHA1	C0023264	Leigh Disease	0.200274726784213	0	0	ORPHANET
5160	PDHA1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
5160	PDHA1	C0034345	Pyruvate Dehydrogenase Complex Deficiency Disease	0.20439562854741	1	0	CTD_human
5160	PDHA1	C0034350	Pyruvate Metabolism, Inborn Errors	0.2	1	0	CTD_human
5160	PDHA1	C0085583	Choreoathetosis	0.2	0	0	HPO
5160	PDHA1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5160	PDHA1	C0235946	Cerebral atrophy	0.2	0	0	HPO
5160	PDHA1	C1720189	Episodic Ataxia	0.2	0	0	HPO
5160	PDHA1	C1837251	Basal ganglia cysts	0.2	0	0	HPO
5160	PDHA1	C1839413	Pyruvate Dehydrogenase E1 Alpha Deficiency	0.4	11	27	ORPHANET;UNIPROT
5160	PDHA1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
5160	PDHA1	C4020871	Dystonic disease	0.2	0	0	HPO
51601	LIPT1	C0023264	Leigh Disease	0.200274726784213	0	0	ORPHANET
51601	LIPT1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
51601	LIPT1	C0575059	Spastic tetraparesis	0.2	0	0	HPO
51601	LIPT1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
51601	LIPT1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
51601	LIPT1	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
51601	LIPT1	C4020871	Dystonic disease	0.2	0	0	HPO
51601	LIPT1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
51601	LIPT1	C4225379	LIPOYLTRANSFERASE 1 DEFICIENCY	0.4	2	4	ORPHANET;UNIPROT
51604	PIGT	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
51604	PIGT	C0007196	Restrictive cardiomyopathy	0.2	0	0	HPO
51604	PIGT	C0014544	Epilepsy	0.2	0	0	HPO
51604	PIGT	C0019050	Hemoglobinuria, Paroxysmal	0.2	1	0	CTD_human
51604	PIGT	C0020490	Hyperopia	0.2	0	0	HPO
51604	PIGT	C0022679	Cystic kidney	0.2	0	0	HPO
51604	PIGT	C0024790	Paroxysmal nocturnal hemoglobinuria	0.200549453568426	0	0	HPO
51604	PIGT	C0027709	Nephrocalcinosis	0.2	0	0	HPO
51604	PIGT	C0028738	Nystagmus	0.2	0	0	HPO
51604	PIGT	C0029453	Osteopenia	0.2	0	0	HPO
51604	PIGT	C0038379	Strabismus	0.2	0	0	HPO
51604	PIGT	C0042109	Urticaria	0.2	0	0	HPO
51604	PIGT	C0042798	Low Vision	0.2	0	0	HPO
51604	PIGT	C0235946	Cerebral atrophy	0.2	0	0	HPO
51604	PIGT	C0747078	Generalized osteopenia	0.2	0	0	HPO
51604	PIGT	C3809356	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3	0.400549453568426	1	4	ORPHANET;UNIPROT
51604	PIGT	C4020860	Supratentorial atrophy	0.2	0	0	HPO
5162	PDHB	C0034345	Pyruvate Dehydrogenase Complex Deficiency Disease	0.200274726784213	1	0	CTD_human
5162	PDHB	C3279841	Pyruvate Dehydrogenase E1-Beta Deficiency	0.4	1	2	ORPHANET;UNIPROT
51621	KLF13	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
51626	DYNC2LI1	C0013903	Ellis-Van Creveld Syndrome	0.2	0	0	ORPHANET
51626	DYNC2LI1	C0038379	Strabismus	0.2	0	0	HPO
51626	DYNC2LI1	C1834405	Nail dysplasia	0.2	0	0	HPO
51626	DYNC2LI1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
51635	DHRS7	C0015695	Fatty Liver	0.2	1	0	CTD_human
51635	DHRS7	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
51643	TMBIM4	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
5165	PDK3	C3806702	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6	0.400549453568426	1	1	ORPHANET;UNIPROT
51651	PTRH2	C0015310	Exotropia	0.2	0	0	HPO
51651	PTRH2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
51651	PTRH2	C0020676	Hypothyroidism	0.2	0	0	HPO
51651	PTRH2	C0239946	Fibrosis, Liver	0.2	0	0	HPO
51651	PTRH2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
51651	PTRH2	C0267952	Fibrosis of pancreas	0.2	0	0	HPO
51651	PTRH2	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
51651	PTRH2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
51651	PTRH2	C4015728	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET	0.48	1	2	ORPHANET;UNIPROT
51651	PTRH2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
5166	PDK4	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5166	PDK4	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
51660	MPC1	C0020615	Hypoglycemia	0.2	0	0	HPO
51660	MPC1	C3553607	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.4	1	2	ORPHANET;UNIPROT
5167	ENPP1	C0002982	Angioid Streaks	0.200274726784213	0	0	HPO
5167	ENPP1	C0010278	Craniosynostosis	0.2	0	0	HPO
5167	ENPP1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.294043617989111	0	0	CTD_human
5167	ENPP1	C0014175	Endometriosis	0.2	1	0	CTD_human
5167	ENPP1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5167	ENPP1	C0018801	Heart failure	0.2	0	0	HPO
5167	ENPP1	C0018802	Congestive heart failure	0.2	0	0	HPO
5167	ENPP1	C0027051	Myocardial Infarction	0.209521214158194	0	0	HPO
5167	ENPP1	C0027092	Myopia	0.2	0	0	HPO
5167	ENPP1	C0028754	Obesity	0.242489656420851	0	0	CTD_human
5167	ENPP1	C0029442	Osteomalacia	0.200274726784213	0	0	HPO
5167	ENPP1	C0029464	Osteosclerosis	0.2	0	0	HPO
5167	ENPP1	C0033847	Pseudoxanthoma Elasticum	0.201923087489492	0	0	ORPHANET
5167	ENPP1	C0162323	Polyarthritis	0.2	0	0	HPO
5167	ENPP1	C0264955	Idiopathic arterial calcification of infancy	0.2	0	0	ORPHANET
5167	ENPP1	C0870082	Hyperkeratosis	0.2	0	0	HPO
5167	ENPP1	C1282952	Enthesitis	0.2	0	0	HPO
5167	ENPP1	C1704375	Hypophosphatemic Rickets	0.202472541057918	0	0	HPO
5167	ENPP1	C1859727	Arterial calcification of infancy	0.682472541057918	6	18	CTD_human;ORPHANET;UNIPROT
5167	ENPP1	C1865343	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE	0.482407028523288	1	1	CTD_human;UNIPROT
5167	ENPP1	C2750078	Hypophosphatemic Rickets, Autosomal Recessive, 2	0.4	4	4	CTD_human;UNIPROT
5167	ENPP1	C3809781	Cole disease	0.400274726784213	2	3	ORPHANET;UNIPROT
5167	ENPP1	C4024631	Renal hypophosphatemia	0.2	0	0	HPO
5168	ENPP2	C0019158	Hepatitis	0.2	1	0	CTD_human
51684	SUFU	C0017601	Glaucoma	0.2	0	0	HPO
51684	SUFU	C0020255	Hydrocephalus	0.2	0	0	HPO
51684	SUFU	C0038379	Strabismus	0.2	0	0	HPO
51684	SUFU	C0155285	Orbital cyst	0.2	0	0	HPO
51684	SUFU	C1397139	Calcification of falx cerebri	0.2	0	0	HPO
5170	PDPK1	C0018801	Heart failure	0.2	1	0	CTD_human
51702	PADI3	C0432347	Uncombable hair syndrome	0.28	0	0	ORPHANET
51702	PADI3	C4020850	Generalized trichodysplasia	0.2	0	0	HPO
51702	PADI3	C4025700	Trichodysplasia	0.2	0	0	HPO
5171	PDR	C1845050	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS	0.201373633921065	0	0	CTD_human
51715	RAB23	C0010278	Craniosynostosis	0.200549453568426	0	0	HPO
51715	RAB23	C0018777	Conductive hearing loss	0.2	0	0	HPO
51715	RAB23	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
51715	RAB23	C0020295	Hydronephrosis	0.2	0	0	HPO
51715	RAB23	C0028754	Obesity	0.200274726784213	0	0	HPO
51715	RAB23	C0029124	Optic Atrophy	0.2	0	0	HPO
51715	RAB23	C0034013	Precocious Puberty	0.2	0	0	HPO
51715	RAB23	C0158113	Contracture of joint of hand	0.2	0	0	HPO
51715	RAB23	C0235946	Cerebral atrophy	0.2	0	0	HPO
51715	RAB23	C1275078	Acrocephalopolysyndactyly type 2	0.601373633921066	2	1	CTD_human;ORPHANET;UNIPROT
51715	RAB23	C1833340	Synostotic Posterior Plagiocephaly	0.2	0	0	HPO
51715	RAB23	C1856266	Coronal craniosynostosis	0.2	0	0	HPO
51715	RAB23	C1866339	Preaxial Hallucal Polydactyly	0.2	0	0	HPO
51715	RAB23	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
51715	RAB23	C4020860	Supratentorial atrophy	0.2	0	0	HPO
51715	RAB23	C4020889	Cornela disease	0.2	0	0	HPO
5172	SLC26A4	C0018784	Sensorineural Hearing Loss (disorder)	0.441167179657098	3	0	CTD_human;HPO
5172	SLC26A4	C0020676	Hypothyroidism	0.201373633921065	0	0	HPO
5172	SLC26A4	C0024421	Macroglossia	0.2	0	0	HPO
5172	SLC26A4	C0151516	Thyroid Hypoplasia	0.400274726784213	0	0	HPO;ORPHANET
5172	SLC26A4	C0271829	Pendred's syndrome	0.721287206812288	22	114	CTD_human;ORPHANET;UNIPROT
5172	SLC26A4	C0342162	Compensated hypothyroidism	0.2	0	0	HPO
5172	SLC26A4	C0917799	Hypersomnia	0.2	0	0	HPO
5172	SLC26A4	C3538946	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	0.480549453568426	17	24	CTD_human;UNIPROT
5173	PDYN	C0008370	Cholestasis	0.2	1	0	CTD_human
5173	PDYN	C0013384	Dyskinetic syndrome	0.20328236603324	1	0	CTD_human
5173	PDYN	C0013386	Dyskinesia, Drug-Induced	0.2	2	0	CTD_human
5173	PDYN	C0262404	Cerebellar degeneration	0.2	0	0	HPO
5173	PDYN	C0338474	Central nervous system demyelination	0.2	0	0	HPO
5173	PDYN	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
5173	PDYN	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
5173	PDYN	C1853250	SPINOCEREBELLAR ATAXIA 23	0.600549453568426	4	6	CTD_human;ORPHANET;UNIPROT
5173	PDYN	C4020873	Infratentorial atrophy	0.2	0	0	HPO
51733	UPB1	C0005689	Bladder Exstrophy	0.2	0	0	HPO
51733	UPB1	C0037769	West Syndrome	0.2	1	0	CTD_human
51733	UPB1	C1291512	Beta-Ureidopropionase Deficiency	0.600549453568426	1	4	CTD_human;ORPHANET;UNIPROT
51733	UPB1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
51733	UPB1	C4020871	Dystonic disease	0.2	0	0	HPO
51738	GHRL	C0009319	Colitis	0.2	1	0	CTD_human
51738	GHRL	C0009324	Ulcerative Colitis	0.2	1	0	CTD_human
51738	GHRL	C0018801	Heart failure	0.200549453568426	1	0	CTD_human
51738	GHRL	C0028754	Obesity	0.232312088759273	0	0	CTD_human
51738	GHRL	C0038358	Gastric ulcer	0.2	2	0	CTD_human
51741	WWOX	C0004509	Azoospermia	0.2	0	0	HPO
51741	WWOX	C0014544	Epilepsy	0.200824180352639	0	0	HPO
51741	WWOX	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
51741	WWOX	C0018418	Gynecomastia	0.2	0	0	HPO
51741	WWOX	C0029456	Osteoporosis	0.2	0	0	HPO
51741	WWOX	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
51741	WWOX	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
51741	WWOX	C0262404	Cerebellar degeneration	0.2	0	0	HPO
51741	WWOX	C0266427	Testicular regression syndrome	0.2	0	0	HPO
51741	WWOX	C0271390	Nystagmus, End-Position	0.2	0	0	HPO
51741	WWOX	C0543888	Epileptic encephalopathy	0.200274726784213	0	0	HPO
51741	WWOX	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
51741	WWOX	C0948896	Primary hypogonadism	0.2	0	0	HPO
51741	WWOX	C3280452	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12	0.4	1	4	ORPHANET;UNIPROT
51741	WWOX	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
51741	WWOX	C4015519	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28	0.2	1	6	UNIPROT
51741	WWOX	C4020873	Infratentorial atrophy	0.2	0	0	HPO
51744	CD244	C0003873	Rheumatoid Arthritis	0.208920603432455	1	1	CTD_human
51750	RTEL1	C0002871	Anemia	0.2	0	0	HPO
51750	RTEL1	C0011334	Dental caries	0.2	0	0	HPO
51750	RTEL1	C0023530	Leukopenia	0.2	0	0	HPO
51750	RTEL1	C0031099	Periodontitis	0.2	0	0	HPO
51750	RTEL1	C0034069	Pulmonary Fibrosis	0.200824180352639	0	0	HPO
51750	RTEL1	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
51750	RTEL1	C0221260	Dystrophia unguium	0.2	0	0	HPO
51750	RTEL1	C0235946	Cerebral atrophy	0.2	0	0	HPO
51750	RTEL1	C0265965	Dyskeratosis Congenita	0.201648360705279	0	0	ORPHANET
51750	RTEL1	C0266039	Taurodontism	0.2	0	0	HPO
51750	RTEL1	C1800706	Idiopathic Pulmonary Fibrosis	0.4	1	9	CTD_human;ORPHANET
51750	RTEL1	C1846142	HOYERAAL-HREIDARSSON SYNDROME	0.202472541057918	0	0	ORPHANET
51750	RTEL1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
51750	RTEL1	C3554656	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5	0.2	4	13	UNIPROT
51750	RTEL1	C4023400	Generalized hypopigmentation of hair	0.2	0	0	HPO
51750	RTEL1	C4225346	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3	0.2	1	3	UNIPROT
51752	ERAP1	C0003864	Arthritis	0.2	0	0	HPO
51752	ERAP1	C0004943	Behcet Syndrome	0.403021994626344	1	1	CTD_human;ORPHANET
51752	ERAP1	C0025289	Meningitis	0.2	0	0	HPO
51752	ERAP1	C0033860	Psoriasis	0.20357144819477	4	3	CTD_human
51752	ERAP1	C0038013	Ankylosing spondylitis	0.234482871009967	4	3	CTD_human
51752	ERAP1	C0038363	Aphthous Stomatitis	0.2	0	0	HPO
51752	ERAP1	C0042384	Vasculitis	0.2	0	0	HPO
51752	ERAP1	C0149745	Oral Ulcer	0.2	0	0	HPO
51752	ERAP1	C0702166	Acne	0.2	0	0	HPO
51752	ERAP1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
51752	ERAP1	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
51752	ERAP1	C2937365	Recurrent aphthous ulcer	0.2	0	0	HPO
5176	SERPINF1	C0010043	Corneal Ulcer	0.2	1	0	CTD_human
5176	SERPINF1	C0011875	Diabetic Angiopathies	0.200274726784213	1	0	CTD_human
5176	SERPINF1	C0042164	Uveitis	0.203007639249027	1	0	CTD_human
5176	SERPINF1	C0264112	Wedging of vertebra	0.2	0	0	HPO
5176	SERPINF1	C0268362	Osteogenesis imperfecta type III (disorder)	0.2	0	0	ORPHANET
5176	SERPINF1	C0410550	Collapse of vertebra	0.2	0	0	HPO
51761	ATP8A2	C0007789	Cerebral Palsy	0.2	0	0	HPO
51761	ATP8A2	C0014544	Epilepsy	0.2	0	0	HPO
51761	ATP8A2	C0038379	Strabismus	0.2	0	0	HPO
51761	ATP8A2	C0234958	muscle degeneration	0.2	0	0	HPO
51761	ATP8A2	C0235946	Cerebral atrophy	0.2	0	0	HPO
51761	ATP8A2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
51761	ATP8A2	C0394006	Dysequilibrium syndrome	0.200274726784213	0	0	ORPHANET
51761	ATP8A2	C0431370	Atrophy of corpus callosum	0.2	0	0	HPO
51761	ATP8A2	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
51761	ATP8A2	C3808977	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4	0.28	1	1	UNIPROT
51761	ATP8A2	C4020860	Supratentorial atrophy	0.2	0	0	HPO
51761	ATP8A2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
51776	MAP3K20	C4225167	SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY	0.2	1	0	UNIPROT
51778	MYOZ2	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
51778	MYOZ2	C3151204	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16	0.2	1	2	UNIPROT
5179	PENK	C0013386	Dyskinesia, Drug-Induced	0.28	1	0	CTD_human
5179	PENK	C0027404	Narcolepsy	0.2	1	0	CTD_human
5179	PENK	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
51807	TUBA8	C0014544	Epilepsy	0.2	0	0	HPO
51807	TUBA8	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
51807	TUBA8	C2750798	Polymicrogyria With Optic Nerve Hypoplasia	0.400274726784213	0	0	CTD_human;ORPHANET
51816	ADA2	C0002940	Aneurysm	0.2	0	0	HPO
51816	ADA2	C0003864	Arthritis	0.2	0	0	HPO
51816	ADA2	C0014544	Epilepsy	0.2	0	0	HPO
51816	ADA2	C0014743	Erythema Nodosum	0.2	0	0	HPO
51816	ADA2	C0030326	Panniculitis	0.2	0	0	HPO
51816	ADA2	C0034150	Purpura	0.2	0	0	HPO
51816	ADA2	C0263401	Cutis marmorata	0.2	0	0	HPO
51816	ADA2	C0282492	Sneddon Syndrome	0.2	1	2	UNIPROT
51816	ADA2	C0376175	Bell Palsy	0.2	0	0	HPO
51816	ADA2	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
51816	ADA2	C1112433	Thromboembolic stroke	0.2	0	0	HPO
51816	ADA2	C1836830	Developmental regression	0.2	0	0	HPO
51816	ADA2	C3887654	POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.200549453568426	2	8	UNIPROT
51816	ADA2	C4020848	Aneurysmal disease	0.2	0	0	HPO
5184	PEPD	C0002871	Anemia	0.2	0	0	HPO
5184	PEPD	C0004096	Asthma	0.2	0	0	HPO
5184	PEPD	C0011334	Dental caries	0.2	0	0	HPO
5184	PEPD	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202956482091714	1	1	CTD_human
5184	PEPD	C0015300	Exophthalmos	0.2	0	0	HPO
5184	PEPD	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
5184	PEPD	C0024141	Lupus Erythematosus, Systemic	0.202732912464814	0	0	HPO
5184	PEPD	C0031256	Petechiae	0.2	0	0	HPO
5184	PEPD	C0042798	Low Vision	0.2	0	0	HPO
5184	PEPD	C0259817	Xerosis	0.2	0	0	HPO
5184	PEPD	C0268532	Deficiency of prolidase	0.601648360705279	5	12	CTD_human;ORPHANET;UNIPROT
5184	PEPD	C0694550	Recurrent pneumonia	0.2	0	0	HPO
5184	PEPD	C0746102	Chronic lung disease	0.2	0	0	HPO
5184	PEPD	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
5184	PEPD	C1868496	Crusting erythematous dermatitis	0.2	0	0	HPO
5184	PEPD	C3714497	Reactive airway disease	0.2	0	0	HPO
5187	PER1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
5189	PEX1	C0001403	Addison Disease	0.2	0	0	HPO
5189	PEX1	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
5189	PEX1	C0014544	Epilepsy	0.2	0	0	HPO
5189	PEX1	C0017601	Glaucoma	0.2	0	0	HPO
5189	PEX1	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
5189	PEX1	C0020295	Hydronephrosis	0.2	0	0	HPO
5189	PEX1	C0020500	Hyperoxaluria	0.2	0	0	HPO
5189	PEX1	C0022679	Cystic kidney	0.2	0	0	HPO
5189	PEX1	C0023520	Leukodystrophy	0.2	0	0	HPO
5189	PEX1	C0024421	Macroglossia	0.2	0	0	HPO
5189	PEX1	C0028077	Night Blindness	0.2	0	0	HPO
5189	PEX1	C0028738	Nystagmus	0.2	0	0	HPO
5189	PEX1	C0029124	Optic Atrophy	0.2	0	0	HPO
5189	PEX1	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	HPO
5189	PEX1	C0038379	Strabismus	0.2	0	0	HPO
5189	PEX1	C0042798	Low Vision	0.2	0	0	HPO
5189	PEX1	C0043459	Zellweger Syndrome	0.688213092771759	7	63	CTD_human;ORPHANET;UNIPROT
5189	PEX1	C0085605	Liver Failure	0.2	0	0	HPO
5189	PEX1	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
5189	PEX1	C0238621	Aminoaciduria	0.2	0	0	HPO
5189	PEX1	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
5189	PEX1	C0282527	Infantile Refsum Disease (disorder)	0.400824180352639	7	2	ORPHANET;UNIPROT
5189	PEX1	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
5189	PEX1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5189	PEX1	C1836830	Developmental regression	0.2	0	0	HPO
5189	PEX1	C1856186	Deafness enamel hypoplasia nail defects	0.400549453568426	1	7	ORPHANET;UNIPROT
5189	PEX1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
5189	PEX1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5189	PEX1	C3550234	PEROXISOME BIOGENESIS DISORDER 2B	0.2	0	0	CTD_human
5189	PEX1	C3553450	Profound global developmental delay	0.2	0	0	HPO
5189	PEX1	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5190	PEX6	C0001403	Addison Disease	0.2	0	0	HPO
5190	PEX6	C0014544	Epilepsy	0.2	0	0	HPO
5190	PEX6	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5190	PEX6	C0020295	Hydronephrosis	0.2	0	0	HPO
5190	PEX6	C0022679	Cystic kidney	0.2	0	0	HPO
5190	PEX6	C0028077	Night Blindness	0.2	0	0	HPO
5190	PEX6	C0028738	Nystagmus	0.2	0	0	HPO
5190	PEX6	C0029124	Optic Atrophy	0.2	0	0	HPO
5190	PEX6	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5190	PEX6	C0038379	Strabismus	0.2	0	0	HPO
5190	PEX6	C0042798	Low Vision	0.2	0	0	HPO
5190	PEX6	C0043459	Zellweger Syndrome	0.401373633921066	2	0	CTD_human;ORPHANET
5190	PEX6	C0085605	Liver Failure	0.2	0	0	HPO
5190	PEX6	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
5190	PEX6	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
5190	PEX6	C0282527	Infantile Refsum Disease (disorder)	0.200824180352639	0	0	ORPHANET
5190	PEX6	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
5190	PEX6	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5190	PEX6	C1836830	Developmental regression	0.2	0	0	HPO
5190	PEX6	C1856186	Deafness enamel hypoplasia nail defects	0.2	0	0	ORPHANET
5190	PEX6	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
5190	PEX6	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5190	PEX6	C3553450	Profound global developmental delay	0.2	0	0	HPO
5190	PEX6	C3553936	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.2	4	12	UNIPROT
5190	PEX6	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5190	PEX6	C4225267	HEIMLER SYNDROME 2	0.2	3	9	UNIPROT
5191	PEX7	C0002170	Alopecia	0.2	0	0	HPO
5191	PEX7	C0014544	Epilepsy	0.2	0	0	HPO
5191	PEX7	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5191	PEX7	C0018801	Heart failure	0.2	0	0	HPO
5191	PEX7	C0018802	Congestive heart failure	0.2	0	0	HPO
5191	PEX7	C0020757	Ichthyoses	0.2	0	0	HPO
5191	PEX7	C0026205	Miosis disorder	0.2	0	0	HPO
5191	PEX7	C0028077	Night Blindness	0.2	0	0	HPO
5191	PEX7	C0028738	Nystagmus	0.2	0	0	HPO
5191	PEX7	C0034960	Refsum Disease	0.409572371315507	1	2	CTD_human;ORPHANET
5191	PEX7	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5191	PEX7	C0042798	Low Vision	0.2	0	0	HPO
5191	PEX7	C0234958	muscle degeneration	0.2	0	0	HPO
5191	PEX7	C0235946	Cerebral atrophy	0.2	0	0	HPO
5191	PEX7	C0259817	Xerosis	0.2	0	0	HPO
5191	PEX7	C0282529	Chondrodysplasia Punctata, Rhizomelic	0.20328236603324	1	1	CTD_human
5191	PEX7	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
5191	PEX7	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
5191	PEX7	C1834405	Nail dysplasia	0.2	0	0	HPO
5191	PEX7	C1836830	Developmental regression	0.2	0	0	HPO
5191	PEX7	C1859133	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1	0.681923087489492	3	30	CTD_human;ORPHANET;UNIPROT
5191	PEX7	C2749346	Refsum Disease, Adult, 2	0.2	1	1	UNIPROT
5191	PEX7	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
5192	PEX10	C0001403	Addison Disease	0.2	0	0	HPO
5192	PEX10	C0014544	Epilepsy	0.2	0	0	HPO
5192	PEX10	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5192	PEX10	C0020295	Hydronephrosis	0.2	0	0	HPO
5192	PEX10	C0028077	Night Blindness	0.2	0	0	HPO
5192	PEX10	C0028738	Nystagmus	0.2	0	0	HPO
5192	PEX10	C0029124	Optic Atrophy	0.2	0	0	HPO
5192	PEX10	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5192	PEX10	C0038379	Strabismus	0.2	0	0	HPO
5192	PEX10	C0042798	Low Vision	0.2	0	0	HPO
5192	PEX10	C0043459	Zellweger Syndrome	0.400274726784213	4	1	CTD_human;ORPHANET
5192	PEX10	C0085605	Liver Failure	0.2	0	0	HPO
5192	PEX10	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
5192	PEX10	C0262404	Cerebellar degeneration	0.2	0	0	HPO
5192	PEX10	C0282525	Adrenoleukodystrophy, Neonatal	0.200549453568426	0	0	ORPHANET
5192	PEX10	C0282527	Infantile Refsum Disease (disorder)	0.200274726784213	0	0	ORPHANET
5192	PEX10	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
5192	PEX10	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5192	PEX10	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
5192	PEX10	C1836830	Developmental regression	0.2	0	0	HPO
5192	PEX10	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
5192	PEX10	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5192	PEX10	C3550234	PEROXISOME BIOGENESIS DISORDER 2B	0.2	0	0	CTD_human
5192	PEX10	C3553450	Profound global developmental delay	0.2	0	0	HPO
5192	PEX10	C3553948	PEROXISOME BIOGENESIS DISORDER 6B	0.28	1	10	UNIPROT
5192	PEX10	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5192	PEX10	C4020873	Infratentorial atrophy	0.2	0	0	HPO
5193	PEX12	C0001403	Addison Disease	0.2	0	0	HPO
5193	PEX12	C0014544	Epilepsy	0.2	0	0	HPO
5193	PEX12	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5193	PEX12	C0020295	Hydronephrosis	0.2	0	0	HPO
5193	PEX12	C0028077	Night Blindness	0.2	0	0	HPO
5193	PEX12	C0028738	Nystagmus	0.2	0	0	HPO
5193	PEX12	C0029124	Optic Atrophy	0.2	0	0	HPO
5193	PEX12	C0029456	Osteoporosis	0.2	0	0	HPO
5193	PEX12	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5193	PEX12	C0038379	Strabismus	0.2	0	0	HPO
5193	PEX12	C0042798	Low Vision	0.2	0	0	HPO
5193	PEX12	C0043459	Zellweger Syndrome	0.400824180352639	2	0	CTD_human;ORPHANET
5193	PEX12	C0085605	Liver Failure	0.2	0	0	HPO
5193	PEX12	C0151718	Hypocholesterolemia	0.2	0	0	HPO
5193	PEX12	C0152025	Polyneuropathy	0.2	0	0	HPO
5193	PEX12	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
5193	PEX12	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
5193	PEX12	C0282527	Infantile Refsum Disease (disorder)	0.20328236603324	0	0	ORPHANET
5193	PEX12	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
5193	PEX12	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5193	PEX12	C1836830	Developmental regression	0.2	0	0	HPO
5193	PEX12	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5193	PEX12	C3550693	PEROXISOME BIOGENESIS DISORDER 3B	0.2	2	1	UNIPROT
5193	PEX12	C3553450	Profound global developmental delay	0.2	0	0	HPO
5193	PEX12	C3553929	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER)	0.2	1	7	UNIPROT
5193	PEX12	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5194	PEX13	C0001403	Addison Disease	0.2	0	0	HPO
5194	PEX13	C0014544	Epilepsy	0.2	0	0	HPO
5194	PEX13	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5194	PEX13	C0020295	Hydronephrosis	0.2	0	0	HPO
5194	PEX13	C0022679	Cystic kidney	0.2	0	0	HPO
5194	PEX13	C0028077	Night Blindness	0.2	0	0	HPO
5194	PEX13	C0028738	Nystagmus	0.2	0	0	HPO
5194	PEX13	C0029124	Optic Atrophy	0.2	0	0	HPO
5194	PEX13	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5194	PEX13	C0038379	Strabismus	0.2	0	0	HPO
5194	PEX13	C0042798	Low Vision	0.2	0	0	HPO
5194	PEX13	C0043459	Zellweger Syndrome	0.400549453568426	2	0	CTD_human;ORPHANET
5194	PEX13	C0085605	Liver Failure	0.2	0	0	HPO
5194	PEX13	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
5194	PEX13	C0162309	Adrenoleukodystrophy	0.200274726784213	1	0	CTD_human
5194	PEX13	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
5194	PEX13	C0282527	Infantile Refsum Disease (disorder)	0.200274726784213	0	0	ORPHANET
5194	PEX13	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
5194	PEX13	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5194	PEX13	C1836830	Developmental regression	0.2	0	0	HPO
5194	PEX13	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5194	PEX13	C3550234	PEROXISOME BIOGENESIS DISORDER 2B	0.2	0	0	CTD_human
5194	PEX13	C3553450	Profound global developmental delay	0.2	0	0	HPO
5194	PEX13	C3554001	PEROXISOME BIOGENESIS DISORDER 11B	0.2	1	1	UNIPROT
5194	PEX13	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5195	PEX14	C0001403	Addison Disease	0.2	0	0	HPO
5195	PEX14	C0014544	Epilepsy	0.2	0	0	HPO
5195	PEX14	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5195	PEX14	C0020295	Hydronephrosis	0.2	0	0	HPO
5195	PEX14	C0028077	Night Blindness	0.2	0	0	HPO
5195	PEX14	C0028738	Nystagmus	0.2	0	0	HPO
5195	PEX14	C0029124	Optic Atrophy	0.2	0	0	HPO
5195	PEX14	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
5195	PEX14	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5195	PEX14	C0038379	Strabismus	0.2	0	0	HPO
5195	PEX14	C0042798	Low Vision	0.2	0	0	HPO
5195	PEX14	C0043459	Zellweger Syndrome	0.403557092817453	2	0	CTD_human;ORPHANET
5195	PEX14	C0085605	Liver Failure	0.2	0	0	HPO
5195	PEX14	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
5195	PEX14	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
5195	PEX14	C0282527	Infantile Refsum Disease (disorder)	0.200274726784213	0	0	ORPHANET
5195	PEX14	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
5195	PEX14	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5195	PEX14	C1836830	Developmental regression	0.2	0	0	HPO
5195	PEX14	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5195	PEX14	C3553450	Profound global developmental delay	0.2	0	0	HPO
5195	PEX14	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5196	PF4	C0032285	Pneumonia	0.2	1	0	CTD_human
5199	CFP	C0025294	Meningococcal meningitis	0.2	2	0	CTD_human
5199	CFP	C0398762	Properdin deficiency disease	0.200274726784213	0	0	ORPHANET
5199	CFP	C1839454	PROPERDIN DEFICIENCY, X-LINKED	0.4	4	5	CTD_human;UNIPROT
5205	ATP8B1	C0008372	Intrahepatic Cholestasis	0.401648360705279	1	0	CTD_human;HPO
5205	ATP8B1	C0023890	Liver Cirrhosis	0.200274726784213	0	0	HPO
5205	ATP8B1	C0030305	Pancreatitis	0.200549453568426	0	0	HPO
5205	ATP8B1	C0268307	Conjugated hyperbilirubinemia	0.2	0	0	HPO
5205	ATP8B1	C0268312	Progressive intrahepatic cholestasis (disorder)	0.610714344584311	7	19	CTD_human;ORPHANET;UNIPROT
5205	ATP8B1	C0268318	Cholestasis of pregnancy	0.201923087489492	0	0	ORPHANET
5205	ATP8B1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5205	ATP8B1	C3549845	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1	0.2	3	3	UNIPROT
5205	ATP8B1	C4025019	Intrahepatic cholestasis with episodic jaundice	0.2	0	0	HPO
5209	PFKFB3	C0028754	Obesity	0.200274726784213	1	0	CTD_human
5209	PFKFB3	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5213	PFKM	C0002871	Anemia	0.2	0	0	HPO
5213	PFKM	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
5213	PFKM	C0003868	Arthritis, Gouty	0.2	0	0	HPO
5213	PFKM	C0008350	Cholelithiasis	0.2	0	0	HPO
5213	PFKM	C0017926	Glycogen Storage Disease Type VII	0.68350593566014	7	8	CTD_human;ORPHANET;UNIPROT
5213	PFKM	C0018099	Gout	0.2	0	0	HPO
5213	PFKM	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5213	PFKM	C0234958	muscle degeneration	0.2	0	0	HPO
5213	PFKM	C0740394	Hyperuricemia	0.2	0	0	HPO
5216	PFN1	C0002736	Amyotrophic Lateral Sclerosis	0.405494535684262	0	0	HPO;ORPHANET
5216	PFN1	C0234958	muscle degeneration	0.2	0	0	HPO
5216	PFN1	C1145670	Respiratory Failure	0.2	0	0	HPO
5216	PFN1	C3553719	AMYOTROPHIC LATERAL SCLEROSIS 18	0.2	1	4	UNIPROT
5216	PFN1	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
5216	PFN1	C4020884	Anxiety disease	0.2	0	0	HPO
5222	PGA5	C0014868	Esophagitis	0.2	1	0	CTD_human
5224	PGAM2	C0035078	Kidney Failure	0.2	0	0	HPO
5224	PGAM2	C0268149	Glycogen storage disease type X	0.600824180352639	2	4	CTD_human;ORPHANET;UNIPROT
5224	PGAM2	C1565489	Renal Insufficiency	0.2	0	0	HPO
5230	PGK1	C0014544	Epilepsy	0.2	0	0	HPO
5230	PGK1	C0684324	Deficiency of phosphoglycerate kinase	0.200824180352639	0	0	ORPHANET
5230	PGK1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
5230	PGK1	C1970848	Phosphoglycerate Kinase 1 Deficiency	0.401373633921066	8	14	CTD_human;UNIPROT
5236	PGM1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5236	PGM1	C2752015	Glycogen Storage Disease XIV	0.4	1	11	ORPHANET;UNIPROT
5238	PGM3	C0004096	Asthma	0.2	0	0	HPO
5238	PGM3	C0006267	Bronchiectasis	0.2	0	0	HPO
5238	PGM3	C0013595	Eczema	0.200274726784213	0	0	HPO
5238	PGM3	C0018777	Conductive hearing loss	0.2	0	0	HPO
5238	PGM3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5238	PGM3	C0024312	Lymphopenia	0.2	0	0	HPO
5238	PGM3	C0262988	Vasculitis of the skin	0.2	0	0	HPO
5238	PGM3	C2607914	Allergic rhinitis (disorder)	0.2	0	0	HPO
5238	PGM3	C3698239	Cerebral cortex myoclonus	0.2	0	0	HPO
5238	PGM3	C3714497	Reactive airway disease	0.2	0	0	HPO
5238	PGM3	C4014371	IMMUNODEFICIENCY 23	0.4	3	10	ORPHANET;UNIPROT
5239	PGM5	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
5241	PGR	C0014175	Endometriosis	0.329324529651212	2	0	CTD_human
5243	ABCB1	C0003873	Rheumatoid Arthritis	0.215881317595423	2	0	CTD_human
5243	ABCB1	C0014544	Epilepsy	0.278628979161458	2	0	CTD_human
5243	ABCB1	C0027609	Neonatal Abstinence Syndrome	0.200274726784213	1	0	PSYGENET
5243	ABCB1	C0027947	Neutropenia	0.210517806980421	2	0	CTD_human
5243	ABCB1	C0030567	Parkinson Disease	0.234532349435656	1	0	CTD_human
5243	ABCB1	C0030569	Secondary Parkinson Disease	0.2	1	0	CTD_human
5243	ABCB1	C2677101	Inflammatory Bowel Disease 13	0.28	0	0	CTD_human
5243	ABCB1	C4277682	Chemical and Drug Induced Liver Injury	0.28	1	0	CTD_human
5244	ABCB4	C0008311	Cholangitis	0.4	1	0	CTD_human;HPO
5244	ABCB4	C0008313	Cholangitis, Sclerosing	0.202956482091714	1	0	CTD_human
5244	ABCB4	C0008325	Cholecystitis	0.2	0	0	HPO
5244	ABCB4	C0008350	Cholelithiasis	0.21866538721755	0	0	HPO
5244	ABCB4	C0008372	Intrahepatic Cholestasis	0.222757578226112	0	0	HPO
5244	ABCB4	C0022354	Jaundice, Obstructive	0.2	1	0	CTD_human
5244	ABCB4	C0023890	Liver Cirrhosis	0.401373633921066	2	0	CTD_human;HPO
5244	ABCB4	C0023892	Biliary cirrhosis	0.20678830169338	1	0	CTD_human
5244	ABCB4	C0030305	Pancreatitis	0.2	0	0	HPO
5244	ABCB4	C0239946	Fibrosis, Liver	0.200824180352639	0	0	HPO
5244	ABCB4	C0267818	Bile duct proliferation	0.2	0	0	HPO
5244	ABCB4	C0268312	Progressive intrahepatic cholestasis (disorder)	0.209890164231672	1	0	CTD_human
5244	ABCB4	C0268318	Cholestasis of pregnancy	0.408241803526393	0	0	CTD_human;ORPHANET
5244	ABCB4	C0400966	Non-alcoholic Fatty Liver Disease	0.200274726784213	1	0	CTD_human
5244	ABCB4	C0745744	End Stage Liver Disease	0.200274726784213	1	0	CTD_human
5244	ABCB4	C0856727	Cholesterol gallstones	0.201923087489492	0	0	HPO
5244	ABCB4	C1865643	Cholestasis, progressive familial intrahepatic 3	0.681098907136852	10	23	CTD_human;ORPHANET;UNIPROT
5244	ABCB4	C2609268	Low phospholipid-associated cholelithiasis	0.683021994626344	5	13	CTD_human;ORPHANET;UNIPROT
5244	ABCB4	C3554241	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.2	3	8	UNIPROT
525	ATP6V1B1	C0018784	Sensorineural Hearing Loss (disorder)	0.20439562854741	0	0	HPO
525	ATP6V1B1	C0392525	Nephrolithiasis	0.2	0	0	HPO
525	ATP6V1B1	C0403554	Renal Tubular Acidosis, Distal, with Progressive Nerve Deafness	0.4	3	5	CTD_human;UNIPROT
525	ATP6V1B1	C1864498	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	0.201373633921065	0	0	ORPHANET
5250	SLC25A3	C0007194	Hypertrophic Cardiomyopathy	0.202732912464814	0	0	HPO
5250	SLC25A3	C1835845	Mitochondrial Phosphate Carrier Deficiency	0.6	1	1	CTD_human;ORPHANET;UNIPROT
5250	SLC25A3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5250	SLC25A3	C4024201	Low-output congestive heart failure	0.2	0	0	HPO
5251	PHEX	C0010278	Craniosynostosis	0.2	0	0	HPO
5251	PHEX	C0027709	Nephrocalcinosis	0.2	1	0	CTD_human
5251	PHEX	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
5251	PHEX	C0029442	Osteomalacia	0.201098907136852	0	0	HPO
5251	PHEX	C0035579	Rickets	0.204930726738519	0	0	HPO
5251	PHEX	C0037926	Compression of spinal cord	0.2	0	0	HPO
5251	PHEX	C0151747	Renal tubular disorder	0.200274726784213	0	0	HPO
5251	PHEX	C0426824	Beading of ribs	0.2	0	0	HPO
5251	PHEX	C0733682	Hypophosphatemic Rickets, X-Linked Dominant	0.492087978505376	8	16	ORPHANET;UNIPROT
5251	PHEX	C1282952	Enthesitis	0.2	0	0	HPO
5251	PHEX	C1704375	Hypophosphatemic Rickets	0.206593442821114	0	0	HPO
5251	PHEX	C3536983	Familial Hypophosphatemic Rickets	0.221660349820883	2	0	CTD_human
5251	PHEX	C3665628	Hypomineralization of enamel of tooth	0.2	0	0	HPO
5255	PHKA1	C0234958	muscle degeneration	0.2	0	0	HPO
5255	PHKA1	C1845151	Glycogen Storage Disease, Type IXD	0.68	1	3	CTD_human;ORPHANET;UNIPROT
5256	PHKA2	C0020443	Hypercholesterolemia	0.2	0	0	HPO
5256	PHKA2	C0020615	Hypoglycemia	0.2	0	0	HPO
5256	PHKA2	C0022638	Ketosis	0.2	0	0	HPO
5256	PHKA2	C3694531	GLYCOGEN STORAGE DISEASE IXa1	0.4	7	11	CTD_human;UNIPROT
5257	PHKB	C0543514	Glycogen Storage Disease IXB	0.6	1	4	CTD_human;ORPHANET;UNIPROT
526	ATP6V1B2	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
526	ATP6V1B2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
526	ATP6V1B2	C0024421	Macroglossia	0.2	0	0	HPO
526	ATP6V1B2	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
526	ATP6V1B2	C0162361	Hidrotic Ectodermal Dysplasia	0.2	0	0	HPO
526	ATP6V1B2	C0221260	Dystrophia unguium	0.2	0	0	HPO
526	ATP6V1B2	C0796013	Zimmerman Laband syndrome	0.400274726784213	1	1	CTD_human;ORPHANET
526	ATP6V1B2	C2675730	Deafness, Congenital, and Onychodystrophy, Autosomal Dominant	0.2	0	0	ORPHANET
526	ATP6V1B2	C4225321	ZIMMERMANN-LABAND SYNDROME 2	0.2	1	1	UNIPROT
5260	PHKG1	C1845151	Glycogen Storage Disease, Type IXD	0.2	0	0	ORPHANET
5261	PHKG2	C0022638	Ketosis	0.2	0	0	HPO
5261	PHKG2	C0023890	Liver Cirrhosis	0.201373633921065	0	0	HPO
5261	PHKG2	C0267818	Bile duct proliferation	0.2	0	0	HPO
5261	PHKG2	C2751643	Glycogen Storage Disease IXC	0.4	2	7	CTD_human;UNIPROT
5264	PHYH	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5264	PHYH	C0018801	Heart failure	0.2	0	0	HPO
5264	PHYH	C0018802	Congestive heart failure	0.2	0	0	HPO
5264	PHYH	C0020757	Ichthyoses	0.2	0	0	HPO
5264	PHYH	C0026205	Miosis disorder	0.2	0	0	HPO
5264	PHYH	C0028077	Night Blindness	0.2	0	0	HPO
5264	PHYH	C0028738	Nystagmus	0.2	0	0	HPO
5264	PHYH	C0034960	Refsum Disease	0.689861453477037	4	8	CTD_human;ORPHANET;UNIPROT
5264	PHYH	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5264	PHYH	C0042798	Low Vision	0.2	0	0	HPO
5264	PHYH	C0234958	muscle degeneration	0.2	0	0	HPO
5264	PHYH	C0259817	Xerosis	0.2	0	0	HPO
5264	PHYH	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
5264	PHYH	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
5264	PHYH	C1834405	Nail dysplasia	0.2	0	0	HPO
5264	PHYH	C1836830	Developmental regression	0.2	0	0	HPO
5265	SERPINA1	C0003850	Arteriosclerosis	0.200274726784213	1	0	CTD_human
5265	SERPINA1	C0003949	Asbestosis	0.205414667772315	1	0	CTD_human
5265	SERPINA1	C0006267	Bronchiectasis	0.211001748014218	1	0	CTD_human
5265	SERPINA1	C0008370	Cholestasis	0.200824180352639	1	0	CTD_human
5265	SERPINA1	C0019158	Hepatitis	0.203831819601666	0	0	HPO
5265	SERPINA1	C0020615	Hypoglycemia	0.2	1	0	CTD_human
5265	SERPINA1	C0023890	Liver Cirrhosis	0.216822167640005	3	0	CTD_human
5265	SERPINA1	C0024117	Chronic Obstructive Airway Disease	0.462608545471414	2	0	CTD_human;HPO
5265	SERPINA1	C0030328	Panniculitis, Nodular Nonsuppurative	0.200549453568426	2	0	CTD_human
5265	SERPINA1	C0034067	Pulmonary Emphysema	0.437832428309461	1	0	CTD_human;HPO
5265	SERPINA1	C0034069	Pulmonary Fibrosis	0.200824180352639	1	0	CTD_human
5265	SERPINA1	C0039841	Thiamine Deficiency	0.2	1	0	CTD_human
5265	SERPINA1	C0042384	Vasculitis	0.202197814273705	1	0	CTD_human
5265	SERPINA1	C0085605	Liver Failure	0.200549453568426	0	0	HPO
5265	SERPINA1	C0221757	alpha 1-Antitrypsin Deficiency	0.482141179173555	2	25	CTD_human;ORPHANET
5266	PI3	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
5269	SERPINB6	C3150704	DEAFNESS, AUTOSOMAL RECESSIVE 91	0.2	0	0	CTD_human
5271	SERPINB8	C0033860	Psoriasis	0.202407028523288	1	0	CTD_human
5272	SERPINB9	C0263454	Chloracne	0.2	1	0	CTD_human
5274	SERPINI1	C0014544	Epilepsy	0.2	0	0	HPO
5274	SERPINI1	C0028738	Nystagmus	0.2	0	0	HPO
5274	SERPINI1	C0235946	Cerebral atrophy	0.2	0	0	HPO
5274	SERPINI1	C0751778	Myoclonic Epilepsies, Progressive	0.202732912464814	1	0	CTD_human
5274	SERPINI1	C1858680	Familial encephalopathy with neuroserpin inclusion bodies	0.680824180352639	1	4	CTD_human;ORPHANET;UNIPROT
5274	SERPINI1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
5277	PIGA	C0002878	Anemia, Hemolytic	0.202197814273705	0	0	HPO
5277	PIGA	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
5277	PIGA	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
5277	PIGA	C0019050	Hemoglobinuria, Paroxysmal	0.205465824929628	2	0	CTD_human
5277	PIGA	C0024790	Paroxysmal nocturnal hemoglobinuria	0.439560656926686	0	0	HPO;ORPHANET
5277	PIGA	C0037769	West Syndrome	0.2	0	0	ORPHANET
5277	PIGA	C0085307	Embolism and Thrombosis	0.2	0	0	HPO
5277	PIGA	C0155320	Blindness, Cortical	0.2	0	0	HPO
5277	PIGA	C0235946	Cerebral atrophy	0.2	0	0	HPO
5277	PIGA	C0398623	Thrombophilia	0.200274726784213	0	0	HPO
5277	PIGA	C0543888	Epileptic encephalopathy	0.200549453568426	0	0	HPO
5277	PIGA	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
5277	PIGA	C3275508	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2	0.4	2	7	ORPHANET;UNIPROT
5277	PIGA	C3806670	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1	0.2	4	10	UNIPROT
5277	PIGA	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
5284	PIGR	C0017661	IGA Glomerulonephritis	0.202956482091714	0	0	CTD_human
5290	PIK3CA	C0002982	Angioid Streaks	0.2	0	0	HPO
5290	PIK3CA	C0012819	Diverticular disease of colon	0.2	0	0	HPO
5290	PIK3CA	C0014544	Epilepsy	0.200274726784213	0	0	HPO
5290	PIK3CA	C0015923	Fetal Alcohol Syndrome	0.200549453568426	1	0	PSYGENET
5290	PIK3CA	C0018418	Gynecomastia	0.2	0	0	HPO
5290	PIK3CA	C0020255	Hydrocephalus	0.2	0	0	HPO
5290	PIK3CA	C0020550	Hyperthyroidism	0.2	0	0	HPO
5290	PIK3CA	C0020676	Hypothyroidism	0.2	0	0	HPO
5290	PIK3CA	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
5290	PIK3CA	C0022603	Seborrheic keratosis	0.404381273170092	4	4	CTD_human;UNIPROT
5290	PIK3CA	C0024421	Macroglossia	0.2	0	0	HPO
5290	PIK3CA	C0027092	Myopia	0.2	0	0	HPO
5290	PIK3CA	C0029927	Ovarian Cysts	0.200274726784213	0	0	HPO
5290	PIK3CA	C0040147	Thyroiditis	0.2	0	0	HPO
5290	PIK3CA	C0040412	Fissured tongue	0.2	0	0	HPO
5290	PIK3CA	C0042341	Varicocele	0.2	0	0	HPO
5290	PIK3CA	C0151740	Intracranial Hypertension	0.2	0	0	HPO
5290	PIK3CA	C0263401	Cutis marmorata	0.2	0	0	HPO
5290	PIK3CA	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
5290	PIK3CA	C0334082	NEVUS, EPIDERMAL (disorder)	0.201098907136852	0	0	CTD_human
5290	PIK3CA	C0431391	Hemimegalencephaly	0.200824180352639	0	0	ORPHANET
5290	PIK3CA	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
5290	PIK3CA	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
5290	PIK3CA	C1863924	Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	0.2	1	0	CTD_human
5290	PIK3CA	C1865285	Megalencephaly cutis marmorata telangiectatica congenita	0.401098907136852	15	12	ORPHANET;UNIPROT
5290	PIK3CA	C1955869	Malformations of Cortical Development	0.200274726784213	1	0	CTD_human
5290	PIK3CA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5290	PIK3CA	C2752042	Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi	0.400824180352639	17	3	ORPHANET;UNIPROT
5290	PIK3CA	C3554518	COWDEN SYNDROME 5	0.2	3	7	UNIPROT
5290	PIK3CA	C4020884	Anxiety disease	0.2	0	0	HPO
5290	PIK3CA	C4021849	Conjunctival hamartoma	0.2	0	0	HPO
5290	PIK3CA	C4021977	Visceral angiomatosis	0.2	0	0	HPO
5292	PIM1	C0034186	Pyelonephritis	0.200274726784213	1	0	CTD_human
5292	PIM1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
5293	PIK3CD	C0006267	Bronchiectasis	0.2	0	0	HPO
5293	PIK3CD	C0086438	Hypogammaglobulinemia	0.200274726784213	0	0	HPO
5293	PIK3CD	C3714976	ACTIVATED PI3K-DELTA SYNDROME	0.400549453568426	1	4	ORPHANET;UNIPROT
5294	PIK3CG	C0018801	Heart failure	0.201098907136852	1	0	CTD_human
5295	PIK3R1	C0001768	Agammaglobulinemia	0.200274726784213	0	0	HPO
5295	PIK3R1	C0003864	Arthritis	0.2	0	0	HPO
5295	PIK3R1	C0009763	Conjunctivitis	0.2	0	0	HPO
5295	PIK3R1	C0014306	Enophthalmos	0.2	0	0	HPO
5295	PIK3R1	C0017601	Glaucoma	0.2	0	0	HPO
5295	PIK3R1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5295	PIK3R1	C0020456	Hyperglycemia	0.200274726784213	0	0	HPO
5295	PIK3R1	C0023787	Lipodystrophy	0.200824180352639	0	0	HPO
5295	PIK3R1	C0024636	Malocclusion	0.2	0	0	HPO
5295	PIK3R1	C0027092	Myopia	0.2	0	0	HPO
5295	PIK3R1	C0029443	Osteomyelitis	0.2	0	0	HPO
5295	PIK3R1	C0037199	Sinusitis	0.2	0	0	HPO
5295	PIK3R1	C0086438	Hypogammaglobulinemia	0.200274726784213	0	0	HPO
5295	PIK3R1	C0265341	Rieger syndrome	0.200549453568426	0	0	HPO
5295	PIK3R1	C0271441	Chronic otitis media	0.2	0	0	HPO
5295	PIK3R1	C0743359	ear infection chronic	0.2	0	0	HPO
5295	PIK3R1	C0854110	Insulin resistant diabetes	0.2	0	0	HPO
5295	PIK3R1	C0878684	SHORT syndrome	0.401098907136852	2	10	ORPHANET;UNIPROT
5295	PIK3R1	C1280433	Lipoatrophy	0.200549453568426	0	0	HPO
5295	PIK3R1	C2242472	Infection of bone	0.2	0	0	HPO
5295	PIK3R1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5295	PIK3R1	C3152144	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
5295	PIK3R1	C3714976	ACTIVATED PI3K-DELTA SYNDROME	0.2	0	0	ORPHANET
5295	PIK3R1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
5296	PIK3R2	C0014544	Epilepsy	0.2	0	0	HPO
5296	PIK3R2	C0020255	Hydrocephalus	0.2	0	0	HPO
5296	PIK3R2	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
5296	PIK3R2	C0234958	muscle degeneration	0.2	0	0	HPO
5296	PIK3R2	C0271215	Blindness, Legal	0.2	0	0	HPO
5296	PIK3R2	C1863924	Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	0.200274726784213	1	2	CTD_human
5296	PIK3R2	C4012727	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1	0.2	3	3	UNIPROT
5297	PI4KA	C0003886	Arthrogryposis	0.200274726784213	0	0	HPO
5297	PI4KA	C4225295	POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS	0.2	1	2	UNIPROT
5304	PIP	C0037199	Sinusitis	0.2	1	0	CTD_human
5307	PITX1	C1861313	Synostosis, Carpal, with Dysplastic Elbow Joints and Brachydactyly	0.200549453568426	0	0	ORPHANET
5308	PITX2	C0017601	Glaucoma	0.207938365987545	0	0	HPO
5308	PITX2	C0038379	Strabismus	0.2	0	0	HPO
5308	PITX2	C0265341	Rieger syndrome	0.406043989252688	0	0	HPO;ORPHANET
5308	PITX2	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5308	PITX2	C1842031	IRIDOGONIODYSGENESIS, TYPE 2	0.400824180352639	2	3	CTD_human;UNIPROT
5308	PITX2	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
5308	PITX2	C1867155	RING DERMOID OF CORNEA	0.6	2	2	CTD_human;ORPHANET;UNIPROT
5308	PITX2	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
5308	PITX2	C3714873	Axenfeld-Rieger Syndrome, Type 1	0.480274726784213	10	6	CTD_human;UNIPROT
5308	PITX2	C4020889	Cornela disease	0.2	0	0	HPO
5309	PITX3	C1862839	Anterior segment mesenchymal dysgenesis	0.481373633921066	2	0	CTD_human;ORPHANET
5309	PITX3	C1864567	CATARACT, POSTERIOR POLAR, 4 (disorder)	0.4	2	1	CTD_human;UNIPROT
5309	PITX3	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
5310	PKD1	C0010709	Cyst	0.215616360568195	1	0	CTD_human
5310	PKD1	C0012819	Diverticular disease of colon	0.2	0	0	HPO
5310	PKD1	C0035078	Kidney Failure	0.203021994626344	0	0	HPO
5310	PKD1	C0267834	Liver cyst	0.201373633921065	0	0	HPO
5310	PKD1	C0751003	Brain Aneurysm	0.2	0	0	HPO
5310	PKD1	C1290398	Cerebral arterial aneurysm	0.2	0	0	HPO
5310	PKD1	C1565489	Renal Insufficiency	0.200824180352639	0	0	HPO
5310	PKD1	C1838327	Polycystic kidneys, severe infantile with tuberous sclerosis	0.2	0	0	ORPHANET
5310	PKD1	C3149841	POLYCYSTIC KIDNEY DISEASE 1	0.285978476718058	26	34	UNIPROT
5311	PKD2	C0035078	Kidney Failure	0.201098907136852	0	0	HPO
5311	PKD2	C1565489	Renal Insufficiency	0.200274726784213	0	0	HPO
5311	PKD2	C2751306	Polycystic kidney disease, type 2	0.281098907136852	6	8	UNIPROT
5313	PKLR	C0008325	Cholecystitis	0.2	0	0	HPO
5313	PKLR	C0008350	Cholelithiasis	0.2	0	0	HPO
5313	PKLR	C0032461	Polycythemia	0.2	0	0	HPO
5313	PKLR	C0268306	Unconjugated hyperbilirubinemia	0.2	0	0	HPO
5313	PKLR	C0340968	Deficiency of pyruvate kinase	0.683296721410557	16	42	CTD_human;ORPHANET;UNIPROT
5313	PKLR	C1387532	Chronic hemolytic anemia	0.202407028523288	0	0	HPO
5313	PKLR	C1863224	Adenosine Triphosphate, Elevated, Of Erythrocytes	0.4	1	1	CTD_human;UNIPROT
5314	PKHD1	C0020541	Hypertension, Portal	0.2	0	0	HPO
5314	PKHD1	C0022679	Cystic kidney	0.2	0	0	HPO
5314	PKHD1	C0030283	Pancreatic Cyst	0.2	0	0	HPO
5314	PKHD1	C0035078	Kidney Failure	0.200274726784213	0	0	HPO
5314	PKHD1	C0267834	Liver cyst	0.200274726784213	0	0	HPO
5314	PKHD1	C1565489	Renal Insufficiency	0.2	0	0	HPO
5314	PKHD1	C1833541	Caroli disease isolated	0.2	0	0	ORPHANET
5315	PKM	C0029456	Osteoporosis	0.2	1	0	CTD_human
5317	PKP1	C0002170	Alopecia	0.2	0	0	HPO
5317	PKP1	C0005741	Blepharitis	0.2	0	0	HPO
5317	PKP1	C0022596	Palmoplantar Keratosis	0.200274726784213	0	0	HPO
5317	PKP1	C0040412	Fissured tongue	0.2	0	0	HPO
5317	PKP1	C0259817	Xerosis	0.2	0	0	HPO
5317	PKP1	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
5317	PKP1	C0401151	Chronic diarrhea	0.2	0	0	HPO
5317	PKP1	C1858302	Ectodermal dysplasia/ skin fragility syndrome	0.402197814273705	0	0	CTD_human;ORPHANET
5317	PKP1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5318	PKP2	C0002940	Aneurysm	0.2	0	0	HPO
5318	PKP2	C0085612	Ventricular arrhythmia	0.200274726784213	0	0	HPO
5318	PKP2	C0392464	Ventricular aneurysm	0.2	0	0	HPO
5318	PKP2	C1836906	Arrhythmogenic Right Ventricular Dysplasia, Familial, 9	0.4	3	14	CTD_human;UNIPROT
5318	PKP2	C2063326	Cardiomyopathy, right ventricular	0.2	0	0	HPO
5318	PKP2	C4020848	Aneurysmal disease	0.2	0	0	HPO
5320	PLA2G2A	C0004153	Atherosclerosis	0.206579087443797	1	0	CTD_human
5320	PLA2G2A	C0014175	Endometriosis	0.2	1	0	CTD_human
5320	PLA2G2A	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5321	PLA2G4A	C0002736	Amyotrophic Lateral Sclerosis	0.200274726784213	1	0	CTD_human
5321	PLA2G4A	C0011603	Dermatitis	0.2	1	0	CTD_human
5321	PLA2G4A	C0013295	Duodenal Ulcer	0.200274726784213	1	0	CTD_human
5321	PLA2G4A	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
5322	PLA2G5	C1856718	Fleck Retina, Familial Benign	0.4	1	3	ORPHANET;UNIPROT
5325	PLAGL1	C0003886	Arthrogryposis	0.2	0	0	HPO
5325	PLAGL1	C0020456	Hyperglycemia	0.200274726784213	0	0	HPO
5325	PLAGL1	C0162275	Ketonuria	0.2	0	0	HPO
5325	PLAGL1	C0342273	Transient neonatal diabetes mellitus	0.202472541057918	0	0	HPO
5325	PLAGL1	C1832386	Diabetes Mellitus, Transient Neonatal, 1	0.401648360705279	0	0	CTD_human;ORPHANET
5325	PLAGL1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5327	PLAT	C0004153	Atherosclerosis	0.206513574909167	1	0	CTD_human
5327	PLAT	C0004610	Bacteremia	0.2	1	0	CTD_human
5327	PLAT	C0007177	Cardiac Tamponade	0.2	1	0	CTD_human
5327	PLAT	C0007781	Intracranial Embolism and Thrombosis	0.2	2	0	CTD_human
5327	PLAT	C0007785	Cerebral Infarction	0.200824180352639	6	0	CTD_human
5327	PLAT	C0007786	Brain Ischemia	0.207221085569864	25	0	CTD_human
5327	PLAT	C0010072	Coronary Thrombosis	0.200549453568426	3	0	CTD_human
5327	PLAT	C0018801	Heart failure	0.2	1	0	CTD_human
5327	PLAT	C0025309	Meningoencephalitis	0.2	1	0	CTD_human
5327	PLAT	C0027051	Myocardial Infarction	0.213027149818335	35	0	CTD_human
5327	PLAT	C0031039	Pericardial effusion	0.2	1	0	CTD_human
5327	PLAT	C0034065	Pulmonary Embolism	0.200274726784213	9	0	CTD_human
5327	PLAT	C0037926	Compression of spinal cord	0.2	1	0	CTD_human
5327	PLAT	C0085307	Embolism and Thrombosis	0.2	1	0	CTD_human
5327	PLAT	C0149649	Cholesterol Embolism	0.2	1	0	CTD_human
5327	PLAT	C0162820	Dermatitis, Allergic Contact	0.200274726784213	1	0	CTD_human
5327	PLAT	C0398623	Thrombophilia	0.2	0	0	HPO
5327	PLAT	C0740392	Infarction, Middle Cerebral Artery	0.28	4	0	CTD_human
5327	PLAT	C0751895	Vasospasm, Intracranial	0.2	1	0	CTD_human
5327	PLAT	C0751955	Brain Infarction	0.2	1	0	CTD_human
5327	PLAT	C0752143	Intracranial Thrombosis	0.2	1	0	CTD_human
5327	PLAT	C2676721	Thrombophilia, Familial, Due To Decreased Release Of Tissue Plasminogen Activator	0.2	0	0	CTD_human
5327	PLAT	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
5328	PLAU	C0002395	Alzheimer's Disease	0.307296908488475	0	0	CTD_human
5328	PLAU	C0002965	Angina, Unstable	0.2	1	0	CTD_human
5328	PLAU	C0004096	Asthma	0.208748190962867	1	0	CTD_human
5328	PLAU	C0007781	Intracranial Embolism and Thrombosis	0.2	1	0	CTD_human
5328	PLAU	C0007785	Cerebral Infarction	0.2	3	0	CTD_human
5328	PLAU	C0007786	Brain Ischemia	0.2	4	0	CTD_human
5328	PLAU	C0010068	Coronary heart disease	0.200274726784213	2	0	CTD_human
5328	PLAU	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
5328	PLAU	C0018814	Heart Rupture, Post-Infarction	0.2	1	0	CTD_human
5328	PLAU	C0023890	Liver Cirrhosis	0.200274726784213	2	0	CTD_human
5328	PLAU	C0027051	Myocardial Infarction	0.282681755307501	6	0	CTD_human
5328	PLAU	C0027697	Nephritis	0.2	1	0	CTD_human
5328	PLAU	C0034065	Pulmonary Embolism	0.2	6	0	CTD_human
5328	PLAU	C0034152	Henoch-Schoenlein Purpura	0.2	2	0	CTD_human
5328	PLAU	C0042510	Ventricular Fibrillation	0.2	1	0	CTD_human
5328	PLAU	C0149649	Cholesterol Embolism	0.2	1	0	CTD_human
5328	PLAU	C0338575	Sagittal Sinus Thrombosis	0.2	1	0	CTD_human
5328	PLAU	C0403823	Asthenozoospermia	0.28	1	0	CTD_human
5328	PLAU	C0740392	Infarction, Middle Cerebral Artery	0.2	3	0	CTD_human
5328	PLAU	C1800706	Idiopathic Pulmonary Fibrosis	0.203007639249027	1	0	CTD_human
5328	PLAU	C1866423	Quebec platelet disorder	0.203780662444353	0	0	ORPHANET
5329	PLAUR	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
5332	PLCB4	C0024636	Malocclusion	0.2	0	0	HPO
5332	PLCB4	C1865295	Auriculo-condylar syndrome	0.201098907136852	0	0	ORPHANET
5332	PLCB4	C3553404	AURICULOCONDYLAR SYNDROME 2	0.2	1	8	UNIPROT
5332	PLCB4	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
5333	PLCD1	C0005741	Blepharitis	0.2	0	0	HPO
5333	PLCD1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
5333	PLCD1	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
5333	PLCD1	C0392525	Nephrolithiasis	0.2	0	0	HPO
53335	BCL11A	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
53341	MHAC	C1857977	MICROHYDRANENCEPHALY	0.200274726784213	0	0	CTD_human
53345	TM6SF2	C0023891	Liver Cirrhosis, Alcoholic	0.200274726784213	1	0	CTD_human
53345	TM6SF2	C0027051	Myocardial Infarction	0.200274726784213	1	0	CTD_human
53345	TM6SF2	C0400966	Non-alcoholic Fatty Liver Disease	0.205494535684262	1	0	CTD_human
5336	PLCG2	C0006271	Bronchiolitis	0.2	0	0	HPO
5336	PLCG2	C0042109	Urticaria	0.2	0	0	HPO
5336	PLCG2	C0042900	Vitiligo	0.2	0	0	HPO
5336	PLCG2	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
5336	PLCG2	C0206061	Pneumonia, Interstitial	0.2	0	0	HPO
5336	PLCG2	C0677607	Hashimoto Disease	0.2	0	0	HPO
5336	PLCG2	C2607914	Allergic rhinitis (disorder)	0.2	0	0	HPO
5336	PLCG2	C3280914	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3	0.2	0	0	ORPHANET
5336	PLCG2	C3553961	AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED	0.4	1	1	ORPHANET;UNIPROT
53368	MDC1B	C1858118	Muscular Dystrophy, Congenital, 1B	0.2	0	0	CTD_human
53369	HDL3	C1858114	HUNTINGTON DISEASE-LIKE 3 (disorder)	0.2	0	0	CTD_human
5337	PLD1	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
53373	TPCN1	C0028960	Oligospermia	0.2	1	0	CTD_human
5339	PLEC	C0002871	Anemia	0.2	0	0	HPO
5339	PLEC	C0003886	Arthrogryposis	0.2	0	0	HPO
5339	PLEC	C0011334	Dental caries	0.2	0	0	HPO
5339	PLEC	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
5339	PLEC	C0013592	Ectropion	0.2	0	0	HPO
5339	PLEC	C0014306	Enophthalmos	0.2	0	0	HPO
5339	PLEC	C0020295	Hydronephrosis	0.2	0	0	HPO
5339	PLEC	C0022568	Keratitis	0.2	0	0	HPO
5339	PLEC	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
5339	PLEC	C0026850	Muscular Dystrophy	0.208516530310606	0	0	HPO
5339	PLEC	C0036690	Septicemia	0.2	0	0	HPO
5339	PLEC	C0178664	Glomerulosclerosis (disorder)	0.2	0	0	HPO
5339	PLEC	C0221260	Dystrophia unguium	0.2	0	0	HPO
5339	PLEC	C0234958	muscle degeneration	0.2	0	0	HPO
5339	PLEC	C0263537	Onychogryposis	0.2	0	0	HPO
5339	PLEC	C0432317	Epidermolysis bullosa simplex, Ogna type	0.68	1	1	CTD_human;ORPHANET;UNIPROT
5339	PLEC	C0743178	Diarrhea, intractable	0.2	0	0	HPO
5339	PLEC	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
5339	PLEC	C1562761	Punctate epithelial keratitis	0.2	0	0	HPO
5339	PLEC	C1834405	Nail dysplasia	0.2	0	0	HPO
5339	PLEC	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5339	PLEC	C2677349	Epidermolysis Bullosa Simplex With Pyloric Atresia	0.400824180352639	0	0	CTD_human;ORPHANET
5339	PLEC	C2931072	Epidermolysa bullosa simplex and limb girdle muscular dystrophy	0.483846174978983	0	0	CTD_human;ORPHANET
5339	PLEC	C3150989	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q	0.600274726784213	2	1	CTD_human;ORPHANET;UNIPROT
5339	PLEC	C3887524	Skin Erosion	0.2	0	0	HPO
5339	PLEC	C4021730	Junctional split	0.2	0	0	HPO
5340	PLG	C0009763	Conjunctivitis	0.2	0	0	HPO
5340	PLG	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
5340	PLG	C0013295	Duodenal Ulcer	0.2	0	0	HPO
5340	PLG	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
5340	PLG	C0017574	Gingivitis	0.2	0	0	HPO
5340	PLG	C0020255	Hydrocephalus	0.2	0	0	HPO
5340	PLG	C0022573	Keratoconjunctivitis	0.2	0	0	HPO
5340	PLG	C0031099	Periodontitis	0.201373633921065	0	0	HPO
5340	PLG	C0038362	Stomatitis	0.2	0	0	HPO
5340	PLG	C0149704	Gingivostomatitis	0.2	0	0	HPO
5340	PLG	C0152227	Excessive tearing	0.2	0	0	HPO
5340	PLG	C0271215	Blindness, Legal	0.2	0	0	HPO
5340	PLG	C0392525	Nephrolithiasis	0.2	0	0	HPO
5340	PLG	C0398621	Hypoplasminogenemia	0.202747267842131	0	0	ORPHANET
5340	PLG	C0399385	Early tooth exfoliation	0.2	0	0	HPO
5340	PLG	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
5340	PLG	C0694550	Recurrent pneumonia	0.2	0	0	HPO
5340	PLG	C0741796	Recurrent bronchitis	0.2	0	0	HPO
5340	PLG	C0747085	Recurrent otitis media	0.2	0	0	HPO
5340	PLG	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
5340	PLG	C1274789	Ligneous conjunctivitis	0.203296721410557	0	0	ORPHANET
5340	PLG	C1535950	Gastrointestinal inflammation	0.2	0	0	HPO
5340	PLG	C1968804	Plasminogen Deficiency, Type I	0.482472541057918	6	12	CTD_human;UNIPROT
5340	PLG	C4024810	Chronic irritative conjunctivitis	0.2	0	0	HPO
5340	PLG	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
53405	CLIC5	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
53405	CLIC5	C0235927	Vestibulocerebellar ataxia	0.2	0	0	HPO
5341	PLEK	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
5341	PLEK	C0029456	Osteoporosis	0.2	1	0	CTD_human
5345	SERPINF2	C2752081	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY	0.48	1	2	ORPHANET;UNIPROT
5345	SERPINF2	C3489734	Anti-plasmin deficiency, congenital	0.2	0	0	CTD_human
5346	PLIN1	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
5346	PLIN1	C0020459	Hyperinsulinism	0.200274726784213	0	0	HPO
5346	PLIN1	C0028754	Obesity	0.228596938849549	1	0	CTD_human
5346	PLIN1	C0032460	Polycystic Ovary Syndrome	0.202681755307501	0	0	HPO
5346	PLIN1	C0239946	Fibrosis, Liver	0.2	0	0	HPO
5346	PLIN1	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
5346	PLIN1	C1280433	Lipoatrophy	0.2	0	0	HPO
5346	PLIN1	C2711227	Steatohepatitis	0.200549453568426	0	0	HPO
5346	PLIN1	C3151268	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4	0.2	0	0	ORPHANET
5350	PLN	C0004238	Atrial Fibrillation	0.200549453568426	0	0	HPO
5350	PLN	C0027051	Myocardial Infarction	0.280274726784213	2	0	CTD_human
5350	PLN	C0085612	Ventricular arrhythmia	0.201098907136852	0	0	HPO
5350	PLN	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
5350	PLN	C0206146	Myocardial Stunning	0.2	1	0	CTD_human
5350	PLN	C1835928	CARDIOMYOPATHY, DILATED, 1P	0.4	2	4	CTD_human;UNIPROT
5350	PLN	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
5350	PLN	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
5351	PLOD1	C0002949	Aneurysm, Dissecting	0.2	0	0	HPO
5351	PLOD1	C0017601	Glaucoma	0.2	0	0	HPO
5351	PLOD1	C0018801	Heart failure	0.2	0	0	HPO
5351	PLOD1	C0018802	Congestive heart failure	0.2	0	0	HPO
5351	PLOD1	C0022578	Keratoconus	0.2	0	0	HPO
5351	PLOD1	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
5351	PLOD1	C0027092	Myopia	0.2	0	0	HPO
5351	PLOD1	C0029456	Osteoporosis	0.202407028523288	0	0	HPO
5351	PLOD1	C0035305	Retinal Detachment	0.2	0	0	HPO
5351	PLOD1	C0042798	Low Vision	0.2	0	0	HPO
5351	PLOD1	C0268342	Ehlers-Danlos syndrome type 6	0.682197814273705	5	12	CTD_human;ORPHANET;UNIPROT
5351	PLOD1	C0271215	Blindness, Legal	0.2	0	0	HPO
5351	PLOD1	C0340643	Dissection of aorta	0.2	0	0	HPO
5351	PLOD1	C0694550	Recurrent pneumonia	0.2	0	0	HPO
5351	PLOD1	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
5351	PLOD1	C0854107	Haemorrhage subcutaneous	0.2	0	0	HPO
5351	PLOD1	C1844597	Molluscoid pseudotumors	0.2	0	0	HPO
5351	PLOD1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
5351	PLOD1	C2936777	Nevo syndrome (disorder)	0.2	1	0	CTD_human
5351	PLOD1	C4023719	Spontaneous rupture of the globe	0.2	0	0	HPO
5352	PLOD2	C0003886	Arthrogryposis	0.2	0	0	HPO
5352	PLOD2	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
5352	PLOD2	C0029408	Degenerative polyarthritis	0.200274726784213	1	0	CTD_human
5352	PLOD2	C0029453	Osteopenia	0.2	0	0	HPO
5352	PLOD2	C0029456	Osteoporosis	0.2	0	0	HPO
5352	PLOD2	C0033999	Pterygium	0.2	0	0	HPO
5352	PLOD2	C0432253	Bruck syndrome	0.201923087489492	0	0	ORPHANET
5352	PLOD2	C0747078	Generalized osteopenia	0.2	0	0	HPO
5352	PLOD2	C1836602	Bruck syndrome 2	0.4	2	3	CTD_human;UNIPROT
5352	PLOD2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
5354	PLP1	C0015732	Fecal Incontinence	0.2	0	0	HPO
5354	PLP1	C0028738	Nystagmus	0.201098907136852	0	0	HPO
5354	PLP1	C0029124	Optic Atrophy	0.2	0	0	HPO
5354	PLP1	C0037772	Spastic Paraplegia	0.201923087489492	0	0	HPO
5354	PLP1	C0085583	Choreoathetosis	0.2	0	0	HPO
5354	PLP1	C0205711	Pelizaeus-Merzbacher Disease	0.740599776292557	31	16	CTD_human;HPO;UNIPROT
5354	PLP1	C0234958	muscle degeneration	0.2	0	0	HPO
5354	PLP1	C0240595	Rotary Nystagmus	0.2	0	0	HPO
5354	PLP1	C0751916	Classic Pelizaeus-Merzbacher Disease	0.2	0	0	ORPHANET
5354	PLP1	C0751917	Pelizaeus-Merzbacher Disease, Transitional	0.2	0	0	ORPHANET
5354	PLP1	C1839264	SPASTIC PARAPLEGIA 2, X-LINKED (disorder)	0.684670355331623	9	6	CTD_human;ORPHANET;UNIPROT
5354	PLP1	C1866751	Spinocerebellar tract degeneration	0.2	0	0	HPO
5354	PLP1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5354	PLP1	C4020871	Dystonic disease	0.2	0	0	HPO
5358	PLS3	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
5358	PLS3	C0029453	Osteopenia	0.2	0	0	HPO
5358	PLS3	C0029456	Osteoporosis	0.201373633921065	0	0	HPO
5358	PLS3	C0747078	Generalized osteopenia	0.2	0	0	HPO
5359	PLSCR1	C0021400	Influenza	0.2	1	0	CTD_human
53630	BCO1	C0042842	Vitamin A Deficiency	0.200274726784213	0	0	HPO
53630	BCO1	C2676023	Hypercarotenemia And Vitamin A Deficiency, Autosomal Dominant	0.6	1	1	CTD_human;ORPHANET;UNIPROT
5367	PMCH	C0028754	Obesity	0.201098907136852	1	0	CTD_human
5371	PML	C0029401	Osteitis Deformans	0.2	1	1	CTD_human
5371	PML	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
5373	PMM2	C0014544	Epilepsy	0.2	0	0	HPO
5373	PMM2	C0014877	Esotropia	0.2	0	0	HPO
5373	PMM2	C0015523	Factor XI Deficiency	0.2	0	0	HPO
5373	PMM2	C0020676	Hypothyroidism	0.2	0	0	HPO
5373	PMM2	C0022679	Cystic kidney	0.2	0	0	HPO
5373	PMM2	C0028738	Nystagmus	0.2	0	0	HPO
5373	PMM2	C0029453	Osteopenia	0.2	0	0	HPO
5373	PMM2	C0031039	Pericardial effusion	0.2	0	0	HPO
5373	PMM2	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	HPO
5373	PMM2	C0085215	Ovarian Failure, Premature	0.200274726784213	0	0	HPO
5373	PMM2	C0151718	Hypocholesterolemia	0.2	0	0	HPO
5373	PMM2	C0152025	Polyneuropathy	0.2	0	0	HPO
5373	PMM2	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
5373	PMM2	C0162539	IgG Deficiency	0.2	0	0	HPO
5373	PMM2	C0239946	Fibrosis, Liver	0.2	0	0	HPO
5373	PMM2	C0239981	Hypoalbuminemia	0.2	0	0	HPO
5373	PMM2	C0272375	Antithrombin III Deficiency	0.2	0	0	HPO
5373	PMM2	C0349653	Congenital disorder of glycosylation type 1A	0.689065983879032	9	55	CTD_human;ORPHANET;UNIPROT
5373	PMM2	C0455988	Hydrops Fetalis, Non-Immune	0.2	0	0	HPO
5373	PMM2	C0747078	Generalized osteopenia	0.2	0	0	HPO
5373	PMM2	C0836924	Thrombocytosis	0.2	0	0	HPO
5373	PMM2	C0948896	Primary hypogonadism	0.2	0	0	HPO
5373	PMM2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5373	PMM2	C2711227	Steatohepatitis	0.2	0	0	HPO
5376	PMP22	C0007959	Charcot-Marie-Tooth Disease	0.265801724410261	3	0	CTD_human
5376	PMP22	C0011195	Dejerine-Sottas Disease (disorder)	0.494154767709821	18	6	ORPHANET;UNIPROT
5376	PMP22	C0014550	Epilepsies, Myoclonic	0.2	1	0	CTD_human
5376	PMP22	C0018784	Sensorineural Hearing Loss (disorder)	0.200549453568426	0	0	HPO
5376	PMP22	C0034372	Quadriplegia	0.2	1	0	CTD_human
5376	PMP22	C0037921	Spinal ataxia	0.2	0	0	HPO
5376	PMP22	C0042928	Vocal Cord Paralysis	0.2	0	0	HPO
5376	PMP22	C0085684	Foot-drop	0.2	0	0	HPO
5376	PMP22	C0205713	Roussy-Levy Syndrome (disorder)	0.28	0	0	ORPHANET
5376	PMP22	C0270911	Charcot-Marie-Tooth Disease, Type Ia (disorder)	0.505968019430985	14	12	ORPHANET;UNIPROT
5376	PMP22	C0393814	Hereditary liability to pressure palsies	0.71543975516349	3	7	CTD_human;ORPHANET;UNIPROT
5376	PMP22	C1848736	Distal amyotrophy	0.200274726784213	0	0	HPO
5376	PMP22	C1861669	Charcot-Marie-Tooth disease and deafness	0.200274726784213	0	0	ORPHANET
5376	PMP22	C2931686	Charcot-Marie-Tooth disease, Type 1E	0.200274726784213	0	0	ORPHANET
5376	PMP22	C3495591	Charcot-Marie-Tooth Disease, Demyelinating, Type 1e	0.480549453568426	3	2	CTD_human;UNIPROT
5376	PMP22	C3542501	Acute inflammatory demyelinating polyneuropathy	0.200274726784213	0	0	ORPHANET
5378	PMS1	C0014544	Epilepsy	0.2	0	0	HPO
5378	PMS1	C0151740	Intracranial Hypertension	0.2	0	0	HPO
5378	PMS1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
5378	PMS1	C4020884	Anxiety disease	0.2	0	0	HPO
538	ATP7A	C0002871	Anemia	0.2	1	0	CTD_human
538	ATP7A	C0002940	Aneurysm	0.2	0	0	HPO
538	ATP7A	C0003496	Aortic Rupture	0.2	2	0	CTD_human
538	ATP7A	C0010495	Cutis Laxa	0.2	0	0	HPO
538	ATP7A	C0014544	Epilepsy	0.200549453568426	0	0	HPO
538	ATP7A	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
538	ATP7A	C0020295	Hydronephrosis	0.2	0	0	HPO
538	ATP7A	C0022716	Menkes Kinky Hair Syndrome	0.72793363346412	35	84	CTD_human;ORPHANET;UNIPROT
538	ATP7A	C0026847	Spinal Muscular Atrophy	0.2	0	0	HPO
538	ATP7A	C0029456	Osteoporosis	0.2	0	0	HPO
538	ATP7A	C0042485	Venous Insufficiency	0.2	0	0	HPO
538	ATP7A	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
538	ATP7A	C0259817	Xerosis	0.2	0	0	HPO
538	ATP7A	C0401151	Chronic diarrhea	0.2	0	0	HPO
538	ATP7A	C1836830	Developmental regression	0.2	0	0	HPO
538	ATP7A	C1845359	Spinal Muscular Atrophy, Distal, X-Linked 3	0.6	1	2	CTD_human;ORPHANET;UNIPROT
538	ATP7A	C1848736	Distal amyotrophy	0.2	0	0	HPO
538	ATP7A	C2930812	Generalized elastolysis	0.2	0	0	HPO
538	ATP7A	C3489393	Hiatal Hernia	0.2	0	0	HPO
538	ATP7A	C4020848	Aneurysmal disease	0.2	0	0	HPO
53834	FGFRL1	C0014544	Epilepsy	0.2	0	0	HPO
53834	FGFRL1	C0015300	Exophthalmos	0.2	0	0	HPO
53834	FGFRL1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
53834	FGFRL1	C0028738	Nystagmus	0.2	0	0	HPO
53834	FGFRL1	C0034013	Precocious Puberty	0.2	0	0	HPO
53834	FGFRL1	C0038379	Strabismus	0.2	0	0	HPO
53834	FGFRL1	C0265341	Rieger syndrome	0.2	0	0	HPO
53834	FGFRL1	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
53834	FGFRL1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
53904	MYO3A	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
53904	MYO3A	C1846784	Deafness, Autosomal Recessive 30	0.28	0	0	CTD_human
5395	PMS2	C0014544	Epilepsy	0.2	0	0	HPO
5395	PMS2	C0151740	Intracranial Hypertension	0.2	0	0	HPO
5395	PMS2	C0265325	Turcot syndrome (disorder)	0.603846174978984	4	12	CTD_human;ORPHANET;UNIPROT
5395	PMS2	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
5395	PMS2	C1838333	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4	0.2	0	0	UNIPROT
5395	PMS2	C4020884	Anxiety disease	0.2	0	0	HPO
5396	PRRX1	C0004238	Atrial Fibrillation	0.200549453568426	1	0	CTD_human
5396	PRRX1	C0018777	Conductive hearing loss	0.2	0	0	HPO
5396	PRRX1	C0948187	Tracheomalacia	0.2	0	0	HPO
5396	PRRX1	C1876185	Dysgnathia complex	0.600274726784213	2	3	CTD_human;ORPHANET;UNIPROT
54	ACP5	C0003873	Rheumatoid Arthritis	0.207114185634906	0	0	HPO
54	ACP5	C0020503	Hyperparathyroidism, Secondary	0.2	2	0	CTD_human
54	ACP5	C0020676	Hypothyroidism	0.2	0	0	HPO
54	ACP5	C0028754	Obesity	0.200274726784213	1	0	CTD_human
54	ACP5	C0032285	Pneumonia	0.2	0	0	HPO
54	ACP5	C0034150	Purpura	0.2	0	0	HPO
54	ACP5	C0042900	Vitiligo	0.2	0	0	HPO
54	ACP5	C0085581	Restrictive lung disease	0.2	0	0	HPO
54	ACP5	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
54	ACP5	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
54	ACP5	C0432222	Spondyloenchondrodysplasia	0.400549453568426	2	0	CTD_human;ORPHANET
54	ACP5	C0494261	Combined immunodeficiency	0.2	0	0	HPO
54	ACP5	C0581354	Recurrent sinusitis	0.2	0	0	HPO
54	ACP5	C0700635	Strudwick syndrome	0.2	0	0	HPO
54	ACP5	C0747085	Recurrent otitis media	0.2	0	0	HPO
54	ACP5	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
54	ACP5	C1842763	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION	0.2	2	10	UNIPROT
54	ACP5	C2931322	T-Lymphocytopenia	0.2	0	0	HPO
54	ACP5	C4280333	Recurrent sinus disease	0.2	0	0	HPO
540	ATP7B	C0002871	Anemia	0.2	0	0	HPO
540	ATP7B	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
540	ATP7B	C0003864	Arthritis	0.2	0	0	HPO
540	ATP7B	C0015695	Fatty Liver	0.2	1	0	CTD_human
540	ATP7B	C0019158	Hepatitis	0.20328236603324	2	0	CTD_human
540	ATP7B	C0019202	Hepatolenticular Degeneration	0.885769420275516	96	174	CTD_human;ORPHANET;UNIPROT
540	ATP7B	C0020626	Hypoparathyroidism	0.2	0	0	HPO
540	ATP7B	C0023890	Liver Cirrhosis	0.400274726784213	1	0	CTD_human;HPO
540	ATP7B	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
540	ATP7B	C0029442	Osteomalacia	0.2	0	0	HPO
540	ATP7B	C0029456	Osteoporosis	0.2	0	0	HPO
540	ATP7B	C0037036	Sialorrhea	0.2	0	0	HPO
540	ATP7B	C0085605	Liver Failure	0.200549453568426	0	0	HPO
540	ATP7B	C0151747	Renal tubular disorder	0.2	0	0	HPO
540	ATP7B	C0152457	Kayser-Fleischer ring	0.200549453568426	0	0	HPO
540	ATP7B	C0162557	Liver Failure, Acute	0.403231208875927	1	0	CTD_human;HPO
540	ATP7B	C0238621	Aminoaciduria	0.2	0	0	HPO
540	ATP7B	C0267797	Acute hepatitis	0.2	0	0	HPO
540	ATP7B	C0392525	Nephrolithiasis	0.2	0	0	HPO
540	ATP7B	C0553730	Calcium pyrophosphate deposition disease	0.2	0	0	HPO
540	ATP7B	C1848456	Atypical or prolonged hepatitis	0.2	0	0	HPO
540	ATP7B	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
540	ATP7B	C2711227	Steatohepatitis	0.200274726784213	0	0	HPO
540	ATP7B	C4020871	Dystonic disease	0.2	0	0	HPO
540	ATP7B	C4024907	Mixed demyelinating and axonal polyneuropathy	0.2	0	0	HPO
54014	BRWD1	C0028960	Oligospermia	0.2	1	0	CTD_human
5406	PNLIP	C0002888	Anemia, Megaloblastic	0.2	0	0	HPO
5406	PNLIP	C0030293	Pancreatic Insufficiency	0.2	0	0	HPO
5406	PNLIP	C0267963	Exocrine pancreatic insufficiency	0.2	0	0	HPO
5406	PNLIP	C0268241	Pancreatic colipase deficiency	0.2	0	0	ORPHANET
5406	PNLIP	C0401151	Chronic diarrhea	0.2	0	0	HPO
54084	TSPEAR	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
54101	RIPK4	C0263504	Alopecia totalis	0.2	0	0	HPO
54101	RIPK4	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
54101	RIPK4	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
54101	RIPK4	C1849718	POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE	0.481923087489492	2	3	ORPHANET;UNIPROT
54106	TLR9	C0010346	Crohn Disease	0.210727021230004	2	0	CTD_human
54106	TLR9	C0036330	Schistosomiasis mansoni	0.2	1	0	CTD_human
54109	CORD8	C1854180	CONE-ROD DYSTROPHY 8 (disorder)	0.2	0	0	CTD_human
54110	RP29	C2677325	RETINITIS PIGMENTOSA 29 (disorder)	0.2	0	0	CTD_human
54113	VUR	C0042580	Vesico-Ureteral Reflux	0.201098907136852	0	0	CTD_human
54114	ODPF	C1846129	Terminal Osseous Dysplasia and Pigmentary Defects	0.2	0	0	CTD_human
54115	PTOS2	C1846128	Ptosis, Hereditary Congenital 2	0.2	0	0	CTD_human
54119	EIM	C0917800	Epilepsy, Myoclonic, Infantile	0.2	0	0	CTD_human
5413	SEPT5	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
541461	PSHK2	C1836705	Pseudohyperkalemia, Familial, 2, due to Red Cell Leak	0.2	0	0	CTD_human
54187	NANS	C0028738	Nystagmus	0.2	0	0	HPO
54187	NANS	C1864872	Spondyloepimetaphyseal dysplasia, Genevieve type	0.4	1	8	ORPHANET;UNIPROT
5420	PODXL	C3809811	PARKINSON DISEASE 19, JUVENILE-ONSET	0.2	0	0	ORPHANET
5420	PODXL	C4275179	Young onset Parkinson disease	0.2	0	0	ORPHANET
54205	CYCS	C0007786	Brain Ischemia	0.2	1	0	CTD_human
54205	CYCS	C0007787	Transient Ischemic Attack	0.2	1	0	CTD_human
54205	CYCS	C0015695	Fatty Liver	0.2	1	0	CTD_human
54205	CYCS	C0028754	Obesity	0.2	1	0	CTD_human
54205	CYCS	C0263454	Chloracne	0.2	1	0	CTD_human
54205	CYCS	C2677608	Thrombocytopenia 4	0.400274726784213	1	2	CTD_human;UNIPROT
54206	ERRFI1	C0014175	Endometriosis	0.2	1	0	CTD_human
54206	ERRFI1	C0032460	Polycystic Ovary Syndrome	0.200274726784213	1	0	CTD_human
54209	TREM2	C0002395	Alzheimer's Disease	0.220864880222878	1	1	CTD_human
54209	TREM2	C0002736	Amyotrophic Lateral Sclerosis	0.402197814273705	0	0	HPO;ORPHANET
54209	TREM2	C0014544	Epilepsy	0.2	0	0	HPO
54209	TREM2	C0234958	muscle degeneration	0.2	0	0	HPO
54209	TREM2	C0235946	Cerebral atrophy	0.2	0	0	HPO
54209	TREM2	C0338451	Frontotemporal dementia	0.20357144819477	0	0	HPO
54209	TREM2	C0338455	Dementia of frontal lobe type	0.2	0	0	HPO
54209	TREM2	C1145670	Respiratory Failure	0.2	0	0	HPO
54209	TREM2	C1836830	Developmental regression	0.2	0	0	HPO
54209	TREM2	C1857316	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	0.606043989252688	1	13	CTD_human;ORPHANET;UNIPROT
54209	TREM2	C3489733	Oculomotor apraxia	0.2	0	0	HPO
54209	TREM2	C4011788	Behavioral variant of frontotemporal dementia	0.2	0	0	ORPHANET
54209	TREM2	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
54209	TREM2	C4020858	Choreatic disease	0.2	0	0	HPO
54209	TREM2	C4020860	Supratentorial atrophy	0.2	0	0	HPO
54209	TREM2	C4020884	Anxiety disease	0.2	0	0	HPO
54209	TREM2	C4021584	Frontotemporal cerebral atrophy	0.2	0	0	HPO
54209	TREM2	C4024936	Temporal cortical atrophy	0.2	0	0	HPO
54209	TREM2	C4024956	Grammar-specific speech disorder	0.2	0	0	HPO
5422	POLA1	C0002726	Amyloidosis	0.2	0	0	HPO
5422	POLA1	C0014544	Epilepsy	0.2	0	0	HPO
5422	POLA1	C0042798	Low Vision	0.2	0	0	HPO
5422	POLA1	C0694550	Recurrent pneumonia	0.2	0	0	HPO
5422	POLA1	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
5422	POLA1	C1845050	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS	0.2	0	0	ORPHANET
5422	POLA1	C4082764	Gastrointestinal infection	0.2	0	0	HPO
5424	POLD1	C0015300	Exophthalmos	0.2	0	0	HPO
5424	POLD1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5424	POLD1	C0020619	Hypogonadism	0.4	1	0	CTD_human;HPO
5424	POLD1	C0023787	Lipodystrophy	0.400549453568426	1	0	CTD_human;HPO
5424	POLD1	C0029456	Osteoporosis	0.2	0	0	HPO
5424	POLD1	C0039446	Telangiectasis	0.2	0	0	HPO
5424	POLD1	C2711227	Steatohepatitis	0.2	0	0	HPO
5424	POLD1	C3715192	ANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME	0.200549453568426	0	0	ORPHANET
5426	POLE	C3554576	FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE	0.200274726784213	0	0	ORPHANET
5428	POLG	C0007795	Diffuse Cerebral Sclerosis of Schilder	0.219932121203657	3	0	CTD_human
5428	POLG	C0014544	Epilepsy	0.403021994626344	1	0	CTD_human;HPO
5428	POLG	C0018784	Sensorineural Hearing Loss (disorder)	0.202732912464814	0	0	HPO
5428	POLG	C0021847	Intestinal Pseudo-Obstruction	0.2	0	0	HPO
5428	POLG	C0023264	Leigh Disease	0.200274726784213	1	2	UNIPROT
5428	POLG	C0025322	Premature Menopause	0.200274726784213	0	0	HPO
5428	POLG	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
5428	POLG	C0028738	Nystagmus	0.200274726784213	0	0	HPO
5428	POLG	C0085543	Epilepsia Partialis Continua	0.200549453568426	0	0	HPO
5428	POLG	C0085583	Choreoathetosis	0.2	0	0	HPO
5428	POLG	C0085605	Liver Failure	0.201373633921065	0	0	HPO
5428	POLG	C0152020	Gastroparesis	0.200274726784213	0	0	HPO
5428	POLG	C0155320	Blindness, Cortical	0.202732912464814	0	0	HPO
5428	POLG	C0156312	Atrophy of testis	0.2	0	0	HPO
5428	POLG	C0162429	Malnutrition	0.2	0	0	HPO
5428	POLG	C0162674	Chronic progressive external ophthalmoplegia	0.440608554848007	1	0	CTD_human;HPO
5428	POLG	C0205710	Alpers Syndrome (disorder)	0.61153852493695	4	15	CTD_human;ORPHANET;UNIPROT
5428	POLG	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
5428	POLG	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
5428	POLG	C0234958	muscle degeneration	0.2	0	0	HPO
5428	POLG	C0262404	Cerebellar degeneration	0.2	0	0	HPO
5428	POLG	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
5428	POLG	C0267818	Bile duct proliferation	0.2	0	0	HPO
5428	POLG	C0376175	Bell Palsy	0.2	0	0	HPO
5428	POLG	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
5428	POLG	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
5428	POLG	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
5428	POLG	C0872218	MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME	0.4	0	0	CTD_human;ORPHANET
5428	POLG	C0948896	Primary hypogonadism	0.2	0	0	HPO
5428	POLG	C1389113	Generalized amyotrophy	0.2	0	0	HPO
5428	POLG	C1834846	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1	0.6	8	7	CTD_human;ORPHANET;UNIPROT
5428	POLG	C1836830	Developmental regression	0.2	0	0	HPO
5428	POLG	C1843851	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis	0.601648360705279	14	12	CTD_human;ORPHANET;UNIPROT
5428	POLG	C1843852	SPINOCEREBELLAR ATAXIA WITH EPILEPSY	0.200824180352639	0	0	ORPHANET
5428	POLG	C1848736	Distal amyotrophy	0.2	0	0	HPO
5428	POLG	C1850303	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE	0.200549453568426	0	0	CTD_human
5428	POLG	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5428	POLG	C2749861	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.2	0	0	ORPHANET
5428	POLG	C3150914	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE)	0.6	1	8	CTD_human;ORPHANET;UNIPROT
5428	POLG	C3696376	3-Methylglutaconic Aciduria	0.200274726784213	0	0	HPO
5428	POLG	C4020873	Infratentorial atrophy	0.2	0	0	HPO
5428	POLG	C4225153	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1	0.2	25	22	UNIPROT
5428	POLG	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
5429	POLH	C0009763	Conjunctivitis	0.2	0	0	HPO
5429	POLH	C0013592	Ectropion	0.2	0	0	HPO
5429	POLH	C0014390	Entropion	0.2	0	0	HPO
5429	POLH	C0022568	Keratitis	0.2	0	0	HPO
5429	POLH	C0039446	Telangiectasis	0.2	0	0	HPO
5429	POLH	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
5429	POLH	C0259817	Xerosis	0.2	0	0	HPO
5429	POLH	C0392777	Poikiloderma	0.2	0	0	HPO
5429	POLH	C1848410	Xeroderma pigmentosum, variant type	0.681098907136852	3	13	CTD_human;ORPHANET;UNIPROT
54332	GDAP1	C0085684	Foot-drop	0.2	0	0	HPO
54332	GDAP1	C0751576	Partial Paralysis (Paresis) Vocal Cords	0.200824180352639	0	0	HPO
54332	GDAP1	C1842197	Charcot-Marie-Tooth Disease, Recessive Intermediate A	0.6	4	3	CTD_human;ORPHANET;UNIPROT
54332	GDAP1	C1842983	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K	0.680274726784213	1	12	CTD_human;ORPHANET;UNIPROT
54332	GDAP1	C1843173	Charcot-Marie-Tooth disease, Type 2H	0.2	0	0	ORPHANET
54332	GDAP1	C1843183	Charcot-Marie-Tooth disease, Type 4A, axonal form	0.4	2	2	CTD_human;UNIPROT
54332	GDAP1	C1848736	Distal amyotrophy	0.2	0	0	HPO
54332	GDAP1	C1859198	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A (disorder)	0.603021994626344	4	8	CTD_human;ORPHANET;UNIPROT
54344	DPM3	C2752007	Congenital Disorder of Glycosylation, Type Io	0.6	1	1	CTD_human;ORPHANET;UNIPROT
54345	SOX18	C0002170	Alopecia	0.2	0	0	HPO
54345	SOX18	C0017662	Glomerulonephritis, Membranoproliferative	0.2	0	0	HPO
54345	SOX18	C0024236	Lymphedema	0.206187690967642	0	0	HPO
54345	SOX18	C0263401	Cutis marmorata	0.2	0	0	HPO
54345	SOX18	C0455988	Hydrops Fetalis, Non-Immune	0.2	0	0	HPO
54345	SOX18	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
54345	SOX18	C1843004	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME	0.481373633921066	1	3	CTD_human;UNIPROT
54361	WNT4	C0028754	Obesity	0.200274726784213	0	0	HPO
54361	WNT4	C0232939	Primary physiologic amenorrhea	0.200274726784213	0	0	HPO
54361	WNT4	C0702166	Acne	0.2	0	0	HPO
54361	WNT4	C1698581	Rokitansky Kuster Hauser syndrome	0.201923087489492	0	0	CTD_human
54361	WNT4	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
54361	WNT4	C2675014	Mullerian Aplasia and Hyperandrogenism	0.6	3	3	CTD_human;ORPHANET;UNIPROT
54361	WNT4	C2678492	Sex Reversal, Female, With Dysgenesis Of Kidneys, Adrenals, And Lungs	0.6	1	1	CTD_human;ORPHANET;UNIPROT
54361	WNT4	C4083212	Alopecia, Male Pattern	0.2	0	0	HPO
54386	TERF2IP	C0259817	Xerosis	0.2	0	0	HPO
54413	NLGN3	C1845341	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1 (disorder)	0.4	0	0	CTD_human;UNIPROT
5443	POMC	C0001231	ACTH Syndrome, Ectopic	0.204670355331623	4	0	CTD_human
5443	POMC	C0003868	Arthritis, Gouty	0.2	1	0	CTD_human
5443	POMC	C0007194	Hypertrophic Cardiomyopathy	0.2	5	0	CTD_human
5443	POMC	C0007789	Cerebral Palsy	0.200274726784213	1	0	CTD_human
5443	POMC	C0008370	Cholestasis	0.400549453568426	1	0	CTD_human;HPO
5443	POMC	C0010481	Cushing Syndrome	0.223872519471905	2	0	CTD_human
5443	POMC	C0010692	Cystitis	0.2	1	0	CTD_human
5443	POMC	C0011848	Diabetes Insipidus	0.2	1	0	CTD_human
5443	POMC	C0014544	Epilepsy	0.200549453568426	1	0	CTD_human
5443	POMC	C0014549	Tonic-Clonic Epilepsy	0.2	1	0	CTD_human
5443	POMC	C0014550	Epilepsies, Myoclonic	0.2	1	0	CTD_human
5443	POMC	C0015469	Facial paralysis	0.2	1	0	CTD_human
5443	POMC	C0015695	Fatty Liver	0.2	1	0	CTD_human
5443	POMC	C0015814	Femur Head Necrosis	0.2	1	0	CTD_human
5443	POMC	C0017658	Glomerulonephritis	0.2	2	0	CTD_human
5443	POMC	C0018801	Heart failure	0.202681755307501	2	0	CTD_human
5443	POMC	C0022650	Kidney Calculi	0.2	1	0	CTD_human
5443	POMC	C0022672	Acute Kidney Tubular Necrosis	0.2	2	0	CTD_human
5443	POMC	C0023976	Long QT Syndrome	0.2	1	0	CTD_human
5443	POMC	C0026769	Multiple Sclerosis	0.200549453568426	2	0	CTD_human
5443	POMC	C0026896	Myasthenia Gravis	0.2	1	0	CTD_human
5443	POMC	C0027709	Nephrocalcinosis	0.2	1	0	CTD_human
5443	POMC	C0028754	Obesity	0.528115217174373	2	0	CTD_human;HPO
5443	POMC	C0029456	Osteoporosis	0.203007639249027	5	0	CTD_human
5443	POMC	C0032285	Pneumonia	0.200274726784213	1	0	CTD_human
5443	POMC	C0035258	Restless Legs Syndrome	0.2	1	0	CTD_human
5443	POMC	C0037052	Sick Sinus Syndrome	0.2	1	0	CTD_human
5443	POMC	C0037769	West Syndrome	0.203021994626344	20	0	CTD_human
5443	POMC	C0039103	Synovitis	0.2	1	0	CTD_human
5443	POMC	C0151744	Myocardial Ischemia	0.200274726784213	1	0	CTD_human
5443	POMC	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
5443	POMC	C0162835	Hypopigmentation disorder	0.200274726784213	0	0	HPO
5443	POMC	C0221406	Pituitary-dependent Cushing's disease	0.217828530219217	1	0	CTD_human
5443	POMC	C0340375	Subaortic stenosis	0.2	1	0	CTD_human
5443	POMC	C0342388	Adrenocorticotropic hormone (ACTH) deficiency (disorder)	0.201373633921065	0	0	HPO
5443	POMC	C0393626	Opsoclonus-Myoclonus Syndrome	0.2	1	0	CTD_human
5443	POMC	C0553730	Calcium pyrophosphate deposition disease	0.2	1	0	CTD_human
5443	POMC	C0574960	Sacroiliitis	0.2	1	0	CTD_human
5443	POMC	C0877056	Hypoglycaemic seizure	0.2	0	0	HPO
5443	POMC	C0948387	Secondary Adrenal Insufficiency	0.200549453568426	0	0	HPO
5443	POMC	C1857854	Proopiomelanocortin Deficiency	0.48	0	0	CTD_human;ORPHANET
54433	GAR1	C0265965	Dyskeratosis Congenita	0.200549453568426	1	0	CTD_human
5444	PON1	C0002736	Amyotrophic Lateral Sclerosis	0.430476960207089	0	0	HPO;ORPHANET
5444	PON1	C0003873	Rheumatoid Arthritis	0.209195330216668	1	0	CTD_human
5444	PON1	C0004153	Atherosclerosis	0.286433413191035	6	0	CTD_human
5444	PON1	C0010068	Coronary heart disease	0.275696622204046	2	0	CTD_human
5444	PON1	C0010073	Coronary Artery Vasospasm	0.202956482091714	1	0	CTD_human
5444	PON1	C0011884	Diabetic Retinopathy	0.210177567661578	2	0	CTD_human
5444	PON1	C0015695	Fatty Liver	0.2	1	0	CTD_human
5444	PON1	C0017662	Glomerulonephritis, Membranoproliferative	0.203007639249027	1	0	CTD_human
5444	PON1	C0018801	Heart failure	0.2	1	0	CTD_human
5444	PON1	C0019112	Hemorrhoids	0.200274726784213	1	0	CTD_human
5444	PON1	C0020443	Hypercholesterolemia	0.210727021230004	1	0	CTD_human
5444	PON1	C0020445	Hypercholesterolemia, Familial	0.204381273170092	2	0	CTD_human
5444	PON1	C0020476	Hyperlipoproteinemias	0.2	1	0	CTD_human
5444	PON1	C0020550	Hyperthyroidism	0.2	1	0	CTD_human
5444	PON1	C0030569	Secondary Parkinson Disease	0.2	1	0	CTD_human
5444	PON1	C0234958	muscle degeneration	0.2	0	0	HPO
5444	PON1	C0282550	Persian Gulf Syndrome	0.201098907136852	1	0	CTD_human
5444	PON1	C0524620	Metabolic Syndrome X	0.207286598104494	1	0	CTD_human
5444	PON1	C0598608	Hyperhomocysteinemia	0.20350593566014	2	0	CTD_human
5444	PON1	C0948089	Acute Coronary Syndrome	0.208869446275143	1	0	CTD_human
5444	PON1	C1145670	Respiratory Failure	0.2	0	0	HPO
5444	PON1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
5444	PON1	C1956346	Coronary Artery Disease	0.298077159331319	3	0	CTD_human
5444	PON1	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
5444	PON1	C4020884	Anxiety disease	0.2	0	0	HPO
5444	PON1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
54443	ANLN	C0017668	Focal glomerulosclerosis	0.2	0	0	HPO
54443	ANLN	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
54443	ANLN	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
54443	ANLN	C4014993	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8	0.2	1	1	UNIPROT
5445	PON2	C0002736	Amyotrophic Lateral Sclerosis	0.409628114093152	0	0	HPO;ORPHANET
5445	PON2	C0020445	Hypercholesterolemia, Familial	0.203231208875927	1	0	CTD_human
5445	PON2	C0234958	muscle degeneration	0.2	0	0	HPO
5445	PON2	C1145670	Respiratory Failure	0.2	0	0	HPO
5445	PON2	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
5445	PON2	C4020884	Anxiety disease	0.2	0	0	HPO
54453	RIN2	C0002170	Alopecia	0.2	0	0	HPO
54453	RIN2	C0010495	Cutis Laxa	0.2	0	0	HPO
54453	RIN2	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
54453	RIN2	C2751321	Macrocephaly, Alopecia, Cutis Laxa, and Scoliosis	0.400549453568426	0	0	CTD_human;ORPHANET
54453	RIN2	C2930812	Generalized elastolysis	0.2	0	0	HPO
5446	PON3	C0002736	Amyotrophic Lateral Sclerosis	0.407221085569864	0	0	HPO;ORPHANET
5446	PON3	C0234958	muscle degeneration	0.2	0	0	HPO
5446	PON3	C1145670	Respiratory Failure	0.2	0	0	HPO
5446	PON3	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
5446	PON3	C4020884	Anxiety disease	0.2	0	0	HPO
54463	FAM134B	C0003028	Anhidrosis	0.2	0	0	HPO
54463	FAM134B	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
54463	FAM134B	C0029443	Osteomyelitis	0.2	0	0	HPO
54463	FAM134B	C0030578	Paronychia Inflammation	0.2	0	0	HPO
54463	FAM134B	C0234958	muscle degeneration	0.2	0	0	HPO
54463	FAM134B	C0270914	Hereditary Motor and Sensory-Neuropathy Type II	0.2	0	0	ORPHANET
54463	FAM134B	C0270921	Axonal neuropathy	0.2	0	0	HPO
54463	FAM134B	C0917990	Acro-Osteolysis	0.2	0	0	HPO
54463	FAM134B	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
54463	FAM134B	C2242472	Infection of bone	0.2	0	0	HPO
54463	FAM134B	C2751092	Neuropathy, Hereditary Sensory And Autonomic, Type IIB	0.2	0	0	CTD_human
54466	SPIN2A	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
5447	POR	C0010278	Craniosynostosis	0.203007639249027	0	0	HPO
5447	POR	C0015300	Exophthalmos	0.2	0	0	HPO
5447	POR	C0018777	Conductive hearing loss	0.2	0	0	HPO
5447	POR	C0020255	Hydrocephalus	0.2	0	0	HPO
5447	POR	C0029456	Osteoporosis	0.2	0	0	HPO
5447	POR	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
5447	POR	C0042582	Vesicovaginal Fistula	0.2	0	0	HPO
5447	POR	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
5447	POR	C0158113	Contracture of joint of hand	0.2	0	0	HPO
5447	POR	C0264353	Bronchomalacia	0.2	0	0	HPO
5447	POR	C0302280	Adrenogenital Syndrome	0.2	0	0	HPO
5447	POR	C0342527	Deficiency of testosterone biosynthesis	0.2	0	0	HPO
5447	POR	C0342546	Premature adrenarche	0.2	0	0	HPO
5447	POR	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
5447	POR	C0740852	Upper airway obstruction	0.2	0	0	HPO
5447	POR	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
5447	POR	C1833340	Synostotic Posterior Plagiocephaly	0.2	0	0	HPO
5447	POR	C1856266	Coronal craniosynostosis	0.2	0	0	HPO
5447	POR	C1860042	Antley-Bixler Syndrome with Disordered Steroidogenesis	0.400824180352639	2	13	ORPHANET;UNIPROT
5447	POR	C2350233	Antley-Bixler Syndrome Phenotype	0.202732912464814	4	0	CTD_human
5447	POR	C2930865	Ramer Ladda syndrome	0.2	0	0	HPO
5447	POR	C3150099	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	0.4	4	0	CTD_human;UNIPROT
5447	POR	C4020713	Penile melanosis	0.2	0	0	HPO
5447	POR	C4024641	Enlarged polycystic ovaries	0.2	0	0	HPO
54476	RNF216	C0018418	Gynecomastia	0.2	0	0	HPO
54476	RNF216	C0028738	Nystagmus	0.2	0	0	HPO
54476	RNF216	C0029124	Optic Atrophy	0.2	0	0	HPO
54476	RNF216	C0235946	Cerebral atrophy	0.2	0	0	HPO
54476	RNF216	C0262404	Cerebellar degeneration	0.2	0	0	HPO
54476	RNF216	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
54476	RNF216	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
54476	RNF216	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
54476	RNF216	C1857627	Chorioretinal dystrophy	0.2	0	0	HPO
54476	RNF216	C1859305	Cerebellar Ataxia and Hypogonadotropic Hypogonadism	0.400549453568426	1	6	ORPHANET;UNIPROT
54476	RNF216	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
54476	RNF216	C4020860	Supratentorial atrophy	0.2	0	0	HPO
54476	RNF216	C4020873	Infratentorial atrophy	0.2	0	0	HPO
54487	DGCR8	C0042454	Velopharyngeal Insufficiency	0.2	0	0	HPO
54487	DGCR8	C4021592	Unilateral primary pulmonary dysgenesis	0.2	0	0	HPO
5449	POU1F1	C0013338	Pituitary dwarfism	0.201098907136852	1	0	CTD_human
5449	POU1F1	C0014306	Enophthalmos	0.2	0	0	HPO
5449	POU1F1	C0020615	Hypoglycemia	0.2	0	0	HPO
5449	POU1F1	C0020676	Hypothyroidism	0.204930726738519	0	0	HPO
5449	POU1F1	C0024421	Macroglossia	0.2	0	0	HPO
5449	POU1F1	C0029453	Osteopenia	0.2	0	0	HPO
5449	POU1F1	C0271567	Isolated Growth Hormone Deficiency, Type II	0.2	0	0	ORPHANET
5449	POU1F1	C0271623	Hypogonadotropic hypogonadism	0.200274726784213	0	0	HPO
5449	POU1F1	C0271801	Central hypothyroidism	0.2	0	0	HPO
5449	POU1F1	C0747078	Generalized osteopenia	0.2	0	0	HPO
5449	POU1F1	C0878683	Pituitary Dwarfism Type 3	0.2	0	0	CTD_human
5449	POU1F1	C0948740	Pituitary hypoplasia	0.201923087489492	0	0	HPO
5449	POU1F1	C2751608	Pituitary Hormone Deficiency, Combined, 1	0.6	10	19	CTD_human;ORPHANET;UNIPROT
5449	POU1F1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
5449	POU1F1	C3665349	Secondary hypothyroidism	0.200274726784213	0	0	HPO
54499	TMCO1	C0017612	Glaucoma, Open-Angle	0.200274726784213	1	1	CTD_human
54499	TMCO1	C0038379	Strabismus	0.2	0	0	HPO
54499	TMCO1	C0235946	Cerebral atrophy	0.2	0	0	HPO
54499	TMCO1	C1859252	Cerebrofaciothoracic Dysplasia	0.280549453568426	0	0	ORPHANET
545	ATR	C0002170	Alopecia	0.2	0	0	HPO
545	ATR	C0010278	Craniosynostosis	0.2	0	0	HPO
545	ATR	C0011334	Dental caries	0.2	0	0	HPO
545	ATR	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
545	ATR	C0014544	Epilepsy	0.2	0	0	HPO
545	ATR	C0017601	Glaucoma	0.2	0	0	HPO
545	ATR	C0024636	Malocclusion	0.2	0	0	HPO
545	ATR	C0030312	Pancytopenia	0.2	0	0	HPO
545	ATR	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
545	ATR	C0038379	Strabismus	0.2	0	0	HPO
545	ATR	C0039446	Telangiectasis	0.2	0	0	HPO
545	ATR	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
545	ATR	C0265202	Seckel syndrome	0.48357144819477	0	0	CTD_human;ORPHANET
545	ATR	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
5450	POU2AF1	C0008312	Primary biliary cirrhosis	0.400274726784213	0	0	HPO;ORPHANET
5450	POU2AF1	C0020541	Hypertension, Portal	0.2	0	0	HPO
5450	POU2AF1	C0023890	Liver Cirrhosis	0.2	0	0	HPO
5450	POU2AF1	C0023892	Biliary cirrhosis	0.2	0	0	HPO
5450	POU2AF1	C0040261	Onychomycosis	0.2	0	0	HPO
5450	POU2AF1	C0085605	Liver Failure	0.2	0	0	HPO
5450	POU2AF1	C0239946	Fibrosis, Liver	0.2	0	0	HPO
5450	POU2AF1	C0268307	Conjugated hyperbilirubinemia	0.2	0	0	HPO
5450	POU2AF1	C0343065	Symptomatic dermographism	0.2	0	0	HPO
5450	POU2AF1	C0859942	Hanot's cirrhosis	0.2	0	0	ORPHANET
54502	RBM47	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
54503	ZDHHC13	C0002170	Alopecia	0.200274726784213	1	0	CTD_human
54503	ZDHHC13	C0002726	Amyloidosis	0.2	1	0	CTD_human
54503	ZDHHC13	C0029456	Osteoporosis	0.2	1	0	CTD_human
54507	ADAMTSL4	C3541474	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE	0.2	0	0	CTD_human
5453	POU3F1	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
54539	NDUFB11	C0014544	Epilepsy	0.2	0	0	HPO
54539	NDUFB11	C0018790	Cardiac Arrest	0.2	0	0	HPO
54539	NDUFB11	C0027092	Myopia	0.2	0	0	HPO
54539	NDUFB11	C0028738	Nystagmus	0.2	0	0	HPO
54539	NDUFB11	C0038379	Strabismus	0.2	0	0	HPO
54539	NDUFB11	C0042510	Ventricular Fibrillation	0.2	0	0	HPO
54539	NDUFB11	C0042514	Tachycardia, Ventricular	0.2	0	0	HPO
54539	NDUFB11	C0796070	MICROPHTHALMIA, SYNDROMIC 7	0.200274726784213	0	0	ORPHANET
54539	NDUFB11	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
54541	DDIT4	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
54541	DDIT4	C0030567	Parkinson Disease	0.201098907136852	1	0	CTD_human
5455	POU3F3	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
54551	MAGEL2	C0014877	Esotropia	0.2	0	0	HPO
54551	MAGEL2	C0020459	Hyperinsulinism	0.2	0	0	HPO
54551	MAGEL2	C0020490	Hyperopia	0.2	0	0	HPO
54551	MAGEL2	C0020619	Hypogonadism	0.2	0	0	HPO
54551	MAGEL2	C0027092	Myopia	0.2	0	0	HPO
54551	MAGEL2	C0028754	Obesity	0.200274726784213	0	0	HPO
54551	MAGEL2	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
54551	MAGEL2	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
54551	MAGEL2	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
54551	MAGEL2	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
54551	MAGEL2	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
54551	MAGEL2	C3809877	SCHAAF-YANG SYNDROME	0.200274726784213	0	0	ORPHANET
5456	POU3F4	C0018777	Conductive hearing loss	0.200274726784213	0	0	HPO
5456	POU3F4	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
5456	POU3F4	C1844678	Progressive hearing loss stapes fixation	0.681648360705279	3	11	CTD_human;ORPHANET;UNIPROT
54567	DLL4	C0020255	Hydrocephalus	0.2	0	0	HPO
54567	DLL4	C0038379	Strabismus	0.2	0	0	HPO
54567	DLL4	C0040961	Tricuspid Valve Insufficiency	0.2	0	0	HPO
54567	DLL4	C0263401	Cutis marmorata	0.2	0	0	HPO
54567	DLL4	C0265268	Adams Oliver syndrome	0.200274726784213	0	0	ORPHANET
54567	DLL4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
54567	DLL4	C4225271	ADAMS-OLIVER SYNDROME 6	0.2	1	7	UNIPROT
54578	UGT1A6	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
54583	EGLN1	C1853286	Erythrocytosis, Familial, 3	0.4	2	3	CTD_human;UNIPROT
54585	LZTFL1	C0020619	Hypogonadism	0.2	0	0	HPO
54585	LZTFL1	C0022679	Cystic kidney	0.2	0	0	HPO
54585	LZTFL1	C0028738	Nystagmus	0.2	0	0	HPO
54585	LZTFL1	C0028754	Obesity	0.2	0	0	HPO
54585	LZTFL1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
54585	LZTFL1	C0730290	Cone dystrophy	0.2	0	0	HPO
54585	LZTFL1	C0752166	Bardet-Biedl Syndrome	0.200549453568426	0	0	ORPHANET
54585	LZTFL1	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
54585	LZTFL1	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
54585	LZTFL1	C3714980	BARDET-BIEDL SYNDROME 17	0.28	1	4	UNIPROT
54585	LZTFL1	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
5459	POU4F3	C1865366	Deafness, Autosomal Dominant 15	0.400274726784213	1	4	CTD_human;UNIPROT
546	ATRX	C0014544	Epilepsy	0.200274726784213	0	0	HPO
546	ATRX	C0015310	Exotropia	0.2	0	0	HPO
546	ATRX	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
546	ATRX	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
546	ATRX	C0020295	Hydronephrosis	0.2	0	0	HPO
546	ATRX	C0020619	Hypogonadism	0.2	0	0	HPO
546	ATRX	C0024421	Macroglossia	0.2	0	0	HPO
546	ATRX	C0029124	Optic Atrophy	0.2	0	0	HPO
546	ATRX	C0037036	Sialorrhea	0.2	0	0	HPO
546	ATRX	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
546	ATRX	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
546	ATRX	C0235946	Cerebral atrophy	0.2	0	0	HPO
546	ATRX	C0271901	Microcytic hypochromic anemia (disorder)	0.2	0	0	HPO
546	ATRX	C0796003	Juberg-Marsidi syndrome	0.600274726784213	5	2	CTD_human;ORPHANET;UNIPROT
546	ATRX	C0796159	Mental retardation Smith Fineman Myers type	0.200274726784213	0	0	ORPHANET
546	ATRX	C0850715	Abnormality of blood and blood-forming tissues	0.2	0	0	HPO
546	ATRX	C1136249	Mental Retardation, X-Linked	0.204120901763196	1	0	CTD_human
546	ATRX	C1845055	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED	0.690989071368524	11	18	CTD_human;ORPHANET;UNIPROT
546	ATRX	C3161174	Hemoglobin H Disease	0.200824180352639	0	0	HPO
546	ATRX	C3553450	Profound global developmental delay	0.2	0	0	HPO
546	ATRX	C4020860	Supratentorial atrophy	0.2	0	0	HPO
5460	POU5F1	C2931618	Gestational trophoblastic disease	0.200274726784213	1	0	CTD_human
54600	UGT1A9	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
54620	FBXL19	C0003872	Arthritis, Psoriatic	0.202956482091714	1	0	CTD_human
54620	FBXL19	C0033860	Psoriasis	0.200274726784213	1	1	CTD_human
5465	PPARA	C0010346	Crohn Disease	0.2	1	0	CTD_human
5465	PPARA	C0011615	Dermatitis, Atopic	0.203831819601666	1	0	CTD_human
5465	PPARA	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.236209420895569	1	0	CTD_human
5465	PPARA	C0015695	Fatty Liver	0.212217324843012	1	0	CTD_human
5465	PPARA	C0015696	Fatty Liver, Alcoholic	0.200274726784213	1	0	CTD_human
5465	PPARA	C0020473	Hyperlipidemia	0.204604842796993	1	0	CTD_human
5465	PPARA	C0020476	Hyperlipoproteinemias	0.2	1	0	CTD_human
5465	PPARA	C0020615	Hypoglycemia	0.2	1	0	CTD_human
5465	PPARA	C0022661	Kidney Failure, Chronic	0.203007639249027	1	0	CTD_human
5465	PPARA	C0022672	Acute Kidney Tubular Necrosis	0.200274726784213	1	0	CTD_human
5465	PPARA	C0028754	Obesity	0.228387724599966	1	0	CTD_human
5465	PPARA	C0400966	Non-alcoholic Fatty Liver Disease	0.204945082115836	1	0	CTD_human
5465	PPARA	C2930930	Abdominal obesity metabolic syndrome	0.2	1	0	CTD_human
5465	PPARA	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
54657	UGT1A4	C0010324	Crigler Najjar syndrome, type 1	0.201648360705279	1	23	UNIPROT
54657	UGT1A4	C2931132	Crigler Najjar syndrome, type 2	0.2	2	19	UNIPROT
54658	UGT1A1	C0007789	Cerebral Palsy	0.2	0	0	HPO
54658	UGT1A1	C0010324	Crigler Najjar syndrome, type 1	0.702730546203101	10	23	CTD_human;ORPHANET;UNIPROT
54658	UGT1A1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
54658	UGT1A1	C0017551	Gilbert Disease (disorder)	0.473206220363782	8	10	CTD_human;UNIPROT
54658	UGT1A1	C0020433	Hyperbilirubinemia	0.304641891397799	5	7	CTD_human
54658	UGT1A1	C0022610	Kernicterus	0.40328236603324	1	0	CTD_human;HPO
54658	UGT1A1	C0027947	Neutropenia	0.230651051408301	1	0	CTD_human
54658	UGT1A1	C0268306	Unconjugated hyperbilirubinemia	0.210164891015885	0	0	HPO
54658	UGT1A1	C0270210	Lucey-Driscoll syndrome (disorder)	0.6	0	0	CTD_human;ORPHANET;UNIPROT
54658	UGT1A1	C0559506	Neonatal unconjugated hyperbilirubinemia	0.200549453568426	0	0	HPO
54658	UGT1A1	C0857007	Hyperbilirubinemia, Neonatal	0.250790708129918	0	0	HPO
54658	UGT1A1	C2931132	Crigler Najjar syndrome, type 2	0.60357144819477	18	18	CTD_human;ORPHANET;UNIPROT
5467	PPARD	C0015695	Fatty Liver	0.20350593566014	1	0	CTD_human
5467	PPARD	C0028754	Obesity	0.214847922993201	2	0	CTD_human
5467	PPARD	C0400966	Non-alcoholic Fatty Liver Disease	0.200549453568426	1	0	CTD_human
5468	PPARG	C0000889	Acanthosis Nigricans	0.200274726784213	0	0	HPO
5468	PPARG	C0001206	Acromegaly	0.201098907136852	0	0	HPO
5468	PPARG	C0002395	Alzheimer's Disease	0.225193317504034	2	0	CTD_human
5468	PPARG	C0004153	Atherosclerosis	0.235212828073342	1	0	CTD_human
5468	PPARG	C0004763	Barrett Esophagus	0.200274726784213	1	0	CTD_human
5468	PPARG	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
5468	PPARG	C0010346	Crohn Disease	0.207561324888707	1	0	CTD_human
5468	PPARG	C0011859	Lipoatrophic Diabetes Mellitus	0.200274726784213	0	0	ORPHANET
5468	PPARG	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.357358110129556	5	1	CTD_human
5468	PPARG	C0017658	Glomerulonephritis	0.2	1	0	CTD_human
5468	PPARG	C0018801	Heart failure	0.205689394556528	1	0	CTD_human
5468	PPARG	C0020456	Hyperglycemia	0.209470057000881	0	0	HPO
5468	PPARG	C0020459	Hyperinsulinism	0.210019510569308	0	0	HPO
5468	PPARG	C0023787	Lipodystrophy	0.209535569535511	0	0	HPO
5468	PPARG	C0023794	Lipoidosis	0.2	1	0	CTD_human
5468	PPARG	C0023890	Liver Cirrhosis	0.202681755307501	0	0	HPO
5468	PPARG	C0028754	Obesity	0.72697828010044	2	2	CTD_human;HPO;UNIPROT
5468	PPARG	C0029408	Degenerative polyarthritis	0.203021994626344	1	0	CTD_human
5468	PPARG	C0033860	Psoriasis	0.20328236603324	1	0	CTD_human
5468	PPARG	C0034013	Precocious Puberty	0.2	0	0	HPO
5468	PPARG	C0043325	Xanthomatosis	0.2	0	0	HPO
5468	PPARG	C0085605	Liver Failure	0.2	0	0	HPO
5468	PPARG	C0221406	Pituitary-dependent Cushing's disease	0.200274726784213	1	0	CTD_human
5468	PPARG	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
5468	PPARG	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
5468	PPARG	C0271694	Familial partial lipodystrophy	0.206029633875371	1	1	CTD_human
5468	PPARG	C0282548	Leukostasis	0.200549453568426	1	0	CTD_human
5468	PPARG	C0473527	Hypoalphalipoproteinemias	0.2	0	0	HPO
5468	PPARG	C0740394	Hyperuricemia	0.200274726784213	0	0	HPO
5468	PPARG	C0854110	Insulin resistant diabetes	0.2	0	0	HPO
5468	PPARG	C1280433	Lipoatrophy	0.200274726784213	0	0	HPO
5468	PPARG	C1720861	Familial Partial Lipodystrophy, Type 3	0.481098907136852	2	6	ORPHANET;UNIPROT
5468	PPARG	C1836302	Carotid Intimal Medial Thickness 1	0.2	0	0	CTD_human
5468	PPARG	C2711227	Steatohepatitis	0.204120901763196	0	0	HPO
5468	PPARG	C4020778	maternal hyperglycemia	0.2	0	0	HPO
5469	MED1	C0014175	Endometriosis	0.2	1	0	CTD_human
5469	MED1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
547	KIF1A	C0003028	Anhidrosis	0.2	0	0	HPO
547	KIF1A	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
547	KIF1A	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
547	KIF1A	C0020255	Hydrocephalus	0.2	0	0	HPO
547	KIF1A	C0029124	Optic Atrophy	0.2	0	0	HPO
547	KIF1A	C0030578	Paronychia Inflammation	0.2	0	0	HPO
547	KIF1A	C0037772	Spastic Paraplegia	0.200549453568426	0	0	HPO
547	KIF1A	C0234958	muscle degeneration	0.2	0	0	HPO
547	KIF1A	C0235946	Cerebral atrophy	0.2	0	0	HPO
547	KIF1A	C0262404	Cerebellar degeneration	0.2	0	0	HPO
547	KIF1A	C0270914	Hereditary Motor and Sensory-Neuropathy Type II	0.2	0	0	ORPHANET
547	KIF1A	C0270921	Axonal neuropathy	0.2	0	0	HPO
547	KIF1A	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
547	KIF1A	C0796122	Progressive encephalopathy with edema, hypsarrhythmia and optic atrophy syndrome	0.2	0	0	ORPHANET
547	KIF1A	C0917990	Acro-Osteolysis	0.2	0	0	HPO
547	KIF1A	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
547	KIF1A	C1835896	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE (disorder)	0.280274726784213	0	0	ORPHANET
547	KIF1A	C1850055	PEHO syndrome	0.2	0	0	ORPHANET
547	KIF1A	C3280283	MENTAL RETARDATION, AUTOSOMAL DOMINANT 9	0.2	2	14	UNIPROT
547	KIF1A	C3887898	Infantile Spasm	0.2	0	0	HPO
547	KIF1A	C4020873	Infratentorial atrophy	0.2	0	0	HPO
547	KIF1A	C4024900	Brainstem atrophy	0.2	0	0	HPO
547	KIF1A	C4082173	Porencephaly	0.2	0	0	HPO
54704	PDP1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
54704	PDP1	C0028738	Nystagmus	0.2	0	0	HPO
54704	PDP1	C1837429	Pyruvate dehydrogenase phosphatase deficiency	0.4	0	0	CTD_human;ORPHANET
5471	PPAT	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
54714	CNGB3	C0015310	Exotropia	0.2	0	0	HPO
54714	CNGB3	C0020490	Hyperopia	0.2	0	0	HPO
54714	CNGB3	C0024437	Macular degeneration	0.200274726784213	0	0	HPO
54714	CNGB3	C0028077	Night Blindness	0.2	0	0	HPO
54714	CNGB3	C0042798	Low Vision	0.2	0	0	HPO
54714	CNGB3	C0152200	Achromatopsia	0.409275198128616	0	0	HPO;ORPHANET
54714	CNGB3	C0271092	Progressive cone dystrophy (without rod involvement)	0.2	0	0	ORPHANET
54714	CNGB3	C0271183	Severe myopia	0.2	0	0	HPO
54714	CNGB3	C0271388	Pendular Nystagmus	0.2	0	0	HPO
54714	CNGB3	C0302129	Achromatopsia 1	0.206868169605328	0	0	HPO
54714	CNGB3	C0858618	Dyschromatopsia	0.2	0	0	HPO
54714	CNGB3	C1301509	Severe visual impairment	0.2	0	0	HPO
54714	CNGB3	C1849792	Achromatopsia 3	0.480824180352639	6	30	CTD_human;UNIPROT
54714	CNGB3	C1855465	STARGARDT DISEASE 1 (disorder)	0.400274726784213	1	2	CTD_human;UNIPROT
54714	CNGB3	C1857618	Achromatopsia 2	0.2	0	0	HPO
54714	CNGB3	C1866180	Horizontal pendular nystagmus	0.2	0	0	HPO
54714	CNGB3	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
54714	CNGB3	C4021559	Retinitis pigmentosa inversa	0.2	0	0	HPO
54716	SLC6A20	C0268534	Prolinuria	0.2	0	0	HPO
54716	SLC6A20	C0543541	HYPERGLYCINURIA (disorder)	0.4	0	0	CTD_human;HPO
54716	SLC6A20	C1833683	NEPHROLITHIASIS, CALCIUM OXALATE	0.2	0	0	HPO
54738	FEV	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
54739	XAF1	C0021400	Influenza	0.2	1	0	CTD_human
54749	EPDR1	C0017605	Angle Closure Glaucoma	0.2	1	0	CTD_human
54756	IL17RD	C0018418	Gynecomastia	0.2	0	0	HPO
54756	IL17RD	C0020619	Hypogonadism	0.2	0	0	HPO
54756	IL17RD	C0162809	Kallmann Syndrome	0.2	0	0	ORPHANET
54756	IL17RD	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
54756	IL17RD	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
54756	IL17RD	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
54756	IL17RD	C3808975	HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA	0.2	1	5	UNIPROT
54756	IL17RD	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
54757	FAM20A	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
54757	FAM20A	C0027709	Nephrocalcinosis	0.200549453568426	0	0	HPO
54757	FAM20A	C0035078	Kidney Failure	0.2	0	0	HPO
54757	FAM20A	C0399440	Hereditary gingival fibromatosis	0.2	0	0	HPO
54757	FAM20A	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
54757	FAM20A	C1565489	Renal Insufficiency	0.2	0	0	HPO
54757	FAM20A	C2931783	Amelogenesis imperfecta nephrocalcinosis	0.401373633921066	3	10	ORPHANET;UNIPROT
54757	FAM20A	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
5476	CTSA	C0014544	Epilepsy	0.2	0	0	HPO
5476	CTSA	C0085131	Gangliosidosis GM1	0.201098907136852	0	0	HPO
5476	CTSA	C0086795	Pfaundler-Hurler Syndrome	0.2	0	0	HPO
5476	CTSA	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
5476	CTSA	C0268233	GALACTOSIALIDOSIS	0.686593442821114	3	14	CTD_human;ORPHANET;UNIPROT
5476	CTSA	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
54765	TRIM44	C0017601	Glaucoma	0.2	0	0	HPO
54765	TRIM44	C0028738	Nystagmus	0.2	0	0	HPO
54768	HYDIN	C0006267	Bronchiectasis	0.2	0	0	HPO
54768	HYDIN	C0020255	Hydrocephalus	0.200824180352639	2	0	CTD_human
54768	HYDIN	C0022521	Kartagener Syndrome	0.200274726784213	0	0	ORPHANET
54768	HYDIN	C0027430	Nasal Polyps	0.2	0	0	HPO
54768	HYDIN	C0035455	Rhinitis	0.2	0	0	HPO
54768	HYDIN	C0581354	Recurrent sinusitis	0.2	0	0	HPO
54768	HYDIN	C0741796	Recurrent bronchitis	0.2	0	0	HPO
54768	HYDIN	C0747085	Recurrent otitis media	0.2	0	0	HPO
54768	HYDIN	C4280333	Recurrent sinus disease	0.2	0	0	HPO
5479	PPIB	C0268362	Osteogenesis imperfecta type III (disorder)	0.2	0	0	ORPHANET
5479	PPIB	C1850169	OSTEOGENESIS IMPERFECTA, TYPE IX (disorder)	0.480549453568426	1	6	CTD_human;UNIPROT
54790	TET2	C0002893	Refractory anemias	0.200274726784213	0	0	ORPHANET
54790	TET2	C0027051	Myocardial Infarction	0.2	0	0	HPO
54790	TET2	C0040028	Thrombocythemia, Essential	0.206462417751855	0	0	ORPHANET
54790	TET2	C0917805	Transient Cerebral Ischemia	0.2	0	0	HPO
54795	TRPM4	C0264912	Left anterior fascicular block	0.2	0	0	HPO
54795	TRPM4	C1142166	Brugada Syndrome (disorder)	0.200274726784213	0	0	ORPHANET
54795	TRPM4	C1879286	Hereditary bundle branch system defect	0.200824180352639	0	0	ORPHANET
54795	TRPM4	C1970298	Progressive Familial Heart Block, Type Ib	0.4	3	11	CTD_human;UNIPROT
54805	CNNM2	C0014544	Epilepsy	0.2	0	0	HPO
54805	CNNM2	C0039621	Tetany	0.2	1	0	CTD_human
54805	CNNM2	C3151295	HYPOMAGNESEMIA 6, RENAL	0.2	1	1	UNIPROT
54805	CNNM2	C4225333	HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION	0.2	1	3	UNIPROT
54806	AHI1	C0028738	Nystagmus	0.2	0	0	HPO
54806	AHI1	C0035334	Retinitis Pigmentosa	0.200549453568426	0	0	HPO
54806	AHI1	C0042798	Low Vision	0.2	0	0	HPO
54806	AHI1	C0162538	Immunoglobulin A deficiency (disorder)	0.2	1	0	CTD_human
54806	AHI1	C0431399	Familial aplasia of the vermis	0.205769262468475	0	0	ORPHANET
54806	AHI1	C0520680	Sleep Apnea, Central	0.2	0	0	HPO
54806	AHI1	C0687120	Nephronophthisis	0.201373633921065	0	0	HPO
54806	AHI1	C1837713	JOUBERT SYNDROME 3	0.48	5	45	CTD_human;UNIPROT
54806	AHI1	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
54806	AHI1	C3489733	Oculomotor apraxia	0.2	0	0	HPO
54806	AHI1	C4274118	Joubert syndrome with ocular defect	0.2	0	0	ORPHANET
54808	DYM	C0264112	Wedging of vertebra	0.2	0	0	HPO
54808	DYM	C0264142	Spade-like hand	0.2	0	0	HPO
54808	DYM	C0265286	Dyggve-Melchior-Clausen syndrome	0.681923087489492	2	5	CTD_human;ORPHANET;UNIPROT
54808	DYM	C0410653	Atlantoaxial instability	0.2	0	0	HPO
54808	DYM	C1846431	SMITH-MCCORT DYSPLASIA	0.400274726784213	0	0	CTD_human;ORPHANET
54808	DYM	C3888088	SMITH-MCCORT DYSPLASIA 1	0.280274726784213	3	2	UNIPROT
54809	SAMD9	C0009763	Conjunctivitis	0.2	0	0	HPO
54809	SAMD9	C0017574	Gingivitis	0.2	0	0	HPO
54809	SAMD9	C0021400	Influenza	0.2	1	0	CTD_human
54809	SAMD9	C0220766	Congenital hypoplasia of adrenal gland	0.2	1	0	CTD_human
54809	SAMD9	C1864861	Tumoral Calcinosis, Normophosphatemic, Familial	0.6	1	1	CTD_human;ORPHANET;UNIPROT
54820	NDE1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
54820	NDE1	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
54820	NDE1	C0015300	Exophthalmos	0.2	0	0	HPO
54820	NDE1	C0234958	muscle degeneration	0.2	0	0	HPO
54820	NDE1	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
54820	NDE1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
54820	NDE1	C1857977	MICROHYDRANENCEPHALY	0.200274726784213	0	0	ORPHANET
54820	NDE1	C1956147	Microlissencephaly	0.200274726784213	0	0	ORPHANET
54820	NDE1	C3553450	Profound global developmental delay	0.2	0	0	HPO
54820	NDE1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
54821	ERCC6L	C0015923	Fetal Alcohol Syndrome	0.2	1	0	PSYGENET
54822	TRPM7	C0022650	Kidney Calculi	0.2	1	0	CTD_human
54822	TRPM7	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
54822	TRPM7	C0543859	Amyotrophic Lateral Sclerosis, Guam Form	0.4	0	0	CTD_human;ORPHANET
54826	GIN1	C0003873	Rheumatoid Arthritis	0.202407028523288	1	0	CTD_human
54829	ASPN	C0029408	Degenerative polyarthritis	0.2373307744351	0	0	CTD_human
54832	VPS13C	C3809811	PARKINSON DISEASE 19, JUVENILE-ONSET	0.2	0	0	ORPHANET
54832	VPS13C	C4225186	PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.2	1	2	UNIPROT
54832	VPS13C	C4275179	Young onset Parkinson disease	0.2	0	0	ORPHANET
54840	APTX	C0020443	Hypercholesterolemia	0.200274726784213	0	0	HPO
54840	APTX	C0162674	Chronic progressive external ophthalmoplegia	0.2	0	0	HPO
54840	APTX	C0239981	Hypoalbuminemia	0.203831819601666	0	0	HPO
54840	APTX	C0262404	Cerebellar degeneration	0.200274726784213	0	0	HPO
54840	APTX	C0271390	Nystagmus, End-Position	0.2	0	0	HPO
54840	APTX	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
54840	APTX	C1848736	Distal amyotrophy	0.2	0	0	HPO
54840	APTX	C1859598	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	0.606593442821114	5	10	CTD_human;ORPHANET;UNIPROT
54840	APTX	C3489733	Oculomotor apraxia	0.20357144819477	0	0	HPO
54840	APTX	C3551954	COENZYME Q10 DEFICIENCY, PRIMARY, 1	0.2	0	0	CTD_human
54840	APTX	C4020871	Dystonic disease	0.2	0	0	HPO
54840	APTX	C4020873	Infratentorial atrophy	0.2	0	0	HPO
54862	CC2D1A	C1838023	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3	0.2	0	0	CTD_human
54877	ZCCHC2	C0021400	Influenza	0.2	1	0	CTD_human
54880	BCOR	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
54880	BCOR	C0014544	Epilepsy	0.2	0	0	HPO
54880	BCOR	C0015310	Exotropia	0.2	0	0	HPO
54880	BCOR	C0017601	Glaucoma	0.2	0	0	HPO
54880	BCOR	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
54880	BCOR	C0020295	Hydronephrosis	0.2	0	0	HPO
54880	BCOR	C0023882	Little's Disease	0.2	0	0	HPO
54880	BCOR	C0024636	Malocclusion	0.2	0	0	HPO
54880	BCOR	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
54880	BCOR	C0034888	Rectal Prolapse	0.2	0	0	HPO
54880	BCOR	C0155299	Coloboma of optic disc	0.2	0	0	HPO
54880	BCOR	C0158113	Contracture of joint of hand	0.2	0	0	HPO
54880	BCOR	C0264142	Spade-like hand	0.2	0	0	HPO
54880	BCOR	C0271215	Blindness, Legal	0.2	0	0	HPO
54880	BCOR	C0747085	Recurrent otitis media	0.2	0	0	HPO
54880	BCOR	C1846265	Microphthalmia, syndromic 2	0.603021994626344	2	8	CTD_human;ORPHANET;UNIPROT
54880	BCOR	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
54880	BCOR	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
54880	BCOR	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
54887	UHRF1BP1	C0024141	Lupus Erythematosus, Systemic	0.202956482091714	1	2	CTD_human
54888	NSUN2	C0013595	Eczema	0.2	0	0	HPO
54888	NSUN2	C0038379	Strabismus	0.2	0	0	HPO
54888	NSUN2	C0175691	Dubowitz syndrome	0.200274726784213	0	0	ORPHANET
54888	NSUN2	C1970199	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.2	1	3	UNIPROT
54899	PXK	C0003873	Rheumatoid Arthritis	0.204814057046576	1	0	CTD_human
54899	PXK	C0024141	Lupus Erythematosus, Systemic	0.211602358739956	1	2	CTD_human
549	AUH	C0009952	Febrile Convulsions	0.2	0	0	HPO
549	AUH	C0029124	Optic Atrophy	0.2	0	0	HPO
549	AUH	C0235946	Cerebral atrophy	0.2	0	0	HPO
549	AUH	C0342727	3-@METHYLGLUTACONIC ACIDURIA, TYPE I	0.601098907136852	1	10	CTD_human;ORPHANET;UNIPROT
549	AUH	C0342728	3-Methylglutaconic aciduria type 1	0.2	0	0	ORPHANET
549	AUH	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
549	AUH	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
549	AUH	C3696376	3-Methylglutaconic Aciduria	0.200274726784213	0	0	HPO
549	AUH	C4020860	Supratentorial atrophy	0.2	0	0	HPO
549	AUH	C4020871	Dystonic disease	0.2	0	0	HPO
54901	CDKAL1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.382527596305474	3	12	CTD_human
54902	TTC19	C0028738	Nystagmus	0.2	0	0	HPO
54902	TTC19	C0234958	muscle degeneration	0.2	0	0	HPO
54902	TTC19	C0235946	Cerebral atrophy	0.2	0	0	HPO
54902	TTC19	C0262404	Cerebellar degeneration	0.2	0	0	HPO
54902	TTC19	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
54902	TTC19	C0751830	Gait Disorders, Neurologic	0.2	1	0	CTD_human
54902	TTC19	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
54902	TTC19	C4020860	Supratentorial atrophy	0.2	0	0	HPO
54902	TTC19	C4020871	Dystonic disease	0.2	0	0	HPO
54902	TTC19	C4020873	Infratentorial atrophy	0.2	0	0	HPO
54902	TTC19	C4020884	Anxiety disease	0.2	0	0	HPO
54903	MKS1	C0010964	Dandy-Walker Syndrome	0.200274726784213	0	0	HPO
54903	MKS1	C0020255	Hydrocephalus	0.2	0	0	HPO
54903	MKS1	C0020619	Hypogonadism	0.2	0	0	HPO
54903	MKS1	C0028738	Nystagmus	0.2	0	0	HPO
54903	MKS1	C0028754	Obesity	0.2	0	0	HPO
54903	MKS1	C0029124	Optic Atrophy	0.2	0	0	HPO
54903	MKS1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
54903	MKS1	C0265215	Meckel-Gruber syndrome	0.200824180352639	0	0	ORPHANET
54903	MKS1	C0267818	Bile duct proliferation	0.2	0	0	HPO
54903	MKS1	C0431399	Familial aplasia of the vermis	0.201373633921065	0	0	ORPHANET
54903	MKS1	C0752166	Bardet-Biedl Syndrome	0.403831819601666	1	0	CTD_human;ORPHANET
54903	MKS1	C1853235	Sclerocornea	0.2	0	0	HPO
54903	MKS1	C2673873	BARDET-BIEDL SYNDROME 13	0.2	1	6	UNIPROT
54903	MKS1	C3489733	Oculomotor apraxia	0.2	0	0	HPO
54903	MKS1	C3714506	Meckel syndrome type 1	0.490033865946625	1	20	CTD_human;UNIPROT
54903	MKS1	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
54903	MKS1	C4274118	Joubert syndrome with ocular defect	0.2	0	0	ORPHANET
54919	DNAAF5	C0008677	Bronchitis, Chronic	0.2	0	0	HPO
54919	DNAAF5	C0022521	Kartagener Syndrome	0.200549453568426	0	0	ORPHANET
54919	DNAAF5	C0035455	Rhinitis	0.2	0	0	HPO
54919	DNAAF5	C0581354	Recurrent sinusitis	0.2	0	0	HPO
54919	DNAAF5	C0747085	Recurrent otitis media	0.2	0	0	HPO
54919	DNAAF5	C3543825	CILIARY DYSKINESIA, PRIMARY, 18	0.2	1	1	UNIPROT
54919	DNAAF5	C4280333	Recurrent sinus disease	0.2	0	0	HPO
54928	IMPAD1	C0015300	Exophthalmos	0.2	0	0	HPO
54928	IMPAD1	C1856266	Coronal craniosynostosis	0.2	0	0	HPO
54928	IMPAD1	C3279757	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.400274726784213	1	4	ORPHANET;UNIPROT
54938	SARS2	C0002871	Anemia	0.2	0	0	HPO
54938	SARS2	C0023530	Leukopenia	0.2	0	0	HPO
54938	SARS2	C0740394	Hyperuricemia	0.200274726784213	0	0	HPO
54938	SARS2	C0740895	Hypochloremic metabolic alkalosis	0.2	0	0	HPO
54938	SARS2	C1145670	Respiratory Failure	0.2	0	0	HPO
54938	SARS2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
54938	SARS2	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
54938	SARS2	C3151209	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.400274726784213	1	1	ORPHANET;UNIPROT
54938	SARS2	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
54941	RNF125	C0007789	Cerebral Palsy	0.2	0	0	HPO
54941	RNF125	C0013238	Dry Eye Syndromes	0.2	0	0	HPO
54941	RNF125	C0014544	Epilepsy	0.2	0	0	HPO
54941	RNF125	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
54941	RNF125	C0020255	Hydrocephalus	0.2	0	0	HPO
54941	RNF125	C0020555	Hypertrichosis	0.2	0	0	HPO
54941	RNF125	C0020615	Hypoglycemia	0.2	0	0	HPO
54941	RNF125	C0022575	Keratoconjunctivitis Sicca	0.2	0	0	HPO
54941	RNF125	C0024421	Macroglossia	0.2	0	0	HPO
54941	RNF125	C0029453	Osteopenia	0.2	0	0	HPO
54941	RNF125	C0032285	Pneumonia	0.2	0	0	HPO
54941	RNF125	C0043349	Xerophthalmia	0.2	0	0	HPO
54941	RNF125	C0235946	Cerebral atrophy	0.2	0	0	HPO
54941	RNF125	C0747078	Generalized osteopenia	0.2	0	0	HPO
54941	RNF125	C2748055	Hypoinsulinaemia (disorder)	0.2	0	0	HPO
54941	RNF125	C2930821	Keratitis sicca	0.2	0	0	HPO
54941	RNF125	C4015710	TENORIO SYNDROME	0.2	1	3	UNIPROT
54941	RNF125	C4020884	Anxiety disease	0.2	0	0	HPO
54947	LPCAT2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
54949	SDHAF2	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
54949	SDHAF2	C0042928	Vocal Cord Paralysis	0.2	0	0	HPO
54949	SDHAF2	C1866552	PARAGANGLIOMAS 2 (disorder)	0.400274726784213	1	1	CTD_human;UNIPROT
5495	PPM1B	C0010691	Cystinuria	0.2	0	0	HPO
5495	PPM1B	C0014544	Epilepsy	0.2	0	0	HPO
5495	PPM1B	C0020619	Hypogonadism	0.2	0	0	HPO
5495	PPM1B	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5495	PPM1B	C0392525	Nephrolithiasis	0.2	0	0	HPO
5495	PPM1B	C1848030	Hypotonia-Cystinuria Syndrome	0.400274726784213	1	0	CTD_human;ORPHANET
5495	PPM1B	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
54968	TMEM70	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
54968	TMEM70	C0014038	Encephalitis	0.2	0	0	HPO
54968	TMEM70	C0018801	Heart failure	0.2	0	0	HPO
54968	TMEM70	C0018802	Congestive heart failure	0.2	0	0	HPO
54968	TMEM70	C0162666	Mitochondrial Encephalomyopathies	0.2	1	0	CTD_human
54968	TMEM70	C0235946	Cerebral atrophy	0.2	0	0	HPO
54968	TMEM70	C1145670	Respiratory Failure	0.2	0	0	HPO
54968	TMEM70	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
54968	TMEM70	C3276276	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1	0.2	0	0	CTD_human
54968	TMEM70	C3279699	Encephalocardiomyopathy, Mitochondrial, Neonatal, Due To Atp Synthase Deficiency	0.4	1	3	ORPHANET;UNIPROT
54968	TMEM70	C3696376	3-Methylglutaconic Aciduria	0.200549453568426	0	0	HPO
54977	SLC25A38	C0002871	Anemia	0.2	0	0	HPO
54977	SLC25A38	C0002896	Sideroblastic anemia	0.200824180352639	1	0	CTD_human
54977	SLC25A38	C2673914	Anemia, Sideroblastic, Pyridoxine-Refractory, Autosomal Recessive	0.2	0	0	CTD_human
54977	SLC25A38	C3854388	Hyperferritinaemia	0.2	0	0	HPO
54977	SLC25A38	C4225425	ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY	0.2	1	3	UNIPROT
54977	SLC25A38	C4274077	Autosomal recessive sideroblastic anemia	0.200549453568426	0	0	ORPHANET
5498	PPOX	C0151861	Porphyruria	0.2	0	0	HPO
5498	PPOX	C0162532	Variegate Porphyria	0.497502646277691	23	17	ORPHANET;UNIPROT
5498	PPOX	C2936913	Porphyria, South African type	0.2	0	0	CTD_human
54982	CLN6	C0014544	Epilepsy	0.2	0	0	HPO
54982	CLN6	C0022797	Adult Neuronal Ceroid Lipofuscinosis	0.400549453568426	1	6	ORPHANET;UNIPROT
54982	CLN6	C0027877	Neuronal Ceroid-Lipofuscinoses	0.2166353997931	1	0	CTD_human
54982	CLN6	C0235946	Cerebral atrophy	0.2	0	0	HPO
54982	CLN6	C0751778	Myoclonic Epilepsies, Progressive	0.200549453568426	1	0	CTD_human
54982	CLN6	C1866282	CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.680274726784213	6	21	CTD_human;ORPHANET;UNIPROT
54982	CLN6	C4020860	Supratentorial atrophy	0.2	0	0	HPO
55	ACPP	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
55005	RMND1	C0235946	Cerebral atrophy	0.2	0	0	HPO
55005	RMND1	C3554067	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11	0.4	1	4	ORPHANET;UNIPROT
55008	HERC6	C0021400	Influenza	0.2	1	0	CTD_human
55014	STX17	C0002171	Alopecia Areata	0.2	1	1	CTD_human
5502	PPP1R1A	C0018801	Heart failure	0.201648360705279	1	0	CTD_human
55023	PHIP	C1527336	Sjogren's Syndrome	0.2	1	0	CTD_human
55024	BANK1	C0024141	Lupus Erythematosus, Systemic	0.220471805015099	1	3	CTD_human
55033	FKBP14	C0027092	Myopia	0.2	0	0	HPO
55033	FKBP14	C0029453	Osteopenia	0.2	0	0	HPO
55033	FKBP14	C0234958	muscle degeneration	0.2	0	0	HPO
55033	FKBP14	C0334013	Phrynoderma	0.2	0	0	HPO
55033	FKBP14	C0747078	Generalized osteopenia	0.2	0	0	HPO
55033	FKBP14	C3281160	EHLERS-DANLOS SYNDROME WITH PROGRESSIVE KYPHOSCOLIOSIS, MYOPATHY, AND HEARING LOSS	0.200274726784213	0	0	ORPHANET
55033	FKBP14	C4021775	High-frequency sensorineural hearing impairment	0.2	0	0	HPO
55034	MOCOS	C1863688	Xanthinuria, Type II	0.400274726784213	2	5	ORPHANET;UNIPROT
55036	CCDC40	C0006267	Bronchiectasis	0.2	0	0	HPO
55036	CCDC40	C0022521	Kartagener Syndrome	0.400824180352639	1	0	CTD_human;ORPHANET
55036	CCDC40	C0037199	Sinusitis	0.2	0	0	HPO
55036	CCDC40	C0747085	Recurrent otitis media	0.2	0	0	HPO
55054	ATG16L1	C0010346	Crohn Disease	0.335090885230978	2	7	CTD_human
55054	ATG16L1	C1970207	Inflammatory Bowel Disease 10	0.48	1	1	CTD_human;UNIPROT
5506	PPP1R3A	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
5506	PPP1R3A	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.502552949596861	1	1	HPO;UNIPROT
5506	PPP1R3A	C0020456	Hyperglycemia	0.2	0	0	HPO
5506	PPP1R3A	C0020459	Hyperinsulinism	0.2	0	0	HPO
5506	PPP1R3A	C0023787	Lipodystrophy	0.2	0	0	HPO
5506	PPP1R3A	C0023890	Liver Cirrhosis	0.2	0	0	HPO
5506	PPP1R3A	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
5506	PPP1R3A	C0271694	Familial partial lipodystrophy	0.2	0	0	CTD_human
5506	PPP1R3A	C0473527	Hypoalphalipoproteinemias	0.2	0	0	HPO
5506	PPP1R3A	C0740394	Hyperuricemia	0.2	0	0	HPO
5506	PPP1R3A	C0854110	Insulin resistant diabetes	0.2	0	0	HPO
5506	PPP1R3A	C2711227	Steatohepatitis	0.2	0	0	HPO
5506	PPP1R3A	C4020778	maternal hyperglycemia	0.2	0	0	HPO
55062	WIPI1	C0023794	Lipoidosis	0.2	3	0	CTD_human
550624	KTCN4	C1836473	Keratoconus 4	0.2	0	0	CTD_human
550626	FHASD	C1836603	Foveal Hypoplasia and Anterior Segment Dysgenesis	0.2	0	0	CTD_human
55065	SLC52A1	C0020615	Hypoglycemia	0.2	0	0	HPO
55065	SLC52A1	C0035528	Riboflavin Deficiency	0.400274726784213	0	0	HPO;ORPHANET
55072	RNF31	C4014605	POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY	0.2	0	0	ORPHANET
55084	SOBP	C3150924	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS	0.200274726784213	0	0	CTD_human
551	AVP	C0011848	Diabetes Insipidus	0.608227448149076	2	0	CTD_human;HPO;ORPHANET
551	AVP	C0018801	Heart failure	0.200824180352639	1	0	CTD_human
551	AVP	C0020541	Hypertension, Portal	0.2	1	0	CTD_human
551	AVP	C0029453	Osteopenia	0.2	0	0	HPO
551	AVP	C0037019	Shy-Drager Syndrome	0.2	1	0	CTD_human
551	AVP	C0687720	Central Diabetes Insipidus	0.714412772855005	22	17	CTD_human;HPO;ORPHANET;UNIPROT
551	AVP	C0747078	Generalized osteopenia	0.2	0	0	HPO
55109	AGGF1	C0034065	Pulmonary Embolism	0.2	0	0	HPO
55109	AGGF1	C0042485	Venous Insufficiency	0.2	0	0	HPO
55110	MAGOHB	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
55112	WDR60	C0020295	Hydronephrosis	0.2	0	0	HPO
55112	WDR60	C0020305	Hydrops Fetalis	0.2	0	0	HPO
55112	WDR60	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
55112	WDR60	C0267952	Fibrosis of pancreas	0.2	0	0	HPO
55112	WDR60	C0432197	Short rib-polydactyly syndrome, Verma-Naumoff type	0.2	0	0	ORPHANET
55112	WDR60	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
55112	WDR60	C3809691	SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY	0.2	1	3	UNIPROT
55120	FANCL	C0002871	Anemia	0.2	0	0	HPO
55120	FANCL	C0015625	Fanconi Anemia	0.406029633875371	2	2	CTD_human;ORPHANET
55120	FANCL	C0023530	Leukopenia	0.2	0	0	HPO
55120	FANCL	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
55129	ANO10	C0028738	Nystagmus	0.2	0	0	HPO
55129	ANO10	C0262404	Cerebellar degeneration	0.2	0	0	HPO
55129	ANO10	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
55129	ANO10	C3150998	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10	0.400274726784213	1	9	ORPHANET;UNIPROT
55129	ANO10	C4020873	Infratentorial atrophy	0.2	0	0	HPO
55130	ARMC4	C0006267	Bronchiectasis	0.2	0	0	HPO
55130	ARMC4	C0008677	Bronchitis, Chronic	0.2	0	0	HPO
55130	ARMC4	C0022521	Kartagener Syndrome	0.200549453568426	0	0	ORPHANET
55130	ARMC4	C0035455	Rhinitis	0.2	0	0	HPO
55130	ARMC4	C0037199	Sinusitis	0.2	0	0	HPO
55130	ARMC4	C0581354	Recurrent sinusitis	0.2	0	0	HPO
55130	ARMC4	C0747085	Recurrent otitis media	0.2	0	0	HPO
55130	ARMC4	C3809548	CILIARY DYSKINESIA, PRIMARY, 23	0.28	1	9	UNIPROT
55130	ARMC4	C4280333	Recurrent sinus disease	0.2	0	0	HPO
55131	RBM28	C0002170	Alopecia	0.200274726784213	0	0	HPO
55131	RBM28	C0011334	Dental caries	0.2	0	0	HPO
55131	RBM28	C0018418	Gynecomastia	0.2	0	0	HPO
55131	RBM28	C0020619	Hypogonadism	0.2	0	0	HPO
55131	RBM28	C0234958	muscle degeneration	0.2	0	0	HPO
55131	RBM28	C0948387	Secondary Adrenal Insufficiency	0.2	0	0	HPO
55131	RBM28	C1504405	Pyramidal tract syndrome	0.2	0	0	HPO
55131	RBM28	C2677535	Alopecia, Neurologic Defects, and Endocrinopathy Syndrome	0.600549453568426	1	1	CTD_human;ORPHANET;UNIPROT
55135	WRAP53	C0002871	Anemia	0.2	0	0	HPO
55135	WRAP53	C0011334	Dental caries	0.2	0	0	HPO
55135	WRAP53	C0030312	Pancytopenia	0.2	0	0	HPO
55135	WRAP53	C0031099	Periodontitis	0.2	0	0	HPO
55135	WRAP53	C0221260	Dystrophia unguium	0.2	0	0	HPO
55135	WRAP53	C0265965	Dyskeratosis Congenita	0.200824180352639	0	0	ORPHANET
55135	WRAP53	C0266039	Taurodontism	0.2	0	0	HPO
55135	WRAP53	C1834405	Nail dysplasia	0.2	0	0	HPO
55135	WRAP53	C3151442	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3	0.2	1	4	UNIPROT
55145	THAP1	C0013423	Dystonia Musculorum Deformans	0.202472541057918	0	0	HPO
55145	THAP1	C0154676	Organic writer's cramp	0.2	0	0	HPO
55145	THAP1	C1414216	Dystonia 6, torsion (disorder)	0.601648360705279	15	15	CTD_human;ORPHANET;UNIPROT
55145	THAP1	C1963946	Laryngeal dystonia	0.200824180352639	0	0	HPO
55149	MTPAP	C0028738	Nystagmus	0.2	0	0	HPO
55149	MTPAP	C0029124	Optic Atrophy	0.2	0	0	HPO
55149	MTPAP	C1849156	Spastic Ataxia	0.200274726784213	0	0	HPO
55149	MTPAP	C3150925	SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE	0.6	1	1	CTD_human;ORPHANET;UNIPROT
5515	PPP2CA	C0004096	Asthma	0.2	1	0	CTD_human
5515	PPP2CA	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
55151	TMEM38B	C0029453	Osteopenia	0.2	0	0	HPO
55151	TMEM38B	C0747078	Generalized osteopenia	0.2	0	0	HPO
55151	TMEM38B	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
55157	DARS2	C0028738	Nystagmus	0.2	0	0	HPO
55157	DARS2	C0234958	muscle degeneration	0.2	0	0	HPO
55157	DARS2	C0270921	Axonal neuropathy	0.2	0	0	HPO
55157	DARS2	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
55157	DARS2	C1970180	Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation	0.601098907136852	1	15	CTD_human;ORPHANET;UNIPROT
55163	PNPO	C0002871	Anemia	0.2	0	0	HPO
55163	PNPO	C0014544	Epilepsy	0.200824180352639	0	0	HPO
55163	PNPO	C0020615	Hypoglycemia	0.2	0	0	HPO
55163	PNPO	C0038220	Status Epilepticus	0.2	1	0	CTD_human
55163	PNPO	C1864723	Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency	0.6	1	7	CTD_human;ORPHANET;UNIPROT
55163	PNPO	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
55165	CEP55	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
55172	DNAAF2	C0022521	Kartagener Syndrome	0.2	0	0	ORPHANET
55172	DNAAF2	C0149516	Chronic sinusitis	0.2	0	0	HPO
55172	DNAAF2	C0271441	Chronic otitis media	0.2	0	0	HPO
55172	DNAAF2	C0581354	Recurrent sinusitis	0.2	0	0	HPO
55172	DNAAF2	C0743359	ear infection chronic	0.2	0	0	HPO
55172	DNAAF2	C0748720	Chronic sinus disease	0.2	0	0	HPO
55172	DNAAF2	C2675867	CILIARY DYSKINESIA, PRIMARY, 10	0.2	0	0	CTD_human
55172	DNAAF2	C4280333	Recurrent sinus disease	0.2	0	0	HPO
5518	PPP2R1A	C0014544	Epilepsy	0.2	0	0	HPO
5518	PPP2R1A	C0020255	Hydrocephalus	0.2	0	0	HPO
5518	PPP2R1A	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
5518	PPP2R1A	C1837658	Gross motor development delay	0.2	0	0	HPO
55209	SETD5	C0037036	Sialorrhea	0.2	0	0	HPO
55209	SETD5	C3810406	MENTAL RETARDATION, AUTOSOMAL DOMINANT 23	0.2	0	0	ORPHANET
5521	PPP2R2B	C0087012	Ataxia, Spinocerebellar	0.204879569581206	1	0	CTD_human
5521	PPP2R2B	C0235946	Cerebral atrophy	0.200274726784213	0	0	HPO
5521	PPP2R2B	C0262404	Cerebellar degeneration	0.2	0	0	HPO
5521	PPP2R2B	C0393525	Progressive cerebellar ataxia	0.2	0	0	HPO
5521	PPP2R2B	C0740279	Atrophy of cerebellum	0.200549453568426	0	0	HPO
5521	PPP2R2B	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
5521	PPP2R2B	C1858501	Spinocerebellar Ataxia 12	0.401648360705279	0	0	CTD_human;ORPHANET
5521	PPP2R2B	C4020873	Infratentorial atrophy	0.2	0	0	HPO
5521	PPP2R2B	C4020884	Anxiety disease	0.2	0	0	HPO
55212	BBS7	C0020619	Hypogonadism	0.2	0	0	HPO
55212	BBS7	C0028738	Nystagmus	0.2	0	0	HPO
55212	BBS7	C0028754	Obesity	0.202407028523288	0	0	HPO
55212	BBS7	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
55212	BBS7	C0752166	Bardet-Biedl Syndrome	0.409521214158194	0	0	CTD_human;ORPHANET
55212	BBS7	C1859565	BARDET-BIEDL SYNDROME 7	0.2	4	10	UNIPROT
55212	BBS7	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
55214	P3H2	C0271183	Severe myopia	0.200549453568426	0	0	HPO
55214	P3H2	C3280346	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION	0.2	1	3	UNIPROT
55215	FANCI	C0015625	Fanconi Anemia	0.215327278406665	0	0	ORPHANET
55215	FANCI	C0023530	Leukopenia	0.2	0	0	HPO
55215	FANCI	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
55215	FANCI	C1836861	FANCONI ANEMIA, COMPLEMENTATION GROUP I	0.4	2	3	CTD_human;UNIPROT
55217	TMLHE	C3550875	AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.2	1	4	UNIPROT
55219	TMEM57	C0010068	Coronary heart disease	0.202407028523288	1	0	CTD_human
55240	STEAP3	C0002871	Anemia	0.2	0	0	HPO
55240	STEAP3	C0004509	Azoospermia	0.2	0	0	HPO
55240	STEAP3	C0020619	Hypogonadism	0.2	0	0	HPO
55240	STEAP3	C3808920	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2	0.2	0	0	ORPHANET
55240	STEAP3	C3854388	Hyperferritinaemia	0.2	0	0	HPO
55275	VPS53	C0014544	Epilepsy	0.2	0	0	HPO
55275	VPS53	C0029456	Osteoporosis	0.2	0	0	HPO
55275	VPS53	C0235946	Cerebral atrophy	0.2	0	0	HPO
55275	VPS53	C0262404	Cerebellar degeneration	0.2	0	0	HPO
55275	VPS53	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
55275	VPS53	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
55275	VPS53	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
55275	VPS53	C4014488	PONTOCEREBELLAR HYPOPLASIA, TYPE 2E	0.2	1	2	UNIPROT
55275	VPS53	C4020860	Supratentorial atrophy	0.2	0	0	HPO
55275	VPS53	C4020873	Infratentorial atrophy	0.2	0	0	HPO
5528	PPP2R5D	C0014306	Enophthalmos	0.2	0	0	HPO
5528	PPP2R5D	C0014544	Epilepsy	0.2	0	0	HPO
5528	PPP2R5D	C0020255	Hydrocephalus	0.2	0	0	HPO
5528	PPP2R5D	C0020615	Hypoglycemia	0.2	0	0	HPO
5528	PPP2R5D	C0027092	Myopia	0.2	0	0	HPO
5528	PPP2R5D	C0038379	Strabismus	0.2	0	0	HPO
5528	PPP2R5D	C0401151	Chronic diarrhea	0.2	0	0	HPO
5528	PPP2R5D	C4225354	MENTAL RETARDATION, AUTOSOMAL DOMINANT 35	0.4	1	5	ORPHANET;UNIPROT
55280	CWF19L1	C4015301	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17	0.2	0	0	ORPHANET
5530	PPP3CA	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
5530	PPP3CA	C0030305	Pancreatitis	0.2	1	0	CTD_human
5530	PPP3CA	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
55315	SLC29A3	C0011644	Scleroderma	0.2	0	0	HPO
55315	SLC29A3	C0011854	Diabetes Mellitus, Insulin-Dependent	0.203780662444353	2	0	CTD_human
55315	SLC29A3	C0014583	Episcleritis	0.2	0	0	HPO
55315	SLC29A3	C0015300	Exophthalmos	0.2	0	0	HPO
55315	SLC29A3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
55315	SLC29A3	C0019625	Sinus histiocytosis	0.201648360705279	1	0	CTD_human
55315	SLC29A3	C0020555	Hypertrichosis	0.400824180352639	2	0	CTD_human;HPO
55315	SLC29A3	C0020619	Hypogonadism	0.200274726784213	1	0	CTD_human
55315	SLC29A3	C0028738	Nystagmus	0.2	0	0	HPO
55315	SLC29A3	C0029124	Optic Atrophy	0.2	0	0	HPO
55315	SLC29A3	C0029464	Osteosclerosis	0.2	0	0	HPO
55315	SLC29A3	C0432262	Dysosteosclerosis	0.200274726784213	0	0	ORPHANET
55315	SLC29A3	C0948896	Primary hypogonadism	0.2	0	0	HPO
55315	SLC29A3	C1274865	Scleroderma-like secondary cutaneous sclerosis	0.2	0	0	HPO
55315	SLC29A3	C1836830	Developmental regression	0.2	0	0	HPO
55315	SLC29A3	C1864445	Histiocytosis with joint contractures and sensorineural deafness	0.60439562854741	7	15	CTD_human;ORPHANET;UNIPROT
55315	SLC29A3	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
553190	MYP7	C1836506	MYOPIA 7 (disorder)	0.2	0	0	CTD_human
553192	MYP8	C1836505	MYOPIA 8 (disorder)	0.2	0	0	CTD_human
553194	MYP9	C1836504	MYOPIA 9 (disorder)	0.2	0	0	CTD_human
553195	MYP10	C1836503	MYOPIA 10 (disorder)	0.2	0	0	CTD_human
5532	PPP3CB	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
55325	UFSP2	C0023234	Legg-Calve-Perthes Disease	0.2	0	0	HPO
55325	UFSP2	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
55325	UFSP2	C1840572	HIP DYSPLASIA, BEUKES TYPE	0.4	1	1	ORPHANET;UNIPROT
5534	PPP3R1	C0149721	Left Ventricular Hypertrophy	0.205414667772315	1	0	CTD_human
5534	PPP3R1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
55343	SLC35C1	C0014544	Epilepsy	0.2	0	0	HPO
55343	SLC35C1	C0029882	Otitis Media	0.2	0	0	HPO
55343	SLC35C1	C0031099	Periodontitis	0.2	0	0	HPO
55343	SLC35C1	C0032285	Pneumonia	0.2	0	0	HPO
55343	SLC35C1	C0235946	Cerebral atrophy	0.2	0	0	HPO
55343	SLC35C1	C0398739	Congenital disorder of glycosylation, type 2C	0.68	1	5	CTD_human;ORPHANET;UNIPROT
55350	VNN3	C0033860	Psoriasis	0.200549453568426	1	0	CTD_human
5538	PPT1	C0014544	Epilepsy	0.2	0	0	HPO
5538	PPT1	C0024437	Macular degeneration	0.2	0	0	HPO
5538	PPT1	C0029124	Optic Atrophy	0.2	0	0	HPO
5538	PPT1	C0235946	Cerebral atrophy	0.2	0	0	HPO
5538	PPT1	C0271215	Blindness, Legal	0.2	0	0	HPO
5538	PPT1	C1850451	CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.680824180352639	4	74	CTD_human;ORPHANET;UNIPROT
5538	PPT1	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	0.205494535684262	2	0	CTD_human
5538	PPT1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
55384	MEG3	C1842466	Uniparental disomy, paternal, chromosome 14	0.200274726784213	0	0	ORPHANET
553989	LFS3	C1836481	Li-Fraumeni Syndrome 3	0.2	0	0	CTD_human
553991	LGMD1G	C1836765	LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G (disorder)	0.2	0	0	CTD_human
553992	MGR7	C0154723	Migraine with Aura	0.2	0	0	CTD_human
554	AVPR2	C0003123	Anorexia	0.2	0	0	HPO
554	AVPR2	C0011848	Diabetes Insipidus	0.200824180352639	0	0	HPO
554	AVPR2	C0014544	Epilepsy	0.2	0	0	HPO
554	AVPR2	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
554	AVPR2	C0162283	Nephrogenic Diabetes Insipidus	0.643761574543611	5	15	CTD_human;HPO;ORPHANET
554	AVPR2	C1112601	Hypertonic dehydration	0.2	0	0	HPO
554	AVPR2	C1563705	Nephrogenic Diabetes Insipidus, Type I	0.296483607052786	23	22	UNIPROT
554	AVPR2	C1845202	Nephrogenic Syndrome of Inappropriate Antidiuresis	0.601373633921066	1	2	CTD_human;ORPHANET;UNIPROT
554	AVPR2	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
554	AVPR2	C3671887	Sodium concentration in urine above normal	0.2	0	0	HPO
554188	FCMTE2	C1842852	EPILEPSY, MYOCLONIC, BENIGN ADULT FAMILIAL, TYPE 2	0.2	0	0	CTD_human
5548	PRD	C3887971	RETINAL DYSPLASIA, PRIMARY	0.2	0	0	CTD_human
55500	ETNK1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
55503	TRPV6	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
55505	NOP10	C0002871	Anemia	0.2	0	0	HPO
55505	NOP10	C0002874	Aplastic Anemia	0.2	0	0	HPO
55505	NOP10	C0011334	Dental caries	0.2	0	0	HPO
55505	NOP10	C0029456	Osteoporosis	0.2	0	0	HPO
55505	NOP10	C0031099	Periodontitis	0.2	0	0	HPO
55505	NOP10	C0034069	Pulmonary Fibrosis	0.2	0	0	HPO
55505	NOP10	C0152227	Excessive tearing	0.2	0	0	HPO
55505	NOP10	C0221260	Dystrophia unguium	0.2	0	0	HPO
55505	NOP10	C0239946	Fibrosis, Liver	0.2	0	0	HPO
55505	NOP10	C0265965	Dyskeratosis Congenita	0.204381273170092	0	0	ORPHANET
55505	NOP10	C0266039	Taurodontism	0.2	0	0	HPO
55505	NOP10	C1834405	Nail dysplasia	0.2	0	0	HPO
55505	NOP10	C1857144	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1	0.2	1	1	UNIPROT
55509	BATF3	C0023343	Leprosy	0.200274726784213	1	1	CTD_human
5551	PRF1	C0002871	Anemia	0.2	0	0	HPO
5551	PRF1	C0002874	Aplastic Anemia	0.2	0	0	HPO
5551	PRF1	C0014038	Encephalitis	0.200549453568426	0	0	HPO
5551	PRF1	C0014544	Epilepsy	0.2	0	0	HPO
5551	PRF1	C0020639	Hypoproteinemia	0.2	0	0	HPO
5551	PRF1	C0023530	Leukopenia	0.2	0	0	HPO
5551	PRF1	C0025289	Meningitis	0.200274726784213	0	0	HPO
5551	PRF1	C0034372	Quadriplegia	0.2	0	0	HPO
5551	PRF1	C0151740	Intracranial Hypertension	0.2	0	0	HPO
5551	PRF1	C0151857	Pleocytosis	0.2	0	0	HPO
5551	PRF1	C0239981	Hypoalbuminemia	0.2	0	0	HPO
5551	PRF1	C0348890	Aplastic anemia, idiopathic	0.2	0	0	ORPHANET
5551	PRF1	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
5551	PRF1	C0553681	Hypofibrinogenemia	0.2	0	0	HPO
5551	PRF1	C0876991	Histiocytosis haematophagic	0.200274726784213	0	0	HPO
5551	PRF1	C1863727	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.481373633921066	2	13	CTD_human;UNIPROT
5551	PRF1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5551	PRF1	C3854388	Hyperferritinaemia	0.2	0	0	HPO
55526	DHTKD1	C0234958	muscle degeneration	0.2	0	0	HPO
55526	DHTKD1	C0238621	Aminoaciduria	0.2	0	0	HPO
55526	DHTKD1	C3554366	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q	0.2	0	0	ORPHANET
55532	SLC30A10	C0023890	Liver Cirrhosis	0.4	1	0	CTD_human;HPO
55532	SLC30A10	C0030567	Parkinson Disease	0.2	1	0	CTD_human
55532	SLC30A10	C0032461	Polycythemia	0.4	1	0	CTD_human;HPO
55532	SLC30A10	C2750442	Hypermanganesemia with Dystonia Polycythemia and Cirrhosis	0.600549453568426	3	9	CTD_human;ORPHANET;UNIPROT
55532	SLC30A10	C4020871	Dystonic disease	0.2	0	0	HPO
55572	FOXRED1	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
55572	FOXRED1	C0014544	Epilepsy	0.2	0	0	HPO
55572	FOXRED1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
55572	FOXRED1	C0020555	Hypertrichosis	0.2	0	0	HPO
55572	FOXRED1	C0020615	Hypoglycemia	0.2	0	0	HPO
55572	FOXRED1	C0023264	Leigh Disease	0.4	0	0	CTD_human;ORPHANET
55572	FOXRED1	C0023520	Leukodystrophy	0.2	0	0	HPO
55572	FOXRED1	C0028738	Nystagmus	0.2	0	0	HPO
55572	FOXRED1	C0029124	Optic Atrophy	0.2	0	0	HPO
55572	FOXRED1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
55572	FOXRED1	C0038379	Strabismus	0.2	0	0	HPO
55572	FOXRED1	C0085605	Liver Failure	0.2	0	0	HPO
55572	FOXRED1	C0162666	Mitochondrial Encephalomyopathies	0.2	1	0	CTD_human
55572	FOXRED1	C0234958	muscle degeneration	0.2	0	0	HPO
55572	FOXRED1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
55572	FOXRED1	C0271215	Blindness, Legal	0.2	0	0	HPO
55572	FOXRED1	C0338474	Central nervous system demyelination	0.2	0	0	HPO
55572	FOXRED1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
55572	FOXRED1	C1145670	Respiratory Failure	0.2	0	0	HPO
55572	FOXRED1	C1836830	Developmental regression	0.2	0	0	HPO
55572	FOXRED1	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.4	2	4	CTD_human;UNIPROT
55572	FOXRED1	C1855020	Acute necrotizing encephalopathy	0.2	0	0	HPO
55572	FOXRED1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
55572	FOXRED1	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
55572	FOXRED1	C4020871	Dystonic disease	0.2	0	0	HPO
55572	FOXRED1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
55600	ITLN1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202681755307501	1	0	CTD_human
55601	DDX60	C0021400	Influenza	0.2	1	0	CTD_human
55605	KIF21A	C0014877	Esotropia	0.2	0	0	HPO
55605	KIF21A	C0015310	Exotropia	0.200274726784213	0	0	HPO
55605	KIF21A	C1302995	Congenital Fibrosis of the Extraocular Muscles	0.212846646323386	0	0	HPO
55605	KIF21A	C1851102	Fibrosis Of Extraocular Muscles, Congenital, 1	0.401648360705279	4	7	ORPHANET;UNIPROT
55605	KIF21A	C2751105	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B (disorder)	0.2	0	0	CTD_human
55612	FERMT1	C0007971	Cheilitis	0.2	0	0	HPO
55612	FERMT1	C0009319	Colitis	0.200274726784213	0	0	HPO
55612	FERMT1	C0011334	Dental caries	0.2	0	0	HPO
55612	FERMT1	C0013595	Eczema	0.2	0	0	HPO
55612	FERMT1	C0014868	Esophagitis	0.2	0	0	HPO
55612	FERMT1	C0017574	Gingivitis	0.2	0	0	HPO
55612	FERMT1	C0020757	Ichthyoses	0.2	0	0	HPO
55612	FERMT1	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
55612	FERMT1	C0031099	Periodontitis	0.2	0	0	HPO
55612	FERMT1	C0042109	Urticaria	0.2	0	0	HPO
55612	FERMT1	C0334166	Pseudoainhum	0.2	0	0	HPO
55612	FERMT1	C0392777	Poikiloderma	0.201923087489492	0	0	HPO
55612	FERMT1	C0406556	Hereditary acrokeratotic poikiloderma of Weary	0.2	0	0	ORPHANET
55612	FERMT1	C0406557	Poikiloderma of Kindler	0.688791257094819	1	21	CTD_human;ORPHANET;UNIPROT
55612	FERMT1	C4024863	Diffuse skin atrophy	0.2	0	0	HPO
55624	POMGNT1	C0014544	Epilepsy	0.2	0	0	HPO
55624	POMGNT1	C0017601	Glaucoma	0.2	0	0	HPO
55624	POMGNT1	C0018777	Conductive hearing loss	0.2	0	0	HPO
55624	POMGNT1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
55624	POMGNT1	C0020255	Hydrocephalus	0.200274726784213	0	0	HPO
55624	POMGNT1	C0020459	Hyperinsulinism	0.2	0	0	HPO
55624	POMGNT1	C0020619	Hypogonadism	0.2	0	0	HPO
55624	POMGNT1	C0022578	Keratoconus	0.2	0	0	HPO
55624	POMGNT1	C0026850	Muscular Dystrophy	0.209470057000881	0	0	HPO
55624	POMGNT1	C0027092	Myopia	0.2	0	0	HPO
55624	POMGNT1	C0028738	Nystagmus	0.2	0	0	HPO
55624	POMGNT1	C0028754	Obesity	0.2	0	0	HPO
55624	POMGNT1	C0029124	Optic Atrophy	0.2	0	0	HPO
55624	POMGNT1	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
55624	POMGNT1	C0038379	Strabismus	0.2	0	0	HPO
55624	POMGNT1	C0042798	Low Vision	0.2	0	0	HPO
55624	POMGNT1	C0265221	Walker-Warburg congenital muscular dystrophy	0.401373633921066	0	0	CTD_human;ORPHANET
55624	POMGNT1	C0271215	Blindness, Legal	0.2	0	0	HPO
55624	POMGNT1	C0457133	Muscle eye brain disease	0.205769262468475	0	0	ORPHANET
55624	POMGNT1	C0521694	Atrophic retina	0.2	0	0	HPO
55624	POMGNT1	C0699743	Congenital muscular dystrophy (disorder)	0.201373633921065	0	0	HPO
55624	POMGNT1	C1847759	MUSCULAR DYSTROPHY, CONGENITAL, 1C	0.2	0	0	ORPHANET
55624	POMGNT1	C3150412	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3	0.4	5	6	CTD_human;UNIPROT
55624	POMGNT1	C3150415	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	0.2	0	0	ORPHANET
55624	POMGNT1	C3150416	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.2	0	0	ORPHANET
55624	POMGNT1	C3150417	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3	0.6	1	2	CTD_human;ORPHANET;UNIPROT
55624	POMGNT1	C3151519	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	0.28	8	12	UNIPROT
55624	POMGNT1	C3809221	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14	0.2	0	0	ORPHANET
55630	SLC39A4	C0001197	Acrodermatitis	0.206015278498054	5	0	CTD_human
55630	SLC39A4	C0002170	Alopecia	0.2	0	0	HPO
55630	SLC39A4	C0005741	Blepharitis	0.2	0	0	HPO
55630	SLC39A4	C0007971	Cheilitis	0.2	0	0	HPO
55630	SLC39A4	C0009763	Conjunctivitis	0.2	0	0	HPO
55630	SLC39A4	C0017675	Glossitis	0.2	0	0	HPO
55630	SLC39A4	C0020619	Hypogonadism	0.2	0	0	HPO
55630	SLC39A4	C0030578	Paronychia Inflammation	0.2	0	0	HPO
55630	SLC39A4	C0040412	Fissured tongue	0.2	0	0	HPO
55630	SLC39A4	C0221036	Acrodermatitis enteropathica	0.68439562854741	6	7	CTD_human;ORPHANET;UNIPROT
55630	SLC39A4	C0235946	Cerebral atrophy	0.2	0	0	HPO
55630	SLC39A4	C0259817	Xerosis	0.2	0	0	HPO
55630	SLC39A4	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
55630	SLC39A4	C0401151	Chronic diarrhea	0.2	0	0	HPO
55630	SLC39A4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
55636	CHD7	C0002170	Alopecia	0.2	0	0	HPO
55636	CHD7	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
55636	CHD7	C0014457	Eosinophilia	0.2	0	0	HPO
55636	CHD7	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
55636	CHD7	C0018418	Gynecomastia	0.2	0	0	HPO
55636	CHD7	C0020295	Hydronephrosis	0.2	0	0	HPO
55636	CHD7	C0020676	Hypothyroidism	0.200274726784213	0	0	HPO
55636	CHD7	C0024312	Lymphopenia	0.200274726784213	0	0	HPO
55636	CHD7	C0028738	Nystagmus	0.2	0	0	HPO
55636	CHD7	C0029124	Optic Atrophy	0.2	0	0	HPO
55636	CHD7	C0029453	Osteopenia	0.2	0	0	HPO
55636	CHD7	C0029456	Osteoporosis	0.2	0	0	HPO
55636	CHD7	C0032285	Pneumonia	0.2	0	0	HPO
55636	CHD7	C0038379	Strabismus	0.2	0	0	HPO
55636	CHD7	C0085110	Severe Combined Immunodeficiency	0.203007639249027	0	0	HPO
55636	CHD7	C0151721	Testicular hypogonadism	0.2	0	0	HPO
55636	CHD7	C0162809	Kallmann Syndrome	0.411993755216112	0	0	CTD_human;ORPHANET
55636	CHD7	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
55636	CHD7	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
55636	CHD7	C0242350	Erectile dysfunction	0.2	0	0	HPO
55636	CHD7	C0259817	Xerosis	0.2	0	0	HPO
55636	CHD7	C0265354	CHARGE Syndrome	0.709879706944598	14	97	CTD_human;ORPHANET;UNIPROT
55636	CHD7	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
55636	CHD7	C0271623	Hypogonadotropic hypogonadism	0.201373633921065	0	0	HPO
55636	CHD7	C0342384	Idiopathic hypogonadotropic hypogonadism	0.200549453568426	0	0	CTD_human
55636	CHD7	C0376175	Bell Palsy	0.200549453568426	0	0	HPO
55636	CHD7	C0401151	Chronic diarrhea	0.2	0	0	HPO
55636	CHD7	C0747078	Generalized osteopenia	0.2	0	0	HPO
55636	CHD7	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
55636	CHD7	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
55636	CHD7	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
55636	CHD7	C2700553	Omenn Syndrome	0.200274726784213	0	0	ORPHANET
55636	CHD7	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
55636	CHD7	C3552553	HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.2	4	10	UNIPROT
55636	CHD7	C4020884	Anxiety disease	0.2	0	0	HPO
55636	CHD7	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
55636	CHD7	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
55640	FLVCR2	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
55640	FLVCR2	C0020255	Hydrocephalus	0.2	0	0	HPO
55640	FLVCR2	C1856972	Encephaloclastic Proliferative Vasculopathy	0.400549453568426	3	5	CTD_human;UNIPROT
55640	FLVCR2	C3203738	Fowler syndrome	0.201373633921065	0	0	ORPHANET
55650	PIGV	C1855923	Hyperphosphatasia with Mental Retardation	0.400824180352639	1	5	CTD_human;UNIPROT
55651	NHP2	C0002871	Anemia	0.2	0	0	HPO
55651	NHP2	C0002874	Aplastic Anemia	0.2	0	0	HPO
55651	NHP2	C0011334	Dental caries	0.2	0	0	HPO
55651	NHP2	C0023890	Liver Cirrhosis	0.2	0	0	HPO
55651	NHP2	C0029456	Osteoporosis	0.2	0	0	HPO
55651	NHP2	C0030312	Pancytopenia	0.2	0	0	HPO
55651	NHP2	C0031099	Periodontitis	0.2	0	0	HPO
55651	NHP2	C0034069	Pulmonary Fibrosis	0.2	0	0	HPO
55651	NHP2	C0152227	Excessive tearing	0.2	0	0	HPO
55651	NHP2	C0156312	Atrophy of testis	0.2	0	0	HPO
55651	NHP2	C0221260	Dystrophia unguium	0.2	0	0	HPO
55651	NHP2	C0239946	Fibrosis, Liver	0.2	0	0	HPO
55651	NHP2	C0265965	Dyskeratosis Congenita	0.200549453568426	0	0	ORPHANET
55651	NHP2	C0266039	Taurodontism	0.2	0	0	HPO
55651	NHP2	C1834405	Nail dysplasia	0.2	0	0	HPO
55651	NHP2	C3151441	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2	0.2	1	3	UNIPROT
5566	PRKACA	C0002170	Alopecia	0.2	0	0	HPO
5566	PRKACA	C0020619	Hypogonadism	0.2	0	0	HPO
5566	PRKACA	C0029453	Osteopenia	0.2	0	0	HPO
5566	PRKACA	C0029456	Osteoporosis	0.2	0	0	HPO
5566	PRKACA	C0234958	muscle degeneration	0.2	0	0	HPO
5566	PRKACA	C0702166	Acne	0.2	0	0	HPO
5566	PRKACA	C0747078	Generalized osteopenia	0.2	0	0	HPO
5566	PRKACA	C1621895	Adrenal hyperplasia	0.200549453568426	0	0	HPO
5566	PRKACA	C4014425	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.2	1	2	UNIPROT
5566	PRKACA	C4025760	Primary hypercorticolism	0.2	0	0	HPO
55669	MFN1	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	0.2	1	0	CTD_human
55670	PEX26	C0001403	Addison Disease	0.2	0	0	HPO
55670	PEX26	C0014544	Epilepsy	0.2	0	0	HPO
55670	PEX26	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
55670	PEX26	C0020295	Hydronephrosis	0.2	0	0	HPO
55670	PEX26	C0028077	Night Blindness	0.2	0	0	HPO
55670	PEX26	C0028738	Nystagmus	0.2	0	0	HPO
55670	PEX26	C0029124	Optic Atrophy	0.2	0	0	HPO
55670	PEX26	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
55670	PEX26	C0038379	Strabismus	0.2	0	0	HPO
55670	PEX26	C0042798	Low Vision	0.2	0	0	HPO
55670	PEX26	C0043459	Zellweger Syndrome	0.400549453568426	2	1	CTD_human;ORPHANET
55670	PEX26	C0085605	Liver Failure	0.2	0	0	HPO
55670	PEX26	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
55670	PEX26	C0162309	Adrenoleukodystrophy	0.2	1	0	CTD_human
55670	PEX26	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
55670	PEX26	C0282527	Infantile Refsum Disease (disorder)	0.400274726784213	1	0	CTD_human;ORPHANET
55670	PEX26	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
55670	PEX26	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
55670	PEX26	C1836830	Developmental regression	0.2	0	0	HPO
55670	PEX26	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
55670	PEX26	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
55670	PEX26	C3550234	PEROXISOME BIOGENESIS DISORDER 2B	0.2	0	0	CTD_human
55670	PEX26	C3553450	Profound global developmental delay	0.2	0	0	HPO
55670	PEX26	C3553951	PEROXISOME BIOGENESIS DISORDER 7B	0.2	3	4	UNIPROT
55670	PEX26	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
55670	PEX26	C3888385	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)	0.2	3	2	UNIPROT
55676	SLC30A6	C0002395	Alzheimer's Disease	0.203557092817453	1	0	CTD_human
55679	LIMS2	C4225192	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W	0.2	0	0	ORPHANET
5568	PRKACG	C0002871	Anemia	0.2	0	0	HPO
5568	PRKACG	C1697453	Spontaneous haematoma	0.2	0	0	HPO
5568	PRKACG	C2751260	Macrothrombocytopenia	0.200824180352639	0	0	HPO
5568	PRKACG	C4015405	BLEEDING DISORDER, PLATELET-TYPE, 19	0.4	1	1	ORPHANET;UNIPROT
55687	TRMU	C0162557	Liver Failure, Acute	0.200274726784213	0	0	HPO
55687	TRMU	C1838854	DEAFNESS, AMINOGLYCOSIDE-INDUCED	0.4	0	0	CTD_human;ORPHANET
55687	TRMU	C3151897	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	0.2	0	0	ORPHANET
55687	TRMU	C3151898	MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT	0.2	0	0	ORPHANET
55687	TRMU	C3278664	LIVER FAILURE, INFANTILE, TRANSIENT	0.6	1	6	CTD_human;ORPHANET;UNIPROT
55690	PACS1	C0014544	Epilepsy	0.2	0	0	HPO
55690	PACS1	C0028754	Obesity	0.2	1	1	CTD_human
55690	PACS1	C0042961	Intestinal Volvulus	0.2	0	0	HPO
55690	PACS1	C0264611	Apraxia of Phonation	0.2	0	0	HPO
55690	PACS1	C3554343	MENTAL RETARDATION, AUTOSOMAL DOMINANT 17	0.4	1	1	ORPHANET;UNIPROT
55691	FRMD4A	C4225193	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA	0.2	0	0	ORPHANET
55699	IARS2	C0014848	Esophageal Achalasia	0.2	0	0	HPO
55699	IARS2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
55699	IARS2	C0028738	Nystagmus	0.2	0	0	HPO
55699	IARS2	C0029453	Osteopenia	0.2	0	0	HPO
55699	IARS2	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
55699	IARS2	C0038015	Spondyloepiphyseal Dysplasia	0.2	0	0	HPO
55699	IARS2	C0151313	Sensory neuropathy	0.2	0	0	HPO
55699	IARS2	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
55699	IARS2	C0747078	Generalized osteopenia	0.2	0	0	HPO
55699	IARS2	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
55699	IARS2	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
55699	IARS2	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
55699	IARS2	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
55699	IARS2	C4014942	CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA	0.4	1	1	ORPHANET;UNIPROT
55699	IARS2	C4021806	Prelingual sensorineural hearing impairment	0.2	0	0	HPO
55703	POLR3B	C0018418	Gynecomastia	0.2	0	0	HPO
55703	POLR3B	C0023520	Leukodystrophy	0.202197814273705	0	0	HPO
55703	POLR3B	C0027092	Myopia	0.2	0	0	HPO
55703	POLR3B	C0037036	Sialorrhea	0.2	0	0	HPO
55703	POLR3B	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
55703	POLR3B	C0235946	Cerebral atrophy	0.2	0	0	HPO
55703	POLR3B	C0262404	Cerebellar degeneration	0.2	0	0	HPO
55703	POLR3B	C0271385	Horizontal Nystagmus	0.2	0	0	HPO
55703	POLR3B	C0271623	Hypogonadotropic hypogonadism	0.201098907136852	0	0	HPO
55703	POLR3B	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
55703	POLR3B	C0948896	Primary hypogonadism	0.2	0	0	HPO
55703	POLR3B	C2676243	Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism	0.200549453568426	0	0	ORPHANET
55703	POLR3B	C3280644	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.2	3	10	UNIPROT
55703	POLR3B	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
55703	POLR3B	C4020871	Dystonic disease	0.2	0	0	HPO
55703	POLR3B	C4020873	Infratentorial atrophy	0.2	0	0	HPO
55704	CCDC88A	C0014544	Epilepsy	0.2	0	0	HPO
55704	CCDC88A	C0029124	Optic Atrophy	0.200274726784213	0	0	HPO
55704	CCDC88A	C0262404	Cerebellar degeneration	0.2	0	0	HPO
55704	CCDC88A	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
55704	CCDC88A	C1850055	PEHO syndrome	0.2	0	0	ORPHANET
55704	CCDC88A	C1850056	PEHO-Like Syndrome	0.200549453568426	0	0	ORPHANET
55704	CCDC88A	C4020873	Infratentorial atrophy	0.2	0	0	HPO
55714	TENM3	C0264423	Asthma, Occupational	0.2	1	0	CTD_human
55714	TENM3	C1845877	Microphthalmia, Isolated, with Coloboma 1	0.2	0	0	ORPHANET
55717	WDR11	C0162809	Kallmann Syndrome	0.200824180352639	0	0	ORPHANET
55717	WDR11	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
55717	WDR11	C3540450	HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA	0.2	1	5	UNIPROT
55721	IQCC	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
55726	INTS13	C0263454	Chloracne	0.2	1	0	CTD_human
5573	PRKAR1A	C0001206	Acromegaly	0.200274726784213	0	0	HPO
5573	PRKAR1A	C0010481	Cushing Syndrome	0.20790156420755	1	0	CTD_human
5573	PRKAR1A	C0014121	Bacterial Endocarditis	0.2	0	0	HPO
5573	PRKAR1A	C0018801	Heart failure	0.2	0	0	HPO
5573	PRKAR1A	C0018802	Congestive heart failure	0.2	0	0	HPO
5573	PRKAR1A	C0020255	Hydrocephalus	0.2	0	0	HPO
5573	PRKAR1A	C0020619	Hypogonadism	0.2	0	0	HPO
5573	PRKAR1A	C0024636	Malocclusion	0.2	0	0	HPO
5573	PRKAR1A	C0028754	Obesity	0.200549453568426	0	0	HPO
5573	PRKAR1A	C0029124	Optic Atrophy	0.2	0	0	HPO
5573	PRKAR1A	C0029453	Osteopenia	0.2	0	0	HPO
5573	PRKAR1A	C0029456	Osteoporosis	0.200274726784213	0	0	HPO
5573	PRKAR1A	C0033806	Pseudohypoparathyroidism	0.200274726784213	0	0	HPO
5573	PRKAR1A	C0036651	Senile lentigo	0.2	0	0	HPO
5573	PRKAR1A	C0038379	Strabismus	0.2	0	0	HPO
5573	PRKAR1A	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
5573	PRKAR1A	C0151740	Intracranial Hypertension	0.2	0	0	HPO
5573	PRKAR1A	C0151945	Thrombosis of cerebral veins	0.2	0	0	HPO
5573	PRKAR1A	C0220659	Acrodysostosis	0.202472541057918	0	0	ORPHANET
5573	PRKAR1A	C0234958	muscle degeneration	0.2	0	0	HPO
5573	PRKAR1A	C0264142	Spade-like hand	0.2	0	0	HPO
5573	PRKAR1A	C0406810	Carney Complex	0.428022131989736	0	0	CTD_human;ORPHANET
5573	PRKAR1A	C0747078	Generalized osteopenia	0.2	0	0	HPO
5573	PRKAR1A	C1328931	Multiple lentigines	0.2	0	0	HPO
5573	PRKAR1A	C1621895	Adrenal hyperplasia	0.2	0	0	HPO
5573	PRKAR1A	C1864846	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1 (disorder)	0.28	0	0	CTD_human
5573	PRKAR1A	C2607929	Carney Complex, Type 1	0.480549453568426	3	23	ORPHANET;UNIPROT
5573	PRKAR1A	C3276228	ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE	0.2	6	4	UNIPROT
5573	PRKAR1A	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
5573	PRKAR1A	C3887949	Apparent mineralocorticoid excess	0.2	1	0	CTD_human
5573	PRKAR1A	C4020884	Anxiety disease	0.2	0	0	HPO
5573	PRKAR1A	C4024641	Enlarged polycystic ovaries	0.2	0	0	HPO
5573	PRKAR1A	C4025760	Primary hypercorticolism	0.2	0	0	HPO
5573	PRKAR1A	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
55733	HHAT	C1838654	Nivelon Nivelon Mabille syndrome	0.28	0	0	ORPHANET
55737	VPS35	C0030567	Parkinson Disease	0.209615437447459	1	0	CTD_human
55737	VPS35	C3280133	PARKINSON DISEASE 17	0.28	1	1	UNIPROT
55737	VPS35	C4274355	Autosomal dominant late onset Parkinson disease	0.200824180352639	0	0	ORPHANET
55748	CNDP2	C0011881	Diabetic Nephropathy	0.206238848124954	1	0	CTD_human
55748	CNDP2	C0015695	Fatty Liver	0.2	1	0	CTD_human
55750	AGK	C1859317	Cataract and cardiomyopathy	0.401373633921066	1	4	CTD_human;ORPHANET
55755	CDK5RAP2	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
55755	CDK5RAP2	C1858108	Microcephaly, Primary Autosomal Recessive, 3	0.2	0	0	CTD_human
55759	WDR12	C0027051	Myocardial Infarction	0.202681755307501	2	1	CTD_human
55759	WDR12	C1956346	Coronary Artery Disease	0.202681755307501	1	0	CTD_human
55764	IFT122	C0010278	Craniosynostosis	0.2	1	0	CTD_human
55764	IFT122	C0013608	Edema, Cardiac	0.2	1	0	CTD_human
55764	IFT122	C0020255	Hydrocephalus	0.2	1	0	CTD_human
55768	NGLY1	C3808991	CONGENITAL DISORDER OF DEGLYCOSYLATION	0.2	0	0	ORPHANET
5577	PRKAR2B	C0018801	Heart failure	0.2	1	0	CTD_human
5577	PRKAR2B	C0028754	Obesity	0.200274726784213	1	0	CTD_human
55775	TDP1	C1846574	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY	0.681648360705279	1	1	CTD_human;ORPHANET;UNIPROT
55777	MBD5	C1969562	Mental Retardation, Autosomal Dominant 1	0.48	0	0	CTD_human;ORPHANET
5578	PRKCA	C0162283	Nephrogenic Diabetes Insipidus	0.2	1	0	CTD_human
55780	ERMARD	C1868720	Periventricular Nodular Heterotopia	0.200274726784213	0	0	ORPHANET
55780	ERMARD	C3809872	PERIVENTRICULAR NODULAR HETEROTOPIA 6	0.2	1	1	UNIPROT
55783	CMTR2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
55784	MCTP2	C2675463	Chromosome 15q26-Qter Deletion Syndrome	0.2	0	0	ORPHANET
55785	FGD6	C2237660	exudative macular degeneration	0.2	1	1	CTD_human
55788	LMBRD1	C1848578	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE (disorder)	0.400824180352639	0	0	CTD_human;ORPHANET
5579	PRKCB	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.205638237399215	1	0	CTD_human
5579	PRKCB	C0020456	Hyperglycemia	0.200274726784213	1	0	CTD_human
558	AXL	C0011881	Diabetic Nephropathy	0.2	1	0	CTD_human
558	AXL	C0018418	Gynecomastia	0.2	0	0	HPO
558	AXL	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
558	AXL	C0271623	Hypogonadotropic hypogonadism	0.200274726784213	0	0	HPO
558	AXL	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
5580	PRKCD	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
5580	PRKCD	C0006267	Bronchiectasis	0.2	0	0	HPO
5580	PRKCD	C0009447	Common Variable Immunodeficiency	0.2	0	0	ORPHANET
5580	PRKCD	C0017665	Membranous glomerulonephritis	0.2	0	0	HPO
5580	PRKCD	C0024312	Lymphopenia	0.2	0	0	HPO
5580	PRKCD	C0032285	Pneumonia	0.2	0	0	HPO
5580	PRKCD	C0034150	Purpura	0.2	0	0	HPO
5580	PRKCD	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
5580	PRKCD	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
5580	PRKCD	C0271441	Chronic otitis media	0.2	0	0	HPO
5580	PRKCD	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
5580	PRKCD	C0741796	Recurrent bronchitis	0.2	0	0	HPO
5580	PRKCD	C0743359	ear infection chronic	0.2	0	0	HPO
5580	PRKCD	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
5580	PRKCD	C1328840	Autoimmune Lymphoproliferative Syndrome	0.200274726784213	0	0	ORPHANET
5580	PRKCD	C3280742	SYSTEMIC LUPUS ERYTHEMATOSUS 16	0.2	0	0	ORPHANET
55800	SCN3B	C1142166	Brugada Syndrome (disorder)	0.200824180352639	0	0	ORPHANET
55800	SCN3B	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
55800	SCN3B	C2751088	Brugada Syndrome 7	0.48	2	4	CTD_human;UNIPROT
55806	HR	C0002170	Alopecia	0.20328236603324	1	0	CTD_human
55806	HR	C0263505	Alopecia universalis	0.400274726784213	0	0	CTD_human;ORPHANET
55806	HR	C1859592	ATRICHIA WITH PAPULAR LESIONS	0.48	0	0	CTD_human;ORPHANET
55806	HR	C2931059	Marie Unna congenital hypotrichosis	0.400274726784213	1	0	CTD_human;ORPHANET
5581	PRKCE	C0011881	Diabetic Nephropathy	0.2	1	0	CTD_human
5581	PRKCE	C0027051	Myocardial Infarction	0.200274726784213	1	0	CTD_human
5581	PRKCE	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5581	PRKCE	C0242231	Coronary Stenosis	0.2	1	0	CTD_human
55811	ADCY10	C0543800	idiopathic hypercalciuria	0.2	0	0	ORPHANET
55812	SPATA7	C0035334	Retinitis Pigmentosa	0.400824180352639	1	0	CTD_human;ORPHANET
55812	SPATA7	C0339527	Leber Congenital Amaurosis	0.401648360705279	1	0	CTD_human;ORPHANET
55812	SPATA7	C1858677	LEBER CONGENITAL AMAUROSIS 3 (disorder)	0.28	0	0	CTD_human
55812	SPATA7	C4274354	Severe early childhood onset retinal dystrophy	0.2	0	0	ORPHANET
5582	PRKCG	C0028738	Nystagmus	0.200274726784213	0	0	HPO
5582	PRKCG	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
5582	PRKCG	C0087012	Ataxia, Spinocerebellar	0.218023389091483	1	0	CTD_human
5582	PRKCG	C0262404	Cerebellar degeneration	0.2	0	0	HPO
5582	PRKCG	C0393525	Progressive cerebellar ataxia	0.200274726784213	0	0	HPO
5582	PRKCG	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
5582	PRKCG	C0743332	Focal Dystonia	0.2	0	0	HPO
5582	PRKCG	C1854369	Spinocerebellar ataxia 14	0.601098907136852	1	26	CTD_human;ORPHANET;UNIPROT
5582	PRKCG	C4020873	Infratentorial atrophy	0.2	0	0	HPO
55823	VPS11	C4225247	LEUKODYSTROPHY, HYPOMYELINATING, 12	0.4	1	1	ORPHANET;UNIPROT
5583	PRKCH	C0007785	Cerebral Infarction	0.203557092817453	0	0	CTD_human
5583	PRKCH	C0028754	Obesity	0.2	1	1	CTD_human
55835	CENPJ	C0265202	Seckel syndrome	0.200274726784213	0	0	ORPHANET
55835	CENPJ	C1842109	Microcephaly, Primary Autosomal Recessive, 6	0.400274726784213	1	7	CTD_human;UNIPROT
55835	CENPJ	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
55835	CENPJ	C3888212	SECKEL SYNDROME 4	0.28	0	0	CTD_human
55851	PSENEN	C1840560	Hidradenitis suppurativa, familial	0.2	1	0	CTD_human
55857	KIZ	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
55858	TMEM165	C3553571	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk	0.4	1	4	ORPHANET;UNIPROT
55862	ECHDC1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
55863	TMEM126B	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
55869	HDAC8	C0270972	Cornelia De Lange Syndrome	0.204120901763196	0	0	ORPHANET
55869	HDAC8	C1839736	WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME	0.2	0	0	ORPHANET
55869	HDAC8	C3550903	CORNELIA DE LANGE SYNDROME 5	0.2	1	15	UNIPROT
55872	PBK	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
55876	GSDMB	C0004096	Asthma	0.215397376561627	1	4	CTD_human
5588	PRKCQ	C0003873	Rheumatoid Arthritis	0.217673380015655	3	0	CTD_human
5588	PRKCQ	C0011854	Diabetes Mellitus, Insulin-Dependent	0.202407028523288	1	1	CTD_human
5589	PRKCSH	C0022679	Cystic kidney	0.2	0	0	HPO
55905	RNF114	C0033860	Psoriasis	0.206187690967642	1	2	CTD_human
55906	ZC4H2	C0796200	Wieacker-Wolff syndrome	0.400274726784213	1	4	ORPHANET;UNIPROT
5591	PRKDC	C0019151	Hepatic Encephalopathy	0.2	1	0	CTD_human
5591	PRKDC	C0038363	Aphthous Stomatitis	0.2	0	0	HPO
5591	PRKDC	C0085110	Severe Combined Immunodeficiency	0.202472541057918	0	0	HPO
5591	PRKDC	C2937365	Recurrent aphthous ulcer	0.2	0	0	HPO
5591	PRKDC	C4014833	IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES	0.4	2	3	ORPHANET;UNIPROT
5591	PRKDC	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
5592	PRKG1	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
5592	PRKG1	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
5592	PRKG1	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
5592	PRKG1	C0162872	Aortic Aneurysm, Thoracic	0.200274726784213	0	0	HPO
5592	PRKG1	C0263401	Cutis marmorata	0.2	0	0	HPO
5592	PRKG1	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
5592	PRKG1	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.2	0	0	ORPHANET
5592	PRKG1	C1956346	Coronary Artery Disease	0.2	0	0	HPO
5592	PRKG1	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
5592	PRKG1	C3809513	AORTIC ANEURYSM, FAMILIAL THORACIC 8	0.2	1	1	UNIPROT
5594	MAPK1	C0007786	Brain Ischemia	0.2	1	0	CTD_human
5594	MAPK1	C0014306	Enophthalmos	0.2	0	0	HPO
5594	MAPK1	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
5594	MAPK1	C0155862	Streptococcal pneumonia	0.2	1	0	CTD_human
5594	MAPK1	C0243026	Sepsis	0.200274726784213	1	0	CTD_human
5594	MAPK1	C1866282	CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.2	1	0	CTD_human
5594	MAPK1	C2678480	Chromosome 22q11.2 Deletion Syndrome, Distal	0.2	0	0	ORPHANET
5594	MAPK1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
5595	MAPK3	C0007786	Brain Ischemia	0.2	1	0	CTD_human
5595	MAPK3	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
5595	MAPK3	C0155862	Streptococcal pneumonia	0.2	1	0	CTD_human
5595	MAPK3	C0243026	Sepsis	0.2	1	0	CTD_human
5595	MAPK3	C1866282	CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.2	1	0	CTD_human
55959	SULF2	C0014175	Endometriosis	0.2	2	0	CTD_human
55967	NDUFA12	C0023264	Leigh Disease	0.200274726784213	0	0	ORPHANET
55971	BAIAP2L1	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
55975	KLHL7	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
55975	KLHL7	C1848947	COLD-INDUCED SWEATING SYNDROME 1	0.2	0	0	ORPHANET
55975	KLHL7	C2751986	RETINITIS PIGMENTOSA 42	0.4	1	3	CTD_human;UNIPROT
5599	MAPK8	C0011615	Dermatitis, Atopic	0.2	1	0	CTD_human
5599	MAPK8	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
5599	MAPK8	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
55997	CFC1	C1415817	HETEROTAXY, VISCERAL, 2, AUTOSOMAL	0.4	1	3	CTD_human;UNIPROT
55997	CFC1	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	0.28	0	0	CTD_human
55997	CFC1	C4274029	Biliary atresia with splenic malformation syndrome	0.2	0	0	ORPHANET
560	AZF1	C1839071	Spermatogenic Failure, Nonobstructive, Y-Linked	0.2	0	0	CTD_human
5601	MAPK9	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
5602	MAPK10	C0238111	Lennox-Gastaut syndrome	0.2	0	0	ORPHANET
5602	MAPK10	C0270846	Epileptic drop attack	0.2	0	0	HPO
5602	MAPK10	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
5602	MAPK10	C0595948	Atypical absence seizure	0.2	0	0	HPO
5602	MAPK10	C3665601	Epileptic encephalopathy, Lennox-Gastaut type	0.2	0	0	CTD_human
5603	MAPK13	C0008370	Cholestasis	0.2	1	0	CTD_human
5604	MAP2K1	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
5604	MAP2K1	C0007786	Brain Ischemia	0.2	1	0	CTD_human
5604	MAP2K1	C0014544	Epilepsy	0.2	0	0	HPO
5604	MAP2K1	C0015526	Factor XII Deficiency	0.2	0	0	HPO
5604	MAP2K1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5604	MAP2K1	C0020757	Ichthyoses	0.2	0	0	HPO
5604	MAP2K1	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
5604	MAP2K1	C0024236	Lymphedema	0.2	0	0	HPO
5604	MAP2K1	C0024636	Malocclusion	0.2	0	0	HPO
5604	MAP2K1	C0027092	Myopia	0.2	0	0	HPO
5604	MAP2K1	C0028326	Noonan Syndrome	0.208371149864029	1	0	CTD_human
5604	MAP2K1	C0028738	Nystagmus	0.2	0	0	HPO
5604	MAP2K1	C0036651	Senile lentigo	0.2	0	0	HPO
5604	MAP2K1	C0038379	Strabismus	0.2	0	0	HPO
5604	MAP2K1	C0039103	Synovitis	0.2	0	0	HPO
5604	MAP2K1	C0259817	Xerosis	0.2	0	0	HPO
5604	MAP2K1	C0263490	Brittle hair	0.2	0	0	HPO
5604	MAP2K1	C0398639	Amegakaryocytic thrombocytopenia	0.2	0	0	HPO
5604	MAP2K1	C0587248	Costello syndrome (disorder)	0.201098907136852	1	0	CTD_human
5604	MAP2K1	C1328931	Multiple lentigines	0.2	0	0	HPO
5604	MAP2K1	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
5604	MAP2K1	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
5604	MAP2K1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5604	MAP2K1	C3809006	CARDIOFACIOCUTANEOUS SYNDROME 3	0.2	2	6	UNIPROT
5604	MAP2K1	C4073145	Hyperkeratosis pilaris	0.2	0	0	HPO
5604	MAP2K1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
5605	MAP2K2	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
5605	MAP2K2	C0020757	Ichthyoses	0.2	0	0	HPO
5605	MAP2K2	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
5605	MAP2K2	C0027092	Myopia	0.2	0	0	HPO
5605	MAP2K2	C0028326	Noonan Syndrome	0.205638237399215	1	0	CTD_human
5605	MAP2K2	C0028738	Nystagmus	0.2	0	0	HPO
5605	MAP2K2	C0036651	Senile lentigo	0.2	0	0	HPO
5605	MAP2K2	C0038379	Strabismus	0.2	0	0	HPO
5605	MAP2K2	C0259817	Xerosis	0.2	0	0	HPO
5605	MAP2K2	C0263490	Brittle hair	0.2	0	0	HPO
5605	MAP2K2	C0553586	Cafe-au-lait macules with pulmonary stenosis	0.2	0	0	ORPHANET
5605	MAP2K2	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
5605	MAP2K2	C0587248	Costello syndrome (disorder)	0.201098907136852	1	0	CTD_human
5605	MAP2K2	C1328931	Multiple lentigines	0.2	0	0	HPO
5605	MAP2K2	C1861975	Cafe au lait spots, multiple	0.200274726784213	0	0	HPO
5605	MAP2K2	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
5605	MAP2K2	C2931482	Neurofibromatosis-Noonan syndrome	0.2	0	0	ORPHANET
5605	MAP2K2	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
5605	MAP2K2	C3809007	CARDIOFACIOCUTANEOUS SYNDROME 4	0.2	3	5	UNIPROT
56052	ALG1	C2931005	Congenital disorder of glycosylation type 1K	0.601098907136852	2	18	CTD_human;ORPHANET;UNIPROT
5609	MAP2K7	C0018801	Heart failure	0.2	1	0	CTD_human
5610	EIF2AK2	C0021400	Influenza	0.200824180352639	1	0	CTD_human
5610	EIF2AK2	C0038220	Status Epilepticus	0.2	1	0	CTD_human
5611	DNAJC3	C0011854	Diabetes Mellitus, Insulin-Dependent	0.2	0	0	HPO
5611	DNAJC3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5611	DNAJC3	C0235946	Cerebral atrophy	0.2	0	0	HPO
5611	DNAJC3	C0262404	Cerebellar degeneration	0.2	0	0	HPO
5611	DNAJC3	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
5611	DNAJC3	C4015436	ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS	0.2	0	0	ORPHANET
5611	DNAJC3	C4020860	Supratentorial atrophy	0.2	0	0	HPO
5611	DNAJC3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
56159	TEX11	C1839841	SPERMATOGENIC FAILURE, X-LINKED, 2	0.2	1	3	UNIPROT
5617	PRL	C0002871	Anemia	0.2	1	0	CTD_human
5617	PRL	C0014175	Endometriosis	0.201098907136852	1	0	CTD_human
5617	PRL	C0015951	Fetal Resorption	0.2	1	0	CTD_human
5617	PRL	C0018418	Gynecomastia	0.2	2	0	CTD_human
5617	PRL	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
5617	PRL	C0020514	Hyperprolactinemia	0.211798896343846	4	0	CTD_human
5617	PRL	C0020619	Hypogonadism	0.2	1	0	CTD_human
5617	PRL	C0020635	Hypopituitarism	0.200274726784213	1	0	CTD_human
5617	PRL	C0024141	Lupus Erythematosus, Systemic	0.222273637192316	1	0	CTD_human
5617	PRL	C0032963	Pregnancy Complications, Cardiovascular	0.2	1	0	CTD_human
5617	PRL	C0242350	Erectile dysfunction	0.200274726784213	5	0	CTD_human
5617	PRL	C2937421	Prostatic Hyperplasia	0.200274726784213	1	0	CTD_human
5617	PRL	C3665358	Galactorrhea	0.200274726784213	1	0	CTD_human
56172	ANKH	C0014175	Endometriosis	0.2	1	0	CTD_human
56172	ANKH	C0409896	Familial chondrocalcinosis	0.201098907136852	0	0	ORPHANET
56172	ANKH	C0856830	Calcium pyrophosphate arthropathy	0.601373633921066	3	4	CTD_human;ORPHANET;UNIPROT
56172	ANKH	C1852502	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.482197814273705	1	6	CTD_human;UNIPROT
5618	PRLR	C0014175	Endometriosis	0.2	1	0	CTD_human
5618	PRLR	C0020514	Hyperprolactinemia	0.600824180352639	1	1	HPO;ORPHANET;UNIPROT
5618	PRLR	C3665358	Galactorrhea	0.2	0	0	HPO
5618	PRLR	C3809918	MULTIPLE FIBROADENOMAS OF THE BREAST	0.4	1	1	ORPHANET;UNIPROT
56203	LMOD3	C4015360	NEMALINE MYOPATHY 10	0.28	1	5	UNIPROT
5621	PRNP	C0002395	Alzheimer's Disease	0.268074370401041	1	0	CTD_human
5621	PRNP	C0013363	Dysautonomia	0.200274726784213	0	0	HPO
5621	PRNP	C0017495	Gerstmann-Straussler-Scheinker Disease	0.725980008546589	13	13	CTD_human;ORPHANET;UNIPROT
5621	PRNP	C0019202	Hepatolenticular Degeneration	0.208096423079816	1	0	CTD_human
5621	PRNP	C0022336	Creutzfeldt-Jakob disease	0.862766760370725	11	9	CTD_human;ORPHANET;UNIPROT
5621	PRNP	C0022802	Kuru	0.204814057046576	0	0	ORPHANET
5621	PRNP	C0036457	Scrapie	0.201373633921065	4	0	CTD_human
5621	PRNP	C0042798	Low Vision	0.2	0	0	HPO
5621	PRNP	C0206042	Fatal Familial Insomnia	0.707876751543159	4	3	CTD_human;ORPHANET;UNIPROT
5621	PRNP	C0262404	Cerebellar degeneration	0.200824180352639	0	0	HPO
5621	PRNP	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
5621	PRNP	C0751778	Myoclonic Epilepsies, Progressive	0.2	1	0	CTD_human
5621	PRNP	C1847650	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	0.4	3	3	CTD_human;UNIPROT
5621	PRNP	C1864112	HUNTINGTON DISEASE-LIKE 1	0.4	0	0	CTD_human;ORPHANET
5621	PRNP	C4020858	Choreatic disease	0.2	0	0	HPO
5621	PRNP	C4020873	Infratentorial atrophy	0.2	0	0	HPO
5621	PRNP	C4020884	Anxiety disease	0.2	0	0	HPO
5624	PROC	C0012739	Disseminated Intravascular Coagulation	0.200274726784213	1	0	CTD_human
5624	PROC	C0014544	Epilepsy	0.2	0	0	HPO
5624	PROC	C0034065	Pulmonary Embolism	0.200274726784213	0	0	HPO
5624	PROC	C0034150	Purpura	0.2	0	0	HPO
5624	PROC	C0085650	Purpura Fulminans	0.200549453568426	1	0	CTD_human
5624	PROC	C0149871	Deep Vein Thrombosis	0.203231208875927	0	0	HPO
5624	PROC	C0151945	Thrombosis of cerebral veins	0.2	0	0	HPO
5624	PROC	C0243026	Sepsis	0.285139940988102	2	0	CTD_human
5624	PROC	C0398623	Thrombophilia	0.210228724818891	0	0	HPO
5624	PROC	C0398625	Protein C Deficiency	0.418818858689488	3	0	CTD_human;HPO
5624	PROC	C1510431	Superficial thrombophlebitis	0.2	0	0	HPO
5624	PROC	C2674321	Thrombophilia, Hereditary, Due To Protein C Deficiency, Autosomal Dominant	0.2	18	28	UNIPROT
5624	PROC	C2676759	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	0.4	6	12	CTD_human;UNIPROT
5624	PROC	C2930896	Congenital thrombotic disease, due to Protein C deficiency	0.200274726784213	1	0	CTD_human
56244	BTNL2	C0036202	Sarcoidosis	0.424695021092921	0	0	CTD_human;ORPHANET
56246	MRAP	C1846284	GLUCOCORTICOID DEFICIENCY 2	0.2	0	0	CTD_human
56246	MRAP	C1859974	GLUCOCORTICOID DEFICIENCY 1	0.2	0	0	ORPHANET
56247	FMR3	C0751157	FRAXE Syndrome	0.2	0	0	ORPHANET
5625	PRODH	C0038220	Status Epilepticus	0.2	0	0	HPO
5625	PRODH	C0268528	Hyperprolinemia	0.201923087489492	0	0	HPO
5625	PRODH	C0268529	Proline dehydrogenase deficiency	0.682197814273705	5	10	CTD_human;ORPHANET;UNIPROT
5625	PRODH	C0268534	Prolinuria	0.2	0	0	HPO
5625	PRODH	C0543541	HYPERGLYCINURIA (disorder)	0.2	0	0	HPO
5625	PRODH	C1833247	SCHIZOPHRENIA 4 (disorder)	0.2	2	10	UNIPROT
5626	PROP1	C0020615	Hypoglycemia	0.2	0	0	HPO
5626	PROP1	C0020619	Hypogonadism	0.202732912464814	0	0	HPO
5626	PROP1	C0020676	Hypothyroidism	0.200549453568426	0	0	HPO
5626	PROP1	C0029453	Osteopenia	0.2	0	0	HPO
5626	PROP1	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
5626	PROP1	C0242343	Panhypopituitarism	0.416627308767739	0	0	HPO;ORPHANET
5626	PROP1	C0271623	Hypogonadotropic hypogonadism	0.201648360705279	0	0	HPO
5626	PROP1	C0271801	Central hypothyroidism	0.200549453568426	0	0	HPO
5626	PROP1	C0747078	Generalized osteopenia	0.2	0	0	HPO
5626	PROP1	C0877056	Hypoglycaemic seizure	0.2	0	0	HPO
5626	PROP1	C0878683	Pituitary Dwarfism Type 3	0.48	7	22	CTD_human;UNIPROT
5626	PROP1	C0948740	Pituitary hypoplasia	0.200274726784213	0	0	HPO
5626	PROP1	C2751608	Pituitary Hormone Deficiency, Combined, 1	0.2	0	0	ORPHANET
5626	PROP1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.200274726784213	0	0	HPO
5626	PROP1	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
56262	LRRC8A	C0001768	Agammaglobulinemia	0.200274726784213	0	0	CTD_human
56262	LRRC8A	C3152144	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
5627	PROS1	C0012739	Disseminated Intravascular Coagulation	0.2	0	0	HPO
5627	PROS1	C0034065	Pulmonary Embolism	0.200274726784213	0	0	HPO
5627	PROS1	C0034150	Purpura	0.2	0	0	HPO
5627	PROS1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
5627	PROS1	C0040046	Thrombophlebitis	0.2	0	0	HPO
5627	PROS1	C0149871	Deep Vein Thrombosis	0.204055389228567	0	0	HPO
5627	PROS1	C0151945	Thrombosis of cerebral veins	0.2	0	0	HPO
5627	PROS1	C0242666	Protein S Deficiency	0.229937276395648	0	0	HPO
5627	PROS1	C0271215	Blindness, Legal	0.2	0	0	HPO
5627	PROS1	C0338575	Sagittal Sinus Thrombosis	0.2	1	0	CTD_human
5627	PROS1	C0398623	Thrombophilia	0.20328236603324	0	0	HPO
5627	PROS1	C0600433	Activated Protein C Resistance	0.207872853452916	1	0	CTD_human
5627	PROS1	C1510431	Superficial thrombophlebitis	0.2	0	0	HPO
5627	PROS1	C3278211	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT	0.4	26	30	CTD_human;UNIPROT
5627	PROS1	C3281092	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE	0.2	1	4	UNIPROT
5627	PROS1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
56287	GKN1	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
5629	PROX1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.205638237399215	1	1	CTD_human
563	AZGP1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
563	AZGP1	C0037199	Sinusitis	0.2	1	0	CTD_human
5630	PRPH	C0002736	Amyotrophic Lateral Sclerosis	0.407403267796436	0	0	HPO;ORPHANET
5630	PRPH	C0234958	muscle degeneration	0.2	0	0	HPO
5630	PRPH	C1145670	Respiratory Failure	0.2	0	0	HPO
5630	PRPH	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	0	0	CTD_human
5630	PRPH	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
5630	PRPH	C4020884	Anxiety disease	0.2	0	0	HPO
5631	PRPS1	C0003868	Arthritis, Gouty	0.2	0	0	HPO
5631	PRPS1	C0014544	Epilepsy	0.2	0	0	HPO
5631	PRPS1	C0018099	Gout	0.2	0	0	HPO
5631	PRPS1	C0018784	Sensorineural Hearing Loss (disorder)	0.201923087489492	0	0	HPO
5631	PRPS1	C0028738	Nystagmus	0.2	0	0	HPO
5631	PRPS1	C0029124	Optic Atrophy	0.2	0	0	HPO
5631	PRPS1	C0034372	Quadriplegia	0.2	0	0	HPO
5631	PRPS1	C0035078	Kidney Failure	0.2	0	0	HPO
5631	PRPS1	C0037036	Sialorrhea	0.2	0	0	HPO
5631	PRPS1	C0042798	Low Vision	0.2	0	0	HPO
5631	PRPS1	C0151313	Sensory neuropathy	0.2	0	0	HPO
5631	PRPS1	C0152025	Polyneuropathy	0.2	0	0	HPO
5631	PRPS1	C0403719	Uric acid urolithiasis	0.2	0	0	HPO
5631	PRPS1	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
5631	PRPS1	C0796028	ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION	0.601923087489492	1	4	CTD_human;ORPHANET;UNIPROT
5631	PRPS1	C1565489	Renal Insufficiency	0.2	0	0	HPO
5631	PRPS1	C1839566	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.600549453568426	1	6	CTD_human;ORPHANET;UNIPROT
5631	PRPS1	C1844677	DEAFNESS, X-LINKED 1 (disorder)	0.401098907136852	1	7	CTD_human;UNIPROT
5631	PRPS1	C1848736	Distal amyotrophy	0.2	0	0	HPO
5631	PRPS1	C1970827	Phosphoribosylpyrophosphate Synthetase Superactivity	0.400274726784213	1	6	CTD_human;UNIPROT
5631	PRPS1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
5640	PRS	C1839730	Prieto X-linked mental retardation syndrome	0.2	0	0	CTD_human
5644	PRSS1	C0020639	Hypoproteinemia	0.2	0	0	HPO
5644	PRSS1	C0030293	Pancreatic Insufficiency	0.2	0	0	HPO
5644	PRSS1	C0030299	Pancreatic Pseudocyst	0.2	0	0	HPO
5644	PRSS1	C0030305	Pancreatitis	0.494168977222734	1	1	CTD_human;HPO
5644	PRSS1	C0149521	Pancreatitis, Chronic	0.254181652829739	1	0	CTD_human
5644	PRSS1	C0238339	Hereditary pancreatitis	0.628571585558163	9	16	CTD_human;ORPHANET;UNIPROT
5644	PRSS1	C0267963	Exocrine pancreatic insufficiency	0.202407028523288	0	0	HPO
5644	PRSS1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5645	PRSS2	C0149521	Pancreatitis, Chronic	0.220574119329724	2	0	CTD_human
5645	PRSS2	C0238339	Hereditary pancreatitis	0.200824180352639	0	0	ORPHANET
56475	RPRM	C0004763	Barrett Esophagus	0.2	1	0	CTD_human
56479	KCNQ5	C0027092	Myopia	0.2	1	0	CTD_human
5648	MASP1	C0010278	Craniosynostosis	0.2	0	0	HPO
5648	MASP1	C0017601	Glaucoma	0.2	0	0	HPO
5648	MASP1	C0018777	Conductive hearing loss	0.2	0	0	HPO
5648	MASP1	C0020295	Hydronephrosis	0.2	0	0	HPO
5648	MASP1	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
5648	MASP1	C0796032	Malpuech facial clefting syndrome	0.2	1	0	CTD_human
5648	MASP1	C0796059	Oculopalatoskeletal syndrome	0.200549453568426	1	4	CTD_human
5648	MASP1	C0796279	Carnevale syndrome	0.2	1	0	CTD_human
5648	MASP1	C1833340	Synostotic Posterior Plagiocephaly	0.2	0	0	HPO
5648	MASP1	C1856266	Coronal craniosynostosis	0.2	0	0	HPO
5649	RELN	C0002395	Alzheimer's Disease	0.209535569535511	1	1	CTD_human
5649	RELN	C0149958	Complex partial seizures	0.2	0	0	HPO
5649	RELN	C0270834	Complex partial seizure with impairment of consciousness	0.2	0	0	HPO
5649	RELN	C0431375	Classical Lissencephaly	0.2	0	0	HPO
5649	RELN	C0796089	LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE	0.4	0	0	CTD_human;ORPHANET
5649	RELN	C0877017	Partial seizures with secondary generalisation	0.2	0	0	HPO
5649	RELN	C1838062	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.2	0	0	ORPHANET
5649	RELN	C4225327	EPILEPSY, FAMILIAL TEMPORAL LOBE, 7	0.2	1	7	UNIPROT
5651	TMPRSS15	C0020639	Hypoproteinemia	0.2	0	0	HPO
5651	TMPRSS15	C0268416	Enterokinase Deficiency	0.400549453568426	0	0	CTD_human;ORPHANET
5651	TMPRSS15	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
56521	DNAJC12	C0008370	Cholestasis	0.2	1	0	CTD_human
56521	DNAJC12	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
5654	HTRA1	C0002170	Alopecia	0.200274726784213	0	0	HPO
5654	HTRA1	C0917805	Transient Cerebral Ischemia	0.2	0	0	HPO
5654	HTRA1	C1838577	Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy	0.402747267842131	1	10	ORPHANET;UNIPROT
5654	HTRA1	C1857813	Macular Degeneration, Age-Related, 7	0.2	0	0	CTD_human
5654	HTRA1	C4025270	Arteriosclerosis of small cerebral arteries	0.2	0	0	HPO
5654	HTRA1	C4225211	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2	0.2	1	4	UNIPROT
5654	HTRA1	C4280575	Progressive brain disease	0.2	0	0	HPO
5657	PRTN3	C0007786	Brain Ischemia	0.2	0	0	HPO
5657	PRTN3	C0024117	Chronic Obstructive Airway Disease	0.200274726784213	0	0	HPO
5657	PRTN3	C0034069	Pulmonary Fibrosis	0.2	0	0	HPO
5657	PRTN3	C0037199	Sinusitis	0.2	0	0	HPO
5657	PRTN3	C0042384	Vasculitis	0.210699989206994	0	0	HPO
5657	PRTN3	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
5657	PRTN3	C0521173	Granulomatosis	0.2	0	0	HPO
5657	PRTN3	C0917798	Cerebral Ischemia	0.2	0	0	HPO
5657	PRTN3	C3495801	Granulomatosis with polyangiitis	0.422339149726945	1	0	CTD_human;ORPHANET
5660	PSAP	C0002871	Anemia	0.2	0	0	HPO
5660	PSAP	C0014544	Epilepsy	0.2	0	0	HPO
5660	PSAP	C0029453	Osteopenia	0.2	0	0	HPO
5660	PSAP	C0152025	Polyneuropathy	0.2	0	0	HPO
5660	PSAP	C0268262	Metachromatic Leukodystrophy due to Saposin B Deficiency	0.480274726784213	5	4	CTD_human;UNIPROT
5660	PSAP	C0338474	Central nervous system demyelination	0.2	0	0	HPO
5660	PSAP	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
5660	PSAP	C0520680	Sleep Apnea, Central	0.2	0	0	HPO
5660	PSAP	C0575059	Spastic tetraparesis	0.2	0	0	HPO
5660	PSAP	C0747078	Generalized osteopenia	0.2	0	0	HPO
5660	PSAP	C0751273	Infantile Globoid Cell Leukodystrophy	0.2	0	0	ORPHANET
5660	PSAP	C0751276	Metachromatic leukodystrophy, juvenile type	0.2	0	0	ORPHANET
5660	PSAP	C0751279	Metachromatic Leukodystrophy, Adult-Type (disorder)	0.2	0	0	ORPHANET
5660	PSAP	C1145670	Respiratory Failure	0.2	0	0	HPO
5660	PSAP	C1836830	Developmental regression	0.2	0	0	HPO
5660	PSAP	C1864651	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.6	2	5	CTD_human;ORPHANET;UNIPROT
5660	PSAP	C2673266	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY	0.200274726784213	0	0	CTD_human
5660	PSAP	C2673635	Combined Saposin Deficiency	0.400274726784213	0	0	CTD_human;ORPHANET
5660	PSAP	C4020871	Dystonic disease	0.2	0	0	HPO
5660	PSAP	C4023499	Generalized clonic seizures	0.2	0	0	HPO
56603	CYP26B1	C0028754	Obesity	0.2	1	0	CTD_human
56603	CYP26B1	C3280729	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES	0.4	1	2	ORPHANET;UNIPROT
56606	SLC2A9	C0018099	Gout	0.216849199663016	2	5	CTD_human
56606	SLC2A9	C0473219	Renal hypouricemia	0.404120901763197	2	2	CTD_human;ORPHANET
56606	SLC2A9	C0740394	Hyperuricemia	0.208869446275143	1	0	CTD_human
56606	SLC2A9	C2677549	Hypouricemia, Renal, 2	0.400274726784213	3	6	CTD_human;UNIPROT
56616	DIABLO	C0007786	Brain Ischemia	0.2	1	0	CTD_human
56616	DIABLO	C0020179	Huntington Disease	0.2	1	0	CTD_human
56616	DIABLO	C3279948	DEAFNESS, AUTOSOMAL DOMINANT 64	0.2	1	1	UNIPROT
56623	INPP5E	C0028754	Obesity	0.2	1	0	CTD_human
56623	INPP5E	C0431399	Familial aplasia of the vermis	0.601648360705279	3	20	CTD_human;ORPHANET;UNIPROT
56623	INPP5E	C1857662	COACH syndrome	0.2	0	0	ORPHANET
56623	INPP5E	C1857802	MORM syndrome	0.400274726784213	0	0	CTD_human;ORPHANET
56623	INPP5E	C4274118	Joubert syndrome with ocular defect	0.2	0	0	ORPHANET
5663	PSEN1	C0002395	Alzheimer's Disease	0.92	12	0	CTD_human;HPO;ORPHANET
5663	PSEN1	C0002726	Amyloidosis	0.248077187237293	1	0	CTD_human
5663	PSEN1	C0002736	Amyotrophic Lateral Sclerosis	0.202956482091714	0	0	HPO
5663	PSEN1	C0004045	Asphyxia Neonatorum	0.2	1	0	CTD_human
5663	PSEN1	C0014544	Epilepsy	0.200824180352639	0	0	HPO
5663	PSEN1	C0018801	Heart failure	0.200274726784213	0	0	HPO
5663	PSEN1	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
5663	PSEN1	C0162836	Hidradenitis Suppurativa	0.2	0	0	HPO
5663	PSEN1	C0235946	Cerebral atrophy	0.200549453568426	0	0	HPO
5663	PSEN1	C0236642	Pick Disease of the Brain	0.207128541012223	2	1	CTD_human
5663	PSEN1	C0263006	Perifolliculitis	0.2	0	0	HPO
5663	PSEN1	C0338451	Frontotemporal dementia	0.609484412378199	1	1	CTD_human;HPO;UNIPROT
5663	PSEN1	C0338455	Dementia of frontal lobe type	0.2	0	0	HPO
5663	PSEN1	C0575059	Spastic tetraparesis	0.2	0	0	HPO
5663	PSEN1	C1840560	Hidradenitis suppurativa, familial	0.200274726784213	1	0	CTD_human
5663	PSEN1	C1843013	Alzheimer disease, familial, type 3	0.280274726784213	38	73	UNIPROT
5663	PSEN1	C1843015	Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia	0.2	0	0	CTD_human
5663	PSEN1	C1863051	ALZHEIMER DISEASE 2	0.200824180352639	0	0	HPO
5663	PSEN1	C3160720	Cardiomyopathy, Dilated, 1u	0.4	1	1	CTD_human;UNIPROT
5663	PSEN1	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
5663	PSEN1	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
5663	PSEN1	C4011788	Behavioral variant of frontotemporal dementia	0.2	0	0	ORPHANET
5663	PSEN1	C4020871	Dystonic disease	0.2	0	0	HPO
5663	PSEN1	C4020884	Anxiety disease	0.2	0	0	HPO
5663	PSEN1	C4021584	Frontotemporal cerebral atrophy	0.2	0	0	HPO
5663	PSEN1	C4023521	Chronic furunculosis	0.2	0	0	HPO
5663	PSEN1	C4024936	Temporal cortical atrophy	0.2	0	0	HPO
5663	PSEN1	C4024956	Grammar-specific speech disorder	0.2	0	0	HPO
5664	PSEN2	C0002395	Alzheimer's Disease	0.701621575503079	3	2	CTD_human;HPO;ORPHANET
5664	PSEN2	C0004045	Asphyxia Neonatorum	0.2	1	0	CTD_human
5664	PSEN2	C0018801	Heart failure	0.200274726784213	0	0	HPO
5664	PSEN2	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
5664	PSEN2	C0085220	Cerebral Amyloid Angiopathy	0.2	0	0	HPO
5664	PSEN2	C1847200	ALZHEIMER DISEASE 4	0.4	3	10	CTD_human;UNIPROT
5664	PSEN2	C1863051	ALZHEIMER DISEASE 2	0.2	0	0	HPO
5664	PSEN2	C3150958	Cardiomyopathy, Dilated, 1V	0.2	0	0	CTD_human
5664	PSEN2	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
5664	PSEN2	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
56652	TWNK	C1834846	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1	0.2	0	0	ORPHANET
56652	TWNK	C1836439	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 3	0.48	13	12	CTD_human;UNIPROT
56652	TWNK	C1843851	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis	0.400274726784213	0	0	CTD_human;ORPHANET
56652	TWNK	C1849096	Infantile onset spinocerebellar ataxia	0.601923087489492	5	9	CTD_human;ORPHANET;UNIPROT
56652	TWNK	C3151513	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.2	0	0	CTD_human
56652	TWNK	C4015307	PERRAULT SYNDROME 5	0.2	1	4	UNIPROT
56683	C21orf59	C0022521	Kartagener Syndrome	0.200274726784213	0	0	ORPHANET
56694	BMIQ8	C0028754	Obesity	0.2	0	0	CTD_human
567	B2M	C0008370	Cholestasis	0.2	0	0	HPO
567	B2M	C0013238	Dry Eye Syndromes	0.2	0	0	HPO
567	B2M	C0015732	Fecal Incontinence	0.2	0	0	HPO
567	B2M	C0020455	Hypergammaglobulinemia	0.2	1	0	CTD_human
567	B2M	C0020639	Hypoproteinemia	0.2	0	0	HPO
567	B2M	C0022575	Keratoconjunctivitis Sicca	0.2	0	0	HPO
567	B2M	C0043349	Xerophthalmia	0.2	0	0	HPO
567	B2M	C0162539	IgG Deficiency	0.2	0	0	HPO
567	B2M	C0239981	Hypoalbuminemia	0.200274726784213	0	0	HPO
567	B2M	C0268389	Amyloidosis, familial visceral	0.2	1	1	UNIPROT
567	B2M	C0401151	Chronic diarrhea	0.2	0	0	HPO
567	B2M	C0451695	Major histocompatibility complex class I deficiency	0.2	0	0	ORPHANET
567	B2M	C1855796	Hypoproteinemia, Hypercatabolic	0.400274726784213	1	2	CTD_human;UNIPROT
567	B2M	C1858266	Bare Lymphocyte Syndrome, Type I	0.2	0	0	ORPHANET
567	B2M	C2930821	Keratitis sicca	0.2	0	0	HPO
567	B2M	C4025212	Autonomic bladder dysfunction	0.2	0	0	HPO
56729	RETN	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.264712136455854	0	0	CTD_human
56729	RETN	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
56729	RETN	C0022661	Kidney Failure, Chronic	0.205414667772315	1	0	CTD_human
56729	RETN	C0403447	Chronic Kidney Insufficiency	0.2	1	0	CTD_human
56729	RETN	C0524620	Metabolic Syndrome X	0.210792533764634	1	0	CTD_human
5673	PSG5	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
56797	HTGS	C0020480	Hyperlipoproteinemia Type IV	0.2	0	0	CTD_human
5683	PSMA2	C0029456	Osteoporosis	0.2	1	0	CTD_human
56848	SPHK2	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
5685	PSMA4	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
5686	PSMA5	C0015695	Fatty Liver	0.2	1	0	CTD_human
5686	PSMA5	C0029456	Osteoporosis	0.2	1	0	CTD_human
5687	PSMA6	C0027051	Myocardial Infarction	0.217790049707598	1	1	CTD_human
5689	PSMB1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
5689	PSMB1	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
56899	ANKS1B	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
56901	NDUFA4L2	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
56922	MCCC1	C0268600	3-methylcrotonyl CoA carboxylase 1 deficiency	0.600549453568426	5	33	CTD_human;ORPHANET;UNIPROT
5693	PSMB5	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
56945	MRPS22	C2673642	Combined Oxidative Phosphorylation Deficiency 5	0.6	1	2	CTD_human;ORPHANET;UNIPROT
56946	EMSY	C0011615	Dermatitis, Atopic	0.200549453568426	1	0	CTD_human
56946	EMSY	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
56955	MEPE	C3887650	Adult Rickets	0.200824180352639	1	0	CTD_human
5696	PSMB8	C0003886	Arthrogryposis	0.2	0	0	HPO
5696	PSMB8	C0009763	Conjunctivitis	0.2	0	0	HPO
5696	PSMB8	C0014583	Episcleritis	0.2	0	0	HPO
5696	PSMB8	C0014743	Erythema Nodosum	0.2	0	0	HPO
5696	PSMB8	C0018801	Heart failure	0.2	0	0	HPO
5696	PSMB8	C0018802	Congestive heart failure	0.2	0	0	HPO
5696	PSMB8	C0020455	Hypergammaglobulinemia	0.2	0	0	HPO
5696	PSMB8	C0020492	Hyperostosis	0.2	0	0	HPO
5696	PSMB8	C0023787	Lipodystrophy	0.201098907136852	0	0	HPO
5696	PSMB8	C0024421	Macroglossia	0.2	0	0	HPO
5696	PSMB8	C0029453	Osteopenia	0.2	0	0	HPO
5696	PSMB8	C0030326	Panniculitis	0.200549453568426	0	0	HPO
5696	PSMB8	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
5696	PSMB8	C0234958	muscle degeneration	0.2	0	0	HPO
5696	PSMB8	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
5696	PSMB8	C0747078	Generalized osteopenia	0.2	0	0	HPO
5696	PSMB8	C1280433	Lipoatrophy	0.2	0	0	HPO
5696	PSMB8	C1850568	Nakajo syndrome	0.401648360705279	2	2	ORPHANET;UNIPROT
5696	PSMB8	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5697	PYY	C0002395	Alzheimer's Disease	0.2	1	0	CTD_human
5697	PYY	C0003123	Anorexia	0.200824180352639	1	0	CTD_human
5697	PYY	C0028754	Obesity	0.214847922993201	1	0	CTD_human
56975	FAM20C	C1850106	RAINE SYNDROME	0.603021994626344	3	13	CTD_human;ORPHANET;UNIPROT
56978	PRDM8	C4225258	EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.4	1	1	ORPHANET;UNIPROT
56983	POGLUT1	C3714534	dowling-degos disease	0.200274726784213	0	0	ORPHANET
56992	KIF15	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
56994	CHPT1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
56997	COQ8A	C2677589	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 9	0.6	4	21	CTD_human;ORPHANET;UNIPROT
56997	COQ8A	C3551954	COENZYME Q10 DEFICIENCY, PRIMARY, 1	0.2	1	0	CTD_human
56999	ADAMTS9	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.254328261433402	2	0	CTD_human
570	BAAT	C0035579	Rickets	0.2	0	0	HPO
570	BAAT	C0042880	Vitamin K Deficiency	0.2	0	0	HPO
570	BAAT	C1843139	Hypercholanemia, Familial	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
570	BAAT	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
57007	ACKR3	C0003873	Rheumatoid Arthritis	0.200549453568426	1	0	CTD_human
57010	CABP4	C4041558	Cone-rod synaptic disorder, congenital nonprogressive	0.4	1	1	CTD_human;UNIPROT
57016	AKR1B10	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
57017	COQ9	C3551954	COENZYME Q10 DEFICIENCY, PRIMARY, 1	0.2	0	0	CTD_human
57017	COQ9	C3553374	COENZYME Q10 DEFICIENCY, PRIMARY, 5	0.28	0	0	ORPHANET
57038	RARS2	C1843504	Pontocerebellar Hypoplasia Type 1	0.200274726784213	0	0	ORPHANET
57038	RARS2	C1969084	Pontocerebellar Hypoplasia Type 6	0.401373633921066	0	0	CTD_human;ORPHANET
57042	IBD7	C1854573	INFLAMMATORY BOWEL DISEASE 7	0.2	0	0	CTD_human
57044	IDDM18	C1854125	DIABETES MELLITUS, INSULIN-DEPENDENT, 18	0.2	0	0	CTD_human
5705	PSMC5	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
57061	HYMAI	C1832386	Diabetes Mellitus, Transient Neonatal, 1	0.400549453568426	0	0	CTD_human;ORPHANET
57082	KNL1	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
57082	KNL1	C1858516	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE	0.2	1	3	UNIPROT
57094	CPA6	C3280730	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.2	1	1	UNIPROT
57094	CPA6	C3280734	FEBRILE SEIZURES, FAMILIAL, 11	0.4	1	1	ORPHANET;UNIPROT
57096	RPGRIP1	C0028738	Nystagmus	0.200274726784213	1	0	CTD_human
57096	RPGRIP1	C0035334	Retinitis Pigmentosa	0.404930726738519	1	0	CTD_human;ORPHANET
57096	RPGRIP1	C0265215	Meckel-Gruber syndrome	0.2	0	0	ORPHANET
57096	RPGRIP1	C0339527	Leber Congenital Amaurosis	0.403846174978983	2	2	CTD_human;ORPHANET
57096	RPGRIP1	C2750720	Cone-Rod Dystrophy 13	0.4	2	5	CTD_human;UNIPROT
57104	PNPLA2	C0032460	Polycystic Ovary Syndrome	0.200274726784213	1	0	CTD_human
57104	PNPLA2	C1853136	Neutral Lipid Storage Disease with Myopathy	0.604670355331623	1	11	CTD_human;ORPHANET;UNIPROT
57105	CYSLTR2	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
57105	CYSLTR2	C1319853	Asthma, Aspirin-Induced	0.200274726784213	2	0	CTD_human
57107	PDSS2	C3551954	COENZYME Q10 DEFICIENCY, PRIMARY, 1	0.28	0	0	CTD_human
57107	PDSS2	C3553358	COENZYME Q10 DEFICIENCY, PRIMARY, 3	0.2	1	2	UNIPROT
57122	NUP107	C4225228	NEPHROTIC SYNDROME, TYPE 11	0.2	1	4	UNIPROT
57128	LYRM4	C3810055	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19	0.2	1	1	UNIPROT
57152	SLURP1	C0022596	Palmoplantar Keratosis	0.201648360705279	1	0	CTD_human
57158	JPH2	C3151264	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17	0.2	1	2	UNIPROT
57165	GJC2	C1837355	Leukodystrophy, Hypomyelinating, 2	0.680549453568426	2	11	CTD_human;ORPHANET;UNIPROT
57165	GJC2	C2750784	SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE (disorder)	0.6	1	1	CTD_human;ORPHANET;UNIPROT
57165	GJC2	C3150732	LYMPHEDEMA, HEREDITARY, IC	0.4	1	2	CTD_human;UNIPROT
57167	SALL4	C0013261	Duane Retraction Syndrome	0.215038196245134	1	0	CTD_human
57167	SALL4	C1327918	Oculootoradial syndrome	0.400274726784213	0	0	CTD_human;ORPHANET
57167	SALL4	C1623209	Okihiro Syndrome	0.48357144819477	1	8	ORPHANET;UNIPROT
57176	VARS2	C4014660	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.4	2	3	ORPHANET;UNIPROT
57178	ZMIZ1	C0007570	Celiac Disease	0.2	1	2	CTD_human
5718	PSMD12	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
57187	THOC2	C0796218	MENTAL RETARDATION, X-LINKED 12	0.4	1	4	ORPHANET;UNIPROT
57190	SELENON	C0026850	Muscular Dystrophy	0.207114185634906	1	0	CTD_human
57190	SELENON	C0410180	Eichsfeld type congenital muscular dystrophy	0.68357144819477	7	17	CTD_human;ORPHANET;UNIPROT
57192	MCOLN1	C0026697	Mucolipidoses	0.213562248009443	2	0	CTD_human
57192	MCOLN1	C0238286	Mucolipidosis Type IV	0.494220280244451	4	33	ORPHANET;UNIPROT
572	BAD	C0007787	Transient Ischemic Attack	0.2	1	0	CTD_human
57211	ADGRG6	C4225303	LETHAL CONGENITAL CONTRACTURE SYNDROME 9	0.2	1	4	UNIPROT
5723	PSPH	C0014544	Epilepsy	0.2	0	0	HPO
5723	PSPH	C1291463	Deficiency of phosphoserine phosphatase	0.4	1	4	ORPHANET;UNIPROT
57231	SNX14	C4225355	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20	0.200274726784213	0	0	ORPHANET
5724	PTAFR	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
5727	PTCH1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
5727	PTCH1	C0017601	Glaucoma	0.2	0	0	HPO
5727	PTCH1	C0020255	Hydrocephalus	0.2	0	0	HPO
5727	PTCH1	C0024636	Malocclusion	0.2	0	0	HPO
5727	PTCH1	C0038379	Strabismus	0.2	0	0	HPO
5727	PTCH1	C0155285	Orbital cyst	0.2	0	0	HPO
5727	PTCH1	C0242343	Panhypopituitarism	0.2	0	0	HPO
5727	PTCH1	C1397139	Calcification of falx cerebri	0.2	0	0	HPO
5727	PTCH1	C1835820	HOLOPROSENCEPHALY 7	0.400274726784213	3	7	CTD_human;UNIPROT
5727	PTCH1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
5728	PTEN	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
5728	PTEN	C0001202	Acrokeratosis	0.2	0	0	HPO
5728	PTEN	C0002982	Angioid Streaks	0.2	0	0	HPO
5728	PTEN	C0003081	Anisometropia	0.2	1	0	CTD_human
5728	PTEN	C0004096	Asthma	0.200549453568426	1	0	CTD_human
5728	PTEN	C0009451	Communicating Hydrocephalus	0.2	0	0	HPO
5728	PTEN	C0012819	Diverticular disease of colon	0.2	0	0	HPO
5728	PTEN	C0014173	Endometrial Hyperplasia	0.202747267842131	1	0	CTD_human
5728	PTEN	C0014544	Epilepsy	0.201373633921065	0	0	HPO
5728	PTEN	C0015695	Fatty Liver	0.200274726784213	1	0	CTD_human
5728	PTEN	C0018418	Gynecomastia	0.2	0	0	HPO
5728	PTEN	C0020255	Hydrocephalus	0.200274726784213	0	0	HPO
5728	PTEN	C0020492	Hyperostosis	0.2	0	0	HPO
5728	PTEN	C0020550	Hyperthyroidism	0.2	0	0	HPO
5728	PTEN	C0020615	Hypoglycemia	0.200274726784213	0	0	HPO
5728	PTEN	C0020676	Hypothyroidism	0.2	0	0	HPO
5728	PTEN	C0021933	Intussusception	0.2	0	0	HPO
5728	PTEN	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
5728	PTEN	C0023801	Lipomatosis	0.201098907136852	1	0	CTD_human
5728	PTEN	C0023976	Long QT Syndrome	0.2	1	0	CTD_human
5728	PTEN	C0024236	Lymphedema	0.2	0	0	HPO
5728	PTEN	C0024421	Macroglossia	0.2	0	0	HPO
5728	PTEN	C0027092	Myopia	0.2	0	0	HPO
5728	PTEN	C0028754	Obesity	0.201098907136852	0	0	HPO
5728	PTEN	C0029927	Ovarian Cysts	0.200824180352639	0	0	HPO
5728	PTEN	C0034065	Pulmonary Embolism	0.2	0	0	HPO
5728	PTEN	C0035305	Retinal Detachment	0.2	0	0	HPO
5728	PTEN	C0038379	Strabismus	0.2	0	0	HPO
5728	PTEN	C0040046	Thrombophlebitis	0.2	0	0	HPO
5728	PTEN	C0040147	Thyroiditis	0.2	0	0	HPO
5728	PTEN	C0040412	Fissured tongue	0.2	0	0	HPO
5728	PTEN	C0042341	Varicocele	0.2	0	0	HPO
5728	PTEN	C0042485	Venous Insufficiency	0.2	0	0	HPO
5728	PTEN	C0151311	Cranial nerve palsies	0.2	0	0	HPO
5728	PTEN	C0151740	Intracranial Hypertension	0.2	0	0	HPO
5728	PTEN	C0155300	Pseudopapilledema	0.2	0	0	HPO
5728	PTEN	C0175704	LEOPARD Syndrome	0.2	1	0	CTD_human
5728	PTEN	C0265326	Bannayan-Riley-Ruvalcaba Syndrome	0.495659426700147	6	14	ORPHANET;UNIPROT
5728	PTEN	C0334082	NEVUS, EPIDERMAL (disorder)	0.200549453568426	0	0	HPO
5728	PTEN	C0677607	Hashimoto Disease	0.2	0	0	HPO
5728	PTEN	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
5728	PTEN	C0854107	Haemorrhage subcutaneous	0.2	0	0	HPO
5728	PTEN	C1145670	Respiratory Failure	0.2	0	0	HPO
5728	PTEN	C1257915	Intestinal Polyposis	0.2	0	0	HPO
5728	PTEN	C1837658	Gross motor development delay	0.2	0	0	HPO
5728	PTEN	C1848599	VACTERL Association With Hydrocephalus	0.200274726784213	1	0	CTD_human
5728	PTEN	C1854416	MACROCEPHALY/AUTISM SYNDROME	0.68	2	13	CTD_human;ORPHANET;UNIPROT
5728	PTEN	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
5728	PTEN	C1866398	Proteus-Like Syndrome (disorder)	0.201373633921065	0	0	ORPHANET
5728	PTEN	C2936786	Aqueductal Stenosis	0.2	0	0	HPO
5728	PTEN	C4021849	Conjunctival hamartoma	0.2	0	0	HPO
5728	PTEN	C4021977	Visceral angiomatosis	0.2	0	0	HPO
5728	PTEN	C4225669	CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.2	0	0	ORPHANET
57282	SLC4A10	C0014544	Epilepsy	0.200549453568426	1	0	CTD_human
57282	SLC4A10	C0085541	Epilepsy, Frontal Lobe	0.2	1	0	CTD_human
57282	SLC4A10	C0151740	Intracranial Hypertension	0.2	1	0	CTD_human
5729	PTGDR	C1846534	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1	0.2	0	0	CTD_human
57306	CUP2Q35	C1861380	Syndactyly, Type I	0.2	0	0	CTD_human
57309	SPG14	C1854568	SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE (disorder)	0.4	0	0	CTD_human;ORPHANET
5732	PTGER2	C0014175	Endometriosis	0.2	1	0	CTD_human
5732	PTGER2	C1319853	Asthma, Aspirin-Induced	0.2	1	0	CTD_human
5732	PTGER2	C1859648	Asthma, Nasal Polyps, And Aspirin Intolerance	0.2	0	0	CTD_human
5733	PTGER3	C0030804	Pemphigoid, Benign Mucous Membrane	0.2	1	0	CTD_human
5733	PTGER3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
5733	PTGER3	C0038325	Stevens-Johnson Syndrome	0.200274726784213	1	0	CTD_human
57333	RCN3	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
57338	JPH3	C1847987	HUNTINGTON DISEASE-LIKE 2	0.402747267842131	0	0	CTD_human;ORPHANET
5734	PTGER4	C0014175	Endometriosis	0.200549453568426	1	0	CTD_human
5734	PTGER4	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
5734	PTGER4	C0038013	Ankylosing spondylitis	0.200549453568426	1	0	CTD_human
5734	PTGER4	C0263454	Chloracne	0.2	1	0	CTD_human
57369	GJD2	C0027092	Myopia	0.20350593566014	1	0	CTD_human
5737	PTGFR	C0014175	Endometriosis	0.2	1	0	CTD_human
57379	AICDA	C0272236	Hyperimmunoglobulin M syndrome	0.203021994626344	0	0	CTD_human
57379	AICDA	C1720956	Hyper-IgM Immunodeficiency Syndrome, Type 2	0.400824180352639	4	11	ORPHANET;UNIPROT
5739	PTGIR	C1319853	Asthma, Aspirin-Induced	0.2	1	0	CTD_human
5740	PTGIS	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
5740	PTGIS	C0085580	Essential Hypertension	0.200824180352639	0	0	CTD_human
574043	CDAGS	C1864186	CDAGS SYNDROME	0.2	0	0	CTD_human
574044	EPRPDC	C1842531	Epilepsy, rolandic with paroxysmal exercise-induced dystonia and writer's cramp	0.2	0	0	CTD_human
574045	HNP1	C0848548	hypertensive nephropathy	0.200274726784213	0	0	CTD_human
574047	MRXSMP	C1845285	Martin-Probst Deafness-Mental Retardation Syndrome	0.2	0	0	CTD_human
574049	TUKLS	C1836217	Tukel syndrome	0.2	0	0	CTD_human
574077	GLC1K	C1837527	GLAUCOMA 1, OPEN ANGLE, K	0.2	0	0	CTD_human
574078	GLC1J	C1837528	GLAUCOMA 1, OPEN ANGLE, J	0.2	0	0	CTD_human
5741	PTH	C0002871	Anemia	0.2	2	0	CTD_human
5741	PTH	C0014544	Epilepsy	0.200549453568426	0	0	HPO
5741	PTH	C0018801	Heart failure	0.2	1	0	CTD_human
5741	PTH	C0020437	Hypercalcemia	0.307747405205523	6	0	CTD_human
5741	PTH	C0020492	Hyperostosis	0.2	1	0	CTD_human
5741	PTH	C0020503	Hyperparathyroidism, Secondary	0.289615437447459	2	0	CTD_human
5741	PTH	C0020626	Hypoparathyroidism	0.212073623128059	0	0	HPO
5741	PTH	C0029456	Osteoporosis	0.291956953436117	5	0	CTD_human
5741	PTH	C0029458	Osteoporosis, Postmenopausal	0.203231208875927	1	0	CTD_human
5741	PTH	C0035579	Rickets	0.201923087489492	1	0	CTD_human
5741	PTH	C0039621	Tetany	0.2	0	0	HPO
5741	PTH	C0041948	Uremia	0.281098907136852	1	0	CTD_human
5741	PTH	C0085681	Hyperphosphatemia (disorder)	0.489340710663245	1	0	CTD_human;HPO
5741	PTH	C1832648	Hypoparathyroidism familial isolated	0.601098907136852	2	2	CTD_human;ORPHANET;UNIPROT
57410	SCYL1	C4225236	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.2	0	0	ORPHANET
5742	PTGS1	C0018801	Heart failure	0.2	1	0	CTD_human
5742	PTGS1	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
5742	PTGS1	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
5742	PTGS1	C0038358	Gastric ulcer	0.208697033805555	2	0	CTD_human
5742	PTGS1	C0085129	Bronchial Hyperreactivity	0.2	1	0	CTD_human
5742	PTGS1	C0264423	Asthma, Occupational	0.2	1	0	CTD_human
5743	PTGS2	C0002736	Amyotrophic Lateral Sclerosis	0.203780662444353	2	0	CTD_human
5743	PTGS2	C0003873	Rheumatoid Arthritis	0.214415139116717	2	0	CTD_human
5743	PTGS2	C0004045	Asphyxia Neonatorum	0.2	1	0	CTD_human
5743	PTGS2	C0004153	Atherosclerosis	0.219214840785976	1	0	CTD_human
5743	PTGS2	C0004763	Barrett Esophagus	0.212543208784538	3	0	CTD_human
5743	PTGS2	C0005694	Bladder neck obstruction	0.2	1	0	CTD_human
5743	PTGS2	C0007786	Brain Ischemia	0.204814057046576	4	0	CTD_human
5743	PTGS2	C0009319	Colitis	0.282472541057918	1	0	CTD_human
5743	PTGS2	C0013295	Duodenal Ulcer	0.2	1	0	CTD_human
5743	PTGS2	C0014175	Endometriosis	0.314146137096152	1	0	CTD_human
5743	PTGS2	C0017168	Gastroesophageal reflux disease	0.201648360705279	1	0	CTD_human
5743	PTGS2	C0017612	Glaucoma, Open-Angle	0.2	1	0	CTD_human
5743	PTGS2	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
5743	PTGS2	C0020295	Hydronephrosis	0.2	1	0	CTD_human
5743	PTGS2	C0020452	Hyperemia	0.2	1	0	CTD_human
5743	PTGS2	C0020456	Hyperglycemia	0.206015278498054	1	0	CTD_human
5743	PTGS2	C0022661	Kidney Failure, Chronic	0.202681755307501	1	0	CTD_human
5743	PTGS2	C0024141	Lupus Erythematosus, Systemic	0.200549453568426	1	0	CTD_human
5743	PTGS2	C0028754	Obesity	0.201648360705279	1	0	CTD_human
5743	PTGS2	C0029172	Oral Submucous Fibrosis	0.202681755307501	1	0	CTD_human
5743	PTGS2	C0030305	Pancreatitis	0.200274726784213	1	0	CTD_human
5743	PTGS2	C0031039	Pericardial effusion	0.2	1	0	CTD_human
5743	PTGS2	C0034013	Precocious Puberty	0.2	1	0	CTD_human
5743	PTGS2	C0038220	Status Epilepticus	0.2	1	0	CTD_human
5743	PTGS2	C0038358	Gastric ulcer	0.207114185634906	5	0	CTD_human
5743	PTGS2	C0162871	Aortic Aneurysm, Abdominal	0.200549453568426	1	0	CTD_human
5743	PTGS2	C0264423	Asthma, Occupational	0.2	1	0	CTD_human
5743	PTGS2	C0339143	Thyroid associated opthalmopathies	0.200274726784213	1	0	CTD_human
5743	PTGS2	C1319853	Asthma, Aspirin-Induced	0.200274726784213	2	0	CTD_human
5743	PTGS2	C1956346	Coronary Artery Disease	0.212426539092596	1	0	CTD_human
5743	PTGS2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
5744	PTHLH	C0020437	Hypercalcemia	0.226865803343615	4	0	CTD_human
5744	PTHLH	C0038833	Superior Vena Cava Syndrome	0.2	1	0	CTD_human
5744	PTHLH	C0149521	Pancreatitis, Chronic	0.200549453568426	1	0	CTD_human
5744	PTHLH	C0265312	Brachydactyly syndrome type E	0.2	0	0	ORPHANET
5744	PTHLH	C0267941	Pancreatitis, Acute Necrotizing	0.2	1	0	CTD_human
5744	PTHLH	C0376670	Pancreatitis, Alcoholic	0.200274726784213	1	0	CTD_human
5744	PTHLH	C3150644	BRACHYDACTYLY, TYPE E2	0.4	1	4	CTD_human;UNIPROT
574434	MIR410	C0015695	Fatty Liver	0.2	1	0	CTD_human
574434	MIR410	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
574447	MIR146B	C1956346	Coronary Artery Disease	0.2	1	0	CTD_human
57447	NDRG2	C0007787	Transient Ischemic Attack	0.2	1	0	CTD_human
57449	PLEKHG5	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
57449	PLEKHG5	C1970211	Spinal Muscular Atrophy, Distal, Autosomal Recessive, 4	0.6	1	1	CTD_human;ORPHANET;UNIPROT
57449	PLEKHG5	C3809309	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	0.4	1	4	ORPHANET;UNIPROT
5745	PTH1R	C0014084	Enchondromatosis	0.606839458850693	0	0	CTD_human;HPO;ORPHANET
5745	PTH1R	C0015300	Exophthalmos	0.2	0	0	HPO
5745	PTH1R	C0020305	Hydrops Fetalis	0.2	0	0	HPO
5745	PTH1R	C0020437	Hypercalcemia	0.2	0	0	HPO
5745	PTH1R	C0020502	Hyperparathyroidism	0.2	1	0	CTD_human
5745	PTH1R	C0020626	Hypoparathyroidism	0.2	0	0	HPO
5745	PTH1R	C0027709	Nephrocalcinosis	0.2	0	0	HPO
5745	PTH1R	C0029453	Osteopenia	0.2	0	0	HPO
5745	PTH1R	C0029464	Osteosclerosis	0.2	0	0	HPO
5745	PTH1R	C0035579	Rickets	0.2	1	0	CTD_human
5745	PTH1R	C0264142	Spade-like hand	0.2	0	0	HPO
5745	PTH1R	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
5745	PTH1R	C0747078	Generalized osteopenia	0.2	0	0	HPO
5745	PTH1R	C1838779	Eiken Skeletal Dysplasia	0.4	0	0	CTD_human;ORPHANET
5745	PTH1R	C1852222	Failure of Tooth Eruption, Primary	0.400274726784213	0	0	CTD_human;ORPHANET
5745	PTH1R	C1859148	Chondrodysplasia, blomstrand type	0.600274726784213	1	3	CTD_human;ORPHANET;UNIPROT
5745	PTH1R	C1859158	Laryngeal calcification	0.2	0	0	HPO
5745	PTH1R	C4021977	Visceral angiomatosis	0.2	0	0	HPO
574506	MIR503	C0015695	Fatty Liver	0.2	1	0	CTD_human
574506	MIR503	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
574506	MIR503	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
57455	REXO1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
57459	GATAD2B	C3554448	MENTAL RETARDATION, AUTOSOMAL DOMINANT 18	0.2	0	0	ORPHANET
57465	TBC1D24	C0751778	Myoclonic Epilepsies, Progressive	0.2	1	0	CTD_human
57465	TBC1D24	C0795934	Digitorenocerebral Syndrome	0.401098907136852	1	10	ORPHANET;UNIPROT
57465	TBC1D24	C0917800	Epilepsy, Myoclonic, Infantile	0.601373633921066	2	3	CTD_human;ORPHANET;UNIPROT
57465	TBC1D24	C2829265	DEAFNESS, AUTOSOMAL RECESSIVE 86	0.2	1	4	UNIPROT
57465	TBC1D24	C3809173	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16	0.4	1	3	ORPHANET;UNIPROT
57465	TBC1D24	C3892048	DEAFNESS, AUTOSOMAL DOMINANT 65	0.2	2	1	UNIPROT
57468	SLC12A5	C0014544	Epilepsy	0.201373633921065	2	0	CTD_human
57468	SLC12A5	C0014556	Epilepsy, Temporal Lobe	0.200274726784213	1	0	CTD_human
57468	SLC12A5	C0038220	Status Epilepticus	0.200274726784213	1	0	CTD_human
57468	SLC12A5	C4225257	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34	0.2	1	3	UNIPROT
5747	PTK2	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
57477	SHROOM4	C1845530	Stocco dos Santos syndrome	0.6	1	1	CTD_human;ORPHANET;UNIPROT
57492	ARID1B	C0265338	Coffin-Siris syndrome	0.401648360705279	2	13	CTD_human;ORPHANET
57492	ARID1B	C1303073	Nicolaides Baraitser syndrome	0.2	0	0	ORPHANET
57492	ARID1B	C3150215	CHROMOSOME 6q24-q25 DELETION SYNDROME	0.2	0	0	ORPHANET
57502	NLGN4X	C0015923	Fetal Alcohol Syndrome	0.2	1	0	PSYGENET
57505	AARS2	C1847967	OVARIOLEUKODYSTROPHY	0.2	0	0	ORPHANET
57505	AARS2	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	0.2	0	0	ORPHANET
57505	AARS2	C3279793	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8	0.4	1	3	ORPHANET;UNIPROT
57505	AARS2	C4014588	LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE	0.2	1	4	UNIPROT
57510	XPO5	C1868672	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	0.2	1	0	CTD_human
57511	COG6	C3553230	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl	0.400274726784213	1	4	ORPHANET;UNIPROT
57511	COG6	C3809160	SHAHEEN SYNDROME	0.200274726784213	0	0	ORPHANET
57514	ARHGAP31	C0265268	Adams Oliver syndrome	0.200824180352639	0	0	ORPHANET
57526	PCDH19	C0014544	Epilepsy	0.211524169559633	1	0	CTD_human
57526	PCDH19	C0751122	Infantile Severe Myoclonic Epilepsy	0.202472541057918	0	0	ORPHANET
57526	PCDH19	C1136249	Mental Retardation, X-Linked	0.2	1	0	CTD_human
57526	PCDH19	C1848137	EPILEPSY, FEMALE-RESTRICTED, WITH MENTAL RETARDATION (disorder)	0.600549453568426	9	17	CTD_human;ORPHANET;UNIPROT
57531	HACE1	C2931189	Neural crest tumor	0.2	0	0	ORPHANET
57531	HACE1	C4225215	SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.2	0	0	ORPHANET
57534	MIB1	C1960469	Left ventricular noncompaction	0.2	0	0	ORPHANET
57534	MIB1	C3554496	LEFT VENTRICULAR NONCOMPACTION 7	0.2	1	2	UNIPROT
57539	WDR35	C0010278	Craniosynostosis	0.200274726784213	1	0	CTD_human
57539	WDR35	C0432197	Short rib-polydactyly syndrome, Verma-Naumoff type	0.2	0	0	ORPHANET
57539	WDR35	C3150874	CRANIOECTODERMAL DYSPLASIA 2	0.4	1	11	CTD_human;UNIPROT
57545	CC2D2A	C0265215	Meckel-Gruber syndrome	0.200549453568426	0	0	ORPHANET
57545	CC2D2A	C1855675	Arima syndrome	0.2	0	0	ORPHANET
57545	CC2D2A	C1857662	COACH syndrome	0.600274726784213	2	3	CTD_human;ORPHANET;UNIPROT
57545	CC2D2A	C2676788	JOUBERT SYNDROME 9 (disorder)	0.4	8	45	CTD_human;UNIPROT
57545	CC2D2A	C2676790	MECKEL SYNDROME, TYPE 6 (disorder)	0.48	2	22	CTD_human;UNIPROT
57560	IFT80	C0432197	Short rib-polydactyly syndrome, Verma-Naumoff type	0.2	0	0	ORPHANET
57560	IFT80	C1970005	Asphyxiating Thoracic Dystrophy 2	0.48	1	5	CTD_human;UNIPROT
57562	CEP126	C1865384	Amyotrophy, monomelic	0.2	0	0	ORPHANET
5757	PTMA	C0015695	Fatty Liver	0.2	1	0	CTD_human
57570	TRMT5	C4225290	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26	0.2	1	2	UNIPROT
57572	DOCK6	C0265268	Adams Oliver syndrome	0.201373633921065	0	0	ORPHANET
57582	KCNT1	C0014547	Epilepsies, Partial	0.200549453568426	1	0	CTD_human
57582	KCNT1	C0085541	Epilepsy, Frontal Lobe	0.2	1	0	CTD_human
57582	KCNT1	C3554195	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14	0.2	1	8	UNIPROT
57582	KCNT1	C3554306	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5	0.2	1	7	UNIPROT
57592	ZNF687	C4085250	PAGET DISEASE OF BONE 6	0.2	1	2	UNIPROT
57608	KIAA1462	C1956346	Coronary Artery Disease	0.200824180352639	1	1	CTD_human
57609	DIP2B	C1969893	Mental Retardation, Fra12a Type	0.2	0	0	CTD_human
57623	ZFAT	C0920350	Autoimmune thyroiditis	0.2	0	0	CTD_human
57636	ARHGAP23	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
57644	MYH7B	C1960469	Left ventricular noncompaction	0.2	0	0	ORPHANET
5765	PTOS1	C1867438	PTOSIS, HEREDITARY CONGENITAL 1 (disorder)	0.2	0	0	CTD_human
57654	UVSSA	C3551173	UV-SENSITIVE SYNDROME 1	0.2	2	0	CTD_human
57654	UVSSA	C3553328	UV-SENSITIVE SYNDROME 3	0.2	1	2	UNIPROT
57661	PHRF1	C0024141	Lupus Erythematosus, Systemic	0.214009387263244	1	2	CTD_human
57674	RNF213	C0026654	Moyamoya Disease	0.210439617800098	0	0	ORPHANET
57674	RNF213	C1846689	MOYAMOYA DISEASE 2	0.2	3	4	UNIPROT
57674	RNF213	C2931384	Moyamoya disease 1	0.210164891015885	0	0	ORPHANET
57679	ALS2	C1853396	Primary lateral sclerosis juvenile	0.401373633921066	0	0	CTD_human;ORPHANET
57679	ALS2	C1859807	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE (disorder)	0.202747267842131	0	0	CTD_human
57679	ALS2	C2931441	Hereditary spastic paralysis, infantile onset ascending	0.405703749933845	0	0	CTD_human;ORPHANET
57688	ZSWIM6	C0796182	Acromelic frontonasal dysplasia	0.2	0	0	ORPHANET
57688	ZSWIM6	C1863616	ACROMELIC FRONTONASAL DYSOSTOSIS	0.200274726784213	1	1	UNIPROT
57697	FANCM	C0015625	Fanconi Anemia	0.408502174933289	1	0	CTD_human;ORPHANET
5770	PTPN1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.22853142631492	0	0	CTD_human
5770	PTPN1	C0028754	Obesity	0.21229719275496	1	0	CTD_human
5770	PTPN1	C0035372	Rett Syndrome	0.2	1	0	CTD_human
57704	GBA2	C2828721	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE	0.400274726784213	2	5	ORPHANET;UNIPROT
57709	SLC7A14	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
57709	SLC7A14	C3810380	RETINITIS PIGMENTOSA 68	0.2	1	4	UNIPROT
5771	PTPN2	C0003873	Rheumatoid Arthritis	0.206187690967642	1	2	CTD_human
5771	PTPN2	C0009324	Ulcerative Colitis	0.209470057000881	1	1	CTD_human
5771	PTPN2	C0010346	Crohn Disease	0.23197184944043	1	1	CTD_human
5771	PTPN2	C0022073	Iridocyclitis	0.2	0	0	HPO
5771	PTPN2	C0024636	Malocclusion	0.2	0	0	HPO
5771	PTPN2	C0157917	Pauciarticular juvenile rheumatoid arthritis	0.2	0	0	ORPHANET
5771	PTPN2	C0162323	Polyarthritis	0.2	0	0	HPO
5771	PTPN2	C3714757	Juvenile rheumatoid arthritis	0.200549453568426	0	0	HPO
5771	PTPN2	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
57716	PRX	C0011195	Dejerine-Sottas Disease (disorder)	0.202197814273705	0	0	ORPHANET
57716	PRX	C3540453	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F	0.400549453568426	1	9	ORPHANET;UNIPROT
57724	EPG5	C0162835	Hypopigmentation disorder	0.200274726784213	1	0	CTD_human
57724	EPG5	C1855772	Absent corpus callosum cataract immunodeficiency	0.601648360705279	1	7	CTD_human;ORPHANET;UNIPROT
57728	WDR19	C0403553	Renal dysplasia and retinal aplasia (disorder)	0.200549453568426	0	0	ORPHANET
57728	WDR19	C1855681	Nephronophthisis, familial juvenile	0.2	0	0	ORPHANET
57728	WDR19	C3280598	SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY	0.2	1	1	UNIPROT
57728	WDR19	C3280612	NEPHRONOPHTHISIS 13	0.200274726784213	1	4	UNIPROT
57728	WDR19	C3280616	CRANIOECTODERMAL DYSPLASIA 4	0.2	2	2	UNIPROT
57728	WDR19	C4225376	SENIOR-LOKEN SYNDROME 8	0.2	2	11	UNIPROT
57731	SPTBN4	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
57760	SPG16	C1846046	SPASTIC PARAPLEGIA 16, X-LINKED (disorder)	0.4	0	0	CTD_human;ORPHANET
57761	TRIB3	C0524620	Metabolic Syndrome X	0.202681755307501	1	0	CTD_human
57762	NS2	C1854469	Noonan Syndrome 2	0.2	0	0	CTD_human
57791	MRXSA	C1846057	Armfield X-Linked Mental Retardation Syndrome	0.2	0	0	CTD_human
57792	MRXSAB	C1846056	Abidi X-linked mental retardation syndrome	0.2	0	0	CTD_human
57798	GATAD1	C3553409	CARDIOMYOPATHY, DILATED, 2B	0.2	1	1	UNIPROT
57798	GATAD1	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
57798	GATAD1	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
5781	PTPN11	C0006384	Bundle-Branch Block	0.2	0	0	HPO
5781	PTPN11	C0007194	Hypertrophic Cardiomyopathy	0.204945082115836	0	0	HPO
5781	PTPN11	C0014084	Enchondromatosis	0.400274726784213	2	0	CTD_human;HPO
5781	PTPN11	C0015300	Exophthalmos	0.2	0	0	HPO
5781	PTPN11	C0015526	Factor XII Deficiency	0.2	0	0	HPO
5781	PTPN11	C0018784	Sensorineural Hearing Loss (disorder)	0.200549453568426	0	0	HPO
5781	PTPN11	C0024236	Lymphedema	0.202407028523288	0	0	HPO
5781	PTPN11	C0024636	Malocclusion	0.2	0	0	HPO
5781	PTPN11	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
5781	PTPN11	C0027092	Myopia	0.2	0	0	HPO
5781	PTPN11	C0028326	Noonan Syndrome	0.818072426807894	24	50	CTD_human;ORPHANET;UNIPROT
5781	PTPN11	C0036651	Senile lentigo	0.2	0	0	HPO
5781	PTPN11	C0038379	Strabismus	0.2	0	0	HPO
5781	PTPN11	C0039103	Synovitis	0.2	0	0	HPO
5781	PTPN11	C0151517	Complete atrioventricular block	0.2	0	0	HPO
5781	PTPN11	C0175704	LEOPARD Syndrome	0.72123787632838	10	11	CTD_human;ORPHANET;UNIPROT
5781	PTPN11	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
5781	PTPN11	C0340375	Subaortic stenosis	0.2	0	0	HPO
5781	PTPN11	C0398639	Amegakaryocytic thrombocytopenia	0.2	0	0	HPO
5781	PTPN11	C0410530	Metachondromatosis	0.481098907136852	0	0	CTD_human;ORPHANET
5781	PTPN11	C0587248	Costello syndrome (disorder)	0.201098907136852	1	0	CTD_human
5781	PTPN11	C0949173	Delayed menarche	0.2	0	0	HPO
5781	PTPN11	C1328931	Multiple lentigines	0.201373633921065	0	0	HPO
5781	PTPN11	C1956257	Pulmonary Stenosis	0.202197814273705	0	0	HPO
5781	PTPN11	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
5781	PTPN11	C4021533	Severe sensorineural hearing impairment	0.2	0	0	HPO
5781	PTPN11	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
57817	HAMP	C0002871	Anemia	0.31234598365056	3	0	CTD_human
57817	HAMP	C0005283	beta Thalassemia	0.206253203502271	1	0	CTD_human
57817	HAMP	C0018995	Hemochromatosis	0.249572224412414	6	0	CTD_human
57817	HAMP	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
57817	HAMP	C0022661	Kidney Failure, Chronic	0.203831819601666	1	0	CTD_human
57817	HAMP	C0268060	Juvenile hemochromatosis	0.407142896389541	0	0	CTD_human;ORPHANET
57817	HAMP	C0282193	Iron Overload	0.332688442328023	2	0	CTD_human
57817	HAMP	C1865614	HEMOCHROMATOSIS, TYPE 2A	0.2	0	0	ORPHANET
57817	HAMP	C1865616	HEMOCHROMATOSIS, TYPE 2B	0.4	3	3	CTD_human;UNIPROT
57822	GRHL3	C0175697	Van der Woude syndrome	0.201373633921065	0	0	ORPHANET
57822	GRHL3	C1847604	Van der Woude syndrome 2	0.28	1	5	UNIPROT
5784	PTPN14	C0024236	Lymphedema	0.200274726784213	0	0	HPO
5784	PTPN14	C0031039	Pericardial effusion	0.2	0	0	HPO
5784	PTPN14	C3150875	CHOANAL ATRESIA AND LYMPHEDEMA	0.4	0	0	CTD_human;ORPHANET
5786	PTPRA	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5788	PTPRC	C0003873	Rheumatoid Arthritis	0.211276474798431	2	0	CTD_human
5788	PTPRC	C0013595	Eczema	0.2	0	0	HPO
5788	PTPRC	C0019196	Hepatitis C	0.205414667772315	0	0	CTD_human
5788	PTPRC	C0026769	Multiple Sclerosis	0.227362421023105	0	0	CTD_human
5788	PTPRC	C0029882	Otitis Media	0.2	0	0	HPO
5788	PTPRC	C0085110	Severe Combined Immunodeficiency	0.204055389228567	0	0	HPO
5788	PTPRC	C1837028	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive	0.4	0	0	CTD_human;ORPHANET
5788	PTPRC	C4025203	Severe T lymphocytopenia	0.2	0	0	HPO
5789	PTPRD	C0035258	Restless Legs Syndrome	0.204381273170092	1	2	CTD_human
579	NKX3-2	C0265294	Pyle metaphyseal dysplasia	0.2	0	0	HPO
579	NKX3-2	C2750066	Spondylo-Megaepiphyseal-Metaphyseal Dysplasia	0.400274726784213	0	0	CTD_human;ORPHANET
58	ACTA1	C0003886	Arthrogryposis	0.2	0	0	HPO
58	ACTA1	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
58	ACTA1	C0270969	Zebra body myopathy	0.200274726784213	0	0	ORPHANET
58	ACTA1	C0376175	Bell Palsy	0.2	0	0	HPO
58	ACTA1	C0410180	Eichsfeld type congenital muscular dystrophy	0.2	0	0	ORPHANET
58	ACTA1	C0546125	Nemaline Myopathy, Childhood Onset	0.2	0	0	ORPHANET
58	ACTA1	C1301959	Bulbar weakness	0.2	0	0	HPO
58	ACTA1	C1834336	Nemaline myopathy 3	0.68	13	16	CTD_human;ORPHANET;UNIPROT
58	ACTA1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
58	ACTA1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
58	ACTA1	C2678065	Myofibrillar Myopathy	0.200274726784213	0	0	HPO
58	ACTA1	C3711389	Actin-Accumulation Myopathy	0.200549453568426	0	0	ORPHANET
58	ACTA1	C4082299	Bulbar palsy	0.2	0	0	HPO
58	ACTA1	C4225181	MYOPATHY, SCAPULOHUMEROPERONEAL	0.4	1	1	ORPHANET;UNIPROT
5800	PTPRO	C0017668	Focal glomerulosclerosis	0.200549453568426	0	0	HPO
5800	PTPRO	C0239981	Hypoalbuminemia	0.2	0	0	HPO
5803	PTPRZ1	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
5805	PTS	C0014544	Epilepsy	0.2	0	0	HPO
5805	PTS	C0037036	Sialorrhea	0.2	0	0	HPO
5805	PTS	C0085583	Choreoathetosis	0.2	0	0	HPO
5805	PTS	C0751435	Hyperphenylalaninaemia	0.201373633921065	0	0	HPO
5805	PTS	C0878676	6-pyruvoyl-tetrahydropterin synthase deficiency	0.68	9	15	CTD_human;ORPHANET;UNIPROT
5805	PTS	C4020871	Dystonic disease	0.2	0	0	HPO
5806	PTX3	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
581	BAX	C0002395	Alzheimer's Disease	0.280274726784213	1	0	CTD_human
581	BAX	C0027051	Myocardial Infarction	0.200824180352639	2	0	CTD_human
581	BAX	C0032460	Polycystic Ovary Syndrome	0.200274726784213	1	0	CTD_human
581	BAX	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
5813	PURA	C0014544	Epilepsy	0.200274726784213	0	0	HPO
5813	PURA	C0028738	Nystagmus	0.2	0	0	HPO
5813	PURA	C0038379	Strabismus	0.2	0	0	HPO
5813	PURA	C2267233	Neonatal Hypotonia	0.200274726784213	0	0	HPO
5813	PURA	C4015357	MENTAL RETARDATION, AUTOSOMAL DOMINANT 31	0.4	2	12	ORPHANET;UNIPROT
58156	OPA4	C1854430	OPTIC ATROPHY 4 (disorder)	0.2	0	0	CTD_human
5817	PVR	C0032371	Poliomyelitis	0.202747267842131	1	0	CTD_human
5818	NECTIN1	C0002170	Alopecia	0.2	0	0	HPO
5818	NECTIN1	C0011334	Dental caries	0.2	0	0	HPO
5818	NECTIN1	C0020619	Hypogonadism	0.2	0	0	HPO
5818	NECTIN1	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
5818	NECTIN1	C0796139	Rosselli-Gulienetti syndrome	0.2	0	0	CTD_human
5818	NECTIN1	C1834405	Nail dysplasia	0.2	0	0	HPO
5818	NECTIN1	C2931488	Zlotogora-Ogur syndrome	0.400824180352639	1	3	CTD_human;ORPHANET
582	BBS1	C0004096	Asthma	0.2	0	0	HPO
582	BBS1	C0020619	Hypogonadism	0.2	0	0	HPO
582	BBS1	C0028738	Nystagmus	0.2	0	0	HPO
582	BBS1	C0028754	Obesity	0.283231208875927	0	0	HPO
582	BBS1	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	HPO
582	BBS1	C0038379	Strabismus	0.2	0	0	HPO
582	BBS1	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
582	BBS1	C0162283	Nephrogenic Diabetes Insipidus	0.2	0	0	HPO
582	BBS1	C0239946	Fibrosis, Liver	0.2	0	0	HPO
582	BBS1	C0752166	Bardet-Biedl Syndrome	0.410425262422781	0	0	CTD_human;ORPHANET
582	BBS1	C2936862	Bardet-Biedl syndrome 1 (disorder)	0.281098907136852	3	11	UNIPROT
582	BBS1	C3714497	Reactive airway disease	0.2	0	0	HPO
582	BBS1	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5820	PVT1	C0162538	Immunoglobulin A deficiency (disorder)	0.2	1	0	CTD_human
5824	PEX19	C0001403	Addison Disease	0.2	0	0	HPO
5824	PEX19	C0008350	Cholelithiasis	0.2	0	0	HPO
5824	PEX19	C0014544	Epilepsy	0.2	0	0	HPO
5824	PEX19	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5824	PEX19	C0020295	Hydronephrosis	0.2	0	0	HPO
5824	PEX19	C0028077	Night Blindness	0.2	0	0	HPO
5824	PEX19	C0028738	Nystagmus	0.2	0	0	HPO
5824	PEX19	C0029124	Optic Atrophy	0.2	0	0	HPO
5824	PEX19	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5824	PEX19	C0038379	Strabismus	0.2	0	0	HPO
5824	PEX19	C0042798	Low Vision	0.2	0	0	HPO
5824	PEX19	C0043459	Zellweger Syndrome	0.4	1	0	CTD_human;ORPHANET
5824	PEX19	C0085605	Liver Failure	0.2	0	0	HPO
5824	PEX19	C0151747	Renal tubular disorder	0.2	0	0	HPO
5824	PEX19	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
5824	PEX19	C0235946	Cerebral atrophy	0.2	0	0	HPO
5824	PEX19	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
5824	PEX19	C0282527	Infantile Refsum Disease (disorder)	0.2	0	0	ORPHANET
5824	PEX19	C0338474	Central nervous system demyelination	0.2	0	0	HPO
5824	PEX19	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
5824	PEX19	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5824	PEX19	C1836830	Developmental regression	0.2	0	0	HPO
5824	PEX19	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5824	PEX19	C3553450	Profound global developmental delay	0.2	0	0	HPO
5824	PEX19	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5824	PEX19	C4020860	Supratentorial atrophy	0.2	0	0	HPO
5825	ABCD3	C0043459	Zellweger Syndrome	0.200549453568426	1	0	CTD_human
5825	ABCD3	C0085605	Liver Failure	0.2	0	0	HPO
5825	ABCD3	C0162316	Iron deficiency anemia	0.2	0	0	HPO
5826	ABCD4	C0002871	Anemia	0.2	0	0	HPO
5826	ABCD4	C0019880	Homocystinuria	0.2	0	0	HPO
5826	ABCD4	C0042847	Vitamin B 12 Deficiency	0.200274726784213	1	0	CTD_human
5826	ABCD4	C1855119	Methylmalonic aciduria	0.2	0	0	HPO
5826	ABCD4	C3553915	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE	0.4	1	2	ORPHANET;UNIPROT
5828	PEX2	C0001403	Addison Disease	0.2	0	0	HPO
5828	PEX2	C0014544	Epilepsy	0.2	0	0	HPO
5828	PEX2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5828	PEX2	C0020295	Hydronephrosis	0.2	0	0	HPO
5828	PEX2	C0022679	Cystic kidney	0.2	0	0	HPO
5828	PEX2	C0028077	Night Blindness	0.2	0	0	HPO
5828	PEX2	C0028738	Nystagmus	0.2	0	0	HPO
5828	PEX2	C0029124	Optic Atrophy	0.2	0	0	HPO
5828	PEX2	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5828	PEX2	C0038379	Strabismus	0.2	0	0	HPO
5828	PEX2	C0042798	Low Vision	0.2	0	0	HPO
5828	PEX2	C0043459	Zellweger Syndrome	0.401373633921066	1	0	CTD_human;ORPHANET
5828	PEX2	C0085605	Liver Failure	0.2	0	0	HPO
5828	PEX2	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
5828	PEX2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
5828	PEX2	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
5828	PEX2	C0282527	Infantile Refsum Disease (disorder)	0.400824180352639	1	0	CTD_human;ORPHANET
5828	PEX2	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
5828	PEX2	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5828	PEX2	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
5828	PEX2	C1836830	Developmental regression	0.2	0	0	HPO
5828	PEX2	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
5828	PEX2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5828	PEX2	C3489733	Oculomotor apraxia	0.2	0	0	HPO
5828	PEX2	C3542026	PEROXISOME BIOGENESIS DISORDER 5B	0.2	1	6	UNIPROT
5828	PEX2	C3553450	Profound global developmental delay	0.2	0	0	HPO
5828	PEX2	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5828	PEX2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
583	BBS2	C0017601	Glaucoma	0.2	0	0	HPO
583	BBS2	C0018777	Conductive hearing loss	0.2	0	0	HPO
583	BBS2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
583	BBS2	C0020459	Hyperinsulinism	0.2	0	0	HPO
583	BBS2	C0020619	Hypogonadism	0.2	0	0	HPO
583	BBS2	C0022578	Keratoconus	0.2	0	0	HPO
583	BBS2	C0028738	Nystagmus	0.2	0	0	HPO
583	BBS2	C0028754	Obesity	0.202956482091714	0	0	HPO
583	BBS2	C0029124	Optic Atrophy	0.2	0	0	HPO
583	BBS2	C0035334	Retinitis Pigmentosa	0.400549453568426	0	0	HPO;ORPHANET
583	BBS2	C0271215	Blindness, Legal	0.2	0	0	HPO
583	BBS2	C0752166	Bardet-Biedl Syndrome	0.419202164140282	0	0	CTD_human;ORPHANET
583	BBS2	C2936863	Bardet-Biedl syndrome 2 (disorder)	0.280274726784213	9	17	UNIPROT
583	BBS2	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
583	BBS2	C4225281	RETINITIS PIGMENTOSA 74	0.2	1	2	UNIPROT
5830	PEX5	C0001403	Addison Disease	0.2	0	0	HPO
5830	PEX5	C0004096	Asthma	0.2	0	0	HPO
5830	PEX5	C0014544	Epilepsy	0.2	0	0	HPO
5830	PEX5	C0014877	Esotropia	0.2	0	0	HPO
5830	PEX5	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5830	PEX5	C0020295	Hydronephrosis	0.2	0	0	HPO
5830	PEX5	C0028077	Night Blindness	0.2	0	0	HPO
5830	PEX5	C0028738	Nystagmus	0.2	0	0	HPO
5830	PEX5	C0029124	Optic Atrophy	0.2	0	0	HPO
5830	PEX5	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
5830	PEX5	C0038379	Strabismus	0.2	0	0	HPO
5830	PEX5	C0039239	Sinus Tachycardia	0.2	0	0	HPO
5830	PEX5	C0042798	Low Vision	0.2	0	0	HPO
5830	PEX5	C0043459	Zellweger Syndrome	0.40328236603324	0	0	CTD_human;ORPHANET
5830	PEX5	C0085605	Liver Failure	0.2	0	0	HPO
5830	PEX5	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
5830	PEX5	C0158113	Contracture of joint of hand	0.2	0	0	HPO
5830	PEX5	C0238621	Aminoaciduria	0.2	0	0	HPO
5830	PEX5	C0271386	Vertical Nystagmus	0.2	0	0	HPO
5830	PEX5	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
5830	PEX5	C0282527	Infantile Refsum Disease (disorder)	0.200274726784213	0	0	ORPHANET
5830	PEX5	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
5830	PEX5	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5830	PEX5	C1389113	Generalized amyotrophy	0.2	0	0	HPO
5830	PEX5	C1836830	Developmental regression	0.2	0	0	HPO
5830	PEX5	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5830	PEX5	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
5830	PEX5	C3550234	PEROXISOME BIOGENESIS DISORDER 2B	0.4	1	1	CTD_human;UNIPROT
5830	PEX5	C3553450	Profound global developmental delay	0.2	0	0	HPO
5830	PEX5	C3714497	Reactive airway disease	0.2	0	0	HPO
5830	PEX5	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5830	PEX5	C4225237	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5	0.2	0	0	ORPHANET
5831	PYCR1	C0010495	Cutis Laxa	0.400549453568426	1	0	CTD_human;HPO
5831	PYCR1	C0014306	Enophthalmos	0.2	0	0	HPO
5831	PYCR1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
5831	PYCR1	C0020255	Hydrocephalus	0.2	0	0	HPO
5831	PYCR1	C0029453	Osteopenia	0.200274726784213	0	0	HPO
5831	PYCR1	C0029456	Osteoporosis	0.2	0	0	HPO
5831	PYCR1	C0033300	Progeria	0.2	1	0	CTD_human
5831	PYCR1	C0264112	Wedging of vertebra	0.2	0	0	HPO
5831	PYCR1	C0410550	Collapse of vertebra	0.2	0	0	HPO
5831	PYCR1	C0432255	Geroderma osteodysplastica	0.200274726784213	0	0	ORPHANET
5831	PYCR1	C0747078	Generalized osteopenia	0.2	0	0	HPO
5831	PYCR1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5831	PYCR1	C2751987	Cutis Laxa, Autosomal Recessive, Type IIB	0.601098907136852	2	5	CTD_human;ORPHANET;UNIPROT
5831	PYCR1	C2930812	Generalized elastolysis	0.2	0	0	HPO
5831	PYCR1	C3280799	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB	0.4	2	4	ORPHANET;UNIPROT
5832	ALDH18A1	C0003742	Arcus Senilis	0.2	0	0	HPO
5832	ALDH18A1	C0010495	Cutis Laxa	0.200824180352639	0	0	HPO
5832	ALDH18A1	C0014544	Epilepsy	0.2	0	0	HPO
5832	ALDH18A1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
5832	ALDH18A1	C0027092	Myopia	0.2	0	0	HPO
5832	ALDH18A1	C0037772	Spastic Paraplegia	0.2	0	0	HPO
5832	ALDH18A1	C0038379	Strabismus	0.2	0	0	HPO
5832	ALDH18A1	C0234958	muscle degeneration	0.2	0	0	HPO
5832	ALDH18A1	C0235025	Peripheral motor neuropathy	0.2	0	0	HPO
5832	ALDH18A1	C0268350	Cutis Laxa, Autosomal Dominant	0.2	0	0	ORPHANET
5832	ALDH18A1	C0268354	De Barsy syndrome	0.4	6	7	ORPHANET;UNIPROT
5832	ALDH18A1	C0271683	Polyneuropathy, Motor	0.2	0	0	HPO
5832	ALDH18A1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5832	ALDH18A1	C1389113	Generalized amyotrophy	0.2	0	0	HPO
5832	ALDH18A1	C1394691	Bowel diverticula	0.2	0	0	HPO
5832	ALDH18A1	C1395674	Bowel diverticulosis	0.2	0	0	HPO
5832	ALDH18A1	C1832669	SPASTIC PARAPLEGIA 9, AUTOSOMAL DOMINANT (disorder)	0.4	2	4	ORPHANET;UNIPROT
5832	ALDH18A1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5832	ALDH18A1	C2930812	Generalized elastolysis	0.2	0	0	HPO
5832	ALDH18A1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
5832	ALDH18A1	C3489393	Hiatal Hernia	0.2	0	0	HPO
5832	ALDH18A1	C4225268	CUTIS LAXA, AUTOSOMAL DOMINANT 3	0.2	1	2	UNIPROT
5832	ALDH18A1	C4225272	SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE	0.4	1	3	ORPHANET;UNIPROT
5834	PYGB	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
5836	PYGL	C0017925	Glycogen Storage Disease Type VI	0.600274726784213	2	21	CTD_human;ORPHANET;UNIPROT
5836	PYGL	C0020473	Hyperlipidemia	0.2	0	0	HPO
5836	PYGL	C0020615	Hypoglycemia	0.2	0	0	HPO
5837	PYGM	C0017924	Glycogen Storage Disease Type V	0.722322428087915	6	52	CTD_human;ORPHANET;UNIPROT
58484	NLRC4	C0014356	Enterocolitis	0.200274726784213	1	0	CTD_human
58484	NLRC4	C0343068	Familial cold urticaria	0.200274726784213	0	0	ORPHANET
58484	NLRC4	C1096155	Macrophage Activation Syndrome	0.200549453568426	1	0	CTD_human
58484	NLRC4	C4015067	AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS	0.4	2	3	ORPHANET;UNIPROT
58484	NLRC4	C4015276	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4	0.28	1	1	UNIPROT
58495	OVOL2	C0339284	Polymorphous corneal dystrophy	0.401648360705279	1	4	CTD_human;ORPHANET
58495	OVOL2	C1562689	Congenital hereditary endothelial dystrophy	0.201648360705279	0	0	ORPHANET
58498	MYL7	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	1	0	CTD_human
585	BBS4	C0004096	Asthma	0.2	0	0	HPO
585	BBS4	C0020619	Hypogonadism	0.2	0	0	HPO
585	BBS4	C0022679	Cystic kidney	0.2	0	0	HPO
585	BBS4	C0028077	Night Blindness	0.2	0	0	HPO
585	BBS4	C0028738	Nystagmus	0.2	0	0	HPO
585	BBS4	C0028754	Obesity	0.283780662444354	0	0	HPO
585	BBS4	C0035334	Retinitis Pigmentosa	0.203007639249027	0	0	HPO
585	BBS4	C0038379	Strabismus	0.2	0	0	HPO
585	BBS4	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
585	BBS4	C0162283	Nephrogenic Diabetes Insipidus	0.2	0	0	HPO
585	BBS4	C0239946	Fibrosis, Liver	0.2	0	0	HPO
585	BBS4	C0752166	Bardet-Biedl Syndrome	0.409861453477037	0	0	CTD_human;ORPHANET
585	BBS4	C2936864	Bardet-Biedl syndrome 4 (disorder)	0.280274726784213	5	8	UNIPROT
585	BBS4	C3714497	Reactive airway disease	0.2	0	0	HPO
585	BBS4	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5858	PZP	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
5859	QARS	C0038220	Status Epilepticus	0.2	0	0	HPO
5859	QARS	C0235946	Cerebral atrophy	0.2	0	0	HPO
5859	QARS	C4014239	MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.4	1	4	ORPHANET;UNIPROT
5859	QARS	C4020860	Supratentorial atrophy	0.2	0	0	HPO
5860	QDPR	C0014544	Epilepsy	0.2	0	0	HPO
5860	QDPR	C0037036	Sialorrhea	0.2	0	0	HPO
5860	QDPR	C0085583	Choreoathetosis	0.2	0	0	HPO
5860	QDPR	C0268465	Phenylketonuria II	0.601373633921066	5	9	CTD_human;ORPHANET;UNIPROT
5860	QDPR	C0751435	Hyperphenylalaninaemia	0.202197814273705	0	0	HPO
5860	QDPR	C4020871	Dystonic disease	0.2	0	0	HPO
5862	RAB2A	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
5868	RAB5A	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
587	BCAT2	C0024776	Maple Syrup Urine Disease	0.280274726784213	1	0	CTD_human
5873	RAB27A	C0014544	Epilepsy	0.2	0	0	HPO
5873	RAB27A	C0020473	Hyperlipidemia	0.2	0	0	HPO
5873	RAB27A	C0030312	Pancytopenia	0.2	0	0	HPO
5873	RAB27A	C0162835	Hypopigmentation disorder	0.200824180352639	0	0	HPO
5873	RAB27A	C0876991	Histiocytosis haematophagic	0.200274726784213	0	0	HPO
5873	RAB27A	C1868679	GRISCELLI SYNDROME, TYPE 2	0.603846174978984	1	5	CTD_human;ORPHANET;UNIPROT
5879	RAC1	C0018801	Heart failure	0.2	1	0	CTD_human
5880	RAC2	C1842398	Neutrophil Immunodeficiency Syndrome	0.602681755307501	1	1	CTD_human;ORPHANET;UNIPROT
5885	RAD21	C0005741	Blepharitis	0.2	0	0	HPO
5885	RAD21	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
5885	RAD21	C0018777	Conductive hearing loss	0.2	0	0	HPO
5885	RAD21	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5885	RAD21	C0027092	Myopia	0.2	0	0	HPO
5885	RAD21	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
5885	RAD21	C0263401	Cutis marmorata	0.2	0	0	HPO
5885	RAD21	C0270972	Cornelia De Lange Syndrome	0.203296721410557	0	0	ORPHANET
5885	RAD21	C0271007	Phthisis bulbi	0.2	0	0	HPO
5885	RAD21	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
5885	RAD21	C1857079	Atretic auditory canal	0.2	0	0	HPO
5885	RAD21	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5885	RAD21	C3553517	CORNELIA DE LANGE SYNDROME 4	0.200274726784213	1	6	UNIPROT
5885	RAD21	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
5885	RAD21	C4020884	Anxiety disease	0.2	0	0	HPO
5888	RAD51	C0015625	Fanconi Anemia	0.205219808900049	0	0	ORPHANET
5888	RAD51	C0023530	Leukopenia	0.2	0	0	HPO
5888	RAD51	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
5888	RAD51	C0454455	Mirror movements disorder	0.201373633921065	0	0	HPO
5889	RAD51C	C0015625	Fanconi Anemia	0.404120901763197	1	0	CTD_human;ORPHANET
5889	RAD51C	C0020295	Hydronephrosis	0.2	0	0	HPO
5889	RAD51C	C0022679	Cystic kidney	0.2	0	0	HPO
5889	RAD51C	C0023530	Leukopenia	0.2	0	0	HPO
5889	RAD51C	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
5889	RAD51C	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
5889	RAD51C	C3150653	FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.4	2	20	CTD_human;UNIPROT
5891	MOK	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.218837799687138	1	0	CTD_human
5894	RAF1	C0006384	Bundle-Branch Block	0.2	0	0	HPO
5894	RAF1	C0007194	Hypertrophic Cardiomyopathy	0.405754907091158	2	0	CTD_human;HPO
5894	RAF1	C0015300	Exophthalmos	0.2	0	0	HPO
5894	RAF1	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
5894	RAF1	C0028326	Noonan Syndrome	0.425244474661347	2	16	CTD_human;ORPHANET
5894	RAF1	C0036651	Senile lentigo	0.2	0	0	HPO
5894	RAF1	C0038379	Strabismus	0.2	0	0	HPO
5894	RAF1	C0175704	LEOPARD Syndrome	0.408920603432455	1	4	CTD_human;ORPHANET
5894	RAF1	C0259817	Xerosis	0.2	0	0	HPO
5894	RAF1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
5894	RAF1	C1328931	Multiple lentigines	0.200549453568426	0	0	HPO
5894	RAF1	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
5894	RAF1	C1969056	LEOPARD SYNDROME 2	0.4	0	0	CTD_human;UNIPROT
5894	RAF1	C1969057	Noonan Syndrome 5	0.480274726784213	3	8	CTD_human;UNIPROT
5894	RAF1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
5894	RAF1	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
5894	RAF1	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
5894	RAF1	C4014656	CARDIOMYOPATHY, DILATED, 1NN	0.2	1	4	UNIPROT
5894	RAF1	C4021533	Severe sensorineural hearing impairment	0.2	0	0	HPO
5896	RAG1	C0002170	Alopecia	0.2	0	0	HPO
5896	RAG1	C0002871	Anemia	0.2	0	0	HPO
5896	RAG1	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
5896	RAG1	C0003864	Arthritis	0.2	0	0	HPO
5896	RAG1	C0009763	Conjunctivitis	0.2	0	0	HPO
5896	RAG1	C0011606	Exfoliative dermatitis	0.200274726784213	0	0	HPO
5896	RAG1	C0014457	Eosinophilia	0.2	0	0	HPO
5896	RAG1	C0020639	Hypoproteinemia	0.2	0	0	HPO
5896	RAG1	C0024904	Mastoiditis	0.2	0	0	HPO
5896	RAG1	C0025289	Meningitis	0.2	0	0	HPO
5896	RAG1	C0029882	Otitis Media	0.2	0	0	HPO
5896	RAG1	C0032285	Pneumonia	0.2	0	0	HPO
5896	RAG1	C0036690	Septicemia	0.200549453568426	0	0	HPO
5896	RAG1	C0085110	Severe Combined Immunodeficiency	0.225346788975972	0	0	HPO
5896	RAG1	C0162539	IgG Deficiency	0.2	0	0	HPO
5896	RAG1	C0206061	Pneumonia, Interstitial	0.2	0	0	HPO
5896	RAG1	C0259817	Xerosis	0.2	0	0	HPO
5896	RAG1	C0340971	Autoimmune neutropenia	0.2	0	0	HPO
5896	RAG1	C0401151	Chronic diarrhea	0.200274726784213	0	0	HPO
5896	RAG1	C0494261	Combined immunodeficiency	0.200549453568426	0	0	HPO
5896	RAG1	C1832322	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive	0.4	0	0	CTD_human;ORPHANET
5896	RAG1	C1835931	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY	0.6	1	2	CTD_human;ORPHANET;UNIPROT
5896	RAG1	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
5896	RAG1	C2673536	Combined Cellular And Humoral Immune Defects With Granulomas	0.6	2	6	CTD_human;ORPHANET;UNIPROT
5896	RAG1	C2700553	Omenn Syndrome	0.40796707674218	7	24	ORPHANET;UNIPROT
5896	RAG1	C2931322	T-Lymphocytopenia	0.2	0	0	HPO
5896	RAG1	C2931884	Reticuloendotheliosis, familial, with eosinophilia	0.2	0	0	CTD_human
5896	RAG1	C4025203	Severe T lymphocytopenia	0.2	0	0	HPO
5897	RAG2	C0002170	Alopecia	0.2	0	0	HPO
5897	RAG2	C0002871	Anemia	0.2	0	0	HPO
5897	RAG2	C0003864	Arthritis	0.200274726784213	0	0	HPO
5897	RAG2	C0009763	Conjunctivitis	0.2	0	0	HPO
5897	RAG2	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
5897	RAG2	C0014457	Eosinophilia	0.200274726784213	0	0	HPO
5897	RAG2	C0020639	Hypoproteinemia	0.2	0	0	HPO
5897	RAG2	C0024904	Mastoiditis	0.2	0	0	HPO
5897	RAG2	C0025289	Meningitis	0.2	0	0	HPO
5897	RAG2	C0029882	Otitis Media	0.2	0	0	HPO
5897	RAG2	C0032285	Pneumonia	0.2	0	0	HPO
5897	RAG2	C0085110	Severe Combined Immunodeficiency	0.218782056909492	0	0	HPO
5897	RAG2	C0162539	IgG Deficiency	0.2	0	0	HPO
5897	RAG2	C0259817	Xerosis	0.2	0	0	HPO
5897	RAG2	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
5897	RAG2	C0401151	Chronic diarrhea	0.2	0	0	HPO
5897	RAG2	C0494261	Combined immunodeficiency	0.200274726784213	0	0	HPO
5897	RAG2	C1832322	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive	0.48	0	0	CTD_human;ORPHANET
5897	RAG2	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
5897	RAG2	C2673536	Combined Cellular And Humoral Immune Defects With Granulomas	0.6	1	2	CTD_human;ORPHANET;UNIPROT
5897	RAG2	C2700553	Omenn Syndrome	0.484670355331623	1	2	ORPHANET;UNIPROT
5897	RAG2	C2931322	T-Lymphocytopenia	0.2	0	0	HPO
5897	RAG2	C2931884	Reticuloendotheliosis, familial, with eosinophilia	0.2	0	0	CTD_human
5897	RAG2	C4025203	Severe T lymphocytopenia	0.2	0	0	HPO
59	ACTA2	C0003486	Aortic Aneurysm	0.203557092817453	0	0	HPO
59	ACTA2	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
59	ACTA2	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
59	ACTA2	C0014175	Endometriosis	0.2	1	0	CTD_human
59	ACTA2	C0014544	Epilepsy	0.2	0	0	HPO
59	ACTA2	C0017668	Focal glomerulosclerosis	0.2	1	0	CTD_human
59	ACTA2	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
59	ACTA2	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
59	ACTA2	C0023890	Liver Cirrhosis	0.2	2	0	CTD_human
59	ACTA2	C0026654	Moyamoya Disease	0.202197814273705	0	0	ORPHANET
59	ACTA2	C0027051	Myocardial Infarction	0.200274726784213	1	0	CTD_human
59	ACTA2	C0036421	Systemic Scleroderma	0.2	1	0	CTD_human
59	ACTA2	C0039446	Telangiectasis	0.2	0	0	HPO
59	ACTA2	C0162872	Aortic Aneurysm, Thoracic	0.407352110639124	1	0	CTD_human;HPO
59	ACTA2	C0263401	Cutis marmorata	0.2	0	0	HPO
59	ACTA2	C0281967	Retinal infarction	0.2	0	0	HPO
59	ACTA2	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
59	ACTA2	C0751003	Brain Aneurysm	0.2	0	0	HPO
59	ACTA2	C1290398	Cerebral arterial aneurysm	0.2	0	0	HPO
59	ACTA2	C1619692	Nephrogenic Fibrosing Dermopathy	0.2	1	0	CTD_human
59	ACTA2	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.2	0	0	ORPHANET
59	ACTA2	C1876165	Copper-Overload Cirrhosis	0.2	1	0	CTD_human
59	ACTA2	C1956346	Coronary Artery Disease	0.200824180352639	0	0	HPO
59	ACTA2	C2673186	Aortic Aneurysm, Familial Thoracic 6	0.4	3	11	CTD_human;UNIPROT
59	ACTA2	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
59	ACTA2	C2931384	Moyamoya disease 1	0.201373633921065	0	0	ORPHANET
59	ACTA2	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
59	ACTA2	C3151201	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.400824180352639	0	0	ORPHANET;UNIPROT
59	ACTA2	C3203102	Idiopathic pulmonary arterial hypertension	0.200274726784213	0	0	HPO
59	ACTA2	C3279690	MOYAMOYA DISEASE 5	0.2	2	3	UNIPROT
59	ACTA2	C4023169	Moyamoya phenomenon	0.2	0	0	HPO
590	BCHE	C0002395	Alzheimer's Disease	0.296182782596462	1	0	CTD_human
590	BCHE	C0014549	Tonic-Clonic Epilepsy	0.2	1	0	CTD_human
590	BCHE	C0026769	Multiple Sclerosis	0.2	1	0	CTD_human
590	BCHE	C0026850	Muscular Dystrophy	0.2	1	0	CTD_human
590	BCHE	C0028754	Obesity	0.204879569581206	4	0	CTD_human
590	BCHE	C0037315	Sleep Apnea Syndromes	0.2	1	0	CTD_human
590	BCHE	C0041105	Trismus	0.2	1	0	CTD_human
590	BCHE	C1283400	Butyrylcholinesterase deficiency	0.400549453568426	5	28	CTD_human;ORPHANET
590	BCHE	C1855794	Bamforth syndrome	0.2	1	0	CTD_human
5901	RAN	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
5906	RAP1A	C0018777	Conductive hearing loss	0.2	0	0	HPO
5906	RAP1A	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5906	RAP1A	C0020255	Hydrocephalus	0.2	0	0	HPO
5906	RAP1A	C0038379	Strabismus	0.2	0	0	HPO
5906	RAP1A	C0235946	Cerebral atrophy	0.2	0	0	HPO
5906	RAP1A	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
59067	IL21	C0007570	Celiac Disease	0.214074899797874	1	0	CTD_human
59067	IL21	C0024141	Lupus Erythematosus, Systemic	0.211132773083477	1	0	CTD_human
59067	IL21	C4014258	IMMUNODEFICIENCY, COMMON VARIABLE, 11	0.2	1	1	UNIPROT
5908	RAP1B	C0018777	Conductive hearing loss	0.2	0	0	HPO
5908	RAP1B	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5908	RAP1B	C0020255	Hydrocephalus	0.2	0	0	HPO
5908	RAP1B	C0038379	Strabismus	0.2	0	0	HPO
5908	RAP1B	C0235946	Cerebral atrophy	0.2	0	0	HPO
5908	RAP1B	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
59081	MNG2	C1846033	Goiter, Multinodular 2	0.2	0	0	CTD_human
5911	RAP2A	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
5913	RAPSN	C0003886	Arthrogryposis	0.2	0	0	HPO
5913	RAPSN	C0015300	Exophthalmos	0.2	0	0	HPO
5913	RAPSN	C0020255	Hydrocephalus	0.2	0	0	HPO
5913	RAPSN	C0085623	Akinesia	0.2	0	0	HPO
5913	RAPSN	C0409477	Ankylosis of the elbow joint	0.2	0	0	HPO
5913	RAPSN	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	0.2	0	0	ORPHANET
5913	RAPSN	C1276035	Pena-Shokeir syndrome type I	0.600824180352639	1	3	CTD_human;HPO;ORPHANET;UNIPROT
5913	RAPSN	C1389113	Generalized amyotrophy	0.2	0	0	HPO
5913	RAPSN	C1837091	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.2	0	0	CTD_human
5913	RAPSN	C1854678	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	0.2	0	0	ORPHANET
5913	RAPSN	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
5913	RAPSN	C4225367	MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.2	9	6	UNIPROT
5914	RARA	C0149940	Sciatic Neuropathy	0.2	1	0	CTD_human
5915	RARB	C0014175	Endometriosis	0.2	1	0	CTD_human
5915	RARB	C0149940	Sciatic Neuropathy	0.2	1	0	CTD_human
5915	RARB	C1832661	ANOPHTHALMIA AND PULMONARY HYPOPLASIA	0.2	0	0	ORPHANET
5915	RARB	C3809803	MICROPHTHALMIA, SYNDROMIC 12	0.2	1	5	UNIPROT
5917	RARS	C0023520	Leukodystrophy	0.2	0	0	HPO
5917	RARS	C0028738	Nystagmus	0.2	0	0	HPO
5917	RARS	C4015323	LEUKODYSTROPHY, HYPOMYELINATING, 9	0.4	1	6	ORPHANET;UNIPROT
5921	RASA1	C0042345	Varicosity	0.2	0	0	HPO
5921	RASA1	C1842180	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION (disorder)	0.60439562854741	2	5	CTD_human;ORPHANET;UNIPROT
5922	RASA2	C0015300	Exophthalmos	0.2	0	0	HPO
5922	RASA2	C0028326	Noonan Syndrome	0.200274726784213	0	0	ORPHANET
5922	RASA2	C0038379	Strabismus	0.2	0	0	HPO
5922	RASA2	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
5922	RASA2	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
5923	RASGRF1	C0013386	Dyskinesia, Drug-Induced	0.2	1	0	CTD_human
5923	RASGRF1	C0027092	Myopia	0.200274726784213	1	0	CTD_human
5925	RB1	C0007786	Brain Ischemia	0.2	1	0	CTD_human
5925	RB1	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
5925	RB1	C0152458	Leukocoria	0.2	0	0	HPO
5925	RB1	C3151302	Chromosome 13q14 deletion syndrome	0.2	0	0	ORPHANET
59272	ACE2	C0011881	Diabetic Nephropathy	0.211393144490373	1	0	CTD_human
59272	ACE2	C0162871	Aortic Aneurysm, Abdominal	0.200274726784213	1	0	CTD_human
593	BCKDHA	C0014544	Epilepsy	0.2	0	0	HPO
593	BCKDHA	C0020615	Hypoglycemia	0.2	0	0	HPO
593	BCKDHA	C0022638	Ketosis	0.2	0	0	HPO
593	BCKDHA	C0024776	Maple Syrup Urine Disease	0.610620121295047	5	35	CTD_human;ORPHANET;UNIPROT
593	BCKDHA	C0030305	Pancreatitis	0.2	0	0	HPO
593	BCKDHA	C0268568	Classic Maple Syrup Urine Disease	0.2	0	0	ORPHANET
593	BCKDHA	C0268569	Intermittent Maple Syrup Urine Disease	0.2	0	0	ORPHANET
593	BCKDHA	C0751285	Maple Syrup Urine Disease, Thiamine Responsive	0.2	0	0	ORPHANET
593	BCKDHA	C1621920	Intermediate Maple Syrup Urine Disease	0.2	0	0	ORPHANET
5932	RBBP8	C0010278	Craniosynostosis	0.2	0	0	HPO
5932	RBBP8	C0017601	Glaucoma	0.2	0	0	HPO
5932	RBBP8	C0265202	Seckel syndrome	0.200274726784213	0	0	ORPHANET
5932	RBBP8	C0796063	microcephaly-digital anomalies syndrome	0.200274726784213	0	0	ORPHANET
5932	RBBP8	C1847572	SECKEL SYNDROME 2	0.2	1	3	UNIPROT
59330	GER	C0017168	Gastroesophageal reflux disease	0.200274726784213	0	0	CTD_human
59331	RFH1	C0403443	Renal Failure, Progressive, with Hypertension	0.2	0	0	CTD_human
59332	VSPA	C1839262	SPATIAL VISUALIZATION, APTITUDE FOR	0.2	0	0	CTD_human
59333	NMSR	C1854449	Neuropathy, hereditary motor and sensory, Russe type	0.2	0	0	CTD_human
59335	PRDM12	C0002768	Congenital Pain Insensitivity	0.2	1	0	CTD_human
59335	PRDM12	C4225308	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII	0.2	1	6	UNIPROT
59338	PLEKHA1	C1864205	Macular Degeneration, Age-Related, 1	0.2	0	0	CTD_human
59341	TRPV4	C0007959	Charcot-Marie-Tooth Disease	0.201373633921065	1	4	CTD_human
59341	TRPV4	C0024117	Chronic Obstructive Airway Disease	0.203231208875927	1	0	CTD_human
59341	TRPV4	C0026847	Spinal Muscular Atrophy	0.201098907136852	1	0	CTD_human
59341	TRPV4	C0029408	Degenerative polyarthritis	0.200274726784213	1	0	CTD_human
59341	TRPV4	C0751335	Scapuloperoneal Form of Spinal Muscular Atrophy	0.601098907136852	2	3	CTD_human;ORPHANET;UNIPROT
59341	TRPV4	C1838492	SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE (disorder)	0.4	5	7	ORPHANET;UNIPROT
59341	TRPV4	C1847406	Digital Arthropathy-Brachydactyly, Familial	0.4	1	3	ORPHANET;UNIPROT
59341	TRPV4	C1853710	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC (disorder)	0.600824180352639	5	7	CTD_human;ORPHANET;UNIPROT
59341	TRPV4	C1868616	Parastremmatic dwarfism	0.600824180352639	0	0	CTD_human;ORPHANET;UNIPROT
59341	TRPV4	C3159322	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE	0.400274726784213	0	0	CTD_human;ORPHANET
59344	ALOXE3	C1855789	Self-Healing Collodion Baby	0.2	0	0	ORPHANET
59344	ALOXE3	C1855792	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1	0.2	0	0	CTD_human
59344	ALOXE3	C3539888	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	0.2	4	5	UNIPROT
59345	GNB4	C3554654	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F	0.4	1	2	ORPHANET;UNIPROT
59350	RXFP1	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
594	BCKDHB	C0014544	Epilepsy	0.2	0	0	HPO
594	BCKDHB	C0020615	Hypoglycemia	0.2	0	0	HPO
594	BCKDHB	C0022638	Ketosis	0.2	0	0	HPO
594	BCKDHB	C0024776	Maple Syrup Urine Disease	0.6141772141125	3	48	CTD_human;ORPHANET;UNIPROT
594	BCKDHB	C0030305	Pancreatitis	0.2	0	0	HPO
594	BCKDHB	C0268568	Classic Maple Syrup Urine Disease	0.2	0	0	ORPHANET
594	BCKDHB	C0268569	Intermittent Maple Syrup Urine Disease	0.2	0	0	ORPHANET
594	BCKDHB	C0751285	Maple Syrup Urine Disease, Thiamine Responsive	0.2	0	0	ORPHANET
594	BCKDHB	C1621920	Intermediate Maple Syrup Urine Disease	0.2	0	0	ORPHANET
5940	RBMY1A1	C0004509	Azoospermia	0.200274726784213	0	0	HPO
5940	RBMY1A1	C0028960	Oligospermia	0.200274726784213	0	0	HPO
5940	RBMY1A1	C1839071	Spermatogenic Failure, Nonobstructive, Y-Linked	0.2	0	0	CTD_human
5940	RBMY1A1	C4021107	Non-obstructive azoospermia	0.200274726784213	0	0	HPO
5947	RBP1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
594832	MYP11	C1864941	MYOPIA 11 (disorder)	0.2	0	0	CTD_human
5949	RBP3	C0017601	Glaucoma	0.2	0	0	HPO
5949	RBP3	C0018777	Conductive hearing loss	0.2	0	0	HPO
5949	RBP3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5949	RBP3	C0020459	Hyperinsulinism	0.2	0	0	HPO
5949	RBP3	C0020619	Hypogonadism	0.2	0	0	HPO
5949	RBP3	C0022578	Keratoconus	0.2	0	0	HPO
5949	RBP3	C0028077	Night Blindness	0.2	0	0	HPO
5949	RBP3	C0028738	Nystagmus	0.2	0	0	HPO
5949	RBP3	C0028754	Obesity	0.2	0	0	HPO
5949	RBP3	C0029124	Optic Atrophy	0.2	0	0	HPO
5949	RBP3	C0035334	Retinitis Pigmentosa	0.604055389228567	1	0	CTD_human;HPO;ORPHANET
5949	RBP3	C0042164	Uveitis	0.202472541057918	1	0	CTD_human
5949	RBP3	C0042798	Low Vision	0.200274726784213	0	0	HPO
5949	RBP3	C0271215	Blindness, Legal	0.2	0	0	HPO
5949	RBP3	C0858617	Posterior subcapsular cataract	0.2	0	0	HPO
5949	RBP3	C3715216	RETINITIS PIGMENTOSA 66	0.2	1	1	UNIPROT
595	CCND1	C0002871	Anemia	0.2	0	0	HPO
595	CCND1	C0003123	Anorexia	0.2	0	0	HPO
595	CCND1	C0019562	Von Hippel-Lindau Syndrome	0.203557092817453	0	0	CTD_human
595	CCND1	C0020502	Hyperparathyroidism	0.203831819601666	1	0	CTD_human
595	CCND1	C0022660	Kidney Failure, Acute	0.2	0	0	HPO
595	CCND1	C0029453	Osteopenia	0.2	0	0	HPO
595	CCND1	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
595	CCND1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
595	CCND1	C0267988	Hyperproteinemia	0.2	0	0	HPO
595	CCND1	C0747078	Generalized osteopenia	0.2	0	0	HPO
5950	RBP4	C0018801	Heart failure	0.2	1	0	CTD_human
5950	RBP4	C0032460	Polycystic Ovary Syndrome	0.205740551713841	1	0	CTD_human
5950	RBP4	C0042798	Low Vision	0.2	0	0	HPO
5950	RBP4	C0042842	Vitamin A Deficiency	0.200274726784213	1	0	CTD_human
5950	RBP4	C0152455	Keratomalacia	0.2	1	0	CTD_human
5950	RBP4	C1845877	Microphthalmia, Isolated, with Coloboma 1	0.2	0	0	ORPHANET
5950	RBP4	C3553016	Peripheral retinal atrophy	0.2	0	0	HPO
5950	RBP4	C3554593	RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.4	2	3	ORPHANET;UNIPROT
5950	RBP4	C4225330	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10	0.2	1	2	UNIPROT
5953	RCD1	C1867326	RETINAL CONE DYSTROPHY 1	0.2	0	0	CTD_human
5956	OPN1LW	C0027092	Myopia	0.2	0	0	HPO
5956	OPN1LW	C0028077	Night Blindness	0.2	0	0	HPO
5956	OPN1LW	C0028738	Nystagmus	0.2	0	0	HPO
5956	OPN1LW	C0035334	Retinitis Pigmentosa	0.2	0	0	ORPHANET
5956	OPN1LW	C0042798	Low Vision	0.2	0	0	HPO
5956	OPN1LW	C0155015	Color Blindness, Red	0.2	0	0	HPO
5956	OPN1LW	C0271388	Pendular Nystagmus	0.2	0	0	HPO
5956	OPN1LW	C0339537	Cone monochromatism	0.600549453568426	2	2	CTD_human;HPO;ORPHANET;UNIPROT
5956	OPN1LW	C2931753	Achromatopsia incomplete, X-linked	0.2	0	0	ORPHANET
5956	OPN1LW	C3887980	COLORBLINDNESS, PARTIAL, PROTAN SERIES	0.6	1	0	CTD_human;HPO;UNIPROT
5956	OPN1LW	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
5959	RDH5	C0027092	Myopia	0.200274726784213	1	0	CTD_human
5959	RDH5	C0028077	Night Blindness	0.207114185634906	0	0	HPO
5959	RDH5	C0311338	Fundus Albipunctatus	0.614913435527831	10	13	CTD_human;ORPHANET;UNIPROT
5959	RDH5	C1405854	Retinitis punctata albescens (disorder)	0.200274726784213	0	0	ORPHANET
596	BCL2	C0002395	Alzheimer's Disease	0.286253203502271	1	0	CTD_human
596	BCL2	C0004096	Asthma	0.201373633921065	1	0	CTD_human
596	BCL2	C0004509	Azoospermia	0.202681755307501	1	0	CTD_human
596	BCL2	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
596	BCL2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.280274726784213	1	0	CTD_human
596	BCL2	C0015923	Fetal Alcohol Syndrome	0.200824180352639	2	0	PSYGENET
596	BCL2	C0023891	Liver Cirrhosis, Alcoholic	0.2	1	0	CTD_human
596	BCL2	C0027051	Myocardial Infarction	0.200274726784213	1	0	CTD_human
596	BCL2	C0032460	Polycystic Ovary Syndrome	0.281098907136852	1	0	CTD_human
596	BCL2	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
596	BCL2	C0242350	Erectile dysfunction	0.28	1	0	CTD_human
596	BCL2	C0520743	Mediastinal lymphadenopathy	0.2	0	0	HPO
5961	PRPH2	C0008525	Choroideremia	0.2	0	0	HPO
5961	PRPH2	C0017601	Glaucoma	0.2	0	0	HPO
5961	PRPH2	C0018777	Conductive hearing loss	0.2	0	0	HPO
5961	PRPH2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5961	PRPH2	C0020459	Hyperinsulinism	0.2	0	0	HPO
5961	PRPH2	C0020619	Hypogonadism	0.2	0	0	HPO
5961	PRPH2	C0022578	Keratoconus	0.2	0	0	HPO
5961	PRPH2	C0024437	Macular degeneration	0.201648360705279	0	0	HPO
5961	PRPH2	C0028077	Night Blindness	0.2	0	0	HPO
5961	PRPH2	C0028738	Nystagmus	0.200274726784213	0	0	HPO
5961	PRPH2	C0028754	Obesity	0.2	0	0	HPO
5961	PRPH2	C0029124	Optic Atrophy	0.2	0	0	HPO
5961	PRPH2	C0035334	Retinitis Pigmentosa	0.423401255083802	0	0	HPO;ORPHANET
5961	PRPH2	C0042798	Low Vision	0.200549453568426	0	0	HPO
5961	PRPH2	C0271215	Blindness, Legal	0.2	0	0	HPO
5961	PRPH2	C0311338	Fundus Albipunctatus	0.4	0	0	CTD_human;ORPHANET
5961	PRPH2	C0339510	Vitelliform Macular Dystrophy	0.400549453568426	0	0	CTD_human;HPO
5961	PRPH2	C0344297	Choroidal sclerosis	0.2	0	0	ORPHANET
5961	PRPH2	C0730292	Macular dystrophy	0.203846174978983	0	0	HPO
5961	PRPH2	C1288283	Atrophoderma maculatum	0.200274726784213	0	0	HPO
5961	PRPH2	C1405854	Retinitis punctata albescens (disorder)	0.201098907136852	0	0	ORPHANET
5961	PRPH2	C1536451	Central areolar choroidal sclerosis	0.201373633921065	0	0	ORPHANET
5961	PRPH2	C1842475	Retinitis Pigmentosa 7	0.480274726784213	11	9	CTD_human;UNIPROT
5961	PRPH2	C1842914	Adult-Onset Vitelliform Macular Dystrophy	0.403780662444354	4	7	ORPHANET;UNIPROT
5961	PRPH2	C1864690	Microphthalmia, Syndromic 5	0.2	0	0	ORPHANET
5961	PRPH2	C1868569	Patterned dystrophy of retinal pigment epithelium	0.4	6	7	CTD_human;UNIPROT
5961	PRPH2	C2751290	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2	0.400274726784213	4	4	CTD_human;UNIPROT
5961	PRPH2	C4024776	Reticular retinal dystrophy	0.2	0	0	HPO
5961	PRPH2	C4024790	Adult-onset night blindness	0.2	0	0	HPO
5961	PRPH2	C4048273	Chorioretinal atrophy	0.2	0	0	HPO
5962	RDX	C0008370	Cholestasis	0.200274726784213	1	0	CTD_human
5962	RDX	C1970239	DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.4	1	2	CTD_human;UNIPROT
5962	RDX	C4023338	Profound sensorineural hearing impairment	0.2	0	0	HPO
5966	REL	C0003873	Rheumatoid Arthritis	0.208869446275143	3	2	CTD_human
5966	REL	C0033860	Psoriasis	0.204055389228567	1	0	CTD_human
597	BCL2A1	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
5970	RELA	C0004763	Barrett Esophagus	0.2	1	0	CTD_human
5970	RELA	C0007786	Brain Ischemia	0.2	1	0	CTD_human
5970	RELA	C0008370	Cholestasis	0.2	1	0	CTD_human
5970	RELA	C0009319	Colitis	0.200549453568426	1	0	CTD_human
5970	RELA	C0009324	Ulcerative Colitis	0.204106546385879	1	0	CTD_human
5970	RELA	C0010692	Cystitis	0.2	1	0	CTD_human
5970	RELA	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200274726784213	1	0	CTD_human
5970	RELA	C0011875	Diabetic Angiopathies	0.2	1	0	CTD_human
5970	RELA	C0011881	Diabetic Nephropathy	0.200274726784213	1	0	CTD_human
5970	RELA	C0022661	Kidney Failure, Chronic	0.200274726784213	1	0	CTD_human
5970	RELA	C0023891	Liver Cirrhosis, Alcoholic	0.2	1	0	CTD_human
5972	REN	C0002871	Anemia	0.401373633921066	1	0	CTD_human;HPO
5972	REN	C0004775	Bartter Disease	0.200824180352639	3	0	CTD_human
5972	REN	C0017668	Focal glomerulosclerosis	0.201098907136852	0	0	HPO
5972	REN	C0018801	Heart failure	0.212846646323386	3	0	CTD_human
5972	REN	C0020540	Malignant Hypertension	0.201923087489492	1	0	CTD_human
5972	REN	C0023890	Liver Cirrhosis	0.200549453568426	1	0	CTD_human
5972	REN	C0027051	Myocardial Infarction	0.214205924867134	1	0	CTD_human
5972	REN	C0027720	Nephrosis	0.2	2	0	CTD_human
5972	REN	C0029456	Osteoporosis	0.200549453568426	1	0	CTD_human
5972	REN	C0033860	Psoriasis	0.200274726784213	1	0	CTD_human
5972	REN	C0149721	Left Ventricular Hypertrophy	0.287417623173754	2	0	CTD_human
5972	REN	C0221043	Liddle Syndrome	0.201098907136852	1	0	CTD_human
5972	REN	C0242528	Azotemia	0.2	1	0	CTD_human
5972	REN	C0266313	Allanson Pantzar McLeod syndrome	0.602197814273705	1	5	CTD_human;HPO;ORPHANET;UNIPROT
5972	REN	C0740394	Hyperuricemia	0.200549453568426	0	0	HPO
5972	REN	C2751310	Hyperuricemic Nephropathy, Familial Juvenile 2	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
5978	REST	C0015923	Fetal Alcohol Syndrome	0.2	1	0	PSYGENET
5979	RET	C0012819	Diverticular disease of colon	0.2	0	0	HPO
5979	RET	C0013363	Dysautonomia	0.2	0	0	HPO
5979	RET	C0014544	Epilepsy	0.200274726784213	0	0	HPO
5979	RET	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
5979	RET	C0018023	Nodular Goiter	0.200549453568426	0	0	HPO
5979	RET	C0018801	Heart failure	0.2	0	0	HPO
5979	RET	C0018802	Congestive heart failure	0.2	0	0	HPO
5979	RET	C0020437	Hypercalcemia	0.203557092817453	0	0	HPO
5979	RET	C0020502	Hyperparathyroidism	0.204945082115836	0	0	HPO
5979	RET	C0021843	Intestinal Obstruction	0.200274726784213	0	0	HPO
5979	RET	C0038220	Status Epilepticus	0.2	1	0	CTD_human
5979	RET	C0038379	Strabismus	0.2	0	0	HPO
5979	RET	C0149887	Slipped Capital Femoral Epiphyses	0.2	0	0	HPO
5979	RET	C0152132	Hypertensive Retinopathy	0.2	0	0	HPO
5979	RET	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
5979	RET	C0271844	Parathyroid hyperplasia	0.200549453568426	0	0	HPO
5979	RET	C0520680	Sleep Apnea, Central	0.2	0	0	HPO
5979	RET	C0740340	Amyloidosis, Familial	0.2	1	0	CTD_human
5979	RET	C1275808	Congenital central hypoventilation	0.601098907136852	4	4	CTD_human;ORPHANET;UNIPROT
5979	RET	C1609433	Congenital absence of kidneys syndrome	0.401373633921066	1	0	CTD_human;ORPHANET
5979	RET	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5979	RET	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
598	BCL2L1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	0	CTD_human
598	BCL2L1	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
598	BCL2L1	C0242350	Erectile dysfunction	0.2	1	0	CTD_human
598	BCL2L1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
5980	REV3L	C0038379	Strabismus	0.2	0	0	HPO
5980	REV3L	C0221060	Mobius Syndrome	0.200274726784213	0	0	ORPHANET
5980	REV3L	C0376175	Bell Palsy	0.2	0	0	HPO
5980	REV3L	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
5982	RFC2	C0003499	Supravalvular aortic stenosis	0.2	0	0	HPO
5982	RFC2	C0007786	Brain Ischemia	0.2	0	0	HPO
5982	RFC2	C0012819	Diverticular disease of colon	0.2	0	0	HPO
5982	RFC2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5982	RFC2	C0020437	Hypercalcemia	0.2	0	0	HPO
5982	RFC2	C0020545	Hypertension, Renovascular	0.2	0	0	HPO
5982	RFC2	C0024421	Macroglossia	0.2	0	0	HPO
5982	RFC2	C0024636	Malocclusion	0.2	0	0	HPO
5982	RFC2	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
5982	RFC2	C0028754	Obesity	0.200274726784213	0	0	HPO
5982	RFC2	C0035078	Kidney Failure	0.2	0	0	HPO
5982	RFC2	C0038379	Strabismus	0.2	0	0	HPO
5982	RFC2	C0042798	Low Vision	0.2	0	0	HPO
5982	RFC2	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
5982	RFC2	C0175702	Williams Syndrome	0.200824180352639	0	0	ORPHANET
5982	RFC2	C0271441	Chronic otitis media	0.2	0	0	HPO
5982	RFC2	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
5982	RFC2	C0743359	ear infection chronic	0.2	0	0	HPO
5982	RFC2	C0917798	Cerebral Ischemia	0.2	0	0	HPO
5982	RFC2	C1565489	Renal Insufficiency	0.2	0	0	HPO
5982	RFC2	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
5982	RFC2	C4020884	Anxiety disease	0.2	0	0	HPO
5982	RFC2	C4025788	Nystagmus-induced head nodding	0.2	0	0	HPO
5982	RFC2	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
5993	RFX5	C0001768	Agammaglobulinemia	0.2	0	0	HPO
5993	RFX5	C0006845	Candidiasis, Chronic Mucocutaneous	0.2	0	0	HPO
5993	RFX5	C0009319	Colitis	0.2	0	0	HPO
5993	RFX5	C0014038	Encephalitis	0.2	0	0	HPO
5993	RFX5	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
5993	RFX5	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
5993	RFX5	C0393441	Chronic lymphocytic meningitis	0.2	0	0	HPO
5993	RFX5	C0451696	Major histocompatibility complex class II deficiency	0.200274726784213	0	0	ORPHANET
5993	RFX5	C0473133	Protracted diarrhea	0.2	0	0	HPO
5993	RFX5	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
5993	RFX5	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5993	RFX5	C2931418	Bare lymphocyte syndrome 2	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
5994	RFXAP	C0001768	Agammaglobulinemia	0.2	0	0	HPO
5994	RFXAP	C0006845	Candidiasis, Chronic Mucocutaneous	0.2	0	0	HPO
5994	RFXAP	C0009319	Colitis	0.2	0	0	HPO
5994	RFXAP	C0014038	Encephalitis	0.2	0	0	HPO
5994	RFXAP	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
5994	RFXAP	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
5994	RFXAP	C0393441	Chronic lymphocytic meningitis	0.2	0	0	HPO
5994	RFXAP	C0451696	Major histocompatibility complex class II deficiency	0.2	0	0	ORPHANET
5994	RFXAP	C0473133	Protracted diarrhea	0.2	0	0	HPO
5994	RFXAP	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
5994	RFXAP	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
5994	RFXAP	C2931418	Bare lymphocyte syndrome 2	0.401098907136852	0	0	CTD_human;ORPHANET
5995	RGR	C0017601	Glaucoma	0.2	0	0	HPO
5995	RGR	C0018777	Conductive hearing loss	0.2	0	0	HPO
5995	RGR	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
5995	RGR	C0020459	Hyperinsulinism	0.2	0	0	HPO
5995	RGR	C0020619	Hypogonadism	0.2	0	0	HPO
5995	RGR	C0022578	Keratoconus	0.2	0	0	HPO
5995	RGR	C0028738	Nystagmus	0.2	0	0	HPO
5995	RGR	C0028754	Obesity	0.2	0	0	HPO
5995	RGR	C0029124	Optic Atrophy	0.2	0	0	HPO
5995	RGR	C0035334	Retinitis Pigmentosa	0.605363510615002	2	0	CTD_human;HPO;ORPHANET
5995	RGR	C0042798	Low Vision	0.2	0	0	HPO
5995	RGR	C0271215	Blindness, Legal	0.2	0	0	HPO
5995	RGR	C3151068	RETINITIS PIGMENTOSA 44	0.2	1	1	UNIPROT
5996	RGS1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
5997	RGS2	C0030569	Secondary Parkinson Disease	0.2	1	0	CTD_human
5999	RGS4	C0014175	Endometriosis	0.2	1	0	CTD_human
60	ACTB	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
60	ACTB	C0013393	Dysostoses	0.2	1	0	CTD_human
60	ACTB	C0014544	Epilepsy	0.2	0	0	HPO
60	ACTB	C0014848	Esophageal Achalasia	0.2	0	0	HPO
60	ACTB	C0018784	Sensorineural Hearing Loss (disorder)	0.4	1	0	CTD_human;HPO
60	ACTB	C0024421	Macroglossia	0.2	0	0	HPO
60	ACTB	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
60	ACTB	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
60	ACTB	C0271215	Blindness, Legal	0.2	0	0	HPO
60	ACTB	C1846331	Juvenile-onset dystonia	0.6	1	1	CTD_human;ORPHANET;UNIPROT
60	ACTB	C1855722	Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation	0.401373633921066	1	16	ORPHANET;UNIPROT
6005	RHAG	C0002878	Anemia, Hemolytic	0.200274726784213	0	0	HPO
6005	RHAG	C0268306	Unconjugated hyperbilirubinemia	0.2	0	0	HPO
6005	RHAG	C0272052	Rh Deficiency Syndrome	0.2	0	0	ORPHANET
6005	RHAG	C1849387	Rh-Null, Regulator Type	0.4	4	4	CTD_human;UNIPROT
6005	RHAG	C1861455	STOMATOCYTOSIS I	0.400274726784213	3	2	ORPHANET;UNIPROT
6006	RHCE	C0272052	Rh Deficiency Syndrome	0.2	0	0	ORPHANET
6007	RHD	C0272052	Rh Deficiency Syndrome	0.2	0	0	ORPHANET
6010	RHO	C0017601	Glaucoma	0.2	0	0	HPO
6010	RHO	C0018777	Conductive hearing loss	0.2	0	0	HPO
6010	RHO	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6010	RHO	C0020459	Hyperinsulinism	0.2	0	0	HPO
6010	RHO	C0020619	Hypogonadism	0.2	0	0	HPO
6010	RHO	C0022578	Keratoconus	0.2	0	0	HPO
6010	RHO	C0028077	Night Blindness	0.20678830169338	0	0	HPO
6010	RHO	C0028738	Nystagmus	0.2	0	0	HPO
6010	RHO	C0028754	Obesity	0.2	0	0	HPO
6010	RHO	C0029124	Optic Atrophy	0.2	0	0	HPO
6010	RHO	C0035334	Retinitis Pigmentosa	0.708339779041496	7	6	CTD_human;HPO;ORPHANET
6010	RHO	C0271183	Severe myopia	0.2	0	0	HPO
6010	RHO	C0271215	Blindness, Legal	0.2	0	0	HPO
6010	RHO	C0311338	Fundus Albipunctatus	0.400549453568426	0	0	CTD_human;ORPHANET
6010	RHO	C1405854	Retinitis punctata albescens (disorder)	0.202956482091714	0	0	ORPHANET
6010	RHO	C1864869	Night Blindness, Congenital Stationary, Autosomal Dominant 1	0.48	3	3	CTD_human;UNIPROT
6010	RHO	C3151001	Retinitis Pigmentosa 4	0.48	21	39	CTD_human;UNIPROT
6010	RHO	C3551052	Night blindness, stationary	0.200549453568426	0	0	HPO
6011	GRK1	C0028077	Night Blindness	0.2	0	0	HPO
6011	GRK1	C0271183	Severe myopia	0.2	0	0	HPO
6011	GRK1	C3150678	OGUCHI DISEASE 2	0.28	2	2	UNIPROT
6011	GRK1	C3551052	Night blindness, stationary	0.200549453568426	0	0	HPO
6012	RIEG2	C1832229	Rieger syndrome 2 (disorder)	0.2	0	0	CTD_human
6016	RIT1	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
6016	RIT1	C0015300	Exophthalmos	0.2	0	0	HPO
6016	RIT1	C0028326	Noonan Syndrome	0.201648360705279	0	0	ORPHANET
6016	RIT1	C0038379	Strabismus	0.2	0	0	HPO
6016	RIT1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
6016	RIT1	C0870082	Hyperkeratosis	0.2	0	0	HPO
6016	RIT1	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
6016	RIT1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6016	RIT1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
6016	RIT1	C3809233	NOONAN SYNDROME 8	0.2	2	7	UNIPROT
6017	RLBP1	C0017601	Glaucoma	0.2	0	0	HPO
6017	RLBP1	C0018777	Conductive hearing loss	0.2	0	0	HPO
6017	RLBP1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6017	RLBP1	C0020459	Hyperinsulinism	0.2	0	0	HPO
6017	RLBP1	C0020619	Hypogonadism	0.2	0	0	HPO
6017	RLBP1	C0022578	Keratoconus	0.2	0	0	HPO
6017	RLBP1	C0024437	Macular degeneration	0.2	0	0	HPO
6017	RLBP1	C0028077	Night Blindness	0.2	0	0	HPO
6017	RLBP1	C0028738	Nystagmus	0.2	0	0	HPO
6017	RLBP1	C0028754	Obesity	0.2	0	0	HPO
6017	RLBP1	C0029124	Optic Atrophy	0.2	0	0	HPO
6017	RLBP1	C0035334	Retinitis Pigmentosa	0.405964121340741	0	0	CTD_human;ORPHANET
6017	RLBP1	C0042798	Low Vision	0.2	0	0	HPO
6017	RLBP1	C0271215	Blindness, Legal	0.2	0	0	HPO
6017	RLBP1	C0311338	Fundus Albipunctatus	0.600824180352639	3	3	CTD_human;ORPHANET;UNIPROT
6017	RLBP1	C1405854	Retinitis punctata albescens (disorder)	0.205429023149632	0	0	ORPHANET
6017	RLBP1	C1843815	Newfoundland Rod-Cone Dystrophy	0.200274726784213	0	0	CTD_human
6017	RLBP1	C1843816	Bothnia Retinal Dystrophy	0.68	1	2	CTD_human;ORPHANET;UNIPROT
6022	RMD1	C1838254	RIPPLING MUSCLE DISEASE 1	0.2	0	0	CTD_human
6023	RMRP	C0002170	Alopecia	0.2	0	0	HPO
6023	RMRP	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6023	RMRP	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
6023	RMRP	C0014457	Eosinophilia	0.2	0	0	HPO
6023	RMRP	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
6023	RMRP	C0024312	Lymphopenia	0.2	0	0	HPO
6023	RMRP	C0027092	Myopia	0.2	0	0	HPO
6023	RMRP	C0032285	Pneumonia	0.2	0	0	HPO
6023	RMRP	C0038379	Strabismus	0.2	0	0	HPO
6023	RMRP	C0040583	Tracheal Stenosis	0.2	0	0	HPO
6023	RMRP	C0042798	Low Vision	0.2	0	0	HPO
6023	RMRP	C0085110	Severe Combined Immunodeficiency	0.200274726784213	0	0	HPO
6023	RMRP	C0259817	Xerosis	0.2	0	0	HPO
6023	RMRP	C0265294	Pyle metaphyseal dysplasia	0.201098907136852	0	0	HPO
6023	RMRP	C0401151	Chronic diarrhea	0.2	0	0	HPO
6023	RMRP	C1834821	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS	0.200824180352639	0	0	CTD_human
6023	RMRP	C1846796	Anauxetic dysplasia	0.400824180352639	0	0	CTD_human;ORPHANET
6023	RMRP	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6023	RMRP	C2700553	Omenn Syndrome	0.2	0	0	ORPHANET
6037	RNASE3	C0004096	Asthma	0.224731822872916	3	0	CTD_human
60386	SLC25A19	C1846648	MICROCEPHALY, AMISH TYPE (disorder)	0.680274726784213	1	1	CTD_human;ORPHANET;UNIPROT
60386	SLC25A19	C3150973	THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE)	0.4	1	1	ORPHANET;UNIPROT
604	BCL6	C0520743	Mediastinal lymphadenopathy	0.2	0	0	HPO
60401	EDA2R	C0162359	Christ-Siemens-Touraine syndrome	0.2	0	0	ORPHANET
60468	BACH2	C0007570	Celiac Disease	0.202681755307501	1	2	CTD_human
60468	BACH2	C0010346	Crohn Disease	0.200549453568426	1	1	CTD_human
60468	BACH2	C0011854	Diabetes Mellitus, Insulin-Dependent	0.205638237399215	1	2	CTD_human
60468	BACH2	C0042900	Vitiligo	0.2	1	1	CTD_human
60481	ELOVL5	C4014812	SPINOCEREBELLAR ATAXIA 38	0.400274726784213	1	2	ORPHANET;UNIPROT
60482	SLC5A7	C0751884	Congenital Myasthenic Syndromes, Presynaptic	0.2	0	0	ORPHANET
60498	IGAN1	C0017661	IGA Glomerulonephritis	0.206043989252688	0	0	CTD_human
60502	CPAT1	C0394005	Ataxic cerebral palsy	0.200274726784213	0	0	CTD_human
60506	NYX	C3495587	Night Blindness, Congenital Stationary, Type 1A	0.280274726784213	2	19	UNIPROT
60509	AGBL5	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
60528	ELAC2	C3809526	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.4	1	5	ORPHANET;UNIPROT
60529	ALX4	C1832588	Chromosome 11p11.2 Deletion Syndrome	0.201648360705279	0	0	ORPHANET
60529	ALX4	C1865044	PARIETAL FORAMINA 2	0.48	2	9	CTD_human;UNIPROT
60529	ALX4	C3150703	FRONTONASAL DYSPLASIA 2	0.48	0	0	CTD_human;ORPHANET
60529	ALX4	C3806917	CRANIOSYNOSTOSIS 4	0.2	0	0	ORPHANET
60558	GUF1	C0037769	West Syndrome	0.2	0	0	ORPHANET
60674	GAS5	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
60675	PROK2	C0162809	Kallmann Syndrome	0.417133696204214	0	0	CTD_human;ORPHANET
60675	PROK2	C0342384	Idiopathic hypogonadotropic hypogonadism	0.201098907136852	0	0	CTD_human
60675	PROK2	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
60675	PROK2	C3552343	HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA	0.2	4	4	UNIPROT
60681	FKBP10	C0268362	Osteogenesis imperfecta type III (disorder)	0.200549453568426	0	0	ORPHANET
60681	FKBP10	C0432253	Bruck syndrome	0.202197814273705	0	0	ORPHANET
60681	FKBP10	C1850168	Bruck syndrome 1	0.2	1	5	UNIPROT
60681	FKBP10	C1853147	MACULAR DEGENERATION, AGE-RELATED, 4 (disorder)	0.2	0	0	CTD_human
60681	FKBP10	C3839326	Kuskokwim syndrome	0.200274726784213	0	0	ORPHANET
60684	TRAPPC11	C3809236	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2S	0.4	1	4	ORPHANET;UNIPROT
60685	ZFAND3	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	1	CTD_human
60685	ZFAND3	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
6092	ROBO2	C0042580	Vesico-Ureteral Reflux	0.41433527120477	0	0	HPO;ORPHANET
6092	ROBO2	C1970483	Vesicoureteral Reflux 2	0.4	1	2	CTD_human;UNIPROT
6094	ROM1	C0017601	Glaucoma	0.2	0	0	HPO
6094	ROM1	C0018777	Conductive hearing loss	0.2	0	0	HPO
6094	ROM1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6094	ROM1	C0020459	Hyperinsulinism	0.2	0	0	HPO
6094	ROM1	C0020619	Hypogonadism	0.2	0	0	HPO
6094	ROM1	C0022578	Keratoconus	0.2	0	0	HPO
6094	ROM1	C0028077	Night Blindness	0.2	0	0	HPO
6094	ROM1	C0028738	Nystagmus	0.2	0	0	HPO
6094	ROM1	C0028754	Obesity	0.2	0	0	HPO
6094	ROM1	C0029124	Optic Atrophy	0.2	0	0	HPO
6094	ROM1	C0035334	Retinitis Pigmentosa	0.404604842796993	0	0	HPO;ORPHANET
6094	ROM1	C0271215	Blindness, Legal	0.2	0	0	HPO
6094	ROM1	C4024790	Adult-onset night blindness	0.2	0	0	HPO
6096	RORB	C0014175	Endometriosis	0.2	1	0	CTD_human
6097	RORC	C4225266	IMMUNODEFICIENCY 42	0.2	1	3	UNIPROT
6100	RP9	C0017601	Glaucoma	0.2	0	0	HPO
6100	RP9	C0018777	Conductive hearing loss	0.2	0	0	HPO
6100	RP9	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6100	RP9	C0020459	Hyperinsulinism	0.2	0	0	HPO
6100	RP9	C0020619	Hypogonadism	0.2	0	0	HPO
6100	RP9	C0022578	Keratoconus	0.2	0	0	HPO
6100	RP9	C0028077	Night Blindness	0.2	0	0	HPO
6100	RP9	C0028738	Nystagmus	0.2	0	0	HPO
6100	RP9	C0028754	Obesity	0.2	0	0	HPO
6100	RP9	C0029124	Optic Atrophy	0.2	0	0	HPO
6100	RP9	C0035334	Retinitis Pigmentosa	0.402732912464814	0	0	HPO;ORPHANET
6100	RP9	C0271215	Blindness, Legal	0.2	0	0	HPO
6100	RP9	C1867300	RETINITIS PIGMENTOSA 9	0.400549453568426	1	2	CTD_human;UNIPROT
6101	RP1	C0017601	Glaucoma	0.2	0	0	HPO
6101	RP1	C0018777	Conductive hearing loss	0.2	0	0	HPO
6101	RP1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6101	RP1	C0020459	Hyperinsulinism	0.2	0	0	HPO
6101	RP1	C0020480	Hyperlipoproteinemia Type IV	0.2	0	0	CTD_human
6101	RP1	C0020619	Hypogonadism	0.2	0	0	HPO
6101	RP1	C0022578	Keratoconus	0.2	0	0	HPO
6101	RP1	C0028077	Night Blindness	0.2	0	0	HPO
6101	RP1	C0028738	Nystagmus	0.2	0	0	HPO
6101	RP1	C0028754	Obesity	0.2	0	0	HPO
6101	RP1	C0029124	Optic Atrophy	0.2	0	0	HPO
6101	RP1	C0035334	Retinitis Pigmentosa	0.432213279849676	0	0	HPO;ORPHANET
6101	RP1	C0220701	RETINITIS PIGMENTOSA 1	0.48	5	14	CTD_human;UNIPROT
6101	RP1	C0271215	Blindness, Legal	0.2	0	0	HPO
6102	RP2	C0017601	Glaucoma	0.2	0	0	HPO
6102	RP2	C0018777	Conductive hearing loss	0.2	0	0	HPO
6102	RP2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6102	RP2	C0020459	Hyperinsulinism	0.2	0	0	HPO
6102	RP2	C0020619	Hypogonadism	0.2	0	0	HPO
6102	RP2	C0022578	Keratoconus	0.2	0	0	HPO
6102	RP2	C0027092	Myopia	0.200274726784213	0	0	HPO
6102	RP2	C0028077	Night Blindness	0.200274726784213	0	0	HPO
6102	RP2	C0028738	Nystagmus	0.2	0	0	HPO
6102	RP2	C0028754	Obesity	0.2	0	0	HPO
6102	RP2	C0029124	Optic Atrophy	0.2	0	0	HPO
6102	RP2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
6102	RP2	C0035334	Retinitis Pigmentosa	0.416844614042683	0	0	HPO;ORPHANET
6102	RP2	C0271215	Blindness, Legal	0.2	0	0	HPO
6102	RP2	C0521683	Chorioretinal degeneration	0.2	0	0	HPO
6102	RP2	C1845136	Chromosome Xp11.3 Deletion Syndrome	0.2	0	0	CTD_human
6102	RP2	C2681923	RETINITIS PIGMENTOSA 2 (disorder)	0.480549453568426	6	7	CTD_human;UNIPROT
6103	RPGR	C0015310	Exotropia	0.2	0	0	HPO
6103	RPGR	C0017601	Glaucoma	0.2	0	0	HPO
6103	RPGR	C0018777	Conductive hearing loss	0.2	0	0	HPO
6103	RPGR	C0018780	Hearing Loss, High-Frequency	0.2	0	0	HPO
6103	RPGR	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6103	RPGR	C0020459	Hyperinsulinism	0.2	0	0	HPO
6103	RPGR	C0020490	Hyperopia	0.2	0	0	HPO
6103	RPGR	C0020619	Hypogonadism	0.2	0	0	HPO
6103	RPGR	C0022521	Kartagener Syndrome	0.200824180352639	0	0	ORPHANET
6103	RPGR	C0022578	Keratoconus	0.2	0	0	HPO
6103	RPGR	C0024437	Macular degeneration	0.200549453568426	0	0	HPO
6103	RPGR	C0027092	Myopia	0.200824180352639	0	0	HPO
6103	RPGR	C0028077	Night Blindness	0.200274726784213	0	0	HPO
6103	RPGR	C0028738	Nystagmus	0.2	0	0	HPO
6103	RPGR	C0028754	Obesity	0.2	0	0	HPO
6103	RPGR	C0029124	Optic Atrophy	0.2	0	0	HPO
6103	RPGR	C0029882	Otitis Media	0.2	0	0	HPO
6103	RPGR	C0035334	Retinitis Pigmentosa	0.661639583188517	3	6	CTD_human;HPO;ORPHANET
6103	RPGR	C0042798	Low Vision	0.2	0	0	HPO
6103	RPGR	C0149516	Chronic sinusitis	0.2	0	0	HPO
6103	RPGR	C0152200	Achromatopsia	0.2	0	0	ORPHANET
6103	RPGR	C0242383	Age related macular degeneration	0.20328236603324	1	0	CTD_human
6103	RPGR	C0271215	Blindness, Legal	0.2	0	0	HPO
6103	RPGR	C0271388	Pendular Nystagmus	0.2	0	0	HPO
6103	RPGR	C0730290	Cone dystrophy	0.201373633921065	0	0	HPO
6103	RPGR	C0741796	Recurrent bronchitis	0.2	0	0	HPO
6103	RPGR	C0748720	Chronic sinus disease	0.2	0	0	HPO
6103	RPGR	C0858618	Dyschromatopsia	0.2	0	0	HPO
6103	RPGR	C1844776	CONE-ROD DYSTROPHY, X-LINKED, 1	0.28	0	0	CTD_human
6103	RPGR	C1845667	RETINITIS PIGMENTOSA 3	0.481923087489492	15	24	CTD_human;UNIPROT
6103	RPGR	C2749137	Retinitis Pigmentosa, X-Linked, And Sinorespiratory Infections, With Or Without Deafness	0.6	2	1	CTD_human;ORPHANET;UNIPROT
6103	RPGR	C4020734	Nystagmus, continuous pendular	0.2	0	0	HPO
6103	RPGR	C4072827	Cone/cone-rod dystrophy	0.200274726784213	0	0	HPO
6104	RP6	C1839368	RETINITIS PIGMENTOSA 6 (disorder)	0.2	0	0	CTD_human
611	OPN1SW	C0155017	Color Blindness, Blue	0.602681755307501	2	3	CTD_human;HPO;ORPHANET;UNIPROT
6114	RP22	C0035334	Retinitis Pigmentosa	0.2	0	0	CTD_human
6116	RP24	C0035334	Retinitis Pigmentosa	0.2	0	0	CTD_human
6117	RPA1	C0263454	Chloracne	0.2	1	0	CTD_human
6121	RPE65	C0014544	Epilepsy	0.2	0	0	HPO
6121	RPE65	C0017601	Glaucoma	0.2	0	0	HPO
6121	RPE65	C0018777	Conductive hearing loss	0.2	0	0	HPO
6121	RPE65	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
6121	RPE65	C0020459	Hyperinsulinism	0.2	0	0	HPO
6121	RPE65	C0020619	Hypogonadism	0.2	0	0	HPO
6121	RPE65	C0022578	Keratoconus	0.2	0	0	HPO
6121	RPE65	C0028077	Night Blindness	0.2	0	0	HPO
6121	RPE65	C0028738	Nystagmus	0.200274726784213	0	0	HPO
6121	RPE65	C0028754	Obesity	0.2	0	0	HPO
6121	RPE65	C0029124	Optic Atrophy	0.2	0	0	HPO
6121	RPE65	C0035334	Retinitis Pigmentosa	0.612803580191434	3	2	CTD_human;HPO;ORPHANET
6121	RPE65	C0042798	Low Vision	0.200549453568426	0	0	HPO
6121	RPE65	C0271215	Blindness, Legal	0.2	0	0	HPO
6121	RPE65	C0339527	Leber Congenital Amaurosis	0.417033060621212	3	0	CTD_human;ORPHANET
6121	RPE65	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
6121	RPE65	C0917796	Optic Atrophy, Hereditary, Leber	0.202681755307501	2	0	CTD_human
6121	RPE65	C1301509	Severe visual impairment	0.200824180352639	0	0	HPO
6121	RPE65	C1859844	LEBER CONGENITAL AMAUROSIS, TYPE II (disorder)	0.481098907136852	12	25	CTD_human;UNIPROT
6121	RPE65	C3151086	Retinitis Pigmentosa 20	0.28	10	14	UNIPROT
6121	RPE65	C4274354	Severe early childhood onset retinal dystrophy	0.200274726784213	0	0	ORPHANET
6125	RPL5	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6125	RPL5	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
6125	RPL5	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6125	RPL5	C2931850	Aase Smith syndrome 2	0.4	2	1	CTD_human;UNIPROT
6125	RPL5	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
6128	RPL6	C0030567	Parkinson Disease	0.2	1	0	CTD_human
613	BCR	C0014306	Enophthalmos	0.2	0	0	HPO
613	BCR	C0836924	Thrombocytosis	0.200549453568426	0	0	HPO
613	BCR	C2678480	Chromosome 22q11.2 Deletion Syndrome, Distal	0.2	0	0	ORPHANET
6134	RPL10	C0014544	Epilepsy	0.2	0	0	HPO
6134	RPL10	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
6134	RPL10	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6135	RPL11	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6135	RPL11	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6135	RPL11	C2675512	Diamond-Blackfan Anemia 7	0.4	1	3	CTD_human;UNIPROT
6135	RPL11	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
6138	RPL15	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6138	RPL15	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6138	RPL15	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
6139	RPL17	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
6144	RPL21	C0002170	Alopecia	0.2	0	0	HPO
6144	RPL21	C1854310	Hypotrichosis simplex	0.200274726784213	0	0	ORPHANET
6144	RPL21	C4014563	HYPOTRICHOSIS 12	0.2	1	1	UNIPROT
6147	RPL23A	C0030567	Parkinson Disease	0.2	1	0	CTD_human
6154	RPL26	C0002871	Anemia	0.2	0	0	HPO
6154	RPL26	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6154	RPL26	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
6154	RPL26	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6154	RPL26	C1857079	Atretic auditory canal	0.2	0	0	HPO
6154	RPL26	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
6157	RPL27A	C0030312	Pancytopenia	0.2	1	0	CTD_human
6165	RPL35A	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6165	RPL35A	C0023530	Leukopenia	0.2	0	0	HPO
6165	RPL35A	C0178416	Hypoplastic anemia	0.2	0	0	HPO
6165	RPL35A	C0542035	Erythroid hypoplasia	0.2	0	0	HPO
6165	RPL35A	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6165	RPL35A	C2675859	Diamond-Blackfan Anemia 5	0.4	1	3	CTD_human;UNIPROT
6165	RPL35A	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
6168	RPL37A	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
617	BCS1L	C0002170	Alopecia	0.2	0	0	HPO
617	BCS1L	C0003028	Anhidrosis	0.2	0	0	HPO
617	BCS1L	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
617	BCS1L	C0008311	Cholangitis	0.2	0	0	HPO
617	BCS1L	C0008370	Cholestasis	0.2	0	0	HPO
617	BCS1L	C0014544	Epilepsy	0.200274726784213	0	0	HPO
617	BCS1L	C0018784	Sensorineural Hearing Loss (disorder)	0.200549453568426	0	0	HPO
617	BCS1L	C0020555	Hypertrichosis	0.2	0	0	HPO
617	BCS1L	C0020615	Hypoglycemia	0.2	0	0	HPO
617	BCS1L	C0020619	Hypogonadism	0.2	0	0	HPO
617	BCS1L	C0023264	Leigh Disease	0.2	0	0	CTD_human
617	BCS1L	C0023890	Liver Cirrhosis	0.2	0	0	HPO
617	BCS1L	C0028738	Nystagmus	0.2	0	0	HPO
617	BCS1L	C0029124	Optic Atrophy	0.2	0	0	HPO
617	BCS1L	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
617	BCS1L	C0038379	Strabismus	0.2	0	0	HPO
617	BCS1L	C0041349	Nephritis, Tubulointerstitial	0.2	0	0	HPO
617	BCS1L	C0235946	Cerebral atrophy	0.2	0	0	HPO
617	BCS1L	C0238621	Aminoaciduria	0.2	0	0	HPO
617	BCS1L	C0262404	Cerebellar degeneration	0.2	0	0	HPO
617	BCS1L	C0263490	Brittle hair	0.2	0	0	HPO
617	BCS1L	C0266006	Pili torti-deafness syndrome	0.600824180352639	2	5	CTD_human;ORPHANET;UNIPROT
617	BCS1L	C0338474	Central nervous system demyelination	0.2	0	0	HPO
617	BCS1L	C0341703	Adult Fanconi syndrome	0.2	0	0	HPO
617	BCS1L	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
617	BCS1L	C1145670	Respiratory Failure	0.2	0	0	HPO
617	BCS1L	C1852372	MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)	0.200274726784213	0	0	CTD_human
617	BCS1L	C1852373	Mitochondrial encephalopathy	0.200274726784213	0	0	HPO
617	BCS1L	C1864002	GRACILE SYNDROME (disorder)	0.681923087489492	2	15	CTD_human;ORPHANET;UNIPROT
617	BCS1L	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
617	BCS1L	C2711227	Steatohepatitis	0.2	0	0	HPO
617	BCS1L	C3541471	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.4	7	9	ORPHANET;UNIPROT
617	BCS1L	C3854388	Hyperferritinaemia	0.2	0	0	HPO
617	BCS1L	C4020860	Supratentorial atrophy	0.2	0	0	HPO
617	BCS1L	C4020871	Dystonic disease	0.2	0	0	HPO
617	BCS1L	C4020873	Infratentorial atrophy	0.2	0	0	HPO
619379	SPG29	C1857855	SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.4	0	0	CTD_human;ORPHANET
619394	SPOAN	C1836010	Spastic Paraplegia, Optic Atrophy, and Neuropathy	0.200824180352639	0	0	CTD_human
619397	FEB6	C1836518	FEBRILE CONVULSIONS, FAMILIAL, 6	0.2	0	0	CTD_human
619398	FEB5	C1836507	FEBRILE CONVULSIONS, FAMILIAL, 5	0.2	0	0	CTD_human
619399	ETL2	C1842564	Temporal epilepsy, familial	0.2	0	0	CTD_human
619404	CTRCT35	C1836272	Cataract, Congenital Nuclear, Autosomal Recessive 1	0.2	0	0	CTD_human
619406	HPE8	C1836254	Holoprosencephaly 8	0.2	0	0	CTD_human
619407	MSSD	C1836206	Syndactyly, Mesoaxial Synostotic, with Phalangeal Reduction	0.2	0	0	CTD_human
619408	PSNP2	C1836148	Supranuclear Palsy, Progressive, 2	0.2	0	0	CTD_human
619409	MDCMP	C1836133	Muscular Dystrophy, Congenital, Merosin-Positive	0.2	0	0	CTD_human
619410	NEDE	C1836119	Nephropathy, Progressive, with Deafness	0.2	0	0	CTD_human
619411	LVNC2	C1836118	LEFT VENTRICULAR NONCOMPACTION 2	0.2	0	0	CTD_human
619468	RCM2	C1865071	Cardiomyopathy, Familial Restrictive, 2	0.2	0	0	CTD_human
619469	DELYQ11	C1839073	Sertoli cell-only syndrome, Y-linked	0.2	0	0	CTD_human
619471	PPR3	C1835966	PHOTOPAROXYSMAL RESPONSE 3	0.2	0	0	CTD_human
619475	PFM3	C1835980	PARIETAL FORAMINA 3	0.2	0	0	CTD_human
619477	GCCD3	C1836621	GLUCOCORTICOID DEFICIENCY 3 (disorder)	0.2	0	0	CTD_human
619478	ATFB2	C1837812	Atrial Fibrillation, Familial, 2	0.2	0	0	CTD_human
619480	MDBS2	C1868569	Patterned dystrophy of retinal pigment epithelium	0.2	0	0	CTD_human
619496	CMT2H	C1843173	Charcot-Marie-Tooth disease, Type 2H	0.2	0	0	CTD_human
619509	WTRS	C0796202	Wittwer syndrome	0.2	1	0	CTD_human
619509	WTRS	C1956097	Wolf-Hirschhorn Syndrome	0.2	1	0	CTD_human
619510	AMCX5	C1846273	ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED	0.2	0	0	CTD_human
619511	MHB	C1850709	Myopathy, Hyaline Body, Autosomal Recessive	0.2	0	0	CTD_human
619536	BPPV	C0155502	Benign Paroxysmal Positional Vertigo	0.200274726784213	0	0	CTD_human
619537	VV	C0042345	Varicosity	0.2	0	0	CTD_human
619538	OMS	C0029882	Otitis Media	0.2	0	0	CTD_human
6197	RPS6KA3	C0010495	Cutis Laxa	0.2	0	0	HPO
6197	RPS6KA3	C0014544	Epilepsy	0.2	0	0	HPO
6197	RPS6KA3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6197	RPS6KA3	C0024636	Malocclusion	0.2	0	0	HPO
6197	RPS6KA3	C0034888	Rectal Prolapse	0.2	0	0	HPO
6197	RPS6KA3	C0263401	Cutis marmorata	0.2	0	0	HPO
6197	RPS6KA3	C0264142	Spade-like hand	0.2	0	0	HPO
6197	RPS6KA3	C0265252	Coffin-Lowry syndrome	0.712526487145508	6	11	CTD_human;ORPHANET;UNIPROT
6197	RPS6KA3	C0796225	Mental Retardation, X-Linked 19	0.200274726784213	2	6	UNIPROT
6197	RPS6KA3	C2930812	Generalized elastolysis	0.2	0	0	HPO
6197	RPS6KA3	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
6198	RPS6KB1	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
6198	RPS6KB1	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	0.2	1	0	CTD_human
6201	RPS7	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6201	RPS7	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6201	RPS7	C2675511	Diamond-Blackfan Anemia 8	0.2	0	0	CTD_human
6201	RPS7	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
6202	RPS8	C0030567	Parkinson Disease	0.2	1	0	CTD_human
6204	RPS10	C0002871	Anemia	0.2	0	0	HPO
6204	RPS10	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6204	RPS10	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6204	RPS10	C2750081	Diamond-Blackfan Anemia 9	0.2	0	0	CTD_human
6204	RPS10	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
6208	RPS14	C0178416	Hypoplastic anemia	0.200274726784213	0	0	HPO
6208	RPS14	C0542035	Erythroid hypoplasia	0.2	0	0	HPO
6208	RPS14	C0740302	5q-syndrome	0.405494535684262	0	0	CTD_human;ORPHANET
6208	RPS14	C2675059	Macrocytic anemia, refractory	0.2	0	0	HPO
6208	RPS14	C4025777	Autosomal dominant contiguous gene syndrome	0.2	0	0	HPO
6218	RPS17	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6218	RPS17	C0178416	Hypoplastic anemia	0.2	0	0	HPO
6218	RPS17	C0542035	Erythroid hypoplasia	0.2	0	0	HPO
6218	RPS17	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6218	RPS17	C2675860	Diamond-Blackfan Anemia 4	0.2	0	0	CTD_human
6218	RPS17	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
622	BDH1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6223	RPS19	C0002886	Anemia, Macrocytic	0.200824180352639	0	0	HPO
6223	RPS19	C0018801	Heart failure	0.2	0	0	HPO
6223	RPS19	C0018802	Congestive heart failure	0.2	0	0	HPO
6223	RPS19	C0038379	Strabismus	0.2	0	0	HPO
6223	RPS19	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6223	RPS19	C0836924	Thrombocytosis	0.2	0	0	HPO
6223	RPS19	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6223	RPS19	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
6229	RPS24	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6229	RPS24	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6229	RPS24	C1857719	Anemia, Diamond-Blackfan, 3	0.2	0	0	CTD_human
6229	RPS24	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
623	BDKRB1	C0014556	Epilepsy, Temporal Lobe	0.2	1	0	CTD_human
6231	RPS26	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6231	RPS26	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6231	RPS26	C2750080	Diamond-Blackfan Anemia 10	0.4	1	7	CTD_human;UNIPROT
6231	RPS26	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
6234	RPS28	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6234	RPS28	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
6234	RPS28	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6234	RPS28	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
6235	RPS29	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6235	RPS29	C0085577	Normocytic anemia	0.2	0	0	HPO
6235	RPS29	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6235	RPS29	C4014641	DIAMOND-BLACKFAN ANEMIA 13	0.2	1	2	UNIPROT
6235	RPS29	C4021821	Abnormality of the urinary system	0.2	0	0	HPO
6239	RREB1	C0011334	Dental caries	0.2	0	0	HPO
6239	RREB1	C0012236	DiGeorge Syndrome	0.2	0	0	ORPHANET
6239	RREB1	C0018777	Conductive hearing loss	0.2	0	0	HPO
6239	RREB1	C0020626	Hypoparathyroidism	0.2	0	0	HPO
6239	RREB1	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
6239	RREB1	C0039621	Tetany	0.2	0	0	HPO
6239	RREB1	C0085109	Corneal Neovascularization	0.2	0	0	HPO
6239	RREB1	C0220704	Shprintzen syndrome	0.2	0	0	ORPHANET
6239	RREB1	C0271441	Chronic otitis media	0.2	0	0	HPO
6239	RREB1	C0702166	Acne	0.2	0	0	HPO
6239	RREB1	C0743359	ear infection chronic	0.2	0	0	HPO
6239	RREB1	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	0.2	0	0	ORPHANET
6239	RREB1	C2936346	22q11 Deletion Syndrome	0.2	0	0	ORPHANET
6239	RREB1	C3266101	22q11 partial monosomy syndrome	0.2	0	0	ORPHANET
6239	RREB1	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
6239	RREB1	C4024912	Occipital myelomeningocele	0.2	0	0	HPO
624	BDKRB2	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
624	BDKRB2	C0014556	Epilepsy, Temporal Lobe	0.2	1	0	CTD_human
624	BDKRB2	C0020452	Hyperemia	0.2	1	0	CTD_human
6241	RRM2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
6247	RS1	C0017601	Glaucoma	0.2	0	0	HPO
6247	RS1	C0020490	Hyperopia	0.2	0	0	HPO
6247	RS1	C0035305	Retinal Detachment	0.2	0	0	HPO
6247	RS1	C0152439	Retinoschisis	0.423735230050689	2	0	CTD_human;HPO
6247	RS1	C0521694	Atrophic retina	0.2	0	0	HPO
6247	RS1	C3714753	RETINOSCHISIS 1, X-LINKED, JUVENILE	0.480274726784213	9	55	ORPHANET;UNIPROT
6247	RS1	C4048273	Chorioretinal atrophy	0.2	0	0	HPO
6251	RSU1	C0029456	Osteoporosis	0.2	1	0	CTD_human
6251	RSU1	C0263454	Chloracne	0.2	1	0	CTD_human
6252	RTN1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
6253	RTN2	C0037772	Spastic Paraplegia	0.200549453568426	0	0	HPO
6253	RTN2	C0085606	Urgency of micturition	0.2	0	0	HPO
6253	RTN2	C1858106	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT (disorder)	0.4	1	1	ORPHANET;UNIPROT
6253	RTN2	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
6253	RTN2	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
6256	RXRA	C0149940	Sciatic Neuropathy	0.2	1	0	CTD_human
6256	RXRA	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
6258	RXRG	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
6261	RYR1	C0020305	Hydrops Fetalis	0.2	0	0	HPO
6261	RYR1	C0024591	Malignant hyperpyrexia due to anesthesia	0.798598893346645	49	94	CTD_human;HPO;ORPHANET;UNIPROT
6261	RYR1	C0026850	Muscular Dystrophy	0.2	0	0	HPO
6261	RYR1	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
6261	RYR1	C0162292	External Ophthalmoplegia	0.200824180352639	0	0	HPO
6261	RYR1	C0162674	Chronic progressive external ophthalmoplegia	0.2	0	0	HPO
6261	RYR1	C0234958	muscle degeneration	0.2	0	0	HPO
6261	RYR1	C0376175	Bell Palsy	0.2	0	0	HPO
6261	RYR1	C0751951	Central Core Myopathy (disorder)	0.725713372787737	37	100	CTD_human;ORPHANET;UNIPROT
6261	RYR1	C0752282	Congenital Structural Myopathy	0.2	1	0	CTD_human
6261	RYR1	C1301959	Bulbar weakness	0.2	0	0	HPO
6261	RYR1	C1834558	Myopathy, Centronuclear, Autosomal Dominant	0.2	0	0	ORPHANET
6261	RYR1	C1840365	King Denborough syndrome	0.200824180352639	0	0	ORPHANET
6261	RYR1	C1850674	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA (disorder)	0.684670355331623	3	17	CTD_human;ORPHANET;UNIPROT
6261	RYR1	C1854678	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	0.200274726784213	0	0	ORPHANET
6261	RYR1	C2267233	Neonatal Hypotonia	0.200274726784213	0	0	HPO
6261	RYR1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6261	RYR1	C4082299	Bulbar palsy	0.2	0	0	HPO
6262	RYR2	C0014544	Epilepsy	0.2	0	0	HPO
6262	RYR2	C0042514	Tachycardia, Ventricular	0.41335303375986	2	0	CTD_human;HPO
6262	RYR2	C0085612	Ventricular arrhythmia	0.206043989252688	0	0	HPO
6262	RYR2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
6262	RYR2	C0392464	Ventricular aneurysm	0.2	0	0	HPO
6262	RYR2	C0853897	Diabetic Cardiomyopathies	0.2	1	0	CTD_human
6262	RYR2	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	0.706099044500245	12	36	CTD_human;ORPHANET;UNIPROT
6262	RYR2	C1832931	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2	0.480274726784213	2	4	CTD_human;UNIPROT
6262	RYR2	C2063326	Cardiomyopathy, right ventricular	0.2	0	0	HPO
627	BDNF	C0002395	Alzheimer's Disease	0.38637929125569	1	0	CTD_human
627	BDNF	C0007786	Brain Ischemia	0.200549453568426	1	0	CTD_human
627	BDNF	C0014544	Epilepsy	0.2121661676857	1	0	CTD_human
627	BDNF	C0014549	Tonic-Clonic Epilepsy	0.2	1	0	CTD_human
627	BDNF	C0028738	Nystagmus	0.2	0	0	HPO
627	BDNF	C0028756	Obesity, Morbid	0.200549453568426	1	0	CTD_human
627	BDNF	C0030567	Parkinson Disease	0.251405674232974	1	1	CTD_human
627	BDNF	C0038220	Status Epilepticus	0.280824180352639	2	0	CTD_human
627	BDNF	C0042798	Low Vision	0.2	0	0	HPO
627	BDNF	C0206115	WAGR Syndrome	0.206238848124954	0	0	ORPHANET
627	BDNF	C1275808	Congenital central hypoventilation	0.400549453568426	1	1	CTD_human;UNIPROT
627	BDNF	C2675904	Wilms Tumor, Aniridia, Genitourinary Anomalies, Mental Retardation, and Obesity Syndrome	0.200274726784213	0	0	CTD_human
627	BDNF	C2931803	Deletion 11p13	0.2	0	0	ORPHANET
6271	S100A1	C0751895	Vasospasm, Intracranial	0.2	1	0	CTD_human
6272	SORT1	C1956346	Coronary Artery Disease	0.205429023149632	1	0	CTD_human
6275	S100A4	C0029408	Degenerative polyarthritis	0.20328236603324	1	0	CTD_human
6275	S100A4	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
6275	S100A4	C0751895	Vasospasm, Intracranial	0.2	1	0	CTD_human
6276	S100A5	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
6277	S100A6	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	0	CTD_human
6277	S100A6	C0751895	Vasospasm, Intracranial	0.2	1	0	CTD_human
6278	S100A7	C0033860	Psoriasis	0.203846174978983	1	0	CTD_human
6279	S100A8	C0011615	Dermatitis, Atopic	0.203231208875927	1	0	CTD_human
6279	S100A8	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
6280	S100A9	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
6282	S100A11	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6285	S100B	C0013080	Down Syndrome	0.21096036061389	1	0	CTD_human
6285	S100B	C0027051	Myocardial Infarction	0.201373633921065	1	0	CTD_human
6285	S100B	C0751895	Vasospasm, Intracranial	0.2	1	0	CTD_human
6286	S100P	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
6288	SAA1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
6288	SAA1	C0221014	Reactive systemic amyloidosis	0.206868169605328	0	0	ORPHANET
629	CFB	C0024141	Lupus Erythematosus, Systemic	0.209628114093152	1	1	CTD_human
629	CFB	C0026896	Myasthenia Gravis	0.2	1	0	CTD_human
629	CFB	C0031154	Peritonitis	0.2	0	0	HPO
629	CFB	C0032285	Pneumonia	0.2	0	0	HPO
629	CFB	C0242383	Age related macular degeneration	0.276854179007252	1	3	CTD_human
629	CFB	C1864205	Macular Degeneration, Age-Related, 1	0.2	0	0	CTD_human
629	CFB	C2931788	Atypical Hemolytic Uremic Syndrome	0.201373633921065	1	1	CTD_human
6295	SAG	C0017601	Glaucoma	0.2	0	0	HPO
6295	SAG	C0018777	Conductive hearing loss	0.2	0	0	HPO
6295	SAG	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6295	SAG	C0018975	Hemeralopia	0.2	0	0	HPO
6295	SAG	C0020459	Hyperinsulinism	0.2	0	0	HPO
6295	SAG	C0020619	Hypogonadism	0.2	0	0	HPO
6295	SAG	C0022578	Keratoconus	0.2	0	0	HPO
6295	SAG	C0028077	Night Blindness	0.202407028523288	0	0	HPO
6295	SAG	C0028738	Nystagmus	0.2	0	0	HPO
6295	SAG	C0028754	Obesity	0.2	0	0	HPO
6295	SAG	C0029124	Optic Atrophy	0.2	0	0	HPO
6295	SAG	C0035334	Retinitis Pigmentosa	0.604381273170092	1	0	CTD_human;HPO;ORPHANET
6295	SAG	C0042164	Uveitis	0.2	1	0	CTD_human
6295	SAG	C0042798	Low Vision	0.2	0	0	HPO
6295	SAG	C0271183	Severe myopia	0.2	0	0	HPO
6295	SAG	C0271215	Blindness, Legal	0.2	0	0	HPO
6295	SAG	C3551052	Night blindness, stationary	0.200549453568426	0	0	HPO
6295	SAG	C4048273	Chorioretinal atrophy	0.2	0	0	HPO
6297	SALL2	C0042798	Low Vision	0.2	0	0	HPO
6299	SALL1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
6299	SALL1	C0020676	Hypothyroidism	0.2	0	0	HPO
6299	SALL1	C0035078	Kidney Failure	0.200274726784213	0	0	HPO
6299	SALL1	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
6299	SALL1	C1565489	Renal Insufficiency	0.2	0	0	HPO
6303	SAT1	C0005741	Blepharitis	0.2	0	0	HPO
6303	SAT1	C0009763	Conjunctivitis	0.2	0	0	HPO
6303	SAT1	C0010036	Corneal dystrophy	0.2	0	0	HPO
6303	SAT1	C0013592	Ectropion	0.2	0	0	HPO
6303	SAT1	C0022568	Keratitis	0.2	0	0	HPO
6303	SAT1	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
6303	SAT1	C0028754	Obesity	0.201923087489492	1	0	CTD_human
6303	SAT1	C0035854	Rosacea	0.2	0	0	HPO
6303	SAT1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
6303	SAT1	C0259817	Xerosis	0.2	0	0	HPO
6303	SAT1	C0334013	Phrynoderma	0.2	0	0	HPO
6303	SAT1	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
6303	SAT1	C1834405	Nail dysplasia	0.2	0	0	HPO
6305	SBF1	C3695063	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3	0.400274726784213	1	3	ORPHANET;UNIPROT
6307	MSMO1	C4225189	MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.2	1	3	UNIPROT
6309	SC5D	C0008372	Intrahepatic Cholestasis	0.2	0	0	HPO
6309	SC5D	C0014544	Epilepsy	0.2	0	0	HPO
6309	SC5D	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
6309	SC5D	C0025299	Meningocele	0.2	0	0	HPO
6309	SC5D	C0085605	Liver Failure	0.2	0	0	HPO
6309	SC5D	C1846421	Lathosterolosis	0.680549453568426	2	3	CTD_human;ORPHANET;UNIPROT
6309	SC5D	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6309	SC5D	C4024710	Cerebellar cortical atrophy	0.2	0	0	HPO
631	BFSP1	C0392557	Nuclear cataract	0.200274726784213	0	0	ORPHANET
631	BFSP1	C1112705	Nuclear non-senile cataract	0.200274726784213	0	0	ORPHANET
631	BFSP1	C1969644	Cataract, Cortical, Juvenile-Onset	0.2	0	0	CTD_human
6310	ATXN1	C0029124	Optic Atrophy	0.2	0	0	HPO
6310	ATXN1	C0087012	Ataxia, Spinocerebellar	0.441828717297135	4	0	CTD_human;HPO
6310	ATXN1	C0271390	Nystagmus, End-Position	0.2	0	0	HPO
6310	ATXN1	C0393525	Progressive cerebellar ataxia	0.200824180352639	0	0	HPO
6310	ATXN1	C0752120	Spinocerebellar Ataxia Type 1	0.304725410579179	0	0	ORPHANET
6310	ATXN1	C1301959	Bulbar weakness	0.2	0	0	HPO
6310	ATXN1	C1408507	Supranuclear ophthalmoplegia	0.2	0	0	HPO
6310	ATXN1	C1848736	Distal amyotrophy	0.2	0	0	HPO
6310	ATXN1	C1866751	Spinocerebellar tract degeneration	0.200274726784213	0	0	HPO
6310	ATXN1	C4020858	Choreatic disease	0.2	0	0	HPO
6310	ATXN1	C4082299	Bulbar palsy	0.2	0	0	HPO
6311	ATXN2	C0002736	Amyotrophic Lateral Sclerosis	0.411813251721163	0	0	HPO;ORPHANET
6311	ATXN2	C0035334	Retinitis Pigmentosa	0.200549453568426	0	0	HPO
6311	ATXN2	C0087012	Ataxia, Spinocerebellar	0.224643863935608	2	0	CTD_human
6311	ATXN2	C0234958	muscle degeneration	0.2	0	0	HPO
6311	ATXN2	C0271390	Nystagmus, End-Position	0.200274726784213	0	0	HPO
6311	ATXN2	C0339573	Glaucoma, Primary Open Angle	0.200274726784213	1	0	CTD_human
6311	ATXN2	C0393525	Progressive cerebellar ataxia	0.2	0	0	HPO
6311	ATXN2	C0752121	Spinocerebellar Ataxia Type 2	0.298406694542278	0	0	ORPHANET
6311	ATXN2	C1145670	Respiratory Failure	0.2	0	0	HPO
6311	ATXN2	C1848736	Distal amyotrophy	0.2	0	0	HPO
6311	ATXN2	C1866751	Spinocerebellar tract degeneration	0.2	0	0	HPO
6311	ATXN2	C3489733	Oculomotor apraxia	0.2	0	0	HPO
6311	ATXN2	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
6311	ATXN2	C4020884	Anxiety disease	0.2	0	0	HPO
6314	ATXN7	C0024437	Macular degeneration	0.200549453568426	0	0	HPO
6314	ATXN7	C0087012	Ataxia, Spinocerebellar	0.2251646067494	1	0	CTD_human
6314	ATXN7	C0152115	Lingual-Facial-Buccal Dyskinesia	0.2	0	0	HPO
6314	ATXN7	C0752125	Spinocerebellar Ataxia Type 7	0.293461612426442	0	0	ORPHANET
6314	ATXN7	C1408507	Supranuclear ophthalmoplegia	0.2	0	0	HPO
6314	ATXN7	C4020858	Choreatic disease	0.2	0	0	HPO
6315	ATXN8OS	C0028738	Nystagmus	0.2	0	0	HPO
6315	ATXN8OS	C0262404	Cerebellar degeneration	0.2	0	0	HPO
6315	ATXN8OS	C0393525	Progressive cerebellar ataxia	0.200274726784213	0	0	HPO
6315	ATXN8OS	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
6315	ATXN8OS	C1837454	SPINOCEREBELLAR ATAXIA 8	0.403296721410557	0	0	CTD_human;ORPHANET
6315	ATXN8OS	C4020859	Pyramidal tract disease	0.2	0	0	HPO
6315	ATXN8OS	C4020873	Infratentorial atrophy	0.2	0	0	HPO
6317	SERPINB3	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
6318	SERPINB4	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
6319	SCD	C0023794	Lipoidosis	0.2	1	0	CTD_human
6319	SCD	C0339143	Thyroid associated opthalmopathies	0.200274726784213	1	0	CTD_human
632	BGLAP	C0004096	Asthma	0.2	1	0	CTD_human
6323	SCN1A	C0009952	Febrile Convulsions	0.436791090623658	3	1	CTD_human;HPO
6323	SCN1A	C0014544	Epilepsy	0.487966782935994	3	2	CTD_human;HPO
6323	SCN1A	C0014548	Epilepsy, Generalized	0.224457096088703	1	1	CTD_human
6323	SCN1A	C0014550	Epilepsies, Myoclonic	0.451771865359523	1	0	CTD_human;HPO
6323	SCN1A	C0014553	Absence Epilepsy	0.200274726784213	0	0	HPO
6323	SCN1A	C0028738	Nystagmus	0.2	0	0	HPO
6323	SCN1A	C0038220	Status Epilepticus	0.203831819601666	0	0	HPO
6323	SCN1A	C0149958	Complex partial seizures	0.2	0	0	HPO
6323	SCN1A	C0154723	Migraine with Aura	0.20328236603324	0	0	HPO
6323	SCN1A	C0155320	Blindness, Cortical	0.2	0	0	HPO
6323	SCN1A	C0235946	Cerebral atrophy	0.2	0	0	HPO
6323	SCN1A	C0238111	Lennox-Gastaut syndrome	0.200274726784213	0	0	ORPHANET
6323	SCN1A	C0270834	Complex partial seizure with impairment of consciousness	0.2	0	0	HPO
6323	SCN1A	C0270846	Epileptic drop attack	0.200274726784213	0	0	HPO
6323	SCN1A	C0271215	Blindness, Legal	0.2	0	0	HPO
6323	SCN1A	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
6323	SCN1A	C0494475	Tonic - clonic seizures	0.201098907136852	0	0	HPO
6323	SCN1A	C0543888	Epileptic encephalopathy	0.203296721410557	0	0	HPO
6323	SCN1A	C0595948	Atypical absence seizure	0.2	0	0	HPO
6323	SCN1A	C0751122	Infantile Severe Myoclonic Epilepsy	0.534330390739564	39	374	ORPHANET;UNIPROT
6323	SCN1A	C0751778	Myoclonic Epilepsies, Progressive	0.200274726784213	0	0	HPO
6323	SCN1A	C0752323	Focal Clonic Seizures	0.2	0	0	HPO
6323	SCN1A	C1858672	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1	0.48	0	0	CTD_human;ORPHANET
6323	SCN1A	C1858673	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	0.400824180352639	33	67	CTD_human;UNIPROT
6323	SCN1A	C1864987	Migraine, Familial Hemiplegic, 3	0.4	4	4	CTD_human;UNIPROT
6323	SCN1A	C4020860	Supratentorial atrophy	0.2	0	0	HPO
6323	SCN1A	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
6323	SCN1A	C4023511	Obtundation status	0.2	0	0	HPO
6324	SCN1B	C0006384	Bundle-Branch Block	0.2	0	0	HPO
6324	SCN1B	C0009952	Febrile Convulsions	0.407388912419119	1	0	CTD_human;HPO
6324	SCN1B	C0014550	Epilepsies, Myoclonic	0.202407028523288	0	0	HPO
6324	SCN1B	C0014553	Absence Epilepsy	0.200274726784213	0	0	HPO
6324	SCN1B	C0038644	Sudden infant death syndrome	0.2	1	0	CTD_human
6324	SCN1B	C0042510	Ventricular Fibrillation	0.2	0	0	HPO
6324	SCN1B	C0235480	Paroxysmal atrial fibrillation	0.2	0	0	HPO
6324	SCN1B	C0270846	Epileptic drop attack	0.2	0	0	HPO
6324	SCN1B	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
6324	SCN1B	C0751122	Infantile Severe Myoclonic Epilepsy	0.201648360705279	0	0	ORPHANET
6324	SCN1B	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
6324	SCN1B	C0752323	Focal Clonic Seizures	0.2	0	0	HPO
6324	SCN1B	C1142166	Brugada Syndrome (disorder)	0.40350593566014	1	0	CTD_human;ORPHANET
6324	SCN1B	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
6324	SCN1B	C1858672	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1	0.68	3	3	CTD_human;ORPHANET;UNIPROT
6324	SCN1B	C1879286	Hereditary bundle branch system defect	0.2	0	0	ORPHANET
6324	SCN1B	C2748541	Brugada Syndrome 5	0.2	0	0	CTD_human
6324	SCN1B	C3809311	ATRIAL FIBRILLATION, FAMILIAL, 13	0.2	1	3	UNIPROT
6324	SCN1B	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
6324	SCN1B	C4023511	Obtundation status	0.2	0	0	HPO
6326	SCN2A	C0009952	Febrile Convulsions	0.406737144536068	1	1	CTD_human;HPO
6326	SCN2A	C0013384	Dyskinetic syndrome	0.2	0	0	HPO
6326	SCN2A	C0014306	Enophthalmos	0.2	0	0	HPO
6326	SCN2A	C0014544	Epilepsy	0.423177685456902	2	0	CTD_human;HPO
6326	SCN2A	C0014550	Epilepsies, Myoclonic	0.200549453568426	0	0	HPO
6326	SCN2A	C0037769	West Syndrome	0.200824180352639	0	0	ORPHANET
6326	SCN2A	C0038220	Status Epilepticus	0.2	0	0	HPO
6326	SCN2A	C0085583	Choreoathetosis	0.2	0	0	HPO
6326	SCN2A	C0220669	Familial benign neonatal epilepsy	0.203846174978983	0	0	ORPHANET
6326	SCN2A	C0393706	Early infantile epileptic encephalopathy with suppression bursts	0.200824180352639	0	0	ORPHANET
6326	SCN2A	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
6326	SCN2A	C0494475	Tonic - clonic seizures	0.200274726784213	0	0	HPO
6326	SCN2A	C0543888	Epileptic encephalopathy	0.200824180352639	0	0	HPO
6326	SCN2A	C0751122	Infantile Severe Myoclonic Epilepsy	0.202472541057918	0	0	ORPHANET
6326	SCN2A	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
6326	SCN2A	C0752323	Focal Clonic Seizures	0.2	0	0	HPO
6326	SCN2A	C0877017	Partial seizures with secondary generalisation	0.2	0	0	HPO
6326	SCN2A	C1842382	Epilepsy, Benign Neonatal, 3	0.2	0	0	CTD_human
6326	SCN2A	C1843140	SEIZURES, BENIGN FAMILIAL INFANTILE, 3	0.201923087489492	5	13	UNIPROT
6326	SCN2A	C1858672	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1	0.28	0	0	ORPHANET
6326	SCN2A	C3150987	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11	0.4	5	13	CTD_human;UNIPROT
6326	SCN2A	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
6326	SCN2A	C4023511	Obtundation status	0.2	0	0	HPO
6326	SCN2A	C4023515	Dialeptic seizures	0.2	0	0	HPO
6326	SCN2A	C4049830	Focal seizures, afebril	0.2	0	0	HPO
6327	SCN2B	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
6327	SCN2B	C3809312	ATRIAL FIBRILLATION, FAMILIAL, 14	0.2	1	2	UNIPROT
6328	SCN3A	C0085417	Epilepsy, Complex Partial	0.2	1	0	CTD_human
6329	SCN4A	C0007789	Cerebral Palsy	0.2	0	0	HPO
6329	SCN4A	C0027127	Myotonia Congenita	0.203780662444353	1	1	CTD_human
6329	SCN4A	C0162292	External Ophthalmoplegia	0.2	0	0	HPO
6329	SCN4A	C0162674	Chronic progressive external ophthalmoplegia	0.2	0	0	HPO
6329	SCN4A	C0221055	Paramyotonia Congenita (disorder)	0.408241803526393	15	14	ORPHANET;UNIPROT
6329	SCN4A	C0238357	Hyperkalemic periodic paralysis	0.688227448149076	7	17	CTD_human;HPO;ORPHANET;UNIPROT
6329	SCN4A	C0238358	Hypokalemic periodic paralysis	0.41013618026125	1	0	CTD_human;ORPHANET
6329	SCN4A	C0751882	Myasthenic Syndromes, Congenital	0.201098907136852	1	3	CTD_human
6329	SCN4A	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	0.2	0	0	ORPHANET
6329	SCN4A	C0752355	Myotonia Fluctuans (disorder)	0.2	0	0	ORPHANET
6329	SCN4A	C0947912	Myasthenias	0.2	0	0	HPO
6329	SCN4A	C1279412	periodic paralysis (finding)	0.202747267842131	0	0	HPO
6329	SCN4A	C2750061	Hypokalemic Periodic Paralysis, Type 2	0.480274726784213	12	8	CTD_human;UNIPROT
6329	SCN4A	C2931826	Potassium aggravated myotonia	0.601648360705279	16	10	CTD_human;ORPHANET;UNIPROT
6329	SCN4A	C3280112	MYASTHENIC SYNDROME, CONGENITAL, 16	0.2	3	2	UNIPROT
6329	SCN4A	C3714580	Hypokalemic periodic paralysis type 1	0.201923087489492	0	0	CTD_human
6329	SCN4A	C4021553	Periodic hypokalemic paresis	0.2	0	0	HPO
6329	SCN4A	C4023179	Paradoxical myotonia	0.2	0	0	HPO
6329	SCN4A	C4275008	Acetazolamide responsive myotonia	0.2	0	0	ORPHANET
633	BGN	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
633	BGN	C1848097	Spondyloepimetaphyseal Dysplasia, X-Linked	0.4	1	2	ORPHANET;UNIPROT
6330	SCN4B	C0004245	Atrioventricular Block	0.2	0	0	HPO
6330	SCN4B	C0035828	Romano-Ward Syndrome	0.2	0	0	ORPHANET
6330	SCN4B	C1841659	Atrioventricular nodal disease	0.2	0	0	HPO
6330	SCN4B	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
6330	SCN4B	C2678484	Long Qt Syndrome 10	0.4	2	4	CTD_human;UNIPROT
6331	SCN5A	C0004238	Atrial Fibrillation	0.430384415649449	1	3	CTD_human;HPO
6331	SCN5A	C0004245	Atrioventricular Block	0.20433011601278	0	0	HPO
6331	SCN5A	C0018790	Cardiac Arrest	0.201648360705279	0	0	HPO
6331	SCN5A	C0023211	Left Bundle-Branch Block	0.200274726784213	0	0	HPO
6331	SCN5A	C0023976	Long QT Syndrome	0.295647684405353	8	13	CTD_human
6331	SCN5A	C0035828	Romano-Ward Syndrome	0.201373633921065	0	0	ORPHANET
6331	SCN5A	C0037052	Sick Sinus Syndrome	0.407114185634906	0	0	HPO;ORPHANET
6331	SCN5A	C0038644	Sudden infant death syndrome	0.426552596047783	2	7	CTD_human;UNIPROT
6331	SCN5A	C0040479	Torsades de Pointes	0.40761248204602	2	0	CTD_human;HPO
6331	SCN5A	C0042510	Ventricular Fibrillation	0.21790671939954	0	0	HPO
6331	SCN5A	C0042514	Tachycardia, Ventricular	0.208436662398659	1	0	CTD_human
6331	SCN5A	C0085615	Right bundle branch block	0.200824180352639	0	0	HPO
6331	SCN5A	C0235480	Paroxysmal atrial fibrillation	0.200274726784213	0	0	HPO
6331	SCN5A	C0264912	Left anterior fascicular block	0.2	0	0	HPO
6331	SCN5A	C0264913	Left posterior fascicular block	0.2	0	0	HPO
6331	SCN5A	C0340493	Paroxysmal familial ventricular fibrillation	0.203846174978983	0	0	CTD_human
6331	SCN5A	C1142166	Brugada Syndrome (disorder)	0.843535885475808	51	124	CTD_human;ORPHANET;UNIPROT
6331	SCN5A	C1832680	CARDIOMYOPATHY, DILATED, 1E	0.4	4	7	CTD_human;UNIPROT
6331	SCN5A	C1837845	SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE	0.400274726784213	5	7	CTD_human;UNIPROT
6331	SCN5A	C1838539	CARDIOMYOPATHY, FAMILIAL, WITH CONDUCTION DISTURBANCE	0.401923087489492	0	0	ORPHANET;UNIPROT
6331	SCN5A	C1841659	Atrioventricular nodal disease	0.2	0	0	HPO
6331	SCN5A	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
6331	SCN5A	C1859062	LONG QT SYNDROME 3	0.48796707674218	29	76	CTD_human;UNIPROT
6331	SCN5A	C1879286	Hereditary bundle branch system defect	0.681648360705279	6	12	CTD_human;ORPHANET;UNIPROT
6331	SCN5A	C2751898	Ventricular Fibrillation, Paroxysmal Familial, 1	0.4	1	2	ORPHANET;UNIPROT
6331	SCN5A	C2931401	Long QT syndrome type 3	0.204120901763196	1	0	CTD_human
6331	SCN5A	C3151464	ATRIAL FIBRILLATION, FAMILIAL, 10	0.2	2	13	UNIPROT
6331	SCN5A	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
6331	SCN5A	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
6334	SCN8A	C0013384	Dyskinetic syndrome	0.2	0	0	HPO
6334	SCN8A	C0014306	Enophthalmos	0.2	0	0	HPO
6334	SCN8A	C0014544	Epilepsy	0.404670355331623	1	0	CTD_human;HPO
6334	SCN8A	C0032768	Postherpetic neuralgia	0.2	1	0	CTD_human
6334	SCN8A	C0037769	West Syndrome	0.2	0	0	HPO
6334	SCN8A	C0038220	Status Epilepticus	0.2	1	0	CTD_human
6334	SCN8A	C0085583	Choreoathetosis	0.2	0	0	HPO
6334	SCN8A	C0220669	Familial benign neonatal epilepsy	0.2	0	0	ORPHANET
6334	SCN8A	C0234533	Generalized seizures	0.2	0	0	HPO
6334	SCN8A	C0543888	Epileptic encephalopathy	0.202472541057918	0	0	HPO
6334	SCN8A	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6334	SCN8A	C0752210	Dyskinesias, Paroxysmal	0.2	0	0	HPO
6334	SCN8A	C1527366	Salaam Seizures	0.2	0	0	HPO
6334	SCN8A	C1836830	Developmental regression	0.2	0	0	HPO
6334	SCN8A	C1865926	Infantile convulsions and paroxysmal choreoathetosis, familial (disorder)	0.2	0	0	ORPHANET
6334	SCN8A	C3281191	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.200274726784213	9	40	UNIPROT
6335	SCN9A	C0002768	Congenital Pain Insensitivity	0.209311999908611	0	0	ORPHANET
6335	SCN9A	C0003028	Anhidrosis	0.200274726784213	0	0	HPO
6335	SCN9A	C0009952	Febrile Convulsions	0.200824180352639	0	0	HPO
6335	SCN9A	C0013363	Dysautonomia	0.2	0	0	HPO
6335	SCN9A	C0014544	Epilepsy	0.201098907136852	0	0	HPO
6335	SCN9A	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
6335	SCN9A	C0014553	Absence Epilepsy	0.2	0	0	HPO
6335	SCN9A	C0014804	Erythromelalgia	0.419144742631014	3	0	CTD_human;ORPHANET
6335	SCN9A	C0014805	Primary Erythermalgia	0.40439562854741	11	13	ORPHANET;UNIPROT
6335	SCN9A	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
6335	SCN9A	C0020075	Hereditary Sensory Autonomic Neuropathy, Type 5	0.2	0	0	ORPHANET
6335	SCN9A	C0020620	Hypohidrosis	0.2	0	0	HPO
6335	SCN9A	C0030578	Paronychia Inflammation	0.2	0	0	HPO
6335	SCN9A	C0032768	Postherpetic neuralgia	0.2	1	0	CTD_human
6335	SCN9A	C0234958	muscle degeneration	0.2	0	0	HPO
6335	SCN9A	C0270846	Epileptic drop attack	0.2	0	0	HPO
6335	SCN9A	C0270914	Hereditary Motor and Sensory-Neuropathy Type II	0.2	0	0	ORPHANET
6335	SCN9A	C0494475	Tonic - clonic seizures	0.200274726784213	0	0	HPO
6335	SCN9A	C0751122	Infantile Severe Myoclonic Epilepsy	0.200824180352639	0	0	ORPHANET
6335	SCN9A	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
6335	SCN9A	C0752323	Focal Clonic Seizures	0.2	0	0	HPO
6335	SCN9A	C0917990	Acro-Osteolysis	0.2	0	0	HPO
6335	SCN9A	C1833661	PAROXYSMAL EXTREME PAIN DISORDER	0.603846174978984	2	10	CTD_human;ORPHANET;UNIPROT
6335	SCN9A	C1855739	Indifference to Pain, Congenital, Autosomal Recessive	0.481648360705279	1	6	CTD_human;UNIPROT
6335	SCN9A	C1858672	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1	0.2	0	0	ORPHANET
6335	SCN9A	C1858673	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	0.2	0	0	CTD_human
6335	SCN9A	C2751778	Generalized Epilepsy With Febrile Seizures Plus, 7	0.2	1	4	UNIPROT
6335	SCN9A	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
6335	SCN9A	C4023511	Obtundation status	0.2	0	0	HPO
6336	SCN10A	C0002768	Congenital Pain Insensitivity	0.200274726784213	0	0	ORPHANET
6336	SCN10A	C0004238	Atrial Fibrillation	0.201648360705279	1	0	CTD_human
6336	SCN10A	C0014544	Epilepsy	0.2	0	0	HPO
6336	SCN10A	C0014805	Primary Erythermalgia	0.2	0	0	ORPHANET
6336	SCN10A	C0018794	Heart Block	0.200549453568426	1	0	CTD_human
6336	SCN10A	C0020075	Hereditary Sensory Autonomic Neuropathy, Type 5	0.2	0	0	ORPHANET
6336	SCN10A	C0042510	Ventricular Fibrillation	0.2	1	0	CTD_human
6336	SCN10A	C1142166	Brugada Syndrome (disorder)	0.401648360705279	1	1	CTD_human;ORPHANET
6336	SCN10A	C1833661	PAROXYSMAL EXTREME PAIN DISORDER	0.2	0	0	ORPHANET
6336	SCN10A	C3809893	EPISODIC PAIN SYNDROME, FAMILIAL, 2	0.2	1	2	UNIPROT
6337	SCNN1A	C0006267	Bronchiectasis	0.2	0	0	HPO
6337	SCNN1A	C0008677	Bronchitis, Chronic	0.2	0	0	HPO
6337	SCNN1A	C0010674	Cystic Fibrosis	0.20678830169338	2	0	CTD_human
6337	SCNN1A	C0020428	Hyperaldosteronism	0.2	0	0	HPO
6337	SCNN1A	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
6337	SCNN1A	C0033805	Pseudohypoaldosteronism	0.406015278498054	1	0	CTD_human;HPO
6337	SCNN1A	C0221043	Liddle Syndrome	0.200824180352639	1	0	CTD_human
6337	SCNN1A	C0339985	Idiopathic bronchiectasis	0.2	0	0	ORPHANET
6337	SCNN1A	C1449843	Pseudohypoaldosteronism, Type I, Autosomal Recessive	0.400274726784213	3	2	ORPHANET;UNIPROT
6337	SCNN1A	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6337	SCNN1A	C2751666	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2	0.4	1	4	CTD_human;UNIPROT
6338	SCNN1B	C0006267	Bronchiectasis	0.202732912464814	0	0	HPO
6338	SCNN1B	C0007786	Brain Ischemia	0.2	0	0	HPO
6338	SCNN1B	C0008677	Bronchitis, Chronic	0.2	0	0	HPO
6338	SCNN1B	C0010674	Cystic Fibrosis	0.293301876602548	2	0	CTD_human
6338	SCNN1B	C0020428	Hyperaldosteronism	0.2	0	0	HPO
6338	SCNN1B	C0020595	Hypoaldosteronism	0.2	0	0	HPO
6338	SCNN1B	C0033805	Pseudohypoaldosteronism	0.405740551713841	0	0	CTD_human;HPO
6338	SCNN1B	C0035078	Kidney Failure	0.2	0	0	HPO
6338	SCNN1B	C0085570	Hypokalemic alkalosis	0.2	0	0	HPO
6338	SCNN1B	C0221043	Liddle Syndrome	0.683021994626344	8	5	CTD_human;ORPHANET;UNIPROT
6338	SCNN1B	C0339985	Idiopathic bronchiectasis	0.2	0	0	ORPHANET
6338	SCNN1B	C0917798	Cerebral Ischemia	0.2	0	0	HPO
6338	SCNN1B	C1449843	Pseudohypoaldosteronism, Type I, Autosomal Recessive	0.48	1	1	ORPHANET;UNIPROT
6338	SCNN1B	C1565489	Renal Insufficiency	0.2	0	0	HPO
6338	SCNN1B	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6338	SCNN1B	C2749757	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	0.4	3	7	CTD_human;UNIPROT
6340	SCNN1G	C0006267	Bronchiectasis	0.202732912464814	0	0	HPO
6340	SCNN1G	C0007786	Brain Ischemia	0.2	0	0	HPO
6340	SCNN1G	C0008677	Bronchitis, Chronic	0.2	0	0	HPO
6340	SCNN1G	C0010674	Cystic Fibrosis	0.211653515897269	1	0	CTD_human
6340	SCNN1G	C0020428	Hyperaldosteronism	0.2	0	0	HPO
6340	SCNN1G	C0020595	Hypoaldosteronism	0.200274726784213	0	0	HPO
6340	SCNN1G	C0033805	Pseudohypoaldosteronism	0.403007639249027	1	0	CTD_human;HPO
6340	SCNN1G	C0035078	Kidney Failure	0.2	0	0	HPO
6340	SCNN1G	C0085570	Hypokalemic alkalosis	0.2	0	0	HPO
6340	SCNN1G	C0221043	Liddle Syndrome	0.403021994626344	0	0	CTD_human;ORPHANET
6340	SCNN1G	C0339985	Idiopathic bronchiectasis	0.2	0	0	ORPHANET
6340	SCNN1G	C0917798	Cerebral Ischemia	0.2	0	0	HPO
6340	SCNN1G	C1449843	Pseudohypoaldosteronism, Type I, Autosomal Recessive	0.28	0	0	ORPHANET
6340	SCNN1G	C1565489	Renal Insufficiency	0.2	0	0	HPO
6340	SCNN1G	C2315100	Pediatric failure to thrive	0.200549453568426	0	0	HPO
6340	SCNN1G	C2751324	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3	0.2	0	0	CTD_human
6341	SCO1	C0002871	Anemia	0.2	0	0	HPO
6341	SCO1	C0007194	Hypertrophic Cardiomyopathy	0.200549453568426	0	0	HPO
6341	SCO1	C0014544	Epilepsy	0.2	0	0	HPO
6341	SCO1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6341	SCO1	C0029124	Optic Atrophy	0.2	0	0	HPO
6341	SCO1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
6341	SCO1	C0151747	Renal tubular disorder	0.2	0	0	HPO
6341	SCO1	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
6341	SCO1	C0238621	Aminoaciduria	0.2	0	0	HPO
6341	SCO1	C0341703	Adult Fanconi syndrome	0.2	0	0	HPO
6341	SCO1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6341	SCO1	C4273730	Fatal infantile cytochrome C oxidase deficiency	0.2	0	0	ORPHANET
6342	SCP2	C0004509	Azoospermia	0.2	0	0	HPO
6342	SCP2	C0152025	Polyneuropathy	0.2	1	0	CTD_human
6342	SCP2	C0948896	Primary hypogonadism	0.2	0	0	HPO
6342	SCP2	C3150990	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.4	0	0	CTD_human;ORPHANET
6343	SCT	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
6346	CCL1	C0017658	Glomerulonephritis	0.2	1	0	CTD_human
6346	CCL1	C0027707	Nephritis, Interstitial	0.2	1	0	CTD_human
6347	CCL2	C0004096	Asthma	0.214782410458571	1	0	CTD_human
6347	CCL2	C0004153	Atherosclerosis	0.244040886948157	3	0	CTD_human
6347	CCL2	C0007786	Brain Ischemia	0.28	2	0	CTD_human
6347	CCL2	C0010346	Crohn Disease	0.211825928366857	1	0	CTD_human
6347	CCL2	C0011881	Diabetic Nephropathy	0.20685381422801	1	0	CTD_human
6347	CCL2	C0013264	Muscular Dystrophy, Duchenne	0.2	1	0	CTD_human
6347	CCL2	C0017658	Glomerulonephritis	0.201923087489492	1	0	CTD_human
6347	CCL2	C0020500	Hyperoxaluria	0.2	1	0	CTD_human
6347	CCL2	C0021400	Influenza	0.204106546385879	1	0	CTD_human
6347	CCL2	C0022661	Kidney Failure, Chronic	0.287887208830233	2	0	CTD_human
6347	CCL2	C0023283	Leishmaniasis, Cutaneous	0.203231208875927	1	0	CTD_human
6347	CCL2	C0023890	Liver Cirrhosis	0.202956482091714	1	0	CTD_human
6347	CCL2	C0027707	Nephritis, Interstitial	0.2	1	0	CTD_human
6347	CCL2	C0032285	Pneumonia	0.280549453568426	1	0	CTD_human
6347	CCL2	C0034069	Pulmonary Fibrosis	0.28328236603324	3	0	CTD_human
6347	CCL2	C0035222	Respiratory Distress Syndrome, Adult	0.200549453568426	1	0	CTD_human
6347	CCL2	C0037116	Silicosis	0.200274726784213	1	0	CTD_human
6347	CCL2	C0037926	Compression of spinal cord	0.28	1	0	CTD_human
6347	CCL2	C0038220	Status Epilepticus	0.2	2	0	CTD_human
6347	CCL2	C0041327	Tuberculosis, Pulmonary	0.216807812262688	2	0	CTD_human
6347	CCL2	C0085129	Bronchial Hyperreactivity	0.282407028523288	1	0	CTD_human
6347	CCL2	C0151744	Myocardial Ischemia	0.206462417751855	1	0	CTD_human
6347	CCL2	C0241910	Hepatitis, Autoimmune	0.2	1	0	CTD_human
6347	CCL2	C0524620	Metabolic Syndrome X	0.205154296365419	2	0	CTD_human
6347	CCL2	C0740392	Infarction, Middle Cerebral Artery	0.2	3	0	CTD_human
6347	CCL2	C1956346	Coronary Artery Disease	0.301962108628107	2	0	CTD_human
6347	CCL2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6348	CCL3	C0004153	Atherosclerosis	0.200274726784213	1	0	CTD_human
6348	CCL3	C0007786	Brain Ischemia	0.2	2	0	CTD_human
6348	CCL3	C0017658	Glomerulonephritis	0.2	1	0	CTD_human
6348	CCL3	C0034069	Pulmonary Fibrosis	0.2	2	0	CTD_human
6348	CCL3	C0038220	Status Epilepticus	0.28	1	0	CTD_human
6348	CCL3	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
635	BHMT	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	0	CTD_human
635	BHMT	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
6351	CCL4	C0004153	Atherosclerosis	0.200549453568426	1	0	CTD_human
6351	CCL4	C0007786	Brain Ischemia	0.2	1	0	CTD_human
6351	CCL4	C0017658	Glomerulonephritis	0.2	1	0	CTD_human
6351	CCL4	C0032285	Pneumonia	0.2	1	0	CTD_human
6351	CCL4	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
6351	CCL4	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
6352	CCL5	C0004096	Asthma	0.260367665065757	1	0	CTD_human
6352	CCL5	C0011615	Dermatitis, Atopic	0.207887208830233	1	0	CTD_human
6352	CCL5	C0017658	Glomerulonephritis	0.200549453568426	1	0	CTD_human
6352	CCL5	C0019187	Hepatitis, Alcoholic	0.200274726784213	1	0	CTD_human
6352	CCL5	C0020500	Hyperoxaluria	0.2	1	0	CTD_human
6352	CCL5	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
6352	CCL5	C0034069	Pulmonary Fibrosis	0.203007639249027	1	0	CTD_human
6352	CCL5	C0241910	Hepatitis, Autoimmune	0.2	1	0	CTD_human
6354	CCL7	C0008370	Cholestasis	0.2	1	0	CTD_human
6354	CCL7	C0017658	Glomerulonephritis	0.28	1	0	CTD_human
6354	CCL7	C0027707	Nephritis, Interstitial	0.28	1	0	CTD_human
6354	CCL7	C0032285	Pneumonia	0.2	1	0	CTD_human
6354	CCL7	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
6355	CCL8	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
6355	CCL8	C0021400	Influenza	0.2	1	0	CTD_human
6355	CCL8	C0032285	Pneumonia	0.2	1	0	CTD_human
6355	CCL8	C1619692	Nephrogenic Fibrosing Dermopathy	0.2	1	0	CTD_human
6356	CCL11	C0004096	Asthma	0.318741210136161	0	0	CTD_human
6356	CCL11	C0007786	Brain Ischemia	0.202407028523288	1	0	CTD_human
6356	CCL11	C0011615	Dermatitis, Atopic	0.205964121340741	1	0	CTD_human
6356	CCL11	C0032285	Pneumonia	0.200274726784213	1	0	CTD_human
6356	CCL11	C0034069	Pulmonary Fibrosis	0.203007639249027	2	0	CTD_human
6361	CCL17	C0011615	Dermatitis, Atopic	0.223251289016893	1	0	CTD_human
6361	CCL17	C0032285	Pneumonia	0.2	1	0	CTD_human
6363	CCL19	C0032285	Pneumonia	0.2	1	0	CTD_human
6363	CCL19	C0162820	Dermatitis, Allergic Contact	0.202732912464814	1	0	CTD_human
6364	CCL20	C0009324	Ulcerative Colitis	0.201098907136852	1	0	CTD_human
6364	CCL20	C0011854	Diabetes Mellitus, Insulin-Dependent	0.2	1	0	CTD_human
6364	CCL20	C0032285	Pneumonia	0.200274726784213	1	0	CTD_human
6366	CCL21	C0003873	Rheumatoid Arthritis	0.229052169128711	3	2	CTD_human
6367	CCL22	C0011615	Dermatitis, Atopic	0.212305283780321	2	0	CTD_human
6369	CCL24	C0011615	Dermatitis, Atopic	0.200274726784213	1	0	CTD_human
6369	CCL24	C0032285	Pneumonia	0.200549453568426	1	0	CTD_human
6372	CXCL6	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
6372	CXCL6	C0029408	Degenerative polyarthritis	0.200274726784213	1	0	CTD_human
6373	CXCL11	C0282488	Interstitial Cystitis	0.2	1	0	CTD_human
6374	CXCL5	C0032285	Pneumonia	0.200824180352639	1	0	CTD_human
6376	CX3CL1	C0032285	Pneumonia	0.2	1	0	CTD_human
6376	CX3CL1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
6386	SDCBP	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
63869	PSORS6	C0033860	Psoriasis	0.203780662444353	0	0	CTD_human
6387	CXCL12	C0266929	Chronic Periodontitis	0.200274726784213	1	0	CTD_human
6387	CXCL12	C1956346	Coronary Artery Disease	0.208385505241346	1	0	CTD_human
63870	PSORS5	C0033860	Psoriasis	0.20350593566014	0	0	CTD_human
6389	SDHA	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
6389	SDHA	C0014544	Epilepsy	0.2	0	0	HPO
6389	SDHA	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6389	SDHA	C0020555	Hypertrichosis	0.2	0	0	HPO
6389	SDHA	C0021843	Intestinal Obstruction	0.2	0	0	HPO
6389	SDHA	C0023264	Leigh Disease	0.600549453568426	3	2	CTD_human;ORPHANET;UNIPROT
6389	SDHA	C0028738	Nystagmus	0.2	0	0	HPO
6389	SDHA	C0029124	Optic Atrophy	0.200274726784213	0	0	HPO
6389	SDHA	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
6389	SDHA	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
6389	SDHA	C0038379	Strabismus	0.2	0	0	HPO
6389	SDHA	C0042798	Low Vision	0.2	0	0	HPO
6389	SDHA	C0338474	Central nervous system demyelination	0.2	0	0	HPO
6389	SDHA	C1145670	Respiratory Failure	0.2	0	0	HPO
6389	SDHA	C1836830	Developmental regression	0.2	0	0	HPO
6389	SDHA	C1855008	Mitochondrial Complex II Deficiency	0.6	2	12	CTD_human;ORPHANET;UNIPROT
6389	SDHA	C1960469	Left ventricular noncompaction	0.2	0	0	HPO
6389	SDHA	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
6389	SDHA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6389	SDHA	C3150898	CARDIOMYOPATHY, DILATED, 1GG	0.2	0	0	UNIPROT
6389	SDHA	C3279992	PARAGANGLIOMAS 5	0.2	1	12	UNIPROT
6389	SDHA	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
6389	SDHA	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
6389	SDHA	C4020801	Respiratory complex II deficiency	0.2	0	0	HPO
6389	SDHA	C4020871	Dystonic disease	0.2	0	0	HPO
6389	SDHA	C4025278	Stress/infection-induced lactic acidosis	0.2	0	0	HPO
63892	THADA	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.254602988217615	1	1	CTD_human
63894	VIPAS39	C1859722	Arthrogryposis renal dysfunction cholestasis syndrome	0.401648360705279	1	0	CTD_human;ORPHANET
63895	PIEZO2	C0220666	ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA	0.400274726784213	1	2	ORPHANET;UNIPROT
63895	PIEZO2	C0796033	MARDEN-WALKER SYNDROME	0.400274726784213	1	1	ORPHANET;UNIPROT
63895	PIEZO2	C1834523	ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.2	0	0	ORPHANET
63895	PIEZO2	C1862472	Oculomelic amyoplasia	0.400824180352639	2	11	ORPHANET;UNIPROT
639	PRDM1	C0003873	Rheumatoid Arthritis	0.205638237399215	3	0	CTD_human
639	PRDM1	C0009324	Ulcerative Colitis	0.2	1	1	CTD_human
639	PRDM1	C0024141	Lupus Erythematosus, Systemic	0.283780662444354	1	0	CTD_human
639	PRDM1	C1527336	Sjogren's Syndrome	0.2	1	0	CTD_human
6390	SDHB	C0018801	Heart failure	0.2	0	0	HPO
6390	SDHB	C0018802	Congestive heart failure	0.2	0	0	HPO
6390	SDHB	C0020437	Hypercalcemia	0.2	0	0	HPO
6390	SDHB	C0021843	Intestinal Obstruction	0.2	0	0	HPO
6390	SDHB	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
6390	SDHB	C0024421	Macroglossia	0.2	0	0	HPO
6390	SDHB	C0040412	Fissured tongue	0.2	0	0	HPO
6390	SDHB	C0042109	Urticaria	0.2	0	0	HPO
6390	SDHB	C0151311	Cranial nerve palsies	0.2	0	0	HPO
6390	SDHB	C0152132	Hypertensive Retinopathy	0.2	0	0	HPO
6390	SDHB	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
6390	SDHB	C0751559	Pulsatile Tinnitus	0.2	0	0	HPO
6390	SDHB	C1855008	Mitochondrial Complex II Deficiency	0.200549453568426	0	0	ORPHANET
6390	SDHB	C2676500	COWDEN-LIKE SYNDROME (disorder)	0.2	0	0	CTD_human
6390	SDHB	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
6390	SDHB	C4021849	Conjunctival hamartoma	0.2	0	0	HPO
6390	SDHB	C4025693	Hypertension associated with pheochromocytoma	0.2	0	0	HPO
63901	FAM111A	C0265291	Kenny-Caffey syndrome	0.400274726784213	3	2	ORPHANET;UNIPROT
63901	FAM111A	C1865639	Gracile bone dysplasia	0.400274726784213	1	3	ORPHANET;UNIPROT
6391	SDHC	C0021843	Intestinal Obstruction	0.2	0	0	HPO
6391	SDHC	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
6391	SDHC	C0024421	Macroglossia	0.2	0	0	HPO
6391	SDHC	C0040412	Fissured tongue	0.2	0	0	HPO
6391	SDHC	C0042109	Urticaria	0.2	0	0	HPO
6391	SDHC	C0042928	Vocal Cord Paralysis	0.2	0	0	HPO
6391	SDHC	C0151311	Cranial nerve palsies	0.2	0	0	HPO
6391	SDHC	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
6391	SDHC	C1854336	PARAGANGLIOMAS 3	0.200824180352639	0	0	CTD_human
6391	SDHC	C4021849	Conjunctival hamartoma	0.2	0	0	HPO
6391	SDHC	C4025693	Hypertension associated with pheochromocytoma	0.2	0	0	HPO
63910	SLC17A9	C0265970	Porokeratosis, Disseminated Superficial Actinic	0.200274726784213	0	0	ORPHANET
63910	SLC17A9	C4015128	POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE	0.2	1	2	UNIPROT
63916	ELMO2	C1847197	Vascular Malformation, Primary Intraosseous	0.2	0	0	ORPHANET
6392	SDHD	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
6392	SDHD	C0014544	Epilepsy	0.2	0	0	HPO
6392	SDHD	C0018777	Conductive hearing loss	0.2	0	0	HPO
6392	SDHD	C0018801	Heart failure	0.2	0	0	HPO
6392	SDHD	C0018802	Congestive heart failure	0.2	0	0	HPO
6392	SDHD	C0020437	Hypercalcemia	0.2	0	0	HPO
6392	SDHD	C0021843	Intestinal Obstruction	0.2	0	0	HPO
6392	SDHD	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
6392	SDHD	C0024421	Macroglossia	0.2	0	0	HPO
6392	SDHD	C0024586	Malignant Carcinoid Syndrome	0.2	0	0	ORPHANET
6392	SDHD	C0028738	Nystagmus	0.2	0	0	HPO
6392	SDHD	C0029124	Optic Atrophy	0.2	0	0	HPO
6392	SDHD	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
6392	SDHD	C0040412	Fissured tongue	0.2	0	0	HPO
6392	SDHD	C0042798	Low Vision	0.2	0	0	HPO
6392	SDHD	C0042928	Vocal Cord Paralysis	0.2	0	0	HPO
6392	SDHD	C0151311	Cranial nerve palsies	0.2	0	0	HPO
6392	SDHD	C0152132	Hypertensive Retinopathy	0.2	0	0	HPO
6392	SDHD	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
6392	SDHD	C1836830	Developmental regression	0.2	0	0	HPO
6392	SDHD	C1855008	Mitochondrial Complex II Deficiency	0.400549453568426	2	3	ORPHANET;UNIPROT
6392	SDHD	C1960469	Left ventricular noncompaction	0.2	0	0	HPO
6392	SDHD	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
6392	SDHD	C2676500	COWDEN-LIKE SYNDROME (disorder)	0.2	0	0	CTD_human
6392	SDHD	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
6392	SDHD	C4020801	Respiratory complex II deficiency	0.2	0	0	HPO
6392	SDHD	C4020871	Dystonic disease	0.2	0	0	HPO
6392	SDHD	C4021849	Conjunctival hamartoma	0.2	0	0	HPO
6392	SDHD	C4025278	Stress/infection-induced lactic acidosis	0.2	0	0	HPO
6392	SDHD	C4025693	Hypertension associated with pheochromocytoma	0.2	0	0	HPO
63924	CIDEC	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
63924	CIDEC	C3808940	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5	0.2	0	0	ORPHANET
63925	ZNF335	C3554499	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE	0.48	1	2	ORPHANET;UNIPROT
63929	XPNPEP3	C3150419	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.4	1	1	CTD_human;UNIPROT
63976	PRDM16	C1842870	Chromosome 1p36 Deletion Syndrome	0.200549453568426	0	0	ORPHANET
63976	PRDM16	C1960469	Left ventricular noncompaction	0.200274726784213	0	0	ORPHANET
63976	PRDM16	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
63976	PRDM16	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.4	1	2	ORPHANET;UNIPROT
63982	ANO3	C0009952	Febrile Convulsions	0.200274726784213	1	1	CTD_human
63982	ANO3	C3554374	DYSTONIA 24	0.400274726784213	1	2	ORPHANET;UNIPROT
6399	TRAPPC2	C0029410	Osteoarthritis of hip	0.2	0	0	HPO
6399	TRAPPC2	C0038015	Spondyloepiphyseal Dysplasia	0.402747267842131	0	0	HPO;ORPHANET
640	BLK	C0003873	Rheumatoid Arthritis	0.20433011601278	2	1	CTD_human
640	BLK	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200274726784213	0	0	ORPHANET
640	BLK	C0024141	Lupus Erythematosus, Systemic	0.22853142631492	1	3	CTD_human
640	BLK	C0026691	Mucocutaneous Lymph Node Syndrome	0.201098907136852	1	0	CTD_human
640	BLK	C0028754	Obesity	0.200274726784213	0	0	HPO
640	BLK	C0342276	Maturity onset diabetes mellitus in young	0.200549453568426	0	0	HPO
640	BLK	C3150618	Maturity-onset diabetes of the young, type 11	0.2	0	0	CTD_human
6401	SELE	C0004238	Atrial Fibrillation	0.202732912464814	1	0	CTD_human
6401	SELE	C0007786	Brain Ischemia	0.204814057046576	1	0	CTD_human
6401	SELE	C0011615	Dermatitis, Atopic	0.20328236603324	1	0	CTD_human
6401	SELE	C0017661	IGA Glomerulonephritis	0.205414667772315	0	0	CTD_human
6401	SELE	C0020443	Hypercholesterolemia	0.208422307021342	1	0	CTD_human
6401	SELE	C0026769	Multiple Sclerosis	0.205363510615002	1	0	CTD_human
6401	SELE	C0042109	Urticaria	0.2	1	0	CTD_human
6401	SELE	C0085580	Essential Hypertension	0.201373633921065	0	0	CTD_human
6401	SELE	C0151744	Myocardial Ischemia	0.202407028523288	1	0	CTD_human
6401	SELE	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
6402	SELL	C0017661	IGA Glomerulonephritis	0.208422307021342	0	0	CTD_human
6402	SELL	C0027051	Myocardial Infarction	0.200274726784213	1	0	CTD_human
6403	SELP	C0032231	Pleurisy	0.2	1	0	CTD_human
6403	SELP	C0151744	Myocardial Ischemia	0.200274726784213	1	0	CTD_human
6403	SELP	C1840253	IgE RESPONSIVENESS, ATOPIC	0.2	0	0	CTD_human
6404	SELPLG	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
64069	ATOD1	C1864155	Dermatitis, Atopic, 1	0.2	0	0	CTD_human
64072	CDH23	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
64072	CDH23	C1568247	Usher Syndrome, Type I	0.202472541057918	0	0	ORPHANET
64072	CDH23	C1832394	Deafness, Autosomal Recessive 12	0.480549453568426	8	9	CTD_human;UNIPROT
64072	CDH23	C1832845	USHER SYNDROME, TYPE ID	0.281923087489492	6	40	UNIPROT
64072	CDH23	C2931208	Usher syndrome, type 1D	0.202472541057918	0	0	CTD_human
64087	MCCC2	C0268600	3-methylcrotonyl CoA carboxylase 1 deficiency	0.200549453568426	0	0	ORPHANET
64087	MCCC2	C1859499	3-methylcrotonyl CoA carboxylase 2 deficiency	0.4	5	40	CTD_human;UNIPROT
64093	SMOC1	C0599973	Waardenburg Anophthalmia Syndrome	0.481098907136852	2	3	ORPHANET;UNIPROT
64094	SMOC2	C0399379	Dentin dysplasia, type 1	0.200274726784213	0	0	ORPHANET
641	BLM	C0004509	Azoospermia	0.2	0	0	HPO
641	BLM	C0005859	Bloom Syndrome	0.739615860116024	4	73	CTD_human;ORPHANET;UNIPROT
641	BLM	C0006267	Bronchiectasis	0.2	0	0	HPO
641	BLM	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	0	0	HPO
641	BLM	C0020555	Hypertrichosis	0.2	0	0	HPO
641	BLM	C0037199	Sinusitis	0.2	0	0	HPO
641	BLM	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
641	BLM	C0162539	IgG Deficiency	0.2	0	0	HPO
641	BLM	C0746102	Chronic lung disease	0.2	0	0	HPO
64108	RTP4	C0021400	Influenza	0.2	1	0	CTD_human
64116	SLC39A8	C4225234	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn	0.4	1	5	ORPHANET;UNIPROT
64127	NOD2	C0003872	Arthritis, Psoriatic	0.219922351446673	0	0	CTD_human
64127	NOD2	C0009324	Ulcerative Colitis	0.315642705061117	1	0	CTD_human
64127	NOD2	C0010346	Crohn Disease	0.52	6	4	CTD_human
64127	NOD2	C0036202	Sarcoidosis	0.22867054240954	0	0	CTD_human
64127	NOD2	C1836122	SARCOIDOSIS, EARLY-ONSET	0.402197814273705	3	10	CTD_human;UNIPROT
64127	NOD2	C1861303	SYNOVITIS, GRANULOMATOUS, WITH UVEITIS AND CRANIAL NEUROPATHIES (disorder)	0.62377020515728	11	7	CTD_human;ORPHANET;UNIPROT
64131	XYLT1	C0033847	Pseudoxanthoma Elasticum	0.40328236603324	1	1	CTD_human;UNIPROT
64131	XYLT1	C0432242	Desbuquois syndrome	0.200274726784213	0	0	ORPHANET
64131	XYLT1	C4014294	DESBUQUOIS DYSPLASIA 2	0.2	2	6	UNIPROT
64132	XYLT2	C0033847	Pseudoxanthoma Elasticum	0.400549453568426	1	1	CTD_human;UNIPROT
64132	XYLT2	C4225412	Spondylo-ocular syndrome	0.200274726784213	0	0	ORPHANET
641339	ZNF674	C1136249	Mental Retardation, X-Linked	0.203007639249027	1	0	CTD_human
64135	IFIH1	C0018213	Graves Disease	0.20350593566014	1	0	CTD_human
64135	IFIH1	C0021400	Influenza	0.200824180352639	1	0	CTD_human
64135	IFIH1	C0024141	Lupus Erythematosus, Systemic	0.288385505241346	2	1	CTD_human
64135	IFIH1	C0033860	Psoriasis	0.205638237399215	1	2	CTD_human
64135	IFIH1	C0042900	Vitiligo	0.2	1	0	CTD_human
64135	IFIH1	C0162538	Immunoglobulin A deficiency (disorder)	0.202407028523288	2	0	CTD_human
64135	IFIH1	C0393591	AICARDI-GOUTIERES SYNDROME	0.201923087489492	0	0	ORPHANET
64135	IFIH1	C0796126	AICARDI-GOUTIERES SYNDROME 1	0.201923087489492	1	0	CTD_human
64135	IFIH1	C1857808	DIABETES MELLITUS, INSULIN-DEPENDENT, 19 (disorder)	0.2	0	0	CTD_human
64135	IFIH1	C3888244	AICARDI-GOUTIERES SYNDROME 7	0.2	2	8	UNIPROT
64135	IFIH1	C4225427	SINGLETON-MERTEN SYNDROME 1	0.4	1	1	ORPHANET;UNIPROT
6414	SELENOP	C0014175	Endometriosis	0.2	1	0	CTD_human
641433	RP32	C1835927	RETINITIS PIGMENTOSA 32 (disorder)	0.2	0	0	CTD_human
6415	SELENOW	C0014544	Epilepsy	0.2	1	0	CTD_human
64167	ERAP2	C0010346	Crohn Disease	0.200274726784213	1	3	CTD_human
64170	CARD9	C0009324	Ulcerative Colitis	0.203231208875927	1	4	CTD_human
64170	CARD9	C0017661	IGA Glomerulonephritis	0.2	1	1	CTD_human
64170	CARD9	C0038013	Ankylosing spondylitis	0.201098907136852	1	2	CTD_human
64170	CARD9	C1859353	Candidiasis, Familial, 2	0.6	2	5	CTD_human;ORPHANET;UNIPROT
64175	P3H1	C0268362	Osteogenesis imperfecta type III (disorder)	0.2	0	0	ORPHANET
64175	P3H1	C1970458	Osteogenesis imperfecta, type VIII	0.280274726784213	0	0	CTD_human
642	BLMH	C0002395	Alzheimer's Disease	0.212151812308383	0	0	CTD_human
64218	SEMA4A	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
64218	SEMA4A	C1846529	CONE-ROD DYSTROPHY 10	0.4	0	0	CTD_human;UNIPROT
64218	SEMA4A	C1853214	RETINITIS PIGMENTOSA 35	0.4	1	3	CTD_human;UNIPROT
64220	STRA6	C1832661	ANOPHTHALMIA AND PULMONARY HYPOPLASIA	0.601648360705279	3	14	CTD_human;ORPHANET;UNIPROT
64220	STRA6	C1845877	Microphthalmia, Isolated, with Coloboma 1	0.2	0	0	ORPHANET
64221	ROBO3	C1846496	Gaze Palsy, Familial Horizontal, with Progressive Scoliosis	0.68357144819477	1	9	CTD_human;ORPHANET;UNIPROT
64224	HERPUD2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
64231	MS4A6A	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
64239	RSCIS	C1854244	Radiation Sensitivity Chromosome Instability Syndrome, Autosomal Dominant	0.2	0	0	CTD_human
6424	SFRP4	C0011334	Dental caries	0.2	0	0	HPO
6424	SFRP4	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200549453568426	1	0	CTD_human
6424	SFRP4	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
6424	SFRP4	C0265294	Pyle metaphyseal dysplasia	0.480274726784213	0	0	HPO;ORPHANET
64240	ABCG5	C0004153	Atherosclerosis	0.206462417751855	1	0	CTD_human
64240	ABCG5	C0010068	Coronary heart disease	0.207495812354077	1	0	CTD_human
64240	ABCG5	C0043325	Xanthomatosis	0.2	1	0	CTD_human
64240	ABCG5	C1956346	Coronary Artery Disease	0.200549453568426	2	0	CTD_human
64241	ABCG8	C1956346	Coronary Artery Disease	0.211001748014218	1	0	CTD_human
64241	ABCG8	C1969115	GALLBLADDER DISEASE 4	0.2	0	0	CTD_human
643	CXCR5	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
64321	SOX17	C0042580	Vesico-Ureteral Reflux	0.200274726784213	0	0	ORPHANET
64321	SOX17	C3150927	VESICOURETERAL REFLUX 3	0.4	1	2	CTD_human;UNIPROT
64324	NSD1	C0004903	Beckwith-Wiedemann Syndrome	0.20328236603324	0	0	CTD_human
64324	NSD1	C0175695	Sotos' syndrome	0.627550867601633	14	181	CTD_human;ORPHANET;UNIPROT
64324	NSD1	C0265210	Weaver syndrome	0.401373633921066	1	0	CTD_human;ORPHANET
64327	LMBR1	C1851100	LAURIN-SANDROW SYNDROME	0.2	0	0	ORPHANET
64327	LMBR1	C1861098	Tibia, Hypoplasia of, with Polydactyly	0.2	0	0	ORPHANET
64327	LMBR1	C1861355	Syndactyly, Type IV	0.400274726784213	0	0	CTD_human;ORPHANET
64327	LMBR1	C1868114	POLYDACTYLY, PREAXIAL II (disorder)	0.400549453568426	0	0	CTD_human;ORPHANET
64333	ARHGAP9	C0010073	Coronary Artery Vasospasm	0.200274726784213	1	0	CTD_human
64374	SIL1	C0024814	Marinesco-Sjogren syndrome	0.284945082115836	0	0	ORPHANET
64375	IKZF4	C0002171	Alopecia Areata	0.202407028523288	1	1	CTD_human
64375	IKZF4	C0042900	Vitiligo	0.2	1	2	CTD_human
64377	CHST8	C4015729	PEELING SKIN SYNDROME 3	0.4	1	1	ORPHANET;UNIPROT
6439	SFTPB	C0034050	Pulmonary Alveolar Proteinosis	0.201098907136852	0	0	HPO
6439	SFTPB	C0035220	Respiratory Distress Syndrome, Newborn	0.229630333451772	0	0	ORPHANET
6439	SFTPB	C0238378	Desquamative interstitial pneumonia	0.2	0	0	HPO
6439	SFTPB	C1145670	Respiratory Failure	0.20357144819477	0	0	HPO
6439	SFTPB	C1968593	Respiratory Distress Syndrome In Premature Infants	0.2	0	0	ORPHANET
6439	SFTPB	C1968602	Surfactant Metabolism Dysfunction, Pulmonary, 1	0.6	1	1	CTD_human;ORPHANET;UNIPROT
6439	SFTPB	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6439	SFTPB	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
6439	SFTPB	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
644	BLVRA	C0008350	Cholelithiasis	0.2	0	0	HPO
644	BLVRA	C0008370	Cholestasis	0.4	1	0	CTD_human;HPO
644	BLVRA	C3279964	HYPERBILIVERDINEMIA	0.200274726784213	0	0	ORPHANET
6440	SFTPC	C0020455	Hypergammaglobulinemia	0.2	0	0	HPO
6440	SFTPC	C0023890	Liver Cirrhosis	0.2	0	0	HPO
6440	SFTPC	C0032285	Pneumonia	0.200824180352639	0	0	HPO
6440	SFTPC	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
6440	SFTPC	C0034050	Pulmonary Alveolar Proteinosis	0.200549453568426	0	0	HPO
6440	SFTPC	C0034069	Pulmonary Fibrosis	0.205703749933845	0	0	HPO
6440	SFTPC	C0035220	Respiratory Distress Syndrome, Newborn	0.207561324888707	0	0	ORPHANET
6440	SFTPC	C0206061	Pneumonia, Interstitial	0.201923087489492	0	0	HPO
6440	SFTPC	C1800706	Idiopathic Pulmonary Fibrosis	0.40357144819477	0	0	CTD_human;ORPHANET
6440	SFTPC	C1968593	Respiratory Distress Syndrome In Premature Infants	0.2	0	0	ORPHANET
6440	SFTPC	C1968602	Surfactant Metabolism Dysfunction, Pulmonary, 1	0.2	0	0	CTD_human
6440	SFTPC	C1970470	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2 (disorder)	0.6	5	6	CTD_human;ORPHANET;UNIPROT
6440	SFTPC	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6440	SFTPC	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
6440	SFTPC	C3203102	Idiopathic pulmonary arterial hypertension	0.200274726784213	0	0	HPO
644096	SDHAF1	C0011269	Dementia, Vascular	0.2	1	0	CTD_human
644096	SDHAF1	C1855008	Mitochondrial Complex II Deficiency	0.6	1	2	CTD_human;ORPHANET;UNIPROT
64419	MTMR14	C1834558	Myopathy, Centronuclear, Autosomal Dominant	0.6	1	2	CTD_human;ORPHANET;UNIPROT
6442	SGCA	C1404521	Limb-girdle myopathy	0.2	0	0	HPO
6442	SGCA	C1842552	Limb-girdle muscle atrophy	0.2	0	0	HPO
6442	SGCA	C2936331	Sarcoglycanopathies	0.200274726784213	0	0	CTD_human
6442	SGCA	C2936332	Alpha-Sarcoglycanopathies	0.48439562854741	6	35	ORPHANET;UNIPROT
64421	DCLRE1C	C1865370	Severe combined immunodeficiency with sensitivity to ionizing radiation	0.680274726784213	1	4	CTD_human;ORPHANET;UNIPROT
64421	DCLRE1C	C1865371	SEVERE COMBINED IMMUNODEFICIENCY, ATHABASKAN-TYPE	0.2	0	0	ORPHANET
64421	DCLRE1C	C2700553	Omenn Syndrome	0.401373633921066	1	1	ORPHANET;UNIPROT
64421	DCLRE1C	C2931884	Reticuloendotheliosis, familial, with eosinophilia	0.2	0	0	CTD_human
64423	INF2	C0017668	Focal glomerulosclerosis	0.206043989252688	1	0	CTD_human
64423	INF2	C2750475	Focal Segmental Glomerulosclerosis 5	0.4	5	6	CTD_human;UNIPROT
64423	INF2	C3280845	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E	0.4	5	5	ORPHANET;UNIPROT
6443	SGCB	C0026850	Muscular Dystrophy	0.201648360705279	0	0	HPO
6443	SGCB	C0240679	Pelvic girdle muscle atrophy	0.2	0	0	HPO
6443	SGCB	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
6443	SGCB	C1858593	Limb-girdle muscular dystrophy, type 2E	0.680824180352639	3	22	CTD_human;ORPHANET;UNIPROT
6444	SGCD	C0026850	Muscular Dystrophy	0.201923087489492	0	0	HPO
6444	SGCD	C1832525	Limb-girdle muscular dystrophy type 2F	0.681098907136852	2	6	CTD_human;ORPHANET;UNIPROT
6444	SGCD	C1847667	CARDIOMYOPATHY, DILATED, 1L	0.48	1	1	CTD_human;UNIPROT
6444	SGCD	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
6444	SGCD	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
6444	SGCD	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
64446	DNAI2	C0022521	Kartagener Syndrome	0.203831819601666	0	0	ORPHANET
64446	DNAI2	C2676235	CILIARY DYSKINESIA, PRIMARY, 9	0.2	0	0	CTD_human
6445	SGCG	C0026850	Muscular Dystrophy	0.203296721410557	0	0	HPO
6445	SGCG	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
6445	SGCG	C0032285	Pneumonia	0.2	0	0	HPO
6445	SGCG	C0085581	Restrictive lung disease	0.2	0	0	HPO
6445	SGCG	C0162770	Right Ventricular Hypertrophy	0.2	0	0	HPO
6445	SGCG	C0234958	muscle degeneration	0.200274726784213	0	0	HPO
6445	SGCG	C0410173	Severe autosomal recessive muscular dystrophy of childhood - North African type (disorder)	0.68357144819477	2	14	CTD_human;ORPHANET;UNIPROT
6446	SGK1	C0041948	Uremia	0.2	1	0	CTD_human
64478	CSMD1	C0033860	Psoriasis	0.202681755307501	1	1	CTD_human
6448	SGSH	C0014544	Epilepsy	0.2	0	0	HPO
6448	SGSH	C0026706	Mucopolysaccharidosis III	0.204381273170092	0	0	CTD_human
6448	SGSH	C0086647	Mucopolysaccharidosis Type IIIA	0.490439617800098	13	37	ORPHANET;UNIPROT
6448	SGSH	C0086795	Pfaundler-Hurler Syndrome	0.200274726784213	0	0	HPO
6448	SGSH	C0205700	Asymmetric Septal Hypertrophy	0.2	0	0	HPO
6448	SGSH	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
6452	SH3BP2	C0008029	Cherubism	0.690974715991207	3	4	CTD_human;ORPHANET;UNIPROT
6452	SH3BP2	C0015300	Exophthalmos	0.2	0	0	HPO
6452	SH3BP2	C0042798	Low Vision	0.2	0	0	HPO
6452	SH3BP2	C0549122	Relative afferent pupillary defect	0.2	0	0	HPO
6452	SH3BP2	C3887709	Optic Neuropathy	0.2	0	0	HPO
64581	CLEC7A	C0006845	Candidiasis, Chronic Mucocutaneous	0.200274726784213	0	0	ORPHANET
64581	CLEC7A	C1859353	Candidiasis, Familial, 2	0.2	0	0	CTD_human
64585	BOS2	C1852718	Branchiootic Syndrome 2	0.2	0	0	CTD_human
6462	SHBG	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.209484412378199	1	0	CTD_human
6462	SHBG	C0242350	Erectile dysfunction	0.2	1	0	CTD_human
6462	SHBG	C0524620	Metabolic Syndrome X	0.20357144819477	2	0	CTD_human
6463	SHFM2	C1839258	SPLIT-HAND/FOOT MALFORMATION 2	0.200824180352639	0	0	CTD_human
6464	SHC1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
64644	GINGF2	C0399440	Hereditary gingival fibromatosis	0.200549453568426	0	0	CTD_human
64644	GINGF2	C1854181	FIBROMATOSIS, GINGIVAL, 2	0.2	0	0	CTD_human
6469	SHH	C0014544	Epilepsy	0.200274726784213	0	0	HPO
6469	SHH	C0015923	Fetal Alcohol Syndrome	0.2	1	0	PSYGENET
6469	SHH	C0020295	Hydronephrosis	0.2	0	0	HPO
6469	SHH	C0030569	Secondary Parkinson Disease	0.2	1	0	CTD_human
6469	SHH	C0038379	Strabismus	0.2	0	0	HPO
6469	SHH	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
6469	SHH	C1840529	HOLOPROSENCEPHALY 3	0.48	13	30	CTD_human;UNIPROT
6469	SHH	C1845877	Microphthalmia, Isolated, with Coloboma 1	0.2	0	0	ORPHANET
6469	SHH	C1861098	Tibia, Hypoplasia of, with Polydactyly	0.2	0	0	ORPHANET
6469	SHH	C1861355	Syndactyly, Type IV	0.200824180352639	0	0	ORPHANET
6469	SHH	C1868114	POLYDACTYLY, PREAXIAL II (disorder)	0.400274726784213	0	0	CTD_human;ORPHANET
6469	SHH	C1968843	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5 (disorder)	0.2	0	0	CTD_human
6469	SHH	C4082173	Porencephaly	0.2	0	0	HPO
64695	SLEB3	C0024141	Lupus Erythematosus, Systemic	0.202732912464814	0	0	CTD_human
646960	PRSS56	C0017605	Angle Closure Glaucoma	0.200824180352639	1	0	CTD_human
646960	PRSS56	C0027092	Myopia	0.200549453568426	1	0	CTD_human
646960	PRSS56	C3150757	MICROPHTHALMIA, ISOLATED 6	0.28	3	10	UNIPROT
64699	TMPRSS3	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
64699	TMPRSS3	C1832827	DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.4	4	7	CTD_human;UNIPROT
64711	HS3ST6	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
6473	SHOX	C0028754	Obesity	0.2	0	0	HPO
6473	SHOX	C1858656	Short Stature, Idiopathic, Autosomal	0.2	0	0	CTD_human
64756	ATPAF1	C0028754	Obesity	0.2	1	0	CTD_human
6476	SI	C0392525	Nephrolithiasis	0.2	0	0	HPO
6476	SI	C1283620	Sucrase-isomaltase deficiency, congenital	0.401923087489492	5	10	CTD_human;UNIPROT
64761	PARP12	C0021400	Influenza	0.2	1	0	CTD_human
64778	FNDC3B	C0022578	Keratoconus	0.201098907136852	1	0	CTD_human
64778	FNDC3B	C0339573	Glaucoma, Primary Open Angle	0.200549453568426	1	0	CTD_human
64788	LMF1	C1855498	Lipase deficiency combined	0.200824180352639	0	0	CTD_human
6480	ST6GAL1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	1	CTD_human
6480	ST6GAL1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
64802	NMNAT1	C0029124	Optic Atrophy	0.200274726784213	1	0	CTD_human
64802	NMNAT1	C0242383	Age related macular degeneration	0.2	1	0	CTD_human
64802	NMNAT1	C0339527	Leber Congenital Amaurosis	0.403021994626344	4	0	CTD_human;ORPHANET
64802	NMNAT1	C1837873	LEBER CONGENITAL AMAUROSIS 9 (disorder)	0.200274726784213	4	19	UNIPROT
64805	P2RY12	C0024141	Lupus Erythematosus, Systemic	0.202732912464814	1	0	CTD_human
64805	P2RY12	C0027051	Myocardial Infarction	0.210177567661578	1	0	CTD_human
64805	P2RY12	C1853278	Bleeding Disorder Due To P2RY12 Defect	0.68	2	2	CTD_human;ORPHANET;UNIPROT
64837	KLC2	C1836010	Spastic Paraplegia, Optic Atrophy, and Neuropathy	0.200274726784213	0	0	ORPHANET
64838	FNDC4	C0023794	Lipoidosis	0.2	3	0	CTD_human
64840	PORCN	C0016395	Focal Dermal Hypoplasia	0.695891087352408	7	6	CTD_human;ORPHANET;UNIPROT
64851	AD6	C0002395	Alzheimer's Disease	0.200274726784213	0	0	CTD_human
64851	AD6	C1854187	ALZHEIMER DISEASE 6, LATE-ONSET	0.2	0	0	CTD_human
6487	ST3GAL3	C0037769	West Syndrome	0.200274726784213	0	0	ORPHANET
6487	ST3GAL3	C1970200	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12	0.2	1	1	UNIPROT
6487	ST3GAL3	C3554316	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15	0.2	1	0	UNIPROT
649	BMP1	C0234958	muscle degeneration	0.2	0	0	HPO
649	BMP1	C0268362	Osteogenesis imperfecta type III (disorder)	0.2	0	0	ORPHANET
649	BMP1	C3553887	OSTEOGENESIS IMPERFECTA, TYPE XIII	0.2	3	6	UNIPROT
6491	STIL	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
6491	STIL	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
6491	STIL	C2675187	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 7 (disorder)	0.400274726784213	1	6	CTD_human;UNIPROT
6492	SIM1	C0013363	Dysautonomia	0.2	0	0	HPO
6492	SIM1	C0020456	Hyperglycemia	0.2	1	0	CTD_human
6492	SIM1	C0020459	Hyperinsulinism	0.2	0	0	HPO
6492	SIM1	C0028754	Obesity	0.491891440901487	0	0	CTD_human;HPO
6492	SIM1	C0038379	Strabismus	0.2	0	0	HPO
6492	SIM1	C0039841	Thiamine Deficiency	0.2	0	0	HPO
6495	SIX1	C0008373	Cholesteatoma	0.2	0	0	HPO
6495	SIX1	C0018777	Conductive hearing loss	0.2	0	0	HPO
6495	SIX1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6495	SIX1	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
6495	SIX1	C0155552	Hearing Loss, Mixed Conductive-Sensorineural	0.2	0	0	HPO
6495	SIX1	C0265234	Branchio-Oto-Renal Syndrome	0.291495458804998	0	0	ORPHANET
6495	SIX1	C0266063	Deep overbite	0.2	0	0	HPO
6495	SIX1	C0302859	Euthyroid Goiter	0.2	0	0	HPO
6495	SIX1	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
6495	SIX1	C1842124	BRANCHIOOTIC SYNDROME 3 (disorder)	0.400274726784213	4	8	CTD_human;UNIPROT
6495	SIX1	C1854594	DEAFNESS, AUTOSOMAL DOMINANT 23	0.2	0	0	CTD_human
6495	SIX1	C1857079	Atretic auditory canal	0.2	0	0	HPO
6495	SIX1	C1865143	BRANCHIOOTIC SYNDROME 1	0.200274726784213	0	0	ORPHANET
6495	SIX1	C4021796	Renal steatosis	0.2	0	0	HPO
6496	SIX3	C0011848	Diabetes Insipidus	0.2	0	0	HPO
6496	SIX3	C0014544	Epilepsy	0.2	0	0	HPO
6496	SIX3	C0038379	Strabismus	0.2	0	0	HPO
6496	SIX3	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
6496	SIX3	C1834877	HOLOPROSENCEPHALY 2 (disorder)	0.480549453568426	6	9	CTD_human;UNIPROT
6496	SIX3	C4082173	Porencephaly	0.2	0	0	HPO
64968	MRPS6	C1956346	Coronary Artery Disease	0.202407028523288	1	0	CTD_human
6497	SKI	C0003486	Aortic Aneurysm	0.200274726784213	1	0	CTD_human
6497	SKI	C0010278	Craniosynostosis	0.2	0	0	HPO
6497	SKI	C0014306	Enophthalmos	0.2	0	0	HPO
6497	SKI	C0014544	Epilepsy	0.2	0	0	HPO
6497	SKI	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
6497	SKI	C0018777	Conductive hearing loss	0.2	0	0	HPO
6497	SKI	C0020255	Hydrocephalus	0.2	0	0	HPO
6497	SKI	C0024636	Malocclusion	0.2	0	0	HPO
6497	SKI	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
6497	SKI	C0027092	Myopia	0.2	0	0	HPO
6497	SKI	C0029453	Osteopenia	0.2	0	0	HPO
6497	SKI	C0038379	Strabismus	0.2	0	0	HPO
6497	SKI	C0158113	Contracture of joint of hand	0.2	0	0	HPO
6497	SKI	C0235946	Cerebral atrophy	0.2	0	0	HPO
6497	SKI	C0520679	Sleep Apnea, Obstructive	0.2	0	0	HPO
6497	SKI	C0747078	Generalized osteopenia	0.2	0	0	HPO
6497	SKI	C1842870	Chromosome 1p36 Deletion Syndrome	0.200549453568426	0	0	ORPHANET
6497	SKI	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6497	SKI	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
6498	SKIL	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
6498	SKIL	C2931434	Paraquat lung	0.2	1	0	CTD_human
6499	SKIV2L	C0009319	Colitis	0.2	0	0	HPO
6499	SKIV2L	C0019158	Hepatitis	0.2	0	0	HPO
6499	SKIV2L	C0023890	Liver Cirrhosis	0.2	0	0	HPO
6499	SKIV2L	C0263485	Clastothrix	0.2	0	0	HPO
6499	SKIV2L	C0263490	Brittle hair	0.2	0	0	HPO
6499	SKIV2L	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
6499	SKIV2L	C1857276	Trichohepatoenteric Syndrome	0.201098907136852	0	0	ORPHANET
6499	SKIV2L	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6499	SKIV2L	C3281289	TRICHOHEPATOENTERIC SYNDROME 2	0.2	1	1	UNIPROT
650	BMP2	C0010278	Craniosynostosis	0.200274726784213	1	0	CTD_human
650	BMP2	C0018995	Hemochromatosis	0.202407028523288	0	0	CTD_human
650	BMP2	C0027092	Myopia	0.200549453568426	1	0	CTD_human
650	BMP2	C0041948	Uremia	0.2	1	0	CTD_human
650	BMP2	C0043202	Wolff-Parkinson-White Syndrome	0.200549453568426	0	0	HPO
65014	CMD1K	C1854159	CARDIOMYOPATHY, DILATED, 1K (disorder)	0.2	0	0	CTD_human
65018	PINK1	C0030567	Parkinson Disease	0.397570682881075	5	0	CTD_human
65018	PINK1	C1853833	Parkinson Disease 6, Autosomal Recessive Early-Onset	0.480274726784213	17	19	CTD_human;UNIPROT
65018	PINK1	C3809811	PARKINSON DISEASE 19, JUVENILE-ONSET	0.2	0	0	ORPHANET
65018	PINK1	C4275179	Young onset Parkinson disease	0.210439617800098	0	0	ORPHANET
6503	SLA	C0042900	Vitiligo	0.2	1	0	CTD_human
6505	SLC1A1	C0014175	Endometriosis	0.2	1	0	CTD_human
6505	SLC1A1	C0014544	Epilepsy	0.200824180352639	1	0	CTD_human
6505	SLC1A1	C0014556	Epilepsy, Temporal Lobe	0.200274726784213	1	0	CTD_human
6505	SLC1A1	C1857253	Dicarboxylicaminoaciduria	0.480274726784213	1	2	ORPHANET;UNIPROT
6505	SLC1A1	C1955869	Malformations of Cortical Development	0.2	1	0	CTD_human
65055	REEP1	C1853247	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT	0.600549453568426	4	7	CTD_human;ORPHANET;UNIPROT
65057	ACD	C1846142	HOYERAAL-HREIDARSSON SYNDROME	0.200274726784213	0	0	ORPHANET
65057	ACD	C4225284	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6	0.2	1	2	UNIPROT
6506	SLC1A2	C0002736	Amyotrophic Lateral Sclerosis	0.212608721319168	1	0	CTD_human
6506	SLC1A2	C0014544	Epilepsy	0.200824180352639	1	0	CTD_human
65062	TMEM237	C0431399	Familial aplasia of the vermis	0.200274726784213	0	0	ORPHANET
65062	TMEM237	C1846790	JOUBERT SYNDROME 4 (disorder)	0.2	0	0	ORPHANET
65062	TMEM237	C1855675	Arima syndrome	0.2	0	0	ORPHANET
6507	SLC1A3	C0014544	Epilepsy	0.400274726784213	1	0	CTD_human;HPO
6507	SLC1A3	C0338488	Alternating hemiplegia of childhood	0.200824180352639	0	0	ORPHANET
6507	SLC1A3	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6507	SLC1A3	C1720189	Episodic Ataxia	0.200549453568426	0	0	HPO
6507	SLC1A3	C2675211	EPISODIC ATAXIA, TYPE 6 (disorder)	0.600274726784213	1	3	CTD_human;ORPHANET;UNIPROT
65076	AOMS1	C2930930	Abdominal obesity metabolic syndrome	0.2	0	0	CTD_human
65080	MRPL44	C3809339	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16	0.4	1	1	ORPHANET;UNIPROT
6509	SLC1A4	C0235946	Cerebral atrophy	0.2	0	0	HPO
6509	SLC1A4	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
6509	SLC1A4	C4020860	Supratentorial atrophy	0.2	0	0	HPO
6509	SLC1A4	C4225254	SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY	0.4	1	3	ORPHANET;UNIPROT
65109	UPF3B	C1136249	Mental Retardation, X-Linked	0.200549453568426	1	0	CTD_human
65109	UPF3B	C1970822	Mental Retardation, X-Linked, Syndromic 14	0.4	1	3	CTD_human;UNIPROT
65125	WNK1	C0033805	Pseudohypoaldosteronism	0.200274726784213	1	0	CTD_human
65125	WNK1	C0270914	Hereditary Motor and Sensory-Neuropathy Type II	0.201098907136852	0	0	ORPHANET
65125	WNK1	C1840391	Pseudohypoaldosteronism, Type IIc	0.28	0	0	ORPHANET
65125	WNK1	C2752089	Neuropathy, Hereditary Sensory And Autonomic, Type IIA	0.2	0	0	CTD_human
6513	SLC2A1	C0002878	Anemia, Hemolytic	0.203007639249027	0	0	HPO
6513	SLC2A1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.243797777807287	1	0	CTD_human
6513	SLC2A1	C0014544	Epilepsy	0.209275198128616	0	0	HPO
6513	SLC2A1	C0028738	Nystagmus	0.2	0	0	HPO
6513	SLC2A1	C0029408	Degenerative polyarthritis	0.200274726784213	1	0	CTD_human
6513	SLC2A1	C1832855	CHOREOATHETOSIS/SPASTICITY, EPISODIC	0.400274726784213	0	0	ORPHANET;UNIPROT
6513	SLC2A1	C1837206	Cryohydrocytosis, Stomatin-Deficient, with Mental Retardation, Seizures, Cataracts, and Massive Hepatosplenomegaly	0.4	2	2	ORPHANET;UNIPROT
6513	SLC2A1	C1838604	EPILEPSY, CHILDHOOD ABSENCE, 1	0.2	0	0	ORPHANET
6513	SLC2A1	C1842534	DYSTONIA 18 (disorder)	0.601098907136852	11	10	CTD_human;ORPHANET;UNIPROT
6513	SLC2A1	C1847501	Glut1 Deficiency Syndrome	0.608516530310606	14	24	CTD_human;ORPHANET;UNIPROT
6514	SLC2A2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.330245840181824	1	1	CTD_human
6514	SLC2A2	C0015624	Fanconi Syndrome	0.2	1	0	CTD_human
6514	SLC2A2	C0015695	Fatty Liver	0.2	1	0	CTD_human
6514	SLC2A2	C0029442	Osteomalacia	0.2	0	0	HPO
6514	SLC2A2	C0151747	Renal tubular disorder	0.200274726784213	0	0	HPO
6514	SLC2A2	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
6514	SLC2A2	C3495427	Fanconi-Bickel Syndrome	0.407692349957967	2	7	ORPHANET;UNIPROT
6515	SLC2A3	C0020179	Huntington Disease	0.200549453568426	0	0	ORPHANET
6515	SLC2A3	C0023794	Lipoidosis	0.2	2	0	CTD_human
6515	SLC2A3	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
6515	SLC2A3	C0235946	Cerebral atrophy	0.2	0	0	HPO
6515	SLC2A3	C1836830	Developmental regression	0.2	0	0	HPO
6515	SLC2A3	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
6517	SLC2A4	C0002395	Alzheimer's Disease	0.202407028523288	1	0	CTD_human
6517	SLC2A4	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.513267294181172	4	1	CTD_human;UNIPROT
6519	SLC3A1	C0010691	Cystinuria	0.728030763642093	10	34	CTD_human;HPO;ORPHANET;UNIPROT
6519	SLC3A1	C0014544	Epilepsy	0.2	0	0	HPO
6519	SLC3A1	C0020619	Hypogonadism	0.2	0	0	HPO
6519	SLC3A1	C0035078	Kidney Failure	0.2	0	0	HPO
6519	SLC3A1	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
6519	SLC3A1	C0392525	Nephrolithiasis	0.200274726784213	0	0	HPO
6519	SLC3A1	C1565489	Renal Insufficiency	0.2	0	0	HPO
6519	SLC3A1	C1848030	Hypotonia-Cystinuria Syndrome	0.401373633921066	1	0	CTD_human;ORPHANET
6519	SLC3A1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
652	BMP4	C0003872	Arthritis, Psoriatic	0.2	1	0	CTD_human
652	BMP4	C0003873	Rheumatoid Arthritis	0.203007639249027	1	0	CTD_human
652	BMP4	C0011848	Diabetes Insipidus	0.2	0	0	HPO
652	BMP4	C0015300	Exophthalmos	0.2	0	0	HPO
652	BMP4	C0029408	Degenerative polyarthritis	0.203007639249027	1	0	CTD_human
652	BMP4	C0042842	Vitamin A Deficiency	0.2	1	0	CTD_human
652	BMP4	C0948740	Pituitary hypoplasia	0.2	0	0	HPO
652	BMP4	C1857079	Atretic auditory canal	0.2	0	0	HPO
652	BMP4	C1864689	MICROPHTHALMIA, SYNDROMIC 6 (disorder)	0.6	1	3	CTD_human;ORPHANET;UNIPROT
652	BMP4	C1864825	Frias syndrome	0.200274726784213	0	0	ORPHANET
652	BMP4	C2677434	OROFACIAL CLEFT 11	0.400274726784213	3	5	CTD_human;UNIPROT
6521	SLC4A1	C0002878	Anemia, Hemolytic	0.406839458850693	1	3	CTD_human;HPO
6521	SLC4A1	C0013902	Elliptocytosis, Hereditary	0.403231208875927	1	0	CTD_human;HPO
6521	SLC4A1	C0024530	Malaria	0.209572371315507	0	0	CTD_human
6521	SLC4A1	C0027709	Nephrocalcinosis	0.20328236603324	0	0	HPO
6521	SLC4A1	C0029442	Osteomalacia	0.2	0	0	HPO
6521	SLC4A1	C0035579	Rickets	0.2	0	0	HPO
6521	SLC4A1	C0037889	Hereditary spherocytosis	0.409861453477037	1	0	CTD_human;ORPHANET
6521	SLC4A1	C0221409	Anemia, hereditary spherocytic hemolytic	0.2	0	0	ORPHANET
6521	SLC4A1	C0272051	Xerocytosis	0.2	0	0	ORPHANET
6521	SLC4A1	C1279412	periodic paralysis (finding)	0.2	0	0	HPO
6521	SLC4A1	C1704380	Distal Renal Tubular Acidosis	0.612637432073803	5	4	HPO;ORPHANET;UNIPROT
6521	SLC4A1	C1861453	Pseudohyperkalemia Cardiff	0.400549453568426	1	3	ORPHANET;UNIPROT
6521	SLC4A1	C1862323	OVALOCYTOSIS, SOUTHEAST ASIAN	0.204120901763196	0	0	ORPHANET
6521	SLC4A1	C1864498	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	0.280549453568426	0	0	CTD_human
6521	SLC4A1	C1969038	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA (disorder)	0.6	4	5	CTD_human;ORPHANET;UNIPROT
6521	SLC4A1	C2315100	Pediatric failure to thrive	0.200549453568426	0	0	HPO
6521	SLC4A1	C2675212	Spherocytosis, Type 4	0.48	16	16	CTD_human;UNIPROT
6521	SLC4A1	C4021553	Periodic hypokalemic paresis	0.2	0	0	HPO
65211	FRTS1	C0015624	Fanconi Syndrome	0.2	0	0	CTD_human
65217	PCDH15	C0271097	Usher Syndrome	0.209297644531294	1	0	CTD_human
65217	PCDH15	C1568247	Usher Syndrome, Type I	0.202472541057918	0	0	ORPHANET
65217	PCDH15	C1832845	USHER SYNDROME, TYPE ID	0.2	1	1	UNIPROT
65217	PCDH15	C1836027	Deafness, Autosomal Recessive 23	0.480549453568426	2	4	CTD_human;UNIPROT
65217	PCDH15	C1865885	Usher Syndrome, Type IF	0.281923087489492	2	47	UNIPROT
65217	PCDH15	C2931208	Usher syndrome, type 1D	0.2	0	0	CTD_human
65217	PCDH15	C2931210	Usher syndrome, type 1F	0.202197814273705	0	0	CTD_human
6522	SLC4A2	C0023892	Biliary cirrhosis	0.204814057046576	1	0	CTD_human
6523	SLC5A1	C0401151	Chronic diarrhea	0.2	0	0	HPO
6523	SLC5A1	C1112601	Hypertonic dehydration	0.2	0	0	HPO
6523	SLC5A1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6524	SLC5A2	C0017980	Glycosuria, Renal	0.602472541057918	1	7	CTD_human;ORPHANET;UNIPROT
65245	PSORS7	C0033860	Psoriasis	0.200274726784213	0	0	CTD_human
65250	C5orf42	C0431399	Familial aplasia of the vermis	0.201373633921065	0	0	ORPHANET
65250	C5orf42	C1865384	Amyotrophy, monomelic	0.2	0	0	ORPHANET
65250	C5orf42	C2745997	OROFACIODIGITAL SYNDROME VI	0.400549453568426	2	8	ORPHANET;UNIPROT
65250	C5orf42	C3553264	JOUBERT SYNDROME 17	0.28	2	44	UNIPROT
65266	WNK4	C0033805	Pseudohypoaldosteronism	0.200274726784213	1	0	CTD_human
65266	WNK4	C1840390	Pseudohypoaldosteronism, Type IIb	0.48	3	4	ORPHANET;UNIPROT
6528	SLC5A5	C0020676	Hypothyroidism	0.204655999954305	0	0	HPO
6528	SLC5A5	C0024421	Macroglossia	0.2	0	0	HPO
6528	SLC5A5	C0259817	Xerosis	0.2	0	0	HPO
6528	SLC5A5	C0917799	Hypersomnia	0.2	0	0	HPO
6528	SLC5A5	C1848805	Thyroid Dyshormonogenesis 1	0.6	3	7	CTD_human;ORPHANET;UNIPROT
6529	SLC6A1	C0002736	Amyotrophic Lateral Sclerosis	0.200274726784213	1	0	CTD_human
6529	SLC6A1	C0014553	Absence Epilepsy	0.2	0	0	HPO
6529	SLC6A1	C0038220	Status Epilepticus	0.2	0	0	HPO
6529	SLC6A1	C0270846	Epileptic drop attack	0.2	0	0	HPO
6529	SLC6A1	C0393702	Myoclonic Astatic Epilepsy	0.200274726784213	0	0	HPO
6529	SLC6A1	C0543888	Epileptic encephalopathy	0.2	0	0	HPO
6529	SLC6A1	C1836830	Developmental regression	0.2	0	0	HPO
6529	SLC6A1	C4085238	MYOCLONIC-ATONIC EPILEPSY	0.200274726784213	1	5	UNIPROT
6531	SLC6A3	C0013384	Dyskinetic syndrome	0.201098907136852	0	0	HPO
6531	SLC6A3	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
6531	SLC6A3	C0030567	Parkinson Disease	0.256248442034184	4	0	CTD_human
6531	SLC6A3	C1837658	Gross motor development delay	0.2	0	0	HPO
6531	SLC6A3	C2751067	Parkinsonism-Dystonia, Infantile	0.601373633921066	1	6	CTD_human;ORPHANET;UNIPROT
6531	SLC6A3	C4020858	Choreatic disease	0.2	0	0	HPO
6531	SLC6A3	C4020859	Pyramidal tract disease	0.2	0	0	HPO
6532	SLC6A4	C0038644	Sudden infant death syndrome	0.306263513886252	1	0	CTD_human
6533	SLC6A6	C0151744	Myocardial Ischemia	0.200274726784213	1	0	CTD_human
653361	NCF1	C0003873	Rheumatoid Arthritis	0.201098907136852	1	0	CTD_human
653361	NCF1	C0007766	Intracranial Aneurysm	0.2	1	0	CTD_human
653361	NCF1	C0020443	Hypercholesterolemia	0.2	1	0	CTD_human
653361	NCF1	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
653361	NCF1	C0162871	Aortic Aneurysm, Abdominal	0.2	1	0	CTD_human
653361	NCF1	C1856251	Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I	0.48	1	5	CTD_human;UNIPROT
6535	SLC6A8	C0014544	Epilepsy	0.200549453568426	0	0	HPO
6535	SLC6A8	C0015310	Exotropia	0.2	0	0	HPO
6535	SLC6A8	C0020490	Hyperopia	0.2	0	0	HPO
6535	SLC6A8	C1136249	Mental Retardation, X-Linked	0.207388912419119	1	0	CTD_human
6535	SLC6A8	C1258215	Ileus	0.2	0	0	HPO
6535	SLC6A8	C1845862	Creatine deficiency, X-linked	0.685219808900049	6	11	CTD_human;ORPHANET;UNIPROT
6535	SLC6A8	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
6535	SLC6A8	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6535	SLC6A8	C4020858	Choreatic disease	0.2	0	0	HPO
6535	SLC6A8	C4020871	Dystonic disease	0.2	0	0	HPO
653509	SFTPA1	C1800706	Idiopathic Pulmonary Fibrosis	0.401098907136852	0	0	CTD_human;ORPHANET
653545	DUX4L5	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
654	BMP6	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
654	BMP6	C0018995	Hemochromatosis	0.200824180352639	2	0	CTD_human
654	BMP6	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
654	BMP6	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
6546	SLC8A1	C0038220	Status Epilepticus	0.2	1	0	CTD_human
6546	SLC8A1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
6547	SLC8A3	C0038220	Status Epilepticus	0.2	1	0	CTD_human
6548	SLC9A1	C0004763	Barrett Esophagus	0.200274726784213	1	0	CTD_human
6548	SLC9A1	C0007194	Hypertrophic Cardiomyopathy	0.2	1	0	CTD_human
6548	SLC9A1	C0018801	Heart failure	0.20328236603324	1	0	CTD_human
6548	SLC9A1	C4225383	LICHTENSTEIN-KNORR SYNDROME	0.400274726784213	1	1	ORPHANET;UNIPROT
655	BMP7	C0014175	Endometriosis	0.2	1	0	CTD_human
655	BMP7	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
6550	SLC9A3	C0021843	Intestinal Obstruction	0.2	1	0	CTD_human
6550	SLC9A3	C1859047	CYSTIC FIBROSIS MODIFIER 1	0.2	1	0	CTD_human
6554	SLC10A1	C0019163	Hepatitis B	0.20357144819477	1	0	CTD_human
6555	SLC10A2	C0401151	Chronic diarrhea	0.2	0	0	HPO
6555	SLC10A2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6555	SLC10A2	C2750087	Bile Acid Malabsorption, Primary	0.400274726784213	1	3	CTD_human;UNIPROT
6556	SLC11A1	C0003873	Rheumatoid Arthritis	0.223255874637225	1	0	CTD_human
6556	SLC11A1	C0009324	Ulcerative Colitis	0.208319992706716	1	0	CTD_human
6556	SLC11A1	C0010346	Crohn Disease	0.225062292434775	1	0	CTD_human
6556	SLC11A1	C0011615	Dermatitis, Atopic	0.2	1	0	CTD_human
6556	SLC11A1	C0011854	Diabetes Mellitus, Insulin-Dependent	0.213408776537506	1	0	CTD_human
6556	SLC11A1	C0023290	Leishmaniasis, Visceral	0.20678830169338	1	0	CTD_human
6556	SLC11A1	C0023343	Leprosy	0.217254951516489	1	0	CTD_human
6556	SLC11A1	C0025294	Meningococcal meningitis	0.2	1	0	CTD_human
6556	SLC11A1	C0026769	Multiple Sclerosis	0.211602358739956	1	0	CTD_human
6556	SLC11A1	C0036202	Sarcoidosis	0.213785817636344	1	0	CTD_human
6556	SLC11A1	C0041296	Tuberculosis	0.502042910890954	1	0	CTD_human;ORPHANET
6556	SLC11A1	C0085568	Buruli Ulcer	0.203557092817453	0	0	CTD_human
6556	SLC11A1	C3495559	Juvenile arthritis	0.205638237399215	1	0	CTD_human
6557	SLC12A1	C0004775	Bartter Disease	0.214517453431343	1	0	CTD_human
6557	SLC12A1	C0014544	Epilepsy	0.2	0	0	HPO
6557	SLC12A1	C0020428	Hyperaldosteronism	0.200274726784213	0	0	HPO
6557	SLC12A1	C0027709	Nephrocalcinosis	0.200274726784213	0	0	HPO
6557	SLC12A1	C0029453	Osteopenia	0.2	0	0	HPO
6557	SLC12A1	C0039621	Tetany	0.2	0	0	HPO
6557	SLC12A1	C0085680	Hypochloremia (disorder)	0.2	0	0	HPO
6557	SLC12A1	C0553730	Calcium pyrophosphate deposition disease	0.2	0	0	HPO
6557	SLC12A1	C0740898	Hypokalemic metabolic alkalosis	0.2	0	0	HPO
6557	SLC12A1	C0747078	Generalized osteopenia	0.2	0	0	HPO
6557	SLC12A1	C1866495	Bartter syndrome, antenatal type 1	0.680274726784213	1	5	CTD_human;ORPHANET;UNIPROT
6557	SLC12A1	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
6558	SLC12A2	C0014544	Epilepsy	0.200549453568426	1	0	CTD_human
6558	SLC12A2	C0014556	Epilepsy, Temporal Lobe	0.200274726784213	1	0	CTD_human
6559	SLC12A3	C0014544	Epilepsy	0.200549453568426	0	0	HPO
6559	SLC12A3	C0039621	Tetany	0.2	0	0	HPO
6559	SLC12A3	C0085570	Hypokalemic alkalosis	0.200824180352639	0	0	HPO
6559	SLC12A3	C0268450	Gitelman Syndrome	0.732645376196071	15	84	CTD_human;ORPHANET;UNIPROT
6559	SLC12A3	C0553730	Calcium pyrophosphate deposition disease	0.2	0	0	HPO
6559	SLC12A3	C1835171	Hypomagnesemia 2, renal	0.200274726784213	0	0	HPO
6563	SLC14A1	C0002880	Autoimmune hemolytic anemia	0.2	1	0	CTD_human
6566	SLC16A1	C0020617	Hypoglycemic coma	0.2	0	0	HPO
6566	SLC16A1	C0877056	Hypoglycaemic seizure	0.2	0	0	HPO
6566	SLC16A1	C1855577	Erythrocyte Lactate Transporter Defect	0.6	1	2	CTD_human;ORPHANET;UNIPROT
6566	SLC16A1	C1864902	Hyperinsulinemic hypoglycemia, familial, 7	0.4	0	0	CTD_human;ORPHANET
6566	SLC16A1	C1864903	Hyperinsulinaemic hypoglycaemia	0.200549453568426	0	0	HPO
6566	SLC16A1	C4015186	MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY	0.4	1	1	ORPHANET;UNIPROT
6567	SLC16A2	C0015732	Fecal Incontinence	0.2	0	0	HPO
6567	SLC16A2	C0020676	Hypothyroidism	0.201648360705279	0	0	HPO
6567	SLC16A2	C0023520	Leukodystrophy	0.200549453568426	0	0	HPO
6567	SLC16A2	C0037036	Sialorrhea	0.2	0	0	HPO
6567	SLC16A2	C0037772	Spastic Paraplegia	0.200824180352639	0	0	HPO
6567	SLC16A2	C0234958	muscle degeneration	0.2	0	0	HPO
6567	SLC16A2	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
6567	SLC16A2	C0795889	Allan-Herndon-Dudley syndrome (AHDS)	0.687417623173754	7	28	CTD_human;ORPHANET;UNIPROT
6567	SLC16A2	C1389113	Generalized amyotrophy	0.2	0	0	HPO
6567	SLC16A2	C2267233	Neonatal Hypotonia	0.200274726784213	0	0	HPO
6569	SLC34A1	C0015624	Fanconi Syndrome	0.2	0	0	CTD_human
6569	SLC34A1	C0020437	Hypercalcemia	0.200549453568426	1	0	CTD_human
6569	SLC34A1	C0029453	Osteopenia	0.2	0	0	HPO
6569	SLC34A1	C0029456	Osteoporosis	0.2	0	0	HPO
6569	SLC34A1	C0035078	Kidney Failure	0.2	0	0	HPO
6569	SLC34A1	C0035579	Rickets	0.2	0	0	HPO
6569	SLC34A1	C0341703	Adult Fanconi syndrome	0.2	0	0	ORPHANET
6569	SLC34A1	C0392525	Nephrolithiasis	0.201098907136852	0	0	HPO
6569	SLC34A1	C0747078	Generalized osteopenia	0.2	0	0	HPO
6569	SLC34A1	C1565489	Renal Insufficiency	0.2	0	0	HPO
6569	SLC34A1	C2676786	Nephrolithiasis-Osteoporosis, Hypophosphatemic, 1	0.4	1	2	CTD_human;UNIPROT
657	BMPR1A	C0002871	Anemia	0.2	0	0	HPO
657	BMPR1A	C0236048	Polyposis, Gastric	0.200824180352639	0	0	HPO
657	BMPR1A	C0239981	Hypoalbuminemia	0.2	0	0	HPO
657	BMPR1A	C1832587	POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.2	0	0	ORPHANET
657	BMPR1A	C1864730	Polyposis Syndrome, Hereditary Mixed, 2	0.2	0	0	CTD_human
657	BMPR1A	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
657	BMPR1A	C4023006	Juvenile colonic polyposis	0.2	0	0	HPO
657	BMPR1A	C4225669	CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.28	0	0	ORPHANET
6571	SLC18A2	C0030567	Parkinson Disease	0.213902487328286	1	0	CTD_human
6571	SLC18A2	C0152115	Lingual-Facial-Buccal Dyskinesia	0.2	0	0	HPO
6571	SLC18A2	C0575059	Spastic tetraparesis	0.2	0	0	HPO
6572	SLC18A3	C0751884	Congenital Myasthenic Syndromes, Presynaptic	0.2	0	0	ORPHANET
6573	SLC19A1	C0013080	Down Syndrome	0.21538302118431	2	0	CTD_human
6574	SLC20A1	C0014175	Endometriosis	0.2	1	0	CTD_human
6574	SLC20A1	C0428791	Aortic valve calcification	0.2	1	0	CTD_human
6575	SLC20A2	C0014544	Epilepsy	0.200274726784213	0	0	HPO
6575	SLC20A2	C0393590	Fahr's syndrome (disorder)	0.681923087489492	6	10	CTD_human;ORPHANET;UNIPROT
6575	SLC20A2	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
6575	SLC20A2	C0854107	Haemorrhage subcutaneous	0.2	0	0	HPO
6575	SLC20A2	C4020858	Choreatic disease	0.2	0	0	HPO
6575	SLC20A2	C4020871	Dystonic disease	0.2	0	0	HPO
6576	SLC25A1	C0014544	Epilepsy	0.2	0	0	HPO
6576	SLC25A1	C0751884	Congenital Myasthenic Syndromes, Presynaptic	0.2	0	0	ORPHANET
6576	SLC25A1	C1855995	L-2-HYDROXYGLUTARIC ACIDURIA	0.2	0	0	HPO
6576	SLC25A1	C2746066	Combined D-2- and L-2-hydroxyglutaric aciduria	0.400274726784213	2	7	ORPHANET;UNIPROT
6578	SLCO2A1	C0003864	Arthritis	0.2	0	0	HPO
6578	SLCO2A1	C0029411	Osteoarthropathy, Primary Hypertrophic	0.201923087489492	0	0	ORPHANET
6578	SLCO2A1	C0029443	Osteomyelitis	0.2	0	0	HPO
6578	SLCO2A1	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
6578	SLCO2A1	C0263417	Cutis verticis gyrata	0.2	0	0	HPO
6578	SLCO2A1	C0702166	Acne	0.2	0	0	HPO
6578	SLCO2A1	C1409412	Periostosis	0.2	0	0	HPO
6578	SLCO2A1	C2242472	Infection of bone	0.2	0	0	HPO
6578	SLCO2A1	C3280800	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2	0.2	4	6	UNIPROT
6578	SLCO2A1	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
6578	SLCO2A1	C4072877	Scalp folds	0.2	0	0	HPO
658	BMPR1B	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
658	BMPR1B	C0265260	Chondrodysplasia, Grebe type	0.200274726784213	0	0	ORPHANET
658	BMPR1B	C0948896	Primary hypogonadism	0.2	0	0	HPO
658	BMPR1B	C1300268	Brachydactyly syndrome type C	0.2	0	0	ORPHANET
658	BMPR1B	C1836182	Chondrodysplasia, acromesomelic, with genital anomalies	0.2	1	4	CTD_human
658	BMPR1B	C1856738	Fibular hypoplasia and complex brachydactyly	0.2	0	0	ORPHANET
658	BMPR1B	C1862151	BRACHYDACTYLY, TYPE A1 (disorder)	0.200274726784213	0	0	ORPHANET
658	BMPR1B	C4225183	BRACHYDACTYLY, TYPE A1, D	0.2	1	2	UNIPROT
658	BMPR1B	C4225404	ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE	0.2	1	1	UNIPROT
6580	SLC22A1	C0028754	Obesity	0.200549453568426	1	0	CTD_human
6581	SLC22A3	C0027059	Myocarditis	0.2	1	0	CTD_human
6583	SLC22A4	C0003873	Rheumatoid Arthritis	0.24054762793371	0	0	CTD_human
6583	SLC22A4	C0027059	Myocarditis	0.2	1	0	CTD_human
6584	SLC22A5	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
6584	SLC22A5	C0014117	Endocardial Fibroelastosis	0.2	0	0	HPO
6584	SLC22A5	C0018801	Heart failure	0.200274726784213	0	0	HPO
6584	SLC22A5	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
6584	SLC22A5	C0027059	Myocarditis	0.2	1	0	CTD_human
6584	SLC22A5	C0342788	Renal carnitine transport defect	0.68439562854741	8	71	CTD_human;ORPHANET;UNIPROT
6584	SLC22A5	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6584	SLC22A5	C2711227	Steatohepatitis	0.200274726784213	0	0	HPO
659	BMPR2	C0034091	Pulmonary Veno-Occlusive Disease (disorder)	0.600549453568426	0	0	CTD_human;HPO;ORPHANET
659	BMPR2	C0039446	Telangiectasis	0.2	0	0	HPO
659	BMPR2	C0162770	Right Ventricular Hypertrophy	0.200549453568426	0	0	HPO
659	BMPR2	C0206081	Hyperandrogenism	0.200274726784213	1	0	CTD_human
659	BMPR2	C0235527	Heart Failure, Right-Sided	0.2	0	0	HPO
659	BMPR2	C0340543	Familial primary pulmonary hypertension	0.409340710663245	1	0	CTD_human;ORPHANET
659	BMPR2	C0340544	Pulmonary arterial hypertension induced by drug	0.2	0	0	ORPHANET
659	BMPR2	C1504382	Pulmonary artery wall hypertrophy	0.2	0	0	HPO
659	BMPR2	C2939447	Right ventricular failure	0.2	0	0	HPO
659	BMPR2	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
659	BMPR2	C3203102	Idiopathic pulmonary arterial hypertension	0.515989208731916	7	8	HPO;UNIPROT
659	BMPR2	C4020753	Intimal fibrosis	0.2	0	0	HPO
659	BMPR2	C4023403	Arterial intimal fibrosis	0.2	0	0	HPO
659	BMPR2	C4025217	Pulmonary aterial intimal fibrosis	0.2	0	0	HPO
6590	SLPI	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6591	SNAI2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6591	SNAI2	C1837203	WAARDENBURG SYNDROME, TYPE IID	0.28	0	0	CTD_human
6591	SNAI2	C2700265	Waardenburg Syndrome Type 2	0.200549453568426	0	0	ORPHANET
6591	SNAI2	C4024848	Absent pigmentation of the ventral chest	0.2	0	0	HPO
6595	SMARCA2	C0014544	Epilepsy	0.2	0	0	HPO
6595	SMARCA2	C0265338	Coffin-Siris syndrome	0.2	1	0	CTD_human
6595	SMARCA2	C1303073	Nicolaides Baraitser syndrome	0.601098907136852	2	33	CTD_human;ORPHANET;UNIPROT
6595	SMARCA2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6597	SMARCA4	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
6597	SMARCA4	C0014544	Epilepsy	0.2	0	0	HPO
6597	SMARCA4	C0028738	Nystagmus	0.2	0	0	HPO
6597	SMARCA4	C0038379	Strabismus	0.2	0	0	HPO
6597	SMARCA4	C0265338	Coffin-Siris syndrome	0.400824180352639	1	0	CTD_human;ORPHANET
6597	SMARCA4	C2750074	Rhabdoid Tumor Predisposition Syndrome 2	0.2	0	0	CTD_human
6597	SMARCA4	C3553249	MENTAL RETARDATION, AUTOSOMAL DOMINANT 16	0.2	1	7	UNIPROT
6598	SMARCB1	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
6598	SMARCB1	C0014544	Epilepsy	0.2	0	0	HPO
6598	SMARCB1	C0020255	Hydrocephalus	0.2	0	0	HPO
6598	SMARCB1	C0028738	Nystagmus	0.2	0	0	HPO
6598	SMARCB1	C0038379	Strabismus	0.2	0	0	HPO
6598	SMARCB1	C0265338	Coffin-Siris syndrome	0.401098907136852	1	0	CTD_human;ORPHANET
6598	SMARCB1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
6598	SMARCB1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6598	SMARCB1	C3553248	MENTAL RETARDATION, AUTOSOMAL DOMINANT 15	0.2	2	4	UNIPROT
6605	SMARCE1	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
6605	SMARCE1	C0014544	Epilepsy	0.2	0	0	HPO
6605	SMARCE1	C0028738	Nystagmus	0.2	0	0	HPO
6605	SMARCE1	C0038379	Strabismus	0.2	0	0	HPO
6605	SMARCE1	C0265338	Coffin-Siris syndrome	0.400549453568426	1	0	CTD_human;ORPHANET
6606	SMN1	C0026847	Spinal Muscular Atrophy	0.569786025321018	4	0	CTD_human;HPO
6606	SMN1	C0043116	HMN (Hereditary Motor Neuropathy) Proximal Type I	0.488516530310606	6	5	ORPHANET;UNIPROT
6606	SMN1	C0152109	Juvenile Spinal Muscular Atrophy	0.482197814273705	6	8	ORPHANET;UNIPROT
6606	SMN1	C0393538	Muscular Atrophy, Spinal, Type II	0.401098907136852	5	4	ORPHANET;UNIPROT
6606	SMN1	C0700595	Spinal Muscular Atrophies of Childhood	0.212361026557966	1	0	CTD_human
6606	SMN1	C1145670	Respiratory Failure	0.201648360705279	0	0	HPO
6606	SMN1	C1838230	SPINAL MUSCULAR ATROPHY, TYPE IV	0.2	0	0	ORPHANET
6606	SMN1	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
6606	SMN1	C2931844	Spinal muscular atrophy 4	0.2	0	0	CTD_human
6607	SMN2	C0026847	Spinal Muscular Atrophy	0.352936825658002	1	0	CTD_human
6607	SMN2	C0043116	HMN (Hereditary Motor Neuropathy) Proximal Type I	0.286593442821114	0	0	ORPHANET
6607	SMN2	C0152109	Juvenile Spinal Muscular Atrophy	0.282747267842131	0	0	ORPHANET
6607	SMN2	C0393538	Muscular Atrophy, Spinal, Type II	0.201098907136852	0	0	ORPHANET
6607	SMN2	C0700595	Spinal Muscular Atrophies of Childhood	0.209953998034678	0	0	CTD_human
6607	SMN2	C1838230	SPINAL MUSCULAR ATROPHY, TYPE IV	0.2	0	0	ORPHANET
6608	SMO	C0010278	Craniosynostosis	0.2	0	0	HPO
6608	SMO	C0795915	Winter Shortland Temple syndrome	0.4	1	1	ORPHANET;UNIPROT
6609	SMPD1	C0020445	Hypercholesterolemia, Familial	0.2	0	0	HPO
6609	SMPD1	C0029456	Osteoporosis	0.2	0	0	HPO
6609	SMPD1	C0036489	Sea-Blue Histiocyte Syndrome	0.2	0	0	HPO
6609	SMPD1	C0043325	Xanthomatosis	0.2	0	0	HPO
6609	SMPD1	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
6609	SMPD1	C0268242	Niemann-Pick Disease, Type A	0.681098907136852	20	55	CTD_human;ORPHANET;UNIPROT
6609	SMPD1	C0268243	Niemann-Pick Disease, Type B	0.684381273170092	25	22	CTD_human;ORPHANET;UNIPROT
6609	SMPD1	C0473527	Hypoalphalipoproteinemias	0.2	0	0	HPO
6609	SMPD1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6611	SMS	C0003873	Rheumatoid Arthritis	0.200549453568426	1	0	CTD_human
6611	SMS	C0014544	Epilepsy	0.200274726784213	0	0	HPO
6611	SMS	C0029456	Osteoporosis	0.200274726784213	0	0	HPO
6611	SMS	C0271183	Severe myopia	0.2	0	0	HPO
6611	SMS	C0796160	MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE	0.603021994626344	5	8	CTD_human;ORPHANET;UNIPROT
6614	SIGLEC1	C0021400	Influenza	0.2	1	0	CTD_human
6615	SNAI1	C0008370	Cholestasis	0.2	1	0	CTD_human
6615	SNAI1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
6616	SNAP25	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.280274726784213	1	0	CTD_human
6616	SNAP25	C0751884	Congenital Myasthenic Syndromes, Presynaptic	0.2	0	0	ORPHANET
6616	SNAP25	C4225364	MYASTHENIC SYNDROME, CONGENITAL, 18	0.2	1	0	UNIPROT
6620	SNCB	C0752347	Lewy Body Disease	0.202197814273705	0	0	CTD_human
6622	SNCA	C0013363	Dysautonomia	0.200274726784213	0	0	HPO
6622	SNCA	C0017205	Gaucher Disease	0.200274726784213	1	0	CTD_human
6622	SNCA	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
6622	SNCA	C0030567	Parkinson Disease	0.44	27	1	CTD_human
6622	SNCA	C0085606	Urgency of micturition	0.2	0	0	HPO
6622	SNCA	C0752347	Lewy Body Disease	0.629504492519164	2	1	CTD_human;HPO;UNIPROT
6622	SNCA	C1850100	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE (disorder)	0.200274726784213	0	0	ORPHANET
6622	SNCA	C1854182	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY (disorder)	0.28	0	0	CTD_human
6622	SNCA	C1868595	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)	0.48	9	5	CTD_human;UNIPROT
6622	SNCA	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
6622	SNCA	C3809811	PARKINSON DISEASE 19, JUVENILE-ONSET	0.2	0	0	ORPHANET
6622	SNCA	C4020871	Dystonic disease	0.2	0	0	HPO
6622	SNCA	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
6622	SNCA	C4274355	Autosomal dominant late onset Parkinson disease	0.2	0	0	ORPHANET
6622	SNCA	C4275179	Young onset Parkinson disease	0.20357144819477	0	0	ORPHANET
6628	SNRPB	C0018777	Conductive hearing loss	0.2	0	0	HPO
6628	SNRPB	C0022679	Cystic kidney	0.2	0	0	HPO
6628	SNRPB	C0265342	Cerebrocostomandibular Syndrome	0.401098907136852	2	4	ORPHANET;UNIPROT
6628	SNRPB	C0267048	Glossoptosis	0.2	0	0	HPO
6628	SNRPB	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
6628	SNRPB	C0948187	Tracheomalacia	0.2	0	0	HPO
6628	SNRPB	C1857079	Atretic auditory canal	0.2	0	0	HPO
6628	SNRPB	C4082173	Porencephaly	0.2	0	0	HPO
6635	SNRPE	C0002170	Alopecia	0.2	0	0	HPO
6635	SNRPE	C1854310	Hypotrichosis simplex	0.200274726784213	0	0	ORPHANET
6635	SNRPE	C3554409	HYPOTRICHOSIS 11	0.2	1	2	UNIPROT
6638	SNRPN	C0014544	Epilepsy	0.2	0	0	HPO
6638	SNRPN	C0020459	Hyperinsulinism	0.2	0	0	HPO
6638	SNRPN	C0020490	Hyperopia	0.2	0	0	HPO
6638	SNRPN	C0028754	Obesity	0.200549453568426	0	0	HPO
6638	SNRPN	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
6638	SNRPN	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
6638	SNRPN	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
6638	SNRPN	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
6640	SNTA1	C0035828	Romano-Ward Syndrome	0.2	0	0	ORPHANET
6640	SNTA1	C0038220	Status Epilepticus	0.28	1	0	CTD_human
6640	SNTA1	C0040479	Torsades de Pointes	0.2	0	0	HPO
6640	SNTA1	C0042510	Ventricular Fibrillation	0.2	0	0	HPO
6640	SNTA1	C2751830	Long Qt Syndrome 12	0.4	2	2	CTD_human;UNIPROT
664617	MIR542	C0015695	Fatty Liver	0.2	1	0	CTD_human
6647	SOD1	C0002736	Amyotrophic Lateral Sclerosis	0.798512456372608	24	0	CTD_human;HPO;ORPHANET
6647	SOD1	C0004045	Asphyxia Neonatorum	0.2	1	0	CTD_human
6647	SOD1	C0004096	Asthma	0.201098907136852	1	0	CTD_human
6647	SOD1	C0004153	Atherosclerosis	0.208697033805555	1	0	CTD_human
6647	SOD1	C0007786	Brain Ischemia	0.206015278498054	1	0	CTD_human
6647	SOD1	C0007787	Transient Ischemic Attack	0.2	4	0	CTD_human
6647	SOD1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
6647	SOD1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.211551201582644	1	0	CTD_human
6647	SOD1	C0011884	Diabetic Retinopathy	0.202681755307501	1	0	CTD_human
6647	SOD1	C0013080	Down Syndrome	0.221660349820883	1	0	CTD_human
6647	SOD1	C0015696	Fatty Liver, Alcoholic	0.2	1	0	CTD_human
6647	SOD1	C0018801	Heart failure	0.2	1	0	CTD_human
6647	SOD1	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
6647	SOD1	C0020550	Hyperthyroidism	0.2	1	0	CTD_human
6647	SOD1	C0022650	Kidney Calculi	0.2	1	0	CTD_human
6647	SOD1	C0024796	Marfan Syndrome	0.2	1	0	CTD_human
6647	SOD1	C0027051	Myocardial Infarction	0.202732912464814	1	0	CTD_human
6647	SOD1	C0027720	Nephrosis	0.2	1	0	CTD_human
6647	SOD1	C0028754	Obesity	0.2	1	0	CTD_human
6647	SOD1	C0030567	Parkinson Disease	0.209586726692824	3	0	CTD_human
6647	SOD1	C0033626	Protein Deficiency	0.2	1	0	CTD_human
6647	SOD1	C0033790	Pseudobulbar Palsy	0.2	0	0	HPO
6647	SOD1	C0036330	Schistosomiasis mansoni	0.2	1	0	CTD_human
6647	SOD1	C0036457	Scrapie	0.2	1	0	CTD_human
6647	SOD1	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
6647	SOD1	C0041408	Turner Syndrome	0.200274726784213	1	0	CTD_human
6647	SOD1	C0085084	Motor Neuron Disease	0.246574354920372	1	0	CTD_human
6647	SOD1	C0162316	Iron deficiency anemia	0.2	1	0	CTD_human
6647	SOD1	C0162671	MELAS Syndrome	0.2	1	0	CTD_human
6647	SOD1	C0162674	Chronic progressive external ophthalmoplegia	0.2	1	0	CTD_human
6647	SOD1	C0234958	muscle degeneration	0.200274726784213	0	0	HPO
6647	SOD1	C0751830	Gait Disorders, Neurologic	0.2	1	0	CTD_human
6647	SOD1	C1145670	Respiratory Failure	0.200274726784213	0	0	HPO
6647	SOD1	C1456865	Ureteral Calculi	0.2	1	0	CTD_human
6647	SOD1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.493736339210655	51	32	CTD_human;UNIPROT
6647	SOD1	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
6647	SOD1	C4020884	Anxiety disease	0.2	0	0	HPO
6647	SOD1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
664728	CMD1Q	C1835926	CARDIOMYOPATHY, DILATED, 1Q (disorder)	0.2	0	0	CTD_human
664780	MYP12	C1864940	MYOPIA 12 (disorder)	0.2	0	0	CTD_human
6648	SOD2	C0002395	Alzheimer's Disease	0.206513574909167	1	0	CTD_human
6648	SOD2	C0002736	Amyotrophic Lateral Sclerosis	0.200824180352639	1	0	CTD_human
6648	SOD2	C0002871	Anemia	0.200274726784213	1	0	CTD_human
6648	SOD2	C0002896	Sideroblastic anemia	0.200274726784213	2	0	CTD_human
6648	SOD2	C0003873	Rheumatoid Arthritis	0.203231208875927	3	0	CTD_human
6648	SOD2	C0004045	Asphyxia Neonatorum	0.2	1	0	CTD_human
6648	SOD2	C0004153	Atherosclerosis	0.20777053913829	2	0	CTD_human
6648	SOD2	C0007786	Brain Ischemia	0.2	3	0	CTD_human
6648	SOD2	C0007787	Transient Ischemic Attack	0.2	1	0	CTD_human
6648	SOD2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.225234704904362	1	0	CTD_human
6648	SOD2	C0011881	Diabetic Nephropathy	0.208371149864029	1	0	CTD_human
6648	SOD2	C0014868	Esophagitis	0.200274726784213	1	0	CTD_human
6648	SOD2	C0015695	Fatty Liver	0.2	1	0	CTD_human
6648	SOD2	C0018801	Heart failure	0.200274726784213	5	0	CTD_human
6648	SOD2	C0020550	Hyperthyroidism	0.2	1	0	CTD_human
6648	SOD2	C0020615	Hypoglycemia	0.2	1	0	CTD_human
6648	SOD2	C0022672	Acute Kidney Tubular Necrosis	0.2	1	0	CTD_human
6648	SOD2	C0023891	Liver Cirrhosis, Alcoholic	0.20777053913829	1	0	CTD_human
6648	SOD2	C0024796	Marfan Syndrome	0.2	1	0	CTD_human
6648	SOD2	C0027051	Myocardial Infarction	0.205088783830789	1	0	CTD_human
6648	SOD2	C0028754	Obesity	0.203780662444353	2	0	CTD_human
6648	SOD2	C0029408	Degenerative polyarthritis	0.200824180352639	3	0	CTD_human
6648	SOD2	C0029456	Osteoporosis	0.200824180352639	1	0	CTD_human
6648	SOD2	C0030567	Parkinson Disease	0.214232956890145	3	0	CTD_human
6648	SOD2	C0033860	Psoriasis	0.200274726784213	1	0	CTD_human
6648	SOD2	C0035222	Respiratory Distress Syndrome, Adult	0.28	1	0	CTD_human
6648	SOD2	C0036202	Sarcoidosis	0.2	1	0	CTD_human
6648	SOD2	C0041408	Turner Syndrome	0.2	1	0	CTD_human
6648	SOD2	C0042164	Uveitis	0.2	2	0	CTD_human
6648	SOD2	C0151744	Myocardial Ischemia	0.200274726784213	1	0	CTD_human
6648	SOD2	C0162309	Adrenoleukodystrophy	0.200549453568426	1	0	CTD_human
6648	SOD2	C0162671	MELAS Syndrome	0.2	1	0	CTD_human
6648	SOD2	C0162674	Chronic progressive external ophthalmoplegia	0.200549453568426	2	0	CTD_human
6648	SOD2	C0162871	Aortic Aneurysm, Abdominal	0.2	1	0	CTD_human
6648	SOD2	C0268255	Farber Lipogranulomatosis	0.200274726784213	1	0	CTD_human
6648	SOD2	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
6648	SOD2	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
6648	SOD2	C0752347	Lewy Body Disease	0.2	1	0	CTD_human
6648	SOD2	C0948089	Acute Coronary Syndrome	0.200274726784213	1	0	CTD_human
6648	SOD2	C1859317	Cataract and cardiomyopathy	0.2	1	0	CTD_human
6648	SOD2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6649	SOD3	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
6649	SOD3	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
6649	SOD3	C0024117	Chronic Obstructive Airway Disease	0.218548717525607	2	0	CTD_human
6649	SOD3	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
6649	SOD3	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6652	SORD	C0520459	Necrotizing Enterocolitis	0.2	1	0	CTD_human
6652	SORD	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6653	SORL1	C0002395	Alzheimer's Disease	0.498192150291638	0	0	CTD_human;ORPHANET
6653	SORL1	C0008370	Cholestasis	0.2	1	0	CTD_human
6653	SORL1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6654	SOS1	C0007194	Hypertrophic Cardiomyopathy	0.200824180352639	0	0	HPO
6654	SOS1	C0015300	Exophthalmos	0.2	0	0	HPO
6654	SOS1	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
6654	SOS1	C0024636	Malocclusion	0.2	0	0	HPO
6654	SOS1	C0028326	Noonan Syndrome	0.433615624525376	2	23	CTD_human;ORPHANET
6654	SOS1	C0038379	Strabismus	0.2	0	0	HPO
6654	SOS1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
6654	SOS1	C0399440	Hereditary gingival fibromatosis	0.601648360705279	0	0	CTD_human;HPO;ORPHANET
6654	SOS1	C1853120	Noonan Syndrome 4	0.48	6	26	CTD_human;UNIPROT
6654	SOS1	C1956257	Pulmonary Stenosis	0.200824180352639	0	0	HPO
6654	SOS1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
6654	SOS1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
6655	SOS2	C0015300	Exophthalmos	0.2	0	0	HPO
6655	SOS2	C0028326	Noonan Syndrome	0.200549453568426	0	0	ORPHANET
6655	SOS2	C0038379	Strabismus	0.2	0	0	HPO
6655	SOS2	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
6655	SOS2	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
6655	SOS2	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
6655	SOS2	C4073145	Hyperkeratosis pilaris	0.2	0	0	HPO
6655	SOS2	C4225282	NOONAN SYNDROME 9	0.2	1	2	UNIPROT
6657	SOX2	C0014544	Epilepsy	0.200549453568426	0	0	HPO
6657	SOX2	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
6657	SOX2	C0023882	Little's Disease	0.2	0	0	HPO
6657	SOX2	C0028738	Nystagmus	0.2	0	0	HPO
6657	SOX2	C0038379	Strabismus	0.2	0	0	HPO
6657	SOX2	C0042798	Low Vision	0.2	0	0	HPO
6657	SOX2	C0271623	Hypogonadotropic hypogonadism	0.201923087489492	0	0	HPO
6657	SOX2	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
6657	SOX2	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
6657	SOX2	C0948740	Pituitary hypoplasia	0.200824180352639	0	0	HPO
6657	SOX2	C1855052	MICROPHTHALMIA, ISOLATED 1	0.2	0	0	ORPHANET
6657	SOX2	C1859773	Microphthalmia, Syndromic 3	0.401098907136852	0	0	CTD_human;ORPHANET
6657	SOX2	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.200824180352639	0	0	HPO
6658	SOX3	C0013338	Pituitary dwarfism	0.200274726784213	0	0	HPO
6658	SOX3	C0014544	Epilepsy	0.2	0	0	HPO
6658	SOX3	C0020615	Hypoglycemia	0.2	0	0	HPO
6658	SOX3	C0020676	Hypothyroidism	0.2	0	0	HPO
6658	SOX3	C0028738	Nystagmus	0.2	0	0	HPO
6658	SOX3	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
6658	SOX3	C0038379	Strabismus	0.2	0	0	HPO
6658	SOX3	C0042798	Low Vision	0.2	0	0	HPO
6658	SOX3	C0151721	Testicular hypogonadism	0.2	0	0	HPO
6658	SOX3	C0242343	Panhypopituitarism	0.401098907136852	0	0	HPO;ORPHANET
6658	SOX3	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
6658	SOX3	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
6658	SOX3	C0432475	XX males	0.200824180352639	0	0	ORPHANET
6658	SOX3	C0948740	Pituitary hypoplasia	0.2	0	0	HPO
6658	SOX3	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
6658	SOX3	C1855900	HYPERTRICHOSIS, CONGENITAL GENERALIZED	0.2	0	0	ORPHANET
6658	SOX3	C2678223	Mental Retardation, X-Linked, With Panhypopituitarism	0.48	0	0	CTD_human;ORPHANET
6658	SOX3	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
6658	SOX3	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
6658	SOX3	C3714796	Isolated somatotropin deficiency	0.201098907136852	0	0	HPO
6660	SOX5	C0004238	Atrial Fibrillation	0.200549453568426	1	0	CTD_human
6660	SOX5	C0015310	Exotropia	0.2	0	0	HPO
6660	SOX5	C0027092	Myopia	0.2	0	0	HPO
6660	SOX5	C0029124	Optic Atrophy	0.2	0	0	HPO
6660	SOX5	C4020884	Anxiety disease	0.2	0	0	HPO
6660	SOX5	C4225202	LAMB-SHAFFER SYNDROME	0.2	0	0	ORPHANET
6662	SOX9	C0004509	Azoospermia	0.2	0	0	HPO
6662	SOX9	C0015300	Exophthalmos	0.2	0	0	HPO
6662	SOX9	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
6662	SOX9	C0018418	Gynecomastia	0.2	0	0	HPO
6662	SOX9	C0020255	Hydrocephalus	0.2	0	0	HPO
6662	SOX9	C0020295	Hydronephrosis	0.2	0	0	HPO
6662	SOX9	C0029456	Osteoporosis	0.2	0	0	HPO
6662	SOX9	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
6662	SOX9	C0151721	Testicular hypogonadism	0.2	0	0	HPO
6662	SOX9	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
6662	SOX9	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
6662	SOX9	C0266427	Testicular regression syndrome	0.2	0	0	HPO
6662	SOX9	C0267048	Glossoptosis	0.200274726784213	0	0	HPO
6662	SOX9	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
6662	SOX9	C0340231	Tracheobronchomalacia	0.2	0	0	HPO
6662	SOX9	C0432475	XX males	0.200549453568426	0	0	ORPHANET
6662	SOX9	C0740852	Upper airway obstruction	0.2	0	0	HPO
6662	SOX9	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
6662	SOX9	C0948896	Primary hypogonadism	0.2	0	0	HPO
6662	SOX9	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
6662	SOX9	C1861922	CAMPOMELIC DYSPLASIA	0.698667065949174	9	10	CTD_human;ORPHANET;UNIPROT
6662	SOX9	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6662	SOX9	C2936694	Swyer Syndrome	0.200274726784213	0	0	ORPHANET
6662	SOX9	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
6663	SOX10	C0014544	Epilepsy	0.2	0	0	HPO
6663	SOX10	C0018784	Sensorineural Hearing Loss (disorder)	0.200549453568426	0	0	HPO
6663	SOX10	C0020619	Hypogonadism	0.2	0	0	HPO
6663	SOX10	C0021843	Intestinal Obstruction	0.2	0	0	HPO
6663	SOX10	C0028738	Nystagmus	0.2	0	0	HPO
6663	SOX10	C0162809	Kallmann Syndrome	0.201098907136852	0	0	ORPHANET
6663	SOX10	C0270922	Peripheral demyelinating neuropathy	0.201098907136852	0	0	HPO
6663	SOX10	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
6663	SOX10	C0344505	Alacrima	0.2	0	0	HPO
6663	SOX10	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
6663	SOX10	C1258215	Ileus	0.2	0	0	HPO
6663	SOX10	C1836727	Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease	0.680549453568426	2	7	CTD_human;ORPHANET;UNIPROT
6663	SOX10	C1848519	WAARDENBURG SYNDROME, TYPE 4A	0.409065983879032	0	0	CTD_human;ORPHANET
6663	SOX10	C1848736	Distal amyotrophy	0.2	0	0	HPO
6663	SOX10	C1866425	Yemenite deaf-blind hypopigmentation syndrome	0.200824180352639	0	0	CTD_human
6663	SOX10	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
6663	SOX10	C2700265	Waardenburg Syndrome Type 2	0.401648360705279	0	0	CTD_human;ORPHANET
6663	SOX10	C2700405	WAARDENBURG SYNDROME, TYPE IIE	0.2	2	3	UNIPROT
6663	SOX10	C2750452	Waardenburg Syndrome, Type 4c	0.4	2	8	CTD_human;UNIPROT
6663	SOX10	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
6663	SOX10	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
6664	SOX11	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
6664	SOX11	C0014544	Epilepsy	0.200274726784213	0	0	HPO
6664	SOX11	C0020555	Hypertrichosis	0.2	0	0	HPO
6664	SOX11	C0028738	Nystagmus	0.2	0	0	HPO
6664	SOX11	C0038379	Strabismus	0.2	0	0	HPO
6664	SOX11	C0265338	Coffin-Siris syndrome	0.200549453568426	0	0	ORPHANET
6664	SOX11	C4014528	MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.2	1	3	UNIPROT
6665	SOX15	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
6667	SP1	C0020456	Hyperglycemia	0.200274726784213	1	0	CTD_human
667	DST	C0151313	Sensory neuropathy	0.200549453568426	0	0	HPO
667	DST	C0344505	Alacrima	0.2	0	0	HPO
667	DST	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
667	DST	C3539003	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI	0.2	0	0	ORPHANET
667	DST	C3809470	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 2	0.2	0	0	ORPHANET
6674	SPAG1	C0006267	Bronchiectasis	0.2	0	0	HPO
6674	SPAG1	C0008677	Bronchitis, Chronic	0.2	0	0	HPO
6674	SPAG1	C0022521	Kartagener Syndrome	0.200274726784213	0	0	ORPHANET
6674	SPAG1	C0035455	Rhinitis	0.2	0	0	HPO
6674	SPAG1	C0037199	Sinusitis	0.2	0	0	HPO
6674	SPAG1	C0581354	Recurrent sinusitis	0.2	0	0	HPO
6674	SPAG1	C0747085	Recurrent otitis media	0.2	0	0	HPO
6674	SPAG1	C4280333	Recurrent sinus disease	0.2	0	0	HPO
6678	SPARC	C0019158	Hepatitis	0.2	1	0	CTD_human
6678	SPARC	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
6678	SPARC	C0029456	Osteoporosis	0.205689394556528	0	0	HPO
6678	SPARC	C0041948	Uremia	0.2	1	0	CTD_human
6678	SPARC	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
6678	SPARC	C0158266	Intervertebral Disc Degeneration	0.200549453568426	1	0	CTD_human
6678	SPARC	C0410550	Collapse of vertebra	0.2	0	0	HPO
6678	SPARC	C4225301	OSTEOGENESIS IMPERFECTA, TYPE XVII	0.2	1	2	UNIPROT
668	FOXL2	C0020490	Hyperopia	0.2	0	0	HPO
668	FOXL2	C0025322	Premature Menopause	0.209890164231672	0	0	HPO
668	FOXL2	C0028738	Nystagmus	0.2	0	0	HPO
668	FOXL2	C0038379	Strabismus	0.2	0	0	HPO
668	FOXL2	C0220663	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS (disorder)	0.492022465970747	9	53	CTD_human;UNIPROT
668	FOXL2	C1837008	PREMATURE OVARIAN FAILURE 3 (disorder)	0.4	3	2	CTD_human;UNIPROT
668	FOXL2	C1862264	Bpes With Duane Retraction Syndrome	0.2	1	0	CTD_human
668	FOXL2	C2931135	Blepharophimosis syndrome type 1	0.2	3	11	CTD_human
6683	SPAST	C0028738	Nystagmus	0.2	0	0	HPO
6683	SPAST	C0030486	Paraplegia	0.211206376643468	0	0	HPO
6683	SPAST	C0037772	Spastic Paraplegia	0.206253203502271	0	0	HPO
6683	SPAST	C0085606	Urgency of micturition	0.2	0	0	HPO
6683	SPAST	C1866855	Spastic paraplegia 4, autosomal dominant	0.682747267842131	32	38	CTD_human;ORPHANET;UNIPROT
6683	SPAST	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
6683	SPAST	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
6687	SPG7	C0028738	Nystagmus	0.2	0	0	HPO
6687	SPG7	C0029124	Optic Atrophy	0.200274726784213	0	0	HPO
6687	SPG7	C0030486	Paraplegia	0.2	1	0	CTD_human
6687	SPG7	C0037772	Spastic Paraplegia	0.201648360705279	0	0	HPO
6687	SPG7	C0085606	Urgency of micturition	0.2	0	0	HPO
6687	SPG7	C0154682	Lateral Sclerosis	0.2	0	0	ORPHANET
6687	SPG7	C0235946	Cerebral atrophy	0.2	0	0	HPO
6687	SPG7	C0262404	Cerebellar degeneration	0.2	0	0	HPO
6687	SPG7	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
6687	SPG7	C1846564	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	0.680549453568426	2	18	CTD_human;ORPHANET;UNIPROT
6687	SPG7	C1968845	Primary Lateral Sclerosis, Adult, 1	0.2	0	0	ORPHANET
6687	SPG7	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
6687	SPG7	C4020873	Infratentorial atrophy	0.2	0	0	HPO
6687	SPG7	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
6689	SPIB	C0008312	Primary biliary cirrhosis	0.400549453568426	0	0	HPO;ORPHANET
6689	SPIB	C0020541	Hypertension, Portal	0.2	0	0	HPO
6689	SPIB	C0023890	Liver Cirrhosis	0.2	0	0	HPO
6689	SPIB	C0023892	Biliary cirrhosis	0.4	1	1	CTD_human;HPO
6689	SPIB	C0040261	Onychomycosis	0.2	0	0	HPO
6689	SPIB	C0085605	Liver Failure	0.2	0	0	HPO
6689	SPIB	C0239946	Fibrosis, Liver	0.2	0	0	HPO
6689	SPIB	C0268307	Conjugated hyperbilirubinemia	0.2	0	0	HPO
6689	SPIB	C0343065	Symptomatic dermographism	0.2	0	0	HPO
6689	SPIB	C0859942	Hanot's cirrhosis	0.2	0	0	ORPHANET
669	BPGM	C0008325	Cholecystitis	0.2	0	0	HPO
669	BPGM	C0008350	Cholelithiasis	0.2	0	0	HPO
669	BPGM	C0085577	Normocytic anemia	0.2	0	0	HPO
669	BPGM	C1291620	Deficiency of bisphosphoglycerate mutase	0.6	2	3	CTD_human;ORPHANET;UNIPROT
669	BPGM	C4025735	Nonspherocytic hemolytic anemia	0.2	0	0	HPO
6690	SPINK1	C0030293	Pancreatic Insufficiency	0.200274726784213	0	0	HPO
6690	SPINK1	C0030299	Pancreatic Pseudocyst	0.2	0	0	HPO
6690	SPINK1	C0030305	Pancreatitis	0.520986530297745	1	0	CTD_human;HPO
6690	SPINK1	C0149521	Pancreatitis, Chronic	0.49971116465928	1	0	CTD_human;HPO
6690	SPINK1	C0238339	Hereditary pancreatitis	0.605219808900049	5	11	CTD_human;ORPHANET;UNIPROT
6690	SPINK1	C0267963	Exocrine pancreatic insufficiency	0.200274726784213	0	0	HPO
6690	SPINK1	C1842402	TROPICAL CALCIFIC PANCREATITIS	0.605429023149632	0	0	CTD_human;ORPHANET;UNIPROT
6696	SPP1	C0003949	Asbestosis	0.2	2	0	CTD_human
6696	SPP1	C0017668	Focal glomerulosclerosis	0.2	1	0	CTD_human
6696	SPP1	C0022650	Kidney Calculi	0.287063028477594	2	0	CTD_human
6696	SPP1	C0023890	Liver Cirrhosis	0.200549453568426	1	0	CTD_human
6696	SPP1	C0032285	Pneumonia	0.2	1	0	CTD_human
6696	SPP1	C0034069	Pulmonary Fibrosis	0.200274726784213	1	0	CTD_human
6696	SPP1	C0041948	Uremia	0.200274726784213	1	0	CTD_human
6696	SPP1	C0162820	Dermatitis, Allergic Contact	0.200274726784213	1	0	CTD_human
6696	SPP1	C0853897	Diabetic Cardiomyopathies	0.200274726784213	1	0	CTD_human
6696	SPP1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6697	SPR	C0014544	Epilepsy	0.2	0	0	HPO
6697	SPR	C0085583	Choreoathetosis	0.2	0	0	HPO
6697	SPR	C0268468	Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency	0.680274726784213	3	7	CTD_human;ORPHANET;UNIPROT
6697	SPR	C3489733	Oculomotor apraxia	0.2	0	0	HPO
6697	SPR	C4020871	Dystonic disease	0.2	0	0	HPO
6701	SPRR2B	C0004096	Asthma	0.200274726784213	1	0	CTD_human
6708	SPTA1	C0002878	Anemia, Hemolytic	0.205465824929628	0	0	HPO
6708	SPTA1	C0013902	Elliptocytosis, Hereditary	0.401373633921066	0	0	HPO;ORPHANET
6708	SPTA1	C0037889	Hereditary spherocytosis	0.200824180352639	0	0	ORPHANET
6708	SPTA1	C0221409	Anemia, hereditary spherocytic hemolytic	0.2	0	0	ORPHANET
6708	SPTA1	C0520739	Hereditary pyropoikilocytosis	0.600549453568426	1	7	CTD_human;HPO;UNIPROT
6708	SPTA1	C1851741	ELLIPTOCYTOSIS 2 (disorder)	0.4	12	18	CTD_human;UNIPROT
6708	SPTA1	C2678338	SPHEROCYTOSIS, TYPE 3 (disorder)	0.28	0	0	CTD_human
6708	SPTA1	C4025285	Microspherocytosis	0.2	0	0	HPO
6709	SPTAN1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
6709	SPTAN1	C0037769	West Syndrome	0.201373633921065	0	0	ORPHANET
6709	SPTAN1	C0235946	Cerebral atrophy	0.200824180352639	0	0	HPO
6709	SPTAN1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
6709	SPTAN1	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
6709	SPTAN1	C0543888	Epileptic encephalopathy	0.200274726784213	0	0	HPO
6709	SPTAN1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
6709	SPTAN1	C3150731	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.2	0	0	CTD_human
6709	SPTAN1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
6709	SPTAN1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
6710	SPTB	C0002878	Anemia, Hemolytic	0.4	1	0	CTD_human;HPO
6710	SPTB	C0002891	Anemia, Neonatal	0.2	1	0	CTD_human
6710	SPTB	C0013902	Elliptocytosis, Hereditary	0.401098907136852	1	0	CTD_human;ORPHANET
6710	SPTB	C0037889	Hereditary spherocytosis	0.400549453568426	2	0	CTD_human;ORPHANET
6710	SPTB	C0221409	Anemia, hereditary spherocytic hemolytic	0.2	0	0	ORPHANET
6710	SPTB	C2674219	SPHEROCYTOSIS, HEREDITARY, 2	0.2	1	5	UNIPROT
6712	SPTBN2	C0087012	Ataxia, Spinocerebellar	0.205139940988102	0	0	CTD_human
6712	SPTBN2	C0262404	Cerebellar degeneration	0.200274726784213	0	0	HPO
6712	SPTBN2	C0271390	Nystagmus, End-Position	0.2	0	0	HPO
6712	SPTBN2	C0740279	Atrophy of cerebellum	0.200274726784213	0	0	HPO
6712	SPTBN2	C0752123	Spinocerebellar Ataxia Type 5	0.483021994626344	2	3	ORPHANET;UNIPROT
6712	SPTBN2	C3809327	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.2	0	0	ORPHANET
6712	SPTBN2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
6714	SRC	C0009319	Colitis	0.2	1	0	CTD_human
6714	SRC	C0038220	Status Epilepticus	0.2	1	0	CTD_human
6715	SRD5A1	C0014175	Endometriosis	0.2	2	0	CTD_human
6715	SRD5A1	C0032460	Polycystic Ovary Syndrome	0.205964121340741	2	0	CTD_human
6716	SRD5A2	C0002170	Alopecia	0.201098907136852	1	0	CTD_human
6716	SRD5A2	C0014175	Endometriosis	0.2	1	0	CTD_human
6716	SRD5A2	C0268297	Pseudovaginal Perineoscrotal Hypospadias	0.602197814273705	11	14	CTD_human;ORPHANET;UNIPROT
6716	SRD5A2	C2937421	Prostatic Hyperplasia	0.222640908534169	1	0	CTD_human
6718	AKR1D1	C0008372	Intrahepatic Cholestasis	0.2	0	0	HPO
6718	AKR1D1	C0018995	Hemochromatosis	0.2	1	0	CTD_human
6718	AKR1D1	C0023890	Liver Cirrhosis	0.2	0	0	HPO
6718	AKR1D1	C0085605	Liver Failure	0.200274726784213	0	0	HPO
6718	AKR1D1	C1856127	Bile acid synthesis defect, congenital, 2	0.6	4	5	CTD_human;ORPHANET;UNIPROT
6718	AKR1D1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6718	AKR1D1	C2936476	Chronic Liver Failure	0.2	0	0	HPO
672	BRCA1	C0031154	Peritonitis	0.200274726784213	0	0	HPO
6720	SREBF1	C0015695	Fatty Liver	0.210685633829676	1	0	CTD_human
6720	SREBF1	C0022661	Kidney Failure, Chronic	0.202407028523288	1	0	CTD_human
6720	SREBF1	C0028754	Obesity	0.211891440901487	1	0	CTD_human
6720	SREBF1	C0400966	Non-alcoholic Fatty Liver Disease	0.202472541057918	2	0	CTD_human
6721	SREBF2	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
6722	SRF	C0015923	Fetal Alcohol Syndrome	0.2	2	0	PSYGENET
673	BRAF	C0006384	Bundle-Branch Block	0.2	0	0	HPO
673	BRAF	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
673	BRAF	C0011615	Dermatitis, Atopic	0.2	0	0	HPO
673	BRAF	C0014544	Epilepsy	0.200549453568426	0	0	HPO
673	BRAF	C0015300	Exophthalmos	0.2	0	0	HPO
673	BRAF	C0015526	Factor XII Deficiency	0.2	0	0	HPO
673	BRAF	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
673	BRAF	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
673	BRAF	C0020255	Hydrocephalus	0.2	0	0	HPO
673	BRAF	C0020295	Hydronephrosis	0.2	0	0	HPO
673	BRAF	C0020514	Hyperprolactinemia	0.2	0	0	HPO
673	BRAF	C0020757	Ichthyoses	0.200274726784213	0	0	HPO
673	BRAF	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
673	BRAF	C0024236	Lymphedema	0.2	0	0	HPO
673	BRAF	C0024636	Malocclusion	0.2	0	0	HPO
673	BRAF	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
673	BRAF	C0027092	Myopia	0.2	0	0	HPO
673	BRAF	C0028326	Noonan Syndrome	0.408319992706716	1	3	CTD_human;ORPHANET
673	BRAF	C0028738	Nystagmus	0.2	0	0	HPO
673	BRAF	C0028754	Obesity	0.2	0	0	HPO
673	BRAF	C0029453	Osteopenia	0.2	0	0	HPO
673	BRAF	C0030353	Papilledema	0.2	0	0	HPO
673	BRAF	C0036651	Senile lentigo	0.2	0	0	HPO
673	BRAF	C0038379	Strabismus	0.2	0	0	HPO
673	BRAF	C0039103	Synovitis	0.2	0	0	HPO
673	BRAF	C0175704	LEOPARD Syndrome	0.200549453568426	0	0	ORPHANET
673	BRAF	C0235946	Cerebral atrophy	0.2	0	0	HPO
673	BRAF	C0259817	Xerosis	0.2	0	0	HPO
673	BRAF	C0263490	Brittle hair	0.2	0	0	HPO
673	BRAF	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
673	BRAF	C0398639	Amegakaryocytic thrombocytopenia	0.2	0	0	HPO
673	BRAF	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
673	BRAF	C0587248	Costello syndrome (disorder)	0.201098907136852	1	0	CTD_human
673	BRAF	C0687720	Central Diabetes Insipidus	0.200274726784213	0	0	HPO
673	BRAF	C0747078	Generalized osteopenia	0.2	0	0	HPO
673	BRAF	C0870082	Hyperkeratosis	0.200549453568426	0	0	HPO
673	BRAF	C0948387	Secondary Adrenal Insufficiency	0.2	0	0	HPO
673	BRAF	C1275336	Hashimoto-Pritzker syndrome	0.2	0	0	ORPHANET
673	BRAF	C1328931	Multiple lentigines	0.2	0	0	HPO
673	BRAF	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
673	BRAF	C1956257	Pulmonary Stenosis	0.200274726784213	0	0	HPO
673	BRAF	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
673	BRAF	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
673	BRAF	C3150970	NOONAN SYNDROME 7	0.4	3	4	CTD_human;UNIPROT
673	BRAF	C3150971	LEOPARD SYNDROME 3	0.4	0	0	CTD_human;UNIPROT
673	BRAF	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
673	BRAF	C3489733	Oculomotor apraxia	0.2	0	0	HPO
673	BRAF	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
673	BRAF	C4021533	Severe sensorineural hearing impairment	0.2	0	0	HPO
673	BRAF	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
6731	SRP72	C0002874	Aplastic Anemia	0.2	0	0	HPO
6731	SRP72	C0008370	Cholestasis	0.2	1	0	CTD_human
6731	SRP72	C3808553	BONE MARROW FAILURE SYNDROME 1	0.4	1	2	ORPHANET;UNIPROT
6731	SRP72	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6736	SRY	C0004509	Azoospermia	0.200549453568426	0	0	HPO
6736	SRY	C0018055	Gonadal Dysgenesis, Mixed	0.201648360705279	0	0	HPO
6736	SRY	C0018418	Gynecomastia	0.200274726784213	0	0	HPO
6736	SRY	C0029456	Osteoporosis	0.2	0	0	HPO
6736	SRY	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
6736	SRY	C0151721	Testicular hypogonadism	0.200274726784213	0	0	HPO
6736	SRY	C0156394	Hypertrophy of clitoris	0.200274726784213	0	0	HPO
6736	SRY	C0232939	Primary physiologic amenorrhea	0.200274726784213	0	0	HPO
6736	SRY	C0266427	Testicular regression syndrome	0.200274726784213	0	0	HPO
6736	SRY	C0271623	Hypogonadotropic hypogonadism	0.200274726784213	0	0	HPO
6736	SRY	C0432475	XX males	0.210164891015885	0	0	ORPHANET
6736	SRY	C0948896	Primary hypogonadism	0.200274726784213	0	0	HPO
6736	SRY	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
6736	SRY	C2748896	46,Xy Gonadal Dysgenesis, Complete, Sry-Related	0.4	22	21	CTD_human;UNIPROT
6736	SRY	C2936694	Swyer Syndrome	0.206527930286485	0	0	ORPHANET
6736	SRY	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
6736	SRY	C3900199	45,X/46,XY Mixed Gonadal Dysgenesis	0.2	0	0	ORPHANET
6748	SSR4	C0014306	Enophthalmos	0.2	0	0	HPO
6748	SSR4	C0014544	Epilepsy	0.2	0	0	HPO
6748	SSR4	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
6748	SSR4	C0038379	Strabismus	0.2	0	0	HPO
6748	SSR4	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6748	SSR4	C4012395	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy	0.2	0	0	ORPHANET
675	BRCA2	C0015625	Fanconi Anemia	0.43040044975839	0	0	CTD_human;ORPHANET
675	BRCA2	C0023530	Leukopenia	0.200274726784213	0	0	HPO
675	BRCA2	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
675	BRCA2	C1838457	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.680549453568426	4	13	CTD_human;ORPHANET;UNIPROT
6750	SST	C0004763	Barrett Esophagus	0.200274726784213	1	0	CTD_human
6750	SST	C0014175	Endometriosis	0.200549453568426	1	0	CTD_human
6750	SST	C0030305	Pancreatitis	0.2	1	0	CTD_human
6751	SSTR1	C0038220	Status Epilepticus	0.2	1	0	CTD_human
6752	SSTR2	C0038220	Status Epilepticus	0.2	1	0	CTD_human
6753	SSTR3	C0038220	Status Epilepticus	0.2	1	0	CTD_human
6754	SSTR4	C0038220	Status Epilepticus	0.2	1	0	CTD_human
6755	SSTR5	C0038220	Status Epilepticus	0.2	1	0	CTD_human
6762	ST3	C1860658	SUPPRESSOR OF TUMORIGENICITY 3	0.2	0	0	CTD_human
6768	ST14	C0020757	Ichthyoses	0.209022917747081	0	0	HPO
6768	ST14	C1835851	Ichthyosis with hypotrichosis, autosomal recessive	0.601098907136852	2	4	CTD_human;ORPHANET;UNIPROT
6769	STAC	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
6770	STAR	C0032460	Polycystic Ovary Syndrome	0.201373633921065	1	0	CTD_human
6770	STAR	C0302280	Adrenogenital Syndrome	0.2	0	0	HPO
6770	STAR	C0342474	Lipoid congenital adrenal hyperplasia	0.483846174978983	5	12	CTD_human;UNIPROT
6770	STAR	C1859974	GLUCOCORTICOID DEFICIENCY 1	0.2	0	0	ORPHANET
6772	STAT1	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
6772	STAT1	C0003873	Rheumatoid Arthritis	0.202747267842131	1	0	CTD_human
6772	STAT1	C0006267	Bronchiectasis	0.2	0	0	HPO
6772	STAT1	C0006845	Candidiasis, Chronic Mucocutaneous	0.405219808900049	1	0	CTD_human;HPO
6772	STAT1	C0011854	Diabetes Mellitus, Insulin-Dependent	0.200274726784213	0	0	HPO
6772	STAT1	C0013595	Eczema	0.200274726784213	0	0	HPO
6772	STAT1	C0014356	Enterocolitis	0.2	0	0	HPO
6772	STAT1	C0020545	Hypertension, Renovascular	0.2	0	0	HPO
6772	STAT1	C0021400	Influenza	0.200824180352639	1	0	CTD_human
6772	STAT1	C0023890	Liver Cirrhosis	0.202681755307501	1	0	CTD_human
6772	STAT1	C0024312	Lymphopenia	0.2	0	0	HPO
6772	STAT1	C0029453	Osteopenia	0.2	0	0	HPO
6772	STAT1	C0029456	Osteoporosis	0.202956482091714	0	0	HPO
6772	STAT1	C0040147	Thyroiditis	0.2	0	0	HPO
6772	STAT1	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
6772	STAT1	C0276226	Herpes encephalitis	0.200824180352639	0	0	HPO
6772	STAT1	C0340639	Carotid artery aneurysm	0.2	0	0	HPO
6772	STAT1	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
6772	STAT1	C0700502	Acquired hypothyroidism	0.2	0	0	HPO
6772	STAT1	C0747078	Generalized osteopenia	0.2	0	0	HPO
6772	STAT1	C0751003	Brain Aneurysm	0.2	0	0	HPO
6772	STAT1	C1290398	Cerebral arterial aneurysm	0.2	0	0	HPO
6772	STAT1	C3151088	IMMUNODEFICIENCY 31B	0.4	3	5	ORPHANET;UNIPROT
6772	STAT1	C3279990	CANDIDIASIS, FAMILIAL, 7	0.4	5	16	ORPHANET;UNIPROT
6772	STAT1	C3805887	Generalized osteoporosis with pathologic fractures	0.2	0	0	HPO
6772	STAT1	C4013950	IMMUNODEFICIENCY 31A	0.4	3	5	ORPHANET;UNIPROT
6773	STAT2	C4225260	IMMUNODEFICIENCY 44	0.2	0	0	ORPHANET
6774	STAT3	C0004153	Atherosclerosis	0.201373633921065	1	0	CTD_human
6774	STAT3	C0007570	Celiac Disease	0.2	0	0	HPO
6774	STAT3	C0007786	Brain Ischemia	0.2	1	0	CTD_human
6774	STAT3	C0009324	Ulcerative Colitis	0.214899080150514	2	1	CTD_human
6774	STAT3	C0011854	Diabetes Mellitus, Insulin-Dependent	0.202407028523288	1	0	CTD_human
6774	STAT3	C0013595	Eczema	0.202472541057918	0	0	HPO
6774	STAT3	C0014306	Enophthalmos	0.2	0	0	HPO
6774	STAT3	C0014457	Eosinophilia	0.2	0	0	HPO
6774	STAT3	C0017574	Gingivitis	0.2	0	0	HPO
6774	STAT3	C0019189	Hepatitis, Chronic	0.200274726784213	1	0	CTD_human
6774	STAT3	C0029453	Osteopenia	0.2	0	0	HPO
6774	STAT3	C0030578	Paronychia Inflammation	0.2	0	0	HPO
6774	STAT3	C0033860	Psoriasis	0.202197814273705	1	0	CTD_human
6774	STAT3	C0271441	Chronic otitis media	0.2	0	0	HPO
6774	STAT3	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
6774	STAT3	C0743359	ear infection chronic	0.2	0	0	HPO
6774	STAT3	C0747078	Generalized osteopenia	0.2	0	0	HPO
6774	STAT3	C1876165	Copper-Overload Cirrhosis	0.2	1	0	CTD_human
6774	STAT3	C2936739	Hyper-Immunoglobulin E Syndrome, Autosomal Dominant	0.206868169605328	0	0	ORPHANET
6774	STAT3	C3489795	Hyper-Ige Recurrent Infection Syndrome, Autosomal Dominant	0.68	4	12	CTD_human;ORPHANET;UNIPROT
6774	STAT3	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
6774	STAT3	C3887645	Job Syndrome	0.230529796096026	1	0	CTD_human
6774	STAT3	C4014795	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET	0.4	1	12	ORPHANET;UNIPROT
6775	STAT4	C0003864	Arthritis	0.202956482091714	0	0	HPO
6775	STAT4	C0003873	Rheumatoid Arthritis	0.276798436229607	2	2	CTD_human
6775	STAT4	C0004943	Behcet Syndrome	0.403780662444354	1	3	CTD_human;ORPHANET
6775	STAT4	C0022073	Iridocyclitis	0.2	0	0	HPO
6775	STAT4	C0023892	Biliary cirrhosis	0.2	1	1	CTD_human
6775	STAT4	C0024141	Lupus Erythematosus, Systemic	0.278172070150672	2	7	CTD_human
6775	STAT4	C0024636	Malocclusion	0.2	0	0	HPO
6775	STAT4	C0025289	Meningitis	0.2	0	0	HPO
6775	STAT4	C0026769	Multiple Sclerosis	0.200549453568426	1	0	CTD_human
6775	STAT4	C0036421	Systemic Scleroderma	0.212650108719496	1	3	CTD_human
6775	STAT4	C0038363	Aphthous Stomatitis	0.2	0	0	HPO
6775	STAT4	C0042384	Vasculitis	0.2	0	0	HPO
6775	STAT4	C0149745	Oral Ulcer	0.200549453568426	0	0	HPO
6775	STAT4	C0157917	Pauciarticular juvenile rheumatoid arthritis	0.2	0	0	ORPHANET
6775	STAT4	C0162323	Polyarthritis	0.2	0	0	HPO
6775	STAT4	C0702166	Acne	0.2	0	0	HPO
6775	STAT4	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6775	STAT4	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
6775	STAT4	C1527336	Sjogren's Syndrome	0.213459933694818	2	1	CTD_human
6775	STAT4	C2937365	Recurrent aphthous ulcer	0.2	0	0	HPO
6775	STAT4	C3714757	Juvenile rheumatoid arthritis	0.200549453568426	0	0	HPO
6775	STAT4	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
6776	STAT5A	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
677662	PARK12	C1845165	PARKINSON DISEASE 12	0.2	0	0	CTD_human
677662	PARK12	C3160718	PARKINSON DISEASE, LATE-ONSET	0.2	0	0	CTD_human
6777	STAT5B	C1855548	Laron syndrome type 2	0.6	3	2	CTD_human;ORPHANET;UNIPROT
6777	STAT5B	C2931322	T-Lymphocytopenia	0.2	1	0	CTD_human
6777	STAT5B	C3714796	Isolated somatotropin deficiency	0.200274726784213	0	0	HPO
677764	MYP13	C1845096	MYOPIA 13	0.2	0	0	CTD_human
6778	STAT6	C0011615	Dermatitis, Atopic	0.205754907091158	1	0	CTD_human
6783	SULT1E1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6785	ELOVL4	C0020620	Hypohidrosis	0.2	0	0	HPO
6785	ELOVL4	C0024437	Macular degeneration	0.203846174978983	0	0	HPO
6785	ELOVL4	C0028077	Night Blindness	0.2	0	0	HPO
6785	ELOVL4	C0028738	Nystagmus	0.2	0	0	HPO
6785	ELOVL4	C0042109	Urticaria	0.2	0	0	HPO
6785	ELOVL4	C0259817	Xerosis	0.2	0	0	HPO
6785	ELOVL4	C0393525	Progressive cerebellar ataxia	0.2	0	0	HPO
6785	ELOVL4	C1838644	Stargardt disease 3	0.282747267842131	0	0	CTD_human
6785	ELOVL4	C1851481	Erythrokeratodermia with ataxia	0.400274726784213	1	1	ORPHANET;UNIPROT
6785	ELOVL4	C3280856	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION	0.2	0	0	ORPHANET
6786	STIM1	C0002871	Anemia	0.2	0	0	HPO
6786	STIM1	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
6786	STIM1	C0014306	Enophthalmos	0.2	0	0	HPO
6786	STIM1	C0020757	Ichthyoses	0.2	0	0	HPO
6786	STIM1	C0026205	Miosis disorder	0.200274726784213	0	0	HPO
6786	STIM1	C0034150	Purpura	0.2	0	0	HPO
6786	STIM1	C0040015	Thrombasthenia	0.2	0	0	HPO
6786	STIM1	C0410207	Tubular Aggregate Myopathy	0.202472541057918	0	0	ORPHANET
6786	STIM1	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
6786	STIM1	C1861451	Stormorken Syndrome	0.401098907136852	4	2	ORPHANET;UNIPROT
6786	STIM1	C2748557	Immune dysfunction with T-cell inactivation due to calcium entry defect 2	0.600549453568426	1	3	CTD_human;ORPHANET;UNIPROT
6786	STIM1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
6786	STIM1	C4011726	MYOPATHY, TUBULAR AGGREGATE, 1	0.2	4	6	UNIPROT
6786	STIM1	C4020863	Blood platelet disease	0.2	0	0	HPO
6789	STK4	C0024312	Lymphopenia	0.2	0	0	HPO
6789	STK4	C3553943	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS	0.200549453568426	0	0	ORPHANET
6792	CDKL5	C0014306	Enophthalmos	0.2	0	0	HPO
6792	CDKL5	C0014544	Epilepsy	0.222129935477362	0	0	HPO
6792	CDKL5	C0014550	Epilepsies, Myoclonic	0.200824180352639	0	0	HPO
6792	CDKL5	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
6792	CDKL5	C0035372	Rett Syndrome	0.446066288752274	1	2	CTD_human;ORPHANET
6792	CDKL5	C0037769	West Syndrome	0.212883448103381	0	0	ORPHANET
6792	CDKL5	C0162635	Angelman Syndrome	0.200274726784213	1	1	CTD_human
6792	CDKL5	C0235946	Cerebral atrophy	0.2	0	0	HPO
6792	CDKL5	C0392525	Nephrolithiasis	0.2	0	0	HPO
6792	CDKL5	C0393706	Early infantile epileptic encephalopathy with suppression bursts	0.2	0	0	ORPHANET
6792	CDKL5	C0543888	Epileptic encephalopathy	0.206318716036901	0	0	HPO
6792	CDKL5	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
6792	CDKL5	C1836830	Developmental regression	0.2	0	0	HPO
6792	CDKL5	C1839333	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	0.480274726784213	9	92	CTD_human;UNIPROT
6792	CDKL5	C2748910	Rett Syndrome, Atypical	0.202747267842131	0	0	ORPHANET
6792	CDKL5	C3463992	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	0.2	0	0	CTD_human
6792	CDKL5	C3887898	Infantile Spasm	0.206318716036901	0	0	HPO
6792	CDKL5	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
6794	STK11	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
6794	STK11	C0018418	Gynecomastia	0.200274726784213	0	0	HPO
6794	STK11	C0021933	Intussusception	0.200274726784213	0	0	HPO
6794	STK11	C0027430	Nasal Polyps	0.200274726784213	0	0	HPO
6794	STK11	C0029927	Ovarian Cysts	0.2	0	0	HPO
6794	STK11	C0031269	Peutz-Jeghers Syndrome	0.789007581033489	7	32	CTD_human;ORPHANET;UNIPROT
6794	STK11	C0034888	Rectal Prolapse	0.2	0	0	HPO
6794	STK11	C0036651	Senile lentigo	0.2	0	0	HPO
6794	STK11	C0149721	Left Ventricular Hypertrophy	0.2	1	0	CTD_human
6794	STK11	C0162316	Iron deficiency anemia	0.2	0	0	HPO
6794	STK11	C1257915	Intestinal Polyposis	0.2	1	0	CTD_human
6794	STK11	C1328931	Multiple lentigines	0.2	0	0	HPO
6795	AURKC	C0403812	Male Infertility with Large-Headed, Multiflagellar, Polyploid Spermatozoa	0.4	0	0	CTD_human;ORPHANET
6804	STX1A	C0008312	Primary biliary cirrhosis	0.2	0	0	HPO
6804	STX1A	C0010674	Cystic Fibrosis	0.200274726784213	0	0	ORPHANET
6804	STX1A	C0023892	Biliary cirrhosis	0.2	0	0	HPO
6804	STX1A	C0030293	Pancreatic Insufficiency	0.2	0	0	HPO
6804	STX1A	C0034069	Pulmonary Fibrosis	0.2	0	0	HPO
6804	STX1A	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
6804	STX1A	C0267963	Exocrine pancreatic insufficiency	0.2	0	0	HPO
6809	STX3	C0341306	Microvillus inclusion disease	0.200274726784213	0	0	ORPHANET
6812	STXBP1	C0009952	Febrile Convulsions	0.2	0	0	HPO
6812	STXBP1	C0014550	Epilepsies, Myoclonic	0.4	1	0	CTD_human;HPO
6812	STXBP1	C0037769	West Syndrome	0.202197814273705	0	0	HPO
6812	STXBP1	C0037772	Spastic Paraplegia	0.2	0	0	HPO
6812	STXBP1	C0038220	Status Epilepticus	0.2	0	0	HPO
6812	STXBP1	C0235946	Cerebral atrophy	0.2	0	0	HPO
6812	STXBP1	C0393706	Early infantile epileptic encephalopathy with suppression bursts	0.203846174978983	0	0	ORPHANET
6812	STXBP1	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
6812	STXBP1	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
6812	STXBP1	C0543888	Epileptic encephalopathy	0.20357144819477	0	0	HPO
6812	STXBP1	C0751122	Infantile Severe Myoclonic Epilepsy	0.200549453568426	0	0	ORPHANET
6812	STXBP1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
6812	STXBP1	C0752323	Focal Clonic Seizures	0.2	0	0	HPO
6812	STXBP1	C1527366	Salaam Seizures	0.200274726784213	0	0	HPO
6812	STXBP1	C1836830	Developmental regression	0.2	0	0	HPO
6812	STXBP1	C2677326	Epileptic Encephalopathy, Early Infantile, 4	0.4	5	21	CTD_human;UNIPROT
6812	STXBP1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
6812	STXBP1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
6812	STXBP1	C4023511	Obtundation status	0.2	0	0	HPO
6813	STXBP2	C0876991	Histiocytosis haematophagic	0.200274726784213	0	0	HPO
6813	STXBP2	C2751293	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5	0.2	2	6	UNIPROT
6813	STXBP2	C3854388	Hyperferritinaemia	0.2	0	0	HPO
6817	SULT1A1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
682	BSG	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
6821	SUOX	C0013595	Eczema	0.2	0	0	HPO
6821	SUOX	C0014544	Epilepsy	0.2	0	0	HPO
6821	SUOX	C0085583	Choreoathetosis	0.2	0	0	HPO
6821	SUOX	C0268624	Sulfite oxidase deficiency	0.400824180352639	0	0	CTD_human;HPO
6821	SUOX	C2931746	Sulfocysteinuria	0.4	4	6	ORPHANET;UNIPROT
683	BST1	C0030567	Parkinson Disease	0.211341987333061	1	3	CTD_human
6832	SUPV3L1	C0002170	Alopecia	0.2	1	0	CTD_human
6832	SUPV3L1	C0020757	Ichthyoses	0.200274726784213	1	0	CTD_human
6833	ABCC8	C0003886	Arthrogryposis	0.2	0	0	HPO
6833	ABCC8	C0011854	Diabetes Mellitus, Insulin-Dependent	0.203231208875927	1	0	CTD_human
6833	ABCC8	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.677469145110308	2	2	CTD_human;HPO;ORPHANET
6833	ABCC8	C0014544	Epilepsy	0.200274726784213	0	0	HPO
6833	ABCC8	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
6833	ABCC8	C0020456	Hyperglycemia	0.201923087489492	0	0	HPO
6833	ABCC8	C0020615	Hypoglycemia	0.212477696249908	0	0	HPO
6833	ABCC8	C0020617	Hypoglycemic coma	0.2	0	0	HPO
6833	ABCC8	C0038379	Strabismus	0.2	0	0	HPO
6833	ABCC8	C0039841	Thiamine Deficiency	0.2	0	0	HPO
6833	ABCC8	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
6833	ABCC8	C0162275	Ketonuria	0.2	0	0	HPO
6833	ABCC8	C0271714	Hypoglycemia, leucine-induced	0.4	1	1	CTD_human;UNIPROT
6833	ABCC8	C0342273	Transient neonatal diabetes mellitus	0.201098907136852	0	0	HPO
6833	ABCC8	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
6833	ABCC8	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
6833	ABCC8	C0877056	Hypoglycaemic seizure	0.2	0	0	HPO
6833	ABCC8	C1832386	Diabetes Mellitus, Transient Neonatal, 1	0.201373633921065	0	0	ORPHANET
6833	ABCC8	C1833104	DIABETES MELLITUS, PERMANENT NEONATAL	0.604670355331623	4	17	CTD_human;ORPHANET;UNIPROT
6833	ABCC8	C1835887	DIABETES MELLITUS, TRANSIENT NEONATAL, 2 (disorder)	0.48	1	4	CTD_human;UNIPROT
6833	ABCC8	C1864903	Hyperinsulinaemic hypoglycaemia	0.203846174978983	0	0	HPO
6833	ABCC8	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6833	ABCC8	C2931832	Hyperinsulinemic hypoglycemia, familial, 1	0.48	19	82	ORPHANET;UNIPROT
6833	ABCC8	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
6833	ABCC8	C4274080	Autosomal dominant hyperinsulinism due to SUR1 deficiency	0.2	0	0	ORPHANET
6834	SURF1	C0014544	Epilepsy	0.2	0	0	HPO
6834	SURF1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6834	SURF1	C0020555	Hypertrichosis	0.200824180352639	0	0	HPO
6834	SURF1	C0023264	Leigh Disease	0.706539919402089	6	10	CTD_human;ORPHANET;UNIPROT
6834	SURF1	C0028738	Nystagmus	0.2	0	0	HPO
6834	SURF1	C0029124	Optic Atrophy	0.2	0	0	HPO
6834	SURF1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
6834	SURF1	C0038379	Strabismus	0.2	0	0	HPO
6834	SURF1	C0338474	Central nervous system demyelination	0.2	0	0	HPO
6834	SURF1	C1145670	Respiratory Failure	0.2	0	0	HPO
6834	SURF1	C1857355	Leigh syndrome , French Canadian type	0.2	1	0	CTD_human
6834	SURF1	C2315100	Pediatric failure to thrive	0.200274726784213	0	0	HPO
6834	SURF1	C4020871	Dystonic disease	0.2	0	0	HPO
6834	SURF1	C4225246	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K	0.2	0	0	ORPHANET
6843	VAMP1	C0037772	Spastic Paraplegia	0.200274726784213	0	0	HPO
6843	VAMP1	C1849156	Spastic Ataxia	0.200274726784213	0	0	HPO
6843	VAMP1	C1970107	ATAXIA, SPASTIC, 1, AUTOSOMAL DOMINANT	0.2	0	0	ORPHANET
6843	VAMP1	C4020871	Dystonic disease	0.2	0	0	HPO
6845	VAMP7	C0004509	Azoospermia	0.2	0	0	HPO
6845	VAMP7	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
6845	VAMP7	C0018418	Gynecomastia	0.2	0	0	HPO
6845	VAMP7	C0029456	Osteoporosis	0.2	0	0	HPO
6845	VAMP7	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
6845	VAMP7	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
6845	VAMP7	C0266427	Testicular regression syndrome	0.2	0	0	HPO
6845	VAMP7	C0948896	Primary hypogonadism	0.2	0	0	HPO
685	BTC	C0162568	Erythropoietic Protoporphyria	0.2	1	0	CTD_human
6853	SYN1	C0014544	Epilepsy	0.201373633921065	0	0	HPO
6853	SYN1	C1845343	Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders	0.48	0	0	CTD_human;ORPHANET
6855	SYP	C1136249	Mental Retardation, X-Linked	0.2	1	0	CTD_human
6855	SYP	C1866282	CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.2	1	0	CTD_human
6855	SYP	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	0.2	1	0	CTD_human
6855	SYP	C3275408	MENTAL RETARDATION, X-LINKED 96	0.4	1	1	CTD_human;UNIPROT
686	BTD	C0002170	Alopecia	0.2	0	0	HPO
686	BTD	C0009763	Conjunctivitis	0.2	0	0	HPO
686	BTD	C0014544	Epilepsy	0.2	0	0	HPO
686	BTD	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
686	BTD	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
686	BTD	C0022573	Keratoconjunctivitis	0.2	0	0	HPO
686	BTD	C0029124	Optic Atrophy	0.200274726784213	0	0	HPO
686	BTD	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
686	BTD	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
686	BTD	C1396126	Perioral eczema	0.2	0	0	HPO
686	BTD	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
686	BTD	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
686	BTD	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6862	T	C3810343	SACRAL AGENESIS WITH VERTEBRAL ANOMALIES	0.4	1	1	ORPHANET;UNIPROT
6863	TAC1	C0017168	Gastroesophageal reflux disease	0.200549453568426	1	0	CTD_human
6863	TAC1	C0020452	Hyperemia	0.2	2	0	CTD_human
6863	TAC1	C0027404	Narcolepsy	0.2	1	0	CTD_human
6863	TAC1	C0037036	Sialorrhea	0.2	1	0	CTD_human
6863	TAC1	C0085129	Bronchial Hyperreactivity	0.200274726784213	1	0	CTD_human
6863	TAC1	C0338480	Common Migraine	0.2	1	0	CTD_human
6866	TAC3	C0018418	Gynecomastia	0.2	0	0	HPO
6866	TAC3	C0020619	Hypogonadism	0.2	1	0	CTD_human
6866	TAC3	C0029453	Osteopenia	0.2	0	0	HPO
6866	TAC3	C0029456	Osteoporosis	0.2	0	0	HPO
6866	TAC3	C0151721	Testicular hypogonadism	0.2	0	0	HPO
6866	TAC3	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
6866	TAC3	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
6866	TAC3	C0242350	Erectile dysfunction	0.2	0	0	HPO
6866	TAC3	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
6866	TAC3	C0271623	Hypogonadotropic hypogonadism	0.200824180352639	0	0	HPO
6866	TAC3	C0342384	Idiopathic hypogonadotropic hypogonadism	0.201098907136852	0	0	CTD_human
6866	TAC3	C0747078	Generalized osteopenia	0.2	0	0	HPO
6866	TAC3	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
6866	TAC3	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.200274726784213	0	0	HPO
6866	TAC3	C3553843	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA	0.2	2	3	UNIPROT
6866	TAC3	C4020884	Anxiety disease	0.2	0	0	HPO
6866	TAC3	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
6868	ADAM17	C0005741	Blepharitis	0.2	0	0	HPO
6868	ADAM17	C0009319	Colitis	0.200274726784213	1	0	CTD_human
6868	ADAM17	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
6868	ADAM17	C0014457	Eosinophilia	0.2	0	0	HPO
6868	ADAM17	C0030578	Paronychia Inflammation	0.2	0	0	HPO
6868	ADAM17	C0263537	Onychogryposis	0.2	0	0	HPO
6868	ADAM17	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
6868	ADAM17	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
687	KLF9	C0014175	Endometriosis	0.200549453568426	1	0	CTD_human
6870	TACR3	C0018418	Gynecomastia	0.2	0	0	HPO
6870	TACR3	C0020619	Hypogonadism	0.200274726784213	1	0	CTD_human
6870	TACR3	C0029453	Osteopenia	0.2	0	0	HPO
6870	TACR3	C0029456	Osteoporosis	0.2	0	0	HPO
6870	TACR3	C0151721	Testicular hypogonadism	0.2	0	0	HPO
6870	TACR3	C0162809	Kallmann Syndrome	0.2	0	0	ORPHANET
6870	TACR3	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
6870	TACR3	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
6870	TACR3	C0242350	Erectile dysfunction	0.2	0	0	HPO
6870	TACR3	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
6870	TACR3	C0271623	Hypogonadotropic hypogonadism	0.200824180352639	0	0	HPO
6870	TACR3	C0342384	Idiopathic hypogonadotropic hypogonadism	0.201098907136852	0	0	CTD_human
6870	TACR3	C0747078	Generalized osteopenia	0.2	0	0	HPO
6870	TACR3	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
6870	TACR3	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.200549453568426	0	0	HPO
6870	TACR3	C3553844	HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA	0.28	3	7	UNIPROT
6870	TACR3	C4020884	Anxiety disease	0.2	0	0	HPO
6870	TACR3	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
6870	TACR3	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
6872	TAF1	C0013423	Dystonia Musculorum Deformans	0.200274726784213	0	0	HPO
6872	TAF1	C1839130	Dystonia 3, Torsion, X-Linked	0.404670355331623	0	0	CTD_human;ORPHANET
6872	TAF1	C4020858	Choreatic disease	0.2	0	0	HPO
6872	TAF1	C4225418	MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.2	1	5	UNIPROT
6873	TAF2	C3810080	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40	0.4	1	1	ORPHANET;UNIPROT
6875	TAF4B	C0004509	Azoospermia	0.2	0	0	HPO
6875	TAF4B	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
6875	TAF4B	C4023106	Obstructive azoospermia	0.2	0	0	HPO
6876	TAGLN	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
6876	TAGLN	C0023794	Lipoidosis	0.2	3	0	CTD_human
6885	MAP3K7	C0018777	Conductive hearing loss	0.2	0	0	HPO
6885	MAP3K7	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
6885	MAP3K7	C1834818	Mitral Regurgitation, Conductive Deafness, and Fusion of Cervical Vertebrae and of Carpal and Tarsal Bones	0.4	1	4	ORPHANET;UNIPROT
6888	TALDO1	C0002871	Anemia	0.2	0	0	HPO
6888	TALDO1	C0004096	Asthma	0.2	0	0	HPO
6888	TALDO1	C0023890	Liver Cirrhosis	0.200549453568426	0	0	HPO
6888	TALDO1	C0030312	Pancytopenia	0.2	0	0	HPO
6888	TALDO1	C0030567	Parkinson Disease	0.2	1	0	CTD_human
6888	TALDO1	C0039446	Telangiectasis	0.2	0	0	HPO
6888	TALDO1	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
6888	TALDO1	C0239946	Fibrosis, Liver	0.2	0	0	HPO
6888	TALDO1	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
6888	TALDO1	C1291329	Transaldolase Deficiency	0.401098907136852	0	0	CTD_human;ORPHANET
6888	TALDO1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6888	TALDO1	C3714497	Reactive airway disease	0.2	0	0	HPO
6888	TALDO1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6890	TAP1	C0006267	Bronchiectasis	0.205414667772315	0	0	HPO
6890	TAP1	C0006271	Bronchiolitis	0.2	0	0	HPO
6890	TAP1	C0027430	Nasal Polyps	0.2	0	0	HPO
6890	TAP1	C0034067	Pulmonary Emphysema	0.2	0	0	HPO
6890	TAP1	C0149516	Chronic sinusitis	0.2	0	0	HPO
6890	TAP1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
6890	TAP1	C0271441	Chronic otitis media	0.2	0	0	HPO
6890	TAP1	C0451695	Major histocompatibility complex class I deficiency	0.2	0	0	ORPHANET
6890	TAP1	C0741796	Recurrent bronchitis	0.2	0	0	HPO
6890	TAP1	C0743359	ear infection chronic	0.2	0	0	HPO
6890	TAP1	C0748720	Chronic sinus disease	0.2	0	0	HPO
6890	TAP1	C1858266	Bare Lymphocyte Syndrome, Type I	0.4	0	0	CTD_human;ORPHANET
6891	TAP2	C0006267	Bronchiectasis	0.205689394556528	0	0	HPO
6891	TAP2	C0006271	Bronchiolitis	0.2	0	0	HPO
6891	TAP2	C0027430	Nasal Polyps	0.2	0	0	HPO
6891	TAP2	C0034067	Pulmonary Emphysema	0.2	0	0	HPO
6891	TAP2	C0149516	Chronic sinusitis	0.2	0	0	HPO
6891	TAP2	C0271441	Chronic otitis media	0.2	0	0	HPO
6891	TAP2	C0451695	Major histocompatibility complex class I deficiency	0.2	0	0	ORPHANET
6891	TAP2	C0741796	Recurrent bronchitis	0.2	0	0	HPO
6891	TAP2	C0743359	ear infection chronic	0.2	0	0	HPO
6891	TAP2	C0748720	Chronic sinus disease	0.2	0	0	HPO
6891	TAP2	C1858266	Bare Lymphocyte Syndrome, Type I	0.400274726784213	0	0	CTD_human;ORPHANET
6892	TAPBP	C0006267	Bronchiectasis	0.2	0	0	HPO
6892	TAPBP	C0006271	Bronchiolitis	0.2	0	0	HPO
6892	TAPBP	C0027430	Nasal Polyps	0.2	0	0	HPO
6892	TAPBP	C0034067	Pulmonary Emphysema	0.2	0	0	HPO
6892	TAPBP	C0149516	Chronic sinusitis	0.2	0	0	HPO
6892	TAPBP	C0271441	Chronic otitis media	0.2	0	0	HPO
6892	TAPBP	C0451695	Major histocompatibility complex class I deficiency	0.2	0	0	ORPHANET
6892	TAPBP	C0741796	Recurrent bronchitis	0.2	0	0	HPO
6892	TAPBP	C0743359	ear infection chronic	0.2	0	0	HPO
6892	TAPBP	C0748720	Chronic sinus disease	0.2	0	0	HPO
6892	TAPBP	C1858266	Bare Lymphocyte Syndrome, Type I	0.400274726784213	0	0	CTD_human;ORPHANET
6897	TARS	C0027121	Myositis	0.2	1	0	CTD_human
6898	TAT	C0268483	Tyrosinemias	0.200824180352639	0	0	CTD_human
6898	TAT	C0268487	Tyrosine Transaminase Deficiency Disease	0.402747267842131	1	5	ORPHANET;UNIPROT
6898	TAT	C1879362	Hypertyrosinemia	0.200549453568426	0	0	HPO
6898	TAT	C4020911	Herpetiform corneal ulceration	0.2	0	0	HPO
6899	TBX1	C0008350	Cholelithiasis	0.2	0	0	HPO
6899	TBX1	C0011334	Dental caries	0.2	0	0	HPO
6899	TBX1	C0012236	DiGeorge Syndrome	0.704421973040331	4	1	CTD_human;ORPHANET;UNIPROT
6899	TBX1	C0014544	Epilepsy	0.2	0	0	HPO
6899	TBX1	C0014877	Esotropia	0.2	0	0	HPO
6899	TBX1	C0015300	Exophthalmos	0.2	0	0	HPO
6899	TBX1	C0015310	Exotropia	0.2	0	0	HPO
6899	TBX1	C0018777	Conductive hearing loss	0.2	0	0	HPO
6899	TBX1	C0020295	Hydronephrosis	0.2	0	0	HPO
6899	TBX1	C0020626	Hypoparathyroidism	0.200274726784213	0	0	HPO
6899	TBX1	C0020676	Hypothyroidism	0.2	0	0	HPO
6899	TBX1	C0028754	Obesity	0.200549453568426	0	0	HPO
6899	TBX1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
6899	TBX1	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
6899	TBX1	C0039621	Tetany	0.2	0	0	HPO
6899	TBX1	C0042454	Velopharyngeal Insufficiency	0.200274726784213	0	0	HPO
6899	TBX1	C0085109	Corneal Neovascularization	0.2	0	0	HPO
6899	TBX1	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
6899	TBX1	C0220704	Shprintzen syndrome	0.493736339210655	1	2	ORPHANET;UNIPROT
6899	TBX1	C0271441	Chronic otitis media	0.2	0	0	HPO
6899	TBX1	C0702166	Acne	0.2	0	0	HPO
6899	TBX1	C0743359	ear infection chronic	0.2	0	0	HPO
6899	TBX1	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	0.200274726784213	0	0	ORPHANET
6899	TBX1	C1853235	Sclerocornea	0.2	0	0	HPO
6899	TBX1	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	0.400274726784213	1	1	CTD_human;UNIPROT
6899	TBX1	C2675369	Chromosome 22q11.2 Microduplication Syndrome	0.2	0	0	ORPHANET
6899	TBX1	C2936346	22q11 Deletion Syndrome	0.202472541057918	0	0	ORPHANET
6899	TBX1	C3266101	22q11 partial monosomy syndrome	0.200274726784213	0	0	ORPHANET
6899	TBX1	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
6899	TBX1	C4021592	Unilateral primary pulmonary dysgenesis	0.2	0	0	HPO
6899	TBX1	C4024912	Occipital myelomeningocele	0.2	0	0	HPO
6900	CNTN2	C0014544	Epilepsy	0.200274726784213	0	0	HPO
6900	CNTN2	C0234533	Generalized seizures	0.2	0	0	HPO
6900	CNTN2	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
6900	CNTN2	C1832841	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1	0.2	0	0	ORPHANET
6901	TAZ	C0001824	Agranulocytosis	0.2	0	0	HPO
6901	TAZ	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
6901	TAZ	C0014117	Endocardial Fibroelastosis	0.200274726784213	0	0	HPO
6901	TAZ	C0014306	Enophthalmos	0.2	0	0	HPO
6901	TAZ	C0018801	Heart failure	0.200549453568426	0	0	HPO
6901	TAZ	C0018802	Congestive heart failure	0.200549453568426	0	0	HPO
6901	TAZ	C0574083	3-Methylglutaconic aciduria type 2	0.614560519563294	6	18	CTD_human;ORPHANET;UNIPROT
6901	TAZ	C1844917	Intermittent lactic acidemia	0.2	0	0	HPO
6901	TAZ	C1960469	Left ventricular noncompaction	0.201098907136852	0	0	ORPHANET
6901	TAZ	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6901	TAZ	C3696376	3-Methylglutaconic Aciduria	0.200824180352639	0	0	HPO
6901	TAZ	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
6901	TAZ	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
6902	TBCA	C0007194	Hypertrophic Cardiomyopathy	0.2	1	0	CTD_human
6905	TBCE	C0002871	Anemia	0.2	0	0	HPO
6905	TBCE	C0011334	Dental caries	0.2	0	0	HPO
6905	TBCE	C0014306	Enophthalmos	0.2	0	0	HPO
6905	TBCE	C0014544	Epilepsy	0.2	0	0	HPO
6905	TBCE	C0029464	Osteosclerosis	0.200274726784213	1	0	CTD_human
6905	TBCE	C0039621	Tetany	0.2	0	0	HPO
6905	TBCE	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
6905	TBCE	C0265291	Kenny-Caffey syndrome	0.200549453568426	1	0	CTD_human
6905	TBCE	C1855648	KENNY-CAFFEY SYNDROME, TYPE 1	0.400549453568426	0	0	CTD_human;ORPHANET
6905	TBCE	C1855840	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.401098907136852	1	2	CTD_human;ORPHANET
6905	TBCE	C1855841	Hypocalcaemic seizure	0.2	0	0	HPO
6908	TBP	C0014544	Epilepsy	0.2	0	0	HPO
6908	TBP	C0262404	Cerebellar degeneration	0.200274726784213	0	0	HPO
6908	TBP	C0271390	Nystagmus, End-Position	0.2	0	0	HPO
6908	TBP	C0338455	Dementia of frontal lobe type	0.2	0	0	HPO
6908	TBP	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
6908	TBP	C1846707	SPINOCEREBELLAR ATAXIA 17	0.482747267842131	0	0	CTD_human;ORPHANET
6908	TBP	C3160718	PARKINSON DISEASE, LATE-ONSET	0.2	0	0	CTD_human
6908	TBP	C4020858	Choreatic disease	0.2	0	0	HPO
6908	TBP	C4020871	Dystonic disease	0.2	0	0	HPO
6908	TBP	C4020873	Infratentorial atrophy	0.2	0	0	HPO
6909	TBX2	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
6909	TBX2	C3150607	CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.2	0	0	ORPHANET
6909	TBX2	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
6910	TBX5	C0085614	First degree atrioventricular block	0.2	0	0	HPO
6910	TBX5	C0152101	Hypoplastic Left Heart Syndrome	0.2	0	0	HPO
6910	TBX5	C0235480	Paroxysmal atrial fibrillation	0.200274726784213	0	0	HPO
6910	TBX5	C0265264	Holt-Oram syndrome	0.698275669473018	3	8	CTD_human;ORPHANET;UNIPROT
6911	TBX6	C1853223	Deafness, Autosomal Recessive 67	0.2	0	0	CTD_human
6911	TBX6	C4083048	SPONDYLOCOSTAL DYSOSTOSIS 5	0.2	0	0	ORPHANET
6911	TBX6	C4274761	Autosomal dominant spondylocostal dysostosis	0.200274726784213	0	0	ORPHANET
6913	TBX15	C0014306	Enophthalmos	0.2	0	0	HPO
6913	TBX15	C0020255	Hydrocephalus	0.2	0	0	HPO
6913	TBX15	C0020295	Hydronephrosis	0.2	0	0	HPO
6913	TBX15	C0038379	Strabismus	0.2	0	0	HPO
6913	TBX15	C0158113	Contracture of joint of hand	0.2	0	0	HPO
6913	TBX15	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
6913	TBX15	C1850040	Pelviscapular dysplasia	0.400549453568426	1	0	CTD_human;ORPHANET
6913	TBX15	C2930865	Ramer Ladda syndrome	0.2	0	0	HPO
6915	TBXA2R	C0034065	Pulmonary Embolism	0.2	1	0	CTD_human
6915	TBXA2R	C0035455	Rhinitis	0.200274726784213	1	0	CTD_human
6915	TBXA2R	C1319853	Asthma, Aspirin-Induced	0.200549453568426	2	0	CTD_human
6915	TBXA2R	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6916	TBXAS1	C0002871	Anemia	0.2	0	0	HPO
6916	TBXAS1	C0002893	Refractory anemias	0.2	0	0	HPO
6916	TBXAS1	C0011989	Camurati-Engelmann Syndrome	0.2	0	0	HPO
6916	TBXAS1	C0029464	Osteosclerosis	0.2	0	0	HPO
692157	SNORA16B	C0022336	Creutzfeldt-Jakob disease	0.2	1	0	CTD_human
692219	DFNB65	C1853248	DEAFNESS, AUTOSOMAL RECESSIVE 65	0.2	0	0	CTD_human
692220	DFNB62	C1857820	DEAFNESS, AUTOSOMAL RECESSIVE 62	0.2	0	0	CTD_human
692222	OPA5	C1853139	OPTIC ATROPHY 5 (disorder)	0.2	0	0	CTD_human
6925	TCF4	C0004106	Astigmatism	0.2	0	0	HPO
6925	TCF4	C0013363	Dysautonomia	0.2	0	0	HPO
6925	TCF4	C0014306	Enophthalmos	0.2	0	0	HPO
6925	TCF4	C0014544	Epilepsy	0.200274726784213	0	0	HPO
6925	TCF4	C0016781	Fuchs Endothelial Dystrophy	0.206868169605328	0	0	ORPHANET
6925	TCF4	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
6925	TCF4	C0027092	Myopia	0.2	0	0	HPO
6925	TCF4	C0038379	Strabismus	0.2	0	0	HPO
6925	TCF4	C0566602	Primary sclerosing cholangitis	0.200549453568426	0	0	ORPHANET
6925	TCF4	C1970431	PITT-HOPKINS SYNDROME	0.607417623173754	4	29	CTD_human;ORPHANET;UNIPROT
6926	TBX3	C0028754	Obesity	0.2	0	0	HPO
6926	TBX3	C0948740	Pituitary hypoplasia	0.2	0	0	HPO
6926	TBX3	C1838608	Radial aplasia	0.2	0	0	HPO
6926	TBX3	C1866994	Ulnar-mammary syndrome	0.688516530310606	2	2	CTD_human;ORPHANET;UNIPROT
6926	TBX3	C4053775	Pituitary stalk interruption syndrome	0.2	0	0	HPO
6927	HNF1A	C0011854	Diabetes Mellitus, Insulin-Dependent	0.442424143886221	0	0	CTD_human;HPO
6927	HNF1A	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.812068890604634	0	0	CTD_human;HPO;ORPHANET
6927	HNF1A	C0014544	Epilepsy	0.2	0	0	HPO
6927	HNF1A	C0020456	Hyperglycemia	0.205429023149632	0	0	HPO
6927	HNF1A	C0020615	Hypoglycemia	0.201648360705279	1	0	CTD_human
6927	HNF1A	C0032460	Polycystic Ovary Syndrome	0.2	0	0	HPO
6927	HNF1A	C0158986	Neonatal hypoglycemia	0.200549453568426	0	0	HPO
6927	HNF1A	C0342276	Maturity onset diabetes mellitus in young	0.232417760537146	0	0	HPO
6927	HNF1A	C1136382	Sclerocystic Ovaries	0.2	0	0	HPO
6927	HNF1A	C1838100	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3 (disorder)	0.488791257094819	15	35	CTD_human;UNIPROT
6927	HNF1A	C1840646	Hepatic Adenomas, Familial	0.2	0	0	CTD_human
6927	HNF1A	C1864903	Hyperinsulinaemic hypoglycaemia	0.200824180352639	0	0	HPO
6927	HNF1A	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
6927	HNF1A	C2675866	DIABETES MELLITUS, INSULIN-DEPENDENT, 20 (disorder)	0.4	5	3	CTD_human;UNIPROT
6928	HNF1B	C0003868	Arthritis, Gouty	0.2	0	0	HPO
6928	HNF1B	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.683990811044836	2	3	CTD_human;HPO;UNIPROT
6928	HNF1B	C0018099	Gout	0.202732912464814	0	0	HPO
6928	HNF1B	C0037859	Spermatocele	0.2	0	0	HPO
6928	HNF1B	C0235946	Cerebral atrophy	0.2	0	0	HPO
6928	HNF1B	C0392525	Nephrolithiasis	0.2	0	0	HPO
6928	HNF1B	C0431693	Renal cysts and diabetes syndrome	0.607142896389541	9	22	CTD_human;ORPHANET;UNIPROT
6928	HNF1B	C1835171	Hypomagnesemia 2, renal	0.200549453568426	0	0	ORPHANET
6928	HNF1B	C2316810	Chronic kidney disease stage 5	0.200824180352639	0	0	HPO
6928	HNF1B	C3281138	CHROMOSOME 17q12 DELETION SYNDROME	0.2	0	0	ORPHANET
6928	HNF1B	C3714581	Multicystic Dysplastic Kidney	0.200824180352639	0	0	HPO
6929	TCF3	C0001768	Agammaglobulinemia	0.2	0	0	HPO
6929	TCF3	C0003864	Arthritis	0.2	0	0	HPO
6929	TCF3	C0009763	Conjunctivitis	0.2	0	0	HPO
6929	TCF3	C0029443	Osteomyelitis	0.2	0	0	HPO
6929	TCF3	C0037199	Sinusitis	0.2	0	0	HPO
6929	TCF3	C0271441	Chronic otitis media	0.2	0	0	HPO
6929	TCF3	C0743359	ear infection chronic	0.2	0	0	HPO
6929	TCF3	C2242472	Infection of bone	0.2	0	0	HPO
6929	TCF3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6929	TCF3	C3152144	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
693121	MIR411	C0008370	Cholestasis	0.2	1	0	CTD_human
693177	MIR592	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
6932	TCF7	C0010346	Crohn Disease	0.200274726784213	1	0	CTD_human
6932	TCF7	C0024141	Lupus Erythematosus, Systemic	0.2	1	0	CTD_human
6934	TCF7L2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.379130387253696	2	6	CTD_human
6934	TCF7L2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
6935	ZEB1	C0010036	Corneal dystrophy	0.200824180352639	0	0	HPO
6935	ZEB1	C0016781	Fuchs Endothelial Dystrophy	0.204604842796993	0	0	ORPHANET
6935	ZEB1	C0029172	Oral Submucous Fibrosis	0.200274726784213	1	0	CTD_human
6935	ZEB1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
6935	ZEB1	C0271288	Corneal guttata	0.2	0	0	HPO
6935	ZEB1	C0339284	Polymorphous corneal dystrophy	0.204120901763196	0	0	ORPHANET
6935	ZEB1	C1836724	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3 (disorder)	0.28	0	0	CTD_human
6935	ZEB1	C2750448	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6	0.4	3	7	CTD_human;UNIPROT
6938	TCF12	C0010278	Craniosynostosis	0.400824180352639	1	0	CTD_human;HPO
6938	TCF12	C0015300	Exophthalmos	0.2	0	0	HPO
6938	TCF12	C0038379	Strabismus	0.2	0	0	HPO
6938	TCF12	C0151740	Intracranial Hypertension	0.2	0	0	HPO
6938	TCF12	C3715051	CRANIOSYNOSTOSIS 3	0.2	2	13	UNIPROT
6939	TCF15	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
694	BTG1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
6943	TCF21	C1956346	Coronary Artery Disease	0.201098907136852	2	0	CTD_human
6945	MLX	C0002871	Anemia	0.2	0	0	HPO
6945	MLX	C0002940	Aneurysm	0.2	0	0	HPO
6945	MLX	C0003123	Anorexia	0.2	0	0	HPO
6945	MLX	C0003864	Arthritis	0.2	0	0	HPO
6945	MLX	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
6945	MLX	C0014544	Epilepsy	0.2	0	0	HPO
6945	MLX	C0017086	Gangrene	0.2	0	0	HPO
6945	MLX	C0027051	Myocardial Infarction	0.2	0	0	HPO
6945	MLX	C0039263	Takayasu Arteritis	0.200549453568426	0	0	ORPHANET
6945	MLX	C0042384	Vasculitis	0.2	0	0	HPO
6945	MLX	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
6945	MLX	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
6945	MLX	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
6945	MLX	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
6945	MLX	C4020848	Aneurysmal disease	0.2	0	0	HPO
6947	TCN1	C0002888	Anemia, Megaloblastic	0.2	1	0	CTD_human
6948	TCN2	C0002886	Anemia, Macrocytic	0.2	0	0	HPO
6948	TCN2	C0002888	Anemia, Megaloblastic	0.203557092817453	1	0	CTD_human
6948	TCN2	C0022660	Kidney Failure, Acute	0.2	0	0	HPO
6948	TCN2	C0024312	Lymphopenia	0.2	0	0	HPO
6948	TCN2	C0030312	Pancytopenia	0.2	0	0	HPO
6948	TCN2	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
6948	TCN2	C0162539	IgG Deficiency	0.2	0	0	HPO
6948	TCN2	C0342701	Transcobalamin II deficiency	0.400824180352639	0	0	CTD_human;ORPHANET
6948	TCN2	C1855119	Methylmalonic aciduria	0.2	0	0	HPO
6948	TCN2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
6949	TCOF1	C0018777	Conductive hearing loss	0.200549453568426	0	0	HPO
6949	TCOF1	C0038379	Strabismus	0.2	0	0	HPO
6949	TCOF1	C0042798	Low Vision	0.2	0	0	HPO
6949	TCOF1	C0265241	Franceschetti-Klein syndrome	0.2	0	0	ORPHANET
695	BTK	C0001768	Agammaglobulinemia	0.424233526461803	1	0	CTD_human;HPO
695	BTK	C0003864	Arthritis	0.200549453568426	0	0	HPO
695	BTK	C0009763	Conjunctivitis	0.2	0	0	HPO
695	BTK	C0014038	Encephalitis	0.200274726784213	0	0	HPO
695	BTK	C0014534	Epididymitis	0.2	0	0	HPO
695	BTK	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
695	BTK	C0025289	Meningitis	0.2	0	0	HPO
695	BTK	C0029882	Otitis Media	0.2	0	0	HPO
695	BTK	C0032285	Pneumonia	0.2	0	0	HPO
695	BTK	C0033581	prostatitis	0.2	0	0	HPO
695	BTK	C0034072	Cor pulmonale	0.2	0	0	HPO
695	BTK	C0034212	Pyoderma	0.200274726784213	0	0	HPO
695	BTK	C0036690	Septicemia	0.2	0	0	HPO
695	BTK	C0037199	Sinusitis	0.2	0	0	HPO
695	BTK	C0221026	X-linked agammaglobulinemia	0.730275001510997	21	48	CTD_human;ORPHANET;UNIPROT
695	BTK	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
695	BTK	C0267048	Glossoptosis	0.2	0	0	HPO
695	BTK	C0271441	Chronic otitis media	0.2	0	0	HPO
695	BTK	C0401151	Chronic diarrhea	0.2	0	0	HPO
695	BTK	C0472813	X-linked agammaglobulinemia with growth hormone deficiency	0.4	0	0	CTD_human;ORPHANET
695	BTK	C0694550	Recurrent pneumonia	0.2	0	0	HPO
695	BTK	C0743359	ear infection chronic	0.2	0	0	HPO
695	BTK	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
695	BTK	C1843995	Enteroviral hepatitis	0.2	0	0	HPO
695	BTK	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
695	BTK	C3714796	Isolated somatotropin deficiency	0.200549453568426	0	0	HPO
695	BTK	C3806660	Enteroviral dermatomyositis syndrome	0.2	0	0	HPO
695	BTK	C4280547	Infected joint	0.2	0	0	HPO
6955	TRA	C0027404	Narcolepsy	0.203231208875927	1	0	CTD_human
699	BUB1	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
699	BUB1	C0017601	Glaucoma	0.2	0	0	HPO
699	BUB1	C0026850	Muscular Dystrophy	0.2	0	0	HPO
699	BUB1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
699	BUB1	C1850343	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.2	0	0	ORPHANET
6997	TDGF1	C3178805	Heterotaxy Syndrome	0.2	1	0	CTD_human
6999	TDO2	C0220702	SCHIZOPHRENIA 1 (disorder)	0.2	1	0	PSYGENET
70	ACTC1	C0007194	Hypertrophic Cardiomyopathy	0.216416415786532	0	0	HPO
70	ACTC1	C0018801	Heart failure	0.200274726784213	0	0	HPO
70	ACTC1	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
70	ACTC1	C1960469	Left ventricular noncompaction	0.2	0	0	ORPHANET
70	ACTC1	C2677506	Cardiomyopathy, Familial Hypertrophic, 11	0.4	4	7	CTD_human;UNIPROT
70	ACTC1	C3150681	CARDIOMYOPATHY, DILATED, 1R	0.28	1	3	UNIPROT
70	ACTC1	C3495498	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	0.2	0	0	CTD_human
70	ACTC1	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
70	ACTC1	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
7001	PRDX2	C0003949	Asbestosis	0.2	1	0	CTD_human
7001	PRDX2	C0013080	Down Syndrome	0.208748190962867	1	0	CTD_human
7003	TEAD1	C0004106	Astigmatism	0.2	0	0	HPO
7003	TEAD1	C0027092	Myopia	0.2	0	0	HPO
7003	TEAD1	C1862382	SVEINSSON CHORIORETINAL ATROPHY	0.600549453568426	1	1	CTD_human;ORPHANET;UNIPROT
7003	TEAD1	C4024765	Peripapillary chorioretinal atrophy	0.2	0	0	HPO
7007	TECTA	C0018784	Sensorineural Hearing Loss (disorder)	0.204055389228567	0	0	HPO
7007	TECTA	C1832187	Deafness, Autosomal Dominant 12	0.48	8	22	CTD_human;UNIPROT
7007	TECTA	C1863655	Deafness, Autosomal Recessive 21	0.2	0	0	CTD_human
701	BUB1B	C0010964	Dandy-Walker Syndrome	0.200549453568426	0	0	HPO
701	BUB1B	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
701	BUB1B	C0017601	Glaucoma	0.2	0	0	HPO
701	BUB1B	C0020255	Hydrocephalus	0.2	0	0	HPO
701	BUB1B	C0022679	Cystic kidney	0.2	0	0	HPO
701	BUB1B	C0026850	Muscular Dystrophy	0.2	0	0	HPO
701	BUB1B	C0028738	Nystagmus	0.2	0	0	HPO
701	BUB1B	C0494261	Combined immunodeficiency	0.2	0	0	HPO
701	BUB1B	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
701	BUB1B	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
701	BUB1B	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
701	BUB1B	C1850343	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.681923087489492	1	7	CTD_human;ORPHANET;UNIPROT
701	BUB1B	C1864389	PREMATURE CHROMATID SEPARATION TRAIT	0.401098907136852	1	7	CTD_human;UNIPROT
701	BUB1B	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
7010	TEK	C0014556	Epilepsy, Temporal Lobe	0.2	1	0	CTD_human
7010	TEK	C0042961	Intestinal Volvulus	0.2	0	0	HPO
7010	TEK	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
7010	TEK	C4021977	Visceral angiomatosis	0.2	0	0	HPO
7012	TERC	C0002170	Alopecia	0.2	0	0	HPO
7012	TERC	C0002871	Anemia	0.2	0	0	HPO
7012	TERC	C0002874	Aplastic Anemia	0.41739406761111	0	0	CTD_human;HPO
7012	TERC	C0011334	Dental caries	0.2	0	0	HPO
7012	TERC	C0023890	Liver Cirrhosis	0.201098907136852	0	0	HPO
7012	TERC	C0024312	Lymphopenia	0.2	0	0	HPO
7012	TERC	C0029456	Osteoporosis	0.202681755307501	0	0	HPO
7012	TERC	C0031099	Periodontitis	0.2	0	0	HPO
7012	TERC	C0034069	Pulmonary Fibrosis	0.20350593566014	0	0	HPO
7012	TERC	C0206061	Pneumonia, Interstitial	0.2	0	0	HPO
7012	TERC	C0221260	Dystrophia unguium	0.2	0	0	HPO
7012	TERC	C0265965	Dyskeratosis Congenita	0.431398869254021	1	0	CTD_human;ORPHANET
7012	TERC	C0266039	Taurodontism	0.2	0	0	HPO
7012	TERC	C0348890	Aplastic anemia, idiopathic	0.2	0	0	ORPHANET
7012	TERC	C0399385	Early tooth exfoliation	0.2	0	0	HPO
7012	TERC	C1800706	Idiopathic Pulmonary Fibrosis	0.401098907136852	3	1	CTD_human;ORPHANET
7012	TERC	C1851970	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT	0.201648360705279	0	0	CTD_human
7015	TERT	C0002170	Alopecia	0.2	0	0	HPO
7015	TERT	C0002871	Anemia	0.202732912464814	0	0	HPO
7015	TERT	C0002874	Aplastic Anemia	0.60761248204602	4	15	CTD_human;HPO;UNIPROT
7015	TERT	C0010314	Cri-du-Chat Syndrome	0.203557092817453	1	0	CTD_human
7015	TERT	C0011334	Dental caries	0.2	0	0	HPO
7015	TERT	C0020455	Hypergammaglobulinemia	0.2	0	0	HPO
7015	TERT	C0023890	Liver Cirrhosis	0.201648360705279	0	0	HPO
7015	TERT	C0024141	Lupus Erythematosus, Systemic	0.2	1	0	CTD_human
7015	TERT	C0024312	Lymphopenia	0.2	0	0	HPO
7015	TERT	C0029456	Osteoporosis	0.2	0	0	HPO
7015	TERT	C0031099	Periodontitis	0.2	0	0	HPO
7015	TERT	C0032285	Pneumonia	0.2	0	0	HPO
7015	TERT	C0034069	Pulmonary Fibrosis	0.210843690921947	0	0	HPO
7015	TERT	C0206061	Pneumonia, Interstitial	0.2	0	0	HPO
7015	TERT	C0221260	Dystrophia unguium	0.2	0	0	HPO
7015	TERT	C0235946	Cerebral atrophy	0.2	0	0	HPO
7015	TERT	C0259817	Xerosis	0.2	0	0	HPO
7015	TERT	C0265965	Dyskeratosis Congenita	0.424024312212219	3	0	CTD_human;ORPHANET
7015	TERT	C0266039	Taurodontism	0.2	0	0	HPO
7015	TERT	C0348890	Aplastic anemia, idiopathic	0.2	0	0	ORPHANET
7015	TERT	C0399385	Early tooth exfoliation	0.2	0	0	HPO
7015	TERT	C1800706	Idiopathic Pulmonary Fibrosis	0.410671278452359	4	16	CTD_human;ORPHANET
7015	TERT	C1846142	HOYERAAL-HREIDARSSON SYNDROME	0.400549453568426	1	0	CTD_human;ORPHANET
7015	TERT	C1851970	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT	0.201098907136852	0	0	CTD_human
7015	TERT	C1956346	Coronary Artery Disease	0.202956482091714	1	0	CTD_human
7015	TERT	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7015	TERT	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
7015	TERT	C3151443	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2	0.2	6	10	UNIPROT
7015	TERT	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
7015	TERT	C3553617	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1	0.2	9	16	UNIPROT
7015	TERT	C4023400	Generalized hypopigmentation of hair	0.2	0	0	HPO
7018	TF	C0002395	Alzheimer's Disease	0.239988404608299	2	1	CTD_human
7018	TF	C0002871	Anemia	0.28	0	0	HPO
7018	TF	C0002884	Hypochromic anemia	0.2	0	0	HPO
7018	TF	C0013502	Echinococcosis	0.2	1	0	CTD_human
7018	TF	C0015695	Fatty Liver	0.2	2	0	CTD_human
7018	TF	C0018801	Heart failure	0.2	0	0	HPO
7018	TF	C0018802	Congestive heart failure	0.2	0	0	HPO
7018	TF	C0019158	Hepatitis	0.2	1	0	CTD_human
7018	TF	C0028754	Obesity	0.2	1	0	CTD_human
7018	TF	C0030524	Paratuberculosis	0.2	1	0	CTD_human
7018	TF	C0035258	Restless Legs Syndrome	0.200274726784213	1	0	CTD_human
7018	TF	C0271901	Microcytic hypochromic anemia (disorder)	0.2	1	0	CTD_human
7018	TF	C0282193	Iron Overload	0.2	1	0	CTD_human
7018	TF	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
7019	TFAM	C0002395	Alzheimer's Disease	0.223362774572183	1	0	CTD_human
7019	TFAM	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	0.2	1	0	CTD_human
7020	TFAP2A	C0014544	Epilepsy	0.2	0	0	HPO
7020	TFAP2A	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
7020	TFAP2A	C0018777	Conductive hearing loss	0.2	0	0	HPO
7020	TFAP2A	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
7020	TFAP2A	C0022679	Cystic kidney	0.200274726784213	0	0	HPO
7020	TFAP2A	C0027092	Myopia	0.2	0	0	HPO
7020	TFAP2A	C0028738	Nystagmus	0.2	0	0	HPO
7020	TFAP2A	C0038379	Strabismus	0.2	0	0	HPO
7020	TFAP2A	C0265234	Branchio-Oto-Renal Syndrome	0.2	1	0	CTD_human
7020	TFAP2A	C0376524	Branchio-Oculo-Facial Syndrome	0.404670355331623	1	7	ORPHANET;UNIPROT
7020	TFAP2A	C0431399	Familial aplasia of the vermis	0.2	0	0	HPO
7020	TFAP2A	C4020952	Fingernail dysplasia	0.2	0	0	HPO
7021	TFAP2B	C0038379	Strabismus	0.2	0	0	HPO
7021	TFAP2B	C1868570	CHAR SYNDROME	0.681648360705279	2	7	CTD_human;ORPHANET;UNIPROT
7025	NR2F1	C0028738	Nystagmus	0.2	0	0	HPO
7025	NR2F1	C0029124	Optic Atrophy	0.200549453568426	0	0	HPO
7025	NR2F1	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
7025	NR2F1	C0038379	Strabismus	0.2	0	0	HPO
7025	NR2F1	C0042798	Low Vision	0.2	0	0	HPO
7025	NR2F1	C3810363	BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME	0.4	1	5	ORPHANET;UNIPROT
7026	NR2F2	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
7026	NR2F2	C0014175	Endometriosis	0.200549453568426	1	0	CTD_human
7026	NR2F2	C0152101	Hypoplastic Left Heart Syndrome	0.2	0	0	HPO
7026	NR2F2	C4014310	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4	0.2	1	5	UNIPROT
7027	TFDP1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
7033	TFF3	C0019188	Hepatitis, Animal	0.2	1	0	CTD_human
7035	TFPI	C0034155	Purpura, Thrombotic Thrombocytopenic	0.2	1	0	CTD_human
7035	TFPI	C0600433	Activated Protein C Resistance	0.202732912464814	1	0	CTD_human
7035	TFPI	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
7036	TFR2	C0005283	beta Thalassemia	0.200274726784213	1	0	CTD_human
7036	TFR2	C0018995	Hemochromatosis	0.226134167548616	4	0	CTD_human
7036	TFR2	C0023890	Liver Cirrhosis	0.200549453568426	0	0	HPO
7036	TFR2	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
7036	TFR2	C1858664	HEMOCHROMATOSIS, TYPE 3	0.682472541057918	3	17	CTD_human;ORPHANET;UNIPROT
7036	TFR2	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
7036	TFR2	C3854388	Hyperferritinaemia	0.2	0	0	HPO
7037	TFRC	C0005283	beta Thalassemia	0.203557092817453	1	0	CTD_human
7037	TFRC	C0028754	Obesity	0.200549453568426	2	0	CTD_human
7037	TFRC	C0032460	Polycystic Ovary Syndrome	0.200274726784213	1	0	CTD_human
7037	TFRC	C0085110	Severe Combined Immunodeficiency	0.2	1	0	CTD_human
7037	TFRC	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
7037	TFRC	C0162316	Iron deficiency anemia	0.203831819601666	3	0	CTD_human
7037	TFRC	C4225219	IMMUNODEFICIENCY 46	0.4	1	1	ORPHANET;UNIPROT
7038	TG	C0020676	Hypothyroidism	0.219671749796762	0	0	HPO
7038	TG	C0024421	Macroglossia	0.2	0	0	HPO
7038	TG	C0342162	Compensated hypothyroidism	0.200274726784213	0	0	HPO
7038	TG	C0342194	Thyroid Dyshormonogenesis 3	0.48	5	14	CTD_human;UNIPROT
7038	TG	C0917799	Hypersomnia	0.2	0	0	HPO
7038	TG	C0920350	Autoimmune thyroiditis	0.209209685593986	0	0	CTD_human
7038	TG	C1848805	Thyroid Dyshormonogenesis 1	0.2	0	0	ORPHANET
7039	TGFA	C0033860	Psoriasis	0.202472541057918	1	0	CTD_human
7039	TGFA	C0034069	Pulmonary Fibrosis	0.201648360705279	1	0	CTD_human
7039	TGFA	C0162770	Right Ventricular Hypertrophy	0.2	1	0	CTD_human
7040	TGFB1	C0003504	Aortic Valve Insufficiency	0.2	1	0	CTD_human
7040	TGFB1	C0004096	Asthma	0.292753357385021	2	0	CTD_human
7040	TGFB1	C0008312	Primary biliary cirrhosis	0.200549453568426	0	0	HPO
7040	TGFB1	C0010674	Cystic Fibrosis	0.432609261946164	0	0	CTD_human;ORPHANET
7040	TGFB1	C0011334	Dental caries	0.200274726784213	0	0	HPO
7040	TGFB1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.311408040494687	1	0	CTD_human
7040	TGFB1	C0011881	Diabetic Nephropathy	0.326470361874123	2	0	CTD_human
7040	TGFB1	C0011989	Camurati-Engelmann Syndrome	0.610085023103938	4	6	CTD_human;HPO;ORPHANET;UNIPROT
7040	TGFB1	C0013238	Dry Eye Syndromes	0.2	1	0	CTD_human
7040	TGFB1	C0013264	Muscular Dystrophy, Duchenne	0.201098907136852	1	0	CTD_human
7040	TGFB1	C0013295	Duodenal Ulcer	0.20328236603324	1	0	CTD_human
7040	TGFB1	C0015300	Exophthalmos	0.2	0	0	HPO
7040	TGFB1	C0017661	IGA Glomerulonephritis	0.233535756613429	1	0	CTD_human
7040	TGFB1	C0017668	Focal glomerulosclerosis	0.205912964183428	3	0	CTD_human
7040	TGFB1	C0019189	Hepatitis, Chronic	0.203831819601666	1	0	CTD_human
7040	TGFB1	C0020492	Hyperostosis	0.2	0	0	HPO
7040	TGFB1	C0022661	Kidney Failure, Chronic	0.314192110116813	1	0	CTD_human
7040	TGFB1	C0023890	Liver Cirrhosis	0.24294030107968	1	0	CTD_human
7040	TGFB1	C0023891	Liver Cirrhosis, Alcoholic	0.205088783830789	1	0	CTD_human
7040	TGFB1	C0023892	Biliary cirrhosis	0.2	0	0	HPO
7040	TGFB1	C0024117	Chronic Obstructive Airway Disease	0.246032393860987	1	0	CTD_human
7040	TGFB1	C0027051	Myocardial Infarction	0.29882344430982	1	0	CTD_human
7040	TGFB1	C0029172	Oral Submucous Fibrosis	0.205638237399215	1	0	CTD_human
7040	TGFB1	C0029456	Osteoporosis	0.315565744037879	1	0	CTD_human
7040	TGFB1	C0029458	Osteoporosis, Postmenopausal	0.205912964183428	1	0	CTD_human
7040	TGFB1	C0030293	Pancreatic Insufficiency	0.2	0	0	HPO
7040	TGFB1	C0030848	Peyronie Disease	0.20678830169338	1	0	CTD_human
7040	TGFB1	C0032285	Pneumonia	0.200824180352639	1	0	CTD_human
7040	TGFB1	C0034067	Pulmonary Emphysema	0.204055389228567	1	0	CTD_human
7040	TGFB1	C0034069	Pulmonary Fibrosis	0.417502646277691	7	0	CTD_human;HPO
7040	TGFB1	C0036202	Sarcoidosis	0.213785817636344	1	0	CTD_human
7040	TGFB1	C0040028	Thrombocythemia, Essential	0.200274726784213	1	0	CTD_human
7040	TGFB1	C0041948	Uremia	0.2	1	0	CTD_human
7040	TGFB1	C0042109	Urticaria	0.204814057046576	1	0	CTD_human
7040	TGFB1	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
7040	TGFB1	C0158266	Intervertebral Disc Degeneration	0.200274726784213	1	0	CTD_human
7040	TGFB1	C0234958	muscle degeneration	0.2	0	0	HPO
7040	TGFB1	C0241910	Hepatitis, Autoimmune	0.202407028523288	1	0	CTD_human
7040	TGFB1	C0243026	Sepsis	0.200274726784213	1	0	CTD_human
7040	TGFB1	C0264423	Asthma, Occupational	0.2	1	0	CTD_human
7040	TGFB1	C0265294	Pyle metaphyseal dysplasia	0.2	0	0	HPO
7040	TGFB1	C0267963	Exocrine pancreatic insufficiency	0.2	0	0	HPO
7040	TGFB1	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
7040	TGFB1	C0521607	Peritoneal Fibrosis	0.201098907136852	1	0	CTD_human
7040	TGFB1	C1876165	Copper-Overload Cirrhosis	0.2	1	0	CTD_human
7042	TGFB2	C0003504	Aortic Valve Insufficiency	0.4	1	0	CTD_human;HPO
7042	TGFB2	C0008311	Cholangitis	0.2	1	0	CTD_human
7042	TGFB2	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
7042	TGFB2	C0014175	Endometriosis	0.200549453568426	1	0	CTD_human
7042	TGFB2	C0017601	Glaucoma	0.202197814273705	1	0	CTD_human
7042	TGFB2	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
7042	TGFB2	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
7042	TGFB2	C0162872	Aortic Aneurysm, Thoracic	0.201373633921065	2	0	CTD_human
7042	TGFB2	C0263401	Cutis marmorata	0.2	0	0	HPO
7042	TGFB2	C0340643	Dissection of aorta	0.2	0	0	HPO
7042	TGFB2	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
7042	TGFB2	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.28	0	0	ORPHANET
7042	TGFB2	C1956346	Coronary Artery Disease	0.2	0	0	HPO
7042	TGFB2	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
7042	TGFB2	C2697932	Loeys-Dietz Syndrome	0.201373633921065	1	3	CTD_human
7042	TGFB2	C3553762	LOEYS-DIETZ SYNDROME 4	0.2	1	8	UNIPROT
7043	TGFB3	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
7043	TGFB3	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
7043	TGFB3	C0015300	Exophthalmos	0.2	0	0	HPO
7043	TGFB3	C0015310	Exotropia	0.2	0	0	HPO
7043	TGFB3	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
7043	TGFB3	C0085612	Ventricular arrhythmia	0.2	0	0	HPO
7043	TGFB3	C0263401	Cutis marmorata	0.2	0	0	HPO
7043	TGFB3	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
7043	TGFB3	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.2	0	0	ORPHANET
7043	TGFB3	C1862511	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1 (disorder)	0.2	0	0	CTD_human
7043	TGFB3	C1956346	Coronary Artery Disease	0.2	0	0	HPO
7043	TGFB3	C2063326	Cardiomyopathy, right ventricular	0.2	0	0	HPO
7043	TGFB3	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
7043	TGFB3	C3489393	Hiatal Hernia	0.2	0	0	HPO
7043	TGFB3	C3810012	RIENHOFF SYNDROME	0.200274726784213	1	6	UNIPROT
7044	LEFTY2	C3178805	Heterotaxy Syndrome	0.2	1	0	CTD_human
7045	TGFBI	C0010036	Corneal dystrophy	0.228780799807746	0	0	HPO
7045	TGFBI	C0010043	Corneal Ulcer	0.2	0	0	HPO
7045	TGFBI	C0011881	Diabetic Nephropathy	0.205740551713841	1	0	CTD_human
7045	TGFBI	C0018179	Granular Dystrophy, Corneal	0.208725744560189	0	0	HPO
7045	TGFBI	C0038379	Strabismus	0.2	0	0	HPO
7045	TGFBI	C0042798	Low Vision	0.2	0	0	HPO
7045	TGFBI	C0155119	Recurrent erosion of cornea	0.200274726784213	0	0	HPO
7045	TGFBI	C0155127	Familial Amyloid Polyneuropathy, Type V	0.211263798152737	0	0	HPO
7045	TGFBI	C0271285	Microscopic cystic corneal dystrophy	0.2	0	0	HPO
7045	TGFBI	C0339278	Reis-Bucklers' corneal dystrophy	0.604120901763197	5	2	CTD_human;ORPHANET;UNIPROT
7045	TGFBI	C0392163	Corneal erosion	0.2	0	0	HPO
7045	TGFBI	C0521723	Corneal dystrophy, epithelial basement membrane	0.6	1	2	CTD_human;ORPHANET;UNIPROT
7045	TGFBI	C1275685	Avellino corneal dystrophy	0.609615437447459	6	1	CTD_human;ORPHANET;UNIPROT
7045	TGFBI	C1562894	Thiel-Behnke corneal dystrophy	0.601373633921066	4	1	CTD_human;ORPHANET;UNIPROT
7045	TGFBI	C1641846	Groenouw corneal dystrophy type I (disorder)	0.600824180352639	7	2	CTD_human;ORPHANET;UNIPROT
7045	TGFBI	C1690006	Lattice corneal dystrophy Type I	0.613670826676025	12	4	CTD_human;ORPHANET;UNIPROT
7045	TGFBI	C1837974	Corneal Dystrophy, Lattice Type IIIA	0.400824180352639	5	2	CTD_human;UNIPROT
7046	TGFBR1	C0002949	Aneurysm, Dissecting	0.402681755307501	1	0	CTD_human;HPO
7046	TGFBR1	C0003486	Aortic Aneurysm	0.200274726784213	0	0	HPO
7046	TGFBR1	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
7046	TGFBR1	C0010278	Craniosynostosis	0.2	0	0	HPO
7046	TGFBR1	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
7046	TGFBR1	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
7046	TGFBR1	C0041948	Uremia	0.2	1	0	CTD_human
7046	TGFBR1	C0263401	Cutis marmorata	0.2	0	0	HPO
7046	TGFBR1	C0340643	Dissection of aorta	0.2	0	0	HPO
7046	TGFBR1	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
7046	TGFBR1	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.480824180352639	6	6	ORPHANET;UNIPROT
7046	TGFBR1	C1836743	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.2	0	0	CTD_human
7046	TGFBR1	C1956346	Coronary Artery Disease	0.2	0	0	HPO
7046	TGFBR1	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
7046	TGFBR1	C2697932	Loeys-Dietz Syndrome	0.206593442821114	2	5	CTD_human
7048	TGFBR2	C0002949	Aneurysm, Dissecting	0.405088783830789	2	0	CTD_human;HPO
7048	TGFBR2	C0003486	Aortic Aneurysm	0.405689394556528	1	0	CTD_human;HPO
7048	TGFBR2	C0003504	Aortic Valve Insufficiency	0.200274726784213	0	0	HPO
7048	TGFBR2	C0010278	Craniosynostosis	0.200274726784213	0	0	HPO
7048	TGFBR2	C0011881	Diabetic Nephropathy	0.203007639249027	1	0	CTD_human
7048	TGFBR2	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
7048	TGFBR2	C0014544	Epilepsy	0.2	0	0	HPO
7048	TGFBR2	C0015300	Exophthalmos	0.2	0	0	HPO
7048	TGFBR2	C0015310	Exotropia	0.2	0	0	HPO
7048	TGFBR2	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
7048	TGFBR2	C0024796	Marfan Syndrome	0.221804051535836	1	9	CTD_human
7048	TGFBR2	C0151740	Intracranial Hypertension	0.2	0	0	HPO
7048	TGFBR2	C0158113	Contracture of joint of hand	0.2	0	0	HPO
7048	TGFBR2	C0162872	Aortic Aneurysm, Thoracic	0.213474289072135	1	0	CTD_human
7048	TGFBR2	C0263401	Cutis marmorata	0.2	0	0	HPO
7048	TGFBR2	C0340643	Dissection of aorta	0.200549453568426	0	0	HPO
7048	TGFBR2	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
7048	TGFBR2	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
7048	TGFBR2	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.200824180352639	0	0	ORPHANET
7048	TGFBR2	C1956346	Coronary Artery Disease	0.200549453568426	0	0	HPO
7048	TGFBR2	C2674574	Aortic aneurysm, familial thoracic 3	0.68	11	14	CTD_human;ORPHANET;UNIPROT
7048	TGFBR2	C2697932	Loeys-Dietz Syndrome	0.210164891015885	5	16	CTD_human
7048	TGFBR2	C2931058	Marfan Syndrome type 2	0.201373633921065	0	0	ORPHANET
7048	TGFBR2	C4020884	Anxiety disease	0.2	0	0	HPO
7049	TGFBR3	C1862932	ANEURYSM, INTRACRANIAL BERRY, 1 (disorder)	0.2	0	0	ORPHANET
7050	TGIF1	C1840528	HOLOPROSENCEPHALY 4 (disorder)	0.4	2	6	CTD_human;UNIPROT
7050	TGIF1	C1854310	Hypotrichosis simplex	0.200274726784213	0	0	CTD_human
7051	TGM1	C0002170	Alopecia	0.200274726784213	0	0	HPO
7051	TGM1	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
7051	TGM1	C0013238	Dry Eye Syndromes	0.200274726784213	1	0	CTD_human
7051	TGM1	C0013592	Ectropion	0.200274726784213	0	0	HPO
7051	TGM1	C0020620	Hypohidrosis	0.200274726784213	0	0	HPO
7051	TGM1	C0020757	Ichthyoses	0.210946005236572	0	0	HPO
7051	TGM1	C0022568	Keratitis	0.2	0	0	HPO
7051	TGM1	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
7051	TGM1	C0042842	Vitamin A Deficiency	0.2	1	0	CTD_human
7051	TGM1	C0079583	Ichthyosiform Erythroderma, Congenital	0.209759139162412	0	0	HPO
7051	TGM1	C0259817	Xerosis	0.2	0	0	HPO
7051	TGM1	C0263454	Chloracne	0.200549453568426	1	0	CTD_human
7051	TGM1	C0392163	Corneal erosion	0.2	0	0	HPO
7051	TGM1	C0870082	Hyperkeratosis	0.200274726784213	0	0	HPO
7051	TGM1	C1855789	Self-Healing Collodion Baby	0.200824180352639	0	0	ORPHANET
7051	TGM1	C1855792	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1	0.2	0	0	CTD_human
7051	TGM1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7052	TGM2	C0007570	Celiac Disease	0.235657060438434	1	0	CTD_human
7052	TGM2	C0029408	Degenerative polyarthritis	0.200549453568426	1	0	CTD_human
7053	TGM3	C0432347	Uncombable hair syndrome	0.2	0	0	ORPHANET
7053	TGM3	C4020850	Generalized trichodysplasia	0.2	0	0	HPO
7053	TGM3	C4025700	Trichodysplasia	0.2	0	0	HPO
7054	TH	C0013386	Dyskinesia, Drug-Induced	0.2	1	0	CTD_human
7054	TH	C2673535	DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE (disorder)	0.600824180352639	7	29	CTD_human;ORPHANET;UNIPROT
7055	THAS	C0020255	Hydrocephalus	0.2	1	0	CTD_human
7055	THAS	C0559483	Pentalogy of Cantrell	0.2	1	0	CTD_human
7056	THBD	C0012739	Disseminated Intravascular Coagulation	0.200824180352639	1	0	CTD_human
7056	THBD	C0027051	Myocardial Infarction	0.224685251335936	2	0	CTD_human
7056	THBD	C0034065	Pulmonary Embolism	0.200274726784213	1	0	CTD_human
7056	THBD	C0034155	Purpura, Thrombotic Thrombocytopenic	0.2	1	0	CTD_human
7056	THBD	C0035222	Respiratory Distress Syndrome, Adult	0.200824180352639	1	0	CTD_human
7056	THBD	C0149871	Deep Vein Thrombosis	0.202956482091714	0	0	HPO
7056	THBD	C0398623	Thrombophilia	0.409144173059356	1	0	CTD_human;HPO
7056	THBD	C1850383	Neuropathy, Painful	0.2	1	0	CTD_human
7056	THBD	C2931788	Atypical Hemolytic Uremic Syndrome	0.201648360705279	1	1	CTD_human
7056	THBD	C3280976	Thrombophilia due to Thrombomodulin Defect	0.48	4	3	ORPHANET;UNIPROT
7057	THBS1	C0011875	Diabetic Angiopathies	0.200549453568426	1	0	CTD_human
7057	THBS1	C0011884	Diabetic Retinopathy	0.2	1	0	CTD_human
7057	THBS1	C0023890	Liver Cirrhosis	0.202407028523288	1	0	CTD_human
7057	THBS1	C0027707	Nephritis, Interstitial	0.2	1	0	CTD_human
7057	THBS1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
7058	THBS2	C0011875	Diabetic Angiopathies	0.2	1	0	CTD_human
706	TSPO	C0019151	Hepatic Encephalopathy	0.2	2	0	CTD_human
706	TSPO	C0745744	End Stage Liver Disease	0.200274726784213	1	0	CTD_human
7066	THPO	C0040028	Thrombocythemia, Essential	0.207952721364863	0	0	CTD_human
7066	THPO	C0750145	vascular disease occlusive	0.2	0	0	HPO
7066	THPO	C0836924	Thrombocytosis	0.418898726601435	1	0	CTD_human;HPO
7066	THPO	C0917805	Transient Cerebral Ischemia	0.2	0	0	HPO
7066	THPO	C1306889	Peripheral arterial occlusive disease	0.2	0	0	HPO
7066	THPO	C1401086	Peripheral vascular insufficiency	0.2	0	0	HPO
7066	THPO	C3275998	THROMBOCYTHEMIA 2	0.2	0	0	ORPHANET
7066	THPO	C3277671	THROMBOCYTHEMIA 1	0.2	0	0	ORPHANET
7066	THPO	C3281125	THROMBOCYTHEMIA 3	0.2	0	0	ORPHANET
7067	THRA	C0002871	Anemia	0.2	0	0	HPO
7067	THRA	C0014175	Endometriosis	0.2	1	0	CTD_human
7067	THRA	C0020676	Hypothyroidism	0.200824180352639	0	0	HPO
7067	THRA	C0024421	Macroglossia	0.2	0	0	HPO
7067	THRA	C0259817	Xerosis	0.2	0	0	HPO
7067	THRA	C2940786	Thyroid Hormone Resistance Syndrome	0.202472541057918	0	0	HPO
7067	THRA	C3280817	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6	0.2	2	5	UNIPROT
7068	THRB	C0015300	Exophthalmos	0.2	0	0	HPO
7068	THRB	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
7068	THRB	C0020550	Hyperthyroidism	0.200824180352639	0	0	HPO
7068	THRB	C0020676	Hypothyroidism	0.200274726784213	0	0	HPO
7068	THRB	C0024421	Macroglossia	0.2	0	0	HPO
7068	THRB	C1840364	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY	0.6	3	4	CTD_human;ORPHANET;UNIPROT
7068	THRB	C2937288	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.48357144819477	19	22	CTD_human;UNIPROT
7068	THRB	C2940786	Thyroid Hormone Resistance Syndrome	0.639111838941262	2	0	CTD_human;HPO;ORPHANET
7068	THRB	C3489796	Thyroid Hormone Resistance, Generalized, Autosomal Recessive	0.28357144819477	0	0	CTD_human
7072	TIA1	C0221054	Welander Distal Myopathy	0.200549453568426	1	1	UNIPROT
7072	TIA1	C1848736	Distal amyotrophy	0.2	0	0	HPO
7072	TIA1	C2931290	Welander distal myopathy, Swedish type	0.2	0	0	ORPHANET
7074	TIAM1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
7076	TIMP1	C0003504	Aortic Valve Insufficiency	0.200274726784213	1	0	CTD_human
7076	TIMP1	C0008311	Cholangitis	0.2	1	0	CTD_human
7076	TIMP1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200824180352639	1	0	CTD_human
7076	TIMP1	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
7076	TIMP1	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
7076	TIMP1	C0023891	Liver Cirrhosis, Alcoholic	0.2	1	0	CTD_human
7076	TIMP1	C0029172	Oral Submucous Fibrosis	0.200549453568426	1	0	CTD_human
7076	TIMP1	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
7076	TIMP1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
7076	TIMP1	C0042345	Varicosity	0.200274726784213	1	0	CTD_human
7077	TIMP2	C0027051	Myocardial Infarction	0.202407028523288	1	0	CTD_human
7078	TIMP3	C0004096	Asthma	0.200549453568426	1	0	CTD_human
7078	TIMP3	C0009319	Colitis	0.200274726784213	1	0	CTD_human
7078	TIMP3	C0036323	Schistosomiasis	0.2	1	0	CTD_human
7078	TIMP3	C0242383	Age related macular degeneration	0.208711389182872	1	0	CTD_human
7078	TIMP3	C0730292	Macular dystrophy	0.200274726784213	0	0	HPO
7078	TIMP3	C1850938	FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY	0.690164891015885	5	5	CTD_human;ORPHANET;UNIPROT
7080	NKX2-1	C0085583	Choreoathetosis	0.200549453568426	0	0	HPO
7080	NKX2-1	C0342162	Compensated hypothyroidism	0.2	0	0	HPO
7080	NKX2-1	C0393584	Benign Hereditary Chorea	0.404670355331623	2	5	ORPHANET;UNIPROT
7080	NKX2-1	C0852283	Respiratory Distress Syndrome	0.200824180352639	0	0	HPO
7080	NKX2-1	C1970269	Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress	0.600824180352639	2	6	CTD_human;ORPHANET;UNIPROT
7080	NKX2-1	C4020858	Choreatic disease	0.2	0	0	HPO
7080	NKX2-1	C4020871	Dystonic disease	0.2	0	0	HPO
7080	NKX2-1	C4020884	Anxiety disease	0.2	0	0	HPO
7084	TK2	C0014544	Epilepsy	0.200549453568426	0	0	HPO
7084	TK2	C0235946	Cerebral atrophy	0.2	0	0	HPO
7084	TK2	C0238621	Aminoaciduria	0.2	0	0	HPO
7084	TK2	C1389113	Generalized amyotrophy	0.2	0	0	HPO
7084	TK2	C1837658	Gross motor development delay	0.2	0	0	HPO
7084	TK2	C3149750	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.68	6	29	CTD_human;ORPHANET;UNIPROT
7084	TK2	C3151513	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.2	0	0	CTD_human
7084	TK2	C4020860	Supratentorial atrophy	0.2	0	0	HPO
7085	TKCR	C1839129	TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA (disorder)	0.2	0	0	CTD_human
7086	TKT	C0043121	Wernicke Encephalopathy	0.200549453568426	1	0	CTD_human
7090	TLE3	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
7090	TLE3	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
7091	TLE4	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
7094	TLN1	C0029456	Osteoporosis	0.2	1	0	CTD_human
7096	TLR1	C0023343	Leprosy	0.20859471949093	0	0	CTD_human
7097	TLR2	C0003873	Rheumatoid Arthritis	0.216598598013105	1	0	CTD_human
7097	TLR2	C0014457	Eosinophilia	0.200549453568426	1	0	CTD_human
7097	TLR2	C0022568	Keratitis	0.280824180352639	1	0	CTD_human
7097	TLR2	C0023343	Leprosy	0.211825928366857	0	0	CTD_human
7098	TLR3	C0276226	Herpes encephalitis	0.403846174978983	0	0	CTD_human;ORPHANET
7098	TLR3	C0477341	Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.2	0	0	ORPHANET
7098	TLR3	C1864205	Macular Degeneration, Age-Related, 1	0.2	0	0	CTD_human
7099	TLR4	C0003864	Arthritis	0.207337755261807	0	0	HPO
7099	TLR4	C0004153	Atherosclerosis	0.241307974483343	1	0	CTD_human
7099	TLR4	C0004943	Behcet Syndrome	0.214884724773196	0	0	ORPHANET
7099	TLR4	C0010346	Crohn Disease	0.266229472091873	1	0	CTD_human
7099	TLR4	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
7099	TLR4	C0014457	Eosinophilia	0.200274726784213	1	0	CTD_human
7099	TLR4	C0015695	Fatty Liver	0.200824180352639	2	0	CTD_human
7099	TLR4	C0025289	Meningitis	0.200549453568426	0	0	HPO
7099	TLR4	C0032285	Pneumonia	0.203846174978983	1	0	CTD_human
7099	TLR4	C0038363	Aphthous Stomatitis	0.2	0	0	HPO
7099	TLR4	C0042384	Vasculitis	0.203007639249027	0	0	HPO
7099	TLR4	C0149745	Oral Ulcer	0.2	0	0	HPO
7099	TLR4	C0242383	Age related macular degeneration	0.216416415786532	1	0	CTD_human
7099	TLR4	C0243026	Sepsis	0.24315577968122	1	0	CTD_human
7099	TLR4	C0340288	Stable angina	0.201648360705279	1	0	CTD_human
7099	TLR4	C0520459	Necrotizing Enterocolitis	0.287938365987545	1	0	CTD_human
7099	TLR4	C0702166	Acne	0.200274726784213	0	0	HPO
7099	TLR4	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
7099	TLR4	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
7099	TLR4	C0948089	Acute Coronary Syndrome	0.209744783785095	1	0	CTD_human
7099	TLR4	C1956346	Coronary Artery Disease	0.214726667680926	1	0	CTD_human
7099	TLR4	C1969108	Macular Degeneration, Age-Related, 10	0.2	0	0	CTD_human
7099	TLR4	C2937365	Recurrent aphthous ulcer	0.200274726784213	0	0	HPO
71	ACTG1	C0029456	Osteoporosis	0.2	1	0	CTD_human
71	ACTG1	C0452138	Sensorineural hearing loss, bilateral	0.2	0	0	HPO
71	ACTG1	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
71	ACTG1	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
71	ACTG1	C1855722	Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation	0.201373633921065	0	0	ORPHANET
71	ACTG1	C1858172	Deafness, Autosomal Dominant 20	0.4	5	9	CTD_human;UNIPROT
71	ACTG1	C3281235	BARAITSER-WINTER SYNDROME 2	0.2	1	8	UNIPROT
710	SERPING1	C0019243	Angioedemas, Hereditary	0.247499022914232	6	0	CTD_human
710	SERPING1	C0021400	Influenza	0.2	1	0	CTD_human
710	SERPING1	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
710	SERPING1	C0024141	Lupus Erythematosus, Systemic	0.200549453568426	0	0	HPO
710	SERPING1	C0024143	Lupus Nephritis	0.2	1	0	CTD_human
710	SERPING1	C0270921	Axonal neuropathy	0.2	0	0	HPO
710	SERPING1	C0398775	Hereditary C1 esterase inhibitor deficiency - deficient factor	0.2	0	0	ORPHANET
710	SERPING1	C0398776	Hereditary C1 esterase inhibitor deficiency - dysfunctional factor	0.2	0	0	ORPHANET
710	SERPING1	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
710	SERPING1	C1852700	Complement Component 4, Partial Deficiency Of	0.4	0	0	CTD_human;ORPHANET
710	SERPING1	C1862892	Hereditary Angioedema Type II	0.2	0	0	ORPHANET
710	SERPING1	C2717905	Hereditary Angioedema Types I and II	0.2	3	0	CTD_human
710	SERPING1	C2717906	Hereditary Angioedema Type I	0.400549453568426	10	18	ORPHANET;UNIPROT
710	SERPING1	C2931758	Acquired angioedema	0.203021994626344	2	0	CTD_human
710	SERPING1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
7100	TLR5	C0023241	Legionnaires' Disease	0.200549453568426	0	0	CTD_human
7100	TLR5	C0024141	Lupus Erythematosus, Systemic	0.213027149818335	0	0	CTD_human
7102	TSPAN7	C1846174	Mental Retardation, X-Linked 58	0.4	1	2	CTD_human;UNIPROT
7103	TSPAN8	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
7110	TMF1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
7111	TMOD1	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
7112	TMPO	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
7112	TMPO	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
7112	TMPO	C3151039	Cardiomyopathy, Dilated, 1t	0.2	0	0	CTD_human
7112	TMPO	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
7112	TMPO	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
7114	TMSB4X	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
712	C1QA	C0017661	IGA Glomerulonephritis	0.2	2	0	CTD_human
712	C1QA	C0017662	Glomerulonephritis, Membranoproliferative	0.2	1	0	CTD_human
712	C1QA	C0024141	Lupus Erythematosus, Systemic	0.291551201582644	1	0	CTD_human
7124	TNF	C0002395	Alzheimer's Disease	0.293671761026925	1	0	CTD_human
7124	TNF	C0002871	Anemia	0.212869092726064	1	0	CTD_human
7124	TNF	C0002893	Refractory anemias	0.207626837423337	1	0	CTD_human
7124	TNF	C0002895	Anemia, Sickle Cell	0.21105290517153	1	0	CTD_human
7124	TNF	C0003123	Anorexia	0.201923087489492	1	0	CTD_human
7124	TNF	C0003165	Anthracosis	0.207011871320281	1	0	CTD_human
7124	TNF	C0003872	Arthritis, Psoriatic	0.238392879791957	2	0	CTD_human
7124	TNF	C0003873	Rheumatoid Arthritis	0.50558989915553	4	0	CTD_human
7124	TNF	C0003949	Asbestosis	0.2	1	0	CTD_human
7124	TNF	C0004096	Asthma	0.350678535044538	5	0	CTD_human
7124	TNF	C0004153	Atherosclerosis	0.256090384941914	1	0	CTD_human
7124	TNF	C0006267	Bronchiectasis	0.200549453568426	1	0	CTD_human
7124	TNF	C0007786	Brain Ischemia	0.212309869400653	1	0	CTD_human
7124	TNF	C0008370	Cholestasis	0.200274726784213	1	0	CTD_human
7124	TNF	C0009319	Colitis	0.215095617754403	2	0	CTD_human
7124	TNF	C0009324	Ulcerative Colitis	0.268818682841733	3	0	CTD_human
7124	TNF	C0010346	Crohn Disease	0.389367989507067	2	1	CTD_human
7124	TNF	C0011633	Dermatomyositis	0.226538240670465	1	0	CTD_human
7124	TNF	C0011854	Diabetes Mellitus, Insulin-Dependent	0.30935269977885	1	0	CTD_human
7124	TNF	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.398404328280565	1	0	CTD_human
7124	TNF	C0015625	Fanconi Anemia	0.208213092771759	1	0	CTD_human
7124	TNF	C0015695	Fatty Liver	0.224787565650561	1	0	CTD_human
7124	TNF	C0017658	Glomerulonephritis	0.208660232025559	2	0	CTD_human
7124	TNF	C0018790	Cardiac Arrest	0.201923087489492	1	0	CTD_human
7124	TNF	C0018801	Heart failure	0.303870840740281	4	0	CTD_human
7124	TNF	C0018995	Hemochromatosis	0.210727021230004	1	0	CTD_human
7124	TNF	C0019061	Hemolytic-Uremic Syndrome	0.200274726784213	1	0	CTD_human
7124	TNF	C0019151	Hepatic Encephalopathy	0.2	2	0	CTD_human
7124	TNF	C0019187	Hepatitis, Alcoholic	0.212202969465695	1	0	CTD_human
7124	TNF	C0019202	Hepatolenticular Degeneration	0.200549453568426	1	0	CTD_human
7124	TNF	C0020433	Hyperbilirubinemia	0.2	1	0	CTD_human
7124	TNF	C0020437	Hypercalcemia	0.200824180352639	1	0	CTD_human
7124	TNF	C0020615	Hypoglycemia	0.2	1	0	CTD_human
7124	TNF	C0022661	Kidney Failure, Chronic	0.241255138594406	1	0	CTD_human
7124	TNF	C0023281	Leishmaniasis	0.203831819601666	1	0	CTD_human
7124	TNF	C0023283	Leishmaniasis, Cutaneous	0.206737144536068	1	0	CTD_human
7124	TNF	C0023290	Leishmaniasis, Visceral	0.201373633921065	2	0	CTD_human
7124	TNF	C0023860	Listeriosis	0.200549453568426	1	0	CTD_human
7124	TNF	C0023891	Liver Cirrhosis, Alcoholic	0.20859471949093	1	0	CTD_human
7124	TNF	C0024117	Chronic Obstructive Airway Disease	0.346946752509554	1	0	CTD_human
7124	TNF	C0024530	Malaria	0.238560706641212	0	0	CTD_human
7124	TNF	C0027051	Myocardial Infarction	0.329798700928023	2	0	CTD_human
7124	TNF	C0027059	Myocarditis	0.203780662444353	1	0	CTD_human
7124	TNF	C0028754	Obesity	0.325926280335148	3	0	CTD_human
7124	TNF	C0029172	Oral Submucous Fibrosis	0.202681755307501	1	0	CTD_human
7124	TNF	C0029458	Osteoporosis, Postmenopausal	0.20777053913829	1	0	CTD_human
7124	TNF	C0030567	Parkinson Disease	0.234858233377182	1	0	CTD_human
7124	TNF	C0032231	Pleurisy	0.280274726784213	1	0	CTD_human
7124	TNF	C0032285	Pneumonia	0.21544853371894	1	0	CTD_human
7124	TNF	C0032963	Pregnancy Complications, Cardiovascular	0.2	1	0	CTD_human
7124	TNF	C0033860	Psoriasis	0.269919268710209	2	0	CTD_human
7124	TNF	C0034067	Pulmonary Emphysema	0.20433011601278	1	0	CTD_human
7124	TNF	C0034069	Pulmonary Fibrosis	0.212151812308383	5	0	CTD_human
7124	TNF	C0036420	Localized scleroderma	0.200274726784213	1	0	CTD_human
7124	TNF	C0037926	Compression of spinal cord	0.2	1	0	CTD_human
7124	TNF	C0038220	Status Epilepticus	0.200274726784213	1	0	CTD_human
7124	TNF	C0038358	Gastric ulcer	0.213408776537506	1	0	CTD_human
7124	TNF	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
7124	TNF	C0042109	Urticaria	0.202956482091714	3	0	CTD_human
7124	TNF	C0085655	Polymyositis	0.205754907091158	1	0	CTD_human
7124	TNF	C0151744	Myocardial Ischemia	0.21105290517153	2	0	CTD_human
7124	TNF	C0162557	Liver Failure, Acute	0.209744783785095	1	0	CTD_human
7124	TNF	C0162820	Dermatitis, Allergic Contact	0.212635753342179	1	0	CTD_human
7124	TNF	C0206146	Myocardial Stunning	0.2	1	0	CTD_human
7124	TNF	C0243026	Sepsis	0.366297203985123	3	0	CTD_human
7124	TNF	C0264423	Asthma, Occupational	0.200549453568426	1	0	CTD_human
7124	TNF	C0268318	Cholestasis of pregnancy	0.200274726784213	1	0	CTD_human
7124	TNF	C0340288	Stable angina	0.200824180352639	1	0	CTD_human
7124	TNF	C0343755	HIV Wasting Syndrome	0.200274726784213	1	0	CTD_human
7124	TNF	C0598608	Hyperhomocysteinemia	0.2	1	0	CTD_human
7124	TNF	C0853897	Diabetic Cardiomyopathies	0.2	1	0	CTD_human
7124	TNF	C0948089	Acute Coronary Syndrome	0.212202969465695	1	0	CTD_human
7124	TNF	C0948480	Coronary Restenosis	0.20754696951139	1	0	CTD_human
7124	TNF	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
7124	TNF	C4277682	Chemical and Drug Induced Liver Injury	0.2	6	0	CTD_human
7126	TNFAIP1	C0011881	Diabetic Nephropathy	0.2	1	0	CTD_human
7127	TNFAIP2	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
7128	TNFAIP3	C0003873	Rheumatoid Arthritis	0.242973597454648	4	2	CTD_human
7128	TNFAIP3	C0024141	Lupus Erythematosus, Systemic	0.223493799641443	4	3	CTD_human
7128	TNFAIP3	C0026769	Multiple Sclerosis	0.202956482091714	1	0	CTD_human
7128	TNFAIP3	C0033860	Psoriasis	0.209810296319724	2	3	CTD_human
7128	TNFAIP3	C1527336	Sjogren's Syndrome	0.200274726784213	2	1	CTD_human
7128	TNFAIP3	C4225218	AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.4	1	6	ORPHANET;UNIPROT
713	C1QB	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
713	C1QB	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
713	C1QB	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
713	C1QB	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
713	C1QB	C3150902	C1q DEFICIENCY	0.200274726784213	1	0	UNIPROT
7130	TNFAIP6	C0021400	Influenza	0.2	1	0	CTD_human
7130	TNFAIP6	C0162820	Dermatitis, Allergic Contact	0.2	2	0	CTD_human
7130	TNFAIP6	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
7130	TNFAIP6	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
7132	TNFRSF1A	C0002726	Amyloidosis	0.21105290517153	0	0	HPO
7132	TNFRSF1A	C0003123	Anorexia	0.2	1	0	CTD_human
7132	TNFRSF1A	C0003864	Arthritis	0.205414667772315	0	0	HPO
7132	TNFRSF1A	C0007786	Brain Ischemia	0.2	1	0	CTD_human
7132	TNFRSF1A	C0010674	Cystic Fibrosis	0.205414667772315	1	0	CTD_human
7132	TNFRSF1A	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.207821696295603	1	0	CTD_human
7132	TNFRSF1A	C0014733	Erysipelas	0.2	0	0	HPO
7132	TNFRSF1A	C0018801	Heart failure	0.200549453568426	1	0	CTD_human
7132	TNFRSF1A	C0021843	Intestinal Obstruction	0.2	0	0	HPO
7132	TNFRSF1A	C0023892	Biliary cirrhosis	0.2	1	1	CTD_human
7132	TNFRSF1A	C0026769	Multiple Sclerosis	0.218353858653341	2	2	CTD_human
7132	TNFRSF1A	C0031046	Pericarditis	0.203231208875927	0	0	HPO
7132	TNFRSF1A	C0032231	Pleurisy	0.2	0	0	HPO
7132	TNFRSF1A	C0032285	Pneumonia	0.200274726784213	1	0	CTD_human
7132	TNFRSF1A	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
7132	TNFRSF1A	C0149910	Intermittent joint effusion	0.2	0	0	ORPHANET
7132	TNFRSF1A	C0267839	Hepatic amyloidosis	0.2	0	0	HPO
7133	TNFRSF1B	C0002170	Alopecia	0.2	0	0	HPO
7133	TNFRSF1B	C0007786	Brain Ischemia	0.2	1	0	CTD_human
7133	TNFRSF1B	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
7133	TNFRSF1B	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.213734660479031	1	0	CTD_human
7133	TNFRSF1B	C0013595	Eczema	0.200274726784213	0	0	HPO
7133	TNFRSF1B	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
7133	TNFRSF1B	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
7133	TNFRSF1B	C0028754	Obesity	0.209418899843569	1	0	CTD_human
7133	TNFRSF1B	C0032285	Pneumonia	0.202407028523288	1	0	CTD_human
7133	TNFRSF1B	C0221260	Dystrophia unguium	0.2	0	0	HPO
7133	TNFRSF1B	C0239981	Hypoalbuminemia	0.2	1	0	CTD_human
7133	TNFRSF1B	C0259817	Xerosis	0.2	0	0	HPO
7133	TNFRSF1B	C0392777	Poikiloderma	0.2	0	0	HPO
7133	TNFRSF1B	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
7134	TNNC1	C0007194	Hypertrophic Cardiomyopathy	0.21111841770616	0	0	HPO
7134	TNNC1	C2678475	Cardiomyopathy, Dilated, 1z	0.4	1	2	CTD_human;UNIPROT
7134	TNNC1	C2750472	Cardiomyopathy, Familial Hypertrophic, 13	0.4	4	6	CTD_human;UNIPROT
7134	TNNC1	C3495498	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	0.2	0	0	CTD_human
7134	TNNC1	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
7134	TNNC1	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
7136	TNNI2	C0003886	Arthrogryposis	0.203007639249027	0	0	HPO
7136	TNNI2	C0265213	Distal arthrogryposis syndrome	0.201373633921065	0	0	HPO
7136	TNNI2	C1834523	ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.601098907136852	1	4	CTD_human;ORPHANET;UNIPROT
7137	TNNI3	C0007196	Restrictive cardiomyopathy	0.413627760544073	1	2	CTD_human;HPO
7137	TNNI3	C0018801	Heart failure	0.200549453568426	0	0	HPO
7137	TNNI3	C0018802	Congestive heart failure	0.200549453568426	0	0	HPO
7137	TNNI3	C0027051	Myocardial Infarction	0.206015278498054	1	0	CTD_human
7137	TNNI3	C0340279	Ventricular hypertrophy	0.200274726784213	0	0	HPO
7137	TNNI3	C0348616	Other restrictive cardiomyopathy	0.2	0	0	ORPHANET
7137	TNNI3	C0948089	Acute Coronary Syndrome	0.205465824929628	1	0	CTD_human
7137	TNNI3	C0949658	Cardiomyopathy, Hypertrophic, Familial	0.2166353997931	3	19	CTD_human
7137	TNNI3	C1860752	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7	0.4	6	15	CTD_human;UNIPROT
7137	TNNI3	C1861861	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)	0.401923087489492	1	9	CTD_human;UNIPROT
7137	TNNI3	C2678474	CARDIOMYOPATHY, DILATED, 2A (disorder)	0.4	1	1	CTD_human;UNIPROT
7137	TNNI3	C2750091	Cardiomyopathy, Dilated, 1FF	0.4	2	4	CTD_human;UNIPROT
7137	TNNI3	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
7137	TNNI3	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
7138	TNNT1	C1837658	Gross motor development delay	0.2	0	0	HPO
7138	TNNT1	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
7138	TNNT1	C1854380	NEMALINE MYOPATHY 5	0.480824180352639	0	0	CTD_human;ORPHANET
7139	TNNT2	C0007194	Hypertrophic Cardiomyopathy	0.438811308291123	1	0	CTD_human;HPO
7139	TNNT2	C0018801	Heart failure	0.400549453568426	2	0	CTD_human;HPO
7139	TNNT2	C0018802	Congestive heart failure	0.200549453568426	0	0	HPO
7139	TNNT2	C0024117	Chronic Obstructive Airway Disease	0.202732912464814	1	0	CTD_human
7139	TNNT2	C0035220	Respiratory Distress Syndrome, Newborn	0.2	1	0	CTD_human
7139	TNNT2	C0042514	Tachycardia, Ventricular	0.202407028523288	1	0	CTD_human
7139	TNNT2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
7139	TNNT2	C0348616	Other restrictive cardiomyopathy	0.2	0	0	ORPHANET
7139	TNNT2	C0948089	Acute Coronary Syndrome	0.200274726784213	1	0	CTD_human
7139	TNNT2	C0949658	Cardiomyopathy, Hypertrophic, Familial	0.215862376597774	2	24	CTD_human
7139	TNNT2	C1832243	CARDIOMYOPATHY, DILATED, 1D (disorder)	0.48	4	10	CTD_human;UNIPROT
7139	TNNT2	C1861864	Cardiomyopathy, Familial Hypertrophic, 2	0.48	13	18	CTD_human;UNIPROT
7139	TNNT2	C1960469	Left ventricular noncompaction	0.200274726784213	0	0	ORPHANET
7139	TNNT2	C2676271	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3 (disorder)	0.2	0	0	CTD_human
7139	TNNT2	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
7139	TNNT2	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
714	C1QC	C3150902	C1q DEFICIENCY	0.2	1	1	UNIPROT
7140	TNNT3	C0003886	Arthrogryposis	0.202681755307501	0	0	HPO
7140	TNNT3	C0265213	Distal arthrogryposis syndrome	0.200824180352639	0	0	HPO
7140	TNNT3	C1834523	ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
7148	TNXB	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
7148	TNXB	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
7148	TNXB	C0042580	Vesico-Ureteral Reflux	0.400274726784213	0	0	HPO;ORPHANET
7148	TNXB	C0151313	Sensory neuropathy	0.2	0	0	HPO
7148	TNXB	C0234958	muscle degeneration	0.2	0	0	HPO
7148	TNXB	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
7148	TNXB	C0268337	Ehlers-Danlos syndrome, type 3 (disorder)	0.400549453568426	0	0	CTD_human;ORPHANET
7148	TNXB	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
7148	TNXB	C1848029	Ehlers-Danlos syndrome caused by tenascin-X deficiency	0.680274726784213	2	4	CTD_human;ORPHANET;UNIPROT
7148	TNXB	C3489393	Hiatal Hernia	0.2	0	0	HPO
7148	TNXB	C4014831	VESICOURETERAL REFLUX 8	0.2	1	2	UNIPROT
715	C1R	C0003864	Arthritis	0.2	0	0	HPO
715	C1R	C0014175	Endometriosis	0.2	1	0	CTD_human
715	C1R	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
715	C1R	C0024138	Lupus Erythematosus, Discoid	0.2	0	0	HPO
715	C1R	C0027697	Nephritis	0.2	0	0	HPO
715	C1R	C0030524	Paratuberculosis	0.2	1	0	CTD_human
715	C1R	C0031099	Periodontitis	0.2	0	0	HPO
715	C1R	C0268347	Ehlers-Danlos Syndrome, Type VIII	0.4	1	6	ORPHANET;UNIPROT
715	C1R	C0399385	Early tooth exfoliation	0.2	0	0	HPO
715	C1R	C0741796	Recurrent bronchitis	0.2	0	0	HPO
715	C1R	C3150274	COMPLEMENT COMPONENT C1r/C1s DEFICIENCY	0.2	0	0	CTD_human
7153	TOP2A	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
7153	TOP2A	C2931189	Neural crest tumor	0.2	0	0	ORPHANET
7157	TP53	C0002736	Amyotrophic Lateral Sclerosis	0.201648360705279	1	0	CTD_human
7157	TP53	C0004698	Balkan Nephropathy	0.206513574909167	1	0	CTD_human
7157	TP53	C0007194	Hypertrophic Cardiomyopathy	0.2	1	0	CTD_human
7157	TP53	C0007786	Brain Ischemia	0.2	1	0	CTD_human
7157	TP53	C0014544	Epilepsy	0.2	0	0	HPO
7157	TP53	C0020255	Hydrocephalus	0.2	0	0	HPO
7157	TP53	C0022593	Keratosis	0.212752423034121	1	0	CTD_human
7157	TP53	C0022783	Vulvar Lichen Sclerosus	0.200274726784213	1	0	CTD_human
7157	TP53	C0024117	Chronic Obstructive Airway Disease	0.210452294445791	1	0	CTD_human
7157	TP53	C0027051	Myocardial Infarction	0.280824180352639	0	0	HPO
7157	TP53	C0030353	Papilledema	0.2	0	0	HPO
7157	TP53	C0033860	Psoriasis	0.205754907091158	1	0	CTD_human
7157	TP53	C0040028	Thrombocythemia, Essential	0.200824180352639	0	0	ORPHANET
7157	TP53	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
7157	TP53	C0917805	Transient Cerebral Ischemia	0.200274726784213	0	0	HPO
7157	TP53	C1835398	LI-FRAUMENI SYNDROME 1	0.480274726784213	19	55	CTD_human;UNIPROT
7157	TP53	C4280575	Progressive brain disease	0.2	0	0	HPO
716	C1S	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
716	C1S	C0019158	Hepatitis	0.2	0	0	HPO
716	C1S	C0024141	Lupus Erythematosus, Systemic	0.2	0	0	HPO
716	C1S	C0031099	Periodontitis	0.2	0	0	HPO
716	C1S	C0241910	Hepatitis, Autoimmune	0.2	1	0	CTD_human
716	C1S	C0268347	Ehlers-Danlos Syndrome, Type VIII	0.2	0	0	ORPHANET
716	C1S	C0677607	Hashimoto Disease	0.4	1	0	CTD_human;HPO
716	C1S	C2717905	Hereditary Angioedema Types I and II	0.2	1	0	CTD_human
7167	TPI1	C0002395	Alzheimer's Disease	0.200274726784213	1	0	CTD_human
7167	TPI1	C0002878	Anemia, Hemolytic	0.401923087489492	1	0	CTD_human;HPO
7167	TPI1	C0002882	Anemia, Hemolytic, Congenital Nonspherocytic	0.2	1	0	CTD_human
7167	TPI1	C0008325	Cholecystitis	0.2	0	0	HPO
7167	TPI1	C0008350	Cholelithiasis	0.2	0	0	HPO
7167	TPI1	C0018801	Heart failure	0.200274726784213	0	0	HPO
7167	TPI1	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
7167	TPI1	C0029456	Osteoporosis	0.2	1	0	CTD_human
7167	TPI1	C0085577	Normocytic anemia	0.2	0	0	HPO
7167	TPI1	C0234958	muscle degeneration	0.2	0	0	HPO
7167	TPI1	C0398562	Triose phosphate isomerase deficiency	0.200274726784213	0	0	ORPHANET
7167	TPI1	C1387532	Chronic hemolytic anemia	0.2	0	0	HPO
7167	TPI1	C1860808	Triosephosphate Isomerase Deficiency	0.2	3	8	UNIPROT
7167	TPI1	C4020871	Dystonic disease	0.2	0	0	HPO
7168	TPM1	C0007194	Hypertrophic Cardiomyopathy	0.236037008425981	0	0	HPO
7168	TPM1	C0018801	Heart failure	0.200274726784213	0	0	HPO
7168	TPM1	C0018802	Congestive heart failure	0.200274726784213	0	0	HPO
7168	TPM1	C0042514	Tachycardia, Ventricular	0.2	0	0	HPO
7168	TPM1	C0949658	Cardiomyopathy, Hypertrophic, Familial	0.20767799458065	1	13	CTD_human
7168	TPM1	C1861863	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3 (disorder)	0.4	5	7	CTD_human;UNIPROT
7168	TPM1	C1960469	Left ventricular noncompaction	0.200274726784213	0	0	ORPHANET
7168	TPM1	C2678476	Cardiomyopathy, Dilated, 1y	0.4	2	6	CTD_human;UNIPROT
7168	TPM1	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
7168	TPM1	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
7169	TPM2	C0003886	Arthrogryposis	0.205689394556528	0	0	HPO
7169	TPM2	C0234958	muscle degeneration	0.2	0	0	HPO
7169	TPM2	C0265213	Distal arthrogryposis syndrome	0.203021994626344	0	0	HPO
7169	TPM2	C0376175	Bell Palsy	0.2	0	0	HPO
7169	TPM2	C0546125	Nemaline Myopathy, Childhood Onset	0.2	0	0	ORPHANET
7169	TPM2	C1301959	Bulbar weakness	0.2	0	0	HPO
7169	TPM2	C1834523	ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.600824180352639	2	1	CTD_human;ORPHANET;UNIPROT
7169	TPM2	C1836447	Nemaline myopathy 4	0.6	4	7	CTD_human;ORPHANET;UNIPROT
7169	TPM2	C1836448	Nemaline myopathy 1	0.2	0	0	ORPHANET
7169	TPM2	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
7169	TPM2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7169	TPM2	C4082299	Bulbar palsy	0.2	0	0	HPO
717	C2	C0011633	Dermatomyositis	0.2	1	0	CTD_human
717	C2	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
717	C2	C0024141	Lupus Erythematosus, Systemic	0.210727021230004	0	0	HPO
717	C2	C0034150	Purpura	0.2	0	0	HPO
717	C2	C0242383	Age related macular degeneration	0.248308397315015	1	2	CTD_human
717	C2	C1864205	Macular Degeneration, Age-Related, 1	0.2	0	0	CTD_human
717	C2	C3150275	COMPLEMENT COMPONENT 2 DEFICIENCY	0.401098907136852	2	5	CTD_human;UNIPROT
7170	TPM3	C0376175	Bell Palsy	0.2	0	0	HPO
7170	TPM3	C0546125	Nemaline Myopathy, Childhood Onset	0.2	0	0	ORPHANET
7170	TPM3	C1301959	Bulbar weakness	0.2	0	0	HPO
7170	TPM3	C1836447	Nemaline myopathy 4	0.2	0	0	ORPHANET
7170	TPM3	C1836448	Nemaline myopathy 1	0.6	9	10	CTD_human;ORPHANET;UNIPROT
7170	TPM3	C1836451	Muscle atrophy, lower limb, distal	0.2	0	0	HPO
7170	TPM3	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
7170	TPM3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7170	TPM3	C4082299	Bulbar palsy	0.2	0	0	HPO
7171	TPM4	C0003949	Asbestosis	0.2	1	0	CTD_human
7171	TPM4	C0029456	Osteoporosis	0.2	1	0	CTD_human
7171	TPM4	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
7172	TPMT	C0023530	Leukopenia	0.214978948062461	3	0	CTD_human
7172	TPMT	C0027947	Neutropenia	0.203780662444353	1	0	CTD_human
7172	TPMT	C0342801	Thiopurine S methyltranferase deficiency	0.283296721410557	0	0	CTD_human
7173	TPO	C0020676	Hypothyroidism	0.218130289026441	0	0	HPO
7173	TPO	C0024421	Macroglossia	0.2	0	0	HPO
7173	TPO	C0917799	Hypersomnia	0.2	0	0	HPO
7173	TPO	C1291299	Deficiency of iodide peroxidase (disorder)	0.48	15	16	CTD_human;UNIPROT
7173	TPO	C1848805	Thyroid Dyshormonogenesis 1	0.200274726784213	0	0	ORPHANET
7174	TPP2	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
7174	TPP2	C0019158	Hepatitis	0.2	0	0	HPO
7174	TPP2	C0024141	Lupus Erythematosus, Systemic	0.2	0	0	HPO
7174	TPP2	C0024312	Lymphopenia	0.2	0	0	HPO
7174	TPP2	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
7174	TPP2	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
7174	TPP2	C0747085	Recurrent otitis media	0.2	0	0	HPO
7174	TPP2	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
7177	TPSAB1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
7177	TPSAB1	C0013363	Dysautonomia	0.2	1	0	CTD_human
7177	TPSAB1	C0022104	Irritable Bowel Syndrome	0.2	1	0	CTD_human
718	C3	C0007787	Transient Ischemic Attack	0.28	1	0	CTD_human
718	C3	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200549453568426	1	0	CTD_human
718	C3	C0017665	Membranous glomerulonephritis	0.2	1	0	CTD_human
718	C3	C0030524	Paratuberculosis	0.2	1	0	CTD_human
718	C3	C0030807	Pemphigus	0.2	1	0	CTD_human
718	C3	C0034152	Henoch-Schoenlein Purpura	0.2	1	0	CTD_human
718	C3	C0035078	Kidney Failure	0.2	0	0	HPO
718	C3	C0242383	Age related macular degeneration	0.264017302440851	4	2	CTD_human
718	C3	C0740392	Infarction, Middle Cerebral Artery	0.28	1	0	CTD_human
718	C3	C1565489	Renal Insufficiency	0.2	0	0	HPO
718	C3	C1969651	Macular Degeneration, Age-Related, 9	0.4	1	1	CTD_human;UNIPROT
718	C3	C2931788	Atypical Hemolytic Uremic Syndrome	0.201923087489492	0	0	CTD_human
718	C3	C3151071	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE	0.48	2	0	ORPHANET;UNIPROT
718	C3	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
7181	NR2C1	C0014175	Endometriosis	0.2	1	0	CTD_human
7182	NR2C2	C0014175	Endometriosis	0.2	1	0	CTD_human
7185	TRAF1	C0003873	Rheumatoid Arthritis	0.270596389884648	2	1	CTD_human
7187	TRAF3	C0276226	Herpes encephalitis	0.200824180352639	0	0	ORPHANET
7187	TRAF3	C0477341	Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.2	0	0	ORPHANET
7189	TRAF6	C0003873	Rheumatoid Arthritis	0.206737144536068	2	0	CTD_human
7189	TRAF6	C0265331	Autosomal dominant hypohidrotic ectodermal dysplasia syndrome (disorder)	0.2	0	0	ORPHANET
7189	TRAF6	C1956346	Coronary Artery Disease	0.200549453568426	1	0	CTD_human
72	ACTG2	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
72	ACTG2	C0042781	Visceral Myopathy	0.200274726784213	3	10	UNIPROT
72	ACTG2	C0266833	Visceral Myopathy, Familial	0.400549453568426	1	0	CTD_human;ORPHANET
72	ACTG2	C1608393	Megacystis microcolon intestinal hypoperistalsis syndrome	0.401373633921066	2	0	CTD_human;ORPHANET
72	ACTG2	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
720	C4A	C0003864	Arthritis	0.2	0	0	HPO
720	C4A	C0004943	Behcet Syndrome	0.2	0	0	ORPHANET
720	C4A	C0017658	Glomerulonephritis	0.2	0	0	HPO
720	C4A	C0024141	Lupus Erythematosus, Systemic	0.513708169083017	0	0	CTD_human;HPO
720	C4A	C0025289	Meningitis	0.2	0	0	HPO
720	C4A	C0038363	Aphthous Stomatitis	0.2	0	0	HPO
720	C4A	C0042384	Vasculitis	0.2	0	0	HPO
720	C4A	C0149745	Oral Ulcer	0.2	0	0	HPO
720	C4A	C0702166	Acne	0.2	0	0	HPO
720	C4A	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
720	C4A	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
720	C4A	C2937365	Recurrent aphthous ulcer	0.2	0	0	HPO
7200	TRH	C0014175	Endometriosis	0.2	1	0	CTD_human
7200	TRH	C0027404	Narcolepsy	0.2	1	0	CTD_human
7200	TRH	C0220998	Hypothalamic hypothyroidism	0.200274726784213	0	0	HPO
7200	TRH	C0259817	Xerosis	0.2	0	0	HPO
7200	TRH	C3887992	THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.4	0	0	CTD_human;ORPHANET
7201	TRHR	C0020676	Hypothyroidism	0.4	1	0	CTD_human;HPO
7201	TRHR	C0024421	Macroglossia	0.2	0	0	HPO
7201	TRHR	C2940786	Thyroid Hormone Resistance Syndrome	0.2	1	0	CTD_human
721	C4B	C0025289	Meningitis	0.2	0	0	HPO
721	C4B	C0520463	Chronic active hepatitis	0.200549453568426	0	0	HPO
721	C4B	C3280641	COMPLEMENT COMPONENT 4B DEFICIENCY	0.200824180352639	0	0	HPO
7222	TRPC3	C0262404	Cerebellar degeneration	0.2	0	0	HPO
7222	TRPC3	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
7222	TRPC3	C4020873	Infratentorial atrophy	0.2	0	0	HPO
7222	TRPC3	C4225158	SPINOCEREBELLAR ATAXIA 41	0.4	1	1	ORPHANET;UNIPROT
7225	TRPC6	C0017668	Focal glomerulosclerosis	0.295839930195095	0	0	HPO
7225	TRPC6	C1858915	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2	0.48	3	7	CTD_human;UNIPROT
7227	TRPS1	C0011334	Dental caries	0.2	0	0	HPO
7227	TRPS1	C0023003	Langer-Giedion Syndrome	0.402472541057918	1	0	CTD_human;ORPHANET
7227	TRPS1	C0023234	Legg-Calve-Perthes Disease	0.2	0	0	HPO
7227	TRPS1	C0024636	Malocclusion	0.2	0	0	HPO
7227	TRPS1	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
7227	TRPS1	C0029453	Osteopenia	0.2	0	0	HPO
7227	TRPS1	C0432233	Trichorhinophalangeal dysplasia type I	0.481098907136852	1	9	CTD_human;UNIPROT
7227	TRPS1	C0747078	Generalized osteopenia	0.2	0	0	HPO
7227	TRPS1	C1860823	Trichorhinophalangeal Syndrome, Type III	0.4	2	3	CTD_human;UNIPROT
7227	TRPS1	C1860826	Coxa Magna	0.2	0	0	HPO
7227	TRPS1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
724058	ANIB4	C1857749	ANEURYSM, INTRACRANIAL BERRY, 4 (disorder)	0.2	0	0	CTD_human
724066	ATXN8	C1837454	SPINOCEREBELLAR ATAXIA 8	0.401373633921066	0	0	CTD_human;ORPHANET
724074	DFNY1	C3888076	DEAFNESS, Y-LINKED 1	0.2	0	0	CTD_human
724107	SPG32	C1970009	SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE	0.4	0	0	CTD_human;ORPHANET
724110	SPG34	C2677897	SPASTIC PARAPLEGIA 34, X-LINKED (disorder)	0.4	0	0	CTD_human;ORPHANET
7248	TSC1	C0008733	Chylothorax	0.2	0	0	HPO
7248	TSC1	C0014544	Epilepsy	0.403846174978983	2	0	CTD_human;HPO
7248	TSC1	C0020676	Hypothyroidism	0.2	0	0	HPO
7248	TSC1	C0022679	Cystic kidney	0.2	0	0	HPO
7248	TSC1	C0029124	Optic Atrophy	0.2	0	0	HPO
7248	TSC1	C0034013	Precocious Puberty	0.2	0	0	HPO
7248	TSC1	C0034067	Pulmonary Emphysema	0.2	0	0	HPO
7248	TSC1	C0037769	West Syndrome	0.20328236603324	1	0	CTD_human
7248	TSC1	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
7248	TSC1	C0085581	Restrictive lung disease	0.2	0	0	HPO
7248	TSC1	C0149958	Complex partial seizures	0.2	0	0	HPO
7248	TSC1	C0270834	Complex partial seizure with impairment of consciousness	0.2	0	0	HPO
7248	TSC1	C0399440	Hereditary gingival fibromatosis	0.2	0	0	HPO
7248	TSC1	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
7248	TSC1	C0751778	Myoclonic Epilepsies, Progressive	0.2	1	0	CTD_human
7248	TSC1	C1846385	FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.400274726784213	1	0	CTD_human;ORPHANET
7248	TSC1	C1854465	TUBEROUS SCLEROSIS 1 (disorder)	0.484879569581206	6	38	CTD_human;UNIPROT
7248	TSC1	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
7248	TSC1	C3887898	Infantile Spasm	0.200549453568426	0	0	HPO
7249	TSC2	C0008733	Chylothorax	0.2	0	0	HPO
7249	TSC2	C0014544	Epilepsy	0.406253203502271	1	0	CTD_human;HPO
7249	TSC2	C0020676	Hypothyroidism	0.2	0	0	HPO
7249	TSC2	C0022679	Cystic kidney	0.201098907136852	0	0	HPO
7249	TSC2	C0029124	Optic Atrophy	0.2	0	0	HPO
7249	TSC2	C0034013	Precocious Puberty	0.2	0	0	HPO
7249	TSC2	C0034067	Pulmonary Emphysema	0.2	0	0	HPO
7249	TSC2	C0037769	West Syndrome	0.201923087489492	1	0	CTD_human
7249	TSC2	C0043202	Wolff-Parkinson-White Syndrome	0.2	0	0	HPO
7249	TSC2	C0085581	Restrictive lung disease	0.2	0	0	HPO
7249	TSC2	C0399440	Hereditary gingival fibromatosis	0.2	0	0	HPO
7249	TSC2	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
7249	TSC2	C1838327	Polycystic kidneys, severe infantile with tuberous sclerosis	0.2	0	0	ORPHANET
7249	TSC2	C1854465	TUBEROUS SCLEROSIS 1 (disorder)	0.203021994626344	0	0	CTD_human
7249	TSC2	C1860707	TUBEROUS SCLEROSIS 2 (disorder)	0.483296721410557	13	112	CTD_human;UNIPROT
7249	TSC2	C1861975	Cafe au lait spots, multiple	0.2	0	0	HPO
7249	TSC2	C3887898	Infantile Spasm	0.201648360705279	0	0	HPO
7252	TSHB	C0020676	Hypothyroidism	0.403231208875927	2	0	CTD_human;HPO
7252	TSHB	C0024421	Macroglossia	0.2	0	0	HPO
7252	TSHB	C0271789	Hypothyroidism, Congenital, Nongoitrous, 4	0.200274726784213	0	0	ORPHANET
7253	TSHR	C0018213	Graves Disease	0.275937904671511	2	1	CTD_human
7253	TSHR	C0020550	Hyperthyroidism	0.447701972811859	3	0	CTD_human;HPO
7253	TSHR	C0020676	Hypothyroidism	0.22125459796741	0	0	HPO
7253	TSHR	C0024421	Macroglossia	0.2	0	0	HPO
7253	TSHR	C0040156	Thyrotoxicosis	0.209260842751298	1	0	CTD_human
7253	TSHR	C0151516	Thyroid Hypoplasia	0.402747267842131	0	0	HPO;ORPHANET
7253	TSHR	C0259817	Xerosis	0.2	0	0	HPO
7253	TSHR	C0342122	Toxic diffuse goiter	0.2	0	0	HPO
7253	TSHR	C0917799	Hypersomnia	0.2	0	0	HPO
7253	TSHR	C0920350	Autoimmune thyroiditis	0.203231208875927	1	0	CTD_human
7253	TSHR	C1836706	Hyperthyroidism, Nonautoimmune	0.607142896389541	22	11	CTD_human;ORPHANET;UNIPROT
7253	TSHR	C1863959	Hyperthyroidism, Familial Gestational	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
7253	TSHR	C3493776	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	0.483021994626344	12	16	ORPHANET;UNIPROT
7258	TSPY1	C0028960	Oligospermia	0.2	0	0	HPO
7258	TSPY1	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
7259	TSPYL1	C0013363	Dysautonomia	0.2	0	0	HPO
7259	TSPYL1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
7259	TSPYL1	C0018790	Cardiac Arrest	0.2	0	0	HPO
7259	TSPYL1	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
7259	TSPYL1	C1837371	Sudden Infant Death with Dysgenesis of the Testes Syndrome	0.400824180352639	0	0	CTD_human;ORPHANET
726	CAPN5	C0035305	Retinal Detachment	0.200274726784213	0	0	HPO
726	CAPN5	C0042164	Uveitis	0.201098907136852	0	0	HPO
726	CAPN5	C0242852	Proliferative vitreoretinopathy	0.4	1	2	ORPHANET;UNIPROT
726	CAPN5	C0271215	Blindness, Legal	0.2	0	0	HPO
726	CAPN5	C0474355	Peripheral retinal neovascularization	0.2	0	0	HPO
7263	TST	C0009319	Colitis	0.2	1	0	CTD_human
727	C5	C0031154	Peritonitis	0.2	2	0	CTD_human
727	C5	C0343047	Complement component 5 deficiency	0.2	0	0	CTD_human
727	C5	C0743178	Diarrhea, intractable	0.2	0	0	HPO
727	C5	C0746495	Recurrent meningitis	0.2	0	0	HPO
727	C5	C4024844	Generalized seborrheic dermatitis	0.2	0	0	HPO
7272	TTK	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
7273	TTN	C0026850	Muscular Dystrophy	0.201373633921065	0	0	HPO
7273	TTN	C0085684	Foot-drop	0.2	0	0	HPO
7273	TTN	C0340427	Familial dilated cardiomyopathy	0.200274726784213	1	0	CTD_human
7273	TTN	C0376175	Bell Palsy	0.2	0	0	HPO
7273	TTN	C0410180	Eichsfeld type congenital muscular dystrophy	0.2	0	0	ORPHANET
7273	TTN	C1837342	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J	0.48	0	0	CTD_human;ORPHANET
7273	TTN	C1838244	TIBIAL MUSCULAR DYSTROPHY, TARDIVE	0.482197814273705	2	48	ORPHANET;UNIPROT
7273	TTN	C1858763	Cardiomyopathy, Dilated, 1g	0.48	3	54	CTD_human;UNIPROT
7273	TTN	C1861065	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9	0.4	2	37	CTD_human;UNIPROT
7273	TTN	C1863599	Hereditary Myopathy with Early Respiratory Failure	0.603296721410557	1	44	CTD_human;ORPHANET;UNIPROT
7273	TTN	C2673677	Myopathy, Early-Onset, with Fatal Cardiomyopathy	0.400274726784213	0	0	CTD_human;ORPHANET
7273	TTN	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
7273	TTN	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
7274	TTPA	C0004153	Atherosclerosis	0.2	1	0	CTD_human
7274	TTPA	C0020443	Hypercholesterolemia	0.2	0	0	HPO
7274	TTPA	C0020445	Hypercholesterolemia, Familial	0.2	0	0	HPO
7274	TTPA	C0028077	Night Blindness	0.2	0	0	HPO
7274	TTPA	C0028738	Nystagmus	0.2	0	0	HPO
7274	TTPA	C0035334	Retinitis Pigmentosa	0.201373633921065	1	0	CTD_human
7274	TTPA	C0042875	Vitamin E Deficiency	0.407663639203332	1	0	CTD_human;HPO
7274	TTPA	C0151313	Sensory neuropathy	0.2	0	0	HPO
7274	TTPA	C0155210	Eyelid Xanthoma	0.2	0	0	HPO
7274	TTPA	C0221253	Xanthoma tendinosum	0.2	0	0	HPO
7274	TTPA	C0302314	Xanthoma	0.2	0	0	HPO
7274	TTPA	C1848533	Ataxia with vitamin E deficiency	0.686043989252688	7	23	CTD_human;ORPHANET;UNIPROT
7274	TTPA	C4280602	Xanthelasma of periocular region	0.2	0	0	HPO
7275	TUB	C0004106	Astigmatism	0.2	0	0	HPO
7275	TUB	C0017601	Glaucoma	0.2	0	0	HPO
7275	TUB	C0018777	Conductive hearing loss	0.2	0	0	HPO
7275	TUB	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
7275	TUB	C0020459	Hyperinsulinism	0.2	0	0	HPO
7275	TUB	C0020619	Hypogonadism	0.2	0	0	HPO
7275	TUB	C0022578	Keratoconus	0.2	0	0	HPO
7275	TUB	C0027092	Myopia	0.2	0	0	HPO
7275	TUB	C0028738	Nystagmus	0.2	0	0	HPO
7275	TUB	C0028754	Obesity	0.289418899843569	0	0	HPO
7275	TUB	C0029124	Optic Atrophy	0.2	0	0	HPO
7275	TUB	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
7275	TUB	C0042798	Low Vision	0.2	0	0	HPO
7275	TUB	C0271215	Blindness, Legal	0.2	0	0	HPO
7276	TTR	C0002726	Amyloidosis	0.498804503312171	1	0	CTD_human;HPO
7276	TTR	C0007286	Carpal Tunnel Syndrome	0.40685381422801	1	1	CTD_human;UNIPROT
7276	TTR	C0013363	Dysautonomia	0.2	0	0	HPO
7276	TTR	C0014544	Epilepsy	0.2	0	0	HPO
7276	TTR	C0028738	Nystagmus	0.2	0	0	HPO
7276	TTR	C0030486	Paraplegia	0.2	0	0	HPO
7276	TTR	C0042798	Low Vision	0.2	0	0	HPO
7276	TTR	C0152025	Polyneuropathy	0.260931924586039	0	0	HPO
7276	TTR	C0242350	Erectile dysfunction	0.2	0	0	HPO
7276	TTR	C0270921	Axonal neuropathy	0.200549453568426	0	0	HPO
7276	TTR	C0494497	Polyneuropathy in other endocrine and metabolic diseases	0.2	0	0	ORPHANET
7276	TTR	C0740340	Amyloidosis, Familial	0.210714344584311	2	0	CTD_human
7276	TTR	C0936215	Vitamin B 6 Deficiency	0.2	0	0	HPO
7276	TTR	C1263857	Peripheral axonal neuropathy	0.200274726784213	0	0	HPO
7276	TTR	C2750824	Dystransthyretinemic Euthyroidal Hyperthyroxinemia	0.4	2	2	CTD_human;UNIPROT
7276	TTR	C2751492	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.643132105121457	72	46	CTD_human;ORPHANET;UNIPROT
7276	TTR	C4275067	Transthyretin related familial amyloid cardiomyopathy	0.2	0	0	ORPHANET
7276	TTR	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
727699	LINC00163	C1834372	Narcolepsy 1	0.2	0	0	CTD_human
7277	TUBA4A	C4015512	AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	0.2	1	6	UNIPROT
727714	SCAX2	C1844885	SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.2	0	0	CTD_human
727715	SCAX3	C1844936	SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.2	0	0	CTD_human
727716	SCAX4	C1844933	SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.2	0	0	CTD_human
727857	BHLHA9	C1836206	Syndactyly, Mesoaxial Synostotic, with Phalangeal Reduction	0.400274726784213	1	3	ORPHANET;UNIPROT
727897	MUC5B	C0878555	Diffuse panbronchiolitis	0.200549453568426	0	0	ORPHANET
727897	MUC5B	C1800706	Idiopathic Pulmonary Fibrosis	0.406043989252688	1	0	CTD_human;ORPHANET
7280	TUBB2A	C0014544	Epilepsy	0.200274726784213	0	0	HPO
7280	TUBB2A	C0022336	Creutzfeldt-Jakob disease	0.2	1	0	CTD_human
7280	TUBB2A	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
7280	TUBB2A	C3810407	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5	0.2	1	5	UNIPROT
728294	D2HGDH	C2746066	Combined D-2- and L-2-hydroxyglutaric aciduria	0.201098907136852	0	0	CTD_human
728294	D2HGDH	C3152055	D-2-HYDROXYGLUTARIC ACIDURIA 1	0.400824180352639	3	5	ORPHANET;UNIPROT
7283	TUBG1	C0014544	Epilepsy	0.2	0	0	HPO
7283	TUBG1	C1955869	Malformations of Cortical Development	0.200274726784213	1	0	CTD_human
7283	TUBG1	C3809420	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4	0.2	1	3	UNIPROT
7284	TUFM	C0028738	Nystagmus	0.2	0	0	HPO
7284	TUFM	C1836830	Developmental regression	0.2	0	0	HPO
7284	TUFM	C1857682	Combined Oxidative Phosphorylation Deficiency 4	0.6	1	3	CTD_human;ORPHANET;UNIPROT
7287	TULP1	C0014544	Epilepsy	0.2	0	0	HPO
7287	TULP1	C0017601	Glaucoma	0.2	0	0	HPO
7287	TULP1	C0018777	Conductive hearing loss	0.2	0	0	HPO
7287	TULP1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
7287	TULP1	C0020459	Hyperinsulinism	0.2	0	0	HPO
7287	TULP1	C0020619	Hypogonadism	0.2	0	0	HPO
7287	TULP1	C0022578	Keratoconus	0.2	0	0	HPO
7287	TULP1	C0027092	Myopia	0.2	0	0	HPO
7287	TULP1	C0028077	Night Blindness	0.2	0	0	HPO
7287	TULP1	C0028738	Nystagmus	0.200274726784213	0	0	HPO
7287	TULP1	C0028754	Obesity	0.200549453568426	0	0	HPO
7287	TULP1	C0029124	Optic Atrophy	0.2	0	0	HPO
7287	TULP1	C0035334	Retinitis Pigmentosa	0.408986115967085	0	0	HPO;ORPHANET
7287	TULP1	C0042798	Low Vision	0.2	0	0	HPO
7287	TULP1	C0271215	Blindness, Legal	0.2	0	0	HPO
7287	TULP1	C0339527	Leber Congenital Amaurosis	0.201648360705279	0	0	ORPHANET
7287	TULP1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
7287	TULP1	C1301509	Severe visual impairment	0.2	0	0	HPO
7287	TULP1	C1838603	Retinitis Pigmentosa 14	0.480274726784213	5	10	CTD_human;UNIPROT
7287	TULP1	C3151206	LEBER CONGENITAL AMAUROSIS 15	0.4	1	4	CTD_human;UNIPROT
729	C6	C2676232	Complement Component 6 Deficiency	0.200549453568426	0	0	CTD_human
7290	HIRA	C0011334	Dental caries	0.2	0	0	HPO
7290	HIRA	C0012236	DiGeorge Syndrome	0.203021994626344	0	0	ORPHANET
7290	HIRA	C0018777	Conductive hearing loss	0.2	0	0	HPO
7290	HIRA	C0020626	Hypoparathyroidism	0.2	0	0	HPO
7290	HIRA	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
7290	HIRA	C0039621	Tetany	0.2	0	0	HPO
7290	HIRA	C0085109	Corneal Neovascularization	0.2	0	0	HPO
7290	HIRA	C0220704	Shprintzen syndrome	0.200824180352639	0	0	ORPHANET
7290	HIRA	C0271441	Chronic otitis media	0.2	0	0	HPO
7290	HIRA	C0702166	Acne	0.2	0	0	HPO
7290	HIRA	C0743359	ear infection chronic	0.2	0	0	HPO
7290	HIRA	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	0.2	0	0	ORPHANET
7290	HIRA	C2936346	22q11 Deletion Syndrome	0.200549453568426	0	0	ORPHANET
7290	HIRA	C3266101	22q11 partial monosomy syndrome	0.2	0	0	ORPHANET
7290	HIRA	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
7290	HIRA	C4024912	Occipital myelomeningocele	0.2	0	0	HPO
7291	TWIST1	C0005747	Blepharospasm	0.2	0	0	HPO
7291	TWIST1	C0010278	Craniosynostosis	0.626134167548616	2	2	CTD_human;HPO;UNIPROT
7291	TWIST1	C0015300	Exophthalmos	0.2	0	0	HPO
7291	TWIST1	C0038379	Strabismus	0.2	0	0	HPO
7291	TWIST1	C0151740	Intracranial Hypertension	0.200274726784213	0	0	HPO
7291	TWIST1	C0175699	Saethre-Chotzen Syndrome	0.494560519563294	3	8	ORPHANET;UNIPROT
7291	TWIST1	C1833340	Synostotic Posterior Plagiocephaly	0.200274726784213	0	0	HPO
7291	TWIST1	C1856266	Coronal craniosynostosis	0.201098907136852	0	0	HPO
7291	TWIST1	C1863370	Saethre-Chotzen Syndrome with Eyelid Anomalies	0.2	1	1	CTD_human
7291	TWIST1	C3806917	CRANIOSYNOSTOSIS 4	0.2	0	0	ORPHANET
7292	TNFSF4	C0007384	Cataplexy	0.2	0	0	HPO
7292	TNFSF4	C0024141	Lupus Erythematosus, Systemic	0.220970101426213	2	8	CTD_human
7292	TNFSF4	C0027051	Myocardial Infarction	0.205154296365419	0	0	CTD_human
7292	TNFSF4	C0027404	Narcolepsy	0.202956482091714	0	0	ORPHANET
7292	TNFSF4	C0751362	Narcolepsy-Cataplexy Syndrome	0.2	0	0	ORPHANET
729230	CCR2	C0032285	Pneumonia	0.2	1	0	CTD_human
729230	CCR2	C0034069	Pulmonary Fibrosis	0.200549453568426	1	0	CTD_human
729230	CCR2	C0038220	Status Epilepticus	0.2	2	0	CTD_human
729230	CCR2	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
729230	CCR2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
729238	SFTPA2	C1800706	Idiopathic Pulmonary Fibrosis	0.600549453568426	1	2	CTD_human;ORPHANET;UNIPROT
7293	TNFRSF4	C0030312	Pancytopenia	0.2	0	0	HPO
7293	TNFRSF4	C0520736	Coombs positive hemolytic anemia	0.2	0	0	HPO
7293	TNFRSF4	C3810053	IMMUNODEFICIENCY 16	0.400274726784213	1	1	ORPHANET;UNIPROT
7295	TXN	C0006287	Bronchopulmonary Dysplasia	0.200274726784213	1	0	CTD_human
7295	TXN	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
7296	TXNRD1	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
7296	TXNRD1	C0014544	Epilepsy	0.200274726784213	1	0	CTD_human
7296	TXNRD1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
7296	TXNRD1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
7297	TYK2	C0003873	Rheumatoid Arthritis	0.201098907136852	1	1	CTD_human
7297	TYK2	C0010346	Crohn Disease	0.202956482091714	1	1	CTD_human
7297	TYK2	C0022073	Iridocyclitis	0.2	0	0	HPO
7297	TYK2	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
7297	TYK2	C0024636	Malocclusion	0.2	0	0	HPO
7297	TYK2	C0026769	Multiple Sclerosis	0.214507683674358	1	0	CTD_human
7297	TYK2	C0033860	Psoriasis	0.201373633921065	1	2	CTD_human
7297	TYK2	C0157917	Pauciarticular juvenile rheumatoid arthritis	0.2	0	0	ORPHANET
7297	TYK2	C0162323	Polyarthritis	0.2	0	0	HPO
7297	TYK2	C1969086	Tyrosine Kinase 2 Deficiency	0.400274726784213	0	0	CTD_human;ORPHANET
7297	TYK2	C3714757	Juvenile rheumatoid arthritis	0.2	0	0	HPO
7297	TYK2	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
7298	TYMS	C0002871	Anemia	0.200549453568426	1	0	CTD_human
7299	TYR	C0004106	Astigmatism	0.2	0	0	HPO
7299	TYR	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
7299	TYR	C0020490	Hyperopia	0.2	0	0	HPO
7299	TYR	C0027092	Myopia	0.2	0	0	HPO
7299	TYR	C0028738	Nystagmus	0.2	0	0	HPO
7299	TYR	C0036651	Senile lentigo	0.200274726784213	0	0	HPO
7299	TYR	C0038379	Strabismus	0.2	0	0	HPO
7299	TYR	C0042798	Low Vision	0.2	0	0	HPO
7299	TYR	C0162835	Hypopigmentation disorder	0.202747267842131	0	0	HPO
7299	TYR	C0268494	Oculocutaneous albinism type 1	0.691263798152737	21	79	CTD_human;ORPHANET;UNIPROT
7299	TYR	C1328931	Multiple lentigines	0.2	0	0	HPO
7299	TYR	C1845069	ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS (disorder)	0.2	0	0	CTD_human
7299	TYR	C1847024	ALBINISM, OCULOCUTANEOUS, TYPE IB (disorder)	0.680274726784213	8	18	CTD_human;ORPHANET;UNIPROT
7299	TYR	C1863198	ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS (disorder)	0.2	0	0	ORPHANET
729920	ISPD	C0020255	Hydrocephalus	0.2	1	0	CTD_human
729920	ISPD	C0265221	Walker-Warburg congenital muscular dystrophy	0.401098907136852	2	0	CTD_human;ORPHANET
729920	ISPD	C1847759	MUSCULAR DYSTROPHY, CONGENITAL, 1C	0.2	0	0	ORPHANET
729920	ISPD	C3553330	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	0.2	2	15	UNIPROT
729920	ISPD	C4015095	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7	0.4	1	3	ORPHANET;UNIPROT
730	C7	C1864694	Complement Component 7 Deficiency	0.405363510615002	3	7	CTD_human;UNIPROT
7305	TYROBP	C0014544	Epilepsy	0.2	0	0	HPO
7305	TYROBP	C0235946	Cerebral atrophy	0.2	0	0	HPO
7305	TYROBP	C0338455	Dementia of frontal lobe type	0.2	0	0	HPO
7305	TYROBP	C1836830	Developmental regression	0.2	0	0	HPO
7305	TYROBP	C1857316	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	0.48357144819477	0	0	CTD_human;ORPHANET
7305	TYROBP	C3489733	Oculomotor apraxia	0.2	0	0	HPO
7305	TYROBP	C4020858	Choreatic disease	0.2	0	0	HPO
7305	TYROBP	C4020860	Supratentorial atrophy	0.2	0	0	HPO
7306	TYRP1	C0028738	Nystagmus	0.2	0	0	HPO
7306	TYRP1	C0038379	Strabismus	0.2	0	0	HPO
7306	TYRP1	C0342683	ALBINISM, OCULOCUTANEOUS, TYPE III	0.401373633921066	2	8	ORPHANET;UNIPROT
7306	TYRP1	C2931599	Oculocutaneous albinism type 3	0.401373633921066	0	0	CTD_human;ORPHANET
7307	U2AF1	C0029456	Osteoporosis	0.2	1	0	CTD_human
731	C8A	C0024141	Lupus Erythematosus, Systemic	0.2	0	0	HPO
731	C8A	C0025289	Meningitis	0.4	1	0	CTD_human;HPO
731	C8A	C3151081	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I	0.2	0	0	CTD_human
7314	UBB	C0014544	Epilepsy	0.2	0	0	HPO
7314	UBB	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
7314	UBB	C0266063	Deep overbite	0.2	0	0	HPO
7314	UBB	C1970095	Cleft Palate, Isolated, And Mental Retardation	0.2	0	0	CTD_human
7317	UBA1	C0003886	Arthrogryposis	0.2	0	0	HPO
7317	UBA1	C0026847	Spinal Muscular Atrophy	0.200824180352639	0	0	HPO
7317	UBA1	C0376175	Bell Palsy	0.2	0	0	HPO
7317	UBA1	C1844934	Arthrogryposis multiplex congenita, distal, X-linked	0.600549453568426	2	3	CTD_human;ORPHANET;UNIPROT
7319	UBE2A	C0014306	Enophthalmos	0.2	0	0	HPO
7319	UBE2A	C0014544	Epilepsy	0.2	0	0	HPO
7319	UBE2A	C0221260	Dystrophia unguium	0.2	0	0	HPO
7319	UBE2A	C0259817	Xerosis	0.2	0	0	HPO
7319	UBE2A	C1834405	Nail dysplasia	0.2	0	0	HPO
7319	UBE2A	C3275464	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE	0.48	1	2	ORPHANET;UNIPROT
732	C8B	C0025289	Meningitis	0.4	1	0	CTD_human;HPO
732	C8B	C3151080	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II	0.200549453568426	0	0	CTD_human
732	C8B	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
7324	UBE2E1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
7325	UBE2E2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.20350593566014	1	2	CTD_human
7328	UBE2H	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
7332	UBE2L3	C0524909	Hepatitis B, Chronic	0.2	1	0	CTD_human
7337	UBE3A	C0014306	Enophthalmos	0.2	0	0	HPO
7337	UBE3A	C0014544	Epilepsy	0.401373633921066	1	0	CTD_human;HPO
7337	UBE3A	C0015310	Exotropia	0.2	0	0	HPO
7337	UBE3A	C0024421	Macroglossia	0.2	0	0	HPO
7337	UBE3A	C0027092	Myopia	0.2	0	0	HPO
7337	UBE3A	C0028738	Nystagmus	0.2	0	0	HPO
7337	UBE3A	C0028754	Obesity	0.200549453568426	0	0	HPO
7337	UBE3A	C0037036	Sialorrhea	0.2	0	0	HPO
7337	UBE3A	C0038379	Strabismus	0.2	0	0	HPO
7337	UBE3A	C0162635	Angelman Syndrome	0.327115717463437	1	113	CTD_human
7337	UBE3A	C0162835	Hypopigmentation disorder	0.200274726784213	0	0	HPO
7337	UBE3A	C0235946	Cerebral atrophy	0.2	0	0	HPO
7337	UBE3A	C2675336	Duplication 15q11-q13 Syndrome	0.2	0	0	ORPHANET
7345	UCHL1	C0028738	Nystagmus	0.2	0	0	HPO
7345	UCHL1	C0029124	Optic Atrophy	0.200274726784213	0	0	HPO
7345	UCHL1	C0235946	Cerebral atrophy	0.2	0	0	HPO
7345	UCHL1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
7345	UCHL1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
7345	UCHL1	C3150899	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT	0.48	4	1	CTD_human;UNIPROT
7345	UCHL1	C3160718	PARKINSON DISEASE, LATE-ONSET	0.200274726784213	0	0	CTD_human
7345	UCHL1	C3809665	NEURODEGENERATION WITH OPTIC ATROPHY, CHILDHOOD-ONSET	0.4	1	1	ORPHANET;UNIPROT
7345	UCHL1	C3809811	PARKINSON DISEASE 19, JUVENILE-ONSET	0.2	0	0	ORPHANET
7345	UCHL1	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
7345	UCHL1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
7345	UCHL1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
7345	UCHL1	C4275179	Young onset Parkinson disease	0.2	0	0	ORPHANET
735	C9	C0011633	Dermatomyositis	0.200274726784213	1	0	CTD_human
735	C9	C0015456	Facial Dermatoses	0.2	1	0	CTD_human
735	C9	C0025294	Meningococcal meningitis	0.2	1	0	CTD_human
735	C9	C0242383	Age related macular degeneration	0.202407028523288	1	1	CTD_human
735	C9	C3151189	C9 Deficiency	0.201373633921065	1	4	UNIPROT
735	C9	C3810042	MACULAR DEGENERATION, AGE-RELATED, 15	0.2	1	1	UNIPROT
7350	UCP1	C0018801	Heart failure	0.2	1	0	CTD_human
7350	UCP1	C0028754	Obesity	0.250313031448078	1	0	CTD_human
7351	UCP2	C0007786	Brain Ischemia	0.200274726784213	1	0	CTD_human
7351	UCP2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.353190186254841	2	0	CTD_human
7351	UCP2	C0015695	Fatty Liver	0.280824180352639	1	0	CTD_human
7351	UCP2	C0028754	Obesity	0.306923224852884	1	0	CTD_human
7351	UCP2	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
7351	UCP2	C1864903	Hyperinsulinaemic hypoglycaemia	0.200274726784213	0	0	HPO
7352	UCP3	C0028754	Obesity	0.474592530930541	1	1	CTD_human;UNIPROT
7353	UFD1L	C0011334	Dental caries	0.2	0	0	HPO
7353	UFD1L	C0012236	DiGeorge Syndrome	0.200824180352639	0	0	ORPHANET
7353	UFD1L	C0018777	Conductive hearing loss	0.2	0	0	HPO
7353	UFD1L	C0020626	Hypoparathyroidism	0.2	0	0	HPO
7353	UFD1L	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
7353	UFD1L	C0039621	Tetany	0.2	0	0	HPO
7353	UFD1L	C0085109	Corneal Neovascularization	0.2	0	0	HPO
7353	UFD1L	C0220704	Shprintzen syndrome	0.200549453568426	0	0	ORPHANET
7353	UFD1L	C0271441	Chronic otitis media	0.2	0	0	HPO
7353	UFD1L	C0702166	Acne	0.2	0	0	HPO
7353	UFD1L	C0743359	ear infection chronic	0.2	0	0	HPO
7353	UFD1L	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	0.2	0	0	ORPHANET
7353	UFD1L	C2936346	22q11 Deletion Syndrome	0.200549453568426	0	0	ORPHANET
7353	UFD1L	C3266101	22q11 partial monosomy syndrome	0.2	0	0	ORPHANET
7353	UFD1L	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
7353	UFD1L	C4024912	Occipital myelomeningocele	0.2	0	0	HPO
7355	SLC35A2	C0014544	Epilepsy	0.200824180352639	0	0	HPO
7355	SLC35A2	C0028738	Nystagmus	0.2	0	0	HPO
7355	SLC35A2	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
7355	SLC35A2	C0235946	Cerebral atrophy	0.2	0	0	HPO
7355	SLC35A2	C0543888	Epileptic encephalopathy	0.200274726784213	0	0	HPO
7355	SLC35A2	C3806688	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm	0.4	2	7	ORPHANET;UNIPROT
7355	SLC35A2	C4020860	Supratentorial atrophy	0.2	0	0	HPO
7356	SCGB1A1	C0004096	Asthma	0.261503373982605	0	0	CTD_human
7357	UGCG	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
7361	UGT1A	C0017551	Gilbert Disease (disorder)	0.205494535684262	1	0	CTD_human
7367	UGT2B17	C0018133	Graft-vs-Host Disease	0.205638237399215	1	0	CTD_human
7369	UMOD	C0003868	Arthritis, Gouty	0.2	0	0	HPO
7369	UMOD	C0018099	Gout	0.202407028523288	0	0	HPO
7369	UMOD	C0035078	Kidney Failure	0.20357144819477	0	0	HPO
7369	UMOD	C0268113	Familial juvenile gout	0.690164891015885	13	11	CTD_human;ORPHANET;UNIPROT
7369	UMOD	C0687120	Nephronophthisis	0.202472541057918	0	0	HPO
7369	UMOD	C0740394	Hyperuricemia	0.212594365941851	0	0	HPO
7369	UMOD	C1565489	Renal Insufficiency	0.202197814273705	0	0	HPO
7369	UMOD	C1835934	Glomerulocystic Kidney Disease with Hyperuricemia and Isosthenuria	0.4	2	1	CTD_human;UNIPROT
7369	UMOD	C1859040	Medullary Cystic Kidney Disease Type 2	0.482472541057918	5	3	CTD_human;UNIPROT
7369	UMOD	C4020705	Glomerulocystic Disease	0.201923087489492	0	0	HPO
7369	UMOD	C4020790	Medullary sponge kidney disease	0.2	0	0	HPO
7369	UMOD	C4024644	Multiple small medullary renal cysts	0.2	0	0	HPO
7372	UMPS	C0002871	Anemia	0.2	0	0	HPO
7372	UMPS	C0002895	Anemia, Sickle Cell	0.2	1	0	CTD_human
7372	UMPS	C0005283	beta Thalassemia	0.2	1	0	CTD_human
7372	UMPS	C0037889	Hereditary spherocytosis	0.2	1	0	CTD_human
7372	UMPS	C0220987	Hereditary orotic aciduria	0.200274726784213	0	0	ORPHANET
7372	UMPS	C0238621	Aminoaciduria	0.2	0	0	HPO
7372	UMPS	C0268130	Hereditary orotic aciduria, type 1	0.600274726784213	1	3	CTD_human;ORPHANET;UNIPROT
7372	UMPS	C0949116	Congenital hypoplastic anemia	0.2	1	0	CTD_human
7372	UMPS	C4021731	Pyrimidine-responsive megaloblastic anemia	0.2	0	0	HPO
7372	UMPS	C4025287	Folate-unresponsive megaloblastic anemia	0.2	0	0	HPO
7373	COL14A1	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
7373	COL14A1	C1835662	Keratosis palmoplantaris papulosa	0.2	0	0	ORPHANET
7373	COL14A1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
7374	UNG	C0005859	Bloom Syndrome	0.201373633921065	1	0	CTD_human
7374	UNG	C0014534	Epididymitis	0.2	0	0	HPO
7374	UNG	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
7374	UNG	C0162539	IgG Deficiency	0.2	0	0	HPO
7374	UNG	C0272236	Hyperimmunoglobulin M syndrome	0.201098907136852	0	0	CTD_human
7374	UNG	C1720958	Hyper-IgM Immunodeficiency Syndrome, Type 5	0.4	1	1	ORPHANET;UNIPROT
7376	NR1H2	C0008370	Cholestasis	0.2	1	0	CTD_human
7378	UPP1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
7380	UPK3A	C1609433	Congenital absence of kidneys syndrome	0.2	0	0	CTD_human
7381	UQCRB	C0020615	Hypoglycemia	0.200274726784213	0	0	HPO
7381	UQCRB	C1852372	MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)	0.2	0	0	CTD_human
7385	UQCRC2	C0020615	Hypoglycemia	0.2	0	0	HPO
7385	UQCRC2	C0028754	Obesity	0.2	1	0	CTD_human
7385	UQCRC2	C3554608	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5	0.2	1	1	UNIPROT
7386	UQCRFS1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
7389	UROD	C0002170	Alopecia	0.2	0	0	HPO
7389	UROD	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
7389	UROD	C0011644	Scleroderma	0.2	0	0	HPO
7389	UROD	C0023890	Liver Cirrhosis	0.2	0	0	HPO
7389	UROD	C0085661	Onycholysis	0.2	0	0	HPO
7389	UROD	C0162566	Porphyria Cutanea Tarda	0.628672221141164	16	19	CTD_human;ORPHANET;UNIPROT
7389	UROD	C0162569	Hepatoerythropoietic Porphyria	0.207417623173754	0	0	ORPHANET
7389	UROD	C1274865	Scleroderma-like secondary cutaneous sclerosis	0.2	0	0	HPO
7390	UROS	C0002170	Alopecia	0.2	0	0	HPO
7390	UROS	C0002878	Anemia, Hemolytic	0.200549453568426	0	0	HPO
7390	UROS	C0008350	Cholelithiasis	0.2	0	0	HPO
7390	UROS	C0009763	Conjunctivitis	0.2	0	0	HPO
7390	UROS	C0011644	Scleroderma	0.2	0	0	HPO
7390	UROS	C0020555	Hypertrichosis	0.2	0	0	HPO
7390	UROS	C0029453	Osteopenia	0.2	0	0	HPO
7390	UROS	C0158113	Contracture of joint of hand	0.2	0	0	HPO
7390	UROS	C0162530	Porphyria, Erythropoietic	0.694546164185977	12	26	CTD_human;ORPHANET;UNIPROT
7390	UROS	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
7390	UROS	C0410550	Collapse of vertebra	0.2	0	0	HPO
7390	UROS	C0747078	Generalized osteopenia	0.2	0	0	HPO
7390	UROS	C1274865	Scleroderma-like secondary cutaneous sclerosis	0.2	0	0	HPO
7391	USF1	C0020474	Hyperlipidemia, Familial Combined	0.229453335361852	0	0	CTD_human
7396	USH1E	C1568247	Usher Syndrome, Type I	0.200274726784213	0	0	ORPHANET
7396	USH1E	C2931209	Usher syndrome, type 1E	0.2	0	0	CTD_human
7399	USH2A	C0017601	Glaucoma	0.2	0	0	HPO
7399	USH2A	C0018777	Conductive hearing loss	0.2	0	0	HPO
7399	USH2A	C0018784	Sensorineural Hearing Loss (disorder)	0.20328236603324	0	0	HPO
7399	USH2A	C0018979	Hemianopsia	0.2	0	0	HPO
7399	USH2A	C0020459	Hyperinsulinism	0.2	0	0	HPO
7399	USH2A	C0020619	Hypogonadism	0.2	0	0	HPO
7399	USH2A	C0022578	Keratoconus	0.2	0	0	HPO
7399	USH2A	C0027092	Myopia	0.2	0	0	HPO
7399	USH2A	C0028077	Night Blindness	0.200274726784213	0	0	HPO
7399	USH2A	C0028738	Nystagmus	0.2	0	0	HPO
7399	USH2A	C0028754	Obesity	0.2	0	0	HPO
7399	USH2A	C0029124	Optic Atrophy	0.2	0	0	HPO
7399	USH2A	C0035334	Retinitis Pigmentosa	0.623372544329168	3	16	CTD_human;HPO;ORPHANET
7399	USH2A	C0042798	Low Vision	0.2	0	0	HPO
7399	USH2A	C0271215	Blindness, Legal	0.2	0	0	HPO
7399	USH2A	C1568249	Usher Syndrome, Type II	0.206318716036901	0	0	ORPHANET
7399	USH2A	C1848634	USHER SYNDROME, TYPE IIA	0.482197814273705	24	143	CTD_human;UNIPROT
7399	USH2A	C3151138	RETINITIS PIGMENTOSA 39 (disorder)	0.2	12	33	UNIPROT
7401	CLRN1	C0004106	Astigmatism	0.2	0	0	HPO
7401	CLRN1	C0017601	Glaucoma	0.2	0	0	HPO
7401	CLRN1	C0018777	Conductive hearing loss	0.2	0	0	HPO
7401	CLRN1	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
7401	CLRN1	C0018979	Hemianopsia	0.2	0	0	HPO
7401	CLRN1	C0020459	Hyperinsulinism	0.2	0	0	HPO
7401	CLRN1	C0020619	Hypogonadism	0.2	0	0	HPO
7401	CLRN1	C0022578	Keratoconus	0.2	0	0	HPO
7401	CLRN1	C0028077	Night Blindness	0.2	0	0	HPO
7401	CLRN1	C0028738	Nystagmus	0.2	0	0	HPO
7401	CLRN1	C0028754	Obesity	0.2	0	0	HPO
7401	CLRN1	C0029124	Optic Atrophy	0.2	0	0	HPO
7401	CLRN1	C0035334	Retinitis Pigmentosa	0.401373633921066	0	0	HPO;ORPHANET
7401	CLRN1	C0042798	Low Vision	0.2	0	0	HPO
7401	CLRN1	C0271215	Blindness, Legal	0.2	0	0	HPO
7401	CLRN1	C1568248	Usher Syndrome, Type III	0.68439562854741	6	14	CTD_human;ORPHANET;UNIPROT
7401	CLRN1	C3280041	RETINITIS PIGMENTOSA 61	0.2	1	2	UNIPROT
7403	KDM6A	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
7403	KDM6A	C0014544	Epilepsy	0.2	0	0	HPO
7403	KDM6A	C0018777	Conductive hearing loss	0.2	0	0	HPO
7403	KDM6A	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
7403	KDM6A	C0020255	Hydrocephalus	0.2	0	0	HPO
7403	KDM6A	C0024636	Malocclusion	0.2	0	0	HPO
7403	KDM6A	C0038379	Strabismus	0.2	0	0	HPO
7403	KDM6A	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
7403	KDM6A	C0235946	Cerebral atrophy	0.2	0	0	HPO
7403	KDM6A	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
7403	KDM6A	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
7403	KDM6A	C0747085	Recurrent otitis media	0.2	0	0	HPO
7403	KDM6A	C0747651	Recurrent aspiration pneumonia	0.2	0	0	HPO
7403	KDM6A	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
7403	KDM6A	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7403	KDM6A	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
7412	VCAM1	C0002895	Anemia, Sickle Cell	0.207011871320281	1	0	CTD_human
7412	VCAM1	C0004153	Atherosclerosis	0.223112172922272	1	0	CTD_human
7412	VCAM1	C0008370	Cholestasis	0.2	1	0	CTD_human
7412	VCAM1	C0009324	Ulcerative Colitis	0.2	1	0	CTD_human
7412	VCAM1	C0020443	Hypercholesterolemia	0.201373633921065	1	0	CTD_human
7412	VCAM1	C0026769	Multiple Sclerosis	0.202681755307501	1	0	CTD_human
7412	VCAM1	C0041948	Uremia	0.2	1	0	CTD_human
7412	VCAM1	C0042109	Urticaria	0.2	1	0	CTD_human
7412	VCAM1	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
7414	VCL	C0007194	Hypertrophic Cardiomyopathy	0.205964121340741	0	0	HPO
7414	VCL	C0029456	Osteoporosis	0.2	1	0	CTD_human
7414	VCL	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
7414	VCL	C1969639	Cardiomyopathy, Dilated, 1w	0.4	2	2	CTD_human;UNIPROT
7414	VCL	C2750459	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15	0.4	1	3	CTD_human;UNIPROT
7414	VCL	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
7414	VCL	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
7415	VCP	C0002736	Amyotrophic Lateral Sclerosis	0.412846646323386	0	0	HPO;ORPHANET
7415	VCP	C0037772	Spastic Paraplegia	0.2	0	0	HPO
7415	VCP	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
7415	VCP	C0234958	muscle degeneration	0.2	0	0	HPO
7415	VCP	C0240679	Pelvic girdle muscle atrophy	0.2	0	0	HPO
7415	VCP	C0338451	Frontotemporal dementia	0.218406694542278	0	0	HPO
7415	VCP	C1145670	Respiratory Failure	0.2	0	0	HPO
7415	VCP	C1833662	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	0.688791257094819	8	7	CTD_human;ORPHANET;UNIPROT
7415	VCP	C1848736	Distal amyotrophy	0.2	0	0	HPO
7415	VCP	C3151403	AMYOTROPHIC LATERAL SCLEROSIS 14 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	0.2	8	4	UNIPROT
7415	VCP	C4011788	Behavioral variant of frontotemporal dementia	0.2	0	0	ORPHANET
7415	VCP	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
7415	VCP	C4020871	Dystonic disease	0.2	0	0	HPO
7415	VCP	C4020884	Anxiety disease	0.2	0	0	HPO
7415	VCP	C4021528	Pelvic girdle amyotrophy	0.2	0	0	HPO
7415	VCP	C4021584	Frontotemporal cerebral atrophy	0.2	0	0	HPO
7415	VCP	C4024936	Temporal cortical atrophy	0.2	0	0	HPO
7415	VCP	C4024956	Grammar-specific speech disorder	0.2	0	0	HPO
7415	VCP	C4225244	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y	0.4	2	2	ORPHANET;UNIPROT
7416	VDAC1	C0011881	Diabetic Nephropathy	0.2	1	0	CTD_human
7416	VDAC1	C0014544	Epilepsy	0.2	1	0	CTD_human
7416	VDAC1	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
7417	VDAC2	C0011881	Diabetic Nephropathy	0.2	1	0	CTD_human
7417	VDAC2	C0014544	Epilepsy	0.2	1	0	CTD_human
7417	VDAC2	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
7421	VDR	C0002170	Alopecia	0.412883448103381	2	0	CTD_human;HPO
7421	VDR	C0011334	Dental caries	0.200549453568426	0	0	HPO
7421	VDR	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
7421	VDR	C0014556	Epilepsy, Temporal Lobe	0.200549453568426	1	0	CTD_human
7421	VDR	C0020502	Hyperparathyroidism	0.215760062283148	0	0	HPO
7421	VDR	C0020503	Hyperparathyroidism, Secondary	0.306003142479356	0	0	HPO
7421	VDR	C0029442	Osteomalacia	0.201373633921065	0	0	HPO
7421	VDR	C0029456	Osteoporosis	0.601165951500013	0	0	CTD_human;HPO
7421	VDR	C0035579	Rickets	0.43866760657617	3	0	CTD_human;HPO
7421	VDR	C0041948	Uremia	0.204055389228567	1	0	CTD_human
7421	VDR	C0042870	Vitamin D Deficiency	0.220668342618989	1	0	CTD_human
7421	VDR	C0263505	Alopecia universalis	0.200274726784213	0	0	HPO
7421	VDR	C0342646	Vitamin D-Dependent Rickets, Type 2A	0.680274726784213	9	15	CTD_human;ORPHANET;UNIPROT
7421	VDR	C0392525	Nephrolithiasis	0.206253203502271	0	0	HPO
7421	VDR	C1855841	Hypocalcaemic seizure	0.2	0	0	HPO
7421	VDR	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7422	VEGFA	C0002395	Alzheimer's Disease	0.232949501265007	1	0	CTD_human
7422	VEGFA	C0003873	Rheumatoid Arthritis	0.226423249710147	1	0	CTD_human
7422	VEGFA	C0004096	Asthma	0.228405585382312	3	0	CTD_human
7422	VEGFA	C0004153	Atherosclerosis	0.227376776400422	1	0	CTD_human
7422	VEGFA	C0008677	Bronchitis, Chronic	0.200549453568426	1	0	CTD_human
7422	VEGFA	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
7422	VEGFA	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.263603459562017	0	0	CTD_human
7422	VEGFA	C0011881	Diabetic Nephropathy	0.22759576040699	1	0	CTD_human
7422	VEGFA	C0011884	Diabetic Retinopathy	0.293611432628947	3	0	CTD_human
7422	VEGFA	C0014556	Epilepsy, Temporal Lobe	0.2	1	0	CTD_human
7422	VEGFA	C0018801	Heart failure	0.207561324888707	2	0	CTD_human
7422	VEGFA	C0020541	Hypertension, Portal	0.201098907136852	1	0	CTD_human
7422	VEGFA	C0023890	Liver Cirrhosis	0.219042428316388	1	0	CTD_human
7422	VEGFA	C0033860	Psoriasis	0.23201842097741	1	0	CTD_human
7422	VEGFA	C0035328	Retinal Vein Occlusion	0.283007639249027	1	0	CTD_human
7422	VEGFA	C0038220	Status Epilepticus	0.2	1	0	CTD_human
7422	VEGFA	C0038358	Gastric ulcer	0.207114185634906	1	0	CTD_human
7422	VEGFA	C0085109	Corneal Neovascularization	0.205219808900049	1	0	CTD_human
7422	VEGFA	C0085605	Liver Failure	0.2	1	0	CTD_human
7422	VEGFA	C0151744	Myocardial Ischemia	0.210648832049681	5	0	CTD_human
7422	VEGFA	C0242350	Erectile dysfunction	0.200549453568426	1	0	CTD_human
7422	VEGFA	C0242383	Age related macular degeneration	0.270794606220161	1	0	CTD_human
7422	VEGFA	C0271051	Macular retinal edema	0.208161935614446	1	0	CTD_human
7422	VEGFA	C0752308	Hypoxia-Ischemia, Brain	0.2	1	0	CTD_human
7422	VEGFA	C1956346	Coronary Artery Disease	0.232010329952049	2	0	CTD_human
7424	VEGFC	C0024236	Lymphedema	0.206737144536068	0	0	HPO
7425	VGF	C0038358	Gastric ulcer	0.2	1	0	CTD_human
7428	VHL	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
7428	VHL	C0018801	Heart failure	0.2	0	0	HPO
7428	VHL	C0018802	Congestive heart failure	0.2	0	0	HPO
7428	VHL	C0019562	Von Hippel-Lindau Syndrome	0.782391691809696	17	119	CTD_human;ORPHANET;UNIPROT
7428	VHL	C0020255	Hydrocephalus	0.2	0	0	HPO
7428	VHL	C0020437	Hypercalcemia	0.2	0	0	HPO
7428	VHL	C0028738	Nystagmus	0.2	0	0	HPO
7428	VHL	C0030283	Pancreatic Cyst	0.200549453568426	0	0	HPO
7428	VHL	C0032461	Polycythemia	0.215774417660466	0	0	HPO
7428	VHL	C0037859	Spermatocele	0.200274726784213	0	0	HPO
7428	VHL	C0042345	Varicosity	0.200274726784213	0	0	HPO
7428	VHL	C0042798	Low Vision	0.2	0	0	HPO
7428	VHL	C0151313	Sensory neuropathy	0.2	0	0	HPO
7428	VHL	C0152132	Hypertensive Retinopathy	0.2	0	0	HPO
7428	VHL	C0340548	Pulmonary capillary hemangiomatosis	0.2	0	0	HPO
7428	VHL	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
7428	VHL	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
7428	VHL	C1837915	ERYTHROCYTOSIS, FAMILIAL, 2	0.68	5	11	CTD_human;ORPHANET;UNIPROT
7428	VHL	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
7428	VHL	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
7428	VHL	C4021977	Visceral angiomatosis	0.2	0	0	HPO
7430	EZR	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
7431	VIM	C0023890	Liver Cirrhosis	0.200274726784213	2	0	CTD_human
7431	VIM	C0027720	Nephrosis	0.28	1	0	CTD_human
7431	VIM	C0029408	Degenerative polyarthritis	0.2	2	0	CTD_human
7431	VIM	C0085084	Motor Neuron Disease	0.2	1	0	CTD_human
7431	VIM	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
7431	VIM	C1833118	Cataract, Pulverulent	0.2	0	0	ORPHANET
7431	VIM	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
7431	VIM	C3805411	CATARACT 30	0.2	1	1	UNIPROT
7431	VIM	C4024821	Diffuse nuclear cataract	0.2	0	0	HPO
7431	VIM	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
7432	VIP	C0013080	Down Syndrome	0.200274726784213	1	0	CTD_human
7432	VIP	C0015923	Fetal Alcohol Syndrome	0.2	1	0	PSYGENET
7432	VIP	C0035455	Rhinitis	0.2	2	0	CTD_human
7432	VIP	C0085129	Bronchial Hyperreactivity	0.2	2	0	CTD_human
7432	VIP	C0242350	Erectile dysfunction	0.2	1	0	CTD_human
7432	VIP	C1542327	Fetus or newborn affected by alcohol transmitted via placenta or breast milk	0.2	1	0	PSYGENET
7436	VLDLR	C0007789	Cerebral Palsy	0.2	0	0	HPO
7436	VLDLR	C0014544	Epilepsy	0.2	0	0	HPO
7436	VLDLR	C0028754	Obesity	0.200824180352639	1	0	CTD_human
7436	VLDLR	C0038379	Strabismus	0.2	0	0	HPO
7436	VLDLR	C0234958	muscle degeneration	0.2	0	0	HPO
7436	VLDLR	C0262404	Cerebellar degeneration	0.2	0	0	HPO
7436	VLDLR	C0271390	Nystagmus, End-Position	0.2	0	0	HPO
7436	VLDLR	C0394006	Dysequilibrium syndrome	0.401648360705279	0	0	CTD_human;ORPHANET
7436	VLDLR	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
7436	VLDLR	C4020873	Infratentorial atrophy	0.2	0	0	HPO
7438	VMD1	C1835178	MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.2	0	0	CTD_human
7439	BEST1	C0008525	Choroideremia	0.2	0	0	HPO
7439	BEST1	C0017601	Glaucoma	0.2	0	0	HPO
7439	BEST1	C0018777	Conductive hearing loss	0.2	0	0	HPO
7439	BEST1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
7439	BEST1	C0020459	Hyperinsulinism	0.2	0	0	HPO
7439	BEST1	C0020490	Hyperopia	0.2	0	0	HPO
7439	BEST1	C0020619	Hypogonadism	0.2	0	0	HPO
7439	BEST1	C0022578	Keratoconus	0.2	0	0	HPO
7439	BEST1	C0028077	Night Blindness	0.2	0	0	HPO
7439	BEST1	C0028738	Nystagmus	0.2	0	0	HPO
7439	BEST1	C0028754	Obesity	0.200274726784213	0	0	HPO
7439	BEST1	C0029124	Optic Atrophy	0.2	0	0	HPO
7439	BEST1	C0035305	Retinal Detachment	0.2	0	0	HPO
7439	BEST1	C0035334	Retinitis Pigmentosa	0.400824180352639	0	0	HPO;ORPHANET
7439	BEST1	C0038379	Strabismus	0.2	0	0	HPO
7439	BEST1	C0042798	Low Vision	0.2	0	0	HPO
7439	BEST1	C0154850	Cystoid macular retinal degeneration	0.2	0	0	HPO
7439	BEST1	C0271215	Blindness, Legal	0.2	0	0	HPO
7439	BEST1	C0339510	Vitelliform Macular Dystrophy	0.700879235600196	21	84	CTD_human;HPO;ORPHANET;UNIPROT
7439	BEST1	C0730292	Macular dystrophy	0.200274726784213	0	0	HPO
7439	BEST1	C1833118	Cataract, Pulverulent	0.2	0	0	HPO
7439	BEST1	C1842914	Adult-Onset Vitelliform Macular Dystrophy	0.201373633921065	0	0	ORPHANET
7439	BEST1	C1860406	VITREORETINOCHOROIDOPATHY (disorder)	0.602197814273705	1	6	CTD_human;ORPHANET;UNIPROT
7439	BEST1	C2750789	RETINITIS PIGMENTOSA, CONCENTRIC (disorder)	0.4	2	4	CTD_human;UNIPROT
7439	BEST1	C3888198	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE	0.684120901763197	3	10	CTD_human;ORPHANET;UNIPROT
7442	TRPV1	C0004153	Atherosclerosis	0.2	1	0	CTD_human
7442	TRPV1	C0014556	Epilepsy, Temporal Lobe	0.200274726784213	1	0	CTD_human
7442	TRPV1	C0014868	Esophagitis	0.2	1	0	CTD_human
7442	TRPV1	C0028754	Obesity	0.203231208875927	1	0	CTD_human
7442	TRPV1	C0030305	Pancreatitis	0.200274726784213	1	0	CTD_human
7443	VRK1	C0026847	Spinal Muscular Atrophy	0.200824180352639	0	0	HPO
7443	VRK1	C1843504	Pontocerebellar Hypoplasia Type 1	0.400549453568426	0	0	CTD_human;ORPHANET
7446	AVSD1	C3275750	ATRIOVENTRICULAR SEPTAL DEFECT 3	0.2	0	0	CTD_human
7447	VSNL1	C0002395	Alzheimer's Disease	0.204106546385879	1	1	CTD_human
7448	VTN	C0010346	Crohn Disease	0.2	1	0	CTD_human
7448	VTN	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
7450	VWF	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
7450	VWF	C0004238	Atrial Fibrillation	0.203557092817453	1	0	CTD_human
7450	VWF	C0018801	Heart failure	0.2	1	0	CTD_human
7450	VWF	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
7450	VWF	C0752143	Intracranial Thrombosis	0.2	1	0	CTD_human
7450	VWF	C0854242	Gastrointestinal angiodysplasia	0.200274726784213	0	0	HPO
7450	VWF	C1264039	von Willebrand Disease, Type 1	0.710429160513024	2	7	CTD_human;ORPHANET;UNIPROT
7450	VWF	C1264040	von Willebrand Disease, Type 2	0.409890164231672	29	36	CTD_human;UNIPROT
7450	VWF	C1264041	von Willebrand Disease, Type 3	0.614560519563294	3	10	CTD_human;ORPHANET;UNIPROT
7450	VWF	C1282968	von Willebrand Disease, Type 2A	0.208241803526393	0	0	ORPHANET
7450	VWF	C1282971	von Willebrand Disease, Type 2B	0.212637432073803	0	0	ORPHANET
7450	VWF	C1282974	von Willebrand disease type 2M	0.203846174978983	0	0	ORPHANET
7450	VWF	C1282975	von Willebrand Disease, Type 2N	0.206527930286485	0	0	ORPHANET
7450	VWF	C3494187	Factor VIII Deficiency	0.200824180352639	0	0	HPO
7454	WAS	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
7454	WAS	C0013595	Eczema	0.201648360705279	0	0	HPO
7454	WAS	C0024117	Chronic Obstructive Airway Disease	0.2	0	0	HPO
7454	WAS	C0024312	Lymphopenia	0.2	0	0	HPO
7454	WAS	C0031256	Petechiae	0.2	0	0	HPO
7454	WAS	C0034150	Purpura	0.2	0	0	HPO
7454	WAS	C0037199	Sinusitis	0.2	0	0	HPO
7454	WAS	C0043194	Wiskott-Aldrich Syndrome	0.773119999086109	12	13	CTD_human;ORPHANET;UNIPROT
7454	WAS	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
7454	WAS	C0271441	Chronic otitis media	0.2	0	0	HPO
7454	WAS	C0401151	Chronic diarrhea	0.2	0	0	HPO
7454	WAS	C0743359	ear infection chronic	0.2	0	0	HPO
7454	WAS	C1697453	Spontaneous haematoma	0.2	0	0	HPO
7454	WAS	C1839163	THROMBOCYTOPENIA 1 (disorder)	0.612846646323386	8	6	CTD_human;ORPHANET;UNIPROT
7454	WAS	C1845987	Neutropenia, Severe Congenital, X-Linked	0.6	2	4	CTD_human;ORPHANET;UNIPROT
7456	WIPF1	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
7456	WIPF1	C0013595	Eczema	0.2	0	0	HPO
7456	WIPF1	C0024117	Chronic Obstructive Airway Disease	0.2	0	0	HPO
7456	WIPF1	C0024312	Lymphopenia	0.2	0	0	HPO
7456	WIPF1	C0031256	Petechiae	0.2	0	0	HPO
7456	WIPF1	C0034150	Purpura	0.2	0	0	HPO
7456	WIPF1	C0037199	Sinusitis	0.2	0	0	HPO
7456	WIPF1	C0043194	Wiskott-Aldrich Syndrome	0.205480180306945	0	0	ORPHANET
7456	WIPF1	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
7456	WIPF1	C0271441	Chronic otitis media	0.2	0	0	HPO
7456	WIPF1	C0401151	Chronic diarrhea	0.2	0	0	HPO
7456	WIPF1	C0743359	ear infection chronic	0.2	0	0	HPO
7456	WIPF1	C1697453	Spontaneous haematoma	0.2	0	0	HPO
7461	CLIP2	C0003499	Supravalvular aortic stenosis	0.2	0	0	HPO
7461	CLIP2	C0007786	Brain Ischemia	0.2	0	0	HPO
7461	CLIP2	C0012819	Diverticular disease of colon	0.2	0	0	HPO
7461	CLIP2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
7461	CLIP2	C0020437	Hypercalcemia	0.2	0	0	HPO
7461	CLIP2	C0020545	Hypertension, Renovascular	0.2	0	0	HPO
7461	CLIP2	C0024421	Macroglossia	0.2	0	0	HPO
7461	CLIP2	C0024636	Malocclusion	0.2	0	0	HPO
7461	CLIP2	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
7461	CLIP2	C0028754	Obesity	0.2	0	0	HPO
7461	CLIP2	C0035078	Kidney Failure	0.2	0	0	HPO
7461	CLIP2	C0038379	Strabismus	0.2	0	0	HPO
7461	CLIP2	C0042798	Low Vision	0.2	0	0	HPO
7461	CLIP2	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
7461	CLIP2	C0175702	Williams Syndrome	0.281923087489492	0	0	ORPHANET
7461	CLIP2	C0271441	Chronic otitis media	0.2	0	0	HPO
7461	CLIP2	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
7461	CLIP2	C0743359	ear infection chronic	0.2	0	0	HPO
7461	CLIP2	C0917798	Cerebral Ischemia	0.2	0	0	HPO
7461	CLIP2	C1565489	Renal Insufficiency	0.2	0	0	HPO
7461	CLIP2	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
7461	CLIP2	C4020884	Anxiety disease	0.2	0	0	HPO
7461	CLIP2	C4025788	Nystagmus-induced head nodding	0.2	0	0	HPO
7461	CLIP2	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
7466	WFS1	C0002888	Anemia, Megaloblastic	0.2	0	0	HPO
7466	WFS1	C0002896	Sideroblastic anemia	0.2	0	0	HPO
7466	WFS1	C0005697	Neurogenic Urinary Bladder	0.2	0	0	HPO
7466	WFS1	C0011848	Diabetes Insipidus	0.202472541057918	0	0	HPO
7466	WFS1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.286868169605328	1	3	CTD_human
7466	WFS1	C0014544	Epilepsy	0.2	0	0	HPO
7466	WFS1	C0017601	Glaucoma	0.2	0	0	HPO
7466	WFS1	C0018784	Sensorineural Hearing Loss (disorder)	0.218060190871478	0	0	HPO
7466	WFS1	C0020295	Hydronephrosis	0.2	0	0	HPO
7466	WFS1	C0020676	Hypothyroidism	0.2	0	0	HPO
7466	WFS1	C0028738	Nystagmus	0.2	0	0	HPO
7466	WFS1	C0029124	Optic Atrophy	0.203846174978983	0	0	HPO
7466	WFS1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
7466	WFS1	C0043207	Wolfram Syndrome	0.74762782966356	7	32	CTD_human;ORPHANET;UNIPROT
7466	WFS1	C0151721	Testicular hypogonadism	0.2	0	0	HPO
7466	WFS1	C0156312	Atrophy of testis	0.2	0	0	HPO
7466	WFS1	C0235946	Cerebral atrophy	0.2	0	0	HPO
7466	WFS1	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
7466	WFS1	C0270921	Axonal neuropathy	0.2	0	0	HPO
7466	WFS1	C0392557	Nuclear cataract	0.4	0	0	HPO;ORPHANET
7466	WFS1	C0393525	Progressive cerebellar ataxia	0.2	0	0	HPO
7466	WFS1	C0687720	Central Diabetes Insipidus	0.200549453568426	0	0	HPO
7466	WFS1	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
7466	WFS1	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
7466	WFS1	C1833021	DEAFNESS, AUTOSOMAL DOMINANT 6	0.4	8	14	CTD_human;UNIPROT
7466	WFS1	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
7466	WFS1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
7466	WFS1	C3280358	Wolfram-Like Syndrome, Autosomal Dominant	0.4	4	3	ORPHANET;UNIPROT
7466	WFS1	C3805412	CATARACT 41	0.2	1	1	UNIPROT
7466	WFS1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
7466	WFS1	C4020884	Anxiety disease	0.2	0	0	HPO
7467	WHCR	C1956097	Wolf-Hirschhorn Syndrome	0.2	0	0	CTD_human
7468	NSD2	C0014544	Epilepsy	0.2	0	0	HPO
7468	NSD2	C0015300	Exophthalmos	0.2	0	0	HPO
7468	NSD2	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
7468	NSD2	C0028738	Nystagmus	0.2	0	0	HPO
7468	NSD2	C0029124	Optic Atrophy	0.2	0	0	HPO
7468	NSD2	C0034013	Precocious Puberty	0.2	0	0	HPO
7468	NSD2	C0038379	Strabismus	0.2	0	0	HPO
7468	NSD2	C0080218	Tethered Cord Syndrome	0.2	0	0	HPO
7468	NSD2	C0265341	Rieger syndrome	0.2	0	0	HPO
7468	NSD2	C0395837	Stenosis of external auditory canal	0.2	0	0	HPO
7468	NSD2	C1956097	Wolf-Hirschhorn Syndrome	0.484120901763197	1	0	CTD_human;ORPHANET
7468	NSD2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7469	NELFA	C0014544	Epilepsy	0.2	0	0	HPO
7469	NELFA	C0029124	Optic Atrophy	0.2	0	0	HPO
7469	NELFA	C0080218	Tethered Cord Syndrome	0.2	0	0	HPO
7469	NELFA	C1956097	Wolf-Hirschhorn Syndrome	0.200824180352639	0	0	ORPHANET
7469	NELFA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7471	WNT1	C0029456	Osteoporosis	0.400824180352639	2	2	HPO;UNIPROT
7471	WNT1	C0264080	Juvenile osteoporosis	0.2	0	0	ORPHANET
7471	WNT1	C0268362	Osteogenesis imperfecta type III (disorder)	0.200274726784213	0	0	ORPHANET
7471	WNT1	C0410550	Collapse of vertebra	0.2	0	0	HPO
7471	WNT1	C3808844	OSTEOGENESIS IMPERFECTA, TYPE XV	0.2	3	7	UNIPROT
7473	WNT3	C0020255	Hydrocephalus	0.2	0	0	HPO
7473	WNT3	C0029124	Optic Atrophy	0.2	0	0	HPO
7473	WNT3	C0040583	Tracheal Stenosis	0.2	0	0	HPO
7473	WNT3	C2931218	Tetraamelia multiple malformations	0.2	0	0	ORPHANET
7473	WNT3	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
7474	WNT5A	C0015300	Exophthalmos	0.2	0	0	HPO
7474	WNT5A	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
7474	WNT5A	C0020295	Hydronephrosis	0.2	0	0	HPO
7474	WNT5A	C0024421	Macroglossia	0.2	0	0	HPO
7474	WNT5A	C0265205	Robinow Syndrome	0.401373633921066	1	5	ORPHANET;UNIPROT
7476	WNT7A	C0409477	Ankylosis of the elbow joint	0.2	0	0	HPO
7476	WNT7A	C1834405	Nail dysplasia	0.2	0	0	HPO
7476	WNT7A	C1848651	Al Awadi syndrome	0.601648360705279	4	5	CTD_human;ORPHANET;UNIPROT
7476	WNT7A	C1856728	Fuhrmann syndrome	0.680824180352639	1	1	CTD_human;ORPHANET;UNIPROT
7476	WNT7A	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
7476	WNT7A	C2930865	Ramer Ladda syndrome	0.2	0	0	HPO
7478	WNT8A	C0004238	Atrial Fibrillation	0.200274726784213	1	1	CTD_human
7480	WNT10B	C2749665	SPLIT-HAND/FOOT MALFORMATION 6 (disorder)	0.4	1	1	CTD_human;UNIPROT
7486	WRN	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.210228724818891	0	0	HPO
7486	WRN	C0018801	Heart failure	0.2	0	0	HPO
7486	WRN	C0018802	Congestive heart failure	0.2	0	0	HPO
7486	WRN	C0020619	Hypogonadism	0.2	0	0	HPO
7486	WRN	C0027051	Myocardial Infarction	0.204814057046576	0	0	HPO
7486	WRN	C0029456	Osteoporosis	0.200274726784213	0	0	HPO
7486	WRN	C0029464	Osteosclerosis	0.2	0	0	HPO
7486	WRN	C0043119	Werner Syndrome	0.742652210119685	3	20	CTD_human;ORPHANET;UNIPROT
7486	WRN	C0231341	Premature aging syndrome	0.211813251721163	1	0	CTD_human
7486	WRN	C0234958	muscle degeneration	0.2	0	0	HPO
7486	WRN	C0263625	Subcutaneous calcification	0.2	0	0	HPO
7486	WRN	C0553730	Calcium pyrophosphate deposition disease	0.2	0	0	HPO
7486	WRN	C0870082	Hyperkeratosis	0.2	0	0	HPO
7486	WRN	C1280433	Lipoatrophy	0.2	0	0	HPO
7486	WRN	C1848486	Premature arteriosclerosis	0.2	0	0	HPO
7486	WRN	C4280503	Premature hardening of arteries	0.2	0	0	HPO
7488	WS2B	C1838447	WAARDENBURG SYNDROME, TYPE 2B (disorder)	0.2	0	0	CTD_human
7489	WSN	C0796195	Waisman syndrome	0.200549453568426	0	0	CTD_human
7490	WT1	C0017601	Glaucoma	0.2	0	0	HPO
7490	WT1	C0017658	Glomerulonephritis	0.202732912464814	1	0	CTD_human
7490	WT1	C0017668	Focal glomerulosclerosis	0.208645876648242	0	0	HPO
7490	WT1	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
7490	WT1	C0028738	Nystagmus	0.2	0	0	HPO
7490	WT1	C0035078	Kidney Failure	0.200549453568426	0	0	HPO
7490	WT1	C0042798	Low Vision	0.2	0	0	HPO
7490	WT1	C0085215	Ovarian Failure, Premature	0.200274726784213	1	0	CTD_human
7490	WT1	C0206115	WAGR Syndrome	0.405978476718058	0	0	CTD_human;ORPHANET
7490	WT1	C0232939	Primary physiologic amenorrhea	0.200274726784213	0	0	HPO
7490	WT1	C0268747	Diffuse mesangial sclerosis (disorder)	0.202956482091714	0	0	HPO
7490	WT1	C0520743	Mediastinal lymphadenopathy	0.2	0	0	HPO
7490	WT1	C0950121	Denys-Drash Syndrome	0.693107017730282	17	11	CTD_human;ORPHANET;UNIPROT
7490	WT1	C0950122	Frasier Syndrome	0.60767799458065	1	5	CTD_human;ORPHANET;UNIPROT
7490	WT1	C1258215	Ileus	0.2	0	0	HPO
7490	WT1	C1565489	Renal Insufficiency	0.200274726784213	0	0	HPO
7490	WT1	C1837026	MEACHAM SYNDROME (disorder)	0.4	0	0	ORPHANET;UNIPROT
7490	WT1	C1855496	Contiguous gene syndrome	0.2	0	0	HPO
7490	WT1	C2316810	Chronic kidney disease stage 5	0.200549453568426	0	0	HPO
7490	WT1	C2931752	Meacham Winn Culler syndrome	0.2	0	0	CTD_human
7490	WT1	C2931803	Deletion 11p13	0.2	0	0	ORPHANET
7490	WT1	C3151568	NEPHROTIC SYNDROME, TYPE 4	0.4	4	0	CTD_human;UNIPROT
7491	WT2	C1853800	Familial Wilms tumor 2	0.2	0	0	CTD_human
7494	XBP1	C0015695	Fatty Liver	0.200549453568426	1	0	CTD_human
7494	XBP1	C0400966	Non-alcoholic Fatty Liver Disease	0.200549453568426	1	0	CTD_human
7498	XDH	C0018801	Heart failure	0.200549453568426	1	0	CTD_human
7498	XDH	C0020295	Hydronephrosis	0.2	0	0	HPO
7498	XDH	C0034065	Pulmonary Embolism	0.2	1	0	CTD_human
7498	XDH	C0034186	Pyelonephritis	0.2	0	0	HPO
7498	XDH	C0220988	Xanthinuria	0.201098907136852	0	0	HPO
7498	XDH	C0268118	Xanthinuria, Type I	0.601923087489492	1	2	CTD_human;HPO;ORPHANET;UNIPROT
7498	XDH	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
7503	XIST	C0021400	Influenza	0.2	1	0	CTD_human
7504	XK	C0234533	Generalized seizures	0.2	0	0	HPO
7504	XK	C0393576	Chorea Acanthocytosis Syndrome	0.200824180352639	2	0	CTD_human
7504	XK	C0398568	Blood group deletion syndrome	0.404814057046576	3	3	ORPHANET;UNIPROT
7504	XK	C0687751	Acanthocytosis	0.200549453568426	0	0	HPO
7507	XPA	C0009763	Conjunctivitis	0.2	0	0	HPO
7507	XPA	C0013592	Ectropion	0.2	0	0	HPO
7507	XPA	C0014390	Entropion	0.2	0	0	HPO
7507	XPA	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
7507	XPA	C0020619	Hypogonadism	0.2	0	0	HPO
7507	XPA	C0022568	Keratitis	0.2	0	0	HPO
7507	XPA	C0029124	Optic Atrophy	0.2	0	0	HPO
7507	XPA	C0038379	Strabismus	0.2	0	0	HPO
7507	XPA	C0039446	Telangiectasis	0.2	0	0	HPO
7507	XPA	C0085583	Choreoathetosis	0.2	0	0	HPO
7507	XPA	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
7507	XPA	C0259817	Xerosis	0.2	0	0	HPO
7507	XPA	C0268135	Xeroderma pigmentosum, group A	0.216758333836999	4	9	UNIPROT
7507	XPA	C0392777	Poikiloderma	0.2	0	0	HPO
7507	XPA	C0870082	Hyperkeratosis	0.2	0	0	HPO
7507	XPA	C1836830	Developmental regression	0.2	0	0	HPO
7507	XPA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7508	XPC	C0009763	Conjunctivitis	0.2	0	0	HPO
7508	XPC	C0013592	Ectropion	0.2	0	0	HPO
7508	XPC	C0014390	Entropion	0.2	0	0	HPO
7508	XPC	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
7508	XPC	C0020619	Hypogonadism	0.2	0	0	HPO
7508	XPC	C0022568	Keratitis	0.2	0	0	HPO
7508	XPC	C0029124	Optic Atrophy	0.2	0	0	HPO
7508	XPC	C0038379	Strabismus	0.2	0	0	HPO
7508	XPC	C0039446	Telangiectasis	0.2	0	0	HPO
7508	XPC	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
7508	XPC	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
7508	XPC	C0259817	Xerosis	0.2	0	0	HPO
7508	XPC	C0392777	Poikiloderma	0.2	0	0	HPO
7508	XPC	C0870082	Hyperkeratosis	0.2	0	0	HPO
7508	XPC	C1836830	Developmental regression	0.2	0	0	HPO
7508	XPC	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7512	XPNPEP2	C0085215	Ovarian Failure, Premature	0.200274726784213	1	0	CTD_human
7515	XRCC1	C0038362	Stomatitis	0.200549453568426	1	0	CTD_human
7516	XRCC2	C0015625	Fanconi Anemia	0.200549453568426	0	0	ORPHANET
7516	XRCC2	C0023530	Leukopenia	0.2	0	0	HPO
7516	XRCC2	C0272027	Pyridoxine-responsive sideroblastic anemia	0.2	0	0	HPO
751798	AUNX1	C1845095	DEAFNESS, X-LINKED 5 (disorder)	0.2	0	0	CTD_human
7518	XRCC4	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
7518	XRCC4	C0014306	Enophthalmos	0.2	0	0	HPO
7518	XRCC4	C0020676	Hypothyroidism	0.2	0	0	HPO
7518	XRCC4	C0024312	Lymphopenia	0.2	0	0	HPO
7518	XRCC4	C0028738	Nystagmus	0.2	0	0	HPO
7518	XRCC4	C0030312	Pancytopenia	0.2	0	0	HPO
7518	XRCC4	C0085110	Severe Combined Immunodeficiency	0.200274726784213	0	0	HPO
7518	XRCC4	C0151313	Sensory neuropathy	0.2	0	0	HPO
7518	XRCC4	C0854110	Insulin resistant diabetes	0.2	0	0	HPO
7518	XRCC4	C1847827	LIG4 Syndrome	0.2	0	0	ORPHANET
7518	XRCC4	C1860105	Severe short-limb dwarfism	0.2	0	0	HPO
7518	XRCC4	C2711227	Steatohepatitis	0.2	0	0	HPO
7518	XRCC4	C4225288	SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION	0.2	2	9	UNIPROT
7531	YWHAE	C0014544	Epilepsy	0.2	0	0	HPO
7531	YWHAE	C0235946	Cerebral atrophy	0.2	0	0	HPO
7531	YWHAE	C0265219	Miller Dieker syndrome	0.282472541057918	0	0	ORPHANET
7531	YWHAE	C1955870	Classical Lissencephalies and Subcortical Band Heterotopias	0.2	0	0	CTD_human
7531	YWHAE	C3808300	CHROMOSOME 17p13.3, CENTROMERIC, DUPLICATION SYNDROME	0.2	0	0	ORPHANET
7535	ZAP70	C0013595	Eczema	0.200274726784213	0	0	HPO
7535	ZAP70	C0032285	Pneumonia	0.2	0	0	HPO
7535	ZAP70	C0085110	Severe Combined Immunodeficiency	0.203021994626344	1	0	CTD_human
7535	ZAP70	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7535	ZAP70	C2931299	ZAP70 deficiency	0.400549453568426	4	3	ORPHANET;UNIPROT
7535	ZAP70	C2931320	T cell immunodeficiency primary	0.2	1	0	CTD_human
7538	ZFP36	C0002170	Alopecia	0.2	1	0	CTD_human
7538	ZFP36	C0003864	Arthritis	0.201373633921065	1	0	CTD_human
7538	ZFP36	C0011603	Dermatitis	0.200274726784213	1	0	CTD_human
7538	ZFP36	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
7545	ZIC1	C0010278	Craniosynostosis	0.200274726784213	0	0	HPO
7545	ZIC1	C0015300	Exophthalmos	0.2	0	0	HPO
7545	ZIC1	C0030353	Papilledema	0.2	0	0	HPO
7545	ZIC1	C0038379	Strabismus	0.2	0	0	HPO
7545	ZIC1	C0151740	Intracranial Hypertension	0.2	0	0	HPO
7545	ZIC1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
7545	ZIC1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
7545	ZIC1	C1856266	Coronal craniosynostosis	0.200274726784213	0	0	HPO
7545	ZIC1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
7545	ZIC1	C4225269	CRANIOSYNOSTOSIS 6	0.2	1	4	UNIPROT
7546	ZIC2	C0020255	Hydrocephalus	0.2	0	0	HPO
7546	ZIC2	C1864827	HOLOPROSENCEPHALY 5	0.48	2	5	CTD_human;UNIPROT
7547	ZIC3	C0020255	Hydrocephalus	0.2	0	0	HPO
7547	ZIC3	C0020295	Hydronephrosis	0.2	0	0	HPO
7547	ZIC3	C1838608	Radial aplasia	0.2	0	0	HPO
7547	ZIC3	C1844020	HETEROTAXY, VISCERAL, 1, X-LINKED	0.480274726784213	7	11	CTD_human;UNIPROT
7547	ZIC3	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
7547	ZIC3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7547	ZIC3	C2931228	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS	0.2	1	1	UNIPROT
755	C21orf2	C0002736	Amyotrophic Lateral Sclerosis	0.2	1	0	CTD_human
7552	ZNF711	C1136249	Mental Retardation, X-Linked	0.200274726784213	1	0	CTD_human
7555	CNBP	C0020619	Hypogonadism	0.2	0	0	HPO
7555	CNBP	C0027126	Myotonic Dystrophy	0.210858046299264	0	0	CTD_human
7555	CNBP	C0028960	Oligospermia	0.2	0	0	HPO
7555	CNBP	C0162539	IgG Deficiency	0.2	0	0	HPO
7555	CNBP	C2931689	Dystrophia myotonica 2	0.212637432073803	0	0	ORPHANET
7555	CNBP	C4083212	Alopecia, Male Pattern	0.2	0	0	HPO
759	CA1	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
7592	ZNF41	C1136249	Mental Retardation, X-Linked	0.200549453568426	1	0	CTD_human
760	CA2	C0002871	Anemia	0.2	0	0	HPO
760	CA2	C0011334	Dental caries	0.2	0	0	HPO
760	CA2	C0011989	Camurati-Engelmann Syndrome	0.2	0	0	HPO
760	CA2	C0024636	Malocclusion	0.2	0	0	HPO
760	CA2	C0029454	Osteopetrosis	0.203021994626344	0	0	HPO
760	CA2	C0029456	Osteoporosis	0.202407028523288	1	0	CTD_human
760	CA2	C0345407	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3	0.682197814273705	1	4	CTD_human;ORPHANET;UNIPROT
760	CA2	C1704380	Distal Renal Tubular Acidosis	0.200274726784213	0	0	HPO
760	CA2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
760	CA2	C2613439	Extramedullary Hematopoiesis (disorder)	0.2	0	0	HPO
760	CA2	C4021553	Periodic hypokalemic paresis	0.2	0	0	HPO
760	CA2	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
761	CA3	C0028754	Obesity	0.2	1	0	CTD_human
761	CA3	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
762	CA4	C0017601	Glaucoma	0.2	0	0	HPO
762	CA4	C0018777	Conductive hearing loss	0.2	0	0	HPO
762	CA4	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
762	CA4	C0020459	Hyperinsulinism	0.2	0	0	HPO
762	CA4	C0020619	Hypogonadism	0.2	0	0	HPO
762	CA4	C0022578	Keratoconus	0.2	0	0	HPO
762	CA4	C0028738	Nystagmus	0.2	0	0	HPO
762	CA4	C0028754	Obesity	0.2	0	0	HPO
762	CA4	C0029124	Optic Atrophy	0.2	0	0	HPO
762	CA4	C0035334	Retinitis Pigmentosa	0.407388912419119	0	0	HPO;ORPHANET
762	CA4	C0271215	Blindness, Legal	0.2	0	0	HPO
762	CA4	C1833245	Retinitis Pigmentosa 17	0.401098907136852	3	3	CTD_human;UNIPROT
763	CA5A	C0020615	Hypoglycemia	0.2	0	0	HPO
763	CA5A	C3810404	CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.4	1	2	ORPHANET;UNIPROT
767	CA8	C0007789	Cerebral Palsy	0.2	0	0	HPO
767	CA8	C0014544	Epilepsy	0.2	0	0	HPO
767	CA8	C0038379	Strabismus	0.2	0	0	HPO
767	CA8	C0234958	muscle degeneration	0.2	0	0	HPO
767	CA8	C0394006	Dysequilibrium syndrome	0.200274726784213	0	0	ORPHANET
767	CA8	C2750509	Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 3	0.4	1	2	CTD_human;UNIPROT
7681	MKRN3	C0020459	Hyperinsulinism	0.2	0	0	HPO
7681	MKRN3	C0020490	Hyperopia	0.2	0	0	HPO
7681	MKRN3	C0028754	Obesity	0.2	0	0	HPO
7681	MKRN3	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
7681	MKRN3	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
7681	MKRN3	C0342543	Precocious Puberty, Central	0.203021994626344	1	0	CTD_human
7681	MKRN3	C0342544	Idiopathic central precocious puberty	0.200549453568426	0	0	ORPHANET
7681	MKRN3	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
7681	MKRN3	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
7681	MKRN3	C3809199	PRECOCIOUS PUBERTY, CENTRAL, 2	0.2	4	5	UNIPROT
768206	PRCD	C0035334	Retinitis Pigmentosa	0.201373633921065	0	0	ORPHANET
768206	PRCD	C1864621	RETINITIS PIGMENTOSA 36	0.4	1	3	CTD_human;UNIPROT
7700	ZNF141	C3808889	POLYDACTYLY, POSTAXIAL, TYPE A6	0.2	1	1	UNIPROT
7704	ZBTB16	C0038379	Strabismus	0.2	0	0	HPO
7704	ZBTB16	C2676231	Skeletal Defects, Genital Hypoplasia, And Mental Retardation	0.4	1	1	CTD_human;UNIPROT
771	CA12	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
772	CACD	C0344297	Choroidal sclerosis	0.2	0	0	CTD_human
773	CACNA1A	C0014553	Absence Epilepsy	0.281373633921066	1	0	CTD_human
773	CACNA1A	C0028738	Nystagmus	0.203296721410557	0	0	HPO
773	CACNA1A	C0087012	Ataxia, Spinocerebellar	0.230421217429444	2	0	CTD_human
773	CACNA1A	C0151313	Sensory neuropathy	0.2	0	0	HPO
773	CACNA1A	C0154723	Migraine with Aura	0.216309515851574	0	0	HPO
773	CACNA1A	C0206368	Exfoliation Syndrome	0.200274726784213	1	1	CTD_human
773	CACNA1A	C0262404	Cerebellar degeneration	0.200549453568426	0	0	HPO
773	CACNA1A	C0271390	Nystagmus, End-Position	0.2	0	0	HPO
773	CACNA1A	C0338488	Alternating hemiplegia of childhood	0.200274726784213	0	0	ORPHANET
773	CACNA1A	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
773	CACNA1A	C0393525	Progressive cerebellar ataxia	0.202197814273705	0	0	HPO
773	CACNA1A	C0740279	Atrophy of cerebellum	0.202747267842131	0	0	HPO
773	CACNA1A	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
773	CACNA1A	C0752124	Spinocerebellar Ataxia Type 6 (disorder)	0.49586864094973	2	6	ORPHANET;UNIPROT
773	CACNA1A	C1720189	Episodic Ataxia	0.206593442821114	0	0	HPO
773	CACNA1A	C1720416	Episodic ataxia type 2 (disorder)	0.697242274870795	13	33	CTD_human;ORPHANET;UNIPROT
773	CACNA1A	C1832884	Hemiplegic migraine, familial type 1	0.49153852493695	9	15	CTD_human;UNIPROT
773	CACNA1A	C4020871	Dystonic disease	0.2	0	0	HPO
773	CACNA1A	C4020873	Infratentorial atrophy	0.2	0	0	HPO
773	CACNA1A	C4020884	Anxiety disease	0.2	0	0	HPO
7737	RNF113A	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
7737	RNF113A	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
7737	RNF113A	C0263401	Cutis marmorata	0.2	0	0	HPO
7737	RNF113A	C0263490	Brittle hair	0.2	0	0	HPO
7737	RNF113A	C0401151	Chronic diarrhea	0.2	0	0	HPO
7737	RNF113A	C1955934	Trichothiodystrophy Syndromes	0.200274726784213	0	0	ORPHANET
774	CACNA1B	C0154676	Organic writer's cramp	0.2	0	0	HPO
774	CACNA1B	C3538999	DYSTONIA 23	0.2	1	1	UNIPROT
775	CACNA1C	C0004238	Atrial Fibrillation	0.200274726784213	0	0	HPO
775	CACNA1C	C0020615	Hypoglycemia	0.2	1	0	CTD_human
775	CACNA1C	C0085612	Ventricular arrhythmia	0.2	0	0	HPO
775	CACNA1C	C1142166	Brugada Syndrome (disorder)	0.204106546385879	0	0	ORPHANET
775	CACNA1C	C1832916	Timothy syndrome	0.684945082115836	6	5	CTD_human;ORPHANET;UNIPROT
775	CACNA1C	C2678478	Brugada Syndrome 3	0.4	1	2	CTD_human;UNIPROT
7755	ZNF205	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
776	CACNA1D	C0007789	Cerebral Palsy	0.200274726784213	0	0	HPO
776	CACNA1D	C0020428	Hyperaldosteronism	0.400274726784213	1	0	CTD_human;HPO
776	CACNA1D	C0037772	Spastic Paraplegia	0.2	0	0	HPO
776	CACNA1D	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
776	CACNA1D	C0149958	Complex partial seizures	0.2	0	0	HPO
776	CACNA1D	C0155320	Blindness, Cortical	0.2	0	0	HPO
776	CACNA1D	C0220983	Metabolic alkalosis	0.2	0	0	HPO
776	CACNA1D	C0264906	Second degree atrioventricular block	0.2	0	0	HPO
776	CACNA1D	C0270834	Complex partial seizure with impairment of consciousness	0.2	0	0	HPO
776	CACNA1D	C0340279	Ventricular hypertrophy	0.2	0	0	HPO
776	CACNA1D	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
776	CACNA1D	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
776	CACNA1D	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
776	CACNA1D	C3554018	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS	0.200274726784213	0	0	ORPHANET
776	CACNA1D	C3809609	PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.400549453568426	1	2	ORPHANET;UNIPROT
776	CACNA1D	C4023501	Focal myoclonic seizures	0.2	0	0	HPO
777642	RP34	C1845104	RETINITIS PIGMENTOSA 34 (disorder)	0.2	0	0	CTD_human
777643	GLC1M	C1864653	GLAUCOMA 1, OPEN ANGLE, M (disorder)	0.200274726784213	0	0	CTD_human
777645	GLC1N	C1969812	GLAUCOMA 1, OPEN ANGLE, N (disorder)	0.2	0	0	CTD_human
777778	OPA6	C1850281	OPTIC ATROPHY 6 (disorder)	0.2	0	0	CTD_human
778	CACNA1F	C0004106	Astigmatism	0.200274726784213	0	0	HPO
778	CACNA1F	C0027092	Myopia	0.200274726784213	0	0	HPO
778	CACNA1F	C0028077	Night Blindness	0.211155219486155	0	0	HPO
778	CACNA1F	C0028738	Nystagmus	0.200549453568426	0	0	HPO
778	CACNA1F	C0035334	Retinitis Pigmentosa	0.400824180352639	0	0	HPO;ORPHANET
778	CACNA1F	C0042798	Low Vision	0.2	0	0	HPO
778	CACNA1F	C0268505	Ocular albinism, type II	0.601648360705279	1	1	CTD_human;ORPHANET;UNIPROT
778	CACNA1F	C0271183	Severe myopia	0.2	0	0	HPO
778	CACNA1F	C0730290	Cone dystrophy	0.2	0	0	HPO
778	CACNA1F	C1301509	Severe visual impairment	0.2	0	0	HPO
778	CACNA1F	C1845407	CONE-ROD DYSTROPHY, X-LINKED, 3	0.200274726784213	0	0	CTD_human
778	CACNA1F	C1848172	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	0.285219808900049	5	10	UNIPROT
778	CACNA1F	C3551052	Night blindness, stationary	0.2	0	0	HPO
778	CACNA1F	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
7780	SLC30A2	C0013595	Eczema	0.2	0	0	HPO
7780	SLC30A2	C1842486	Zinc Deficiency, Neonatal, due to Low Breast Milk Zinc	0.200549453568426	2	2	UNIPROT
7782	SLC30A4	C0002395	Alzheimer's Disease	0.202732912464814	1	0	CTD_human
779	CACNA1S	C0018213	Graves Disease	0.2	0	0	HPO
779	CACNA1S	C0024591	Malignant hyperpyrexia due to anesthesia	0.211667871274586	0	0	ORPHANET
779	CACNA1S	C0028754	Obesity	0.2	0	0	HPO
779	CACNA1S	C0034372	Quadriplegia	0.2	0	0	HPO
779	CACNA1S	C0154141	Thyrotoxicosis with toxic single thyroid nodule	0.2	0	0	HPO
779	CACNA1S	C0154143	Toxic multinodular goiter	0.2	0	0	HPO
779	CACNA1S	C0238357	Hyperkalemic periodic paralysis	0.2	0	0	HPO
779	CACNA1S	C0238358	Hypokalemic periodic paralysis	0.417264721273474	2	1	CTD_human;ORPHANET
779	CACNA1S	C0268446	Thyrotoxic periodic paralysis	0.202956482091714	0	0	ORPHANET
779	CACNA1S	C3714580	Hypokalemic periodic paralysis type 1	0.484670355331623	5	8	CTD_human;UNIPROT
779	CACNA1S	C4021553	Periodic hypokalemic paresis	0.2	0	0	HPO
7792	CCV	C1861833	CATARACT, CONGENITAL, VOLKMANN TYPE	0.2	0	0	CTD_human
7804	LRP8	C0027051	Myocardial Infarction	0.206462417751855	0	0	CTD_human
7805	LAPTM5	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
780851	SNORD3A	C0022336	Creutzfeldt-Jakob disease	0.2	1	0	CTD_human
780895	DUPC1	C0013312	Dupuytren Contracture	0.2	0	0	CTD_human
780897	HPP1	C1840392	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE	0.2	0	0	CTD_human
780898	APMR1	C1859878	Alopecia-Mental Retardation Syndrome 1	0.2	0	0	CTD_human
7809	BSND	C0018784	Sensorineural Hearing Loss (disorder)	0.201923087489492	0	0	HPO
7809	BSND	C0020305	Hydrops Fetalis	0.2	0	0	HPO
7809	BSND	C0020428	Hyperaldosteronism	0.2	0	0	HPO
7809	BSND	C0035078	Kidney Failure	0.200824180352639	0	0	HPO
7809	BSND	C0085680	Hypochloremia (disorder)	0.2	0	0	HPO
7809	BSND	C0740896	Hypokalemic hypochloremic metabolic alkalosis	0.2	0	0	HPO
7809	BSND	C1565489	Renal Insufficiency	0.200274726784213	0	0	HPO
7809	BSND	C1865270	BARTTER SYNDROME, TYPE 4A	0.480274726784213	3	6	CTD_human;UNIPROT
7809	BSND	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7809	BSND	C3671887	Sodium concentration in urine above normal	0.2	0	0	HPO
780900	FGS5	C1845119	FG SYNDROME 5 (disorder)	0.2	0	0	CTD_human
780901	NYS5	C1845116	Nystagmus 5, Infantile Periodic Alternating	0.2	0	0	CTD_human
780903	HHT3	C1832774	Osler-rendu-weber syndrome 3	0.2	0	0	CTD_human
780904	PSS	C1832588	Chromosome 11p11.2 Deletion Syndrome	0.200274726784213	0	0	CTD_human
780905	EA3	C1847839	Episodic Ataxia, Type 3	0.2	0	0	CTD_human
780906	SLI3	C1846719	SPECIFIC LANGUAGE IMPAIRMENT 3	0.2	0	0	CTD_human
780910	PPR2	C1835967	PHOTOPAROXYSMAL RESPONSE 2	0.2	0	0	CTD_human
780912	AD10	C0002395	Alzheimer's Disease	0.200274726784213	0	0	CTD_human
780912	AD10	C1864828	ALZHEIMER DISEASE 10	0.2	0	0	CTD_human
780913	EIG4	C0270850	Idiopathic generalized epilepsy	0.2	0	0	CTD_human
780914	ZD1	C1853294	Zygodactyly 1	0.2	0	0	CTD_human
780915	CHNG3	C2940785	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3	0.200274726784213	0	0	CTD_human
780916	GINGF3	C1864960	Fibromatosis, gingival, 3	0.2	0	0	CTD_human
780917	NKCD	C1864947	Natural Killer Cell Deficiency, Familial Isolated	0.2	0	0	CTD_human
780919	HRPT3	C1864729	HYPERPARATHYROIDISM 3	0.2	0	0	CTD_human
780921	KYPSC1	C1857795	Kyphoscoliosis 1	0.2	0	0	CTD_human
780922	SPD3	C1853255	Synpolydactyly 3	0.200274726784213	0	0	CTD_human
780923	IHPS2	C1853228	Pyloric Stenosis, Infantile Hypertrophic, 2	0.2	0	0	CTD_human
780925	CHMRQ	C2750234	Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 2	0.2	0	0	CTD_human
781	CACNA2D1	C1142166	Brugada Syndrome (disorder)	0.203007639249027	0	0	ORPHANET
781	CACNA2D1	C1865020	Short QT Syndrome 1	0.2	0	0	ORPHANET
7827	NPHS2	C0017668	Focal glomerulosclerosis	0.429328574644548	1	0	CTD_human;HPO
7827	NPHS2	C0020473	Hyperlipidemia	0.2	0	0	HPO
7827	NPHS2	C0027720	Nephrosis	0.203231208875927	1	0	CTD_human
7827	NPHS2	C0239981	Hypoalbuminemia	0.2	0	0	HPO
7827	NPHS2	C1868672	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	0.200274726784213	2	28	CTD_human
7827	NPHS2	C2316810	Chronic kidney disease stage 5	0.202472541057918	0	0	HPO
7827	NPHS2	C3496337	Idiopathic Nephrotic Syndrome	0.281923087489492	10	17	UNIPROT
783	CACNB2	C0004238	Atrial Fibrillation	0.200274726784213	0	0	HPO
783	CACNB2	C1142166	Brugada Syndrome (disorder)	0.202732912464814	0	0	ORPHANET
783	CACNB2	C2678477	Brugada Syndrome 4	0.4	1	2	CTD_human;UNIPROT
7830	PHA2A	C0033805	Pseudohypoaldosteronism	0.2	0	0	CTD_human
7832	BTG2	C0263454	Chloracne	0.2	1	0	CTD_human
7837	PXDN	C1853235	Sclerocornea	0.2	0	0	HPO
7837	PXDN	C3151617	CORNEAL OPACIFICATION WITH OTHER OCULAR ANOMALIES	0.48	1	1	ORPHANET;UNIPROT
784	CACNB3	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
7840	ALMS1	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
7840	ALMS1	C0002170	Alopecia	0.2	0	0	HPO
7840	ALMS1	C0004096	Asthma	0.2	0	0	HPO
7840	ALMS1	C0004153	Atherosclerosis	0.2	0	0	HPO
7840	ALMS1	C0011848	Diabetes Insipidus	0.2	0	0	HPO
7840	ALMS1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.201373633921065	0	0	HPO
7840	ALMS1	C0017574	Gingivitis	0.2	0	0	HPO
7840	ALMS1	C0018418	Gynecomastia	0.2	0	0	HPO
7840	ALMS1	C0018801	Heart failure	0.2	0	0	HPO
7840	ALMS1	C0018802	Congestive heart failure	0.2	0	0	HPO
7840	ALMS1	C0020459	Hyperinsulinism	0.200274726784213	0	0	HPO
7840	ALMS1	C0020494	Hyperostosis Frontalis Interna	0.2	0	0	HPO
7840	ALMS1	C0020676	Hypothyroidism	0.2	0	0	HPO
7840	ALMS1	C0027697	Nephritis	0.2	0	0	HPO
7840	ALMS1	C0028738	Nystagmus	0.2	0	0	HPO
7840	ALMS1	C0029882	Otitis Media	0.2	0	0	HPO
7840	ALMS1	C0035078	Kidney Failure	0.2	0	0	HPO
7840	ALMS1	C0035334	Retinitis Pigmentosa	0.200549453568426	0	0	HPO
7840	ALMS1	C0041349	Nephritis, Tubulointerstitial	0.2	0	0	HPO
7840	ALMS1	C0268425	Alstrom Syndrome	0.490374105265468	1	20	CTD_human;ORPHANET
7840	ALMS1	C0271215	Blindness, Legal	0.2	0	0	HPO
7840	ALMS1	C0271441	Chronic otitis media	0.2	0	0	HPO
7840	ALMS1	C0342208	Multinodular goiter	0.2	0	0	HPO
7840	ALMS1	C0473527	Hypoalphalipoproteinemias	0.2	0	0	HPO
7840	ALMS1	C0520463	Chronic active hepatitis	0.2	0	0	HPO
7840	ALMS1	C0694550	Recurrent pneumonia	0.2	0	0	HPO
7840	ALMS1	C0730290	Cone dystrophy	0.2	0	0	HPO
7840	ALMS1	C0740394	Hyperuricemia	0.2	0	0	HPO
7840	ALMS1	C0743359	ear infection chronic	0.2	0	0	HPO
7840	ALMS1	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
7840	ALMS1	C0854110	Insulin resistant diabetes	0.2	0	0	HPO
7840	ALMS1	C0948896	Primary hypogonadism	0.2	0	0	HPO
7840	ALMS1	C1565489	Renal Insufficiency	0.2	0	0	HPO
7840	ALMS1	C1843156	Hearing loss, progressive sensorineural	0.2	0	0	HPO
7840	ALMS1	C2711227	Steatohepatitis	0.2	0	0	HPO
7840	ALMS1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
7840	ALMS1	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
7840	ALMS1	C3714497	Reactive airway disease	0.2	0	0	HPO
7840	ALMS1	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
7840	ALMS1	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
7841	MOGS	C0014544	Epilepsy	0.2	0	0	HPO
7841	MOGS	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
7841	MOGS	C0029124	Optic Atrophy	0.2	0	0	HPO
7841	MOGS	C0085605	Liver Failure	0.2	0	0	HPO
7841	MOGS	C0086438	Hypogammaglobulinemia	0.200274726784213	0	0	HPO
7841	MOGS	C0235946	Cerebral atrophy	0.2	0	0	HPO
7841	MOGS	C1853736	Congenital Disorder Of Glycosylation, Type IIB	0.600549453568426	1	4	CTD_human;ORPHANET;UNIPROT
7841	MOGS	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
7841	MOGS	C4020860	Supratentorial atrophy	0.2	0	0	HPO
7844	RNF103	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
7846	TUBA1A	C0014544	Epilepsy	0.200274726784213	0	0	HPO
7846	TUBA1A	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
7846	TUBA1A	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
7846	TUBA1A	C1969029	Lissencephaly 3	0.6	1	28	CTD_human;ORPHANET;UNIPROT
7849	PAX8	C0020676	Hypothyroidism	0.204106546385879	0	0	HPO
7849	PAX8	C0024421	Macroglossia	0.2	0	0	HPO
7849	PAX8	C0151516	Thyroid Hypoplasia	0.403021994626344	0	0	HPO;ORPHANET
7849	PAX8	C0259817	Xerosis	0.2	0	0	HPO
7849	PAX8	C0917799	Hypersomnia	0.2	0	0	HPO
785	CACNB4	C0014548	Epilepsy, Generalized	0.2	1	0	CTD_human
785	CACNB4	C0270850	Idiopathic generalized epilepsy	0.200274726784213	0	0	CTD_human
785	CACNB4	C0270853	Myoclonic Epilepsy, Juvenile	0.400274726784213	1	0	CTD_human;ORPHANET
785	CACNB4	C0271390	Nystagmus, End-Position	0.2	0	0	HPO
785	CACNB4	C1720189	Episodic Ataxia	0.200274726784213	0	0	HPO
785	CACNB4	C1866039	EPISODIC ATAXIA, TYPE 5	0.6	1	1	CTD_human;ORPHANET;UNIPROT
7850	IL1R2	C0009324	Ulcerative Colitis	0.200274726784213	1	0	CTD_human
7850	IL1R2	C0032285	Pneumonia	0.2	1	0	CTD_human
7850	IL1R2	C0038013	Ankylosing spondylitis	0.200549453568426	1	0	CTD_human
7850	IL1R2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
7852	CXCR4	C0003873	Rheumatoid Arthritis	0.211524169559633	1	0	CTD_human
7852	CXCR4	C0162539	IgG Deficiency	0.2	0	0	HPO
7852	CXCR4	C0472817	WHIM syndrome	0.489615437447459	1	4	CTD_human;ORPHANET
7852	CXCR4	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
7852	CXCR4	C3495559	Juvenile arthritis	0.201098907136852	2	0	CTD_human
7871	SLMAP	C1142166	Brugada Syndrome (disorder)	0.200274726784213	0	0	ORPHANET
7879	RAB7A	C0085684	Foot-drop	0.2	0	0	HPO
7879	RAB7A	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
7879	RAB7A	C1833219	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)	0.603296721410557	1	4	CTD_human;ORPHANET;UNIPROT
7879	RAB7A	C1848736	Distal amyotrophy	0.2	0	0	HPO
7879	RAB7A	C4025619	Peripheral axonal atrophy	0.2	0	0	HPO
7879	RAB7A	C4025737	Osteomyelitis or necrosis, distal, due to sensory neuropathy (feet)	0.2	0	0	HPO
788	SLC25A20	C0004245	Atrioventricular Block	0.2	0	0	HPO
788	SLC25A20	C0014544	Epilepsy	0.2	0	0	HPO
788	SLC25A20	C0020615	Hypoglycemia	0.2	0	0	HPO
788	SLC25A20	C0042514	Tachycardia, Ventricular	0.2	0	0	HPO
788	SLC25A20	C0340279	Ventricular hypertrophy	0.2	0	0	HPO
788	SLC25A20	C0342791	Carnitine-Acylcarnitine Translocase Deficiency	0.601373633921066	2	10	CTD_human;ORPHANET;UNIPROT
788	SLC25A20	C1841659	Atrioventricular nodal disease	0.2	0	0	HPO
7880	MBS2	C1858717	Facial paresis, hereditary, congenital	0.2	0	0	CTD_human
7885	CRSA	C1833578	Craniosynostosis, Adelaide Type	0.2	0	0	CTD_human
7889	PSORS3	C0033860	Psoriasis	0.200274726784213	0	0	CTD_human
78987	CRELD1	C1853509	Atrioventricular Septal Defect, Partial, with Heterotaxy Syndrome	0.2	0	0	CTD_human
78989	COLEC11	C0796032	Malpuech facial clefting syndrome	0.2	1	0	CTD_human
78989	COLEC11	C0796059	Oculopalatoskeletal syndrome	0.2	1	0	CTD_human
78989	COLEC11	C0796279	Carnevale syndrome	0.4	1	2	CTD_human;UNIPROT
790	CAD	C0002895	Anemia, Sickle Cell	0.2	1	0	CTD_human
790	CAD	C0005283	beta Thalassemia	0.2	1	0	CTD_human
790	CAD	C0014544	Epilepsy	0.2	0	0	HPO
790	CAD	C0037889	Hereditary spherocytosis	0.2	1	0	CTD_human
790	CAD	C0687751	Acanthocytosis	0.2	0	0	HPO
790	CAD	C0949116	Congenital hypoplastic anemia	0.2	1	0	CTD_human
79001	VKORC1	C0003496	Aortic Rupture	0.2	1	0	CTD_human
79001	VKORC1	C0010068	Coronary heart disease	0.206238848124954	1	0	CTD_human
79001	VKORC1	C1843832	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2	0.4	2	1	CTD_human;UNIPROT
79001	VKORC1	C1848534	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1	0.2	0	0	ORPHANET
79026	AHNAK	C0263454	Chloracne	0.2	1	0	CTD_human
79039	DDX54	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
79042	TSEN34	C2676465	Pontocerebellar Hypoplasia Type 2C	0.4	1	1	CTD_human;UNIPROT
79047	KCTD15	C0028754	Obesity	0.233489185076449	1	0	CTD_human
79048	SECISBP2	C1864761	Thyroid Hormone Metabolism, Abnormal	0.600549453568426	1	3	CTD_human;ORPHANET;UNIPROT
7905	REEP5	C0008370	Cholestasis	0.2	1	0	CTD_human
7905	REEP5	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
79051	RPY	C1839079	Retinitis Pigmentosa, Y-Linked	0.2	0	0	CTD_human
79053	ALG8	C2931002	Congenital disorder of glycosylation type 1H	0.601098907136852	1	3	CTD_human;ORPHANET;UNIPROT
79054	TRPM8	C0338480	Common Migraine	0.2	1	0	CTD_human
79068	FTO	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.303626503442327	1	5	CTD_human
79068	FTO	C0028754	Obesity	0.36	6	8	CTD_human
79068	FTO	C2362324	Pediatric Obesity	0.204120901763196	1	0	CTD_human
79071	ELOVL6	C0018801	Heart failure	0.2	1	0	CTD_human
7908	EOS	C0272192	Familial eosinophilia	0.2	0	0	CTD_human
79083	MLPH	C1836573	GRISCELLI SYNDROME, TYPE 3	0.6	1	1	CTD_human;ORPHANET;UNIPROT
79087	ALG12	C2931001	Congenital disorder of glycosylation type 1G	0.600549453568426	4	8	CTD_human;ORPHANET;UNIPROT
7909	HEMC	C1865871	HEMANGIOMA, CAPILLARY INFANTILE	0.200274726784213	0	0	CTD_human
79092	CARD14	C0032027	Pityriasis Rubra Pilaris	0.401923087489492	1	1	ORPHANET;UNIPROT
79092	CARD14	C0033860	Psoriasis	0.205494535684262	2	0	CTD_human
79092	CARD14	C1864497	PSORIASIS 2	0.200274726784213	2	5	UNIPROT
790955	UQCC3	C4015253	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.2	1	1	UNIPROT
791087	HHT4	C1857688	Telangiectasia, Hereditary Hemorrhagic, Type 4	0.2	0	0	CTD_human
7911	SM1	C0036330	Schistosomiasis mansoni	0.2	0	0	CTD_human
791121	SHFL1	C1861553	Split-Hand-Foot Malformation With Long Bone Deficiency 1	0.2	0	0	CTD_human
791123	SHFLD2	C1853156	Split-Hand-Foot Malformation With Long Bone Deficiency 2	0.2	0	0	CTD_human
791228	SPG36	C2936879	SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT	0.4	0	0	CTD_human;ORPHANET
791229	MACOM	C1865286	MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA	0.200274726784213	0	0	CTD_human
791254	EDS8	C0268347	Ehlers-Danlos Syndrome, Type VIII	0.2	0	0	CTD_human
791255	SPDA2	C1866738	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.2	0	0	CTD_human
79133	NDUFAF5	C0023264	Leigh Disease	0.400549453568426	2	2	ORPHANET;UNIPROT
79133	NDUFAF5	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.4	1	2	CTD_human;UNIPROT
79133	NDUFAF5	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
79139	DERL1	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
79143	MBOAT7	C0023891	Liver Cirrhosis, Alcoholic	0.2	1	1	CTD_human
79147	FKRP	C0265221	Walker-Warburg congenital muscular dystrophy	0.402747267842131	0	0	CTD_human;ORPHANET
79147	FKRP	C0457133	Muscle eye brain disease	0.200824180352639	0	0	ORPHANET
79147	FKRP	C1837229	Muscular Dystrophy, Congenital, Type 1D	0.2	0	0	ORPHANET
79147	FKRP	C1846672	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I	0.681373633921066	8	25	CTD_human;ORPHANET;UNIPROT
79147	FKRP	C1847759	MUSCULAR DYSTROPHY, CONGENITAL, 1C	0.681648360705279	8	11	CTD_human;ORPHANET;UNIPROT
79147	FKRP	C3150413	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5	0.48	2	8	CTD_human;UNIPROT
79147	FKRP	C3150415	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	0.2	0	0	ORPHANET
79147	FKRP	C3150416	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.2	0	0	ORPHANET
79147	FKRP	C3809221	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14	0.2	0	0	ORPHANET
7915	ALDH5A1	C0014550	Epilepsies, Myoclonic	0.2	0	0	HPO
7915	ALDH5A1	C0014553	Absence Epilepsy	0.2	0	0	HPO
7915	ALDH5A1	C0038220	Status Epilepticus	0.200549453568426	0	0	HPO
7915	ALDH5A1	C0268631	succinic semialdehyde dehydrogenase deficiency	0.682472541057918	5	11	CTD_human;ORPHANET;UNIPROT
7915	ALDH5A1	C0494475	Tonic - clonic seizures	0.200274726784213	0	0	HPO
7915	ALDH5A1	C0751778	Myoclonic Epilepsies, Progressive	0.2	0	0	HPO
7915	ALDH5A1	C4020884	Anxiety disease	0.2	0	0	HPO
7915	ALDH5A1	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
79152	FA2H	C3496228	Leukodystrophy, Dysmyelinating, And Spastic Paraparesis With Or Without Dystonia	0.680824180352639	3	3	CTD_human;ORPHANET;UNIPROT
79152	FA2H	C3668943	Fatty Acid Hydroxylase-Associated Neurodegeneration	0.200274726784213	0	0	ORPHANET
79153	GDPD3	C0023794	Lipoidosis	0.2	3	0	CTD_human
79158	GNPTAB	C0020725	Type II Mucolipidosis	0.203021994626344	0	0	ORPHANET
79158	GNPTAB	C0033788	Pseudo-Hurler Polydystrophy	0.600274726784213	14	38	CTD_human;ORPHANET;UNIPROT
79158	GNPTAB	C2673377	MUCOLIPIDOSIS II ALPHA/BETA (disorder)	0.480824180352639	10	95	CTD_human;UNIPROT
79158	GNPTAB	C2931894	Mucolipidosis 2	0.2	0	0	ORPHANET
79179	FHII	C1854107	Hyperaldosteronism, Familial, Type II	0.2	0	0	CTD_human
79184	BRCC3	C3151857	MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, AND FACIAL DYSMORPHISM	0.2	0	0	ORPHANET
79188	TMEM43	C0410190	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	0.2	0	0	ORPHANET
79188	TMEM43	C1858379	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5 (disorder)	0.4	1	2	CTD_human;UNIPROT
79188	TMEM43	C3553060	EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT	0.2	1	2	UNIPROT
79228	THOC6	C3150939	BEAULIEU-BOYCOTT-INNES SYNDROME	0.400274726784213	1	1	ORPHANET;UNIPROT
79258	MMEL1	C0003873	Rheumatoid Arthritis	0.205638237399215	1	1	CTD_human
79258	MMEL1	C0008312	Primary biliary cirrhosis	0.200274726784213	0	0	ORPHANET
79258	MMEL1	C0023892	Biliary cirrhosis	0.202407028523288	1	0	CTD_human
79258	MMEL1	C0859942	Hanot's cirrhosis	0.2	0	0	ORPHANET
7933	OPLL	C1865343	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE	0.2	0	0	CTD_human
794	CALB2	C0042164	Uveitis	0.2	1	0	CTD_human
794	CALB2	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
7941	PLA2G7	C0004096	Asthma	0.203231208875927	1	0	CTD_human
7941	PLA2G7	C0010068	Coronary heart disease	0.222837446138059	1	0	CTD_human
7941	PLA2G7	C1840253	IgE RESPONSIVENESS, ATOPIC	0.2	0	0	CTD_human
7941	PLA2G7	C3280315	Platelet-Activating Factor Acetylhydrolase Deficiency	0.4	2	2	HPO;UNIPROT
79443	FYCO1	C0392557	Nuclear cataract	0.2	0	0	ORPHANET
79443	FYCO1	C1112705	Nuclear non-senile cataract	0.2	0	0	ORPHANET
79443	FYCO1	C1864908	Cataract, autosomal recessive congenital 2	0.2	1	4	UNIPROT
79465	ULBP3	C0002171	Alopecia Areata	0.202407028523288	1	0	CTD_human
7948	PBCRA1	C1833321	CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.200274726784213	0	0	CTD_human
7952	TNDM	C1832386	Diabetes Mellitus, Transient Neonatal, 1	0.200274726784213	0	0	CTD_human
7957	EPM2A	C0014550	Epilepsies, Myoclonic	0.200549453568426	0	0	HPO
7957	EPM2A	C0014553	Absence Epilepsy	0.2	0	0	HPO
7957	EPM2A	C0085605	Liver Failure	0.2	0	0	HPO
7957	EPM2A	C0751778	Myoclonic Epilepsies, Progressive	0.406579087443797	1	0	CTD_human;HPO
7957	EPM2A	C0751783	Lafora Disease	0.710371739003755	6	10	CTD_human;ORPHANET;UNIPROT
7957	EPM2A	C0877017	Partial seizures with secondary generalisation	0.2	0	0	HPO
7957	EPM2A	C1850765	Simple partial occipital seizures	0.2	0	0	HPO
7957	EPM2A	C4021759	Generalized myoclonic seizures	0.2	0	0	HPO
79574	EPS8L3	C2931059	Marie Unna congenital hypotrichosis	0.200274726784213	0	0	ORPHANET
79577	CDC73	C1840402	HYPERPARATHYROIDISM 1	0.605769262468475	3	4	CTD_human;ORPHANET;UNIPROT
79581	SLC52A2	C0796274	Brown-Vialetto-Van Laere syndrome	0.201098907136852	0	0	ORPHANET
79581	SLC52A2	C3553538	BROWN-VIALETTO-VAN LAERE SYNDROME 2	0.2	4	17	UNIPROT
79583	TMEM231	C0265215	Meckel-Gruber syndrome	0.200274726784213	0	0	ORPHANET
79583	TMEM231	C1855675	Arima syndrome	0.2	0	0	ORPHANET
79583	TMEM231	C3554235	JOUBERT SYNDROME 20	0.2	2	2	UNIPROT
79583	TMEM231	C3809352	MECKEL SYNDROME, TYPE 11	0.2	1	2	UNIPROT
79587	CARS2	C4225251	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27	0.2	1	3	UNIPROT
796	CALCA	C0013080	Down Syndrome	0.2	1	0	CTD_human
796	CALCA	C0020437	Hypercalcemia	0.201373633921065	2	0	CTD_human
796	CALCA	C0029408	Degenerative polyarthritis	0.203231208875927	1	0	CTD_human
796	CALCA	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
796	CALCA	C0040997	Trigeminal Neuralgia	0.2	1	0	CTD_human
796	CALCA	C0085129	Bronchial Hyperreactivity	0.2	2	0	CTD_human
796	CALCA	C0149940	Sciatic Neuropathy	0.2	1	0	CTD_human
796	CALCA	C0338480	Common Migraine	0.200549453568426	2	0	CTD_human
79600	TCTN1	C0431399	Familial aplasia of the vermis	0.400274726784213	1	0	CTD_human;ORPHANET
79600	TCTN1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
7962	PBCA	C1838655	Pancreatic beta cell agenesis with neonatal diabetes mellitus	0.2	0	0	CTD_human
79621	RNASEH2B	C0393591	AICARDI-GOUTIERES SYNDROME	0.200274726784213	0	0	ORPHANET
79621	RNASEH2B	C0796126	AICARDI-GOUTIERES SYNDROME 1	0.201373633921065	0	0	CTD_human
79621	RNASEH2B	C3489724	Aicardi-Goutieres Syndrome 2	0.2	2	14	UNIPROT
79625	NDNF	C0014175	Endometriosis	0.2	1	0	CTD_human
79628	SH3TC2	C1866636	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C	0.681648360705279	1	24	CTD_human;ORPHANET;UNIPROT
79628	SH3TC2	C3150596	MONONEUROPATHY OF THE MEDIAN NERVE, MILD	0.4	1	2	CTD_human;UNIPROT
79633	FAT4	C0340834	Hennekam lymphangiectasia lymphedema syndrome	0.2	0	0	ORPHANET
79633	FAT4	C1832390	Van Maldergem Wetzburger Verloes syndrome	0.400274726784213	1	0	CTD_human;ORPHANET
79633	FAT4	C1842563	Heterotopia, Periventricular, Autosomal Recessive	0.2	1	0	CTD_human
79633	FAT4	C3809875	VAN MALDERGEM SYNDROME 2	0.2	2	6	UNIPROT
79633	FAT4	C4014939	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2	0.2	1	5	UNIPROT
79641	ROGDI	C0406740	Kohlschutter Tonz syndrome	0.200549453568426	0	0	ORPHANET
79644	SRD5A3	C0022336	Creutzfeldt-Jakob disease	0.2	1	0	CTD_human
79644	SRD5A3	C3150191	Coloboma, Ocular, And Ichthyosis, Brain Malformations, And Endocrine Abnormalities	0.4	0	0	CTD_human;ORPHANET
79648	MCPH1	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.681648360705279	1	10	CTD_human;ORPHANET;UNIPROT
79650	USB1	C0265965	Dyskeratosis Congenita	0.201098907136852	0	0	ORPHANET
79650	USB1	C1858723	Poikiloderma with Neutropenia	0.40439562854741	0	0	CTD_human;ORPHANET
79659	DYNC2H1	C0024507	Majewski Syndrome	0.2	0	0	ORPHANET
79659	DYNC2H1	C0036069	Saldino-Noonan Syndrome	0.28	4	39	UNIPROT
79659	DYNC2H1	C0036996	Short Rib-Polydactyly Syndrome	0.200274726784213	1	1	CTD_human
79659	DYNC2H1	C0432197	Short rib-polydactyly syndrome, Verma-Naumoff type	0.401098907136852	0	0	CTD_human;ORPHANET
79661	NEIL1	C0015695	Fatty Liver	0.2	2	0	CTD_human
79661	NEIL1	C0020459	Hyperinsulinism	0.2	1	0	CTD_human
79661	NEIL1	C0020473	Hyperlipidemia	0.2	1	0	CTD_human
79661	NEIL1	C0028754	Obesity	0.28	2	0	CTD_human
79661	NEIL1	C0524620	Metabolic Syndrome X	0.200274726784213	2	0	CTD_human
79685	SAP30L	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
79694	MANEA	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
7971	GHS	C0265240	Goldenhar Syndrome	0.2	0	0	CTD_human
79718	TBL1XR1	C1865644	Plantar Lipomatosis, Unusual Facies, and Developmental Delay	0.2	1	1	UNIPROT
79719	AAGAB	C0022596	Palmoplantar Keratosis	0.200549453568426	1	1	CTD_human
79719	AAGAB	C1835662	Keratosis palmoplantaris papulosa	0.200274726784213	0	0	ORPHANET
79722	ANKRD55	C0003873	Rheumatoid Arthritis	0.202681755307501	1	2	CTD_human
79722	ANKRD55	C0157917	Pauciarticular juvenile rheumatoid arthritis	0.2	0	0	ORPHANET
79722	ANKRD55	C0263454	Chloracne	0.2	1	0	CTD_human
79728	PALB2	C0015625	Fanconi Anemia	0.21446629627403	0	0	ORPHANET
79728	PALB2	C1835817	FANCONI ANEMIA, COMPLEMENTATION GROUP N	0.200274726784213	0	0	CTD_human
79731	NARS2	C0023264	Leigh Disease	0.200274726784213	1	0	UNIPROT
79731	NARS2	C4015643	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24	0.4	1	2	ORPHANET;UNIPROT
79734	KCTD17	C1834570	Myoclonic dystonia	0.200274726784213	0	0	ORPHANET
79734	KCTD17	C4225341	DYSTONIA 26, MYOCLONIC	0.2	1	1	UNIPROT
79738	BBS10	C0752166	Bardet-Biedl Syndrome	0.405480180306945	0	0	CTD_human;ORPHANET
79738	BBS10	C1859568	BARDET-BIEDL SYNDROME 10	0.28	4	49	UNIPROT
79742	CXorf36	C1136249	Mental Retardation, X-Linked	0.200274726784213	1	0	CTD_human
79751	SLC25A22	C0270855	Early myoclonic encephalopathy	0.6	1	4	CTD_human;ORPHANET;UNIPROT
79751	SLC25A22	C0393706	Early infantile epileptic encephalopathy with suppression bursts	0.2	0	0	ORPHANET
79753	SNIP1	C3281055	PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.2	1	1	UNIPROT
79755	ZNF750	C1853258	Seborrhea-Like Dermatitis with Psoriasiform Elements	0.4	0	0	CTD_human;ORPHANET
79763	ISOC2	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
79783	SUGCT	C0342873	Glutaric Aciduria III	0.4	1	3	ORPHANET;UNIPROT
79784	MYH14	C1833503	Deafness, Autosomal Dominant 4	0.4	2	5	CTD_human;UNIPROT
79784	MYH14	C3280556	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS	0.400274726784213	1	1	ORPHANET;UNIPROT
79796	ALG9	C2931006	Congenital disorder of glycosylation type 1L	0.600549453568426	2	2	CTD_human;ORPHANET;UNIPROT
79797	ZNF408	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
79797	ZNF408	C1851402	Exudative vitreoretinopathy 1	0.2	0	0	ORPHANET
79797	ZNF408	C4225315	RETINITIS PIGMENTOSA 72	0.2	1	2	UNIPROT
79797	ZNF408	C4225316	EXUDATIVE VITREORETINOPATHY 6	0.2	1	1	UNIPROT
79798	ARMC5	C1857451	Acth-Independent Macronodular Adrenal Hyperplasia	0.200274726784213	0	0	ORPHANET
79798	ARMC5	C4014803	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2	0.201648360705279	3	7	UNIPROT
7980	TFPI2	C0003873	Rheumatoid Arthritis	0.2	2	0	CTD_human
7980	TFPI2	C0029408	Degenerative polyarthritis	0.200274726784213	1	0	CTD_human
79803	HPS6	C2931875	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells	0.2	0	0	CTD_human
79809	TTC21B	C1865872	NEPHRONOPHTHISIS 2	0.2	0	0	ORPHANET
79809	TTC21B	C2936862	Bardet-Biedl syndrome 1 (disorder)	0.2	1	4	UNIPROT
79809	TTC21B	C3151185	SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY	0.2	1	3	UNIPROT
79809	TTC21B	C3151186	NEPHRONOPHTHISIS 12	0.2	2	8	UNIPROT
79813	EHMT1	C0795833	Kleefstra Syndrome	0.482472541057918	1	20	CTD_human;UNIPROT
79816	TLE6	C4225197	PREIMPLANTATION EMBRYONIC LETHALITY	0.2	1	1	UNIPROT
79822	ARHGAP28	C0014175	Endometriosis	0.2	1	0	CTD_human
79823	CAMKMT	C1848030	Hypotonia-Cystinuria Syndrome	0.480274726784213	1	0	CTD_human;ORPHANET
79827	CLMP	C0021847	Intestinal Pseudo-Obstruction	0.400549453568426	1	5	ORPHANET;UNIPROT
79840	NHEJ1	C1969799	Severe Combined Immunodeficiency with Microcephaly, Growth Retardation, and Sensitivity to Ionizing Radiation	0.600274726784213	2	5	CTD_human;ORPHANET;UNIPROT
79848	CSPP1	C0265215	Meckel-Gruber syndrome	0.200274726784213	0	0	ORPHANET
79848	CSPP1	C0431399	Familial aplasia of the vermis	0.201373633921065	0	0	ORPHANET
7986	GPDS1	C1271398	Pigment dispersion syndrome (disorder)	0.2	0	0	CTD_human
79867	TCTN2	C0265215	Meckel-Gruber syndrome	0.200274726784213	0	0	ORPHANET
79867	TCTN2	C0431399	Familial aplasia of the vermis	0.2	0	0	ORPHANET
79868	ALG13	C3550904	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36	0.2	2	3	UNIPROT
79876	UBA5	C0008370	Cholestasis	0.2	1	0	CTD_human
79876	UBA5	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
79890	RIN3	C0029401	Osteitis Deformans	0.200549453568426	1	1	CTD_human
799	CALCR	C0020437	Hypercalcemia	0.200274726784213	1	0	CTD_human
799	CALCR	C0029456	Osteoporosis	0.207337755261807	0	0	CTD_human
79906	MORN1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
7991	TUSC3	C1970197	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7	0.2	0	0	CTD_human
79924	ADM2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
79932	KIAA0319L	C0206138	CREST Syndrome	0.2	0	0	ORPHANET
79932	KIAA0319L	C0748540	Scleroderma, Limited	0.2	0	0	ORPHANET
79934	COQ8B	C3809965	NEPHROTIC SYNDROME, TYPE 9	0.2	2	7	UNIPROT
7994	KAT6A	C0010278	Craniosynostosis	0.2	0	0	HPO
7994	KAT6A	C0038379	Strabismus	0.2	0	0	HPO
7994	KAT6A	C0155320	Blindness, Cortical	0.2	0	0	HPO
7994	KAT6A	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
7994	KAT6A	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
79944	L2HGDH	C0014544	Epilepsy	0.2	1	0	CTD_human
79944	L2HGDH	C1855995	L-2-HYDROXYGLUTARIC ACIDURIA	0.482747267842131	3	9	ORPHANET;UNIPROT
79944	L2HGDH	C2746066	Combined D-2- and L-2-hydroxyglutaric aciduria	0.202472541057918	3	0	CTD_human
79947	DHDDS	C0035334	Retinitis Pigmentosa	0.200549453568426	0	0	ORPHANET
79947	DHDDS	C3151227	RETINITIS PIGMENTOSA 59	0.2	1	1	UNIPROT
79955	PDZD7	C1568249	Usher Syndrome, Type II	0.2	0	0	ORPHANET
79974	CPED1	C0022336	Creutzfeldt-Jakob disease	0.2	1	0	CTD_human
79977	GRHL2	C1837640	Deafness, Autosomal Dominant 28	0.200274726784213	0	0	CTD_human
79977	GRHL2	C4014987	ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.4	1	2	ORPHANET;UNIPROT
79983	POF1B	C1845105	Premature Ovarian Failure 2b	0.4	1	1	CTD_human;UNIPROT
79991	STN1	C1800706	Idiopathic Pulmonary Fibrosis	0.4	1	0	CTD_human;ORPHANET
800	CALD1	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
800	CALD1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
8000	PSCA	C0013295	Duodenal Ulcer	0.201098907136852	1	1	CTD_human
80025	PANK2	C0018523	Hallervorden-Spatz Syndrome	0.418927437356069	5	25	CTD_human;UNIPROT
80025	PANK2	C1846582	Hypoprebetalipoproteinemia, Acanthocytosis, Retinitis Pigmentosa, And Pallidal Degeneration	0.200549453568426	0	0	CTD_human
80025	PANK2	C2931845	Neurodegeneration with brain iron accumulation (NBIA)	0.206318716036901	1	0	CTD_human
80067	DCAF17	C0342286	Woodhouse Sakati syndrome	0.401648360705279	0	0	CTD_human;ORPHANET
801	CALM1	C0002395	Alzheimer's Disease	0.202747267842131	1	0	CTD_human
801	CALM1	C0018790	Cardiac Arrest	0.201373633921065	0	0	HPO
801	CALM1	C0035828	Romano-Ward Syndrome	0.2	0	0	ORPHANET
801	CALM1	C0042514	Tachycardia, Ventricular	0.200274726784213	0	0	HPO
801	CALM1	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	0.200824180352639	0	0	ORPHANET
801	CALM1	C3554047	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4	0.2	2	2	UNIPROT
801	CALM1	C4015671	LONG QT SYNDROME 14	0.2	2	3	UNIPROT
801	CALM1	C4015695	LONG QT SYNDROME 15	0.2	2	0	UNIPROT
8011	MROS	C0025235	Melkersson-Rosenthal Syndrome	0.2	0	0	CTD_human
80127	BBOF1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
8013	NR4A3	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
8013	NR4A3	C0020443	Hypercholesterolemia	0.200274726784213	1	0	CTD_human
8013	NR4A3	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
80144	FRAS1	C0265233	Cryptophthalmos syndrome	0.484670355331623	1	14	CTD_human;ORPHANET
80150	ASRGL1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
80169	CTC1	C0265965	Dyskeratosis Congenita	0.200549453568426	0	0	ORPHANET
80169	CTC1	C2677299	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS (disorder)	0.401098907136852	2	15	ORPHANET;UNIPROT
80184	CEP290	C0265215	Meckel-Gruber syndrome	0.201098907136852	0	0	ORPHANET
80184	CEP290	C0339527	Leber Congenital Amaurosis	0.206318716036901	0	0	ORPHANET
80184	CEP290	C0403553	Renal dysplasia and retinal aplasia (disorder)	0.201098907136852	0	0	ORPHANET
80184	CEP290	C0752166	Bardet-Biedl Syndrome	0.404930726738519	1	1	CTD_human;ORPHANET
80184	CEP290	C1855675	Arima syndrome	0.2	0	0	ORPHANET
80184	CEP290	C1857779	SENIOR-LOKEN SYNDROME 6	0.4	0	0	CTD_human;UNIPROT
80184	CEP290	C1857780	JOUBERT SYNDROME 5	0.48	3	43	CTD_human;UNIPROT
80184	CEP290	C1857821	LEBER CONGENITAL AMAUROSIS 10 (disorder)	0.28	0	0	CTD_human
80184	CEP290	C1970161	MECKEL SYNDROME, TYPE 4	0.200274726784213	0	0	CTD_human
80185	TTI2	C3809853	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39	0.4	1	2	ORPHANET;UNIPROT
80207	OPA3	C0574084	3-Methylglutaconic aciduria type 3	0.482472541057918	0	0	CTD_human;ORPHANET
80207	OPA3	C1833809	OPTIC ATROPHY AND CATARACT, AUTOSOMAL DOMINANT	0.6	1	3	CTD_human;ORPHANET;UNIPROT
80208	SPG11	C1858479	Spastic paraplegia 11, autosomal recessive	0.681648360705279	1	94	CTD_human;ORPHANET;UNIPROT
80208	SPG11	C2931821	Nakamura Osame syndrome	0.2	0	0	ORPHANET
80208	SPG11	C4225253	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X	0.2	0	0	ORPHANET
8022	LHX3	C0013338	Pituitary dwarfism	0.200274726784213	0	0	HPO
8022	LHX3	C0018784	Sensorineural Hearing Loss (disorder)	0.20328236603324	0	0	HPO
8022	LHX3	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
8022	LHX3	C0271801	Central hypothyroidism	0.2	0	0	HPO
8022	LHX3	C0878683	Pituitary Dwarfism Type 3	0.2	0	0	CTD_human
8022	LHX3	C0948740	Pituitary hypoplasia	0.2	0	0	HPO
8022	LHX3	C3489787	Pituitary Hormone Deficiency, Combined, 3	0.68	2	7	CTD_human;ORPHANET;UNIPROT
8022	LHX3	C3665349	Secondary hypothyroidism	0.200274726784213	0	0	HPO
8022	LHX3	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
80222	TARS2	C4014668	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.4	1	2	ORPHANET;UNIPROT
80224	NUBPL	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.400274726784213	1	6	CTD_human;UNIPROT
80224	NUBPL	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
80254	CEP63	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
8026	DGS2	C1832431	Digeorge Syndrome-Velocardiofacial Syndrome Complex 2	0.2	0	0	CTD_human
80264	ZNF430	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
80270	HSD3B7	C0008370	Cholestasis	0.2	1	0	CTD_human
80270	HSD3B7	C1843116	Bile acid synthesis defect, congenital, 1	0.6	1	6	CTD_human;ORPHANET;UNIPROT
80271	ITPKC	C0026691	Mucocutaneous Lymph Node Syndrome	0.206304360659584	1	1	CTD_human
80271	ITPKC	C2936917	Infantile polyarteritis	0.2	0	0	CTD_human
8029	CUBN	C0002888	Anemia, Megaloblastic	0.201923087489492	0	0	HPO
8029	CUBN	C1306856	Megaloblastic anemia due to inborn errors of metabolism	0.602747267842131	1	30	CTD_human;ORPHANET;UNIPROT
80308	FLAD1	C0410214	Myopathy with Abnormal Lipid Metabolism	0.2	1	1	UNIPROT
80310	PDGFD	C1956346	Coronary Artery Disease	0.200549453568426	1	0	CTD_human
80324	PUS1	C1838103	MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.681373633921066	1	3	CTD_human;ORPHANET;UNIPROT
80326	WNT10A	C0796093	Odontoonychodermal dysplasia	0.400549453568426	5	10	CTD_human;UNIPROT
80326	WNT10A	C1835492	TOOTH AGENESIS, SELECTIVE, 4 (disorder)	0.2	2	6	UNIPROT
80326	WNT10A	C1857069	SCHOPF-SCHULZ-PASSARGE SYNDROME (disorder)	0.601923087489492	1	7	CTD_human;ORPHANET;UNIPROT
80331	DNAJC5	C1834207	Ceroid Lipofuscinosis, Neuronal, Parry Type	0.400549453568426	1	2	ORPHANET;UNIPROT
80332	ADAM33	C0085129	Bronchial Hyperreactivity	0.209209685593986	1	0	CTD_human
80339	PNPLA3	C0015695	Fatty Liver	0.247001954660203	1	0	CTD_human
80339	PNPLA3	C0023891	Liver Cirrhosis, Alcoholic	0.207286598104494	2	1	CTD_human
80339	PNPLA3	C0400966	Non-alcoholic Fatty Liver Disease	0.23104412661608	3	2	CTD_human
80347	COASY	C3810230	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6	0.4	1	2	ORPHANET;UNIPROT
8036	SHOC2	C0007194	Hypertrophic Cardiomyopathy	0.200274726784213	0	0	HPO
8036	SHOC2	C0020255	Hydrocephalus	0.2	0	0	HPO
8036	SHOC2	C0028326	Noonan Syndrome	0.203296721410557	1	1	CTD_human
8036	SHOC2	C0038379	Strabismus	0.2	0	0	HPO
8036	SHOC2	C1843181	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.600274726784213	2	2	CTD_human;ORPHANET;UNIPROT
8036	SHOC2	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
8048	CSRP3	C0014117	Endocardial Fibroelastosis	0.200274726784213	0	0	HPO
8048	CSRP3	C0042514	Tachycardia, Ventricular	0.2	0	0	HPO
8048	CSRP3	C0235480	Paroxysmal atrial fibrillation	0.2	0	0	HPO
8048	CSRP3	C1843808	CARDIOMYOPATHY, DILATED, 1M	0.28	0	0	CTD_human
8048	CSRP3	C2677491	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12	0.48	2	7	CTD_human;UNIPROT
8048	CSRP3	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
8048	CSRP3	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
8048	CSRP3	C4025009	Impaired myocardial contractility	0.2	0	0	HPO
805	CALM2	C0035828	Romano-Ward Syndrome	0.2	0	0	ORPHANET
805	CALM2	C0042514	Tachycardia, Ventricular	0.200274726784213	0	0	HPO
805	CALM2	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	0.201098907136852	0	0	ORPHANET
8050	PDHX	C0014544	Epilepsy	0.2	0	0	HPO
8050	PDHX	C0029124	Optic Atrophy	0.2	0	0	HPO
8050	PDHX	C0037772	Spastic Paraplegia	0.2	0	0	HPO
8050	PDHX	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
8050	PDHX	C1855553	Pyruvate Dehydrogenase E3-Binding Protein Deficiency	0.4	0	0	CTD_human;ORPHANET
8050	PDHX	C1857278	Partial or complete agenesis of corpus callosum	0.2	0	0	HPO
8050	PDHX	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
8050	PDHX	C4020871	Dystonic disease	0.2	0	0	HPO
8056	ECB2	C1837915	ERYTHROCYTOSIS, FAMILIAL, 2	0.2	0	0	CTD_human
80704	SLC19A3	C0023264	Leigh Disease	0.200549453568426	0	0	ORPHANET
80704	SLC19A3	C1843807	Basal ganglia disease, biotin-responsive	0.602747267842131	1	8	CTD_human;ORPHANET;UNIPROT
8074	FGF23	C0029442	Osteomalacia	0.204945082115836	0	0	HPO
8074	FGF23	C0085681	Hyperphosphatemia (disorder)	0.208502174933289	1	0	CTD_human
8074	FGF23	C1704375	Hypophosphatemic Rickets	0.209615437447459	0	0	HPO
8074	FGF23	C1876187	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	0.602747267842131	4	5	CTD_human;ORPHANET;UNIPROT
80746	TSEN2	C2676466	Pontocerebellar Hypoplasia Type 2B	0.4	1	5	CTD_human;UNIPROT
8076	MFAP5	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
8076	MFAP5	C0013405	Dyspnea, Paroxysmal	0.2	0	0	HPO
8076	MFAP5	C0023212	Left-Sided Heart Failure	0.2	0	0	HPO
8076	MFAP5	C0162872	Aortic Aneurysm, Thoracic	0.200274726784213	0	0	HPO
8076	MFAP5	C0263401	Cutis marmorata	0.2	0	0	HPO
8076	MFAP5	C0392775	Cystic medial necrosis of aorta	0.2	0	0	HPO
8076	MFAP5	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	0.2	0	0	ORPHANET
8076	MFAP5	C1956346	Coronary Artery Disease	0.2	0	0	HPO
8076	MFAP5	C2674574	Aortic aneurysm, familial thoracic 3	0.2	0	0	ORPHANET
8076	MFAP5	C4015368	AORTIC ANEURYSM, FAMILIAL THORACIC 9	0.2	1	2	UNIPROT
80767	MMDFS	C3276432	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1	0.2	0	0	CTD_human
80768	HMNJ	C1854023	Spinal muscular atrophy, Jerash type	0.2	0	0	CTD_human
80770	CTRCT25	C1854021	Cataract, Central Saccular, With Sutural Opacities	0.2	0	0	CTD_human
80771	MCOPCB2	C1854018	Microphthalmia, Isolated, with Coloboma 2	0.2	0	0	CTD_human
80776	B9D2	C0265215	Meckel-Gruber syndrome	0.2	0	0	ORPHANET
80776	B9D2	C3280036	MECKEL SYNDROME, TYPE 10	0.2	1	0	UNIPROT
80781	COL18A1	C1849409	Knobloch syndrome	0.482472541057918	0	0	CTD_human;ORPHANET
808	CALM3	C0042514	Tachycardia, Ventricular	0.200274726784213	0	0	HPO
808	CALM3	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	0.200824180352639	0	0	ORPHANET
8080	HTNB	C1862170	Brachydactyly with hypertension	0.2	0	0	CTD_human
8081	AD5	C0002395	Alzheimer's Disease	0.200274726784213	0	0	CTD_human
8081	AD5	C1865868	ALZHEIMER DISEASE 5	0.200549453568426	0	0	CTD_human
80816	ASXL3	C3809650	BAINBRIDGE-ROPERS SYNDROME	0.200549453568426	0	0	ORPHANET
80821	DDHD1	C1836295	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE (disorder)	0.200274726784213	0	0	ORPHANET
80830	APOL6	C0021400	Influenza	0.2	1	0	CTD_human
8085	KMT2D	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
8085	KMT2D	C0014544	Epilepsy	0.2	0	0	HPO
8085	KMT2D	C0018777	Conductive hearing loss	0.2	0	0	HPO
8085	KMT2D	C0018784	Sensorineural Hearing Loss (disorder)	0.200274726784213	0	0	HPO
8085	KMT2D	C0020255	Hydrocephalus	0.2	0	0	HPO
8085	KMT2D	C0038379	Strabismus	0.2	0	0	HPO
8085	KMT2D	C0235946	Cerebral atrophy	0.2	0	0	HPO
8085	KMT2D	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
8085	KMT2D	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
8085	KMT2D	C0747085	Recurrent otitis media	0.2	0	0	HPO
8085	KMT2D	C0747651	Recurrent aspiration pneumonia	0.2	0	0	HPO
8085	KMT2D	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
8085	KMT2D	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8086	AAAS	C0013363	Dysautonomia	0.2	0	0	HPO
8086	AAAS	C0014544	Epilepsy	0.200274726784213	0	0	HPO
8086	AAAS	C0014848	Esophageal Achalasia	0.200824180352639	0	0	HPO
8086	AAAS	C0020595	Hypoaldosteronism	0.2	0	0	HPO
8086	AAAS	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
8086	AAAS	C0029124	Optic Atrophy	0.2	0	0	HPO
8086	AAAS	C0042798	Low Vision	0.2	0	0	HPO
8086	AAAS	C0271742	Glucocorticoid deficiency with achalasia	0.610714344584311	3	7	CTD_human;ORPHANET;UNIPROT
8086	AAAS	C0344505	Alacrima	0.201648360705279	0	0	HPO
8086	AAAS	C4020811	Length dependent motor neuropathy	0.2	0	0	HPO
80870	DKBI	C0265966	Hereditary benign intraepithelial dyskeratosis	0.2	0	0	CTD_human
8090	SPPM	C0751337	X-Linked Emery-Dreifuss Muscular Dystrophy	0.2	0	0	CTD_human
8091	HMGA2	C0029455	Osteopoikilosis (disorder)	0.2	0	0	HPO
8091	HMGA2	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
8091	HMGA2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8092	ALX1	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
8092	ALX1	C3150706	FRONTONASAL DYSPLASIA 3	0.4	0	0	CTD_human;ORPHANET
8094	SMAL	C1838492	SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE (disorder)	0.2	0	0	CTD_human
81	ACTN4	C0017668	Focal glomerulosclerosis	0.415015749842456	0	0	CTD_human;HPO
81	ACTN4	C0020473	Hyperlipidemia	0.2	0	0	HPO
81	ACTN4	C0239981	Hypoalbuminemia	0.2	0	0	HPO
81	ACTN4	C0333497	Segmental glomerulosclerosis	0.28	3	4	UNIPROT
81027	TUBB1	C0948089	Acute Coronary Syndrome	0.202407028523288	1	0	CTD_human
81027	TUBB1	C1861195	Glanzmann Thrombasthenia, Autosomal Dominant	0.2	0	0	ORPHANET
81027	TUBB1	C2751259	Macrothrombocytopenia, Autosomal Dominant, Tubb1-Related	0.4	1	1	CTD_human;UNIPROT
8103	PAPA2	C1865883	Polydactyly, Postaxial, Type A2	0.2	0	0	CTD_human
81031	SLC2A10	C1859726	ARTERIAL TORTUOSITY SYNDROME	0.601923087489492	2	19	CTD_human;ORPHANET;UNIPROT
81034	SLC25A32	C4225187	EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE	0.2	1	2	UNIPROT
8106	PABPN1	C0038016	Spondylolisthesis	0.2	0	0	HPO
8106	PABPN1	C0270952	Muscular Dystrophy, Oculopharyngeal	0.438584831775514	3	1	CTD_human;ORPHANET
8106	PABPN1	C0376175	Bell Palsy	0.2	0	0	HPO
8106	PABPN1	C1834015	Ptosis, progressive	0.2	0	0	HPO
811	CALR	C0027051	Myocardial Infarction	0.2	0	0	HPO
811	CALR	C0040028	Thrombocythemia, Essential	0.21593415348436	0	0	ORPHANET
811	CALR	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
811	CALR	C0836924	Thrombocytosis	0.200549453568426	0	0	HPO
811	CALR	C0917805	Transient Cerebral Ischemia	0.2	0	0	HPO
8113	MCOP1	C1855052	MICROPHTHALMIA, ISOLATED 1	0.2	0	0	CTD_human
8126	MRST	C1864549	Mental Retardation, Severe, With Spasticity And Pigmentary Tapetoretinal Degeneration	0.2	0	0	CTD_human
8129	HBHR	C0795917	Alpha-Thalassemia Mental Retardation Syndrome, Deletion-Type	0.2	0	0	CTD_human
8130	MCOPCT1	C1834919	Microphthalmia, Isolated, with Cataract 1	0.2	0	0	CTD_human
8132	PKDTS	C1838327	Polycystic kidneys, severe infantile with tuberous sclerosis	0.2	0	0	CTD_human
8136	WT3	C1860265	Wilms Tumor 3	0.2	0	0	CTD_human
8137	HYD2	C1865092	TOOTH AGENESIS, SELECTIVE, 2 (disorder)	0.2	0	0	CTD_human
8139	GAN	C0028738	Nystagmus	0.2	0	0	HPO
8139	GAN	C0037772	Spastic Paraplegia	0.2	0	0	HPO
8139	GAN	C0376175	Bell Palsy	0.2	0	0	HPO
8139	GAN	C1848736	Distal amyotrophy	0.2	0	0	HPO
8139	GAN	C1850386	GIANT AXONAL NEUROPATHY 1	0.685494535684262	5	15	CTD_human;ORPHANET;UNIPROT
8139	GAN	C4020811	Length dependent motor neuropathy	0.2	0	0	HPO
8139	GAN	C4020859	Pyramidal tract disease	0.2	0	0	HPO
8140	SLC7A5	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
8144	CMS1A1	C1853949	MYASTHENIA, FAMILIAL INFANTILE, 1	0.2	0	0	CTD_human
81494	CFHR5	C3553720	CFHR5 DEFICIENCY	0.2	0	0	ORPHANET
815	CAMK2A	C0019202	Hepatolenticular Degeneration	0.2	1	0	CTD_human
81501	DCSTAMP	C0014175	Endometriosis	0.2	1	0	CTD_human
81501	DCSTAMP	C0029401	Osteitis Deformans	0.200549453568426	1	1	CTD_human
81545	FBXO38	C3888271	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID	0.2	1	1	UNIPROT
8156	GPSC	C3711381	Hereditary Diffuse Leukoencephalopathy with Spheroids	0.2	0	0	CTD_human
81562	LMAN2L	C4225168	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.2	1	1	UNIPROT
81565	NDEL1	C3495559	Juvenile arthritis	0.200824180352639	1	0	CTD_human
81567	TXNDC5	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
81570	CLPB	C4225393	3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA	0.4	2	19	ORPHANET;UNIPROT
81607	NECTIN4	C3150807	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.600549453568426	1	4	CTD_human;ORPHANET;UNIPROT
81608	FIP1L1	C1540912	Hypereosinophilic syndrome	0.212869092726064	1	0	CTD_human
81620	CDT1	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	0.4	1	0	CTD_human;ORPHANET
81620	CDT1	C3151120	MEIER-GORLIN SYNDROME 4	0.2	2	6	UNIPROT
81622	UNC93B1	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
81622	UNC93B1	C0276226	Herpes encephalitis	0.401098907136852	0	0	CTD_human;ORPHANET
81622	UNC93B1	C0477341	Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.2	0	0	ORPHANET
81622	UNC93B1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
81624	DIAPH3	C1836743	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.280274726784213	0	0	CTD_human
81631	MAP1LC3B	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
8165	AKAP1	C0028754	Obesity	0.2	1	0	CTD_human
81693	AMN	C1306856	Megaloblastic anemia due to inborn errors of metabolism	0.601648360705279	1	20	CTD_human;ORPHANET;UNIPROT
817	CAMK2D	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
817	CAMK2D	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
81704	DOCK8	C1968689	Hyper-Immunoglobulin E Syndrome, Autosomal Recessive	0.403021994626344	1	4	ORPHANET;UNIPROT
81704	DOCK8	C3887645	Job Syndrome	0.20357144819477	0	0	CTD_human
8173	CNSN	C0268632	Homocarnosinosis	0.2	0	0	CTD_human
8174	MADCAM1	C0009319	Colitis	0.200549453568426	1	0	CTD_human
8174	MADCAM1	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
81790	RNF170	C1837015	ATAXIA, SENSORY, AUTOSOMAL DOMINANT	0.2	1	2	UNIPROT
81794	ADAMTS10	C0265313	Weill-Marchesani syndrome	0.400824180352639	0	0	CTD_human;ORPHANET
81794	ADAMTS10	C1869114	Weill-Marchesani Syndrome, Autosomal Recessive	0.200549453568426	1	7	UNIPROT
8181	BFIS1	C0270851	Benign neonatal epilepsy	0.2	0	0	CTD_human
81839	VANGL1	C1838568	Sacral defect and anterior sacral meningocele	0.4	1	1	CTD_human;UNIPROT
8184	HBN1	C1879286	Hereditary bundle branch system defect	0.2	0	0	CTD_human
8184	HBN1	C1970298	Progressive Familial Heart Block, Type Ib	0.2	0	0	CTD_human
81846	SBF2	C1858278	Charcot-Marie-Tooth disease, Type 4B2	0.480549453568426	0	0	CTD_human;ORPHANET
81848	SPRY4	C0162809	Kallmann Syndrome	0.2	0	0	ORPHANET
81848	SPRY4	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
81848	SPRY4	C3808971	HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA	0.2	1	8	UNIPROT
81849	ST6GALNAC5	C0003873	Rheumatoid Arthritis	0.2	2	0	CTD_human
81857	MED25	C1854150	Charcot-Marie-Tooth disease, Type 2B2	0.6	1	1	CTD_human;ORPHANET;UNIPROT
81857	MED25	C4225323	BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME	0.4	1	1	ORPHANET;UNIPROT
81858	SHARPIN	C0011603	Dermatitis	0.200274726784213	1	0	CTD_human
81858	SHARPIN	C0014457	Eosinophilia	0.2	1	0	CTD_human
81861	LPRS	C0023343	Leprosy	0.2	0	0	CTD_human
81863	CTPL1	C1854003	CATARACT, AUTOSOMAL RECESSIVE, EARLY-ONSET, PULVERULENT	0.2	0	0	CTD_human
81864	EVR3	C1854002	EXUDATIVE VITREORETINOPATHY 3	0.2	0	0	CTD_human
81865	BFIC2	C1853995	SEIZURES, BENIGN FAMILIAL INFANTILE, 2	0.200274726784213	0	0	CTD_human
81866	NDIC	C1853984	Nail dysplasia, isolated congenital	0.2	0	0	CTD_human
81876	RAB1B	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
81887	LAS1L	C1839736	WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME	0.2	0	0	ORPHANET
8192	CLPP	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
8192	CLPP	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
8192	CLPP	C0948896	Primary hypogonadism	0.2	0	0	HPO
8192	CLPP	C3808414	PERRAULT SYNDROME 3	0.28	2	2	UNIPROT
8195	MKKS	C0004096	Asthma	0.2	0	0	HPO
8195	MKKS	C0020295	Hydronephrosis	0.2	0	0	HPO
8195	MKKS	C0020619	Hypogonadism	0.2	0	0	HPO
8195	MKKS	C0022679	Cystic kidney	0.200274726784213	0	0	HPO
8195	MKKS	C0028738	Nystagmus	0.2	0	0	HPO
8195	MKKS	C0028754	Obesity	0.286737144536068	0	0	HPO
8195	MKKS	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	HPO
8195	MKKS	C0038379	Strabismus	0.2	0	0	HPO
8195	MKKS	C0042582	Vesicovaginal Fistula	0.2	0	0	HPO
8195	MKKS	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
8195	MKKS	C0162283	Nephrogenic Diabetes Insipidus	0.2	0	0	HPO
8195	MKKS	C0239946	Fibrosis, Liver	0.2	0	0	HPO
8195	MKKS	C0269209	Hydrometrocolpos	0.200824180352639	0	0	HPO
8195	MKKS	C0752166	Bardet-Biedl Syndrome	0.407403267796436	0	0	CTD_human;ORPHANET
8195	MKKS	C0948368	Kaufman-McKusick syndrome	0.602197814273705	5	2	CTD_human;ORPHANET;UNIPROT
8195	MKKS	C1858054	BARDET-BIEDL SYNDROME 6	0.280274726784213	15	14	UNIPROT
8195	MKKS	C3714497	Reactive airway disease	0.2	0	0	HPO
8195	MKKS	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
8200	GDF5	C0003873	Rheumatoid Arthritis	0.203007639249027	1	0	CTD_human
8200	GDF5	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
8200	GDF5	C0029408	Degenerative polyarthritis	0.231706892413202	1	0	CTD_human
8200	GDF5	C0029410	Osteoarthritis of hip	0.205363510615002	0	0	HPO
8200	GDF5	C0175700	Multiple synostosis syndrome	0.200824180352639	0	0	ORPHANET
8200	GDF5	C0265260	Chondrodysplasia, Grebe type	0.681648360705279	1	1	CTD_human;ORPHANET;UNIPROT
8200	GDF5	C0342282	Symphalangism-brachydactyly syndrome	0.2	0	0	ORPHANET
8200	GDF5	C0409477	Ankylosis of the elbow joint	0.2	0	0	HPO
8200	GDF5	C1300268	Brachydactyly syndrome type C	0.2	0	0	ORPHANET
8200	GDF5	C1832708	MULTIPLE SYNOSTOSES SYNDROME 2	0.480274726784213	5	3	CTD_human;UNIPROT
8200	GDF5	C1856738	Fibular hypoplasia and complex brachydactyly	0.680549453568426	5	4	CTD_human;ORPHANET;UNIPROT
8200	GDF5	C1860105	Severe short-limb dwarfism	0.2	0	0	HPO
8200	GDF5	C1861385	SYMPHALANGISM, PROXIMAL	0.600824180352639	0	0	CTD_human;HPO;ORPHANET
8200	GDF5	C1862151	BRACHYDACTYLY, TYPE A1 (disorder)	0.200274726784213	0	0	ORPHANET
8200	GDF5	C2930865	Ramer Ladda syndrome	0.2	0	0	HPO
8200	GDF5	C3554446	BRACHYDACTYLY, TYPE A1, C	0.28	2	1	UNIPROT
8200	GDF5	C3809104	SYMPHALANGISM, PROXIMAL, 1B	0.2	2	3	UNIPROT
8204	NRIP1	C0018801	Heart failure	0.2	1	0	CTD_human
8204	NRIP1	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
821	CANX	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
8212	AABT	C1862289	BETA-AMINO ACIDS, RENAL TRANSPORT OF	0.2	0	0	CTD_human
8214	DGCR6	C0042454	Velopharyngeal Insufficiency	0.2	0	0	HPO
8214	DGCR6	C4021592	Unilateral primary pulmonary dysgenesis	0.2	0	0	HPO
8216	LZTR1	C0015300	Exophthalmos	0.2	0	0	HPO
8216	LZTR1	C0026269	Mitral Valve Stenosis	0.2	0	0	HPO
8216	LZTR1	C0028326	Noonan Syndrome	0.200274726784213	0	0	ORPHANET
8216	LZTR1	C0038379	Strabismus	0.2	0	0	HPO
8216	LZTR1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
8216	LZTR1	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
8216	LZTR1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
8216	LZTR1	C3810283	SCHWANNOMATOSIS 2	0.2	1	7	UNIPROT
8216	LZTR1	C4225280	NOONAN SYNDROME 10	0.2	1	3	UNIPROT
8220	DGCR14	C0042454	Velopharyngeal Insufficiency	0.2	0	0	HPO
8220	DGCR14	C4021592	Unilateral primary pulmonary dysgenesis	0.2	0	0	HPO
8221	OGS2	C1801950	Opitz-G syndrome, type 2	0.2	0	0	CTD_human
823	CAPN1	C0029134	Optic Neuritis	0.2	1	0	CTD_human
8231	CND	C1844671	Dermoids of cornea	0.2	0	0	CTD_human
8239	USP9X	C3806746	MENTAL RETARDATION, X-LINKED 99	0.2	1	2	UNIPROT
8241	RBM10	C0020295	Hydronephrosis	0.2	0	0	HPO
8241	RBM10	C0267048	Glossoptosis	0.2	0	0	HPO
8241	RBM10	C1839463	TARP syndrome	0.400824180352639	0	0	CTD_human;ORPHANET
8241	RBM10	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8242	KDM5C	C0002171	Alopecia Areata	0.2	0	0	HPO
8242	KDM5C	C0014306	Enophthalmos	0.2	0	0	HPO
8242	KDM5C	C0014544	Epilepsy	0.200824180352639	0	0	HPO
8242	KDM5C	C0020490	Hyperopia	0.2	0	0	HPO
8242	KDM5C	C0027092	Myopia	0.2	0	0	HPO
8242	KDM5C	C0040412	Fissured tongue	0.2	0	0	HPO
8242	KDM5C	C1836451	Muscle atrophy, lower limb, distal	0.2	0	0	HPO
8242	KDM5C	C1845243	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE	0.6	4	16	CTD_human;ORPHANET;UNIPROT
8243	SMC1A	C0005741	Blepharitis	0.2	0	0	HPO
8243	SMC1A	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
8243	SMC1A	C0018777	Conductive hearing loss	0.2	0	0	HPO
8243	SMC1A	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
8243	SMC1A	C0027092	Myopia	0.2	0	0	HPO
8243	SMC1A	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
8243	SMC1A	C0263401	Cutis marmorata	0.2	0	0	HPO
8243	SMC1A	C0270972	Cornelia De Lange Syndrome	0.420206847987871	0	0	CTD_human;ORPHANET
8243	SMC1A	C0271007	Phthisis bulbi	0.2	0	0	HPO
8243	SMC1A	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
8243	SMC1A	C1802395	Congenital muscular hypertrophy-cerebral syndrome	0.200824180352639	5	30	UNIPROT
8243	SMC1A	C1854630	Growth Deficiency and Mental Retardation with Facial Dysmorphism	0.200274726784213	0	0	ORPHANET
8243	SMC1A	C1857079	Atretic auditory canal	0.2	0	0	HPO
8243	SMC1A	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8243	SMC1A	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
8243	SMC1A	C4020884	Anxiety disease	0.2	0	0	HPO
8245	IDDMX	C1848042	DIABETES MELLITUS, INSULIN-DEPENDENT, X-LINKED, SUSCEPTIBILITY TO	0.2	0	0	CTD_human
8246	MRXS12	C1839792	Mental Retardation, X-Linked, Syndromic 12	0.2	0	0	CTD_human
825	CAPN3	C0014457	Eosinophilia	0.2	0	0	HPO
825	CAPN3	C0026850	Muscular Dystrophy	0.224354781774078	0	0	HPO
825	CAPN3	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
825	CAPN3	C1869123	Limb-girdle muscular dystrophy type 2A	0.697582514189638	8	103	CTD_human;ORPHANET;UNIPROT
8258	GUST	C0795965	X-linked mental retardation Gustavson type	0.2	0	0	CTD_human
8259	INDX	C1848144	Woods Black Norbury syndrome	0.2	0	0	CTD_human
8260	NAA10	C0014544	Epilepsy	0.2	0	0	HPO
8260	NAA10	C0015300	Exophthalmos	0.2	0	0	HPO
8260	NAA10	C0017601	Glaucoma	0.2	0	0	HPO
8260	NAA10	C0020295	Hydronephrosis	0.2	0	0	HPO
8260	NAA10	C0023882	Little's Disease	0.2	0	0	HPO
8260	NAA10	C0034888	Rectal Prolapse	0.2	0	0	HPO
8260	NAA10	C0039240	Supraventricular tachycardia	0.2	0	0	HPO
8260	NAA10	C0040479	Torsades de Pointes	0.2	0	0	HPO
8260	NAA10	C0042514	Tachycardia, Ventricular	0.2	0	0	HPO
8260	NAA10	C0155299	Coloboma of optic disc	0.2	0	0	HPO
8260	NAA10	C0158113	Contracture of joint of hand	0.2	0	0	HPO
8260	NAA10	C0235946	Cerebral atrophy	0.2	0	0	HPO
8260	NAA10	C0271215	Blindness, Legal	0.2	0	0	HPO
8260	NAA10	C0747085	Recurrent otitis media	0.2	0	0	HPO
8260	NAA10	C3275447	OGDEN SYNDROME	0.400549453568426	2	7	ORPHANET;UNIPROT
8260	NAA10	C4020860	Supratentorial atrophy	0.2	0	0	HPO
8268	IPOX	C2746068	Congenital idiopathic intestinal pseudoobstruction	0.2	0	0	CTD_human
8284	KDM5D	C0004509	Azoospermia	0.2	0	0	HPO
8287	USP9Y	C0004509	Azoospermia	0.208371149864029	0	0	HPO
8287	USP9Y	C0028960	Oligospermia	0.203231208875927	0	0	HPO
8287	USP9Y	C1839071	Spermatogenic Failure, Nonobstructive, Y-Linked	0.2	0	0	CTD_human
8287	USP9Y	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
8288	EPX	C1850000	Presentey Anomaly	0.2	1	3	UNIPROT
8289	ARID1A	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
8289	ARID1A	C0014544	Epilepsy	0.2	0	0	HPO
8289	ARID1A	C0028738	Nystagmus	0.2	0	0	HPO
8289	ARID1A	C0038379	Strabismus	0.2	0	0	HPO
8289	ARID1A	C0265338	Coffin-Siris syndrome	0.400549453568426	1	0	CTD_human;ORPHANET
8290	HIST3H3	C0032273	Pneumoconiosis	0.200274726784213	1	0	CTD_human
8291	DYSF	C0026850	Muscular Dystrophy	0.224942715854123	0	0	HPO
8291	DYSF	C1847532	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET	0.480274726784213	0	0	CTD_human;ORPHANET
8291	DYSF	C1848736	Distal amyotrophy	0.2	0	0	HPO
8291	DYSF	C1850808	Miyoshi myopathy	0.700055055247556	19	102	CTD_human;ORPHANET;UNIPROT
8291	DYSF	C1850889	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	0.69236270528959	8	125	CTD_human;ORPHANET;UNIPROT
8291	DYSF	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
8292	COLQ	C0947912	Myasthenias	0.2	0	0	HPO
8292	COLQ	C1864233	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY (disorder)	0.400824180352639	4	10	CTD_human;UNIPROT
8301	PICALM	C0002395	Alzheimer's Disease	0.227354329997744	2	2	CTD_human
8302	KLRC4	C0003864	Arthritis	0.2	0	0	HPO
8302	KLRC4	C0004943	Behcet Syndrome	0.400549453568426	1	1	CTD_human;ORPHANET
8302	KLRC4	C0025289	Meningitis	0.2	0	0	HPO
8302	KLRC4	C0038363	Aphthous Stomatitis	0.2	0	0	HPO
8302	KLRC4	C0042384	Vasculitis	0.2	0	0	HPO
8302	KLRC4	C0149745	Oral Ulcer	0.2	0	0	HPO
8302	KLRC4	C0702166	Acne	0.2	0	0	HPO
8302	KLRC4	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
8302	KLRC4	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
8302	KLRC4	C2937365	Recurrent aphthous ulcer	0.2	0	0	HPO
831	CAST	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
831	CAST	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
831	CAST	C4225381	PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS	0.200274726784213	0	0	ORPHANET
8312	AXIN1	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
8312	AXIN1	C1842884	Caudal Duplication Anomaly	0.2	0	0	CTD_human
8314	BAP1	C0259817	Xerosis	0.2	0	0	HPO
8314	BAP1	C3280492	TUMOR PREDISPOSITION SYNDROME	0.201373633921065	0	0	ORPHANET
8315	BRAP	C0027051	Myocardial Infarction	0.203780662444353	1	1	CTD_human
8318	CDC45	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	0.2	0	0	ORPHANET
832	CAPZB	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
8322	FZD4	C0035305	Retinal Detachment	0.200549453568426	0	0	HPO
8322	FZD4	C0035344	Retinopathy of Prematurity	0.208319992706716	0	0	ORPHANET
8322	FZD4	C0271215	Blindness, Legal	0.2	0	0	HPO
8322	FZD4	C0423361	Posterior Vitreous Detachment	0.2	0	0	HPO
8322	FZD4	C1851402	Exudative vitreoretinopathy 1	0.681098907136852	9	17	CTD_human;ORPHANET;UNIPROT
8322	FZD4	C4072980	Exudative vitreoretinopathy	0.200549453568426	0	0	HPO
8323	FZD6	C0085661	Onycholysis	0.200274726784213	0	0	HPO
8323	FZD6	C0263536	Hypertrophy of nail	0.2	0	0	HPO
8323	FZD6	C3279974	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10	0.4	1	2	ORPHANET;UNIPROT
8328	GFI1B	C0040015	Thrombasthenia	0.2	0	0	HPO
8328	GFI1B	C0272302	Gray Platelet Syndrome	0.200274726784213	0	0	ORPHANET
8328	GFI1B	C4020863	Blood platelet disease	0.2	0	0	HPO
8339	HIST1H2BG	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
83394	PITPNM3	C0035334	Retinitis Pigmentosa	0.200824180352639	0	0	ORPHANET
83394	PITPNM3	C1832976	Cone-Rod Dystrophy 5	0.400549453568426	1	1	CTD_human;UNIPROT
834	CASP1	C0028754	Obesity	0.2	1	0	CTD_human
834	CASP1	C0032285	Pneumonia	0.200549453568426	1	0	CTD_human
834	CASP1	C0038220	Status Epilepticus	0.2	1	0	CTD_human
834	CASP1	C0598608	Hyperhomocysteinemia	0.2	1	0	CTD_human
834	CASP1	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
83452	RAB33B	C1846431	SMITH-MCCORT DYSPLASIA	0.200274726784213	0	0	ORPHANET
83452	RAB33B	C3714896	SMITH-MCCORT DYSPLASIA 2	0.2	2	2	UNIPROT
83479	DDX59	C1868118	Orofaciodigital syndrome 5	0.4	1	2	ORPHANET;UNIPROT
83481	EPPK1	C0263454	Chloracne	0.2	1	0	CTD_human
83538	TTC25	C0022521	Kartagener Syndrome	0.2	0	0	ORPHANET
83544	DNAL1	C0022521	Kartagener Syndrome	0.203007639249027	0	0	ORPHANET
83544	DNAL1	C3151460	CILIARY DYSKINESIA, PRIMARY, 16	0.2	1	1	UNIPROT
83550	GPR101	C0001206	Acromegaly	0.200549453568426	0	0	ORPHANET
83550	GPR101	C3891556	CHROMOSOME Xq26.3 DUPLICATION SYNDROME	0.200549453568426	0	0	ORPHANET
83550	GPR101	C4012409	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 2	0.2	1	1	UNIPROT
83552	MFRP	C1836006	NANOPHTHALMOS 2 (disorder)	0.4	1	4	CTD_human;UNIPROT
83552	MFRP	C1970236	Microphthalmia, Posterior, With Retinitis Pigmentosa, Foveoschisis, And Optic Disc Drusen	0.4	0	0	CTD_human;ORPHANET
836	CASP3	C0002395	Alzheimer's Disease	0.211235087398103	1	0	CTD_human
836	CASP3	C0007786	Brain Ischemia	0.202732912464814	2	0	CTD_human
836	CASP3	C0009324	Ulcerative Colitis	0.200274726784213	1	0	CTD_human
836	CASP3	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200274726784213	1	0	CTD_human
836	CASP3	C0011875	Diabetic Angiopathies	0.2	1	0	CTD_human
836	CASP3	C0011884	Diabetic Retinopathy	0.2	1	0	CTD_human
836	CASP3	C0019189	Hepatitis, Chronic	0.200274726784213	1	0	CTD_human
836	CASP3	C0027051	Myocardial Infarction	0.200549453568426	1	0	CTD_human
836	CASP3	C0035305	Retinal Detachment	0.2	1	0	CTD_human
836	CASP3	C0038220	Status Epilepticus	0.28	2	0	CTD_human
836	CASP3	C0038525	Subarachnoid Hemorrhage	0.2	1	0	CTD_human
836	CASP3	C0243026	Sepsis	0.200274726784213	1	0	CTD_human
836	CASP3	C1876165	Copper-Overload Cirrhosis	0.2	1	0	CTD_human
8360	HIST1H4D	C0022336	Creutzfeldt-Jakob disease	0.2	1	0	CTD_human
83605	CCM2	C1864041	CEREBRAL CAVERNOUS MALFORMATIONS 2	0.482472541057918	2	4	CTD_human;UNIPROT
83636	C19orf12	C2680446	SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE	0.400274726784213	0	0	ORPHANET;UNIPROT
83636	C19orf12	C3280371	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4	0.4	7	11	ORPHANET;UNIPROT
83696	TRAPPC9	C2750791	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13	0.2	0	0	CTD_human
83699	SH3BGRL2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
83700	JAM3	C3151000	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS	0.68	1	3	CTD_human;ORPHANET;UNIPROT
83706	FERMT3	C0029454	Osteopetrosis	0.2	1	0	CTD_human
83706	FERMT3	C2748536	Leukocyte Adhesion Deficiency, Type III	0.480549453568426	0	0	CTD_human;ORPHANET
83715	ESPN	C1837007	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT	0.4	1	2	CTD_human;UNIPROT
83729	INHBE	C0023794	Lipoidosis	0.2	1	0	CTD_human
83737	ITCH	C3150649	AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM	0.4	0	0	CTD_human;ORPHANET
8379	MAD1L1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
83795	KCNK16	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200274726784213	1	1	CTD_human
83861	RSPH3	C0022521	Kartagener Syndrome	0.200274726784213	0	0	ORPHANET
83872	HMCN1	C1864205	Macular Degeneration, Age-Related, 1	0.4	1	2	CTD_human;UNIPROT
83932	SPRTN	C0033300	Progeria	0.2	1	0	CTD_human
83932	SPRTN	C4015461	RUIJS-AALFS SYNDROME	0.4	1	3	ORPHANET;UNIPROT
83938	C10orf11	C3808786	ALBINISM, OCULOCUTANEOUS, TYPE VII	0.2	0	0	ORPHANET
83939	EIF2A	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
83959	SLC4A11	C0016781	Fuchs Endothelial Dystrophy	0.205429023149632	0	0	ORPHANET
83959	SLC4A11	C1857569	CORNEAL ENDOTHELIAL DYSTROPHY 2	0.682747267842131	12	15	CTD_human;ORPHANET;UNIPROT
83959	SLC4A11	C1857572	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.602747267842131	1	6	CTD_human;ORPHANET;UNIPROT
83959	SLC4A11	C2750450	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4	0.4	4	10	CTD_human;UNIPROT
8398	PLA2G6	C0014544	Epilepsy	0.2	0	0	HPO
8398	PLA2G6	C0028738	Nystagmus	0.200274726784213	0	0	HPO
8398	PLA2G6	C0029124	Optic Atrophy	0.2	0	0	HPO
8398	PLA2G6	C0038379	Strabismus	0.200274726784213	0	0	HPO
8398	PLA2G6	C0042798	Low Vision	0.2	0	0	HPO
8398	PLA2G6	C0235946	Cerebral atrophy	0.200274726784213	0	0	HPO
8398	PLA2G6	C0262404	Cerebellar degeneration	0.2	0	0	HPO
8398	PLA2G6	C0270724	Infantile Neuroaxonal Dystrophy	0.689340710663245	2	8	CTD_human;ORPHANET;UNIPROT
8398	PLA2G6	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
8398	PLA2G6	C0740279	Atrophy of cerebellum	0.200824180352639	0	0	HPO
8398	PLA2G6	C1836830	Developmental regression	0.2	0	0	HPO
8398	PLA2G6	C1857747	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2 (disorder)	0.400549453568426	1	6	CTD_human;UNIPROT
8398	PLA2G6	C2751842	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE	0.601098907136852	1	5	CTD_human;ORPHANET;UNIPROT
8398	PLA2G6	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
8398	PLA2G6	C4020858	Choreatic disease	0.2	0	0	HPO
8398	PLA2G6	C4020859	Pyramidal tract disease	0.2	0	0	HPO
8398	PLA2G6	C4020860	Supratentorial atrophy	0.2	0	0	HPO
8398	PLA2G6	C4020871	Dystonic disease	0.2	0	0	HPO
8398	PLA2G6	C4020873	Infratentorial atrophy	0.2	0	0	HPO
8398	PLA2G6	C4021584	Frontotemporal cerebral atrophy	0.2	0	0	HPO
83987	CCDC8	C1848862	Miller-McKusick-Malvaux-Syndrome (3M Syndrome)	0.201373633921065	0	0	ORPHANET
83987	CCDC8	C1851996	Dwarfism tall vertebrae	0.2	0	0	ORPHANET
83990	BRIP1	C0015625	Fanconi Anemia	0.418088901626113	1	1	CTD_human;ORPHANET
83990	BRIP1	C1836860	FANCONI ANEMIA, COMPLEMENTATION GROUP J	0.401648360705279	3	28	CTD_human;UNIPROT
83992	CTTNBP2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
840	CASP7	C0042900	Vitiligo	0.2	1	1	CTD_human
8402	SLC25A11	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
8404	SPARCL1	C0014175	Endometriosis	0.2	1	0	CTD_human
8404	SPARCL1	C0014544	Epilepsy	0.2	1	0	CTD_human
84059	ADGRV1	C1568249	Usher Syndrome, Type II	0.200274726784213	0	0	ORPHANET
84059	ADGRV1	C1858493	FEBRILE CONVULSIONS, FAMILIAL, 4	0.200549453568426	0	0	CTD_human
84059	ADGRV1	C2931213	Usher syndrome, type 2C	0.480549453568426	1	32	CTD_human;UNIPROT
84061	MAGT1	C2678034	MENTAL RETARDATION, X-LINKED 95	0.2	0	0	CTD_human
84061	MAGT1	C3275445	X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia	0.200274726784213	0	0	ORPHANET
84062	DTNBP1	C2931875	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells	0.2	0	0	CTD_human
84062	DTNBP1	C3279756	HERMANSKY-PUDLAK SYNDROME 7	0.28	0	0	ORPHANET
84068	SLC10A7	C0008370	Cholestasis	0.2	1	0	CTD_human
84068	SLC10A7	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
8407	TAGLN2	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
8407	TAGLN2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
841	CASP8	C0004096	Asthma	0.202681755307501	0	0	HPO
841	CASP8	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
841	CASP8	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.2	1	0	CTD_human
841	CASP8	C0013595	Eczema	0.200549453568426	0	0	HPO
841	CASP8	C0032285	Pneumonia	0.2	0	0	HPO
841	CASP8	C0038220	Status Epilepticus	0.2	1	0	CTD_human
841	CASP8	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
841	CASP8	C0267812	Micronodular cirrhosis	0.2	0	0	HPO
841	CASP8	C0401151	Chronic diarrhea	0.2	0	0	HPO
841	CASP8	C1328840	Autoimmune Lymphoproliferative Syndrome	0.200274726784213	0	0	CTD_human
841	CASP8	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	0.480549453568426	1	1	ORPHANET;UNIPROT
841	CASP8	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
841	CASP8	C3714497	Reactive airway disease	0.2	0	0	HPO
84100	ARL6	C0035334	Retinitis Pigmentosa	0.200274726784213	0	0	ORPHANET
84100	ARL6	C0752166	Bardet-Biedl Syndrome	0.404930726738519	0	0	CTD_human;ORPHANET
84100	ARL6	C1859564	Bardet-Biedl syndrome 3	0.200549453568426	4	6	UNIPROT
84100	ARL6	C3150808	RETINITIS PIGMENTOSA 55	0.4	1	1	CTD_human;UNIPROT
84126	ATRIP	C0265202	Seckel syndrome	0.200274726784213	0	0	ORPHANET
84140	FAM161A	C0035334	Retinitis Pigmentosa	0.403021994626344	0	0	CTD_human;ORPHANET
84146	ZNF644	C3279997	MYOPIA 21, AUTOSOMAL DOMINANT	0.2	2	3	UNIPROT
84152	PPP1R1B	C0013384	Dyskinetic syndrome	0.200274726784213	1	0	CTD_human
84153	RNASEH2C	C0393591	AICARDI-GOUTIERES SYNDROME	0.200274726784213	0	0	ORPHANET
84153	RNASEH2C	C1835916	AICARDI-GOUTIERES SYNDROME 3	0.4	3	7	CTD_human;UNIPROT
84159	ARID5B	C0003873	Rheumatoid Arthritis	0.200274726784213	2	2	CTD_human
84159	ARID5B	C0018213	Graves Disease	0.200549453568426	1	0	CTD_human
84168	ANTXR1	C0406723	Growth retardation, Alopecia, Pseudoanodontia and Optic atrophy	0.200824180352639	0	0	ORPHANET
84168	ANTXR1	C1865871	HEMANGIOMA, CAPILLARY INFANTILE	0.2	0	0	CTD_human
84173	ELMOD3	C2829267	DEAFNESS, AUTOSOMAL RECESSIVE 88	0.2	1	1	UNIPROT
84187	TMEM164	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
84188	FAR1	C4015344	PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER	0.4	1	3	ORPHANET;UNIPROT
84189	SLITRK6	C3806275	DEAFNESS AND MYOPIA	0.2	0	0	ORPHANET
8419	BFSP2	C0027092	Myopia	0.200274726784213	0	0	HPO
8419	BFSP2	C1833118	Cataract, Pulverulent	0.200274726784213	0	0	ORPHANET
8419	BFSP2	C1858679	CATARACT, AUTOSOMAL DOMINANT	0.200274726784213	0	0	CTD_human
8419	BFSP2	C1969032	Cataract, Autosomal Dominant, Multiple Types 1	0.2	0	0	CTD_human
8419	BFSP2	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
8419	BFSP2	C3808115	CATARACT 12, MULTIPLE TYPES	0.2	1	1	UNIPROT
8419	BFSP2	C3808377	CATARACT 16, MULTIPLE TYPES	0.2	0	0	ORPHANET
8419	BFSP2	C4021566	Progressive cataract	0.200274726784213	0	0	HPO
84197	POMK	C0265221	Walker-Warburg congenital muscular dystrophy	0.200274726784213	0	0	ORPHANET
84197	POMK	C1847759	MUSCULAR DYSTROPHY, CONGENITAL, 1C	0.2	0	0	ORPHANET
84197	POMK	C3150415	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	0.2	0	0	ORPHANET
84197	POMK	C3150416	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.2	0	0	ORPHANET
84197	POMK	C3808964	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12	0.2	2	5	UNIPROT
84197	POMK	C3809221	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14	0.2	0	0	ORPHANET
84197	POMK	C4015184	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12	0.2	0	0	ORPHANET
842	CASP9	C0007786	Brain Ischemia	0.2	1	0	CTD_human
842	CASP9	C0007787	Transient Ischemic Attack	0.28	1	0	CTD_human
842	CASP9	C0035305	Retinal Detachment	0.2	1	0	CTD_human
84216	TMEM117	C0008370	Cholestasis	0.2	1	0	CTD_human
84216	TMEM117	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
8422	MEHMO	C1846278	MENTAL RETARDATION, EPILEPTIC SEIZURES, HYPOGONADISM AND HYPOGENITALISM, MICROCEPHALY, AND OBESITY (disorder)	0.2	0	0	CTD_human
84233	TMEM126A	C2751812	OPTIC ATROPHY 7 (disorder)	0.4	0	0	CTD_human;ORPHANET
8425	LTBP4	C0010495	Cutis Laxa	0.2	0	0	HPO
8425	LTBP4	C0013264	Muscular Dystrophy, Duchenne	0.201098907136852	0	0	ORPHANET
8425	LTBP4	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
8425	LTBP4	C0020295	Hydronephrosis	0.2	0	0	HPO
8425	LTBP4	C0034067	Pulmonary Emphysema	0.200274726784213	0	0	HPO
8425	LTBP4	C0034888	Rectal Prolapse	0.2	0	0	HPO
8425	LTBP4	C0264353	Bronchomalacia	0.2	0	0	HPO
8425	LTBP4	C0948187	Tracheomalacia	0.2	0	0	HPO
8425	LTBP4	C2750804	Cutis Laxa With Severe Pulmonary, Gastrointestinal, And Urinary Abnormalities	0.68	1	8	CTD_human;ORPHANET;UNIPROT
8425	LTBP4	C2930812	Generalized elastolysis	0.2	0	0	HPO
84281	C2orf88	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
84282	RNF135	C3280095	MACROCEPHALY, MACROSOMIA, AND FACIAL DYSMORPHISM SYNDROME	0.4	1	4	ORPHANET;UNIPROT
84295	PHF6	C0265339	Borjeson-Forssman-Lehmann syndrome	0.603846174978984	3	11	CTD_human;ORPHANET;UNIPROT
843	CASP10	C0002880	Autoimmune hemolytic anemia	0.200274726784213	0	0	HPO
843	CASP10	C0014457	Eosinophilia	0.2	0	0	HPO
843	CASP10	C0027697	Nephritis	0.2	0	0	HPO
843	CASP10	C0042109	Urticaria	0.2	0	0	HPO
843	CASP10	C0042384	Vasculitis	0.2	0	0	HPO
843	CASP10	C0162316	Iron deficiency anemia	0.2	0	0	HPO
843	CASP10	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
843	CASP10	C0340971	Autoimmune neutropenia	0.2	0	0	HPO
843	CASP10	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
843	CASP10	C0520736	Coombs positive hemolytic anemia	0.2	0	0	HPO
843	CASP10	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
843	CASP10	C1328840	Autoimmune Lymphoproliferative Syndrome	0.201098907136852	0	0	ORPHANET
843	CASP10	C1858968	Autoimmune Lymphoproliferative Syndrome, Type IIA	0.400824180352639	1	2	CTD_human;UNIPROT
8431	NR0B2	C0023794	Lipoidosis	0.2	3	0	CTD_human
8431	NR0B2	C0028754	Obesity	0.41210065515107	0	0	CTD_human;HPO
84342	COG8	C1970021	Congenital Disorder Of Glycosylation, Type IIH	0.400549453568426	0	0	CTD_human;ORPHANET
84343	HPS3	C2931875	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells	0.2	0	0	CTD_human
84343	HPS3	C3888001	HERMANSKY-PUDLAK SYNDROME 3	0.280274726784213	1	6	UNIPROT
84376	HOOK3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
844	CASQ1	C4015624	MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES	0.4	1	1	ORPHANET;UNIPROT
8443	GNPAT	C0029453	Osteopenia	0.2	0	0	HPO
8443	GNPAT	C0747078	Generalized osteopenia	0.2	0	0	HPO
8443	GNPAT	C1857242	Rhizomelic chondrodysplasia punctata, type 2	0.680274726784213	2	3	CTD_human;ORPHANET;UNIPROT
8443	GNPAT	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
84433	CARD11	C0011615	Dermatitis, Atopic	0.2	1	0	CTD_human
84433	CARD11	C1847973	Persistent Polyclonal B-Cell Lymphocytosis	0.4	1	4	ORPHANET;UNIPROT
84433	CARD11	C3554686	IMMUNODEFICIENCY 11	0.2	0	0	ORPHANET
84434	THCYTX	C1845888	THROMBOCYTHEMIA, X-LINKED	0.2	0	0	CTD_human
84439	HHIPL1	C1956346	Coronary Artery Disease	0.2	1	1	CTD_human
84441	MAML2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
84464	SLX4	C0015625	Fanconi Anemia	0.403296721410557	3	1	CTD_human;ORPHANET
84466	MEGF10	C0035220	Respiratory Distress Syndrome, Newborn	0.2	1	0	CTD_human
84466	MEGF10	C3280679	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET	0.400274726784213	1	7	ORPHANET;UNIPROT
845	CASQ2	C0014544	Epilepsy	0.2	0	0	HPO
845	CASQ2	C0042514	Tachycardia, Ventricular	0.419405114037909	1	0	CTD_human;HPO
845	CASQ2	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	0.409890164231672	1	3	CTD_human;ORPHANET
845	CASQ2	C2677794	Stress-induced polymorphic ventricular tachycardia	0.480549453568426	3	8	CTD_human;UNIPROT
8450	CUL4B	C0014544	Epilepsy	0.200274726784213	0	0	HPO
8450	CUL4B	C0018418	Gynecomastia	0.2	0	0	HPO
8450	CUL4B	C0020619	Hypogonadism	0.2	0	0	HPO
8450	CUL4B	C0024421	Macroglossia	0.2	0	0	HPO
8450	CUL4B	C0028754	Obesity	0.200274726784213	0	0	HPO
8450	CUL4B	C1845861	MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT	0.600274726784213	1	5	CTD_human;ORPHANET;UNIPROT
8451	CUL4A	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
84515	MCM8	C4225402	PREMATURE OVARIAN FAILURE 10	0.2	1	1	UNIPROT
84519	ACRBP	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
8452	CUL3	C0033805	Pseudohypoaldosteronism	0.2	0	0	HPO
8452	CUL3	C0085679	Hyperchloremia	0.2	0	0	HPO
8452	CUL3	C3469606	PSEUDOHYPOALDOSTERONISM, TYPE IIE	0.480274726784213	1	2	ORPHANET;UNIPROT
84522	JAGN1	C0027947	Neutropenia	0.2	2	0	CTD_human
84522	JAGN1	C4014954	NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE	0.4	1	5	ORPHANET;UNIPROT
84529	C15orf41	C0271933	Congenital dyserythropoietic anemia, type I	0.2	0	0	ORPHANET
84529	C15orf41	C3810185	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib	0.2	1	2	UNIPROT
8454	CUL1	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
8456	FOXN1	C0002170	Alopecia	0.203557092817453	0	0	HPO
8456	FOXN1	C0221260	Dystrophia unguium	0.200549453568426	0	0	HPO
8456	FOXN1	C1866426	T-cell immunodeficiency, congenital alopecia and nail dystrophy	0.48	0	0	CTD_human;ORPHANET
8456	FOXN1	C2931322	T-Lymphocytopenia	0.2	0	0	HPO
8456	FOXN1	C4025208	Severe T-cell immunodeficiency	0.2	0	0	HPO
84565	LCS1	C0268314	Cholestasis-edema syndrome, Norwegian type	0.200274726784213	0	0	CTD_human
84570	COL25A1	C0013261	Duane Retraction Syndrome	0.2	0	0	ORPHANET
84570	COL25A1	C4015552	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5	0.2	1	2	UNIPROT
84572	GNPTG	C1854896	Mucolipidosis III Gamma	0.600274726784213	2	17	CTD_human;ORPHANET;UNIPROT
846	CASR	C0002170	Alopecia	0.2	0	0	HPO
846	CASR	C0002871	Anemia	0.2	0	0	HPO
846	CASR	C0014544	Epilepsy	0.200274726784213	0	0	HPO
846	CASR	C0020437	Hypercalcemia	0.456847972544619	1	1	CTD_human;HPO
846	CASR	C0020502	Hyperparathyroidism	0.421016672963193	2	0	CTD_human;HPO
846	CASR	C0020626	Hypoparathyroidism	0.213367389137178	1	0	CTD_human
846	CASR	C0027709	Nephrocalcinosis	0.200549453568426	0	0	HPO
846	CASR	C0030305	Pancreatitis	0.204655999954305	0	0	HPO
846	CASR	C0039621	Tetany	0.2	0	0	HPO
846	CASR	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
846	CASR	C0151714	Hypermagnesemia	0.2	0	0	HPO
846	CASR	C0154676	Organic writer's cramp	0.2	0	0	HPO
846	CASR	C0221002	Hyperparathyroidism, Primary	0.220053376515933	0	0	HPO
846	CASR	C0238621	Aminoaciduria	0.2	0	0	HPO
846	CASR	C0259817	Xerosis	0.2	0	0	HPO
846	CASR	C0270850	Idiopathic generalized epilepsy	0.200274726784213	0	0	CTD_human
846	CASR	C0342637	Hypocalciuric hypercalcemia, familial, type 1	0.704659898044549	12	25	CTD_human;ORPHANET;UNIPROT
846	CASR	C0392525	Nephrolithiasis	0.204120901763196	0	0	HPO
846	CASR	C0947912	Myasthenias	0.2	0	0	HPO
846	CASR	C1809471	Familial benign hypercalcemia	0.2230770498739	0	0	ORPHANET
846	CASR	C1832615	HYPERPARATHYROIDISM, NEONATAL SEVERE	0.69153852493695	4	11	CTD_human;ORPHANET;UNIPROT
846	CASR	C1832648	Hypoparathyroidism familial isolated	0.200274726784213	1	2	CTD_human
846	CASR	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
846	CASR	C3698239	Cerebral cortex myoclonus	0.2	0	0	HPO
846	CASR	C3715128	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.480549453568426	15	2	ORPHANET;UNIPROT
846	CASR	C4020884	Anxiety disease	0.2	0	0	HPO
8462	KLF11	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.412375381935283	0	0	HPO;ORPHANET
8462	KLF11	C0342276	Maturity onset diabetes mellitus in young	0.200274726784213	0	0	HPO
8462	KLF11	C1864839	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7 (disorder)	0.4	1	2	CTD_human;UNIPROT
84623	KIRREL3	C2675487	Mental Retardation, Autosomal Dominant 4	0.4	1	3	CTD_human;UNIPROT
84627	ZNF469	C0268344	Ehlers-Danlos syndrome 6B	0.402472541057918	1	5	CTD_human;ORPHANET
8463	TEAD2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
84631	SLITRK2	C0015923	Fetal Alcohol Syndrome	0.2	1	0	PSYGENET
84634	KISS1R	C0162809	Kallmann Syndrome	0.20350593566014	0	0	ORPHANET
84634	KISS1R	C0342384	Idiopathic hypogonadotropic hypogonadism	0.20439562854741	0	0	CTD_human
84634	KISS1R	C0342543	Precocious Puberty, Central	0.202197814273705	0	0	CTD_human
84634	KISS1R	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
84634	KISS1R	C3553841	HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA	0.28	5	6	UNIPROT
84634	KISS1R	C3805879	PRECOCIOUS PUBERTY, CENTRAL, 1	0.2	1	1	UNIPROT
84648	LCE3D	C0033860	Psoriasis	0.200274726784213	2	0	CTD_human
84649	DGAT2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
84662	GLIS2	C1855681	Nephronophthisis, familial juvenile	0.2	0	0	ORPHANET
84662	GLIS2	C1969092	NEPHRONOPHTHISIS 7	0.28	0	0	CTD_human
84665	MYPN	C0348616	Other restrictive cardiomyopathy	0.2	0	0	ORPHANET
84665	MYPN	C3714995	CARDIOMYOPATHY, DILATED, 1KK	0.2	3	15	UNIPROT
84665	MYPN	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
84665	MYPN	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
84667	HES7	C0265343	Jarcho-Levin syndrome	0.200824180352639	0	0	ORPHANET
84667	HES7	C3150942	SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE	0.4	2	3	CTD_human;UNIPROT
84687	PPP1R9B	C0037199	Sinusitis	0.2	1	0	CTD_human
84693	MCEE	C1855100	Methylmalonyl-CoA Epimerase Deficiency	0.4	0	0	CTD_human;ORPHANET
84699	CREB3L3	C0020481	Hyperlipoproteinemia Type V	0.2	0	0	ORPHANET
847	CAT	C0003873	Rheumatoid Arthritis	0.206238848124954	1	0	CTD_human
847	CAT	C0004045	Asphyxia Neonatorum	0.2	1	0	CTD_human
847	CAT	C0004096	Asthma	0.213250719445235	1	0	CTD_human
847	CAT	C0004943	Behcet Syndrome	0.2	1	0	CTD_human
847	CAT	C0007786	Brain Ischemia	0.2	1	0	CTD_human
847	CAT	C0011854	Diabetes Mellitus, Insulin-Dependent	0.209418899843569	1	0	CTD_human
847	CAT	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.212924835503709	2	0	CTD_human
847	CAT	C0013386	Dyskinesia, Drug-Induced	0.2	1	0	CTD_human
847	CAT	C0015695	Fatty Liver	0.200274726784213	1	0	CTD_human
847	CAT	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
847	CAT	C0019158	Hepatitis	0.2	1	0	CTD_human
847	CAT	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
847	CAT	C0020452	Hyperemia	0.2	1	0	CTD_human
847	CAT	C0020550	Hyperthyroidism	0.28	1	0	CTD_human
847	CAT	C0022593	Keratosis	0.2	1	0	CTD_human
847	CAT	C0022650	Kidney Calculi	0.2	1	0	CTD_human
847	CAT	C0022661	Kidney Failure, Chronic	0.282681755307501	2	0	CTD_human
847	CAT	C0023891	Liver Cirrhosis, Alcoholic	0.202681755307501	1	0	CTD_human
847	CAT	C0024141	Lupus Erythematosus, Systemic	0.211653515897269	1	0	CTD_human
847	CAT	C0024796	Marfan Syndrome	0.2	1	0	CTD_human
847	CAT	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
847	CAT	C0029458	Osteoporosis, Postmenopausal	0.2	1	0	CTD_human
847	CAT	C0033626	Protein Deficiency	0.2	1	0	CTD_human
847	CAT	C0033860	Psoriasis	0.203007639249027	1	0	CTD_human
847	CAT	C0034065	Pulmonary Embolism	0.2	1	0	CTD_human
847	CAT	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
847	CAT	C0038220	Status Epilepticus	0.2	4	0	CTD_human
847	CAT	C0038358	Gastric ulcer	0.2	1	0	CTD_human
847	CAT	C0041408	Turner Syndrome	0.2	1	0	CTD_human
847	CAT	C0149745	Oral Ulcer	0.2	0	0	HPO
847	CAT	C0268419	Acatalasia	0.40357144819477	5	0	CTD_human;ORPHANET
847	CAT	C1456865	Ureteral Calculi	0.2	1	0	CTD_human
847	CAT	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
84700	MYO18B	C4225285	KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM	0.2	0	0	ORPHANET
84701	COX4I2	C2675184	Exocrine Pancreatic Insufficiency, Dyserythropoietic Anemia, and Calvarial Hyperostosis	0.6	1	1	CTD_human;ORPHANET;UNIPROT
84705	GTPBP3	C4015447	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.4	1	7	ORPHANET;UNIPROT
84709	MGARP	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
84720	PIGO	C3553637	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2	0.2	1	4	UNIPROT
84733	CBX2	C2751317	46, XY Sex Reversal 5	0.4	1	2	CTD_human;UNIPROT
84733	CBX2	C2936694	Swyer Syndrome	0.2	0	0	ORPHANET
84735	CNDP1	C0011881	Diabetic Nephropathy	0.228186601375744	3	0	CTD_human
84735	CNDP1	C0268632	Homocarnosinosis	0.2	1	0	CTD_human
84752	B3GNT9	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
84790	TUBA1C	C0948089	Acute Coronary Syndrome	0.2	1	0	CTD_human
8481	OFD1	C0002170	Alopecia	0.2	0	0	HPO
8481	OFD1	C0011334	Dental caries	0.2	0	0	HPO
8481	OFD1	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
8481	OFD1	C0014544	Epilepsy	0.2	0	0	HPO
8481	OFD1	C0017601	Glaucoma	0.2	0	0	HPO
8481	OFD1	C0018777	Conductive hearing loss	0.2	0	0	HPO
8481	OFD1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
8481	OFD1	C0020255	Hydrocephalus	0.200274726784213	0	0	HPO
8481	OFD1	C0020459	Hyperinsulinism	0.2	0	0	HPO
8481	OFD1	C0020619	Hypogonadism	0.2	0	0	HPO
8481	OFD1	C0022521	Kartagener Syndrome	0.2	0	0	ORPHANET
8481	OFD1	C0022578	Keratoconus	0.2	0	0	HPO
8481	OFD1	C0028738	Nystagmus	0.2	0	0	HPO
8481	OFD1	C0028754	Obesity	0.2	0	0	HPO
8481	OFD1	C0029124	Optic Atrophy	0.2	0	0	HPO
8481	OFD1	C0029927	Ovarian Cysts	0.2	0	0	HPO
8481	OFD1	C0032285	Pneumonia	0.2	0	0	HPO
8481	OFD1	C0035334	Retinitis Pigmentosa	0.4	0	0	HPO;ORPHANET
8481	OFD1	C0078981	Arachnoid Cysts	0.2	0	0	HPO
8481	OFD1	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
8481	OFD1	C0239946	Fibrosis, Liver	0.2	0	0	HPO
8481	OFD1	C0264142	Spade-like hand	0.2	0	0	HPO
8481	OFD1	C0265251	Oto-Palato-digital syndrome type 1	0.2	1	0	CTD_human
8481	OFD1	C0266491	Neuronal heterotopia	0.2	0	0	HPO
8481	OFD1	C0267834	Liver cyst	0.2	0	0	HPO
8481	OFD1	C0271215	Blindness, Legal	0.2	0	0	HPO
8481	OFD1	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
8481	OFD1	C1510460	Orofaciodigital Syndrome I	0.401648360705279	5	99	ORPHANET;UNIPROT
8481	OFD1	C1846175	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2 (disorder)	0.400824180352639	0	0	CTD_human;ORPHANET
8481	OFD1	C2745997	OROFACIODIGITAL SYNDROME VI	0.2	0	0	ORPHANET
8481	OFD1	C2749019	JOUBERT SYNDROME 10 (disorder)	0.200824180352639	0	0	CTD_human
8481	OFD1	C2931426	Orofaciodigital syndrome type1	0.401373633921066	0	0	CTD_human;ORPHANET
8481	OFD1	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
8481	OFD1	C4082173	Porencephaly	0.2	0	0	HPO
84816	RTN4IP1	C4225227	OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.2	1	2	UNIPROT
84818	IL17RC	C0006845	Candidiasis, Chronic Mucocutaneous	0.200274726784213	0	0	ORPHANET
84823	LMNB2	C0220989	Acquired partial lipodystrophy	0.400824180352639	0	0	CTD_human;ORPHANET
84823	LMNB2	C4225289	EPILEPSY, PROGRESSIVE MYOCLONIC, 9	0.4	1	1	ORPHANET;UNIPROT
84830	ADTRP	C1956346	Coronary Artery Disease	0.201098907136852	1	0	CTD_human
84839	RAX2	C0035334	Retinitis Pigmentosa	0.2	0	0	ORPHANET
84839	RAX2	C1835865	Cone-Rod Dystrophy 11	0.4	1	4	CTD_human;UNIPROT
84839	RAX2	C3151060	Macular Degeneration, Age-Related, 6	0.2	1	2	UNIPROT
84876	ORAI1	C0410207	Tubular Aggregate Myopathy	0.200824180352639	0	0	ORPHANET
84876	ORAI1	C2748568	Immune dysfunction with T-cell inactivation due to calcium entry defect 1	0.6	1	4	CTD_human;ORPHANET;UNIPROT
84876	ORAI1	C4014557	MYOPATHY, TUBULAR AGGREGATE, 2	0.2	1	3	UNIPROT
84879	MFSD2A	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
84879	MFSD2A	C4225310	MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.2	2	2	UNIPROT
84892	POMGNT2	C0265221	Walker-Warburg congenital muscular dystrophy	0.200549453568426	0	0	ORPHANET
84892	POMGNT2	C3553813	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.2	1	2	UNIPROT
84894	LINGO1	C0270736	Essential Tremor	0.213055860572969	1	1	CTD_human
8490	RGS5	C0085580	Essential Hypertension	0.200549453568426	0	0	CTD_human
84909	C9orf3	C0004238	Atrial Fibrillation	0.200549453568426	1	1	CTD_human
84909	C9orf3	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
84913	ATOH8	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
84916	UTP4	C1858051	NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS	0.401923087489492	0	0	CTD_human;ORPHANET
84919	PPP1R15B	C4225195	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.2	1	1	UNIPROT
8492	PRSS12	C0028738	Nystagmus	0.2	0	0	HPO
8492	PRSS12	C0038379	Strabismus	0.2	0	0	HPO
8492	PRSS12	C1855304	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.2	0	0	CTD_human
84930	MASTL	C1861185	THROMBOCYTOPENIA 2 (disorder)	0.400274726784213	1	1	CTD_human;UNIPROT
84942	WDR73	C0795949	Galloway Mowat syndrome	0.401648360705279	1	9	CTD_human;ORPHANET
84947	SERAC1	C3553597	3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME	0.4	1	4	ORPHANET;UNIPROT
84981	MIR22HG	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
84984	CEP19	C3810324	MORBID OBESITY AND SPERMATOGENIC FAILURE	0.2	0	0	ORPHANET
84991	RBM17	C0087012	Ataxia, Spinocerebellar	0.2	1	0	CTD_human
84992	PIGY	C4225201	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.2	1	2	UNIPROT
85007	PHYKPL	C3554344	PHOSPHOHYDROXYLYSINURIA	0.200549453568426	1	2	UNIPROT
8504	PEX3	C0001403	Addison Disease	0.2	0	0	HPO
8504	PEX3	C0014544	Epilepsy	0.2	0	0	HPO
8504	PEX3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
8504	PEX3	C0020295	Hydronephrosis	0.2	0	0	HPO
8504	PEX3	C0028077	Night Blindness	0.2	0	0	HPO
8504	PEX3	C0028738	Nystagmus	0.2	0	0	HPO
8504	PEX3	C0029124	Optic Atrophy	0.2	0	0	HPO
8504	PEX3	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
8504	PEX3	C0038379	Strabismus	0.2	0	0	HPO
8504	PEX3	C0042798	Low Vision	0.2	0	0	HPO
8504	PEX3	C0043459	Zellweger Syndrome	0.401648360705279	1	0	CTD_human;ORPHANET
8504	PEX3	C0085605	Liver Failure	0.2	0	0	HPO
8504	PEX3	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
8504	PEX3	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
8504	PEX3	C0282527	Infantile Refsum Disease (disorder)	0.200274726784213	0	0	ORPHANET
8504	PEX3	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
8504	PEX3	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
8504	PEX3	C1836830	Developmental regression	0.2	0	0	HPO
8504	PEX3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8504	PEX3	C3553450	Profound global developmental delay	0.2	0	0	HPO
8504	PEX3	C3553999	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER)	0.2	1	0	UNIPROT
8504	PEX3	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
8506	CNTNAP1	C0003886	Arthrogryposis	0.200274726784213	0	0	HPO
8506	CNTNAP1	C1276035	Pena-Shokeir syndrome type I	0.2	0	0	HPO
8514	KCNAB2	C0014306	Enophthalmos	0.2	0	0	HPO
8514	KCNAB2	C0014544	Epilepsy	0.400274726784213	1	0	CTD_human;HPO
8514	KCNAB2	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
8514	KCNAB2	C0038379	Strabismus	0.2	0	0	HPO
8514	KCNAB2	C0235946	Cerebral atrophy	0.2	0	0	HPO
8514	KCNAB2	C1842870	Chromosome 1p36 Deletion Syndrome	0.280549453568426	0	0	ORPHANET
8514	KCNAB2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8516	ITGA8	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
8516	ITGA8	C1609433	Congenital absence of kidneys syndrome	0.200274726784213	0	0	ORPHANET
8517	IKBKG	C0002170	Alopecia	0.2	0	0	HPO
8517	IKBKG	C0013374	Dysgammaglobulinemia	0.2	0	0	HPO
8517	IKBKG	C0014457	Eosinophilia	0.2	0	0	HPO
8517	IKBKG	C0014544	Epilepsy	0.2	0	0	HPO
8517	IKBKG	C0021171	Bloch Sulzberger syndrome	0.71123272113639	9	6	CTD_human;ORPHANET;UNIPROT
8517	IKBKG	C0022568	Keratitis	0.2	0	0	HPO
8517	IKBKG	C0024236	Lymphedema	0.200824180352639	0	0	HPO
8517	IKBKG	C0029124	Optic Atrophy	0.2	0	0	HPO
8517	IKBKG	C0029454	Osteopetrosis	0.200549453568426	0	0	HPO
8517	IKBKG	C0035305	Retinal Detachment	0.2	0	0	HPO
8517	IKBKG	C0038379	Strabismus	0.2	0	0	HPO
8517	IKBKG	C0042164	Uveitis	0.2	0	0	HPO
8517	IKBKG	C0042798	Low Vision	0.2	0	0	HPO
8517	IKBKG	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
8517	IKBKG	C0162539	IgG Deficiency	0.2	0	0	HPO
8517	IKBKG	C0221260	Dystrophia unguium	0.2	0	0	HPO
8517	IKBKG	C0259817	Xerosis	0.2	0	0	HPO
8517	IKBKG	C0263537	Onychogryposis	0.2	0	0	HPO
8517	IKBKG	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
8517	IKBKG	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
8517	IKBKG	C0870082	Hyperkeratosis	0.2	0	0	HPO
8517	IKBKG	C1834405	Nail dysplasia	0.2	0	0	HPO
8517	IKBKG	C1845073	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2 (disorder)	0.4	1	1	CTD_human;UNIPROT
8517	IKBKG	C1845117	Immunodeficiency without anhidrotic ectodermal dysplasia	0.4	1	1	CTD_human;UNIPROT
8517	IKBKG	C1845919	Ectodermal Dysplasia, Anhidrotic, with Immunodeficiency, Osteopetrosis, and Lymphedema	0.4	0	0	CTD_human;ORPHANET
8517	IKBKG	C1846006	Ectodermal dysplasia, hypohidrotic, with immune deficiency	0.60357144819477	9	12	CTD_human;ORPHANET;UNIPROT
8517	IKBKG	C1970879	ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 1 (disorder)	0.6	3	2	CTD_human;ORPHANET;UNIPROT
8517	IKBKG	C4025314	Atrophic, patchy alopecia	0.2	0	0	HPO
8518	IKBKAP	C0003892	Neurogenic arthropathy	0.2	0	0	HPO
8518	IKBKAP	C0010043	Corneal Ulcer	0.2	0	0	HPO
8518	IKBKAP	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
8518	IKBKAP	C0020620	Hypohidrosis	0.2	0	0	HPO
8518	IKBKAP	C0024591	Malignant hyperpyrexia due to anesthesia	0.2	0	0	HPO
8518	IKBKAP	C0155119	Recurrent erosion of cornea	0.2	0	0	HPO
8518	IKBKAP	C0178664	Glomerulosclerosis (disorder)	0.2	0	0	HPO
8518	IKBKAP	C0344505	Alacrima	0.2	0	0	HPO
8518	IKBKAP	C0392163	Corneal erosion	0.2	0	0	HPO
8518	IKBKAP	C3806285	Recurrent infections due to aspiration	0.2	0	0	HPO
8522	GAS7	C0028754	Obesity	0.200274726784213	1	0	CTD_human
8525	DGKZ	C0027051	Myocardial Infarction	0.2	1	0	CTD_human
8526	DGKE	C0022660	Kidney Failure, Acute	0.2	0	0	HPO
8526	DGKE	C0268742	Membranoproliferative Glomerulonephritis, Type I	0.2	0	0	ORPHANET
8526	DGKE	C1720821	Membranoproliferative Glomerulonephritis, Type III	0.2	0	0	ORPHANET
8526	DGKE	C2931788	Atypical Hemolytic Uremic Syndrome	0.201373633921065	1	7	CTD_human
8526	DGKE	C3554330	NEPHROTIC SYNDROME, TYPE 7	0.4	1	5	ORPHANET;UNIPROT
85300	ATCAY	C1832585	CEREBELLAR ATAXIA, CAYMAN TYPE	0.680274726784213	1	0	CTD_human;ORPHANET;UNIPROT
85301	COL27A1	C3554594	STEEL SYNDROME	0.400274726784213	1	1	ORPHANET;UNIPROT
85358	SHANK3	C1853490	22q13.3 Deletion Syndrome	0.40439562854741	1	3	ORPHANET;UNIPROT
85358	SHANK3	C3151380	SCHIZOPHRENIA 15	0.2	1	2	UNIPROT
85358	SHANK3	C4048800	Telomeric 22q13 Monosomy Syndrome	0.2	1	0	CTD_human
85365	ALG2	C1842836	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii	0.4	0	0	CTD_human;ORPHANET
85365	ALG2	C4015597	MYASTHENIC SYNDROME, CONGENITAL, 14	0.2	1	2	UNIPROT
85366	MYLK2	C3495498	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	0.4	1	2	CTD_human;UNIPROT
85378	TUBGCP6	C3278481	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
8540	AGPS	C1838612	Rhizomelic chondrodysplasia punctata, type 3	0.68	3	4	CTD_human;ORPHANET;UNIPROT
8540	AGPS	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
85413	SLC22A16	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
85439	STON2	C1842605	SCHIZOPHRENIA 11	0.200274726784213	1	0	PSYGENET
8544	PIR	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
85440	DOCK7	C4014492	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23	0.2	0	0	ORPHANET
8546	AP3B1	C0011334	Dental caries	0.2	0	0	HPO
8546	AP3B1	C0028738	Nystagmus	0.2	0	0	HPO
8546	AP3B1	C0031099	Periodontitis	0.2	0	0	HPO
8546	AP3B1	C0034069	Pulmonary Fibrosis	0.200549453568426	0	0	HPO
8546	AP3B1	C0038379	Strabismus	0.2	0	0	HPO
8546	AP3B1	C0042798	Low Vision	0.2	0	0	HPO
8546	AP3B1	C1842362	HERMANSKY-PUDLAK SYNDROME 2	0.681098907136852	1	9	CTD_human;ORPHANET;UNIPROT
85463	ZC3H12C	C0033860	Psoriasis	0.2	1	0	CTD_human
8547	FCN3	C3151226	IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY	0.200274726784213	0	0	ORPHANET
85476	GFM1	C1836797	Combined Oxidative Phosphorylation Deficiency 1	0.6	3	5	CTD_human;ORPHANET;UNIPROT
85478	CCDC65	C0022521	Kartagener Syndrome	0.200549453568426	0	0	ORPHANET
85480	TSLP	C0004096	Asthma	0.226134167548616	1	0	CTD_human
85480	TSLP	C0011615	Dermatitis, Atopic	0.296114656979308	3	0	CTD_human
85480	TSLP	C0017662	Glomerulonephritis, Membranoproliferative	0.200274726784213	1	0	CTD_human
85480	TSLP	C0341106	Eosinophilic esophagitis	0.201923087489492	1	2	CTD_human
85502	SCAR3	C1849094	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.2	0	0	CTD_human
85503	MCOPCB1	C1845877	Microphthalmia, Isolated, with Coloboma 1	0.2	0	0	CTD_human
85504	BDET	C1853831	Bleeding Disorder, East Texas Type	0.2	0	0	CTD_human
85505	ACRPS	C1853812	Acropectoral syndrome	0.2	0	0	CTD_human
85507	DFNA18	C1853760	DEAFNESS, AUTOSOMAL DOMINANT 18 (disorder)	0.2	0	0	CTD_human
8553	BHLHE40	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
8557	TCAP	C0026850	Muscular Dystrophy	0.200549453568426	0	0	HPO
8557	TCAP	C0085684	Foot-drop	0.2	0	0	HPO
8557	TCAP	C1836451	Muscle atrophy, lower limb, distal	0.2	0	0	HPO
8557	TCAP	C1843791	CARDIOMYOPATHY, DILATED, 1N	0.2	0	0	CTD_human
8557	TCAP	C1866008	Muscular Dystrophy, Limb-Girdle, Type 2G	0.48	0	0	CTD_human;ORPHANET
8557	TCAP	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
8557	TCAP	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
8557	TCAP	C4225408	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25	0.2	2	3	UNIPROT
8564	KMO	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
8565	YARS	C1842237	Charcot-Marie-Tooth Disease, Dominant Intermediate C	0.6	1	4	CTD_human;ORPHANET;UNIPROT
8565	YARS	C1848736	Distal amyotrophy	0.2	0	0	HPO
8566	PDXK	C0038220	Status Epilepticus	0.2	1	0	CTD_human
857	CAV1	C0000889	Acanthosis Nigricans	0.2	0	0	HPO
857	CAV1	C0001206	Acromegaly	0.2	0	0	HPO
857	CAV1	C0003864	Arthritis	0.2	0	0	HPO
857	CAV1	C0004238	Atrial Fibrillation	0.202472541057918	2	1	CTD_human
857	CAV1	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
857	CAV1	C0011334	Dental caries	0.2	0	0	HPO
857	CAV1	C0011859	Lipoatrophic Diabetes Mellitus	0.2	0	0	ORPHANET
857	CAV1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
857	CAV1	C0017612	Glaucoma, Open-Angle	0.202407028523288	1	0	CTD_human
857	CAV1	C0020443	Hypercholesterolemia	0.2	0	0	HPO
857	CAV1	C0020459	Hyperinsulinism	0.200274726784213	0	0	HPO
857	CAV1	C0023787	Lipodystrophy	0.203831819601666	0	0	HPO
857	CAV1	C0028738	Nystagmus	0.2	0	0	HPO
857	CAV1	C0030305	Pancreatitis	0.2	0	0	HPO
857	CAV1	C0034013	Precocious Puberty	0.2	0	0	HPO
857	CAV1	C0034069	Pulmonary Fibrosis	0.204381273170092	0	0	HPO
857	CAV1	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
857	CAV1	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
857	CAV1	C0085605	Liver Failure	0.2	0	0	HPO
857	CAV1	C0206138	CREST Syndrome	0.2	0	0	ORPHANET
857	CAV1	C0271694	Familial partial lipodystrophy	0.200549453568426	1	0	CTD_human
857	CAV1	C0340543	Familial primary pulmonary hypertension	0.2	0	0	ORPHANET
857	CAV1	C0748540	Scleroderma, Limited	0.2	0	0	ORPHANET
857	CAV1	C1258104	Diffuse Scleroderma	0.2	0	0	ORPHANET
857	CAV1	C1280433	Lipoatrophy	0.2	0	0	HPO
857	CAV1	C2675861	Lipodystrophy, Congenital Generalized, Type 3	0.200274726784213	0	0	CTD_human
857	CAV1	C2711227	Steatohepatitis	0.2	0	0	HPO
857	CAV1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
857	CAV1	C3203102	Idiopathic pulmonary arterial hypertension	0.202472541057918	0	0	HPO
857	CAV1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
8572	PDLIM4	C0029456	Osteoporosis	0.203007639249027	0	0	CTD_human
8572	PDLIM4	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
8573	CASK	C0014544	Epilepsy	0.2	0	0	HPO
8573	CASK	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
8573	CASK	C0020620	Hypohidrosis	0.2	0	0	HPO
8573	CASK	C0027092	Myopia	0.2	0	0	HPO
8573	CASK	C0028738	Nystagmus	0.200824180352639	0	0	HPO
8573	CASK	C0038379	Strabismus	0.2	0	0	HPO
8573	CASK	C0042798	Low Vision	0.2	0	0	HPO
8573	CASK	C0220769	FG syndrome	0.200824180352639	0	0	CTD_human
8573	CASK	C0235946	Cerebral atrophy	0.2	0	0	HPO
8573	CASK	C0393706	Early infantile epileptic encephalopathy with suppression bursts	0.200274726784213	0	0	ORPHANET
8573	CASK	C1136249	Mental Retardation, X-Linked	0.201098907136852	2	0	CTD_human
8573	CASK	C1845546	FG SYNDROME 4 (disorder)	0.2	1	9	UNIPROT
8573	CASK	C2677903	Mental Retardation And Microcephaly With Pontine And Cerebellar Hypoplasia	0.600274726784213	1	24	CTD_human;ORPHANET;UNIPROT
8575	PRKRA	C1963946	Laryngeal dystonia	0.2	0	0	HPO
8575	PRKRA	C2677567	DYSTONIA 16 (disorder)	0.400274726784213	1	2	ORPHANET;UNIPROT
8575	PRKRA	C3887667	Retrocollis	0.2	0	0	HPO
8575	PRKRA	C4020859	Pyramidal tract disease	0.2	0	0	HPO
858	CAV2	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
858	CAV2	C0004238	Atrial Fibrillation	0.200549453568426	1	0	CTD_human
858	CAV2	C0017612	Glaucoma, Open-Angle	0.2	1	0	CTD_human
859	CAV3	C0018801	Heart failure	0.2	0	0	HPO
859	CAV3	C0018802	Congestive heart failure	0.2	0	0	HPO
859	CAV3	C0026850	Muscular Dystrophy	0.206029633875371	0	0	HPO
859	CAV3	C0035828	Romano-Ward Syndrome	0.2	0	0	ORPHANET
859	CAV3	C0038644	Sudden infant death syndrome	0.204106546385879	1	3	UNIPROT
859	CAV3	C0085612	Ventricular arrhythmia	0.2	0	0	HPO
859	CAV3	C0205700	Asymmetric Septal Hypertrophy	0.2	0	0	HPO
859	CAV3	C0340375	Subaortic stenosis	0.2	0	0	HPO
859	CAV3	C1832567	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C	0.680549453568426	6	13	CTD_human;ORPHANET;UNIPROT
859	CAV3	C1838254	RIPPLING MUSCLE DISEASE 1	0.205494535684262	1	0	CTD_human
859	CAV3	C1853698	Rippling muscle disease	0.406318716036901	5	8	ORPHANET;UNIPROT
859	CAV3	C2678485	LONG QT SYNDROME 9 (disorder)	0.400824180352639	2	6	CTD_human;UNIPROT
859	CAV3	C3280443	MYOPATHY, DISTAL, TATEYAMA TYPE	0.2	0	0	UNIPROT
859	CAV3	C3495498	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	0.4	1	1	CTD_human;UNIPROT
860	RUNX2	C0003872	Arthritis, Psoriatic	0.2	1	0	CTD_human
860	RUNX2	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
860	RUNX2	C0008928	Cleidocranial Dysplasia	0.730918826310469	12	15	CTD_human;ORPHANET;UNIPROT
860	RUNX2	C0011334	Dental caries	0.200274726784213	0	0	HPO
860	RUNX2	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
860	RUNX2	C0029408	Degenerative polyarthritis	0.201923087489492	1	0	CTD_human
860	RUNX2	C0029456	Osteoporosis	0.214609997988983	0	0	HPO
860	RUNX2	C0029464	Osteosclerosis	0.2	0	0	HPO
860	RUNX2	C0037199	Sinusitis	0.2	0	0	HPO
860	RUNX2	C0038016	Spondylolisthesis	0.2	0	0	HPO
860	RUNX2	C0038018	Spondylolysis	0.2	0	0	HPO
860	RUNX2	C0039144	Syringomyelia	0.2	0	0	HPO
860	RUNX2	C0041948	Uremia	0.200274726784213	1	0	CTD_human
860	RUNX2	C0265294	Pyle metaphyseal dysplasia	0.2	0	0	HPO
860	RUNX2	C0271441	Chronic otitis media	0.2	0	0	HPO
860	RUNX2	C0399385	Early tooth exfoliation	0.2	0	0	HPO
860	RUNX2	C0743359	ear infection chronic	0.2	0	0	HPO
860	RUNX2	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
860	RUNX2	C0949690	Spondylarthritis	0.2	1	0	CTD_human
860	RUNX2	C3549874	METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY	0.200549453568426	0	0	ORPHANET
860	RUNX2	C4025170	Osteoporosis of vertebrae	0.2	0	0	HPO
8600	TNFSF11	C0002382	Alveolar Bone Loss	0.205465824929628	1	0	CTD_human
8600	TNFSF11	C0002871	Anemia	0.2	0	0	HPO
8600	TNFSF11	C0008711	Chronic rhinitis	0.2	0	0	HPO
8600	TNFSF11	C0010278	Craniosynostosis	0.2	0	0	HPO
8600	TNFSF11	C0011334	Dental caries	0.2	0	0	HPO
8600	TNFSF11	C0011989	Camurati-Engelmann Syndrome	0.200274726784213	0	0	HPO
8600	TNFSF11	C0015469	Facial paralysis	0.2	0	0	HPO
8600	TNFSF11	C0020255	Hydrocephalus	0.2	0	0	HPO
8600	TNFSF11	C0020437	Hypercalcemia	0.200274726784213	1	0	CTD_human
8600	TNFSF11	C0028738	Nystagmus	0.2	0	0	HPO
8600	TNFSF11	C0029124	Optic Atrophy	0.2	0	0	HPO
8600	TNFSF11	C0029454	Osteopetrosis	0.40656473206648	1	0	CTD_human;HPO
8600	TNFSF11	C0029456	Osteoporosis	0.222548363976529	1	0	CTD_human
8600	TNFSF11	C0029882	Otitis Media	0.2	0	0	HPO
8600	TNFSF11	C0030312	Pancytopenia	0.2	0	0	HPO
8600	TNFSF11	C0042798	Low Vision	0.2	0	0	HPO
8600	TNFSF11	C0242567	Opsoclonus	0.2	0	0	HPO
8600	TNFSF11	C0266929	Chronic Periodontitis	0.203831819601666	1	0	CTD_human
8600	TNFSF11	C0271215	Blindness, Legal	0.2	0	0	HPO
8600	TNFSF11	C1290708	Osteomyelitis of mandible	0.2	0	0	HPO
8600	TNFSF11	C1850126	Osteopetrosis, mild autosomal recessive form	0.48	1	2	CTD_human;UNIPROT
8600	TNFSF11	C2613439	Extramedullary Hematopoiesis (disorder)	0.2	0	0	HPO
8600	TNFSF11	C4025318	Chronic rhinitis due to narrow nasal airway	0.2	0	0	HPO
8604	SLC25A12	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
8604	SLC25A12	C0014544	Epilepsy	0.2	0	0	HPO
8604	SLC25A12	C2751855	Hypomyelination, Global Cerebral	0.6	2	2	CTD_human;ORPHANET;UNIPROT
861	RUNX1	C0003873	Rheumatoid Arthritis	0.215760062283148	1	0	CTD_human
861	RUNX1	C0836924	Thrombocytosis	0.2	0	0	HPO
861	RUNX1	C1832388	Platelet Disorder, Familial, with Associated Myeloid Malignancy	0.600549453568426	1	9	CTD_human;ORPHANET;UNIPROT
8613	PLPP3	C1956346	Coronary Artery Disease	0.201098907136852	1	1	CTD_human
8614	STC2	C0014175	Endometriosis	0.2	1	0	CTD_human
8614	STC2	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
8622	PDE8B	C0020619	Hypogonadism	0.2	0	0	HPO
8622	PDE8B	C0029456	Osteoporosis	0.2	0	0	HPO
8622	PDE8B	C0234958	muscle degeneration	0.2	0	0	HPO
8622	PDE8B	C1621895	Adrenal hyperplasia	0.200824180352639	0	0	HPO
8622	PDE8B	C1836694	Striatal Degeneration, Autosomal Dominant	0.400549453568426	0	0	CTD_human;ORPHANET
8622	PDE8B	C3280094	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3	0.2	1	1	UNIPROT
8622	PDE8B	C4022417	Degeneration of the striatum	0.2	0	0	HPO
8622	PDE8B	C4024947	Symmetric lesions of the basal ganglia	0.2	0	0	HPO
8624	PSMG1	C0009324	Ulcerative Colitis	0.200274726784213	1	0	CTD_human
8625	RFXANK	C0001768	Agammaglobulinemia	0.2	0	0	HPO
8625	RFXANK	C0006845	Candidiasis, Chronic Mucocutaneous	0.2	0	0	HPO
8625	RFXANK	C0009319	Colitis	0.2	0	0	HPO
8625	RFXANK	C0014038	Encephalitis	0.2	0	0	HPO
8625	RFXANK	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
8625	RFXANK	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
8625	RFXANK	C0393441	Chronic lymphocytic meningitis	0.2	0	0	HPO
8625	RFXANK	C0451696	Major histocompatibility complex class II deficiency	0.200274726784213	0	0	ORPHANET
8625	RFXANK	C0473133	Protracted diarrhea	0.2	0	0	HPO
8625	RFXANK	C0581381	Recurrent upper respiratory tract infection	0.2	0	0	HPO
8625	RFXANK	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8625	RFXANK	C2931418	Bare lymphocyte syndrome 2	0.601098907136852	1	1	CTD_human;ORPHANET;UNIPROT
8626	TP63	C0002170	Alopecia	0.2	0	0	HPO
8626	TP63	C0003028	Anhidrosis	0.2	0	0	HPO
8626	TP63	C0005689	Bladder Exstrophy	0.480549453568426	0	0	HPO;ORPHANET
8626	TP63	C0005741	Blepharitis	0.2	0	0	HPO
8626	TP63	C0009763	Conjunctivitis	0.2	0	0	HPO
8626	TP63	C0010930	Dacryocystitis	0.2	0	0	HPO
8626	TP63	C0011334	Dental caries	0.2	0	0	HPO
8626	TP63	C0013595	Eczema	0.2	0	0	HPO
8626	TP63	C0018777	Conductive hearing loss	0.2	0	0	HPO
8626	TP63	C0020295	Hydronephrosis	0.2	0	0	HPO
8626	TP63	C0020620	Hypohidrosis	0.2	0	0	HPO
8626	TP63	C0022568	Keratitis	0.200549453568426	0	0	HPO
8626	TP63	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
8626	TP63	C0042454	Velopharyngeal Insufficiency	0.2	0	0	HPO
8626	TP63	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
8626	TP63	C0158113	Contracture of joint of hand	0.2	0	0	HPO
8626	TP63	C0221260	Dystrophia unguium	0.2	0	0	HPO
8626	TP63	C0259817	Xerosis	0.2	0	0	HPO
8626	TP63	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
8626	TP63	C0263537	Onychogryposis	0.2	0	0	HPO
8626	TP63	C0266039	Taurodontism	0.2	0	0	HPO
8626	TP63	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
8626	TP63	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
8626	TP63	C0392163	Corneal erosion	0.2	0	0	HPO
8626	TP63	C0406704	Rudiger syndrome 1	0.404945082115836	1	0	CTD_human;ORPHANET
8626	TP63	C0687720	Central Diabetes Insipidus	0.2	0	0	HPO
8626	TP63	C0747085	Recurrent otitis media	0.2	0	0	HPO
8626	TP63	C0870082	Hyperkeratosis	0.2	0	0	HPO
8626	TP63	C1785148	RAPP-HODGKIN SYNDROME	0.603296721410557	6	4	CTD_human;ORPHANET;UNIPROT
8626	TP63	C1834405	Nail dysplasia	0.2	0	0	HPO
8626	TP63	C1854442	SPLIT-HAND/FOOT MALFORMATION 4	0.401098907136852	2	3	CTD_human;UNIPROT
8626	TP63	C1857079	Atretic auditory canal	0.2	0	0	HPO
8626	TP63	C1858562	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3	0.480274726784213	5	10	CTD_human;UNIPROT
8626	TP63	C1863204	ADULT SYNDROME	0.602747267842131	1	8	CTD_human;ORPHANET;UNIPROT
8626	TP63	C1863753	LIMB-MAMMARY SYNDROME	0.400549453568426	1	1	CTD_human;ORPHANET
8626	TP63	C1867060	Lacrimal Puncta, Absence of	0.2	0	0	HPO
8626	TP63	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
8626	TP63	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
8626	TP63	C4020952	Fingernail dysplasia	0.2	0	0	HPO
8629	JRK	C0014548	Epilepsy, Generalized	0.2	1	0	CTD_human
8629	JRK	C0014553	Absence Epilepsy	0.200824180352639	1	0	CTD_human
8629	JRK	C0270853	Myoclonic Epilepsy, Juvenile	0.400274726784213	1	0	CTD_human;ORPHANET
8629	JRK	C1838604	EPILEPSY, CHILDHOOD ABSENCE, 1	0.2	0	0	ORPHANET
8635	RNASET2	C0018213	Graves Disease	0.200274726784213	1	0	CTD_human
8635	RNASET2	C2751843	Leukoencephalopathy, Cystic, Without Megalencephaly	0.6	1	1	CTD_human;ORPHANET;UNIPROT
8638	OASL	C0021400	Influenza	0.2	1	0	CTD_human
8639	AOC3	C0011881	Diabetic Nephropathy	0.2	1	0	CTD_human
8639	AOC3	C0030524	Paratuberculosis	0.2	1	0	CTD_human
8639	AOC3	C0403447	Chronic Kidney Insufficiency	0.2	1	0	CTD_human
864	RUNX3	C0007570	Celiac Disease	0.2	1	0	CTD_human
864	RUNX3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
864	RUNX3	C0033860	Psoriasis	0.200274726784213	1	0	CTD_human
864	RUNX3	C0038013	Ankylosing spondylitis	0.201098907136852	1	0	CTD_human
8642	DCHS1	C0018777	Conductive hearing loss	0.2	0	0	HPO
8642	DCHS1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
8642	DCHS1	C0024636	Malocclusion	0.2	0	0	HPO
8642	DCHS1	C0026267	Mitral Valve Prolapse Syndrome	0.280274726784213	0	0	HPO
8642	DCHS1	C0029453	Osteopenia	0.2	0	0	HPO
8642	DCHS1	C0747078	Generalized osteopenia	0.2	0	0	HPO
8642	DCHS1	C0948187	Tracheomalacia	0.2	0	0	HPO
8642	DCHS1	C1832390	Van Maldergem Wetzburger Verloes syndrome	0.6	1	3	CTD_human;ORPHANET;UNIPROT
8642	DCHS1	C1842563	Heterotopia, Periventricular, Autosomal Recessive	0.2	1	0	CTD_human
8642	DCHS1	C1843003	MITRAL VALVE PROLAPSE, MYXOMATOUS 2	0.2	1	2	UNIPROT
8642	DCHS1	C1857079	Atretic auditory canal	0.2	0	0	HPO
8642	DCHS1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
8643	PTCH2	C0017601	Glaucoma	0.2	0	0	HPO
8643	PTCH2	C0020255	Hydrocephalus	0.2	0	0	HPO
8643	PTCH2	C0038379	Strabismus	0.2	0	0	HPO
8643	PTCH2	C0155285	Orbital cyst	0.2	0	0	HPO
8643	PTCH2	C1397139	Calcification of falx cerebri	0.2	0	0	HPO
8643	PTCH2	C3150792	MACROSTOMIA, ISOLATED	0.2	0	0	ORPHANET
8644	AKR1C3	C0014175	Endometriosis	0.200549453568426	2	0	CTD_human
8644	AKR1C3	C0028754	Obesity	0.200549453568426	1	0	CTD_human
8644	AKR1C3	C0032460	Polycystic Ovary Syndrome	0.285912964183428	3	0	CTD_human
8645	KCNK5	C0038220	Status Epilepticus	0.2	1	0	CTD_human
8647	ABCB11	C0001733	Afibrinogenemia	0.2	1	0	CTD_human
8647	ABCB11	C0008350	Cholelithiasis	0.206187690967642	0	0	HPO
8647	ABCB11	C0008370	Cholestasis	0.214704221278248	3	0	CTD_human
8647	ABCB11	C0008372	Intrahepatic Cholestasis	0.420625276487037	1	0	CTD_human;HPO
8647	ABCB11	C0023890	Liver Cirrhosis	0.20433011601278	0	0	HPO
8647	ABCB11	C0268307	Conjugated hyperbilirubinemia	0.2	0	0	HPO
8647	ABCB11	C0268312	Progressive intrahepatic cholestasis (disorder)	0.214011065994868	1	0	CTD_human
8647	ABCB11	C0268318	Cholestasis of pregnancy	0.206318716036901	0	0	ORPHANET
8647	ABCB11	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8647	ABCB11	C2608083	Cholestasis, benign recurrent intrahepatic 2	0.600549453568426	2	16	CTD_human;ORPHANET;UNIPROT
8647	ABCB11	C3489789	Cholestasis, Progressive Familial Intrahepatic, 2	0.602747267842131	6	14	CTD_human;ORPHANET;UNIPROT
8648	NCOA1	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
8651	SOCS1	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
8653	DDX3Y	C0004509	Azoospermia	0.200274726784213	0	0	HPO
8653	DDX3Y	C0028960	Oligospermia	0.201098907136852	0	0	HPO
8653	DDX3Y	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
8655	DYNLL1	C0007786	Brain Ischemia	0.2	1	0	CTD_human
8659	ALDH4A1	C0014544	Epilepsy	0.2	0	0	HPO
8659	ALDH4A1	C0268528	Hyperprolinemia	0.200274726784213	0	0	HPO
8659	ALDH4A1	C0268534	Prolinuria	0.2	0	0	HPO
8659	ALDH4A1	C0543541	HYPERGLYCINURIA (disorder)	0.2	0	0	HPO
8659	ALDH4A1	C2931835	Hyperprolinemia type 2	0.600824180352639	2	3	CTD_human;ORPHANET;UNIPROT
866	SERPINA6	C0015695	Fatty Liver	0.2	1	0	CTD_human
866	SERPINA6	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
866	SERPINA6	C1852529	Corticosteroid-Binding Globulin Deficiency	0.681098907136852	4	2	CTD_human;ORPHANET;UNIPROT
866	SERPINA6	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
8660	IRS2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.31000737455061	0	0	CTD_human
8660	IRS2	C0020456	Hyperglycemia	0.200549453568426	2	0	CTD_human
867	CBL	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
867	CBL	C0042384	Vasculitis	0.2	1	0	CTD_human
867	CBL	C3150803	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.600274726784213	1	8	CTD_human;ORPHANET;UNIPROT
8671	SLC4A4	C0017601	Glaucoma	0.400274726784213	1	0	CTD_human;HPO
8671	SLC4A4	C0085569	Metabolic acidosis, NAG, acidifying salts	0.2	0	0	HPO
8671	SLC4A4	C0155120	Corneal Dystrophy, Band-Shaped	0.200274726784213	0	0	HPO
8671	SLC4A4	C0268435	Renal Tubular Acidosis, Type II	0.286593442821114	0	0	HPO
8671	SLC4A4	C1970309	Renal Tubular Acidosis, Proximal, With Ocular Abnormalities And Mental Retardation	0.6	3	3	CTD_human;ORPHANET;UNIPROT
8675	STX16	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
8675	STX16	C0028738	Nystagmus	0.2	0	0	HPO
8675	STX16	C0033805	Pseudohypoaldosteronism	0.2	0	0	CTD_human
8675	STX16	C0033806	Pseudohypoparathyroidism	0.201098907136852	0	0	HPO
8675	STX16	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
8675	STX16	C2932715	Pseudohypoparathyroidism Type 1B	0.200274726784213	0	0	ORPHANET
8676	STX11	C1863728	Hemophagocytic lymphohistiocytosis, familial, 4	0.280824180352639	0	0	CTD_human
8678	BECN1	C0027051	Myocardial Infarction	0.280274726784213	1	0	CTD_human
8678	BECN1	C0038220	Status Epilepticus	0.28	1	0	CTD_human
8678	BECN1	C0752347	Lewy Body Disease	0.2	1	0	CTD_human
868	CBLB	C0026769	Multiple Sclerosis	0.205912964183428	1	1	CTD_human
8691	IDDM17	C1864068	DIABETES MELLITUS, INSULIN-DEPENDENT, 17	0.2	0	0	CTD_human
8694	DGAT1	C0020443	Hypercholesterolemia	0.2	0	0	HPO
8694	DGAT1	C0020473	Hyperlipidemia	0.2	0	0	HPO
8694	DGAT1	C0239981	Hypoalbuminemia	0.2	0	0	HPO
8694	DGAT1	C4014516	DIARRHEA 7	0.2	0	0	ORPHANET
87	ACTN1	C1861195	Glanzmann Thrombasthenia, Autosomal Dominant	0.2	0	0	ORPHANET
87	ACTN1	C3554663	BLEEDING DISORDER, PLATELET-TYPE, 15	0.2	2	6	UNIPROT
8701	DNAH11	C0006267	Bronchiectasis	0.200274726784213	0	0	HPO
8701	DNAH11	C0010068	Coronary heart disease	0.202407028523288	1	0	CTD_human
8701	DNAH11	C0022521	Kartagener Syndrome	0.21007066772662	0	0	ORPHANET
8701	DNAH11	C2678473	CILIARY DYSKINESIA, PRIMARY, 7 (disorder)	0.48	1	14	CTD_human;UNIPROT
871	SERPINH1	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
871	SERPINH1	C0029453	Osteopenia	0.2	0	0	HPO
871	SERPINH1	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
871	SERPINH1	C0268362	Osteogenesis imperfecta type III (disorder)	0.2	0	0	ORPHANET
871	SERPINH1	C0392525	Nephrolithiasis	0.2	0	0	HPO
871	SERPINH1	C0740392	Infarction, Middle Cerebral Artery	0.2	1	0	CTD_human
871	SERPINH1	C0746102	Chronic lung disease	0.2	0	0	HPO
871	SERPINH1	C0747078	Generalized osteopenia	0.2	0	0	HPO
871	SERPINH1	C3151211	OSTEOGENESIS IMPERFECTA, TYPE X	0.28	1	2	UNIPROT
8710	SERPINB7	C0022596	Palmoplantar Keratosis	0.200549453568426	0	0	HPO
8710	SERPINB7	C1274743	Hyperhidrosis Palmaris Et Plantaris	0.2	0	0	HPO
8710	SERPINB7	C3810072	PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE	0.2	0	0	ORPHANET
8714	ABCC3	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
8714	ABCC3	C0008370	Cholestasis	0.280549453568426	1	0	CTD_human
87178	PNPT1	C1824925	DEAFNESS, AUTOSOMAL RECESSIVE 70	0.2	1	1	UNIPROT
87178	PNPT1	C3554129	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13	0.4	1	5	ORPHANET;UNIPROT
8722	CTSF	C0014544	Epilepsy	0.2	0	0	HPO
8722	CTSF	C0262404	Cerebellar degeneration	0.2	0	0	HPO
8722	CTSF	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
8722	CTSF	C3715049	CEROID LIPOFUSCINOSIS, NEURONAL, 13	0.4	1	6	ORPHANET;UNIPROT
8722	CTSF	C4020873	Infratentorial atrophy	0.2	0	0	HPO
8724	SNX3	C1832440	MICROPHTHALMIA, SYNDROMIC 8	0.200274726784213	0	0	CTD_human
873	CBR1	C0162823	Dermatitis, Irritant	0.2	1	0	CTD_human
8735	MYH13	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
8738	CRADD	C3281044	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34	0.2	1	4	UNIPROT
8740	TNFSF14	C0003873	Rheumatoid Arthritis	0.204655999954305	1	0	CTD_human
8740	TNFSF14	C0026769	Multiple Sclerosis	0.200549453568426	1	1	CTD_human
8741	TNFSF13	C0017661	IGA Glomerulonephritis	0.201373633921065	1	1	CTD_human
8742	TNFSF12	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
8742	TNFSF12	C0006267	Bronchiectasis	0.2	0	0	HPO
8742	TNFSF12	C0009447	Common Variable Immunodeficiency	0.2	0	0	ORPHANET
8742	TNFSF12	C0024312	Lymphopenia	0.2	0	0	HPO
8742	TNFSF12	C0032285	Pneumonia	0.2	0	0	HPO
8742	TNFSF12	C0034150	Purpura	0.2	0	0	HPO
8742	TNFSF12	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
8742	TNFSF12	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
8742	TNFSF12	C0271441	Chronic otitis media	0.2	0	0	HPO
8742	TNFSF12	C0398650	Immune thrombocytopenic purpura	0.200274726784213	0	0	HPO
8742	TNFSF12	C0741796	Recurrent bronchitis	0.2	0	0	HPO
8742	TNFSF12	C0743359	ear infection chronic	0.2	0	0	HPO
8742	TNFSF12	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
8743	TNFSF10	C0021400	Influenza	0.203557092817453	1	0	CTD_human
8744	TNFSF9	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
875	CBS	C0007786	Brain Ischemia	0.204814057046576	0	0	HPO
875	CBS	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202407028523288	1	0	CTD_human
875	CBS	C0014544	Epilepsy	0.2	0	0	HPO
875	CBS	C0017601	Glaucoma	0.2	0	0	HPO
875	CBS	C0019880	Homocystinuria	0.436746197818302	0	0	CTD_human;HPO
875	CBS	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
875	CBS	C0027051	Myocardial Infarction	0.210177567661578	0	0	HPO
875	CBS	C0027092	Myopia	0.2	0	0	HPO
875	CBS	C0029456	Osteoporosis	0.2	0	0	HPO
875	CBS	C0030305	Pancreatitis	0.2	0	0	HPO
875	CBS	C0034065	Pulmonary Embolism	0.200274726784213	0	0	HPO
875	CBS	C0085307	Embolism and Thrombosis	0.2	0	0	HPO
875	CBS	C0162429	Malnutrition	0.202681755307501	1	0	CTD_human
875	CBS	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
875	CBS	C0263401	Cutis marmorata	0.2	0	0	HPO
875	CBS	C0263490	Brittle hair	0.2	0	0	HPO
875	CBS	C0598608	Hyperhomocysteinemia	0.229248706732601	3	0	CTD_human
875	CBS	C0751202	Cystathionine beta-Synthase Deficiency Disease	0.489000471344402	29	53	ORPHANET;UNIPROT
875	CBS	C0917798	Cerebral Ischemia	0.200274726784213	0	0	HPO
875	CBS	C2711227	Steatohepatitis	0.200549453568426	0	0	HPO
875	CBS	C3805887	Generalized osteoporosis with pathologic fractures	0.2	0	0	HPO
8754	ADAM9	C0028077	Night Blindness	0.2	0	0	HPO
8754	ADAM9	C0035334	Retinitis Pigmentosa	0.400824180352639	0	0	HPO;ORPHANET
8754	ADAM9	C0042798	Low Vision	0.2	0	0	HPO
8754	ADAM9	C0730290	Cone dystrophy	0.2	0	0	HPO
8754	ADAM9	C1423873	CONE-ROD DYSTROPHY 9	0.280274726784213	0	0	CTD_human
8754	ADAM9	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
8764	TNFRSF14	C0003873	Rheumatoid Arthritis	0.216141689002319	1	0	CTD_human
8764	TNFRSF14	C0007570	Celiac Disease	0.2	1	0	CTD_human
8766	RAB11A	C0263454	Chloracne	0.2	1	0	CTD_human
8767	RIPK2	C0009324	Ulcerative Colitis	0.200274726784213	1	0	CTD_human
8772	FADD	C0014544	Epilepsy	0.2	0	0	HPO
8772	FADD	C0018784	Sensorineural Hearing Loss (disorder)	0.2	1	0	CTD_human
8772	FADD	C0235946	Cerebral atrophy	0.2	0	0	HPO
8772	FADD	C1833693	Otodental Dysplasia	0.2	0	0	ORPHANET
8772	FADD	C2750325	Oculootodental Syndrome	0.2	0	0	ORPHANET
8772	FADD	C3151062	INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.4	1	1	ORPHANET;UNIPROT
8772	FADD	C4020860	Supratentorial atrophy	0.2	0	0	HPO
8773	SNAP23	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
8777	MPDZ	C0009451	Communicating Hydrocephalus	0.2	0	0	HPO
8777	MPDZ	C0014544	Epilepsy	0.2	0	0	HPO
8777	MPDZ	C0149821	ACUTE ALCOHOL WITHDRAWAL	0.200274726784213	1	0	PSYGENET
8777	MPDZ	C0236663	Alcohol withdrawal syndrome	0.200549453568426	3	0	PSYGENET
8777	MPDZ	C0586323	Alcohol Withdrawal Seizures	0.200274726784213	1	0	PSYGENET
8782	MYP3	C1864111	MYOPIA 3 (disorder)	0.2	0	0	CTD_human
8784	TNFRSF18	C0023281	Leishmaniasis	0.2	1	0	CTD_human
8787	RGS9	C0013386	Dyskinesia, Drug-Induced	0.2	2	0	CTD_human
8787	RGS9	C0042798	Low Vision	0.2	0	0	HPO
8788	DLK1	C1842466	Uniparental disomy, paternal, chromosome 14	0.200274726784213	0	0	ORPHANET
8792	TNFRSF11A	C0002871	Anemia	0.2	0	0	HPO
8792	TNFRSF11A	C0018777	Conductive hearing loss	0.2	0	0	HPO
8792	TNFRSF11A	C0028738	Nystagmus	0.2	0	0	HPO
8792	TNFRSF11A	C0029401	Osteitis Deformans	0.208451017775976	1	0	CTD_human
8792	TNFRSF11A	C0029454	Osteopetrosis	0.204655999954305	0	0	HPO
8792	TNFRSF11A	C0399385	Early tooth exfoliation	0.2	0	0	HPO
8792	TNFRSF11A	C0694550	Recurrent pneumonia	0.2	0	0	HPO
8792	TNFRSF11A	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
8792	TNFRSF11A	C2676766	Osteopetrosis, Autosomal Recessive 7	0.6	1	5	CTD_human;ORPHANET;UNIPROT
8794	TNFRSF10C	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
8797	TNFRSF10A	C0002170	Alopecia	0.2	1	0	CTD_human
8797	TNFRSF10A	C0002871	Anemia	0.2	1	0	CTD_human
8797	TNFRSF10A	C0003123	Anorexia	0.2	1	0	CTD_human
8797	TNFRSF10A	C0027947	Neutropenia	0.2	1	0	CTD_human
8797	TNFRSF10A	C0242383	Age related macular degeneration	0.200824180352639	1	1	CTD_human
8799	PEX11B	C0001403	Addison Disease	0.2	0	0	HPO
8799	PEX11B	C0014544	Epilepsy	0.2	0	0	HPO
8799	PEX11B	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
8799	PEX11B	C0020295	Hydronephrosis	0.2	0	0	HPO
8799	PEX11B	C0028077	Night Blindness	0.2	0	0	HPO
8799	PEX11B	C0028738	Nystagmus	0.2	0	0	HPO
8799	PEX11B	C0029124	Optic Atrophy	0.2	0	0	HPO
8799	PEX11B	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
8799	PEX11B	C0038379	Strabismus	0.2	0	0	HPO
8799	PEX11B	C0042798	Low Vision	0.2	0	0	HPO
8799	PEX11B	C0043459	Zellweger Syndrome	0.200274726784213	0	0	ORPHANET
8799	PEX11B	C0085605	Liver Failure	0.2	0	0	HPO
8799	PEX11B	C0152025	Polyneuropathy	0.2	0	0	HPO
8799	PEX11B	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
8799	PEX11B	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
8799	PEX11B	C0282527	Infantile Refsum Disease (disorder)	0.2	0	0	ORPHANET
8799	PEX11B	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
8799	PEX11B	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
8799	PEX11B	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
8799	PEX11B	C1836830	Developmental regression	0.2	0	0	HPO
8799	PEX11B	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8799	PEX11B	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
8799	PEX11B	C3553450	Profound global developmental delay	0.2	0	0	HPO
8799	PEX11B	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
88	ACTN2	C0014117	Endocardial Fibroelastosis	0.200274726784213	0	0	HPO
88	ACTN2	C2677338	Cardiomyopathy, Dilated, 1AA	0.4	4	6	CTD_human;UNIPROT
88	ACTN2	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
88	ACTN2	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
8800	PEX11A	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
8801	SUCLG2	C0014175	Endometriosis	0.2	1	0	CTD_human
8801	SUCLG2	C0028754	Obesity	0.2	1	0	CTD_human
8802	SUCLG1	C0014544	Epilepsy	0.2	0	0	HPO
8802	SUCLG1	C0020615	Hypoglycemia	0.2	0	0	HPO
8802	SUCLG1	C0234958	muscle degeneration	0.2	0	0	HPO
8802	SUCLG1	C0235946	Cerebral atrophy	0.2	0	0	HPO
8802	SUCLG1	C1145670	Respiratory Failure	0.2	0	0	HPO
8802	SUCLG1	C1855119	Methylmalonic aciduria	0.200549453568426	0	0	HPO
8802	SUCLG1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8802	SUCLG1	C3151476	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	0.6	3	6	CTD_human;ORPHANET;UNIPROT
8802	SUCLG1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
8803	SUCLA2	C0014544	Epilepsy	0.200549453568426	0	0	HPO
8803	SUCLA2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
8803	SUCLA2	C0028754	Obesity	0.2	1	0	CTD_human
8803	SUCLA2	C0038379	Strabismus	0.2	0	0	HPO
8803	SUCLA2	C0042798	Low Vision	0.2	0	0	HPO
8803	SUCLA2	C0234958	muscle degeneration	0.2	0	0	HPO
8803	SUCLA2	C0235946	Cerebral atrophy	0.2	0	0	HPO
8803	SUCLA2	C0238621	Aminoaciduria	0.2	0	0	HPO
8803	SUCLA2	C1837658	Gross motor development delay	0.2	0	0	HPO
8803	SUCLA2	C1855119	Methylmalonic aciduria	0.201098907136852	0	0	HPO
8803	SUCLA2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8803	SUCLA2	C2749864	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA)	0.68	2	4	CTD_human;ORPHANET;UNIPROT
8803	SUCLA2	C3149750	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.2	0	0	CTD_human
8803	SUCLA2	C3151513	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.2	0	0	CTD_human
8803	SUCLA2	C4020860	Supratentorial atrophy	0.2	0	0	HPO
8803	SUCLA2	C4020871	Dystonic disease	0.2	0	0	HPO
8803	SUCLA2	C4280575	Progressive brain disease	0.2	0	0	HPO
8807	IL18RAP	C0009324	Ulcerative Colitis	0.205088783830789	1	0	CTD_human
8813	DPM1	C0014544	Epilepsy	0.2	0	0	HPO
8813	DPM1	C0026850	Muscular Dystrophy	0.2	0	0	HPO
8813	DPM1	C0028738	Nystagmus	0.2	0	0	HPO
8813	DPM1	C0029124	Optic Atrophy	0.2	0	0	HPO
8813	DPM1	C0038379	Strabismus	0.2	0	0	HPO
8813	DPM1	C0039446	Telangiectasis	0.2	0	0	HPO
8813	DPM1	C0155320	Blindness, Cortical	0.2	0	0	HPO
8813	DPM1	C0242666	Protein S Deficiency	0.2	0	0	HPO
8813	DPM1	C0272375	Antithrombin III Deficiency	0.2	0	0	HPO
8813	DPM1	C0398625	Protein C Deficiency	0.2	0	0	HPO
8813	DPM1	C1834405	Nail dysplasia	0.2	0	0	HPO
8813	DPM1	C1837396	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie	0.600824180352639	3	4	CTD_human;ORPHANET;UNIPROT
8813	DPM1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8815	BANF1	C0004153	Atherosclerosis	0.2	0	0	HPO
8815	BANF1	C0015300	Exophthalmos	0.2	0	0	HPO
8815	BANF1	C0029456	Osteoporosis	0.2	0	0	HPO
8815	BANF1	C0039239	Sinus Tachycardia	0.2	0	0	HPO
8815	BANF1	C0085615	Right bundle branch block	0.2	0	0	HPO
8815	BANF1	C1280433	Lipoatrophy	0.2	0	0	HPO
8815	BANF1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8815	BANF1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
8815	BANF1	C3151446	NESTOR-GUILLERMO PROGERIA SYNDROME	0.400549453568426	1	1	ORPHANET;UNIPROT
8815	BANF1	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
8817	FGF18	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
8818	DPM2	C0014544	Epilepsy	0.200274726784213	0	0	HPO
8818	DPM2	C0029124	Optic Atrophy	0.2	0	0	HPO
8818	DPM2	C0038379	Strabismus	0.2	0	0	HPO
8818	DPM2	C3554385	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu	0.4	1	2	ORPHANET;UNIPROT
882	CCAL1	C1833499	CHONDROCALCINOSIS WITH EARLY-ONSET OSTEOARTHRITIS (disorder)	0.2	0	0	CTD_human
8820	HESX1	C0011848	Diabetes Insipidus	0.2	0	0	HPO
8820	HESX1	C0014544	Epilepsy	0.2	0	0	HPO
8820	HESX1	C0020615	Hypoglycemia	0.2	0	0	HPO
8820	HESX1	C0020676	Hypothyroidism	0.2	0	0	HPO
8820	HESX1	C0028738	Nystagmus	0.2	0	0	HPO
8820	HESX1	C0029453	Osteopenia	0.2	0	0	HPO
8820	HESX1	C0038379	Strabismus	0.2	0	0	HPO
8820	HESX1	C0042798	Low Vision	0.2	0	0	HPO
8820	HESX1	C0162809	Kallmann Syndrome	0.200549453568426	0	0	ORPHANET
8820	HESX1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
8820	HESX1	C0271801	Central hypothyroidism	0.2	0	0	HPO
8820	HESX1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
8820	HESX1	C0747078	Generalized osteopenia	0.2	0	0	HPO
8820	HESX1	C0948740	Pituitary hypoplasia	0.2	0	0	HPO
8820	HESX1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8820	HESX1	C2751608	Pituitary Hormone Deficiency, Combined, 1	0.2	0	0	ORPHANET
8820	HESX1	C2930844	Hypopituitarism and septooptic 'dysplasia'	0.200274726784213	0	0	CTD_human
8820	HESX1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
8820	HESX1	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
8820	HESX1	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
8820	HESX1	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
8820	HESX1	C4053775	Pituitary stalk interruption syndrome	0.400274726784213	0	0	HPO;ORPHANET
8822	FGF17	C0018418	Gynecomastia	0.2	0	0	HPO
8822	FGF17	C0020619	Hypogonadism	0.2	0	0	HPO
8822	FGF17	C0029453	Osteopenia	0.2	0	0	HPO
8822	FGF17	C0029456	Osteoporosis	0.2	0	0	HPO
8822	FGF17	C0151721	Testicular hypogonadism	0.2	0	0	HPO
8822	FGF17	C0162809	Kallmann Syndrome	0.2	0	0	ORPHANET
8822	FGF17	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
8822	FGF17	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
8822	FGF17	C0242350	Erectile dysfunction	0.2	0	0	HPO
8822	FGF17	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
8822	FGF17	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
8822	FGF17	C0747078	Generalized osteopenia	0.2	0	0	HPO
8822	FGF17	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
8822	FGF17	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
8822	FGF17	C3808983	HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA	0.2	1	3	UNIPROT
8822	FGF17	C4020884	Anxiety disease	0.2	0	0	HPO
8822	FGF17	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
8822	FGF17	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
8823	FGF16	C1839728	METACARPAL 4-5 FUSION	0.4	1	3	ORPHANET;UNIPROT
8829	NRP1	C0014175	Endometriosis	0.2	1	0	CTD_human
8831	SYNGAP1	C0014544	Epilepsy	0.201373633921065	1	0	CTD_human
8831	SYNGAP1	C1836830	Developmental regression	0.2	0	0	HPO
8831	SYNGAP1	C2675473	Mental Retardation, Autosomal Dominant 5	0.4	1	17	CTD_human;UNIPROT
8835	SOCS2	C0027404	Narcolepsy	0.2	1	0	CTD_human
8835	SOCS2	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
8836	GGH	C0003873	Rheumatoid Arthritis	0.210452294445791	1	0	CTD_human
8836	GGH	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
8838	WISP3	C0029408	Degenerative polyarthritis	0.20328236603324	0	0	HPO
8838	WISP3	C0029456	Osteoporosis	0.2	0	0	HPO
8842	PROM1	C0017601	Glaucoma	0.2	0	0	HPO
8842	PROM1	C0018777	Conductive hearing loss	0.2	0	0	HPO
8842	PROM1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
8842	PROM1	C0020459	Hyperinsulinism	0.2	0	0	HPO
8842	PROM1	C0020619	Hypogonadism	0.2	0	0	HPO
8842	PROM1	C0022578	Keratoconus	0.2	0	0	HPO
8842	PROM1	C0024437	Macular degeneration	0.200274726784213	0	0	HPO
8842	PROM1	C0028077	Night Blindness	0.2	0	0	HPO
8842	PROM1	C0028738	Nystagmus	0.200274726784213	0	0	HPO
8842	PROM1	C0028754	Obesity	0.200274726784213	0	0	HPO
8842	PROM1	C0029124	Optic Atrophy	0.2	0	0	HPO
8842	PROM1	C0035334	Retinitis Pigmentosa	0.402472541057918	0	0	HPO;ORPHANET
8842	PROM1	C0271215	Blindness, Legal	0.2	0	0	HPO
8842	PROM1	C0730290	Cone dystrophy	0.2	0	0	HPO
8842	PROM1	C0730292	Macular dystrophy	0.200824180352639	0	0	HPO
8842	PROM1	C0858618	Dyschromatopsia	0.2	0	0	HPO
8842	PROM1	C1863534	Stargardt disease 4	0.4	0	0	CTD_human;UNIPROT
8842	PROM1	C2675210	CONE-ROD DYSTROPHY 12 (disorder)	0.4	1	4	CTD_human;UNIPROT
8842	PROM1	C2677516	RETINITIS PIGMENTOSA 41 (disorder)	0.28	0	0	CTD_human
8842	PROM1	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
885	CCK	C0003123	Anorexia	0.200274726784213	2	0	CTD_human
885	CCK	C0013386	Dyskinesia, Drug-Induced	0.2	1	0	CTD_human
885	CCK	C0030305	Pancreatitis	0.200824180352639	1	0	CTD_human
885	CCK	C0038358	Gastric ulcer	0.2	6	0	CTD_human
885	CCK	C0236663	Alcohol withdrawal syndrome	0.200824180352639	1	0	PSYGENET
8854	ALDH1A2	C0029408	Degenerative polyarthritis	0.2	1	1	CTD_human
8856	NR1I2	C0004763	Barrett Esophagus	0.2	1	0	CTD_human
8856	NR1I2	C0015695	Fatty Liver	0.200549453568426	1	0	CTD_human
8856	NR1I2	C0028754	Obesity	0.200549453568426	1	0	CTD_human
8856	NR1I2	C0524620	Metabolic Syndrome X	0.200549453568426	1	0	CTD_human
8856	NR1I2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
8863	PER3	C3807327	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1	0.2	0	0	ORPHANET
8864	PER2	C1858496	Advanced Sleep-Phase Syndrome, Familial	0.202472541057918	0	0	CTD_human
8864	PER2	C3807327	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1	0.4	1	1	ORPHANET;UNIPROT
8867	SYNJ1	C0014544	Epilepsy	0.2	0	0	HPO
8867	SYNJ1	C0085623	Akinesia	0.2	0	0	HPO
8867	SYNJ1	C0235946	Cerebral atrophy	0.2	0	0	HPO
8867	SYNJ1	C3809824	PARKINSON DISEASE 20, EARLY-ONSET	0.200274726784213	1	1	UNIPROT
8867	SYNJ1	C4020871	Dystonic disease	0.2	0	0	HPO
8869	ST3GAL5	C0029124	Optic Atrophy	0.2	0	0	HPO
8869	ST3GAL5	C0038220	Status Epilepticus	0.2	0	0	HPO
8869	ST3GAL5	C0085583	Choreoathetosis	0.2	0	0	HPO
8869	ST3GAL5	C0155320	Blindness, Cortical	0.200274726784213	0	0	HPO
8869	ST3GAL5	C0494475	Tonic - clonic seizures	0.2	0	0	HPO
8869	ST3GAL5	C1836824	Amish Infantile Epilepsy Syndrome	0.4	0	0	CTD_human;ORPHANET
8869	ST3GAL5	C1836830	Developmental regression	0.2	0	0	HPO
8869	ST3GAL5	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8875	VNN2	C0011615	Dermatitis, Atopic	0.2	1	0	CTD_human
8875	VNN2	C0033860	Psoriasis	0.200274726784213	1	0	CTD_human
8876	VNN1	C0011615	Dermatitis, Atopic	0.2	1	0	CTD_human
8876	VNN1	C0033860	Psoriasis	0.200274726784213	1	0	CTD_human
8877	SPHK1	C0009324	Ulcerative Colitis	0.2	1	0	CTD_human
8878	SQSTM1	C0002736	Amyotrophic Lateral Sclerosis	0.60439562854741	1	0	CTD_human;HPO;ORPHANET
8878	SQSTM1	C0020676	Hypothyroidism	0.2	0	0	HPO
8878	SQSTM1	C0029401	Osteitis Deformans	0.255774270757373	0	0	CTD_human
8878	SQSTM1	C0085684	Foot-drop	0.2	0	0	HPO
8878	SQSTM1	C0151311	Cranial nerve palsies	0.2	0	0	HPO
8878	SQSTM1	C0234958	muscle degeneration	0.2	0	0	HPO
8878	SQSTM1	C0235946	Cerebral atrophy	0.2	0	0	HPO
8878	SQSTM1	C0242383	Age related macular degeneration	0.2	1	0	CTD_human
8878	SQSTM1	C0270680	Posterior fossa compression syndrome	0.2	0	0	HPO
8878	SQSTM1	C0338451	Frontotemporal dementia	0.201648360705279	0	0	HPO
8878	SQSTM1	C0399385	Early tooth exfoliation	0.2	0	0	HPO
8878	SQSTM1	C0410550	Collapse of vertebra	0.2	0	0	HPO
8878	SQSTM1	C1145670	Respiratory Failure	0.2	0	0	HPO
8878	SQSTM1	C1301959	Bulbar weakness	0.2	0	0	HPO
8878	SQSTM1	C1853926	NONAKA MYOPATHY	0.200274726784213	0	0	ORPHANET
8878	SQSTM1	C4011788	Behavioral variant of frontotemporal dementia	0.2	0	0	ORPHANET
8878	SQSTM1	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
8878	SQSTM1	C4020884	Anxiety disease	0.2	0	0	HPO
8878	SQSTM1	C4021584	Frontotemporal cerebral atrophy	0.2	0	0	HPO
8878	SQSTM1	C4082299	Bulbar palsy	0.2	0	0	HPO
8878	SQSTM1	C4085252	PAGET DISEASE OF BONE 3	0.2	12	7	UNIPROT
8878	SQSTM1	C4225326	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3	0.2	3	21	UNIPROT
889	KRIT1	C0014544	Epilepsy	0.200274726784213	0	0	HPO
8890	EIF2B4	C0014544	Epilepsy	0.200274726784213	0	0	HPO
8890	EIF2B4	C0025322	Premature Menopause	0.2	0	0	HPO
8890	EIF2B4	C0029124	Optic Atrophy	0.2	0	0	HPO
8890	EIF2B4	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
8890	EIF2B4	C0338474	Central nervous system demyelination	0.2	0	0	HPO
8890	EIF2B4	C1836830	Developmental regression	0.2	0	0	HPO
8890	EIF2B4	C1847967	OVARIOLEUKODYSTROPHY	0.400824180352639	1	2	CTD_human;ORPHANET
8890	EIF2B4	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	0.405219808900049	3	8	ORPHANET;UNIPROT
8891	EIF2B3	C0014544	Epilepsy	0.2	0	0	HPO
8891	EIF2B3	C0025322	Premature Menopause	0.2	0	0	HPO
8891	EIF2B3	C0029124	Optic Atrophy	0.2	0	0	HPO
8891	EIF2B3	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
8891	EIF2B3	C0338474	Central nervous system demyelination	0.2	0	0	HPO
8891	EIF2B3	C1836830	Developmental regression	0.2	0	0	HPO
8891	EIF2B3	C1847967	OVARIOLEUKODYSTROPHY	0.4	0	0	CTD_human;ORPHANET
8891	EIF2B3	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	0.4	3	4	ORPHANET;UNIPROT
8892	EIF2B2	C0014544	Epilepsy	0.2	0	0	HPO
8892	EIF2B2	C0025322	Premature Menopause	0.2	0	0	HPO
8892	EIF2B2	C0029124	Optic Atrophy	0.2	0	0	HPO
8892	EIF2B2	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
8892	EIF2B2	C0338474	Central nervous system demyelination	0.2	0	0	HPO
8892	EIF2B2	C1836830	Developmental regression	0.2	0	0	HPO
8892	EIF2B2	C1847967	OVARIOLEUKODYSTROPHY	0.400824180352639	1	4	CTD_human;ORPHANET
8892	EIF2B2	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	0.404945082115836	5	8	ORPHANET;UNIPROT
8893	EIF2B5	C0014544	Epilepsy	0.200274726784213	0	0	HPO
8893	EIF2B5	C0025322	Premature Menopause	0.2	0	0	HPO
8893	EIF2B5	C0029124	Optic Atrophy	0.2	0	0	HPO
8893	EIF2B5	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
8893	EIF2B5	C0338474	Central nervous system demyelination	0.2	0	0	HPO
8893	EIF2B5	C1836830	Developmental regression	0.2	0	0	HPO
8893	EIF2B5	C1847967	OVARIOLEUKODYSTROPHY	0.400274726784213	1	2	CTD_human;ORPHANET
8893	EIF2B5	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	0.481923087489492	6	29	ORPHANET;UNIPROT
8898	MTMR2	C0376175	Bell Palsy	0.2	0	0	HPO
8898	MTMR2	C1832399	Charcot-Marie-Tooth disease, Type 4B1	0.681923087489492	1	3	CTD_human;ORPHANET;UNIPROT
8898	MTMR2	C1848736	Distal amyotrophy	0.2	0	0	HPO
8905	AP1S2	C0020255	Hydrocephalus	0.200274726784213	0	0	HPO
8905	AP1S2	C0023882	Little's Disease	0.2	0	0	HPO
8905	AP1S2	C0038379	Strabismus	0.2	0	0	HPO
8905	AP1S2	C0235946	Cerebral atrophy	0.2	0	0	HPO
8905	AP1S2	C0796254	DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, BASAL GANGLIA DISEASE, AND SEIZURES	0.480274726784213	3	6	CTD_human;ORPHANET
891	CCNB1	C0032460	Polycystic Ovary Syndrome	0.200274726784213	1	0	CTD_human
8910	SGCE	C0154676	Organic writer's cramp	0.200824180352639	0	0	HPO
8910	SGCE	C1834570	Myoclonic dystonia	0.701153962384409	6	9	CTD_human;ORPHANET;UNIPROT
8910	SGCE	C4020884	Anxiety disease	0.2	0	0	HPO
8912	CACNA1H	C0014553	Absence Epilepsy	0.210620121295047	0	0	CTD_human
8912	CACNA1H	C1838604	EPILEPSY, CHILDHOOD ABSENCE, 1	0.2	0	0	ORPHANET
8913	CACNA1G	C4225205	SPINOCEREBELLAR ATAXIA 42	0.4	1	1	ORPHANET;UNIPROT
8915	BCL10	C0002871	Anemia	0.2	0	0	HPO
8915	BCL10	C0014038	Encephalitis	0.2	0	0	HPO
8915	BCL10	C0014544	Epilepsy	0.2	0	0	HPO
8915	BCL10	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
8924	HERC2	C0009324	Ulcerative Colitis	0.210228724818891	1	0	CTD_human
8924	HERC2	C0020459	Hyperinsulinism	0.2	0	0	HPO
8924	HERC2	C0020490	Hyperopia	0.2	0	0	HPO
8924	HERC2	C0028754	Obesity	0.2	0	0	HPO
8924	HERC2	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
8924	HERC2	C0038379	Strabismus	0.2	0	0	HPO
8924	HERC2	C0264423	Asthma, Occupational	0.2	1	0	CTD_human
8924	HERC2	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
8924	HERC2	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
8924	HERC2	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
8924	HERC2	C3809753	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38	0.4	1	1	ORPHANET;UNIPROT
8929	PHOX2B	C0010346	Crohn Disease	0.208045265922503	1	0	CTD_human
8929	PHOX2B	C0013363	Dysautonomia	0.200274726784213	0	0	HPO
8929	PHOX2B	C0014544	Epilepsy	0.200274726784213	0	0	HPO
8929	PHOX2B	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
8929	PHOX2B	C0038379	Strabismus	0.200274726784213	0	0	HPO
8929	PHOX2B	C0520680	Sleep Apnea, Central	0.203231208875927	0	0	HPO
8929	PHOX2B	C1275808	Congenital central hypoventilation	0.710363647978394	3	1	CTD_human;ORPHANET;UNIPROT
8929	PHOX2B	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
8929	PHOX2B	C2931189	Neural crest tumor	0.200274726784213	0	0	ORPHANET
894	CCND2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.202956482091714	1	0	CTD_human
894	CCND2	C0014544	Epilepsy	0.2	0	0	HPO
894	CCND2	C0020255	Hydrocephalus	0.2	0	0	HPO
894	CCND2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
894	CCND2	C1863924	Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	0.2	1	0	CTD_human
894	CCND2	C4014742	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3	0.2	1	6	UNIPROT
8942	KYNU	C0151747	Renal tubular disorder	0.2	0	0	HPO
8942	KYNU	C0238621	Aminoaciduria	0.2	0	0	HPO
8942	KYNU	C4024950	Nonprogressive encephalopathy	0.2	0	0	HPO
8976	WASL	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
89765	RSPH1	C0022521	Kartagener Syndrome	0.201373633921065	0	0	ORPHANET
89765	RSPH1	C3809634	CILIARY DYSKINESIA, PRIMARY, 24	0.2	1	6	UNIPROT
89780	WNT3A	C0264080	Juvenile osteoporosis	0.2	0	0	ORPHANET
89781	HPS4	C2931875	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells	0.2	0	0	CTD_human
8985	PLOD3	C0027092	Myopia	0.2	0	0	HPO
8985	PLOD3	C0029453	Osteopenia	0.2	0	0	HPO
8985	PLOD3	C0747078	Generalized osteopenia	0.2	0	0	HPO
8985	PLOD3	C0751003	Brain Aneurysm	0.2	0	0	HPO
8985	PLOD3	C1290398	Cerebral arterial aneurysm	0.2	0	0	HPO
8985	PLOD3	C1834405	Nail dysplasia	0.2	0	0	HPO
8985	PLOD3	C2676285	Bone Fragility with Contractures, Arterial Rupture, and Deafness	0.6	1	2	CTD_human;ORPHANET;UNIPROT
8988	HSPB3	C0234958	muscle degeneration	0.2	0	0	HPO
8988	HSPB3	C3150619	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC	0.4	1	1	CTD_human;UNIPROT
89884	LHX4	C2678408	PITUITARY HORMONE DEFICIENCY, COMBINED, 4	0.6	2	7	CTD_human;ORPHANET;UNIPROT
89884	LHX4	C2751608	Pituitary Hormone Deficiency, Combined, 1	0.2	0	0	ORPHANET
89884	LHX4	C4053775	Pituitary stalk interruption syndrome	0.200274726784213	0	0	ORPHANET
8989	TRPA1	C0004096	Asthma	0.2	1	0	CTD_human
8989	TRPA1	C0085129	Bronchial Hyperreactivity	0.2	1	0	CTD_human
8989	TRPA1	C0878773	Overactive Bladder	0.28	2	0	CTD_human
8989	TRPA1	C3808667	EPISODIC PAIN SYNDROME, FAMILIAL, 1	0.4	1	1	ORPHANET;UNIPROT
89891	WDR34	C0432197	Short rib-polydactyly syndrome, Verma-Naumoff type	0.200274726784213	0	0	ORPHANET
89891	WDR34	C3810200	SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY	0.2	2	9	UNIPROT
8991	SELENBP1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
89910	UBE3B	C1855663	Kaufman oculocerebrofacial syndrome	0.481098907136852	1	4	ORPHANET;UNIPROT
8996	NOL3	C3539916	MYOCLONUS, FAMILIAL CORTICAL	0.400274726784213	2	2	ORPHANET;UNIPROT
89970	RSPRY1	C4225232	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE	0.4	1	2	ORPHANET;UNIPROT
9	NAT1	C0028796	Dermatitis, Occupational	0.202407028523288	1	0	CTD_human
90	ACVR1	C0002170	Alopecia	0.2	0	0	HPO
90	ACVR1	C0016037	Fibrodysplasia Ossificans Progressiva	0.496208880268573	2	9	ORPHANET;UNIPROT
90	ACVR1	C0018777	Conductive hearing loss	0.2	0	0	HPO
90	ACVR1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
90	ACVR1	C0027122	Myositis Ossificans	0.202732912464814	0	0	CTD_human
90	ACVR1	C0746926	Multiple, subcutaneous nodules	0.2	0	0	HPO
90	ACVR1	C1145670	Respiratory Failure	0.2	0	0	HPO
9002	F2RL3	C0008370	Cholestasis	0.2	1	0	CTD_human
9002	F2RL3	C0030781	Peliosis Hepatis	0.2	1	0	CTD_human
9002	F2RL3	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
90121	TSR2	C4225422	DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS	0.2	1	1	UNIPROT
90167	FRMD7	C1839580	Nystagmus 1, congenital, X- linked	0.4	12	10	CTD_human;UNIPROT
9021	SOCS3	C0004153	Atherosclerosis	0.200824180352639	1	0	CTD_human
9021	SOCS3	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
9021	SOCS3	C1853963	DERMATITIS, ATOPIC, 4	0.2	0	0	CTD_human
90226	UCN2	C0003123	Anorexia	0.2	1	0	CTD_human
90226	UCN2	C0018801	Heart failure	0.200274726784213	1	0	CTD_human
9031	BAZ1B	C0003499	Supravalvular aortic stenosis	0.2	0	0	HPO
9031	BAZ1B	C0007786	Brain Ischemia	0.2	0	0	HPO
9031	BAZ1B	C0012819	Diverticular disease of colon	0.2	0	0	HPO
9031	BAZ1B	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9031	BAZ1B	C0020437	Hypercalcemia	0.200274726784213	0	0	HPO
9031	BAZ1B	C0020545	Hypertension, Renovascular	0.2	0	0	HPO
9031	BAZ1B	C0024421	Macroglossia	0.2	0	0	HPO
9031	BAZ1B	C0024636	Malocclusion	0.2	0	0	HPO
9031	BAZ1B	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
9031	BAZ1B	C0028754	Obesity	0.2	0	0	HPO
9031	BAZ1B	C0035078	Kidney Failure	0.2	0	0	HPO
9031	BAZ1B	C0038379	Strabismus	0.2	0	0	HPO
9031	BAZ1B	C0042798	Low Vision	0.2	0	0	HPO
9031	BAZ1B	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
9031	BAZ1B	C0175702	Williams Syndrome	0.482197814273705	1	0	CTD_human;ORPHANET
9031	BAZ1B	C0271441	Chronic otitis media	0.2	0	0	HPO
9031	BAZ1B	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
9031	BAZ1B	C0743359	ear infection chronic	0.2	0	0	HPO
9031	BAZ1B	C0917798	Cerebral Ischemia	0.2	0	0	HPO
9031	BAZ1B	C1565489	Renal Insufficiency	0.2	0	0	HPO
9031	BAZ1B	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
9031	BAZ1B	C4020884	Anxiety disease	0.2	0	0	HPO
9031	BAZ1B	C4025788	Nystagmus-induced head nodding	0.2	0	0	HPO
9031	BAZ1B	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
90326	THAP3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
9037	SEMA5A	C0010314	Cri-du-Chat Syndrome	0.200274726784213	0	0	ORPHANET
90411	MCFD2	C1856883	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF	0.401923087489492	0	0	CTD_human;ORPHANET
90411	MCFD2	C3150889	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2	0.4	3	6	CTD_human;UNIPROT
9045	RPL14	C0030567	Parkinson Disease	0.2	1	0	CTD_human
9049	AIP	C0001206	Acromegaly	0.40357144819477	0	0	HPO;ORPHANET
9049	AIP	C0007789	Cerebral Palsy	0.2	0	0	HPO
9049	AIP	C0018418	Gynecomastia	0.2	0	0	HPO
9049	AIP	C0020514	Hyperprolactinemia	0.2	0	0	HPO
9049	AIP	C0024421	Macroglossia	0.2	0	0	HPO
9049	AIP	C0029408	Degenerative polyarthritis	0.2	0	0	HPO
9049	AIP	C0029453	Osteopenia	0.2	0	0	HPO
9049	AIP	C0029456	Osteoporosis	0.2	0	0	HPO
9049	AIP	C0034150	Purpura	0.2	0	0	HPO
9049	AIP	C0035854	Rosacea	0.2	0	0	HPO
9049	AIP	C0037315	Sleep Apnea Syndromes	0.2	0	0	HPO
9049	AIP	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
9049	AIP	C0151721	Testicular hypogonadism	0.2	0	0	HPO
9049	AIP	C0234958	muscle degeneration	0.2	0	0	HPO
9049	AIP	C0242350	Erectile dysfunction	0.2	0	0	HPO
9049	AIP	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
9049	AIP	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
9049	AIP	C0342388	Adrenocorticotropic hormone (ACTH) deficiency (disorder)	0.2	0	0	HPO
9049	AIP	C0392525	Nephrolithiasis	0.2	0	0	HPO
9049	AIP	C0410550	Collapse of vertebra	0.2	0	0	HPO
9049	AIP	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
9049	AIP	C0747078	Generalized osteopenia	0.2	0	0	HPO
9049	AIP	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
9049	AIP	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
9049	AIP	C3665358	Galactorrhea	0.2	0	0	HPO
9049	AIP	C4020884	Anxiety disease	0.2	0	0	HPO
9049	AIP	C4023211	Adrenocorticotropin deficient adrenal insufficiency	0.2	0	0	HPO
9049	AIP	C4024716	Secondary growth hormone deficiency	0.2	0	0	HPO
9049	AIP	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
9051	PSTPIP1	C0003864	Arthritis	0.2	0	0	HPO
9051	PSTPIP1	C0020455	Hypergammaglobulinemia	0.2	0	0	HPO
9051	PSTPIP1	C0034212	Pyoderma	0.2	0	0	HPO
9051	PSTPIP1	C0702166	Acne	0.2	0	0	HPO
9051	PSTPIP1	C1858361	Pyogenic Arthritis, Pyoderma Gangrenosum and Acne	0.603296721410557	1	5	CTD_human;ORPHANET;UNIPROT
9052	GPRC5A	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
9055	PRC1	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
9056	SLC7A7	C0002871	Anemia	0.2	0	0	HPO
9056	SLC7A7	C0010495	Cutis Laxa	0.2	0	0	HPO
9056	SLC7A7	C0023530	Leukopenia	0.2	0	0	HPO
9056	SLC7A7	C0029456	Osteoporosis	0.2	0	0	HPO
9056	SLC7A7	C0030305	Pancreatitis	0.2	0	0	HPO
9056	SLC7A7	C0034050	Pulmonary Alveolar Proteinosis	0.200274726784213	0	0	HPO
9056	SLC7A7	C0162429	Malnutrition	0.2	0	0	HPO
9056	SLC7A7	C0234958	muscle degeneration	0.2	0	0	HPO
9056	SLC7A7	C0238621	Aminoaciduria	0.2	0	0	HPO
9056	SLC7A7	C0268647	Lysinuric Protein Intolerance	0.606593442821114	1	45	CTD_human;ORPHANET;UNIPROT
9056	SLC7A7	C0876991	Histiocytosis haematophagic	0.2	0	0	HPO
9056	SLC7A7	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9056	SLC7A7	C2316810	Chronic kidney disease stage 5	0.200274726784213	0	0	HPO
9056	SLC7A7	C2930812	Generalized elastolysis	0.2	0	0	HPO
9056	SLC7A7	C3854388	Hyperferritinaemia	0.2	0	0	HPO
9060	PAPSS2	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
9060	PAPSS2	C0342541	Precocious pubarche	0.200549453568426	0	0	HPO
9060	PAPSS2	C0702166	Acne	0.2	0	0	HPO
9060	PAPSS2	C2748515	Spondyloepimetaphyseal Dysplasia, Pakistani Type	0.680549453568426	2	11	CTD_human;ORPHANET;UNIPROT
9060	PAPSS2	C2748518	Lumbar scoliosis	0.2	0	0	HPO
90624	LYRM7	C4014440	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8	0.2	1	5	UNIPROT
90668	CARMIL3	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
90678	LRSAM1	C0007959	Charcot-Marie-Tooth Disease	0.201098907136852	1	2	CTD_human
90678	LRSAM1	C3280797	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P	0.48	1	6	ORPHANET;UNIPROT
9075	CLDN2	C0030305	Pancreatitis	0.200274726784213	1	0	CTD_human
9076	CLDN1	C0002170	Alopecia	0.2	0	0	HPO
9076	CLDN1	C0008311	Cholangitis	0.2	0	0	HPO
9076	CLDN1	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
9076	CLDN1	C0011616	Contact Dermatitis	0.200274726784213	1	0	CTD_human
9076	CLDN1	C0014175	Endometriosis	0.2	1	0	CTD_human
9076	CLDN1	C0020757	Ichthyoses	0.200274726784213	0	0	HPO
9076	CLDN1	C0030436	Parakeratosis	0.2	0	0	HPO
9076	CLDN1	C0259817	Xerosis	0.2	0	0	HPO
9076	CLDN1	C0850715	Abnormality of blood and blood-forming tissues	0.2	0	0	HPO
9076	CLDN1	C1843355	ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS	0.401098907136852	0	0	CTD_human;ORPHANET
9081	PRY	C0004509	Azoospermia	0.2	0	0	HPO
9082	XKRY	C0004509	Azoospermia	0.2	0	0	HPO
9083	BPY2	C0004509	Azoospermia	0.200274726784213	0	0	HPO
9084	VCY	C0004509	Azoospermia	0.2	0	0	HPO
9085	CDY1	C0004509	Azoospermia	0.203231208875927	0	0	HPO
90865	IL33	C0004096	Asthma	0.216836523017323	4	0	CTD_human
90865	IL33	C0011615	Dermatitis, Atopic	0.202197814273705	1	0	CTD_human
9091	PIGQ	C0393706	Early infantile epileptic encephalopathy with suppression bursts	0.200274726784213	0	0	ORPHANET
9094	UNC119	C0024312	Lymphopenia	0.200274726784213	0	0	HPO
9094	UNC119	C0028077	Night Blindness	0.2	0	0	HPO
9094	UNC119	C0035334	Retinitis Pigmentosa	0.400824180352639	1	1	CTD_human;ORPHANET
9094	UNC119	C0242770	Bronchiolitis Obliterans Organizing Pneumonia	0.2	0	0	HPO
9094	UNC119	C0581354	Recurrent sinusitis	0.2	0	0	HPO
9094	UNC119	C0747085	Recurrent otitis media	0.2	0	0	HPO
9094	UNC119	C3809768	IMMUNODEFICIENCY 13	0.400549453568426	1	1	ORPHANET;UNIPROT
9094	UNC119	C4280333	Recurrent sinus disease	0.2	0	0	HPO
9095	TBX19	C0158986	Neonatal hypoglycemia	0.2	0	0	HPO
9095	TBX19	C0271583	ACTH Deficiency, Isolated	0.680274726784213	2	1	CTD_human;ORPHANET;UNIPROT
9095	TBX19	C0342388	Adrenocorticotropic hormone (ACTH) deficiency (disorder)	0.200549453568426	0	0	HPO
9095	TBX19	C0877056	Hypoglycaemic seizure	0.2	0	0	HPO
9095	TBX19	C4023211	Adrenocorticotropin deficient adrenal insufficiency	0.2	0	0	HPO
9096	TBX18	C0014544	Epilepsy	0.2	0	0	HPO
9096	TBX18	C0020295	Hydronephrosis	0.2	0	0	HPO
9096	TBX18	C0262404	Cerebellar degeneration	0.2	0	0	HPO
9096	TBX18	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
9096	TBX18	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
9096	TBX18	C4020858	Choreatic disease	0.2	0	0	HPO
9096	TBX18	C4020873	Infratentorial atrophy	0.2	0	0	HPO
90993	CREB3L1	C0268362	Osteogenesis imperfecta type III (disorder)	0.2	0	0	ORPHANET
9101	USP8	C0023787	Lipodystrophy	0.2	0	0	HPO
9101	USP8	C0029456	Osteoporosis	0.2	0	0	HPO
9101	USP8	C0221406	Pituitary-dependent Cushing's disease	0.402197814273705	1	4	CTD_human;ORPHANET
9101	USP8	C0392525	Nephrolithiasis	0.2	0	0	HPO
9101	USP8	C0702166	Acne	0.2	0	0	HPO
9101	USP8	C1621895	Adrenal hyperplasia	0.2	0	0	HPO
9101	USP8	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9101	USP8	C4020884	Anxiety disease	0.2	0	0	HPO
9103	FCGR2C	C0398650	Immune thrombocytopenic purpura	0.20328236603324	0	0	CTD_human
91039	DPP9	C1800706	Idiopathic Pulmonary Fibrosis	0.4	1	0	CTD_human;ORPHANET
9104	RGN	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
9104	RGN	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9112	MTA1	C0014175	Endometriosis	0.2	1	0	CTD_human
91137	SLC25A46	C0007959	Charcot-Marie-Tooth Disease	0.2	1	0	CTD_human
91137	SLC25A46	C0029124	Optic Atrophy	0.200274726784213	1	0	CTD_human
91137	SLC25A46	C0393807	Hereditary motor and sensory neuropathy with optic atrophy (disorder)	0.2	0	0	ORPHANET
91137	SLC25A46	C4225302	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB	0.2	1	5	UNIPROT
91147	TMEM67	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
91147	TMEM67	C0265215	Meckel-Gruber syndrome	0.200549453568426	0	0	ORPHANET
91147	TMEM67	C0431399	Familial aplasia of the vermis	0.201648360705279	0	0	ORPHANET
91147	TMEM67	C0752166	Bardet-Biedl Syndrome	0.203007639249027	1	0	CTD_human
91147	TMEM67	C1846357	Meckel syndrome type 3	0.560824180352639	7	37	CTD_human;UNIPROT
91147	TMEM67	C1853153	JOUBERT SYNDROME 6	0.48	4	45	CTD_human;UNIPROT
91147	TMEM67	C1857662	COACH syndrome	0.600824180352639	5	23	CTD_human;ORPHANET;UNIPROT
91147	TMEM67	C3150796	NEPHRONOPHTHISIS 11	0.400274726784213	1	3	CTD_human;UNIPROT
91179	SCARF2	C1833136	Marden Walker like syndrome	0.400549453568426	1	5	ORPHANET;UNIPROT
9118	INA	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
9119	KRT75	C0406468	Loose Anagen Hair Syndrome	0.2	1	1	UNIPROT
9119	KRT75	C0549150	Pseudofolliculitis barbae (disorder)	0.200274726784213	0	0	CTD_human
9120	SLC16A6	C0014175	Endometriosis	0.2	1	0	CTD_human
91252	SLC39A13	C0013720	Ehlers-Danlos Syndrome	0.200824180352639	1	0	CTD_human
91252	SLC39A13	C2676510	Spondylocheirodysplasia, Ehlers-Danlos Syndrome-Like	0.480274726784213	0	0	CTD_human;ORPHANET
9126	SMC3	C0005741	Blepharitis	0.2	0	0	HPO
9126	SMC3	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
9126	SMC3	C0018777	Conductive hearing loss	0.2	0	0	HPO
9126	SMC3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9126	SMC3	C0027092	Myopia	0.2	0	0	HPO
9126	SMC3	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
9126	SMC3	C0263401	Cutis marmorata	0.2	0	0	HPO
9126	SMC3	C0270972	Cornelia De Lange Syndrome	0.412268482000325	0	0	CTD_human;ORPHANET
9126	SMC3	C0271007	Phthisis bulbi	0.2	0	0	HPO
9126	SMC3	C0339063	Cellulitis of eyelid	0.2	0	0	HPO
9126	SMC3	C1857079	Atretic auditory canal	0.2	0	0	HPO
9126	SMC3	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9126	SMC3	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
9126	SMC3	C4020884	Anxiety disease	0.2	0	0	HPO
9128	PRPF4	C0017601	Glaucoma	0.2	0	0	HPO
9128	PRPF4	C0018777	Conductive hearing loss	0.2	0	0	HPO
9128	PRPF4	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9128	PRPF4	C0020459	Hyperinsulinism	0.2	0	0	HPO
9128	PRPF4	C0020619	Hypogonadism	0.2	0	0	HPO
9128	PRPF4	C0022578	Keratoconus	0.2	0	0	HPO
9128	PRPF4	C0028077	Night Blindness	0.2	0	0	HPO
9128	PRPF4	C0028738	Nystagmus	0.2	0	0	HPO
9128	PRPF4	C0028754	Obesity	0.2	0	0	HPO
9128	PRPF4	C0029124	Optic Atrophy	0.2	0	0	HPO
9128	PRPF4	C0035334	Retinitis Pigmentosa	0.400549453568426	0	0	HPO;ORPHANET
9128	PRPF4	C0271215	Blindness, Legal	0.2	0	0	HPO
9128	PRPF4	C4014681	RETINITIS PIGMENTOSA 70	0.2	2	2	UNIPROT
9129	PRPF3	C0017601	Glaucoma	0.2	0	0	HPO
9129	PRPF3	C0018777	Conductive hearing loss	0.2	0	0	HPO
9129	PRPF3	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9129	PRPF3	C0020459	Hyperinsulinism	0.2	0	0	HPO
9129	PRPF3	C0020619	Hypogonadism	0.2	0	0	HPO
9129	PRPF3	C0022578	Keratoconus	0.2	0	0	HPO
9129	PRPF3	C0028077	Night Blindness	0.2	0	0	HPO
9129	PRPF3	C0028738	Nystagmus	0.2	0	0	HPO
9129	PRPF3	C0028754	Obesity	0.2	0	0	HPO
9129	PRPF3	C0029124	Optic Atrophy	0.2	0	0	HPO
9129	PRPF3	C0035334	Retinitis Pigmentosa	0.406290005282267	0	0	HPO;ORPHANET
9129	PRPF3	C0271215	Blindness, Legal	0.2	0	0	HPO
9129	PRPF3	C1832378	Retinitis Pigmentosa 18	0.480824180352639	2	3	CTD_human;UNIPROT
9131	AIFM1	C0011854	Diabetes Mellitus, Insulin-Dependent	0.2	1	0	CTD_human
9131	AIFM1	C0020179	Huntington Disease	0.200549453568426	1	0	CTD_human
9131	AIFM1	C0035305	Retinal Detachment	0.28	1	0	CTD_human
9131	AIFM1	C0151313	Sensory neuropathy	0.2	0	0	HPO
9131	AIFM1	C0234958	muscle degeneration	0.2	0	0	HPO
9131	AIFM1	C0795910	COWCHOCK SYNDROME	0.400274726784213	1	2	ORPHANET;UNIPROT
9131	AIFM1	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
9131	AIFM1	C1836830	Developmental regression	0.2	0	0	HPO
9131	AIFM1	C1845095	DEAFNESS, X-LINKED 5 (disorder)	0.4	1	16	ORPHANET;UNIPROT
9131	AIFM1	C3151753	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6	0.6	1	2	CTD_human;ORPHANET;UNIPROT
9131	AIFM1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9132	KCNQ4	C2677637	Deafness, Autosomal Dominant 2A	0.4	5	22	CTD_human;UNIPROT
9134	CCNE2	C0014175	Endometriosis	0.2	1	0	CTD_human
9134	CCNE2	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
914	CD2	C0003873	Rheumatoid Arthritis	0.202681755307501	1	0	CTD_human
9145	SYNGR1	C0024141	Lupus Erythematosus, Systemic	0.2	1	0	CTD_human
9149	DYRK1B	C0020443	Hypercholesterolemia	0.2	0	0	HPO
9149	DYRK1B	C4014361	ABDOMINAL OBESITY-METABOLIC SYNDROME 3	0.2	1	2	UNIPROT
915	CD3D	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
915	CD3D	C0024312	Lymphopenia	0.200274726784213	0	0	HPO
915	CD3D	C0085110	Severe Combined Immunodeficiency	0.203557092817453	1	0	CTD_human
915	CD3D	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
915	CD3D	C0747085	Recurrent otitis media	0.2	0	0	HPO
915	CD3D	C1833275	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, NK Cell-Negative	0.2	0	0	CTD_human
915	CD3D	C1837028	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive	0.4	0	0	CTD_human;ORPHANET
915	CD3D	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9150	CTDP1	C0020615	Hypoglycemia	0.2	0	0	HPO
9150	CTDP1	C0028738	Nystagmus	0.2	0	0	HPO
9150	CTDP1	C0029456	Osteoporosis	0.2	0	0	HPO
9150	CTDP1	C0038379	Strabismus	0.2	0	0	HPO
9150	CTDP1	C0235025	Peripheral motor neuropathy	0.2	0	0	HPO
9150	CTDP1	C0235946	Cerebral atrophy	0.2	0	0	HPO
9150	CTDP1	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
9150	CTDP1	C0271683	Polyneuropathy, Motor	0.2	0	0	HPO
9150	CTDP1	C0948896	Primary hypogonadism	0.2	0	0	HPO
9150	CTDP1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
9150	CTDP1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
9150	CTDP1	C4020811	Length dependent motor neuropathy	0.2	0	0	HPO
9150	CTDP1	C4020858	Choreatic disease	0.2	0	0	HPO
9150	CTDP1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
9152	SLC6A5	C1835614	Hereditary Hyperexplexia	0.4	1	0	CTD_human;ORPHANET
9152	SLC6A5	C3553288	HYPEREKPLEXIA 3	0.28	1	10	UNIPROT
91543	RSAD2	C0021400	Influenza	0.200274726784213	1	0	CTD_human
91543	RSAD2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
91574	C12orf65	C0162666	Mitochondrial Encephalomyopathies	0.2	1	0	CTD_human
91574	C12orf65	C0221061	Behr syndrome	0.2	0	0	ORPHANET
91574	C12orf65	C3150801	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7	0.4	0	0	CTD_human;ORPHANET
91574	C12orf65	C3539506	SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE	0.200274726784213	0	0	ORPHANET
916	CD3E	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
916	CD3E	C0085110	Severe Combined Immunodeficiency	0.200549453568426	1	0	CTD_human
916	CD3E	C0747085	Recurrent otitis media	0.2	0	0	HPO
916	CD3E	C1837028	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive	0.4	0	0	CTD_human;ORPHANET
91608	RASL10B	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
91624	NEXN	C2751084	Cardiomyopathy, Dilated, 1CC	0.4	1	3	CTD_human;UNIPROT
91624	NEXN	C3151267	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20	0.28	1	3	UNIPROT
91624	NEXN	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
91624	NEXN	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
91647	ATPAF2	C3276276	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1	0.4	1	1	CTD_human;UNIPROT
91662	NLRP12	C2673198	Familial Cold Autoinflammatory Syndrome 2	0.4	0	0	CTD_human;ORPHANET
9168	TMSB10	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
917	CD3G	C0013595	Eczema	0.2	0	0	HPO
917	CD3G	C3810107	IMMUNODEFICIENCY 17	0.2	0	0	ORPHANET
9173	IL1RL1	C0004096	Asthma	0.225076647812092	5	3	CTD_human
91754	NEK9	C3280309	ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY	0.2	1	1	UNIPROT
9179	AP4M1	C0007789	Cerebral Palsy	0.200824180352639	0	0	HPO
9179	AP4M1	C0014544	Epilepsy	0.2	0	0	HPO
9179	AP4M1	C0037036	Sialorrhea	0.2	0	0	HPO
9179	AP4M1	C0037772	Spastic Paraplegia	0.2	0	0	HPO
9179	AP4M1	C0038379	Strabismus	0.2	0	0	HPO
9179	AP4M1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
9179	AP4M1	C0426970	Spastic Quadriplegia	0.2	0	0	HPO
9179	AP4M1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
9179	AP4M1	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
9179	AP4M1	C2752008	Spastic Paraplegia-50, Autosomal Recessive	0.2	0	0	CTD_human
9179	AP4M1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
9180	OSMR	C0002726	Amyloidosis	0.2	0	0	HPO
9180	OSMR	C0010495	Cutis Laxa	0.2	0	0	HPO
9180	OSMR	C0155127	Familial Amyloid Polyneuropathy, Type V	0.2	0	0	HPO
9180	OSMR	C0268398	Familial lichen amyloidosis	0.600274726784213	2	5	CTD_human;ORPHANET;UNIPROT
9180	OSMR	C2930812	Generalized elastolysis	0.2	0	0	HPO
9184	BUB3	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
9184	BUB3	C0017601	Glaucoma	0.2	0	0	HPO
9184	BUB3	C0026850	Muscular Dystrophy	0.2	0	0	HPO
9184	BUB3	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
9184	BUB3	C1850343	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.2	0	0	ORPHANET
91869	RFT1	C2677590	Congenital Disorder Of Glycosylation, Type In	0.600274726784213	1	6	CTD_human;ORPHANET;UNIPROT
9187	SLC24A1	C0028077	Night Blindness	0.2	0	0	HPO
9187	SLC24A1	C0271183	Severe myopia	0.2	0	0	HPO
9187	SLC24A1	C3551052	Night blindness, stationary	0.2	0	0	HPO
919	CD247	C0014457	Eosinophilia	0.2	0	0	HPO
919	CD247	C0022073	Iridocyclitis	0.2	0	0	HPO
919	CD247	C0024636	Malocclusion	0.2	0	0	HPO
919	CD247	C0036421	Systemic Scleroderma	0.200824180352639	1	1	CTD_human
919	CD247	C0157917	Pauciarticular juvenile rheumatoid arthritis	0.2	0	0	ORPHANET
919	CD247	C0162323	Polyarthritis	0.2	0	0	HPO
919	CD247	C0473133	Protracted diarrhea	0.2	0	0	HPO
919	CD247	C1837028	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive	0.2	0	0	ORPHANET
919	CD247	C1857798	Immunodeficiency due to Defect in CD3-Zeta	0.2	0	0	CTD_human
919	CD247	C2931322	T-Lymphocytopenia	0.2	0	0	HPO
919	CD247	C3714757	Juvenile rheumatoid arthritis	0.2	0	0	HPO
919	CD247	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
9193	SPG9	C1832669	SPASTIC PARAPLEGIA 9, AUTOSOMAL DOMINANT (disorder)	0.2	0	0	CTD_human
91937	TIMD4	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
9194	SLC16A7	C0028754	Obesity	0.2	1	0	CTD_human
91942	NDUFAF2	C0023264	Leigh Disease	0.400274726784213	0	0	CTD_human;ORPHANET
91942	NDUFAF2	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	0.2	0	0	CTD_human
91942	NDUFAF2	C2936907	NADH:Q(1) Oxidoreductase deficiency	0.2	0	0	ORPHANET
91949	COG7	C2931010	Congenital disorder of glycosylation type 2E	0.4	0	0	CTD_human;ORPHANET
9197	SLC33A1	C0028738	Nystagmus	0.2	0	0	HPO
9197	SLC33A1	C0037772	Spastic Paraplegia	0.200549453568426	0	0	HPO
9197	SLC33A1	C0234958	muscle degeneration	0.2	0	0	HPO
9197	SLC33A1	C0235946	Cerebral atrophy	0.2	0	0	HPO
9197	SLC33A1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
9197	SLC33A1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
9197	SLC33A1	C2675528	Spastic Paraplegia 42, Autosomal Dominant	0.600274726784213	2	1	CTD_human;ORPHANET;UNIPROT
9197	SLC33A1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
9197	SLC33A1	C3280965	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION	0.4	1	2	ORPHANET;UNIPROT
9197	SLC33A1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
9197	SLC33A1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
920	CD4	C0013264	Muscular Dystrophy, Duchenne	0.2	1	0	CTD_human
9200	HACD1	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
92002	FAM58A	C2678045	TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS	0.400549453568426	0	0	CTD_human;ORPHANET
9205	ZMYM5	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
921	CD5	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
9210	BMP15	C0018055	Gonadal Dysgenesis, Mixed	0.2	0	0	HPO
9210	BMP15	C0025322	Premature Menopause	0.20357144819477	0	0	HPO
9210	BMP15	C0029453	Osteopenia	0.2	0	0	HPO
9210	BMP15	C0032460	Polycystic Ovary Syndrome	0.210019510569308	1	0	CTD_human
9210	BMP15	C0085215	Ovarian Failure, Premature	0.217031381889588	0	0	HPO
9210	BMP15	C0232939	Primary physiologic amenorrhea	0.200274726784213	0	0	HPO
9210	BMP15	C0747078	Generalized osteopenia	0.2	0	0	HPO
9210	BMP15	C0948896	Primary hypogonadism	0.2	0	0	HPO
9210	BMP15	C1845294	Ovarian Dysgenesis 2	0.4	4	10	CTD_human;UNIPROT
9210	BMP15	C4025170	Osteoporosis of vertebrae	0.2	0	0	HPO
9211	LGI1	C0149958	Complex partial seizures	0.2	0	0	HPO
9211	LGI1	C0270834	Complex partial seizure with impairment of consciousness	0.2	0	0	HPO
9211	LGI1	C0877017	Partial seizures with secondary generalisation	0.2	0	0	HPO
9211	LGI1	C1838062	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.688516530310606	11	11	CTD_human;ORPHANET;UNIPROT
9212	AURKB	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
9213	XPR1	C0014544	Epilepsy	0.2	0	0	HPO
9213	XPR1	C0085583	Choreoathetosis	0.2	0	0	HPO
9213	XPR1	C0393590	Fahr's syndrome (disorder)	0.2	0	0	ORPHANET
9213	XPR1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
9213	XPR1	C0854107	Haemorrhage subcutaneous	0.2	0	0	HPO
9213	XPR1	C4225335	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6	0.2	1	4	UNIPROT
9214	FCMR	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9215	LARGE1	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
9215	LARGE1	C0014544	Epilepsy	0.2	0	0	HPO
9215	LARGE1	C0017601	Glaucoma	0.2	0	0	HPO
9215	LARGE1	C0020255	Hydrocephalus	0.2	0	0	HPO
9215	LARGE1	C0024421	Macroglossia	0.2	0	0	HPO
9215	LARGE1	C0026850	Muscular Dystrophy	0.205363510615002	0	0	HPO
9215	LARGE1	C0027092	Myopia	0.2	0	0	HPO
9215	LARGE1	C0029124	Optic Atrophy	0.2	0	0	HPO
9215	LARGE1	C0035305	Retinal Detachment	0.2	0	0	HPO
9215	LARGE1	C0038379	Strabismus	0.2	0	0	HPO
9215	LARGE1	C0042798	Low Vision	0.2	0	0	HPO
9215	LARGE1	C0158113	Contracture of joint of hand	0.2	0	0	HPO
9215	LARGE1	C0265221	Walker-Warburg congenital muscular dystrophy	0.4	0	0	CTD_human;ORPHANET
9215	LARGE1	C0271215	Blindness, Legal	0.2	0	0	HPO
9215	LARGE1	C0271385	Horizontal Nystagmus	0.2	0	0	HPO
9215	LARGE1	C0376175	Bell Palsy	0.2	0	0	HPO
9215	LARGE1	C0457133	Muscle eye brain disease	0.200274726784213	0	0	ORPHANET
9215	LARGE1	C0521694	Atrophic retina	0.2	0	0	HPO
9215	LARGE1	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
9215	LARGE1	C0699743	Congenital muscular dystrophy (disorder)	0.201373633921065	0	0	HPO
9215	LARGE1	C1837229	Muscular Dystrophy, Congenital, Type 1D	0.68	1	1	CTD_human;ORPHANET;UNIPROT
9215	LARGE1	C1847759	MUSCULAR DYSTROPHY, CONGENITAL, 1C	0.2	0	0	ORPHANET
9215	LARGE1	C1857079	Atretic auditory canal	0.2	0	0	HPO
9215	LARGE1	C3150414	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6	0.48	3	2	CTD_human;UNIPROT
9215	LARGE1	C3150415	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	0.2	0	0	ORPHANET
9215	LARGE1	C3150416	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.2	0	0	ORPHANET
9215	LARGE1	C3809221	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14	0.2	0	0	ORPHANET
9217	VAPB	C0002736	Amyotrophic Lateral Sclerosis	0.411733383809216	0	0	HPO;ORPHANET
9217	VAPB	C0026847	Spinal Muscular Atrophy	0.200274726784213	0	0	HPO
9217	VAPB	C0234958	muscle degeneration	0.2	0	0	HPO
9217	VAPB	C1145670	Respiratory Failure	0.2	0	0	HPO
9217	VAPB	C1837728	AMYOTROPHIC LATERAL SCLEROSIS 8 (disorder)	0.400824180352639	4	2	CTD_human;UNIPROT
9217	VAPB	C1854058	SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE	0.4	0	0	ORPHANET;UNIPROT
9217	VAPB	C1866777	Spinal Muscular Atrophy, Proximal, Adult, Autosomal Dominant	0.2	0	0	CTD_human
9217	VAPB	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
9217	VAPB	C4020859	Pyramidal tract disease	0.2	0	0	HPO
9217	VAPB	C4020884	Anxiety disease	0.2	0	0	HPO
9219	MTA2	C0014175	Endometriosis	0.2	1	0	CTD_human
92211	CDHR1	C0035334	Retinitis Pigmentosa	0.203231208875927	0	0	ORPHANET
92211	CDHR1	C3150912	CONE-ROD DYSTROPHY 15	0.4	1	2	CTD_human;UNIPROT
9227	LRAT	C0014544	Epilepsy	0.2	0	0	HPO
9227	LRAT	C0017601	Glaucoma	0.2	0	0	HPO
9227	LRAT	C0018777	Conductive hearing loss	0.2	0	0	HPO
9227	LRAT	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9227	LRAT	C0020459	Hyperinsulinism	0.2	0	0	HPO
9227	LRAT	C0020619	Hypogonadism	0.2	0	0	HPO
9227	LRAT	C0022578	Keratoconus	0.2	0	0	HPO
9227	LRAT	C0028077	Night Blindness	0.2	0	0	HPO
9227	LRAT	C0028738	Nystagmus	0.2	0	0	HPO
9227	LRAT	C0028754	Obesity	0.2	0	0	HPO
9227	LRAT	C0029124	Optic Atrophy	0.2	0	0	HPO
9227	LRAT	C0035334	Retinitis Pigmentosa	0.402407028523288	0	0	HPO;ORPHANET
9227	LRAT	C0042842	Vitamin A Deficiency	0.2	1	0	CTD_human
9227	LRAT	C0271215	Blindness, Legal	0.2	0	0	HPO
9227	LRAT	C0339527	Leber Congenital Amaurosis	0.401373633921066	1	0	CTD_human;ORPHANET
9227	LRAT	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
9227	LRAT	C0917796	Optic Atrophy, Hereditary, Leber	0.2	2	0	CTD_human
9227	LRAT	C1301509	Severe visual impairment	0.200274726784213	0	0	HPO
9227	LRAT	C2750063	Leber Congenital Amaurosis 14	0.48	1	1	CTD_human;UNIPROT
9227	LRAT	C4274354	Severe early childhood onset retinal dystrophy	0.2	0	0	ORPHANET
9227	LRAT	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
923	CD6	C0026769	Multiple Sclerosis	0.210452294445791	2	1	CTD_human
92304	SCGB3A1	C0014175	Endometriosis	0.2	1	0	CTD_human
9232	PTTG1	C0033860	Psoriasis	0.202681755307501	1	0	CTD_human
9232	PTTG1	C1527336	Sjogren's Syndrome	0.2	1	0	CTD_human
92335	STRADA	C1970203	Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy	0.2	0	0	CTD_human
92344	GORAB	C0029456	Osteoporosis	0.200549453568426	1	0	CTD_human
92344	GORAB	C0432255	Geroderma osteodysplastica	0.401373633921066	1	3	CTD_human;ORPHANET
9235	IL32	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
924	CD7	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
9241	NOG	C0018777	Conductive hearing loss	0.201098907136852	0	0	HPO
9241	NOG	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9241	NOG	C0020490	Hyperopia	0.20328236603324	0	0	HPO
9241	NOG	C0038379	Strabismus	0.2	0	0	HPO
9241	NOG	C0175700	Multiple synostosis syndrome	0.20357144819477	0	0	ORPHANET
9241	NOG	C0342282	Symphalangism-brachydactyly syndrome	0.601373633921066	2	3	CTD_human;ORPHANET;UNIPROT
9241	NOG	C0409477	Ankylosis of the elbow joint	0.2	0	0	HPO
9241	NOG	C1861305	TARSAL-CARPAL COALITION SYNDROME	0.601923087489492	1	3	CTD_human;ORPHANET;UNIPROT
9241	NOG	C1861385	SYMPHALANGISM, PROXIMAL	0.605219808900049	0	0	CTD_human;HPO;ORPHANET
9241	NOG	C1866656	STAPES ANKYLOSIS WITH BROAD THUMB AND TOES (disorder)	0.400824180352639	0	0	CTD_human;ORPHANET
9241	NOG	C1969652	BRACHYDACTYLY, TYPE B2 (disorder)	0.600549453568426	1	2	CTD_human;ORPHANET;UNIPROT
9241	NOG	C3714899	SYMPHALANGISM, PROXIMAL, 1A	0.202472541057918	6	8	UNIPROT
9244	CRLF1	C0011334	Dental caries	0.2	0	0	HPO
9244	CRLF1	C0020620	Hypohidrosis	0.2	0	0	HPO
9244	CRLF1	C0024591	Malignant hyperpyrexia due to anesthesia	0.2	0	0	HPO
9244	CRLF1	C0376175	Bell Palsy	0.2	0	0	HPO
9244	CRLF1	C1832409	Crisponi syndrome	0.403296721410557	0	0	CTD_human;ORPHANET
9244	CRLF1	C1848947	COLD-INDUCED SWEATING SYNDROME 1	0.400549453568426	6	19	ORPHANET;UNIPROT
9246	UBE2L6	C0021400	Influenza	0.2	1	0	CTD_human
9247	GCM2	C0014544	Epilepsy	0.2	0	0	HPO
9247	GCM2	C0020626	Hypoparathyroidism	0.210345394510833	0	0	HPO
9247	GCM2	C0039621	Tetany	0.2	0	0	HPO
9247	GCM2	C0085681	Hyperphosphatemia (disorder)	0.2	0	0	HPO
9247	GCM2	C1832648	Hypoparathyroidism familial isolated	0.28	3	5	UNIPROT
9247	GCM2	C1855841	Hypocalcaemic seizure	0.2	0	0	HPO
92482	BBIP1	C0752166	Bardet-Biedl Syndrome	0.200274726784213	0	0	ORPHANET
925	CD8A	C0006267	Bronchiectasis	0.2	0	0	HPO
925	CD8A	C0024117	Chronic Obstructive Airway Disease	0.202732912464814	1	0	CTD_human
925	CD8A	C1837065	CD8 Deficiency, Familial	0.6	1	1	CTD_human;ORPHANET;UNIPROT
9254	CACNA2D2	C0014553	Absence Epilepsy	0.200274726784213	1	0	CTD_human
9255	AIMP1	C0003886	Arthrogryposis	0.2	0	0	HPO
9255	AIMP1	C0007795	Diffuse Cerebral Sclerosis of Schilder	0.2	0	0	HPO
9255	AIMP1	C0014544	Epilepsy	0.2	0	0	HPO
9255	AIMP1	C0023520	Leukodystrophy	0.2	0	0	HPO
9255	AIMP1	C0042798	Low Vision	0.2	0	0	HPO
9255	AIMP1	C0205711	Pelizaeus-Merzbacher Disease	0.2	0	0	HPO
9255	AIMP1	C0431370	Atrophy of corpus callosum	0.2	0	0	HPO
9255	AIMP1	C1850053	Pelizaeus-Merzbacher-like disease, autosomal recessive, 2	0.2	0	0	ORPHANET
9255	AIMP1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
92579	G6PC3	C2675526	Neutropenia, Severe Congenital, Autosomal Recessive 4	0.600274726784213	5	15	CTD_human;ORPHANET;UNIPROT
926	CD8B	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
92667	MGME1	C3554462	MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.4	1	2	ORPHANET;UNIPROT
92749	DRC1	C0022521	Kartagener Syndrome	0.400274726784213	1	2	CTD_human;ORPHANET
928	CD9	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
9282	MED14	C0014175	Endometriosis	0.2	1	0	CTD_human
9289	ADGRG1	C0014544	Epilepsy	0.200549453568426	0	0	HPO
9289	ADGRG1	C0014877	Esotropia	0.2	0	0	HPO
9289	ADGRG1	C0015310	Exotropia	0.2	0	0	HPO
9289	ADGRG1	C0028738	Nystagmus	0.2	0	0	HPO
9289	ADGRG1	C1847352	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.605769262468475	4	23	CTD_human;ORPHANET;UNIPROT
929	CD14	C0004096	Asthma	0.298695032323084	1	0	CTD_human
929	CD14	C0013595	Eczema	0.202197814273705	1	0	CTD_human
929	CD14	C0018099	Gout	0.2	1	0	CTD_human
929	CD14	C0023890	Liver Cirrhosis	0.206737144536068	1	0	CTD_human
929	CD14	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
929	CD14	C3495559	Juvenile arthritis	0.202681755307501	1	0	CTD_human
92935	MARS2	C1969645	Ataxia, Spastic, 3, Autosomal Recessive	0.200274726784213	0	0	ORPHANET
92935	MARS2	C4225329	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25	0.4	1	2	ORPHANET;UNIPROT
9294	S1PR2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9294	S1PR2	C1835854	DEAFNESS, AUTOSOMAL RECESSIVE 68	0.2	1	2	UNIPROT
93	ACVR2B	C3151057	HETEROTAXY, VISCERAL, 4, AUTOSOMAL	0.28	1	2	UNIPROT
93	ACVR2B	C3178805	Heterotaxy Syndrome	0.200274726784213	1	1	CTD_human
930	CD19	C0001768	Agammaglobulinemia	0.200274726784213	1	0	CTD_human
930	CD19	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
930	CD19	C0006267	Bronchiectasis	0.2	0	0	HPO
930	CD19	C0009447	Common Variable Immunodeficiency	0.40357144819477	1	0	CTD_human;ORPHANET
930	CD19	C0009763	Conjunctivitis	0.2	0	0	HPO
930	CD19	C0024312	Lymphopenia	0.200549453568426	0	0	HPO
930	CD19	C0025289	Meningitis	0.2	0	0	HPO
930	CD19	C0032285	Pneumonia	0.2	0	0	HPO
930	CD19	C0034150	Purpura	0.2	0	0	HPO
930	CD19	C0086438	Hypogammaglobulinemia	0.200824180352639	0	0	HPO
930	CD19	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
930	CD19	C0162539	IgG Deficiency	0.2	0	0	HPO
930	CD19	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
930	CD19	C0271441	Chronic otitis media	0.2	0	0	HPO
930	CD19	C0398650	Immune thrombocytopenic purpura	0.200824180352639	0	0	HPO
930	CD19	C0581354	Recurrent sinusitis	0.2	0	0	HPO
930	CD19	C0694550	Recurrent pneumonia	0.2	0	0	HPO
930	CD19	C0741796	Recurrent bronchitis	0.2	0	0	HPO
930	CD19	C0743359	ear infection chronic	0.2	0	0	HPO
930	CD19	C0747085	Recurrent otitis media	0.2	0	0	HPO
930	CD19	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
930	CD19	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
930	CD19	C4280333	Recurrent sinus disease	0.2	0	0	HPO
9308	CD83	C0003873	Rheumatoid Arthritis	0.203007639249027	1	0	CTD_human
9308	CD83	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
931	MS4A1	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
931	MS4A1	C0006267	Bronchiectasis	0.2	0	0	HPO
931	MS4A1	C0009447	Common Variable Immunodeficiency	0.400274726784213	0	0	CTD_human;ORPHANET
931	MS4A1	C0024312	Lymphopenia	0.2	0	0	HPO
931	MS4A1	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
931	MS4A1	C0032285	Pneumonia	0.2	0	0	HPO
931	MS4A1	C0034150	Purpura	0.2	0	0	HPO
931	MS4A1	C0086438	Hypogammaglobulinemia	0.200274726784213	0	0	HPO
931	MS4A1	C0242584	Autoimmune thrombocytopenia	0.200274726784213	0	0	HPO
931	MS4A1	C0271441	Chronic otitis media	0.2	0	0	HPO
931	MS4A1	C0398650	Immune thrombocytopenic purpura	0.203007639249027	0	0	HPO
931	MS4A1	C0741796	Recurrent bronchitis	0.2	0	0	HPO
931	MS4A1	C0743359	ear infection chronic	0.2	0	0	HPO
931	MS4A1	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
9313	MMP20	C2675858	Amelogenesis Imperfecta, Hypomaturation Type, Iia2	0.28	0	0	CTD_human
9314	KLF4	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
9314	KLF4	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
9315	NREP	C0015695	Fatty Liver	0.2	1	0	CTD_human
9315	NREP	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9318	COPS2	C0014175	Endometriosis	0.2	1	0	CTD_human
93183	PIGM	C1853205	Glycosylphosphatidylinositol deficiency	0.400549453568426	0	0	CTD_human;ORPHANET
9321	TRIP11	C0020305	Hydrops Fetalis	0.2	0	0	HPO
9321	TRIP11	C0426824	Beading of ribs	0.2	0	0	HPO
93210	PGAP3	C3810354	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.2	1	12	UNIPROT
93233	CCDC114	C0022521	Kartagener Syndrome	0.200549453568426	0	0	ORPHANET
9332	CD163	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
9333	TGM5	C0013595	Eczema	0.200274726784213	0	0	HPO
9333	TGM5	C0020757	Ichthyoses	0.203007639249027	0	0	HPO
9333	TGM5	C1849193	PEELING SKIN SYNDROME	0.2	0	0	CTD_human
9333	TGM5	C1853354	Peeling skin syndrome, acral type	0.601098907136852	1	6	CTD_human;ORPHANET;UNIPROT
9334	B4GALT5	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
9342	SNAP29	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9342	SNAP29	C0020757	Ichthyoses	0.20328236603324	0	0	HPO
9342	SNAP29	C0022584	Keratoderma, Palmoplantar, Diffuse	0.2	0	0	HPO
9342	SNAP29	C0022596	Palmoplantar Keratosis	0.203007639249027	0	0	HPO
9342	SNAP29	C0029124	Optic Atrophy	0.2	0	0	HPO
9342	SNAP29	C0152025	Polyneuropathy	0.2	0	0	HPO
9342	SNAP29	C1836033	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	0.480274726784213	0	0	CTD_human;ORPHANET
9342	SNAP29	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9343	EFTUD2	C0018777	Conductive hearing loss	0.2	0	0	HPO
9343	EFTUD2	C1857079	Atretic auditory canal	0.2	0	0	HPO
9343	EFTUD2	C1864652	Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate	0.401923087489492	1	12	ORPHANET;UNIPROT
9353	SLIT2	C0014556	Epilepsy, Temporal Lobe	0.200274726784213	1	0	CTD_human
9355	LHX2	C0003873	Rheumatoid Arthritis	0.200274726784213	1	0	CTD_human
93587	TRMT10A	C4014997	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1	0.2	1	2	UNIPROT
93589	CACNA2D4	C0035334	Retinitis Pigmentosa	0.2	0	0	ORPHANET
93589	CACNA2D4	C1864849	RETINAL CONE DYSTROPHY 4	0.2	0	0	CTD_human
9361	LONP1	C0011351	Dental Enamel Hypoplasia	0.2	0	0	HPO
9361	LONP1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9361	LONP1	C0265294	Pyle metaphyseal dysplasia	0.2	0	0	HPO
9361	LONP1	C0751576	Partial Paralysis (Paresis) Vocal Cords	0.2	0	0	HPO
9361	LONP1	C1838180	CODAS syndrome	0.400824180352639	2	9	ORPHANET;UNIPROT
9361	LONP1	C3277059	Congenital Bilateral Cataracts	0.2	0	0	HPO
93611	FBXO44	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
93627	TBCK	C4225161	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3	0.2	2	7	UNIPROT
9364	RAB28	C0028077	Night Blindness	0.2	0	0	HPO
9364	RAB28	C0035334	Retinitis Pigmentosa	0.400824180352639	0	0	HPO;ORPHANET
9364	RAB28	C0271183	Severe myopia	0.2	0	0	HPO
9364	RAB28	C0730290	Cone dystrophy	0.2	0	0	HPO
9364	RAB28	C4072827	Cone/cone-rod dystrophy	0.2	0	0	HPO
9365	KL	C0003850	Arteriosclerosis	0.20357144819477	1	0	CTD_human
9365	KL	C0020437	Hypercalcemia	0.202956482091714	1	0	CTD_human
9365	KL	C0029456	Osteoporosis	0.201098907136852	1	0	CTD_human
9365	KL	C0085681	Hyperphosphatemia (disorder)	0.203846174978983	1	0	CTD_human
9365	KL	C0231341	Premature aging syndrome	0.204670355331623	2	0	CTD_human
9365	KL	C0268080	Hypercalcemia, Idiopathic, of Infancy	0.2	1	0	CTD_human
9365	KL	C1876187	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
9365	KL	C1956346	Coronary Artery Disease	0.202747267842131	1	0	CTD_human
9365	KL	C2931105	Hypercalciuria, childhood idiopathic	0.2	1	0	CTD_human
93659	CGB5	C0032460	Polycystic Ovary Syndrome	0.200549453568426	1	0	CTD_human
93664	CADPS2	C0008370	Cholestasis	0.2	1	0	CTD_human
93664	CADPS2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9368	SLC9A3R1	C0029453	Osteopenia	0.2	0	0	HPO
9368	SLC9A3R1	C0029456	Osteoporosis	0.2	0	0	HPO
9368	SLC9A3R1	C0392525	Nephrolithiasis	0.2	0	0	HPO
9368	SLC9A3R1	C0747078	Generalized osteopenia	0.2	0	0	HPO
9368	SLC9A3R1	C2676782	Nephrolithiasis-Osteoporosis, Hypophosphatemic, 2	0.4	2	4	CTD_human;UNIPROT
9370	ADIPOQ	C0003873	Rheumatoid Arthritis	0.208748190962867	1	0	CTD_human
9370	ADIPOQ	C0004153	Atherosclerosis	0.22619341573129	1	0	CTD_human
9370	ADIPOQ	C0010346	Crohn Disease	0.2	1	0	CTD_human
9370	ADIPOQ	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.324723044317466	3	0	CTD_human
9370	ADIPOQ	C0011881	Diabetic Nephropathy	0.213525446229448	1	0	CTD_human
9370	ADIPOQ	C0018801	Heart failure	0.2	2	0	CTD_human
9370	ADIPOQ	C0020452	Hyperemia	0.202732912464814	1	0	CTD_human
9370	ADIPOQ	C0022661	Kidney Failure, Chronic	0.307124496018887	1	0	CTD_human
9370	ADIPOQ	C0028754	Obesity	0.389121039126589	2	0	CTD_human
9370	ADIPOQ	C0034069	Pulmonary Fibrosis	0.2	1	0	CTD_human
9370	ADIPOQ	C0151744	Myocardial Ischemia	0.202732912464814	1	0	CTD_human
9370	ADIPOQ	C0400966	Non-alcoholic Fatty Liver Disease	0.283296721410557	1	0	CTD_human
9370	ADIPOQ	C0524620	Metabolic Syndrome X	0.265811043592707	4	0	CTD_human
9370	ADIPOQ	C0948480	Coronary Restenosis	0.2	1	0	CTD_human
9370	ADIPOQ	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9376	SLC22A8	C0015695	Fatty Liver	0.2	1	0	CTD_human
9376	SLC22A8	C0021400	Influenza	0.200274726784213	1	0	CTD_human
9376	SLC22A8	C0023890	Liver Cirrhosis	0.2	1	0	CTD_human
9376	SLC22A8	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9378	NRXN1	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
9378	NRXN1	C0037036	Sialorrhea	0.2	0	0	HPO
9378	NRXN1	C0038379	Strabismus	0.2	0	0	HPO
9378	NRXN1	C0543888	Epileptic encephalopathy	0.2	0	0	HPO
9378	NRXN1	C1864887	Cortical Dysplasia-Focal Epilepsy Syndrome	0.2	0	0	ORPHANET
9378	NRXN1	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
9378	NRXN1	C1970431	PITT-HOPKINS SYNDROME	0.201098907136852	1	0	CTD_human
9380	GRHPR	C0020500	Hyperoxaluria	0.200274726784213	0	0	HPO
9380	GRHPR	C0027709	Nephrocalcinosis	0.2	0	0	HPO
9380	GRHPR	C0238621	Aminoaciduria	0.2	0	0	HPO
9380	GRHPR	C0268165	Primary hyperoxaluria type 2	0.482472541057918	0	0	CTD_human;ORPHANET
9380	GRHPR	C1833683	NEPHROLITHIASIS, CALCIUM OXALATE	0.2	0	0	HPO
9381	OTOF	C0018784	Sensorineural Hearing Loss (disorder)	0.205638237399215	0	0	HPO
9381	OTOF	C1832828	Deafness, Autosomal Recessive 9	0.481098907136852	2	71	CTD_human;UNIPROT
9382	COG1	C0029453	Osteopenia	0.2	0	0	HPO
9382	COG1	C0747078	Generalized osteopenia	0.2	0	0	HPO
9382	COG1	C2931011	Congenital disorder of glycosylation, type 2G	0.4	0	0	CTD_human;ORPHANET
939	CD27	C0086438	Hypogammaglobulinemia	0.200274726784213	0	0	HPO
939	CD27	C3554540	LYMPHOPROLIFERATIVE SYNDROME 2	0.200274726784213	1	2	UNIPROT
9394	HS6ST1	C0018418	Gynecomastia	0.2	0	0	HPO
9394	HS6ST1	C0029453	Osteopenia	0.2	0	0	HPO
9394	HS6ST1	C0029456	Osteoporosis	0.2	0	0	HPO
9394	HS6ST1	C0151721	Testicular hypogonadism	0.2	0	0	HPO
9394	HS6ST1	C0162809	Kallmann Syndrome	0.2	0	0	ORPHANET
9394	HS6ST1	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
9394	HS6ST1	C0232940	Secondary physiologic amenorrhea	0.2	0	0	HPO
9394	HS6ST1	C0242350	Erectile dysfunction	0.2	0	0	HPO
9394	HS6ST1	C0271578	Female hypogonadism syndrome	0.2	0	0	HPO
9394	HS6ST1	C0271623	Hypogonadotropic hypogonadism	0.200274726784213	0	0	HPO
9394	HS6ST1	C0747078	Generalized osteopenia	0.2	0	0	HPO
9394	HS6ST1	C1563720	Kallmann Syndrome 2 (disorder)	0.2	0	0	ORPHANET
9394	HS6ST1	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
9394	HS6ST1	C3553977	HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.2	2	5	UNIPROT
9394	HS6ST1	C4020884	Anxiety disease	0.2	0	0	HPO
9394	HS6ST1	C4021107	Non-obstructive azoospermia	0.2	0	0	HPO
9394	HS6ST1	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
93956	AOCH	C1853757	Acromegaloid features, overgrowth, cleft palate, and hernia	0.2	0	0	CTD_human
9397	NMT2	C0029927	Ovarian Cysts	0.2	1	0	CTD_human
93974	ATPIF1	C0015695	Fatty Liver	0.2	1	0	CTD_human
93983	DYT13	C1843264	DYSTONIA 13, TORSION	0.4	0	0	CTD_human;ORPHANET
93985	FGS3	C0220769	FG syndrome	0.200274726784213	0	0	CTD_human
93986	FOXP2	C0175693	Russell-Silver syndrome	0.200274726784213	1	0	CTD_human
93991	MRX77	C1845499	MENTAL RETARDATION, X-LINKED 77	0.2	0	0	CTD_human
93999	OTSC2	C1854022	OTOSCLEROSIS 2	0.2	0	0	CTD_human
94	ACVRL1	C0002871	Anemia	0.2	0	0	HPO
94	ACVRL1	C0006105	Brain Abscess	0.202732912464814	0	0	HPO
94	ACVRL1	C0008325	Cholecystitis	0.2	0	0	HPO
94	ACVRL1	C0014544	Epilepsy	0.2	0	0	HPO
94	ACVRL1	C0020541	Hypertension, Portal	0.2	0	0	HPO
94	ACVRL1	C0023890	Liver Cirrhosis	0.202407028523288	0	0	HPO
94	ACVRL1	C0032461	Polycythemia	0.2	0	0	HPO
94	ACVRL1	C0038525	Subarachnoid Hemorrhage	0.2	0	0	HPO
94	ACVRL1	C0039445	Hereditary hemorrhagic telangiectasia	0.466127756293567	1	0	CTD_human;ORPHANET
94	ACVRL1	C0085576	Iron-Refractory Iron Deficiency Anemia	0.2	0	0	HPO
94	ACVRL1	C0239105	Conjunctival telangiectasis	0.2	0	0	HPO
94	ACVRL1	C0340543	Familial primary pulmonary hypertension	0.201098907136852	0	0	ORPHANET
94	ACVRL1	C0744641	Intermittent migraine headaches	0.2	0	0	HPO
94	ACVRL1	C0854242	Gastrointestinal angiodysplasia	0.2	0	0	HPO
94	ACVRL1	C0917805	Transient Cerebral Ischemia	0.2	0	0	HPO
94	ACVRL1	C0948008	Ischemic stroke	0.2	0	0	HPO
94	ACVRL1	C1619711	Gastrointestinal telangiectasia	0.2	0	0	HPO
94	ACVRL1	C1697453	Spontaneous haematoma	0.2	0	0	HPO
94	ACVRL1	C1838163	OSLER-RENDU-WEBER SYNDROME 2	0.481648360705279	11	23	CTD_human;UNIPROT
94	ACVRL1	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
94	ACVRL1	C3203102	Idiopathic pulmonary arterial hypertension	0.20796707674218	0	0	HPO
94	ACVRL1	C4021977	Visceral angiomatosis	0.2	0	0	HPO
940	CD28	C0002170	Alopecia	0.2	0	0	HPO
940	CD28	C0003873	Rheumatoid Arthritis	0.218470528345284	3	0	CTD_human
940	CD28	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
940	CD28	C0013595	Eczema	0.201098907136852	0	0	HPO
940	CD28	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
940	CD28	C0221260	Dystrophia unguium	0.2	0	0	HPO
940	CD28	C0259817	Xerosis	0.2	0	0	HPO
940	CD28	C0263454	Chloracne	0.2	1	0	CTD_human
940	CD28	C0392777	Poikiloderma	0.2	0	0	HPO
94003	PDB4	C0029401	Osteitis Deformans	0.2	0	0	CTD_human
94003	PDB4	C1853473	PAGET DISEASE OF BONE 4	0.2	0	0	CTD_human
94008	SCA18	C1843884	SPINOCEREBELLAR ATAXIA 18	0.2	0	0	CTD_human
9401	RECQL4	C0002170	Alopecia	0.2	0	0	HPO
9401	RECQL4	C0014544	Epilepsy	0.2	0	0	HPO
9401	RECQL4	C0015300	Exophthalmos	0.2	0	0	HPO
9401	RECQL4	C0017601	Glaucoma	0.2	0	0	HPO
9401	RECQL4	C0018777	Conductive hearing loss	0.2	0	0	HPO
9401	RECQL4	C0020255	Hydrocephalus	0.2	0	0	HPO
9401	RECQL4	C0020619	Hypogonadism	0.2	0	0	HPO
9401	RECQL4	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
9401	RECQL4	C0027092	Myopia	0.2	0	0	HPO
9401	RECQL4	C0029124	Optic Atrophy	0.2	0	0	HPO
9401	RECQL4	C0029456	Osteoporosis	0.2	0	0	HPO
9401	RECQL4	C0032339	Rothmund-Thomson syndrome	0.313588592502365	1	14	CTD_human
9401	RECQL4	C0038379	Strabismus	0.2	0	0	HPO
9401	RECQL4	C0039446	Telangiectasis	0.2	0	0	HPO
9401	RECQL4	C0221260	Dystrophia unguium	0.2	0	0	HPO
9401	RECQL4	C0263490	Brittle hair	0.2	0	0	HPO
9401	RECQL4	C0265308	Baller-Gerold syndrome	0.601098907136852	1	7	CTD_human;ORPHANET;UNIPROT
9401	RECQL4	C0392777	Poikiloderma	0.201648360705279	0	0	HPO
9401	RECQL4	C0578682	Madarosis of eyebrow	0.2	0	0	HPO
9401	RECQL4	C1833340	Synostotic Posterior Plagiocephaly	0.2	0	0	HPO
9401	RECQL4	C1838608	Radial aplasia	0.2	0	0	HPO
9401	RECQL4	C1849453	Rapadilino syndrome	0.401373633921066	0	0	CTD_human;ORPHANET
9401	RECQL4	C1856266	Coronal craniosynostosis	0.2	0	0	HPO
94014	TRICY1	C1864801	TRICHILEMMAL CYST 1	0.2	0	0	CTD_human
9409	PEX16	C0001403	Addison Disease	0.2	0	0	HPO
9409	PEX16	C0014544	Epilepsy	0.2	0	0	HPO
9409	PEX16	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9409	PEX16	C0020295	Hydronephrosis	0.2	0	0	HPO
9409	PEX16	C0028077	Night Blindness	0.2	0	0	HPO
9409	PEX16	C0028738	Nystagmus	0.2	0	0	HPO
9409	PEX16	C0029124	Optic Atrophy	0.2	0	0	HPO
9409	PEX16	C0035334	Retinitis Pigmentosa	0.2	0	0	HPO
9409	PEX16	C0038379	Strabismus	0.2	0	0	HPO
9409	PEX16	C0042798	Low Vision	0.2	0	0	HPO
9409	PEX16	C0043459	Zellweger Syndrome	0.403831819601666	1	0	CTD_human;ORPHANET
9409	PEX16	C0085605	Liver Failure	0.2	0	0	HPO
9409	PEX16	C0156394	Hypertrophy of clitoris	0.2	0	0	HPO
9409	PEX16	C0282525	Adrenoleukodystrophy, Neonatal	0.2	0	0	ORPHANET
9409	PEX16	C0282527	Infantile Refsum Disease (disorder)	0.2	0	0	ORPHANET
9409	PEX16	C0405580	Adrenal cortical hypofunction	0.2	0	0	HPO
9409	PEX16	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
9409	PEX16	C1836830	Developmental regression	0.2	0	0	HPO
9409	PEX16	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
9409	PEX16	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9409	PEX16	C3553450	Profound global developmental delay	0.2	0	0	HPO
9409	PEX16	C3553960	PEROXISOME BIOGENESIS DISORDER 8B	0.2	1	2	UNIPROT
9409	PEX16	C3714581	Multicystic Dysplastic Kidney	0.2	0	0	HPO
941	CD80	C0007570	Celiac Disease	0.200274726784213	1	0	CTD_human
941	CD80	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
941	CD80	C0042900	Vitiligo	0.2	1	0	CTD_human
94103	ORMDL3	C0004096	Asthma	0.249822826062325	2	0	CTD_human
94103	ORMDL3	C0009324	Ulcerative Colitis	0.200824180352639	1	0	CTD_human
94137	RP1L1	C3150833	OCCULT MACULAR DYSTROPHY	0.602747267842131	2	2	CTD_human;ORPHANET;UNIPROT
9414	TJP2	C0008372	Intrahepatic Cholestasis	0.4	1	0	CTD_human;HPO
9414	TJP2	C0020541	Hypertension, Portal	0.2	0	0	HPO
9414	TJP2	C0035579	Rickets	0.2	0	0	HPO
9414	TJP2	C0042880	Vitamin K Deficiency	0.2	0	0	HPO
9414	TJP2	C0085605	Liver Failure	0.2	0	0	HPO
9414	TJP2	C1843139	Hypercholanemia, Familial	0.600274726784213	1	1	CTD_human;ORPHANET;UNIPROT
9414	TJP2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9414	TJP2	C3489789	Cholestasis, Progressive Familial Intrahepatic, 2	0.2	0	0	ORPHANET
9415	FADS2	C0023794	Lipoidosis	0.2	1	0	CTD_human
9415	FADS2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9419	CRIPT	C0002871	Anemia	0.2	0	0	HPO
9419	CRIPT	C0015300	Exophthalmos	0.2	0	0	HPO
9419	CRIPT	C3553450	Profound global developmental delay	0.2	0	0	HPO
942	CD86	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
9420	CYP7B1	C0008370	Cholestasis	0.2	1	0	CTD_human
9420	CYP7B1	C0008372	Intrahepatic Cholestasis	0.2	0	0	HPO
9420	CYP7B1	C0015695	Fatty Liver	0.2	1	0	CTD_human
9420	CYP7B1	C0019158	Hepatitis	0.2	0	0	HPO
9420	CYP7B1	C0023890	Liver Cirrhosis	0.2	0	0	HPO
9420	CYP7B1	C0029124	Optic Atrophy	0.2	0	0	HPO
9420	CYP7B1	C0030486	Paraplegia	0.2	0	0	HPO
9420	CYP7B1	C0037772	Spastic Paraplegia	0.201648360705279	0	0	HPO
9420	CYP7B1	C0037773	Spastic Paraplegia, Hereditary	0.201923087489492	1	0	CTD_human
9420	CYP7B1	C0085605	Liver Failure	0.200274726784213	0	0	HPO
9420	CYP7B1	C1849115	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE (disorder)	0.2	4	12	UNIPROT
9420	CYP7B1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9420	CYP7B1	C2931356	Spastic paraplegia type 5A, recessive	0.4	1	0	CTD_human;ORPHANET
9420	CYP7B1	C3151147	Bile Acid Synthesis Defect, Congenital, 3	0.2	0	0	ORPHANET
9426	CDY2A	C0004509	Azoospermia	0.200274726784213	0	0	HPO
9427	ECEL1	C0003886	Arthrogryposis	0.200824180352639	0	0	HPO
9427	ECEL1	C0040412	Fissured tongue	0.2	0	0	HPO
9427	ECEL1	C3554415	ARTHROGRYPOSIS, DISTAL, TYPE 5D	0.4	4	13	ORPHANET;UNIPROT
9429	ABCG2	C0003873	Rheumatoid Arthritis	0.2	1	0	CTD_human
9429	ABCG2	C0023892	Biliary cirrhosis	0.2	1	0	CTD_human
94337	MNG3	C1853686	Goiter, Multinodular 3	0.2	0	0	CTD_human
9439	MED23	C3280265	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18	0.2	1	3	UNIPROT
9440	MED17	C0014175	Endometriosis	0.2	1	0	CTD_human
9440	MED17	C0014544	Epilepsy	0.2	0	0	HPO
9440	MED17	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9440	MED17	C3150921	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.6	1	2	CTD_human;ORPHANET;UNIPROT
9445	ITM2B	C0085220	Cerebral Amyloid Angiopathy	0.200549453568426	0	0	HPO
9445	ITM2B	C1861735	Dementia, familial Danish	0.48439562854741	0	0	CTD_human;ORPHANET
9445	ITM2B	C1867773	Dementia, familial British	0.48357144819477	0	0	CTD_human;ORPHANET
9445	ITM2B	C4015146	RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES	0.4	1	1	ORPHANET;UNIPROT
945	CD33	C0002395	Alzheimer's Disease	0.204945082115836	2	2	CTD_human
9451	EIF2AK3	C0011854	Diabetes Mellitus, Insulin-Dependent	0.200824180352639	0	0	HPO
9451	EIF2AK3	C0020456	Hyperglycemia	0.2	0	0	HPO
9451	EIF2AK3	C0020490	Hyperopia	0.2	0	0	HPO
9451	EIF2AK3	C0029453	Osteopenia	0.2	0	0	HPO
9451	EIF2AK3	C0029456	Osteoporosis	0.2	0	0	HPO
9451	EIF2AK3	C0035078	Kidney Failure	0.2	0	0	HPO
9451	EIF2AK3	C0038220	Status Epilepticus	0.2	1	0	CTD_human
9451	EIF2AK3	C0038868	Progressive supranuclear palsy	0.200274726784213	1	1	CTD_human
9451	EIF2AK3	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
9451	EIF2AK3	C0151747	Renal tubular disorder	0.2	0	0	HPO
9451	EIF2AK3	C0162557	Liver Failure, Acute	0.2	0	0	HPO
9451	EIF2AK3	C0342273	Transient neonatal diabetes mellitus	0.2	0	0	HPO
9451	EIF2AK3	C0432217	Wolcott-Rallison syndrome	0.685219808900049	1	6	CTD_human;ORPHANET;UNIPROT
9451	EIF2AK3	C0740394	Hyperuricemia	0.2	0	0	HPO
9451	EIF2AK3	C0747078	Generalized osteopenia	0.2	0	0	HPO
9451	EIF2AK3	C0854110	Insulin resistant diabetes	0.2	0	0	HPO
9451	EIF2AK3	C1565489	Renal Insufficiency	0.2	0	0	HPO
9451	EIF2AK3	C2936476	Chronic Liver Failure	0.2	0	0	HPO
9455	HOMER2	C4225240	DEAFNESS, AUTOSOMAL DOMINANT 68	0.2	1	1	UNIPROT
9456	HOMER1	C0013386	Dyskinesia, Drug-Induced	0.2	1	0	CTD_human
9459	ARHGEF6	C1845526	Mental Retardation, X-Linked 46	0.2	0	0	CTD_human
946	SIGLEC6	C0024141	Lupus Erythematosus, Systemic	0.2	1	0	CTD_human
9466	IL27RA	C0032273	Pneumoconiosis	0.2	1	0	CTD_human
9468	PCYT1B	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
9469	CHST3	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
9469	CHST3	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
9469	CHST3	C0010495	Cutis Laxa	0.2	0	0	HPO
9469	CHST3	C0014877	Esotropia	0.2	0	0	HPO
9469	CHST3	C0020255	Hydrocephalus	0.2	0	0	HPO
9469	CHST3	C0020490	Hyperopia	0.2	0	0	HPO
9469	CHST3	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
9469	CHST3	C0026269	Mitral Valve Stenosis	0.2	0	0	HPO
9469	CHST3	C0029453	Osteopenia	0.2	0	0	HPO
9469	CHST3	C0038015	Spondyloepiphyseal Dysplasia	0.2	0	0	HPO
9469	CHST3	C0040961	Tricuspid Valve Insufficiency	0.2	0	0	HPO
9469	CHST3	C0040963	Tricuspid Valve Stenosis	0.2	0	0	HPO
9469	CHST3	C0149721	Left Ventricular Hypertrophy	0.2	0	0	HPO
9469	CHST3	C0238669	Aortic root dilatation	0.2	0	0	HPO
9469	CHST3	C0340279	Ventricular hypertrophy	0.2	0	0	HPO
9469	CHST3	C0747078	Generalized osteopenia	0.2	0	0	HPO
9469	CHST3	C1837657	Spondyloepiphyseal dysplasia, Omani type	0.601098907136852	2	12	CTD_human;ORPHANET;UNIPROT
9469	CHST3	C1837658	Gross motor development delay	0.2	0	0	HPO
9469	CHST3	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
9469	CHST3	C2930812	Generalized elastolysis	0.2	0	0	HPO
9469	CHST3	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
9469	CHST3	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
9474	ATG5	C0002871	Anemia	0.2	1	0	CTD_human
9474	ATG5	C0024312	Lymphopenia	0.2	1	0	CTD_human
9474	ATG5	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9479	MAPK8IP1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.400274726784213	1	1	CTD_human;UNIPROT
948	CD36	C0010068	Coronary heart disease	0.204930726738519	0	0	CTD_human
948	CD36	C0024530	Malaria	0.215239319469357	0	0	CTD_human
948	CD36	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
948	CD36	C0162820	Dermatitis, Allergic Contact	0.2	1	0	CTD_human
948	CD36	C1842090	Platelet Glycoprotein IV Deficiency	0.484670355331623	1	5	CTD_human;UNIPROT
9487	PIGL	C0014544	Epilepsy	0.2	0	0	HPO
9487	PIGL	C0018777	Conductive hearing loss	0.2	0	0	HPO
9487	PIGL	C0020295	Hydronephrosis	0.2	0	0	HPO
9487	PIGL	C0022596	Palmoplantar Keratosis	0.2	0	0	HPO
9487	PIGL	C0158113	Contracture of joint of hand	0.2	0	0	HPO
9487	PIGL	C0235946	Cerebral atrophy	0.2	0	0	HPO
9487	PIGL	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
9487	PIGL	C1848392	Zunich neuroectodermal syndrome	0.400274726784213	1	2	ORPHANET;UNIPROT
9487	PIGL	C4020860	Supratentorial atrophy	0.2	0	0	HPO
949	SCARB1	C0019196	Hepatitis C	0.214162858735182	1	0	CTD_human
949	SCARB1	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
949	SCARB1	C0400966	Non-alcoholic Fatty Liver Disease	0.2	1	0	CTD_human
9493	KIF23	C0271934	Congenital dyserythropoietic anemia, type III	0.2	0	0	ORPHANET
9496	TBX4	C0340543	Familial primary pulmonary hypertension	0.2	0	0	ORPHANET
9496	TBX4	C1840061	SMALL PATELLA SYNDROME	0.600549453568426	1	3	CTD_human;ORPHANET;UNIPROT
9496	TBX4	C1868581	Patella aplasia, coxa vara, tarsal synostosis	0.2	0	0	ORPHANET
9496	TBX4	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
9496	TBX4	C3150607	CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.2	0	0	ORPHANET
9496	TBX4	C3150880	CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME	0.2	0	0	ORPHANET
9496	TBX4	C3203102	Idiopathic pulmonary arterial hypertension	0.200274726784213	0	0	HPO
9499	MYOT	C0026850	Muscular Dystrophy	0.201373633921065	0	0	HPO
9499	MYOT	C0152025	Polyneuropathy	0.2	0	0	HPO
9499	MYOT	C0234958	muscle degeneration	0.200274726784213	0	0	HPO
9499	MYOT	C1834659	Muscular dystrophy, limb-girdle, type 1A	0.600549453568426	3	4	CTD_human;ORPHANET;UNIPROT
9499	MYOT	C1836607	MYOTILINOPATHY	0.201373633921065	1	3	CTD_human
9499	MYOT	C1848736	Distal amyotrophy	0.2	0	0	HPO
9499	MYOT	C1850794	Muscle atrophy, proximal	0.2	0	0	HPO
9499	MYOT	C1866785	Spheroid body myopathy	0.600549453568426	1	1	CTD_human;ORPHANET;UNIPROT
9499	MYOT	C2678065	Myofibrillar Myopathy	0.206043989252688	0	0	HPO
9499	MYOT	C3714934	MYOPATHY, MYOFIBRILLAR, 3	0.4	1	0	ORPHANET;UNIPROT
95	ACY1	C0014544	Epilepsy	0.2	0	0	HPO
95	ACY1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
95	ACY1	C0235946	Cerebral atrophy	0.2	0	0	HPO
95	ACY1	C0262404	Cerebellar degeneration	0.2	0	0	HPO
95	ACY1	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
95	ACY1	C1306587	Acute encephalopathy	0.2	0	0	HPO
95	ACY1	C1835922	Aminoacylase 1 deficiency	0.6	2	10	CTD_human;ORPHANET;UNIPROT
95	ACY1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
95	ACY1	C4020873	Infratentorial atrophy	0.2	0	0	HPO
950	SCARB2	C0002871	Anemia	0.2	0	0	HPO
950	SCARB2	C0003123	Anorexia	0.2	0	0	HPO
950	SCARB2	C0017668	Focal glomerulosclerosis	0.200274726784213	0	0	HPO
950	SCARB2	C0020532	Hypersplenism	0.2	0	0	HPO
950	SCARB2	C0029453	Osteopenia	0.2	0	0	HPO
950	SCARB2	C0029464	Osteosclerosis	0.2	0	0	HPO
950	SCARB2	C0030312	Pancytopenia	0.2	0	0	HPO
950	SCARB2	C0035078	Kidney Failure	0.200824180352639	0	0	HPO
950	SCARB2	C0234533	Generalized seizures	0.2	0	0	HPO
950	SCARB2	C0262404	Cerebellar degeneration	0.2	0	0	HPO
950	SCARB2	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
950	SCARB2	C0747078	Generalized osteopenia	0.2	0	0	HPO
950	SCARB2	C0751779	Action Myoclonus-Renal Failure Syndrome	0.682472541057918	1	19	CTD_human;ORPHANET;UNIPROT
950	SCARB2	C0751785	Unverricht-Lundborg Syndrome	0.201923087489492	0	0	ORPHANET
950	SCARB2	C1565489	Renal Insufficiency	0.200824180352639	0	0	HPO
950	SCARB2	C1961835	Gaucher Disease, Type 1	0.2	0	0	ORPHANET
950	SCARB2	C4020873	Infratentorial atrophy	0.2	0	0	HPO
9509	ADAMTS2	C0005742	Blepharochalasis	0.2	0	0	HPO
9509	ADAMTS2	C0017567	Gingival Hypertrophy	0.2	0	0	HPO
9509	ADAMTS2	C0027092	Myopia	0.2	0	0	HPO
9509	ADAMTS2	C0029453	Osteopenia	0.2	0	0	HPO
9509	ADAMTS2	C0747078	Generalized osteopenia	0.2	0	0	HPO
9509	ADAMTS2	C1857013	Gingival hyperkeratosis	0.2	0	0	HPO
9509	ADAMTS2	C2700425	EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE	0.481373633921066	0	0	CTD_human;ORPHANET
9516	LITAF	C0270913	Charcot-Marie-Tooth disease, Type 1C	0.601923087489492	2	10	CTD_human;ORPHANET;UNIPROT
9516	LITAF	C1848736	Distal amyotrophy	0.2	0	0	HPO
9517	SPTLC2	C0003028	Anhidrosis	0.2	0	0	HPO
9517	SPTLC2	C0020071	Hereditary Sensory Autonomic Neuropathy, Type 1	0.201648360705279	0	0	ORPHANET
9517	SPTLC2	C0029443	Osteomyelitis	0.2	0	0	HPO
9517	SPTLC2	C1112256	Peripheral sensorimotor neuropathy	0.2	0	0	HPO
9517	SPTLC2	C2242472	Infection of bone	0.2	0	0	HPO
9517	SPTLC2	C3150896	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC	0.4	2	4	CTD_human;UNIPROT
9518	GDF15	C0002896	Sideroblastic anemia	0.2	1	0	CTD_human
9518	GDF15	C0018801	Heart failure	0.200549453568426	1	0	CTD_human
9518	GDF15	C0149721	Left Ventricular Hypertrophy	0.202681755307501	1	0	CTD_human
9518	GDF15	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
9518	GDF15	C1956346	Coronary Artery Disease	0.200274726784213	1	0	CTD_human
952	CD38	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
9524	TECR	C3151462	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.2	1	1	UNIPROT
9526	MPDU1	C0011606	Exfoliative dermatitis	0.2	0	0	HPO
9526	MPDU1	C0014544	Epilepsy	0.2	0	0	HPO
9526	MPDU1	C0028738	Nystagmus	0.2	0	0	HPO
9526	MPDU1	C0029124	Optic Atrophy	0.2	0	0	HPO
9526	MPDU1	C0038379	Strabismus	0.2	0	0	HPO
9526	MPDU1	C0235946	Cerebral atrophy	0.2	0	0	HPO
9526	MPDU1	C0259817	Xerosis	0.2	0	0	HPO
9526	MPDU1	C0870082	Hyperkeratosis	0.2	0	0	HPO
9526	MPDU1	C1836669	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If	0.600824180352639	2	4	CTD_human;ORPHANET;UNIPROT
9526	MPDU1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9526	MPDU1	C4020860	Supratentorial atrophy	0.2	0	0	HPO
953	ENTPD1	C0234958	muscle degeneration	0.2	0	0	HPO
953	ENTPD1	C3810289	SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE	0.4	1	1	ORPHANET;UNIPROT
9531	BAG3	C0007194	Hypertrophic Cardiomyopathy	0.2	0	0	HPO
9531	BAG3	C0018801	Heart failure	0.201373633921065	0	0	HPO
9531	BAG3	C0018802	Congestive heart failure	0.201373633921065	0	0	HPO
9531	BAG3	C0026850	Muscular Dystrophy	0.200824180352639	0	0	HPO
9531	BAG3	C0270922	Peripheral demyelinating neuropathy	0.2	0	0	HPO
9531	BAG3	C0376175	Bell Palsy	0.2	0	0	HPO
9531	BAG3	C1389113	Generalized amyotrophy	0.2	0	0	HPO
9531	BAG3	C2678065	Myofibrillar Myopathy	0.20357144819477	0	0	HPO
9531	BAG3	C2751831	Myopathy, Myofibrillar, Bag3-Related	0.6	3	1	CTD_human;ORPHANET;UNIPROT
9531	BAG3	C3151293	CARDIOMYOPATHY, DILATED, 1HH	0.2	3	6	UNIPROT
9531	BAG3	C3715165	LEFT VENTRICULAR NONCOMPACTION 10	0.2	0	0	ORPHANET
9531	BAG3	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	0.2	0	0	ORPHANET
9533	POLR1C	C0018777	Conductive hearing loss	0.2	0	0	HPO
9533	POLR1C	C0023520	Leukodystrophy	0.200274726784213	0	0	HPO
9533	POLR1C	C0038379	Strabismus	0.2	0	0	HPO
9533	POLR1C	C0042798	Low Vision	0.2	0	0	HPO
9533	POLR1C	C0265241	Franceschetti-Klein syndrome	0.2	0	0	ORPHANET
9533	POLR1C	C0948896	Primary hypogonadism	0.2	0	0	HPO
9533	POLR1C	C1855433	Mandibulofacial dysostosis, Treacher Collins type, autosomal recessive	0.4	2	3	CTD_human;UNIPROT
9533	POLR1C	C2676243	Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism	0.2	0	0	ORPHANET
9533	POLR1C	C4225305	LEUKODYSTROPHY, HYPOMYELINATING, 11	0.2	1	10	UNIPROT
9536	PTGES	C0020295	Hydronephrosis	0.2	2	0	CTD_human
954	ENTPD2	C0023892	Biliary cirrhosis	0.202732912464814	1	0	CTD_human
9547	CXCL14	C0004096	Asthma	0.202407028523288	1	0	CTD_human
9547	CXCL14	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
9547	CXCL14	C0014175	Endometriosis	0.200274726784213	1	0	CTD_human
9559	VPS26A	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200274726784213	1	1	CTD_human
9563	H6PD	C0028754	Obesity	0.200549453568426	0	0	HPO
9563	H6PD	C0702166	Acne	0.2	0	0	HPO
9563	H6PD	C1291245	Cortisone reductase deficiency	0.201373633921065	0	0	CTD_human
9563	H6PD	C3551716	CORTISONE REDUCTASE DEFICIENCY 1	0.2	2	6	UNIPROT
95681	CEP41	C0431399	Familial aplasia of the vermis	0.200274726784213	0	0	ORPHANET
95681	CEP41	C4274118	Joubert syndrome with ocular defect	0.2	0	0	ORPHANET
9569	GTF2IRD1	C0003499	Supravalvular aortic stenosis	0.200274726784213	0	0	HPO
9569	GTF2IRD1	C0007786	Brain Ischemia	0.2	0	0	HPO
9569	GTF2IRD1	C0012819	Diverticular disease of colon	0.2	0	0	HPO
9569	GTF2IRD1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9569	GTF2IRD1	C0020437	Hypercalcemia	0.2	0	0	HPO
9569	GTF2IRD1	C0020545	Hypertension, Renovascular	0.2	0	0	HPO
9569	GTF2IRD1	C0024421	Macroglossia	0.2	0	0	HPO
9569	GTF2IRD1	C0024636	Malocclusion	0.2	0	0	HPO
9569	GTF2IRD1	C0026267	Mitral Valve Prolapse Syndrome	0.2	0	0	HPO
9569	GTF2IRD1	C0028754	Obesity	0.2	0	0	HPO
9569	GTF2IRD1	C0035078	Kidney Failure	0.2	0	0	HPO
9569	GTF2IRD1	C0038379	Strabismus	0.2	0	0	HPO
9569	GTF2IRD1	C0042798	Low Vision	0.2	0	0	HPO
9569	GTF2IRD1	C0149754	Cellulitis of periorbital region	0.2	0	0	HPO
9569	GTF2IRD1	C0175702	Williams Syndrome	0.485769262468475	1	0	CTD_human;ORPHANET
9569	GTF2IRD1	C0271441	Chronic otitis media	0.2	0	0	HPO
9569	GTF2IRD1	C0345030	Peripheral pulmonary artery stenosis	0.2	0	0	HPO
9569	GTF2IRD1	C0743359	ear infection chronic	0.2	0	0	HPO
9569	GTF2IRD1	C0917798	Cerebral Ischemia	0.2	0	0	HPO
9569	GTF2IRD1	C1565489	Renal Insufficiency	0.2	0	0	HPO
9569	GTF2IRD1	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
9569	GTF2IRD1	C4020884	Anxiety disease	0.2	0	0	HPO
9569	GTF2IRD1	C4025788	Nystagmus-induced head nodding	0.2	0	0	HPO
9569	GTF2IRD1	C4280614	Angle class 2 malocclusion	0.2	0	0	HPO
9570	GOSR2	C0014553	Absence Epilepsy	0.2	0	0	HPO
9570	GOSR2	C0270846	Epileptic drop attack	0.2	0	0	HPO
9570	GOSR2	C3279627	EPILEPSY, PROGRESSIVE MYOCLONIC, 6	0.4	1	3	ORPHANET;UNIPROT
9573	GDF3	C0028738	Nystagmus	0.2	0	0	HPO
9573	GDF3	C0042798	Low Vision	0.2	0	0	HPO
9573	GDF3	C1845877	Microphthalmia, Isolated, with Coloboma 1	0.2	0	0	ORPHANET
9573	GDF3	C1855052	MICROPHTHALMIA, ISOLATED 1	0.2	0	0	ORPHANET
9573	GDF3	C3150967	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT	0.4	1	1	CTD_human;UNIPROT
9573	GDF3	C3150968	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.4	1	2	CTD_human;UNIPROT
9573	GDF3	C3150969	MICROPHTHALMIA, ISOLATED 7	0.4	1	2	CTD_human;UNIPROT
9575	CLOCK	C0001957	Alcohol Withdrawal Delirium	0.200274726784213	1	0	PSYGENET
958	CD40	C0003873	Rheumatoid Arthritis	0.235854826199409	3	2	CTD_human
958	CD40	C0026691	Mucocutaneous Lymph Node Syndrome	0.20350593566014	2	0	CTD_human
958	CD40	C0026769	Multiple Sclerosis	0.210792533764634	1	0	CTD_human
958	CD40	C0038220	Status Epilepticus	0.2	1	0	CTD_human
958	CD40	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
958	CD40	C0162539	IgG Deficiency	0.2	0	0	HPO
958	CD40	C0272236	Hyperimmunoglobulin M syndrome	0.206029633875371	0	0	CTD_human
958	CD40	C1720957	Hyper-IgM Immunodeficiency Syndrome, Type 3	0.4	2	1	ORPHANET;UNIPROT
9581	PREPL	C0010691	Cystinuria	0.200549453568426	0	0	HPO
9581	PREPL	C0014544	Epilepsy	0.2	0	0	HPO
9581	PREPL	C0020619	Hypogonadism	0.2	0	0	HPO
9581	PREPL	C0392525	Nephrolithiasis	0.2	0	0	HPO
9581	PREPL	C1848030	Hypotonia-Cystinuria Syndrome	0.401923087489492	1	0	CTD_human;ORPHANET
9581	PREPL	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9588	PRDX6	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
9588	PRDX6	C0013080	Down Syndrome	0.202732912464814	1	0	CTD_human
9588	PRDX6	C0035222	Respiratory Distress Syndrome, Adult	0.2	1	0	CTD_human
9588	PRDX6	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
959	CD40LG	C0002736	Amyotrophic Lateral Sclerosis	0.200274726784213	1	0	CTD_human
959	CD40LG	C0002878	Anemia, Hemolytic	0.200274726784213	0	0	HPO
959	CD40LG	C0013374	Dysgammaglobulinemia	0.200274726784213	0	0	HPO
959	CD40LG	C0017574	Gingivitis	0.2	0	0	HPO
959	CD40LG	C0019158	Hepatitis	0.2	0	0	HPO
959	CD40LG	C0019189	Hepatitis, Chronic	0.2	0	0	HPO
959	CD40LG	C0032285	Pneumonia	0.200549453568426	1	0	CTD_human
959	CD40LG	C0038362	Stomatitis	0.2	0	0	HPO
959	CD40LG	C0149704	Gingivostomatitis	0.2	0	0	HPO
959	CD40LG	C0162538	Immunoglobulin A deficiency (disorder)	0.200274726784213	0	0	HPO
959	CD40LG	C0162539	IgG Deficiency	0.200274726784213	0	0	HPO
959	CD40LG	C0398689	Hyper-IgM Immunodeficiency Syndrome, Type 1	0.628296858773949	11	11	CTD_human;ORPHANET;UNIPROT
959	CD40LG	C1956346	Coronary Artery Disease	0.286015278498054	1	0	CTD_human
960	CD44	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
960	CD44	C0017661	IGA Glomerulonephritis	0.2	1	0	CTD_human
960	CD44	C0042900	Vitiligo	0.2	1	0	CTD_human
9607	CARTPT	C0020550	Hyperthyroidism	0.2	1	0	CTD_human
9607	CARTPT	C0028754	Obesity	0.218013619334498	0	0	CTD_human
9611	NCOR1	C0014175	Endometriosis	0.2	1	0	CTD_human
9619	ABCG1	C0022661	Kidney Failure, Chronic	0.2	1	0	CTD_human
9622	KLK4	C0011334	Dental caries	0.200274726784213	0	0	HPO
9627	SNCAIP	C0085606	Urgency of micturition	0.2	0	0	HPO
9627	SNCAIP	C0752347	Lewy Body Disease	0.200824180352639	0	0	HPO
9627	SNCAIP	C3160718	PARKINSON DISEASE, LATE-ONSET	0.2	0	0	CTD_human
9627	SNCAIP	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
9627	SNCAIP	C4020871	Dystonic disease	0.2	0	0	HPO
9627	SNCAIP	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
9631	NUP155	C0004238	Atrial Fibrillation	0.203007639249027	0	0	HPO
9631	NUP155	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
9631	NUP155	C4014269	ATRIAL FIBRILLATION, FAMILIAL, 15	0.2	1	1	UNIPROT
9632	SEC24C	C0011334	Dental caries	0.2	0	0	HPO
9632	SEC24C	C0012236	DiGeorge Syndrome	0.2	0	0	ORPHANET
9632	SEC24C	C0018777	Conductive hearing loss	0.2	0	0	HPO
9632	SEC24C	C0020626	Hypoparathyroidism	0.2	0	0	HPO
9632	SEC24C	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
9632	SEC24C	C0039621	Tetany	0.2	0	0	HPO
9632	SEC24C	C0085109	Corneal Neovascularization	0.2	0	0	HPO
9632	SEC24C	C0220704	Shprintzen syndrome	0.2	0	0	ORPHANET
9632	SEC24C	C0271441	Chronic otitis media	0.2	0	0	HPO
9632	SEC24C	C0702166	Acne	0.2	0	0	HPO
9632	SEC24C	C0743359	ear infection chronic	0.2	0	0	HPO
9632	SEC24C	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	0.2	0	0	ORPHANET
9632	SEC24C	C2936346	22q11 Deletion Syndrome	0.2	0	0	ORPHANET
9632	SEC24C	C3266101	22q11 partial monosomy syndrome	0.2	0	0	ORPHANET
9632	SEC24C	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
9632	SEC24C	C4024912	Occipital myelomeningocele	0.2	0	0	HPO
9636	ISG15	C0021400	Influenza	0.201098907136852	1	0	CTD_human
9636	ISG15	C4015293	IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION	0.2	0	0	ORPHANET
9637	FEZ2	C0151744	Myocardial Ischemia	0.2	1	0	CTD_human
9639	ARHGEF10	C1842357	Slowed Nerve Conduction Velocity, Autosomal Dominant	0.6	1	1	CTD_human;ORPHANET;UNIPROT
9640	ZNF592	C0014544	Epilepsy	0.2	0	0	HPO
9640	ZNF592	C0017668	Focal glomerulosclerosis	0.2	0	0	HPO
9640	ZNF592	C0028738	Nystagmus	0.2	0	0	HPO
9640	ZNF592	C0029124	Optic Atrophy	0.2	0	0	HPO
9640	ZNF592	C0035078	Kidney Failure	0.2	0	0	HPO
9640	ZNF592	C0038379	Strabismus	0.2	0	0	HPO
9640	ZNF592	C0158113	Contracture of joint of hand	0.2	0	0	HPO
9640	ZNF592	C0162835	Hypopigmentation disorder	0.2	0	0	HPO
9640	ZNF592	C0235946	Cerebral atrophy	0.2	0	0	HPO
9640	ZNF592	C0239981	Hypoalbuminemia	0.2	0	0	HPO
9640	ZNF592	C0262404	Cerebellar degeneration	0.2	0	0	HPO
9640	ZNF592	C0268747	Diffuse mesangial sclerosis (disorder)	0.2	0	0	HPO
9640	ZNF592	C0740279	Atrophy of cerebellum	0.2	0	0	HPO
9640	ZNF592	C1565489	Renal Insufficiency	0.2	0	0	HPO
9640	ZNF592	C1847114	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 5	0.200274726784213	1	0	CTD_human
9640	ZNF592	C3489393	Hiatal Hernia	0.2	0	0	HPO
9640	ZNF592	C4020860	Supratentorial atrophy	0.2	0	0	HPO
9640	ZNF592	C4020873	Infratentorial atrophy	0.2	0	0	HPO
965	CD58	C0026769	Multiple Sclerosis	0.232181063690013	2	3	CTD_human
9652	TTC37	C0008370	Cholestasis	0.2	0	0	HPO
9652	TTC37	C0015300	Exophthalmos	0.2	0	0	HPO
9652	TTC37	C0023890	Liver Cirrhosis	0.200274726784213	0	0	HPO
9652	TTC37	C0085605	Liver Failure	0.2	0	0	HPO
9652	TTC37	C0239946	Fibrosis, Liver	0.2	0	0	HPO
9652	TTC37	C0239981	Hypoalbuminemia	0.2	0	0	HPO
9652	TTC37	C0263485	Clastothrix	0.200274726784213	0	0	HPO
9652	TTC37	C0263490	Brittle hair	0.2	0	0	HPO
9652	TTC37	C0267456	Villous atrophy of intestine	0.2	0	0	HPO
9652	TTC37	C0268621	Hepatic methionine adenosyltransferase deficiency	0.2	0	0	HPO
9652	TTC37	C0743178	Diarrhea, intractable	0.200549453568426	0	0	HPO
9652	TTC37	C1857276	Trichohepatoenteric Syndrome	0.401923087489492	1	6	ORPHANET;UNIPROT
9652	TTC37	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9657	IQCB1	C0014544	Epilepsy	0.2	0	0	HPO
9657	IQCB1	C0022578	Keratoconus	0.2	0	0	HPO
9657	IQCB1	C0025322	Premature Menopause	0.2	0	0	HPO
9657	IQCB1	C0028738	Nystagmus	0.2	0	0	HPO
9657	IQCB1	C0035334	Retinitis Pigmentosa	0.200549453568426	0	0	HPO
9657	IQCB1	C0042798	Low Vision	0.2	0	0	HPO
9657	IQCB1	C0339527	Leber Congenital Amaurosis	0.202956482091714	0	0	ORPHANET
9657	IQCB1	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
9657	IQCB1	C0403553	Renal dysplasia and retinal aplasia (disorder)	0.201648360705279	0	0	ORPHANET
9657	IQCB1	C0687120	Nephronophthisis	0.200549453568426	0	0	HPO
9657	IQCB1	C1301509	Severe visual impairment	0.2	0	0	HPO
9657	IQCB1	C1836517	Senior-Loken Syndrome 5	0.2	0	0	CTD_human
9657	IQCB1	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
966	CD59	C0002878	Anemia, Hemolytic	0.200274726784213	0	0	HPO
966	CD59	C0024790	Paroxysmal nocturnal hemoglobinuria	0.208241803526393	0	0	HPO
966	CD59	C0234958	muscle degeneration	0.2	0	0	HPO
966	CD59	C2676767	CD59 Deficiency	0.601373633921066	1	2	CTD_human;ORPHANET;UNIPROT
9662	CEP135	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
9662	CEP135	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.2	0	0	ORPHANET
9663	LPIN2	C0029464	Osteosclerosis	0.2	0	0	HPO
9663	LPIN2	C0039103	Synovitis	0.2	0	0	HPO
9663	LPIN2	C0271901	Microcytic hypochromic anemia (disorder)	0.2	0	0	HPO
9663	LPIN2	C0410422	Chronic multifocal osteomyelitis	0.200549453568426	0	0	HPO
9663	LPIN2	C0702166	Acne	0.2	0	0	HPO
9663	LPIN2	C1864997	Majeed syndrome	0.681098907136852	1	4	CTD_human;ORPHANET;UNIPROT
9663	LPIN2	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9672	SDC3	C0028754	Obesity	0.205638237399215	0	0	CTD_human
968	CD68	C0003872	Arthritis, Psoriatic	0.2	1	0	CTD_human
968	CD68	C0022661	Kidney Failure, Chronic	0.200274726784213	1	0	CTD_human
968	CD68	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	0.2	1	0	CTD_human
9681	DEPDC5	C0014544	Epilepsy	0.201098907136852	0	0	HPO
9681	DEPDC5	C1838062	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.2	0	0	ORPHANET
9681	DEPDC5	C1858477	Epilepsy, Partial, with Variable Foci	0.4	3	56	CTD_human;UNIPROT
9687	GREB1	C0014175	Endometriosis	0.201098907136852	1	1	CTD_human
9688	NUP93	C1868672	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	0.2	1	0	CTD_human
9688	NUP93	C4225166	NEPHROTIC SYNDROME, TYPE 12	0.2	1	5	UNIPROT
969	CD69	C0003864	Arthritis	0.200824180352639	1	0	CTD_human
969	CD69	C0011854	Diabetes Mellitus, Insulin-Dependent	0.202407028523288	1	1	CTD_human
9690	UBE3C	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
9695	EDEM1	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9702	CEP57	C0003504	Aortic Valve Insufficiency	0.2	0	0	HPO
9702	CEP57	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
9702	CEP57	C0017601	Glaucoma	0.2	0	0	HPO
9702	CEP57	C0026850	Muscular Dystrophy	0.2	0	0	HPO
9702	CEP57	C0340375	Subaortic stenosis	0.2	0	0	HPO
9702	CEP57	C0521719	Clouding of corneal stroma	0.2	0	0	HPO
9702	CEP57	C1850343	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.400549453568426	1	0	CTD_human;ORPHANET
9711	RUBCN	C0014544	Epilepsy	0.2	0	0	HPO
9711	RUBCN	C0028738	Nystagmus	0.2	0	0	HPO
9711	RUBCN	C3810326	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15	0.2	0	0	ORPHANET
9719	ADAMTSL2	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
9719	ADAMTSL2	C0014544	Epilepsy	0.2	0	0	HPO
9719	ADAMTSL2	C0018801	Heart failure	0.2	0	0	HPO
9719	ADAMTSL2	C0018802	Congestive heart failure	0.2	0	0	HPO
9719	ADAMTSL2	C0026269	Mitral Valve Stenosis	0.2	0	0	HPO
9719	ADAMTSL2	C0029453	Osteopenia	0.2	0	0	HPO
9719	ADAMTSL2	C0040583	Tracheal Stenosis	0.2	0	0	HPO
9719	ADAMTSL2	C0040963	Tricuspid Valve Stenosis	0.2	0	0	HPO
9719	ADAMTSL2	C0747078	Generalized osteopenia	0.2	0	0	HPO
9719	ADAMTSL2	C3278147	GELEOPHYSIC DYSPLASIA 1	0.48	2	9	CTD_human;UNIPROT
972	CD74	C0162557	Liver Failure, Acute	0.2	1	0	CTD_human
9722	NOS1AP	C0035828	Romano-Ward Syndrome	0.2	0	0	ORPHANET
9722	NOS1AP	C1857828	QT INTERVAL, VARIATION IN	0.2	0	0	CTD_human
9723	SEMA3E	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
9723	SEMA3E	C0018418	Gynecomastia	0.2	0	0	HPO
9723	SEMA3E	C0020295	Hydronephrosis	0.2	0	0	HPO
9723	SEMA3E	C0020676	Hypothyroidism	0.2	0	0	HPO
9723	SEMA3E	C0024312	Lymphopenia	0.2	0	0	HPO
9723	SEMA3E	C0028738	Nystagmus	0.2	0	0	HPO
9723	SEMA3E	C0029124	Optic Atrophy	0.2	0	0	HPO
9723	SEMA3E	C0038379	Strabismus	0.2	0	0	HPO
9723	SEMA3E	C0232939	Primary physiologic amenorrhea	0.2	0	0	HPO
9723	SEMA3E	C0265354	CHARGE Syndrome	0.4	0	0	CTD_human;ORPHANET
9723	SEMA3E	C0271623	Hypogonadotropic hypogonadism	0.2	0	0	HPO
9723	SEMA3E	C0376175	Bell Palsy	0.2	0	0	HPO
9723	SEMA3E	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
9723	SEMA3E	C3489396	Hypogonadism, Isolated Hypogonadotropic	0.2	0	0	HPO
9723	SEMA3E	C4025821	Anterior hypopituitarism	0.2	0	0	HPO
973	CD79A	C0001768	Agammaglobulinemia	0.400274726784213	0	0	CTD_human;HPO
973	CD79A	C0003864	Arthritis	0.2	0	0	HPO
973	CD79A	C0009763	Conjunctivitis	0.2	0	0	HPO
973	CD79A	C0029443	Osteomyelitis	0.2	0	0	HPO
973	CD79A	C0037199	Sinusitis	0.2	0	0	HPO
973	CD79A	C0271441	Chronic otitis media	0.2	0	0	HPO
973	CD79A	C0741796	Recurrent bronchitis	0.2	0	0	HPO
973	CD79A	C0743359	ear infection chronic	0.2	0	0	HPO
973	CD79A	C0747085	Recurrent otitis media	0.2	0	0	HPO
973	CD79A	C2242472	Infection of bone	0.2	0	0	HPO
973	CD79A	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
973	CD79A	C3152144	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
9731	CEP104	C0028738	Nystagmus	0.2	0	0	HPO
9731	CEP104	C0431399	Familial aplasia of the vermis	0.200274726784213	0	0	ORPHANET
9731	CEP104	C3489733	Oculomotor apraxia	0.2	0	0	HPO
9733	SART3	C1867981	POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 1	0.2	0	0	CTD_human
974	CD79B	C0001768	Agammaglobulinemia	0.200274726784213	0	0	HPO
974	CD79B	C0003864	Arthritis	0.2	0	0	HPO
974	CD79B	C0009763	Conjunctivitis	0.2	0	0	HPO
974	CD79B	C0029443	Osteomyelitis	0.2	0	0	HPO
974	CD79B	C0037199	Sinusitis	0.2	0	0	HPO
974	CD79B	C0149516	Chronic sinusitis	0.2	0	0	HPO
974	CD79B	C0271441	Chronic otitis media	0.2	0	0	HPO
974	CD79B	C0694550	Recurrent pneumonia	0.2	0	0	HPO
974	CD79B	C0741796	Recurrent bronchitis	0.2	0	0	HPO
974	CD79B	C0743359	ear infection chronic	0.2	0	0	HPO
974	CD79B	C0747085	Recurrent otitis media	0.2	0	0	HPO
974	CD79B	C0748140	Multiple pulmonary infections	0.2	0	0	HPO
974	CD79B	C0748720	Chronic sinus disease	0.2	0	0	HPO
974	CD79B	C2242472	Infection of bone	0.2	0	0	HPO
974	CD79B	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
974	CD79B	C3150207	AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE	0.4	1	2	CTD_human;UNIPROT
974	CD79B	C3152144	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
9742	IFT140	C0002871	Anemia	0.2	0	0	HPO
9742	IFT140	C0008370	Cholestasis	0.2	0	0	HPO
9742	IFT140	C0014544	Epilepsy	0.2	0	0	HPO
9742	IFT140	C0017601	Glaucoma	0.2	0	0	HPO
9742	IFT140	C0018777	Conductive hearing loss	0.2	0	0	HPO
9742	IFT140	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9742	IFT140	C0020459	Hyperinsulinism	0.2	0	0	HPO
9742	IFT140	C0020619	Hypogonadism	0.2	0	0	HPO
9742	IFT140	C0022578	Keratoconus	0.2	0	0	HPO
9742	IFT140	C0022679	Cystic kidney	0.200274726784213	0	0	HPO
9742	IFT140	C0028738	Nystagmus	0.2	0	0	HPO
9742	IFT140	C0028754	Obesity	0.2	0	0	HPO
9742	IFT140	C0029124	Optic Atrophy	0.2	0	0	HPO
9742	IFT140	C0035334	Retinitis Pigmentosa	0.400549453568426	0	0	HPO;ORPHANET
9742	IFT140	C0239946	Fibrosis, Liver	0.2	0	0	HPO
9742	IFT140	C0271215	Blindness, Legal	0.2	0	0	HPO
9742	IFT140	C0339527	Leber Congenital Amaurosis	0.2	0	0	ORPHANET
9742	IFT140	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
9742	IFT140	C0687120	Nephronophthisis	0.2	0	0	HPO
9742	IFT140	C1301509	Severe visual impairment	0.2	0	0	HPO
9742	IFT140	C1849437	Mainzer-Saldino Disease	0.480549453568426	2	12	ORPHANET;UNIPROT
9742	IFT140	C2316810	Chronic kidney disease stage 5	0.2	0	0	HPO
975	CD81	C0002878	Anemia, Hemolytic	0.2	0	0	HPO
975	CD81	C0006267	Bronchiectasis	0.2	0	0	HPO
975	CD81	C0009447	Common Variable Immunodeficiency	0.400274726784213	0	0	CTD_human;ORPHANET
975	CD81	C0019196	Hepatitis C	0.258705547499481	1	0	CTD_human
975	CD81	C0024312	Lymphopenia	0.2	0	0	HPO
975	CD81	C0032285	Pneumonia	0.2	0	0	HPO
975	CD81	C0034150	Purpura	0.2	0	0	HPO
975	CD81	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
975	CD81	C0242584	Autoimmune thrombocytopenia	0.2	0	0	HPO
975	CD81	C0271441	Chronic otitis media	0.2	0	0	HPO
975	CD81	C0398650	Immune thrombocytopenic purpura	0.2	0	0	HPO
975	CD81	C0741796	Recurrent bronchitis	0.2	0	0	HPO
975	CD81	C0743359	ear infection chronic	0.2	0	0	HPO
975	CD81	C0920163	Idiopathic thrombocytopenia	0.2	0	0	HPO
9750	FAM65B	C4021806	Prelingual sensorineural hearing impairment	0.2	0	0	HPO
9755	TBKBP1	C0038013	Ankylosing spondylitis	0.200824180352639	1	0	CTD_human
9759	HDAC4	C0011616	Contact Dermatitis	0.2	1	0	CTD_human
9759	HDAC4	C0013595	Eczema	0.2	0	0	HPO
9759	HDAC4	C0014306	Enophthalmos	0.2	0	0	HPO
9759	HDAC4	C0014544	Epilepsy	0.2	0	0	HPO
9759	HDAC4	C0028754	Obesity	0.200549453568426	0	0	HPO
9759	HDAC4	C0340543	Familial primary pulmonary hypertension	0.2	1	0	CTD_human
9759	HDAC4	C2931817	Chromosome 2q37 deletion syndrome	0.401923087489492	1	0	CTD_human;ORPHANET
977	CD151	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
977	CD151	C0027697	Nephritis	0.2	0	0	HPO
977	CD151	C0221260	Dystrophia unguium	0.2	0	0	HPO
977	CD151	C1836823	Nephropathy with Pretibial Epidermolysis Bullosa and Deafness	0.48	0	0	CTD_human;ORPHANET
977	CD151	C2316810	Chronic kidney disease stage 5	0.200274726784213	0	0	HPO
9775	EIF4A3	C1849348	Richieri Costa Pereira syndrome	0.400549453568426	1	1	ORPHANET;UNIPROT
9780	PIEZO1	C0272051	Xerocytosis	0.402197814273705	4	12	ORPHANET;UNIPROT
9780	PIEZO1	C4025182	Exercise-induced hemolysis	0.2	0	0	HPO
9782	MATR3	C0002736	Amyotrophic Lateral Sclerosis	0.401923087489492	0	0	HPO;ORPHANET
9782	MATR3	C0234958	muscle degeneration	0.2	0	0	HPO
9782	MATR3	C1145670	Respiratory Failure	0.2	0	0	HPO
9782	MATR3	C1301959	Bulbar weakness	0.2	0	0	HPO
9782	MATR3	C1853723	MYOPATHY, DISTAL 2	0.201098907136852	0	0	ORPHANET
9782	MATR3	C3807521	AMYOTROPHIC LATERAL SCLEROSIS 21	0.4	2	3	ORPHANET;UNIPROT
9782	MATR3	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
9782	MATR3	C4020884	Anxiety disease	0.2	0	0	HPO
9782	MATR3	C4082299	Bulbar palsy	0.2	0	0	HPO
9786	KIAA0586	C0020255	Hydrocephalus	0.2	0	0	HPO
9786	KIAA0586	C0028738	Nystagmus	0.2	0	0	HPO
9786	KIAA0586	C0220697	POLYDACTYLY, POSTAXIAL	0.2	0	0	HPO
9786	KIAA0586	C0431399	Familial aplasia of the vermis	0.201098907136852	0	0	ORPHANET
9786	KIAA0586	C3489733	Oculomotor apraxia	0.2	0	0	HPO
9786	KIAA0586	C4084822	JOUBERT SYNDROME 23	0.200274726784213	1	10	UNIPROT
9788	MTSS1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
9791	PTDSS1	C0010495	Cutis Laxa	0.2	0	0	HPO
9791	PTDSS1	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9791	PTDSS1	C0263401	Cutis marmorata	0.2	0	0	HPO
9791	PTDSS1	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
9791	PTDSS1	C2930812	Generalized elastolysis	0.2	0	0	HPO
9791	PTDSS1	C2930865	Ramer Ladda syndrome	0.2	0	0	HPO
9805	SCRN1	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
9817	KEAP1	C0019158	Hepatitis	0.2	1	0	CTD_human
9817	KEAP1	C0022593	Keratosis	0.2	1	0	CTD_human
982	CDB2	C1562894	Thiel-Behnke corneal dystrophy	0.200549453568426	0	0	CTD_human
9820	CUL7	C0852283	Respiratory Distress Syndrome	0.2	0	0	HPO
9820	CUL7	C1848862	Miller-McKusick-Malvaux-Syndrome (3M Syndrome)	0.40357144819477	0	0	CTD_human;ORPHANET
9820	CUL7	C1851996	Dwarfism tall vertebrae	0.2	0	0	ORPHANET
9820	CUL7	C2678312	Three M Syndrome 1	0.2	2	4	UNIPROT
9829	DNAJC6	C0014544	Epilepsy	0.200274726784213	0	0	HPO
9829	DNAJC6	C0085623	Akinesia	0.2	0	0	HPO
9829	DNAJC6	C0235946	Cerebral atrophy	0.2	0	0	HPO
9829	DNAJC6	C3809811	PARKINSON DISEASE 19, JUVENILE-ONSET	0.2	0	0	ORPHANET
9829	DNAJC6	C4020871	Dystonic disease	0.2	0	0	HPO
9829	DNAJC6	C4275179	Young onset Parkinson disease	0.200274726784213	0	0	ORPHANET
9839	ZEB2	C0037036	Sialorrhea	0.2	0	0	HPO
9839	ZEB2	C1856113	Mowat-Wilson syndrome	0.489340710663245	5	83	CTD_human;UNIPROT
9839	ZEB2	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
9841	ZBTB24	C0002871	Anemia	0.2	0	0	HPO
9841	ZBTB24	C0008677	Bronchitis, Chronic	0.2	0	0	HPO
9841	ZBTB24	C0009451	Communicating Hydrocephalus	0.2	0	0	HPO
9841	ZBTB24	C0024312	Lymphopenia	0.2	0	0	HPO
9841	ZBTB24	C0032285	Pneumonia	0.2	0	0	HPO
9841	ZBTB24	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
9841	ZBTB24	C3279748	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2	0.200274726784213	1	3	UNIPROT
9842	PLEKHM1	C0029454	Osteopetrosis	0.20656473206648	0	0	HPO
9842	PLEKHM1	C0432261	Osteopetrosis - intermediate type	0.2	0	0	ORPHANET
9842	PLEKHM1	C1969093	Osteopetrosis, Autosomal Recessive 6	0.2	0	0	CTD_human
9844	ELMO1	C0011881	Diabetic Nephropathy	0.220522962172412	1	0	CTD_human
9844	ELMO1	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
9851	KIAA0753	C2745997	OROFACIODIGITAL SYNDROME VI	0.2	0	0	ORPHANET
9855	FARP2	C2931817	Chromosome 2q37 deletion syndrome	0.2	1	0	CTD_human
9860	LRIG2	C0020295	Hydronephrosis	0.2	0	0	HPO
9860	LRIG2	C0035078	Kidney Failure	0.2	0	0	HPO
9860	LRIG2	C0041972	Urethral Obstruction	0.2	0	0	HPO
9860	LRIG2	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
9860	LRIG2	C0262655	Recurrent urinary tract infection	0.2	0	0	HPO
9860	LRIG2	C1565489	Renal Insufficiency	0.2	0	0	HPO
9861	PSMD6	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.200274726784213	1	1	CTD_human
987	LRBA	C0002880	Autoimmune hemolytic anemia	0.2	0	0	HPO
987	LRBA	C0003864	Arthritis	0.2	0	0	HPO
987	LRBA	C0004096	Asthma	0.2	0	0	HPO
987	LRBA	C0006267	Bronchiectasis	0.2	0	0	HPO
987	LRBA	C0009319	Colitis	0.2	0	0	HPO
987	LRBA	C0009763	Conjunctivitis	0.2	0	0	HPO
987	LRBA	C0017152	Gastritis	0.2	0	0	HPO
987	LRBA	C0020676	Hypothyroidism	0.2	0	0	HPO
987	LRBA	C0032285	Pneumonia	0.2	0	0	HPO
987	LRBA	C0162538	Immunoglobulin A deficiency (disorder)	0.2	0	0	HPO
987	LRBA	C0401151	Chronic diarrhea	0.2	0	0	HPO
987	LRBA	C0581354	Recurrent sinusitis	0.2	0	0	HPO
987	LRBA	C0746102	Chronic lung disease	0.2	0	0	HPO
987	LRBA	C0747085	Recurrent otitis media	0.2	0	0	HPO
987	LRBA	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
987	LRBA	C3553512	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY	0.4	1	5	ORPHANET;UNIPROT
987	LRBA	C3714497	Reactive airway disease	0.2	0	0	HPO
987	LRBA	C4280333	Recurrent sinus disease	0.2	0	0	HPO
9871	SEC24D	C0009451	Communicating Hydrocephalus	0.2	0	0	HPO
9871	SEC24D	C0015300	Exophthalmos	0.2	0	0	HPO
9871	SEC24D	C0020255	Hydrocephalus	0.2	0	0	HPO
9871	SEC24D	C0029453	Osteopenia	0.2	0	0	HPO
9871	SEC24D	C0747078	Generalized osteopenia	0.2	0	0	HPO
9871	SEC24D	C1833340	Synostotic Posterior Plagiocephaly	0.2	0	0	HPO
9871	SEC24D	C1856266	Coronal craniosynostosis	0.2	0	0	HPO
9871	SEC24D	C1862178	Cole Carpenter syndrome	0.2	0	0	ORPHANET
9871	SEC24D	C4225382	COLE-CARPENTER SYNDROME 2	0.2	1	3	UNIPROT
9873	FCHSD2	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
9885	OSBPL2	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9886	RHOBTB1	C3495559	Juvenile arthritis	0.2	1	0	CTD_human
9895	TECPR2	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
9895	TECPR2	C0037772	Spastic Paraplegia	0.2	0	0	HPO
9895	TECPR2	C0037773	Spastic Paraplegia, Hereditary	0.2	1	0	CTD_human
9895	TECPR2	C0235946	Cerebral atrophy	0.2	0	0	HPO
9895	TECPR2	C0520680	Sleep Apnea, Central	0.2	0	0	HPO
9895	TECPR2	C3542549	SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.2	0	0	ORPHANET
9895	TECPR2	C4020860	Supratentorial atrophy	0.2	0	0	HPO
9896	FIG4	C0002736	Amyotrophic Lateral Sclerosis	0.400274726784213	0	0	HPO;ORPHANET
9896	FIG4	C0007959	Charcot-Marie-Tooth Disease	0.202472541057918	1	0	CTD_human
9896	FIG4	C0015300	Exophthalmos	0.2	0	0	HPO
9896	FIG4	C0020305	Hydrops Fetalis	0.2	0	0	HPO
9896	FIG4	C0038220	Status Epilepticus	0.2	0	0	HPO
9896	FIG4	C0149958	Complex partial seizures	0.2	0	0	HPO
9896	FIG4	C0234958	muscle degeneration	0.2	0	0	HPO
9896	FIG4	C0265213	Distal arthrogryposis syndrome	0.2	0	0	HPO
9896	FIG4	C0270834	Complex partial seizure with impairment of consciousness	0.2	0	0	HPO
9896	FIG4	C0850715	Abnormality of blood and blood-forming tissues	0.2	0	0	HPO
9896	FIG4	C1145670	Respiratory Failure	0.2	0	0	HPO
9896	FIG4	C1504405	Pyramidal tract syndrome	0.2	0	0	HPO
9896	FIG4	C1853235	Sclerocornea	0.2	0	0	HPO
9896	FIG4	C1857663	Yunis Varon syndrome	0.481373633921066	1	4	ORPHANET;UNIPROT
9896	FIG4	C1970011	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.682472541057918	3	6	CTD_human;ORPHANET;UNIPROT
9896	FIG4	C2675491	AMYOTROPHIC LATERAL SCLEROSIS 11	0.4	1	2	CTD_human;UNIPROT
9896	FIG4	C2973725	Pulmonary arterial hypertension	0.2	0	0	HPO
9896	FIG4	C3203102	Idiopathic pulmonary arterial hypertension	0.2	0	0	HPO
9896	FIG4	C4013648	POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL	0.4	1	1	ORPHANET;UNIPROT
9896	FIG4	C4020854	Neuro-degenerative disease	0.2	0	0	HPO
9896	FIG4	C4020884	Anxiety disease	0.2	0	0	HPO
9897	WASHC5	C0003507	Aortic Valve Stenosis	0.2	0	0	HPO
9897	WASHC5	C0010964	Dandy-Walker Syndrome	0.2	0	0	HPO
9897	WASHC5	C0020255	Hydrocephalus	0.2	0	0	HPO
9897	WASHC5	C0020295	Hydronephrosis	0.2	0	0	HPO
9897	WASHC5	C0037772	Spastic Paraplegia	0.200549453568426	0	0	HPO
9897	WASHC5	C0085606	Urgency of micturition	0.2	0	0	HPO
9897	WASHC5	C0152101	Hypoplastic Left Heart Syndrome	0.2	0	0	HPO
9897	WASHC5	C0796137	3C syndrome	0.200274726784213	0	0	ORPHANET
9897	WASHC5	C1863704	Spastic paraplegia 8, autosomal dominant	0.600274726784213	4	5	CTD_human;ORPHANET;UNIPROT
9897	WASHC5	C1956257	Pulmonary Stenosis	0.2	0	0	HPO
9897	WASHC5	C3544092	Urgency frequency syndrome	0.2	0	0	HPO
9897	WASHC5	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
9897	WASHC5	C4020898	Overactive bladder syndrome	0.2	0	0	HPO
990	CDC6	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
990	CDC6	C0032460	Polycystic Ovary Syndrome	0.2	1	0	CTD_human
990	CDC6	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	0.400549453568426	1	0	CTD_human;ORPHANET
990	CDC6	C2315100	Pediatric failure to thrive	0.2	0	0	HPO
990	CDC6	C3151126	MEIER-GORLIN SYNDROME 5	0.2	1	1	UNIPROT
9907	AP5Z1	C0037772	Spastic Paraplegia	0.200274726784213	0	0	HPO
9907	AP5Z1	C3150901	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE	0.4	0	0	CTD_human;ORPHANET
9915	ARNT2	C0005697	Neurogenic Urinary Bladder	0.2	0	0	HPO
9915	ARNT2	C0011848	Diabetes Insipidus	0.2	0	0	HPO
9915	ARNT2	C0014306	Enophthalmos	0.2	0	0	HPO
9915	ARNT2	C0014544	Epilepsy	0.2	0	0	HPO
9915	ARNT2	C0017168	Gastroesophageal reflux disease	0.2	0	0	HPO
9915	ARNT2	C0020295	Hydronephrosis	0.2	0	0	HPO
9915	ARNT2	C0028738	Nystagmus	0.2	0	0	HPO
9915	ARNT2	C0038379	Strabismus	0.2	0	0	HPO
9915	ARNT2	C0042580	Vesico-Ureteral Reflux	0.2	0	0	HPO
9915	ARNT2	C0042798	Low Vision	0.2	0	0	HPO
9915	ARNT2	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
9915	ARNT2	C0948740	Pituitary hypoplasia	0.2	0	0	HPO
9915	ARNT2	C3665349	Secondary hypothyroidism	0.2	0	0	HPO
9915	ARNT2	C3714796	Isolated somatotropin deficiency	0.2	0	0	HPO
9924	PAN2	C0008370	Cholestasis	0.2	1	0	CTD_human
9924	PAN2	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9927	MFN2	C0029124	Optic Atrophy	0.203296721410557	0	0	HPO
9927	MFN2	C0037773	Spastic Paraplegia, Hereditary	0.200274726784213	0	0	ORPHANET
9927	MFN2	C0085684	Foot-drop	0.2	0	0	HPO
9927	MFN2	C0393807	Hereditary motor and sensory neuropathy with optic atrophy (disorder)	0.601648360705279	2	5	CTD_human;ORPHANET;UNIPROT
9927	MFN2	C0751576	Partial Paralysis (Paresis) Vocal Cords	0.2	0	0	HPO
9927	MFN2	C1836485	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2 (disorder)	0.6	3	27	CTD_human;ORPHANET;UNIPROT
9927	MFN2	C1848736	Distal amyotrophy	0.2	0	0	HPO
9927	MFN2	C2931642	Benign symmetrical lipomatosis	0.2	0	0	ORPHANET
9927	MFN2	C4025619	Peripheral axonal atrophy	0.2	0	0	HPO
9928	KIF14	C0003886	Arthrogryposis	0.2	0	0	HPO
9928	KIF14	C4015701	MECKEL SYNDROME 12	0.2	0	0	ORPHANET
9935	MAFB	C0013261	Duane Retraction Syndrome	0.2	0	0	ORPHANET
9935	MAFB	C0014306	Enophthalmos	0.2	0	0	HPO
9935	MAFB	C0015300	Exophthalmos	0.2	0	0	HPO
9935	MAFB	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9935	MAFB	C0028866	Oculomotor Nerve Paralysis	0.2	0	0	HPO
9935	MAFB	C0029453	Osteopenia	0.2	0	0	HPO
9935	MAFB	C0035078	Kidney Failure	0.2	0	0	HPO
9935	MAFB	C0038379	Strabismus	0.2	0	0	HPO
9935	MAFB	C0747078	Generalized osteopenia	0.2	0	0	HPO
9935	MAFB	C1565489	Renal Insufficiency	0.2	0	0	HPO
9935	MAFB	C2674705	Osteolysis, Hereditary, Of Carpal Bones With Or Without Nephropathy	0.400824180352639	1	6	ORPHANET;UNIPROT
9939	RBM8A	C0002871	Anemia	0.2	0	0	HPO
9939	RBM8A	C0014457	Eosinophilia	0.2	0	0	HPO
9939	RBM8A	C0014544	Epilepsy	0.2	0	0	HPO
9939	RBM8A	C0030283	Pancreatic Cyst	0.2	0	0	HPO
9939	RBM8A	C0036508	Seborrheic dermatitis	0.2	0	0	HPO
9939	RBM8A	C0086438	Hypogammaglobulinemia	0.2	0	0	HPO
9939	RBM8A	C1838608	Radial aplasia	0.2	0	0	HPO
9939	RBM8A	C3806554	Dysseborrheic dermatitis	0.2	0	0	HPO
994	CDC25B	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9948	WDR1	C0029456	Osteoporosis	0.2	1	0	CTD_human
9949	AMMECR1	C0013902	Elliptocytosis, Hereditary	0.200274726784213	0	0	HPO
9949	AMMECR1	C0035078	Kidney Failure	0.2	0	0	HPO
9949	AMMECR1	C1565489	Renal Insufficiency	0.2	0	0	HPO
9949	AMMECR1	C1846242	Alport Syndrome, Mental Retardation, Midface Hypoplasia, and Elliptocytosis	0.400274726784213	0	0	CTD_human;ORPHANET
9953	HS3ST3B1	C0014175	Endometriosis	0.2	1	0	CTD_human
9961	MVP	C0029408	Degenerative polyarthritis	0.2	1	0	CTD_human
9962	SLC23A2	C0008370	Cholestasis	0.200274726784213	1	0	CTD_human
9963	SLC23A1	C0008370	Cholestasis	0.2	1	0	CTD_human
9966	TNFSF15	C0008312	Primary biliary cirrhosis	0.401098907136852	0	0	HPO;ORPHANET
9966	TNFSF15	C0009324	Ulcerative Colitis	0.217306108673802	1	1	CTD_human
9966	TNFSF15	C0014335	Enteritis	0.2	1	0	CTD_human
9966	TNFSF15	C0020541	Hypertension, Portal	0.2	0	0	HPO
9966	TNFSF15	C0023890	Liver Cirrhosis	0.2	0	0	HPO
9966	TNFSF15	C0023892	Biliary cirrhosis	0.2	0	0	HPO
9966	TNFSF15	C0040261	Onychomycosis	0.2	0	0	HPO
9966	TNFSF15	C0085605	Liver Failure	0.2	0	0	HPO
9966	TNFSF15	C0239946	Fibrosis, Liver	0.2	0	0	HPO
9966	TNFSF15	C0268307	Conjugated hyperbilirubinemia	0.2	0	0	HPO
9966	TNFSF15	C0343065	Symptomatic dermographism	0.2	0	0	HPO
9966	TNFSF15	C0859942	Hanot's cirrhosis	0.2	0	0	ORPHANET
9968	MED12	C0014544	Epilepsy	0.2	0	0	HPO
9968	MED12	C0018784	Sensorineural Hearing Loss (disorder)	0.2	0	0	HPO
9968	MED12	C0020255	Hydrocephalus	0.2	0	0	HPO
9968	MED12	C0038379	Strabismus	0.2	0	0	HPO
9968	MED12	C0158113	Contracture of joint of hand	0.2	0	0	HPO
9968	MED12	C0220769	FG syndrome	0.603296721410557	1	8	CTD_human;ORPHANET;UNIPROT
9968	MED12	C1857278	Partial or complete agenesis of corpus callosum	0.2	0	0	HPO
9968	MED12	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
9968	MED12	C3698541	Ohdo syndrome, Maat-Kievit-Brunner type	0.400824180352639	1	4	ORPHANET;UNIPROT
9970	NR1I3	C0028754	Obesity	0.200549453568426	1	0	CTD_human
9970	NR1I3	C0524620	Metabolic Syndrome X	0.2	1	0	CTD_human
9970	NR1I3	C4277682	Chemical and Drug Induced Liver Injury	0.2	2	0	CTD_human
9971	NR1H4	C0008370	Cholestasis	0.206029633875371	2	0	CTD_human
9971	NR1H4	C0010346	Crohn Disease	0.201098907136852	1	0	CTD_human
9971	NR1H4	C0268318	Cholestasis of pregnancy	0.201648360705279	0	0	ORPHANET
9971	NR1H4	C4277682	Chemical and Drug Induced Liver Injury	0.2	1	0	CTD_human
9973	CCS	C0019189	Hepatitis, Chronic	0.2	1	0	CTD_human
9975	NR1D2	C0014175	Endometriosis	0.2	1	0	CTD_human
9978	RBX1	C0038325	Stevens-Johnson Syndrome	0.2	1	0	CTD_human
998	CDC42	C4225222	TAKENOUCHI-KOSAKI SYNDROME	0.2	1	1	UNIPROT
9987	HNRNPDL	C1836765	LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G (disorder)	0.4	1	1	ORPHANET;UNIPROT
999	CDH1	C0009324	Ulcerative Colitis	0.202747267842131	1	0	CTD_human
999	CDH1	C0017154	Gastritis, Atrophic	0.2	0	0	HPO
9990	SLC12A6	C0014544	Epilepsy	0.200274726784213	0	0	HPO
9990	SLC12A6	C0151313	Sensory neuropathy	0.2	0	0	HPO
9990	SLC12A6	C0152025	Polyneuropathy	0.2	0	0	HPO
9990	SLC12A6	C0234958	muscle degeneration	0.2	0	0	HPO
9990	SLC12A6	C0235025	Peripheral motor neuropathy	0.2	0	0	HPO
9990	SLC12A6	C0270921	Axonal neuropathy	0.2	0	0	HPO
9990	SLC12A6	C0271683	Polyneuropathy, Motor	0.2	0	0	HPO
9990	SLC12A6	C0375206	Hemiplegia and hemiparesis	0.2	0	0	HPO
9990	SLC12A6	C0795950	Corpus callosum agenesis neuronopathy	0.481923087489492	0	0	CTD_human;ORPHANET
9990	SLC12A6	C1263857	Peripheral axonal neuropathy	0.2	0	0	HPO
9990	SLC12A6	C2267233	Neonatal Hypotonia	0.2	0	0	HPO
9990	SLC12A6	C2936786	Aqueductal Stenosis	0.2	0	0	HPO
9992	KCNE2	C0004238	Atrial Fibrillation	0.403557092817453	1	0	CTD_human;HPO
9992	KCNE2	C0023976	Long QT Syndrome	0.233410995896125	3	2	CTD_human
9992	KCNE2	C0035828	Romano-Ward Syndrome	0.200549453568426	0	0	ORPHANET
9992	KCNE2	C0040479	Torsades de Pointes	0.202681755307501	0	0	HPO
9992	KCNE2	C0042510	Ventricular Fibrillation	0.400274726784213	1	0	CTD_human;HPO
9992	KCNE2	C1837014	Atrial Fibrillation, Familial, 3	0.2	0	0	CTD_human
9992	KCNE2	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	0.2	0	0	ORPHANET
9992	KCNE2	C1862394	Atrial Fibrillation, Familial, 4	0.4	1	1	CTD_human;UNIPROT
9992	KCNE2	C3150953	Long Qt Syndrome 6	0.400274726784213	4	6	CTD_human;UNIPROT
9993	DGCR2	C0042454	Velopharyngeal Insufficiency	0.2	0	0	HPO
9993	DGCR2	C4021592	Unilateral primary pulmonary dysgenesis	0.2	0	0	HPO
9997	SCO2	C0007194	Hypertrophic Cardiomyopathy	0.407938365987545	2	0	CTD_human;HPO
9997	SCO2	C0021400	Influenza	0.2	1	0	CTD_human
9997	SCO2	C0023264	Leigh Disease	0.401098907136852	1	1	ORPHANET;UNIPROT
9997	SCO2	C0027092	Myopia	0.200549453568426	0	0	HPO
9997	SCO2	C0162666	Mitochondrial Encephalomyopathies	0.2	2	0	CTD_human
9997	SCO2	C1837148	MYOPIA 6 (disorder)	0.2	2	4	UNIPROT
9997	SCO2	C1858424	Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency	0.4	10	8	CTD_human;UNIPROT
9997	SCO2	C4273730	Fatal infantile cytochrome C oxidase deficiency	0.2	0	0	ORPHANET
